Citrus Sinensis ID: 045453
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 346 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SA25 | 720 | Wall-associated receptor | no | no | 0.907 | 0.436 | 0.357 | 4e-48 | |
| Q9LMT9 | 764 | Putative wall-associated | no | no | 0.930 | 0.421 | 0.350 | 1e-46 | |
| O64798 | 389 | Inactive serine/threonine | no | no | 0.895 | 0.796 | 0.368 | 6e-46 | |
| Q9LMN6 | 738 | Wall-associated receptor | no | no | 0.953 | 0.447 | 0.334 | 6e-45 | |
| Q8VYA3 | 769 | Wall-associated receptor | no | no | 0.939 | 0.422 | 0.329 | 3e-44 | |
| Q9M092 | 786 | Wall-associated receptor | no | no | 0.890 | 0.391 | 0.347 | 3e-44 | |
| Q9LMP1 | 732 | Wall-associated receptor | no | no | 0.959 | 0.453 | 0.330 | 4e-44 | |
| Q39191 | 735 | Wall-associated receptor | no | no | 0.959 | 0.451 | 0.327 | 5e-44 | |
| Q9LSV3 | 433 | Putative wall-associated | no | no | 0.930 | 0.743 | 0.325 | 6e-44 | |
| Q8RY17 | 751 | Wall-associated receptor | no | no | 0.901 | 0.415 | 0.336 | 7e-44 |
| >sp|Q9SA25|WAKLG_ARATH Wall-associated receptor kinase-like 8 OS=Arabidopsis thaliana GN=WAKL8 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 192 bits (487), Expect = 4e-48, Method: Compositional matrix adjust.
Identities = 117/327 (35%), Positives = 184/327 (56%), Gaps = 13/327 (3%)
Query: 10 RKHFEKTENREFMIENGKILVETLVVCCYGKFNPIRGFTIRELEIATNNFDARNVIKDGY 69
RK + R+F NG +L++ +G N + F+ +LE AT+ F+A ++ G
Sbjct: 341 RKRKVAKQKRKFFQRNGGLLLQQQTSFLHGSVNRTKVFSSNDLENATDRFNASRILGQGG 400
Query: 70 AYKFYKGFVED-RTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIP 128
YKG +ED V+V K + + E+ N II S+++ H+NV+K+ GCCLET +P
Sbjct: 401 QGTVYKGMLEDGMIVAVKKSKALKEENLEEFINEIILLSQIN-HRNVVKILGCCLETEVP 459
Query: 129 VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRP 188
++V+E + NR L DH++ F P+ RL IA +A+A++YLH S PI HR ++
Sbjct: 460 ILVYEFIPNRNLFDHLHNPSEDF-PMSWEVRLCIACEVADALSYLHSAVSIPIYHRDVKS 518
Query: 189 SRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFG 248
+ I LDE + AK+ DF +S S+ +T + V GT+G++ PEY+ + F K DV+SFG
Sbjct: 519 TNILLDEKHRAKVSDFGISRSVAIDDTHLTTIVQGTIGYVDPEYLQSNHFTGKSDVYSFG 578
Query: 249 MLLLVLLTGQKIFDPSRGDEIGA-GHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKE 307
+LL+ LLTG+K R E+ G Y+L + + N+ EI+D I E R
Sbjct: 579 VLLIELLTGEKPVSLLRRQEVRMLGAYFL-----EAMRNDRLHEILDARIKEECDR---- 629
Query: 308 KQLQGFRELALMCVCESAEDRPTTVDV 334
+++ +LA C+ ++E RPT DV
Sbjct: 630 EEVLAVAKLARRCLSLNSEHRPTMRDV 656
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9LMT9|WAKLL_ARATH Putative wall-associated receptor kinase-like 13 OS=Arabidopsis thaliana GN=WAKL13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 187 bits (474), Expect = 1e-46, Method: Compositional matrix adjust.
Identities = 117/334 (35%), Positives = 184/334 (55%), Gaps = 12/334 (3%)
Query: 10 RKHFEKTENREFMIENGKILVETLVVCCYGKFNPIRGFTIRELEIATNNFDARNVIKDGY 69
RK R+F NG +L++ + G+ + F+ RELE AT+NF+ VI G
Sbjct: 405 RKRRMTNRKRKFFKRNGGLLLQQQLNTTQGRVEKTKLFSSRELEKATDNFNDNRVIGQGG 464
Query: 70 AYKFYKG-FVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIP 128
YKG V+ R+V+V K N + D ++ N +I S+++ H++V+KL GCCLET +P
Sbjct: 465 QGTVYKGMLVDGRSVAVKKSNVVDEDKLQEFINEVIILSQIN-HRHVVKLLGCCLETEVP 523
Query: 129 VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRP 188
++V+E + N L H+++ + L R+RIAV I+ A +YLH PI HR I+
Sbjct: 524 ILVYEFIPNGNLFQHLHEEFDDYTALW-GVRMRIAVDISGAFSYLHTAACSPIYHRDIKS 582
Query: 189 SRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFG 248
+ I LDE Y AK+ DF S S+ T ++GT+G++ PEY + F EK DV+SFG
Sbjct: 583 TNILLDEKYRAKVSDFGTSRSVSIDHTHWTTVISGTVGYVDPEYYGSSHFTEKSDVYSFG 642
Query: 249 MLLLVLLTGQK-IFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKE 307
++L+ L+TG+K + S EI L Y + + N EI+D I ++ K
Sbjct: 643 VVLVELITGEKPVITLSETQEITG----LADYFRLAMRENRLFEIIDARIRND----CKL 694
Query: 308 KQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341
+Q+ LAL C+ ++ + RP +V+ L++I
Sbjct: 695 EQVIAVANLALRCLKKTGKTRPDMREVSTALERI 728
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O64798|Y1747_ARATH Inactive serine/threonine-protein kinase At1g67470 OS=Arabidopsis thaliana GN=At1g67470 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 184 bits (468), Expect = 6e-46, Method: Compositional matrix adjust.
Identities = 125/339 (36%), Positives = 182/339 (53%), Gaps = 29/339 (8%)
Query: 14 EKTENREFMIENGKILVETLVVCCYGKFNPIRGFTIRELEIATNNFDARNVIKD---GYA 70
+K E E G L++ L+ CC GK NPI+ F+ E+ ATNNF N++ + +
Sbjct: 7 KKKPKSEIASERGAKLLKDLIECCDGKSNPIKFFSADEIRKATNNFGVSNLVSELSHDFD 66
Query: 71 YKFYKGFVEDRTVSVMKFNDILNDGHEDCF-NNIIFASKLSSHKNVLKLTGCCLETRIPV 129
YK+Y G E+ + +++ + ++D F +I +S +S HKN LKL G CLE PV
Sbjct: 67 YKWYSGKNENHDMILVRKAFSQSVYYKDTFFRDIAVSSMVSGHKNFLKLIGYCLEFEEPV 126
Query: 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPS 189
+V+ VK Y + +P +R++IA IA A+AYLH F RP ++R + +
Sbjct: 127 MVYHGVKKH------YHLESSEQPW--KRRMKIAEDIATALAYLHTAFPRPFVYRCLSLT 178
Query: 190 RIFLDEGYIAKLFDFSLSVSIPEGETCVK-DKVTGTMGFLAPEYINTGDFNEKCDVFSFG 248
I LDE +AKL DFS VSIPEGET V+ D + GT+ +L P Y+ G +E+ DVF+ G
Sbjct: 179 NILLDEDGVAKLMDFSFCVSIPEGETFVQVDYIAGTVDYLKPNYLKHGVVSEETDVFAVG 238
Query: 249 MLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEK 308
+ +LL G+KIFD K +E + DEI DP E + +E+
Sbjct: 239 HSMQMLLMGEKIFDRIMRRPFPTS---------KFMEEPKMDEIADP----EMGEISEEE 285
Query: 309 --QLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHL 345
Q++ F L+L C E PT V+VAK LK I + L
Sbjct: 286 LCQMKAFLLLSLRCTGHVGE-VPTMVEVAKELKSIQRCL 323
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LMN6|WAK4_ARATH Wall-associated receptor kinase 4 OS=Arabidopsis thaliana GN=WAK4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 181 bits (459), Expect = 6e-45, Method: Compositional matrix adjust.
Identities = 115/344 (33%), Positives = 185/344 (53%), Gaps = 14/344 (4%)
Query: 1 LDMSCFLRTRKHFEKTENRE--FMIENGKILVETLVVCCYGKFN-PIRGFTIRELEIATN 57
L +SC K+ + TE R+ F G +L++ L G N ++ FT ++ AT+
Sbjct: 351 LAISCIEHKMKNTKDTELRQQFFEQNGGGMLMQRLSGA--GPSNVDVKIFTEEGMKEATD 408
Query: 58 NFDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLK 117
+D ++ G YKG + D ++ +K + ++ + F N + +H+NV+K
Sbjct: 409 GYDENRILGQGGQGTVYKGILPDNSIVAIKKARLGDNSQVEQFINEVLVLSQINHRNVVK 468
Query: 118 LTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGF 177
L GCCLET +P++V+E + + TL DH++ + L RLR+AV IA +AYLH
Sbjct: 469 LLGCCLETEVPLLVYEFISSGTLFDHLHGSM-FDSSLTWEHRLRMAVEIAGTLAYLHSSA 527
Query: 178 SRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGD 237
S PI+HR I+ + I LDE AK+ DF S IP + + V GT+G+L PEY NTG
Sbjct: 528 SIPIIHRDIKTANILLDENLTAKVADFGASRLIPMDKEDLATMVQGTLGYLDPEYYNTGL 587
Query: 238 FNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPII 297
NEK DV+SFG++L+ LL+GQK R + H ++ Y + N EI+D +
Sbjct: 588 LNEKSDVYSFGVVLMELLSGQKALCFERPQT--SKH--IVSYFASATKENRLHEIIDGQV 643
Query: 298 VSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341
++E ++++Q +A+ C + E+RP +VA L+ +
Sbjct: 644 MNE----NNQREIQKAARIAVECTRLTGEERPGMKEVAAELEAL 683
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8VYA3|WAKLJ_ARATH Wall-associated receptor kinase-like 10 OS=Arabidopsis thaliana GN=WAKL10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 179 bits (454), Expect = 3e-44, Method: Compositional matrix adjust.
Identities = 111/337 (32%), Positives = 179/337 (53%), Gaps = 12/337 (3%)
Query: 10 RKHFEKTENREFMIENGKILVETLVVCCYGKFNPIRGFTIRELEIATNNFDARNVIKDGY 69
R+ + ++F NG +L++ + G + R F RELE AT NF ++ +G
Sbjct: 384 RRQRRLNQKKKFFKRNGGLLLQQQLTTTEGNVDSTRVFNSRELEKATENFSLTRILGEGG 443
Query: 70 AYKFYKG-FVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIP 128
YKG V+ R V+V K + D E+ N ++ S+++ H+N++KL GCCLET +P
Sbjct: 444 QGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVILSQIN-HRNIVKLLGCCLETDVP 502
Query: 129 VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRP 188
++V+E + N L +H++ + + RLRIAV IA A++YLH S PI HR I+
Sbjct: 503 ILVYEFIPNGNLFEHLHDDSDDYTMTTWEVRLRIAVDIAGALSYLHSAASSPIYHRDIKS 562
Query: 189 SRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFG 248
+ I LDE + AK+ DF S ++ T + V+GT+G++ PEY + F +K DV+SFG
Sbjct: 563 TNIMLDEKHRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMDPEYFQSSQFTDKSDVYSFG 622
Query: 249 MLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVG-KE 307
++L L+TG+K R E + L Y ++ N +I+D I R G K
Sbjct: 623 VVLAELITGEKSVSFLRSQE----YRTLATYFTLAMKENRLSDIIDARI-----RDGCKL 673
Query: 308 KQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344
Q+ ++A C+ RP+ V+ L++I +
Sbjct: 674 NQVTAAAKIARKCLNMKGRKRPSMRQVSMELEKIRSY 710
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9M092|WAKLM_ARATH Wall-associated receptor kinase-like 17 OS=Arabidopsis thaliana GN=WAKL17 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 179 bits (454), Expect = 3e-44, Method: Compositional matrix adjust.
Identities = 111/319 (34%), Positives = 173/319 (54%), Gaps = 11/319 (3%)
Query: 25 NGKILVETLVVCCYGKFNPIRGFTIRELEIATNNFDARNVIKDGYAYKFYKG-FVEDRTV 83
NG +L++ + G R FT +ELE AT NF V+ G YKG V+ RTV
Sbjct: 410 NGGLLLQQELNTRQGVVEKARIFTSKELEKATENFSENRVLGHGGQGTVYKGMLVDGRTV 469
Query: 84 SVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADH 143
+V K I D ++ N ++ S+++ H++V+KL GCCLET +P++V+E + N L H
Sbjct: 470 AVKKSKVIDEDKLQEFINEVVILSQIN-HRHVVKLLGCCLETEVPILVYEFIINGNLFKH 528
Query: 144 IYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFD 203
I++ + ++ RLRIAV IA A++YLH S PI HR I+ + I LDE Y AK+ D
Sbjct: 529 IHEEEADDYTMIWGMRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRAKVAD 588
Query: 204 FSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQK-IFD 262
F S S+ +T ++GT+G++ PEY + + EK DV+SFG++L L+TG K +
Sbjct: 589 FGTSRSVTIDQTHWTTVISGTVGYVDPEYYRSSQYTEKSDVYSFGVILAELITGDKPVIM 648
Query: 263 PSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVC 322
EI A L + + ++ +I+D I + K +Q+ LA+ C+
Sbjct: 649 VQNTQEIIA----LAEHFRVAMKERRLSDIMDARIRDD----SKPEQVMAVANLAMKCLS 700
Query: 323 ESAEDRPTTVDVAKRLKQI 341
+RP +V L++I
Sbjct: 701 SRGRNRPNMREVFTELERI 719
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMP1|WAK2_ARATH Wall-associated receptor kinase 2 OS=Arabidopsis thaliana GN=WAK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 179 bits (453), Expect = 4e-44, Method: Compositional matrix adjust.
Identities = 113/342 (33%), Positives = 180/342 (52%), Gaps = 10/342 (2%)
Query: 1 LDMSCFLRTRKHFEKTENRE-FMIENGKILVETLVVCCYGKFNPIRGFTIRELEIATNNF 59
L +SC + KH + TE R+ F +NG ++ V ++ FT + ++ ATN +
Sbjct: 345 LGISCLQQKIKHRKNTELRQKFFEQNGGGMLIQRVSGAGPSNVDVKIFTEKGMKEATNGY 404
Query: 60 DARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLT 119
++ G YKG + D ++ +K + N + F N + +H+NV+K+
Sbjct: 405 HESRILGQGGQGTVYKGILPDNSIVAIKKARLGNRSQVEQFINEVLVLSQINHRNVVKVL 464
Query: 120 GCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSR 179
GCCLET +P++V+E + + TL DH++ + L RLRIA +A ++AYLH S
Sbjct: 465 GCCLETEVPLLVYEFINSGTLFDHLH-GSLYDSSLTWEHRLRIATEVAGSLAYLHSSASI 523
Query: 180 PILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFN 239
PI+HR I+ + I LD+ AK+ DF S IP + + V GT+G+L PEY NTG N
Sbjct: 524 PIIHRDIKTANILLDKNLTAKVADFGASRLIPMDKEQLTTIVQGTLGYLDPEYYNTGLLN 583
Query: 240 EKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVS 299
EK DV+SFG++L+ LL+GQK R L+ +NN F EI+D +++
Sbjct: 584 EKSDVYSFGVVLMELLSGQKALCFERPHCPKN----LVSCFASATKNNRFHEIIDGQVMN 639
Query: 300 EGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341
E ++++Q +A C E+RP +VA L+ +
Sbjct: 640 E----DNQREIQEAARIAAECTRLMGEERPRMKEVAAELEAL 677
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q39191|WAK1_ARATH Wall-associated receptor kinase 1 OS=Arabidopsis thaliana GN=WAK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 178 bits (452), Expect = 5e-44, Method: Compositional matrix adjust.
Identities = 112/342 (32%), Positives = 180/342 (52%), Gaps = 10/342 (2%)
Query: 1 LDMSCFLRTRKHFEKTENRE-FMIENGKILVETLVVCCYGKFNPIRGFTIRELEIATNNF 59
L ++C + KH + T+ RE F +NG ++ + ++ FT ++ ATN +
Sbjct: 350 LGVACIQQRMKHLKDTKLREQFFEQNGGGMLTQRLSGAGPSNVDVKIFTEDGMKKATNGY 409
Query: 60 DARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLT 119
++ G YKG + D ++ +K + + + F N + +H+NV+KL
Sbjct: 410 AESRILGQGGQGTVYKGILPDNSIVAIKKARLGDSSQVEQFINEVLVLSQINHRNVVKLL 469
Query: 120 GCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSR 179
GCCLET +P++V+E + N TL DH++ + L RL+IA+ +A +AYLH S
Sbjct: 470 GCCLETEVPLLVYEFITNGTLFDHLHGSMID-SSLTWEHRLKIAIEVAGTLAYLHSSASI 528
Query: 180 PILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFN 239
PI+HR I+ + I LD AK+ DF S IP + ++ V GT+G+L PEY NTG N
Sbjct: 529 PIIHRDIKTANILLDVNLTAKVADFGASRLIPMDKEELETMVQGTLGYLDPEYYNTGLLN 588
Query: 240 EKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVS 299
EK DV+SFG++L+ LL+GQK R + H L+ Y + N DEI+ +++
Sbjct: 589 EKSDVYSFGVVLMELLSGQKALCFKRPQS--SKH--LVSYFATATKENRLDEIIGGEVMN 644
Query: 300 EGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341
E K++Q +A C E+RP +VA +L+ +
Sbjct: 645 E----DNLKEIQEAARIAAECTRLMGEERPRMKEVAAKLEAL 682
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Required during plant's response to pathogen infection and in plant defense against heavy metal toxicity. Phosphorylates the oxygen-evolving enhancer protein 2 (OEE2) in an GRP-3-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LSV3|WAKLS_ARATH Putative wall-associated receptor kinase-like 16 OS=Arabidopsis thaliana GN=WAKL16 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 178 bits (451), Expect = 6e-44, Method: Compositional matrix adjust.
Identities = 109/335 (32%), Positives = 178/335 (53%), Gaps = 13/335 (3%)
Query: 10 RKHFEKTE-NREFMIE--NGKILVETLVVCCYGKFNPIRGFTIRELEIATNNFDARNVIK 66
RKH + T+ R+ E G +L+E L + + FT +++ ATN +D ++
Sbjct: 57 RKHQKDTKIQRQLFFEKNGGGMLIERLSGAGSSNID-FKIFTEEDMKEATNGYDVSRILG 115
Query: 67 DGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETR 126
G + YKG + D ++ +K + ++ + F N + +H+NV+KL GCCLET
Sbjct: 116 QGGQWTVYKGILPDNSIVAIKKTRLGDNNQVEQFINEVLVLSQINHRNVVKLLGCCLETE 175
Query: 127 IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKI 186
+P++V+E + +L DH++ + L RL IA+ +A AIAYLH G S PI+HR I
Sbjct: 176 VPLLVYEFITGGSLFDHLHGSM-FVSSLTWEHRLEIAIEVAGAIAYLHSGASIPIIHRDI 234
Query: 187 RPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFS 246
+ I LDE AK+ DF S P + + V GT+G+L PEY T NEK DV+S
Sbjct: 235 KTENILLDENLTAKVADFGASKLKPMDKEQLTTMVQGTLGYLDPEYYTTWLLNEKSDVYS 294
Query: 247 FGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGK 306
FG++L+ L++GQK R + + H L+ Y + N EI+D +++E
Sbjct: 295 FGVVLMELISGQKALCFERPET--SKH--LVSYFVLATKENRLHEIIDDQVLNE----EN 346
Query: 307 EKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341
++++ +A+ C E+RP ++VA L+ +
Sbjct: 347 QREIHEAARVAVECTRLKGEERPRMIEVAAELETL 381
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8RY17|WAKLI_ARATH Wall-associated receptor kinase-like 22 OS=Arabidopsis thaliana GN=WAKL22 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 177 bits (450), Expect = 7e-44, Method: Compositional matrix adjust.
Identities = 108/321 (33%), Positives = 176/321 (54%), Gaps = 9/321 (2%)
Query: 21 FMIENGKILVETLVVCCYGKFNPIRGFTIRELEIATNNFDARNVIKDGYAYKFYKGFVED 80
F NG +L++ + G + F+ +ELE AT+NF+ V+ G YKG + D
Sbjct: 383 FFKRNGGLLLKQQLTTRGGNVQSSKIFSSKELEKATDNFNMNRVLGQGGQGTVYKGMLVD 442
Query: 81 RTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTL 140
+ +K + +L++ + F N + +H+N++KL GCCLET +P++V+E + N L
Sbjct: 443 GRIVAVKRSKVLDEDKVEEFINEVGVLSQINHRNIVKLMGCCLETEVPILVYEHIPNGDL 502
Query: 141 ADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAK 200
++ + + + RLRI+V IA A+AYLH S P+ HR ++ + I LDE Y AK
Sbjct: 503 FKRLHHDSDDYT-MTWDVRLRISVEIAGALAYLHSAASTPVYHRDVKTTNILLDEKYRAK 561
Query: 201 LFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKI 260
+ DF S SI +T + V GT G+L PEY T F +K DV+SFG++L+ L+TG+K
Sbjct: 562 VSDFGTSRSINVDQTHLTTLVAGTFGYLDPEYFQTSQFTDKSDVYSFGVVLVELITGEKP 621
Query: 261 FDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMC 320
F R +E + L+ + + ++ N +IVD I EG + +Q+ +LA C
Sbjct: 622 FSVMRPEE----NRGLVSHFNEAMKQNRVLDIVDSRI-KEGCTL---EQVLAVAKLARRC 673
Query: 321 VCESAEDRPTTVDVAKRLKQI 341
+ + RP +V+ L++I
Sbjct: 674 LSLKGKKRPNMREVSVELERI 694
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Required during plant's response to pathogen infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 346 | ||||||
| 224123144 | 344 | predicted protein [Populus trichocarpa] | 0.962 | 0.968 | 0.488 | 2e-87 | |
| 255582635 | 331 | receptor protein kinase, putative [Ricin | 0.930 | 0.972 | 0.493 | 3e-86 | |
| 255542662 | 330 | serine-threonine protein kinase, plant-t | 0.924 | 0.969 | 0.507 | 2e-82 | |
| 255542658 | 356 | serine-threonine protein kinase, plant-t | 0.930 | 0.904 | 0.465 | 7e-74 | |
| 255542656 | 331 | serine-threonine protein kinase, plant-t | 0.939 | 0.981 | 0.441 | 4e-71 | |
| 359493231 | 497 | PREDICTED: inactive serine/threonine-pro | 0.924 | 0.643 | 0.435 | 3e-63 | |
| 296081092 | 1111 | unnamed protein product [Vitis vinifera] | 0.953 | 0.297 | 0.438 | 6e-63 | |
| 255542668 | 307 | serine-threonine protein kinase, plant-t | 0.705 | 0.794 | 0.534 | 8e-63 | |
| 225460075 | 380 | PREDICTED: wall-associated receptor kina | 0.907 | 0.826 | 0.412 | 6e-60 | |
| 297740944 | 375 | unnamed protein product [Vitis vinifera] | 0.898 | 0.829 | 0.416 | 8e-60 |
| >gi|224123144|ref|XP_002319005.1| predicted protein [Populus trichocarpa] gi|222857381|gb|EEE94928.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 328 bits (841), Expect = 2e-87, Method: Compositional matrix adjust.
Identities = 167/342 (48%), Positives = 238/342 (69%), Gaps = 9/342 (2%)
Query: 3 MSCFLRTRKHFEKTENRE-FMIENGKILVETLVVCCYGKFNPIRGFTIRELEIATNNFDA 61
MS T+K +K N+E I+NG L+E LV C GK N IR F+ EL+ ATNN+D
Sbjct: 1 MSTCWETKK--DKKVNKETAFIKNGSKLLEKLVDICDGKCNSIRSFSATELKKATNNYDP 58
Query: 62 RNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGC 121
+ ++ YK YKGF++ R VSV KF D ++ +E CFN+I++ASK+S HK+ +KL GC
Sbjct: 59 QKILTGDSGYKLYKGFLQGRPVSVKKFKDD-DEQYEYCFNDIVYASKMSVHKSFMKLLGC 117
Query: 122 CLETRIPVIVFESVKNRTLADHIY-QNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRP 180
CLE RIP++VFE V + TL+D ++ + +PLL R +IA+ +ANA+A+LH FS+P
Sbjct: 118 CLEARIPILVFEYVGDWTLSDFLWGSEEARCQPLLWIPRSKIAMDMANAVAFLHAAFSKP 177
Query: 181 ILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNE 240
I+ R I+P I LD+ + AKL DFS+S+SIP+GE+ V+D V G G +APEY+ TG+FNE
Sbjct: 178 IVFRNIKPLNILLDDNHEAKLSDFSISISIPKGESHVRDSVAGATGLIAPEYLTTGNFNE 237
Query: 241 KCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSE 300
K DVF+FG+ LLVLL+GQ + D SR ++ L +VKKCIE++ F++++D I++E
Sbjct: 238 KQDVFNFGVFLLVLLSGQMVVDFSRPEK----EILLQDHVKKCIEDDRFNKVIDSTIIAE 293
Query: 301 GPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIY 342
G GKE+QLQ + L+L C+ E AEDRPT +DV+K L++IY
Sbjct: 294 GTWPGKEQQLQAYTALSLRCISELAEDRPTMIDVSKELRKIY 335
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255582635|ref|XP_002532098.1| receptor protein kinase, putative [Ricinus communis] gi|223528232|gb|EEF30288.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 325 bits (832), Expect = 3e-86, Method: Compositional matrix adjust.
Identities = 164/332 (49%), Positives = 229/332 (68%), Gaps = 10/332 (3%)
Query: 14 EKTENREFMIENGKILVETLVVCCYGKFNPIRGFTIRELEIATNNFDARNVIKDGYAYKF 73
+K E+ + NG++L+E L+ C G+ NPIR F+ EL AT+++D R +I YK
Sbjct: 4 KKAESERISLMNGRMLLEKLIASCDGRCNPIRIFSADELSRATDDYDPRKIITQDSGYKL 63
Query: 74 YKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133
Y G + +RT+SV KF D ++ ++ C+N+I+FA+++S HKN LKL GCCLET+IPV+VFE
Sbjct: 64 YNGLLHERTISVKKFKD-KSEQYKYCYNDIMFATQMSKHKNFLKLLGCCLETQIPVLVFE 122
Query: 134 SVKNRTLADHIY-QNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIF 192
++ TLA +Y N+ ++PLL RL+IAV IANA++YLH FSRPI+ R I+P IF
Sbjct: 123 PIEYGTLAGRLYGPNKTLYQPLLWRHRLKIAVEIANAVSYLHTAFSRPIVFRNIKPLNIF 182
Query: 193 LDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLL 252
LDE ++AKL DFSL+VSIPEGE+ VKD + G G +APEY T FNE DV++FG+ LL
Sbjct: 183 LDECHVAKLSDFSLAVSIPEGESHVKDMLAGAWGLIAPEYAKTSCFNESQDVYNFGVFLL 242
Query: 253 VLLTGQKIFD---PSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQ 309
+LLTGQK+ D P G+E+G L+ +VKK I ++ F E VD II+ EG K++Q
Sbjct: 243 MLLTGQKVVDSYRPQAGEELG-----LVDHVKKFIADDRFYETVDSIILGEGSLPEKDQQ 297
Query: 310 LQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341
LQ F L+ C+ E+ EDRP +DVAK L++I
Sbjct: 298 LQAFTLLSFRCISEADEDRPMMIDVAKELRKI 329
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542662|ref|XP_002512394.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548355|gb|EEF49846.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 311 bits (798), Expect = 2e-82, Method: Compositional matrix adjust.
Identities = 167/329 (50%), Positives = 226/329 (68%), Gaps = 9/329 (2%)
Query: 17 ENREFMIENGKILVETLVVCCYGKFNPIRGFTIRELEIATNNFDARNVIK-DGYAYKFYK 75
E +E + NG L+E V C G+ NPIR F+ ELE AT N++ + V+K DGY ++ YK
Sbjct: 2 EVKEAFLINGSKLLEKSVAFCNGRCNPIRNFSSEELEKATRNYNEKQVLKLDGY-FELYK 60
Query: 76 GFVEDRTVSVMKFNDILNDGHED-CFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFES 134
GF++DR V V KF ++ G E N I++AS +S H N +KL GCCLET P++VFES
Sbjct: 61 GFLQDRPVIVKKFLEV---GVEQLAINEIVYASAMSVHINSIKLLGCCLETPSPILVFES 117
Query: 135 VKNRTLADHIY-QNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFL 193
K +TLAD I +N HFEP+ RL+I IAN + Y+H F RPI+HR I+ S I L
Sbjct: 118 AKEKTLADRIIDRNDDHFEPVKWKLRLKIVADIANVVVYIHTAFPRPIVHRNIKASNILL 177
Query: 194 DEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLV 253
DE Y+AKL DFSL VSIPEG++ V+D + GTMG +A E + TG FNEK DV+SFG++LLV
Sbjct: 178 DEDYVAKLSDFSLCVSIPEGKSRVRDIMAGTMGLIASESLATGYFNEKSDVYSFGVVLLV 237
Query: 254 LLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGF 313
+LTGQ+ FD SR + + L+++VKK IE F E+VDPIIV+E K ++L+ F
Sbjct: 238 VLTGQRSFDFSRTE--TGEQFLLVNHVKKHIETGGFKEMVDPIIVAEEAGNRKGQELEDF 295
Query: 314 RELALMCVCESAEDRPTTVDVAKRLKQIY 342
R+LAL C+ +SAE+RPT ++VAK+L+ IY
Sbjct: 296 RDLALRCIHDSAEERPTMIEVAKQLRHIY 324
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542658|ref|XP_002512392.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548353|gb|EEF49844.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 283 bits (725), Expect = 7e-74, Method: Compositional matrix adjust.
Identities = 161/346 (46%), Positives = 216/346 (62%), Gaps = 24/346 (6%)
Query: 17 ENREFMIENGKILVETLVVCCYGKFNPIRGFTIRELEIATNNFDARNVIKDGYAYKFYKG 76
EN ++ NG IL+E + G+ NPIR F++ EL+ ATN++ NVI +G + YKG
Sbjct: 11 ENETALMRNGGILLEKSIAFNNGRGNPIRWFSVDELQTATNSYSQNNVIYEGGWHTLYKG 70
Query: 77 FVEDRTVSVMKFNDILNDGHEDC--FNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFES 134
F+ DR V V ++ N+ HE N+I+FAS++S HKNVLKL GCCLE+ IP++VFE
Sbjct: 71 FLRDRPVIVKRYR---NNIHERVCPINDIVFASEMSRHKNVLKLLGCCLESEIPILVFEY 127
Query: 135 VKNRTLADHIYQ-NQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFL 193
+ L D+IY+ + F PLL RL+IAV AN IAYLH RP++HR I S I+L
Sbjct: 128 AEKGKLQDYIYKTDSASFRPLLWKSRLKIAVDAANVIAYLHTACPRPVVHRDITLSNIWL 187
Query: 194 DEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLV 253
DE Y+AK+ DF++S+SI EGET ++D V GT G+ APEY+ +G FNEK DVFSFG+LLLV
Sbjct: 188 DEDYVAKVTDFTVSMSILEGETHIEDFVLGTCGYAAPEYVRSGIFNEKIDVFSFGVLLLV 247
Query: 254 LLTGQK--------IFDPSRGDEIGAGHYWL---LHYVKKCIEN------NEFDEIVDPI 296
LLT QK I +R DEI G + L K+ +E + D +DPI
Sbjct: 248 LLTDQKPFQGNWENILKDARFDEI-IGSLIVEKGLWSEKEQLETFLTRTRQKLDLTIDPI 306
Query: 297 IVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIY 342
IV EGP KE+QL+ F L + C+ E+RP DVAK+L+ Y
Sbjct: 307 IVEEGPWPEKEQQLKAFLMLGVQCIDPDEENRPEITDVAKQLRHFY 352
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542656|ref|XP_002512391.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548352|gb|EEF49843.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 274 bits (701), Expect = 4e-71, Method: Compositional matrix adjust.
Identities = 151/342 (44%), Positives = 212/342 (61%), Gaps = 17/342 (4%)
Query: 4 SCFLRTRKHFEKTENREFMIENGKILVETLVVCCYGKFNPIRGFTIRELEIATNNFDARN 63
SCF ++ +EK ++ NG+ L+E V G+ NP+R F+++EL+ ATN++ N
Sbjct: 3 SCFGDSK--YEKA-----LMRNGRSLLEKSVALNNGRGNPVRCFSVKELQNATNSYSQHN 55
Query: 64 VIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCL 123
V + YKG + DR V V K++ ED ++I+ AS++S H+NVLKL GCCL
Sbjct: 56 VFYIDGTCRLYKGLIRDRPVIVKKYD--YKHPSEDPVSDIVIASEMSVHRNVLKLLGCCL 113
Query: 124 ETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILH 183
E+ IP+ VFE + TL D++ + LL RL+IAV +A+ IAYLH F RPI+H
Sbjct: 114 ESEIPIPVFEYAEKGTLEDYVQKTA-----LLWKDRLKIAVDVASVIAYLHTAFPRPIVH 168
Query: 184 RKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCD 243
R I + I LDE AK+ FSLS+SIPEGET ++D+V GT+G++APEY FNEK D
Sbjct: 169 RDISLASILLDEDCAAKVTGFSLSISIPEGETHIEDEVAGTIGYVAPEYFMKRMFNEKID 228
Query: 244 VFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPR 303
V+SFG++LLVLLTG P + L+ +V+ I+N F+EI+DP I+ EGP
Sbjct: 229 VYSFGVVLLVLLTGH---GPILRSPTTNESHALVVFVEAKIKNERFNEIIDPAILEEGPW 285
Query: 304 VGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHL 345
KE+QL+ F LA+ C + EDRP DVAK+L+ IY L
Sbjct: 286 PEKEQQLKSFLTLAMQCTRKDEEDRPEITDVAKQLRHIYHSL 327
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493231|ref|XP_002265528.2| PREDICTED: inactive serine/threonine-protein kinase At1g67470-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 248 bits (633), Expect = 3e-63, Method: Compositional matrix adjust.
Identities = 145/333 (43%), Positives = 203/333 (60%), Gaps = 13/333 (3%)
Query: 17 ENREFMIENGKILVETLVVCCYGKFNPIRGFTIRELEIATNNFDARNVIKDGYAY-KFYK 75
+ EF ++NG +L+E LV G+ NPIR F+I+ELE ATN +++ ++I D + Y ++YK
Sbjct: 4 KREEFFLKNGSLLLEKLVSSLNGRSNPIRNFSIKELEQATNKYNS-SLIFDRWTYSEWYK 62
Query: 76 GFVEDRTVSVMKFNDILNDGH-EDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFES 134
G +E R VSV KF+ +++D E I FA++LS+HKNVLKL GCCLET+ PV+V+E
Sbjct: 63 GSLEGRFVSVRKFHPVIDDAFLERVIKEITFATQLSAHKNVLKLFGCCLETQTPVLVYEY 122
Query: 135 VKNRTL----ADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSR 190
N + H + + L RLRI+ IA+ IAYLH F R I+HR++ S
Sbjct: 123 PVNGVVPLYDVIHPSTDGKSRQRLPWKSRLRISGDIAHVIAYLHTAFPRAIIHREVTLSF 182
Query: 191 IFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGML 250
FLDE + KL +F ++++PEG V D V G GF+APEY TG EK DVFSFG L
Sbjct: 183 FFLDEDCVPKLSNFFFAIALPEGRKYVVDGVMGIEGFIAPEYEMTGMVTEKVDVFSFGKL 242
Query: 251 LLVLLTGQKIFD--PSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEK 308
LL LLTG++ D P D G L +K +E++E D VD I+ G + +E
Sbjct: 243 LLELLTGRRTIDFGPLGND----GELLLQDCIKTYVEDHELDGFVDASILPRGGEIHEEL 298
Query: 309 QLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341
QL +LAL C+ +AE RPT V++AK L++I
Sbjct: 299 QLLAVTKLALRCIMTAAEQRPTMVEIAKELRRI 331
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296081092|emb|CBI18286.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 247 bits (631), Expect = 6e-63, Method: Compositional matrix adjust.
Identities = 149/340 (43%), Positives = 208/340 (61%), Gaps = 10/340 (2%)
Query: 8 RTRKHFEKTENREFMIENGKILVETLVVCCYGKFNPIRGFTIRELEIATNNFDARNVIKD 67
+T+K K + EF ++NG +L+E LV G+ NPIR F+I+ELE ATN +++ ++I D
Sbjct: 610 QTKKLMAK-KREEFFLKNGSLLLEKLVSSLNGRSNPIRNFSIKELEQATNKYNS-SLIFD 667
Query: 68 GYAY-KFYKGFVEDRTVSVMKFNDILNDGH-EDCFNNIIFASKLSSHKNVLKLTGCCLET 125
+ Y ++YKG +E R VSV KF+ +++D E I FA++LS+HKNVLKL GCCLET
Sbjct: 668 RWTYSEWYKGSLEGRFVSVRKFHPVIDDAFLERVIKEITFATQLSAHKNVLKLFGCCLET 727
Query: 126 RIPVIVFESVKNRT--LAD--HIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPI 181
+ PV+V+E N L D H + + L RLRI+ IA+ IAYLH F R I
Sbjct: 728 QTPVLVYEYPVNGVVPLYDVIHPSTDGKSRQRLPWKSRLRISGDIAHVIAYLHTAFPRAI 787
Query: 182 LHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEK 241
+HR++ S FLDE + KL +F ++++PEG V D V G GF+APEY TG EK
Sbjct: 788 IHREVTLSFFFLDEDCVPKLSNFFFAIALPEGRKYVVDGVMGIEGFIAPEYEMTGMVTEK 847
Query: 242 CDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEG 301
DVFSFG LLL LLTG++ D G G L +K +E++E D VD I+ G
Sbjct: 848 VDVFSFGKLLLELLTGRRTID--FGPLGNDGELLLQDCIKTYVEDHELDGFVDASILPRG 905
Query: 302 PRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341
+ +E QL +LAL C+ +AE RPT V++AK L++I
Sbjct: 906 GEIHEELQLLAVTKLALRCIMTAAEQRPTMVEIAKELRRI 945
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542668|ref|XP_002512397.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548358|gb|EEF49849.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 246 bits (629), Expect = 8e-63, Method: Compositional matrix adjust.
Identities = 133/249 (53%), Positives = 172/249 (69%), Gaps = 5/249 (2%)
Query: 97 EDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLL 156
ED N+I+FAS++S HKNVLKL GCCLE++IP++VFE + L D+ Y+ LL
Sbjct: 60 EDPINDIVFASEMSVHKNVLKLLGCCLESKIPILVFECAQKGILKDYFYKTDS--ASLLW 117
Query: 157 SQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETC 216
RLRIAV +A+ I+YLH F RPI+HR I S I LDE YIAK+ FSLS+SIPEG+T
Sbjct: 118 QIRLRIAVDVASVISYLHSAFPRPIVHRDITLSNILLDEDYIAKVTGFSLSMSIPEGKTH 177
Query: 217 VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWL 276
++D+V GT G+LAP Y T FNEK DV+SFG+LLLVLLTGQ+ P Y L
Sbjct: 178 IEDEVVGTPGYLAPAYFKTLMFNEKIDVYSFGVLLLVLLTGQQ---PILHSPTTTARYSL 234
Query: 277 LHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336
+++VK+ IE+ FDEI+DP+I+ EGP KE+QL+ F LA+ C E+ EDRP DVAK
Sbjct: 235 VNFVKEKIEDERFDEIIDPVILEEGPWPEKERQLEIFLTLAMQCTHENEEDRPEITDVAK 294
Query: 337 RLKQIYQHL 345
+L+ IY L
Sbjct: 295 QLRHIYHSL 303
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225460075|ref|XP_002271888.1| PREDICTED: wall-associated receptor kinase-like 8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 237 bits (604), Expect = 6e-60, Method: Compositional matrix adjust.
Identities = 135/327 (41%), Positives = 198/327 (60%), Gaps = 13/327 (3%)
Query: 22 MIENGKILVETLVVCCYGKF-NPIRGFTIRELEIATNNFDARNVIKDGYA--YKFYKGFV 78
M++NG +L+E + G++ NPI F+I+E++ AT+NF+ + D + YK+YKG +
Sbjct: 16 MLKNGSLLLEKRISYFGGRYSNPIHNFSIQEIQRATDNFNGNLIFNDDVSSFYKWYKGSL 75
Query: 79 EDRTVSVMK-FNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKN 137
E R + + K F + + N I A+++SSHKN LKL GCCLETR+P++V+E
Sbjct: 76 EGRVICIRKIFRSSFAENPQIVTNEIAVATQMSSHKNALKLLGCCLETRVPILVYEFSSC 135
Query: 138 RTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGY 197
LA+ I+ EP L RL+IA IA+ IAYLH F RPI+HR I+P FLD G
Sbjct: 136 EPLAEKIFDCN---EPFPLKGRLKIAYEIASVIAYLHTAFPRPIIHRDIKPHHFFLDNGS 192
Query: 198 IAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTG 257
KL +F LS+++PEGET VKD GT+G+LAPE + ++ EK DVFSFG L+L LLT
Sbjct: 193 TPKLSNFELSIALPEGETRVKDVPRGTLGYLAPELF-SWEYTEKTDVFSFGTLILELLTR 251
Query: 258 QKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELA 317
++ ++ + + H IE +I+DP + EG V +++Q + +LA
Sbjct: 252 RRASFLAKRKGVSMRKHGEDH-----IETYGIHDILDPSSLVEGGGVLEQQQFEAVCQLA 306
Query: 318 LMCVCESAEDRPTTVDVAKRLKQIYQH 344
L C E AEDRPT VD AK +++I ++
Sbjct: 307 LKCTEEFAEDRPTIVDAAKEIRRIQRY 333
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297740944|emb|CBI31256.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 237 bits (604), Expect = 8e-60, Method: Compositional matrix adjust.
Identities = 135/324 (41%), Positives = 196/324 (60%), Gaps = 13/324 (4%)
Query: 22 MIENGKILVETLVVCCYGKF-NPIRGFTIRELEIATNNFDARNVIKDGYA--YKFYKGFV 78
M++NG +L+E + G++ NPI F+I+E++ AT+NF+ + D + YK+YKG +
Sbjct: 16 MLKNGSLLLEKRISYFGGRYSNPIHNFSIQEIQRATDNFNGNLIFNDDVSSFYKWYKGSL 75
Query: 79 EDRTVSVMK-FNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKN 137
E R + + K F + + N I A+++SSHKN LKL GCCLETR+P++V+E
Sbjct: 76 EGRVICIRKIFRSSFAENPQIVTNEIAVATQMSSHKNALKLLGCCLETRVPILVYEFSSC 135
Query: 138 RTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGY 197
LA+ I+ EP L RL+IA IA+ IAYLH F RPI+HR I+P FLD G
Sbjct: 136 EPLAEKIFDCN---EPFPLKGRLKIAYEIASVIAYLHTAFPRPIIHRDIKPHHFFLDNGS 192
Query: 198 IAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTG 257
KL +F LS+++PEGET VKD GT+G+LAPE + ++ EK DVFSFG L+L LLT
Sbjct: 193 TPKLSNFELSIALPEGETRVKDVPRGTLGYLAPELF-SWEYTEKTDVFSFGTLILELLTR 251
Query: 258 QKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELA 317
++ ++ + + H IE +I+DP + EG V +++Q + +LA
Sbjct: 252 RRASFLAKRKGVSMRKHGEDH-----IETYGIHDILDPSSLVEGGGVLEQQQFEAVCQLA 306
Query: 318 LMCVCESAEDRPTTVDVAKRLKQI 341
L C E AEDRPT VD AK +++I
Sbjct: 307 LKCTEEFAEDRPTIVDAAKEIRRI 330
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 346 | ||||||
| TAIR|locus:2076586 | 351 | AT3G57710 [Arabidopsis thalian | 0.933 | 0.920 | 0.385 | 1.1e-55 | |
| TAIR|locus:2076671 | 355 | AT3G57730 [Arabidopsis thalian | 0.953 | 0.929 | 0.397 | 7.8e-55 | |
| TAIR|locus:2076596 | 340 | AT3G57700 [Arabidopsis thalian | 0.953 | 0.970 | 0.391 | 5.5e-54 | |
| TAIR|locus:2076681 | 359 | AT3G57720 [Arabidopsis thalian | 0.939 | 0.905 | 0.367 | 4.4e-52 | |
| TAIR|locus:2076656 | 357 | AT3G57740 [Arabidopsis thalian | 0.693 | 0.672 | 0.410 | 4.7e-50 | |
| TAIR|locus:2076646 | 334 | AT3G57750 [Arabidopsis thalian | 0.913 | 0.946 | 0.390 | 1.5e-49 | |
| TAIR|locus:2032875 | 720 | AT1G16260 [Arabidopsis thalian | 0.907 | 0.436 | 0.357 | 5.5e-48 | |
| TAIR|locus:2079959 | 351 | AT3G52530 [Arabidopsis thalian | 0.898 | 0.886 | 0.400 | 3.8e-46 | |
| TAIR|locus:2030988 | 764 | AT1G17910 [Arabidopsis thalian | 0.930 | 0.421 | 0.353 | 7.3e-46 | |
| TAIR|locus:2019843 | 769 | WAKL10 "WALL ASSOCIATED KINASE | 0.939 | 0.422 | 0.326 | 2.7e-45 |
| TAIR|locus:2076586 AT3G57710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 574 (207.1 bits), Expect = 1.1e-55, P = 1.1e-55
Identities = 132/342 (38%), Positives = 203/342 (59%)
Query: 9 TRKHFEKTENREFMIENGKILVETLVVCCYGKFNPIRGFTIRELEIATNNFDARNVIKDG 68
TRK EK + + + ++NG I + LV C GK PIR F+ ++ ATNNFD+ +
Sbjct: 12 TRK--EKDKAKRWFLDNGSIFLRELVADCNGKSIPIRSFSPEQILKATNNFDSSCFVSQD 69
Query: 69 YAYKFYKGFVEDRTVSVMKFND--ILNDGH--EDCFNNIIFASKLSSHKNVLKLTGCCLE 124
YK+Y+G +EDR+ + +F++ I H ++ +N+I+ ++++S+H N L+L GCCLE
Sbjct: 70 VYYKWYRGEIEDRSYMIKRFSEDEITGKRHRVKEVYNDIVLSARMSNHSNFLQLLGCCLE 129
Query: 125 TRIPVIVFESVKNRTLADH--IYQNQPHFEPLL-LSQRLRIAVHIANAIAYLHIGFSRPI 181
PV+VFE ++ + + N E LL S RL+I IANA+ YLH F + I
Sbjct: 130 FPFPVLVFEFAEHGAMNQRGGVIVNGE--ESLLPWSVRLKIGKEIANAVTYLHTAFPKII 187
Query: 182 LHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDK-VTGTMGFLAPEYINTGDFNE 240
+HR ++P +FLD+ + AKL D S S+S+PEG++ ++ + V GT G++ P Y T E
Sbjct: 188 IHRDVKPMHVFLDKNWTAKLSDLSFSISLPEGKSRIEAEWVLGTFGYIDPLYHKTCFVTE 247
Query: 241 KCDVFSFGMLLLVLLTGQK-IFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVS 299
DV+SFG+ LLV++TG+ I S GD G +L V++ EN + DE++DP ++
Sbjct: 248 YTDVYSFGICLLVIITGKPAIMTISDGDLQG-----ILSLVRELCENGKLDEVIDPRLMK 302
Query: 300 EGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341
+ G+ Q++ LAL C E EDRP + VAK LKQI
Sbjct: 303 DITS-GQRLQVEACVVLALRCCKERDEDRPKMIQVAKELKQI 343
|
|
| TAIR|locus:2076671 AT3G57730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 566 (204.3 bits), Expect = 7.8e-55, P = 7.8e-55
Identities = 139/350 (39%), Positives = 208/350 (59%)
Query: 7 LRTR--KHFEKTENRE-FMIENGKILVETLVVCCYGKFNPIRGFTIRELEIATNNFDARN 63
LRT K EK+ +E + +ENG I ++ L+V C GK PIR FT ++ AT NFD
Sbjct: 12 LRTGSWKKKEKSMKKERWFLENGSIFLKELIVDCNGKSIPIRSFTSSQIRKATKNFDLSC 71
Query: 64 -VIKDGYAYKFYKGFVEDRTVSVMKFNDI-LNDGH-EDCFNNIIFASKLSSHKNVLKLTG 120
V ++G+ Y +YKG +EDR+ + +F++ + D + + +I+ ++++S+H N LKL G
Sbjct: 72 FVAEEGF-YIWYKGVIEDRSYMIKRFSEYKVTDYRVSEVYKDIVLSARMSNHNNFLKLLG 130
Query: 121 CCLETRIPVIVFESVKNRTL--ADHIYQNQPHFEPLL-LSQRLRIAVHIANAIAYLHIGF 177
CCLE PV+VFE ++ L I N E LL LS RL+I IANA+AYLH+ F
Sbjct: 131 CCLEFPFPVLVFEFAEHGVLNYRGGITVNGE--ESLLPLSLRLKIGKEIANALAYLHMAF 188
Query: 178 SRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVK-DKVTGTMGFLAPEYINTG 236
+ I++R ++P +FLD + AKL D S S+S+ EG++ ++ + V GT G+L P Y T
Sbjct: 189 PKIIIYRDVKPLHVFLDNNWTAKLSDLSFSISLEEGKSQIEAEDVLGTYGYLDPLYFATR 248
Query: 237 DFNEKCDVFSFGMLLLVLLTGQKI-FDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDP 295
E DV+SFG+ L+V++TG + F S G +G +L Y+K EN + +EIV P
Sbjct: 249 IVTEYTDVYSFGVFLMVVITGISVYFTGSDGYPVG-----ILGYMKGLAENGKLNEIVYP 303
Query: 296 IIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHL 345
+I+ E + Q++ LAL C E EDRP + VAK LK+I H+
Sbjct: 304 MIMKEMTSA-QRLQVEACVLLALRCCEERVEDRPKMIQVAKELKRIEHHV 352
|
|
| TAIR|locus:2076596 AT3G57700 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 558 (201.5 bits), Expect = 5.5e-54, P = 5.5e-54
Identities = 133/340 (39%), Positives = 197/340 (57%)
Query: 10 RKHFEKTENREFMIENGKILVETLVVCCYGKFNPIRGFTIRELEIATNNFDARNVIKDGY 69
+K +K E + +NG +L+E L+ G +NPIR F+ ++ ATN+FD VI +
Sbjct: 7 KKKKQKKEEEINLQKNGSLLLEELIATSGGIYNPIRTFSSDQILQATNHFDWNYVISED- 65
Query: 70 AYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV 129
+ +YKG +E+R V + KF D ++ + +I +S +SSHKNVLKL GCCLE PV
Sbjct: 66 RFVWYKGMIENRPVLIKKFQDCSVFDADNFYRDIAVSSLMSSHKNVLKLLGCCLEFPRPV 125
Query: 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPS 189
+V E ++ L + I + + RLRIA IA+A+AYLH F R I+HR ++ +
Sbjct: 126 LVCEYPEHGAL-NCIRCGKEGVRSFPWNVRLRIAKEIADAVAYLHTEFPRTIIHRDLKLA 184
Query: 190 RIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGM 249
IFLDE + AKL FSLS+ +PEGET V D V T ++ P+Y NTG E D++S G+
Sbjct: 185 NIFLDENWSAKLSSFSLSIVLPEGETGVNDMVCRTSSYIEPDYFNTGLVTENVDIYSLGI 244
Query: 250 LLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIV-SEGPRVGKEK 308
++L++LTG+ ++ E+ L YV K +E E++DP I+ S + K
Sbjct: 245 IMLIILTGKSEYN----SEVAVYLPVLPVYVGKFLERGLLTELIDPSILDSTSDDIPKHS 300
Query: 309 QLQ--GFRELALMCV-CESAEDRPTTVDVAKRLKQIYQHL 345
+LQ F ELA CV E+ P +DVAK LK+I +H+
Sbjct: 301 RLQMEAFIELAFRCVRFRPGENVPRMIDVAKELKKIEKHI 340
|
|
| TAIR|locus:2076681 AT3G57720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 540 (195.1 bits), Expect = 4.4e-52, P = 4.4e-52
Identities = 127/346 (36%), Positives = 203/346 (58%)
Query: 7 LRTRKHFEKT-ENREFMIENGKILVETLVVCCYGKFNPIRGFTIRELEIATNNFDARN-V 64
L RK EK + ++ ++NG I ++ L+ C GK PIR F+ ++ AT+NF + V
Sbjct: 17 LEKRKEKEKDIQEEKWFLDNGSIFLKELIADCNGKSIPIRNFSSDQILKATSNFGSSCFV 76
Query: 65 IKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHE--DCFNNIIFASKLSSHKNVLKLTGCC 122
+G+ Y +YKG +EDR+ + +F++ + + +N I+ ++++S+H N LKL G C
Sbjct: 77 TAEGF-YVWYKGIIEDRSYMIKRFSEYKVTQYRVAEVYNEIVLSARMSNHNNFLKLIGFC 135
Query: 123 LETRIPVIVFESVKNRTLADH----IYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFS 178
LE +PV+VFE ++ L +H I + PL L RL+I IANA+ YLH+ F
Sbjct: 136 LEFSLPVLVFEYAEHGVL-NHRGGVIVNGEEVILPLSL--RLKIGKEIANAVTYLHMAFP 192
Query: 179 RPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVK-DKVTGTMGFLAPEYINTGD 237
+ ++HR I+P +FLDE + KL DFS+S+++PEG++ ++ + V GT+G+L P Y T
Sbjct: 193 KILIHRHIKPRNVFLDENWTPKLSDFSISINLPEGKSRIEVECVQGTIGYLDPVYYTTKM 252
Query: 238 FNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHY-WLLHYVKKCIENNEFDEIVDPI 296
E DV+SFG+ L+V+LTG+ + D G Y + YVK EN + D ++DP
Sbjct: 253 VTEYTDVYSFGVFLMVILTGKPALASTSSD----GDYKHIASYVKGFHENGQLDGVIDPK 308
Query: 297 IVSEGPRVGKEKQLQGFRELALMCVCESA-EDRPTTVDVAKRLKQI 341
++ E ++ ++ LAL C CE E+RP + +AK LKQI
Sbjct: 309 VM-EDITSAQKVHVEACVVLALRC-CELRDENRPKMIQIAKELKQI 352
|
|
| TAIR|locus:2076656 AT3G57740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 436 (158.5 bits), Expect = 4.7e-50, Sum P(2) = 4.7e-50
Identities = 106/258 (41%), Positives = 151/258 (58%)
Query: 3 MSCFLRT--RKHFEKTENREFMIENGKILVETLVVCCYGKFNPIRGFTIRELEIATNNFD 60
MSC+ + +K+ E + + + ENGK+L+E L+ C GK NPI+ F+ E+ AT+NF
Sbjct: 1 MSCWRKKSKKKNSEANQRQRWFQENGKVLLEDLIELCNGKSNPIKTFSAEEILQATDNFS 60
Query: 61 ARNVIKDGYAYKF-YKGFVEDRTVSVMK--FNDILNDGHEDCFNNIIFASKLSSHKNVLK 117
N++ + F Y+G +++R V + + +N +D E +I +S +S HKN LK
Sbjct: 61 ESNLV---IRFNFMYRGILQNRPVLIKRATWNYYKSDTLEKICRDIAVSSMVSGHKNFLK 117
Query: 118 LTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLL-LSQRLRIAVHIANAIAYLHIG 176
L GCCLE PV+V E A+ I N P+ E LL R++IA IA A++YLH
Sbjct: 118 LLGCCLEFEHPVLVCE------YAERIPFNTPNPEMLLPWRMRIKIAKEIAIAVSYLHTA 171
Query: 177 FSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVK---DKVTGTMGFLAPEYI 233
SR ++H I+P IF+D AKL DF L ++IPEGET VK D+V GT+ +L Y
Sbjct: 172 LSRTMIHTDIQPFNIFVDSNGTAKLSDFCLCIAIPEGETFVKVHADRVEGTLDYLEYNYA 231
Query: 234 NTGDFNEKCDVFSFGMLL 251
TG E DVFSFG+LL
Sbjct: 232 ATGLITEYTDVFSFGVLL 249
|
|
| TAIR|locus:2076646 AT3G57750 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 516 (186.7 bits), Expect = 1.5e-49, P = 1.5e-49
Identities = 130/333 (39%), Positives = 193/333 (57%)
Query: 17 ENREFMIENGKILVETLVVCCYGKFNPIRGFTIRELEIATNNFDARNVIKD-GYAYKFYK 75
+ R + ++NG IL+E L+ GK NPIR F+ ++ AT+NF +I GY + +YK
Sbjct: 7 KKRRWDLKNGGILLEELIASFDGKTNPIRCFSSDQILKATDNFSESRIISSWGY-FIWYK 65
Query: 76 GFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESV 135
G +E+R VS+ K++ + + +I +S++S HKN LKL GCCLE +P +V E
Sbjct: 66 GVIEERQVSIKKWSSQNLSSFTEAYRDISVSSQMSGHKNALKLIGCCLEFDLPALVCEYT 125
Query: 136 KNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE 195
++ L + P + RL+IA IA+++ YLH F I+HR I P+ IF+DE
Sbjct: 126 EHGPLNRDGGLSSGVVLPWKV--RLKIAKEIASSVTYLHTAFPETIVHRNINPTNIFIDE 183
Query: 196 GYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLL 255
+ AKL DF V+IPEGE V+D V G +GF+ P+Y T EK D++SFG+++LVLL
Sbjct: 184 NWTAKLSDFWFCVAIPEGELYVEDDVKGVIGFVDPDYYWTMKVTEKVDIYSFGVVMLVLL 243
Query: 256 TGQK-IFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSE--G--PRVGKEKQL 310
+G+ +F+ DE L +V + +E EFDEIVD I ++ G V + Q+
Sbjct: 244 SGRAAVFNGP--DEAPMS---LNDHVSEVMEKGEFDEIVDKEIWNDLGGDDDLVLRRSQV 298
Query: 311 QGFRELALMCVCESAEDRPTT--VDVAKRLKQI 341
+ F LAL CV ED P + ++VAK LK I
Sbjct: 299 KAFLRLALRCVRYKKED-PVSGMLEVAKELKLI 330
|
|
| TAIR|locus:2032875 AT1G16260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 502 (181.8 bits), Expect = 5.5e-48, P = 5.5e-48
Identities = 117/327 (35%), Positives = 184/327 (56%)
Query: 10 RKHFEKTENREFMIENGKILVETLVVCCYGKFNPIRGFTIRELEIATNNFDARNVIKDGY 69
RK + R+F NG +L++ +G N + F+ +LE AT+ F+A ++ G
Sbjct: 341 RKRKVAKQKRKFFQRNGGLLLQQQTSFLHGSVNRTKVFSSNDLENATDRFNASRILGQGG 400
Query: 70 AYKFYKGFVED-RTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIP 128
YKG +ED V+V K + + E+ N II S+++ H+NV+K+ GCCLET +P
Sbjct: 401 QGTVYKGMLEDGMIVAVKKSKALKEENLEEFINEIILLSQIN-HRNVVKILGCCLETEVP 459
Query: 129 VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRP 188
++V+E + NR L DH++ F P+ RL IA +A+A++YLH S PI HR ++
Sbjct: 460 ILVYEFIPNRNLFDHLHNPSEDF-PMSWEVRLCIACEVADALSYLHSAVSIPIYHRDVKS 518
Query: 189 SRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFG 248
+ I LDE + AK+ DF +S S+ +T + V GT+G++ PEY+ + F K DV+SFG
Sbjct: 519 TNILLDEKHRAKVSDFGISRSVAIDDTHLTTIVQGTIGYVDPEYLQSNHFTGKSDVYSFG 578
Query: 249 MLLLVLLTGQKIFDPSRGDEIGA-GHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKE 307
+LL+ LLTG+K R E+ G Y+L + + N+ EI+D I E R
Sbjct: 579 VLLIELLTGEKPVSLLRRQEVRMLGAYFL-----EAMRNDRLHEILDARIKEECDR---- 629
Query: 308 KQLQGFRELALMCVCESAEDRPTTVDV 334
+++ +LA C+ ++E RPT DV
Sbjct: 630 EEVLAVAKLARRCLSLNSEHRPTMRDV 656
|
|
| TAIR|locus:2079959 AT3G52530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 484 (175.4 bits), Expect = 3.8e-46, P = 3.8e-46
Identities = 139/347 (40%), Positives = 190/347 (54%)
Query: 11 KHFEKTEN--REFMIENGKILVETLVVCCYGKFNPIRGFTIRELEIATNNFDARNVI-KD 67
K F KTE+ R+ +NG +L E L+ C GK+NPIR F+ ++ ATNNFDA ++I KD
Sbjct: 2 KGFFKTESETRKHSDKNGSLLHEELIACSDGKYNPIRMFSSDQILKATNNFDADHIIAKD 61
Query: 68 GYAYKFYKGFVEDRTVSVMKFND--ILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLET 125
+ + YKG +E+R V + K+ +L E+ + +I S +SSHKNVLKL GCC+E
Sbjct: 62 RFIW--YKGTIEERRVLIKKWEGDYVLFSSPENVYRDIAVLSMMSSHKNVLKLLGCCVEF 119
Query: 126 RIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRK 185
PV+V E + L P L S RL+I IANA+AYLH F R I++R
Sbjct: 120 YKPVLVCELAEKGPLKLEDMDGTP----LPWSARLKIGKDIANAVAYLHTAFPRVIINRD 175
Query: 186 IRPSRIFLDEGYIAKLFDFSLSVSIPEGETCV-KDKVTGTMGFLAPEYINTGDFNEKCDV 244
+RP IFLDE AKL F L +SIPEGE+ V DKV + + PEY TG +EK DV
Sbjct: 176 VRPQNIFLDEDGTAKLSSFCLRISIPEGESSVYDDKVVYGVS-VDPEYNGTGLVSEKFDV 234
Query: 245 FSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKK-------CIEN--NEFDEIVDP 295
+SFG+ +L LL G E+G WL + + C E ++F ++D
Sbjct: 235 YSFGVTMLFLL----------GGELGLT--WLSAIIGEFGFPFPGCGEELADQFMYVIDS 282
Query: 296 IIVSEGPRVGKEKQLQGFRELALMCV-CESAEDRPTTVDVAKRLKQI 341
I + G Q++ F LAL C+ +D T +DVAK LK I
Sbjct: 283 NIWN-GESEASAVQVETFFGLALRCIRFWPGQDVLTMIDVAKELKGI 328
|
|
| TAIR|locus:2030988 AT1G17910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 486 (176.1 bits), Expect = 7.3e-46, P = 7.3e-46
Identities = 118/334 (35%), Positives = 185/334 (55%)
Query: 10 RKHFEKTENREFMIENGKILVETLVVCCYGKFNPIRGFTIRELEIATNNFDARNVIKDGY 69
RK R+F NG +L++ + G+ + F+ RELE AT+NF+ VI G
Sbjct: 405 RKRRMTNRKRKFFKRNGGLLLQQQLNTTQGRVEKTKLFSSRELEKATDNFNDNRVIGQGG 464
Query: 70 AYKFYKGFVED-RTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIP 128
YKG + D R+V+V K N + D ++ N +I S+++ H++V+KL GCCLET +P
Sbjct: 465 QGTVYKGMLVDGRSVAVKKSNVVDEDKLQEFINEVIILSQIN-HRHVVKLLGCCLETEVP 523
Query: 129 VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRP 188
++V+E + N L H+++ + L R+RIAV I+ A +YLH PI HR I+
Sbjct: 524 ILVYEFIPNGNLFQHLHEEFDDYTALW-GVRMRIAVDISGAFSYLHTAACSPIYHRDIKS 582
Query: 189 SRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFG 248
+ I LDE Y AK+ DF S S+ T ++GT+G++ PEY + F EK DV+SFG
Sbjct: 583 TNILLDEKYRAKVSDFGTSRSVSIDHTHWTTVISGTVGYVDPEYYGSSHFTEKSDVYSFG 642
Query: 249 MLLLVLLTGQK-IFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKE 307
++L+ L+TG+K + S EI G L Y + + N EI+D I ++ K
Sbjct: 643 VVLVELITGEKPVITLSETQEI-TG---LADYFRLAMRENRLFEIIDARIRNDC----KL 694
Query: 308 KQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341
+Q+ LAL C+ ++ + RP +V+ L++I
Sbjct: 695 EQVIAVANLALRCLKKTGKTRPDMREVSTALERI 728
|
|
| TAIR|locus:2019843 WAKL10 "WALL ASSOCIATED KINASE (WAK)-LIKE 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 481 (174.4 bits), Expect = 2.7e-45, P = 2.7e-45
Identities = 110/337 (32%), Positives = 182/337 (54%)
Query: 6 FLRTRKHFEKTENREFMIENGKILVETLVVCCYGKFNPIRGFTIRELEIATNNFDARNVI 65
F+R ++ + ++F NG +L++ + G + R F RELE AT NF ++
Sbjct: 382 FIRRQRRLN--QKKKFFKRNGGLLLQQQLTTTEGNVDSTRVFNSRELEKATENFSLTRIL 439
Query: 66 KDGYAYKFYKGFVED-RTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLE 124
+G YKG + D R V+V K + D E+ N ++ S+++ H+N++KL GCCLE
Sbjct: 440 GEGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVILSQIN-HRNIVKLLGCCLE 498
Query: 125 TRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHR 184
T +P++V+E + N L +H++ + + RLRIAV IA A++YLH S PI HR
Sbjct: 499 TDVPILVYEFIPNGNLFEHLHDDSDDYTMTTWEVRLRIAVDIAGALSYLHSAASSPIYHR 558
Query: 185 KIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDV 244
I+ + I LDE + AK+ DF S ++ T + V+GT+G++ PEY + F +K DV
Sbjct: 559 DIKSTNIMLDEKHRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMDPEYFQSSQFTDKSDV 618
Query: 245 FSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRV 304
+SFG++L L+TG+K R E + L Y ++ N +I+D I +G ++
Sbjct: 619 YSFGVVLAELITGEKSVSFLRSQE----YRTLATYFTLAMKENRLSDIIDARI-RDGCKL 673
Query: 305 GKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341
Q+ ++A C+ RP+ V+ L++I
Sbjct: 674 N---QVTAAAKIARKCLNMKGRKRPSMRQVSMELEKI 707
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
No EC number assignment, probably not an enzyme!
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 346 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-29 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-24 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-23 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-23 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-21 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-21 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-20 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-18 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-16 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-14 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-14 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-13 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-13 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-13 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-12 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-12 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-12 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-12 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-11 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-11 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-11 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-11 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-11 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-11 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-10 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-10 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-10 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-10 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-10 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-10 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-10 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-09 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-09 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-09 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-09 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-09 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-09 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-09 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-09 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-08 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-08 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-08 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-08 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-08 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-08 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-08 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-08 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-08 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-08 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-08 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-08 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-08 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 9e-08 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-07 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-07 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-07 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-07 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-07 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-07 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-07 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-07 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-07 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-07 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-07 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-07 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-07 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-07 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-07 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-06 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-06 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-06 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-06 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-06 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-06 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-06 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-06 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-06 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-06 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-06 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-06 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-06 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-06 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-06 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-06 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-06 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-06 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-06 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-06 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 8e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 9e-06 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 9e-06 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-06 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-05 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-05 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-05 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-05 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-05 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-05 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-05 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-05 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-05 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-05 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-05 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-05 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-05 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-05 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-05 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-05 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-05 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-05 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-05 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-05 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-05 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-05 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-04 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-04 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-04 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-04 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-04 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-04 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-04 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-04 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-04 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-04 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-04 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-04 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-04 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-04 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-04 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-04 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-04 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-04 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-04 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-04 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-04 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-04 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-04 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-04 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-04 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-04 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-04 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 9e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.001 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 0.001 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.001 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 0.001 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 0.001 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 0.001 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.001 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 0.001 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 0.001 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 0.001 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 0.002 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.002 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 0.002 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 0.002 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 0.002 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 0.002 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 0.003 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 0.003 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 0.003 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 0.003 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-29
Identities = 48/170 (28%), Positives = 79/170 (46%), Gaps = 9/170 (5%)
Query: 87 KFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQ 146
+ + I K +H N++KL G + +V E + +L D + +
Sbjct: 25 IIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKE 84
Query: 147 NQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEG-YIAKLFDFS 205
N+ + LRI + I + YLH S I+HR ++P I LD KL DF
Sbjct: 85 NEGKLSE---DEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFG 138
Query: 206 LSVSIPEGETCVKDKVTGTMGFLAPEYI-NTGDFNEKCDVFSFGMLLLVL 254
LS + ++ +K V GT ++APE + G ++EK D++S G++L L
Sbjct: 139 LSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 6e-24
Identities = 46/141 (32%), Positives = 70/141 (49%), Gaps = 6/141 (4%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAI 170
H NV+KL G C E IV E ++ L ++ +N+P L LS L A+ IA +
Sbjct: 59 DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK---LSLSDLLSFALQIARGM 115
Query: 171 AYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAP 230
YL S+ +HR + + E + K+ DF LS + + + K + ++AP
Sbjct: 116 EYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAP 172
Query: 231 EYINTGDFNEKCDVFSFGMLL 251
E + G F K DV+SFG+LL
Sbjct: 173 ESLKEGKFTSKSDVWSFGVLL 193
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 1e-23
Identities = 63/237 (26%), Positives = 100/237 (42%), Gaps = 36/237 (15%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFE-----PLLLSQRLRIAVH 165
H NV++L G C E +V E ++ L D++ +++P F L L L A+
Sbjct: 54 GHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQ 113
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTM 225
IA + YL S+ +HR + + E + K+ DF LS + + + K G +
Sbjct: 114 IAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKT-GGKL 169
Query: 226 GF--LAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKK 282
+APE + G F K DV+SFG+LL + T G + +E+ L Y++K
Sbjct: 170 PIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV-------LEYLRK 222
Query: 283 CIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLK 339
E + EL L C EDRPT ++ +RL+
Sbjct: 223 G-YRLPKPEYCPDEL----------------YELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 96.8 bits (242), Expect = 2e-23
Identities = 48/144 (33%), Positives = 72/144 (50%), Gaps = 11/144 (7%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAI 170
H N++KL G C E +IV E + L D++ +N+P L LS L A+ IA +
Sbjct: 59 DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE--LSLSDLLSFALQIARGM 116
Query: 171 AYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMG---F 227
YL S+ +HR + + E + K+ DF LS + + + KV G +
Sbjct: 117 EYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY---YKVKGGKLPIRW 170
Query: 228 LAPEYINTGDFNEKCDVFSFGMLL 251
+APE + G F K DV+SFG+LL
Sbjct: 171 MAPESLKEGKFTSKSDVWSFGVLL 194
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 91.4 bits (228), Expect = 2e-21
Identities = 48/147 (32%), Positives = 71/147 (48%), Gaps = 17/147 (11%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAI 170
SH N+++L G C + IV E + L D + ++ E L L L++A+ IA +
Sbjct: 59 SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHG---EKLTLKDLLQMALQIAKGM 115
Query: 171 AYLHIGFSRPILHRKIRPSR-IFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFL- 228
YL S+ +HR + +R + E + K+ DF LS I E + K G L
Sbjct: 116 EYLE---SKNFVHRDLA-ARNCLVTENLVVKISDFGLSRDIYEDDYYRK----RGGGKLP 167
Query: 229 ----APEYINTGDFNEKCDVFSFGMLL 251
APE + G F K DV+SFG+LL
Sbjct: 168 IKWMAPESLKDGKFTSKSDVWSFGVLL 194
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 8e-21
Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 9/151 (5%)
Query: 112 HKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIA 171
H N+++L + +V E + L D + + L + I +A+
Sbjct: 56 HPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR----LSEDEARFYLRQILSALE 111
Query: 172 YLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPE 231
YLH S+ I+HR ++P I LDE KL DF L+ + GE GT ++APE
Sbjct: 112 YLH---SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL--TTFVGTPEYMAPE 166
Query: 232 YINTGDFNEKCDVFSFGMLLLVLLTGQKIFD 262
+ + + D++S G++L LLTG+ F
Sbjct: 167 VLLGKGYGKAVDIWSLGVILYELLTGKPPFP 197
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 3e-20
Identities = 60/238 (25%), Positives = 100/238 (42%), Gaps = 34/238 (14%)
Query: 108 KLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIA 167
+ SH N+++L + +V E + L D++ + P + +IA+ I
Sbjct: 53 RRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP-LSE---DEAKKIALQIL 108
Query: 168 NAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGF 227
+ YLH S I+HR ++P I LDE + K+ DF L+ + + + + GT +
Sbjct: 109 RGLEYLH---SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPWY 164
Query: 228 LAPEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIEN 286
+APE + G + K DV+S G++L LLTG+ F E L+ +
Sbjct: 165 MAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFS----GENILDQLQLIRRILGPP-- 218
Query: 287 NEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344
EFDE E ++L C+ + RPT ++I QH
Sbjct: 219 LEFDEPKWSSGSEE------------AKDLIKKCLNKDPSKRPT-------AEEILQH 257
|
Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 3e-20
Identities = 85/347 (24%), Positives = 145/347 (41%), Gaps = 61/347 (17%)
Query: 6 FLRTRKHFE--KTENREFMIE----NGKILVETLVVCCYGKFNPIRGFTIRELEIATNNF 59
F+R R + E + EN + E + K+ + TI ++ +
Sbjct: 651 FIRGRNNLELKRVENEDGTWELQFFDSKVS---------------KSITINDILSSLKE- 694
Query: 60 DARNVIKDGYAYKFYKGFVEDRTVS--VMKFNDILNDGHEDCFNNIIFASKLSS-----H 112
NVI G YKG + V + ND+ N I +S+++ H
Sbjct: 695 --ENVISRGKKGASYKGKSIKNGMQFVVKEINDV----------NSIPSSEIADMGKLQH 742
Query: 113 KNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAY 172
N++KL G C + ++ E ++ + L++ + +N L +R +IA+ IA A+ +
Sbjct: 743 PNIVKLIGLCRSEKGAYLIHEYIEGKNLSE-VLRN------LSWERRRKIAIGIAKALRF 795
Query: 173 LHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEY 232
LH S ++ + P +I +D L +S+P G C K + ++APE
Sbjct: 796 LHCRCSPAVVVGNLSPEKIIIDGKDEPHL-----RLSLP-GLLCTDTKCFISSAYVAPET 849
Query: 233 INTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEI 292
T D EK D++ FG++L+ LLTG+ D G H ++ + + C + D
Sbjct: 850 RETKDITEKSDIYGFGLILIELLTGKSPADAEFG-----VHGSIVEWARYCYSDCHLDMW 904
Query: 293 VDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLK 339
+DP I G + ++ LAL C RP DV K L+
Sbjct: 905 IDPSI--RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 85.2 bits (209), Expect = 2e-18
Identities = 57/242 (23%), Positives = 98/242 (40%), Gaps = 25/242 (10%)
Query: 105 FASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAV 164
+ L+ N++KL + +V E V +L D + + PL S+ L I
Sbjct: 50 ILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLL-KKIGRKGPLSESEALFILA 108
Query: 165 HIANAIAYLHIGFSRPILHRKIRPSRIFLDE-GYIAKLFDFSLSVSIPEGETCVKDK--- 220
I +A+ YLH S+ I+HR I+P I LD G + KL DF L+ +P+ +
Sbjct: 109 QILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALP 165
Query: 221 --VTGTMGFLAPEYI---NTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYW 275
GT G++APE + + + D++S G+ L LLTG F+ + +
Sbjct: 166 STSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL- 224
Query: 276 LLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVA 335
K I + P+ S + K +L + + ++R ++
Sbjct: 225 ------KIILELPTPSLASPLSPSNPELISKA-----ASDLLKKLLAKDPKNRLSSSSDL 273
Query: 336 KR 337
Sbjct: 274 SH 275
|
Length = 384 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 2e-16
Identities = 40/158 (25%), Positives = 71/158 (44%), Gaps = 11/158 (6%)
Query: 107 SKLSSHKNVLKLTGCCLETRIPV--IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAV 164
S L H N+++ G + I E V +L+ + + ++ + R
Sbjct: 54 SSLQ-HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGK-LPEPVIRKYTR--- 108
Query: 165 HIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDK-VTG 223
I +AYLH S I+HR I+ + I +D + KL DF + + + ET V G
Sbjct: 109 QILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRG 165
Query: 224 TMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIF 261
T ++APE I ++ D++S G ++ + TG+ +
Sbjct: 166 TPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPW 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (185), Expect = 2e-15
Identities = 60/197 (30%), Positives = 86/197 (43%), Gaps = 26/197 (13%)
Query: 78 VEDRTVSVMKFNDILNDG---HEDCFNNIIFASKLSSHKNVLK-----LTGCCLETRIPV 129
D + V+K D+ N ED N + KL+ H N++K L
Sbjct: 22 KSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLN-HPNIIKYYESFEEKGKL-----C 75
Query: 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPS 189
IV E L+ I + + +P Q L V + A+ YLH SR ILHR I+P
Sbjct: 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQ 132
Query: 190 RIFLDEGYIAKLFDF----SLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVF 245
IFL + KL DF LS ++ +T V GT +L+PE +N K D++
Sbjct: 133 NIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-----GTPYYLSPELCQNKPYNYKSDIW 187
Query: 246 SFGMLLLVLLTGQKIFD 262
S G +L L T + F+
Sbjct: 188 SLGCVLYELCTLKHPFE 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-14
Identities = 70/293 (23%), Positives = 124/293 (42%), Gaps = 39/293 (13%)
Query: 58 NFDARNVIKDGYAYKFYKG--FVEDRTVSVMK---FNDILNDGHEDCFNNIIFASKLSSH 112
NF I G + Y+ ++ + V++ K F + +DC I +L+ H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-H 61
Query: 113 KNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHF--EPLLLSQRL--RIAVHIAN 168
NV+K +E IV E L+ I +F + L+ +R + V + +
Sbjct: 62 PNVIKYLDSFIEDNELNIVLELADAGDLSQMI----KYFKKQKRLIPERTVWKYFVQLCS 117
Query: 169 AIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFL 228
A+ ++H SR ++HR I+P+ +F+ + KL D L +T + GT ++
Sbjct: 118 AVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLG-RFFSSKTTAAHSLVGTPYYM 173
Query: 229 APEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE 288
+PE I+ +N K D++S G LL + Q P GD++ + L +++C
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQS---PFYGDKMNL--FSLCQKIEQC----- 223
Query: 289 FDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341
+ P + E + REL MC+ + RP V + KQ+
Sbjct: 224 -----------DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 4e-14
Identities = 59/246 (23%), Positives = 96/246 (39%), Gaps = 35/246 (14%)
Query: 95 GHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPL 154
D N I+ S L H N++ ++ +I E TL D I + +
Sbjct: 42 ERRDALNEIVILSLLQ-HPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKG----Q 96
Query: 155 LLSQRLRIAV--HIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212
L + + + I +A++Y+H ILHR I+ IFL + + KL DF +S I
Sbjct: 97 LFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGIS-KILG 152
Query: 213 GETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAG 272
E + + V GT +++PE +N K D+++ G +L LLT ++ FD +
Sbjct: 153 SEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN------- 205
Query: 273 HYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTV 332
L+ V K IV L + + E RPT
Sbjct: 206 ---PLNLVVK--------------IVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTAD 248
Query: 333 DVAKRL 338
+V +
Sbjct: 249 EVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 45/145 (31%), Positives = 70/145 (48%), Gaps = 5/145 (3%)
Query: 112 HKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIA 171
H +++L C E IV E + +L D + + L L Q + +A IA +A
Sbjct: 60 HDKLVQLYAVCSEEEPIYIVTEYMSKGSLLD--FLKSGEGKKLRLPQLVDMAAQIAEGMA 117
Query: 172 YLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPE 231
YL SR +HR + I + E + K+ DF L+ I + E ++ + + APE
Sbjct: 118 YLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPE 174
Query: 232 YINTGDFNEKCDVFSFGMLLLVLLT 256
N G F K DV+SFG+LL ++T
Sbjct: 175 AANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 47/178 (26%), Positives = 83/178 (46%), Gaps = 10/178 (5%)
Query: 83 VSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLET--RIPVIVFESVKNRTL 140
V+V N + H F I + H+N++K G C + R ++ E + + +L
Sbjct: 36 VAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSL 95
Query: 141 ADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAK 200
D++ Q H + + L + L + I + YL S+ +HR + I ++ + K
Sbjct: 96 RDYL---QRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVK 149
Query: 201 LFDFSLSVSIPEGETC--VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT 256
+ DF L+ +PE + VK+ + + APE + T F+ DV+SFG+ L L T
Sbjct: 150 ISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 4e-13
Identities = 47/192 (24%), Positives = 82/192 (42%), Gaps = 19/192 (9%)
Query: 74 YKGFVED--RTVSV--MKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV 129
YKG + V++ + I + + I L H N++K G +
Sbjct: 17 YKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK-HPNIVKYIGSIETSDSLY 75
Query: 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIAN---AIAYLHIGFSRPILHRKI 186
I+ E +N +L I + P E L +AV++ +AYLH + ++HR I
Sbjct: 76 IILEYAENGSLRQIIKKFGPFPESL-------VAVYVYQVLQGLAYLH---EQGVIHRDI 125
Query: 187 RPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFS 246
+ + I + + KL DF ++ + + V GT ++APE I + D++S
Sbjct: 126 KAANILTTKDGVVKLADFGVATKLNDVSKDDAS-VVGTPYWMAPEVIEMSGASTASDIWS 184
Query: 247 FGMLLLVLLTGQ 258
G ++ LLTG
Sbjct: 185 LGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 9e-13
Identities = 48/165 (29%), Positives = 73/165 (44%), Gaps = 15/165 (9%)
Query: 97 EDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLL 156
E N I K H N++K G L+ IV E +L D + ++ L
Sbjct: 42 EKIINEIQILKKCK-HPNIVKYYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQ--TLTE 97
Query: 157 SQRLRIAVHIAN---AIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213
SQ IA + YLH S I+HR I+ + I L KL DF LS + +
Sbjct: 98 SQ---IAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151
Query: 214 ETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQ 258
+ + + GT ++APE IN ++ K D++S G+ + L G+
Sbjct: 152 KAR--NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 9e-13
Identities = 59/243 (24%), Positives = 99/243 (40%), Gaps = 43/243 (17%)
Query: 112 HKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHF----------EPLLLSQRLR 161
H+N++K G C E P++VFE +++ L + + P L LSQ L+
Sbjct: 67 HENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQ 126
Query: 162 IAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKV 221
IAV IA+ + YL S+ +HR + + + K+ DF +S + T +V
Sbjct: 127 IAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDV---YTTDYYRV 180
Query: 222 TGT----MGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLL 277
G + ++ PE I F + DV+SFG++L + T K P W
Sbjct: 181 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK--QP-----------WYG 227
Query: 278 HYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKR 337
N E E + + + PR ++ L C + R D+ +R
Sbjct: 228 L------SNEEVIECITQGRLLQRPRTCP----SEVYDIMLGCWKRDPQQRINIKDIHER 277
Query: 338 LKQ 340
L++
Sbjct: 278 LQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 73/293 (24%), Positives = 123/293 (41%), Gaps = 42/293 (14%)
Query: 58 NFDARNVIKDGYAYKFYKG-FVEDRTVSVMK----FNDILNDGHEDCFNNIIFASKLSSH 112
NF I G + Y+ + D +K F+ + DC I +L+ H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-H 61
Query: 113 KNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHF--EPLLLSQRL--RIAVHIAN 168
NV+K +E IV E L+ I HF + L+ ++ + V + +
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMI----KHFKKQKRLIPEKTVWKYFVQLCS 117
Query: 169 AIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFL 228
A+ ++H SR ++HR I+P+ +F+ + KL D L +T + GT ++
Sbjct: 118 ALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLG-RFFSSKTTAAHSLVGTPYYM 173
Query: 229 APEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE 288
+PE I+ +N K D++S G LL + Q P GD++ L+ + K IE +
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQS---PFYGDKMN------LYSLCKKIEQCD 224
Query: 289 FDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTV---DVAKRL 338
+ P + + + R+L MC+ E RP DVAKR+
Sbjct: 225 Y------------PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 52/199 (26%), Positives = 91/199 (45%), Gaps = 18/199 (9%)
Query: 59 FDARNVIKDGYAYKFYKGFVEDR---TVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNV 115
F + GY + ++G ++R + ++K +D+L +D F + A K HK++
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLK--QQD-FQKEVQALKRLRHKHL 64
Query: 116 LKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHI 175
+ L C I+ E ++ +L + P + L ++ + +A +A +AYL
Sbjct: 65 ISLFAVCSVGEPVYIITELMEKGSL--LAFLRSPEGQVLPVASLIDMACQVAEGMAYLE- 121
Query: 176 GFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDK---VTGTMGFLAPEY 232
+ +HR + I + E + K+ DF L+ I E DK T APE
Sbjct: 122 --EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT----APEA 175
Query: 233 INTGDFNEKCDVFSFGMLL 251
+ G F+ K DV+SFG+LL
Sbjct: 176 ASHGTFSTKSDVWSFGILL 194
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 69/292 (23%), Positives = 117/292 (40%), Gaps = 31/292 (10%)
Query: 56 TNNFDARNVIKDGYAYKFYKG--FVEDRTVSVMK---FNDILNDGHEDCFNNIIFASKLS 110
NF I G YK ++ R V++ K F + +DC I +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAI 170
H NV+K +E IV E L+ I + + + V + +A+
Sbjct: 61 -HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 171 AYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAP 230
++H S+ I+HR I+P+ +F+ + KL D L T V GT +++P
Sbjct: 120 EHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSP 175
Query: 231 EYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290
E I+ +N K D++S G LL + Q P GD++ L+ + K IE ++
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQS---PFYGDKMN------LYSLCKKIEKCDY- 225
Query: 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIY 342
P + + + R+L C+ E RP V + K+++
Sbjct: 226 -----------PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 57/231 (24%), Positives = 96/231 (41%), Gaps = 34/231 (14%)
Query: 112 HKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIA 171
H+N+++L G L + ++V E +L D + ++ L+S AV IAN +
Sbjct: 55 HENLIRLYGVVLTHPL-MMVTELAPLGSLLDRLRKDALGH--FLISTLCDYAVQIANGMR 111
Query: 172 YLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGF--LA 229
YL S+ +HR + I L K+ DF L ++P+ E + + F A
Sbjct: 112 YLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCA 168
Query: 230 PEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE 288
PE + T F+ DV+ FG+ L + T G++ + G +I L + K
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI-------LKKIDK------ 215
Query: 289 FDEIVDPIIVSEGPRVGKEKQL-QGFRELALMCVCESAEDRPTTVDVAKRL 338
EG R+ + + Q + L C + DRPT + + L
Sbjct: 216 -----------EGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-12
Identities = 54/203 (26%), Positives = 85/203 (41%), Gaps = 34/203 (16%)
Query: 142 DHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIAK 200
D IY+ P+ + +IAV + + YL+ I+HR I+PS I ++ G I K
Sbjct: 91 DRIYKK---GGPIPVEILGKIAVAVVEGLTYLY--NVHRIMHRDIKPSNILVNSRGQI-K 144
Query: 201 LFDFSLSVSIPEGE--TCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQ 258
L DF +S GE + D GT +++PE I G + K DV+S G+ ++ L G+
Sbjct: 145 LCDFGVS-----GELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199
Query: 259 KIFDPSRGDEIG----AGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFR 314
F S D+ G G LL I+ PR+ + R
Sbjct: 200 FPFAFSNIDDDGQDDPMGILDLLQQ----------------IVQEPPPRLPSSDFPEDLR 243
Query: 315 ELALMCVCESAEDRPTTVDVAKR 337
+ C+ + +RPT +
Sbjct: 244 DFVDACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 56/200 (28%), Positives = 85/200 (42%), Gaps = 39/200 (19%)
Query: 161 RIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE--TCVK 218
+IA + ++YLH SR I+HR I+PS I L KL DF +S GE +
Sbjct: 109 KIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVS-----GELVNSLA 160
Query: 219 DKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLH 278
TGT ++APE I ++ DV+S G+ LL + + F P E G LL
Sbjct: 161 GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEG--EPPLGPIELLS 218
Query: 279 YVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTT------- 331
Y I N E+ D G + ++ + F + C+ + RPT
Sbjct: 219 Y----IVNMPNPELKD----EPGNGIKWSEEFKDFIK---QCLEKDPTRRPTPWDMLEHP 267
Query: 332 ---------VDVAKRLKQIY 342
V++AK + Q++
Sbjct: 268 WIKAQMKKKVNMAKFVAQVW 287
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-12
Identities = 40/141 (28%), Positives = 68/141 (48%), Gaps = 9/141 (6%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAI 170
H N+++L G L+ IV E + +L D++ + L+Q+L A+ + +
Sbjct: 58 RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAV--ITLAQQLGFALDVCEGM 115
Query: 171 AYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAP 230
YL + +HR + + + E +AK+ DF L+ +G+ K V T AP
Sbjct: 116 EYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----AP 168
Query: 231 EYINTGDFNEKCDVFSFGMLL 251
E + F+ K DV+SFG+LL
Sbjct: 169 EALREKKFSTKSDVWSFGILL 189
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 4e-12
Identities = 46/149 (30%), Positives = 77/149 (51%), Gaps = 12/149 (8%)
Query: 112 HKNVLKLTGCCLET--RIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANA 169
H+N++K GCC E + ++ E V +L D++ +++ L L+Q L A I
Sbjct: 65 HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK-----LNLAQLLLFAQQICEG 119
Query: 170 IAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETC--VKDKVTGTMGF 227
+AYLH S+ +HR + + LD + K+ DF L+ ++PEG V++ + +
Sbjct: 120 MAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 176
Query: 228 LAPEYINTGDFNEKCDVFSFGMLLLVLLT 256
A E + F+ DV+SFG+ L LLT
Sbjct: 177 YAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 42/160 (26%), Positives = 77/160 (48%), Gaps = 5/160 (3%)
Query: 108 KLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIA 167
K H +++L + I+ E + +L D + ++ +LL + + + IA
Sbjct: 56 KTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEG--GKVLLPKLIDFSAQIA 113
Query: 168 NAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGF 227
+AY+ + +HR +R + + + E + K+ DF L+ I + E ++ + +
Sbjct: 114 EGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW 170
Query: 228 LAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGD 267
APE IN G F K DV+SFG+LL ++T KI P +
Sbjct: 171 TAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN 210
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-11
Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 45/228 (19%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAI 170
SH+ +++L G C + R IV E + N L +++ ++ F+P SQ L + + +
Sbjct: 57 SHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQP---SQLLEMCKDVCEGM 113
Query: 171 AYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMG---- 226
AYL S+ +HR + +D+ K+ DF LS + + D+ T ++G
Sbjct: 114 AYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYV------LDDEYTSSVGSKFP 164
Query: 227 --FLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCI 284
+ PE + F+ K DV++FG+L+ + + +G Y
Sbjct: 165 VRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYS------------LGKMPYERF------- 205
Query: 285 ENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVC--ESAEDRPT 330
NN E V+ VS+G R+ + L + A+M C E AE+RPT
Sbjct: 206 -NNS--ETVEK--VSQGLRLYR-PHLASEKVYAIMYSCWHEKAEERPT 247
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-11
Identities = 42/142 (29%), Positives = 74/142 (52%), Gaps = 6/142 (4%)
Query: 125 TRIPV-IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILH 183
T+ P+ I+ E ++N +L D + P L +++ + +A IA +A++ + +H
Sbjct: 71 TQEPIYIITEYMENGSLVD--FLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIH 125
Query: 184 RKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCD 243
R +R + I + E K+ DF L+ I + E ++ + + APE IN G F K D
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 185
Query: 244 VFSFGMLLLVLLTGQKIFDPSR 265
V+SFG+LL ++T +I P
Sbjct: 186 VWSFGILLTEIVTYGRIPYPGM 207
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-11
Identities = 38/142 (26%), Positives = 70/142 (49%), Gaps = 7/142 (4%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAI 170
H N++KL G C++ + IV E V +L + + + L + + L++++ A +
Sbjct: 50 DHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKK---NRLTVKKLLQMSLDAAAGM 106
Query: 171 AYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGT-MGFLA 229
YL S+ +HR + + E + K+ DF +S G V D + + + A
Sbjct: 107 EYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTA 163
Query: 230 PEYINTGDFNEKCDVFSFGMLL 251
PE +N G + + DV+S+G+LL
Sbjct: 164 PEALNYGRYTSESDVWSYGILL 185
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-11
Identities = 40/140 (28%), Positives = 73/140 (52%), Gaps = 6/140 (4%)
Query: 125 TRIPV-IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILH 183
T+ P+ I+ E + +L D + ++ +PL + + + IA +A++ R +H
Sbjct: 71 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIE---QRNYIH 125
Query: 184 RKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCD 243
R +R + I + + K+ DF L+ I + E ++ + + APE IN G F K D
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 185
Query: 244 VFSFGMLLLVLLTGQKIFDP 263
V+SFG+LL+ ++T +I P
Sbjct: 186 VWSFGILLMEIVTYGRIPYP 205
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 5e-11
Identities = 32/104 (30%), Positives = 50/104 (48%), Gaps = 3/104 (2%)
Query: 160 LRIAVHIANAIAYLHIGF--SRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCV 217
RI + A+ H +LHR ++P+ IFLD KL DF L+ + +
Sbjct: 108 WRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA 167
Query: 218 KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIF 261
K V GT +++PE +N ++EK D++S G L+ L F
Sbjct: 168 KTYV-GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPF 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 5e-11
Identities = 29/102 (28%), Positives = 51/102 (50%), Gaps = 7/102 (6%)
Query: 162 IAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE-GYIAKLFDFSLSVSIPEGETCVKDK 220
I A+ YLH S+ I+HR I+P I LDE G+ + DF+++ + +
Sbjct: 105 WICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGH-VHITDFNIATKVTPDT--LTTS 158
Query: 221 VTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFD 262
+GT G++APE + ++ D +S G+ L G++ +
Sbjct: 159 TSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYR 200
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 6e-11
Identities = 50/186 (26%), Positives = 83/186 (44%), Gaps = 10/186 (5%)
Query: 80 DRTVSVMKFNDILNDG---HEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVK 136
D+ V MK D+ E+ + +KL +++ L+ IV E +
Sbjct: 24 DKRVYAMKQIDLSKMNRREREEAIDEARVLAKLD-SSYIIRYYESFLDKGKLNIVMEYAE 82
Query: 137 NRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEG 196
N L + + PL Q R + I +A+LH S+ ILHR I+ +FLD
Sbjct: 83 NGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAY 137
Query: 197 YIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT 256
K+ D ++ + + T + + GT +L+PE +NEK DV++ G++L T
Sbjct: 138 DNVKIGDLGVAKLLSD-NTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCT 196
Query: 257 GQKIFD 262
G+ FD
Sbjct: 197 GKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 40/140 (28%), Positives = 67/140 (47%), Gaps = 10/140 (7%)
Query: 112 HKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIA 171
HKN+++L G L + IV E + L + + ++ Q L+ ++ +A +
Sbjct: 58 HKNLVRLLGVILHNGL-YIVMELMSKGNLVNFLRTRGRALVSVI--QLLQFSLDVAEGME 114
Query: 172 YLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPE 231
YL S+ ++HR + I + E +AK+ DF L+ G K V T APE
Sbjct: 115 YLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APE 167
Query: 232 YINTGDFNEKCDVFSFGMLL 251
+ F+ K DV+S+G+LL
Sbjct: 168 ALKHKKFSSKSDVWSYGVLL 187
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-10
Identities = 55/228 (24%), Positives = 93/228 (40%), Gaps = 45/228 (19%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAI 170
SH N+++L G C + R IV E + N L +++ + + L L + + A+
Sbjct: 57 SHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL---LDMCSDVCEAM 113
Query: 171 AYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMG---- 226
YL S +HR + + E + K+ DF L+ + + D+ T + G
Sbjct: 114 EYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYV------LDDQYTSSQGTKFP 164
Query: 227 --FLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCI 284
+ PE + F+ K DV+SFG+L+ + + K+ P
Sbjct: 165 VKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKM--P--------------------Y 202
Query: 285 ENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVC--ESAEDRPT 330
E E+V+ + S G R+ + K L +M C E EDRP
Sbjct: 203 ERFSNSEVVESV--SAGYRLYRPK-LAPTEVYTIMYSCWHEKPEDRPA 247
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 3e-10
Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 161 RIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIAKLFDFSLSVSIPEGETCVKD 219
A I A+ YLH S I++R ++P I LD +G+I KL DF L+ + +
Sbjct: 97 FYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHI-KLTDFGLAKELSSEGSRTNT 152
Query: 220 KVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQ 258
GT +LAPE + + + D +S G+LL +LTG+
Sbjct: 153 -FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 5e-10
Identities = 39/152 (25%), Positives = 71/152 (46%), Gaps = 12/152 (7%)
Query: 112 HKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIA 171
H N+++ G CL+ I E V +++ + + P EP+ + I + +A
Sbjct: 61 HVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFC----KYTKQILDGVA 116
Query: 172 YLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS-----VSIPEGETCVKDKVTGTMG 226
YLH + ++HR I+ + + L I KL DF + V + + + + GT
Sbjct: 117 YLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY 173
Query: 227 FLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQ 258
++APE IN + K D++S G + + TG+
Sbjct: 174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 6e-10
Identities = 41/167 (24%), Positives = 71/167 (42%), Gaps = 9/167 (5%)
Query: 97 EDCFNNI-IFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLL 155
ED N I I AS +H N++ L+ IV E L+ I + + + +
Sbjct: 44 EDAVNEIRILAS--VNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIP 101
Query: 156 LSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGET 215
+ RI + + + LH + ILHR ++ + I L + K+ D +S + +
Sbjct: 102 EQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA 158
Query: 216 CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFD 262
GT ++APE ++ K D++S G LL + T F+
Sbjct: 159 ---KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 7e-10
Identities = 31/107 (28%), Positives = 46/107 (42%), Gaps = 8/107 (7%)
Query: 163 AVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVT 222
+ + LH R I+HR I+P + +D+ KL DF LS + G K
Sbjct: 103 IAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRN---GL--ENKKFV 154
Query: 223 GTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEI 269
GT +LAPE I ++ D +S G ++ L G F D +
Sbjct: 155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV 201
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 9e-10
Identities = 33/105 (31%), Positives = 54/105 (51%), Gaps = 9/105 (8%)
Query: 161 RIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDK 220
+ + +AYLH S I+HR I+P+ IFLD + KL DF +V + T + ++
Sbjct: 103 VYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159
Query: 221 VTGTMG---FLAPEYINTGDFNEK---CDVFSFGMLLLVLLTGQK 259
V G ++APE I G D++S G ++L + TG++
Sbjct: 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 9e-10
Identities = 38/175 (21%), Positives = 74/175 (42%), Gaps = 27/175 (15%)
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFLDE-GYIAKLFDFSLSVSIPE---GETCVKDKV 221
+ ++YLH I+HR ++ + + +D G ++ DF + + G + ++
Sbjct: 112 LLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQL 168
Query: 222 TGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVK 281
GT+ F+APE + + CDV+S G +++ + T + P E + H L+ +
Sbjct: 169 LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK----PPWNAEKHSNHLALIFKIA 224
Query: 282 KCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336
E + P G R++ L C+ EDRP + ++ K
Sbjct: 225 SATTAPSIPEHLSP----------------GLRDVTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 39/149 (26%), Positives = 71/149 (47%), Gaps = 5/149 (3%)
Query: 112 HKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIA 171
H +++L C IV E +K +L +++ L L Q + +A +A+ +A
Sbjct: 60 HPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAG--RALKLPQLIDMAAQVASGMA 117
Query: 172 YLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPE 231
YL ++ +HR + + + E I K+ DF L+ I E ++ + + APE
Sbjct: 118 YLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPE 174
Query: 232 YINTGDFNEKCDVFSFGMLLLVLLTGQKI 260
F+ K DV+SFG+LL ++T ++
Sbjct: 175 AALYNRFSIKSDVWSFGILLTEIVTYGRM 203
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 38/162 (23%), Positives = 73/162 (45%), Gaps = 13/162 (8%)
Query: 112 HKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIA 171
H +V++L G CL +++ +I + + L D++ ++ + L L V IA ++
Sbjct: 68 HPHVVRLLGICLSSQVQLIT-QLMPLGCLLDYVRNHKDNIGSQYL---LNWCVQIAKGMS 123
Query: 172 YLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTM---GFL 228
YL + ++HR + + + K+ DF L+ + E G ++
Sbjct: 124 YLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYH--AEGGKVPIKWM 178
Query: 229 APEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEI 269
A E I + K DV+S+G+ + L+T G K ++ EI
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI 220
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 38/169 (22%), Positives = 73/169 (43%), Gaps = 28/169 (16%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHI--------------------YQNQPH 150
+H +V+KL G C + +++ E K +L + Y + P
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 151 FEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI 210
L + + A I+ + YL ++HR + + + EG K+ DF LS +
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 211 PEGETCVK---DKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT 256
E ++ VK ++ + ++A E + + + DV+SFG+LL ++T
Sbjct: 178 YEEDSYVKRSKGRI--PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 28/79 (35%), Positives = 40/79 (50%), Gaps = 4/79 (5%)
Query: 170 IAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLA 229
+ YLH S +HR I+ I L+E AKL DF +S ++ V GT ++A
Sbjct: 112 LEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVS-GQLTDTMAKRNTVIGTPFWMA 167
Query: 230 PEYINTGDFNEKCDVFSFG 248
PE I +N K D++S G
Sbjct: 168 PEVIQEIGYNNKADIWSLG 186
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-09
Identities = 37/114 (32%), Positives = 59/114 (51%), Gaps = 14/114 (12%)
Query: 162 IAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG-ETCVKDK 220
+A I + IAYLH R I+HR I+PS + ++ K+ DF +S + + + C +
Sbjct: 173 VARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC--NS 227
Query: 221 VTGTMGFLAPEYINTGDFNEKC------DVFSFGMLLLVLLTGQKIFDPSR-GD 267
GT+ +++PE INT D N D++S G+ +L G+ F R GD
Sbjct: 228 SVGTIAYMSPERINT-DLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD 280
|
Length = 353 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 4e-09
Identities = 42/149 (28%), Positives = 74/149 (49%), Gaps = 10/149 (6%)
Query: 112 HKNVLKLTGCCLET--RIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANA 169
H+N++K G C E ++ E + + +L +++ +N+ L Q+L+ AV I
Sbjct: 65 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKIN---LKQQLKYAVQICKG 121
Query: 170 IAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP--EGETCVKDKVTGTMGF 227
+ YL SR +HR + + ++ + K+ DF L+ +I + VKD + + +
Sbjct: 122 MDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFW 178
Query: 228 LAPEYINTGDFNEKCDVFSFGMLLLVLLT 256
APE + F DV+SFG+ L LLT
Sbjct: 179 YAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 4e-09
Identities = 47/173 (27%), Positives = 69/173 (39%), Gaps = 22/173 (12%)
Query: 93 NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLAD-----HIYQN 147
ND H D + KL H N++ L G C I E L D + +
Sbjct: 44 ND-HRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLET 102
Query: 148 QPHF-------EPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAK 200
P F L Q L+ A +A + YL + +HR + + + E +K
Sbjct: 103 DPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASK 159
Query: 201 LFDFSLSVSIPEGETCVKDKVTGTMG--FLAPEYINTGDFNEKCDVFSFGMLL 251
+ DF LS GE K G + ++A E +N + K DV+SFG+LL
Sbjct: 160 IADFGLS----RGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLL 208
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 5e-09
Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 14/152 (9%)
Query: 111 SHKNVLKLTGCCLETR-IPVIVFESVKNRTLADHIY--QNQPHFEPLLLSQRLRIAVHIA 167
SH NVL L G CL + P++V +K+ L + I + P + L+ + +A
Sbjct: 54 SHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLI-----GFGLQVA 108
Query: 168 NAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE-TCVKDKVTGTM- 225
+ YL S+ +HR + LDE + K+ DF L+ I + E V + +
Sbjct: 109 KGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP 165
Query: 226 -GFLAPEYINTGDFNEKCDVFSFGMLLLVLLT 256
++A E + T F K DV+SFG+LL L+T
Sbjct: 166 VKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 5e-09
Identities = 41/155 (26%), Positives = 70/155 (45%), Gaps = 15/155 (9%)
Query: 108 KLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIA 167
K H N++ L +V E + +L D I Q +F + Q + +
Sbjct: 70 KDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQ---NFVRMNEPQIAYVCREVL 126
Query: 168 NAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIAKLFDFSLSVSIPEGETCVKDK---VTG 223
+ YLH S+ ++HR I+ I L +G + KL DF + + + K K V G
Sbjct: 127 QGLEYLH---SQNVIHRDIKSDNILLSKDGSV-KLADFGFAAQLTKE----KSKRNSVVG 178
Query: 224 TMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQ 258
T ++APE I D+ K D++S G++ + + G+
Sbjct: 179 TPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-09
Identities = 46/179 (25%), Positives = 83/179 (46%), Gaps = 7/179 (3%)
Query: 74 YKGFVEDRT-VSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132
+KG ++D+T V+V + L + F + K H N++KL G C + + IV
Sbjct: 12 FKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVM 71
Query: 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIF 192
E V + + + + L Q ++ A+ A +AYL S+ +HR +
Sbjct: 72 ELVPGGDFLSFLRKKK---DELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCL 125
Query: 193 LDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLL 251
+ E + K+ DF +S +G + + APE +N G ++ + DV+S+G+LL
Sbjct: 126 VGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILL 184
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 8e-09
Identities = 33/110 (30%), Positives = 55/110 (50%), Gaps = 3/110 (2%)
Query: 154 LLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213
L L + +A +A +AY+ +HR +R + I + +G + K+ DF L+ I +
Sbjct: 99 LKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155
Query: 214 ETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDP 263
E + + + APE G F K DV+SFG+LL L+T ++ P
Sbjct: 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYP 205
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 8e-09
Identities = 54/236 (22%), Positives = 97/236 (41%), Gaps = 37/236 (15%)
Query: 112 HKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIA 171
H +++L G C + ++V E L ++ + + L +A +A +A
Sbjct: 55 HPCIVRLIGVCKGEPL-MLVMELAPLGPLLKYL-KKRREIPVSDL---KELAHQVAMGMA 109
Query: 172 YLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGT--MGFLA 229
YL S+ +HR + + L + AK+ DF +S ++ G + G + + A
Sbjct: 110 YLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYA 166
Query: 230 PEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE 288
PE IN G F+ K DV+S+G+ L + G K + +G E V +E+ E
Sbjct: 167 PECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE-----------VIAMLESGE 215
Query: 289 FDEIVDPIIVSEGPRVGK-EKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQ 343
R+ + E+ Q + L C EDRPT ++ ++ +
Sbjct: 216 --------------RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDPE 257
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 42/136 (30%), Positives = 64/136 (47%), Gaps = 13/136 (9%)
Query: 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAV-HIANAIAYLHIGFSRPILHRKIRP 188
++ + V L H+YQ + HF +R+ + I A+ +LH I++R I+
Sbjct: 82 LILDYVNGGELFTHLYQRE-HFT----ESEVRVYIAEIVLALDHLH---QLGIIYRDIKL 133
Query: 189 SRIFLD-EGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGD--FNEKCDVF 245
I LD EG++ L DF LS E GT+ ++APE I G ++ D +
Sbjct: 134 ENILLDSEGHV-VLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWW 192
Query: 246 SFGMLLLVLLTGQKIF 261
S G+L LLTG F
Sbjct: 193 SLGVLTFELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 38/120 (31%), Positives = 61/120 (50%), Gaps = 9/120 (7%)
Query: 143 HIYQ-NQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKL 201
HIY P FE + L A I + LH ++R ++P I LD+ ++
Sbjct: 90 HIYNMGNPGFEE---ERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRI 143
Query: 202 FDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIF 261
D L+V IPEGE+ ++ +V GT+G++APE +N + D + G L+ ++ GQ F
Sbjct: 144 SDLGLAVKIPEGES-IRGRV-GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 1e-08
Identities = 31/100 (31%), Positives = 47/100 (47%), Gaps = 12/100 (12%)
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIAKLFDFSLSVSIPEGETCVKD----- 219
I A+ YLH S I+HR ++P I +D G++ KL DF LS +
Sbjct: 102 IVLALEYLH---SNGIIHRDLKPDNILIDSNGHL-KLTDFGLSKVGLVRRQINLNDDEKE 157
Query: 220 --KVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTG 257
++ GT ++APE I ++ D +S G +L L G
Sbjct: 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 40/123 (32%), Positives = 63/123 (51%), Gaps = 13/123 (10%)
Query: 161 RIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE---TCV 217
+IAV + + YLH I+HR ++PS I ++ KL DF +S G+ +
Sbjct: 104 KIAVAVLKGLTYLH--EKHKIIHRDVKPSNILVNSRGQIKLCDFGVS-----GQLVNSLA 156
Query: 218 KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLL 277
K V GT ++APE I D++ K D++S G+ L+ L TG+ + P G + LL
Sbjct: 157 KTFV-GTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI--FELL 213
Query: 278 HYV 280
Y+
Sbjct: 214 QYI 216
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 31/81 (38%), Positives = 49/81 (60%), Gaps = 2/81 (2%)
Query: 181 ILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNE 240
I++R ++P I LD+ ++ D L+V IPEGET V+ +V GT+G++APE IN +
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMAPEVINNEKYTF 180
Query: 241 KCDVFSFGMLLLVLLTGQKIF 261
D + G L+ ++ GQ F
Sbjct: 181 SPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-08
Identities = 39/134 (29%), Positives = 66/134 (49%), Gaps = 5/134 (3%)
Query: 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPS 189
IV E + +L D + + + L L Q + +A IA+ +AY+ +HR +R +
Sbjct: 77 IVTEFMGKGSLLDFLKEGDGKY--LKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAA 131
Query: 190 RIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGM 249
I + + + K+ DF L+ I + E + + + APE G F K DV+SFG+
Sbjct: 132 NILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 191
Query: 250 LLLVLLTGQKIFDP 263
LL L+T ++ P
Sbjct: 192 LLTELVTKGRVPYP 205
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 40/154 (25%), Positives = 72/154 (46%), Gaps = 13/154 (8%)
Query: 111 SHKNVLKLTGCCLE-TRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLR------IA 163
SH+N+L + C+E P +++ + L ++ Q Q L +A
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNL--KLFLQQCRLGEANNPQALSTQQLVHMA 123
Query: 164 VHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI-PEGETCVKDKVT 222
+ IA ++YLH R ++H+ I +DE K+ D +LS + P C+ D
Sbjct: 124 IQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNEN 180
Query: 223 GTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT 256
+ ++A E + +++ DV+SFG+LL L+T
Sbjct: 181 RPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-08
Identities = 58/238 (24%), Positives = 95/238 (39%), Gaps = 37/238 (15%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFE---PLLLSQRLRIAVHIA 167
+H+N+++L G E I+ E + L + +N+P E L + L A +A
Sbjct: 67 NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126
Query: 168 NAIAYLHIGFSRPILHRKIRPSRIFLD---EGYIAKLFDFSLSVSIPEGETCVK-DKVTG 223
YL +HR I L G +AK+ DF ++ I K +
Sbjct: 127 KGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAML 183
Query: 224 TMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKC 283
+ ++ PE G F K DV+SFG+LL +IF L Y+
Sbjct: 184 PIKWMPPEAFLDGIFTSKTDVWSFGVLLW------EIFS--------------LGYMPYP 223
Query: 284 IENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVC--ESAEDRPTTVDVAKRLK 339
N+ E+++ V+ G R+ K G +M C + EDRP + +R++
Sbjct: 224 GRTNQ--EVME--FVTGGGRLDPPKGCPG-PVYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 33/120 (27%), Positives = 57/120 (47%), Gaps = 9/120 (7%)
Query: 143 HIYQNQPHFEPLLLSQRLRI-AVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKL 201
HIY EP R A I + +LH R I++R ++P + LD+ ++
Sbjct: 83 HIYN---VGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRI 136
Query: 202 FDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIF 261
D L+V + G+ +K + GT G++APE + ++ D F+ G L ++ G+ F
Sbjct: 137 SDLGLAVELKGGKK-IKGRA-GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 23/148 (15%)
Query: 181 ILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNE 240
I++R ++P I LD+ ++ D L+V +PEG+T +K +V GT+G++APE + +
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNERYTF 180
Query: 241 KCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSE 300
D ++ G LL ++ GQ F KK I+ E + +V E
Sbjct: 181 SPDWWALGCLLYEMIAGQSPFQQR----------------KKKIKREEVER-----LVKE 219
Query: 301 GPRVGKEKQLQGFRELALMCVCESAEDR 328
EK R L M +C+ ++R
Sbjct: 220 VQEEYSEKFSPDARSLCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 32/102 (31%), Positives = 53/102 (51%), Gaps = 8/102 (7%)
Query: 161 RIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDK 220
++ V I A+ YL ++HR ++PS I LD KL DF +S + + + K +
Sbjct: 118 KMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA--KTR 173
Query: 221 VTGTMGFLAPEYIN----TGDFNEKCDVFSFGMLLLVLLTGQ 258
G ++APE I+ ++ + DV+S G+ L+ L TGQ
Sbjct: 174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 44/152 (28%), Positives = 72/152 (47%), Gaps = 6/152 (3%)
Query: 112 HKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIA 171
H+ +++L E I IV E + +L D + + L L Q + +A IA+ +A
Sbjct: 60 HEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMA 116
Query: 172 YLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPE 231
Y+ +HR +R + I + E + K+ DF L+ I + E + + + APE
Sbjct: 117 YVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 232 YINTGDFNEKCDVFSFGMLLLVLLTGQKIFDP 263
G F K DV+SFG+LL L T ++ P
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELTTKGRVPYP 205
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 45/172 (26%), Positives = 69/172 (40%), Gaps = 21/172 (12%)
Query: 94 DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLAD-----HIYQNQ 148
D H D + KL H N++ L G C + E + L D + +
Sbjct: 49 DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETD 108
Query: 149 PHF-------EPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKL 201
P F L Q L A +A + YL + +HR + I + E Y+AK+
Sbjct: 109 PAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKI 165
Query: 202 FDFSLSVSIPEGETCVKDKVTGTMG--FLAPEYINTGDFNEKCDVFSFGMLL 251
DF LS G+ K G + ++A E +N + DV+S+G+LL
Sbjct: 166 ADFGLS----RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 213
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-08
Identities = 38/121 (31%), Positives = 64/121 (52%), Gaps = 11/121 (9%)
Query: 143 HIYQ-NQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE-GYIAK 200
HIY P F+ + + A I + LH I++R ++P I LD+ G+I +
Sbjct: 90 HIYNMGNPGFDE---ERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHI-R 142
Query: 201 LFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKI 260
+ D L+V IPEGET ++ +V GT+G++APE + + D + G L+ ++ G+
Sbjct: 143 ISDLGLAVEIPEGET-IRGRV-GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
Query: 261 F 261
F
Sbjct: 201 F 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 45/173 (26%), Positives = 70/173 (40%), Gaps = 22/173 (12%)
Query: 93 NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLAD-----HIYQN 147
+D H D + KL H N++ L G C + E + L D + +
Sbjct: 37 DD-HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLET 95
Query: 148 QPHF-------EPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAK 200
P F L Q L A +A + YL + +HR + I + E Y+AK
Sbjct: 96 DPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAK 152
Query: 201 LFDFSLSVSIPEGETCVKDKVTGTMG--FLAPEYINTGDFNEKCDVFSFGMLL 251
+ DF LS G+ K G + ++A E +N + DV+S+G+LL
Sbjct: 153 IADFGLS----RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 201
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 3e-08
Identities = 42/158 (26%), Positives = 73/158 (46%), Gaps = 17/158 (10%)
Query: 112 HKNVLKLTGCCLETRIPVIVFESVK----NRTLADH--------IYQNQPHFEPLLLSQR 159
H+++++ G C E R ++VFE ++ NR L H ++ L L Q
Sbjct: 66 HQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVA-PGQLTLGQM 124
Query: 160 LRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETC-VK 218
L IA IA+ + YL S +HR + + +G + K+ DF +S I + V
Sbjct: 125 LAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 181
Query: 219 DKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT 256
+ + ++ PE I F + D++SFG++L + T
Sbjct: 182 GRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-08
Identities = 55/227 (24%), Positives = 98/227 (43%), Gaps = 43/227 (18%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAI 170
SH +++L G C E +VFE +++ L+D++ + F L L + + + +
Sbjct: 57 SHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETL---LGMCLDVCEGM 113
Query: 171 AYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMG---- 226
AYL S ++HR + + E + K+ DF ++ + + D+ T + G
Sbjct: 114 AYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFV------LDDQYTSSTGTKFP 164
Query: 227 --FLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCI 284
+ +PE + ++ K DV+SFG+L+ + + K P
Sbjct: 165 VKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKT--P--------------------Y 202
Query: 285 ENNEFDEIVDPIIVSEGPRVGKEKQL-QGFRELALMCVCESAEDRPT 330
EN E+V+ I + G R+ K + Q EL C E EDRP+
Sbjct: 203 ENRSNSEVVETI--NAGFRLYKPRLASQSVYELMQHCWKERPEDRPS 247
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 5e-08
Identities = 39/161 (24%), Positives = 71/161 (44%), Gaps = 19/161 (11%)
Query: 111 SHKNVLKL--TGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIAN 168
H N++ L +G + VFE V RTL + + L + R+ + + +
Sbjct: 36 YHPNIVALLDSGEAPPGLL-FAVFEYVPGRTLRE-VLAAD---GALPAGETGRLMLQVLD 90
Query: 169 AIAYLHIGFSRPILHRKIRPSRIFL---DEGYIAKLFDFSLSVSIPEGETCVKDKVT--- 222
A+A H ++ I+HR ++P I + AK+ DF + +P +T
Sbjct: 91 ALACAH---NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTT 147
Query: 223 ---GTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKI 260
GT + APE + D++++G++ L LTGQ++
Sbjct: 148 EVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRV 188
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (128), Expect = 6e-08
Identities = 44/169 (26%), Positives = 73/169 (43%), Gaps = 27/169 (15%)
Query: 111 SHKNVLKLTG-CCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANA 169
H N++KL E ++ +VFE + L ++ + P + I +
Sbjct: 56 KHPNIVKLLDVIHTERKL-YLVFEYC-DMDLKKYLDKRPGPLSP---NLIKSIMYQLLRG 110
Query: 170 IAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS--VSIPEGETCVKDKVTGTMGF 227
+AY H S ILHR ++P I ++ + KL DF L+ IP +V T+ +
Sbjct: 111 LAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP--LRTYTHEVV-TLWY 164
Query: 228 LAPEYINTGDFNEKC-----DVFSFGMLLLVLLTGQKIFDPSRGD-EIG 270
APE + K D++S G + ++TG+ +F GD EI
Sbjct: 165 RAPEIL----LGSKHYSTAVDIWSVGCIFAEMITGKPLF---PGDSEID 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 6e-08
Identities = 43/156 (27%), Positives = 76/156 (48%), Gaps = 8/156 (5%)
Query: 108 KLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIA 167
KL SH N+++ LE + +IV E TLA++I + L L V I
Sbjct: 54 KLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYI--QKRCNSLLDEDTILHFFVQIL 111
Query: 168 NAIAYLHIGFSRPILHRKIRPSRIFLDE-GYIAKLFDFSLSVSIPEGETCVKDKVTGTMG 226
A+ ++H ++ ILHR ++ I LD+ + K+ DF +S + V GT
Sbjct: 112 LALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL--SSKSKAYTVVGTPC 166
Query: 227 FLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFD 262
+++PE +N+K D+++ G +L L + ++ F+
Sbjct: 167 YISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 6e-08
Identities = 40/149 (26%), Positives = 69/149 (46%), Gaps = 15/149 (10%)
Query: 108 KLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIA 167
K SH N+++L G C + + IV E V+ + P L + + +++ + A
Sbjct: 48 KQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPR---LKVKELIQMVENAA 104
Query: 168 NAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTM-- 225
+ YL S+ +HR + + E + K+ DF +S +G TG M
Sbjct: 105 AGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY----ASTGGMKQ 157
Query: 226 ---GFLAPEYINTGDFNEKCDVFSFGMLL 251
+ APE +N G ++ + DV+SFG+LL
Sbjct: 158 IPVKWTAPEALNYGRYSSESDVWSFGILL 186
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 6e-08
Identities = 46/216 (21%), Positives = 75/216 (34%), Gaps = 45/216 (20%)
Query: 107 SKLSSHKNVLKLTGC-----CLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLR 161
++L+ H ++KL L V E N L +I + L
Sbjct: 56 TRLNGHPGIIKLYYTFQDEENL-----YFVLEYAPNGELLQYIR----KYGSLDEKCTRF 106
Query: 162 IAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDF----------------- 204
A I A+ YLH S+ I+HR ++P I LD+ K+ DF
Sbjct: 107 YAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKG 163
Query: 205 --SLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFD 262
+ S E GT +++PE +N + D+++ G ++ +LTG+ F
Sbjct: 164 DATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223
Query: 263 PSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIV 298
G+ Y + K F P
Sbjct: 224 -------GSNEYLTFQKILKL--EYSFPPNFPPDAK 250
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 7e-08
Identities = 51/205 (24%), Positives = 87/205 (42%), Gaps = 29/205 (14%)
Query: 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPS 189
IV E + +LAD + + EP+L IA I + YLH R I+HR I+PS
Sbjct: 76 IVLEYMDGGSLADLLKKVGKIPEPVLAY----IARQILKGLDYLH--TKRHIIHRDIKPS 129
Query: 190 RIFLD-EGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFG 248
+ ++ +G + K+ DF +S + V GT+ +++PE I ++ D++S G
Sbjct: 130 NLLINSKGEV-KIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYSYAADIWSLG 187
Query: 249 MLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEK 308
+ LL G+ F P F E++ I P + E+
Sbjct: 188 LTLLECALGKFPFLPP--------------------GQPSFFELMQAICDGPPPSLPAEE 227
Query: 309 QLQGFRELALMCVCESAEDRPTTVD 333
FR+ C+ + + RP+ +
Sbjct: 228 FSPEFRDFISACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 9e-08
Identities = 45/168 (26%), Positives = 74/168 (44%), Gaps = 17/168 (10%)
Query: 97 EDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPH------ 150
++ S L H N++ L G C + + ++FE + + L + + +N PH
Sbjct: 53 QEFRQEAELMSDLQ-HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAE 111
Query: 151 ------FEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDF 204
L S L IA+ IA + YL S +HR + + EG K+ DF
Sbjct: 112 SGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDF 168
Query: 205 SLSVSIPEGETC-VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLL 251
LS I + V+ K + ++ PE I G F + D++SFG++L
Sbjct: 169 GLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVL 216
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 9e-08
Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 7/94 (7%)
Query: 168 NAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETC---VKDKVTGT 224
+ YLH S +HR I+ I L E K+ DF +S S+ +G V+ GT
Sbjct: 113 KGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGT 169
Query: 225 MGFLAPEYINTGD-FNEKCDVFSFGMLLLVLLTG 257
++APE + ++ K D++SFG+ + L TG
Sbjct: 170 PCWMAPEVMEQVHGYDFKADIWSFGITAIELATG 203
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 61/213 (28%), Positives = 91/213 (42%), Gaps = 41/213 (19%)
Query: 74 YKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTG---------CCLE 124
KG E V V+K + IL D +C K VL L G C +
Sbjct: 16 LKGTDELYAVKVLKKDVILQDDDVECTMT---------EKRVLALAGKHPFLTQLHSCFQ 66
Query: 125 TRIPV-IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRI-AVHIANAIAYLHIGFSRPIL 182
T+ + V E V L HI ++ EP R R A I + +LH R I+
Sbjct: 67 TKDRLFFVMEYVNGGDLMFHIQRSGRFDEP-----RARFYAAEIVLGLQFLH---ERGII 118
Query: 183 HRKIRPSRIFLD-EGYIAKLFDFSLSVSIPEGETCVKDKVT-----GTMGFLAPEYINTG 236
+R ++ + LD EG+I K+ DF + EG + VT GT ++APE ++
Sbjct: 119 YRDLKLDNVLLDSEGHI-KIADFGMC---KEG---ILGGVTTSTFCGTPDYIAPEILSYQ 171
Query: 237 DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEI 269
+ D ++ G+LL +L GQ F+ DE+
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL 204
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 35/134 (26%), Positives = 57/134 (42%), Gaps = 33/134 (24%)
Query: 160 LRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFL---------DEGYIAKLF-----DFS 205
L I I I Y+H S+ +LHR ++P I L D G A +F +
Sbjct: 116 LSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG--AAIFKKLEEEDL 170
Query: 206 LSVSIPEGETC-----VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT---- 256
L + + E C + K+ GT ++APE + +E D+++ G++L +LT
Sbjct: 171 LDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
Query: 257 -----GQKIFDPSR 265
G+KI
Sbjct: 231 YRRKKGRKISYRDV 244
|
Length = 932 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 43/136 (31%), Positives = 67/136 (49%), Gaps = 23/136 (16%)
Query: 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIF 192
+ +K+R + ++ H LL Q L +AVH ++H S+ ++HR I+ + I
Sbjct: 128 QEIKSRAKTNRTFRE--HEAGLLFIQVL-LAVH------HVH---SKHMIHRDIKSANIL 175
Query: 193 LDEGYIAKLFDFSLS------VSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFS 246
L + KL DF S VS G T GT ++APE +++K D+FS
Sbjct: 176 LCSNGLVKLGDFGFSKMYAATVSDDVGRT-----FCGTPYYVAPEIWRRKPYSKKADMFS 230
Query: 247 FGMLLLVLLTGQKIFD 262
G+LL LLT ++ FD
Sbjct: 231 LGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 42/156 (26%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAI 170
H+N+++ G L+ I E V ++A + N FE L+ +R I +
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGGSVAA-LLNNYGAFEETLVRNFVR---QILKGL 119
Query: 171 AYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDK-----VTGTM 225
YLH +R I+HR I+ + I +D K+ DF +S + K + G++
Sbjct: 120 NYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176
Query: 226 GFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIF 261
++APE + + K D++S G L++ +LTG+ F
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 39/146 (26%), Positives = 69/146 (47%), Gaps = 6/146 (4%)
Query: 107 SKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHI 166
S L +H+N++ L G C +++ E L + + + + F L L L + +
Sbjct: 93 SHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF--LTLEDLLSFSYQV 150
Query: 167 ANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI-PEGETCVKDKVTGTM 225
A +A+L S+ +HR + + L G I K+ DF L+ I + VK +
Sbjct: 151 AKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPV 207
Query: 226 GFLAPEYINTGDFNEKCDVFSFGMLL 251
++APE I + + DV+S+G+LL
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILL 233
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 41/185 (22%), Positives = 77/185 (41%), Gaps = 23/185 (12%)
Query: 91 ILNDGHEDCFNNIIFASKLSSHKNVLKL-------TGCCLETRIPVIVFESVKNRTLADH 143
L G + I A + H V+KL +G V+V E + L++
Sbjct: 37 RLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGF-------VLVMEYMP-SDLSEV 88
Query: 144 IYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFD 203
+ +++ PL +Q + +AY+H + I+HR ++P+ + + + K+ D
Sbjct: 89 L-RDEER--PLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIAD 142
Query: 204 FSLSVSIPEGETCVKDKVTGTMGFLAPEYI-NTGDFNEKCDVFSFGMLLLVLLTGQKIFD 262
F L+ E E + T + APE + ++ D+++ G + LL G +F
Sbjct: 143 FGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLF- 201
Query: 263 PSRGD 267
P D
Sbjct: 202 PGEND 206
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 37/104 (35%), Positives = 54/104 (51%), Gaps = 13/104 (12%)
Query: 164 VHIANAIAYLHIGFSRPILHRKIRPSRIFLDE-GYIAKLFDF----SLSVSIPEGETCVK 218
V I+ + ++H R ILHR I+ IFL + G +AKL DF L+ S+ TCV
Sbjct: 108 VQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV- 163
Query: 219 DKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFD 262
GT +L+PE +N K D++S G +L L T + F+
Sbjct: 164 ----GTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 43/158 (27%), Positives = 72/158 (45%), Gaps = 16/158 (10%)
Query: 112 HKNVLKLTGCCLETRIPVIVFESVK----NRTLADH------IYQNQPHFE--PLLLSQR 159
H++++K G C + ++VFE +K N+ L H + QP L LSQ
Sbjct: 66 HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125
Query: 160 LRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETC-VK 218
L IA IA+ + YL S+ +HR + + + K+ DF +S + + V
Sbjct: 126 LHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 182
Query: 219 DKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT 256
+ ++ PE I F + DV+SFG++L + T
Sbjct: 183 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-07
Identities = 39/143 (27%), Positives = 69/143 (48%), Gaps = 11/143 (7%)
Query: 112 HKNVLKLTGCCLETRIP--VIVFESVKNRTLADHIYQ-NQPHFEPLLLSQRLRIAVHIAN 168
H N+++L G C TR P I+ E + L D++ + N+ ++L L +A I++
Sbjct: 61 HPNLVQLLGVC--TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISS 115
Query: 169 AIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFL 228
A+ YL + +HR + + E ++ K+ DF LS + + +
Sbjct: 116 AMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 172
Query: 229 APEYINTGDFNEKCDVFSFGMLL 251
APE + F+ K DV++FG+LL
Sbjct: 173 APESLAYNKFSIKSDVWAFGVLL 195
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 3e-07
Identities = 44/164 (26%), Positives = 70/164 (42%), Gaps = 27/164 (16%)
Query: 182 LHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGT--MGFLAPEYINTGDFN 239
+HR + + L + AK+ DF LS ++ E K K G + + APE +N F+
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176
Query: 240 EKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIV 298
K DV+SFG+L+ + GQK + +G+E V + IE+ E +
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQKPYKGMKGNE-----------VTQMIESGER--------M 217
Query: 299 SEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIY 342
R E +L +C ++RP V RL+ Y
Sbjct: 218 ECPQRCPPE-----MYDLMKLCWTYGVDERPGFAVVELRLRNYY 256
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-07
Identities = 38/163 (23%), Positives = 75/163 (46%), Gaps = 12/163 (7%)
Query: 112 HKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIA 171
H N+++ G I E V ++ + FE L+ + +A
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGS-CLRTYGRFEEQLVRFFTE---QVLEGLA 122
Query: 172 YLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKD-KVTGTMGFLAP 230
YLH S+ ILHR ++ + +D I K+ DF +S + ++ + G++ ++AP
Sbjct: 123 YLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
Query: 231 EYINT--GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGA 271
E I++ ++ K D++S G ++L + G++ + S + I A
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW--SDEEAIAA 220
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-07
Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 12/103 (11%)
Query: 164 VHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFS----LSVSIPEGETCVKD 219
V I A+ ++H R ILHR I+ IFL + KL DF L+ ++ TC+
Sbjct: 108 VQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-- 162
Query: 220 KVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFD 262
GT +L+PE +N K D+++ G +L + T + F+
Sbjct: 163 ---GTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 3e-07
Identities = 42/163 (25%), Positives = 69/163 (42%), Gaps = 8/163 (4%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFE-----PLLLSQRLRIAVH 165
SHKNV++L G C E ++ E L + + E PL Q++ +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTM 225
IA + H+ +R +HR + + K+ SLS + E +
Sbjct: 126 IALGMD--HLSNAR-FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL 182
Query: 226 GFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDE 268
+LAPE + DF+ K DV+SFG+L+ + T ++ DE
Sbjct: 183 RWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE 225
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 4e-07
Identities = 33/96 (34%), Positives = 50/96 (52%), Gaps = 13/96 (13%)
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIAKLFDFSLSVSIPEGE---TCVKDKV 221
+ A YLH +R I++R ++P + LD GY+ KL DF + + G+ T
Sbjct: 102 VVLAFEYLH---NRGIIYRDLKPENLLLDSNGYV-KLVDFGFAKKLKSGQKTWTFC---- 153
Query: 222 TGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTG 257
GT ++APE I ++ D +S G+LL LLTG
Sbjct: 154 -GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTG 188
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 5e-07
Identities = 45/168 (26%), Positives = 77/168 (45%), Gaps = 16/168 (9%)
Query: 112 HKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIA 171
H N++ L G ++R +I+ E ++N L + QN F + L LR IA +
Sbjct: 64 HPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMK 120
Query: 172 YLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMG----- 226
YL +HR + I ++ + K+ DF LS + + + T ++G
Sbjct: 121 YLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS--DPTYTSSLGGKIPI 175
Query: 227 -FLAPEYINTGDFNEKCDVFSFGMLLL-VLLTGQKIF-DPSRGDEIGA 271
+ APE I F DV+S+G+++ V+ G++ + D S D I A
Sbjct: 176 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINA 223
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 6e-07
Identities = 42/169 (24%), Positives = 73/169 (43%), Gaps = 12/169 (7%)
Query: 97 EDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIY---QNQPHFEP 153
D + + + H N+++ LE IV + ++ L +H + + F
Sbjct: 53 GDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFT- 111
Query: 154 LLLSQRL-RIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212
+R+ I V + A+ YLH + I+HR + P+ I L E + DF L+ +
Sbjct: 112 ---EERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ--K 164
Query: 213 GETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIF 261
V GT+ + PE + + EK DV++FG +L + T Q F
Sbjct: 165 QPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 6e-07
Identities = 35/131 (26%), Positives = 66/131 (50%), Gaps = 13/131 (9%)
Query: 143 HIY---QNQPHF-EPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYI 198
HIY + P F EP + I + + +LH R I++R ++P + LD
Sbjct: 83 HIYNVDEENPGFPEP----RACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGN 135
Query: 199 AKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQ 258
++ D L+V + +G++ K GT GF+APE + +++ D F+ G+ L ++ +
Sbjct: 136 VRISDLGLAVELKDGQSKTKG-YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
Query: 259 KIFDPSRGDEI 269
F +RG+++
Sbjct: 195 GPFR-ARGEKV 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 7e-07
Identities = 61/211 (28%), Positives = 90/211 (42%), Gaps = 39/211 (18%)
Query: 75 KGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTG---------CCLET 125
KG E + ++K + I+ D +C K VL L G C +T
Sbjct: 22 KGTDELYAIKILKKDVIIQDDDVEC---------TMVEKRVLALPGKPPFLTQLHSCFQT 72
Query: 126 --RIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILH 183
R+ V E V L HI Q EP + A IA + +LH S+ I++
Sbjct: 73 MDRL-YFVMEYVNGGDLMYHIQQVGKFKEP----HAVFYAAEIAIGLFFLH---SKGIIY 124
Query: 184 RKIRPSRIFLD-EGYIAKLFDFSLSVSIPEGETCVKDKVT----GTMGFLAPEYINTGDF 238
R ++ + LD EG+I K+ DF + E K T GT ++APE I +
Sbjct: 125 RDLKLDNVMLDAEGHI-KIADFGMC-----KENIFGGKTTRTFCGTPDYIAPEIIAYQPY 178
Query: 239 NEKCDVFSFGMLLLVLLTGQKIFDPSRGDEI 269
+ D ++FG+LL +L GQ FD DE+
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 7e-07
Identities = 47/185 (25%), Positives = 81/185 (43%), Gaps = 16/185 (8%)
Query: 83 VSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVK----NR 138
V+V D ++ +D + L H++++K G C+E ++VFE +K N+
Sbjct: 38 VAVKTLKDASDNARKDFHREAELLTNLQ-HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNK 96
Query: 139 TLADH------IYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIF 192
L H + + E L SQ L IA IA + YL S+ +HR +
Sbjct: 97 FLRAHGPDAVLMAEGNRPAE-LTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCL 152
Query: 193 LDEGYIAKLFDFSLSVSIPEGETC-VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLL 251
+ E + K+ DF +S + + V + ++ PE I F + DV+S G++L
Sbjct: 153 VGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVL 212
Query: 252 LVLLT 256
+ T
Sbjct: 213 WEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 7e-07
Identities = 44/162 (27%), Positives = 71/162 (43%), Gaps = 11/162 (6%)
Query: 108 KLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIA 167
+ H+N++ L +VFE V+ RTL + + + P + +
Sbjct: 55 RQLRHENIVNLKEAFRRKGRLYLVFEYVE-RTLLELLEASPGGLPPDAVR---SYIWQLL 110
Query: 168 NAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGF 227
AIAY H S I+HR I+P I + E + KL DF + ++ T +
Sbjct: 111 QAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWY 167
Query: 228 LAPEYINTGDFN--EKCDVFSFGMLLLVLLTGQKIFDPSRGD 267
APE + GD N + DV++ G ++ LL G+ +F P D
Sbjct: 168 RAPELL-VGDTNYGKPVDVWAIGCIMAELLDGEPLF-PGDSD 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 8e-07
Identities = 49/229 (21%), Positives = 92/229 (40%), Gaps = 31/229 (13%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAI 170
SH +++L G C + + IV E ++N L +++ Q Q +L L + + +
Sbjct: 57 SHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML---LSMCQDVCEGM 113
Query: 171 AYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAP 230
YL +HR + + + K+ DF ++ + + E + + P
Sbjct: 114 EYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPP 170
Query: 231 EYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290
E N ++ K DV+SFG+L+ + T K+ P E
Sbjct: 171 EVFNFSKYSSKSDVWSFGVLMWEVFTEGKM--P--------------------FEKKSNY 208
Query: 291 EIVDPIIVSEGPRVGKEK-QLQGFRELALMCVCESAEDRPTTVDVAKRL 338
E+V+ ++S G R+ + K E+ C E E RPT ++ + +
Sbjct: 209 EVVE--MISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 8e-07
Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 6/98 (6%)
Query: 161 RIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDK 220
RIAV + + YL +S ILHR ++PS + ++ KL DF +S + +
Sbjct: 99 RIAVAVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKT 152
Query: 221 VTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQ 258
GT ++APE I+ + DV+S G+ + L G+
Sbjct: 153 YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 8e-07
Identities = 58/240 (24%), Positives = 102/240 (42%), Gaps = 37/240 (15%)
Query: 112 HKNVLKLTGCCLETR------IPVIVFESVKNRTLADHIYQNQPHFEPLLL-SQRL-RIA 163
H NV++L G CL+T PV++ +K+ L + ++ P L +Q L +
Sbjct: 59 HPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFM 118
Query: 164 VHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTG 223
IA+ + YL S+ +HR + L+E + DF LS I G+ + ++
Sbjct: 119 TDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAK 175
Query: 224 T-MGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKK 282
+ ++A E + + K DV+SFG+ + + T RG G
Sbjct: 176 MPVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT--------RGQTPYPG---------- 217
Query: 283 CIENNEFDEIVDPIIVSEGPRVGKEKQ-LQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341
+EN+ EI D + +G R+ + L G L C + +DRP+ + L++
Sbjct: 218 -VENS---EIYD--YLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 9e-07
Identities = 52/170 (30%), Positives = 79/170 (46%), Gaps = 24/170 (14%)
Query: 92 LNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHF 151
N+ +D + F +L H N ++ GC L+ +V E + +D + + H
Sbjct: 61 TNEKWQDIIKEVKFLQQLK-HPNTIEYKGCYLKEHTAWLVMEYCLG-SASDLL---EVHK 115
Query: 152 EPLLLSQRLRIA--VHIA-NAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDF-SLS 207
+PL Q + IA H A +AYLH S ++HR I+ I L E KL DF S S
Sbjct: 116 KPL---QEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSAS 169
Query: 208 VSIPEGETCVKDKVTGTMGFLAPEYI---NTGDFNEKCDVFSFGMLLLVL 254
S P + GT ++APE I + G ++ K DV+S G+ + L
Sbjct: 170 KSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 9e-07
Identities = 40/150 (26%), Positives = 69/150 (46%), Gaps = 12/150 (8%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAI 170
SH N+++L G + + +I+ E ++N L ++ + F L LR IA +
Sbjct: 64 SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGM 120
Query: 171 AYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI---PEGE-TCVKDKVTGTMG 226
YL +HR + I ++ K+ DF LS + PEG T K+ +
Sbjct: 121 KYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIR 175
Query: 227 FLAPEYINTGDFNEKCDVFSFGMLLLVLLT 256
+ APE I F DV+SFG+++ +++
Sbjct: 176 WTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 9e-07
Identities = 33/101 (32%), Positives = 54/101 (53%), Gaps = 8/101 (7%)
Query: 161 RIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDK 220
+IAV I A+ YLH S ++HR ++PS + ++ KL DF +S + ++ K
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLV--DSVAKTI 162
Query: 221 VTGTMGFLAPEYIN----TGDFNEKCDVFSFGMLLLVLLTG 257
G ++APE IN ++ K DV+S G+ ++ L TG
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATG 203
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 41/160 (25%), Positives = 68/160 (42%), Gaps = 17/160 (10%)
Query: 111 SHKNVLKLTGCCLETR------IPVIVFESVKNRTLADHIY----QNQPHFEPLLLSQRL 160
H NV+KL G C E P+++ +K+ L + P PL L
Sbjct: 59 DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPL--QTLL 116
Query: 161 RIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDK 220
+ V IA + YL +R +HR + L E + DF LS I G+ + +
Sbjct: 117 KFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGR 173
Query: 221 VTGT-MGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQ 258
+ + ++A E + + K DV++FG+ + + T GQ
Sbjct: 174 IAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 18/154 (11%)
Query: 114 NVLKLTGCCLETRIPVIVFESVKNRTLADHI------YQNQPHFEPLLLSQRLRIAVHIA 167
+V++L G + + +++ E + L ++ +N P P L + +++A IA
Sbjct: 70 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129
Query: 168 NAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGF 227
+ +AYL+ + +HR + + E + K+ DF ++ I E + K G G
Sbjct: 130 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK----GGKGL 182
Query: 228 L-----APEYINTGDFNEKCDVFSFGMLLLVLLT 256
L +PE + G F DV+SFG++L + T
Sbjct: 183 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 50/164 (30%), Positives = 77/164 (46%), Gaps = 24/164 (14%)
Query: 93 NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFE 152
N+ +D + F KL H N ++ GC L +V E + +D + + H +
Sbjct: 56 NEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAWLVMEYCLG-SASDLL---EVHKK 110
Query: 153 PLLLSQRLRIA--VHIA-NAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDF-SLSV 208
PL Q + IA H A +AYLH S ++HR ++ I L E + KL DF S S+
Sbjct: 111 PL---QEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI 164
Query: 209 SIPEGETCVKDKVTGTMGFLAPEYI---NTGDFNEKCDVFSFGM 249
P + GT ++APE I + G ++ K DV+S G+
Sbjct: 165 MAP------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 36/97 (37%), Positives = 55/97 (56%), Gaps = 14/97 (14%)
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFLDE-GYIAKLFDFSLSVSIPEGETCVKDKVT-- 222
+A A+ +LH S I++R ++P I LDE G+I KL DF LS E+ +K
Sbjct: 107 LALALDHLH---SLGIIYRDLKPENILLDEEGHI-KLTDFGLS-----KESIDHEKKAYS 157
Query: 223 --GTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTG 257
GT+ ++APE +N + D +SFG+L+ +LTG
Sbjct: 158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 38/150 (25%), Positives = 71/150 (47%), Gaps = 10/150 (6%)
Query: 114 NVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPH------FEPLLLSQRLRIAVHIA 167
+V++L G + ++V E + L ++ +P P L + +++A IA
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129
Query: 168 NAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKD-KVTGTMG 226
+ +AYL ++ +HR + + E K+ DF ++ I E + K K +
Sbjct: 130 DGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 227 FLAPEYINTGDFNEKCDVFSFGMLLLVLLT 256
++APE + G F K DV+SFG++L + T
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 44/141 (31%), Positives = 68/141 (48%), Gaps = 12/141 (8%)
Query: 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSR 190
V E V L HI Q EP Q + A I+ + +LH R I++R ++
Sbjct: 79 VMEYVNGGDLMYHIQQVGKFKEP----QAVFYAAEISVGLFFLH---RRGIIYRDLKLDN 131
Query: 191 IFLD-EGYIAKLFDFSL-SVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFG 248
+ LD EG+I K+ DF + + +G T GT ++APE I + + D +++G
Sbjct: 132 VMLDSEGHI-KIADFGMCKEHMVDGVT--TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYG 188
Query: 249 MLLLVLLTGQKIFDPSRGDEI 269
+LL +L GQ FD DE+
Sbjct: 189 VLLYEMLAGQPPFDGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 39/166 (23%), Positives = 67/166 (40%), Gaps = 32/166 (19%)
Query: 112 HKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQP------------HFEPLLLSQR 159
HKN++ L G C + +V E + L D + +P E L
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 160 LRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE------- 212
+ A +A + +L S+ +HR + + + E ++ K+ DF L+ I
Sbjct: 135 VSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191
Query: 213 --GETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT 256
G VK ++APE + + + DV+SFG+LL + T
Sbjct: 192 TNGRLPVK--------WMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 33/94 (35%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSV---SIPEGETCVKDKVT 222
I + YLH S I+HR I+ + I D KL DF S +I T +K VT
Sbjct: 113 ILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMK-SVT 168
Query: 223 GTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT 256
GT +++PE I+ + K DV+S G ++ +LT
Sbjct: 169 GTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 38/148 (25%), Positives = 68/148 (45%), Gaps = 19/148 (12%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAI 170
H N+++L G ++R +I+ E ++N +L + +N F L LR IA+ +
Sbjct: 63 DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLR---GIASGM 119
Query: 171 AYL-HIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMG--- 226
YL + + +HR + I ++ + K+ DF LS + + + T G
Sbjct: 120 KYLSEMNY----VHRDLAARNILVNSNLVCKVSDFGLSRRLED-----SEATYTTKGGKI 170
Query: 227 ---FLAPEYINTGDFNEKCDVFSFGMLL 251
+ APE I F DV+SFG+++
Sbjct: 171 PIRWTAPEAIAYRKFTSASDVWSFGIVM 198
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 47/178 (26%), Positives = 78/178 (43%), Gaps = 20/178 (11%)
Query: 112 HKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLR-IAVHIANAI 170
H+N++ L + +VFE V + L D + L R+R I I
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDD-----LEKYPNGLDESRVRKYLFQILRGI 113
Query: 171 AYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAP 230
+ H S I+HR I+P I + + + KL DF + ++ D V T + AP
Sbjct: 114 EFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-ATRWYRAP 169
Query: 231 EYINTGD--FNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIEN 286
E + GD + D+++ G L+ +LTG+ +F P D L+++ KC+ N
Sbjct: 170 ELL-VGDTKYGRAVDIWAVGCLVTEMLTGEPLF-PGDSD------IDQLYHIIKCLGN 219
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 41/183 (22%), Positives = 85/183 (46%), Gaps = 18/183 (9%)
Query: 80 DRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRT 139
R V+V K + E FN ++ + H N++++ L +V E ++
Sbjct: 44 GRQVAVKKMDLRKQQRRELLFNEVVIM-RDYQHPNIVEMYSSYLVGDELWVVMEFLEGGA 102
Query: 140 LADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIA 199
L D + + + E Q + + + A+++LH ++ ++HR I+ I L
Sbjct: 103 LTDIVTHTRMNEE-----QIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRV 154
Query: 200 KLFDF----SLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLL 255
KL DF +S +P ++ V GT ++APE I+ + + D++S G++++ ++
Sbjct: 155 KLSDFGFCAQVSKEVPRRKSLV-----GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMV 209
Query: 256 TGQ 258
G+
Sbjct: 210 DGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 42/181 (23%), Positives = 81/181 (44%), Gaps = 16/181 (8%)
Query: 81 RTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTL 140
+ V+V K + E FN ++ H+NV+ + L +V E ++ L
Sbjct: 48 KQVAVKKMDLRKQQRRELLFNEVVIMRDYH-HENVVDMYNSYLVGDELWVVMEFLEGGAL 106
Query: 141 AD---HIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGY 197
D H N+ + LS + A++YLH ++ ++HR I+ I L
Sbjct: 107 TDIVTHTRMNEEQIATVCLS--------VLRALSYLH---NQGVIHRDIKSDSILLTSDG 155
Query: 198 IAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTG 257
KL DF + + E + + GT ++APE I+ + + D++S G++++ ++ G
Sbjct: 156 RIKLSDFGFCAQVSK-EVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214
Query: 258 Q 258
+
Sbjct: 215 E 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 43/152 (28%), Positives = 69/152 (45%), Gaps = 10/152 (6%)
Query: 112 HKNVLKLTGCCLETRIPV-IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAI 170
H +++KL G E PV IV E L ++ N+ L L+ + + ++ A+
Sbjct: 66 HPHIVKLIGVITEN--PVWIVMELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTAL 120
Query: 171 AYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAP 230
AYL S+ +HR I + + KL DF LS + + K + ++AP
Sbjct: 121 AYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAP 177
Query: 231 EYINTGDFNEKCDVFSFGMLLL-VLLTGQKIF 261
E IN F DV+ FG+ + +L+ G K F
Sbjct: 178 ESINFRRFTSASDVWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 3e-06
Identities = 60/243 (24%), Positives = 108/243 (44%), Gaps = 41/243 (16%)
Query: 112 HKNVLKLTGCCLETR------IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQR--LRIA 163
H NV+KL G L +R IP+++ +K+ L + ++ EP L + +R
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 164 VHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTG 223
+ IA+ + YL S+ +HR + L+E + DF LS I G+ + +
Sbjct: 120 IDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176
Query: 224 -TMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKK 282
+ +LA E + + DV++FG+ + ++T RG AG
Sbjct: 177 LPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT--------RGQTPYAG---------- 218
Query: 283 CIENNEFDEIVDPIIVSEGPRVGKEKQLQGFREL-ALMCVCESAED--RPTTVDVAKRLK 339
+EN+ EI + +I +G R+ ++ ++ LMC C S E RP+ + +L+
Sbjct: 219 -VENS---EIYNYLI--KGNRL--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLE 270
Query: 340 QIY 342
I+
Sbjct: 271 LIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-06
Identities = 38/142 (26%), Positives = 68/142 (47%), Gaps = 12/142 (8%)
Query: 112 HKNVLKLTGCCLETRIPV-IVFESVKNRTLADHIYQNQPHFEPLLLSQRL-RIAVHIANA 169
H N+++L G +E + + IV E + +L D++ + +L L + ++ + A
Sbjct: 58 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEA 114
Query: 170 IAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLA 229
+ YL + +HR + + + E +AK+ DF L+ + K V T A
Sbjct: 115 MEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----A 167
Query: 230 PEYINTGDFNEKCDVFSFGMLL 251
PE + F+ K DV+SFG+LL
Sbjct: 168 PEALREKKFSTKSDVWSFGILL 189
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 31/114 (27%), Positives = 53/114 (46%), Gaps = 17/114 (14%)
Query: 162 IAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS---VSIPEGETCVK 218
I + I N + LH +HR + P+ IF++ I K+ DF L+ P +T K
Sbjct: 124 ILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 219 DKVTG----------TMGFLAPEYINTGD-FNEKCDVFSFGMLLLVLLTGQKIF 261
D+ T+ + APE + + ++ D++S G + LLTG+ +F
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF 234
|
Length = 335 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 4e-06
Identities = 32/146 (21%), Positives = 68/146 (46%), Gaps = 8/146 (5%)
Query: 112 HKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIA 171
H +++L G C + ++ + +L DH+ Q++ +P L L V IA +
Sbjct: 68 HAYIVRLLGICPGASLQLVT-QLSPLGSLLDHVRQHRDSLDPQRL---LNWCVQIAKGMY 123
Query: 172 YLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS-VSIPEGETCVKDKVTGTMGFLAP 230
YL ++HR + I L I ++ DF ++ + P+ + + + ++A
Sbjct: 124 YLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMAL 180
Query: 231 EYINTGDFNEKCDVFSFGMLLLVLLT 256
E I G + + DV+S+G+ + +++
Sbjct: 181 ESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 4e-06
Identities = 39/178 (21%), Positives = 82/178 (46%), Gaps = 10/178 (5%)
Query: 81 RTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTL 140
+ V+V K + E FN ++ H+NV+++ L +V E ++ L
Sbjct: 46 KLVAVKKMDLRKQQRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELWVVMEFLEGGAL 104
Query: 141 ADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAK 200
D + + + E Q + + + A++ LH ++ ++HR I+ I L K
Sbjct: 105 TDIVTHTRMNEE-----QIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVK 156
Query: 201 LFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQ 258
L DF + + E + + GT ++APE I+ + + D++S G++++ ++ G+
Sbjct: 157 LSDFGFCAQVSK-EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 4e-06
Identities = 44/154 (28%), Positives = 70/154 (45%), Gaps = 13/154 (8%)
Query: 107 SKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLL-LSQRLRIAVH 165
SKL H N+++ G E I E V +LA + + EP++ L R
Sbjct: 57 SKLQ-HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-----Q 110
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTM 225
I + YLH R +HR I+ + I +D + KL DF ++ + E K G+
Sbjct: 111 ILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFK--GSP 165
Query: 226 GFLAPEYIN-TGDFNEKCDVFSFGMLLLVLLTGQ 258
++APE I G + D++S G +L + TG+
Sbjct: 166 YWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 4e-06
Identities = 28/108 (25%), Positives = 55/108 (50%), Gaps = 5/108 (4%)
Query: 154 LLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213
L + + + + I I +LH S I++R ++P + LD+ +L D L+V + +G
Sbjct: 92 LEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG 148
Query: 214 ETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIF 261
+T + GT G++APE + ++ D F+ G + ++ G+ F
Sbjct: 149 KTITQR--AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 5e-06
Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 31/207 (14%)
Query: 75 KGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTG---------CCLET 125
KG E + ++K + ++ D +C K VL L+G C +T
Sbjct: 22 KGTDELYAIKILKKDVVIQDDDVEC---------TMVEKRVLALSGKPPFLTQLHSCFQT 72
Query: 126 RIPV-IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHR 184
+ V E V L I Q EP + A IA + +LH S+ I++R
Sbjct: 73 MDRLYFVMEYVNGGDLMYQIQQVGRFKEP----HAVFYAAEIAIGLFFLH---SKGIIYR 125
Query: 185 KIRPSRIFLD-EGYIAKLFDFSL-SVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKC 242
++ + LD EG+I K+ DF + ++ +G T GT ++APE I + +
Sbjct: 126 DLKLDNVMLDSEGHI-KIADFGMCKENMWDGVT--TKTFCGTPDYIAPEIIAYQPYGKSV 182
Query: 243 DVFSFGMLLLVLLTGQKIFDPSRGDEI 269
D ++FG+LL +L GQ F+ DE+
Sbjct: 183 DWWAFGVLLYEMLAGQAPFEGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 5e-06
Identities = 27/111 (24%), Positives = 56/111 (50%), Gaps = 5/111 (4%)
Query: 161 RIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDK 220
++++ + +AYL I+HR ++PS I ++ KL DF +S + + + +
Sbjct: 107 KVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS 161
Query: 221 VTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGA 271
GT +++PE + ++ + D++S G+ L+ L G+ P E+ A
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEA 212
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 7e-06
Identities = 34/108 (31%), Positives = 54/108 (50%), Gaps = 6/108 (5%)
Query: 163 AVHIANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIAKLFDFSLSVSIPEGETCVKDKV 221
A I + +LH + I++R ++ + LD +G+I K+ DF + GE
Sbjct: 102 AAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHI-KIADFGMCKENMNGEG-KASTF 156
Query: 222 TGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEI 269
GT ++APE + +NE D +SFG+LL +L GQ F DE+
Sbjct: 157 CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 7e-06
Identities = 39/177 (22%), Positives = 73/177 (41%), Gaps = 29/177 (16%)
Query: 169 AIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFL 228
A+ Y+H ++HR I+ + I + KL DF ++ + + + + GT ++
Sbjct: 113 ALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN-SSKRSTFVGTPYWM 168
Query: 229 APEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENN 287
APE I G ++ K D++S G+ + + TG +P D
Sbjct: 169 APEVITEGKYYDTKADIWSLGITIYEMATG----NPPYSDV------------------- 205
Query: 288 EFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344
+ + I S+ PR+ + RE C+ E ++R + ++ K K I H
Sbjct: 206 DAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK-SKWIKAH 261
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 7e-06
Identities = 50/169 (29%), Positives = 79/169 (46%), Gaps = 24/169 (14%)
Query: 93 NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFE 152
N+ +D + F ++ H N ++ GC L +V E + +D + + H +
Sbjct: 66 NEKWQDIIKEVKFLQRIK-HPNSIEYKGCYLREHTAWLVMEYCLG-SASDLL---EVHKK 120
Query: 153 PLLLSQRLRIA--VHIA-NAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDF-SLSV 208
PL Q + IA H A +AYLH S ++HR I+ I L E KL DF S S+
Sbjct: 121 PL---QEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASI 174
Query: 209 SIPEGETCVKDKVTGTMGFLAPEYI---NTGDFNEKCDVFSFGMLLLVL 254
+ P + GT ++APE I + G ++ K DV+S G+ + L
Sbjct: 175 ASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 8e-06
Identities = 35/111 (31%), Positives = 57/111 (51%), Gaps = 21/111 (18%)
Query: 155 LLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE 214
L+ Q LR + Y+H S I+HR ++PS I ++E K+ DF L+
Sbjct: 123 LVYQILR-------GLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARH----- 167
Query: 215 TCVKDKVTG---TMGFLAPEYI-NTGDFNEKCDVFSFGMLLLVLLTGQKIF 261
D++TG T + APE + N +N+ D++S G ++ LLTG+ +F
Sbjct: 168 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLF 216
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 8e-06
Identities = 34/98 (34%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIAKLFDFSL-SVSIPEGETCVKDKVTG 223
I+ A+ +LH + I++R ++P I LD +G++ KL DF L SI EG V G
Sbjct: 109 ISLALEHLH---QQGIIYRDLKPENILLDAQGHV-KLTDFGLCKESIHEGT--VTHTFCG 162
Query: 224 TMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIF 261
T+ ++APE + + D +S G L+ +LTG F
Sbjct: 163 TIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPF 200
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 9e-06
Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 1/93 (1%)
Query: 178 SRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETC-VKDKVTGTMGFLAPEYINTG 236
SR ++HR ++ + IFL I KL DF S + + V GT +LAPE
Sbjct: 187 SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERK 246
Query: 237 DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEI 269
+++K D++S G++L LLT + F EI
Sbjct: 247 RYSKKADMWSLGVILYELLTLHRPFKGPSQREI 279
|
Length = 478 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 9e-06
Identities = 37/116 (31%), Positives = 52/116 (44%), Gaps = 13/116 (11%)
Query: 156 LSQRLRIAVH--------IANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS 207
LSQR R I A+ +LH I++R I+ I LD L DF LS
Sbjct: 96 LSQRERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLS 152
Query: 208 VSIPEGETCVKDKVTGTMGFLAPEYINTGD--FNEKCDVFSFGMLLLVLLTGQKIF 261
E E GT+ ++AP+ + GD ++ D +S G+L+ LLTG F
Sbjct: 153 KEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 9e-06
Identities = 30/109 (27%), Positives = 55/109 (50%), Gaps = 4/109 (3%)
Query: 154 LLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213
L +Q + V IA A+ YLH + ILHR ++ +FL I K+ D ++ + E
Sbjct: 99 LPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIA-RVLEN 154
Query: 214 ETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFD 262
+ + + GT +++PE + +N K DV++ G + + T + F+
Sbjct: 155 QCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 9e-06
Identities = 50/186 (26%), Positives = 82/186 (44%), Gaps = 32/186 (17%)
Query: 112 HKNVLKLTGCCLETRIPVIVFESVKNRTLADHIY--QNQPHFEPLL-LSQRLRIAVHIAN 168
H N++KL G CL I+ E ++ L ++ + + PLL L + L I + +A
Sbjct: 58 HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117
Query: 169 AIAYLHIGFSRPILHRKIRPSRIFLDE-GY----IAKLFDFSLSVSI-------PEGETC 216
YL +HR + + E GY + K+ DF L+ I EGE
Sbjct: 118 GCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174
Query: 217 VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYW 275
+ + ++APE + G F + DV+SFG+L+ +LT GQ+ + E+
Sbjct: 175 LPVR------WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV------ 222
Query: 276 LLHYVK 281
L +V
Sbjct: 223 -LQHVT 227
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 49/199 (24%), Positives = 90/199 (45%), Gaps = 19/199 (9%)
Query: 64 VIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCL 123
++ +G A KG E R V+V N+ + F N K + +V++L G
Sbjct: 21 MVYEGNARDIIKGEAETR-VAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS 79
Query: 124 ETRIPVIVFESVKNRTLADHIY------QNQPHFEPLLLSQRLRIAVHIANAIAYLHIGF 177
+ + ++V E + + L ++ +N P P L + +++A IA+ +AYL+
Sbjct: 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN--- 136
Query: 178 SRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFL-----APEY 232
++ +HR + + + K+ DF ++ I E + K G G L APE
Sbjct: 137 AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK----GGKGLLPVRWMAPES 192
Query: 233 INTGDFNEKCDVFSFGMLL 251
+ G F D++SFG++L
Sbjct: 193 LKDGVFTTSSDMWSFGVVL 211
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 49/212 (23%), Positives = 82/212 (38%), Gaps = 28/212 (13%)
Query: 55 ATNNFDARNVIKDGYAYKFYKGF-VEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHK 113
T F+ VI +G K YK + + +K DI+ D E+ K S+H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHP 63
Query: 114 NVLKLTGCCLETRIPV------IVFESVKNRTLADHI----YQNQPHFEPLLLSQRLRIA 163
N+ G ++ P +V E ++ D + + + E + I
Sbjct: 64 NIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY----IL 119
Query: 164 VHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS--VSIPEGETCVKDKV 221
+AYLH ++HR I+ I L + KL DF +S + G ++
Sbjct: 120 RETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGR---RNTF 173
Query: 222 TGTMGFLAPEYIN-----TGDFNEKCDVFSFG 248
GT ++APE I ++ + DV+S G
Sbjct: 174 IGTPYWMAPEVIACDEQPDASYDARSDVWSLG 205
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 38/145 (26%), Positives = 67/145 (46%), Gaps = 6/145 (4%)
Query: 107 SKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHI 166
SKL H ++K LE I+ E + R L + + + + L +Q + +
Sbjct: 57 SKLD-HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQL 115
Query: 167 ANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMG 226
+ Y+H R ILHR ++ IFL + K+ DF +S + G + TGT
Sbjct: 116 LLGVHYMHQ---RRILHRDLKAKNIFLKNN-LLKIGDFGVS-RLLMGSCDLATTFTGTPY 170
Query: 227 FLAPEYINTGDFNEKCDVFSFGMLL 251
+++PE + ++ K D++S G +L
Sbjct: 171 YMSPEALKHQGYDSKSDIWSLGCIL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 36/109 (33%), Positives = 57/109 (52%), Gaps = 18/109 (16%)
Query: 163 AVHIANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIAKLFDFSLSVSIPEGETCVKDK- 220
A I A+ YLH S+ I++R ++P I LD EG+I KL DF + ++D+
Sbjct: 107 ASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHI-KLTDFGFAKK-------LRDRT 155
Query: 221 --VTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGD 267
+ GT +LAPE I + N+ D ++ G+L+ +L G + P D
Sbjct: 156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG---YPPFFDD 201
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 1e-05
Identities = 30/106 (28%), Positives = 52/106 (49%), Gaps = 4/106 (3%)
Query: 153 PLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212
PL +Q I I + YLH S +HR I+ + + L E KL DF ++ + +
Sbjct: 97 PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153
Query: 213 GETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQ 258
+ ++ GT ++APE I ++ K D++S G+ + L G+
Sbjct: 154 TQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 42/160 (26%), Positives = 73/160 (45%), Gaps = 26/160 (16%)
Query: 112 HKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLR------IAVH 165
H+NV+ L L+ P E + L H+ ++ Q+L +
Sbjct: 75 HENVIGL----LDVFTPARSLEEFNDVYLVTHLMGAD--LNNIVKCQKLTDDHVQFLIYQ 128
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTG-- 223
I + Y+H S I+HR ++PS + ++E K+ DF L+ D++TG
Sbjct: 129 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH-------TDDEMTGYV 178
Query: 224 -TMGFLAPE-YINTGDFNEKCDVFSFGMLLLVLLTGQKIF 261
T + APE +N +N+ D++S G ++ LLTG+ +F
Sbjct: 179 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 218
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 28/100 (28%), Positives = 49/100 (49%), Gaps = 7/100 (7%)
Query: 163 AVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVT 222
A I + ++H +R +++R ++P+ I LDE ++ D L+ + +
Sbjct: 103 ATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---V 156
Query: 223 GTMGFLAPEYINTGD-FNEKCDVFSFGMLLLVLLTGQKIF 261
GT G++APE + G ++ D FS G +L LL G F
Sbjct: 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 50/172 (29%), Positives = 76/172 (44%), Gaps = 30/172 (17%)
Query: 84 SVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADH 143
S K+ DI+ + + F +L H N ++ GC L +V E + +D
Sbjct: 55 SNEKWQDIIKE--------VRFLQQLR-HPNTIEYKGCYLREHTAWLVMEYCLG-SASDI 104
Query: 144 IYQNQPHFEPLLLSQRLRIAVHIANAI---AYLHIGFSRPILHRKIRPSRIFLDEGYIAK 200
+ + H +PL Q + IA A+ AYLH S +HR I+ I L E K
Sbjct: 105 L---EVHKKPL---QEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVK 155
Query: 201 LFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYI---NTGDFNEKCDVFSFGM 249
L DF S S+ + GT ++APE I + G ++ K DV+S G+
Sbjct: 156 LADFG-SASL----VSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 38/156 (24%), Positives = 71/156 (45%), Gaps = 12/156 (7%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRI--AVHIAN 168
H+N+++ G E I E V +L+ + + + PL +++ I I
Sbjct: 63 KHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALL---RSKWGPLKDNEQTIIFYTKQILE 119
Query: 169 AIAYLHIGFSRPILHRKIRPSRIFLDE-GYIAKLFDFSLSVSIPEGETCVKDKVTGTMGF 227
+ YLH I+HR I+ + ++ + K+ DF S + G + TGT+ +
Sbjct: 120 GLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA-GINPCTETFTGTLQY 175
Query: 228 LAPEYINTG--DFNEKCDVFSFGMLLLVLLTGQKIF 261
+APE I+ G + D++S G ++ + TG+ F
Sbjct: 176 MAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 7/99 (7%)
Query: 162 IAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKV 221
IAV A+ YL I+HR ++PS I LD KL DF +S + ++ K +
Sbjct: 112 IAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLV--DSIAKTRD 167
Query: 222 TGTMGFLAPEYINTGD---FNEKCDVFSFGMLLLVLLTG 257
G ++APE I+ ++ + DV+S G+ L + TG
Sbjct: 168 AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 2e-05
Identities = 36/143 (25%), Positives = 68/143 (47%), Gaps = 10/143 (6%)
Query: 112 HKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIA 171
H N++ L G +++ +IV E ++N +L + ++ F + L LR IA+ +
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR---GIASGMK 120
Query: 172 YLH-IGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMG--FL 228
YL +G+ +HR + I ++ + K+ DF LS + + G + +
Sbjct: 121 YLSDMGY----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 176
Query: 229 APEYINTGDFNEKCDVFSFGMLL 251
APE I F DV+S+G+++
Sbjct: 177 APEAIAYRKFTSASDVWSYGIVM 199
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 30/93 (32%), Positives = 45/93 (48%), Gaps = 9/93 (9%)
Query: 170 IAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDK-VTGTMGFL 228
+AYLH +HR I+ + I L E KL DF +S + T K K GT ++
Sbjct: 114 LAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQL--TATIAKRKSFIGTPYWM 168
Query: 229 APEYIN---TGDFNEKCDVFSFGMLLLVLLTGQ 258
APE G ++ KCD+++ G+ + L Q
Sbjct: 169 APEVAAVERKGGYDGKCDIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 3e-05
Identities = 40/150 (26%), Positives = 69/150 (46%), Gaps = 13/150 (8%)
Query: 112 HKNVLKLTGCCLE--TRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANA 169
H+ +++ GC + + I E + ++ D + + L S + I
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEG 118
Query: 170 IAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS---VSIPEGETCVKDKVTGTMG 226
++YLH S I+HR I+ + I D KL DF S +I T ++ VTGT
Sbjct: 119 MSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIR-SVTGTPY 174
Query: 227 FLAPEYINTGDFNEKCDVFSFGMLLLVLLT 256
+++PE I+ + K DV+S G ++ +LT
Sbjct: 175 WMSPEVISGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 33/99 (33%), Positives = 48/99 (48%), Gaps = 7/99 (7%)
Query: 161 RIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE---GETCV 217
R I ++YLH S I+HR I+ + I D KL DF S I T +
Sbjct: 110 RYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGI 166
Query: 218 KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT 256
K VTGT +++PE I+ + K DV+S ++ +LT
Sbjct: 167 K-SVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 3e-05
Identities = 50/192 (26%), Positives = 81/192 (42%), Gaps = 17/192 (8%)
Query: 83 VSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLET--RIPVIVFESVKNRTL 140
V V+K + IL D +C L+ + L CC +T R+ V E V L
Sbjct: 25 VKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRL-FFVMEFVNGGDL 83
Query: 141 ADHIYQNQPHFEPLLLSQRLRI-AVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIA 199
HI +++ E R R A I +A+ +LH + I++R ++ + LD
Sbjct: 84 MFHIQKSRRFDEA-----RARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHC 135
Query: 200 KLFDFSLSVSIPEG--ETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTG 257
KL DF + EG GT ++APE + + D ++ G+LL +L G
Sbjct: 136 KLADFGMC---KEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192
Query: 258 QKIFDPSRGDEI 269
F+ D++
Sbjct: 193 HAPFEAENEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 4e-05
Identities = 41/161 (25%), Positives = 64/161 (39%), Gaps = 24/161 (14%)
Query: 111 SHKNVLKLTGCCLETRIPVI--VFESVKNRTLADH-----IYQNQPHFEPLLLSQRLRIA 163
H N+++L I VFE DH + + F SQ
Sbjct: 56 RHPNIVRLKEIVTSKGKGSIYMVFE------YMDHDLTGLLDSPEVKFTE---SQIKCYM 106
Query: 164 VHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI-PEGETCVKDKVT 222
+ + YLH S ILHR I+ S I ++ + KL DF L+ ++V
Sbjct: 107 KQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI 163
Query: 223 GTMGFLAPEYINTG--DFNEKCDVFSFGMLLLVLLTGQKIF 261
T+ + PE + G + + D++S G +L L G+ IF
Sbjct: 164 -TLWYRPPE-LLLGATRYGPEVDMWSVGCILAELFLGKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 27/101 (26%), Positives = 47/101 (46%), Gaps = 4/101 (3%)
Query: 165 HIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGT 224
+ A + L S ++HR ++P + LD+ KL DF + + E D GT
Sbjct: 147 YTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGT 206
Query: 225 MGFLAPEYINT----GDFNEKCDVFSFGMLLLVLLTGQKIF 261
+++PE + + G + +CD +S G+ L +L G F
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 4e-05
Identities = 34/98 (34%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 163 AVHIANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIAKLFDFSLSVSIPEGETCVKDKV 221
A IA+A+ YLH S I++R ++P I LD +G++ L DF L EG K
Sbjct: 102 AAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVV-LTDFGLC---KEGIEHSKTTS 154
Query: 222 T--GTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTG 257
T GT +LAPE + ++ D + G +L +L G
Sbjct: 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 4e-05
Identities = 42/159 (26%), Positives = 80/159 (50%), Gaps = 13/159 (8%)
Query: 112 HKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIA 171
H ++++L G CL I ++ + + + L D++++++ + LL L V IA +
Sbjct: 68 HPHLVRLLGVCLSPTIQLVT-QLMPHGCLLDYVHEHKDNIGSQLL---LNWCVQIAKGMM 123
Query: 172 YLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTM--GFLA 229
YL R ++HR + + + K+ DF L+ + EG+ + G M ++A
Sbjct: 124 YLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLA-RLLEGDEKEYNADGGKMPIKWMA 179
Query: 230 PEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFD--PSR 265
E I+ F + DV+S+G+ + L+T G K +D P+R
Sbjct: 180 LECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR 218
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 4e-05
Identities = 25/90 (27%), Positives = 44/90 (48%), Gaps = 4/90 (4%)
Query: 169 AIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFL 228
A+ +LH S ++HR I+ I L KL DF I E + + GT ++
Sbjct: 128 ALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTMVGTPYWM 183
Query: 229 APEYINTGDFNEKCDVFSFGMLLLVLLTGQ 258
APE + + K D++S G++ + ++ G+
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 4e-05
Identities = 25/101 (24%), Positives = 47/101 (46%)
Query: 161 RIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDK 220
++ +I I +H I+HR I+P + + + KL DF + ++ EG +
Sbjct: 101 KVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTE 160
Query: 221 VTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIF 261
T + +PE + + + D++S G +L L GQ +F
Sbjct: 161 YVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 4e-05
Identities = 41/178 (23%), Positives = 82/178 (46%), Gaps = 10/178 (5%)
Query: 81 RTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTL 140
R V+V K D+ + N + + H+NV+++ L ++ E ++ L
Sbjct: 47 RQVAV-KMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105
Query: 141 ADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAK 200
D + Q + + E Q + + A+ YLH S+ ++HR I+ I L K
Sbjct: 106 TDIVSQTRLNEE-----QIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVK 157
Query: 201 LFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQ 258
L DF I + + + + GT ++APE I+ + + D++S G++++ ++ G+
Sbjct: 158 LSDFGFCAQISK-DVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 5e-05
Identities = 47/211 (22%), Positives = 89/211 (42%), Gaps = 18/211 (8%)
Query: 59 FDARNVIKDGYAYKFYKG-FVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLK 117
F+ ++ +G + YKG V+ ++ +K D+ D E+ I K S H+N+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 118 LTGCCLETRIP------VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIA 171
G ++ P +V E ++ D I + + L I I ++
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN--TLKEEWIAYICREILRGLS 125
Query: 172 YLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPE 231
+LH ++HR I+ + L E KL DF +S + + ++ GT ++APE
Sbjct: 126 HLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL-DRTVGRRNTFIGTPYWMAPE 181
Query: 232 YINTGD-----FNEKCDVFSFGMLLLVLLTG 257
I + ++ K D++S G+ + + G
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-05
Identities = 36/162 (22%), Positives = 68/162 (41%), Gaps = 18/162 (11%)
Query: 109 LSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQP------------HFEPLLL 156
+ HKN++ L G C + ++ E L + + +P E L
Sbjct: 74 IGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133
Query: 157 SQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETC 216
+ A +A + YL SR +HR + + + E + K+ DF L+ + + +
Sbjct: 134 KDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDY- 189
Query: 217 VKDKVTGTM--GFLAPEYINTGDFNEKCDVFSFGMLLLVLLT 256
K G + ++APE + + + DV+SFG+L+ + T
Sbjct: 190 YKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 6e-05
Identities = 33/102 (32%), Positives = 54/102 (52%), Gaps = 10/102 (9%)
Query: 163 AVHIANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIAKLFDFSLSVS--IPEGETCVKD 219
A I + +LH S+ I++R ++ I LD +G+I K+ DF + + + +TC
Sbjct: 102 AAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHI-KIADFGMCKENMLGDAKTCT-- 155
Query: 220 KVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIF 261
GT ++APE + +N D +SFG+LL +L GQ F
Sbjct: 156 -FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 6e-05
Identities = 41/131 (31%), Positives = 61/131 (46%), Gaps = 16/131 (12%)
Query: 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRI-AVHIANAIAYLHIGFSRPILHRKIRPS 189
V + V L H+ + + EP R R A +A+AI YLH S I++R ++P
Sbjct: 74 VLDYVNGGELFFHLQRERCFLEP-----RARFYAAEVASAIGYLH---SLNIIYRDLKPE 125
Query: 190 RIFLD-EGYIAKLFDFSLSVS--IPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFS 246
I LD +G++ L DF L PE T GT +LAPE + ++ D +
Sbjct: 126 NILLDSQGHVV-LTDFGLCKEGVEPEETT---STFCGTPEYLAPEVLRKEPYDRTVDWWC 181
Query: 247 FGMLLLVLLTG 257
G +L +L G
Sbjct: 182 LGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 6e-05
Identities = 44/150 (29%), Positives = 64/150 (42%), Gaps = 13/150 (8%)
Query: 104 IFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIA 163
IF K H N++ G L I E +L D IY PL Q +
Sbjct: 57 IFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQD-IYHVT---GPLSELQIAYVC 112
Query: 164 VHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDK-VT 222
+AYLH S+ +HR I+ + I L + KL DF ++ I T K K
Sbjct: 113 RETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKIT--ATIAKRKSFI 167
Query: 223 GTMGFLAPEYI---NTGDFNEKCDVFSFGM 249
GT ++APE G +N+ CD+++ G+
Sbjct: 168 GTPYWMAPEVAAVEKNGGYNQLCDIWAVGI 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 7e-05
Identities = 41/136 (30%), Positives = 63/136 (46%), Gaps = 14/136 (10%)
Query: 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAV-HIANAIAYLH-IGFSRPILHRKIR 187
++ + V + H+YQ +F +R I A+ +LH +G I++R I+
Sbjct: 82 LILDYVSGGEMFTHLYQRD-NFS----EDEVRFYSGEIILALEHLHKLG----IVYRDIK 132
Query: 188 PSRIFLD-EGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVF 245
I LD EG++ L DF LS E GT+ ++APE I G + D +
Sbjct: 133 LENILLDSEGHVV-LTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWW 191
Query: 246 SFGMLLLVLLTGQKIF 261
S G+L+ LLTG F
Sbjct: 192 SLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 7e-05
Identities = 36/159 (22%), Positives = 68/159 (42%), Gaps = 22/159 (13%)
Query: 112 HKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFE------------------P 153
H N++KL G C + ++FE + L + + P + P
Sbjct: 67 HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLP 126
Query: 154 LLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213
L +++L IA +A +AYL R +HR + + E + K+ DF LS +I
Sbjct: 127 LSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 183
Query: 214 ETCVKDKVTGT-MGFLAPEYINTGDFNEKCDVFSFGMLL 251
+ + + ++ PE I + + DV+++G++L
Sbjct: 184 DYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 222
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 8e-05
Identities = 38/114 (33%), Positives = 54/114 (47%), Gaps = 11/114 (9%)
Query: 152 EPLLLSQRLRI-AVHIANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIAKLFDFSLSVS 209
E L R R A IA+A+ YLH S I++R ++P I LD +G+I L DF L
Sbjct: 90 ERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIV-LTDFGLCKE 145
Query: 210 --IPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIF 261
G T GT +LAPE ++ ++ D + G +L +L G F
Sbjct: 146 NIEHNGTTST---FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 8e-05
Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 15/204 (7%)
Query: 59 FDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDI----LNDGHEDCFNNIIFASKLSSHKN 114
F I G + +KG +++RT V+ I D ED I S+ S
Sbjct: 6 FTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PY 63
Query: 115 VLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLH 174
V K G L+ I+ E + + D + + P F+ ++ L+ I + YLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALD-LLRAGP-FDEFQIATMLK---EILKGLDYLH 118
Query: 175 IGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYIN 234
S +HR I+ + + L E KL DF ++ + + + ++ GT ++APE I
Sbjct: 119 ---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIQ 174
Query: 235 TGDFNEKCDVFSFGMLLLVLLTGQ 258
++ K D++S G+ + L G+
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 8e-05
Identities = 40/193 (20%), Positives = 78/193 (40%), Gaps = 19/193 (9%)
Query: 79 EDRTVSV-MKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKN 137
E TV+V M +D D + + + HKN++ L G C + ++ E
Sbjct: 46 EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 105
Query: 138 RTLADHIYQNQP------------HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRK 185
L +++ +P E + + +A + YL S+ +HR
Sbjct: 106 GNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRD 162
Query: 186 IRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTM--GFLAPEYINTGDFNEKCD 243
+ + + E + K+ DF L+ + + K G + ++APE + + + D
Sbjct: 163 LAARNVLVTENNVMKIADFGLARDVNNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSD 221
Query: 244 VFSFGMLLLVLLT 256
V+SFG+L+ + T
Sbjct: 222 VWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 8e-05
Identities = 37/162 (22%), Positives = 69/162 (42%), Gaps = 18/162 (11%)
Query: 109 LSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQP----------HFEPLLLSQ 158
+ HKN++ L G C + ++ E L +++ +P LS
Sbjct: 80 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSF 139
Query: 159 R--LRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETC 216
+ + A +A + YL S+ +HR + + + E + K+ DF L+ I +
Sbjct: 140 KDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY- 195
Query: 217 VKDKVTGTM--GFLAPEYINTGDFNEKCDVFSFGMLLLVLLT 256
K G + ++APE + + + DV+SFG+LL + T
Sbjct: 196 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 30/112 (26%), Positives = 52/112 (46%), Gaps = 10/112 (8%)
Query: 163 AVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVT 222
A I + ++H +R +++R ++P+ I LDE ++ D L+ + +
Sbjct: 103 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---V 156
Query: 223 GTMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGH 273
GT G++APE + G ++ D FS G +L LL G P R + H
Sbjct: 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS---PFRQHKTKDKH 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 1e-04
Identities = 25/90 (27%), Positives = 44/90 (48%), Gaps = 4/90 (4%)
Query: 169 AIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFL 228
A+ +LH S ++HR I+ I L KL DF I E + + GT ++
Sbjct: 127 ALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTMVGTPYWM 182
Query: 229 APEYINTGDFNEKCDVFSFGMLLLVLLTGQ 258
APE + + K D++S G++ + ++ G+
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 26/94 (27%), Positives = 49/94 (52%), Gaps = 3/94 (3%)
Query: 179 RPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGT--MGFLAPEYINTG 236
+ +HR + + L + AK+ DF LS ++ ++ K + G + + APE IN
Sbjct: 114 KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR 173
Query: 237 DFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEI 269
F+ + DV+S+G+ + + GQK + +G E+
Sbjct: 174 KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV 207
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 4/101 (3%)
Query: 152 EPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211
PL L Q + I + A+AYLH R I+HR ++ IFLDE A L DF + +
Sbjct: 180 GPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236
Query: 212 EGETCVKD-KVTGTMGFLAPEYINTGDFNEKCDVFSFGMLL 251
+ +GT+ +PE + + K D++S G++L
Sbjct: 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVL 277
|
Length = 392 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 1e-04
Identities = 31/119 (26%), Positives = 53/119 (44%), Gaps = 14/119 (11%)
Query: 97 EDCFN--NIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPL 154
E+C N + KL+ H N++KL E VFE ++ ++YQ +
Sbjct: 40 EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEG-----NLYQLMKDRKGK 94
Query: 155 LLSQ-RLR-IAVHIANAIAYLH-IGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI 210
S+ +R I I +A++H GF HR ++P + + + K+ DF L+ I
Sbjct: 95 PFSESVIRSIIYQILQGLAHIHKHGF----FHRDLKPENLLVSGPEVVKIADFGLAREI 149
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 1e-04
Identities = 30/98 (30%), Positives = 50/98 (51%), Gaps = 13/98 (13%)
Query: 163 AVHIANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIAKLFDFSLSVSIPEG--ETCVKD 219
A + A+ YLH S I++R ++P + LD +GYI K+ DF + + C
Sbjct: 107 AAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYI-KITDFGFAKRVKGRTYTLC--- 159
Query: 220 KVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTG 257
GT +LAPE I + + + D ++ G+L+ +L G
Sbjct: 160 ---GTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 40/176 (22%), Positives = 78/176 (44%), Gaps = 13/176 (7%)
Query: 90 DILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQ- 148
D+ D I S+L + N+++L G C+ ++ E ++N L + Q +
Sbjct: 55 DVTKTARNDFLKEIKIMSRLK-NPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREI 113
Query: 149 -------PHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKL 201
+ + ++ L +AV IA+ + YL S +HR + + Y K+
Sbjct: 114 ESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLVGNHYTIKI 170
Query: 202 FDFSLSVSIPEGETC-VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT 256
DF +S ++ G+ ++ + + ++A E I G F DV++FG+ L + T
Sbjct: 171 ADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 1e-04
Identities = 30/100 (30%), Positives = 51/100 (51%), Gaps = 4/100 (4%)
Query: 153 PLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI-P 211
PL L LR + +A + +L S+ +HR + + L +G +AK+ DF L+ I
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264
Query: 212 EGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLL 251
+ VK + ++APE I + + DV+S+G+LL
Sbjct: 265 DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 304
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 47/200 (23%), Positives = 78/200 (39%), Gaps = 23/200 (11%)
Query: 72 KFYKGFV------EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLET 125
K YKG + + V++ DI N F H N++ L G +
Sbjct: 20 KIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE 79
Query: 126 RIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQR-------------LRIAVHIANAIAY 172
+ ++FE + L + + PH + S L IA+ IA + Y
Sbjct: 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEY 139
Query: 173 LHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETC-VKDKVTGTMGFLAPE 231
L F +H+ + I + E K+ D LS I + V+ K + ++ PE
Sbjct: 140 LSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPE 196
Query: 232 YINTGDFNEKCDVFSFGMLL 251
I G F+ D++SFG++L
Sbjct: 197 AIMYGKFSSDSDIWSFGVVL 216
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 24/109 (22%), Positives = 54/109 (49%), Gaps = 5/109 (4%)
Query: 161 RIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDK 220
++++ + + YL I+HR ++PS I ++ KL DF +S + + + +
Sbjct: 107 KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS 161
Query: 221 VTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEI 269
GT +++PE + ++ + D++S G+ L+ + G+ P E+
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 30/102 (29%), Positives = 54/102 (52%), Gaps = 8/102 (7%)
Query: 163 AVHIANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIAKLFDFSL-SVSIPEGETCVKDK 220
+ I+ A+ YLH R I++R ++ + LD EG+I KL D+ + + G+T
Sbjct: 102 SAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHI-KLTDYGMCKEGLRPGDT--TST 155
Query: 221 VTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFD 262
GT ++APE + D+ D ++ G+L+ ++ G+ FD
Sbjct: 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 31/101 (30%), Positives = 49/101 (48%), Gaps = 4/101 (3%)
Query: 152 EPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211
EPL L + + +A + +L SR +HR + I L E + K+ DF L+ I
Sbjct: 168 EPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIY 224
Query: 212 EGETCV-KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLL 251
+ V K + ++APE I + + DV+SFG+LL
Sbjct: 225 KDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLL 265
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 39/163 (23%), Positives = 72/163 (44%), Gaps = 18/163 (11%)
Query: 105 FASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQR----- 159
S+LS N+ +L G C ++ E ++N L + ++ L + +
Sbjct: 72 ILSRLS-DPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFS 130
Query: 160 --LRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCV 217
L +A IA+ + YL S +HR + + + Y K+ DF +S ++ +
Sbjct: 131 TLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYY- 186
Query: 218 KDKVTGT----MGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT 256
+V G + ++A E + G F K DV++FG+ L +LT
Sbjct: 187 --RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 2e-04
Identities = 47/156 (30%), Positives = 69/156 (44%), Gaps = 15/156 (9%)
Query: 104 IFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIA 163
I K H N++ G L I E +L D IY PL SQ ++
Sbjct: 57 IIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVT---GPLSESQIAYVS 112
Query: 164 VHIANAIAYLHIGFSRPILHRKIRPSRIFL-DEGYIAKLFDFSLSVSIPEGETCVKDK-V 221
+ YLH S+ +HR I+ + I L D G++ KL DF +S I T K K
Sbjct: 113 RETLQGLYYLH---SKGKMHRDIKGANILLTDNGHV-KLADFGVSAQI--TATIAKRKSF 166
Query: 222 TGTMGFLAPEYI---NTGDFNEKCDVFSFGMLLLVL 254
GT ++APE G +N+ CD+++ G+ + L
Sbjct: 167 IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 2e-04
Identities = 51/191 (26%), Positives = 78/191 (40%), Gaps = 60/191 (31%)
Query: 100 FNNIIFASKLSSHKNVLKLTGCCLETRIPVI----------VFESV---------KNRTL 140
F I+F +L H N++KL + VI VFE + N
Sbjct: 54 FREIMFLQELGDHPNIVKL--------LNVIKAENDKDIYLVFEYMETDLHAVIRANILE 105
Query: 141 ADH----IYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEG 196
H +YQ LL A+ Y+H S ++HR ++PS I L+
Sbjct: 106 DVHKRYIMYQ--------LL-----------KALKYIH---SGNVIHRDLKPSNILLNSD 143
Query: 197 YIAKLFDFSLSVSIPEGETCVKDKV----TGTMGFLAPEYINTGD--FNEKCDVFSFGML 250
KL DF L+ S+ E E ++ V T + APE I G + + D++S G +
Sbjct: 144 CRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPE-ILLGSTRYTKGVDMWSVGCI 202
Query: 251 LLVLLTGQKIF 261
L +L G+ +F
Sbjct: 203 LGEMLLGKPLF 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 27/98 (27%), Positives = 47/98 (47%), Gaps = 9/98 (9%)
Query: 169 AIAYLH-IGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGF 227
A+ +H +GF +HR ++P + LD+ KL DF + + D GT +
Sbjct: 154 ALDAIHSMGF----IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDY 209
Query: 228 LAPEYINT----GDFNEKCDVFSFGMLLLVLLTGQKIF 261
++PE + + G + +CD +S G+ L +L G F
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 40/150 (26%), Positives = 69/150 (46%), Gaps = 13/150 (8%)
Query: 112 HKNVLKLTGCCLET--RIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANA 169
H+ +++ GC + R I E + ++ D + + L + + I
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL----KSYGALTENVTRKYTRQILEG 118
Query: 170 IAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS---VSIPEGETCVKDKVTGTMG 226
++YLH S I+HR I+ + I D KL DF S +I T +K VTGT
Sbjct: 119 VSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMK-SVTGTPY 174
Query: 227 FLAPEYINTGDFNEKCDVFSFGMLLLVLLT 256
+++PE I+ + K D++S G ++ +LT
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 26/91 (28%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 169 AIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI-PEGETCVKDKVTGTMGF 227
A+ +LH S ++HR I+ I L KL DF I PE + + GT +
Sbjct: 127 ALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYW 181
Query: 228 LAPEYINTGDFNEKCDVFSFGMLLLVLLTGQ 258
+APE + + K D++S G++ + ++ G+
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 43/190 (22%), Positives = 78/190 (41%), Gaps = 19/190 (10%)
Query: 82 TVSVMKFNDILNDGH-EDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTL 140
TV+V D D D + + + HKN++ L G C + ++ E L
Sbjct: 46 TVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNL 105
Query: 141 ADHIYQNQP-----HF-------EPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRP 188
+++ +P F E L + A +A + YL S+ +HR +
Sbjct: 106 REYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAA 162
Query: 189 SRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTM--GFLAPEYINTGDFNEKCDVFS 246
+ + E + K+ DF L+ + + K G + ++APE + + + DV+S
Sbjct: 163 RNVLVTEDNVMKIADFGLARDVHNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 221
Query: 247 FGMLLLVLLT 256
FG+LL + T
Sbjct: 222 FGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 24/88 (27%), Positives = 42/88 (47%), Gaps = 4/88 (4%)
Query: 178 SRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINT-- 235
S +HR ++P + LD+ KL DF + + + D GT +++PE + +
Sbjct: 160 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 219
Query: 236 --GDFNEKCDVFSFGMLLLVLLTGQKIF 261
G + +CD +S G+ L +L G F
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 3e-04
Identities = 27/89 (30%), Positives = 43/89 (48%), Gaps = 4/89 (4%)
Query: 169 AIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFL 228
+ YLH +HR I+ + I L E KL DF +S + ++ GT ++
Sbjct: 110 GLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQL-TSTMSKRNTFVGTPFWM 165
Query: 229 APEYINTGDFNEKCDVFSFGMLLLVLLTG 257
APE I ++EK D++S G+ + L G
Sbjct: 166 APEVIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 3e-04
Identities = 26/93 (27%), Positives = 47/93 (50%), Gaps = 4/93 (4%)
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTM 225
I + YLH S +HR I+ + + L E KL DF ++ + + + ++ GT
Sbjct: 110 ILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNTFVGTP 165
Query: 226 GFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQ 258
++APE I ++ K D++S G+ + L G+
Sbjct: 166 FWMAPEVIKQSAYDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 3e-04
Identities = 27/93 (29%), Positives = 45/93 (48%), Gaps = 7/93 (7%)
Query: 169 AIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFL 228
A YLH S+ I++R ++P + LD K+ DF + +P+ + GT +L
Sbjct: 130 AFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF----TLCGTPEYL 182
Query: 229 APEYINTGDFNEKCDVFSFGMLLLVLLTGQKIF 261
APE I + + D ++ G+LL + G F
Sbjct: 183 APEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 33/103 (32%), Positives = 51/103 (49%), Gaps = 12/103 (11%)
Query: 163 AVHIANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIAKLFDFSL---SVSIPEGETCVK 218
A IA+A+ YLH S I++R ++P I LD +G++ L DF L ++ + T
Sbjct: 102 AAEIASALGYLH---SINIVYRDLKPENILLDSQGHVV-LTDFGLCKEGIAQSDTTT--- 154
Query: 219 DKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIF 261
GT +LAPE I ++ D + G +L +L G F
Sbjct: 155 -TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 3e-04
Identities = 34/123 (27%), Positives = 56/123 (45%), Gaps = 25/123 (20%)
Query: 162 IAVHIANAIAYLHIGFSRP----ILHRKIRPSRIFLDEGY-----------------IAK 200
I + +A+AY H P +LHR ++P IFL G IAK
Sbjct: 123 ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182
Query: 201 LFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYI--NTGDFNEKCDVFSFGMLLLVLLTGQ 258
+ DF LS +I G + GT + +PE + T +++K D+++ G ++ L +G+
Sbjct: 183 IGDFGLSKNI--GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
Query: 259 KIF 261
F
Sbjct: 241 TPF 243
|
Length = 1021 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 4e-04
Identities = 23/85 (27%), Positives = 40/85 (47%), Gaps = 5/85 (5%)
Query: 182 LHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINT-----G 236
+HR I+P I +D +L DF + + E T GT +++PE + G
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKG 183
Query: 237 DFNEKCDVFSFGMLLLVLLTGQKIF 261
+ +CD +S G+ + +L G+ F
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 4e-04
Identities = 37/131 (28%), Positives = 63/131 (48%), Gaps = 28/131 (21%)
Query: 135 VKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLD 194
VK + L+D Q L+ Q LR + Y+H S I+HR ++PS + ++
Sbjct: 110 VKCQKLSDEHVQ-------FLIYQLLR-------GLKYIH---SAGIIHRDLKPSNVAVN 152
Query: 195 EGYIAKLFDFSLSVSIPEGETCVKDKVTG---TMGFLAPE-YINTGDFNEKCDVFSFGML 250
E ++ DF L+ D++TG T + APE +N +N+ D++S G +
Sbjct: 153 EDCELRILDFGLARQ-------ADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCI 205
Query: 251 LLVLLTGQKIF 261
+ LL G+ +F
Sbjct: 206 MAELLKGKALF 216
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 40.9 bits (95), Expect = 5e-04
Identities = 23/90 (25%), Positives = 44/90 (48%), Gaps = 4/90 (4%)
Query: 169 AIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFL 228
A+ +LH + ++HR I+ + L KL DF I E + + GT ++
Sbjct: 127 ALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP-EQSKRSTMVGTPYWM 182
Query: 229 APEYINTGDFNEKCDVFSFGMLLLVLLTGQ 258
APE + + K D++S G++ + ++ G+
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 6e-04
Identities = 29/100 (29%), Positives = 48/100 (48%), Gaps = 4/100 (4%)
Query: 153 PLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212
PL + + + +A + +L SR +HR + I L E + K+ DF L+ I +
Sbjct: 170 PLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 226
Query: 213 GETCV-KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLL 251
V K + ++APE I + + DV+SFG+LL
Sbjct: 227 DPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLL 266
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 6e-04
Identities = 39/169 (23%), Positives = 78/169 (46%), Gaps = 22/169 (13%)
Query: 112 HKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIA 171
H N+++L G +IV E + N L + + H L+ Q + + +A+ +
Sbjct: 65 HSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL---RKHEGQLVAGQLMGMLPGLASGMK 121
Query: 172 YL-HIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMG---- 226
YL +G+ +H+ + ++ ++ + K+ F + E ++ + + TM
Sbjct: 122 YLSEMGY----VHKGLAAHKVLVNSDLVCKISGFR---RLQEDKS---EAIYTTMSGKSP 171
Query: 227 --FLAPEYINTGDFNEKCDVFSFGMLLL-VLLTGQKIF-DPSRGDEIGA 271
+ APE I F+ DV+SFG+++ V+ G++ + D S D I A
Sbjct: 172 VLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKA 220
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 6e-04
Identities = 35/125 (28%), Positives = 58/125 (46%), Gaps = 15/125 (12%)
Query: 169 AIAYLH-IGFSRPILHRKIRPSRIFLDE-GYIAKLFDFSLSVSIPEGETCVKDKVTGTMG 226
A+ LH +G +HR ++P +D G+I KL DF LS I + V G+
Sbjct: 113 AVDALHELG----YIHRDLKPENFLIDASGHI-KLTDFGLSKGIVT----YANSVVGSPD 163
Query: 227 FLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIEN 286
++APE + ++ D +S G +L L G F S +E + L Y K+ ++
Sbjct: 164 YMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET----WENLKYWKETLQR 219
Query: 287 NEFDE 291
+D+
Sbjct: 220 PVYDD 224
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 6e-04
Identities = 36/152 (23%), Positives = 62/152 (40%), Gaps = 9/152 (5%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAI 170
+H N++KL +VFE + L I Q L+ + +
Sbjct: 56 NHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKS---YLYQLLQGL 111
Query: 171 AYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAP 230
A+ H S ILHR ++P + ++ + KL DF L+ S V T + AP
Sbjct: 112 AFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-TRWYRAP 167
Query: 231 EYI-NTGDFNEKCDVFSFGMLLLVLLTGQKIF 261
E + ++ D++S G + LL+ + +F
Sbjct: 168 ELLLGDKGYSTPVDIWSVGCIFAELLSRRPLF 199
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 7e-04
Identities = 36/157 (22%), Positives = 67/157 (42%), Gaps = 18/157 (11%)
Query: 112 HKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHF----EPLLLSQRLRIAVHIA 167
H NVL+ G C+E+ ++V E L +++ N+ + +L R+A +A
Sbjct: 54 HPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVL---QRMACEVA 110
Query: 168 NAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVS-IPEGETCVKDKVTGTMG 226
+ + +LH +H + L K+ D+ L++ PE KD +
Sbjct: 111 SGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR 167
Query: 227 FLAPEYIN-------TGDFNEKCDVFSFGMLLLVLLT 256
+LAPE + D +K +++S G+ + L T
Sbjct: 168 WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 8e-04
Identities = 47/211 (22%), Positives = 89/211 (42%), Gaps = 18/211 (8%)
Query: 59 FDARNVIKDGYAYKFYKG-FVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLK 117
F+ V+ +G + YKG V+ ++ +K D+ D E+ I K S H+N+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 118 LTGCCLETRIP------VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIA 171
G ++ P +V E ++ D + + + L I I +A
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN--ALKEDWIAYICREILRGLA 135
Query: 172 YLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPE 231
+LH ++HR I+ + L E KL DF +S + + ++ GT ++APE
Sbjct: 136 HLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL-DRTVGRRNTFIGTPYWMAPE 191
Query: 232 YINTGD-----FNEKCDVFSFGMLLLVLLTG 257
I + ++ + D++S G+ + + G
Sbjct: 192 VIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 8e-04
Identities = 36/148 (24%), Positives = 62/148 (41%), Gaps = 11/148 (7%)
Query: 112 HKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIA 171
H N+L+ G C+E ++VFE + L ++ Q Q H L R+A IA +
Sbjct: 54 HPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVT 113
Query: 172 YLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVS-IPEGETCVKDKVTGTMGFLAP 230
++H LH + FL K+ D+ + S E +D + +LAP
Sbjct: 114 HMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAP 170
Query: 231 EYIN-------TGDFNEKCDVFSFGMLL 251
E + T + + +V++ G+ L
Sbjct: 171 ELVGEFHGGLITAEQTKPSNVWALGVTL 198
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 9e-04
Identities = 34/122 (27%), Positives = 56/122 (45%), Gaps = 14/122 (11%)
Query: 153 PLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDF---SLSVS 209
PL + Q L I I + YLH ++ I+HR ++ IF+++ + D V
Sbjct: 153 PLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV 209
Query: 210 IPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQK-IFD--PSRG 266
P + GT+ APE + +N K D++S G++L +L IF+ PS
Sbjct: 210 APAFL-----GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTP 264
Query: 267 DE 268
+E
Sbjct: 265 EE 266
|
Length = 357 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 9e-04
Identities = 42/170 (24%), Positives = 75/170 (44%), Gaps = 24/170 (14%)
Query: 112 HKNVLKLTGCCLETRIP-----VIVFESVKNRTLADHIYQNQPHFEPL-----LLSQRLR 161
H N+++L C +R +VFE V ++ L ++ + P P L+ Q LR
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 162 IAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKV 221
+ +LH + I+HR ++P I + G KL DF L+ I + + V
Sbjct: 120 -------GLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLA-RIYSCQMAL-TPV 167
Query: 222 TGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIF-DPSRGDEIG 270
T+ + APE + + D++S G + + + +F S D++G
Sbjct: 168 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 25/102 (24%), Positives = 46/102 (45%), Gaps = 5/102 (4%)
Query: 165 HIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGT 224
+IA + +H +HR I+P + LD +L DF + + + T GT
Sbjct: 107 YIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGT 166
Query: 225 MGFLAPEYINT-----GDFNEKCDVFSFGMLLLVLLTGQKIF 261
+++PE + G + +CD +S G+ + +L G+ F
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 21/202 (10%)
Query: 75 KGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVI-VFE 133
KG E + V+K + IL D DC L++ L CC +T+ + V E
Sbjct: 17 KGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVME 76
Query: 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRI-AVHIANAIAYLHIGFSRPILHRKIRPSRIF 192
V L I +++ EP R R A + A+ +LH +++R ++ I
Sbjct: 77 YVNGGDLMFQIQRSRKFDEP-----RSRFYAAEVTLALMFLH---RHGVIYRDLKLDNIL 128
Query: 193 LD-EGYIAKLFDFSLSVSIPEGETCVKDKVT----GTMGFLAPEYINTGDFNEKCDVFSF 247
LD EG+ KL DF + E + T GT ++APE + ++ D ++
Sbjct: 129 LDAEGHC-KLADFGMC-----KEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWAL 182
Query: 248 GMLLLVLLTGQKIFDPSRGDEI 269
G+L+ ++ GQ F+ D++
Sbjct: 183 GVLMYEMMAGQPPFEADNEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 38/147 (25%), Positives = 59/147 (40%), Gaps = 50/147 (34%)
Query: 159 RLRIAVHIANAIAYLH-IGFSRPILHRKIRPSRIFLD-EGYIAKLFDFSL---------- 206
R IA + AI +H +GF +HR I+P I +D +G+I KL DF L
Sbjct: 104 RFYIA-ELTCAIESVHKMGF----IHRDIKPDNILIDRDGHI-KLTDFGLCTGFRWTHDS 157
Query: 207 ------------SVSIPE--------------------GETCVKDKVTGTMGFLAPEYIN 234
S+ E + C+ + GT ++APE +
Sbjct: 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL 217
Query: 235 TGDFNEKCDVFSFGMLLLVLLTGQKIF 261
+ + CD +S G++L +L GQ F
Sbjct: 218 RTGYTQLCDWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 27/96 (28%), Positives = 47/96 (48%), Gaps = 4/96 (4%)
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTM 225
I +A+ YLH SR +++R I+ + LD+ K+ DF L +K GT
Sbjct: 104 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK-TFCGTP 159
Query: 226 GFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIF 261
+LAPE + D+ D + G+++ ++ G+ F
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 26/101 (25%), Positives = 49/101 (48%), Gaps = 6/101 (5%)
Query: 163 AVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSL-SVSIPEGETCVKDKV 221
A I A+ +LH R I++R ++ + LD KL D+ + + G+T
Sbjct: 102 AAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTF 156
Query: 222 TGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFD 262
GT ++APE + ++ D ++ G+L+ ++ G+ FD
Sbjct: 157 CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.001
Identities = 30/102 (29%), Positives = 54/102 (52%), Gaps = 8/102 (7%)
Query: 163 AVHIANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIAKLFDFSL-SVSIPEGETCVKDK 220
+ I+ A+ +LH R I++R ++ + LD EG+I KL D+ + I G+T
Sbjct: 102 SAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHI-KLTDYGMCKEGIRPGDT--TST 155
Query: 221 VTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFD 262
GT ++APE + D+ D ++ G+L+ ++ G+ FD
Sbjct: 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 32/122 (26%), Positives = 57/122 (46%), Gaps = 8/122 (6%)
Query: 135 VKNRTLADHIYQNQP----HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSR 190
V+ ++L+D + + + L L + + +A + +L SR +HR +
Sbjct: 153 VEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARN 209
Query: 191 IFLDEGYIAKLFDFSLSVSIPEGETCV-KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGM 249
I L E + K+ DF L+ I + V K + ++APE I + + DV+SFG+
Sbjct: 210 ILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 269
Query: 250 LL 251
LL
Sbjct: 270 LL 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 66/291 (22%), Positives = 113/291 (38%), Gaps = 47/291 (16%)
Query: 56 TNNFDARNVIKDGYAYKFYK-GFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKN 114
T+ ++ I G K YK +D +++ +K D ++D E+ L +H N
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPN 80
Query: 115 VLKLTGCCLETRIPV-----IVFESVKNRTLADHIYQNQPHFEPLLLSQRLR---IAVHI 166
V+K G + V +V E ++ + + L+ QRL I+ +
Sbjct: 81 VVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKG------LLICGQRLDEAMISYIL 134
Query: 167 ANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMG 226
A+ L + I+HR ++ + I L KL DF +S + ++ GT
Sbjct: 135 YGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL-RRNTSVGTPF 193
Query: 227 FLAPEYINT-----GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVK 281
++APE I ++ +CDV+S G+ + L G DP D +H VK
Sbjct: 194 WMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG----DPPLFD---------MHPVK 240
Query: 282 KC--IENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPT 330
I N ++ P EK + F C+ + E RP+
Sbjct: 241 TLFKIPRNPPPTLLHP-----------EKWCRSFNHFISQCLIKDFEARPS 280
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 46/171 (26%), Positives = 75/171 (43%), Gaps = 23/171 (13%)
Query: 100 FNNIIFASKLS--SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQN----QPHFEP 153
F I AS L H N++ L VFE + LA ++ Q+ P+
Sbjct: 48 FTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVR 106
Query: 154 LLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSL--SVSIP 211
L + Q LR +AY+H + ILHR ++P + + KL DF L + SIP
Sbjct: 107 LFMFQLLR-------GLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156
Query: 212 EGETCVKDKVTGTMGFLAPE-YINTGDFNEKCDVFSFGMLLLVLLTGQKIF 261
+T + VT + + P+ + D++ D++ G + + +L GQ F
Sbjct: 157 -SQTYSSEVVT--LWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.001
Identities = 32/119 (26%), Positives = 58/119 (48%), Gaps = 23/119 (19%)
Query: 148 QPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS 207
+ F L Q LR + Y+H S ++HR ++PS I ++E K+ DF L+
Sbjct: 106 EKQFIQYFLYQILR-------GLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLA 155
Query: 208 VSIPEGETCVKD-KVTG---TMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIF 261
++D ++TG T + APE + T ++ + D++S G + +L G+ +F
Sbjct: 156 R--------IQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLF 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 40/140 (28%), Positives = 66/140 (47%), Gaps = 10/140 (7%)
Query: 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSR 190
V E + L HI Q++ F+ L + A I + +LH S+ I++R ++
Sbjct: 74 VMEFLNGGDLMFHI-QDKGRFD---LYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDN 126
Query: 191 IFLD-EGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGM 249
+ LD +G+I K+ DF + G+ GT ++APE + + D +SFG+
Sbjct: 127 VMLDRDGHI-KIADFGMCKENVFGDN-RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGV 184
Query: 250 LLLVLLTGQKIFDPSRGDEI 269
LL +L GQ F DE+
Sbjct: 185 LLYEMLIGQSPFHGDDEDEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 28/102 (27%), Positives = 45/102 (44%), Gaps = 4/102 (3%)
Query: 151 FEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI 210
E L L +A + +L S+ +HR + + L +G I K+ DF L+ I
Sbjct: 231 SEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGKIVKICDFGLARDI 287
Query: 211 PEGETCVKDKVTG-TMGFLAPEYINTGDFNEKCDVFSFGMLL 251
V T + ++APE I + DV+S+G+LL
Sbjct: 288 MHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILL 329
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.002
Identities = 24/99 (24%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 161 RIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE--TCVK 218
+I++ + + YL I+HR ++PS I ++ KL DF +S G+ +
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMA 155
Query: 219 DKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTG 257
+ GT +++PE + + + D++S G+ L+ + G
Sbjct: 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.002
Identities = 43/181 (23%), Positives = 75/181 (41%), Gaps = 20/181 (11%)
Query: 80 DRTVSVMKFNDILNDGHEDC---FNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVK 136
+ V+V K N + + ED II S+ H N+L + +V +
Sbjct: 25 NTLVAVKKIN-LDSCSKEDLKLLQQEIIT-SRQLQHPNILPYVTSFIVDSELYVVSPLMA 82
Query: 137 NRTLADHIYQNQPH-FEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE 195
+ D + + P L ++ L+ + NA+ Y+H S+ +HR ++ S I L
Sbjct: 83 YGSCEDLLKTHFPEGLPELAIAFILKDVL---NALDYIH---SKGFIHRSVKASHILLSG 136
Query: 196 GYIAKLFDFSLSVSIPEG---ETCVKDKVTGT---MGFLAPE--YINTGDFNEKCDVFSF 247
L SVS+ + + V D + + +L+PE N +NEK D++S
Sbjct: 137 DGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSV 196
Query: 248 G 248
G
Sbjct: 197 G 197
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.002
Identities = 27/95 (28%), Positives = 44/95 (46%), Gaps = 8/95 (8%)
Query: 164 VHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS--VSIPEGETCVKDKV 221
V + + ++H + +LHR I+ IFL + KL DF + ++ P C
Sbjct: 107 VQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT---Y 160
Query: 222 TGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT 256
GT ++ PE +N K D++S G +L L T
Sbjct: 161 VGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.002
Identities = 40/226 (17%), Positives = 85/226 (37%), Gaps = 22/226 (9%)
Query: 47 FTIRELEIATNNFDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHE--DCFNNII 104
I+ +E + +IK+ YKG ++ V + F D N I
Sbjct: 10 NDIKCIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEI 69
Query: 105 FASKLSSHKNVLKLTGCCLETRIP----VIVFESVKNRTLADHIYQNQPHFEPLLLSQRL 160
+ N+LK+ G ++ ++ E L + + + + L +L
Sbjct: 70 KNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD----LSFKTKL 125
Query: 161 RIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSL--SVSIPEGETCVK 218
+A+ + L+ ++P ++ + + E Y K+ L +S P
Sbjct: 126 DMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPF----- 178
Query: 219 DKVTGTMGFLAPEYINT--GDFNEKCDVFSFGMLLLVLLTGQKIFD 262
K M + + + +N ++ K D++S G++L + TG+ F+
Sbjct: 179 -KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE 223
|
Length = 283 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.003
Identities = 28/101 (27%), Positives = 50/101 (49%), Gaps = 13/101 (12%)
Query: 169 AIAYLH-IGFSRPILHRKIRPSRIFLDE-GYIAKLFDFSLSVSIPEGETCVKDKVTGTMG 226
AI +H +G+ +HR I+P + +D G+I KL DF + + + GT
Sbjct: 114 AIHSVHQMGY----VHRDIKPENVLIDRTGHI-KLADFGSAARLTANKMVNSKLPVGTPD 168
Query: 227 FLAPEYINT------GDFNEKCDVFSFGMLLLVLLTGQKIF 261
++APE + T G + +CD +S G++ ++ G+ F
Sbjct: 169 YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.003
Identities = 28/101 (27%), Positives = 50/101 (49%), Gaps = 13/101 (12%)
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVT--- 222
I +A+ YLH + +++R ++ + LD+ K+ DF L EG +KD T
Sbjct: 104 IVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLC---KEG---IKDGATMKT 155
Query: 223 --GTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIF 261
GT +LAPE + D+ D + G+++ ++ G+ F
Sbjct: 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.003
Identities = 37/149 (24%), Positives = 69/149 (46%), Gaps = 10/149 (6%)
Query: 112 HKNVLKLTGCCLET--RIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANA 169
H N++K G C R +V E + +L D++ +++ + + L A I
Sbjct: 64 HDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLD---HRKLLLYASQICKG 120
Query: 170 IAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGET--CVKDKVTGTMGF 227
+ YL S+ +HR + I ++ K+ DF L+ +P+ + V++ + +
Sbjct: 121 MEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFW 177
Query: 228 LAPEYINTGDFNEKCDVFSFGMLLLVLLT 256
APE + F+ DV+SFG++L L T
Sbjct: 178 YAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.003
Identities = 29/98 (29%), Positives = 48/98 (48%), Gaps = 8/98 (8%)
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVT--G 223
I +A+ YLH G I++R ++ + LD+ K+ DF L EG T T G
Sbjct: 104 IVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLC---KEGITDAATMKTFCG 157
Query: 224 TMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIF 261
T +LAPE + D+ D + G+++ ++ G+ F
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.003
Identities = 26/93 (27%), Positives = 45/93 (48%), Gaps = 5/93 (5%)
Query: 169 AIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFL 228
I +LH S I+HR ++PS I + K+ DF L+ + G + + T +
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYR 192
Query: 229 APEYINTGDFNEKCDVFSFGMLLLVLLTGQKIF 261
APE I + E D++S G ++ ++ G +F
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 346 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.98 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.86 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.86 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.83 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.83 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.83 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.81 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.8 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.8 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.79 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.79 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.79 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.78 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.72 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.7 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.7 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.66 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.64 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.55 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.52 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.46 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.35 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.35 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.35 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.28 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.22 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.21 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.21 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.19 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.18 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.07 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.07 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.95 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.85 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.8 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.77 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.73 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.6 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.59 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.46 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.44 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.43 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.4 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.33 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.27 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.21 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.21 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.14 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.06 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.05 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.96 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.94 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.91 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.87 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.86 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.7 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.69 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.66 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.57 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.5 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.34 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.29 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.24 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.23 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 97.18 | |
| PLN02236 | 344 | choline kinase | 97.14 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.04 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.03 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.89 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.78 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.75 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.69 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.54 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.42 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.41 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.99 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.73 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.62 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.56 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.5 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.66 | |
| PTZ00296 | 442 | choline kinase; Provisional | 94.62 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 94.58 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-63 Score=453.87 Aligned_cols=289 Identities=40% Similarity=0.664 Sum_probs=252.5
Q ss_pred CccCCCHHHHHHHhcCCCcccccccCCCcEEEEEEE-CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcce
Q 045453 43 PIRGFTIRELEIATNNFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGC 121 (346)
Q Consensus 43 ~~~~~~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~ 121 (346)
+.+.|++++|..||++|+..++||+|+||.||+|.. ++..||||++.........+|.+|+..+.++ +|||+|+|+||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l-~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRL-RHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcC-CCcCcccEEEE
Confidence 678899999999999999999999999999999999 4589999988765433156699999999999 89999999999
Q ss_pred eecCC-cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceE
Q 045453 122 CLETR-IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAK 200 (346)
Q Consensus 122 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~k 200 (346)
|.+.+ +.+||||||++|||.++|+..... +++|..|++||.++|+||+|||+.+..+||||||||+|||||+++++|
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 99999 499999999999999999987643 799999999999999999999998888999999999999999999999
Q ss_pred EeccCCCcccCC-CCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHH
Q 045453 201 LFDFSLSVSIPE-GETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHY 279 (346)
Q Consensus 201 l~Dfgl~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 279 (346)
|+|||+|+..+. .... .....||.+|+|||++..+..+.|+|||||||+|+|++||+++.+....... ..+..|
T Consensus 218 lsDFGLa~~~~~~~~~~-~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~----~~l~~w 292 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTSV-STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGE----LSLVEW 292 (361)
T ss_pred ccCccCcccCCccccce-eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCccc----ccHHHH
Confidence 999999976654 2221 1111899999999999999999999999999999999999999886552222 248999
Q ss_pred HHHHhhcCcccccccccccc-CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 045453 280 VKKCIENNEFDEIVDPIIVS-EGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIY 342 (346)
Q Consensus 280 ~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~ 342 (346)
+...+..+.+.+++|+.+.. .+.. ......+.+++.+|++.+|.+||+|.||++.|+.+.
T Consensus 293 ~~~~~~~~~~~eiiD~~l~~~~~~~---~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 293 AKPLLEEGKLREIVDPRLKEGEYPD---EKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHHHHHCcchhheeCCCccCCCCCh---HHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 99999999999999999873 3221 156777999999999999999999999999997664
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-54 Score=394.44 Aligned_cols=259 Identities=27% Similarity=0.402 Sum_probs=213.4
Q ss_pred cCCCcccccccCCCcEEEEEEECCeE-EEEEEecCccCcc--hHHHHHHHHHHhhhcCCCceeeEcceeecCC-cceEEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFVEDRT-VSVMKFNDILNDG--HEDCFNNIIFASKLSSHKNVLKLTGCCLETR-IPVIVF 132 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~~~~~-vavk~~~~~~~~~--~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~-~~~lv~ 132 (346)
.++.....||+|+||+||+|.|.|.. ||+|++....... ..++.+|+.++.++ +|||||+|+|+|.+.. .+++||
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~f~G~~~~~~~~~~iVt 119 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRL-RHPNIVQFYGACTSPPGSLCIVT 119 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCceEEEE
Confidence 33445566999999999999998888 9999987654322 45889999999998 9999999999999987 799999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-ceecCCCCCCeEEcCCC-ceEEeccCCCccc
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRP-ILHRKIRPSRIFLDEGY-IAKLFDFSLSVSI 210 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-iiH~dlkp~NIll~~~~-~~kl~Dfgl~~~~ 210 (346)
||+++|+|.+++... ....+++..++.++.|||+|+.||| +.+ ||||||||+|||++.++ ++||+|||+++..
T Consensus 120 Ey~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREK 194 (362)
T ss_pred EeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence 999999999999874 1257999999999999999999999 777 99999999999999998 9999999999876
Q ss_pred CCCCceeeccccccCCcCCccccc--cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCc
Q 045453 211 PEGETCVKDKVTGTMGFLAPEYIN--TGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE 288 (346)
Q Consensus 211 ~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (346)
.... ...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||........ +......+.
T Consensus 195 ~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~----------~~~v~~~~~ 263 (362)
T KOG0192|consen 195 VISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV----------ASAVVVGGL 263 (362)
T ss_pred cccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH----------HHHHHhcCC
Confidence 5432 2234478999999999999 56899999999999999999999999987655221 111111111
Q ss_pred cccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 045453 289 FDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHL 345 (346)
Q Consensus 289 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~l 345 (346)
.+. .+..+...+..|+.+||+.+|+.||++.+++..|+.+..+.
T Consensus 264 ------------Rp~-~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 264 ------------RPP-IPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred ------------CCC-CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 111 11135677889999999999999999999999999998754
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-54 Score=394.96 Aligned_cols=293 Identities=25% Similarity=0.347 Sum_probs=244.2
Q ss_pred HHHHHhchhhhHHHHHhhcCC---CCCccCCCHHHHHHHhcCCCcccccccCCCcEEEEEEECCe-EEEEEEecCccCcc
Q 045453 20 EFMIENGKILVETLVVCCYGK---FNPIRGFTIRELEIATNNFDARNVIKDGYAYKFYKGFVEDR-TVSVMKFNDILNDG 95 (346)
Q Consensus 20 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~-~vavk~~~~~~~~~ 95 (346)
..+..+...+...+..+|... ......++.+.|.+..+.+...+.||+|.||.||.|.|++. .||+|.+... ...
T Consensus 166 ~~~~~~~~gl~~~l~~p~~~~~~~~p~~~~~~~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~ 244 (468)
T KOG0197|consen 166 NYYSKNADGLCTRLRDPCSKQGHTKPQTPDLARDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMS 244 (468)
T ss_pred hhhhccCcchhhcccCchhccCCCCCCCCccccCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccC
Confidence 334455666666666666432 12222344667777777777889999999999999999665 9999998764 344
Q ss_pred hHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 045453 96 HEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHI 175 (346)
Q Consensus 96 ~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~ 175 (346)
...|.+|+.+|+++ +|+|||+++|+|...++++||||||+.|+|.++|..... ..+...+.+.++.|||+|++||+
T Consensus 245 ~~~f~~Ea~iMk~L-~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~--~~l~~~~Ll~~a~qIaeGM~YLe- 320 (468)
T KOG0197|consen 245 PEAFLREAQIMKKL-RHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREG--GLLNLPQLLDFAAQIAEGMAYLE- 320 (468)
T ss_pred hhHHHHHHHHHHhC-cccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCC--CccchHHHHHHHHHHHHHHHHHH-
Confidence 56778899999999 999999999999999999999999999999999987332 57899999999999999999999
Q ss_pred CCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHH
Q 045453 176 GFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLL 255 (346)
Q Consensus 176 ~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ell 255 (346)
++++|||||.+.||||+++..+||+|||||+.+.++.........-+..|.|||.+..+.++.|||||||||+||||+
T Consensus 321 --s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~f 398 (468)
T KOG0197|consen 321 --SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELF 398 (468)
T ss_pred --hCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHh
Confidence 999999999999999999999999999999977666665555666778999999999999999999999999999999
Q ss_pred h-CCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 045453 256 T-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDV 334 (346)
Q Consensus 256 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev 334 (346)
| |+.||..+...+. + ..+..++..+.+..++..+.+++..||+.+|++|||++.+
T Consensus 399 T~G~~py~~msn~ev----------~--------------~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L 454 (468)
T KOG0197|consen 399 TYGRVPYPGMSNEEV----------L--------------ELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETL 454 (468)
T ss_pred ccCCCCCCCCCHHHH----------H--------------HHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHH
Confidence 9 9999987765442 1 1233445555666889999999999999999999999999
Q ss_pred HHHHHHHHH
Q 045453 335 AKRLKQIYQ 343 (346)
Q Consensus 335 ~~~L~~i~~ 343 (346)
...|+++..
T Consensus 455 ~~~l~~~~~ 463 (468)
T KOG0197|consen 455 REVLEDFFT 463 (468)
T ss_pred HHHHHHhhh
Confidence 999998865
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-52 Score=364.52 Aligned_cols=251 Identities=19% Similarity=0.327 Sum_probs=210.3
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc-CcchHHHHHHHHHHhhhcCCCceeeEcceeecCC-cceEEEe
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL-NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETR-IPVIVFE 133 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~-~~~lv~e 133 (346)
++...+.||+|..|+||++.+ ++..+|+|.+.... ....++..+|+.++... +||+||.+||.|...+ .+.++||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCceEEeehh
Confidence 344558899999999999999 78999999985444 35567899999999999 9999999999999988 4999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
||++|||.+.+... .++++....+++.++++||.|||+ .++||||||||+|||++..|.+||+|||.+..+...
T Consensus 159 YMDgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 159 YMDGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred hcCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 99999999999765 369999999999999999999994 489999999999999999999999999998776544
Q ss_pred CceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccc
Q 045453 214 ETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIV 293 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (346)
.....+||..|||||.+.+..|+.++||||||+.++|+.+|+.||........ ... +++
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~-----~~~-------------~Ll 291 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYL-----DIF-------------ELL 291 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCC-----CHH-------------HHH
Confidence 34677899999999999999999999999999999999999999987622211 111 112
Q ss_pred ccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 294 DPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 294 d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
+....+..+..+...++.++..++..||++||.+|||+.|+++
T Consensus 292 ~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 292 CAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred HHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 2222222233333247788999999999999999999999874
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-52 Score=348.82 Aligned_cols=258 Identities=25% Similarity=0.369 Sum_probs=212.1
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcc-eeecCCc-ceE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTG-CCLETRI-PVI 130 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g-~~~~~~~-~~l 130 (346)
.+|.+.++||+|+||+||++.. ++..+|.|+++-.. .........|+.++..+ +|||||++++ .+.+... ++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL-~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQL-NHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhc-CCchHHHHHHHhhhccchhhHH
Confidence 3466778999999999999988 89999999987433 34556788999999999 9999999999 4555555 899
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRP--ILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
|||||..|+|.+.+..-......+++.++|++..|++.||..+|+.. .. |+||||||.||+++.+|.+||+|||+++
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHh
Confidence 99999999999999866555678999999999999999999999422 44 9999999999999999999999999999
Q ss_pred ccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCc
Q 045453 209 SIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE 288 (346)
Q Consensus 209 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (346)
.+....+ ...+.+||+-||+||.+.+.+|+.||||||+||++|||+.-++||.+.+- ....+. +.
T Consensus 177 ~l~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~----------~~L~~K-I~--- 241 (375)
T KOG0591|consen 177 FLSSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL----------LSLCKK-IE--- 241 (375)
T ss_pred HhcchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH----------HHHHHH-HH---
Confidence 8865443 45678999999999999999999999999999999999999999987522 111111 12
Q ss_pred cccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 045453 289 FDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQ 340 (346)
Q Consensus 289 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 340 (346)
.+++++.+..-.+..+..|+..|+..||+.||+...++..+.+
T Consensus 242 ---------qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 242 ---------QGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred ---------cCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 2334434444778899999999999999999996555544443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-50 Score=353.26 Aligned_cols=203 Identities=24% Similarity=0.406 Sum_probs=182.6
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
..+|...+.||+|+||+||+|++ ++..||||.+.... ....+....|+.++..+ +|||||.+++++...+.++||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel-~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKEL-KHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhc-CCcceeeEEEEEecCCeEEEE
Confidence 46788888999999999999999 77999999987663 34455568899999999 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCC------CceEEeccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEG------YIAKLFDFS 205 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~------~~~kl~Dfg 205 (346)
||||.||+|.++++..+ .+++.+...++.|+|.||++|| +.+||||||||+|||++.+ -.+||+|||
T Consensus 88 MEyC~gGDLs~yi~~~~----~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRG----RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred EEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 99999999999998874 6999999999999999999999 9999999999999999865 568999999
Q ss_pred CCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc
Q 045453 206 LSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDE 268 (346)
Q Consensus 206 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~ 268 (346)
+|+.+..+.. ....+|++-|||||++..++|+.|+|+||+|+++|++++|+.||+..+..+
T Consensus 161 fAR~L~~~~~--a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e 221 (429)
T KOG0595|consen 161 FARFLQPGSM--AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE 221 (429)
T ss_pred hhhhCCchhH--HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence 9999875433 456789999999999999999999999999999999999999998766544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-49 Score=364.47 Aligned_cols=246 Identities=22% Similarity=0.338 Sum_probs=211.9
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
..|...++||+|||..||.++. +|..||+|++.+.. ........+|+.+...+ +|||||+++++|.+.+++|+|
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L-~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSL-KHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhc-CCCcEEeeeeEeecCCceEEE
Confidence 4588899999999999999998 88999999987643 34566788898888888 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
.|+|++++|..+++.+ .+++++++..++.||+.||.||| +.+|+|||||..|+|++++.++||+|||||..+.
T Consensus 97 LELC~~~sL~el~Krr----k~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRR----KPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred EEecCCccHHHHHHhc----CCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeec
Confidence 9999999999999854 47999999999999999999999 9999999999999999999999999999999887
Q ss_pred CCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccc
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDE 291 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (346)
.+.. .....+||+.|+|||++.....+..+||||+||+||-||.|++||+...-.+.
T Consensus 170 ~~~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket---------------------- 226 (592)
T KOG0575|consen 170 YDGE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET---------------------- 226 (592)
T ss_pred Cccc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH----------------------
Confidence 5433 34567999999999999999999999999999999999999999986433222
Q ss_pred ccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 292 IVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 292 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.++....++..+. ..+....+|+..+|+.+|.+|||+.+|+.
T Consensus 227 -y~~Ik~~~Y~~P~--~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 227 -YNKIKLNEYSMPS--HLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred -HHHHHhcCccccc--ccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1222223333222 45566889999999999999999999975
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-49 Score=347.01 Aligned_cols=250 Identities=23% Similarity=0.333 Sum_probs=205.2
Q ss_pred HhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcc-------hHHHHHHHHHHhhhcCCCceeeEcceeecC
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDG-------HEDCFNNIIFASKLSSHKNVLKLTGCCLET 125 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~-------~~~~~~e~~~~~~~~~h~niv~l~g~~~~~ 125 (346)
..+.|...+.||+|+||.|-+|.. +++.||||.++...... .....+|+.+|+++ +|||||++++++...
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-SHPNIVRIKDFFEVP 248 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhc-CCCCEEEEeeeeecC
Confidence 335566788999999999999988 89999999987543211 22345899999999 999999999999999
Q ss_pred CcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCC---CceEEe
Q 045453 126 RIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEG---YIAKLF 202 (346)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~---~~~kl~ 202 (346)
+..|+||||++||.|.+.+-.+. .+.+..-..++.|++.|+.||| +.||+||||||+|||+..+ ..+||+
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk----~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANK----YLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred CceEEEEEEecCccHHHHHHhcc----ccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEec
Confidence 99999999999999999997764 4666777889999999999999 9999999999999999866 899999
Q ss_pred ccCCCcccCCCCceeeccccccCCcCCccccccCCC---CcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHH
Q 045453 203 DFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDF---NEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHY 279 (346)
Q Consensus 203 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 279 (346)
|||+|+..++.. .....+||+.|.|||++.+..+ ..++|+||+||+||-+++|.+||....++.. +
T Consensus 322 DFGlAK~~g~~s--fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s------l--- 390 (475)
T KOG0615|consen 322 DFGLAKVSGEGS--FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS------L--- 390 (475)
T ss_pred ccchhhccccce--ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc------H---
Confidence 999999887443 4567899999999999987653 3478999999999999999999987655442 0
Q ss_pred HHHHhhcCccccccccccccCCCCc--chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 280 VKKCIENNEFDEIVDPIIVSEGPRV--GKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 280 ~~~~~~~~~~~~~~d~~l~~~~~~~--~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.+....+.+... .-.+..++..+|+.+||..||++|||+.|++.
T Consensus 391 -------------~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 391 -------------KEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred -------------HHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 111122222111 12266788999999999999999999999875
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-49 Score=343.67 Aligned_cols=241 Identities=21% Similarity=0.256 Sum_probs=203.5
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVI 130 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~l 130 (346)
.++|+..++||+|+||+||.++. +++-+|+|++++..- ........|..++..+ +||+||+++..|.+.+.+||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v-~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKI-KHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC-CCCcEeeeEEecccCCeEEE
Confidence 57799999999999999999988 889999999876542 3456778888899997 99999999999999999999
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCccc
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI 210 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~ 210 (346)
|+||+.||.|..+|.+.+ .+++..+..++.+|+.||.||| +.+||||||||+|||+|.+|+++|+|||+|+..
T Consensus 103 Vld~~~GGeLf~hL~~eg----~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREG----RFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EEeccCCccHHHHHHhcC----CcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 999999999999998664 5899999999999999999999 999999999999999999999999999999855
Q ss_pred CCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 211 PEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 211 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
-... ..+...+||+.|||||++.+.+|+..+|+||+|+++|||++|.+||...+.... .
T Consensus 176 ~~~~-~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~----------~---------- 234 (357)
T KOG0598|consen 176 LKDG-DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM----------Y---------- 234 (357)
T ss_pred ccCC-CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH----------H----------
Confidence 4332 234557999999999999999999999999999999999999999987554332 1
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCC
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRP 329 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP 329 (346)
++.+....+. .+.-......+++...|+.+|++|.
T Consensus 235 ---~~I~~~k~~~-~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 235 ---DKILKGKLPL-PPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ---HHHhcCcCCC-CCccCCHHHHHHHHHHhccCHHHhc
Confidence 1111111111 1112556788999999999999996
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=357.57 Aligned_cols=268 Identities=23% Similarity=0.351 Sum_probs=220.1
Q ss_pred CCCHHHHHHHhcCCCcccccccCCCcEEEEEEECCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceee
Q 045453 46 GFTIRELEIATNNFDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCL 123 (346)
Q Consensus 46 ~~~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~ 123 (346)
+.+.++|.+..+.+.....||+|+||+||+|.|.| .||||+++.... .....|.+|+..+.+. +|.||+-|.|+|.
T Consensus 381 s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkT-RH~NIlLFMG~~~ 458 (678)
T KOG0193|consen 381 SDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKT-RHENILLFMGACM 458 (678)
T ss_pred CccccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhc-chhhheeeehhhc
Confidence 34558899999999999999999999999999976 799999986653 3456788889999888 9999999999999
Q ss_pred cCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEec
Q 045453 124 ETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFD 203 (346)
Q Consensus 124 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~D 203 (346)
..+. .+|+.+|+|.||+.+|+... ..+...+.++|+.|+|.|+.||| .++|||||||+.|||+.+++.+||+|
T Consensus 459 ~p~~-AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgD 531 (678)
T KOG0193|consen 459 NPPL-AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGD 531 (678)
T ss_pred CCce-eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEec
Confidence 8776 99999999999999999876 46999999999999999999999 99999999999999999999999999
Q ss_pred cCCCcccCCC-CceeeccccccCCcCCcccccc---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHH
Q 045453 204 FSLSVSIPEG-ETCVKDKVTGTMGFLAPEYINT---GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHY 279 (346)
Q Consensus 204 fgl~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 279 (346)
||++..-..- .........|...|||||++.. .+|++.|||||||+|+|||+||..||.....+.+
T Consensus 532 FGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI---------- 601 (678)
T KOG0193|consen 532 FGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI---------- 601 (678)
T ss_pred ccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe----------
Confidence 9998543211 1112234567889999999974 4689999999999999999999999984433332
Q ss_pred HHHHhhcCcccccccccccc---CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 045453 280 VKKCIENNEFDEIVDPIIVS---EGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHL 345 (346)
Q Consensus 280 ~~~~~~~~~~~~~~d~~l~~---~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~l 345 (346)
+-..-.+ .........++.++.+|+..||++++++||++.+|+..|+.+..++
T Consensus 602 -------------ifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 602 -------------IFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred -------------EEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 1111111 0011112266778999999999999999999999999999887643
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=352.62 Aligned_cols=266 Identities=21% Similarity=0.341 Sum_probs=208.8
Q ss_pred HHHhcCCCcccccccCCCcEEEEEEE-------CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeec
Q 045453 53 EIATNNFDARNVIKDGYAYKFYKGFV-------EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLE 124 (346)
Q Consensus 53 ~~~~~~f~~~~~ig~G~~g~Vy~~~~-------~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~ 124 (346)
....++|...++||+|+||.||+|.+ .+..||+|++..... .....+.+|+..+..+.+||||++++++|..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 34567788899999999999999975 235799999875432 3345678899999888789999999999876
Q ss_pred C-CcceEEEecccCCChhhhhhhcCCC-----------------------------------------------------
Q 045453 125 T-RIPVIVFESVKNRTLADHIYQNQPH----------------------------------------------------- 150 (346)
Q Consensus 125 ~-~~~~lv~e~~~~gsL~~~l~~~~~~----------------------------------------------------- 150 (346)
. +..++||||+++|+|.+++......
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 4 4578999999999999998753210
Q ss_pred -----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCce-eecccccc
Q 045453 151 -----FEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETC-VKDKVTGT 224 (346)
Q Consensus 151 -----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt 224 (346)
..++++.++..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++........ ......++
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 135889999999999999999999 899999999999999999999999999999866433222 12234466
Q ss_pred CCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccccccccCCCC
Q 045453 225 MGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPR 303 (346)
Q Consensus 225 ~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 303 (346)
..|+|||++.+..++.++||||||+++|||++ |..||......+. .. .....+... .
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~------~~----~~~~~~~~~-----~------- 297 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE------FC----QRLKDGTRM-----R------- 297 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH------HH----HHHhcCCCC-----C-------
Confidence 78999999999999999999999999999997 9999976433221 11 111111100 0
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 304 VGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 304 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
.+...+..+.+|+.+||+.+|++|||+.|+++.|+++++.
T Consensus 298 -~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 298 -APENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred -CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0113345688999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-47 Score=339.77 Aligned_cols=262 Identities=17% Similarity=0.254 Sum_probs=209.7
Q ss_pred CCccCCCHHHHHHHhcCCCcccccccCCCcEEEEEEECCeEEEEEEecCccCcc---hHHHHHHHHHHhhhcCCCceeeE
Q 045453 42 NPIRGFTIRELEIATNNFDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDG---HEDCFNNIIFASKLSSHKNVLKL 118 (346)
Q Consensus 42 ~~~~~~~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~---~~~~~~e~~~~~~~~~h~niv~l 118 (346)
..++.++.+++ +......||+|++|.||+|.++++.||||++....... ...+.+|+..+.++ +||||+++
T Consensus 10 ~~~~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~ 83 (283)
T PHA02988 10 NDIKCIESDDI-----DKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-DSNNILKI 83 (283)
T ss_pred CcceecCHHHc-----CCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhc-CCCCEEEE
Confidence 34556677776 23344689999999999999999999999987553322 35667899999998 99999999
Q ss_pred cceeec----CCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCceecCCCCCCeEE
Q 045453 119 TGCCLE----TRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFS-RPILHRKIRPSRIFL 193 (346)
Q Consensus 119 ~g~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~iiH~dlkp~NIll 193 (346)
+|++.+ ....++||||+++|+|.+++... ..++|...+.++.+++.||.||| . .+++||||||+|||+
T Consensus 84 ~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill 156 (283)
T PHA02988 84 YGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLV 156 (283)
T ss_pred eeeEEecccCCCceEEEEEeCCCCcHHHHHhhC----CCCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEE
Confidence 999876 34678999999999999999764 35899999999999999999999 5 488899999999999
Q ss_pred cCCCceEEeccCCCcccCCCCceeeccccccCCcCCcccccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccccc
Q 045453 194 DEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINT--GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGA 271 (346)
Q Consensus 194 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~ 271 (346)
++++.+||+|||+++...... ....++..|+|||++.+ ..++.++|||||||++|||++|..||......+.
T Consensus 157 ~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~-- 230 (283)
T PHA02988 157 TENYKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI-- 230 (283)
T ss_pred CCCCcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH--
Confidence 999999999999987654322 23467889999999976 6899999999999999999999999976433221
Q ss_pred chhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 045453 272 GHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQ 343 (346)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 343 (346)
.. .....+. ....+...+..+.+++.+||+.+|++|||+.|+++.|+.++.
T Consensus 231 -----~~---~i~~~~~-------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 231 -----YD---LIINKNN-------------SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred -----HH---HHHhcCC-------------CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 11 1111110 000011345678999999999999999999999999999875
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=371.92 Aligned_cols=268 Identities=25% Similarity=0.411 Sum_probs=227.1
Q ss_pred CHHHHHHHhcCCCcccccccCCCcEEEEEEE-------CCeEEEEEEecCccCc-chHHHHHHHHHHhhhcCCCceeeEc
Q 045453 48 TIRELEIATNNFDARNVIKDGYAYKFYKGFV-------EDRTVSVMKFNDILND-GHEDCFNNIIFASKLSSHKNVLKLT 119 (346)
Q Consensus 48 ~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~-------~~~~vavk~~~~~~~~-~~~~~~~e~~~~~~~~~h~niv~l~ 119 (346)
..+-.+..+++....+.||+|+||+||+|.. +...||||.++...+. ...+|.+|+..+..+ +|||||+|+
T Consensus 477 ~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l-~H~nIVrLl 555 (774)
T KOG1026|consen 477 DLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAEL-QHPNIVRLL 555 (774)
T ss_pred ccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhc-cCCCeEEEE
Confidence 3344455667777888999999999999987 3468999999877665 677888888888888 999999999
Q ss_pred ceeecCCcceEEEecccCCChhhhhhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCC
Q 045453 120 GCCLETRIPVIVFESVKNRTLADHIYQNQP----------HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPS 189 (346)
Q Consensus 120 g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~ 189 (346)
|+|.++++.++|+|||..|+|.++|..+.. ...+++-.+.+.||.|||.|+.||- ++.+|||||...
T Consensus 556 GVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATR 632 (774)
T KOG1026|consen 556 GVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATR 632 (774)
T ss_pred EEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhh
Confidence 999999999999999999999999975421 1234899999999999999999999 999999999999
Q ss_pred CeEEcCCCceEEeccCCCcccCCCCceeec-cccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCc
Q 045453 190 RIFLDEGYIAKLFDFSLSVSIPEGETCVKD-KVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGD 267 (346)
Q Consensus 190 NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~ 267 (346)
|.||+++..+||+|||+++.+-..+.+... ...-++.|||||-+..+++|++||||||||+|||++| |+-||.+...+
T Consensus 633 NCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~ 712 (774)
T KOG1026|consen 633 NCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ 712 (774)
T ss_pred hceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH
Confidence 999999999999999999988666655543 4456789999999999999999999999999999999 99999887775
Q ss_pred ccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 045453 268 EIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQ 343 (346)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 343 (346)
+. ...+..+.+ ..+++.++..+..|+..||+.+|++|||+.||-.+|+...+
T Consensus 713 EV-----------Ie~i~~g~l-------------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 713 EV-----------IECIRAGQL-------------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HH-----------HHHHHcCCc-------------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 53 122222221 23444788899999999999999999999999999998754
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-48 Score=353.76 Aligned_cols=258 Identities=22% Similarity=0.342 Sum_probs=216.4
Q ss_pred CCCHHHHHHHhcCCCcccccccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecC
Q 045453 46 GFTIRELEIATNNFDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLET 125 (346)
Q Consensus 46 ~~~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~ 125 (346)
.-.-+.|++..+.++....||+|+.|.||+|++.++.||||+++... ..++..|.++ +||||+.|.|+|+..
T Consensus 113 ~qq~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~elk-------ETdIKHLRkL-kH~NII~FkGVCtqs 184 (904)
T KOG4721|consen 113 QQQEELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVRELK-------ETDIKHLRKL-KHPNIITFKGVCTQS 184 (904)
T ss_pred hhhhhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhhh-------hhhHHHHHhc-cCcceeeEeeeecCC
Confidence 33446677777777888999999999999999999999999976432 3456778888 999999999999999
Q ss_pred CcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccC
Q 045453 126 RIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFS 205 (346)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg 205 (346)
..+|||||||+.|-|...|+..+ +++......|..+||.|+.||| .+.|||||||+-||||+-+..+||+|||
T Consensus 185 PcyCIiMEfCa~GqL~~VLka~~----~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFG 257 (904)
T KOG4721|consen 185 PCYCIIMEFCAQGQLYEVLKAGR----PITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFG 257 (904)
T ss_pred ceeEEeeeccccccHHHHHhccC----ccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEecccc
Confidence 99999999999999999998764 6888899999999999999999 9999999999999999999999999999
Q ss_pred CCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhh
Q 045453 206 LSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIE 285 (346)
Q Consensus 206 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (346)
-++-.... .......||..|||||++.+.+.++|+|||||||||||||||..||...+...+
T Consensus 258 TS~e~~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI---------------- 319 (904)
T KOG4721|consen 258 TSKELSDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI---------------- 319 (904)
T ss_pred chHhhhhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee----------------
Confidence 88766443 234567899999999999999999999999999999999999999976554332
Q ss_pred cCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 045453 286 NNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQ 343 (346)
Q Consensus 286 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 343 (346)
+--.-.+.-..+.+..+++.+.=|+++||+..|..|||+.+++.-|+-...
T Consensus 320 -------IwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 320 -------IWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred -------EEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 110000011112233778889999999999999999999999998875443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-47 Score=343.00 Aligned_cols=273 Identities=18% Similarity=0.168 Sum_probs=211.7
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecC--Ccce
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLET--RIPV 129 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~--~~~~ 129 (346)
.+.|+...+||+|.||.||+|++ +|..||+|++..+. ........+|+.+|.++ .||||++|.+..++. ..+|
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l-~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRL-DHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhc-CCCcccceeeEEEecCCceEE
Confidence 35577788999999999999999 88999999987654 34455667899999999 999999999999886 6899
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcc
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVS 209 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~ 209 (346)
||+|||+. +|.-++.... ..++..++..++.|++.||+|+| +.+|+|||||.+|||||.+|.+||+|||||++
T Consensus 195 lVFeYMdh-DL~GLl~~p~---vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPG---VKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARF 267 (560)
T ss_pred EEEecccc-hhhhhhcCCC---cccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceee
Confidence 99999987 9999987754 46999999999999999999999 99999999999999999999999999999998
Q ss_pred cCCCCceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhc-C
Q 045453 210 IPEGETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIEN-N 287 (346)
Q Consensus 210 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 287 (346)
.........+..+.|..|+|||++.+ ..|+.++|+||.||||.||++|++.|++.+.-+.....+.+........+. .
T Consensus 268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 87666655678889999999999987 469999999999999999999999999876544211111111111000000 0
Q ss_pred ccccccccccccCCCCcc---hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 288 EFDEIVDPIIVSEGPRVG---KEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 288 ~~~~~~d~~l~~~~~~~~---~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
++....--.....+.+.. ........++|+..+|..||.+|.|+.+++.
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 111000000000010000 0023466889999999999999999999875
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-47 Score=346.18 Aligned_cols=247 Identities=20% Similarity=0.321 Sum_probs=210.5
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecc
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESV 135 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~ 135 (346)
.|..-.+||+|+.|.||.|.. +++.||||++........+-.++|+.++... +|+|||.++..+..++.+|+|||||
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~-~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDL-HHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhc-cchHHHHHHHHhcccceeEEEEeec
Confidence 355567899999999999988 8889999999877777777789999999999 9999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCc
Q 045453 136 KNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGET 215 (346)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~ 215 (346)
++|+|.+.+... .+++.++..|+.+++.||+||| ..+|+|||||.+|||++.+|.+||+|||+|..+.....
T Consensus 353 ~ggsLTDvVt~~-----~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 353 EGGSLTDVVTKT-----RMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred CCCchhhhhhcc-----cccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 999999999764 4999999999999999999999 99999999999999999999999999999988764433
Q ss_pred eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccccc
Q 045453 216 CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDP 295 (346)
Q Consensus 216 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 295 (346)
.....+||+-|||||++....|.+|.||||||++++||+.|++||-..+.-. ...-...++. .
T Consensus 425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr----------AlyLIa~ng~-P----- 487 (550)
T KOG0578|consen 425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR----------ALYLIATNGT-P----- 487 (550)
T ss_pred -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH----------HHHHHhhcCC-C-----
Confidence 5678899999999999999999999999999999999999999996432211 1111111111 1
Q ss_pred ccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 296 IIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 296 ~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.+ ......+..+.+++.+||+.||++|||+.|+++
T Consensus 488 ~l------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 488 KL------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred Cc------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 11 112255677999999999999999999999985
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-47 Score=350.37 Aligned_cols=269 Identities=23% Similarity=0.342 Sum_probs=221.5
Q ss_pred cCCCHHHHHHHhcCCCcccccccCCCcEEEEEEE--C-C---eEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCce
Q 045453 45 RGFTIRELEIATNNFDARNVIKDGYAYKFYKGFV--E-D---RTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNV 115 (346)
Q Consensus 45 ~~~~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~--~-~---~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~ni 115 (346)
+...-..|+...++....++||+|+||.||+|.+ . + ..||+|...... .....++++|..++..+ +||||
T Consensus 145 ~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-~H~NV 223 (474)
T KOG0194|consen 145 RPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-NHPNV 223 (474)
T ss_pred ccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-CCCCE
Confidence 3345567888889999999999999999999999 2 2 238888877422 35567889999999998 99999
Q ss_pred eeEcceeecCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcC
Q 045453 116 LKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE 195 (346)
Q Consensus 116 v~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~ 195 (346)
|+++|++....++++|||+|+||+|.++|.... ..++..++..++.++|.||+||| +.+++||||...|+|++.
T Consensus 224 Vr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~ 297 (474)
T KOG0194|consen 224 VRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSK 297 (474)
T ss_pred EEEEEEEcCCCccEEEEEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecC
Confidence 999999999999999999999999999998875 36999999999999999999999 999999999999999999
Q ss_pred CCceEEeccCCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchh
Q 045453 196 GYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHY 274 (346)
Q Consensus 196 ~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~ 274 (346)
++.+||+|||+++.-.. .........-+..|+|||.+..+.|++++|||||||++||+.+ |..||.+....+.
T Consensus 298 ~~~vKISDFGLs~~~~~-~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v----- 371 (474)
T KOG0194|consen 298 KGVVKISDFGLSRAGSQ-YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV----- 371 (474)
T ss_pred CCeEEeCccccccCCcc-eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH-----
Confidence 99999999999875431 1111112245678999999999999999999999999999999 8999987655321
Q ss_pred hHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 275 WLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
..++ ....++.+.+...+..+..++.+||..+|++||||.++.+.|+.+...
T Consensus 372 --~~kI----------------~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 372 --KAKI----------------VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred --HHHH----------------HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 1111 122222223335567788899999999999999999999999998764
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=369.95 Aligned_cols=261 Identities=23% Similarity=0.385 Sum_probs=216.9
Q ss_pred hcCCCcccccccCCCcEEEEEEE---CC----eEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCc
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV---ED----RTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRI 127 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~---~~----~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~ 127 (346)
..+.+..+.||+|+||.||.|.+ .+ -.||+|.+....+ ....+|.+|...+..+ +|||||+++|+|.+...
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f-~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKF-DHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCcceeeEEEeecCCCC
Confidence 34455678999999999999998 22 2489999887655 4566777888888887 99999999999999999
Q ss_pred ceEEEecccCCChhhhhhhcC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEecc
Q 045453 128 PVIVFESVKNRTLADHIYQNQ---PHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDF 204 (346)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Df 204 (346)
.++++|||++|+|..+|+..+ .....++....+.++.|+|+|+.||+ ++++|||||...|+||+....+||+||
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEccc
Confidence 999999999999999998762 12357999999999999999999999 999999999999999999999999999
Q ss_pred CCCcccCCCCceeeccc-cccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHH
Q 045453 205 SLSVSIPEGETCVKDKV-TGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKK 282 (346)
Q Consensus 205 gl~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (346)
|+|+.+...+.+..... .-...|||||.+..+.+|.|+|||||||++||++| |..||...+..+. ...
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v-------~~~--- 916 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV-------LLD--- 916 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH-------HHH---
Confidence 99996655555444333 34568999999999999999999999999999999 9999987766443 111
Q ss_pred HhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 283 CIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 283 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
.+.+. ....+..+++.+.+++..||+.+|++||++..+++.+..+.+.
T Consensus 917 -------------~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 917 -------------VLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred -------------HHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 11111 2222337788899999999999999999999999999998764
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-48 Score=361.92 Aligned_cols=256 Identities=18% Similarity=0.312 Sum_probs=223.5
Q ss_pred CCCcccccccCCCcEEEEEEE-----CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 58 NFDARNVIKDGYAYKFYKGFV-----EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~-----~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
...++++||.|.||.|++|.+ ....||||.++.... ....+|+.|..+|.+. +||||++|.|+.+.....++|
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF-dHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC-CCCcEEEEEEEEecCceeEEE
Confidence 344678999999999999999 346999999986553 4567899999999998 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
+|||+||+|+.+|+.+.+ .+++.+..-|+.+||.|+.||- ..++|||||...|||+++|..+|++||||++.+.
T Consensus 709 TEyMENGsLDsFLR~~DG---qftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDG---QFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred hhhhhCCcHHHHHhhcCC---ceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeecc
Confidence 999999999999999874 4999999999999999999999 9999999999999999999999999999999887
Q ss_pred CCCceeecccc--ccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCc
Q 045453 212 EGETCVKDKVT--GTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE 288 (346)
Q Consensus 212 ~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (346)
++.....+... -+..|.|||.+..+++|.+|||||||++|||.++ |.+||-.+.+.+.
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV------------------- 843 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV------------------- 843 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH-------------------
Confidence 66533333333 3568999999999999999999999999999887 9999987766553
Q ss_pred cccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 289 FDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 289 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
-+.+..++..+++.+++..|.+|+++||++|-.+||++.+++..|++++.+
T Consensus 844 -----IkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 844 -----IKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred -----HHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 123444556666779999999999999999999999999999999999864
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=331.83 Aligned_cols=252 Identities=22% Similarity=0.283 Sum_probs=199.4
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCC--cceEEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETR--IPVIVF 132 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~--~~~lv~ 132 (346)
.++...+.||+|+||+||++.. ++...|||..............+|+.++..+ +|||||+.+|.....+ .+++.|
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l-~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRL-NHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhC-CCCCEEeeCCccccccCeeeEeee
Confidence 4466678999999999999999 4799999987655333356678999999999 7999999999865555 589999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcC-CCceEEeccCCCcccC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE-GYIAKLFDFSLSVSIP 211 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~-~~~~kl~Dfgl~~~~~ 211 (346)
||+++|||.+++...++ .+++..+..++.|+++||+||| +++|+||||||+|||++. ++.+||+|||++....
T Consensus 96 Ey~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 99999999999987653 5999999999999999999999 999999999999999999 7999999999987765
Q ss_pred CCC--ceeeccccccCCcCCccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCc
Q 045453 212 EGE--TCVKDKVTGTMGFLAPEYINTGD-FNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE 288 (346)
Q Consensus 212 ~~~--~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (346)
... ........||+.|||||++.++. ...++|||||||++.||+||+.||..... ...++-.......
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~---------~~~~~~~ig~~~~ 240 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE---------EAEALLLIGREDS 240 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc---------hHHHHHHHhccCC
Confidence 311 12234578999999999999643 33599999999999999999999975300 0000100000010
Q ss_pred cccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045453 289 FDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKR 337 (346)
Q Consensus 289 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 337 (346)
-|. -+...+....+++..|++.+|++||||.++++-
T Consensus 241 -----~P~--------ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h 276 (313)
T KOG0198|consen 241 -----LPE--------IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH 276 (313)
T ss_pred -----CCC--------CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence 011 111455678899999999999999999999864
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=317.96 Aligned_cols=270 Identities=17% Similarity=0.209 Sum_probs=207.0
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cch-HHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGH-EDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~-~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
.|+...++|+|+||.||++++ +|+-||||+|....+ ... +-.++|+.++..+ .|||+|.++.+|.....++||+|
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqL-kH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQL-KHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhc-ccchHHHHHHHHHhcceeEEEee
Confidence 466678899999999999999 899999999986654 333 3457888888888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
||+. ++.+-|.... ..++...+.+++.|+++|+.|+| ++++|||||||+|||++.+|.+||+|||+|+.+...
T Consensus 82 ~~dh-TvL~eLe~~p---~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 82 YCDH-TVLHELERYP---NGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred ecch-HHHHHHHhcc---CCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 9987 6666665543 35888899999999999999999 999999999999999999999999999999988743
Q ss_pred CceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccch-hh----HHHHHHHHhhcC
Q 045453 214 ETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGH-YW----LLHYVKKCIENN 287 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~-~~----~~~~~~~~~~~~ 287 (346)
. ...+..+.|..|+|||.+.+ .+|...+||||+||++.||++|.+.|.+..+-+..... .. +.....-...++
T Consensus 155 g-d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 155 G-DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred c-chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 2 23456788999999999987 78999999999999999999999999876654321000 00 011111111122
Q ss_pred ccccccccccccCCCCc-chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 288 EFDEIVDPIIVSEGPRV-GKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 288 ~~~~~~d~~l~~~~~~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
-+..+.-|......+.. -.+.....+.+++..||+.||++|++.+|++.
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 23322222222111100 01134457899999999999999999999874
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=327.74 Aligned_cols=255 Identities=16% Similarity=0.298 Sum_probs=203.8
Q ss_pred hcCCCcccccccCCCcEEEEEEE-----CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcce
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV-----EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV 129 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~-----~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~ 129 (346)
.++|...+.||+|+||.||+|.+ .+..||+|.+..... .....+.+|+..+..+ +||||++++|++..++..+
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF-DHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEecCCCcE
Confidence 35688889999999999999976 356899999875533 2335677888888887 9999999999999999999
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcc
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVS 209 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~ 209 (346)
+||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+|||++.++.++++|||.+..
T Consensus 83 lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred EEEEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCccccc
Confidence 9999999999999997643 36899999999999999999999 89999999999999999999999999998765
Q ss_pred cCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCc
Q 045453 210 IPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE 288 (346)
Q Consensus 210 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (346)
.............++..|+|||++.+..++.++||||||+++||+++ |..||......+. +.. ...+.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~----------~~~-~~~~~ 225 (266)
T cd05064 157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV----------IKA-VEDGF 225 (266)
T ss_pred ccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH----------HHH-HHCCC
Confidence 43222211222335678999999999999999999999999999775 9999975433211 111 11110
Q ss_pred cccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 045453 289 FDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341 (346)
Q Consensus 289 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 341 (346)
. .+.+...+..+.+++..||+.+|++|||+.++.+.|+++
T Consensus 226 ~-------------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 R-------------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred C-------------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0 001113456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=337.23 Aligned_cols=264 Identities=17% Similarity=0.222 Sum_probs=207.8
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCC-cceEEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETR-IPVIVF 132 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~-~~~lv~ 132 (346)
++|...++||.|.||.||+|+. .+..||||++....- ...---++|+..+.++..|||||++..++.+.+ .+++||
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 5577788999999999999998 888999998875542 233345789999999944999999999999887 999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
|||+. +|+++++.++ ..+++..+..|+.||++||+|+| .+|+.|||+||+|||+..+..+||+|||+|+.+..
T Consensus 90 E~Md~-NLYqLmK~R~---r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 90 EFMDC-NLYQLMKDRN---RLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred Hhhhh-hHHHHHhhcC---CcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEeccccccccccc
Confidence 99966 9999998875 68999999999999999999999 99999999999999999999999999999998865
Q ss_pred CCceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccc
Q 045453 213 GETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDE 291 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (346)
... -+..+.|..|+|||++.. +-|+.+.|+|++|||++|+.+-++.|.+.++-+. +--+...+....-..
T Consensus 163 kpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dq-------i~KIc~VLGtP~~~~ 233 (538)
T KOG0661|consen 163 KPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQ-------IYKICEVLGTPDKDS 233 (538)
T ss_pred CCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHH-------HHHHHHHhCCCcccc
Confidence 443 456788999999999875 6689999999999999999999999987654331 011111111111000
Q ss_pred ------------ccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 292 ------------IVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 292 ------------~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
+--+...+..-..-.+.+..++.+++.+|+++||.+|||+.|.++
T Consensus 234 ~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 234 WPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ 290 (538)
T ss_pred chhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence 001111111000001146678999999999999999999999875
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=327.19 Aligned_cols=266 Identities=21% Similarity=0.318 Sum_probs=207.9
Q ss_pred HHHHHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcc-hHHHHHHHHHHhhhcCCCceeeEcceeecCC
Q 045453 50 RELEIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDG-HEDCFNNIIFASKLSSHKNVLKLTGCCLETR 126 (346)
Q Consensus 50 ~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~-~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~ 126 (346)
.++....++|+...+||.|..++||+|.. .+..||||+++-+.... .....+|+..+..+ +||||++++.+|..+.
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~-~HPNIv~~~~sFvv~~ 97 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLI-DHPNIVTYHCSFVVDS 97 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhc-CCCCcceEEEEEEecc
Confidence 34445567899999999999999999999 88999999998665443 45566666666665 9999999999999999
Q ss_pred cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCC
Q 045453 127 IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSL 206 (346)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl 206 (346)
.+|+||.||.+||+.+.++..-. ..+++..+..|+.++++||.||| .+|.||||||+.||||+.+|.+||+|||.
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgv 172 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGV 172 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCcee
Confidence 99999999999999999987543 35999999999999999999999 99999999999999999999999999997
Q ss_pred CcccCCCC-ceee--ccccccCCcCCcccccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHH
Q 045453 207 SVSIPEGE-TCVK--DKVTGTMGFLAPEYINT--GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVK 281 (346)
Q Consensus 207 ~~~~~~~~-~~~~--~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 281 (346)
+..+-... .... ...+||++|||||++.. .+|+.|+||||||++..|+.+|..||....+-.. + -
T Consensus 173 sa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv------L----l 242 (516)
T KOG0582|consen 173 SASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV------L----L 242 (516)
T ss_pred eeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH------H----H
Confidence 65543322 2221 45689999999999543 5799999999999999999999999986543221 1 1
Q ss_pred HHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 282 KCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 282 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
..+.+.... .+ .+..+-.........+.+++..||+.||.+|||+.++++
T Consensus 243 ~tLqn~pp~--~~---t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 243 LTLQNDPPT--LL---TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred HHhcCCCCC--cc---cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 111111100 00 000000011234568999999999999999999999875
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-46 Score=336.91 Aligned_cols=252 Identities=21% Similarity=0.271 Sum_probs=207.1
Q ss_pred HHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCc
Q 045453 53 EIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRI 127 (346)
Q Consensus 53 ~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~ 127 (346)
++..++|...++||.|+|++|++|.. ++..+|||++.+..- ...+-...|-..|..+..||.|++|+..|.+...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 45568899999999999999999998 889999999875432 2233445666677777799999999999999999
Q ss_pred ceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCC
Q 045453 128 PVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS 207 (346)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~ 207 (346)
+|+|+||+++|+|.++|+.-+ .+++.....++.+|+.||+||| +.|||||||||+|||+|+||++||+|||.|
T Consensus 149 LYFvLe~A~nGdll~~i~K~G----sfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYG----SFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhC----cchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeecccc
Confidence 999999999999999998764 6999999999999999999999 999999999999999999999999999999
Q ss_pred cccCCCCce----------ee--ccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhh
Q 045453 208 VSIPEGETC----------VK--DKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYW 275 (346)
Q Consensus 208 ~~~~~~~~~----------~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~ 275 (346)
+.+...... .. ...+||..|.+||++..+..+..+|+|+|||+||.|+.|.+||...+.--.
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli------ 295 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI------ 295 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH------
Confidence 877532211 11 457899999999999999999999999999999999999999986554221
Q ss_pred HHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 276 LLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
+.+ .+.-.+.. ++..++...+|+.+.|..||.+|+|..++.+
T Consensus 296 ---Fqk--------------I~~l~y~f--p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 296 ---FQK--------------IQALDYEF--PEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred ---HHH--------------HHHhcccC--CCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 111 11111111 1134466888999999999999999977754
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=335.78 Aligned_cols=249 Identities=16% Similarity=0.217 Sum_probs=203.5
Q ss_pred HHHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCC
Q 045453 52 LEIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETR 126 (346)
Q Consensus 52 l~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~ 126 (346)
.+...++|+...+||+|+||.||+|+- +|..+|+|++.+.. .....+...|-.+|... .+|+||+|+..|.+.+
T Consensus 136 ~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD~~ 214 (550)
T KOG0605|consen 136 TRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQDKE 214 (550)
T ss_pred ccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecCCC
Confidence 345678899999999999999999987 89999999998653 23455667777777775 9999999999999999
Q ss_pred cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCC
Q 045453 127 IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSL 206 (346)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl 206 (346)
.+||||||++||++..+|...+ .|+..+...++.+++.|+..|| ..|+|||||||+|+|||.+|++||+||||
T Consensus 215 ~LYLiMEylPGGD~mTLL~~~~----~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGL 287 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLLMRKD----TLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGL 287 (550)
T ss_pred eeEEEEEecCCccHHHHHHhcC----cCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccc
Confidence 9999999999999999998764 6999999999999999999999 99999999999999999999999999999
Q ss_pred CcccCC----------------------CCce-----e-------------------eccccccCCcCCccccccCCCCc
Q 045453 207 SVSIPE----------------------GETC-----V-------------------KDKVTGTMGFLAPEYINTGDFNE 240 (346)
Q Consensus 207 ~~~~~~----------------------~~~~-----~-------------------~~~~~gt~~y~aPE~~~~~~~~~ 240 (346)
|..+.. ++.. . .-..+||+.|||||++.+.+|+.
T Consensus 288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~ 367 (550)
T KOG0605|consen 288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGK 367 (550)
T ss_pred cchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCc
Confidence 853310 0000 0 01347999999999999999999
Q ss_pred ccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHc
Q 045453 241 KCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMC 320 (346)
Q Consensus 241 ~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~c 320 (346)
.+|+||+|||+||||.|.+||...+..+. ...+..|...+..+ .......+..+||.+|
T Consensus 368 ~cDwWSLG~ImyEmLvGyPPF~s~tp~~T---~rkI~nwr~~l~fP------------------~~~~~s~eA~DLI~rl 426 (550)
T KOG0605|consen 368 ECDWWSLGCIMYEMLVGYPPFCSETPQET---YRKIVNWRETLKFP------------------EEVDLSDEAKDLITRL 426 (550)
T ss_pred cccHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhhhccCC------------------CcCcccHHHHHHHHHH
Confidence 99999999999999999999998776553 12233333322111 1113346688999999
Q ss_pred ccCCCCCCCC
Q 045453 321 VCESAEDRPT 330 (346)
Q Consensus 321 l~~~p~~RPs 330 (346)
+. ||++|.-
T Consensus 427 l~-d~~~RLG 435 (550)
T KOG0605|consen 427 LC-DPENRLG 435 (550)
T ss_pred hc-CHHHhcC
Confidence 98 9999976
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=327.17 Aligned_cols=262 Identities=20% Similarity=0.326 Sum_probs=202.5
Q ss_pred cCCCcccccccCCCcEEEEEEEC------------------CeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceee
Q 045453 57 NNFDARNVIKDGYAYKFYKGFVE------------------DRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLK 117 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~~------------------~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~ 117 (346)
++|...+.||+|+||.||+|.+. +..||+|.+..... ....++.+|+..+.++ +||||++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 83 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRL-KDPNIIR 83 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhc-CCCCeeE
Confidence 56778899999999999999752 23699998875432 3345678888888888 9999999
Q ss_pred EcceeecCCcceEEEecccCCChhhhhhhcCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCce
Q 045453 118 LTGCCLETRIPVIVFESVKNRTLADHIYQNQP---------------HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPIL 182 (346)
Q Consensus 118 l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ii 182 (346)
+++++.+.+..++||||+++|+|.+++..... ....++|..++.++.|++.||.||| +.+++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence 99999999999999999999999999865321 1135788999999999999999999 89999
Q ss_pred ecCCCCCCeEEcCCCceEEeccCCCcccCCCCce-eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh--CCC
Q 045453 183 HRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETC-VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT--GQK 259 (346)
Q Consensus 183 H~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt--g~~ 259 (346)
||||||+|||++.++.+||+|||+++........ ......++..|+|||++.++.++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999766443322 1233446788999999998999999999999999999987 556
Q ss_pred CCCCCCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 045453 260 IFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLK 339 (346)
Q Consensus 260 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 339 (346)
||......+ ....+............ ... ++.++..+.+|+.+||+.+|++|||+.+|.+.|+
T Consensus 241 p~~~~~~~~-------~~~~~~~~~~~~~~~~~------~~~----~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTDEQ-------VIENAGEFFRDQGRQVY------LFR----PPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCHHH-------HHHHHHHHhhhcccccc------ccC----CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 776543322 12222221111110000 000 0133467899999999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=304.78 Aligned_cols=264 Identities=17% Similarity=0.211 Sum_probs=208.1
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
.|...+++|+|.||.||+|.+ +|+.||||++.... +.-.....+|+..++.+ +||||+.++++|...+.+.||+|
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel-~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQEL-KHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHc-cCcchhhhhhhccCCCceEEEEE
Confidence 466788999999999999999 89999999987543 22345788999999999 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
||+. +|+..+++.. ..++..++..++.++.+||+||| ...|+||||||.|+|++++|.+||+|||+++.++..
T Consensus 82 fm~t-dLe~vIkd~~---i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKN---IILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhcccc---cccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9987 9999998876 57899999999999999999999 999999999999999999999999999999998765
Q ss_pred CceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcC-----
Q 045453 214 ETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENN----- 287 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 287 (346)
.... +..+.|..|+|||.+.+ ..|+..+|+||.|||+.||+-|.+.|.+.++-+. +....+ .+...
T Consensus 155 ~~~~-~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQ------L~~If~-~LGTP~~~~W 226 (318)
T KOG0659|consen 155 NRIQ-THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQ------LSKIFR-ALGTPTPDQW 226 (318)
T ss_pred Cccc-ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHH------HHHHHH-HcCCCCcccC
Confidence 5432 33478999999998876 5799999999999999999999988877654321 111111 11111
Q ss_pred -ccccccccccccCCCCc----chHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045453 288 -EFDEIVDPIIVSEGPRV----GKEKQLQGFRELALMCVCESAEDRPTTVDVAKR 337 (346)
Q Consensus 288 -~~~~~~d~~l~~~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 337 (346)
++..+-|-.-....+.+ -.........+|+..++..||.+|+|+.|+++.
T Consensus 227 P~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 227 PEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11111110000000100 011445667999999999999999999998763
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-45 Score=340.32 Aligned_cols=264 Identities=20% Similarity=0.284 Sum_probs=206.9
Q ss_pred HHHHhcCCCcccccccCCCcEEEEEEE-------CCeEEEEEEecCcc-CcchHHHHHHHHHHhhhcCCCceeeEcceee
Q 045453 52 LEIATNNFDARNVIKDGYAYKFYKGFV-------EDRTVSVMKFNDIL-NDGHEDCFNNIIFASKLSSHKNVLKLTGCCL 123 (346)
Q Consensus 52 l~~~~~~f~~~~~ig~G~~g~Vy~~~~-------~~~~vavk~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~ 123 (346)
+....++|...+.||+|+||.||+|.+ .+..||+|++.... ......+.+|+..+..+.+||||++++++|.
T Consensus 30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 445566788899999999999999974 34589999986443 2334567788888888878999999999999
Q ss_pred cCCcceEEEecccCCChhhhhhhcCC------------------------------------------------------
Q 045453 124 ETRIPVIVFESVKNRTLADHIYQNQP------------------------------------------------------ 149 (346)
Q Consensus 124 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------ 149 (346)
.++..++||||+++|+|.+++.....
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 99999999999999999999865321
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 150 -----------------HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 150 -----------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
....++|..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||+++....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 0125789999999999999999999 89999999999999999999999999999976644
Q ss_pred CCcee-eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 213 GETCV-KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 213 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
..... .....++..|+|||++.+..++.++||||||+++|||++ |..||........ ....+ ..+...
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~------~~~~~----~~~~~~ 336 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK------FYKMI----KEGYRM 336 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH------HHHHH----HhCccC
Confidence 33211 222345678999999999999999999999999999998 8889865432211 11111 111000
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 341 (346)
.. +...+..+.+|+..||+.+|++|||+.||++.|++.
T Consensus 337 ---------~~----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 337 ---------LS----PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ---------CC----CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 00 002245688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-45 Score=339.74 Aligned_cols=266 Identities=20% Similarity=0.334 Sum_probs=207.6
Q ss_pred HHHHHhcCCCcccccccCCCcEEEEEEE-------CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEccee
Q 045453 51 ELEIATNNFDARNVIKDGYAYKFYKGFV-------EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCC 122 (346)
Q Consensus 51 ~l~~~~~~f~~~~~ig~G~~g~Vy~~~~-------~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~ 122 (346)
.|....++|...+.||+|+||.||+|.+ ++..||+|++..... .....+.+|+..+..+.+|||||+++++|
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 4455566888999999999999999985 224799999875432 23445678888888876899999999999
Q ss_pred ecCCcceEEEecccCCChhhhhhhcCC-----------------------------------------------------
Q 045453 123 LETRIPVIVFESVKNRTLADHIYQNQP----------------------------------------------------- 149 (346)
Q Consensus 123 ~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------- 149 (346)
.+.+..++||||+++|+|.+++.....
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 999999999999999999999864210
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCce
Q 045453 150 -------------HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETC 216 (346)
Q Consensus 150 -------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 216 (346)
...++++..++.++.|++.||.||| +.+++||||||+|||++.++.+||+|||+++........
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 0135789999999999999999999 899999999999999999999999999998766433321
Q ss_pred -eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccc
Q 045453 217 -VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVD 294 (346)
Q Consensus 217 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 294 (346)
......++..|+|||++.+..++.++||||||+++|||++ |+.||........ .... ...+. .
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~------~~~~----~~~~~-----~ 333 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK------FYKM----VKRGY-----Q 333 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH------HHHH----HHccc-----C
Confidence 1222345678999999999999999999999999999998 9999975432211 0010 11100 0
Q ss_pred cccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 045453 295 PIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIY 342 (346)
Q Consensus 295 ~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~ 342 (346)
. . .+...+..+.+++.+||+.+|++|||+.+|++.|+++.
T Consensus 334 ~----~----~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 334 M----S----RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred c----c----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 0 0 00022456889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=325.88 Aligned_cols=250 Identities=21% Similarity=0.303 Sum_probs=199.3
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
+|...+.||+|+||+||+|.+ ++..||+|.+..... .....+.+|+..+..+ +|+||+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-CCCcEEEEEEEEccCCeEEEEE
Confidence 367788999999999999988 788999998764321 2234566788888888 9999999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
||+++|+|.+++..... ..+++..+..++.|++.||.||| +.+++||||||+|||+++++.+||+|||++.....
T Consensus 80 e~~~~g~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 80 TIMNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred EecCCCcHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 99999999988865432 35899999999999999999999 89999999999999999999999999999977643
Q ss_pred CCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccc
Q 045453 213 GETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEI 292 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (346)
... .....||..|+|||++.+..++.++|||||||++|||++|+.||........ . ..+........
T Consensus 155 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~------~-~~~~~~~~~~~---- 221 (285)
T cd05631 155 GET--VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK------R-EEVDRRVKEDQ---- 221 (285)
T ss_pred CCe--ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh------H-HHHHHHhhccc----
Confidence 322 2345689999999999999999999999999999999999999986543221 0 00000000000
Q ss_pred cccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 045453 293 VDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPT-----TVDVAK 336 (346)
Q Consensus 293 ~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~ 336 (346)
... .......+.+|+.+||+.+|++||+ +.++++
T Consensus 222 ------~~~----~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 222 ------EEY----SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ------ccC----CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 000 1133456889999999999999997 777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=320.69 Aligned_cols=255 Identities=20% Similarity=0.305 Sum_probs=206.2
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
..+|...+.||+|++|.||+|.+ .+..+++|.+... .....++.+|+..+..+ +||||++++++|...+..++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhC-CCCChhheEEEEcCCCCcEEEEE
Confidence 34577888999999999999998 5788999987643 33456778888989888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
|+++++|.+++..... ..+++..++.++.|++.||+||| +.+++|+||||+||++++++.+||+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 83 FMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred eCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 9999999999976432 45899999999999999999999 899999999999999999999999999998776543
Q ss_pred CceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCccccc
Q 045453 214 ETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEI 292 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (346)
.........++..|+|||++.+..++.++||||||+++|||++ |..||......+. ... .....
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~----------~~~-~~~~~---- 222 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV----------YEL-LEKGY---- 222 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH----------HHH-HHCCC----
Confidence 3322222334668999999999999999999999999999998 9999875432211 111 11110
Q ss_pred cccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 045453 293 VDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341 (346)
Q Consensus 293 ~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 341 (346)
... .+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 223 -----~~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 223 -----RME----RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -----CCC----CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 000 0113346688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=320.89 Aligned_cols=256 Identities=21% Similarity=0.349 Sum_probs=206.2
Q ss_pred HhcCCCcccccccCCCcEEEEEEE-CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
..++|+..+.||+|+||.||+|.+ ++..+|+|.+.... .....+.+|...+..+ +||||+++++++...+..++|||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTL-QHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCcEEEEe
Confidence 346788889999999999999998 66789999876432 2346677888888888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
|+++++|.+++..... ..+++..++.++.+++.||+||| +.+++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 82 YMAKGSLLDFLKSDEG--GKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred cCCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 9999999999976432 46899999999999999999999 899999999999999999999999999999876543
Q ss_pred CceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCccccc
Q 045453 214 ETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEI 292 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (346)
.........++..|+|||++....++.++||||||+++|+|+| |..||....... ....+ .....
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~----~~~~~--- 222 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-------VMSAL----QRGYR--- 222 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-------HHHHH----HcCCC---
Confidence 3322233446678999999998899999999999999999999 999996543221 11111 11100
Q ss_pred cccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 045453 293 VDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341 (346)
Q Consensus 293 ~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 341 (346)
.+.....+..+.+++.+||+.+|++|||+.++.+.|+++
T Consensus 223 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 223 ----------MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred ----------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 000112345688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=331.36 Aligned_cols=249 Identities=25% Similarity=0.319 Sum_probs=204.0
Q ss_pred HHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc----C-cchHHHHHHHHHHhhhcCCCceeeEcceeecCC
Q 045453 54 IATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL----N-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETR 126 (346)
Q Consensus 54 ~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~----~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~ 126 (346)
...+.|...+.||+|+||+|+.|.+ ++..||+|.+.... . .......+|+..+..+..||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4457888999999999999999988 78999999765531 1 223445578888888833999999999999999
Q ss_pred cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCC-CceEEeccC
Q 045453 127 IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEG-YIAKLFDFS 205 (346)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~-~~~kl~Dfg 205 (346)
.+++||||+.+|+|.+++... .++.+.....+..|++.|++|+| +.+|+||||||+|||+|.+ +++||+|||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~----g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNK----GRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred eEEEEEEecCCccHHHHHHHc----CCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 999999999999999999884 36888999999999999999999 9999999999999999999 999999999
Q ss_pred CCcccCCCCceeeccccccCCcCCccccccCC-CC-cccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHH
Q 045453 206 LSVSIPEGETCVKDKVTGTMGFLAPEYINTGD-FN-EKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKC 283 (346)
Q Consensus 206 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 283 (346)
++.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||+..+.... ...
T Consensus 167 ~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l----------~~k- 234 (370)
T KOG0583|consen 167 LSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL----------YRK- 234 (370)
T ss_pred cccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH----------HHH-
Confidence 998774 1222345678999999999999977 85 789999999999999999999987332221 111
Q ss_pred hhcCccccccccccccCCCCcchHHH-HHHHHHHHHHcccCCCCCCCCHHHHH
Q 045453 284 IENNEFDEIVDPIIVSEGPRVGKEKQ-LQGFRELALMCVCESAEDRPTTVDVA 335 (346)
Q Consensus 284 ~~~~~~~~~~d~~l~~~~~~~~~~~~-~~~l~~l~~~cl~~~p~~RPs~~ev~ 335 (346)
+. .+....+. .. ...+..|+.+||..+|..|+|+.+++
T Consensus 235 i~------------~~~~~~p~--~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 235 IR------------KGEFKIPS--YLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred Hh------------cCCccCCC--CcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 11 11111111 22 56788999999999999999999998
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-45 Score=338.74 Aligned_cols=245 Identities=19% Similarity=0.225 Sum_probs=207.0
Q ss_pred HHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCc
Q 045453 53 EIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRI 127 (346)
Q Consensus 53 ~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~ 127 (346)
....++|...++||+|+||+|+++.. +++.+|||.+.+.. +...+....|-.++....+||.++.++++|.+.++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 34457899999999999999999999 78899999988664 35666777777777777689999999999999999
Q ss_pred ceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCC
Q 045453 128 PVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS 207 (346)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~ 207 (346)
+|.||||+.||++..+.+. ..++++.+..+++.|+.||+||| .++|||||||.+|||||.+|++||+|||++
T Consensus 444 l~fvmey~~Ggdm~~~~~~-----~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlc 515 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHT-----DVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLC 515 (694)
T ss_pred EEEEEEecCCCcEEEEEec-----ccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccc
Confidence 9999999999996665554 35999999999999999999999 999999999999999999999999999999
Q ss_pred cccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcC
Q 045453 208 VSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENN 287 (346)
Q Consensus 208 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (346)
+..--.. ..+.+.+||+.|||||++.++.|+.++|+|||||+||||+.|+.||.+.+.++.
T Consensus 516 Ke~m~~g-~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~------------------ 576 (694)
T KOG0694|consen 516 KEGMGQG-DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV------------------ 576 (694)
T ss_pred cccCCCC-CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH------------------
Confidence 7643222 245678999999999999999999999999999999999999999998777554
Q ss_pred ccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCH
Q 045453 288 EFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTT 331 (346)
Q Consensus 288 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 331 (346)
.|..+..+.. .+...+.+...|+.+++..+|++|.-+
T Consensus 577 -----FdsI~~d~~~--yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 577 -----FDSIVNDEVR--YPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -----HHHHhcCCCC--CCCcccHHHHHHHHHHhccCcccccCC
Confidence 2332222211 122566778899999999999999877
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=317.20 Aligned_cols=250 Identities=20% Similarity=0.310 Sum_probs=201.7
Q ss_pred cCCCcccccccCCCcEEEEEEE-CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecc
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESV 135 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~ 135 (346)
++|+..+.||+|+||.||++.+ ++..+|+|.+... .....++.+|+..+..+ +||||+++++++.+.+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKL-SHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHC-CCCCceeEEEEEccCCCEEEEEEcC
Confidence 4577788999999999999999 5568999987633 23356788888989888 9999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCc
Q 045453 136 KNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGET 215 (346)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~ 215 (346)
++|+|.+++.... ..+++..+..++.+++.||.||| +.+++|+||||+||+++.++.+||+|||.++.......
T Consensus 82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 82 ENGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 9999999987643 25899999999999999999999 89999999999999999999999999999876644333
Q ss_pred eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccc
Q 045453 216 CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVD 294 (346)
Q Consensus 216 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 294 (346)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||......+. ...+. . +.. ...
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~-------~~~i~---~-~~~--~~~ 222 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV-------VEMIS---R-GFR--LYR 222 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHH---C-CCC--CCC
Confidence 22233345668999999998899999999999999999999 8999975433221 11111 1 100 000
Q ss_pred cccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 045453 295 PIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRL 338 (346)
Q Consensus 295 ~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 338 (346)
+......+.+++.+||+.+|++|||+.++++.|
T Consensus 223 -----------~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 223 -----------PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred -----------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 002235689999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=338.82 Aligned_cols=266 Identities=21% Similarity=0.293 Sum_probs=229.0
Q ss_pred CHHHHHHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecC
Q 045453 48 TIRELEIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLET 125 (346)
Q Consensus 48 ~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~ 125 (346)
.+++|+....++...++||-|.||.||.|.| ..-.||||.+..+ .....+|+.|..++..+ .|||+|+|+|+|+..
T Consensus 258 n~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKei-kHpNLVqLLGVCT~E 335 (1157)
T KOG4278|consen 258 NADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTHE 335 (1157)
T ss_pred CcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhh-cCccHHHHhhhhccC
Confidence 3489999999999999999999999999999 5678999988654 46778999999999999 999999999999999
Q ss_pred CcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccC
Q 045453 126 RIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFS 205 (346)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg 205 (346)
..+|||+|||.+|+|.++|+..+. ..++-...++|+.||+.|+.||. .+++|||||...|.|+.++..+|++|||
T Consensus 336 pPFYIiTEfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFG 410 (1157)
T KOG4278|consen 336 PPFYIITEFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFG 410 (1157)
T ss_pred CCeEEEEecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccc
Confidence 999999999999999999987653 45777788999999999999999 9999999999999999999999999999
Q ss_pred CCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHh
Q 045453 206 LSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCI 284 (346)
Q Consensus 206 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (346)
|++++..+....-......+-|.|||-+....++.|+|||+|||+|||+.| |..||.+.+-.. |..+
T Consensus 411 LsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-----------VY~L- 478 (1157)
T KOG4278|consen 411 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----------VYGL- 478 (1157)
T ss_pred hhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH-----------HHHH-
Confidence 999998766544444445678999999999999999999999999999999 999997643322 1222
Q ss_pred hcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 285 ENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 285 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
+...+....+..|+..+.+|++.||+++|.+||++.|+-+.++.++.+
T Consensus 479 ------------LEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 479 ------------LEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred ------------HhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 222333333447788899999999999999999999999999998764
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=319.21 Aligned_cols=256 Identities=23% Similarity=0.321 Sum_probs=206.5
Q ss_pred HhcCCCcccccccCCCcEEEEEEE-CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
..++|+..+.||+|++|.||+|.+ .++.||+|.+.... ....++.+|+..+.++ +||||+++++++...+..++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKL-RHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHC-CCCCccceeEEEecCCCeeeeee
Confidence 456788899999999999999998 66789999876432 3456678888888888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
|+++++|.+++.... ...+++..+..++.+++.||.||| +.+++|+||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 82 LMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred cccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 999999999997653 246899999999999999999999 899999999999999999999999999999876533
Q ss_pred CceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCccccc
Q 045453 214 ETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEI 292 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (346)
..........+..|+|||+..+..++.++||||||+++|||+| |+.||........ ...+ ....
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-------~~~~----~~~~---- 221 (261)
T cd05068 157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV-------LQQV----DQGY---- 221 (261)
T ss_pred cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-------HHHH----HcCC----
Confidence 2211222223457999999999999999999999999999999 9999975432211 1111 1100
Q ss_pred cccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 045453 293 VDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341 (346)
Q Consensus 293 ~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 341 (346)
........+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 222 ---------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 222 ---------RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ---------CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 0001113456789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=324.24 Aligned_cols=248 Identities=31% Similarity=0.480 Sum_probs=195.1
Q ss_pred cccccccCCCcEEEEEEEC------CeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 61 ARNVIKDGYAYKFYKGFVE------DRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 61 ~~~~ig~G~~g~Vy~~~~~------~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
..+.||.|+||.||+|.+. +..|+||.+..... .....+.+|+..+.++ +||||++++|+|...+..++|||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEESSSSEEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccc-ccccccccccccccccccccccc
Confidence 3568999999999999996 68999999965433 3467889999999999 99999999999998888999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
|+++|+|.++|..... ..+++..++.|+.|++.||.||| +.+++|+||+++|||+++++.+||+|||++......
T Consensus 82 ~~~~g~L~~~L~~~~~--~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNK--EPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp --TTEBHHHHHHHTCT--TTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred cccccccccccccccc--ccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 9999999999988622 46999999999999999999999 889999999999999999999999999998876433
Q ss_pred Cce-eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCcccc
Q 045453 214 ETC-VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDE 291 (346)
Q Consensus 214 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (346)
... ..........|+|||.+.+..++.++||||||+++||+++ |+.||......+ ..... ..+...
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~----------~~~~~-~~~~~~- 224 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE----------IIEKL-KQGQRL- 224 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH----------HHHHH-HTTEET-
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----------ccccc-cccccc-
Confidence 222 2234456778999999999999999999999999999999 788886543222 11111 111110
Q ss_pred ccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 045453 292 IVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRL 338 (346)
Q Consensus 292 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 338 (346)
..+..++..+.+++..||+.+|++|||+.++++.|
T Consensus 225 ------------~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 ------------PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ------------TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ------------eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 01113456688999999999999999999999987
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=320.94 Aligned_cols=261 Identities=21% Similarity=0.346 Sum_probs=209.1
Q ss_pred hcCCCcccccccCCCcEEEEEEE-------CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcc
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV-------EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIP 128 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~-------~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~ 128 (346)
.++|...+.||+|+||.||++.. ++..+|+|.+..........+.+|+..+.++ +||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcc
Confidence 46788899999999999999985 2356888888765545566788888888888 999999999999999999
Q ss_pred eEEEecccCCChhhhhhhcCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCce
Q 045453 129 VIVFESVKNRTLADHIYQNQP---------HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIA 199 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~---------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~ 199 (346)
++||||+++++|.+++..... ....+++..++.++.|++.||+||| +.+++||||||+|||+++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcE
Confidence 999999999999999975431 1235899999999999999999999 8999999999999999999999
Q ss_pred EEeccCCCcccCCCCc-eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHH
Q 045453 200 KLFDFSLSVSIPEGET-CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLL 277 (346)
Q Consensus 200 kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 277 (346)
||+|||+++....... .......++..|+|||++.+..++.++||||||+++++|++ |..||......+.
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~-------- 231 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV-------- 231 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--------
Confidence 9999999876643322 11223445778999999998999999999999999999999 8999865433211
Q ss_pred HHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 278 HYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 278 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
... ...+.... . ....+..+.+|+.+||+.+|.+|||+.+|.+.|+++.+.
T Consensus 232 --~~~-i~~~~~~~-----~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 232 --IEC-ITQGRVLQ-----R--------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred --HHH-HHcCCcCC-----C--------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 111 11111100 0 002335689999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-45 Score=308.39 Aligned_cols=235 Identities=20% Similarity=0.233 Sum_probs=198.1
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
++|+..+.||.|+||.|.+++. ++..+|+|.+....- ...++..+|-.++..+ .||+++++++.|.+.+.+++|
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v-~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAV-SHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhc-cCceeEEEEEeeccCCeEEEE
Confidence 4577778999999999999998 889999999875432 3345567778888888 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||++||.|..+|+..+ +++.+....++.+|+.||.||| +.+|++|||||+|||+|++|.+||+|||+|+.+.
T Consensus 123 meyv~GGElFS~Lrk~~----rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSG----RFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EeccCCccHHHHHHhcC----CCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 99999999999998764 6999999999999999999999 9999999999999999999999999999998875
Q ss_pred CCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccc
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDE 291 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (346)
.. +-..+||+.|+|||.++..+|+.++|+|||||++|||+.|.+||...+.-..
T Consensus 196 ~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i---------------------- 249 (355)
T KOG0616|consen 196 GR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI---------------------- 249 (355)
T ss_pred Cc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH----------------------
Confidence 43 3457899999999999999999999999999999999999999987655221
Q ss_pred ccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCC
Q 045453 292 IVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDR 328 (346)
Q Consensus 292 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R 328 (346)
-++.+.+....+ .-....+.+|+...|+.|-.+|
T Consensus 250 -Y~KI~~~~v~fP--~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 250 -YEKILEGKVKFP--SYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -HHHHHhCcccCC--cccCHHHHHHHHHHHhhhhHhh
Confidence 111222221111 1344568889999999998888
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=329.32 Aligned_cols=264 Identities=22% Similarity=0.345 Sum_probs=206.5
Q ss_pred HHhcCCCcccccccCCCcEEEEEEE-------CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeec-
Q 045453 54 IATNNFDARNVIKDGYAYKFYKGFV-------EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLE- 124 (346)
Q Consensus 54 ~~~~~f~~~~~ig~G~~g~Vy~~~~-------~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~- 124 (346)
...++|...+.||+|+||.||+|.+ +++.||+|++..... .....+..|+..+.++.+||||++++++|..
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 3445788899999999999999975 236899999874432 2345677888888888789999999998865
Q ss_pred CCcceEEEecccCCChhhhhhhcCCC------------------------------------------------------
Q 045453 125 TRIPVIVFESVKNRTLADHIYQNQPH------------------------------------------------------ 150 (346)
Q Consensus 125 ~~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------ 150 (346)
+...+++|||+++++|.+++......
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 45678999999999999998643210
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCcee-eccccccCC
Q 045453 151 ---FEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCV-KDKVTGTMG 226 (346)
Q Consensus 151 ---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~ 226 (346)
..+++|..+..++.|++.||.||| +.+|+||||||+|||++.++.++|+|||+++.+....... .....++..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 136899999999999999999999 8999999999999999999999999999998764333221 233456678
Q ss_pred cCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcc
Q 045453 227 FLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVG 305 (346)
Q Consensus 227 y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 305 (346)
|+|||++.+..++.++|||||||++|||++ |..||......+. +. ......... ..
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~------~~----~~~~~~~~~-------------~~ 297 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FC----RRLKEGTRM-------------RA 297 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH------HH----HHHhccCCC-------------CC
Confidence 999999999999999999999999999998 9999975332221 10 111111100 00
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 045453 306 KEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQ 343 (346)
Q Consensus 306 ~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 343 (346)
+......+.+++.+||+.+|++|||+.|+++.|+.+++
T Consensus 298 ~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 298 PEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11334568999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=315.77 Aligned_cols=255 Identities=20% Similarity=0.338 Sum_probs=205.0
Q ss_pred hcCCCcccccccCCCcEEEEEEEC-----CeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcce
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFVE-----DRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV 129 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~~-----~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~ 129 (346)
.++|+..+.||+|+||+||+|.+. ...||+|.+..... ....++..|+..+..+ +||||+++++++.+.+..+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF-DHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCcceEeEEEecCCceE
Confidence 467889999999999999999982 34789998765433 2345677888888888 9999999999999999999
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcc
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVS 209 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~ 209 (346)
+||||+++++|.+++.... ..+++..+..++.+++.||+||| +.+++|+||||+|||+++++.++|+|||++..
T Consensus 82 iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 82 IITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred EEEEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhc
Confidence 9999999999999997654 36899999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCC-ceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcC
Q 045453 210 IPEGE-TCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENN 287 (346)
Q Consensus 210 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (346)
..... ........++..|+|||.+.+..++.++||||||+++|++++ |..||....... ....+ ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~----~~~ 224 (266)
T cd05033 156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD-------VIKAV----EDG 224 (266)
T ss_pred ccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH-------HHHHH----HcC
Confidence 75222 222223345678999999999999999999999999999998 999986433211 11111 111
Q ss_pred ccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 045453 288 EFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341 (346)
Q Consensus 288 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 341 (346)
... +.....+..+.+++.+||+.+|++||++.||++.|+++
T Consensus 225 ~~~-------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 225 YRL-------------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCC-------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000 00113346688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=335.22 Aligned_cols=267 Identities=19% Similarity=0.304 Sum_probs=209.8
Q ss_pred HHHHHhcCCCcccccccCCCcEEEEEEEC-------CeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEccee
Q 045453 51 ELEIATNNFDARNVIKDGYAYKFYKGFVE-------DRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCC 122 (346)
Q Consensus 51 ~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~-------~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~ 122 (346)
.+....+.|...++||+|+||.||+|.+. +..||+|++..... .....+.+|+..+..+..||||++++++|
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 34455678888999999999999999862 24699999865433 23456788999998884599999999999
Q ss_pred ecCCcceEEEecccCCChhhhhhhcCC-----------------------------------------------------
Q 045453 123 LETRIPVIVFESVKNRTLADHIYQNQP----------------------------------------------------- 149 (346)
Q Consensus 123 ~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------- 149 (346)
.+.+..++||||+++|+|.++|.....
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 999999999999999999998865321
Q ss_pred ---------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCC
Q 045453 150 ---------------------------------------HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSR 190 (346)
Q Consensus 150 ---------------------------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~N 190 (346)
....+++..++.++.|++.||+||| +.+++|+||||+|
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~N 267 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARN 267 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHh
Confidence 0124788999999999999999999 8999999999999
Q ss_pred eEEcCCCceEEeccCCCcccCCCCce-eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcc
Q 045453 191 IFLDEGYIAKLFDFSLSVSIPEGETC-VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDE 268 (346)
Q Consensus 191 Ill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~ 268 (346)
||++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus 268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 99999999999999998766433221 1233456788999999999999999999999999999997 999987543221
Q ss_pred cccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 045453 269 IGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQ 343 (346)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 343 (346)
. .. .....+. ........+..+.+++.+||+.+|++|||+.+|.+.|+.+.+
T Consensus 348 ~------~~----~~~~~~~-------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 348 T------FY----NKIKSGY-------------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred H------HH----HHHhcCC-------------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 1 00 0011110 000111345678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=318.67 Aligned_cols=257 Identities=22% Similarity=0.346 Sum_probs=209.7
Q ss_pred HHhcCCCcccccccCCCcEEEEEEE-CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 54 IATNNFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 54 ~~~~~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
.+.++|+..+.||.|+||.||+|.+ .+..+++|.+..........+..|+..+..+ +||||+++++++.+.+..++||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRL-RHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcC-CCcchhheeeeEecCCCeEEEE
Confidence 3456788889999999999999999 6788999988765544566778888888888 9999999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
||+++++|.+++..... ..+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.+||+|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 82 ELMEKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred eecccCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 99999999999976432 46899999999999999999999 89999999999999999999999999999876644
Q ss_pred CCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCcccc
Q 045453 213 GETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDE 291 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (346)
... ......++..|+|||...+..++.++||||||+++++|++ |..||......+. ..... . +.
T Consensus 157 ~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~-------~~~~~---~-~~--- 221 (261)
T cd05148 157 DVY-LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV-------YDQIT---A-GY--- 221 (261)
T ss_pred ccc-cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH-------HHHHH---h-CC---
Confidence 322 2223445678999999998899999999999999999998 8999975442221 11111 0 00
Q ss_pred ccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 045453 292 IVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341 (346)
Q Consensus 292 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 341 (346)
..+.....+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 222 ----------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 222 ----------RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ----------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 0001114456788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-44 Score=324.57 Aligned_cols=255 Identities=19% Similarity=0.322 Sum_probs=202.3
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCe----EEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcce
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDR----TVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV 129 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~----~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~ 129 (346)
.+|+..+.||+|+||.||+|.+ ++. .||+|.+..... ....++..|+..+..+ +||||++++|+|... ..+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEcCC-Cce
Confidence 5688899999999999999987 333 489999865433 3345677778888877 999999999999765 578
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcc
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVS 209 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~ 209 (346)
+|+||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+|||++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 85 LITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEcccccccc
Confidence 9999999999999998654 45889999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCceee-ccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcC
Q 045453 210 IPEGETCVK-DKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENN 287 (346)
Q Consensus 210 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (346)
......... ....++..|+|||++.+..++.++||||||+++||+++ |..||......+ +. ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-------~~----~~~~~~ 227 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------IS----SILEKG 227 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------HH----HHHhCC
Confidence 754333221 22334678999999999999999999999999999998 999997532211 11 111111
Q ss_pred ccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 045453 288 EFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQ 343 (346)
Q Consensus 288 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 343 (346)
.. . +.+..+...+.+++..||+.+|++|||+.+++..|..+.+
T Consensus 228 ~~-------~------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 228 ER-------L------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred CC-------C------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 00 0 0011234568899999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-45 Score=324.69 Aligned_cols=247 Identities=22% Similarity=0.294 Sum_probs=207.7
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
..|+....||+|+||.||+|.+ .++.||+|.+.-+.. .......+|+..+..+ +++||.++||.+..+..++++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~-~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQC-DSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhc-CcchHHhhhhheeecccHHHHHH
Confidence 4466778999999999999999 789999999876543 4556777888888888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
||.+|++.+.|.... .+.+..+.-++.++..||.||| ..+.+|||||+.|||+..+|.+||+|||.+-.+...
T Consensus 92 y~~gGsv~~lL~~~~----~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGN----ILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred HhcCcchhhhhccCC----CCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeech
Confidence 999999999997654 4577888889999999999999 999999999999999999999999999998776544
Q ss_pred CceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccc
Q 045453 214 ETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIV 293 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (346)
.. .....+||+.|||||++....|+.|+||||||++.+||++|.+|+....+-. .+
T Consensus 165 ~~-rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr-----------------------vl 220 (467)
T KOG0201|consen 165 VK-RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR-----------------------VL 220 (467)
T ss_pred hh-ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce-----------------------EE
Confidence 33 2367889999999999998899999999999999999999999997654411 11
Q ss_pred ccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 294 DPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 294 d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
--......|.... .+...+.+++..||+.+|+.|||+.++++
T Consensus 221 flIpk~~PP~L~~-~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 221 FLIPKSAPPRLDG-DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred EeccCCCCCcccc-ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 1111122222222 56677999999999999999999999986
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=319.32 Aligned_cols=258 Identities=19% Similarity=0.356 Sum_probs=203.4
Q ss_pred HHhcCCCcccccccCCCcEEEEEEEC-------CeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecC
Q 045453 54 IATNNFDARNVIKDGYAYKFYKGFVE-------DRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLET 125 (346)
Q Consensus 54 ~~~~~f~~~~~ig~G~~g~Vy~~~~~-------~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~ 125 (346)
..+++|+..+.||+|+||.||+|.+. +..+|+|++..... ....++.+|+..+..+ +||||+++++++.++
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~ 81 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQG 81 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCC
Confidence 45678999999999999999999862 35799998764322 3345677888888887 999999999999999
Q ss_pred CcceEEEecccCCChhhhhhhcCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCce
Q 045453 126 RIPVIVFESVKNRTLADHIYQNQPH------FEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIA 199 (346)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~ 199 (346)
+..++||||+++|+|.+++...... ...+++..+..++.|++.||.||| +.+++|+||||+||++++++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCE
Confidence 9999999999999999998753211 134788999999999999999999 8999999999999999999999
Q ss_pred EEeccCCCcccCCCCcee-eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHH
Q 045453 200 KLFDFSLSVSIPEGETCV-KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLL 277 (346)
Q Consensus 200 kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 277 (346)
+|+|||+++......... .....++..|+|||++.++.++.++||||||+++|||++ |..||....... ..
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~-------~~ 231 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ-------VL 231 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HH
Confidence 999999987664333221 122345778999999998899999999999999999999 788886543221 11
Q ss_pred HHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 045453 278 HYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLK 339 (346)
Q Consensus 278 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 339 (346)
..+ ....... . ....+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 232 ~~~----~~~~~~~-----~--------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 232 RFV----MEGGLLD-----K--------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHH----HcCCcCC-----C--------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 111 1111100 0 0133456899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=342.78 Aligned_cols=250 Identities=19% Similarity=0.200 Sum_probs=199.7
Q ss_pred CCcccccccCCCcEEEEEEE--C-CeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecc
Q 045453 59 FDARNVIKDGYAYKFYKGFV--E-DRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESV 135 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~~--~-~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~ 135 (346)
|...+.||+|++|.||+|.. + +..||+|+...........+..|+..+..+ +|||||+++++|...+..+|||||+
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAAC-DHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEECCEEEEEEECC
Confidence 77889999999999999987 3 678888876544333344556788888887 9999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCc
Q 045453 136 KNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGET 215 (346)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~ 215 (346)
++|+|.+++........++++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988654322346899999999999999999999 89999999999999999999999999999987653322
Q ss_pred -eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccc
Q 045453 216 -CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVD 294 (346)
Q Consensus 216 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 294 (346)
.......||+.|+|||++.+..++.++|||||||++|||++|..||......+. ...... +.
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~----------~~~~~~-~~------ 287 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREI----------MQQVLY-GK------ 287 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH----------HHHHHh-CC------
Confidence 123445689999999999999999999999999999999999999965332111 111110 11
Q ss_pred cccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 295 PIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 295 ~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
... .+......+.+++..||+.+|++|||+.+++.
T Consensus 288 ------~~~-~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 288 ------YDP-FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ------CCC-CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 000 01123456889999999999999999999864
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=324.47 Aligned_cols=264 Identities=16% Similarity=0.275 Sum_probs=203.3
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
.++|+..+.||+|+||.||++.+ ++..+|+|.+..... ....++.+|+..+..+ +||||+++++++...+..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEEEe
Confidence 46788999999999999999999 678889988765432 2345678888999888 9999999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSR-PILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
||+++|+|.+++.... .+++..+..++.+++.||.||| +. +|+||||||+|||++.++.+||+|||++....
T Consensus 83 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 83 EHMDGGSLDQVLKEAK----RIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 9999999999997643 5889999999999999999999 54 69999999999999999999999999987654
Q ss_pred CCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhc---Cc
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIEN---NE 288 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 288 (346)
... .....|+..|+|||++.+..++.++|||||||++|||+||+.||......+. .......... ..
T Consensus 156 ~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~-------~~~~~~~~~~~~~~~ 225 (331)
T cd06649 156 DSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL-------EAIFGRPVVDGEEGE 225 (331)
T ss_pred ccc---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHhcccccccccCC
Confidence 322 2345689999999999999999999999999999999999999975433211 0000000000 00
Q ss_pred c---------------------------ccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045453 289 F---------------------------DEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKR 337 (346)
Q Consensus 289 ~---------------------------~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 337 (346)
. ....+-......+..........+.+|+.+||+.||++|||+.|+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 226 PHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0 000000000011111111345678999999999999999999999763
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=319.68 Aligned_cols=272 Identities=19% Similarity=0.215 Sum_probs=200.7
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
++|+..+.||+|+||+||+|.+ +++.+|+|++.... ......+.+|+..+..+ +||||+++++++...+..++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL-KQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhC-CCccccchhhhEecCCEEEEEE
Confidence 4688899999999999999999 67899999886542 22345667888888888 9999999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
||++++++..+.... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++.....
T Consensus 80 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 80 EYVEKNMLELLEEMP----NGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred ecCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 999987665544322 35899999999999999999999 89999999999999999999999999999987654
Q ss_pred CCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhh-----HHHHHHHHhhcC
Q 045453 213 GETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYW-----LLHYVKKCIENN 287 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~ 287 (346)
..........++..|+|||++.+..++.++|||||||++|||++|+.||......+....... ............
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 153 GSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred cccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence 333233345689999999999998999999999999999999999999976543221000000 000000000111
Q ss_pred ccccccccccccCCC--CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 288 EFDEIVDPIIVSEGP--RVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 288 ~~~~~~d~~l~~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.......+....... .......+..+.+|+.+||+.+|++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111100010000000 0000023456999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=317.32 Aligned_cols=256 Identities=24% Similarity=0.403 Sum_probs=204.1
Q ss_pred cCCCcccccccCCCcEEEEEEEC--C-----eEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcc
Q 045453 57 NNFDARNVIKDGYAYKFYKGFVE--D-----RTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIP 128 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~~--~-----~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~ 128 (346)
++|+..+.||+|+||.||+|... + ..+++|.+..... .....+.+|+..+..+ +||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL-QHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhc-CCcccceEEEEEcCCCce
Confidence 45778889999999999999872 2 5799998864433 2334567788888887 999999999999999999
Q ss_pred eEEEecccCCChhhhhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCC
Q 045453 129 VIVFESVKNRTLADHIYQNQPH------------FEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEG 196 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~ 196 (346)
+++|||+++|+|.+++...... ...+++..++.++.|++.||.||| +.+++|+||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCC
Confidence 9999999999999999764211 135889999999999999999999 8999999999999999999
Q ss_pred CceEEeccCCCcccCCCCc-eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchh
Q 045453 197 YIAKLFDFSLSVSIPEGET-CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHY 274 (346)
Q Consensus 197 ~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~ 274 (346)
+.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||......+.
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~----- 235 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV----- 235 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-----
Confidence 9999999999876543322 12233456788999999998999999999999999999998 9999976443221
Q ss_pred hHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 045453 275 WLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQ 340 (346)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 340 (346)
...+ ...... ..+...+..+.+|+.+||+.+|++|||+.||++.|++
T Consensus 236 --~~~i----~~~~~~-------------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 236 --IEMI----RSRQLL-------------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred --HHHH----HcCCcC-------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1111 111100 0112456779999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=315.75 Aligned_cols=256 Identities=19% Similarity=0.313 Sum_probs=199.3
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCe----EEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcce
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDR----TVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV 129 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~----~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~ 129 (346)
++|...+.||+|+||+||+|.+ ++. .+++|.+..... ....++..++..+..+ +||||+++++++. +...+
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l-~h~~iv~~~~~~~-~~~~~ 84 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL-DHAYIVRLLGICP-GASLQ 84 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcC-CCCCcceEEEEEC-CCccE
Confidence 3566778999999999999998 444 477777654322 2234556666677777 9999999999986 45578
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcc
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVS 209 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~ 209 (346)
+++||+++|+|.+++.... ..++|..+..++.|++.||+||| +.+++|+||||+|||++.++.+||+|||+++.
T Consensus 85 ~i~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHR---DSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred EEEEeCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCcccee
Confidence 9999999999999997644 36899999999999999999999 89999999999999999999999999999986
Q ss_pred cCCCCc-eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcC
Q 045453 210 IPEGET-CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENN 287 (346)
Q Consensus 210 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (346)
...... .......++..|+|||++.++.++.++||||||+++||+++ |..||....... .... ...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-------~~~~----~~~~ 227 (279)
T cd05111 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-------VPDL----LEKG 227 (279)
T ss_pred ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHH----HHCC
Confidence 643322 12233456778999999999999999999999999999998 999997543321 1111 1111
Q ss_pred ccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 288 EFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 288 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
... .. ...+...+.+++.+||+.+|++|||+.|+++.|..+.+.
T Consensus 228 ~~~--~~-----------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 228 ERL--AQ-----------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred CcC--CC-----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 100 00 002234578899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=307.85 Aligned_cols=268 Identities=19% Similarity=0.184 Sum_probs=204.7
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeec--CCcceE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLE--TRIPVI 130 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~--~~~~~l 130 (346)
++|...+.|++|+||.||+|++ ++..||+|+++.+.. .-.-...+|+.++.+. +|||||.+..+... -+.+|+
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~-~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKA-RHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhc-CCCCeeeeEEEEeccccceeee
Confidence 4577789999999999999999 889999999875542 2234568999999999 99999999887653 457999
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCccc
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI 210 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~ 210 (346)
|||||+. +|..++.... +++...+...++.|+++|++||| ...|+||||||+|+|++..|.+||+|||+|+..
T Consensus 155 VMe~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eHHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhh
Confidence 9999987 9999998765 68999999999999999999999 899999999999999999999999999999998
Q ss_pred CCCCceeeccccccCCcCCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCc-
Q 045453 211 PEGETCVKDKVTGTMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE- 288 (346)
Q Consensus 211 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 288 (346)
+.... ..+..+.|..|+|||.+.+. .|++..|+||+|||+.|++++++.|.+...-+...-...+.......++.+-
T Consensus 228 gsp~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 228 GSPLK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred cCCcc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 76532 34567789999999999874 5999999999999999999999999876543321100111111111111110
Q ss_pred cccccc---------cccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 289 FDEIVD---------PIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 289 ~~~~~d---------~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
....+. ..+...... . ...+.-++|+...|..||.+|.|+.|.++
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~--~-~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGA--L-SLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred ccchhhccccCCCCchhhhhhccc--c-ccchhHHHHHHHHhccCccccccHHHhhc
Confidence 000000 000000000 0 13366788999999999999999999864
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=326.57 Aligned_cols=251 Identities=16% Similarity=0.210 Sum_probs=201.7
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
++|...+.||+|+||.||+|.+ +++.||+|++.... ......+..|...+..+ +||||+++++++...+..++|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~~~~~lv 79 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT-KSEWLVKLLYAFQDDEYLYLA 79 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhC-CCCCCccEEEEEEcCCEEEEE
Confidence 4688899999999999999999 67899999987542 12345567788888888 899999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+++|+|.+++... ..+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||++....
T Consensus 80 ~e~~~g~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 80 MEYVPGGDFRTLLNNL----GVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV 152 (333)
T ss_pred EeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence 9999999999999764 35889999999999999999999 8999999999999999999999999999987653
Q ss_pred CCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccc
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDE 291 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (346)
. ......||+.|+|||++.+..++.++|||||||++|||++|..||......+. ...+. ... .
T Consensus 153 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-------~~~i~---~~~---~ 215 (333)
T cd05600 153 T----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET-------WENLK---YWK---E 215 (333)
T ss_pred c----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH-------HHHHH---hcc---c
Confidence 3 22345789999999999999999999999999999999999999976443221 00010 000 0
Q ss_pred ccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 292 IVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 292 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.+....... ........+.+++.+||+.+|.+|||+.++++
T Consensus 216 ~~~~~~~~~----~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~ 256 (333)
T cd05600 216 TLQRPVYDD----PRFNLSDEAWDLITKLINDPSRRFGSLEDIKN 256 (333)
T ss_pred cccCCCCCc----cccccCHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence 000000000 00134567889999999999999999999985
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=312.68 Aligned_cols=251 Identities=21% Similarity=0.294 Sum_probs=201.1
Q ss_pred cCCCcccccccCCCcEEEEEEE-CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecc
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESV 135 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~ 135 (346)
++|.....||+|+||+||+|.+ .+..+|+|.+... .....++.+|+..+..+ +||||++++++|.+.+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKL-SHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcC-CCCCeeeEEEEEccCCCcEEEEEcC
Confidence 3466778999999999999998 4456999987643 23346688888988888 9999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCc
Q 045453 136 KNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGET 215 (346)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~ 215 (346)
++|+|.+++.... ..+++..++.++.+++.||+||| +.+++|+||||+||+++.++.+||+|||.++.......
T Consensus 82 ~~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 82 SNGCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 9999999997643 35899999999999999999999 89999999999999999999999999999876654433
Q ss_pred eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccc
Q 045453 216 CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVD 294 (346)
Q Consensus 216 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 294 (346)
.......++..|+|||+..+..++.++||||||+++|+|++ |..||......+. .... ..+...
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~----------~~~~-~~~~~~---- 220 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET----------VEKV-SQGLRL---- 220 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH----------HHHH-hcCCCC----
Confidence 22223345678999999998889999999999999999999 9999865433211 1111 111000
Q ss_pred cccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 045453 295 PIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLK 339 (346)
Q Consensus 295 ~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 339 (346)
. ........+.+++.+||+.+|++|||+.++++.|+
T Consensus 221 -----~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 -----Y----RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -----C----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0 00023467899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=322.01 Aligned_cols=243 Identities=20% Similarity=0.236 Sum_probs=197.3
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
++|...+.||+|+||.||+|.. +++.+|+|.+..... .....+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv 79 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-SHPFIIRLFWTEHDQRFLYML 79 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhC-CCCcHhhhHhhhccCCeEEEE
Confidence 4688889999999999999998 688999999864321 2334566788888888 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+++|+|.+++.... .+++.....++.|++.||+||| +.+++||||||+|||++.++.+||+|||++....
T Consensus 80 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~ 152 (291)
T cd05612 80 MEYVPGGELFSYLRNSG----RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR 152 (291)
T ss_pred EeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence 99999999999997653 5899999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccc
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDE 291 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (346)
... ....||+.|+|||++.+..++.++|||||||++|+|++|..||......+. ..... .+..
T Consensus 153 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~----------~~~i~-~~~~-- 215 (291)
T cd05612 153 DRT----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI----------YEKIL-AGKL-- 215 (291)
T ss_pred CCc----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----------HHHHH-hCCc--
Confidence 321 234689999999999999999999999999999999999999975433211 11111 1100
Q ss_pred ccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 045453 292 IVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPT-----TVDVAK 336 (346)
Q Consensus 292 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~ 336 (346)
.+ + ......+.+|+.+||+.||.+||+ +.|+++
T Consensus 216 ----~~----~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 216 ----EF----P----RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred ----CC----C----ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 00 0 022446889999999999999995 777653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=329.09 Aligned_cols=258 Identities=24% Similarity=0.350 Sum_probs=221.7
Q ss_pred HHhcCCCcccccccCCCcEEEEEEECC------eEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCC
Q 045453 54 IATNNFDARNVIKDGYAYKFYKGFVED------RTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETR 126 (346)
Q Consensus 54 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~------~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~ 126 (346)
.........++||.|.||.||+|.+.+ -.||||......+ ...+.|+.|..++..+ +|||||+++|+|.+.
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnf-dHphIikLIGv~~e~- 463 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNF-DHPHIIKLIGVCVEQ- 463 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhC-CCcchhheeeeeecc-
Confidence 334445566789999999999999922 3688888877554 4456677777777777 999999999999764
Q ss_pred cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCC
Q 045453 127 IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSL 206 (346)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl 206 (346)
+.|+|||+++-|.|..+|..+. ..++..+...++.|++.||+||| +..+|||||...|||+.+..-+||+|||+
T Consensus 464 P~WivmEL~~~GELr~yLq~nk---~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNK---DSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred ceeEEEecccchhHHHHHHhcc---ccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccch
Confidence 6899999999999999998876 46888999999999999999999 99999999999999999999999999999
Q ss_pred CcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhh
Q 045453 207 SVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIE 285 (346)
Q Consensus 207 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (346)
++.+.++..+..+...-++-|||||-+.-..+|.+||||-|||.+||++. |..||.+....+.
T Consensus 538 SR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV---------------- 601 (974)
T KOG4257|consen 538 SRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV---------------- 601 (974)
T ss_pred hhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce----------------
Confidence 99998888777776667788999999999999999999999999999998 9999998766543
Q ss_pred cCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 045453 286 NNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQ 343 (346)
Q Consensus 286 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 343 (346)
+ ..+..+...+.++.++..+..|+.+||+.+|.+||++.|+...|+++++
T Consensus 602 -------I-~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 602 -------I-GHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred -------E-EEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 1 2344444555666899999999999999999999999999999999987
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=311.96 Aligned_cols=259 Identities=25% Similarity=0.381 Sum_probs=207.1
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
++|...+.||+|+||.||+|.. ++..+|+|.+.... ......+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCcceeeeeeeEEECCeEEEE
Confidence 5788899999999999999998 78999999875422 12334567888888888 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
+||+++|+|.+++.........+++..+..++.+++.||.||| +.+++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 9999999999988653322245889999999999999999999 8999999999999999999999999999987664
Q ss_pred CCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccc
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDE 291 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (346)
.... ......++..|+|||.+.+..++.++|+||||+++|||++|..||....... ..+... .....
T Consensus 158 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~--------~~~~~~-~~~~~--- 224 (267)
T cd08228 158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL--------FSLCQK-IEQCD--- 224 (267)
T ss_pred chhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH--------HHHHHH-HhcCC---
Confidence 3322 1223467889999999998889999999999999999999999986433211 111111 11110
Q ss_pred ccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 045453 292 IVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341 (346)
Q Consensus 292 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 341 (346)
.+..........+.+++.+||+.+|++|||+.+|++.|+++
T Consensus 225 ---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 225 ---------YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ---------CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 11111124456789999999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=317.13 Aligned_cols=260 Identities=22% Similarity=0.347 Sum_probs=207.7
Q ss_pred cCCCcccccccCCCcEEEEEEE-------CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcce
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV-------EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV 129 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~-------~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~ 129 (346)
.+|...+.||+|+||.||+|.. ++..+++|.+..........+.+|+..+..+ +||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-QHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCCceE
Confidence 4577788999999999999985 2356888887655444456677888888888 9999999999999999999
Q ss_pred EEEecccCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCC
Q 045453 130 IVFESVKNRTLADHIYQNQP------------HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGY 197 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~ 197 (346)
+||||+++++|.+++..... ....++|..++.++.+++.||+||| +.+++||||||+|||++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCC
Confidence 99999999999999976431 1134899999999999999999999 89999999999999999999
Q ss_pred ceEEeccCCCcccCCCCce-eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhh
Q 045453 198 IAKLFDFSLSVSIPEGETC-VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYW 275 (346)
Q Consensus 198 ~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~ 275 (346)
.++|+|||++......... ......++..|+|||++.+..++.++||||||+++|||+| |..||......+.
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~------ 234 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV------ 234 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH------
Confidence 9999999998765433221 1233456788999999999999999999999999999999 9999865433221
Q ss_pred HHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 276 LLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
.. ....+.... .....+..+.+++.+||+.+|++|||+.+|++.|+++.+.
T Consensus 235 ----~~-~~~~~~~~~-------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 235 ----IE-CITQGRVLE-------------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred ----HH-HHhCCCCCC-------------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 11 111111110 0112345688999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=326.16 Aligned_cols=240 Identities=15% Similarity=0.197 Sum_probs=193.9
Q ss_pred cccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccC
Q 045453 63 NVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKN 137 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~ 137 (346)
+.||+|+||.||++.. +++.+|+|.+.... ......+.+|...+..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT-RHPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 3699999999999988 78899999987542 22334567788888888 999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCcee
Q 045453 138 RTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCV 217 (346)
Q Consensus 138 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 217 (346)
|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~ 151 (323)
T cd05571 80 GELFFHLSRE----RVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-T 151 (323)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-c
Confidence 9999998764 35899999999999999999999 89999999999999999999999999999875322211 1
Q ss_pred eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccccccc
Q 045453 218 KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPII 297 (346)
Q Consensus 218 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 297 (346)
.....||+.|+|||++.+..++.++|||||||++|||++|..||...+.... ...+ ..... .+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~-------~~~~----~~~~~------~~ 214 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-------FELI----LMEEI------RF 214 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH-------HHHH----HcCCC------CC
Confidence 2345699999999999999999999999999999999999999975332111 1110 00100 00
Q ss_pred ccCCCCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 045453 298 VSEGPRVGKEKQLQGFRELALMCVCESAEDRP-----TTVDVAK 336 (346)
Q Consensus 298 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~ 336 (346)
+......+.+++.+||+.||++|| ++.++++
T Consensus 215 --------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 215 --------PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred --------CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 013345688999999999999999 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=316.09 Aligned_cols=257 Identities=22% Similarity=0.394 Sum_probs=205.2
Q ss_pred hcCCCcccccccCCCcEEEEEEE-C------CeEEEEEEecCccCc-chHHHHHHHHHHhhhcCCCceeeEcceeecCCc
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV-E------DRTVSVMKFNDILND-GHEDCFNNIIFASKLSSHKNVLKLTGCCLETRI 127 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~-~------~~~vavk~~~~~~~~-~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~ 127 (346)
.++|...+.||+|+||.||+|.+ . +..+|+|.+...... ....+.+|+..+..+ +||||+++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNF-QHENIVKFYGVCTEGDP 82 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhc-CCCCchheeeEEecCCC
Confidence 35577788999999999999987 2 368999998755443 456778888888888 99999999999999999
Q ss_pred ceEEEecccCCChhhhhhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCC
Q 045453 128 PVIVFESVKNRTLADHIYQNQP----------HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGY 197 (346)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~ 197 (346)
.++||||+++++|.+++..... ....+++..+..++.+++.||.||| +.+++|+||||+||+++.++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~ 159 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDL 159 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCC
Confidence 9999999999999999976421 1245889999999999999999999 89999999999999999999
Q ss_pred ceEEeccCCCcccCCCCce-eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhh
Q 045453 198 IAKLFDFSLSVSIPEGETC-VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYW 275 (346)
Q Consensus 198 ~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~ 275 (346)
.+||+|||++......... ......+++.|+|||++.+..++.++||||||+++|||++ |..||......+.
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~------ 233 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV------ 233 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH------
Confidence 9999999998765433221 1233345778999999999999999999999999999999 9999865433221
Q ss_pred HHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 045453 276 LLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQ 340 (346)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 340 (346)
...+ ..+... . .....+..+.+++.+||+.+|++|||+.||++.|++
T Consensus 234 -~~~~----~~~~~~------------~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 234 -IECI----TQGRLL------------Q-RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred -HHHH----HcCCcC------------C-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1111 111110 0 011344668999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=312.46 Aligned_cols=255 Identities=23% Similarity=0.315 Sum_probs=204.1
Q ss_pred hcCCCcccccccCCCcEEEEEEE-CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEec
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFES 134 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~ 134 (346)
.++|...+.||+|+||.||+|.+ ....||+|++.... ....++..|+..+..+ +||||+++++++. .+..++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKL-RHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhC-CCCCcceEEEEEC-CCCcEEEEEc
Confidence 45688899999999999999988 55679999886432 2345677888888888 9999999999875 4567999999
Q ss_pred ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCC
Q 045453 135 VKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE 214 (346)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~ 214 (346)
+++|+|.+++..... ..+++..+..++.+++.||+||| +.+++|+||||+||++++++.++|+|||.++......
T Consensus 82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 82 MSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred CCCCcHHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 999999999976432 35899999999999999999999 8999999999999999999999999999997765443
Q ss_pred ceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccc
Q 045453 215 TCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIV 293 (346)
Q Consensus 215 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (346)
........++..|+|||+..+..++.++||||||+++|+++| |..||......+. . .. ....
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~-------~---~~-~~~~------ 219 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-------L---DQ-VERG------ 219 (262)
T ss_pred cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH-------H---HH-HhcC------
Confidence 322334456778999999998999999999999999999999 8888865432211 0 01 0100
Q ss_pred ccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 045453 294 DPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIY 342 (346)
Q Consensus 294 d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~ 342 (346)
...+.....+..+.+++.+||+.+|++|||+.++++.|++.+
T Consensus 220 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 220 -------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred -------CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 000111245567899999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=318.56 Aligned_cols=264 Identities=17% Similarity=0.251 Sum_probs=198.9
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
++|...+.||.|+||+||+|.. ++..||+|.+..... .......+|+..+..+ +||||+++++++.+.+..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL-KHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhC-CCCCEeeEEEEEcCCCeEEEEEe
Confidence 4688889999999999999988 678999998864432 2344667888888888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
|+++ +|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~~-~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 84 YLDS-DLKQYLDNCG---NLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred CCCc-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 9975 9999886543 35789999999999999999999 899999999999999999999999999998765432
Q ss_pred CceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhh-------
Q 045453 214 ETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIE------- 285 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 285 (346)
.. ......+++.|+|||++.+ ..++.++||||+||++|+|+||+.||......+. .........
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~-------~~~~~~~~~~~~~~~~ 228 (288)
T cd07871 157 TK-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE-------LHLIFRLLGTPTEETW 228 (288)
T ss_pred Cc-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHHHhCCCChHHh
Confidence 21 1234567899999999875 5689999999999999999999999976543221 111111000
Q ss_pred -----cCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 286 -----NNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 286 -----~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
...+.....+...........+.....+.+|+.+||+.||.+|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 229 PGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000111111110000000000022356789999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=310.76 Aligned_cols=249 Identities=20% Similarity=0.299 Sum_probs=199.6
Q ss_pred CCCcccccccCCCcEEEEEEE-CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEeccc
Q 045453 58 NFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVK 136 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~ 136 (346)
+|+..+.||+|+||.||+|.+ .+..+|+|.+.... .....+.+|+..+..+ +||||+++++++...+..++||||++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKL-SHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhC-CCCCEEEEEEEEcCCCceEEEEecCC
Confidence 467788999999999999998 55688999875432 2345677888888888 99999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCce
Q 045453 137 NRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETC 216 (346)
Q Consensus 137 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 216 (346)
+++|.+++.... ..+++..+..++.|++.||+||| +.+++|+||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 83 NGCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred CCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 999999997654 36899999999999999999999 899999999999999999999999999998766433322
Q ss_pred eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccccc
Q 045453 217 VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDP 295 (346)
Q Consensus 217 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 295 (346)
......++..|+|||.+.+..++.++||||||+++|++++ |..||......+. . ... ... ..
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------~---~~~-~~~-----~~- 219 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV-------V---ESV-SAG-----YR- 219 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH-------H---HHH-HcC-----Cc-
Confidence 2222234567999999999999999999999999999999 8999875433221 1 110 000 00
Q ss_pred ccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 045453 296 IIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRL 338 (346)
Q Consensus 296 ~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 338 (346)
... +...+..+.+++.+||+.+|++|||+.|+++.|
T Consensus 220 ---~~~----~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 220 ---LYR----PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ---CCC----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 000 113455789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=329.23 Aligned_cols=266 Identities=20% Similarity=0.301 Sum_probs=209.3
Q ss_pred HHHHHhcCCCcccccccCCCcEEEEEEEC-------CeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEccee
Q 045453 51 ELEIATNNFDARNVIKDGYAYKFYKGFVE-------DRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCC 122 (346)
Q Consensus 51 ~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~-------~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~ 122 (346)
++....++|...+.||+|+||.||+|.+. +..||+|++..... .....+.+|+..+..+..|||||+++|+|
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 36666778888999999999999999863 35899999875432 23346778999999884499999999999
Q ss_pred ecCCcceEEEecccCCChhhhhhhcCC-----------------------------------------------------
Q 045453 123 LETRIPVIVFESVKNRTLADHIYQNQP----------------------------------------------------- 149 (346)
Q Consensus 123 ~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------- 149 (346)
...+..++||||+++|+|.++++....
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 999999999999999999999965321
Q ss_pred -----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCC
Q 045453 150 -----------------------------------------HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRP 188 (346)
Q Consensus 150 -----------------------------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp 188 (346)
....++|..++.++.|++.||+||| +.+++||||||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp 267 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAA 267 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCc
Confidence 1124788889999999999999999 89999999999
Q ss_pred CCeEEcCCCceEEeccCCCcccCCCCc-eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCC
Q 045453 189 SRIFLDEGYIAKLFDFSLSVSIPEGET-CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRG 266 (346)
Q Consensus 189 ~NIll~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~ 266 (346)
+|||++.++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 999999999999999999876543222 11223456788999999998889999999999999999998 8889865432
Q ss_pred cccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 045453 267 DEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIY 342 (346)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~ 342 (346)
.+. . ......+.. . . .+......+.+|+..||+.+|.+||++.|+++.|++++
T Consensus 348 ~~~------~----~~~~~~~~~-------~--~----~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 NEQ------F----YNAIKRGYR-------M--A----KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred hHH------H----HHHHHcCCC-------C--C----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 221 0 011111100 0 0 01123467899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=311.87 Aligned_cols=260 Identities=24% Similarity=0.350 Sum_probs=207.8
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
++|+..+.||+|++|.||+|.. ++..+++|.+..... ....++.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-cCCchhhhhheeEeCCeEEEE
Confidence 4677888999999999999997 788999998764321 2334677888888888 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+++++|.+++.........+++..++.++.+++.||.||| +.+++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 9999999999998754333356899999999999999999999 8999999999999999999999999999987664
Q ss_pred CCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccc
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDE 291 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (346)
.... ......++..|+|||.+.+..++.++||||||+++|+|++|..||........ .....+ ..
T Consensus 158 ~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~----~~----- 222 (267)
T cd08229 158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-----SLCKKI----EQ----- 222 (267)
T ss_pred cCCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH-----HHhhhh----hc-----
Confidence 3332 12234688899999999988899999999999999999999999864332111 010100 00
Q ss_pred ccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 045453 292 IVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIY 342 (346)
Q Consensus 292 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~ 342 (346)
...+..........+.+++.+||+.+|++||||.+|++.++++.
T Consensus 223 -------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 223 -------CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred -------CCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 00111111145567999999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=322.92 Aligned_cols=236 Identities=17% Similarity=0.203 Sum_probs=190.4
Q ss_pred cccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccCCC
Q 045453 65 IKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRT 139 (346)
Q Consensus 65 ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~gs 139 (346)
||+|+||.||+|.. ++..||+|.+.... ......+..|...+..+ +||||+++++++.+.+..++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 79999999999998 67889999886432 23345667788888888 99999999999999999999999999999
Q ss_pred hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCceeec
Q 045453 140 LADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKD 219 (346)
Q Consensus 140 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 219 (346)
|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 80 L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~ 151 (312)
T cd05585 80 LFHHLQRE----GRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTN 151 (312)
T ss_pred HHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-ccc
Confidence 99999764 35899999999999999999999 89999999999999999999999999999875432221 233
Q ss_pred cccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccccccccc
Q 045453 220 KVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVS 299 (346)
Q Consensus 220 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 299 (346)
...||+.|+|||++.+..++.++|||||||++|||++|..||......+ ......... .
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~----------~~~~~~~~~---------~-- 210 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE----------MYRKILQEP---------L-- 210 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH----------HHHHHHcCC---------C--
Confidence 4578999999999999999999999999999999999999997533211 111111100 0
Q ss_pred CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 045453 300 EGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDV 334 (346)
Q Consensus 300 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev 334 (346)
. .+......+.+++.+||+.+|++||++..+
T Consensus 211 --~--~~~~~~~~~~~li~~~L~~dp~~R~~~~~~ 241 (312)
T cd05585 211 --R--FPDGFDRDAKDLLIGLLSRDPTRRLGYNGA 241 (312)
T ss_pred --C--CCCcCCHHHHHHHHHHcCCCHHHcCCCCCH
Confidence 0 011334568899999999999999865433
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=327.04 Aligned_cols=245 Identities=22% Similarity=0.320 Sum_probs=209.8
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
++|.....||+|+||.||||+. +.+.||+|.+.+... ...+...+|+.++..+ +|||||.++++|.+..++++|+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~l-kHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSL-KHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhc-CCcchhhHHHhhcccceEEEEe
Confidence 4677778899999999999988 778999998876543 3456688999999999 9999999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
||+.| +|..+|.... .+++..+..++.+++.||.||| +.+|+|||+||.|||++.+|.+|++|||+|+.++.
T Consensus 81 e~a~g-~L~~il~~d~----~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~ 152 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDG----KLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST 152 (808)
T ss_pred hhhhh-hHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhccc
Confidence 99977 9999998764 5999999999999999999999 99999999999999999999999999999998876
Q ss_pred CCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccc
Q 045453 213 GETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEI 292 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (346)
.. ...+...||+-|||||++.++.|+..+|.||+||++||+.+|++||... .+.+.++....+.
T Consensus 153 ~t-~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~----------si~~Lv~~I~~d~----- 216 (808)
T KOG0597|consen 153 NT-SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR----------SITQLVKSILKDP----- 216 (808)
T ss_pred Cc-eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH----------HHHHHHHHHhcCC-----
Confidence 44 3456778999999999999999999999999999999999999999632 2333343322211
Q ss_pred cccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 293 VDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 293 ~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
. ..+......+..++...|.+||..|.|..+++.
T Consensus 217 ---------v-~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 217 ---------V-KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred ---------C-CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 1 112266778999999999999999999988763
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=317.44 Aligned_cols=265 Identities=22% Similarity=0.327 Sum_probs=208.8
Q ss_pred HHHHHhcCCCcccccccCCCcEEEEEEEC-------CeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEccee
Q 045453 51 ELEIATNNFDARNVIKDGYAYKFYKGFVE-------DRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCC 122 (346)
Q Consensus 51 ~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~-------~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~ 122 (346)
++....++|+..+.||+|+||.||++.+. ...+|+|.+..... ....++.+|+..+..+.+||||+++++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 34555677888999999999999999872 25789998765432 33455777888887776799999999999
Q ss_pred ecCCcceEEEecccCCChhhhhhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCC
Q 045453 123 LETRIPVIVFESVKNRTLADHIYQNQ------------PHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSR 190 (346)
Q Consensus 123 ~~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~N 190 (346)
...+..++||||+++|+|.+++.... .....+++..++.++.|++.||+||| +.+++|+||||+|
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~N 162 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARN 162 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceee
Confidence 99999999999999999999996532 12346899999999999999999999 8999999999999
Q ss_pred eEEcCCCceEEeccCCCcccCCCCcee-eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcc
Q 045453 191 IFLDEGYIAKLFDFSLSVSIPEGETCV-KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDE 268 (346)
Q Consensus 191 Ill~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~ 268 (346)
||++.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++||+++ |..||......+
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 999999999999999998765433222 122335678999999998999999999999999999998 999986543222
Q ss_pred cccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 045453 269 IGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIY 342 (346)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~ 342 (346)
. .. ....+.. ... +......+.+|+.+||+.+|++|||+.|+++.|+.+.
T Consensus 243 ~----------~~-~~~~~~~---------~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 L----------FK-LLKEGYR---------MEK----PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred H----------HH-HHHcCCc---------CCC----CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1 11 1111100 000 1133456889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=326.14 Aligned_cols=242 Identities=18% Similarity=0.214 Sum_probs=197.0
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
++|...+.||+|+||.||+|.+ +++.+|+|.+.... ......+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEcCCEEEEE
Confidence 5688889999999999999999 67899999986432 12344567888888888 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+++|+|.+++.... .+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 97 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAG----RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred EcCCCCChHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 99999999999997653 5888999999999999999999 8999999999999999999999999999997664
Q ss_pred CCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccc
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDE 291 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (346)
... ....||+.|+|||++.+..++.++|||||||++|||++|..||....... . .... ..+..
T Consensus 170 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-------~---~~~i-~~~~~-- 232 (329)
T PTZ00263 170 DRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR-------I---YEKI-LAGRL-- 232 (329)
T ss_pred CCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH-------H---HHHH-hcCCc--
Confidence 322 23568999999999999999999999999999999999999996533211 1 1111 11110
Q ss_pred ccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCC-----HHHHH
Q 045453 292 IVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPT-----TVDVA 335 (346)
Q Consensus 292 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~ 335 (346)
. .+ ......+.+|+..||+.||++||+ +.+++
T Consensus 233 ------~--~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 233 ------K--FP----NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred ------C--CC----CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 0 00 012345789999999999999997 56655
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=321.50 Aligned_cols=238 Identities=19% Similarity=0.238 Sum_probs=189.9
Q ss_pred cccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccC
Q 045453 63 NVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKN 137 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~ 137 (346)
+.||+|+||.||+|.+ +++.||+|.+.... .........|...+....+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999998 67789999987532 223344556666666666999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCcee
Q 045453 138 RTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCV 217 (346)
Q Consensus 138 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 217 (346)
|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHIQSSG----RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 99999987643 5899999999999999999999 8999999999999999999999999999987653322 22
Q ss_pred eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccccccc
Q 045453 218 KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPII 297 (346)
Q Consensus 218 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 297 (346)
.....||+.|+|||++.+..++.++|||||||++|||++|..||......+. ...... .. +.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~----------~~~i~~-~~------~~~ 215 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL----------FDSILN-DR------PHF 215 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH----------HHHHHc-CC------CCC
Confidence 3445789999999999999999999999999999999999999976433221 111100 00 000
Q ss_pred ccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 045453 298 VSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVD 333 (346)
Q Consensus 298 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e 333 (346)
+......+.+++..||+.+|++||++.+
T Consensus 216 --------~~~~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 216 --------PRWISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred --------CCCCCHHHHHHHHHHccCCHHHcCCChH
Confidence 0123455788999999999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=295.98 Aligned_cols=266 Identities=18% Similarity=0.224 Sum_probs=213.3
Q ss_pred HHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCC----
Q 045453 53 EIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETR---- 126 (346)
Q Consensus 53 ~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~---- 126 (346)
.+..+.|.+.+.+|.|||+.||+++. +++.+|+|++........+...+|+....++ +|||++++++++..+.
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf-~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKF-NSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhh-CCcchHHHHHHHHHhhccCc
Confidence 34457788999999999999999987 8899999998877667777888888888888 9999999999986544
Q ss_pred -cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccC
Q 045453 127 -IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFS 205 (346)
Q Consensus 127 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg 205 (346)
..||+++|...|||.+.+......+..+++.+.+.|+.++++||.+||.. ..++.||||||.|||+++.+.+++.|||
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEecc
Confidence 48999999999999999987766667899999999999999999999932 2349999999999999999999999999
Q ss_pred CCcccCCCCcee--------eccccccCCcCCccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchh
Q 045453 206 LSVSIPEGETCV--------KDKVTGTMGFLAPEYIN---TGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHY 274 (346)
Q Consensus 206 l~~~~~~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~ 274 (346)
.++.....-... ......|..|+|||.+. +...++++|||||||+||+|+.|..||+......
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G------ 248 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG------ 248 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC------
Confidence 987654211110 12234789999999986 3457899999999999999999999997533211
Q ss_pred hHHHHHHHHhhcCcc-ccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 045453 275 WLLHYVKKCIENNEF-DEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIY 342 (346)
Q Consensus 275 ~~~~~~~~~~~~~~~-~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~ 342 (346)
+.+ ..+..+ ....+.....++.+.+++..|++.||.+||++.+++..++++.
T Consensus 249 ------------gSlaLAv~n~----q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 249 ------------GSLALAVQNA----QISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ------------CeEEEeeecc----ccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 111 111111 2222222247788999999999999999999999999998874
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=314.30 Aligned_cols=258 Identities=22% Similarity=0.348 Sum_probs=203.4
Q ss_pred CCCcccccccCCCcEEEEEEECC-------eEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcce
Q 045453 58 NFDARNVIKDGYAYKFYKGFVED-------RTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV 129 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~~~-------~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~ 129 (346)
+|...+.||+|+||.||+|.... ..+++|.+..... ....++.+|+..+..+ +||||++++++|...+..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-NHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCCcE
Confidence 46778899999999999998721 4678887764432 3345677888888888 9999999999999999999
Q ss_pred EEEecccCCChhhhhhhcCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCC
Q 045453 130 IVFESVKNRTLADHIYQNQP--------------------HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPS 189 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~ 189 (346)
+|+||+++++|.+++..... ...++++.+++.++.|++.||.||| +.+++||||||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~ 156 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAAR 156 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhh
Confidence 99999999999999864321 1235889999999999999999999 899999999999
Q ss_pred CeEEcCCCceEEeccCCCcccCCCCce-eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCc
Q 045453 190 RIFLDEGYIAKLFDFSLSVSIPEGETC-VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGD 267 (346)
Q Consensus 190 NIll~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~ 267 (346)
|||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||+| |..||......
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 999999999999999998765433221 1223345678999999998899999999999999999999 99999654322
Q ss_pred ccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 045453 268 EIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQ 343 (346)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 343 (346)
. +...+ ... .... ........+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 237 ~-------~~~~~----~~~---------~~~~----~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 237 R-------LFNLL----KTG---------YRME----RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred H-------HHHHH----hCC---------CCCC----CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 1 11111 111 0000 011334568899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=307.31 Aligned_cols=260 Identities=25% Similarity=0.384 Sum_probs=209.4
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
++|+..+.||+|++|.||+|.. +++.+++|.+.... ......+.+|+..+..+ +|+|++++++++...+..++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCeeeeeeeeecCCeEEEE
Confidence 6788999999999999999999 68899999875322 22355677888888888 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+++++|.+++.........+++..++.++.+++.||+||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 9999999999998764333356899999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccc
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDE 291 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (346)
.... ......++..|+|||.+.+..++.++||||||+++|+|++|..||...... ....... ...+.
T Consensus 158 ~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~-~~~~~--- 224 (267)
T cd08224 158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--------LYSLCKK-IEKCD--- 224 (267)
T ss_pred CCCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc--------HHHHHhh-hhcCC---
Confidence 3322 123346788999999999889999999999999999999999998643321 1111111 01110
Q ss_pred ccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 045453 292 IVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIY 342 (346)
Q Consensus 292 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~ 342 (346)
.+..........+.+++..||+.+|++|||+.+|++.|+++.
T Consensus 225 ---------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 225 ---------YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ---------CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 111111144567889999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=321.20 Aligned_cols=200 Identities=15% Similarity=0.279 Sum_probs=172.9
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
.++|+..+.||+|+||.||++.+ ++..+|+|.+..... .....+.+|+..+..+ +||||++++++|.+.+..++||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCcccceeEEEEECCEEEEEE
Confidence 46789999999999999999999 577888887765432 3345678888999998 9999999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
||+++|+|.+++.... .+++.....++.+++.||.|||+ ..+++|+||||+|||++.++.+||+|||++.....
T Consensus 83 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 83 EHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 9999999999997643 58889999999999999999993 24799999999999999999999999999876532
Q ss_pred CCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 045453 213 GETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSR 265 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~ 265 (346)
.. .....++..|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 157 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 157 SM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred hc---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence 21 234568899999999998899999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=309.71 Aligned_cols=253 Identities=23% Similarity=0.342 Sum_probs=201.6
Q ss_pred hcCCCcccccccCCCcEEEEEEE-CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEec
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFES 134 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~ 134 (346)
.++|...+.||+|+||.||+|.. .+..+|+|.+.... .....+.+|+..+..+ +|||++++++++. .+..++||||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKL-RHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhc-CCCceEEEEeEEC-CCCcEEEEEe
Confidence 35677889999999999999988 66789999886543 2345678888888888 9999999999875 4568999999
Q ss_pred ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCC
Q 045453 135 VKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE 214 (346)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~ 214 (346)
+++++|.+++..... ..+++.++..++.+++.||.||| +.+++|+||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 82 MSKGSLLDFLKDGEG--RALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 999999999976432 45899999999999999999999 8999999999999999999999999999997765433
Q ss_pred ceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccc
Q 045453 215 TCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIV 293 (346)
Q Consensus 215 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (346)
........++..|+|||+..+..++.++||||||+++|+|++ |..||......+. .... ....
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~----------~~~~-~~~~----- 220 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREV----------LEQV-ERGY----- 220 (260)
T ss_pred cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH----------HHHH-HcCC-----
Confidence 222223345678999999988899999999999999999999 8899965432211 1111 1110
Q ss_pred ccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 045453 294 DPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQ 340 (346)
Q Consensus 294 d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 340 (346)
....+...+..+.+++.+||+.+|++|||+.++.+.|++
T Consensus 221 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 221 --------RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred --------CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 000111345668999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=317.04 Aligned_cols=260 Identities=22% Similarity=0.346 Sum_probs=202.5
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCe--EEEEEEecCcc-CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDR--TVSVMKFNDIL-NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVI 130 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~--~vavk~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~l 130 (346)
.++|+..+.||+|+||.||+|.+ ++. .+++|.+.... .....++.+|+..+.++.+||||+++++++.+.+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 46788889999999999999997 343 45777765432 23345677788888888789999999999999999999
Q ss_pred EEecccCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCc
Q 045453 131 VFESVKNRTLADHIYQNQP------------HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYI 198 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~ 198 (346)
||||+++++|.+++..... ....+++.+++.++.|++.||+||| +.+++||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCc
Confidence 9999999999999975431 1235889999999999999999999 899999999999999999999
Q ss_pred eEEeccCCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHH
Q 045453 199 AKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLL 277 (346)
Q Consensus 199 ~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 277 (346)
+||+|||++....... ......++..|+|||++.+..++.++||||||+++|||+| |..||......+.
T Consensus 163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-------- 232 (303)
T cd05088 163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-------- 232 (303)
T ss_pred EEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH--------
Confidence 9999999986432111 1112234567999999988889999999999999999998 9999965433211
Q ss_pred HHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 278 HYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 278 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
.... .... .. ..+ ......+.+|+.+||+.+|++|||+.+++..|+.+.+.
T Consensus 233 --~~~~-~~~~-------~~--~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 233 --YEKL-PQGY-------RL--EKP----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred --HHHH-hcCC-------cC--CCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1110 0000 00 000 02335688999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=339.08 Aligned_cols=259 Identities=17% Similarity=0.202 Sum_probs=205.4
Q ss_pred HHHHHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecC
Q 045453 50 RELEIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLET 125 (346)
Q Consensus 50 ~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~ 125 (346)
.+.....++|...+.||+|+||+||+|.. +++.||||.+.... ......+.+|+..+..+ +|+||++++..+...
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~-~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNC-DFFSIVKCHEDFAKK 103 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcC-CCCcEEEeecceecc
Confidence 34455668999999999999999999988 78999999986543 23345567788888887 999999998877543
Q ss_pred C--------cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCC
Q 045453 126 R--------IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGY 197 (346)
Q Consensus 126 ~--------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~ 197 (346)
+ ..++||||+++|+|.+++........++++..+..++.|++.||.||| +.+|+||||||+|||++.++
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~ 180 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNG 180 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCC
Confidence 2 357999999999999999765444457999999999999999999999 89999999999999999999
Q ss_pred ceEEeccCCCcccCCCCc-eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhH
Q 045453 198 IAKLFDFSLSVSIPEGET-CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWL 276 (346)
Q Consensus 198 ~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~ 276 (346)
.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus 181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~-------- 252 (496)
T PTZ00283 181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE-------- 252 (496)
T ss_pred CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--------
Confidence 999999999876643221 12234578999999999999999999999999999999999999997533211
Q ss_pred HHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 277 LHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 277 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
....... + .... .+...+..+.+++..||+.+|++|||+.+++.
T Consensus 253 --~~~~~~~-~------------~~~~-~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 253 --VMHKTLA-G------------RYDP-LPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred --HHHHHhc-C------------CCCC-CCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 1111111 1 0000 01134566889999999999999999999875
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=309.12 Aligned_cols=251 Identities=22% Similarity=0.316 Sum_probs=206.4
Q ss_pred hcCCCcccccccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecc
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESV 135 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~ 135 (346)
.++|...+.||+|+||.||+|...++.||+|.+..... ...++.+|+..+..+ +|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-AAQAFLAEASVMTTL-RHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh-HHHHHHHHHHHHHhc-CCcceeeeEEEEcCCCCeEEEEEec
Confidence 45788889999999999999999999999999876543 456788899999888 9999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCc
Q 045453 136 KNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGET 215 (346)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~ 215 (346)
++++|.+++..... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 83 AKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred CCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 99999999976542 36899999999999999999999 89999999999999999999999999999876632221
Q ss_pred eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccc
Q 045453 216 CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVD 294 (346)
Q Consensus 216 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 294 (346)
....+..|+|||++.++.++.++||||||+++|++++ |..||......+ +...+. .....
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~----~~~~~---- 218 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPHVE----KGYRM---- 218 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHh----cCCCC----
Confidence 2345668999999998899999999999999999998 999986442211 111111 11000
Q ss_pred cccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 045453 295 PIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341 (346)
Q Consensus 295 ~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 341 (346)
. .+...+..+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus 219 -----~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 219 -----E----APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -----C----CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 0 0112346688999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=322.16 Aligned_cols=240 Identities=17% Similarity=0.207 Sum_probs=193.2
Q ss_pred cccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccC
Q 045453 63 NVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKN 137 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~ 137 (346)
+.||+|+||.||++.. ++..||+|.+.... ......+..|...+..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCEEEEEEeCCCC
Confidence 3699999999999998 78899999987542 12334566788888888 999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCcee
Q 045453 138 RTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCV 217 (346)
Q Consensus 138 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 217 (346)
|+|..++.... .+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||++........ .
T Consensus 80 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~ 151 (323)
T cd05595 80 GELFFHLSRER----VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-T 151 (323)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-c
Confidence 99999887643 5899999999999999999999 89999999999999999999999999999875322221 2
Q ss_pred eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccccccc
Q 045453 218 KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPII 297 (346)
Q Consensus 218 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 297 (346)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... ...... ... .+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~----------~~~~~~-~~~------~~ 214 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL----------FELILM-EEI------RF 214 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH----------HHHHhc-CCC------CC
Confidence 2345689999999999999999999999999999999999999975433221 111000 000 00
Q ss_pred ccCCCCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 045453 298 VSEGPRVGKEKQLQGFRELALMCVCESAEDRP-----TTVDVAK 336 (346)
Q Consensus 298 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~ 336 (346)
+......+.+++..||+.+|++|| ++.++++
T Consensus 215 --------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 215 --------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred --------CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 013345688999999999999998 7877764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=306.94 Aligned_cols=246 Identities=21% Similarity=0.334 Sum_probs=195.1
Q ss_pred cccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccCCC
Q 045453 63 NVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRT 139 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~gs 139 (346)
+.||+|+||.||+|.+ +++.+|+|....... .....+.+|+..+..+ +||||++++++|...+..++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 3699999999999998 788999998764432 3345677888888887 99999999999999999999999999999
Q ss_pred hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCceee-
Q 045453 140 LADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVK- 218 (346)
Q Consensus 140 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~- 218 (346)
|.+++.... ..+++..++.++.|++.||.||| +.+++|+||||+|||++.++.+||+|||++...........
T Consensus 80 L~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 153 (252)
T cd05084 80 FLTFLRTEG---PRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG 153 (252)
T ss_pred HHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence 999997543 45899999999999999999999 89999999999999999999999999999876543221111
Q ss_pred ccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccccccc
Q 045453 219 DKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPII 297 (346)
Q Consensus 219 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 297 (346)
.....+..|+|||.+.++.++.++||||||+++|||++ |..||........ .........
T Consensus 154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~-----------~~~~~~~~~-------- 214 (252)
T cd05084 154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT-----------REAIEQGVR-------- 214 (252)
T ss_pred CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH-----------HHHHHcCCC--------
Confidence 11123457999999999999999999999999999998 8888864332110 111111000
Q ss_pred ccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 045453 298 VSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLK 339 (346)
Q Consensus 298 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 339 (346)
.. .....+..+.+++.+||+.+|++|||+.+|.+.|+
T Consensus 215 -~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 215 -LP----CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred -CC----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 00 11133457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=324.90 Aligned_cols=244 Identities=18% Similarity=0.225 Sum_probs=197.2
Q ss_pred hcCCCcccccccCCCcEEEEEEE--C-CeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcce
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--E-DRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV 129 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~-~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~ 129 (346)
.++|...+.||+|+||.||+|.+ . +..||+|++.... ......+.+|...+..+ +||||+++++++.+.+..+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-NHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCCcceEEEEEeCCEEE
Confidence 45688899999999999999987 2 3589999886432 22345567788888888 9999999999999999999
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcc
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVS 209 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~ 209 (346)
+||||+++|+|.+++.... .+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||++..
T Consensus 108 lv~Ey~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNK----RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 9999999999999997653 5899999999999999999999 89999999999999999999999999999976
Q ss_pred cCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcc
Q 045453 210 IPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEF 289 (346)
Q Consensus 210 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (346)
..... ....||+.|+|||++.+..++.++|||||||++|||++|..||........ .... ..+.
T Consensus 181 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~----------~~~i-~~~~- 244 (340)
T PTZ00426 181 VDTRT----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI----------YQKI-LEGI- 244 (340)
T ss_pred cCCCc----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH----------HHHH-hcCC-
Confidence 64322 245689999999999998899999999999999999999999975432111 1111 1110
Q ss_pred ccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 045453 290 DEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRP-----TTVDVAK 336 (346)
Q Consensus 290 ~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~ 336 (346)
. ..+ ......+.+++.+||+.+|++|+ |+.++++
T Consensus 245 -------~--~~p----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 245 -------I--YFP----KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred -------C--CCC----CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 0 000 12234578999999999999995 7887764
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=322.74 Aligned_cols=251 Identities=18% Similarity=0.206 Sum_probs=196.9
Q ss_pred CCCcccccccCCCcEEEEEEE-----CCeEEEEEEecCcc----CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcc
Q 045453 58 NFDARNVIKDGYAYKFYKGFV-----EDRTVSVMKFNDIL----NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIP 128 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~-----~~~~vavk~~~~~~----~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~ 128 (346)
+|+..+.||+|+||.||++.. ++..+|+|.+.... ......+..|+..+..+.+||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999876 56889999886432 122345667888888885699999999999999999
Q ss_pred eEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 129 VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
++||||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD----NFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 99999999999999997653 5899999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCceeeccccccCCcCCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcC
Q 045453 209 SIPEGETCVKDKVTGTMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENN 287 (346)
Q Consensus 209 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (346)
..............||..|+|||++.+. .++.++|||||||++|||+||..||........ ..........
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------~~~~~~~~~~-- 225 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT------QSEVSRRILK-- 225 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC------HHHHHHHHhc--
Confidence 6544333233345789999999999865 478999999999999999999999975433221 1111111100
Q ss_pred ccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 045453 288 EFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRP-----TTVDVAK 336 (346)
Q Consensus 288 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~ 336 (346)
.++.+ +......+.+++.+||+.||++|| ++.++++
T Consensus 226 -----~~~~~--------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 -----CDPPF--------PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred -----CCCCC--------CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 01111 012345678999999999999999 6666653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=312.36 Aligned_cols=266 Identities=20% Similarity=0.272 Sum_probs=202.2
Q ss_pred hcCCCcccccccCCCcEEEEEEE------CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeec--CCc
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV------EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLE--TRI 127 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~------~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~--~~~ 127 (346)
.++|...+.||+|+||.||++.+ .+..|++|++..........+.+|+..+..+ +||||+++++++.. ...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEccCCCCc
Confidence 35678889999999999999974 4678999998765545556778899999888 99999999998754 346
Q ss_pred ceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCC
Q 045453 128 PVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS 207 (346)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~ 207 (346)
.++||||+++++|.+++.... ..+++..+..++.|++.||+||| ..+++|+||||+||++++++.+||+|||++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~ 155 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLT 155 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCccc
Confidence 789999999999999997543 35899999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCceee--ccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccc---cch--hhHHHHH
Q 045453 208 VSIPEGETCVK--DKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIG---AGH--YWLLHYV 280 (346)
Q Consensus 208 ~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~---~~~--~~~~~~~ 280 (346)
+.......... ....++..|+|||++.+..++.++||||||++++||++|..|+......... ... .......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 87654332111 1222345699999999889999999999999999999988775432211000 000 0000000
Q ss_pred HHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 045453 281 KKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341 (346)
Q Consensus 281 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 341 (346)
.... ......+.....+..+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 236 ~~~~-------------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 236 IELL-------------KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHH-------------hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0000 00000111113456799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=309.36 Aligned_cols=255 Identities=19% Similarity=0.323 Sum_probs=203.0
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CC---eEEEEEEecCcc-CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcce
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--ED---RTVSVMKFNDIL-NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV 129 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~---~~vavk~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~ 129 (346)
+++|+..+.||+|+||.||+|.. .+ ..+++|+..... ......+..|+..+..+ +||||+++.+++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQF-SHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEccCCCcE
Confidence 46788899999999999999998 23 368888876543 23345677888888888 9999999999999999999
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcc
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVS 209 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~ 209 (346)
+||||+++++|.+++.... ..+++..+..++.+++.||+||| +.+++|+||||+||+++.++.+|++|||++..
T Consensus 83 lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 83 IITEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred EEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCcccee
Confidence 9999999999999997643 36899999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCceee--ccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhc
Q 045453 210 IPEGETCVK--DKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIEN 286 (346)
Q Consensus 210 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (346)
......... .....+..|+|||++.+..++.++||||||+++||+++ |..||......+ . .... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~-------~---~~~i-~~ 225 (268)
T cd05063 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-------V---MKAI-ND 225 (268)
T ss_pred cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH-------H---HHHH-hc
Confidence 643322111 11223457999999998899999999999999999998 999996543211 1 1111 11
Q ss_pred CccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 045453 287 NEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341 (346)
Q Consensus 287 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 341 (346)
.. ..+.....+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 226 ~~-------------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 226 GF-------------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CC-------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 10 0000113345688999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=321.35 Aligned_cols=240 Identities=15% Similarity=0.201 Sum_probs=193.6
Q ss_pred cccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccC
Q 045453 63 NVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKN 137 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~ 137 (346)
++||+|+||.||++.. ++..+|+|.+.... ......+.+|...+..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT-RHPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999998 78899999987542 22345667788888887 999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCcee
Q 045453 138 RTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCV 217 (346)
Q Consensus 138 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 217 (346)
|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 80 g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 151 (328)
T cd05593 80 GELFFHLSRE----RVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-AT 151 (328)
T ss_pred CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cc
Confidence 9999988664 35899999999999999999999 8999999999999999999999999999987543221 12
Q ss_pred eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccccccc
Q 045453 218 KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPII 297 (346)
Q Consensus 218 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 297 (346)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+. ..... ... ..+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~----------~~~~~-~~~------~~~ 214 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL----------FELIL-MED------IKF 214 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH----------HHHhc-cCC------ccC
Confidence 2345689999999999999999999999999999999999999975432111 11100 000 000
Q ss_pred ccCCCCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 045453 298 VSEGPRVGKEKQLQGFRELALMCVCESAEDRP-----TTVDVAK 336 (346)
Q Consensus 298 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~ 336 (346)
+......+.+++.+||+.+|++|| ++.|+++
T Consensus 215 --------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 215 --------PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred --------CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 012345688999999999999997 7888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=323.35 Aligned_cols=250 Identities=24% Similarity=0.294 Sum_probs=212.4
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCc-ceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRI-PVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~-~~lv 131 (346)
++|...+++|+|+||.++..++ ++..+++|++.-.. ........+|...+.++ +|||||.+.+.+.+++. .+||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~-~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKL-LHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhc-cCCCeeeeccchhcCCceEEEE
Confidence 4677889999999999998877 78899999987543 34455678888889887 99999999999999988 9999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|+|++||+|.+.+.... +..+++..+..|..|++.|+.||| +..|+|||||++|||++.++.+||+|||+|+.+.
T Consensus 83 m~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred EeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 99999999999998876 356899999999999999999999 8999999999999999999999999999999887
Q ss_pred CCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccc
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDE 291 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (346)
... ......+||+-||.||.+.+.+|+.|+|||||||++|||++-+++|...+-... +..
T Consensus 158 ~~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L----------i~k--------- 217 (426)
T KOG0589|consen 158 PED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL----------ILK--------- 217 (426)
T ss_pred Cch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH----------HHH---------
Confidence 655 235678999999999999999999999999999999999999999986544332 211
Q ss_pred ccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045453 292 IVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKR 337 (346)
Q Consensus 292 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 337 (346)
...+.... -+.....++..++..||+.+|..||++.+++..
T Consensus 218 ----i~~~~~~P-lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 218 ----INRGLYSP-LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ----HhhccCCC-CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 11111111 122567789999999999999999999999876
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=311.52 Aligned_cols=263 Identities=21% Similarity=0.325 Sum_probs=208.0
Q ss_pred HhcCCCcccccccCCCcEEEEEEE-C-----CeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeec-CC
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV-E-----DRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLE-TR 126 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~-~-----~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~-~~ 126 (346)
..++|...++||+|+||.||+|.+ . +..|++|++..... .....+.+|...+..+ +||||+++++++.. +.
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL-SHQNILPILHVCIEDGE 82 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCC
Confidence 456788899999999999999998 3 57888888764332 3345577888888888 99999999998876 46
Q ss_pred cceEEEecccCCChhhhhhhcCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEe
Q 045453 127 IPVIVFESVKNRTLADHIYQNQPH----FEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLF 202 (346)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~ 202 (346)
..++++||+++++|.+++...... ...+++..++.++.+++.||.||| +.+++|+||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEEC
Confidence 789999999999999998764321 146899999999999999999999 8999999999999999999999999
Q ss_pred ccCCCcccCCCCcee-eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHH
Q 045453 203 DFSLSVSIPEGETCV-KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYV 280 (346)
Q Consensus 203 Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 280 (346)
|||+++.+....... .....++..|+|||++.+..++.++||||||+++||+++ |+.||...+..+ +..++
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~ 232 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE-------MAAYL 232 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH-------HHHHH
Confidence 999998664433221 223345678999999998889999999999999999999 999997543211 11111
Q ss_pred HHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 045453 281 KKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHL 345 (346)
Q Consensus 281 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~l 345 (346)
. .+. .+ ......+..+.+++.+||+.+|++|||+.++++.|+++.+.+
T Consensus 233 ~----~~~-------~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~ 280 (280)
T cd05043 233 K----DGY-------RL------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQL 280 (280)
T ss_pred H----cCC-------CC------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhcC
Confidence 1 110 00 001123456889999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=323.91 Aligned_cols=266 Identities=18% Similarity=0.210 Sum_probs=197.6
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
.+.|+..+.||+|+||.||++.+ +++.||+|+.. .....+|+.++..+ +|||||++++++......++|+|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAI-NHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhC-CCCCCCCEeEEEEECCeeEEEEe
Confidence 36799999999999999999998 77899999743 23467888888888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
++. ++|.+++... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 164 ~~~-~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 164 RYK-TDLYCYLAAK----RNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred cCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 995 6898888664 35889999999999999999999 899999999999999999999999999998754322
Q ss_pred CceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccch-hhHHHHHHHHhh-cCcc--
Q 045453 214 ETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGH-YWLLHYVKKCIE-NNEF-- 289 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~-~~~~-- 289 (346)
.........||+.|+|||++.+..++.++|||||||++|||+||..||............ ..+...+...-. ....
T Consensus 236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 222223457999999999999999999999999999999999999887543321110000 011111110000 0000
Q ss_pred ------cccc----ccccccCCCCc---chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 290 ------DEIV----DPIIVSEGPRV---GKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 290 ------~~~~----d~~l~~~~~~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.... ..........+ .....+..+.+|+.+||+.||++|||+.|+++
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 00000000000 01133567899999999999999999999985
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=313.73 Aligned_cols=259 Identities=20% Similarity=0.314 Sum_probs=202.4
Q ss_pred cCCCcccccccCCCcEEEEEEE--CC--eEEEEEEecCcc-CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--ED--RTVSVMKFNDIL-NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~--~~vavk~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
++|+..+.||+|+||.||+|.+ ++ ..+++|.+.... ......+..|+..+.++.+||||+++++++.+.+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 5788899999999999999988 33 246787776432 233456778888888886799999999999999999999
Q ss_pred EecccCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCce
Q 045453 132 FESVKNRTLADHIYQNQP------------HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIA 199 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~ 199 (346)
+||+++++|.+++..... ....+++..++.++.|++.||+||| +.+++||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence 999999999999965421 1135889999999999999999999 8999999999999999999999
Q ss_pred EEeccCCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHH
Q 045453 200 KLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLH 278 (346)
Q Consensus 200 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 278 (346)
||+|||++....... .......+..|+|||+..+..++.++|||||||++|||++ |..||......+.
T Consensus 159 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~--------- 227 (297)
T cd05089 159 KIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL--------- 227 (297)
T ss_pred EECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---------
Confidence 999999986432111 1112223557999999998899999999999999999998 9999965433221
Q ss_pred HHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 279 YVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 279 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
...... .. ... .+......+.+|+.+||+.+|.+|||+.++++.|+.+.+.
T Consensus 228 -~~~~~~-~~-----~~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~ 278 (297)
T cd05089 228 -YEKLPQ-GY-----RME--------KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278 (297)
T ss_pred -HHHHhc-CC-----CCC--------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 111100 00 000 0112345688999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=305.03 Aligned_cols=245 Identities=21% Similarity=0.339 Sum_probs=196.5
Q ss_pred ccccCCCcEEEEEEE-CCeEEEEEEecCccCc-chHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccCCChh
Q 045453 64 VIKDGYAYKFYKGFV-EDRTVSVMKFNDILND-GHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLA 141 (346)
Q Consensus 64 ~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~-~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 141 (346)
+||+|+||.||+|.. ++..+|+|.+...... ....+.+|...+..+ +||||++++++|...+..++||||+++++|.
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQY-DHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 699999999999988 6788999987755432 234567788888887 9999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCceeeccc
Q 045453 142 DHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKV 221 (346)
Q Consensus 142 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 221 (346)
+++.... ..+++..+..++.+++.||.||| ..+++|+||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRKKK---DELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 9987543 35889999999999999999999 89999999999999999999999999999876543322222233
Q ss_pred cccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccccccccC
Q 045453 222 TGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSE 300 (346)
Q Consensus 222 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 300 (346)
.++..|+|||++.++.++.++||||||+++|++++ |..||........ . .. ....... .
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~-------~---~~-~~~~~~~---------~ 214 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA-------R---EQ-VEKGYRM---------S 214 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH-------H---HH-HHcCCCC---------C
Confidence 44678999999999999999999999999999998 9999975433211 0 11 1111000 0
Q ss_pred CCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 045453 301 GPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLK 339 (346)
Q Consensus 301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 339 (346)
.....+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus 215 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 215 ----CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred ----CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 01123467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=307.91 Aligned_cols=255 Identities=23% Similarity=0.373 Sum_probs=199.9
Q ss_pred CCcccccccCCCcEEEEEEEC-----CeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecCCc----
Q 045453 59 FDARNVIKDGYAYKFYKGFVE-----DRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRI---- 127 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~~~-----~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~---- 127 (346)
|...+.||+|+||.||+|.+. +..+|+|++..... ....++..|...+..+ +||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDF-DHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEeeeccCCccccC
Confidence 456789999999999999872 26799998875432 3345677888888888 99999999999876554
Q ss_pred --ceEEEecccCCChhhhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEec
Q 045453 128 --PVIVFESVKNRTLADHIYQNQP--HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFD 203 (346)
Q Consensus 128 --~~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~D 203 (346)
.++|+||+++|+|..++..... ....+++.....++.|++.||+||| +.+++||||||+||++++++.+||+|
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECC
Confidence 7999999999999999865321 2246899999999999999999999 89999999999999999999999999
Q ss_pred cCCCcccCCCCceee-ccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHH
Q 045453 204 FSLSVSIPEGETCVK-DKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVK 281 (346)
Q Consensus 204 fgl~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 281 (346)
||+++.......... ....++..|+|||++.+..++.++||||||+++|||++ |..||......+ ....+
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~-------~~~~~- 228 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE-------IYDYL- 228 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHH-
Confidence 999987654332211 22335678999999988899999999999999999999 889886533211 11111
Q ss_pred HHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 045453 282 KCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341 (346)
Q Consensus 282 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 341 (346)
..+... . .+......+.+++.+||+.+|++|||+.||++.|+++
T Consensus 229 ---~~~~~~------------~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 229 ---RHGNRL------------K-QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ---HcCCCC------------C-CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111100 0 0113445789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=320.70 Aligned_cols=245 Identities=19% Similarity=0.234 Sum_probs=189.9
Q ss_pred cccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccC
Q 045453 63 NVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKN 137 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~ 137 (346)
+.||+|+||.||+|.. +++.+|+|.+..... .....+..|...+..+.+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999998 678999999875421 23344567777777776899999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCcee
Q 045453 138 RTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCV 217 (346)
Q Consensus 138 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 217 (346)
|+|..++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~ 152 (329)
T cd05618 81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-T 152 (329)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-c
Confidence 9999888654 35899999999999999999999 89999999999999999999999999999875322111 2
Q ss_pred eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccccccc
Q 045453 218 KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPII 297 (346)
Q Consensus 218 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 297 (346)
.....||..|+|||++.+..++.++|||||||++|+|++|..||.......... .....++......... .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~--~~~~~~~~~~i~~~~~------~~ 224 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD--QNTEDYLFQVILEKQI------RI 224 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcc--cccHHHHHHHHhcCCC------CC
Confidence 234568999999999999999999999999999999999999996432211100 0111111111111110 00
Q ss_pred ccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCH
Q 045453 298 VSEGPRVGKEKQLQGFRELALMCVCESAEDRPTT 331 (346)
Q Consensus 298 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 331 (346)
+ ......+.+++.+||+.+|++|||+
T Consensus 225 ----p----~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 225 ----P----RSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred ----C----CCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 0 1234567899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=320.20 Aligned_cols=237 Identities=20% Similarity=0.250 Sum_probs=190.9
Q ss_pred cccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccC
Q 045453 63 NVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKN 137 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~ 137 (346)
+.||+|+||.||+|.. +++.||+|.+.... ......+..|...+....+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999998 67899999986432 233455667777777766899999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCcee
Q 045453 138 RTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCV 217 (346)
Q Consensus 138 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 217 (346)
|+|.+++.... .+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~i~~~~----~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~ 152 (320)
T cd05590 81 GDLMFHIQKSR----RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-T 152 (320)
T ss_pred chHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-c
Confidence 99999887653 5899999999999999999999 89999999999999999999999999999875432221 2
Q ss_pred eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccccccc
Q 045453 218 KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPII 297 (346)
Q Consensus 218 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 297 (346)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||......+. ..... ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~----------~~~i~-~~~~-------- 213 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL----------FEAIL-NDEV-------- 213 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH----------HHHHh-cCCC--------
Confidence 2345689999999999999999999999999999999999999975433221 11111 1100
Q ss_pred ccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHH
Q 045453 298 VSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTV 332 (346)
Q Consensus 298 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ 332 (346)
. .+......+.+++..||+.||++||++.
T Consensus 214 ----~--~~~~~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 214 ----V--YPTWLSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred ----C--CCCCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 0 0012345688999999999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=316.99 Aligned_cols=264 Identities=18% Similarity=0.285 Sum_probs=207.1
Q ss_pred HHhcCCCcccccccCCCcEEEEEEEC---------CeEEEEEEecCcc-CcchHHHHHHHHHHhhhcCCCceeeEcceee
Q 045453 54 IATNNFDARNVIKDGYAYKFYKGFVE---------DRTVSVMKFNDIL-NDGHEDCFNNIIFASKLSSHKNVLKLTGCCL 123 (346)
Q Consensus 54 ~~~~~f~~~~~ig~G~~g~Vy~~~~~---------~~~vavk~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~ 123 (346)
...++|...+.||+|+||.||++.+. ...+|+|.+.... .....++..|+..+..+.+||||++++++|.
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 33467889999999999999999862 2469999887543 2334567778888888768999999999999
Q ss_pred cCCcceEEEecccCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCe
Q 045453 124 ETRIPVIVFESVKNRTLADHIYQNQP------------HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRI 191 (346)
Q Consensus 124 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NI 191 (346)
..+..++||||+++|+|.+++..... ....++|.+++.++.|++.||+||| +.+++|+||||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Ni 171 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNV 171 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHhe
Confidence 99999999999999999999976432 1135899999999999999999999 89999999999999
Q ss_pred EEcCCCceEEeccCCCcccCCCCcee-eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccc
Q 045453 192 FLDEGYIAKLFDFSLSVSIPEGETCV-KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEI 269 (346)
Q Consensus 192 ll~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~ 269 (346)
+++.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~- 250 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE- 250 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-
Confidence 99999999999999987664322211 112234568999999998899999999999999999998 888886432211
Q ss_pred ccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 270 GAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
.... ....... . .+......+.+++.+||+.+|++|||+.+|++.|+.+.+.
T Consensus 251 ---------~~~~-~~~~~~~---------~----~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 251 ---------LFKL-LKEGHRM---------D----KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred ---------HHHH-HHcCCCC---------C----CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 1111 1111000 0 0113346788999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=315.96 Aligned_cols=266 Identities=18% Similarity=0.318 Sum_probs=207.7
Q ss_pred HHHhcCCCcccccccCCCcEEEEEEE---------CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEccee
Q 045453 53 EIATNNFDARNVIKDGYAYKFYKGFV---------EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCC 122 (346)
Q Consensus 53 ~~~~~~f~~~~~ig~G~~g~Vy~~~~---------~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~ 122 (346)
....++|...+.||+|+||.||+|.. ....+|+|.+..... ....++..|+..+..+.+||||++++++|
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 34456788899999999999999975 235788888764432 33456778888888875799999999999
Q ss_pred ecCCcceEEEecccCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCC
Q 045453 123 LETRIPVIVFESVKNRTLADHIYQNQP------------HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSR 190 (346)
Q Consensus 123 ~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~N 190 (346)
...+..++||||+++|+|.+++..... ....++|.++..++.|++.||.||| +.+++|+||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~N 164 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARN 164 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecccccee
Confidence 999999999999999999999976421 1235899999999999999999999 8999999999999
Q ss_pred eEEcCCCceEEeccCCCcccCCCCcee-eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcc
Q 045453 191 IFLDEGYIAKLFDFSLSVSIPEGETCV-KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDE 268 (346)
Q Consensus 191 Ill~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~ 268 (346)
||++.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~ 244 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE 244 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999998765332211 122234567999999998899999999999999999999 888886543221
Q ss_pred cccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 045453 269 IGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHL 345 (346)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~l 345 (346)
. .. . ....... . .....+..+.+++.+||+.+|++|||+.++++.|+++...+
T Consensus 245 ~-------~~---~-~~~~~~~---------~----~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 245 L-------FK---L-LREGHRM---------D----KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred H-------HH---H-HHcCCCC---------C----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 1 11 1 1111100 0 01133456889999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=308.00 Aligned_cols=255 Identities=22% Similarity=0.358 Sum_probs=204.4
Q ss_pred HHhcCCCcccccccCCCcEEEEEEE-CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 54 IATNNFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 54 ~~~~~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
+..++|...++||+|+||.||+|.. +++.+|+|.+.... .....+.+|+..+..+ +||||+++++++. .+..++||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQL-QHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhc-CCcCeeeEEEEEc-cCCcEEEE
Confidence 3456788899999999999999998 77899999886443 3345678888888888 9999999999864 56789999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
||+++++|.+++..... ..+++.++..++.+++.||+||| +.+++|+||||+||++++++.++|+|||++.....
T Consensus 80 e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 80 EYMENGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EcCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 99999999999876432 46899999999999999999999 89999999999999999999999999999876653
Q ss_pred CCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCcccc
Q 045453 213 GETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDE 291 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (346)
..........++..|+|||++.+..++.++||||||+++||+++ |+.||......+. ... .......
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~----------~~~-~~~~~~~- 222 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV----------IQN-LERGYRM- 222 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH----------HHH-HHcCCCC-
Confidence 33322333456778999999998899999999999999999999 9999975443221 111 0111000
Q ss_pred ccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 045453 292 IVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQ 340 (346)
Q Consensus 292 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 340 (346)
.. ....+..+.+++.+||+.+|++|||++++.+.|+.
T Consensus 223 --------~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 --------PR----PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred --------CC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 00 01234569999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=306.11 Aligned_cols=246 Identities=20% Similarity=0.337 Sum_probs=194.5
Q ss_pred ccccCCCcEEEEEEE----CCeEEEEEEecCccCc-chHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccCC
Q 045453 64 VIKDGYAYKFYKGFV----EDRTVSVMKFNDILND-GHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNR 138 (346)
Q Consensus 64 ~ig~G~~g~Vy~~~~----~~~~vavk~~~~~~~~-~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~g 138 (346)
.||+|+||.||+|.+ .+..||+|.+...... ....+.+|+..+..+ +||||++++++|. .+..++||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~-~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQL-DNPYIVRMIGVCE-AEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhc-CCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence 389999999999987 2446899988655432 234577888888888 9999999999885 45789999999999
Q ss_pred ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCceee
Q 045453 139 TLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVK 218 (346)
Q Consensus 139 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 218 (346)
+|.+++.... ..+++..++.++.|++.||+||| +.+++|+||||+|||++.++.+||+|||++.....+.....
T Consensus 80 ~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 153 (257)
T cd05115 80 PLNKFLSGKK---DEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK 153 (257)
T ss_pred CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence 9999987543 46899999999999999999999 89999999999999999999999999999876654332222
Q ss_pred --ccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccccc
Q 045453 219 --DKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDP 295 (346)
Q Consensus 219 --~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 295 (346)
....++..|+|||.+.+..++.++||||||+++||+++ |..||......+. . .....+...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-------~----~~~~~~~~~----- 217 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV-------M----SFIEQGKRL----- 217 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH-------H----HHHHCCCCC-----
Confidence 12223568999999998889999999999999999996 9999975433211 1 111111100
Q ss_pred ccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 045453 296 IIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341 (346)
Q Consensus 296 ~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 341 (346)
..+......+.+++.+||+.+|++||++.+|.+.|+.+
T Consensus 218 --------~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 --------DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 01113456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=311.52 Aligned_cols=246 Identities=16% Similarity=0.243 Sum_probs=193.8
Q ss_pred cccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccCCC
Q 045453 65 IKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRT 139 (346)
Q Consensus 65 ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~gs 139 (346)
||+|+||+||++.+ +++.+|+|++..... .....+..|+..+..+ +||||+++.+++......++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-CCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 79999999999988 678999999864321 2234566788888888 99999999999999999999999999999
Q ss_pred hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCceeec
Q 045453 140 LADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKD 219 (346)
Q Consensus 140 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 219 (346)
|.+.+.........+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++........ ...
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~ 155 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTK 155 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-ccc
Confidence 99888653333356899999999999999999999 89999999999999999999999999999876654332 123
Q ss_pred cccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccccccccc
Q 045453 220 KVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVS 299 (346)
Q Consensus 220 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 299 (346)
...||+.|+|||++.+..++.++||||||+++|||++|+.||........ ........ .....
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~------~~~~~~~~---------~~~~~-- 218 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE------NKELKQRI---------LNDSV-- 218 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh------HHHHHHhh---------cccCC--
Confidence 45689999999999999999999999999999999999999975433211 00000000 00000
Q ss_pred CCCCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 045453 300 EGPRVGKEKQLQGFRELALMCVCESAEDRP-----TTVDVAK 336 (346)
Q Consensus 300 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~ 336 (346)
..+...+..+.+++..||+.+|++|| |++++++
T Consensus 219 ----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 219 ----TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred ----CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 00113456688999999999999999 6666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=315.76 Aligned_cols=263 Identities=18% Similarity=0.286 Sum_probs=207.5
Q ss_pred HHhcCCCcccccccCCCcEEEEEEE---------CCeEEEEEEecCcc-CcchHHHHHHHHHHhhhcCCCceeeEcceee
Q 045453 54 IATNNFDARNVIKDGYAYKFYKGFV---------EDRTVSVMKFNDIL-NDGHEDCFNNIIFASKLSSHKNVLKLTGCCL 123 (346)
Q Consensus 54 ~~~~~f~~~~~ig~G~~g~Vy~~~~---------~~~~vavk~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~ 123 (346)
....+|...+.||+|+||.||+|.+ ++..+|+|.+.... .....++.+|+..+..+.+||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 4456788889999999999999975 23478999876443 2344567788888877768999999999999
Q ss_pred cCCcceEEEecccCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCe
Q 045453 124 ETRIPVIVFESVKNRTLADHIYQNQP------------HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRI 191 (346)
Q Consensus 124 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NI 191 (346)
.....++||||+++|+|.+++..... ....++|.++..++.|++.||.||| +.+++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceE
Confidence 99999999999999999999976432 1235889999999999999999999 89999999999999
Q ss_pred EEcCCCceEEeccCCCcccCCCCcee-eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccc
Q 045453 192 FLDEGYIAKLFDFSLSVSIPEGETCV-KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEI 269 (346)
Q Consensus 192 ll~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~ 269 (346)
|++.++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|++++ |..||......+
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~- 247 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE- 247 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-
Confidence 99999999999999998765433222 223345678999999998899999999999999999998 788886432211
Q ss_pred ccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 045453 270 GAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQ 343 (346)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 343 (346)
..... ...... ......+..+.+++.+||+.+|++|||+.|+++.|+++..
T Consensus 248 ---------~~~~~-~~~~~~-------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 248 ---------LFKLL-KEGHRM-------------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred ---------HHHHH-HcCCcC-------------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 11111 111100 0011345678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=310.03 Aligned_cols=266 Identities=23% Similarity=0.293 Sum_probs=200.3
Q ss_pred CCcccccccCCCcEEEEEEE------CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecC--Ccce
Q 045453 59 FDARNVIKDGYAYKFYKGFV------EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLET--RIPV 129 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~~------~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~--~~~~ 129 (346)
|...+.||+|+||+||++.+ ++..||+|.+..... .....+.+|+..+..+ +||||+++++++... ...+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-YHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCceEE
Confidence 36778999999999988653 567899998865432 2345677888888888 999999999998653 3578
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcc
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVS 209 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~ 209 (346)
+||||+++++|.+++... .+++..+..++.|++.||.||| +.+++|+||||+|||+++++.++|+|||+++.
T Consensus 85 lv~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 85 LIMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred EEecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccc
Confidence 999999999999999653 4899999999999999999999 89999999999999999999999999999887
Q ss_pred cCCCCcee--eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcC
Q 045453 210 IPEGETCV--KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENN 287 (346)
Q Consensus 210 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (346)
........ .....++..|+|||.+.+..++.++||||||+++|||+||..|+......... ............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-----~~~~~~~~~~~~ 231 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE-----MIGPKQGQMTVV 231 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh-----hhcccccccchh
Confidence 65433211 12234566799999999888999999999999999999999998654321100 000000000000
Q ss_pred ccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 045453 288 EFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIY 342 (346)
Q Consensus 288 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~ 342 (346)
...+.++...... .+...+..+.+++..||+.+|++|||+.+|++.|+++.
T Consensus 232 ~~~~~~~~~~~~~----~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 232 RLIELLERGMRLP----CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhhcCCCCC----CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0111111111111 11134567999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=326.39 Aligned_cols=250 Identities=17% Similarity=0.217 Sum_probs=200.3
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
++|...+.||+|+||+||+|.. +++.||+|++.... ......+..|...+..+ +||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA-DSPWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc-CCCCccchhhheecCCeEEEE
Confidence 4688899999999999999999 58999999987432 12344566777777777 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+++++|.+++... ..+++..+..++.|++.||+||| +.+++||||||+|||++.++.+||+|||++....
T Consensus 80 ~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 80 MEYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMN 152 (350)
T ss_pred EcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence 9999999999999765 35899999999999999999999 8999999999999999999999999999987665
Q ss_pred CCC----------------------------ceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 045453 212 EGE----------------------------TCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDP 263 (346)
Q Consensus 212 ~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~ 263 (346)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 232 (350)
T cd05573 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232 (350)
T ss_pred ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence 433 1122345689999999999999999999999999999999999999976
Q ss_pred CCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 045453 264 SRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPT-TVDVAK 336 (346)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~ev~~ 336 (346)
....+. ........ ..+ ..+.....+..+.+++.+|++ +|.+||+ +.++++
T Consensus 233 ~~~~~~----------~~~i~~~~-------~~~----~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 233 DTLQET----------YNKIINWK-------ESL----RFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred CCHHHH----------HHHHhccC-------Ccc----cCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 542211 11111100 000 000011235668899999997 9999999 999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=318.11 Aligned_cols=240 Identities=20% Similarity=0.270 Sum_probs=191.4
Q ss_pred cccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccC
Q 045453 63 NVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKN 137 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~ 137 (346)
+.||+|+||.||+|.+ ++..||+|.+.... .........|...+....+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999998 56899999987542 233445666777777666999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCcee
Q 045453 138 RTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCV 217 (346)
Q Consensus 138 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 217 (346)
|+|.+++... ..+++.++..++.|++.||.||| +.+++||||||+|||++.++.+||+|||++........ .
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (316)
T cd05619 81 GDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-K 152 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-c
Confidence 9999999764 35899999999999999999999 89999999999999999999999999999865422221 1
Q ss_pred eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccccccc
Q 045453 218 KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPII 297 (346)
Q Consensus 218 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 297 (346)
.....||..|+|||++.+..++.++|||||||++|||++|..||......+ +...+. .. .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-------~~~~i~----~~------~~~~ 215 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE-------LFQSIR----MD------NPCY 215 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHH----hC------CCCC
Confidence 234568999999999999999999999999999999999999997543221 111111 00 0000
Q ss_pred ccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 045453 298 VSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTV-DVA 335 (346)
Q Consensus 298 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-ev~ 335 (346)
+......+.+++.+||+.+|++||++. ++.
T Consensus 216 --------~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 216 --------PRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred --------CccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 002345578999999999999999997 553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=319.96 Aligned_cols=241 Identities=16% Similarity=0.243 Sum_probs=192.1
Q ss_pred cccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccC
Q 045453 63 NVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKN 137 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~ 137 (346)
++||+|+||.||+|.. .++.+|+|.+.... ......+..|...+..+.+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999998 57799999986532 233345667777777666899999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCcee
Q 045453 138 RTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCV 217 (346)
Q Consensus 138 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 217 (346)
|+|..++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++........ .
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (321)
T cd05591 81 GDLMFQIQRSR----KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-T 152 (321)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-c
Confidence 99999887643 5899999999999999999999 89999999999999999999999999999875432221 2
Q ss_pred eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccccccc
Q 045453 218 KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPII 297 (346)
Q Consensus 218 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 297 (346)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...... ... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~----------~~~i~~-~~~---~---- 214 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL----------FESILH-DDV---L---- 214 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH----------HHHHHc-CCC---C----
Confidence 2345689999999999999999999999999999999999999976443221 111111 000 0
Q ss_pred ccCCCCcchHHHHHHHHHHHHHcccCCCCCCC-------CHHHHHH
Q 045453 298 VSEGPRVGKEKQLQGFRELALMCVCESAEDRP-------TTVDVAK 336 (346)
Q Consensus 298 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-------s~~ev~~ 336 (346)
.+ ......+.+++..||+.+|++|| ++.++++
T Consensus 215 ---~p----~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 215 ---YP----VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred ---CC----CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 00 02345688999999999999999 6666653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=306.49 Aligned_cols=249 Identities=20% Similarity=0.288 Sum_probs=200.5
Q ss_pred cCCCcccccccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceee-cCCcceEEEecc
Q 045453 57 NNFDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCL-ETRIPVIVFESV 135 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~-~~~~~~lv~e~~ 135 (346)
.+|...+.||+|+||.||++...+..+++|..... .....+.+|+..+..+ +|+|++++++++. +++..++|+||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND--ATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCC--chHHHHHHHHHHHHhC-CCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46788899999999999999999999999987643 2345677888888888 9999999999765 456789999999
Q ss_pred cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCc
Q 045453 136 KNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGET 215 (346)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~ 215 (346)
++++|.+++..... ..+++..++.++.+++.||+||| +.+++|+||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 83 AKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 99999999976542 35899999999999999999999 8999999999999999999999999999987553322
Q ss_pred eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccc
Q 045453 216 CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVD 294 (346)
Q Consensus 216 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 294 (346)
....++..|+|||++.+..++.++||||||+++|+|++ |+.||......+ ..... ..+...
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~----------~~~~~-~~~~~~---- 218 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----------VVPRV-EKGYKM---- 218 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH----------HHHHH-hcCCCC----
Confidence 22344568999999998899999999999999999998 999986432211 11111 111000
Q ss_pred cccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 045453 295 PIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341 (346)
Q Consensus 295 ~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 341 (346)
......+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 219 ---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 219 ---------DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ---------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 00113456788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=312.78 Aligned_cols=250 Identities=21% Similarity=0.282 Sum_probs=199.0
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
+|+..+.||+|+||+||++.. ++..||+|++..... .....+.+|+..+..+ +||||+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-CCCCEeeeeeeecCCCeEEEEE
Confidence 477789999999999999998 678999999864321 2234456788888888 9999999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
||+++|+|.+++..... ..+++..+..++.|++.||.||| +.+++|+||||+||++++++.++|+|||++.....
T Consensus 80 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 80 TLMNGGDLKFHIYNMGN--PGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred eccCCCcHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 99999999998865432 46899999999999999999999 89999999999999999999999999999876543
Q ss_pred CCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccc
Q 045453 213 GETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEI 292 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (346)
... .....|+..|+|||++.+..++.++||||||+++|||++|..||........ ...+........
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~-------~~~~~~~~~~~~---- 221 (285)
T cd05605 155 GET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK-------REEVERRVKEDQ---- 221 (285)
T ss_pred CCc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH-------HHHHHHHhhhcc----
Confidence 322 2344689999999999988999999999999999999999999976433211 011111111000
Q ss_pred cccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 045453 293 VDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRP-----TTVDVAK 336 (346)
Q Consensus 293 ~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~ 336 (346)
.. .....+..+.+|+.+||+.||++|| ++.++++
T Consensus 222 ------~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 222 ------EE----YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred ------cc----cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 00 0113456688999999999999999 7778754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=308.03 Aligned_cols=256 Identities=25% Similarity=0.360 Sum_probs=206.2
Q ss_pred HHhcCCCcccccccCCCcEEEEEEE-CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 54 IATNNFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 54 ~~~~~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
...++|...+.||+|+||.||+|.+ ++..+++|.+.... ....++..|+..+..+ +||||+++++++......++||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKL-RHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhC-CCCCEeeeeeeeecCCceEEEE
Confidence 3457788999999999999999998 56789999876432 3456778888888888 9999999999999988999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
||+++++|.+++..... ..+++.++..++.+++.||+||| ..+++|+||||+||++++++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~i~~~~~--~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 81 EYMSKGSLLDFLKSGEG--KKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred eccCCCCHHHHHhcccc--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 99999999999976532 46899999999999999999999 88999999999999999999999999999877654
Q ss_pred CCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCcccc
Q 045453 213 GETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDE 291 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (346)
...........+..|+|||.+.+..++.++||||||++++++++ |+.||........ . ..... ..
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~-------~---~~~~~-~~--- 221 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV-------L---EQVER-GY--- 221 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------H---HHHHc-CC---
Confidence 33222223345678999999998899999999999999999999 9999965432111 1 11100 00
Q ss_pred ccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 045453 292 IVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQ 340 (346)
Q Consensus 292 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 340 (346)
....+...+..+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 222 ----------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 ----------RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ----------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 000011234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=305.30 Aligned_cols=248 Identities=24% Similarity=0.353 Sum_probs=202.3
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCc--cCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDI--LNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
+|+..+.||+|++|.||+|.. ++..+++|.+... .......+.+|+..+..+ +||||+++++++.+.+..++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL-DSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhc-CCCCeehheeeeccCCEEEEEEE
Confidence 477788999999999999998 7789999987643 234456677888888888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
|+++++|.+++..... ..+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 80 YAENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred eCCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 9999999999976532 46899999999999999999999 899999999999999999999999999998776543
Q ss_pred CceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccc
Q 045453 214 ETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIV 293 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (346)
.. ......++..|+|||+..+..++.++||||||+++++|++|+.||....... ... .. ..+
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~---~~-~~~------ 216 (256)
T cd08529 155 TN-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA-------LIL---KI-IRG------ 216 (256)
T ss_pred cc-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-------HHH---HH-HcC------
Confidence 32 1233467889999999999999999999999999999999999997544211 111 10 011
Q ss_pred ccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 294 DPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 294 d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
..+.. .......+.+++.+||+.+|++||++.++++
T Consensus 217 ------~~~~~-~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 217 ------VFPPV-SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred ------CCCCC-ccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 10110 1134466899999999999999999999976
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=311.24 Aligned_cols=256 Identities=23% Similarity=0.366 Sum_probs=201.2
Q ss_pred cCCCcccccccCCCcEEEEEEE------CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcce
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV------EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV 129 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~------~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~ 129 (346)
++|+..+.||+|+||+||+|.+ .+..+++|.+..... .....+.+|+..+..+ +||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL-HHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCceE
Confidence 4577788999999999999985 346899998875432 2335667788888888 9999999999999999999
Q ss_pred EEEecccCCChhhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCC
Q 045453 130 IVFESVKNRTLADHIYQNQP-------------HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEG 196 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~ 196 (346)
+||||+++++|.+++..... ....+++...+.++.+++.||.||| +.+++|+||||+|||++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCC
Confidence 99999999999999864321 1235889999999999999999999 8999999999999999999
Q ss_pred CceEEeccCCCcccCCCCce-eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchh
Q 045453 197 YIAKLFDFSLSVSIPEGETC-VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHY 274 (346)
Q Consensus 197 ~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~ 274 (346)
+.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||.......
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~------ 234 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE------ 234 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH------
Confidence 99999999999766433221 1233445678999999998889999999999999999999 998986543211
Q ss_pred hHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 045453 275 WLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQ 340 (346)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 340 (346)
....+. .... + .........+.+++.+||+.+|++||++.+|.+.|..
T Consensus 235 -~~~~~~----~~~~-------~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 -VIEMVR----KRQL-------L------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHHHH----cCCc-------C------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111111 1110 0 0011334568899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=356.10 Aligned_cols=270 Identities=27% Similarity=0.413 Sum_probs=218.1
Q ss_pred CCHHHHHHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeec
Q 045453 47 FTIRELEIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLE 124 (346)
Q Consensus 47 ~~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~ 124 (346)
++++++. ..|...++||+|+||.||+|.+ ++..||+|++...... ...++..+.++ +|||||+++|+|.+
T Consensus 683 ~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l-~HpnIv~~~~~~~~ 754 (968)
T PLN00113 683 ITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKL-QHPNIVKLIGLCRS 754 (968)
T ss_pred hhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhC-CCCCcceEEEEEEc
Confidence 4555554 4577889999999999999997 7889999988643221 12346677777 99999999999999
Q ss_pred CCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEecc
Q 045453 125 TRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDF 204 (346)
Q Consensus 125 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Df 204 (346)
.+..++||||+++|+|.++++ .++|..+..++.|+|.||+|||+.++.+++||||||+||+++.++.+++. |
T Consensus 755 ~~~~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~ 826 (968)
T PLN00113 755 EKGAYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-L 826 (968)
T ss_pred CCCCEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-e
Confidence 999999999999999999994 38999999999999999999998777899999999999999999988876 6
Q ss_pred CCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHh
Q 045453 205 SLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCI 284 (346)
Q Consensus 205 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (346)
|....... .....+|..|+|||++.+..++.++|||||||++|||+||+.||+...... ..+..|+....
T Consensus 827 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~-----~~~~~~~~~~~ 896 (968)
T PLN00113 827 SLPGLLCT-----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVH-----GSIVEWARYCY 896 (968)
T ss_pred cccccccc-----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCC-----CcHHHHHHHhc
Confidence 65433221 123367899999999999999999999999999999999999996543322 24666776666
Q ss_pred hcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 285 ENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 285 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
........+|+.+..... ........+.+++.+||+.+|++||||.||++.|+++.+.
T Consensus 897 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 897 SDCHLDMWIDPSIRGDVS--VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred CccchhheeCccccCCCC--ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 555556666766544322 1235667789999999999999999999999999998763
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=306.23 Aligned_cols=252 Identities=23% Similarity=0.320 Sum_probs=200.5
Q ss_pred cCCCcccccccCCCcEEEEEEE-CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecc
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESV 135 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~ 135 (346)
++|.....||+|++|.||+|.+ .+..+|+|.+.... .....+.+|+..+..+ +|||++++++++. .+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKL-RHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhC-CCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 4577788999999999999998 44578998875432 3345677888888888 9999999999875 45689999999
Q ss_pred cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCc
Q 045453 136 KNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGET 215 (346)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~ 215 (346)
++++|.+++..... ..++|..+..++.+++.||.||| +.+++|+||||+||++++++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 83 GKGSLLDFLKEGDG--KYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 99999999976432 45899999999999999999999 89999999999999999999999999999977654332
Q ss_pred eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccc
Q 045453 216 CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVD 294 (346)
Q Consensus 216 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 294 (346)
.......++..|+|||+..+..++.++||||||+++|+|+| |..||......+. .... ....
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-------~~~~----~~~~------ 220 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV-------LEQV----ERGY------ 220 (260)
T ss_pred cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHH----HcCC------
Confidence 22233446678999999998899999999999999999999 8999975433221 1111 1010
Q ss_pred cccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 045453 295 PIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQ 340 (346)
Q Consensus 295 ~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 340 (346)
........+..+.+++.+||+.+|++|||+.+|++.|++
T Consensus 221 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 221 -------RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -------CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 000111345678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=307.31 Aligned_cols=255 Identities=22% Similarity=0.366 Sum_probs=196.8
Q ss_pred CCcccccccCCCcEEEEEEE--CC--eEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecC------C
Q 045453 59 FDARNVIKDGYAYKFYKGFV--ED--RTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLET------R 126 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~~--~~--~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~------~ 126 (346)
|...+.||+|+||.||+|.+ .+ ..+|+|.+.... ......+..|...+..+ +||||++++++|... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEF-DHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEccCCcccCCC
Confidence 34568899999999999998 22 268888876432 23345677788888888 999999999987542 2
Q ss_pred cceEEEecccCCChhhhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEecc
Q 045453 127 IPVIVFESVKNRTLADHIYQNQ--PHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDF 204 (346)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Df 204 (346)
..++||||+++|+|.+++.... .....+++.....++.|++.||+||| +.+|+||||||+|||+++++.+||+||
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Df 156 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADF 156 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCC
Confidence 4689999999999999875322 12245899999999999999999999 899999999999999999999999999
Q ss_pred CCCcccCCCCceee-ccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHH
Q 045453 205 SLSVSIPEGETCVK-DKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKK 282 (346)
Q Consensus 205 gl~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (346)
|+++.......... ....+++.|+|||+..+..++.++||||||+++|||++ |..||......+ +...
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~~--- 226 (272)
T cd05075 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-------IYDY--- 226 (272)
T ss_pred CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHH---
Confidence 99987654332221 22345678999999999999999999999999999999 888986533211 1111
Q ss_pred HhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 045453 283 CIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341 (346)
Q Consensus 283 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 341 (346)
...+.... ........+.+++.+||+.+|++|||+.++++.|+++
T Consensus 227 -~~~~~~~~-------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 227 -LRQGNRLK-------------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred -HHcCCCCC-------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11111000 0113345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=305.36 Aligned_cols=245 Identities=22% Similarity=0.349 Sum_probs=194.8
Q ss_pred ccccCCCcEEEEEEE----CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccC
Q 045453 64 VIKDGYAYKFYKGFV----EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKN 137 (346)
Q Consensus 64 ~ig~G~~g~Vy~~~~----~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~ 137 (346)
.||+|+||.||+|.+ ++..+|+|.+..... ....++..|+..+..+ .||||+++++++. .+..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL-DNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhC-CCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 589999999999976 568899998764432 2345677788888887 9999999999885 4567999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCcee
Q 045453 138 RTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCV 217 (346)
Q Consensus 138 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 217 (346)
|+|.+++... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~ 152 (257)
T cd05116 80 GPLNKFLQKN----KHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152 (257)
T ss_pred CcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence 9999999654 35899999999999999999999 8999999999999999999999999999998765443221
Q ss_pred e--ccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccc
Q 045453 218 K--DKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVD 294 (346)
Q Consensus 218 ~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 294 (346)
. ....++..|+|||.+....++.++||||||+++|||++ |..||......+ ....+ ..+...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~i----~~~~~~---- 217 (257)
T cd05116 153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE-------VTQMI----ESGERM---- 217 (257)
T ss_pred eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHH----HCCCCC----
Confidence 1 22234578999999988889999999999999999998 999997543321 11111 111100
Q ss_pred cccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 045453 295 PIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341 (346)
Q Consensus 295 ~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 341 (346)
. .+...+..+.+++.+||+.+|++|||+.+|++.|++.
T Consensus 218 -----~----~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 218 -----E----CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred -----C----CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 0 0113446688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=318.98 Aligned_cols=241 Identities=20% Similarity=0.239 Sum_probs=193.3
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
+|...+.||+|+||.||+|.. ++..+|+|.+.... .........|...+....+||+|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 477889999999999999998 56799999987542 1233445667777777657899999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQVG----RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 9999999999987643 5889999999999999999999 89999999999999999999999999999875432
Q ss_pred CCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccc
Q 045453 213 GETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEI 292 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (346)
... ......||+.|+|||++.+..++.++|||||||++|||+||+.||......+. ...+ .. ..
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~-------~~~i---~~-~~---- 217 (323)
T cd05616 154 DGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-------FQSI---ME-HN---- 217 (323)
T ss_pred CCC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH-------HHHH---Hh-CC----
Confidence 221 22345689999999999999999999999999999999999999975433221 1111 11 10
Q ss_pred cccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCH
Q 045453 293 VDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTT 331 (346)
Q Consensus 293 ~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 331 (346)
. .. +......+.+++.+||+.+|++|++.
T Consensus 218 ----~--~~----p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 ----V--AY----PKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ----C--CC----CCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 0 00 01234567899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=309.76 Aligned_cols=266 Identities=17% Similarity=0.230 Sum_probs=194.0
Q ss_pred cCCCcccccccCCCcEEEEEEE---CCeEEEEEEecCccC--cchHHHHHHHHHHhhh--cCCCceeeEcceeec-----
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV---EDRTVSVMKFNDILN--DGHEDCFNNIIFASKL--SSHKNVLKLTGCCLE----- 124 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~---~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~--~~h~niv~l~g~~~~----- 124 (346)
++|...+.||+|+||.||+|.+ .+..||+|.+..... .......+|+..+..+ .+||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3678889999999999999987 357899998764432 2233455666655544 269999999999852
Q ss_pred CCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEecc
Q 045453 125 TRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDF 204 (346)
Q Consensus 125 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Df 204 (346)
....++||||++ ++|.+++..... ..+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccc
Confidence 456899999996 599999875432 35899999999999999999999 899999999999999999999999999
Q ss_pred CCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHh
Q 045453 205 SLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCI 284 (346)
Q Consensus 205 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (346)
|+++...... ......+|..|+|||.+.+..++.++|||||||++|||++|..||......+. +...+....
T Consensus 155 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~------~~~i~~~~~ 226 (290)
T cd07862 155 GLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ------LGKILDVIG 226 (290)
T ss_pred cceEeccCCc--ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH------HHHHHHHhC
Confidence 9987654331 23345689999999999988999999999999999999999999986543221 111111100
Q ss_pred --hcCcccc---ccccccccCCCCcc---hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 285 --ENNEFDE---IVDPIIVSEGPRVG---KEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 285 --~~~~~~~---~~d~~l~~~~~~~~---~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
....... .............. .+.....+.+++.+||+.+|++|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 227 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred CCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000000 00000000000000 0123456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=308.71 Aligned_cols=256 Identities=20% Similarity=0.297 Sum_probs=201.6
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCe----EEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcc
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDR----TVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIP 128 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~----~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~ 128 (346)
.++|...+.||+|+||+||+|.+ ++. +||+|.+..... .....+.+|...+..+ +||||++++++|.. ...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~-~~~ 83 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV-GSPYVCRLLGICLT-STV 83 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhc-CCCCCceEEEEEcC-CCc
Confidence 35678889999999999999987 443 489998865433 3345667777777777 99999999999975 457
Q ss_pred eEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 129 VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
++++||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+++||||||+|||+++++.+||+|||+++
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENK---DRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred EEEEEcCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCcee
Confidence 89999999999999997643 36899999999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCcee-eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhc
Q 045453 209 SIPEGETCV-KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIEN 286 (346)
Q Consensus 209 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (346)
......... .....++..|+|||...+..++.++||||||+++|||++ |..||....... +...+ ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~----~~ 226 (279)
T cd05109 158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE-------IPDLL----EK 226 (279)
T ss_pred ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHH----HC
Confidence 765333211 122335678999999999999999999999999999998 899986543211 11111 11
Q ss_pred CccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 045453 287 NEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQ 343 (346)
Q Consensus 287 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 343 (346)
.... .........+.+++..||+.+|++|||+.++++.|+.+.+
T Consensus 227 ~~~~-------------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 227 GERL-------------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred CCcC-------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1100 0011334568899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=308.04 Aligned_cols=254 Identities=18% Similarity=0.325 Sum_probs=202.7
Q ss_pred cCCCcccccccCCCcEEEEEEE--C---CeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--E---DRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVI 130 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~---~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~l 130 (346)
++|...+.||+|+||.||+|.+ . +..+|+|.+..... .....+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCccEE
Confidence 5678889999999999999987 2 23788988765432 2345677788888888 99999999999999999999
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCccc
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI 210 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~ 210 (346)
||||+++++|.+++.... ..+++.++..++.|++.||+||| +.+++|+||||+|||++.++.++++|||++...
T Consensus 83 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 83 VTEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 999999999999997653 35899999999999999999999 899999999999999999999999999999877
Q ss_pred CCCCceeec--cccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcC
Q 045453 211 PEGETCVKD--KVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENN 287 (346)
Q Consensus 211 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (346)
......... ...++..|+|||++.+..++.++||||||+++||+++ |..||......+. ...+ ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~-------~~~~----~~~ 225 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV-------IKAI----EEG 225 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH-------HHHH----hCC
Confidence 544332221 1223567999999999899999999999999999887 9999875433211 1111 111
Q ss_pred ccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 045453 288 EFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341 (346)
Q Consensus 288 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 341 (346)
. . . +.....+..+.+++.+||+.+|.+||||.++++.|+++
T Consensus 226 ~-----~--~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 226 Y-----R--L------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred C-----c--C------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 0 0 00113345688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=313.45 Aligned_cols=260 Identities=21% Similarity=0.311 Sum_probs=206.1
Q ss_pred HHhcCCCcccccccCCCcEEEEEEE-------CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecC
Q 045453 54 IATNNFDARNVIKDGYAYKFYKGFV-------EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLET 125 (346)
Q Consensus 54 ~~~~~f~~~~~ig~G~~g~Vy~~~~-------~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~ 125 (346)
...++|...+.||+|+||.||+|.+ .+..+|+|.+..... .....+.+|+..+.++.+||||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 4446788999999999999999975 335799998765432 23445778888888886799999999999999
Q ss_pred CcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccC
Q 045453 126 RIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFS 205 (346)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg 205 (346)
+..++||||+++|+|.+++..... ..+++.++..++.+++.||.||| +.+++|+||||+|||++.++.++++|||
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCc
Confidence 999999999999999999976432 34899999999999999999999 8999999999999999999999999999
Q ss_pred CCcccCCCCce-eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHH
Q 045453 206 LSVSIPEGETC-VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKC 283 (346)
Q Consensus 206 l~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 283 (346)
++......... ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+. . ...
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~------~----~~~ 256 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK------F----YKL 256 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH------H----HHH
Confidence 98766543321 2223345778999999999999999999999999999998 9999875443221 1 111
Q ss_pred hhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 045453 284 IENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341 (346)
Q Consensus 284 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 341 (346)
...+.. .. ........+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 257 ~~~~~~---------~~----~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 257 IKEGYR---------MA----QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHcCCc---------CC----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 111100 00 0112245688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=327.70 Aligned_cols=253 Identities=15% Similarity=0.215 Sum_probs=198.7
Q ss_pred HHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcc
Q 045453 54 IATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIP 128 (346)
Q Consensus 54 ~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~ 128 (346)
...++|...+.||+|+||.||++.. ++..+|+|.+.... ......+..|...+..+ +||||+++++++.+.+..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-NSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCEE
Confidence 4467899999999999999999998 67899999986432 12233455677777777 999999999999999999
Q ss_pred eEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 129 VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
++||||+++|+|.+++... .++...+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++.
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~ 190 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEecccee
Confidence 9999999999999998653 4788888999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCceeeccccccCCcCCccccccC----CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHh
Q 045453 209 SIPEGETCVKDKVTGTMGFLAPEYINTG----DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCI 284 (346)
Q Consensus 209 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (346)
..............||+.|+|||++.+. .++.++|||||||++|||++|..||........ .....
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~----------~~~i~ 260 (370)
T cd05596 191 KMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT----------YSKIM 260 (370)
T ss_pred eccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH----------HHHHH
Confidence 7654333223455799999999998753 478999999999999999999999975432111 11111
Q ss_pred hcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 045453 285 ENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAED--RPTTVDVAK 336 (346)
Q Consensus 285 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~ev~~ 336 (346)
.... .+. . +.....+..+.+++..||+.+|++ |||+.|+++
T Consensus 261 ~~~~-------~~~--~--~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 261 DHKN-------SLT--F--PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred cCCC-------cCC--C--CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 1000 000 0 001123567889999999999988 999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=318.99 Aligned_cols=245 Identities=18% Similarity=0.210 Sum_probs=190.3
Q ss_pred cccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccC
Q 045453 63 NVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKN 137 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~ 137 (346)
++||+|+||.||+|.+ ++..||+|.+..... .....+..|...+..+.+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999998 678999999875421 22344667777777776899999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCcee
Q 045453 138 RTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCV 217 (346)
Q Consensus 138 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 217 (346)
|+|.+++... ..+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (329)
T cd05588 81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DT 152 (329)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cc
Confidence 9999988654 35899999999999999999999 8999999999999999999999999999986432111 12
Q ss_pred eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccccccc
Q 045453 218 KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPII 297 (346)
Q Consensus 218 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 297 (346)
.....||..|+|||++.+..++.++|||||||++|+|++|+.||+.....+... .....+.......... .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~--~~~~~~~~~~~~~~~~------~~ 224 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPD--QNTEDYLFQVILEKQI------RI 224 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccccccc--ccchHHHHHHHHcCCC------CC
Confidence 234578999999999999999999999999999999999999997533222100 0111111111111110 00
Q ss_pred ccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCH
Q 045453 298 VSEGPRVGKEKQLQGFRELALMCVCESAEDRPTT 331 (346)
Q Consensus 298 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 331 (346)
+ ......+.+++.+||+.+|.+|||+
T Consensus 225 ----p----~~~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 225 ----P----RSLSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred ----C----CCCCHHHHHHHHHHhccCHHHcCCC
Confidence 0 1234568899999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=309.70 Aligned_cols=245 Identities=18% Similarity=0.287 Sum_probs=192.9
Q ss_pred cccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccCCC
Q 045453 65 IKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRT 139 (346)
Q Consensus 65 ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~gs 139 (346)
||+|+||.||++.. +++.+|+|++..... ........|..++..+ +||||+++++++.+....++||||+++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-CCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 79999999999988 689999999864321 2233445678888888 99999999999999999999999999999
Q ss_pred hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCceeec
Q 045453 140 LADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKD 219 (346)
Q Consensus 140 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 219 (346)
|.+++..... ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++........ ..
T Consensus 80 L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~ 152 (277)
T cd05607 80 LKYHIYNVGE--RGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--IT 152 (277)
T ss_pred HHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--ee
Confidence 9988865432 45899999999999999999999 89999999999999999999999999999876654322 23
Q ss_pred cccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccccccccc
Q 045453 220 KVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVS 299 (346)
Q Consensus 220 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 299 (346)
...++..|+|||++.+..++.++|||||||++|||++|..||........ .......... .. +
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~------~~~~~~~~~~-~~--------~-- 215 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA------KEELKRRTLE-DE--------V-- 215 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh------HHHHHHHhhc-cc--------c--
Confidence 45688999999999988899999999999999999999999975432111 0111111110 00 0
Q ss_pred CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045453 300 EGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKR 337 (346)
Q Consensus 300 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 337 (346)
.. ........+.+++..||+.+|++||++.|+++.
T Consensus 216 --~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 216 --KF-EHQNFTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred --cc-ccccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 00 001234568899999999999999999876643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=306.55 Aligned_cols=253 Identities=20% Similarity=0.238 Sum_probs=199.5
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
.++|...+.||+|+||.||+|.. ++..+|+|++..........+.+|+..+..+ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~-~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKEC-KHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhc-CCCCeeeeeEEEEeCCEEEEEEe
Confidence 35688889999999999999998 7788999998755444455667788888887 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
|+++++|.+++... .++++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 87 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 87 YCGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence 99999999998654 35899999999999999999999 899999999999999999999999999998765422
Q ss_pred CceeeccccccCCcCCccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 214 ETCVKDKVTGTMGFLAPEYIN---TGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
.. ......++..|+|||.+. ...++.++||||||+++|||++|..||......... .
T Consensus 160 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-------------------~ 219 (267)
T cd06646 160 IA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-------------------F 219 (267)
T ss_pred cc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-------------------e
Confidence 11 123346788999999884 345788999999999999999999998643321110 0
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKR 337 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 337 (346)
............ .........+.+++.+||+.+|++|||+.++++.
T Consensus 220 ~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 220 LMSKSNFQPPKL-KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred eeecCCCCCCCC-ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 000000000000 0011334678899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=307.58 Aligned_cols=256 Identities=23% Similarity=0.318 Sum_probs=204.4
Q ss_pred cCCCcccccccCCCcEEEEEEEC-----CeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFVE-----DRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVI 130 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~~-----~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~l 130 (346)
++|...+.||+|+||.||+|.+. ...+++|....... .....+.+|+..+..+ +||||+++++++.+ +..++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF-DHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCchhceeEEEcC-CCcEE
Confidence 45778899999999999999872 23688888765542 3445677888888888 99999999999865 55789
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCccc
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI 210 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~ 210 (346)
||||+++|+|.+++.... ..+++..++.++.+++.||.||| +.+++|+||||+|||++.++.+||+|||+++..
T Consensus 84 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 84 VMELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeec
Confidence 999999999999997643 35899999999999999999999 899999999999999999999999999998776
Q ss_pred CCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCcc
Q 045453 211 PEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEF 289 (346)
Q Consensus 211 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (346)
............++..|+|||.+....++.++||||||+++||+++ |..||......+. .... ..+..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~-------~~~~----~~~~~ 226 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV-------IGRI----ENGER 226 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH-------HHHH----HcCCc
Confidence 5443333333345568999999988889999999999999999996 9999976543221 1111 11110
Q ss_pred ccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 290 DEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 290 ~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
. ......+..+.+++.+||..+|++|||+.++++.|+++.+.
T Consensus 227 ~-------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 227 L-------------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred C-------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0 00113445788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=307.03 Aligned_cols=252 Identities=22% Similarity=0.345 Sum_probs=196.3
Q ss_pred cccccCCCcEEEEEEE--CCe--EEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccC
Q 045453 63 NVIKDGYAYKFYKGFV--EDR--TVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKN 137 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~--~~~--~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~ 137 (346)
+.||+|+||.||+|.+ ++. .+++|.+..... .....+..|+..+.++.+||||++++++|...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 3689999999999998 332 567887764332 34456778888888887899999999999999999999999999
Q ss_pred CChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccC
Q 045453 138 RTLADHIYQNQP------------HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFS 205 (346)
Q Consensus 138 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg 205 (346)
|+|.+++..... ....+++.++..++.|++.||+||| +.+++|+||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence 999999975431 1235889999999999999999999 8999999999999999999999999999
Q ss_pred CCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHh
Q 045453 206 LSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCI 284 (346)
Q Consensus 206 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (346)
++....... .......+..|+|||++....++.++||||||+++|||++ |..||......+. .....
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~----------~~~~~ 225 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL----------YEKLP 225 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH----------HHHHh
Confidence 985332111 1112233567999999998899999999999999999997 9999965432111 11110
Q ss_pred hcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 045453 285 ENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQ 343 (346)
Q Consensus 285 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 343 (346)
.... . .. .......+.+++.+||+.+|.+|||+.+++..|+.|++
T Consensus 226 ~~~~--------~--~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~~ 270 (270)
T cd05047 226 QGYR--------L--EK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270 (270)
T ss_pred CCCC--------C--CC----CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhhC
Confidence 0000 0 00 01234568899999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=321.76 Aligned_cols=251 Identities=16% Similarity=0.208 Sum_probs=197.5
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
++|...+.||+|+||+||++.. +++.+|+|.+..... .....+..|...+..+ +||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~~~~~~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAFQDKDNLYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCeEEEE
Confidence 4688899999999999999998 788999999875422 1223344555555555 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 80 ~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 153 (330)
T cd05601 80 MEYQPGGDLLSLLNRYE---DQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLT 153 (330)
T ss_pred ECCCCCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECC
Confidence 99999999999997653 36899999999999999999999 8999999999999999999999999999998765
Q ss_pred CCCceeeccccccCCcCCccccc------cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhh
Q 045453 212 EGETCVKDKVTGTMGFLAPEYIN------TGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIE 285 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (346)
...........||+.|+|||++. ...++.++|||||||++|||++|..||....... .......
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~----------~~~~i~~ 223 (330)
T cd05601 154 ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK----------TYNNIMN 223 (330)
T ss_pred CCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH----------HHHHHHc
Confidence 54443334457899999999987 4567899999999999999999999997543211 1111111
Q ss_pred cCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 286 NNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 286 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
...... .+ ........+.+|+..||+ +|++|||+.+++.
T Consensus 224 ~~~~~~---------~~--~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 224 FQRFLK---------FP--EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CCCccC---------CC--CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 110000 00 011234568889999998 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=318.07 Aligned_cols=241 Identities=21% Similarity=0.262 Sum_probs=192.0
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
+|+..+.||+|+||.||+|.. +++.||+|.+.... ......+..|...+..+.+|++|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 477889999999999999998 56789999987532 2334556777777777744567889999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQVG----KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 9999999999987643 5889999999999999999999 89999999999999999999999999999865322
Q ss_pred CCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccc
Q 045453 213 GETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEI 292 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (346)
... ......||..|+|||++.+..++.++|||||||++|+|+||+.||......+. .. ... ...
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~-------~~---~i~-~~~---- 217 (324)
T cd05587 154 GGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL-------FQ---SIM-EHN---- 217 (324)
T ss_pred CCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-------HH---HHH-cCC----
Confidence 211 22345689999999999999999999999999999999999999975433211 11 110 000
Q ss_pred cccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCH
Q 045453 293 VDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTT 331 (346)
Q Consensus 293 ~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 331 (346)
. ..+ ......+.+++.+||+.+|.+||+.
T Consensus 218 ----~--~~~----~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 ----V--SYP----KSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ----C--CCC----CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 0 000 1234567899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=310.67 Aligned_cols=266 Identities=15% Similarity=0.212 Sum_probs=197.7
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
.++|...+.||+|+||.||+|.. ++..+|+|++..... .....+.+|+..+..+ +||||+++++++.+....++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL-KHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhC-CCCCcCeEEEEEecCCeEEEEE
Confidence 46788999999999999999998 678999999864432 2334567788888888 9999999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
||++ ++|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++.....
T Consensus 83 e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 155 (303)
T cd07869 83 EYVH-TDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSV 155 (303)
T ss_pred ECCC-cCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence 9996 58888886543 35888999999999999999999 89999999999999999999999999999875432
Q ss_pred CCceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccc-
Q 045453 213 GETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD- 290 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 290 (346)
.. .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||........ .+.. ...........
T Consensus 156 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-----~~~~-~~~~~~~~~~~~ 228 (303)
T cd07869 156 PS-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD-----QLER-IFLVLGTPNEDT 228 (303)
T ss_pred CC-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH-----HHHH-HHHHhCCCChhh
Confidence 22 12234567899999999875 4588999999999999999999999976433111 1111 11100000000
Q ss_pred -------cccccc-cccCCCCcch-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 291 -------EIVDPI-IVSEGPRVGK-----EKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 291 -------~~~d~~-l~~~~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
...++. .....+.... ......+.+|+..||+.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 229 WPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000 0000000000 011245789999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=310.45 Aligned_cols=257 Identities=22% Similarity=0.367 Sum_probs=203.8
Q ss_pred HhcCCCcccccccCCCcEEEEEEEC-------CeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCC
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFVE-------DRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETR 126 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~~-------~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~ 126 (346)
..++|...+.||+|+||.||+|.+. +..+++|.+..... .....+.+|+..+..+ +||||+++++++....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSTGQ 82 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhC-CCCceeEEEEEEcCCC
Confidence 3567888899999999999999873 26799999764432 3344677788888887 9999999999999999
Q ss_pred cceEEEecccCCChhhhhhhcCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceE
Q 045453 127 IPVIVFESVKNRTLADHIYQNQPH------FEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAK 200 (346)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~k 200 (346)
..++||||+++|+|.+++...... ...++|..++.++.|++.||.||| +.+++|+||||+|||++.++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEE
Confidence 999999999999999999754311 134789999999999999999999 89999999999999999999999
Q ss_pred EeccCCCcccCCCCce-eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHH
Q 045453 201 LFDFSLSVSIPEGETC-VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLH 278 (346)
Q Consensus 201 l~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 278 (346)
|+|||+++.+...... ......++..|+|||.+.++.++.++||||||+++||++| |..||......+ ...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~~~ 232 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE-------VLK 232 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH-------HHH
Confidence 9999998766543321 1233456788999999998899999999999999999998 999986543322 111
Q ss_pred HHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 045453 279 YVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLK 339 (346)
Q Consensus 279 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 339 (346)
.. ..+... .. +...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 233 ~~----~~~~~~-----~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 233 FV----IDGGHL-----DL--------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HH----hcCCCC-----CC--------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 11 111100 00 0123567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=310.62 Aligned_cols=255 Identities=18% Similarity=0.297 Sum_probs=198.9
Q ss_pred CCCcccccccCCCcEEEEEEEC-------CeEEEEEEecCccCcc-hHHHHHHHHHHhhhcCCCceeeEcceeecCCcce
Q 045453 58 NFDARNVIKDGYAYKFYKGFVE-------DRTVSVMKFNDILNDG-HEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV 129 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~~-------~~~vavk~~~~~~~~~-~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~ 129 (346)
+|...+.||+|+||.||+|.+. +..||+|++....... ...+..|...+..+ +||||+++++++.+.+..+
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL-QHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcCCCceE
Confidence 3556788999999999999872 3789999987554332 34455666666666 9999999999999999999
Q ss_pred EEEecccCCChhhhhhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCC
Q 045453 130 IVFESVKNRTLADHIYQNQ------------PHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGY 197 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~ 197 (346)
+++||+++++|.+++.... .....+++..+..++.|++.||.||| +.+++||||||+|||+++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCC
Confidence 9999999999999985321 11235889999999999999999999 89999999999999999999
Q ss_pred ceEEeccCCCcccCCCCce-eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhh
Q 045453 198 IAKLFDFSLSVSIPEGETC-VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYW 275 (346)
Q Consensus 198 ~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~ 275 (346)
.+||+|||+++........ ......+++.|+|||++.++.++.++||||||+++|||++ |..||......+
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------- 234 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD------- 234 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence 9999999998866433321 1233446778999999998899999999999999999998 888886543211
Q ss_pred HHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 045453 276 LLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQ 340 (346)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 340 (346)
.... ....... .....++..+.+++..||+.+|++|||+.+|+..|+.
T Consensus 235 ---~~~~-i~~~~~~-------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 ---VIEM-IRNRQVL-------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ---HHHH-HHcCCcC-------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1111 1111110 0011345668899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=316.79 Aligned_cols=240 Identities=20% Similarity=0.246 Sum_probs=191.0
Q ss_pred cccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccC
Q 045453 63 NVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKN 137 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~ 137 (346)
+.||+|+||.||+|.+ ++..||+|.+.... .........|...+....+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999999 67899999987532 223445566777776666999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCcee
Q 045453 138 RTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCV 217 (346)
Q Consensus 138 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 217 (346)
|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~i~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (316)
T cd05620 81 GDLMFHIQDK----GRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-R 152 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC-c
Confidence 9999998764 35889999999999999999999 89999999999999999999999999999864322211 2
Q ss_pred eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccccccc
Q 045453 218 KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPII 297 (346)
Q Consensus 218 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 297 (346)
.....||..|+|||++.+..++.++|||||||++|||++|..||......+ +...+. .. .+.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~-------~~~~~~----~~------~~~~ 215 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE-------LFESIR----VD------TPHY 215 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHH----hC------CCCC
Confidence 234568999999999999999999999999999999999999997543221 111110 00 0000
Q ss_pred ccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 045453 298 VSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTV-DVA 335 (346)
Q Consensus 298 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-ev~ 335 (346)
+ ......+.+++..||+.||++||++. ++.
T Consensus 216 ----~----~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 216 ----P----RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred ----C----CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 0 02344578899999999999999985 444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=307.94 Aligned_cols=261 Identities=21% Similarity=0.269 Sum_probs=198.2
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCC-----cceE
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETR-----IPVI 130 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~-----~~~l 130 (346)
.|...+++|+|+||.||+|.. +++.||||+.-.+.. -.-+|+.++..+ .|||||++.-++.... ...|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l-~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKL-DHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhc-CCcCeeeEEEEEEecCCCchhHHHH
Confidence 366678999999999999999 779999999764432 224577777777 9999999998876432 3468
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCC-CceEEeccCCCcc
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEG-YIAKLFDFSLSVS 209 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~-~~~kl~Dfgl~~~ 209 (346)
||||||. +|.+.++.--.....++...+.-++.|+.+||+||| +.+|+||||||+|+|+|.+ |.+||+|||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999988 999999853222356888888999999999999999 8999999999999999966 9999999999998
Q ss_pred cCCCCceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhh---
Q 045453 210 IPEGETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIE--- 285 (346)
Q Consensus 210 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 285 (346)
+..++. +.+...|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++.|.+.+..+. +...++ .+.
T Consensus 176 L~~~ep--niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ------L~eIik-~lG~Pt 246 (364)
T KOG0658|consen 176 LVKGEP--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ------LVEIIK-VLGTPT 246 (364)
T ss_pred eccCCC--ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH------HHHHHH-HhCCCC
Confidence 866554 345667889999999987 5699999999999999999999999988655332 222111 111
Q ss_pred -------cCccccccccccccCCC-CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 286 -------NNEFDEIVDPIIVSEGP-RVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 286 -------~~~~~~~~d~~l~~~~~-~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
+....+.-.+.+..... .........+..+|+.++|+.+|.+|.++.|++.
T Consensus 247 ~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 247 REDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred HHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 11111222222222210 1111244567899999999999999999998874
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=318.11 Aligned_cols=264 Identities=20% Similarity=0.326 Sum_probs=204.5
Q ss_pred HhcCCCcccccccCCCcEEEEEEE-------CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecC-
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV-------EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLET- 125 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~-------~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~- 125 (346)
..++|...+.||+|+||.||+|.+ .++.||||++..... .....+.+|+..+..+.+||||++++++|...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 345788899999999999999974 457899999875432 33456788999999987789999999988654
Q ss_pred CcceEEEecccCCChhhhhhhcCCC-------------------------------------------------------
Q 045453 126 RIPVIVFESVKNRTLADHIYQNQPH------------------------------------------------------- 150 (346)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------- 150 (346)
...++||||+++|+|.+++......
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 4678999999999999998653210
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCc-eeeccc
Q 045453 151 --------FEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGET-CVKDKV 221 (346)
Q Consensus 151 --------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~ 221 (346)
...++|..+..++.|++.||+||| +.+++||||||+|||++.++.+||+|||++........ ......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 124788899999999999999999 89999999999999999999999999999876533222 112233
Q ss_pred cccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccccccccC
Q 045453 222 TGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSE 300 (346)
Q Consensus 222 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 300 (346)
.++..|+|||.+.+..++.++||||||+++|+|++ |..||........ .. .....+... .
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------~~----~~~~~~~~~---------~ 302 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FC----RRLKEGTRM---------R 302 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH------HH----HHHhccCCC---------C
Confidence 45678999999998899999999999999999997 9999865432111 11 111111100 0
Q ss_pred CCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 301 GPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
.+ ......+.+++..||+.+|++|||+.||++.|+.+.+.
T Consensus 303 ~~----~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 303 AP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CC----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 00 01234588999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=316.82 Aligned_cols=241 Identities=20% Similarity=0.258 Sum_probs=192.3
Q ss_pred cccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccC
Q 045453 63 NVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKN 137 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~ 137 (346)
+.||+|+||+||+|.+ ++..+|+|.+.... .........|..++..+.+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999 67899999987542 223445566777777665899999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCcee
Q 045453 138 RTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCV 217 (346)
Q Consensus 138 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 217 (346)
|+|.+++.... .+++..+..++.|++.||.||| +.+++||||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (318)
T cd05570 81 GDLMFHIQRSG----RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-T 152 (318)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-c
Confidence 99999887653 5899999999999999999999 89999999999999999999999999999865322221 1
Q ss_pred eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccccccc
Q 045453 218 KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPII 297 (346)
Q Consensus 218 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 297 (346)
.....|+..|+|||++.+..++.++|||||||++|+|++|..||........ .... ..... ..
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~----------~~~i-~~~~~------~~ 215 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL----------FQSI-LEDEV------RY 215 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH----------HHHH-HcCCC------CC
Confidence 2345689999999999999999999999999999999999999975432111 1111 11100 00
Q ss_pred ccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 045453 298 VSEGPRVGKEKQLQGFRELALMCVCESAEDRPTT-----VDVAK 336 (346)
Q Consensus 298 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~-----~ev~~ 336 (346)
+......+.+|+.+||+.+|++|||+ .++++
T Consensus 216 --------~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 216 --------PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred --------CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 01234568899999999999999999 66653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=310.25 Aligned_cols=262 Identities=19% Similarity=0.338 Sum_probs=203.5
Q ss_pred HHHhcCCCcccccccCCCcEEEEEEEC-------CeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeec
Q 045453 53 EIATNNFDARNVIKDGYAYKFYKGFVE-------DRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLE 124 (346)
Q Consensus 53 ~~~~~~f~~~~~ig~G~~g~Vy~~~~~-------~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~ 124 (346)
...+++|+..+.||+|+||.||+|... +..||+|.+..... .....+.+|...+..+ +||||+++++++.+
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 80 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF-TCHHVVRLLGVVSK 80 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcC
Confidence 445678999999999999999999752 34789998764432 2234566777777777 99999999999999
Q ss_pred CCcceEEEecccCCChhhhhhhcCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCc
Q 045453 125 TRIPVIVFESVKNRTLADHIYQNQP------HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYI 198 (346)
Q Consensus 125 ~~~~~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~ 198 (346)
.+..++||||+++|+|.+++..... .....++..+..++.|++.||+||| +.+++||||||+|||+++++.
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~ 157 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFT 157 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCc
Confidence 9999999999999999999975321 1234678889999999999999999 899999999999999999999
Q ss_pred eEEeccCCCcccCCCCcee-eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhH
Q 045453 199 AKLFDFSLSVSIPEGETCV-KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWL 276 (346)
Q Consensus 199 ~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 276 (346)
++|+|||+++......... .....++..|+|||.+.++.++.++|||||||++|||++ |..||......+.
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~------- 230 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV------- 230 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------
Confidence 9999999987654332211 122345678999999999999999999999999999999 7888865332111
Q ss_pred HHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 045453 277 LHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIY 342 (346)
Q Consensus 277 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~ 342 (346)
.... ..+.... .+......+.+++.+||+.+|++|||+.++++.|++..
T Consensus 231 ---~~~~-~~~~~~~-------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 231 ---LKFV-MDGGYLD-------------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred ---HHHH-HcCCCCC-------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 1111 1111000 01123467999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=308.48 Aligned_cols=257 Identities=21% Similarity=0.360 Sum_probs=201.3
Q ss_pred HhcCCCcccccccCCCcEEEEEEEC-------CeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCC
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFVE-------DRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETR 126 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~~-------~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~ 126 (346)
.+++|...+.||+|++|.||+|.+. +..|++|.+..... .....+..|+..+..+ +|+||+++++++.+.+
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF-NHQNIVRLIGVSFERL 82 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEccCC
Confidence 4577889999999999999999983 36788888764432 2345678888888888 9999999999999999
Q ss_pred cceEEEecccCCChhhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCC---ceE
Q 045453 127 IPVIVFESVKNRTLADHIYQNQP---HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGY---IAK 200 (346)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~---~~k 200 (346)
..++||||+++++|.+++..... ....++|..++.++.|++.||.||| +.+++|+||||+||+++.++ .+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceE
Confidence 99999999999999999976532 1235899999999999999999999 88999999999999998765 699
Q ss_pred EeccCCCcccCCCCcee-eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHH
Q 045453 201 LFDFSLSVSIPEGETCV-KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLH 278 (346)
Q Consensus 201 l~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 278 (346)
|+|||+++.+....... ......+..|+|||++.+..++.++|||||||++|||++ |..||........ ..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~-------~~ 232 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV-------ME 232 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HH
Confidence 99999998764322211 112233568999999999999999999999999999997 9999975433221 11
Q ss_pred HHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 045453 279 YVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLK 339 (346)
Q Consensus 279 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 339 (346)
.+. .... ... +...+..+.+++.+||+.+|++|||+.+|++.|+
T Consensus 233 ~~~---~~~~----------~~~----~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 233 FVT---GGGR----------LDP----PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHH---cCCc----------CCC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 110 1000 000 1123456889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=320.12 Aligned_cols=240 Identities=16% Similarity=0.210 Sum_probs=191.9
Q ss_pred cccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccC
Q 045453 63 NVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKN 137 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~ 137 (346)
+.||+|+||.||++.. ++..+|+|.+..... .....+..|...+..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~-~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3699999999999988 788999999875421 2334556777777777 999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCce
Q 045453 138 RTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFS-RPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETC 216 (346)
Q Consensus 138 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 216 (346)
|+|.+++... ..+++..+..++.|++.||.||| + .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 80 ~~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~- 151 (325)
T cd05594 80 GELFFHLSRE----RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA- 151 (325)
T ss_pred CcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-
Confidence 9999988654 35899999999999999999999 6 7999999999999999999999999999875432221
Q ss_pred eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccccc
Q 045453 217 VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPI 296 (346)
Q Consensus 217 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 296 (346)
......||+.|+|||++.+..++.++|||||||++|+|+||..||........ ...+ ..... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~-------~~~i----~~~~~------~ 214 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-------FELI----LMEEI------R 214 (325)
T ss_pred ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH-------HHHH----hcCCC------C
Confidence 12345689999999999999999999999999999999999999975433211 1100 00000 0
Q ss_pred cccCCCCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 045453 297 IVSEGPRVGKEKQLQGFRELALMCVCESAEDRP-----TTVDVAK 336 (346)
Q Consensus 297 l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~ 336 (346)
+ + ......+.+++.+||+.||++|+ ++.++++
T Consensus 215 ~----p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 215 F----P----RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred C----C----CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 0 0 12345688999999999999997 8888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=316.58 Aligned_cols=262 Identities=18% Similarity=0.272 Sum_probs=194.8
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecC-----Ccc
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLET-----RIP 128 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~-----~~~ 128 (346)
.|...+.||+|+||.||+|.. ++..||+|++.... .....++.+|+..+..+ +||||+++++++... ...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhC-CCCCEeeecceEeccCCCCCceE
Confidence 367788999999999999998 78899999986432 23345677888888888 999999999988643 247
Q ss_pred eEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 129 VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
++||||+. ++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 80 ~lv~e~~~-~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~ 151 (338)
T cd07859 80 YVVFELME-SDLHQVIKAN----DDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLAR 151 (338)
T ss_pred EEEEecCC-CCHHHHHHhc----ccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccc
Confidence 99999995 5899988754 35899999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCc--eeeccccccCCcCCcccccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHh
Q 045453 209 SIPEGET--CVKDKVTGTMGFLAPEYINT--GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCI 284 (346)
Q Consensus 209 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (346)
....... .......+|..|+|||++.+ ..++.++|||||||++|||+||+.||........ ...+....
T Consensus 152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~-------~~~~~~~~ 224 (338)
T cd07859 152 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ-------LDLITDLL 224 (338)
T ss_pred ccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHH-------HHHHHHHh
Confidence 6532221 11234578999999999876 6789999999999999999999999976443111 01111000
Q ss_pred hc-----------CccccccccccccCCCCcch---HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 285 EN-----------NEFDEIVDPIIVSEGPRVGK---EKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 285 ~~-----------~~~~~~~d~~l~~~~~~~~~---~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.. ......+.. +....+.... +.....+.+++.+||+.+|++|||+.|+++
T Consensus 225 ~~~~~~~~~~i~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 225 GTPSPETISRVRNEKARRYLSS-MRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred CCCCHHHHHHhhhhhHHHHHHh-hcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00 000000000 0000000000 012355789999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=308.25 Aligned_cols=255 Identities=21% Similarity=0.326 Sum_probs=202.2
Q ss_pred cCCCcccccccCCCcEEEEEEE-------CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcce
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV-------EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV 129 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~-------~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~ 129 (346)
.+|.....||+|+||.||++.. ++..+++|.+..........+.+|+..+..+ +||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVL-QHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcC-CCCCCceEEEEEecCCceE
Confidence 4567788999999999999964 3567888887765555566788888888888 9999999999999999999
Q ss_pred EEEecccCCChhhhhhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCc
Q 045453 130 IVFESVKNRTLADHIYQNQP-----------HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYI 198 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~ 198 (346)
+||||+++++|.+++..... ....+++..++.++.|++.||+||| +.+++|+||||+|||+++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCC
Confidence 99999999999999976431 1135899999999999999999999 899999999999999999999
Q ss_pred eEEeccCCCcccCCCCcee-eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhH
Q 045453 199 AKLFDFSLSVSIPEGETCV-KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWL 276 (346)
Q Consensus 199 ~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 276 (346)
+||+|||+++......... .....+++.|+|||++.+..++.++|||||||++|||++ |..||......+.
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------- 233 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA------- 233 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH-------
Confidence 9999999987654332211 123345678999999999999999999999999999998 8999865433221
Q ss_pred HHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 045453 277 LHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLK 339 (346)
Q Consensus 277 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 339 (346)
.... ..+... .. +...+..+.+++.+||+.+|++||++.||.+.|+
T Consensus 234 ---~~~~-~~~~~~---------~~----~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 234 ---IECI-TQGREL---------ER----PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ---HHHH-HcCccC---------CC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1110 011000 00 0123456889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=307.22 Aligned_cols=263 Identities=21% Similarity=0.322 Sum_probs=204.4
Q ss_pred hcCCCcccccccCCCcEEEEEEECC------------------eEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCcee
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFVED------------------RTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVL 116 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~~~------------------~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv 116 (346)
.++|...+.||+|+||.||+|.+.+ ..+|+|.+..... ....++.+|+..+..+ +||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRL-SDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhc-CCCCEe
Confidence 4568888999999999999988722 4588998875543 3455677888999998 999999
Q ss_pred eEcceeecCCcceEEEecccCCChhhhhhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCC
Q 045453 117 KLTGCCLETRIPVIVFESVKNRTLADHIYQNQP-------HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPS 189 (346)
Q Consensus 117 ~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~ 189 (346)
+++++|..++..++||||+++++|.+++..... ....+++..++.++.|++.||+||| +.+++|+||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~ 159 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATR 159 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchh
Confidence 999999999999999999999999999976531 1136899999999999999999999 899999999999
Q ss_pred CeEEcCCCceEEeccCCCcccCCCCce-eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh--CCCCCCCCCC
Q 045453 190 RIFLDEGYIAKLFDFSLSVSIPEGETC-VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT--GQKIFDPSRG 266 (346)
Q Consensus 190 NIll~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt--g~~p~~~~~~ 266 (346)
||+++.++.++|+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 999999999999999998765433322 2234456778999999998899999999999999999998 6777754332
Q ss_pred cccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 045453 267 DEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLK 339 (346)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 339 (346)
.+ ....+...+.......... . ....+..+.+++.+||+.+|++|||+.||++.|+
T Consensus 240 ~~-------~~~~~~~~~~~~~~~~~~~------~----~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 QQ-------VIENAGHFFRDDGRQIYLP------R----PPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HH-------HHHHHHhccccccccccCC------C----ccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11 1122211111111110000 0 1123467899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=324.28 Aligned_cols=250 Identities=18% Similarity=0.211 Sum_probs=193.9
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
.|...+.||+|+||+||+|.. ++..+|+|++.... ......+..|..++..+ +||||+++++++.+.+..++||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA-DNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc-CCCCeeeeEEEEecCCEEEEEE
Confidence 578889999999999999998 77899999986532 12344567788888887 9999999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~ 153 (381)
T cd05626 81 DYIPGGDMMSLLIRME----VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRW 153 (381)
T ss_pred ecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccc
Confidence 9999999999997643 5888999999999999999999 89999999999999999999999999999754311
Q ss_pred CC----------------------------------------------ceeeccccccCCcCCccccccCCCCcccchHH
Q 045453 213 GE----------------------------------------------TCVKDKVTGTMGFLAPEYINTGDFNEKCDVFS 246 (346)
Q Consensus 213 ~~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s 246 (346)
.. ........||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (381)
T cd05626 154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233 (381)
T ss_pred ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceee
Confidence 00 00012346999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHH--cccCC
Q 045453 247 FGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALM--CVCES 324 (346)
Q Consensus 247 ~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~--cl~~~ 324 (346)
|||++|||+||..||......+. ......... .+. .+ ........+.+|+.+ |+..+
T Consensus 234 lG~il~elltG~~Pf~~~~~~~~----------~~~i~~~~~-------~~~--~~--~~~~~s~~~~dli~~ll~~~~~ 292 (381)
T cd05626 234 VGVILFEMLVGQPPFLAPTPTET----------QLKVINWEN-------TLH--IP--PQVKLSPEAVDLITKLCCSAEE 292 (381)
T ss_pred hhhHHHHHHhCCCCCcCCCHHHH----------HHHHHcccc-------ccC--CC--CCCCCCHHHHHHHHHHccCccc
Confidence 99999999999999976443221 001110000 000 00 000223456677776 56667
Q ss_pred CCCCCCHHHHHH
Q 045453 325 AEDRPTTVDVAK 336 (346)
Q Consensus 325 p~~RPs~~ev~~ 336 (346)
|..||++.|++.
T Consensus 293 ~~~R~~~~~~l~ 304 (381)
T cd05626 293 RLGRNGADDIKA 304 (381)
T ss_pred ccCCCCHHHHhc
Confidence 777999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=317.27 Aligned_cols=238 Identities=18% Similarity=0.214 Sum_probs=187.0
Q ss_pred CCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHH---hhhcCCCceeeEcceeecCCcceE
Q 045453 59 FDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFA---SKLSSHKNVLKLTGCCLETRIPVI 130 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~---~~~~~h~niv~l~g~~~~~~~~~l 130 (346)
|...+.||+|+||.||+|.+ +++.||+|.+.... ......+..|...+ ..+ +||||+++++++.+.+..++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSE-RHPFLVNLFACFQTEDHVCF 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcccc-CCCChhceeeEEEcCCEEEE
Confidence 55678999999999999998 68899999986432 12223344444443 344 89999999999999999999
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCccc
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI 210 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~ 210 (346)
||||+++|+|...+.. ..+++..+..++.|++.||.||| +.+++||||||+|||+++++.+||+|||+++..
T Consensus 80 v~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 80 VMEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EEcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 9999999999988754 35899999999999999999999 899999999999999999999999999998653
Q ss_pred CCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 211 PEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 211 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
..... ......|++.|+|||++.+..++.++|||||||++|||++|+.||......+. ...... ...
T Consensus 152 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~----------~~~i~~-~~~- 218 (324)
T cd05589 152 MGFGD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV----------FDSIVN-DEV- 218 (324)
T ss_pred CCCCC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH----------HHHHHh-CCC-
Confidence 22211 22345689999999999999999999999999999999999999975433211 111111 000
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCH
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTT 331 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 331 (346)
. . +...+..+.+++.+||+.+|++||++
T Consensus 219 -----~----~----p~~~~~~~~~li~~~L~~dP~~R~~~ 246 (324)
T cd05589 219 -----R----Y----PRFLSREAISIMRRLLRRNPERRLGS 246 (324)
T ss_pred -----C----C----CCCCCHHHHHHHHHHhhcCHhHcCCC
Confidence 0 0 01234567899999999999999953
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=319.66 Aligned_cols=246 Identities=20% Similarity=0.274 Sum_probs=190.7
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
++|+..+.||+|+||.||+|.+ +++.||+|.+..... .....+.+|+..+..+ +|+||+++++++...+..++|||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV-NHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhC-CCCCcceeeeEeccCCeEEEEEe
Confidence 3455668899999999999998 688999999865433 2345677888888888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
|+++|+|.+.. ...+..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||+++.+...
T Consensus 153 ~~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 153 FMDGGSLEGTH--------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred cCCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 99999986532 3566778899999999999999 899999999999999999999999999998766432
Q ss_pred CceeeccccccCCcCCcccccc-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCc
Q 045453 214 ETCVKDKVTGTMGFLAPEYINT-----GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE 288 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (346)
.. ......||..|+|||++.. ...+.++|||||||++|||++|+.||......+. ...........
T Consensus 222 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-------~~~~~~~~~~~- 292 (353)
T PLN00034 222 MD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW-------ASLMCAICMSQ- 292 (353)
T ss_pred cc-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH-------HHHHHHHhccC-
Confidence 21 1234578999999998753 2345689999999999999999999974332221 11111100000
Q ss_pred cccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 289 FDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 289 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.. .........+.+|+..||+.+|++|||+.|+++
T Consensus 293 ------------~~-~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 293 ------------PP-EAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred ------------CC-CCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 001134566899999999999999999999986
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=321.85 Aligned_cols=201 Identities=17% Similarity=0.229 Sum_probs=172.3
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
++|+..+.||+|+||+||+|.. +++.+|+|.+.... ......+..|...+..+ +||||+++++++.+....++|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-~~~~iv~~~~~~~~~~~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-DSLWVVKMFYSFQDKLNLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCeEEEE
Confidence 4788899999999999999988 67899999986432 12234456677777777 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus 80 ~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 80 MEFLPGGDMMTLLMKK----DTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred EcCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 9999999999999764 36899999999999999999999 8999999999999999999999999999987543
Q ss_pred CCCc----------------------------------eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhC
Q 045453 212 EGET----------------------------------CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTG 257 (346)
Q Consensus 212 ~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg 257 (346)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 232 (363)
T cd05628 153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (363)
T ss_pred ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhC
Confidence 2110 001234799999999999999999999999999999999999
Q ss_pred CCCCCCCC
Q 045453 258 QKIFDPSR 265 (346)
Q Consensus 258 ~~p~~~~~ 265 (346)
..||....
T Consensus 233 ~~Pf~~~~ 240 (363)
T cd05628 233 YPPFCSET 240 (363)
T ss_pred CCCCCCCC
Confidence 99997544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=305.03 Aligned_cols=254 Identities=21% Similarity=0.333 Sum_probs=202.9
Q ss_pred HhcCCCcccccccCCCcEEEEEEE-CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
..+.|...+.||+|+||.||+|.+ .+..+++|.+... ......+.+|+..+..+ +|+||+++++++.+ ...+++||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTL-QHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhc-CCCCcceEEEEEcC-CCeEEEEE
Confidence 346788899999999999999988 6677888887643 22345677888888887 99999999999887 77899999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
|+++++|.+++..... ..+++..+..++.+++.||.||| +.+++|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 81 FMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred eCCCCcHHHHHHhCCc--cccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 9999999999976432 46889999999999999999999 899999999999999999999999999998766543
Q ss_pred CceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCccccc
Q 045453 214 ETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEI 292 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (346)
.........++..|+|||++....++.++|+||||+++|+++| |..||........ .... ......
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~-------~~~~----~~~~~~-- 222 (260)
T cd05073 156 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV-------IRAL----ERGYRM-- 222 (260)
T ss_pred CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH-------HHHH----hCCCCC--
Confidence 3322233445678999999998889999999999999999999 9999975432211 1111 111000
Q ss_pred cccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 045453 293 VDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQ 340 (346)
Q Consensus 293 ~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 340 (346)
......+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 223 -----------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 -----------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -----------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0011334568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=303.36 Aligned_cols=247 Identities=23% Similarity=0.359 Sum_probs=197.0
Q ss_pred cccccCCCcEEEEEEE--CC---eEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEeccc
Q 045453 63 NVIKDGYAYKFYKGFV--ED---RTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVK 136 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~--~~---~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~ 136 (346)
++||+|+||.||+|.+ .+ ..+|+|.+..... ....++..|+..+..+ .||||+++++++. .+..++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-DHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 4699999999999987 33 6799998875543 2445677888888888 9999999999875 556899999999
Q ss_pred CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCce
Q 045453 137 NRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETC 216 (346)
Q Consensus 137 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 216 (346)
+|+|.+++.... .+++..+..++.|++.||+||| ..+++|+||||+|||++.++.+||+|||+++........
T Consensus 79 ~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 79 LGPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred CCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence 999999997653 5899999999999999999999 899999999999999999999999999999876543332
Q ss_pred ee--ccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccc
Q 045453 217 VK--DKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIV 293 (346)
Q Consensus 217 ~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (346)
.. ....++..|+|||.+.+..++.++||||||+++|++++ |..||......+ ....+. .....
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~-------~~~~~~----~~~~~--- 217 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE-------VIAMLE----SGERL--- 217 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHH----cCCcC---
Confidence 21 12223567999999998999999999999999999998 999997543321 111111 11100
Q ss_pred ccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 045453 294 DPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIY 342 (346)
Q Consensus 294 d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~ 342 (346)
..+...+..+.+++.+||+.+|++|||+.++++.|+++.
T Consensus 218 ----------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 ----------PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 001133456889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=322.76 Aligned_cols=250 Identities=18% Similarity=0.243 Sum_probs=196.5
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
++|+..+.||+|+||+||+|.. +++.||||++.... ......+.+|..++..+ +||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-DNPWVVKLYYSFQDENYLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcCCeEEEE
Confidence 4788899999999999999998 68899999986432 12234456788888888 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++..+.
T Consensus 80 ~E~~~~g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 80 MEYLPGGDMMTLLMKKD----TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred ECCCCCcHHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 99999999999997653 5899999999999999999999 8999999999999999999999999999987543
Q ss_pred CCCce-------------------------------------eeccccccCCcCCccccccCCCCcccchHHHHHHHHHH
Q 045453 212 EGETC-------------------------------------VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVL 254 (346)
Q Consensus 212 ~~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~el 254 (346)
..... .....+||+.|+|||++.+..++.++|||||||++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 232 (364)
T cd05599 153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232 (364)
T ss_pred ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHh
Confidence 21100 01124689999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCC---H
Q 045453 255 LTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPT---T 331 (346)
Q Consensus 255 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~ 331 (346)
++|..||......+. ......... .+.. +........+.+++.+|+. +|.+|++ +
T Consensus 233 ~~G~~Pf~~~~~~~~----------~~~i~~~~~-------~~~~----~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~ 290 (364)
T cd05599 233 LVGYPPFCSDNPQET----------YRKIINWKE-------TLQF----PDEVPLSPEAKDLIKRLCC-EAERRLGNNGV 290 (364)
T ss_pred hcCCCCCCCCCHHHH----------HHHHHcCCC-------ccCC----CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCH
Confidence 999999975433211 111111000 0000 0000234567889999996 9999998 8
Q ss_pred HHHHH
Q 045453 332 VDVAK 336 (346)
Q Consensus 332 ~ev~~ 336 (346)
.|+++
T Consensus 291 ~~ll~ 295 (364)
T cd05599 291 NEIKS 295 (364)
T ss_pred HHHhc
Confidence 87765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=307.40 Aligned_cols=253 Identities=21% Similarity=0.311 Sum_probs=199.3
Q ss_pred HHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecC------
Q 045453 54 IATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLET------ 125 (346)
Q Consensus 54 ~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~------ 125 (346)
.+++.|+..+.||+|+||.||+|.. .+..+|+|.+.... .....+..|+..+..+.+||||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 4677888899999999999999988 67889999886443 34456778888888876799999999998753
Q ss_pred CcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccC
Q 045453 126 RIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFS 205 (346)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg 205 (346)
...++||||+++++|.+++..... ..+++..+..++.|++.||+||| +.+++|+||||+||++++++.++|+|||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCC
Confidence 357899999999999999976432 46899999999999999999999 8999999999999999999999999999
Q ss_pred CCcccCCCCceeeccccccCCcCCccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHH
Q 045453 206 LSVSIPEGETCVKDKVTGTMGFLAPEYIN-----TGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYV 280 (346)
Q Consensus 206 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 280 (346)
++....... .......|+..|+|||++. +..++.++|||||||++|||++|..||........ ..
T Consensus 157 ~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~---------~~ 226 (272)
T cd06637 157 VSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA---------LF 226 (272)
T ss_pred Cceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH---------HH
Confidence 987654322 1233456889999999986 34588899999999999999999999964322111 00
Q ss_pred HHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 281 KKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 281 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
. ..... .+.+ .....+..+.+|+.+||+.+|.+|||+.++++
T Consensus 227 -~-~~~~~-----~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 227 -L-IPRNP-----APRL-------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -H-HhcCC-----CCCC-------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0 00000 0000 01123456889999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=331.01 Aligned_cols=260 Identities=18% Similarity=0.244 Sum_probs=213.5
Q ss_pred HHhcCCCcccccccCCCcEEEEEEE-CC-eEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcc-eeec------
Q 045453 54 IATNNFDARNVIKDGYAYKFYKGFV-ED-RTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTG-CCLE------ 124 (346)
Q Consensus 54 ~~~~~f~~~~~ig~G~~g~Vy~~~~-~~-~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g-~~~~------ 124 (346)
....+..+.++|.+|||+.||.|.. .+ ..+|+|++............+|+.++..+..|+|||.+++ ....
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 3445677889999999999999999 44 8999999876656677788899999999977999999999 3322
Q ss_pred CCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEecc
Q 045453 125 TRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDF 204 (346)
Q Consensus 125 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Df 204 (346)
.-+++|.||||++|+|-+++..+.. ..|++.++++|+.|+++|+++||. +..+|||||||-+||||+.++..|||||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcc
Confidence 1367899999999999999986654 349999999999999999999993 3667999999999999999999999999
Q ss_pred CCCcccCCCCceee--------ccccccCCcCCccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccch
Q 045453 205 SLSVSIPEGETCVK--------DKVTGTMGFLAPEYIN---TGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGH 273 (346)
Q Consensus 205 gl~~~~~~~~~~~~--------~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~ 273 (346)
|.+........... -...-|+.|+|||++. +...++|+|||+|||+||-|+....||+....-.
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la----- 265 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA----- 265 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee-----
Confidence 98765432221110 1223688999999884 5678999999999999999999999997543322
Q ss_pred hhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 045453 274 YWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQ 343 (346)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 343 (346)
.+.+++..+..+.....|.+||..||+.+|++||++-+|++.+-.|..
T Consensus 266 ----------------------Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 266 ----------------------ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred ----------------------EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 344555555556899999999999999999999999999999988764
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=323.37 Aligned_cols=256 Identities=15% Similarity=0.221 Sum_probs=196.0
Q ss_pred HHHHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--C-cchHHHHHHHHHHhhhcCCCceeeEcceeecC
Q 045453 51 ELEIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--N-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLET 125 (346)
Q Consensus 51 ~l~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~ 125 (346)
.+....++|+..+.||+|+||.||++.+ +++.+|+|.+.... . .....+.+|..++..+ +||||+++++++.++
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~ 115 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFCAFQDD 115 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcC
Confidence 3444567899999999999999999998 67899999876421 1 1223344555666655 999999999999999
Q ss_pred CcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccC
Q 045453 126 RIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFS 205 (346)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg 205 (346)
+..++||||+++|+|.+++... .+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG 187 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFG 187 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecc
Confidence 9999999999999999999653 4788899999999999999999 8999999999999999999999999999
Q ss_pred CCcccCCCCceeeccccccCCcCCccccccC----CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHH
Q 045453 206 LSVSIPEGETCVKDKVTGTMGFLAPEYINTG----DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVK 281 (346)
Q Consensus 206 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 281 (346)
++...............||+.|+|||++.+. .++.++|||||||++|||++|..||........ ..
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~----------~~ 257 (370)
T cd05621 188 TCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT----------YS 257 (370)
T ss_pred cceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH----------HH
Confidence 9987654333233456799999999999754 378999999999999999999999975432111 11
Q ss_pred HHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 045453 282 KCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAED--RPTTVDVAK 336 (346)
Q Consensus 282 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~ev~~ 336 (346)
....... .+ ..+........+.+++..|++.+|.. |||+.|+++
T Consensus 258 ~i~~~~~-------~~----~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~ 303 (370)
T cd05621 258 KIMDHKN-------SL----NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ 303 (370)
T ss_pred HHHhCCc-------cc----CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence 1111000 00 00011133556788999999855543 889998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=309.15 Aligned_cols=257 Identities=20% Similarity=0.359 Sum_probs=202.8
Q ss_pred hcCCCcccccccCCCcEEEEEEE-------CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCc
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV-------EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRI 127 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~-------~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~ 127 (346)
.++|...+.||+|+||.||+|.+ ++..+|+|.+..... ....++.+|+..+..+ +||||++++++|..++.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DHPNIVKLLGVCAVGKP 82 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCCc
Confidence 56788999999999999999986 357899998875433 2345677788888888 99999999999999999
Q ss_pred ceEEEecccCCChhhhhhhcCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCC
Q 045453 128 PVIVFESVKNRTLADHIYQNQP------------------HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPS 189 (346)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~ 189 (346)
.++||||+++|+|.+++..... ....+++..++.++.+++.||+||| ..+++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHh
Confidence 9999999999999999974321 1135789999999999999999999 899999999999
Q ss_pred CeEEcCCCceEEeccCCCcccCCCCcee-eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCc
Q 045453 190 RIFLDEGYIAKLFDFSLSVSIPEGETCV-KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGD 267 (346)
Q Consensus 190 NIll~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~ 267 (346)
|||++.++.++|+|||++.......... ......+..|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999987654332211 122334668999999998999999999999999999998 88888644322
Q ss_pred ccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 045453 268 EIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQ 340 (346)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 340 (346)
+. ... ...+... ..+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 240 ~~----------~~~-~~~~~~~-------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 EV----------IYY-VRDGNVL-------------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HH----------HHH-HhcCCCC-------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11 111 1111110 0011334568899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=318.35 Aligned_cols=237 Identities=20% Similarity=0.212 Sum_probs=188.5
Q ss_pred cccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccC
Q 045453 63 NVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKN 137 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~ 137 (346)
+.||+|+||+||+|.+ +++.||+|.+.... .....++..|...+.+..+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 3699999999999999 78899999986432 123344556665554544999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCcee
Q 045453 138 RTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCV 217 (346)
Q Consensus 138 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 217 (346)
|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (323)
T cd05575 81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-T 152 (323)
T ss_pred CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC-c
Confidence 9999998764 35889999999999999999999 89999999999999999999999999999865422221 2
Q ss_pred eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccccccc
Q 045453 218 KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPII 297 (346)
Q Consensus 218 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 297 (346)
.....||+.|+|||++.+..++.++|||||||++|||++|..||......+. ...... . ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~----------~~~i~~-~--------~~ 213 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM----------YDNILN-K--------PL 213 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH----------HHHHHc-C--------CC
Confidence 2345689999999999999999999999999999999999999975432111 111111 0 00
Q ss_pred ccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHH
Q 045453 298 VSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTV 332 (346)
Q Consensus 298 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ 332 (346)
.- .+.....+.+++.+||+.+|++||++.
T Consensus 214 ~~------~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 214 RL------KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CC------CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 00 012345688999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=308.66 Aligned_cols=248 Identities=20% Similarity=0.307 Sum_probs=201.1
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEec
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFES 134 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~ 134 (346)
.+|+..+.||+|++|.||+|.. +++.+++|.+..........+.+|+..+..+ +|||++++++++..+...++||||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~-~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhC-CCCCEeeEEEEEEeCCEEEEeecc
Confidence 4677888999999999999987 7789999998765555556677888888887 999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCC
Q 045453 135 VKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE 214 (346)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~ 214 (346)
+++++|.+++... .+++.++..++.|++.||+||| +.+++|+||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred cCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 9999999998653 4889999999999999999999 8999999999999999999999999999987654322
Q ss_pred ceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccc
Q 045453 215 TCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVD 294 (346)
Q Consensus 215 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 294 (346)
. ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||........ ... ..... .
T Consensus 171 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~------~~~----~~~~~-~----- 233 (296)
T cd06654 171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYL----IATNG-T----- 233 (296)
T ss_pred c-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh------HHH----HhcCC-C-----
Confidence 1 12334688899999999988899999999999999999999999965432111 000 00000 0
Q ss_pred cccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 295 PIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 295 ~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
+.+ .........+.+++.+||..+|++|||+.++++
T Consensus 234 ~~~------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 234 PEL------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCC------CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 000 011134466889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=302.39 Aligned_cols=250 Identities=26% Similarity=0.402 Sum_probs=191.7
Q ss_pred cccccCCCcEEEEEEE-----CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeec-CCcceEEEecc
Q 045453 63 NVIKDGYAYKFYKGFV-----EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLE-TRIPVIVFESV 135 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~-----~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~-~~~~~lv~e~~ 135 (346)
+.||+|+||.||+|.+ ....+|+|++..... .....+.+|...+..+ +||||++++++|.. ++..++|+||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF-SHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccC-CCCCcceEEEEeecCCCCcEEEEecC
Confidence 4689999999999986 235789998754332 3345667777777777 99999999998764 55679999999
Q ss_pred cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCc
Q 045453 136 KNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGET 215 (346)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~ 215 (346)
++|+|.+++.... ...++..+..++.+++.||+||| ..+++||||||+|||+++++.+||+|||+++.......
T Consensus 80 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 80 KHGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred CCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 9999999997643 34678888999999999999999 89999999999999999999999999999876543221
Q ss_pred ee---eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhC-CCCCCCCCCcccccchhhHHHHHHHHhhcCcccc
Q 045453 216 CV---KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTG-QKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDE 291 (346)
Q Consensus 216 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (346)
.. .....++..|+|||++.+..++.++||||||+++|||++| ..||......+ + ...... +.
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~-------~---~~~~~~-~~--- 219 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD-------I---TVYLLQ-GR--- 219 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-------H---HHHHhc-CC---
Confidence 11 1233456789999999988999999999999999999995 55665322111 1 111111 10
Q ss_pred ccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 045453 292 IVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQ 343 (346)
Q Consensus 292 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 343 (346)
+ . ......+..+.+++..||+.+|++||++.||++.|+++..
T Consensus 220 ---~------~-~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 220 ---R------L-LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred ---C------C-CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 0 0 0011234568899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=306.43 Aligned_cols=254 Identities=18% Similarity=0.313 Sum_probs=200.6
Q ss_pred cCCCcccccccCCCcEEEEEEE--CC---eEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--ED---RTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVI 130 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~---~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~l 130 (346)
++|...+.||+|+||.||+|.+ ++ ..||+|.+..... ....++..|+..+..+ +||||+++++++.+++..++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCcCcceEEEEECCCCceEE
Confidence 3467788999999999999998 22 3699998865432 3345677888888887 99999999999999999999
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCccc
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI 210 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~ 210 (346)
||||+++++|.+++.... ..+++.+++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++...
T Consensus 83 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 83 ITEFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred EEecCCCCcHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCcccccc
Confidence 999999999999997653 35899999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCceee--cccc--ccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhh
Q 045453 211 PEGETCVK--DKVT--GTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIE 285 (346)
Q Consensus 211 ~~~~~~~~--~~~~--gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (346)
........ .... .+..|+|||++.+..++.++||||||+++||+++ |..||......+ ....+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~-------~~~~i~---- 225 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-------VINAIE---- 225 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH-------HHHHHH----
Confidence 43322111 1111 2457999999999999999999999999999887 999996543211 111111
Q ss_pred cCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 045453 286 NNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341 (346)
Q Consensus 286 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 341 (346)
.. ...+.....+..+.+++..||+.+|++||++.+|+..|+++
T Consensus 226 ~~-------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 226 QD-------------YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred cC-------------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 00001113445688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=304.98 Aligned_cols=268 Identities=17% Similarity=0.177 Sum_probs=204.1
Q ss_pred HhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecC--ccCcchHHHHHHHHHHhhhcCCCceeeEcceeec-----C
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFND--ILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLE-----T 125 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~--~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~-----~ 125 (346)
....|...+.||+|+||.|..+.+ ++..||+|++.. ......++..+|+..+..+ +|+||+.+++++.. -
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~-~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHL-RHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHh-cCCCcceEEeeccccccccc
Confidence 445566678899999999999999 889999999883 3345667889999999999 89999999999865 4
Q ss_pred CcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccC
Q 045453 126 RIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFS 205 (346)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg 205 (346)
+.+|+|+|+|+ .+|...++.+. .++..+...++.|+++||.|+| +.+|+||||||+|+|++.+...||+|||
T Consensus 99 ~DvYiV~elMe-tDL~~iik~~~----~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 99 NDVYLVFELME-TDLHQIIKSQQ----DLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred ceeEEehhHHh-hHHHHHHHcCc----cccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEecccc
Confidence 57899999994 49999998753 5999999999999999999999 9999999999999999999999999999
Q ss_pred CCcccCCCC-ceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccc--------ccchhh
Q 045453 206 LSVSIPEGE-TCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEI--------GAGHYW 275 (346)
Q Consensus 206 l~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~--------~~~~~~ 275 (346)
+|+...... ....+..+.|..|+|||++.. ..||...||||.|||+.||++|++.|.+.+.-+. +.....
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE 250 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence 999875431 122356778999999999875 6799999999999999999999999988764321 000000
Q ss_pred HHHHHHHHhhcCccccccccccccCCCCcc---hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 276 LLHYVKKCIENNEFDEIVDPIIVSEGPRVG---KEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~---~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
....+ ........+.... ...+.+. .+.......+|+.+||.+||.+|+|++|++.
T Consensus 251 ~l~~i----~s~~ar~yi~slp-~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 251 DLQKI----RSEKARPYIKSLP-QIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHHh----ccHHHHHHHHhCC-CCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000 0000111111000 0000000 0023356789999999999999999999875
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=304.23 Aligned_cols=256 Identities=20% Similarity=0.307 Sum_probs=202.3
Q ss_pred HHHHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcc
Q 045453 51 ELEIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIP 128 (346)
Q Consensus 51 ~l~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~ 128 (346)
|++.+++++.....||+|+||.||+|.+ ++..|++|.+..........+.+|+..+..+ +|+||+++++++..++..
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 80 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYL-KHRNIVQYLGSDSENGFF 80 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeccCCEE
Confidence 4567788898899999999999999997 5678999988765555556777888888888 999999999999999999
Q ss_pred eEEEecccCCChhhhhhhcCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcC-CCceEEeccC
Q 045453 129 VIVFESVKNRTLADHIYQNQPHFEPL--LLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE-GYIAKLFDFS 205 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~-~~~~kl~Dfg 205 (346)
++|+||+++++|.+++.... .++ ++..+..++.|++.||+||| +.+++|+||||+||+++. ++.++|+|||
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg 154 (268)
T cd06624 81 KIFMEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFG 154 (268)
T ss_pred EEEEecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecch
Confidence 99999999999999997643 234 78889999999999999999 899999999999999986 6799999999
Q ss_pred CCcccCCCCceeeccccccCCcCCccccccCC--CCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHH
Q 045453 206 LSVSIPEGETCVKDKVTGTMGFLAPEYINTGD--FNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKC 283 (346)
Q Consensus 206 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 283 (346)
++........ ......++..|+|||++.+.. ++.++||||||+++|+|++|..||........ ..+...
T Consensus 155 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~-------~~~~~~- 225 (268)
T cd06624 155 TSKRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA-------AMFKVG- 225 (268)
T ss_pred hheecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh-------hHhhhh-
Confidence 9876543222 122345788999999987644 78999999999999999999999964322111 000000
Q ss_pred hhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 284 IENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 284 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.....+. .+......+.+++.+||+.+|++|||+.|++.
T Consensus 226 -------------~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 226 -------------MFKIHPE-IPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred -------------hhccCCC-CCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0000000 01134466889999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=302.68 Aligned_cols=249 Identities=20% Similarity=0.291 Sum_probs=199.2
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-----cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcce
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-----DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV 129 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-----~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~ 129 (346)
++|...+.||+|++|.||+|.. ++..+++|.+..... .....+.+|+..+.++ +||||+++++++.+.+..+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQYYGCLRDDETLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEccCCeEE
Confidence 5788999999999999999987 678999998764322 1234567788888888 9999999999999999999
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcc
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVS 209 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~ 209 (346)
+|+||+++++|.+++... ..+++..+..++.+++.||.||| ..+++|+||+|+||++++++.++|+|||+++.
T Consensus 81 ~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~ 153 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAY----GALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKR 153 (263)
T ss_pred EEEEECCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 999999999999998764 35888999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCceee--ccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcC
Q 045453 210 IPEGETCVK--DKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENN 287 (346)
Q Consensus 210 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (346)
......... ....++..|+|||.+.+..++.++||||||+++||+++|+.||........ ........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----------~~~~~~~~ 223 (263)
T cd06625 154 LQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA----------IFKIATQP 223 (263)
T ss_pred ccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH----------HHHHhccC
Confidence 543221111 234577899999999998899999999999999999999999965322111 00000000
Q ss_pred ccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 288 EFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 288 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
. ...+ +......+.+++.+||+.+|++|||+.++++
T Consensus 224 ~-----~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 224 T-----NPQL--------PSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred C-----CCCC--------CccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 0 0000 1134456889999999999999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=314.89 Aligned_cols=244 Identities=18% Similarity=0.204 Sum_probs=191.2
Q ss_pred cccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccC
Q 045453 63 NVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKN 137 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~ 137 (346)
+.||+|+||.||+|.. +++.+|+|.+..... .....+..|...+..+.+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999998 678999999875422 23345667777787876899999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCcee
Q 045453 138 RTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCV 217 (346)
Q Consensus 138 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 217 (346)
|+|..++... ..+++..+..++.|++.||+||| +.+++||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (327)
T cd05617 81 GDLMFHMQRQ----RKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-T 152 (327)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-c
Confidence 9999988654 35999999999999999999999 89999999999999999999999999999875322111 2
Q ss_pred eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccccccc
Q 045453 218 KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPII 297 (346)
Q Consensus 218 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 297 (346)
.....||+.|+|||++.+..++.++|||||||++|||++|..||.......... ............. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~----~~~~~~~~~~~~~--------~ 220 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN----TEDYLFQVILEKP--------I 220 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc----cHHHHHHHHHhCC--------C
Confidence 234578999999999999999999999999999999999999997543322111 1111111111110 0
Q ss_pred ccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHH
Q 045453 298 VSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTV 332 (346)
Q Consensus 298 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ 332 (346)
.. +......+.+++.+||+.||++||++.
T Consensus 221 --~~----p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 221 --RI----PRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred --CC----CCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 00 112345578999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=307.57 Aligned_cols=263 Identities=20% Similarity=0.326 Sum_probs=201.1
Q ss_pred hcCCCcccccccCCCcEEEEEEECC----------------eEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFVED----------------RTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKL 118 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~~~----------------~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l 118 (346)
.++|...+.||+|+||.||++...+ ..||+|.+..... .....+.+|+..+..+ +|||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~ 82 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRL-KNPNIIRL 82 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCcCeE
Confidence 3568888999999999999987622 3588998875432 3345677888888888 99999999
Q ss_pred cceeecCCcceEEEecccCCChhhhhhhcCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCC
Q 045453 119 TGCCLETRIPVIVFESVKNRTLADHIYQNQP--------HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSR 190 (346)
Q Consensus 119 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~N 190 (346)
++++...+..++||||+++++|.+++..... ....+++..++.++.+++.||+||| +.+++|+||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhh
Confidence 9999999999999999999999999865321 1124789999999999999999999 8999999999999
Q ss_pred eEEcCCCceEEeccCCCcccCCCCce-eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh--CCCCCCCCCCc
Q 045453 191 IFLDEGYIAKLFDFSLSVSIPEGETC-VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT--GQKIFDPSRGD 267 (346)
Q Consensus 191 Ill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt--g~~p~~~~~~~ 267 (346)
|+++.++.+||+|||++......... ......++..|+|||+..++.++.++||||||+++++|++ |..||......
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 99999999999999998765433221 1223345678999999998899999999999999999998 56677654332
Q ss_pred ccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 045453 268 EIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLK 339 (346)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 339 (346)
+. ...+......... ...... ....+..+.+|+.+||+.+|++|||+.+|++.|+
T Consensus 240 ~~-------~~~~~~~~~~~~~------~~~~~~----~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 QV-------IENTGEFFRNQGR------QIYLSQ----TPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HH-------HHHHHHhhhhccc------cccCCC----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 21 1111111111100 000000 0023457999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=304.49 Aligned_cols=250 Identities=19% Similarity=0.220 Sum_probs=201.9
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
++|...+.||+|.-|+||++.+ .+..+|+|++.+..- ....+...|-.+|..+ +||.++.||+.+.+....|||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhheeeccceeEEE
Confidence 3455668899999999999999 458999999876542 3334556667777777 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
||||+||+|...+..+.. ..++...+..++.+++-||.||| ..|||+|||||+||||-++|++-|+||.|+....
T Consensus 156 meyCpGGdL~~LrqkQp~--~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPG--KRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred EecCCCccHHHHHhhCCC--CccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 999999999998877654 67999999999999999999999 9999999999999999999999999999864321
Q ss_pred C---------------------------------C-C---------------------ceeeccccccCCcCCccccccC
Q 045453 212 E---------------------------------G-E---------------------TCVKDKVTGTMGFLAPEYINTG 236 (346)
Q Consensus 212 ~---------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~ 236 (346)
. . . .......+||-.|.|||++.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 0 0 0 0112345789999999999999
Q ss_pred CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHH
Q 045453 237 DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFREL 316 (346)
Q Consensus 237 ~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l 316 (346)
..+.++|+|+|||++|||+.|..||.+.+..+. +.. ++-+.+ ..+..+..+..+.+|
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T------l~N-------------Iv~~~l----~Fp~~~~vs~~akDL 367 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET------LRN-------------IVGQPL----KFPEEPEVSSAAKDL 367 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh------HHH-------------HhcCCC----cCCCCCcchhHHHHH
Confidence 999999999999999999999999998877664 111 111111 111122456779999
Q ss_pred HHHcccCCCCCCCC----HHHHH
Q 045453 317 ALMCVCESAEDRPT----TVDVA 335 (346)
Q Consensus 317 ~~~cl~~~p~~RPs----~~ev~ 335 (346)
|+..|.+||.+|.- +.||.
T Consensus 368 Ir~LLvKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 368 IRKLLVKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred HHHHhccChhhhhccccchHHhh
Confidence 99999999999988 66654
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=306.04 Aligned_cols=264 Identities=19% Similarity=0.332 Sum_probs=201.9
Q ss_pred hcCCCcccccccCCCcEEEEEEEC------------------CeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCcee
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFVE------------------DRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVL 116 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~~------------------~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv 116 (346)
.++|+..+.||+|+||.||++.+. ...+|+|.+..... ....++.+|+..+..+ +||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRL-KDPNII 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcc
Confidence 356888899999999999998642 34688888875432 3345677888888888 999999
Q ss_pred eEcceeecCCcceEEEecccCCChhhhhhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCC
Q 045453 117 KLTGCCLETRIPVIVFESVKNRTLADHIYQNQPH-------FEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPS 189 (346)
Q Consensus 117 ~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~ 189 (346)
++++++...+..++||||+++|+|.+++...... ...+++.++..++.|++.||+||| +.+++|+||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~ 159 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATR 159 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChh
Confidence 9999999999999999999999999998764321 134788999999999999999999 899999999999
Q ss_pred CeEEcCCCceEEeccCCCcccCCCCcee-eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh--CCCCCCCCCC
Q 045453 190 RIFLDEGYIAKLFDFSLSVSIPEGETCV-KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT--GQKIFDPSRG 266 (346)
Q Consensus 190 NIll~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt--g~~p~~~~~~ 266 (346)
|||++.++.++|+|||+++.+....... .....++..|+|||...++.++.++||||||+++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 9999999999999999987654332211 222344678999999988899999999999999999998 6788865433
Q ss_pred cccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 045453 267 DEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQ 340 (346)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 340 (346)
.+. ................ . . ....++..+.+++.+||+.+|++|||+.+|++.|++
T Consensus 240 ~~~-------~~~~~~~~~~~~~~~~----~--~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 EQV-------IENTGEFFRDQGRQVY----L--P----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHH-------HHHHHHHHhhcccccc----C--C----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 221 1111111111100000 0 0 011334678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=319.39 Aligned_cols=261 Identities=18% Similarity=0.239 Sum_probs=197.5
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecCC-----cc
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETR-----IP 128 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~-----~~ 128 (346)
+|+..+.||+|+||.||+|.. ++..||+|++..... ....++.+|+..+..+ +||||+++++++...+ ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFF-KHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhC-CCCCcCCHhheecCCCccccceE
Confidence 478889999999999999997 789999999864322 2345678888888888 9999999999998776 78
Q ss_pred eEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 129 VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
++|+||+. ++|.+.+... ..+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||+++
T Consensus 80 ~lv~e~~~-~~l~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~ 151 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSP----QPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR 151 (372)
T ss_pred EEEeeccc-cCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEecccccee
Confidence 99999996 4888887554 36899999999999999999999 8999999999999999999999999999997
Q ss_pred ccCCCCceeeccccccCCcCCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcC
Q 045453 209 SIPEGETCVKDKVTGTMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENN 287 (346)
Q Consensus 209 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (346)
..............++..|+|||++.+. .++.++|||||||++|||++|+.||........ ...+.......
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-------~~~i~~~~g~~ 224 (372)
T cd07853 152 VEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ-------LDLITDLLGTP 224 (372)
T ss_pred ecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH-------HHHHHHHcCCC
Confidence 6543333233345678899999998874 579999999999999999999999976543221 11111100000
Q ss_pred cccc----------ccc-----c-ccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 288 EFDE----------IVD-----P-IIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 288 ~~~~----------~~d-----~-~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.... .+. + ....... ........+.+|+.+||+.||++|||+.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 225 SLEAMRSACEGARAHILRGPHKPPSLPVLYT--LSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred CHHHHHHhhHHHHHHHHhCCCCCCchHHhcc--cCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 0000 000 0 0000000 00122456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=338.71 Aligned_cols=261 Identities=20% Similarity=0.285 Sum_probs=204.6
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
++|...+.||+|+||.||+|.+ .++.||+|++..... ....++.+|+..+..+ +||||+++++++.+++..++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L-~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-IHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhC-CCcCcCeEEEEEeeCCEEEEE
Confidence 4688899999999999999998 688999999875432 2245678888888888 999999999999999999999
Q ss_pred EecccCCChhhhhhhcC-------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEecc
Q 045453 132 FESVKNRTLADHIYQNQ-------PHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDF 204 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~-------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Df 204 (346)
|||+++|+|.+++.... .....+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDF 157 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDW 157 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEec
Confidence 99999999999986421 11234678889999999999999999 899999999999999999999999999
Q ss_pred CCCcccCCCCc-----------------eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc
Q 045453 205 SLSVSIPEGET-----------------CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGD 267 (346)
Q Consensus 205 gl~~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~ 267 (346)
|+++....... .......||+.|+|||++.+..++.++|||||||++|||+||..||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 99976621110 0112346899999999999999999999999999999999999999763332
Q ss_pred ccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHHHH
Q 045453 268 EIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRP-TTVDVAKRLKQIYQ 343 (346)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~ev~~~L~~i~~ 343 (346)
... ... ...++.- .......+..+.+++.+||+.+|++|| +++++.+.|+...+
T Consensus 238 ki~---------~~~--------~i~~P~~-----~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 238 KIS---------YRD--------VILSPIE-----VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhh---------hhh--------hccChhh-----ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 210 000 0001000 000113445688999999999999995 57888888887755
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=301.65 Aligned_cols=250 Identities=22% Similarity=0.371 Sum_probs=200.9
Q ss_pred cCCCcccccccCCCcEEEEEEE-CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecc
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESV 135 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~ 135 (346)
.+|+..+.||+|+||.||+|.+ .+..+|+|.+.... ....++..|+..+..+ +|||++++++++......++||||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKL-SHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhC-CCCCeeeEEEEEccCCceEEEEEcC
Confidence 4577788999999999999988 57889999876432 3345678888888888 9999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCc
Q 045453 136 KNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGET 215 (346)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~ 215 (346)
++++|.+++.... ..+++..+..++.+++.||+||| +.+++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 82 EHGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 9999999987643 35889999999999999999999 88999999999999999999999999999876644322
Q ss_pred eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccc
Q 045453 216 CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVD 294 (346)
Q Consensus 216 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 294 (346)
.......++.+|+|||++.++.++.++||||||+++||+++ |..||....... ..... ..+. ....
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~----------~~~~~-~~~~--~~~~ 222 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE----------VVETI-NAGF--RLYK 222 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH----------HHHHH-hCCC--CCCC
Confidence 22223335678999999998899999999999999999998 999986533221 11111 1000 0000
Q ss_pred cccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 045453 295 PIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRL 338 (346)
Q Consensus 295 ~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 338 (346)
+ ...+..+.+|+.+||+.+|++|||+.++++.|
T Consensus 223 ~-----------~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 223 P-----------RLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred C-----------CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 1 02345689999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=310.21 Aligned_cols=253 Identities=23% Similarity=0.265 Sum_probs=200.2
Q ss_pred HHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--------------cchHHHHHHHHHHhhhcCCCcee
Q 045453 53 EIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--------------DGHEDCFNNIIFASKLSSHKNVL 116 (346)
Q Consensus 53 ~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--------------~~~~~~~~e~~~~~~~~~h~niv 116 (346)
.+..|+|.....||+|.||.|-+|.. ++..||||.+.+... ...+...+|+.++.++ +|||||
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl-~H~nVV 171 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL-HHPNVV 171 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc-CCcCee
Confidence 34558899999999999999999999 889999999864321 1234778999999999 999999
Q ss_pred eEcceeec--CCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEc
Q 045453 117 KLTGCCLE--TRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLD 194 (346)
Q Consensus 117 ~l~g~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~ 194 (346)
+|+.+..+ .+.+|||+|||..|.+...=... ..++..+.++++.+++.||.||| .++||||||||+|+||+
T Consensus 172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~----~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDK----PELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLS 244 (576)
T ss_pred EEEEeecCcccCceEEEEEeccCCccccCCCCc----ccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEc
Confidence 99999876 46889999999888775432221 23899999999999999999999 99999999999999999
Q ss_pred CCCceEEeccCCCcccCCCC----ceeeccccccCCcCCccccccCC----CCcccchHHHHHHHHHHHhCCCCCCCCCC
Q 045453 195 EGYIAKLFDFSLSVSIPEGE----TCVKDKVTGTMGFLAPEYINTGD----FNEKCDVFSFGMLLLVLLTGQKIFDPSRG 266 (346)
Q Consensus 195 ~~~~~kl~Dfgl~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~G~vl~elltg~~p~~~~~~ 266 (346)
++|++||+|||.+.....+. ...-...+||+.|+|||.+.++. .+.+.||||+||+||-|+.|+.||-+...
T Consensus 245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~ 324 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE 324 (576)
T ss_pred CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence 99999999999987653221 11123478999999999998743 35789999999999999999999975443
Q ss_pred cccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 267 DEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
-+. +..+++..+. .+..++..+.+.+|++++|.+||+.|.+..+|..
T Consensus 325 ~~l-------------------~~KIvn~pL~----fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 325 LEL-------------------FDKIVNDPLE----FPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred HHH-------------------HHHHhcCccc----CCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 221 1222222221 1222256788999999999999999999998864
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=301.41 Aligned_cols=268 Identities=17% Similarity=0.208 Sum_probs=204.0
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCc--chHHHHHHHHHHhhhcCCCc-eeeEcceeecCC-----
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILND--GHEDCFNNIIFASKLSSHKN-VLKLTGCCLETR----- 126 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~--~~~~~~~e~~~~~~~~~h~n-iv~l~g~~~~~~----- 126 (346)
..|....+||+|+||+||+|+. +|+.||+|++.-.... ......+|+..+..+ +|+| ||.+++++.+.+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L-~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRL-SHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHh-CCCcceEEEEeeeeeccccccc
Confidence 3455667899999999999999 8899999998866442 334568899999999 9999 999999998877
Q ss_pred -cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccC
Q 045453 127 -IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFS 205 (346)
Q Consensus 127 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg 205 (346)
.+++|+||++. +|..++.........++...+..++.|++.||+||| +++|+||||||+|||++++|.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccc
Confidence 78899999966 999999876532134666889999999999999999 9999999999999999999999999999
Q ss_pred CCcccCCCCceeeccccccCCcCCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHh
Q 045453 206 LSVSIPEGETCVKDKVTGTMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCI 284 (346)
Q Consensus 206 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (346)
+|+....+... .+..++|..|+|||++.+. .|+...||||+||++.||++++..|.+....+ ....+-..+
T Consensus 166 lAra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~-------ql~~If~~l 237 (323)
T KOG0594|consen 166 LARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID-------QLFRIFRLL 237 (323)
T ss_pred hHHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH-------HHHHHHHHc
Confidence 99877644332 3456789999999999886 69999999999999999999999998766522 111111111
Q ss_pred hcC------ccccccccc--cccCC-CCcchHHH---HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045453 285 ENN------EFDEIVDPI--IVSEG-PRVGKEKQ---LQGFRELALMCVCESAEDRPTTVDVAKR 337 (346)
Q Consensus 285 ~~~------~~~~~~d~~--l~~~~-~~~~~~~~---~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 337 (346)
... ......+-. ..... +..-.... .....+++..||+.+|.+|.|+..+++.
T Consensus 238 GtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 238 GTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 111 011111100 00000 00000011 1368899999999999999999998864
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=321.71 Aligned_cols=243 Identities=20% Similarity=0.250 Sum_probs=201.0
Q ss_pred CCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 59 FDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
|...+-||.|+.|.|-+|++ +|+.+|||.+..... .....+.+|+.+|.-+ .|||++++++++.+..++|||.|
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi-~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLI-EHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHh-cCCCeeeeeeeeccCceEEEEEE
Confidence 45667899999999999999 999999999886632 2223445555555555 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
|+++|-|.+++-..+ ++++.+..++..||+.|+.|+| ..+|+||||||+|+|||.++++||+|||+|..-..+
T Consensus 93 yv~gGELFdylv~kG----~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKG----PLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred ecCCchhHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 999999999998764 6999999999999999999999 999999999999999999999999999999765544
Q ss_pred CceeeccccccCCcCCccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccc
Q 045453 214 ETCVKDKVTGTMGFLAPEYINTGDF-NEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEI 292 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (346)
.. -...+|++.|.|||++.+.+| ..++||||.|||||.||||+.||++.+... +..
T Consensus 166 kl--LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~-------LLl-------------- 222 (786)
T KOG0588|consen 166 KL--LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV-------LLL-------------- 222 (786)
T ss_pred cc--ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH-------HHH--------------
Confidence 43 245689999999999999998 578999999999999999999998543322 111
Q ss_pred cccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 293 VDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 293 ~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
+.-.+.+..+ ...+.++.+|+.+|+..||+.|.|++||++
T Consensus 223 --KV~~G~f~MP--s~Is~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 223 --KVQRGVFEMP--SNISSEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred --HHHcCcccCC--CcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence 1112222221 155667889999999999999999999986
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=302.81 Aligned_cols=238 Identities=18% Similarity=0.321 Sum_probs=185.8
Q ss_pred ccccCCCcEEEEEEEC--------------CeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcce
Q 045453 64 VIKDGYAYKFYKGFVE--------------DRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV 129 (346)
Q Consensus 64 ~ig~G~~g~Vy~~~~~--------------~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~ 129 (346)
.||+|+||.||+|.+. ...|++|.+..........+..+...+..+ +||||+++++++......+
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l-~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQV-SHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCCE
Confidence 5899999999999862 125888887654444444566667777777 9999999999999999999
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCc-------eEEe
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYI-------AKLF 202 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~-------~kl~ 202 (346)
+||||+++|+|..++.... ..+++..++.++.|++.||+||| +.+++||||||+|||++.++. ++++
T Consensus 81 lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 9999999999998886543 35899999999999999999999 899999999999999987664 8999
Q ss_pred ccCCCcccCCCCceeeccccccCCcCCccccc-cCCCCcccchHHHHHHHHHHH-hCCCCCCCCCCcccccchhhHHHHH
Q 045453 203 DFSLSVSIPEGETCVKDKVTGTMGFLAPEYIN-TGDFNEKCDVFSFGMLLLVLL-TGQKIFDPSRGDEIGAGHYWLLHYV 280 (346)
Q Consensus 203 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~vl~ell-tg~~p~~~~~~~~~~~~~~~~~~~~ 280 (346)
|||++...... ....++..|+|||.+. +..++.++||||||+++|||+ +|..|+......+.
T Consensus 155 d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~----------- 218 (262)
T cd05077 155 DPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK----------- 218 (262)
T ss_pred CCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-----------
Confidence 99998655322 2345788999999887 467899999999999999998 58888764322111
Q ss_pred HHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 045453 281 KKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLK 339 (346)
Q Consensus 281 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 339 (346)
.. +..... ... . .....+.+|+.+||+.+|++||++.++++.|+
T Consensus 219 ~~-~~~~~~--------~~~-----~-~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 219 ER-FYEGQC--------MLV-----T-PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HH-HHhcCc--------cCC-----C-CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 00 000000 000 0 12356889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=314.25 Aligned_cols=242 Identities=20% Similarity=0.253 Sum_probs=193.3
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
+|+..+.||+|+||+||+|.. +++.||+|.+.... ......+..|...+..+.+|++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 467789999999999999998 67899999987532 2233456677777777756788899999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
||+++|+|.+++... ..+++.++..++.|++.||.||| +.+++||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQV----GKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 999999999998764 35899999999999999999999 89999999999999999999999999999875432
Q ss_pred CCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccc
Q 045453 213 GETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEI 292 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (346)
... ......||+.|+|||++.+..++.++|||||||++|||++|..||........ ...... ..
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~----------~~~i~~-~~---- 217 (323)
T cd05615 154 DGV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL----------FQSIME-HN---- 217 (323)
T ss_pred CCc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH----------HHHHHh-CC----
Confidence 221 22345689999999999999999999999999999999999999976433211 111111 00
Q ss_pred cccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHH
Q 045453 293 VDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTV 332 (346)
Q Consensus 293 ~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ 332 (346)
. ..+ ......+.+++.+||+.+|.+|++..
T Consensus 218 ----~--~~p----~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 218 ----V--SYP----KSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred ----C--CCC----ccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 0 000 12345678899999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=314.14 Aligned_cols=240 Identities=18% Similarity=0.233 Sum_probs=191.0
Q ss_pred cccccCCCcEEEEEEE-----CCeEEEEEEecCcc----CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 63 NVIKDGYAYKFYKGFV-----EDRTVSVMKFNDIL----NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~-----~~~~vavk~~~~~~----~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
+.||+|+||.||++.. .++.+|+|.+.... ......+..|...+..+ +||||+++++++..++..++|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhC-CCCchhceeeEEecCCeEEEEEe
Confidence 5799999999999976 56789999986432 12234456778888888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
|+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 81 YLSGGELFMHLEREG----IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred CCCCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 999999999997653 5788889999999999999999 899999999999999999999999999998754322
Q ss_pred CceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccc
Q 045453 214 ETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIV 293 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (346)
.. ......||+.|+|||++.+..++.++||||||+++|||++|..||....... ...... .+..
T Consensus 154 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~----------~~~~~~-~~~~---- 217 (323)
T cd05584 154 GT-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK----------TIDKIL-KGKL---- 217 (323)
T ss_pred CC-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH----------HHHHHH-cCCC----
Confidence 21 2234568999999999999889999999999999999999999997543211 111111 1100
Q ss_pred ccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 045453 294 DPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRP-----TTVDVAK 336 (346)
Q Consensus 294 d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~ 336 (346)
.+ +......+.+++.+||+.+|++|| ++.++++
T Consensus 218 --~~--------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 --NL--------PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred --CC--------CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 00 012345688999999999999999 7777754
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=316.63 Aligned_cols=240 Identities=21% Similarity=0.223 Sum_probs=188.8
Q ss_pred cccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccC
Q 045453 63 NVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKN 137 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~ 137 (346)
+.||+|+||+||+|.+ +++.+|+|.+.... .........|+..+.+..+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 3699999999999998 66789999986432 122334555555544444999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCcee
Q 045453 138 RTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCV 217 (346)
Q Consensus 138 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 217 (346)
|+|.+++.... .++......++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~ 152 (325)
T cd05602 81 GELFYHLQRER----CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-T 152 (325)
T ss_pred CcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-C
Confidence 99999997643 5788888999999999999999 89999999999999999999999999999875432221 2
Q ss_pred eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccccccc
Q 045453 218 KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPII 297 (346)
Q Consensus 218 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 297 (346)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||......+. ....... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----------~~~i~~~---------~~ 213 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM----------YDNILNK---------PL 213 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH----------HHHHHhC---------Cc
Confidence 3345689999999999999999999999999999999999999975433221 1111110 00
Q ss_pred ccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 045453 298 VSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVA 335 (346)
Q Consensus 298 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~ 335 (346)
. ..+.....+.+++.+||+.+|.+||++.+.+
T Consensus 214 ~------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 214 Q------LKPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred C------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 0 0013345688999999999999999987544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=288.55 Aligned_cols=247 Identities=20% Similarity=0.322 Sum_probs=204.2
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVI 130 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~l 130 (346)
.++|++.+.||+|-||.||.|+. ++--||+|++.+.. ..-..+..+|+.+-..+ +||||+++++++.+....||
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L-~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHL-RHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeeccc-CCccHHhhhhheeccceeEE
Confidence 45688999999999999999999 67789999986543 12334556667666676 99999999999999999999
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCccc
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI 210 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~ 210 (346)
++||.++|+|...|..... ..++......++.|+|.||.|+| .++++||||||+|+|++.++..|++|||-+...
T Consensus 100 ilEya~~gel~k~L~~~~~--~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRM--KRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEEecCCchHHHHHHhccc--ccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 9999999999999985543 46888888999999999999999 999999999999999999999999999987554
Q ss_pred CCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 211 PEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 211 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
. .......+||..|.+||++.+..++..+|+|++|++.||++.|.+||.....++. + ..+.. .
T Consensus 175 p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et----Y---krI~k-------~ 237 (281)
T KOG0580|consen 175 P---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET----Y---KRIRK-------V 237 (281)
T ss_pred C---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH----H---HHHHH-------c
Confidence 3 2234678899999999999999999999999999999999999999987654332 0 00000 1
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
++.+| ...+....+++..|+..+|.+|.+..||++
T Consensus 238 ~~~~p-----------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 238 DLKFP-----------STISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred cccCC-----------cccChhHHHHHHHHhccCccccccHHHHhh
Confidence 11111 144566889999999999999999999875
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=307.14 Aligned_cols=264 Identities=21% Similarity=0.281 Sum_probs=204.9
Q ss_pred CCHHHHHHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceee-
Q 045453 47 FTIRELEIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCL- 123 (346)
Q Consensus 47 ~~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~- 123 (346)
+.++.+..++++|+..+.||+|+||.||+|.. .+..+|+|.+.... ....++..|...+..+.+||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 55677888899999999999999999999988 67899999875432 223556678888888757999999999884
Q ss_pred ----cCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCce
Q 045453 124 ----ETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIA 199 (346)
Q Consensus 124 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~ 199 (346)
.++..++||||+++++|.+++.........+++..+..++.|++.||.||| +.+++||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCE
Confidence 345689999999999999988643322356889999999999999999999 8999999999999999999999
Q ss_pred EEeccCCCcccCCCCceeeccccccCCcCCcccccc-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchh
Q 045453 200 KLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINT-----GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHY 274 (346)
Q Consensus 200 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~ 274 (346)
||+|||++........ ......|+..|+|||++.. ..++.++|||||||++|||++|+.||........
T Consensus 164 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~----- 237 (286)
T cd06638 164 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA----- 237 (286)
T ss_pred EEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-----
Confidence 9999999876643222 2234468899999998853 4578999999999999999999999975432111
Q ss_pred hHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045453 275 WLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKR 337 (346)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 337 (346)
+.. . .... .+.+. .+......+.+++.+||+.+|++|||+.|+++.
T Consensus 238 -~~~----~-~~~~-----~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 238 -LFK----I-PRNP-----PPTLH------QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred -Hhh----c-cccC-----CCccc------CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 000 0 0000 00000 000233568899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=319.70 Aligned_cols=258 Identities=16% Similarity=0.213 Sum_probs=197.6
Q ss_pred HHHHHHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--C-cchHHHHHHHHHHhhhcCCCceeeEcceee
Q 045453 49 IRELEIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--N-DGHEDCFNNIIFASKLSSHKNVLKLTGCCL 123 (346)
Q Consensus 49 ~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~ 123 (346)
++++....++|...+.||+|+||.||++.+ +++.+|+|.+.... . .....+.+|...+..+ +||||+++++++.
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~ 113 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQ 113 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEE
Confidence 455666778999999999999999999999 67899999876421 1 1223344555666665 9999999999999
Q ss_pred cCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEec
Q 045453 124 ETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFD 203 (346)
Q Consensus 124 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~D 203 (346)
+.+..++||||+++|+|.+++... .++...+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~D 185 (371)
T cd05622 114 DDRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLAD 185 (371)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEe
Confidence 999999999999999999998653 4788889999999999999999 99999999999999999999999999
Q ss_pred cCCCcccCCCCceeeccccccCCcCCccccccC----CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHH
Q 045453 204 FSLSVSIPEGETCVKDKVTGTMGFLAPEYINTG----DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHY 279 (346)
Q Consensus 204 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 279 (346)
||+++..............||+.|+|||++.+. .++.++|||||||++|||++|..||....... .
T Consensus 186 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~----------~ 255 (371)
T cd05622 186 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG----------T 255 (371)
T ss_pred CCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH----------H
Confidence 999987654333233456799999999998754 37899999999999999999999997543211 1
Q ss_pred HHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 045453 280 VKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAED--RPTTVDVAK 336 (346)
Q Consensus 280 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~ev~~ 336 (346)
............ .+........+.+++..||+.++.+ ||++.|+++
T Consensus 256 ~~~i~~~~~~~~-----------~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~ 303 (371)
T cd05622 256 YSKIMNHKNSLT-----------FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 303 (371)
T ss_pred HHHHHcCCCccc-----------CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhc
Confidence 111111110000 0011134556788999999844432 678888776
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=317.13 Aligned_cols=240 Identities=20% Similarity=0.195 Sum_probs=189.5
Q ss_pred cccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccC
Q 045453 63 NVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKN 137 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~ 137 (346)
+.||+|+||.||+|.. +++.+|+|.+.... .....++..|...+.+..+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999998 78899999986432 123345556665555544999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCcee
Q 045453 138 RTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCV 217 (346)
Q Consensus 138 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 217 (346)
|+|..++... ..+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 152 (325)
T cd05604 81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DT 152 (325)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CC
Confidence 9999888654 36899999999999999999999 8999999999999999999999999999986532221 12
Q ss_pred eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccccccc
Q 045453 218 KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPII 297 (346)
Q Consensus 218 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 297 (346)
.....||..|+|||++.+..++.++|||||||++|||++|..||......+. ....... .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~----------~~~~~~~---------~~ 213 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM----------YDNILHK---------PL 213 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH----------HHHHHcC---------Cc
Confidence 2345689999999999999999999999999999999999999975432211 1111110 00
Q ss_pred ccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 045453 298 VSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVA 335 (346)
Q Consensus 298 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~ 335 (346)
.. .+.....+.+++.+|++.+|.+||++.+.+
T Consensus 214 ~~------~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 214 VL------RPGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred cC------CCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 00 002345578899999999999999986433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=313.23 Aligned_cols=265 Identities=18% Similarity=0.295 Sum_probs=207.0
Q ss_pred HHHHhcCCCcccccccCCCcEEEEEEEC---------CeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcce
Q 045453 52 LEIATNNFDARNVIKDGYAYKFYKGFVE---------DRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGC 121 (346)
Q Consensus 52 l~~~~~~f~~~~~ig~G~~g~Vy~~~~~---------~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~ 121 (346)
|+....+|...+.||+|+||.||+|.+. ...+|+|.+..... ....++.+|+..+..+.+||||++++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 3334456888999999999999999751 23688998764432 3346778888888888689999999999
Q ss_pred eecCCcceEEEecccCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCC
Q 045453 122 CLETRIPVIVFESVKNRTLADHIYQNQP------------HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPS 189 (346)
Q Consensus 122 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~ 189 (346)
|...+..++|+||+++|+|.+++..... ....++|.+++.++.|++.||+||| ..+++||||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~ 163 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAAR 163 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccc
Confidence 9999999999999999999999975421 1245889999999999999999999 899999999999
Q ss_pred CeEEcCCCceEEeccCCCcccCCCCcee-eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCc
Q 045453 190 RIFLDEGYIAKLFDFSLSVSIPEGETCV-KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGD 267 (346)
Q Consensus 190 NIll~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~ 267 (346)
|||++.++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 243 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 9999999999999999987665433221 122334567999999999999999999999999999999 88888654322
Q ss_pred ccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 045453 268 EIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQ 343 (346)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 343 (346)
+. .... ....... ........+.+++.+||+.+|++|||+.|+++.|+++..
T Consensus 244 ~~----------~~~~-~~~~~~~-------------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 244 EL----------FKLL-KEGHRMD-------------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HH----------HHHH-HcCCCCC-------------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 11 1111 1111000 011334568899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=304.18 Aligned_cols=249 Identities=18% Similarity=0.302 Sum_probs=196.5
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc-CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEec
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL-NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFES 134 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~ 134 (346)
+|...+.||+|+||.||+|.+ +++.+|+|.+.... .....++.+|+..+..+ +||||+++++++...+..++||||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKC-DSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEECCEEEEEEec
Confidence 567788999999999999988 78899999886543 23345677888888888 999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCC
Q 045453 135 VKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE 214 (346)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~ 214 (346)
+++++|..+. .+++..+..++.|++.||.||| +.+++|+||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~ 149 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI 149 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence 9999986542 3788899999999999999999 8999999999999999999999999999987654322
Q ss_pred ceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccc
Q 045453 215 TCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVD 294 (346)
Q Consensus 215 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 294 (346)
.....++..|+|||++.+..++.++||||||+++|+|++|..||........... ........ .... .
T Consensus 150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~-~~~~-----~ 217 (279)
T cd06619 150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM---PLQLLQCI-VDED-----P 217 (279)
T ss_pred ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccc---hHHHHHHH-hccC-----C
Confidence 2345788999999999999999999999999999999999999976443222100 01111110 0000 0
Q ss_pred cccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045453 295 PIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKR 337 (346)
Q Consensus 295 ~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 337 (346)
+.+ ........+.+++.+||+.+|++||++.|+++.
T Consensus 218 ~~~-------~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 218 PVL-------PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCC-------CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 000 011234568899999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=302.93 Aligned_cols=255 Identities=20% Similarity=0.315 Sum_probs=200.8
Q ss_pred CCCcccccccCCCcEEEEEEE---CCeEEEEEEecCcc----------CcchHHHHHHHHHHhhhcCCCceeeEcceeec
Q 045453 58 NFDARNVIKDGYAYKFYKGFV---EDRTVSVMKFNDIL----------NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLE 124 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~---~~~~vavk~~~~~~----------~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~ 124 (346)
+|+..+.||+|+||.||+|.+ .+..+|+|.+.... .....++..|+..+.+..+||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 477788999999999999998 35789999875322 12234566777777765699999999999999
Q ss_pred CCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEecc
Q 045453 125 TRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDF 204 (346)
Q Consensus 125 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Df 204 (346)
++..++||||+++++|.+++.........+++..++.++.|++.||.|||+ ..+++|+||+|+||++++++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence 999999999999999999886533233568999999999999999999993 267999999999999999999999999
Q ss_pred CCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHh
Q 045453 205 SLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCI 284 (346)
Q Consensus 205 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (346)
|++....... ......++..|+|||.+.+..++.++||||||+++|+|++|..||....... .....
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~----------~~~~~- 225 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS----------LATKI- 225 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH----------HHHHH-
Confidence 9987654432 2344568889999999998889999999999999999999999986432211 11111
Q ss_pred hcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 045453 285 ENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLK 339 (346)
Q Consensus 285 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 339 (346)
...... + . ........+.+++.+||+.+|++|||+.||..+++
T Consensus 226 ~~~~~~----~-~-------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 226 VEAVYE----P-L-------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred hhccCC----c-C-------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 111110 0 0 00023456889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=321.21 Aligned_cols=242 Identities=24% Similarity=0.365 Sum_probs=204.8
Q ss_pred CCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 59 FDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
|+..+.||.|+||.||-|.+ +...||||+..-... ..+..+.+|+..+..+ +|||+|.+.|||......|||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l-~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQL-RHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhc-cCCCcccccceeeccchHHHHHH
Confidence 66778999999999999998 889999999876554 3456788999999999 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
||-| |-.|.+.-.. .++-..++..|+.+.+.||+||| +.+.||||||..|||+++.|.+||+|||.|....
T Consensus 107 YClG-SAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~-- 177 (948)
T KOG0577|consen 107 YCLG-SASDLLEVHK---KPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA-- 177 (948)
T ss_pred HHhc-cHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcC--
Confidence 9954 8888886654 57999999999999999999999 9999999999999999999999999999886543
Q ss_pred CceeeccccccCCcCCccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 214 ETCVKDKVTGTMGFLAPEYIN---TGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
.....+||+.|||||++. .+.|+-++||||+|++..|+...++|+-.++.-.. ...
T Consensus 178 ---PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA----------LYH-------- 236 (948)
T KOG0577|consen 178 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----------LYH-------- 236 (948)
T ss_pred ---chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH----------HHH--------
Confidence 345689999999999997 46899999999999999999999999865433110 001
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
...++.|.....+++..+.+++..||++-|.+|||.+++++
T Consensus 237 -----IAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 237 -----IAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred -----HHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 11122333334488999999999999999999999998764
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=322.36 Aligned_cols=200 Identities=17% Similarity=0.217 Sum_probs=169.9
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
.|...+.||+|+||+||+|.. ++..+|+|++..... .....+..|..++..+ +||||+++++++.+.+..++||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-CCCcCCeEEEEEEeCCEEEEEE
Confidence 578889999999999999998 778999999864321 2334566777788887 9999999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
||+++|+|.+++.... .+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~ 153 (382)
T cd05625 81 DYIPGGDMMSLLIRMG----IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (382)
T ss_pred eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccc
Confidence 9999999999987643 5788899999999999999999 89999999999999999999999999999753210
Q ss_pred CC----------------------------------------------ceeeccccccCCcCCccccccCCCCcccchHH
Q 045453 213 GE----------------------------------------------TCVKDKVTGTMGFLAPEYINTGDFNEKCDVFS 246 (346)
Q Consensus 213 ~~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s 246 (346)
.. ........||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (382)
T cd05625 154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence 00 00012346899999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCC
Q 045453 247 FGMLLLVLLTGQKIFDPSR 265 (346)
Q Consensus 247 ~G~vl~elltg~~p~~~~~ 265 (346)
|||++|||++|+.||....
T Consensus 234 lGvil~elltG~~Pf~~~~ 252 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQT 252 (382)
T ss_pred chHHHHHHHhCCCCCCCCC
Confidence 9999999999999997643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=304.86 Aligned_cols=264 Identities=22% Similarity=0.266 Sum_probs=202.0
Q ss_pred cCCCcccccccCCCcEEEEEEE------CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecC--Cc
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV------EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLET--RI 127 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~------~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~--~~ 127 (346)
..|...+.||+|+||.||++.+ .+..+|+|.+..... .....+.+|+..+..+ +||||+++++++... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCCc
Confidence 4567788999999999999974 467899999865432 3345677888888888 999999999998775 56
Q ss_pred ceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCC
Q 045453 128 PVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS 207 (346)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~ 207 (346)
.++||||+++++|.+++.... ..++|..+..++.+++.||+||| +.+++||||||+||+++.++.++|+|||++
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred eEEEEEccCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccc
Confidence 789999999999999986543 35899999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCce--eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccc-----cchhhHHHHH
Q 045453 208 VSIPEGETC--VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIG-----AGHYWLLHYV 280 (346)
Q Consensus 208 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~-----~~~~~~~~~~ 280 (346)
+.+...... ......++..|+|||++.+..++.++||||||+++||++|+..|.......... .........+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 876543321 122345677899999999888999999999999999999987765332111000 0000111111
Q ss_pred HHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 045453 281 KKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341 (346)
Q Consensus 281 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 341 (346)
.. ...+... ......+..+.+|+.+||+.+|++|||+.++++.|+.+
T Consensus 237 ~~-~~~~~~~-------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 237 RV-LEEGKRL-------------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HH-HHcCccC-------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11 1111100 00113456799999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=298.00 Aligned_cols=249 Identities=22% Similarity=0.338 Sum_probs=202.8
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
.++|+..+.||+|+||.||+|.+ ++..+++|.+..... ..++.+|+..+..+ +||||+++++++.+....++++|
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQC-DSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhC-CCCcEeeeeeeeecCCcEEEEEe
Confidence 36788899999999999999999 478999999865432 56778888888888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
|+++++|.+++.... ..+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 79 ~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 79 YCGAGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred cCCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 999999999997543 46899999999999999999999 889999999999999999999999999998776543
Q ss_pred CceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccc
Q 045453 214 ETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIV 293 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (346)
.. ......++..|+|||++.+..++.++||||||+++|+|++|+.||........ ... ... ..
T Consensus 153 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~----------~~~-~~~-----~~ 215 (256)
T cd06612 153 MA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA----------IFM-IPN-----KP 215 (256)
T ss_pred cc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh----------hhh-hcc-----CC
Confidence 21 22344578899999999999999999999999999999999999975433211 000 000 00
Q ss_pred ccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 294 DPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 294 d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.+.+ .........+.+++.+||+.+|++|||+.||++
T Consensus 216 ~~~~------~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 216 PPTL------SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCCC------CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 0000 011134467899999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=303.81 Aligned_cols=238 Identities=19% Similarity=0.317 Sum_probs=184.5
Q ss_pred ccccCCCcEEEEEEEC--------------------------CeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceee
Q 045453 64 VIKDGYAYKFYKGFVE--------------------------DRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLK 117 (346)
Q Consensus 64 ~ig~G~~g~Vy~~~~~--------------------------~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~ 117 (346)
.||+|+||.||+|.+. ...|++|.+..........+.++...+..+ +||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l-~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQV-SHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcC-CCCCeee
Confidence 6999999999999751 135788887654433445666777777666 9999999
Q ss_pred EcceeecCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCC
Q 045453 118 LTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGY 197 (346)
Q Consensus 118 l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~ 197 (346)
++++|.+....++||||+++|+|..++.... ..+++..+..++.|++.||+||| +.+++||||||+|||++.++
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEK---GRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLG 154 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccC
Confidence 9999999999999999999999999986543 35889999999999999999999 89999999999999998654
Q ss_pred -------ceEEeccCCCcccCCCCceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHH-hCCCCCCCCCCcc
Q 045453 198 -------IAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLL-TGQKIFDPSRGDE 268 (346)
Q Consensus 198 -------~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~ell-tg~~p~~~~~~~~ 268 (346)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++||++ +|..||......+
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred cccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 4799999987543221 22356788999998875 56899999999999999985 6999987543322
Q ss_pred cccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 045453 269 IGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLK 339 (346)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 339 (346)
. .... ... ..+ +. .....+.+++.+||+.+|++|||+.+|++.|+
T Consensus 230 ~-------~~~~----~~~-------~~~----~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 K-------ERFY----EKK-------HRL----PE----PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred H-------HHHH----Hhc-------cCC----CC----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1 0100 000 000 00 11235889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=298.77 Aligned_cols=249 Identities=28% Similarity=0.442 Sum_probs=201.7
Q ss_pred cccccCCCcEEEEEEEC-----CeEEEEEEecCccCcc-hHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEeccc
Q 045453 63 NVIKDGYAYKFYKGFVE-----DRTVSVMKFNDILNDG-HEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVK 136 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~~-----~~~vavk~~~~~~~~~-~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~ 136 (346)
+.||+|+||.||+|... +..+++|.+....... ...+..|+..+..+ +|+||+++++++.+....++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhc-CCCChheeeeeecCCCceEEEEEecc
Confidence 46999999999999993 7899999987654433 56777888888888 89999999999999999999999999
Q ss_pred CCChhhhhhhcCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 137 NRTLADHIYQNQPH-----FEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 137 ~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
+++|.+++...... ...+++..+..++.+++.||+||| +.+++|+||+|+||++++++.+||+|||.+....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEcccccccccc
Confidence 99999999875211 256999999999999999999999 8999999999999999999999999999998775
Q ss_pred CCCc-eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCcc
Q 045453 212 EGET-CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEF 289 (346)
Q Consensus 212 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (346)
.... .......++..|+|||.+.+..++.++||||||+++++|++ |..||......+ +..... .+..
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~----~~~~ 225 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-------VLEYLR----KGYR 225 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHH----cCCC
Confidence 4332 12234457889999999998899999999999999999999 699997653211 111111 1100
Q ss_pred ccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 045453 290 DEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLK 339 (346)
Q Consensus 290 ~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 339 (346)
...+...+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 226 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 -------------LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -------------CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0011133567889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=324.01 Aligned_cols=265 Identities=17% Similarity=0.246 Sum_probs=191.6
Q ss_pred HhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecC-------
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLET------- 125 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~------- 125 (346)
...+|...+.||+|+||.||+|.. .+..||||++.... ....+|+..+..+ +|||||++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l-~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNL-NHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhc-CCCCCcceeeeEeecccccCCC
Confidence 346799999999999999999998 67899999875432 2234677788887 999999998876432
Q ss_pred -CcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCC-ceEEec
Q 045453 126 -RIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGY-IAKLFD 203 (346)
Q Consensus 126 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~-~~kl~D 203 (346)
..+++||||+++ +|.+++.........+++..+..++.|++.||+||| +.+|+||||||+|||++.++ .+||+|
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeec
Confidence 235789999975 787777543222356899999999999999999999 89999999999999999665 699999
Q ss_pred cCCCcccCCCCceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHH
Q 045453 204 FSLSVSIPEGETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKK 282 (346)
Q Consensus 204 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (346)
||+++.+..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|.+||.+....+. +...+..
T Consensus 215 FGla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~------~~~i~~~ 286 (440)
T PTZ00036 215 FGSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ------LVRIIQV 286 (440)
T ss_pred cccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHHH
Confidence 999987643322 234567999999999875 4689999999999999999999999976543221 1111110
Q ss_pred Hhh---------cCccccccccccccC-CCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 283 CIE---------NNEFDEIVDPIIVSE-GPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 283 ~~~---------~~~~~~~~d~~l~~~-~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.-. ...+....-+..... .....+...+..+.+|+.+||+.+|.+|||+.|++.
T Consensus 287 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 287 LGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred hCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 000 000000000000000 000000023457889999999999999999999873
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=300.36 Aligned_cols=253 Identities=20% Similarity=0.278 Sum_probs=190.6
Q ss_pred cccccCCCcEEEEEEE----CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccC
Q 045453 63 NVIKDGYAYKFYKGFV----EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKN 137 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~----~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~ 137 (346)
+.||+|+||.||+|.+ .+..+++|++..... .....+.+|+..+..+ +||||+++++++.+....++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSL-QHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 3589999999999986 335789998765432 2334677788888888 999999999999999999999999999
Q ss_pred CChhhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCce
Q 045453 138 RTLADHIYQNQP-HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETC 216 (346)
Q Consensus 138 gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 216 (346)
|+|.+++..... .....++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||+++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 999999975432 1235678888999999999999999 899999999999999999999999999998765433222
Q ss_pred e-eccccccCCcCCccccccC-------CCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcC
Q 045453 217 V-KDKVTGTMGFLAPEYINTG-------DFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENN 287 (346)
Q Consensus 217 ~-~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (346)
. .....++..|+|||++.+. .++.++||||||+++|||++ |..||......+. .... .. .
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-------~~~~---~~-~ 225 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV-------LTYT---VR-E 225 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH-------HHHH---hh-c
Confidence 1 1234567889999998642 35789999999999999997 9999975433221 1110 00 1
Q ss_pred ccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 045453 288 EFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLK 339 (346)
Q Consensus 288 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 339 (346)
......++.+.. .....+.+++..|| .+|++|||+.||+..|+
T Consensus 226 ~~~~~~~~~~~~--------~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 226 QQLKLPKPRLKL--------PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ccCCCCCCccCC--------CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 111111111110 22345778999999 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=300.14 Aligned_cols=249 Identities=18% Similarity=0.244 Sum_probs=200.3
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc-CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEec
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL-NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFES 134 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~ 134 (346)
+|+..+.||+|+||.||++.+ +++.+|+|.+.... ......+..|...+..+ +||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKM-KHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEECCEEEEEEee
Confidence 467788999999999999998 78899999876432 33445667788888877 999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCC
Q 045453 135 VKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE 214 (346)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~ 214 (346)
+++++|.+++..... ..+++...+.++.+++.||.||| +.+++|+||||+||++++++.++++|||++.......
T Consensus 80 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 80 CDGGDLMQKIKLQRG--KLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 999999998865432 45889999999999999999999 8999999999999999999999999999987664322
Q ss_pred ceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccc
Q 045453 215 TCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVD 294 (346)
Q Consensus 215 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 294 (346)
. ......++..|+|||++.+..++.++|+||||+++|+|++|..||....... ..... ..+....
T Consensus 155 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~----------~~~~~-~~~~~~~--- 219 (255)
T cd08219 155 A-YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN----------LILKV-CQGSYKP--- 219 (255)
T ss_pred c-ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH----------HHHHH-hcCCCCC---
Confidence 2 1234568889999999998899999999999999999999999997532211 11111 1111100
Q ss_pred cccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045453 295 PIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKR 337 (346)
Q Consensus 295 ~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 337 (346)
.+......+.+++.+||+.+|++|||+.+++.+
T Consensus 220 ----------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 ----------LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ----------CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 011334568899999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=307.37 Aligned_cols=264 Identities=16% Similarity=0.285 Sum_probs=200.7
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
++|...+.||+|+||.||++.+ ++..+|+|.+..... ....++.+|+..+..+ +||||++++++|.+.+..++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHEC-NSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCEEEEEee
Confidence 4688899999999999999998 677888888765432 2345577888999998 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
|+++++|.+++... ..+++..+..++.|++.||.|||+ ..+++|+||||+|||++.++.+||+|||++......
T Consensus 80 y~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 80 HMDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred ccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 99999999999764 358899999999999999999993 258999999999999999999999999998655322
Q ss_pred CceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCc-----
Q 045453 214 ETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE----- 288 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 288 (346)
. .....++..|+|||.+.+..++.++||||||+++|+|++|..||...+.... ............
T Consensus 154 ~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~~ 223 (308)
T cd06615 154 M---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL-------EAMFGRPVSEGEAKESH 223 (308)
T ss_pred c---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH-------HHhhcCccccccccCCc
Confidence 1 2345688999999999888899999999999999999999999965432211 000000000000
Q ss_pred ---------------cccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045453 289 ---------------FDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKR 337 (346)
Q Consensus 289 ---------------~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 337 (346)
..+..+.......+..........+.+++.+||+.+|++|||+.+|++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 224 RPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred ccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000000000111111234568999999999999999999998864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=302.11 Aligned_cols=255 Identities=20% Similarity=0.310 Sum_probs=202.5
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCe----EEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcce
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDR----TVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV 129 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~----~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~ 129 (346)
.+|...+.||+|+||.||+|.+ ++. .+|+|....... ....++.+|+..+..+ +||||++++++|.. ...+
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV-DHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec-CceE
Confidence 4567788999999999999987 332 588888765543 2345677888888888 99999999999987 7889
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcc
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVS 209 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~ 209 (346)
+||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+++|+||||+||+++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHK---DNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEecCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCccccc
Confidence 9999999999999997654 35899999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCceee-ccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcC
Q 045453 210 IPEGETCVK-DKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENN 287 (346)
Q Consensus 210 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (346)
......... ....++..|+|||.+....++.++||||||+++||+++ |..||......+. ...+ ..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~----~~~ 227 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI-------PDLL----EKG 227 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHH-------HHHH----hCC
Confidence 653332111 12223568999999988899999999999999999999 9999976433221 1111 111
Q ss_pred ccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 045453 288 EFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQ 343 (346)
Q Consensus 288 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 343 (346)
.. ...+..+...+.+++.+||..+|++|||+.++++.|+++.+
T Consensus 228 ~~-------------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 228 ER-------------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CC-------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 00 00011233568899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=314.17 Aligned_cols=262 Identities=20% Similarity=0.307 Sum_probs=213.9
Q ss_pred cCCCcccccccCCCcEEEEEEECC-eEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEec
Q 045453 57 NNFDARNVIKDGYAYKFYKGFVED-RTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFES 134 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~~~-~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~ 134 (346)
+...+.++||+|.||.|.++..++ ..||||+++.... ....+|.+|+..|.++ +|||||+++|+|..++++++|+||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqL-khPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRL-KHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhcc-CCCCeeEEEeeeecCCchHHHHHH
Confidence 344556889999999999999966 9999999997764 4558899999999999 999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCC
Q 045453 135 VKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE 214 (346)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~ 214 (346)
|++|+|.+++..+.. +.+.-..-..|+.|||.|++||. +.++|||||.+.|+|+|.++++||+|||+++.+-.++
T Consensus 617 mEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 617 MENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCC
Confidence 999999999987642 12333455679999999999999 9999999999999999999999999999999877666
Q ss_pred ceee-ccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh--CCCCCCCCCCcccccchhhHHHHHHHHhhcCcccc
Q 045453 215 TCVK-DKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT--GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDE 291 (346)
Q Consensus 215 ~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (346)
.+.. ...+-++.|||||-+..+++|++||||+||+++||+++ ...||....+++. .+-....+..+....
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v-------ven~~~~~~~~~~~~ 764 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV-------VENAGEFFRDQGRQV 764 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH-------HHhhhhhcCCCCcce
Confidence 5443 45567789999999999999999999999999999876 7889976655432 111112222111110
Q ss_pred ccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 045453 292 IVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341 (346)
Q Consensus 292 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 341 (346)
. ...++-++..+.+++++||..+-++|||++++...|.+.
T Consensus 765 ---------~-l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 765 ---------V-LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ---------e-ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 0 111225677899999999999999999999999988764
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=299.45 Aligned_cols=247 Identities=26% Similarity=0.369 Sum_probs=198.5
Q ss_pred cccccCCCcEEEEEEE-C-C---eEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEeccc
Q 045453 63 NVIKDGYAYKFYKGFV-E-D---RTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVK 136 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~-~-~---~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~ 136 (346)
+.||+|++|.||+|.+ . + ..+|+|.+..... .....+.+|+..+.++ +||||+++++++.. ...++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-DHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhc-CCCCccceeEEEcC-CeEEEEEEecC
Confidence 3689999999999988 2 2 3689999876654 4556778888999988 99999999999988 88999999999
Q ss_pred CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCce
Q 045453 137 NRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETC 216 (346)
Q Consensus 137 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 216 (346)
+++|.+++..... ..++|...+.++.|++.||.||| ..+++|+||+|+||+++.++.+||+|||++..+......
T Consensus 79 ~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 79 LGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred CCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 9999999977542 46899999999999999999999 899999999999999999999999999999877543221
Q ss_pred --eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccc
Q 045453 217 --VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIV 293 (346)
Q Consensus 217 --~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (346)
......++..|+|||++.+..++.++||||||+++|+|++ |..||......+. .........
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~----------~~~~~~~~~----- 218 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI----------LKKIDKEGE----- 218 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH----------HHHHHhcCC-----
Confidence 1123456789999999999999999999999999999999 9999965433221 111110000
Q ss_pred ccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 045453 294 DPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLK 339 (346)
Q Consensus 294 d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 339 (346)
... .....+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 219 --~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 219 --RLE------RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred --cCC------CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 000 01133466889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=321.99 Aligned_cols=250 Identities=18% Similarity=0.207 Sum_probs=193.7
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
++|+..+.||+|+||.||+|.. +++.+|+|.+.... ......+.+|+.++..+ +||||+++++.+.+++..++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv 79 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA-DNEWVVKLYYSFQDKDNLYFV 79 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCEEEEE
Confidence 4688899999999999999998 67899999986432 12344566788888888 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+++|+|.+++.... .+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++..+.
T Consensus 80 ~E~~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~ 152 (376)
T cd05598 80 MDYIPGGDMMSLLIRLG----IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 152 (376)
T ss_pred EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccc
Confidence 99999999999997643 5788899999999999999999 8999999999999999999999999999975321
Q ss_pred CC------------------------------------------CceeeccccccCCcCCccccccCCCCcccchHHHHH
Q 045453 212 EG------------------------------------------ETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGM 249 (346)
Q Consensus 212 ~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~ 249 (346)
.. .........||+.|+|||++.+..++.++|||||||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 232 (376)
T cd05598 153 WTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 232 (376)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccc
Confidence 00 000112346899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCC
Q 045453 250 LLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRP 329 (346)
Q Consensus 250 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP 329 (346)
++|||++|+.||......+. ......... .+.. +........+.+++.+|+ .+|.+|+
T Consensus 233 ilyell~G~~Pf~~~~~~~~----------~~~i~~~~~-------~~~~----~~~~~~s~~~~~li~~l~-~~p~~R~ 290 (376)
T cd05598 233 ILYEMLVGQPPFLADTPAET----------QLKVINWET-------TLHI----PSQAKLSREASDLILRLC-CGAEDRL 290 (376)
T ss_pred eeeehhhCCCCCCCCCHHHH----------HHHHhccCc-------cccC----CCCCCCCHHHHHHHHHHh-cCHhhcC
Confidence 99999999999976543221 001000000 0000 000123345677888766 5999999
Q ss_pred ---CHHHHHH
Q 045453 330 ---TTVDVAK 336 (346)
Q Consensus 330 ---s~~ev~~ 336 (346)
|+.|+++
T Consensus 291 ~~~t~~ell~ 300 (376)
T cd05598 291 GKNGADEIKA 300 (376)
T ss_pred CCCCHHHHhC
Confidence 7888764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=301.30 Aligned_cols=266 Identities=18% Similarity=0.270 Sum_probs=206.0
Q ss_pred HhcCCCcccccccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHHHHHHHhhh-cCCCceeeEcceeecCC----cce
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKL-SSHKNVLKLTGCCLETR----IPV 129 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~-~~h~niv~l~g~~~~~~----~~~ 129 (346)
........+.||+|.||.||+|.|.|+.||||.|.. .+...+++|..+.+.. ++|+||+.|++.-..++ .++
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred hhheeEEEEEecCccccceeeccccCCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 345677889999999999999999999999999874 3566788887776654 39999999998865543 579
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCceecCCCCCCeEEcCCCceEEecc
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHI-----GFSRPILHRKIRPSRIFLDEGYIAKLFDF 204 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-----~~~~~iiH~dlkp~NIll~~~~~~kl~Df 204 (346)
||++|-++|||.|+|... +++....++++..+|.||++||. +..+.|.|||||+.|||+.+|+.+.|+|+
T Consensus 286 LvTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred EeeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 999999999999999773 69999999999999999999993 44678999999999999999999999999
Q ss_pred CCCcccCCCCce---eeccccccCCcCCccccccCC------CCcccchHHHHHHHHHHHhC----------CCCCCCCC
Q 045453 205 SLSVSIPEGETC---VKDKVTGTMGFLAPEYINTGD------FNEKCDVFSFGMLLLVLLTG----------QKIFDPSR 265 (346)
Q Consensus 205 gl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~s~G~vl~elltg----------~~p~~~~~ 265 (346)
|||-....+... ..+..+||..|||||++...- .-..+||||||.|+||++.. +.||...-
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 999766544322 235678999999999996431 12459999999999999753 36666554
Q ss_pred CcccccchhhHHHHHHHHhhcCcccccc-ccccccC-CCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 045453 266 GDEIGAGHYWLLHYVKKCIENNEFDEIV-DPIIVSE-GPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQ 343 (346)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-d~~l~~~-~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 343 (346)
+.+... .++.+.+ ..++... .+.-...+....+.+|++.||..+|..|.|+--+.+.|.++.+
T Consensus 441 p~DPs~---------------eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 441 PSDPSF---------------EEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCCH---------------HHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 433210 0111111 1111111 1111223778889999999999999999999999999999874
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=320.82 Aligned_cols=250 Identities=18% Similarity=0.212 Sum_probs=193.1
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
++|...+.||+|+||+||++.. +++.||+|++.... ......+.+|..++..+ +||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-DSPWVVSLYYSFQDAQYLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCeeEEE
Confidence 4688889999999999999988 78899999876432 12234566777888777 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 80 ~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~ 152 (377)
T cd05629 80 MEFLPGGDLMTMLIKY----DTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFH 152 (377)
T ss_pred EeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccc
Confidence 9999999999999764 35889999999999999999999 8999999999999999999999999999986331
Q ss_pred CCCc------------e----------------------------------eeccccccCCcCCccccccCCCCcccchH
Q 045453 212 EGET------------C----------------------------------VKDKVTGTMGFLAPEYINTGDFNEKCDVF 245 (346)
Q Consensus 212 ~~~~------------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~ 245 (346)
.... . ......||+.|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 232 (377)
T cd05629 153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW 232 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeE
Confidence 1000 0 00124689999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCC
Q 045453 246 SFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESA 325 (346)
Q Consensus 246 s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p 325 (346)
||||++|||++|..||......+. ......... .+. .+........+.+++.+|++ +|
T Consensus 233 SlGvil~elltG~~Pf~~~~~~~~----------~~~i~~~~~-------~~~----~p~~~~~s~~~~dli~~lL~-~~ 290 (377)
T cd05629 233 SLGAIMFECLIGWPPFCSENSHET----------YRKIINWRE-------TLY----FPDDIHLSVEAEDLIRRLIT-NA 290 (377)
T ss_pred ecchhhhhhhcCCCCCCCCCHHHH----------HHHHHccCC-------ccC----CCCCCCCCHHHHHHHHHHhc-CH
Confidence 999999999999999975433211 011111000 000 00000233557889999997 67
Q ss_pred CCC---CCHHHHHH
Q 045453 326 EDR---PTTVDVAK 336 (346)
Q Consensus 326 ~~R---Ps~~ev~~ 336 (346)
.+| ||+.|++.
T Consensus 291 ~~r~~r~~~~~~l~ 304 (377)
T cd05629 291 ENRLGRGGAHEIKS 304 (377)
T ss_pred hhcCCCCCHHHHhc
Confidence 765 58888775
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=304.54 Aligned_cols=248 Identities=18% Similarity=0.274 Sum_probs=201.0
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEec
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFES 134 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~ 134 (346)
.+|...+.||+|+||.||+|.. +++.||+|.+..........+.+|+..+..+ +||||+++++++..++..++||||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCEEEEeecc
Confidence 5688889999999999999987 7899999998755444555667777877777 999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCC
Q 045453 135 VKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE 214 (346)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~ 214 (346)
+++++|.+++... .+++..+..++.+++.||.||| +.+++|+||||+|||++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 98 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred cCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 9999999998653 4889999999999999999999 8999999999999999999999999999987654332
Q ss_pred ceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccc
Q 045453 215 TCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVD 294 (346)
Q Consensus 215 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 294 (346)
. ......+++.|+|||.+.+..++.++||||||+++|++++|..||......... ....
T Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~-------------------~~~~- 228 (297)
T cd06656 170 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-------------------YLIA- 228 (297)
T ss_pred c-CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe-------------------eeec-
Confidence 2 123346788999999999988999999999999999999999999654332110 0000
Q ss_pred cccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 295 PIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 295 ~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
..+......+......+.+++.+||+.+|++|||+.++++
T Consensus 229 --~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 229 --TNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred --cCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000011134456889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=303.71 Aligned_cols=248 Identities=20% Similarity=0.267 Sum_probs=195.7
Q ss_pred CCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEeccc
Q 045453 59 FDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVK 136 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~ 136 (346)
|+..+.||+|+||.||+|.+ .+..+++|.+..........+.+|+..+..+ +|||++++++++...+..++|+||++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHC-CCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 44567899999999999999 5678888887654444556677888888888 99999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCce
Q 045453 137 NRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETC 216 (346)
Q Consensus 137 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 216 (346)
+++|..++.... .++++..+..++.|++.||.||| +.+++|+||||+|||++.++.+||+|||++....... .
T Consensus 86 ~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~ 158 (282)
T cd06643 86 GGAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q 158 (282)
T ss_pred CCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccccccc-c
Confidence 999999886533 46899999999999999999999 8999999999999999999999999999987653221 1
Q ss_pred eeccccccCCcCCccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccc
Q 045453 217 VKDKVTGTMGFLAPEYIN-----TGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDE 291 (346)
Q Consensus 217 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (346)
......++..|+|||++. +..++.++|||||||++|+|++|..||......+. +..... ...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~----------~~~~~~-~~~-- 225 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV----------LLKIAK-SEP-- 225 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH----------HHHHhh-cCC--
Confidence 223456889999999984 34578899999999999999999999875432111 111000 000
Q ss_pred ccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 292 IVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 292 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
+.+. .+...+..+.+++..||+.+|++|||+.++++
T Consensus 226 ---~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 226 ---PTLA------QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred ---CCCC------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 01123466889999999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=304.64 Aligned_cols=245 Identities=20% Similarity=0.273 Sum_probs=193.7
Q ss_pred CCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 59 FDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
|...+.||+|+||+||+|.+ +++.+|+|.+..... .....+.+|+..+..+ +|+|++++.+++..++..++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCcCceeEEEEEecCCEEEEEEE
Confidence 56678899999999999999 678999998864321 2233456788888888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
|+++++|.+++..... .++++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 81 IMNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred eccCccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 9999999998865432 36999999999999999999999 899999999999999999999999999998765432
Q ss_pred CceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccc
Q 045453 214 ETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIV 293 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (346)
.. .....|+..|+|||++.+..++.++|+||||+++|+|++|..||........ ... +........
T Consensus 156 ~~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~------~~~-~~~~~~~~~----- 221 (285)
T cd05632 156 ES--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK------REE-VDRRVLETE----- 221 (285)
T ss_pred Cc--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH------HHH-HHHhhhccc-----
Confidence 22 2345689999999999989999999999999999999999999975433211 001 111000000
Q ss_pred ccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHH
Q 045453 294 DPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTV 332 (346)
Q Consensus 294 d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ 332 (346)
. .. .......+.+|+..||+.+|++|||+.
T Consensus 222 -~----~~----~~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 222 -E----VY----SAKFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred -c----cc----CccCCHHHHHHHHHHccCCHhHcCCCc
Confidence 0 00 012345678999999999999999943
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=308.37 Aligned_cols=264 Identities=16% Similarity=0.246 Sum_probs=197.8
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
++|...+.||+|+||+||+|.. ++..+|+|.+..... .....+.+|+..+..+ +||||+++++++...+..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhC-CCCCcceEEEEEeeCCeEEEEEe
Confidence 5688889999999999999988 678899998865432 2334567888888888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
|+++ +|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++......
T Consensus 85 ~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 85 YLDK-DLKQYMDDCG---NIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP 157 (309)
T ss_pred CCCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence 9975 8888886543 35889999999999999999999 899999999999999999999999999998765432
Q ss_pred CceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcC-----
Q 045453 214 ETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENN----- 287 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 287 (346)
.. ......++..|+|||.+.+ ..++.++||||||+++|+|+||+.||......+. ...+.......
T Consensus 158 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-------~~~~~~~~~~~~~~~~ 229 (309)
T cd07872 158 TK-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE-------LHLIFRLLGTPTEETW 229 (309)
T ss_pred cc-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-------HHHHHHHhCCCCHHHH
Confidence 22 1233467889999998865 5689999999999999999999999976543221 00010000000
Q ss_pred -------ccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 288 -------EFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 288 -------~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.....-.+...........+.....+.+++.+||+.||.+|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 230 PGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000000000000000000123456789999999999999999999876
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=312.46 Aligned_cols=201 Identities=17% Similarity=0.229 Sum_probs=170.1
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
++|...+.||+|+||+||++.. +++.+|+|.+.... ......+..|...+..+ +||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQDENNLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEecCCeEEEE
Confidence 4688899999999999999998 67899999986421 12233455666666666 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 80 ~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 153 (331)
T cd05597 80 MDYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLL 153 (331)
T ss_pred EecCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence 99999999999997543 35889999999999999999999 9999999999999999999999999999987665
Q ss_pred CCCceeeccccccCCcCCcccccc-----CCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINT-----GDFNEKCDVFSFGMLLLVLLTGQKIFDPS 264 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~vl~elltg~~p~~~~ 264 (346)
...........||+.|+|||++.. ..++.++|||||||++|+|++|+.||...
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 154 ADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred CCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 443333334568999999999873 45788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=313.25 Aligned_cols=237 Identities=20% Similarity=0.206 Sum_probs=186.8
Q ss_pred cccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccC
Q 045453 63 NVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKN 137 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~ 137 (346)
++||+|+||.||+|.+ ++..+|+|.+.... ......+..|+..+.+..+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999998 67899999986432 122344556665544444999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCcee
Q 045453 138 RTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCV 217 (346)
Q Consensus 138 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 217 (346)
|+|...+... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (321)
T cd05603 81 GELFFHLQRE----RCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ET 152 (321)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cc
Confidence 9999888654 35888899999999999999999 8999999999999999999999999999987532222 12
Q ss_pred eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccccccc
Q 045453 218 KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPII 297 (346)
Q Consensus 218 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 297 (346)
.....||+.|+|||++.+..++.++|||||||++|||++|..||...+.... ...... . .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----------~~~i~~-~--------~~ 213 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM----------YDNILH-K--------PL 213 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH----------HHHHhc-C--------CC
Confidence 3345689999999999988999999999999999999999999975432111 111100 0 00
Q ss_pred ccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHH
Q 045453 298 VSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTV 332 (346)
Q Consensus 298 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ 332 (346)
. .+......+.+++..||+.+|.+||++.
T Consensus 214 ----~--~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 ----Q--LPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred ----C--CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 0 0112345688999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=304.87 Aligned_cols=250 Identities=22% Similarity=0.312 Sum_probs=197.6
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
.|+..+.||+|+||+||++.+ +++.+|+|.+..... .....+..|+..+..+ +|+|++.+++.+.+.+..++||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC-CCCCeeeeeEEEecCCEEEEEE
Confidence 366778999999999999999 778999998764322 1223456788888887 9999999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
||+++++|.+++..... ..+++..+..++.|++.||.||| +.+++|+||||+||++++++.++|+|||++.....
T Consensus 80 e~~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 80 TLMNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 154 (285)
T ss_pred EecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence 99999999999865432 35899999999999999999999 89999999999999999999999999999876543
Q ss_pred CCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccc
Q 045453 213 GETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEI 292 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (346)
... .....|+..|+|||++.+..++.++||||||+++|+|++|..||......... ......... .
T Consensus 155 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~---~~~~~~~~~----~----- 220 (285)
T cd05630 155 GQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLVKE----V----- 220 (285)
T ss_pred Ccc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH---HHHHhhhhh----h-----
Confidence 322 22346899999999999999999999999999999999999999764332110 000000000 0
Q ss_pred cccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 045453 293 VDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPT-----TVDVAK 336 (346)
Q Consensus 293 ~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~ 336 (346)
.. ..+ ......+.+|+..||+.+|++||| +.|+++
T Consensus 221 -~~----~~~----~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 221 -QE----EYS----EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred -hh----hcC----ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 00 000 123445789999999999999999 778775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=306.56 Aligned_cols=256 Identities=20% Similarity=0.344 Sum_probs=199.6
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCe----EEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcc
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDR----TVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIP 128 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~----~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~ 128 (346)
.++|...+.||+|+||.||+|.+ ++. .+|+|.+..... ....++.+|...+..+ +||||++++|+|... ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM-DHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEcCC-Cc
Confidence 35577788999999999999987 443 578888765433 2233567778878887 999999999998754 46
Q ss_pred eEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 129 VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
++++||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|||+++
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHK---DNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred eeeehhcCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccc
Confidence 79999999999999987653 35899999999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCce-eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhc
Q 045453 209 SIPEGETC-VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIEN 286 (346)
Q Consensus 209 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (346)
........ ......++..|+|||++.+..++.++||||||+++||+++ |..||....... ...++ ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-------~~~~~----~~ 226 (303)
T cd05110 158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-------IPDLL----EK 226 (303)
T ss_pred cccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHH----HC
Confidence 66433221 1223345678999999998999999999999999999998 899986542211 11111 11
Q ss_pred CccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 045453 287 NEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQ 343 (346)
Q Consensus 287 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 343 (346)
... . +....+...+.+++..||..+|++||++.++++.|+.+.+
T Consensus 227 ~~~-------~------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 227 GER-------L------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred CCC-------C------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 100 0 0011234568899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=303.13 Aligned_cols=264 Identities=20% Similarity=0.330 Sum_probs=204.4
Q ss_pred cCCCcccccccCCCcEEEEEEEC------CeEEEEEEecCccCc-chHHHHHHHHHHhhhcCCCceeeEcceeec--CCc
Q 045453 57 NNFDARNVIKDGYAYKFYKGFVE------DRTVSVMKFNDILND-GHEDCFNNIIFASKLSSHKNVLKLTGCCLE--TRI 127 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~~------~~~vavk~~~~~~~~-~~~~~~~e~~~~~~~~~h~niv~l~g~~~~--~~~ 127 (346)
..|...+.||+|+||.||+|.+. +..+|+|.+...... ....+.+|+..+..+ +||||+++++++.. ...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l-~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhC-CCCChheEEeeeecCCCCc
Confidence 34666789999999999999873 578999998755443 456778888888888 99999999999877 567
Q ss_pred ceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCC
Q 045453 128 PVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS 207 (346)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~ 207 (346)
.++||||+++++|.+++.... ..+++..+..++.+++.||+||| +.+++|+||||+||+++.++.++|+|||++
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccc
Confidence 899999999999999997654 35999999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCcee--eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccccc-----chhhHHHHH
Q 045453 208 VSIPEGETCV--KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGA-----GHYWLLHYV 280 (346)
Q Consensus 208 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~-----~~~~~~~~~ 280 (346)
.......... .....++..|+|||...+..++.++||||||++++||+||..|+.......... .......+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 8775332211 112334567999999998899999999999999999999999986543322100 000011111
Q ss_pred HHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 045453 281 KKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341 (346)
Q Consensus 281 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 341 (346)
.. ..... ........+..+.+++.+||+.+|++||||.||++.|+.+
T Consensus 237 ~~-~~~~~-------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 237 EL-LKEGE-------------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HH-HHcCC-------------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11 11110 0001113346799999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=300.72 Aligned_cols=247 Identities=23% Similarity=0.335 Sum_probs=200.3
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc-CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL-NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
++|+..+.||.|++|.||+|.+ +++.+++|.+.... ......+.+|+..+..+ +||||+++++++.++...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQC-RSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHc-CCCCeeeeeEEEEECCeEEEEEE
Confidence 3577788999999999999998 77899999986543 23345667788888888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
|+++++|.+++... ++++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||+++.....
T Consensus 80 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 80 YCGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred eeCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 99999999998753 5899999999999999999999 899999999999999999999999999998777543
Q ss_pred CceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccc
Q 045453 214 ETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIV 293 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (346)
.. ......++..|+|||++.+..++.++||||||+++|+|+||..||........ .. . .....
T Consensus 152 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~-------~~---~-~~~~~----- 214 (274)
T cd06609 152 MS-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV-------LF---L-IPKNN----- 214 (274)
T ss_pred cc-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH-------HH---H-hhhcC-----
Confidence 21 22345678899999999998899999999999999999999999975432111 00 0 00000
Q ss_pred ccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 294 DPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 294 d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.+.+ ........+.+++.+||..+|++|||+.++++
T Consensus 215 ~~~~-------~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 215 PPSL-------EGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CCCC-------cccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0111 01013456889999999999999999999965
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=315.72 Aligned_cols=237 Identities=19% Similarity=0.201 Sum_probs=190.9
Q ss_pred cccccCCCcEEEEEEE-----CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecc
Q 045453 63 NVIKDGYAYKFYKGFV-----EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESV 135 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~-----~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~ 135 (346)
+.||+|+||.||++.. .+..+|+|.+..... ........|...+..+ +||||+++++++.+.+..++||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-NHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhC-CCCCcccEEEEEEcCCEEEEEEcCC
Confidence 5799999999999875 568999999875432 2334566788888888 9999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCc
Q 045453 136 KNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGET 215 (346)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~ 215 (346)
++|+|.+++... ..+++..+..++.|++.||+||| +.+++||||||+|||++.++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 153 (318)
T cd05582 81 RGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 153 (318)
T ss_pred CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence 999999999654 35899999999999999999999 89999999999999999999999999999876543321
Q ss_pred eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccccc
Q 045453 216 CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDP 295 (346)
Q Consensus 216 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 295 (346)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. ..... ....
T Consensus 154 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~----------~~~i~-~~~~------ 215 (318)
T cd05582 154 -KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET----------MTMIL-KAKL------ 215 (318)
T ss_pred -ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH----------HHHHH-cCCC------
Confidence 22345689999999999988899999999999999999999999975432111 11110 0000
Q ss_pred ccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 045453 296 IIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVD 333 (346)
Q Consensus 296 ~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e 333 (346)
.. +......+.+++.+||+.+|++|||+.+
T Consensus 216 ----~~----p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 ----GM----PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ----CC----CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 00 0123456889999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=301.76 Aligned_cols=256 Identities=21% Similarity=0.310 Sum_probs=202.5
Q ss_pred cCCCcccccccCCCcEEEEEEE-------CCeEEEEEEecCccCc-chHHHHHHHHHHhhhcCCCceeeEcceeecCCcc
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV-------EDRTVSVMKFNDILND-GHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIP 128 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~-------~~~~vavk~~~~~~~~-~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~ 128 (346)
++|.....||+|+||.||+|.. ....+++|.+...... ....+.+|+..+.++ +||||+++++++.+.+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL-SHKNVVRLLGLCREAEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhc-CCcceeeeEEEECCCCcc
Confidence 5688889999999999999986 2457888887654332 345678888888888 999999999999999999
Q ss_pred eEEEecccCCChhhhhhhcCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEec
Q 045453 129 VIVFESVKNRTLADHIYQNQPH-----FEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFD 203 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~D 203 (346)
++||||+++|+|.+++...... ...+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEcc
Confidence 9999999999999999765421 126899999999999999999999 89999999999999999999999999
Q ss_pred cCCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHH
Q 045453 204 FSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKK 282 (346)
Q Consensus 204 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (346)
||++...............++..|+|||.+.+..++.++||||||++++++++ |..||....... . +..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~-------~---~~~ 230 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-------V---LNR 230 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH-------H---HHH
Confidence 99987554333323334456778999999988889999999999999999999 788886432211 1 111
Q ss_pred HhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 045453 283 CIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLK 339 (346)
Q Consensus 283 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 339 (346)
. ...... .. .....+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus 231 ~-~~~~~~--------~~----~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 231 L-QAGKLE--------LP----VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred H-HcCCcC--------CC----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1 111100 00 00133457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=295.48 Aligned_cols=246 Identities=22% Similarity=0.366 Sum_probs=197.0
Q ss_pred cccccCCCcEEEEEEE-CCeEEEEEEecCccCc-chHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccCCCh
Q 045453 63 NVIKDGYAYKFYKGFV-EDRTVSVMKFNDILND-GHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTL 140 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~-~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 140 (346)
++||+|+||.||++.+ .++.|++|........ ....+.+|+..+..+ +||||+++++++.+.+..++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-DHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 4699999999999998 5899999987654433 455677888888888 999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCceee-c
Q 045453 141 ADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVK-D 219 (346)
Q Consensus 141 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~-~ 219 (346)
.+++.... ..+++..+..++.+++.||+||| +.+++||||+|+||+++.++.+||+|||++........... .
T Consensus 80 ~~~l~~~~---~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 80 LTFLRKKK---NRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 99997643 35889999999999999999999 89999999999999999999999999999876543222111 1
Q ss_pred cccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccccccc
Q 045453 220 KVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIV 298 (346)
Q Consensus 220 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 298 (346)
....+..|+|||.+.++.++.++||||||+++|+|+| |..||........ ...+ ....
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~-------~~~~----~~~~---------- 212 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT-------RERI----ESGY---------- 212 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH-------HHHH----hcCC----------
Confidence 2234567999999998899999999999999999999 8888865432111 1111 0000
Q ss_pred cCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 045453 299 SEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLK 339 (346)
Q Consensus 299 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 339 (346)
....+...+..+.+++.+||+.+|++|||+.||++.|+
T Consensus 213 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 213 ---RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ---CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 00001134457899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=301.97 Aligned_cols=252 Identities=21% Similarity=0.314 Sum_probs=196.5
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
++|+..+.||+|+||.||+|.+ ++..||+|++..... ....+...|+..+.+..+||||+++++++...+..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 4688889999999999999998 689999998865432 3345566677766666699999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSR-PILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
|++ |+|.+++.........+++..++.++.|++.||+||| +. +++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 5898888654333357999999999999999999999 66 999999999999999999999999999876543
Q ss_pred CCceeeccccccCCcCCcccccc----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCc
Q 045453 213 GETCVKDKVTGTMGFLAPEYINT----GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE 288 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (346)
.. ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||........ .+ .......
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-----~~----~~~~~~~- 224 (283)
T cd06617 157 SV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ-----QL----KQVVEEP- 224 (283)
T ss_pred cc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH-----HH----HHHHhcC-
Confidence 21 1233467889999998864 4568899999999999999999999964322110 01 0100000
Q ss_pred cccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 289 FDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 289 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.+.+ .....+..+.+++..||+.+|++|||+.++++
T Consensus 225 -----~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 225 -----SPQL-------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -----CCCC-------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0011 11134567899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=305.06 Aligned_cols=248 Identities=19% Similarity=0.300 Sum_probs=201.0
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEec
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFES 134 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~ 134 (346)
.+|+..+.||.|++|.||+|.. +++.|++|.+..........+.+|...+..+ +||||+++++++...+..++|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKEL-KNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhc-CCCceeeeeeeEecCceEEEEEEe
Confidence 4578888999999999999987 7899999998765445556677788888887 999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCC
Q 045453 135 VKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE 214 (346)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~ 214 (346)
+++++|.+++... .+++.++..++.+++.||+||| +.+++|+||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 98 LAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred cCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 9999999988653 4899999999999999999999 8999999999999999999999999999987654332
Q ss_pred ceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccc
Q 045453 215 TCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVD 294 (346)
Q Consensus 215 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 294 (346)
. ......++..|+|||.+.+..++.++|||||||++|++++|..||........ . ..... ....
T Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~------~----~~~~~-~~~~---- 233 (296)
T cd06655 170 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------L----YLIAT-NGTP---- 233 (296)
T ss_pred c-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------H----HHHHh-cCCc----
Confidence 2 12334688899999999988899999999999999999999999975433111 0 00000 0000
Q ss_pred cccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 295 PIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 295 ~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.+. ........+.+++.+||+.+|++|||+.++++
T Consensus 234 -~~~------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 234 -ELQ------NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred -ccC------CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000 01133456889999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=310.18 Aligned_cols=269 Identities=19% Similarity=0.252 Sum_probs=195.8
Q ss_pred HhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecCC----
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETR---- 126 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~---- 126 (346)
..++|...+.||+|+||.||++.. .+..+|+|++.... ......+.+|+..+..+ +||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV-NHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCCccc
Confidence 347899999999999999999988 68899999986432 23345677888888888 9999999999986543
Q ss_pred --cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEecc
Q 045453 127 --IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDF 204 (346)
Q Consensus 127 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Df 204 (346)
..++||||+++ +|.+.+.. .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Df 167 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDF 167 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecC
Confidence 46999999975 67666642 4788899999999999999999 899999999999999999999999999
Q ss_pred CCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccc--------cch---
Q 045453 205 SLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIG--------AGH--- 273 (346)
Q Consensus 205 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~--------~~~--- 273 (346)
|+++...... ......+|..|+|||.+.+..++.++|||||||++|+|++|+.||...+..... ...
T Consensus 168 g~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 245 (359)
T cd07876 168 GLARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF 245 (359)
T ss_pred CCccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence 9987543222 123456889999999999999999999999999999999999999865432110 000
Q ss_pred -hhHHHHHHHHhhcC-cccccc-cccc---ccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 274 -YWLLHYVKKCIENN-EFDEIV-DPII---VSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 274 -~~~~~~~~~~~~~~-~~~~~~-d~~l---~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
..+...+....... ...... .... ...............+.+|+.+||+.||++|||+.|++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 00001111111100 000000 0000 000000000022456889999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=300.52 Aligned_cols=251 Identities=22% Similarity=0.303 Sum_probs=197.0
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEec
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFES 134 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~ 134 (346)
++|...+.||+|+||.||+|.. ++..+|+|.+..........+.+|+..+..+ +||||+++++++...+..++||||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l-~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDC-KHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEEEEEec
Confidence 4667778899999999999998 6789999988655434445566777777777 999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCC
Q 045453 135 VKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE 214 (346)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~ 214 (346)
+++++|.+++.... .+++.+++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 88 CGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 99999999986543 5899999999999999999999 8899999999999999999999999999987654321
Q ss_pred ceeeccccccCCcCCccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccc
Q 045453 215 TCVKDKVTGTMGFLAPEYIN---TGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDE 291 (346)
Q Consensus 215 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (346)
.......|+..|+|||++. ...++.++|||||||++|+|++|..||........ .... .....
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~------~~~~-----~~~~~-- 226 (267)
T cd06645 161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA------LFLM-----TKSNF-- 226 (267)
T ss_pred -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh------HHhh-----hccCC--
Confidence 1223456889999999874 45688999999999999999999999864332111 0000 00000
Q ss_pred ccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 292 IVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 292 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
..+.... ....+..+.+++.+||+.+|++|||+.++++
T Consensus 227 -~~~~~~~------~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 227 -QPPKLKD------KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred -CCCcccc------cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0000000 0023356889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=298.54 Aligned_cols=247 Identities=22% Similarity=0.353 Sum_probs=198.3
Q ss_pred cCCCcccccccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEeccc
Q 045453 57 NNFDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVK 136 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~ 136 (346)
++|...+.||+|+||.||++...+..+|+|...... ....+.+|+..+..+ +|||++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV--TAQAFLEETAVMTKL-HHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEecccCCCceEEEeecCcc--hHHHHHHHHHHHHhC-CCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 457788999999999999999999999999986432 345677888888887 999999999998664 5799999999
Q ss_pred CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCce
Q 045453 137 NRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETC 216 (346)
Q Consensus 137 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 216 (346)
+++|.+++..... ..+++..++.++.|++.||.||| +.+++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-- 154 (254)
T cd05083 82 KGNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-- 154 (254)
T ss_pred CCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccC--
Confidence 9999999976532 45899999999999999999999 8999999999999999999999999999986543221
Q ss_pred eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccccc
Q 045453 217 VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDP 295 (346)
Q Consensus 217 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 295 (346)
.....+..|+|||.+.++.++.++||||||+++|+|++ |..||......+. .. ....+... +
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~----------~~-~~~~~~~~---~- 217 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV----------KE-CVEKGYRM---E- 217 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH----------HH-HHhCCCCC---C-
Confidence 12234567999999998899999999999999999998 9999875432211 11 11111000 0
Q ss_pred ccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 045453 296 IIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQ 340 (346)
Q Consensus 296 ~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 340 (346)
.....+..+.+++.+||+.+|++|||+.++++.|++
T Consensus 218 ---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 ---------PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ---------CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 011344668899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=297.54 Aligned_cols=247 Identities=23% Similarity=0.312 Sum_probs=200.7
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc-CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL-NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
..|+..+.||.|+||.||+|.+ .+..+|+|.+.... ......+.+|+..+..+ +||||+++++++.++...++|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCEEEEEEe
Confidence 3466778899999999999988 67899999876433 23445677788888888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
|+++++|.+++... ++++.....++.+++.||+||| +.+++|+||+|+||+++.++.++++|||++......
T Consensus 83 ~~~~~~L~~~i~~~-----~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06640 83 YLGGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred cCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence 99999999998642 4888999999999999999999 899999999999999999999999999998766433
Q ss_pred CceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccc
Q 045453 214 ETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIV 293 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (346)
.. ......++..|+|||++.+..++.++||||||+++|||+||..||........ ... ....
T Consensus 155 ~~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~----------~~~-~~~~------ 216 (277)
T cd06640 155 QI-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV----------LFL-IPKN------ 216 (277)
T ss_pred cc-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH----------hhh-hhcC------
Confidence 32 22334678899999999988899999999999999999999999975433221 000 0000
Q ss_pred ccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045453 294 DPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKR 337 (346)
Q Consensus 294 d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 337 (346)
..+ ......+..+.+++..||+.+|++||++.+++..
T Consensus 217 ------~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 217 ------NPP-TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred ------CCC-CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 001 1112456778999999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=300.23 Aligned_cols=249 Identities=23% Similarity=0.372 Sum_probs=195.5
Q ss_pred cccccCCCcEEEEEEECC--------eEEEEEEecCcc-CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 63 NVIKDGYAYKFYKGFVED--------RTVSVMKFNDIL-NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~~~--------~~vavk~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
+.||+|+||.||+|.+.+ ..+++|.+.... ......+.+|+..+..+ +||||++++++|...+..++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhc-CCCCeeeEeeeecCCCCeEEEEe
Confidence 469999999999998732 578888875443 23456677888888888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCC-----ceEEeccC
Q 045453 134 SVKNRTLADHIYQNQP---HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGY-----IAKLFDFS 205 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~-----~~kl~Dfg 205 (346)
|+++++|.+++..... ....+++..++.++.+++.||.||| +.+++|+||||+||+++.++ .++++|||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 9999999999975321 1235889999999999999999999 89999999999999999887 89999999
Q ss_pred CCcccCCCCcee-eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHH
Q 045453 206 LSVSIPEGETCV-KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKC 283 (346)
Q Consensus 206 l~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 283 (346)
++.......... .....++..|+|||++.++.++.++||||||+++|||+| |..||......+ ....+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~-------~~~~~--- 226 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE-------VLQHV--- 226 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH-------HHHHH---
Confidence 987654332211 123345678999999999999999999999999999998 999986433211 11111
Q ss_pred hhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 045453 284 IENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLK 339 (346)
Q Consensus 284 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 339 (346)
..+. .. ......+..+.+++.+||+.+|++|||+.+|++.|+
T Consensus 227 -~~~~-------~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 227 -TAGG-------RL------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred -hcCC-------cc------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0000 00 001134567889999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=311.16 Aligned_cols=254 Identities=17% Similarity=0.216 Sum_probs=192.2
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--Cc-chHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--ND-GHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~-~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
++|...+.||+|+||.||++.+ .+..+|+|.+.... .. ....+..|...+..+ +|+||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAFQDENNLYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCEEEEE
Confidence 4688889999999999999998 56789999876421 11 222344555556665 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 80 ~ey~~~g~L~~~l~~~~---~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~ 153 (332)
T cd05623 80 MDYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 153 (332)
T ss_pred EeccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecc
Confidence 99999999999997643 35899999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCceeeccccccCCcCCccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhc
Q 045453 212 EGETCVKDKVTGTMGFLAPEYIN-----TGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIEN 286 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (346)
...........||+.|+|||++. ...++.++|||||||++|||++|+.||......+. .......
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~----------~~~i~~~ 223 (332)
T cd05623 154 EDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET----------YGKIMNH 223 (332)
T ss_pred cCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH----------HHHHhCC
Confidence 43333334457999999999986 34688999999999999999999999975432111 1111111
Q ss_pred CccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 045453 287 NEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAED--RPTTVDVAKR 337 (346)
Q Consensus 287 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~ev~~~ 337 (346)
.. .. ..+.. .......+.+++.+|+..+++. ||++.|+++.
T Consensus 224 ~~-------~~--~~p~~-~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 224 KE-------RF--QFPAQ-VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred Cc-------cc--cCCCc-cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00 00 00000 0133456788888888654443 6888888653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=296.25 Aligned_cols=253 Identities=23% Similarity=0.302 Sum_probs=203.6
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
.++|...+.||.|+||.||+|.. ++..+++|.+..........+.+|+..+..+ +||||+++++++......+++||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKEC-RHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhC-CCCChhceEEEEEeCCEEEEEEe
Confidence 35788889999999999999998 6788999998765545567778888888888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
|+++++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 81 YCGGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred CCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence 999999999987653 35889999999999999999999 899999999999999999999999999998765432
Q ss_pred CceeeccccccCCcCCccccccC---CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 214 ETCVKDKVTGTMGFLAPEYINTG---DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
.. ......++..|+|||.+.+. .++.++||||||+++|+|+||..||........ ... . ....+.
T Consensus 155 ~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~------~~~----~-~~~~~~ 222 (262)
T cd06613 155 IA-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA------LFL----I-SKSNFP 222 (262)
T ss_pred hh-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH------HHH----H-HhccCC
Confidence 21 12345678899999999876 889999999999999999999999975432111 000 0 000000
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
...+ ......+..+.+++.+||+.+|.+|||+.+|+.
T Consensus 223 ---~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 223 ---PPKL------KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ---Cccc------cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000 011244567899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=311.41 Aligned_cols=253 Identities=17% Similarity=0.218 Sum_probs=192.2
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--Cc-chHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--ND-GHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~-~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
++|...+.||+|+||.||++.. +++.+|+|.+.... .. ....+..|...+..+ +|+||+++++++.+.+..++|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG-DCQWITTLHYAFQDENYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEE
Confidence 4688899999999999999998 67889999886421 11 222344455555555 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 80 ~Ey~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 153 (331)
T cd05624 80 MDYYVGGDLLTLLSKFE---DRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMN 153 (331)
T ss_pred EeCCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeecc
Confidence 99999999999997643 35889999999999999999999 9999999999999999999999999999997765
Q ss_pred CCCceeeccccccCCcCCcccccc-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhc
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINT-----GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIEN 286 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (346)
...........||+.|+|||++.+ +.++.++||||||+++|+|++|+.||......+. .......
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~----------~~~i~~~ 223 (331)
T cd05624 154 QDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET----------YGKIMNH 223 (331)
T ss_pred CCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH----------HHHHHcC
Confidence 444333344579999999999875 4678999999999999999999999975432111 1111110
Q ss_pred CccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 045453 287 NEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAED--RPTTVDVAK 336 (346)
Q Consensus 287 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~ev~~ 336 (346)
.. .+ ..+. .....+..+.+++.+|+..++.+ |+++.++++
T Consensus 224 ~~-------~~--~~p~-~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 224 EE-------RF--QFPS-HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred CC-------cc--cCCC-ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 00 00 0000 00123456888999998865544 457777754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=303.40 Aligned_cols=263 Identities=21% Similarity=0.276 Sum_probs=205.1
Q ss_pred CCHHHHHHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeec
Q 045453 47 FTIRELEIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLE 124 (346)
Q Consensus 47 ~~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~ 124 (346)
++++++..++++|...+.||+|+||.||++.. ++..+|+|.+.... .....+..|+..+.++.+|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 66677888899999999999999999999998 67889999876432 2234566778888877689999999999875
Q ss_pred C-----CcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCce
Q 045453 125 T-----RIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIA 199 (346)
Q Consensus 125 ~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~ 199 (346)
. +..++||||+++++|.+++.........+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCE
Confidence 3 3579999999999999988653322356899999999999999999999 8999999999999999999999
Q ss_pred EEeccCCCcccCCCCceeeccccccCCcCCccccccC-----CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchh
Q 045453 200 KLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTG-----DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHY 274 (346)
Q Consensus 200 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~ 274 (346)
||+|||++........ ......++..|+|||++... .++.++||||||+++|||++|+.||........
T Consensus 168 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~----- 241 (291)
T cd06639 168 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT----- 241 (291)
T ss_pred EEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-----
Confidence 9999999876543222 12334678899999998643 368999999999999999999999975432111
Q ss_pred hHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 275 WLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
+. .... .......+ .......+.+++.+||+.+|++|||+.|+++
T Consensus 242 -~~----~~~~-~~~~~~~~-----------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 242 -LF----KIPR-NPPPTLLH-----------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred -HH----HHhc-CCCCCCCc-----------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11 1000 10000000 1133456899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=301.37 Aligned_cols=250 Identities=20% Similarity=0.248 Sum_probs=198.1
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEec
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFES 134 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~ 134 (346)
+.|...+.||+|+||.||+|.. .+..+++|.+..........+..|+..+..+ +||||+++++++...+..++||||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATC-NHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCcEeeeEEEEEeCCeEEEEEec
Confidence 5577888999999999999998 5789999998765545556677888888888 999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCC
Q 045453 135 VKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE 214 (346)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~ 214 (346)
+++++|..++.... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++.......
T Consensus 91 ~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 91 CPGGAVDAIMLELD---RGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred CCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence 99999988876543 35899999999999999999999 8999999999999999999999999999886543221
Q ss_pred ceeeccccccCCcCCccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcc
Q 045453 215 TCVKDKVTGTMGFLAPEYIN-----TGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEF 289 (346)
Q Consensus 215 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (346)
.......++..|+|||++. ...++.++||||||+++|||++|..||....... ....... ...
T Consensus 165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----------~~~~~~~-~~~ 232 (292)
T cd06644 165 -QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR----------VLLKIAK-SEP 232 (292)
T ss_pred -cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH----------HHHHHhc-CCC
Confidence 1123445788999999985 3457889999999999999999999986533211 0111110 000
Q ss_pred ccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 290 DEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 290 ~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
+... ........+.+++.+||+.+|++||++.++++
T Consensus 233 -----~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 233 -----PTLS------QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred -----ccCC------CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000 01133456889999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=297.82 Aligned_cols=252 Identities=21% Similarity=0.286 Sum_probs=187.2
Q ss_pred ccccCCCcEEEEEEE-CC---eEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccCC
Q 045453 64 VIKDGYAYKFYKGFV-ED---RTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNR 138 (346)
Q Consensus 64 ~ig~G~~g~Vy~~~~-~~---~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~g 138 (346)
.||+|+||.||+|.. .+ ..+++|.+..... .....+.+|+..+..+ +||||++++++|.+....++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRIL-QHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhcc-CCcchhheEEEecCCCccEEEEecCCCC
Confidence 599999999999986 33 2455666554332 3445677787777777 9999999999999999999999999999
Q ss_pred ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCC-cee
Q 045453 139 TLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE-TCV 217 (346)
Q Consensus 139 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~-~~~ 217 (346)
+|.+++..........++..+..++.|++.||+||| +.+++|+||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 999999865433345677888999999999999999 8999999999999999999999999999875432221 112
Q ss_pred eccccccCCcCCcccccc-------CCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCcc
Q 045453 218 KDKVTGTMGFLAPEYINT-------GDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEF 289 (346)
Q Consensus 218 ~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (346)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||......+ ........ ..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~----------~~~~~~~~-~~ 226 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE----------VLNHVIKD-QQ 226 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH----------HHHHHHhh-cc
Confidence 234567889999998753 245789999999999999997 566775433211 11111111 11
Q ss_pred ccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 045453 290 DEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLK 339 (346)
Q Consensus 290 ~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 339 (346)
....++.+.. .....+.+++..|| .+|++|||+.+|++.|.
T Consensus 227 ~~~~~~~~~~--------~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 227 VKLFKPQLEL--------PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cccCCCccCC--------CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1122222211 23355778999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=302.44 Aligned_cols=258 Identities=19% Similarity=0.305 Sum_probs=202.7
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
++|+..+.||+|+||+||++.+ ++..+|+|....... .....+.+|+..+..+ +||||+++++++...+..++|||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHEC-RSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHc-CCCCcceEeeeEecCCEEEEEEe
Confidence 4567778999999999999998 578899998765432 3345677888888888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
|+++++|.+++... .++++.....++.+++.||.|||+ ..+++|+||+|+||++++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 84 FMDCGSLDRIYKKG----GPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred cCCCCCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 99999999988764 358999999999999999999993 368999999999999999999999999998654322
Q ss_pred CceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccccc-chhhHHHHHHHHhhcCccccc
Q 045453 214 ETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGA-GHYWLLHYVKKCIENNEFDEI 292 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 292 (346)
. .....++..|+|||++.+..++.++|||||||++|+++||..||.......... ...............
T Consensus 158 ~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 228 (284)
T cd06620 158 I---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE------ 228 (284)
T ss_pred c---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc------
Confidence 1 234568899999999988899999999999999999999999998654432110 001111222221111
Q ss_pred cccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045453 293 VDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKR 337 (346)
Q Consensus 293 ~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 337 (346)
..+.......+..+.+++.+||+.+|++|||+.|+++.
T Consensus 229 -------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 229 -------PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred -------cCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 01111111345678899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=302.60 Aligned_cols=238 Identities=21% Similarity=0.334 Sum_probs=185.4
Q ss_pred ccccCCCcEEEEEEEC--C-------eEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEec
Q 045453 64 VIKDGYAYKFYKGFVE--D-------RTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFES 134 (346)
Q Consensus 64 ~ig~G~~g~Vy~~~~~--~-------~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~ 134 (346)
.||+|+||+||+|... + ..+++|.+..........+..|...+..+ +|||++++++++..++..++||||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQL-SHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhC-CCCChhheeeEEEeCCCcEEEEec
Confidence 6999999999999872 2 24777776544334445667777777777 999999999999998999999999
Q ss_pred ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCc--------eEEeccCC
Q 045453 135 VKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYI--------AKLFDFSL 206 (346)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~--------~kl~Dfgl 206 (346)
+++|+|.+++.... ..+++..++.++.|++.||.||| +.+++||||||+|||++.++. ++++|||+
T Consensus 81 ~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 99999999997654 35899999999999999999999 899999999999999987765 59999998
Q ss_pred CcccCCCCceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCC-CCCCCCCCcccccchhhHHHHHHHHh
Q 045453 207 SVSIPEGETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQ-KIFDPSRGDEIGAGHYWLLHYVKKCI 284 (346)
Q Consensus 207 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (346)
+..... .....++..|+|||++.+ ..++.++||||||+++|+|++|. .|+........ .. ..
T Consensus 155 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-------~~----~~ 218 (258)
T cd05078 155 SITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-------LQ----FY 218 (258)
T ss_pred ccccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-------HH----HH
Confidence 765432 223467889999999987 45899999999999999999985 55543221110 00 00
Q ss_pred hcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 045453 285 ENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLK 339 (346)
Q Consensus 285 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 339 (346)
... ..+ + ......+.+++..||+.+|++|||+.++++.|+
T Consensus 219 ~~~-------~~~----~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 219 EDR-------HQL----P----APKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred Hcc-------ccC----C----CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 000 0 022356889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=294.90 Aligned_cols=249 Identities=24% Similarity=0.308 Sum_probs=202.9
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
+|+..+.||.|+||.||.+.. ++..+++|.+.... .....++.+|+..+..+ +|+||+++++++.+.+..++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL-QHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhC-CCCCeeEEEeEEecCCeEEEEEE
Confidence 477889999999999988887 78899999876442 34456678888888888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
|+++++|.+++.... ...+++..+..++.+++.||+||| +.+++|+||+|+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 80 YANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred ecCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 999999999997653 246899999999999999999999 889999999999999999999999999998766443
Q ss_pred CceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccc
Q 045453 214 ETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIV 293 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (346)
.. ......++..|+|||+..+..++.++||||||+++|+|++|..||......+ .+.... .+....
T Consensus 155 ~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~----------~~~~~~-~~~~~~-- 220 (256)
T cd08221 155 YS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN----------LVVKIV-QGNYTP-- 220 (256)
T ss_pred cc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH----------HHHHHH-cCCCCC--
Confidence 32 2334568899999999998889999999999999999999999996533211 111111 111100
Q ss_pred ccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045453 294 DPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKR 337 (346)
Q Consensus 294 d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 337 (346)
........+.+++.+||+.+|++|||+.++++.
T Consensus 221 -----------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 221 -----------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred -----------CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 011345668899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=300.48 Aligned_cols=260 Identities=21% Similarity=0.298 Sum_probs=203.8
Q ss_pred CCHHHHHHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeec
Q 045453 47 FTIRELEIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLE 124 (346)
Q Consensus 47 ~~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~ 124 (346)
.++.++..+.+.|+....||.|+||.||+|.+ .++.+|+|...... ....++..|+..+..+.+||||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 45667777889999999999999999999999 67899999875432 3345677788888888689999999999853
Q ss_pred ------CCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCc
Q 045453 125 ------TRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYI 198 (346)
Q Consensus 125 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~ 198 (346)
.+..++||||+++|+|.+++..... ..+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAE 159 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCC
Confidence 4577999999999999999976432 35788889999999999999999 899999999999999999999
Q ss_pred eEEeccCCCcccCCCCceeeccccccCCcCCccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccch
Q 045453 199 AKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYIN-----TGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGH 273 (346)
Q Consensus 199 ~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~ 273 (346)
++|+|||++........ ......++..|+|||.+. +..++.++||||||+++|||++|..||........
T Consensus 160 ~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~---- 234 (282)
T cd06636 160 VKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA---- 234 (282)
T ss_pred EEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh----
Confidence 99999999876532211 123456888999999886 34688899999999999999999999965432111
Q ss_pred hhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 274 YWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
. ... ... ..+.+ .....+..+.+++.+||+.+|.+|||+.|+++
T Consensus 235 --~----~~~-~~~-----~~~~~-------~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 235 --L----FLI-PRN-----PPPKL-------KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred --h----hhH-hhC-----CCCCC-------cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 000 000 00000 11134567999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=289.24 Aligned_cols=250 Identities=19% Similarity=0.312 Sum_probs=205.9
Q ss_pred HhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCc--------chHHHHHHHHHHhhhcCCCceeeEcceeec
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILND--------GHEDCFNNIIFASKLSSHKNVLKLTGCCLE 124 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~--------~~~~~~~e~~~~~~~~~h~niv~l~g~~~~ 124 (346)
..+.|....+||+|..++|-++.. .++..|+|++...... -.+...+|+.++.++..||||+++.+++.+
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 346678889999999999999888 7889999987643321 123456788999999999999999999999
Q ss_pred CCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEecc
Q 045453 125 TRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDF 204 (346)
Q Consensus 125 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Df 204 (346)
....++|+|.|+.|.|.|+|... ..+++.....|+.|+..|++||| ..+|+||||||+|||+|+|.++||+||
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~----VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSK----VTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhh----eeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEecc
Confidence 99999999999999999999875 46999999999999999999999 999999999999999999999999999
Q ss_pred CCCcccCCCCceeeccccccCCcCCcccccc------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHH
Q 045453 205 SLSVSIPEGETCVKDKVTGTMGFLAPEYINT------GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLH 278 (346)
Q Consensus 205 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 278 (346)
|+++.+..++. -...+||++|.|||.+.. .+|+..+|.|++||+||.++.|.+||..... +.-
T Consensus 168 GFa~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ---------mlM 236 (411)
T KOG0599|consen 168 GFACQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ---------MLM 236 (411)
T ss_pred ceeeccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH---------HHH
Confidence 99998876654 456799999999998853 3688899999999999999999999953211 110
Q ss_pred HHHHHhhcCccccccccccccCCCCcc--hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 279 YVKKCIENNEFDEIVDPIIVSEGPRVG--KEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 279 ~~~~~~~~~~~~~~~d~~l~~~~~~~~--~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
-..+..+ .+...+ =.+.+....+|+.+||+.||.+|.|++|++.
T Consensus 237 --LR~ImeG------------kyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 237 --LRMIMEG------------KYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred --HHHHHhc------------ccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 0111122 222111 1255678999999999999999999999874
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=310.48 Aligned_cols=192 Identities=18% Similarity=0.299 Sum_probs=163.6
Q ss_pred HHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 54 IATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 54 ~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
....+|...+.||+|+||.||+|.. .+..||+|..... ....|..++..+ +||||+++++++...+..++|
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNV-NHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhC-CCCCCcChhheEEeCCeeEEE
Confidence 3456799999999999999999999 5678888874322 234577788888 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
+||+. ++|.+++.... .++++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 136 ~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred EEccC-CcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 99995 58998887643 46899999999999999999999 8999999999999999999999999999987543
Q ss_pred CCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCC
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIF 261 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~ 261 (346)
... ......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 209 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 209 VAP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cCc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 221 123456899999999999999999999999999999999965554
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=297.39 Aligned_cols=252 Identities=21% Similarity=0.307 Sum_probs=187.3
Q ss_pred ccccCCCcEEEEEEE----CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccCC
Q 045453 64 VIKDGYAYKFYKGFV----EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNR 138 (346)
Q Consensus 64 ~ig~G~~g~Vy~~~~----~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~g 138 (346)
.||+|+||.||+|.. ....+++|.+..... .....+.+|+..+..+ +||||+++++.|.+....++||||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYREL-NHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhC-CCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 589999999999976 235778887654332 2334567787777777 9999999999999999999999999999
Q ss_pred ChhhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCcee
Q 045453 139 TLADHIYQNQPH-FEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCV 217 (346)
Q Consensus 139 sL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 217 (346)
+|.+++...... ....++.....++.|++.||+||| +.+++||||||+|||++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999999765422 233568888999999999999999 8999999999999999999999999999986543322211
Q ss_pred -eccccccCCcCCcccccc-------CCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCc
Q 045453 218 -KDKVTGTMGFLAPEYINT-------GDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE 288 (346)
Q Consensus 218 -~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (346)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||......+. .........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~----------~~~~~~~~~ 227 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV----------LKQVVREQD 227 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH----------HHHHhhccC
Confidence 223345678999998743 356889999999999999999 7888865432111 111111111
Q ss_pred cccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 045453 289 FDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLK 339 (346)
Q Consensus 289 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 339 (346)
.....+.+. ......+.+++..|| .+|++|||+.+|++.|.
T Consensus 228 -~~~~~~~~~--------~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 228 -IKLPKPQLD--------LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred -ccCCCCccc--------ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111111111 133455677889999 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=301.70 Aligned_cols=198 Identities=22% Similarity=0.288 Sum_probs=161.1
Q ss_pred ccccccCCCcEEEEEEE----CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeec--CCcceEEEecc
Q 045453 62 RNVIKDGYAYKFYKGFV----EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLE--TRIPVIVFESV 135 (346)
Q Consensus 62 ~~~ig~G~~g~Vy~~~~----~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~--~~~~~lv~e~~ 135 (346)
.++||+|+||+||+|.. .+..+|+|.+.... ......+|+..+..+ +||||+++++++.. ....++||||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhc-CCCCCcceeeeEecCCCcEEEEEEecc
Confidence 46899999999999986 45789999876432 234567888888888 99999999998854 45678999999
Q ss_pred cCCChhhhhhhcCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEE----cCCCceEEeccCC
Q 045453 136 KNRTLADHIYQNQP-----HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFL----DEGYIAKLFDFSL 206 (346)
Q Consensus 136 ~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll----~~~~~~kl~Dfgl 206 (346)
.+ +|.+++..... ....+++..+..++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 65 88888754321 1235889999999999999999999 8999999999999999 4667999999999
Q ss_pred CcccCCCCc--eeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Q 045453 207 SVSIPEGET--CVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRG 266 (346)
Q Consensus 207 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~ 266 (346)
++....... .......+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||.....
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~ 221 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcc
Confidence 987643321 11234578999999999976 4589999999999999999999999976544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=294.62 Aligned_cols=250 Identities=28% Similarity=0.466 Sum_probs=201.0
Q ss_pred CCcccccccCCCcEEEEEEECC------eEEEEEEecCccCc-chHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 59 FDARNVIKDGYAYKFYKGFVED------RTVSVMKFNDILND-GHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~~~~------~~vavk~~~~~~~~-~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
|+..+.||.|+||.||++.+.+ ..+|+|.+...... ....+..|+..+..+ +||||+++++++.+.+..+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKL-DHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCCeeEEE
Confidence 3456889999999999999943 78999998765433 556778888888888 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+++++|.+++..... ..+++..+..++.|++.||+||| +.+++|+||||+||++++++.++|+|||++....
T Consensus 80 ~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred EeccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceecc
Confidence 999999999999976532 12899999999999999999999 8999999999999999999999999999998776
Q ss_pred CCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
...........++..|+|||.+.+..++.++||||+|+++++|++ |..||....... ....+ ......
T Consensus 155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~-------~~~~~----~~~~~~ 223 (258)
T smart00219 155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE-------VLEYL----KKGYRL 223 (258)
T ss_pred cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHH----hcCCCC
Confidence 543322222346789999999988889999999999999999999 888886532211 11111 111100
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRL 338 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 338 (346)
. .....+..+.+++.+||+.+|++|||+.|+++.|
T Consensus 224 ---------~----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 ---------P----KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---------C----CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0 0112456688999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=295.54 Aligned_cols=237 Identities=22% Similarity=0.368 Sum_probs=187.7
Q ss_pred cccccCCCcEEEEEEECCe------------EEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceE
Q 045453 63 NVIKDGYAYKFYKGFVEDR------------TVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVI 130 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~~~~------------~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~l 130 (346)
+.||+|+||.||+|.+.+. .+++|.+...... ...+.+|+..+..+ +||||+++++++.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQL-SHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcC-CCcchhheeeEEec-CCcEE
Confidence 3689999999999999322 4777776544322 56677788888887 99999999999988 77899
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCC-------ceEEec
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGY-------IAKLFD 203 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~-------~~kl~D 203 (346)
||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+++|+||||+|||++.++ .+||+|
T Consensus 78 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 78 VEEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCC
Confidence 999999999999997654 26899999999999999999999 89999999999999999888 899999
Q ss_pred cCCCcccCCCCceeeccccccCCcCCccccccC--CCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHH
Q 045453 204 FSLSVSIPEGETCVKDKVTGTMGFLAPEYINTG--DFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYV 280 (346)
Q Consensus 204 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 280 (346)
||++..... .....++..|+|||++.+. .++.++||||||+++|++++ |..||......+. ..+
T Consensus 152 fg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~-------~~~- 218 (259)
T cd05037 152 PGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK-------ERF- 218 (259)
T ss_pred CCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH-------HHH-
Confidence 999876543 2234567789999999876 78999999999999999999 5777765432211 000
Q ss_pred HHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 045453 281 KKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLK 339 (346)
Q Consensus 281 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 339 (346)
..... ..+. .....+.+++.+||+.+|.+|||+.+|++.|+
T Consensus 219 ---~~~~~-----------~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 219 ---YQDQH-----------RLPM----PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred ---HhcCC-----------CCCC----CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00000 0000 11166889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=295.88 Aligned_cols=246 Identities=21% Similarity=0.304 Sum_probs=196.1
Q ss_pred CCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcc---------hHHHHHHHHHHhhhcCCCceeeEcceeecCCc
Q 045453 59 FDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDG---------HEDCFNNIIFASKLSSHKNVLKLTGCCLETRI 127 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~---------~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~ 127 (346)
|.....||+|++|.||+|.. .++.+|+|.+....... ...+.+|+..+..+ +||||+++++++.+.+.
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHENIVQYLGSSLDADH 80 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCc
Confidence 56678999999999999988 67899999876443221 13456777888888 99999999999999999
Q ss_pred ceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCC
Q 045453 128 PVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS 207 (346)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~ 207 (346)
.++||||+++++|.+++... ..+++..+..++.+++.||+||| +.+++|+||+|+||++++++.++|+|||.+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCC
Confidence 99999999999999999764 35889999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCce-----eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHH
Q 045453 208 VSIPEGETC-----VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKK 282 (346)
Q Consensus 208 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (346)
+........ ......++..|+|||.+.+..++.++||||||+++|+|++|..||........ +..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----------~~~ 223 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA----------IFK 223 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH----------HHH
Confidence 776532111 11234578899999999988899999999999999999999999975432110 000
Q ss_pred HhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 283 CIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 283 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
... ...+.+ +......+.+++.+||+.+|++||++.|+++
T Consensus 224 ~~~------~~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 224 IGE------NASPEI--------PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred Hhc------cCCCcC--------CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 000 000111 1134567889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=298.33 Aligned_cols=264 Identities=19% Similarity=0.246 Sum_probs=192.1
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhh--cCCCceeeEcceeec-----CC
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKL--SSHKNVLKLTGCCLE-----TR 126 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~--~~h~niv~l~g~~~~-----~~ 126 (346)
+|...+.||+|+||+||+|.+ +++.||+|.+..... .......+|+..+..+ .+||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 377788999999999999998 678999998764322 2223445565555544 279999999998864 24
Q ss_pred cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCC
Q 045453 127 IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSL 206 (346)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl 206 (346)
..++||||+++ +|.+++..... ..+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCc
Confidence 57999999975 89888876432 35899999999999999999999 89999999999999999999999999999
Q ss_pred CcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhc
Q 045453 207 SVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIEN 286 (346)
Q Consensus 207 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (346)
++....... .....+|..|+|||++.+..++.++|||||||++|+|++|.+||........ +..... ....
T Consensus 155 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~------~~~~~~-~~~~ 225 (288)
T cd07863 155 ARIYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ------LGKIFD-LIGL 225 (288)
T ss_pred cccccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH------HHHHHH-HhCC
Confidence 876643221 2345678999999999988999999999999999999999999965433211 111111 0000
Q ss_pred C---cccccc---ccccccCCCCc---chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 287 N---EFDEIV---DPIIVSEGPRV---GKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 287 ~---~~~~~~---d~~l~~~~~~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
. ...... ........+.. ..+.....+.+++.+||+.||++|||+.|++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 226 PPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 000000 00000000000 00123456789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=303.65 Aligned_cols=264 Identities=18% Similarity=0.273 Sum_probs=197.7
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
+.|...+.||+|+||.||+|.+ ++..||+|.+..... .....+.+|+..+..+ +||||+++++++...+..++|||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhc-CCCCcceEEEEEecCCeEEEEEe
Confidence 4578889999999999999988 678999998864432 2334567788888888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
|++ ++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||||+|||++.++.+||+|||++......
T Consensus 85 ~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 85 YLD-KDLKQYLDDCG---NSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred ccc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 997 59998887643 35889999999999999999999 899999999999999999999999999998765432
Q ss_pred CceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhh-------
Q 045453 214 ETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIE------- 285 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 285 (346)
.. ......++..|+|||.+.+ ..++.++||||||+++|+|+||+.||...+..+. ...+.....
T Consensus 158 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~-------~~~~~~~~~~~~~~~~ 229 (301)
T cd07873 158 TK-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ-------LHFIFRILGTPTEETW 229 (301)
T ss_pred CC-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHHHcCCCChhhc
Confidence 22 1223456889999999875 4578999999999999999999999976543211 111111100
Q ss_pred -----cCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 286 -----NNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 286 -----~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.......-.+.................+.+|+.+||+.||.+|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 230 PGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred hhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000000000000000000123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=336.89 Aligned_cols=258 Identities=19% Similarity=0.264 Sum_probs=198.9
Q ss_pred HHHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeec--C
Q 045453 52 LEIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLE--T 125 (346)
Q Consensus 52 l~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~--~ 125 (346)
.....++|.+.+.||+|+||+||+|.+ .+..+|+|.+.... ......+..|+.++..+ +|||||++++++.. .
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L-~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL-KHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEecCC
Confidence 344567899999999999999999999 67788998876432 23445678889999888 99999999998854 3
Q ss_pred CcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----CCCceecCCCCCCeEEcC------
Q 045453 126 RIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGF----SRPILHRKIRPSRIFLDE------ 195 (346)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~----~~~iiH~dlkp~NIll~~------ 195 (346)
..++|||||+++|+|.++|.........+++..++.|+.||+.||+|||+.. ..+|+||||||+||||+.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 5689999999999999999764333346999999999999999999999421 145999999999999964
Q ss_pred -----------CCceEEeccCCCcccCCCCceeeccccccCCcCCcccccc--CCCCcccchHHHHHHHHHHHhCCCCCC
Q 045453 196 -----------GYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINT--GDFNEKCDVFSFGMLLLVLLTGQKIFD 262 (346)
Q Consensus 196 -----------~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~~ 262 (346)
.+.+||+|||++..+..... .....||+.|+|||++.+ ..++.++|||||||++|||+||..||.
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred cccccccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 34589999999976643322 234578999999999864 458999999999999999999999997
Q ss_pred CCCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 263 PSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
...... ..+... ... +.+ .....+..+.+|+..||+.+|.+|||+.|++.
T Consensus 245 ~~~~~~---------qli~~l-k~~-------p~l-------pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 245 KANNFS---------QLISEL-KRG-------PDL-------PIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred cCCcHH---------HHHHHH-hcC-------CCC-------CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 533211 111111 100 000 00123456889999999999999999999984
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=309.16 Aligned_cols=270 Identities=17% Similarity=0.228 Sum_probs=196.7
Q ss_pred HHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecC----
Q 045453 54 IATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLET---- 125 (346)
Q Consensus 54 ~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~---- 125 (346)
...++|...+.||+|+||.||++.. .+..+|+|++..... .....+.+|+..+..+ +||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHh-CCCchhceeeeeecccccc
Confidence 3457899999999999999999988 788999999865322 3345667788888777 999999999988643
Q ss_pred --CcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEec
Q 045453 126 --RIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFD 203 (346)
Q Consensus 126 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~D 203 (346)
...++||||+++ +|.+.+.. .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~D 162 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD 162 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEee
Confidence 346999999965 77776643 4788999999999999999999 89999999999999999999999999
Q ss_pred cCCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccc-----------
Q 045453 204 FSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAG----------- 272 (346)
Q Consensus 204 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~----------- 272 (346)
||+++...... ......+|..|+|||++.+..++.++|||||||++|+|++|+.||......+....
T Consensus 163 fg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (355)
T cd07874 163 FGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240 (355)
T ss_pred CcccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 99997654322 22345689999999999999999999999999999999999999976432111000
Q ss_pred -hhhHHHHHHHHhhc-CccccccccccccCCCC----cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 273 -HYWLLHYVKKCIEN-NEFDEIVDPIIVSEGPR----VGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 273 -~~~~~~~~~~~~~~-~~~~~~~d~~l~~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
...+...+...... ........+........ .........+.+|+.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 00000001111110 00000000000000000 001123456889999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=299.62 Aligned_cols=244 Identities=23% Similarity=0.341 Sum_probs=196.7
Q ss_pred CCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc-CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecc
Q 045453 59 FDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL-NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESV 135 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~ 135 (346)
|+..+.||+|+||.||+|.+ .+..||+|.+.... ......+.+|+..+..+ +||||+++++++...+..++||||+
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcC-CCCccHhhhcccccCCceEEEEEcc
Confidence 45567899999999999988 67889999876443 23345677888888888 9999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCc
Q 045453 136 KNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGET 215 (346)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~ 215 (346)
++++|.+++.. ..+++..+..++.+++.||.||| +.+++|+||+|+||++++++.++++|||++..+.....
T Consensus 85 ~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 85 GGGSALDLLKP-----GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999998854 35899999999999999999999 89999999999999999999999999999876643321
Q ss_pred eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccccc
Q 045453 216 CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDP 295 (346)
Q Consensus 216 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 295 (346)
......++..|+|||++.+..++.++||||||+++|||++|..|+........ ... ..... .+
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-------~~~----~~~~~-----~~ 219 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV-------LFL----IPKNS-----PP 219 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH-------Hhh----hhcCC-----CC
Confidence 12234578899999999998999999999999999999999999864432211 000 00000 00
Q ss_pred ccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 296 IIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 296 ~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.+ .......+.+++.+||+.+|++|||+.+++.
T Consensus 220 ~~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 220 TL--------EGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred CC--------CcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 11 1134566889999999999999999999987
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=300.12 Aligned_cols=252 Identities=21% Similarity=0.281 Sum_probs=201.0
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
.++|...+.||.|+||.||+|.+ ++..+|+|............+..|+..+..+ +||||+++++++.+....++|||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSEC-KHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhC-CCCceeEEEEEEecCCeEEEEee
Confidence 35677888999999999999998 6789999998755445556778888888888 89999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
|+++++|.+++.... .++++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 83 FCDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred ccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 999999999987643 36899999999999999999999 899999999999999999999999999988665432
Q ss_pred CceeeccccccCCcCCccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCc
Q 045453 214 ETCVKDKVTGTMGFLAPEYIN-----TGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE 288 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (346)
.. ......++..|+|||++. +..++.++||||||+++|+|++|..||........ .... ....
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~----------~~~~-~~~~ 224 (280)
T cd06611 157 LQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV----------LLKI-LKSE 224 (280)
T ss_pred cc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH----------HHHH-hcCC
Confidence 21 223456888999999975 34578899999999999999999999975432111 1111 1110
Q ss_pred cccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045453 289 FDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKR 337 (346)
Q Consensus 289 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 337 (346)
. +.+. .+......+.+++..||+.+|++|||+.++++.
T Consensus 225 ~-----~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 225 P-----PTLD------QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred C-----CCcC------CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0 0000 011334568899999999999999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=315.97 Aligned_cols=202 Identities=18% Similarity=0.240 Sum_probs=172.2
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
++|+..+.||+|+||+||++.. ++..+|+|.+.... ......+..|...+..+ +||||+++++.+.+.+..++|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-DGAWVVKMFYSFQDKRNLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEE
Confidence 4688889999999999999998 67899999986432 12334556677778777 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++..+.
T Consensus 80 ~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 80 MEFLPGGDMMTLLMKK----DTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred EeCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 9999999999999764 35899999999999999999999 9999999999999999999999999999987543
Q ss_pred CCCce----------------------------------eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhC
Q 045453 212 EGETC----------------------------------VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTG 257 (346)
Q Consensus 212 ~~~~~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg 257 (346)
..... ......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG 232 (360)
T cd05627 153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (360)
T ss_pred cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccC
Confidence 21100 01134689999999999999999999999999999999999
Q ss_pred CCCCCCCCC
Q 045453 258 QKIFDPSRG 266 (346)
Q Consensus 258 ~~p~~~~~~ 266 (346)
..||.....
T Consensus 233 ~~Pf~~~~~ 241 (360)
T cd05627 233 YPPFCSETP 241 (360)
T ss_pred CCCCCCCCH
Confidence 999976443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=312.37 Aligned_cols=235 Identities=16% Similarity=0.173 Sum_probs=183.4
Q ss_pred cccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhc--CCCceeeEcceeecCCcceEEEecccC
Q 045453 65 IKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLS--SHKNVLKLTGCCLETRIPVIVFESVKN 137 (346)
Q Consensus 65 ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~--~h~niv~l~g~~~~~~~~~lv~e~~~~ 137 (346)
||+|+||+||+|.. ++..||+|.+..... ........|...+.... .||||+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999998 688999999864321 22334455666665554 799999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCcee
Q 045453 138 RTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCV 217 (346)
Q Consensus 138 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 217 (346)
|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++........ .
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~ 152 (330)
T cd05586 81 GELFWHLQKE----GRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-T 152 (330)
T ss_pred ChHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-C
Confidence 9999988754 35899999999999999999999 89999999999999999999999999999875432221 2
Q ss_pred eccccccCCcCCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccccc
Q 045453 218 KDKVTGTMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPI 296 (346)
Q Consensus 218 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 296 (346)
.....||..|+|||++.+. .++.++|||||||++|+|++|..||......+. ... ...+.. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~----------~~~-i~~~~~------~ 215 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM----------YRN-IAFGKV------R 215 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH----------HHH-HHcCCC------C
Confidence 2345689999999998764 489999999999999999999999975432211 111 111100 0
Q ss_pred cccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCH
Q 045453 297 IVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTT 331 (346)
Q Consensus 297 l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 331 (346)
+ ........+.+++.+||+.+|.+||++
T Consensus 216 ~-------~~~~~~~~~~~li~~~L~~~P~~R~~~ 243 (330)
T cd05586 216 F-------PKNVLSDEGRQFVKGLLNRNPQHRLGA 243 (330)
T ss_pred C-------CCccCCHHHHHHHHHHcCCCHHHCCCC
Confidence 0 001234567889999999999999954
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=294.82 Aligned_cols=248 Identities=22% Similarity=0.277 Sum_probs=200.7
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
+|+..+.||+|+||.||++.. +++.+++|.+.... .....++.+|+..+..+ +||||+++++++.+.+..++|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-KHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhC-CCCCeeeeEeeecCCCeEEEEEe
Confidence 477889999999999999988 77899999886432 23445778888888888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
|+++++|.+++..... ..+++.+++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 80 YCEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154 (256)
T ss_pred cCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence 9999999999876432 35789999999999999999999 899999999999999999999999999998766433
Q ss_pred CceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccc
Q 045453 214 ETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIV 293 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (346)
.. ......++..|+|||+..+..++.++||||||++++++++|..||......+ .+.....
T Consensus 155 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~----------~~~~~~~-------- 215 (256)
T cd08218 155 VE-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN----------LVLKIIR-------- 215 (256)
T ss_pred hh-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH----------HHHHHhc--------
Confidence 22 1223457889999999999999999999999999999999999986432211 1111111
Q ss_pred ccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 294 DPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 294 d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
+..+.. .......+.+++.+||+.+|++||++.+|++
T Consensus 216 -----~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 216 -----GSYPPV-SSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred -----CCCCCC-cccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 111111 1134566899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=309.55 Aligned_cols=269 Identities=18% Similarity=0.245 Sum_probs=196.1
Q ss_pred HhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecC-----
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLET----- 125 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~----- 125 (346)
..++|...+.||+|+||.||++.. .++.+|||++.... ......+.+|+..+..+ +||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhc-CCCCccccceeecccccccc
Confidence 357799999999999999999998 78899999986532 23345667788888877 999999999987543
Q ss_pred -CcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEecc
Q 045453 126 -RIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDF 204 (346)
Q Consensus 126 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Df 204 (346)
...++||||+++ +|.+.+.. .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+||
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Df 170 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDF 170 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeC
Confidence 356999999965 77777742 4788999999999999999999 899999999999999999999999999
Q ss_pred CCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccc------------
Q 045453 205 SLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAG------------ 272 (346)
Q Consensus 205 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~------------ 272 (346)
|+++...... ......+|..|+|||++.+..++.++|||||||++|+|++|+.||...+..+....
T Consensus 171 G~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (364)
T cd07875 171 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 248 (364)
T ss_pred CCccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9997654322 12345689999999999999999999999999999999999999976543221000
Q ss_pred hhhHHHHHHHHhhc-Ccccccc-c---cccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 273 HYWLLHYVKKCIEN-NEFDEIV-D---PIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 273 ~~~~~~~~~~~~~~-~~~~~~~-d---~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
...+...+.....+ ....... . +.................+.+|+.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000000000000 0000000 0 000000000000012356889999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=293.35 Aligned_cols=248 Identities=19% Similarity=0.262 Sum_probs=197.2
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeec-CCcceEEE
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLE-TRIPVIVF 132 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~-~~~~~lv~ 132 (346)
+|+..+.||+|++|.||++.. +++.+++|++.... ......+.+|+..+..+ +|||++++++.+.. ....++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeecCCCCEEEEEe
Confidence 477889999999999999998 67889999986432 23345567777878787 99999999998764 44578999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
||+++++|.+++..... ..+++.++..++.+++.||++|| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 80 e~~~~~~l~~~l~~~~~--~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 80 GFCEGGDLYHKLKEQKG--KLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred cccCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 99999999999976432 46899999999999999999999 89999999999999999999999999999876643
Q ss_pred CCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccc
Q 045453 213 GETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEI 292 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (346)
... ......+++.|+|||+..+..++.++||||||++++++++|..||....... ...... .+...
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~----------~~~~~~-~~~~~-- 220 (257)
T cd08223 155 QCD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS----------LVYRII-EGKLP-- 220 (257)
T ss_pred cCC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH----------HHHHHH-hcCCC--
Confidence 222 2234567889999999999999999999999999999999999987432211 111111 11100
Q ss_pred cccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 293 VDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 293 ~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
. ........+.+++.+||+.+|++|||+.++++
T Consensus 221 ----------~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 221 ----------P-MPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred ----------C-CccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 01134567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=303.35 Aligned_cols=197 Identities=16% Similarity=0.180 Sum_probs=160.1
Q ss_pred ccccccC--CCcEEEEEEE--CCeEEEEEEecCccC-cchHH-HHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecc
Q 045453 62 RNVIKDG--YAYKFYKGFV--EDRTVSVMKFNDILN-DGHED-CFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESV 135 (346)
Q Consensus 62 ~~~ig~G--~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~-~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~ 135 (346)
..+||+| +||+||++.. ++..||+|++..... ....+ +..|...+..+ +||||++++++|...+..++||||+
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLF-NHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCEEEEEEecc
Confidence 5689999 6899999988 789999999875432 22333 34455555555 9999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCc
Q 045453 136 KNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGET 215 (346)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~ 215 (346)
++|+|.+++..... ..+++..++.++.|++.||+||| +.+++||||||+|||++.++.++++||+.+........
T Consensus 82 ~~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 99999999965432 35899999999999999999999 89999999999999999999999999986543321111
Q ss_pred e------eeccccccCCcCCcccccc--CCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 045453 216 C------VKDKVTGTMGFLAPEYINT--GDFNEKCDVFSFGMLLLVLLTGQKIFDPS 264 (346)
Q Consensus 216 ~------~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~~~~ 264 (346)
. ......++..|+|||++.+ ..++.++|||||||++|||++|..||...
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 0 0122346778999999976 46899999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=311.35 Aligned_cols=263 Identities=19% Similarity=0.222 Sum_probs=197.4
Q ss_pred hcCCCcccccccCCCcEEEEEEE----CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV----EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~----~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
...|...+.||+|+||.||++.. .+..|++|.+... ....+|+.++..+ +||||+++++++......++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTI-SHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhc-CCCCccceeeeEeeCCEEEEE
Confidence 45689999999999999999976 3467888886532 2345788888888 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
||++. ++|.+++... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.++|+|||+++...
T Consensus 165 ~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 165 MPKYK-CDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred ehhcC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 99995 5898888433 46999999999999999999999 8999999999999999999999999999987665
Q ss_pred CCCce-eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCc--
Q 045453 212 EGETC-VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE-- 288 (346)
Q Consensus 212 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 288 (346)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....... ..+...+.. +....
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~l~~i~~~-~~~~~~~ 312 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSS---SQLRSIIRC-MQVHPLE 312 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcH---HHHHHHHHH-hccCccc
Confidence 43321 123456899999999999999999999999999999999999999775543211 111111111 11000
Q ss_pred ccc-----c------cccccccCCCCc---chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 289 FDE-----I------VDPIIVSEGPRV---GKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 289 ~~~-----~------~d~~l~~~~~~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
+.. + ...........+ ........+.+++.+||+.+|++|||+.|++.
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 313 FPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred cCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 000 0 000000000000 00012356788999999999999999999875
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=297.10 Aligned_cols=256 Identities=23% Similarity=0.310 Sum_probs=200.6
Q ss_pred HHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCC-----
Q 045453 54 IATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETR----- 126 (346)
Q Consensus 54 ~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~----- 126 (346)
.++++|+..+.||+|++|.||+|.. +++.+++|.+.... ....++.+|+..+.++..||||+++++++.+..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 4678999999999999999999998 66789999876543 234567788888888867999999999997654
Q ss_pred -cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccC
Q 045453 127 -IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFS 205 (346)
Q Consensus 127 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg 205 (346)
..++||||+++++|.+++.........+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCc
Confidence 489999999999999998754322357899999999999999999999 8999999999999999999999999999
Q ss_pred CCcccCCCCceeeccccccCCcCCcccccc-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHH
Q 045453 206 LSVSIPEGETCVKDKVTGTMGFLAPEYINT-----GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYV 280 (346)
Q Consensus 206 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 280 (346)
++....... .......++..|+|||++.. ..++.++||||||+++++|++|..||........ +.
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~--- 228 (275)
T cd06608 159 VSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA------LF--- 228 (275)
T ss_pred cceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH------HH---
Confidence 987654322 12234568889999998753 3468899999999999999999999964322111 11
Q ss_pred HHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 281 KKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 281 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.. ..... +.+ .........+.+++.+||..||++|||+.++++
T Consensus 229 -~~-~~~~~-----~~~------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 229 -KI-PRNPP-----PTL------KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -Hh-hccCC-----CCC------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00 00000 000 111135567899999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=298.42 Aligned_cols=251 Identities=16% Similarity=0.286 Sum_probs=197.8
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEec
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFES 134 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~ 134 (346)
+|+..+.||+|+||.||++.+ .+..+|+|.+..... ....++.+|+..+..+ +||||+++++++...+..++||||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKA-VSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhc-CCCcHHhhhhheecCCeEEEEEee
Confidence 577788999999999999999 688999998765432 3345678888888888 999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCC
Q 045453 135 VKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE 214 (346)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~ 214 (346)
+++++|.+++..... ...+++..+..++.+++.||.|||+ +.+++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGVA-TEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 999999998865421 2368999999999999999999993 3589999999999999999999999999987653222
Q ss_pred ceeeccccccCCcCCccccccCC------CCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCc
Q 045453 215 TCVKDKVTGTMGFLAPEYINTGD------FNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE 288 (346)
Q Consensus 215 ~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (346)
.....++..|+|||.+.+.. ++.++|||||||++|+|++|..||........ ........ .+.
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-------~~~~~~~~-~~~ 226 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI-------FAQLSAIV-DGD 226 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH-------HHHHHHHh-hcC
Confidence 23345788999999986543 58899999999999999999999965322111 11111000 000
Q ss_pred cccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 289 FDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 289 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.+. ........+.+++.+||+.+|++||++.+++.
T Consensus 227 ------------~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 227 ------------PPT-LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred ------------CCC-CCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 000 11135567889999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=296.04 Aligned_cols=251 Identities=28% Similarity=0.447 Sum_probs=197.6
Q ss_pred CCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcch--HHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEec
Q 045453 59 FDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGH--EDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFES 134 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~--~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~ 134 (346)
|...+.||+|+||+||++.. +++.+|+|.+........ ....+|...+..+ +||||+++++++......++||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRL-RHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHH-TBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccc-cccccccccccccccccccccccc
Confidence 34568899999999999999 667899999876543222 2335588888888 999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCC
Q 045453 135 VKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE 214 (346)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~ 214 (346)
+++++|.+++... ..+++..+..++.|++.||.+|| +.+++|+||||+||++++++.++|+|||.+..... .
T Consensus 80 ~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~ 151 (260)
T PF00069_consen 80 CPGGSLQDYLQKN----KPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-N 151 (260)
T ss_dssp ETTEBHHHHHHHH----SSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS-T
T ss_pred ccccccccccccc----ccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc-c
Confidence 9999999999833 36899999999999999999999 88999999999999999999999999999875421 2
Q ss_pred ceeeccccccCCcCCccccc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccc
Q 045453 215 TCVKDKVTGTMGFLAPEYIN-TGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIV 293 (346)
Q Consensus 215 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (346)
........++..|+|||.+. +..++.++||||+|+++++|++|..||........ ..........
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~-------~~~~~~~~~~------- 217 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ-------LEIIEKILKR------- 217 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH-------HHHHHHHHHT-------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhh-------hhhhhhcccc-------
Confidence 22344567889999999998 88899999999999999999999999986521111 1111110000
Q ss_pred ccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 294 DPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 294 d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
....... ........+.+++..||+.+|++|||+.++++
T Consensus 218 --~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 218 --PLPSSSQ--QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp --HHHHHTT--SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred --ccccccc--ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000 00011367999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=298.69 Aligned_cols=198 Identities=21% Similarity=0.275 Sum_probs=160.2
Q ss_pred ccccccCCCcEEEEEEE----CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeec--CCcceEEEecc
Q 045453 62 RNVIKDGYAYKFYKGFV----EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLE--TRIPVIVFESV 135 (346)
Q Consensus 62 ~~~ig~G~~g~Vy~~~~----~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~--~~~~~lv~e~~ 135 (346)
..+||+|+||+||+|.. .+..+|+|.+.... ....+.+|+..+..+ +||||+++++++.. ....++||||+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLREL-KHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhC-CCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 36899999999999997 34689999876432 234567888888888 99999999999854 45779999999
Q ss_pred cCCChhhhhhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEE----cCCCceEEeccCC
Q 045453 136 KNRTLADHIYQNQ-----PHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFL----DEGYIAKLFDFSL 206 (346)
Q Consensus 136 ~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll----~~~~~~kl~Dfgl 206 (346)
++ +|.+++.... .....+++..+..++.|++.||.||| +.+++||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 65 8888775321 11235889999999999999999999 8999999999999999 5678999999999
Q ss_pred CcccCCCCce--eeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Q 045453 207 SVSIPEGETC--VKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRG 266 (346)
Q Consensus 207 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~ 266 (346)
++........ ......+|..|+|||++.+ ..++.++|||||||++|||+||..||.....
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~ 221 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccc
Confidence 9876543221 1234568899999999876 4589999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=296.00 Aligned_cols=252 Identities=20% Similarity=0.340 Sum_probs=202.6
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
++|+..+.||+|++|.||++.+ +++.+++|.+..... ....++.+|+..+..+ +||||+++++++...+..++|+|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKC-NSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHC-CCCchhhhheeeecCCEEEEEEE
Confidence 3577788999999999999999 588999998876543 3445678888888888 89999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFS-RPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
|+++++|.+++.... .++++..+..++.+++.||+||| + .+++|+||||+||+++.++.++|+|||.+.....
T Consensus 80 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~ 153 (265)
T cd06605 80 YMDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN 153 (265)
T ss_pred ecCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence 999999999997653 46889999999999999999999 7 9999999999999999999999999999866532
Q ss_pred CCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccc
Q 045453 213 GETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEI 292 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (346)
... ....++..|+|||.+.+..++.++||||||+++|+|++|..||........ .....+......
T Consensus 154 ~~~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~~------ 219 (265)
T cd06605 154 SLA---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-----GIFELLQYIVNE------ 219 (265)
T ss_pred HHh---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-----cHHHHHHHHhcC------
Confidence 221 125678899999999999999999999999999999999999976532111 111222211111
Q ss_pred cccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 293 VDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 293 ~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
..+..........+.+++..||+.+|++|||+.+++.
T Consensus 220 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 220 -------PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred -------CCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 1111111124566889999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=293.03 Aligned_cols=253 Identities=19% Similarity=0.257 Sum_probs=200.9
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeec--CCcceEE
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLE--TRIPVIV 131 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~--~~~~~lv 131 (346)
+|+..+.||.|+||.||++.. ++..+++|.+.... ......+..|+..+..+ +||||+++++++.. +...+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-KHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhc-CCCccceeeeeeecCCCCEEEEE
Confidence 467788999999999999988 77889999876432 23344566788888888 99999999998764 4567899
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCceecCCCCCCeEEcCCCceEEeccCCCcc
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGF--SRPILHRKIRPSRIFLDEGYIAKLFDFSLSVS 209 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~ 209 (346)
|||+++++|.+++........++++..++.++.+++.||.|||..+ +.+++|+||+|+||++++++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 9999999999999765333457999999999999999999999543 67899999999999999999999999999887
Q ss_pred cCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcc
Q 045453 210 IPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEF 289 (346)
Q Consensus 210 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (346)
....... .....++..|+|||++.+..++.++||||||+++++|++|..||....... ....+ .....
T Consensus 160 ~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~----~~~~~ 227 (265)
T cd08217 160 LGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ-------LASKI----KEGKF 227 (265)
T ss_pred ccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH-------HHHHH----hcCCC
Confidence 6543321 233468899999999999889999999999999999999999997543211 11111 11111
Q ss_pred ccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 290 DEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 290 ~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
. . .+......+.+++.+||+.+|++|||+.+|++
T Consensus 228 ~-----~--------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 228 R-----R--------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred C-----C--------CccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0 0 11144567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=292.89 Aligned_cols=248 Identities=21% Similarity=0.297 Sum_probs=192.1
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-----cchHHHHHHHHHHhhhcCCCceeeEcceeec--CCc
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-----DGHEDCFNNIIFASKLSSHKNVLKLTGCCLE--TRI 127 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-----~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~--~~~ 127 (346)
.+|...+.||+|+||.||+|.. ++..+++|++..... .....+.+|+..+..+ +||||+++++++.+ ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 80 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHERIVQYYGCLRDRAEKT 80 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHc-CCCCeeeEEEEEEcCCCCE
Confidence 5788999999999999999988 678999998764321 1234566788888888 99999999999865 356
Q ss_pred ceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCC
Q 045453 128 PVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS 207 (346)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~ 207 (346)
.++++||+++++|.+++.... .+++...+.++.|++.||.||| +.+++|+||+|+||+++.++.+||+|||++
T Consensus 81 ~~l~~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~ 153 (266)
T cd06651 81 LTIFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGAS 153 (266)
T ss_pred EEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCc
Confidence 789999999999999997643 5889999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCc--eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhh
Q 045453 208 VSIPEGET--CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIE 285 (346)
Q Consensus 208 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (346)
........ .......++..|+|||.+.+..++.++||||||+++||+++|+.||........ +.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~----------~~~~~~ 223 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA----------IFKIAT 223 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH----------HHHHhc
Confidence 76532111 111234578899999999988899999999999999999999999975322111 111000
Q ss_pred cCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 286 NNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 286 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.. ..+.+ +......+.+++ .||..+|++|||+.||++
T Consensus 224 ~~-----~~~~~--------~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 224 QP-----TNPQL--------PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CC-----CCCCC--------chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 00 00100 112334456666 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=299.21 Aligned_cols=244 Identities=21% Similarity=0.279 Sum_probs=207.1
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
..|++...||+|.||.|-+|.. .|+.||||.+.++.. ...-++.+|+.++..+ +||||+.++.+|.+.+.+.||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhhcCCceEEEE
Confidence 4577788899999999999987 899999998876543 4455678899999999 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||..+|.|++++...+ .+++.+...+..||+.|+.|+| ..+++|||||.+|||+|.|+++||+|||++....
T Consensus 132 MEYaS~GeLYDYiSer~----~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 132 MEYASGGELYDYISERG----SLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEecCCccHHHHHHHhc----cccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhc
Confidence 99999999999998874 6999999999999999999999 9999999999999999999999999999998876
Q ss_pred CCCceeeccccccCCcCCccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINTGDF-NEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
.+.. -...+|++-|.+||.+.+.+| .+.+|-||+|++||-++.|.-||++.+.... ++.
T Consensus 205 ~~kf--LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~l----------vrQ-------- 264 (668)
T KOG0611|consen 205 DKKF--LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRL----------VRQ-------- 264 (668)
T ss_pred cccH--HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHH----------HHH--------
Confidence 5543 356789999999999999998 5679999999999999999999987654321 111
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.-.+.+..+ +.+....-|+++||..+|+.|.|+++|..
T Consensus 265 -----Is~GaYrEP---~~PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 265 -----ISRGAYREP---ETPSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred -----hhcccccCC---CCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence 112222222 33444566899999999999999999875
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=301.63 Aligned_cols=244 Identities=19% Similarity=0.295 Sum_probs=196.5
Q ss_pred cccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccCC
Q 045453 61 ARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNR 138 (346)
Q Consensus 61 ~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~g 138 (346)
....||+|+||.||+|.. +++.+|+|.+..........+.+|+..+..+ +||||+++++++..++..++|+||++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~iv~e~~~~~ 103 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHQNVVEMYKSYLVGEELWVLMEFLQGG 103 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhC-CCCchhhhhhheeeCCeEEEEEecCCCC
Confidence 345799999999999988 6889999998655444556677888888888 9999999999999999999999999999
Q ss_pred ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCceee
Q 045453 139 TLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVK 218 (346)
Q Consensus 139 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 218 (346)
+|.+++.. ..+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.+||+|||++........ ..
T Consensus 104 ~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~ 174 (297)
T cd06659 104 ALTDIVSQ-----TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KR 174 (297)
T ss_pred CHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cc
Confidence 99998754 34899999999999999999999 89999999999999999999999999999876543221 22
Q ss_pred ccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccccccc
Q 045453 219 DKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIV 298 (346)
Q Consensus 219 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 298 (346)
....++..|+|||++.+..++.++||||||++++||++|..||......+. ..... ..... ...
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-------~~~~~----~~~~~-----~~~ 238 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-------MKRLR----DSPPP-----KLK 238 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHh----ccCCC-----Ccc
Confidence 345688999999999988999999999999999999999999975332111 11110 00000 000
Q ss_pred cCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 299 SEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 299 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
........+.+++.+||+.+|++|||+.++++
T Consensus 239 ------~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 239 ------NAHKISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred ------ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 00023455889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=299.16 Aligned_cols=244 Identities=23% Similarity=0.357 Sum_probs=194.8
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
..|...+.||+|+||.||+|.. +++.||+|++..... ....++.+|+..+..+ +||||+++.++|...+..++|
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL-RHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEEeCCeEEEE
Confidence 4477888999999999999998 688999998864332 2334577888888888 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||++ |+|.+.+.... .++++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 94 ~e~~~-g~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 94 MEYCL-GSASDILEVHK---KPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HHhhC-CCHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 99997 57877776443 36899999999999999999999 8999999999999999999999999999986553
Q ss_pred CCCceeeccccccCCcCCccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCc
Q 045453 212 EGETCVKDKVTGTMGFLAPEYIN---TGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE 288 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (346)
.. ....++..|+|||++. .+.++.++||||||+++|||+||..||........ +..... .
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~----------~~~~~~-~- 229 (307)
T cd06607 167 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----------LYHIAQ-N- 229 (307)
T ss_pred CC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH----------HHHHhc-C-
Confidence 22 2345788999999884 45688999999999999999999999865322110 000000 0
Q ss_pred cccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 289 FDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 289 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
..+..........+.+++.+||+.+|++|||+.+++.
T Consensus 230 -----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 230 -----------DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred -----------CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0011111245567999999999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=312.98 Aligned_cols=266 Identities=18% Similarity=0.206 Sum_probs=195.8
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEec
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFES 134 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~ 134 (346)
..|...+.||+|+||.||+|.+ .++.||+|... .....+|+.++..+ +|||||++++++..++..++|||+
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L-~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRL-SHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHC-CCCCCCcEEEEEEECCEEEEEEEc
Confidence 4688889999999999999999 57889998632 23356788888888 999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCC
Q 045453 135 VKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE 214 (346)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~ 214 (346)
+. ++|.+++.... ..++|..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 242 ~~-~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 242 YR-SDLYTYLGARL---RPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred cC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 95 68998886543 36999999999999999999999 8999999999999999999999999999997654322
Q ss_pred ce-eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC-cccccchhhHHHHHHHHhh-cCcccc
Q 045453 215 TC-VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRG-DEIGAGHYWLLHYVKKCIE-NNEFDE 291 (346)
Q Consensus 215 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~-~~~~~~ 291 (346)
.. ......||..|+|||++.+..++.++|||||||++|||++|..|+..... .........+...+...-. ...+..
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 21 12245689999999999999999999999999999999998876543221 1111111122222221100 000000
Q ss_pred ccccccc------------cCCCCcc---hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 292 IVDPIIV------------SEGPRVG---KEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 292 ~~d~~l~------------~~~~~~~---~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.....+. ....... .......+.+|+.+||+.||.+|||+.|+++
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 0000000 0000000 0011236889999999999999999999986
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=293.01 Aligned_cols=260 Identities=23% Similarity=0.301 Sum_probs=200.9
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecC--CcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLET--RIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~--~~~~lv 131 (346)
++|...+.||.|++|.||++.+ .++.+|+|.+..... ....++.+|+..+..+ +||||++++++|.+. +..++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSC-KSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEccCCCeEEEE
Confidence 4678889999999999999999 678999998875433 3456678888888888 999999999998654 467999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+++++|.+++.........+++..+..++.+++.||+||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 9999999999987643323356889999999999999999999 8999999999999999999999999999986554
Q ss_pred CCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccc
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDE 291 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (346)
.... ....++..|+|||.+.+..++.++||||||+++|+|++|..||........ .......+... ...
T Consensus 157 ~~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~----~~~-- 225 (287)
T cd06621 157 NSLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL--GPIELLSYIVN----MPN-- 225 (287)
T ss_pred cccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC--ChHHHHHHHhc----CCc--
Confidence 3221 234577899999999999999999999999999999999999986533111 00111111111 000
Q ss_pred ccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 292 IVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 292 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
+.+... + .........+.+++.+||+.+|++|||+.|+++
T Consensus 226 ---~~~~~~-~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 226 ---PELKDE-P-GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred ---hhhccC-C-CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 001000 0 000134567899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=296.66 Aligned_cols=249 Identities=19% Similarity=0.279 Sum_probs=201.6
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEec
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFES 134 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~ 134 (346)
++|...+.||+|+||.||+|.. +++.+++|.+..........+.+|+..+..+ +|||++++++++...+..++|+||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMREN-KHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhc-CCCCeeehhheeeeCCcEEEEEec
Confidence 6788889999999999999987 6788999998655445556678888888888 999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCC
Q 045453 135 VKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE 214 (346)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~ 214 (346)
+++++|.+++... .+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 98 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 9999999998653 4789999999999999999999 8999999999999999999999999999887654332
Q ss_pred ceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccc
Q 045453 215 TCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVD 294 (346)
Q Consensus 215 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 294 (346)
. ......+++.|+|||.+.+..++.++||||||+++|++++|..||......... ..... .
T Consensus 170 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~----------~~~~~--------~ 230 (293)
T cd06647 170 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL----------YLIAT--------N 230 (293)
T ss_pred c-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe----------eehhc--------C
Confidence 2 223346888999999998888999999999999999999999999754332210 00000 0
Q ss_pred cccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045453 295 PIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKR 337 (346)
Q Consensus 295 ~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 337 (346)
. .............+.+++..||+.+|++||++.+++..
T Consensus 231 ~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 231 G----TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred C----CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00001111334568899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=291.34 Aligned_cols=252 Identities=20% Similarity=0.320 Sum_probs=205.6
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
++|+..+.||+|++|.||+|.. +++.+++|++..... .....+.+|+..+..+ +||||+++++++...+..++|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC-ESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEccCCeEEEEEE
Confidence 4688889999999999999999 589999999876543 3456778888889998 89999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFS-RPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
|+++++|.+++... .++++..++.++.|++.||+||| + .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 80 YMDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152 (264)
T ss_pred ecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999999765 36899999999999999999999 8 9999999999999999999999999999877654
Q ss_pred CCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccc
Q 045453 213 GETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEI 292 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (346)
.... .....++..|+|||.+.+..++.++||||||+++|+|+||..||........ ........... .
T Consensus 153 ~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~-------~~~~~~~~~~~-~--- 220 (264)
T cd06623 153 TLDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF-------FELMQAICDGP-P--- 220 (264)
T ss_pred CCCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCH-------HHHHHHHhcCC-C---
Confidence 3322 1234578899999999999999999999999999999999999976543111 11111111100 0
Q ss_pred cccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045453 293 VDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKR 337 (346)
Q Consensus 293 ~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 337 (346)
+.+ .....+..+.+++..||+.+|++|||+.++++.
T Consensus 221 --~~~-------~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 --PSL-------PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred --CCC-------CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000 110145679999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=300.68 Aligned_cols=253 Identities=19% Similarity=0.204 Sum_probs=196.7
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
++|+..+.||+|+||.||++.. .++.|++|.+..... .....+.+|+..+..+ +||||+++++.+.+++..++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv 79 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA-ENPFVVSMFCSFETKRHLCMV 79 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEecCCEEEEE
Confidence 4688899999999999999998 678999998765431 2234566777777777 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+++++|.+++.... ++++..+..++.+++.||.||| +.+++|+||||+||+++.++.+||+|||+++...
T Consensus 80 ~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~ 152 (305)
T cd05609 80 MEYVEGGDCATLLKNIG----ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGL 152 (305)
T ss_pred EecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccC
Confidence 99999999999997643 5899999999999999999999 8999999999999999999999999999886321
Q ss_pred CCC--------------ceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHH
Q 045453 212 EGE--------------TCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLL 277 (346)
Q Consensus 212 ~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~ 277 (346)
... ........++..|+|||++.+..++.++|+||||+++||+++|..||.+....+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~-------- 224 (305)
T cd05609 153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL-------- 224 (305)
T ss_pred cCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--------
Confidence 000 0011224578899999999988999999999999999999999999975432211
Q ss_pred HHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 045453 278 HYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLK 339 (346)
Q Consensus 278 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 339 (346)
...... ... ..+. . ....+..+.+++.+||+.+|++|||+.++.+.|+
T Consensus 225 --~~~~~~-~~~---~~~~-------~-~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 225 --FGQVIS-DDI---EWPE-------G-DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred --HHHHHh-ccc---CCCC-------c-cccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 111000 000 0000 0 0023456889999999999999999766665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=293.31 Aligned_cols=247 Identities=21% Similarity=0.324 Sum_probs=196.6
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc-CcchHHHHHHHHHHhhhc--CCCceeeEcceeecCCcceEEE
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL-NDGHEDCFNNIIFASKLS--SHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~-~~~~~~~~~e~~~~~~~~--~h~niv~l~g~~~~~~~~~lv~ 132 (346)
.|+..+.||+|+||.||+|.+ ++..+++|.+.... .....++.+|+..+..+. .|||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467788999999999999998 77899999886543 234456677777777772 3999999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
||+++++|.+++... .+++...+.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 999999999988653 5899999999999999999999 89999999999999999999999999999877654
Q ss_pred CCceeeccccccCCcCCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccc
Q 045453 213 GETCVKDKVTGTMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDE 291 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (346)
... ......|+..|+|||.+.++ .++.++||||||+++|+|++|..||........ ... ....
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~----------~~~-~~~~---- 217 (277)
T cd06917 154 NSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA----------MML-IPKS---- 217 (277)
T ss_pred Ccc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh----------hhc-cccC----
Confidence 332 22344688899999998754 468999999999999999999999975432111 000 0000
Q ss_pred ccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 292 IVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 292 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
..+.+ ........+.+++.+||+.+|++|||+.|+++
T Consensus 218 -~~~~~-------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 218 -KPPRL-------EDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred -CCCCC-------CcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 00111 11124456889999999999999999999965
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=293.38 Aligned_cols=255 Identities=22% Similarity=0.347 Sum_probs=197.2
Q ss_pred CCcccccccCCCcEEEEEEE-----CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecCC-----
Q 045453 59 FDARNVIKDGYAYKFYKGFV-----EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETR----- 126 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~~-----~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~----- 126 (346)
|...+.||+|+||.||+|.+ ++..+|+|.+.... .....++.+|+..+..+ +||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEF-DHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCCCCCcc
Confidence 45678899999999999986 35789999886543 23345677888888888 9999999999886532
Q ss_pred -cceEEEecccCCChhhhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEec
Q 045453 127 -IPVIVFESVKNRTLADHIYQNQP--HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFD 203 (346)
Q Consensus 127 -~~~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~D 203 (346)
..++++||+++|+|.+++..... ....+++.....++.|++.||+||| +.+++|+||||+||+++.++.+||+|
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECc
Confidence 23789999999999988754321 1135789999999999999999999 89999999999999999999999999
Q ss_pred cCCCcccCCCCcee-eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHH
Q 045453 204 FSLSVSIPEGETCV-KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVK 281 (346)
Q Consensus 204 fgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 281 (346)
||+++....+.... .....++..|++||.+....++.++||||||+++|+|++ |..||......+ +.....
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~ 229 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE-------IYNYLI 229 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH-------HHHHHH
Confidence 99988764433211 123345678999999998889999999999999999999 888886543211 111111
Q ss_pred HHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 045453 282 KCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341 (346)
Q Consensus 282 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 341 (346)
.... +. ........+.+++.+||+.+|++|||+.++++.|+++
T Consensus 230 ----~~~~-------~~------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 ----KGNR-------LK------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ----cCCc-------CC------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1100 00 0013345789999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=295.57 Aligned_cols=265 Identities=18% Similarity=0.229 Sum_probs=198.1
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
++|+....||+|++|.||+|.+ +++.+|+|++..... .....+.+|+..+..+ +|||++++++++...+..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL-KHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhC-CCCCEeeeeeEEeeCCEEEEEE
Confidence 4678889999999999999998 688999998764432 2234566788888887 9999999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
||+++++|..++... ..+++..++.++.|++.||+||| +.+++|+||||+||++++++.++|+|||++.....
T Consensus 80 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 80 EYCDHTVLNELEKNP----RGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTG 152 (286)
T ss_pred eccCccHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCC
Confidence 999998888776543 35899999999999999999999 89999999999999999999999999999877654
Q ss_pred CCceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHH---------
Q 045453 213 GETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKK--------- 282 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------- 282 (346)
... ......++..|+|||++.+ ..++.++||||||+++|+|++|..||......+. +......
T Consensus 153 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~~ 225 (286)
T cd07847 153 PGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ------LYLIRKTLGDLIPRHQ 225 (286)
T ss_pred Ccc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHHHhCCCChHHh
Confidence 332 1223457789999999876 5578999999999999999999999976543221 1110000
Q ss_pred -HhhcCcc-ccccccccccCCCC-cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 283 -CIENNEF-DEIVDPIIVSEGPR-VGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 283 -~~~~~~~-~~~~d~~l~~~~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.+..... .....+......+. ...+.....+.+++.+||+.+|++|||+.|++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 226 QIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred hhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000000 00000000000000 000123467889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=301.03 Aligned_cols=251 Identities=18% Similarity=0.220 Sum_probs=198.8
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCc---chHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILND---GHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~---~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
++|+..+.||+|++|+||+|.. ++..+|+|.+...... ....+..|...+..+ +||||+++++++......++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 79 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DHPFLPTLYASFQTETYLCLV 79 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhC-CCCCchhheeeeecCCEEEEE
Confidence 3678889999999999999998 5799999998754322 344567777888887 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+.+++|.+++..... ..+++..+..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++....
T Consensus 80 ~e~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 80 MDYCPGGELFRLLQRQPG--KCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EEecCCCCHHHHHHhCCC--CccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 999999999999875432 46899999999999999999999 8999999999999999999999999999886543
Q ss_pred CCCce----------------------------eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 045453 212 EGETC----------------------------VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDP 263 (346)
Q Consensus 212 ~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~ 263 (346)
..... ......|+..|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 234 (316)
T cd05574 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234 (316)
T ss_pred ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence 22110 11133578899999999998999999999999999999999999975
Q ss_pred CCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCC----HHHHHH
Q 045453 264 SRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPT----TVDVAK 336 (346)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs----~~ev~~ 336 (346)
...... . . . ..+... ..+........+.+++.+||+.+|++||| +.|++.
T Consensus 235 ~~~~~~------~---~-~---------~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 235 SNRDET------F---S-N---------ILKKEV----TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred CchHHH------H---H-H---------HhcCCc----cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 443221 0 0 0 001000 00011124577999999999999999999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=300.69 Aligned_cols=243 Identities=19% Similarity=0.305 Sum_probs=195.5
Q ss_pred ccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccCCC
Q 045453 62 RNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRT 139 (346)
Q Consensus 62 ~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~gs 139 (346)
...||+|+||.||++.. ++..+|+|++..........+.+|+..+..+ +||||+++++.+..++..++||||+++++
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 105 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDY-HHENVVDMYNSYLVGDELWVVMEFLEGGA 105 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhC-CCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence 45699999999999988 6889999998655445556677888888887 99999999999999999999999999999
Q ss_pred hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCceeec
Q 045453 140 LADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKD 219 (346)
Q Consensus 140 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 219 (346)
|.+++... .+++.++..++.+++.||.||| +.+++||||||+||++++++.++|+|||++........ ...
T Consensus 106 L~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~ 176 (292)
T cd06658 106 LTDIVTHT-----RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRK 176 (292)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCc
Confidence 99988542 4889999999999999999999 89999999999999999999999999999876543221 123
Q ss_pred cccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccccccccc
Q 045453 220 KVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVS 299 (346)
Q Consensus 220 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 299 (346)
...++..|+|||+..+..++.++||||||+++|||++|..||....... ....+.. ...+.+..
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-------~~~~~~~---------~~~~~~~~ 240 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-------AMRRIRD---------NLPPRVKD 240 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHh---------cCCCcccc
Confidence 3568899999999998889999999999999999999999997533211 1111110 01111111
Q ss_pred CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 300 EGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 300 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
. ......+.+++..||+.+|++|||+.|+++
T Consensus 241 ~------~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 241 S------HKVSSVLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred c------cccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0 123446888999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=296.49 Aligned_cols=261 Identities=17% Similarity=0.203 Sum_probs=196.0
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
+|+..+.||+|++|.||+|.. ++..||+|++..... .....+.+|+..+..+ +||||+++++++.+++..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKEL-QHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhc-CCCCEeeeEEEEeeCCeEEEEEe
Confidence 477788999999999999998 688999998764322 2345677888888888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
|++ ++|.+++..... ...+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++......
T Consensus 80 ~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 80 FLS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred cCC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence 997 589888865432 246899999999999999999999 899999999999999999999999999998765432
Q ss_pred CceeeccccccCCcCCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhc------
Q 045453 214 ETCVKDKVTGTMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIEN------ 286 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------ 286 (346)
.. ......+++.|+|||.+.+. .++.++||||||+++++|+||+.||........ ...........
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~ 227 (285)
T cd07861 155 VR-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ------LFRIFRILGTPTEDVWP 227 (285)
T ss_pred cc-cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHHHhCCCChhhhh
Confidence 21 12334568899999988754 578999999999999999999999975433211 00000000000
Q ss_pred -----C----ccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 287 -----N----EFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 287 -----~----~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
. .........+... .......+.+++.+||+.||++|||+.+|++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 228 GVTSLPDYKNTFPKWKKGSLRSA-----VKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred cchhhHHHHhhccccCcchhHHh-----cCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0 0000000000000 0023456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=291.90 Aligned_cols=251 Identities=18% Similarity=0.337 Sum_probs=198.8
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC------cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcce
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN------DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV 129 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~------~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~ 129 (346)
+|+..+.||+|++|.||+|.. ++..+|+|.+..... .....+..|+..+..+ +||||+++++++.+.+..+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 79 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPHIIRMLGATCEDSHFN 79 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHc-CCCceehhhceeccCCeEE
Confidence 477889999999999999987 788999998864331 1245677888888888 9999999999999999999
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCC-ceEEeccCCCc
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGY-IAKLFDFSLSV 208 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~-~~kl~Dfgl~~ 208 (346)
+|+||+++++|.+++... .++++..+..++.|++.||.||| +.+++|+||+|+||+++.++ .+||+|||.+.
T Consensus 80 ~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~ 152 (268)
T cd06630 80 LFVEWMAGGSVSHLLSKY----GAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAA 152 (268)
T ss_pred EEEeccCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccc
Confidence 999999999999999764 35889999999999999999999 89999999999999998776 59999999987
Q ss_pred ccCCCCc---eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhh
Q 045453 209 SIPEGET---CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIE 285 (346)
Q Consensus 209 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (346)
....... .......++..|+|||++.+..++.++||||+|++++++++|..||........ .........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~~~~ 225 (268)
T cd06630 153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-------LALIFKIAS 225 (268)
T ss_pred ccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-------HHHHHHHhc
Confidence 6653321 112234678899999999888899999999999999999999999964332111 000000000
Q ss_pred cCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 286 NNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 286 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
. ......+......+.+++.+||+.+|++|||+.++++
T Consensus 226 ~-------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 226 A-------------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred c-------------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0 0000111144567889999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=291.98 Aligned_cols=249 Identities=19% Similarity=0.329 Sum_probs=196.4
Q ss_pred CCCcccccccCCCcEEEEEEE-CCeEEEEEEecCccC------cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceE
Q 045453 58 NFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILN------DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVI 130 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~------~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~l 130 (346)
+|...+.||+|+||.||+|.. +++.+|+|.+..... .....+.+|+..+..+ +|+||++++++|.+.+..++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-KHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhc-CCCCEeeEeeEeecCCeEEE
Confidence 366788999999999999988 778899998764321 1224466788888888 99999999999999999999
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCccc
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI 210 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~ 210 (346)
|+||+++++|.+++.... ++++..+..++.|++.||+||| +.+++|+||+|+||++++++.++|+|||++...
T Consensus 80 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 80 FMEFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 999999999999997643 5789999999999999999999 899999999999999999999999999998765
Q ss_pred CCCC-----ceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhh
Q 045453 211 PEGE-----TCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIE 285 (346)
Q Consensus 211 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (346)
.... ........++..|+|||++.+..++.++||||||+++|++++|..||........ ..... .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~------~~~~~----~ 222 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA------MFYIG----A 222 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH------HHHhh----h
Confidence 3211 1111234588899999999998899999999999999999999999975432111 00000 0
Q ss_pred cCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 286 NNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 286 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
... ..+.+ .......+.+++.+||+.+|++|||+.|+++
T Consensus 223 ~~~----~~~~~--------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 223 HRG----LMPRL--------PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ccC----CCCCC--------CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 00011 1134566889999999999999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=319.51 Aligned_cols=273 Identities=15% Similarity=0.227 Sum_probs=191.9
Q ss_pred HHHHHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhh-----cCCCceeeEccee
Q 045453 50 RELEIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKL-----SSHKNVLKLTGCC 122 (346)
Q Consensus 50 ~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~-----~~h~niv~l~g~~ 122 (346)
+++...+++|...+.||+|+||+||+|.+ .++.||||++.... ........|+..+..+ ..|++++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 34555678899999999999999999988 67899999986432 1222334454444444 1455689999888
Q ss_pred ecC-CcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCceecCCCCCCeEEcCCC---
Q 045453 123 LET-RIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFS-RPILHRKIRPSRIFLDEGY--- 197 (346)
Q Consensus 123 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~iiH~dlkp~NIll~~~~--- 197 (346)
... .+.++|||++ +++|.+++... ..+++..+..++.|++.||.||| + .+|+||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKH----GPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVV 272 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCccc
Confidence 754 5789999998 67899988764 36899999999999999999999 6 5999999999999998765
Q ss_pred -------------ceEEeccCCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 045453 198 -------------IAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPS 264 (346)
Q Consensus 198 -------------~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~ 264 (346)
.+||+|||.+..... ......||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 499999998754322 223567899999999999999999999999999999999999999865
Q ss_pred CCcccccchhh-----HHHHHH--------HHhhc-Cccccccccc----cccCCCCcchHHHHHHHHHHHHHcccCCCC
Q 045453 265 RGDEIGAGHYW-----LLHYVK--------KCIEN-NEFDEIVDPI----IVSEGPRVGKEKQLQGFRELALMCVCESAE 326 (346)
Q Consensus 265 ~~~~~~~~~~~-----~~~~~~--------~~~~~-~~~~~~~d~~----l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~ 326 (346)
...+....... ...|.. ..+.. .......++. +..... .........+.+|+..||+.||+
T Consensus 349 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~dli~~mL~~dP~ 427 (467)
T PTZ00284 349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARP-VREVIRDDLLCDLIYGLLHYDRQ 427 (467)
T ss_pred ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccc-hhhhhchHHHHHHHHHhCCcChh
Confidence 43221000000 000000 00000 0000000000 000000 00001234578999999999999
Q ss_pred CCCCHHHHHH
Q 045453 327 DRPTTVDVAK 336 (346)
Q Consensus 327 ~RPs~~ev~~ 336 (346)
+|||+.|+++
T Consensus 428 ~R~ta~e~L~ 437 (467)
T PTZ00284 428 KRLNARQMTT 437 (467)
T ss_pred hCCCHHHHhc
Confidence 9999999985
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=294.07 Aligned_cols=246 Identities=20% Similarity=0.310 Sum_probs=208.5
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecc
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESV 135 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~ 135 (346)
-|....+||+|+||.||+|.+ +|+.+|+|+.... +...+..+|+.+++.+ ..|++|++||.+.....+|+|||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC-~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQC-KSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHc-CCchhhhhhhhhccCCceEeehhhc
Confidence 366778999999999999998 8999999997644 5678899999999999 9999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCc
Q 045453 136 KNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGET 215 (346)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~ 215 (346)
.-||..+.++.++ .++++.++..++.+.++||.||| ...-+|||||..|||++-+|++||+|||.+-.+.+ .-
T Consensus 111 GAGSiSDI~R~R~---K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD-TM 183 (502)
T KOG0574|consen 111 GAGSISDIMRARR---KPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD-TM 183 (502)
T ss_pred CCCcHHHHHHHhc---CCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhh-hH
Confidence 9999999998776 68999999999999999999999 88899999999999999999999999999866532 23
Q ss_pred eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccccc
Q 045453 216 CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDP 295 (346)
Q Consensus 216 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 295 (346)
...+.+.||+.|||||++..-.|+.++||||+|+...||..|++||..-.+- .. +-.
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM----------------------RA-IFM 240 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM----------------------RA-IFM 240 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc----------------------ce-eEe
Confidence 3456788999999999999999999999999999999999999999743221 11 111
Q ss_pred ccccCCCC-cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 296 IIVSEGPR-VGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 296 ~l~~~~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
......+. .-++.++..+.++++.||-++|++|-|+.++.+
T Consensus 241 IPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 241 IPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred ccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 11111111 123367788999999999999999999998865
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=302.93 Aligned_cols=250 Identities=21% Similarity=0.281 Sum_probs=210.1
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCc---chHHHHHHHHHHhhhcCCCceeeEcceeecCCcceE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILND---GHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVI 130 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~---~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~l 130 (346)
...|...+.||+|.||.||++.. +|+.+|+|.+.+.... ......+|+.++..+..|||||.+++.+.+....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 45677889999999999999999 6899999998766543 346788999999999449999999999999999999
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCC----CceEEeccCC
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEG----YIAKLFDFSL 206 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~----~~~kl~Dfgl 206 (346)
|||++.||.|.+.+... .+++.....++.|++.++.||| +.+++||||||+|+|+... +.+|++|||+
T Consensus 114 vmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 99999999999999775 2899999999999999999999 9999999999999999633 5799999999
Q ss_pred CcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhc
Q 045453 207 SVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIEN 286 (346)
Q Consensus 207 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (346)
+..... .......+||+.|+|||++....|+..+||||+|+++|.|++|..||......... . .+..
T Consensus 186 a~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~------~-----~i~~ 252 (382)
T KOG0032|consen 186 AKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF------L-----AILR 252 (382)
T ss_pred ceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH------H-----HHHc
Confidence 988766 23456789999999999999999999999999999999999999999876654430 0 1111
Q ss_pred CccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 287 NEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 287 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
+.+ ......-+.....+.+++..|+..||..|+|+.++++
T Consensus 253 ~~~----------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 253 GDF----------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred CCC----------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 111 1111112255778999999999999999999999986
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=289.88 Aligned_cols=247 Identities=23% Similarity=0.313 Sum_probs=198.7
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
+|...+.||+|++|.||++.. +++.+|+|.+.... ......+.+|+..+..+ +|||++++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLL-SHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhC-CCCchhheeeeEecCCEEEEEEe
Confidence 477788999999999999988 78899999986542 23345677888888888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCC-CceEEeccCCCcccCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEG-YIAKLFDFSLSVSIPE 212 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~-~~~kl~Dfgl~~~~~~ 212 (346)
|+++++|.+++..... ..+++..+..++.+++.||.||| +.+++|+||+|+||+++.+ +.+||+|||++.....
T Consensus 80 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 80 YAPGGTLAEYIQKRCN--SLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred cCCCCCHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 9999999999976432 45899999999999999999999 8999999999999999855 4689999999887654
Q ss_pred CCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccc
Q 045453 213 GETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEI 292 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (346)
... .....++..|+|||.+.+..++.++||||||+++|+|++|..||...+.... +..... .....
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~----------~~~~~~-~~~~~- 220 (256)
T cd08220 155 KSK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL----------VLKIMS-GTFAP- 220 (256)
T ss_pred Ccc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH----------HHHHHh-cCCCC-
Confidence 322 2234678899999999988899999999999999999999999965433211 111110 00000
Q ss_pred cccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 293 VDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 293 ~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
+ .......+.+++.+||+.+|++|||+.|++.
T Consensus 221 ----~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 221 ----I--------SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ----C--------CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0 1123456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=306.75 Aligned_cols=259 Identities=15% Similarity=0.233 Sum_probs=193.3
Q ss_pred HhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecC-----
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLET----- 125 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~----- 125 (346)
..++|...+.||+|+||.||+|.. ++..||+|++..... .....+.+|+..+..+ +||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM-KHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhc-CCCchhhhhhhhcccccccc
Confidence 456788899999999999999988 678999999864322 2345567888888888 999999999988643
Q ss_pred -CcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEecc
Q 045453 126 -RIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDF 204 (346)
Q Consensus 126 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Df 204 (346)
...+++++++ +++|.+++.. ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCC
Confidence 3468999998 6799888754 35899999999999999999999 899999999999999999999999999
Q ss_pred CCCcccCCCCceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHH
Q 045453 205 SLSVSIPEGETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKC 283 (346)
Q Consensus 205 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 283 (346)
|+++..... .....+|..|+|||++.+ ..++.++|||||||++|+|++|..||......+. +.... ..
T Consensus 163 g~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~~~-~~ 231 (343)
T cd07878 163 GLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ------LKRIM-EV 231 (343)
T ss_pred ccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH------HHHHH-HH
Confidence 998765432 234468999999999876 5689999999999999999999999975432111 10000 00
Q ss_pred hhcC-----------ccccccccccccCCCCcch----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 284 IENN-----------EFDEIVDPIIVSEGPRVGK----EKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 284 ~~~~-----------~~~~~~d~~l~~~~~~~~~----~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.... .....+. .+.. .+.... ......+.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 232 VGTPSPEVLKKISSEHARKYIQ-SLPH-MPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred hCCCCHHHHHhcchhhHHHHhh-cccc-ccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000 0000000 0000 000000 011234789999999999999999999885
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=289.59 Aligned_cols=256 Identities=22% Similarity=0.361 Sum_probs=202.2
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc-CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL-NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
++|+..+.||.|+||+||+|.. ++..+++|++.... ......+.+|+..+..+ +|+||+++++.+...+..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQC-NHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhc-CCCCEEEEEEEEeeCCEEEEEEe
Confidence 4688899999999999999998 67889999886443 23445677788878777 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
|+++++|.+++..... ...+++.....++.|++.||+||| +.+++|+||+|+||++++++.++|+|||++......
T Consensus 80 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 80 YLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred ccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 9999999999976432 135899999999999999999999 899999999999999999999999999998766543
Q ss_pred Cce---eeccccccCCcCCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcc
Q 045453 214 ETC---VKDKVTGTMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEF 289 (346)
Q Consensus 214 ~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (346)
... ......++..|+|||++... .++.++||||||+++|+|++|+.||........ ..... ...
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~~~~----~~~-- 223 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV------LMLTL----QND-- 223 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh------HHHHh----cCC--
Confidence 322 12334688899999999877 789999999999999999999999975433221 11100 000
Q ss_pred ccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 290 DEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 290 ~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.+.+.... .....+..+.+++..||+.+|++|||+.++++
T Consensus 224 ----~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 224 ----PPSLETGA---DYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ----CCCcCCcc---ccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00010000 01134567889999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=290.44 Aligned_cols=245 Identities=22% Similarity=0.315 Sum_probs=197.1
Q ss_pred CCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-----cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 59 FDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-----DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-----~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
|...+.||+|++|.||+|.. ++..+++|.+..... .....+..|+..+..+ +||||+++++++......++|
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc-CCCCchheeeeEecCCeEEEE
Confidence 66778999999999999998 688999998764331 2345677888888888 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
+||+++++|.+++... .++++..+..++.+++.||+||| +.+++|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 9999999999999764 35889999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCceeeccccccCCcCCccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINTGD-FNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
... ......++..|+|||.+.... ++.++|+||||+++|++++|..||........ ...........
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~----------~~~~~~~~~~~ 221 (258)
T cd06632 154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA----------VFKIGRSKELP 221 (258)
T ss_pred ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH----------HHHHHhcccCC
Confidence 332 223456888999999998776 89999999999999999999999975432110 01100000000
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.+ .......+.+++.+||+.+|++|||+.+++.
T Consensus 222 -----~~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 -----PI--------PDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred -----Cc--------CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 00 0123456788999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=290.71 Aligned_cols=248 Identities=20% Similarity=0.265 Sum_probs=193.6
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-----cchHHHHHHHHHHhhhcCCCceeeEcceeecC--Cc
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-----DGHEDCFNNIIFASKLSSHKNVLKLTGCCLET--RI 127 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-----~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~--~~ 127 (346)
++|...+.||+|+||.||+|.. ++..|++|.+..... .....+.+|+..+..+ +||||+++++++.+. ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-LHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhc-CCCCeeeEEeEeccCCCce
Confidence 5788899999999999999998 678999998753221 1234566788888888 999999999988763 45
Q ss_pred ceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCC
Q 045453 128 PVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS 207 (346)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~ 207 (346)
+++||||+++++|.+++.... .+++.....++.+++.||.||| +.+++|+||||+||+++.++.++|+|||++
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~ 153 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYG----ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGAS 153 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccc
Confidence 789999999999999987643 4788999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCce--eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhh
Q 045453 208 VSIPEGETC--VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIE 285 (346)
Q Consensus 208 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (346)
+........ ......++..|+|||.+.+..++.++||||||+++|+|++|+.||....... . +.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---------~-~~~~~~ 223 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA---------A-IFKIAT 223 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH---------H-HHHHhc
Confidence 765322111 1223458889999999998889999999999999999999999996432211 0 011000
Q ss_pred cCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 286 NNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 286 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.. ..+. .+......+.+++.+||. +|++|||+.|+++
T Consensus 224 ~~------------~~~~-~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 224 QP------------TNPV-LPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred CC------------CCCC-CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 00 0000 112445668889999994 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=289.92 Aligned_cols=250 Identities=23% Similarity=0.352 Sum_probs=199.1
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCc--chHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILND--GHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~--~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
.|+..+.||+|+||.||+|.. +++.+++|.+...... ....+..|+..+..+ +|+||+++++++...+..++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-KHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhC-CCCChhheeeeEecCCEEEEEEe
Confidence 367788999999999999987 6789999998755432 556778888888888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
|+++++|.+++... ..+++..+..++.+++.||.||| +.+++|+||+|+||++++++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 80 YCSGGTLEELLEHG----RILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred cCCCCcHHHHHhhc----CCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 99999999999764 24788999999999999999999 899999999999999999999999999998776543
Q ss_pred Cceeec---cccccCCcCCccccccCC---CCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcC
Q 045453 214 ETCVKD---KVTGTMGFLAPEYINTGD---FNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENN 287 (346)
Q Consensus 214 ~~~~~~---~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (346)
...... ...++..|+|||++.+.. ++.++||||||+++|++++|..||........ ....+. ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~------~~~~~~----~~ 222 (264)
T cd06626 153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ------IMFHVG----AG 222 (264)
T ss_pred CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH------HHHHHh----cC
Confidence 322111 345788999999998766 89999999999999999999999975432110 000000 00
Q ss_pred ccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 288 EFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 288 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
. .+.+. ........+.+++..||+.+|++|||+.|++.
T Consensus 223 ~-----~~~~~------~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 223 H-----KPPIP------DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred C-----CCCCC------cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0 00010 01122456789999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=308.79 Aligned_cols=200 Identities=21% Similarity=0.281 Sum_probs=173.5
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCC-----CceeeEcceeecCCcceE
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSH-----KNVLKLTGCCLETRIPVI 130 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h-----~niv~l~g~~~~~~~~~l 130 (346)
.|....+||+|+||.|-+|.+ +++.||||.+++.. ....+...|+.+|..+..| -|+|++++++...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 456678999999999999999 78999999988653 4556778888888888424 389999999999999999
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcC--CCceEEeccCCCc
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE--GYIAKLFDFSLSV 208 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~--~~~~kl~Dfgl~~ 208 (346)
|+|.+.. +|.++|+.+.- ..++...+..++.||+.||.+|| ..+|||+||||+||||.. ...+||+|||.|+
T Consensus 266 VfELL~~-NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eehhhhh-hHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccccc
Confidence 9999965 99999998764 56999999999999999999999 999999999999999963 3479999999998
Q ss_pred ccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc
Q 045453 209 SIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDE 268 (346)
Q Consensus 209 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~ 268 (346)
.....-. ....+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+.+..+
T Consensus 340 ~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~D 395 (586)
T KOG0667|consen 340 FESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYD 395 (586)
T ss_pred ccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHH
Confidence 7643322 4567789999999999999999999999999999999999998776543
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=294.03 Aligned_cols=264 Identities=18% Similarity=0.238 Sum_probs=200.0
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
+|...+.||+|++|.||+|.+ ++..+++|++.... ......+.+|+..+..+ +||||+++++++......++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC-QHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhC-CCCCCcceeeEEecCCeeEEEec
Confidence 467788999999999999998 67899999987543 23345677888888888 89999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
|+ +++|.+++.... .++++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++......
T Consensus 80 ~~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 80 YM-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred cc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 99 999999987654 46999999999999999999999 899999999999999999999999999998776544
Q ss_pred CceeeccccccCCcCCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcC-----
Q 045453 214 ETCVKDKVTGTMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENN----- 287 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 287 (346)
.........++..|+|||.+.+. .++.++||||+|+++++|++|.+||........ ...+.......
T Consensus 153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~ 225 (286)
T cd07832 153 EPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ-------LAIVFRTLGTPNEETW 225 (286)
T ss_pred CCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH-------HHHHHHHcCCCChHHH
Confidence 32223345688899999998754 468999999999999999999888865433211 11111110000
Q ss_pred -ccccccc--c-ccccCCCCc---chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 288 -EFDEIVD--P-IIVSEGPRV---GKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 288 -~~~~~~d--~-~l~~~~~~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.+.+..+ . ......... ..+.....+.+++.+||+.+|++|||+.+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 226 PGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0000000 0 000000000 00123477899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=291.67 Aligned_cols=251 Identities=18% Similarity=0.252 Sum_probs=194.2
Q ss_pred CCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC---c-------chHHHHHHHHHHhhhcCCCceeeEcceeecCC
Q 045453 59 FDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---D-------GHEDCFNNIIFASKLSSHKNVLKLTGCCLETR 126 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~-------~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~ 126 (346)
|...+.||+|+||.||+|.. +++.+|+|.+..... . ..+.+..|+..+..+ +|||++++++++...+
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DHLNIVQYLGFETTEE 81 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhc-CCCCcceEEEEeccCC
Confidence 55678999999999999987 678999998753211 1 123456777878887 9999999999999999
Q ss_pred cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCC
Q 045453 127 IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSL 206 (346)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl 206 (346)
..++||||+++++|.+++... ..+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++++|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeeccc
Confidence 999999999999999999765 35899999999999999999999 89999999999999999999999999999
Q ss_pred CcccCCCCce-eeccccccCCcCCccccccCC--CCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHH
Q 045453 207 SVSIPEGETC-VKDKVTGTMGFLAPEYINTGD--FNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKC 283 (346)
Q Consensus 207 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 283 (346)
+......... ......++..|+|||++.... ++.++||||||+++|++++|..||......+. .. ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---------~~-~~ 224 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA---------MF-KL 224 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH---------HH-Hh
Confidence 8765432111 123445788999999987654 89999999999999999999999964322110 00 00
Q ss_pred hhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 284 IENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 284 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
..... ...+... ........+.+++..||+.+|++|||+.+|+.
T Consensus 225 ~~~~~-~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 225 GNKRS-APPIPPD--------VSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred hcccc-CCcCCcc--------ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 00000 0000000 01134567889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=296.49 Aligned_cols=264 Identities=22% Similarity=0.337 Sum_probs=197.3
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCc--chHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILND--GHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~--~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
++|+..+.||+|+||.||+|.+ .++.+|+|++...... ....+.+|+..+..+ +||||+++++++...+..++||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-RHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhc-CCcchhhHHHhcccCCeEEEEE
Confidence 4678889999999999999999 5789999987643322 234567788888887 9999999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
||+++++|.++.... ..++|..++.++.|++.||+||| +.+++|+||+|+||++++++.++|+|||++.....
T Consensus 80 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 80 EFVDHTVLDDLEKYP----NGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred ecCCccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 999998888876543 24899999999999999999999 88999999999999999999999999999876644
Q ss_pred CCceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcC----
Q 045453 213 GETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENN---- 287 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 287 (346)
... ......++..|+|||++.+ ..++.++||||||+++|||++|..||......+. ... .......-
T Consensus 153 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~------~~~-~~~~~~~~~~~~ 224 (286)
T cd07846 153 PGE-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQ------LYH-IIKCLGNLIPRH 224 (286)
T ss_pred Ccc-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHH------HHH-HHHHhCCCchhh
Confidence 332 2233457889999999875 4578899999999999999999999965432110 000 00000000
Q ss_pred ----ccccccccccccCCCCc-----chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 288 ----EFDEIVDPIIVSEGPRV-----GKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 288 ----~~~~~~d~~l~~~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
......+.......... ..+.....+.+++.+||+.+|++|||+.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 225 QEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000000000000000 01134567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=294.05 Aligned_cols=246 Identities=19% Similarity=0.298 Sum_probs=197.5
Q ss_pred CCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEeccc
Q 045453 59 FDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVK 136 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~ 136 (346)
|...+.||+|++|.||++.. +++.+++|++..........+.+|+..+..+ +|||++++++++...+..++|+||++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~-~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDY-QHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHc-CCCChheEEEEEEcCCeEEEEEeccC
Confidence 45567999999999999987 6789999988654444455677888888887 99999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCce
Q 045453 137 NRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETC 216 (346)
Q Consensus 137 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 216 (346)
+++|.+++... ++++..+..++.+++.||+||| +.+++||||+|+||+++.++.++|+|||++........
T Consensus 100 ~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~- 170 (285)
T cd06648 100 GGALTDIVTHT-----RMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP- 170 (285)
T ss_pred CCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-
Confidence 99999998762 4889999999999999999999 89999999999999999999999999998876543222
Q ss_pred eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccccc
Q 045453 217 VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPI 296 (346)
Q Consensus 217 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 296 (346)
......++..|+|||...+..++.++||||||+++|+|++|..||....... ...... .... +.
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~----------~~~~~~-~~~~-----~~ 234 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ----------AMKRIR-DNLP-----PK 234 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH----------HHHHHH-hcCC-----CC
Confidence 1233458899999999998889999999999999999999999996532211 111111 0100 00
Q ss_pred cccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 297 IVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 297 l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
+.. .......+.+++.+||+.+|++|||+.++++
T Consensus 235 ~~~------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 235 LKN------LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred Ccc------cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 000 0123457899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=294.98 Aligned_cols=264 Identities=15% Similarity=0.178 Sum_probs=194.9
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
+|...+.||+|+||.||+|.+ ++..+++|.+..... .....+.+|+..+..+ +||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhc-CCCCeeeHHHHhccCCceEEEEe
Confidence 367788999999999999999 788999998864322 2234567788888888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
|+++ +|.+++.... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|||+++.....
T Consensus 80 ~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 80 YCDQ-DLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 152 (284)
T ss_pred cCCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence 9974 8888876543 35899999999999999999999 899999999999999999999999999998765433
Q ss_pred CceeeccccccCCcCCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCc----
Q 045453 214 ETCVKDKVTGTMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE---- 288 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 288 (346)
.. ......++..|+|||.+.+. .++.++||||||+++|+|+||..|+......+. .............
T Consensus 153 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~ 225 (284)
T cd07839 153 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD------QLKRIFRLLGTPTEESW 225 (284)
T ss_pred CC-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH------HHHHHHHHhCCCChHHh
Confidence 22 12334578899999998764 478999999999999999999988654333211 0011100000000
Q ss_pred --cccccccccccCCCC-----cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 289 --FDEIVDPIIVSEGPR-----VGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 289 --~~~~~d~~l~~~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.....+.......+. ...+.....+.+++.+||+.+|.+|||+.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 226 PGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred HHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000000000000000 000123467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=315.78 Aligned_cols=254 Identities=20% Similarity=0.330 Sum_probs=212.9
Q ss_pred CCcccccccCCCcEEEEEEE--CC----eEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 59 FDARNVIKDGYAYKFYKGFV--ED----RTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~~--~~----~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
....++||+|+||+||+|.| ++ -+||+|++..... ....+++.|+..+.++ +|||+++++|+|.... +.||
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masl-dHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASL-DHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcC-CCchHHHHhhhcccch-HHHH
Confidence 34578999999999999999 43 3889998876543 4567788888888888 9999999999998776 8899
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
++||+.|+|.++++.++ .++.....+.|+.|||+|+.||| .++++||||...|||+.+-.++|+.|||+++.+.
T Consensus 776 tq~mP~G~LlDyvr~hr---~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHR---DNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HHhcccchHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 99999999999999876 56888999999999999999999 9999999999999999999999999999999887
Q ss_pred CCCc-eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCcc
Q 045453 212 EGET-CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEF 289 (346)
Q Consensus 212 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (346)
.+.. .......-.+.|||-|.+....|+.+||||||||++||++| |..|+++...+++ ...++.+
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI-----------~dlle~g-- 916 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI-----------PDLLEKG-- 916 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh-----------hHHHhcc--
Confidence 5543 22333344568999999999999999999999999999999 9999998766554 1111111
Q ss_pred ccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 290 DEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 290 ~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
.....++.+.-.+..++.+||..|++.||+++++..+...+.+.
T Consensus 917 -----------eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 917 -----------ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred -----------ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 11223347788899999999999999999999999999887654
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=290.60 Aligned_cols=245 Identities=24% Similarity=0.338 Sum_probs=197.0
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEec
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFES 134 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~ 134 (346)
-|+..+.||+|+||.||+|.. ++..+|+|....... .....+.+|+..+..+ +||||+++++++..+...++||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhc-CCCCEeEEEEEEEeCCeEEEEEEe
Confidence 366778899999999999987 678999998764332 3345566788888887 999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCC
Q 045453 135 VKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE 214 (346)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~ 214 (346)
+++++|.+++... .+++..+..++.+++.|+.||| ..+++|+||+|+||+++.++.++++|||++..+....
T Consensus 84 ~~~~~l~~~i~~~-----~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 84 LGGGSALDLLEPG-----PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence 9999999998642 5899999999999999999999 8999999999999999999999999999987664332
Q ss_pred ceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccc
Q 045453 215 TCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVD 294 (346)
Q Consensus 215 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 294 (346)
. ......++..|+|||.+.+..++.++||||||+++|+|++|..||....... ... . ......
T Consensus 156 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-------~~~---~-~~~~~~----- 218 (277)
T cd06641 156 I-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK-------VLF---L-IPKNNP----- 218 (277)
T ss_pred h-hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH-------HHH---H-HhcCCC-----
Confidence 1 1233467889999999998889999999999999999999999996433211 111 0 000100
Q ss_pred cccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 295 PIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 295 ~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
+.+ ....+..+.+++.+||+.+|++||++.+++.
T Consensus 219 ~~~--------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 219 PTL--------EGNYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred CCC--------CcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 000 1134466889999999999999999999988
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=292.26 Aligned_cols=267 Identities=17% Similarity=0.207 Sum_probs=196.1
Q ss_pred HhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
++++|...+.||+|+||.||+|.. +++.+++|.+..... .....+.+|+..+..+ +|+||+++++++..++..++|
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL-KHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhc-CCCCEeEEEEEEecCCeEEEE
Confidence 457888999999999999999987 688999999865432 2234567788888888 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+. ++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||||+|||++.++.+||+|||+++...
T Consensus 82 ~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 82 FEYMH-TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred Eeccc-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 99996 67877775443 35788899999999999999999 8899999999999999999999999999987653
Q ss_pred CCCceeeccccccCCcCCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcC---
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENN--- 287 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 287 (346)
.... ......++..|+|||.+.+. .++.++||||||+++|+|++|..||........ .+... ...+...
T Consensus 155 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~-----~~~~~-~~~~~~~~~~ 227 (291)
T cd07870 155 IPSQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE-----QLEKI-WTVLGVPTED 227 (291)
T ss_pred CCCC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH-----HHHHH-HHHcCCCChh
Confidence 3221 12334578899999998754 578899999999999999999999975443211 11111 0000000
Q ss_pred ------ccccccccccccCCCCc-----chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 288 ------EFDEIVDPIIVSEGPRV-----GKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 288 ------~~~~~~d~~l~~~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
..............+.. ........+.+++.+|++.+|++|||+.|++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 228 TWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000000000000000 00012356789999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=290.58 Aligned_cols=261 Identities=18% Similarity=0.233 Sum_probs=194.6
Q ss_pred CCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc-CcchHHHHHHHHHHhhhcCCCceeeEcceeecC--CcceEEEe
Q 045453 59 FDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL-NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLET--RIPVIVFE 133 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~--~~~~lv~e 133 (346)
|+..+.||+|+||.||+|.. ++..+|+|++.... ........+|+..+.++..|||++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 45678899999999999998 78899999887543 223334567888888885699999999999887 88999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
|++ ++|.+.+.... ..++|..+..++.|++.||.||| +.+++|+||+|+||+++. +.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 997 58888886643 36899999999999999999999 899999999999999999 99999999998776433
Q ss_pred CceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHH----------
Q 045453 214 ETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKK---------- 282 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------- 282 (346)
.. .....++..|+|||++.. ..++.++|||||||++|||++|..||...+..+. ......
T Consensus 153 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~ 223 (282)
T cd07831 153 PP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ-------IAKIHDVLGTPDAEVL 223 (282)
T ss_pred CC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH-------HHHHHHHcCCCCHHHH
Confidence 22 123457889999997654 5578999999999999999999999976543221 111110
Q ss_pred -HhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 283 -CIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 283 -~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
............+..............+..+.+++.+||+.+|++|||+.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 224 KKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred HhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000000001100000000001134678999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=294.87 Aligned_cols=244 Identities=24% Similarity=0.367 Sum_probs=194.4
Q ss_pred CCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 59 FDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
|+..+.||+|+||.||+|.. ++..+|+|.+..... ....++.+|+..+..+ +|||++++++++.+.+..++|||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeCCeEEEEEe
Confidence 66788999999999999998 678999998864322 2334677888888888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
|+++ +|.+.+.... .+++|..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 106 ~~~g-~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 106 YCLG-SASDLLEVHK---KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred CCCC-CHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 9975 8888776543 46899999999999999999999 899999999999999999999999999988654322
Q ss_pred CceeeccccccCCcCCccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 214 ETCVKDKVTGTMGFLAPEYIN---TGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
....++..|+|||++. .+.++.++||||||+++|+|++|..||........ . .......
T Consensus 179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~----~~~~~~~--- 240 (317)
T cd06635 179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------L----YHIAQNE--- 240 (317)
T ss_pred -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH------H----HHHHhcc---
Confidence 2346788999999984 45689999999999999999999999865322111 0 1111110
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRL 338 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 338 (346)
.+..........+.+++.+||+.+|.+|||+.++++.+
T Consensus 241 ----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 241 ----------SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred ----------CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 00011113455689999999999999999999998743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=283.77 Aligned_cols=248 Identities=25% Similarity=0.373 Sum_probs=203.0
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecc
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESV 135 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~ 135 (346)
+|+..+.||+|++|.||++.. ++..+++|++..........+.+|+..+..+ +|||++++++++...+..++++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKC-KHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCCeEEEEEecC
Confidence 367788999999999999999 5789999998765544567788888888888 8999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCc
Q 045453 136 KNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGET 215 (346)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~ 215 (346)
++++|.+++.... ..+++..+..++.+++.||.+|| ..+++|+||+|+||+++.++.++|+|||.+........
T Consensus 80 ~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 80 SGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred CCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 9999999987653 46899999999999999999999 89999999999999999999999999999877654432
Q ss_pred eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccccc
Q 045453 216 CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDP 295 (346)
Q Consensus 216 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 295 (346)
.....++..|+|||.+.+..++.++||||||+++++|++|..||........ .... .......
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-------~~~~----~~~~~~~---- 216 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA-------LFKI----ATNGPPG---- 216 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH-------HHHH----HhcCCCC----
Confidence 3345688899999999988899999999999999999999999975432111 0000 0010000
Q ss_pred ccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 296 IIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 296 ~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
+. ........+.+++.+||+.+|++|||+.|+++
T Consensus 217 -~~------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 217 -LR------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred -cC------cccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 01022466899999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=288.47 Aligned_cols=248 Identities=24% Similarity=0.338 Sum_probs=198.4
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
+|+..+.||+|+||.||+|.. ++..+|+|.+.... ......+.+|+..+..+ +||||+++++++...+..++|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM-KHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhC-CCCChhhhhheeccCCeEEEEEe
Confidence 477788999999999999999 67889999876432 13345666788888888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCC-ceEEeccCCCcccCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGY-IAKLFDFSLSVSIPE 212 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~-~~kl~Dfgl~~~~~~ 212 (346)
|+++++|.+++..... ..+++..+..++.+++.||+||| +.+++|+||||+||++++++ .+||+|||.+.....
T Consensus 80 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 80 YCDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred cCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 9999999999976432 35899999999999999999999 89999999999999999885 569999999877654
Q ss_pred CCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccc
Q 045453 213 GETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEI 292 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (346)
... ......|++.|+|||+..+..++.++||||||++++++++|..||...... ..+..... ...
T Consensus 155 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----------~~~~~~~~-~~~--- 219 (257)
T cd08225 155 SME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH----------QLVLKICQ-GYF--- 219 (257)
T ss_pred Ccc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH----------HHHHHHhc-ccC---
Confidence 322 223345888999999999889999999999999999999999998643221 11111111 110
Q ss_pred cccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 293 VDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 293 ~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.+ . .+.....+.+++.+||+.+|++|||+.|+++
T Consensus 220 -~~-~--------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 220 -AP-I--------SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred -CC-C--------CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 00 0 0123456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=292.94 Aligned_cols=265 Identities=21% Similarity=0.296 Sum_probs=199.7
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
++|+..+.||+|++|.||+|.+ +++.|++|++..... .....+.+|+..+..+ +|+||+++++++...+..++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhc-CCCCeeehhheEEECCEEEEEE
Confidence 3688889999999999999998 578999998765432 3345677888888888 8999999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
||++++++..+.... ..+++..+..++.+++.||.||| ..+++|+||+|+||+++.++.+||+|||++.....
T Consensus 80 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 80 EYVERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRA 152 (288)
T ss_pred ecCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence 999986666555432 35899999999999999999999 89999999999999999999999999999887755
Q ss_pred CCceeeccccccCCcCCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCc--c
Q 045453 213 GETCVKDKVTGTMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE--F 289 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 289 (346)
..........++..|+|||++.+. .++.++||||||+++|+|++|..||......+. +.. ......... .
T Consensus 153 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~------~~~-~~~~~~~~~~~~ 225 (288)
T cd07833 153 RPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ------LYL-IQKCLGPLPPSH 225 (288)
T ss_pred CccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHH-HHHHhCCCCHHH
Confidence 443233445678899999999887 789999999999999999999999975433211 111 000000000 0
Q ss_pred c--ccccccccc-CCCC---------cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 290 D--EIVDPIIVS-EGPR---------VGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 290 ~--~~~d~~l~~-~~~~---------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
. ...++.... ..+. ..+...+..+.+++..||+.+|++|||+.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 226 QELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred hhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0 000000000 0000 001123577999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=291.04 Aligned_cols=251 Identities=21% Similarity=0.335 Sum_probs=202.5
Q ss_pred HhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
.+++|+..+.||+|++|.||+|.+ ++..+++|.+..... ....+.+|+..+..+ +|+|++++++++...+..++|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDC-KHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHC-CCCCeeEEEEEEEECCEEEEEE
Confidence 456688888999999999999999 588999999875433 456677888888888 9999999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
||+++++|.+++.... ..+++..+..++.+++.||+||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 95 EYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred eccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 9999999999998753 36999999999999999999999 89999999999999999999999999998765543
Q ss_pred CCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccc
Q 045453 213 GETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEI 292 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (346)
... ......++..|+|||.+.+..++.++||||||+++|+|++|..||........ ..... ......
T Consensus 169 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~----------~~~~~-~~~~~~- 235 (286)
T cd06614 169 EKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA----------LFLIT-TKGIPP- 235 (286)
T ss_pred chh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH----------HHHHH-hcCCCC-
Confidence 221 12234577899999999988899999999999999999999999864332111 00000 000000
Q ss_pred cccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 293 VDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 293 ~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
..........+.+++.+||+.+|.+|||+.++++
T Consensus 236 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 236 ----------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred ----------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0011124567889999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=283.15 Aligned_cols=248 Identities=21% Similarity=0.322 Sum_probs=201.0
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCc--cCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDI--LNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
+++|+....||+|.|+.||++.. +|+.+|+|.++.. ...+.++..+|+.+-..+ +||||+++...+.+....++|
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~L-qHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhc-CCCcEeehhhhhcccceeEEE
Confidence 45677778999999999999988 8889998876533 234566777778888777 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEc---CCCceEEeccCCCc
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLD---EGYIAKLFDFSLSV 208 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~---~~~~~kl~Dfgl~~ 208 (346)
+|+|.|++|..-+-.+ ..+++...-..+.||+.+|.|.| ..+|||||+||+|+|+- ...-+||+|||++.
T Consensus 89 Fe~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred EecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEE
Confidence 9999999997766554 35788889999999999999999 99999999999999995 34468999999998
Q ss_pred ccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCc
Q 045453 209 SIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE 288 (346)
Q Consensus 209 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (346)
.+..+ .......||++|||||++...+|+..+|||+.||+||-++.|..||.+.+....
T Consensus 162 ~l~~g--~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rl------------------- 220 (355)
T KOG0033|consen 162 EVNDG--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL------------------- 220 (355)
T ss_pred EeCCc--cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHH-------------------
Confidence 88732 234567899999999999999999999999999999999999999986444221
Q ss_pred cccccccccccCCCCcc--hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 289 FDEIVDPIIVSEGPRVG--KEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 289 ~~~~~d~~l~~~~~~~~--~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
....+.+.+..++ -+...++..+|+.+||..||.+|.|+.|.++
T Consensus 221 ----ye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 221 ----YEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ----HHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 1111112211111 1144577889999999999999999998763
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=298.57 Aligned_cols=248 Identities=22% Similarity=0.298 Sum_probs=207.2
Q ss_pred HhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcce
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV 129 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~ 129 (346)
..+.|..-++||+||||.||-+.. +|..+|.|++.+.. ..+..-.++|-.++.++ +.+.||.+-..+.+.+.+|
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV-~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKV-SSPFIVSLAYAFETKDALC 261 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHh-ccCcEEEEeeeecCCCceE
Confidence 347788899999999999997766 89999999876543 24455567888888888 9999999999999999999
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcc
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVS 209 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~ 209 (346)
||+..|.||+|.-+|.+.+. +.+++...+.++.+|+.||.+|| ..+||+|||||+|||+|++|+++|+|.|||..
T Consensus 262 lVLtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred EEEEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEe
Confidence 99999999999999988764 56999999999999999999999 99999999999999999999999999999998
Q ss_pred cCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcc
Q 045453 210 IPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEF 289 (346)
Q Consensus 210 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (346)
+..+.. ....+||.+|||||++.++.|+.+.|+||+||++|||+.|..||........
T Consensus 337 i~~g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk-------------------- 394 (591)
T KOG0986|consen 337 IPEGKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK-------------------- 394 (591)
T ss_pred cCCCCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh--------------------
Confidence 876665 3445899999999999999999999999999999999999999976544332
Q ss_pred ccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCH
Q 045453 290 DEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTT 331 (346)
Q Consensus 290 ~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 331 (346)
.+-+|++........ +...+++..+|....|+.||++|.-.
T Consensus 395 ~eEvdrr~~~~~~ey-~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 395 REEVDRRTLEDPEEY-SDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred HHHHHHHHhcchhhc-ccccCHHHHHHHHHHHccCHHHhccC
Confidence 112333322221111 13667788899999999999999653
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=291.86 Aligned_cols=264 Identities=18% Similarity=0.179 Sum_probs=196.5
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCc-----chHHHHHHHHHHhhhcCCCceeeEcceeecCCcceE
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILND-----GHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVI 130 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~-----~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~l 130 (346)
+|+..+.||+|++|.||+|.+ +++.|++|++...... ....+..|+..+..+ +|+||+++++++.+.+..++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-KHPNIIGLLDVFGHKSNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhc-CCCCChhhhheeecCCEEEE
Confidence 367778999999999999998 6789999998754322 233456777888887 99999999999999999999
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCccc
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI 210 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~ 210 (346)
||||+ +|+|.+++.... ..+++..++.++.|+++||+||| +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 80 v~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 80 VFEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSF 152 (298)
T ss_pred EEccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeec
Confidence 99999 889999997643 36999999999999999999999 899999999999999999999999999998776
Q ss_pred CCCCceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHh-----
Q 045453 211 PEGETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCI----- 284 (346)
Q Consensus 211 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 284 (346)
..... ......++..|+|||.+.+ ..++.++||||||++++||++|..||......+. +........
T Consensus 153 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~------~~~~~~~~~~~~~~ 225 (298)
T cd07841 153 GSPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ------LGKIFEALGTPTEE 225 (298)
T ss_pred cCCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH------HHHHHHHcCCCchh
Confidence 54322 1122346778999998865 4678999999999999999999887765433111 111100000
Q ss_pred ---hcCccccccccccccCCC-CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 285 ---ENNEFDEIVDPIIVSEGP-RVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 285 ---~~~~~~~~~d~~l~~~~~-~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.................+ ..........+.+++.+||+.+|++|||+.||++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 226 NWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred hhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 000000000000000000 0000133567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=309.03 Aligned_cols=248 Identities=22% Similarity=0.331 Sum_probs=207.6
Q ss_pred CcccccccCCCcEEEEEEE---CC--eEEEEEEecCccCc-chHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 60 DARNVIKDGYAYKFYKGFV---ED--RTVSVMKFNDILND-GHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 60 ~~~~~ig~G~~g~Vy~~~~---~~--~~vavk~~~~~~~~-~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
...+.||+|.||.|++|.| .| -.||||.+...... ....|.+|+..+.++ +|||+++|||+..+ ....+|+|
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L-~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKL-QHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhc-cCcceeEEeeeecc-chhhHHhh
Confidence 3456899999999999999 23 47899998876543 678899999999999 99999999999987 77899999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
+++.|||.+.|+... ...+.....-.++.|||.|+.||. ++++|||||...|+|+-..-.+||+||||.+.++..
T Consensus 191 LaplGSLldrLrka~--~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRKAK--KAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hcccchHHHHHhhcc--ccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 999999999998822 356888899999999999999999 999999999999999999999999999999999866
Q ss_pred Cceee--ccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 214 ETCVK--DKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 214 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
+.... ....-.+.|.|||-+..+.++.+||||+|||++|||+| |+.||-+.....+ .
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qI--------------------L 325 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQI--------------------L 325 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHH--------------------H
Confidence 54332 23345678999999999999999999999999999999 9999987655332 1
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRL 338 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 338 (346)
..+| .......+..+++.++++++.||+.+|++|||+..+.+.+
T Consensus 326 ~~iD----~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 326 KNID----AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred Hhcc----ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 1222 1111222337889999999999999999999999997543
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=318.85 Aligned_cols=267 Identities=22% Similarity=0.346 Sum_probs=218.4
Q ss_pred HHHHHhcCCCcccccccCCCcEEEEEEEC---------CeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcc
Q 045453 51 ELEIATNNFDARNVIKDGYAYKFYKGFVE---------DRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTG 120 (346)
Q Consensus 51 ~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~---------~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g 120 (346)
.|+...++....+.||+|.||.|++|... ...||||.+..... .....+..|+..+..+..||||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 56777777777789999999999999861 45899999875543 456778899999999999999999999
Q ss_pred eeecCCcceEEEecccCCChhhhhhhcC---C-------CC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCC
Q 045453 121 CCLETRIPVIVFESVKNRTLADHIYQNQ---P-------HF--EPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRP 188 (346)
Q Consensus 121 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~-------~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp 188 (346)
+|...+..++|+||+..|+|.++|+..+ . .. ..++....+.++.|||.|+.||+ +.+++||||..
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhh
Confidence 9999999999999999999999998765 0 00 23889999999999999999999 99999999999
Q ss_pred CCeEEcCCCceEEeccCCCcccCCCCceeeccccc--cCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCC
Q 045453 189 SRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTG--TMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSR 265 (346)
Q Consensus 189 ~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~ 265 (346)
.|||+.++..+|++|||+++.......+......+ ...|||||-+....|+.+|||||||++|||++| |..||.+..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 99999999999999999999776666554433333 446999999999999999999999999999999 999997632
Q ss_pred CcccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 045453 266 GDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQ 343 (346)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 343 (346)
..+ .. ...+.++ .....+..+..++.++++.||+.+|++||++.++++.++.++.
T Consensus 527 ~~~---------~l-~~~l~~G-------------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 527 PTE---------EL-LEFLKEG-------------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred cHH---------HH-HHHHhcC-------------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 111 11 1122222 1111222557789999999999999999999999999998653
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=292.42 Aligned_cols=242 Identities=18% Similarity=0.235 Sum_probs=196.9
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
++|+..+.||+|++|.||++.+ +++.+|+|.+..... .....+.+|+..+..+ +||||+++++++.+++..++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHPFLVNLYGSFQDDSNLYLV 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCccceeeEEEcCCeEEEE
Confidence 4688889999999999999998 678999998864321 2345567788888888 899999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||+|+|||++.++.+||+|||++....
T Consensus 80 ~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 152 (290)
T cd05580 80 MEYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK 152 (290)
T ss_pred EecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence 9999999999999765 35899999999999999999999 8999999999999999999999999999987765
Q ss_pred CCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccc
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDE 291 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (346)
.. .....+++.|+|||.+.+..++.++||||||+++|+|++|..||........ ..... .+.
T Consensus 153 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----------~~~~~-~~~--- 214 (290)
T cd05580 153 GR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI----------YEKIL-EGK--- 214 (290)
T ss_pred CC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH----------HHHHh-cCC---
Confidence 43 2344688999999999888899999999999999999999999975432110 00000 110
Q ss_pred ccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHH
Q 045453 292 IVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRP-----TTVDVA 335 (346)
Q Consensus 292 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~ 335 (346)
..+ +......+.+++.+||+.+|.+|| ++.|++
T Consensus 215 ---~~~--------~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 215 ---VRF--------PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred ---ccC--------CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 000 012245688999999999999999 556654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=289.64 Aligned_cols=260 Identities=17% Similarity=0.216 Sum_probs=196.5
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
+|+..+.||.|++|.||+|.. ++..+++|++..... .....+.+|+..+..+ +||||+++++++.+.+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhc-CCCCCcchhhhcccCCcEEEEee
Confidence 578889999999999999998 688999998764432 2335677889999998 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
|+. ++|.+++..... ..+++..+..++.+++.||+||| ..+++|+||+|+||+++.++.+||+|||++......
T Consensus 80 ~~~-~~l~~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 80 FLH-QDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 153 (284)
T ss_pred ccc-cCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 996 589988865432 46899999999999999999999 899999999999999999999999999998765432
Q ss_pred CceeeccccccCCcCCccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhc------
Q 045453 214 ETCVKDKVTGTMGFLAPEYINTGD-FNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIEN------ 286 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------ 286 (346)
.. ......++..|+|||++.+.. ++.++||||||+++|+|+||+.||....... .........-..
T Consensus 154 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07860 154 VR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID------QLFRIFRTLGTPDEVVWP 226 (284)
T ss_pred cc-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHHHhCCCChhhhh
Confidence 21 122334678899999887644 6889999999999999999999997543211 111111100000
Q ss_pred ---------CccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 287 ---------NEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 287 ---------~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
..+.......+... .+.....+.+++.+||+.||++|||+.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 227 GVTSLPDYKPSFPKWARQDFSKV-----VPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhhHHHHHHhhcccccccCHHHH-----cccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000000000 0022355789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=290.36 Aligned_cols=273 Identities=19% Similarity=0.236 Sum_probs=198.1
Q ss_pred CCcccccccCCCcEEEEEEE----CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecC--Ccce
Q 045453 59 FDARNVIKDGYAYKFYKGFV----EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLET--RIPV 129 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~~----~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~--~~~~ 129 (346)
|...+.||+|++|.||+|.. .+..+|+|.+.... ........+|+..+..+ +||||+++++++.+. ...+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-KHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhc-CCCCccceEEEEeCCCCceEE
Confidence 66778899999999999998 46899999987632 33345677888888888 999999999999988 7899
Q ss_pred EEEecccCCChhhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcC----CCceEEecc
Q 045453 130 IVFESVKNRTLADHIYQNQPH-FEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE----GYIAKLFDF 204 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~----~~~~kl~Df 204 (346)
+||||+++ +|.+.+...... ...+++..++.++.|++.||+||| +.+++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 777776543222 136889999999999999999999 899999999999999999 999999999
Q ss_pred CCCcccCCCCc--eeeccccccCCcCCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchh---hHHH
Q 045453 205 SLSVSIPEGET--CVKDKVTGTMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHY---WLLH 278 (346)
Q Consensus 205 gl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~---~~~~ 278 (346)
|++........ .......++..|+|||++.+. .++.++||||||+++++|++|..||............. .+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99887643322 112344678899999988764 58999999999999999999999998765543111111 1111
Q ss_pred HHHHHhh-----------cCccccccccccccCCCCcchH-------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 279 YVKKCIE-----------NNEFDEIVDPIIVSEGPRVGKE-------KQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 279 ~~~~~~~-----------~~~~~~~~d~~l~~~~~~~~~~-------~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.+..... ........+.......+..... .....+.+++.+||+.+|++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1111000 0000000000000000000000 12346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=288.50 Aligned_cols=241 Identities=17% Similarity=0.237 Sum_probs=184.5
Q ss_pred ccccCCCcEEEEEEE--CCeEEEEEEecCccC--cc-hHHHHHHHHHH--hhhcCCCceeeEcceeecCCcceEEEeccc
Q 045453 64 VIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DG-HEDCFNNIIFA--SKLSSHKNVLKLTGCCLETRIPVIVFESVK 136 (346)
Q Consensus 64 ~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~-~~~~~~e~~~~--~~~~~h~niv~l~g~~~~~~~~~lv~e~~~ 136 (346)
+||+|+||.||++.. ++..+|+|.+..... .. ......+...+ ....+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999998 678999998865432 11 12223332222 222379999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCce
Q 045453 137 NRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETC 216 (346)
Q Consensus 137 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 216 (346)
+|+|.+++... ..+++..+..++.|++.||.||| +.+++|+||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQH----GVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 99999998764 35999999999999999999999 8999999999999999999999999999987554322
Q ss_pred eeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccccc
Q 045453 217 VKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDP 295 (346)
Q Consensus 217 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 295 (346)
.....|+..|+|||.+.+ ..++.++||||||+++++|++|..||......... . ...... ....
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-------~-~~~~~~------~~~~ 216 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-------E-IDRMTL------TVNV 216 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-------H-HHHHhh------cCCc
Confidence 223468999999999874 56899999999999999999999999765432210 0 000000 0000
Q ss_pred ccccCCCCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 045453 296 IIVSEGPRVGKEKQLQGFRELALMCVCESAEDRP-----TTVDVAK 336 (346)
Q Consensus 296 ~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~ 336 (346)
.+ +...+..+.+++.+||+.+|++|| |+.|+++
T Consensus 217 ~~--------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 217 EL--------PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred CC--------ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 01 113456788999999999999999 5887765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=290.98 Aligned_cols=268 Identities=16% Similarity=0.174 Sum_probs=196.6
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecCCc-----
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRI----- 127 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~----- 127 (346)
++|+..+.||+|+||.||+|.+ ++..||+|+...... .....+.+|+..+..+.+||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4688899999999999999998 688999998765432 2345677888888888567999999999887665
Q ss_pred ceEEEecccCCChhhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcC-CCceEEeccC
Q 045453 128 PVIVFESVKNRTLADHIYQNQPH-FEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE-GYIAKLFDFS 205 (346)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~-~~~~kl~Dfg 205 (346)
.++||||+++ +|.+++...... ...+++..++.++.|++.||.||| +.+++||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 898888654322 346899999999999999999999 899999999999999998 8999999999
Q ss_pred CCcccCCCCceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHh
Q 045453 206 LSVSIPEGETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCI 284 (346)
Q Consensus 206 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (346)
++........ ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||......+. +...... .
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~------~~~~~~~-~ 228 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ------LLHIFKL-L 228 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHHHH-h
Confidence 9876533211 1223356788999998865 4579999999999999999999999975432211 1111110 0
Q ss_pred hcCcc---ccccccccccCCCC-------cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 285 ENNEF---DEIVDPIIVSEGPR-------VGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 285 ~~~~~---~~~~d~~l~~~~~~-------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
..... .....-......+. ...+.....+.+++.+||+.+|.+|||+.|++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000 00000000000000 000124566889999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=289.46 Aligned_cols=262 Identities=19% Similarity=0.298 Sum_probs=195.5
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
++|+..+.||+|++|.||+|.. ++..||+|.+..... .....+.+|+..+..+ +||||+++++++.+.+..++|||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDL-KHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhC-CCcceeeEEEEEecCCeEEEEEe
Confidence 5688889999999999999998 678999999865432 2234566788888888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
|+++ +|.+++.... ..+++.....++.|++.||.||| +.+++|+||||+||+++.++.+||+|||+++.....
T Consensus 84 ~~~~-~L~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 84 YLDT-DLKQYMDDCG---GGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred cCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 9975 9999887654 36889999999999999999999 899999999999999999999999999998754322
Q ss_pred CceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcC-----
Q 045453 214 ETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENN----- 287 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 287 (346)
.. ......++..|+|||++.+ ..++.++||||||+++|+|++|..||........ ............
T Consensus 157 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~ 229 (291)
T cd07844 157 SK-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED------QLHKIFRVLGTPTEETW 229 (291)
T ss_pred Cc-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH------HHHHHHHhcCCCChhhh
Confidence 21 1122346788999999875 4589999999999999999999999975442110 000010100000
Q ss_pred -------ccccc-----cccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 288 -------EFDEI-----VDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 288 -------~~~~~-----~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
..... ....+....... .....+.+++..||+.+|++|||+.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 230 PGVSSNPEFKPYSFPFYPPRPLINHAPRL---DRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhhhhccccccccccccCChhHHHhCcCC---CCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000 000000000000 11256789999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=286.98 Aligned_cols=243 Identities=20% Similarity=0.174 Sum_probs=189.4
Q ss_pred cccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccC
Q 045453 63 NVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKN 137 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~ 137 (346)
+.||+|+||.||+|.. .++.+|+|.+..... ........|...+....+|||++++++++.+++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999999999998 678999998864321 12233455555555555899999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCcee
Q 045453 138 RTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCV 217 (346)
Q Consensus 138 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 217 (346)
++|.+++.... ++++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 99999997643 5889999999999999999999 89999999999999999999999999998875432
Q ss_pred eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccccccc
Q 045453 218 KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPII 297 (346)
Q Consensus 218 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 297 (346)
.....++..|+|||...+..++.++||||||+++|+|++|..||........ .... ......
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----------~~~~-~~~~~~------- 211 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV----------FDNI-LSRRIN------- 211 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH----------HHHH-HhcccC-------
Confidence 2234578899999999988899999999999999999999999975433211 1110 001000
Q ss_pred ccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 045453 298 VSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRL 338 (346)
Q Consensus 298 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 338 (346)
.+..........+.+++.+||+.+|++|||+.++.+.|
T Consensus 212 ---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 212 ---WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred ---CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 00000113356689999999999999999887665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=285.35 Aligned_cols=248 Identities=19% Similarity=0.278 Sum_probs=202.2
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
+|+..+.||+|++|.||++.. ++..+++|.+.... .....++..|+..+..+ +||||+++++++.+....++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV-NHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhC-CCCCchhhhhhhccCCEEEEEeh
Confidence 477788999999999999988 67899999876432 23345667788888888 89999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
|+++++|.+++.........+++..++.++.+++.||+||| +.+++|+||+|+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 99999999998774433357899999999999999999999 899999999999999999999999999998776543
Q ss_pred CceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccc
Q 045453 214 ETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIV 293 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (346)
......++..|+|||.+.+..++.++|+||||+++|++++|..||......+. .. .......
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~-------~~----~~~~~~~---- 218 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL-------RY----KVQRGKY---- 218 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HH----HHhcCCC----
Confidence 22334578899999999998999999999999999999999999975433211 00 0111111
Q ss_pred ccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 294 DPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 294 d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
+.. .......+.+++..||+.+|++|||+.++++
T Consensus 219 --------~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 219 --------PPI-PPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred --------CCC-chhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 111 1145567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=291.46 Aligned_cols=255 Identities=19% Similarity=0.298 Sum_probs=192.5
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEec
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFES 134 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~ 134 (346)
+|.....||+|+||.||++.+ +++.+|+|++..... .....+.+|+..+.++..||||+++++++...+..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 445567899999999999998 678999999864432 34456778888888885599999999999999999999999
Q ss_pred ccCCChhhhhhhc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 135 VKNRTLADHIYQN-QPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 135 ~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
+.. +|.++.... ......+++.....++.+++.||+|||+ ..+++||||||+||+++.++.+||+|||++......
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 655543211 0011468999999999999999999993 358999999999999999999999999998765432
Q ss_pred CceeeccccccCCcCCccccccC---CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 214 ETCVKDKVTGTMGFLAPEYINTG---DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
.. .....++..|+|||++.+. .++.++||||||+++|+|++|+.||..... ....+..... ..
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---------~~~~~~~~~~-~~-- 227 (288)
T cd06616 162 IA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS---------VFDQLTQVVK-GD-- 227 (288)
T ss_pred Cc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch---------HHHHHhhhcC-CC--
Confidence 21 2234678899999999876 689999999999999999999999964321 0111111100 00
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.+.+.... ....+..+.+|+.+||+.+|++|||+.+|++
T Consensus 228 ---~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 228 ---PPILSNSE----EREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred ---CCcCCCcC----CCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01111110 0134567899999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=294.14 Aligned_cols=266 Identities=21% Similarity=0.284 Sum_probs=196.3
Q ss_pred CCcccccccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHHHHHH--HhhhcCCCceeeEcceeecCC----cceEEE
Q 045453 59 FDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIF--ASKLSSHKNVLKLTGCCLETR----IPVIVF 132 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~--~~~~~~h~niv~l~g~~~~~~----~~~lv~ 132 (346)
.....+||+|+||.||+|.+.++.||||++... ....+..|-.+ +..+ .|+||++|++.-..+. +++||+
T Consensus 212 l~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m-~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGM-KHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hhhHHHhhcCccceeehhhccCceeEEEecCHH---HHHHHHhHHHHHhccCc-cchhHHHhhchhccCCccccceeEEe
Confidence 345578999999999999999999999999754 23444444333 3344 8999999999866555 889999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCCceecCCCCCCeEEcCCCceEEeccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIG------FSRPILHRKIRPSRIFLDEGYIAKLFDFSL 206 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl 206 (346)
+|-+.|||.++|..+ .++|....+|+..+++||+|||+. ..++|+|||||+.||||.+|+++.|+|||+
T Consensus 288 ~fh~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eeccCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 999999999999875 599999999999999999999952 345799999999999999999999999999
Q ss_pred CcccCCCCce-eeccccccCCcCCccccccCC-C-----CcccchHHHHHHHHHHHhCCCCCCCC--------CCccccc
Q 045453 207 SVSIPEGETC-VKDKVTGTMGFLAPEYINTGD-F-----NEKCDVFSFGMLLLVLLTGQKIFDPS--------RGDEIGA 271 (346)
Q Consensus 207 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~-----~~~~Dv~s~G~vl~elltg~~p~~~~--------~~~~~~~ 271 (346)
|..+..+... .....+||..|||||++.+.- . -.+.||||+|.|||||++...-++.. ...+.+.
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 9887644332 223468999999999997632 2 23689999999999999977655421 1111111
Q ss_pred chhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 045453 272 GHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIY 342 (346)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~ 342 (346)
.. .+.+......... ..|.+.+..... .....+.+.+..||..||+.|.|+.-|.+++.++.
T Consensus 443 hP-t~e~mq~~VV~kK-----~RP~~p~~W~~h---~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 443 HP-TLEEMQELVVRKK-----QRPKIPDAWRKH---AGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred CC-CHHHHHHHHHhhc-----cCCCChhhhhcC---ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 10 1111111111111 111111111110 33566889999999999999999999999998875
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=306.67 Aligned_cols=245 Identities=22% Similarity=0.362 Sum_probs=196.6
Q ss_pred ccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccCCC
Q 045453 62 RNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRT 139 (346)
Q Consensus 62 ~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~gs 139 (346)
.-+||+|.||+||-|++ +...+|||-+....+....-...|+..-..+ +|.|||+++|+|.+++.+-+.||-+||||
T Consensus 580 rvVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~L-rHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 580 RVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTL-RHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred eEEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHH-hhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 34799999999999999 5567888888765544444444455555555 99999999999999999999999999999
Q ss_pred hhhhhhhcCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEc-CCCceEEeccCCCcccCCCCce
Q 045453 140 LADHIYQNQPHFEPL--LLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIAKLFDFSLSVSIPEGETC 216 (346)
Q Consensus 140 L~~~l~~~~~~~~~l--~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~-~~~~~kl~Dfgl~~~~~~~~~~ 216 (346)
|.++|... +.|+ ++.++-.+..||+.||.||| ...|||||||-+|||++ -.|.+||+|||-++.+..-..
T Consensus 659 LSsLLrsk---WGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP- 731 (1226)
T KOG4279|consen 659 LSSLLRSK---WGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP- 731 (1226)
T ss_pred HHHHHHhc---cCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCCc-
Confidence 99999864 3456 78899999999999999999 99999999999999996 678999999999877643222
Q ss_pred eeccccccCCcCCccccccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccc
Q 045453 217 VKDKVTGTMGFLAPEYINTG--DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVD 294 (346)
Q Consensus 217 ~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 294 (346)
.+....||..|||||++..+ +|..++|||||||.+.||.||++||........ ..+.-+-+. +.
T Consensus 732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA------------AMFkVGmyK--vH 797 (1226)
T KOG4279|consen 732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA------------AMFKVGMYK--VH 797 (1226)
T ss_pred cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH------------hhhhhccee--cC
Confidence 24567799999999999764 599999999999999999999999975443321 222222111 11
Q ss_pred cccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 295 PIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 295 ~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
|. -+.+.+.....++++|...+|.+||++.+++.
T Consensus 798 P~--------iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 798 PP--------IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CC--------CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 11 23377888999999999999999999999874
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=289.13 Aligned_cols=262 Identities=19% Similarity=0.234 Sum_probs=196.9
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecC--CcceE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLET--RIPVI 130 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~--~~~~l 130 (346)
++|+..+.||+|+||.||+|.+ ++..+++|.+..... .....+.+|+..+..+ +||||+++++++... +..++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL-QHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhc-CCCCEEEEEEEEEecCCCcEEE
Confidence 4688889999999999999999 578899998864432 2233566788888888 899999999998877 88999
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCccc
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI 210 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~ 210 (346)
||||+++ +|.+++.... ..+++..++.++.|++.||+||| +.+++|+||||+||+++.++.+||+|||++...
T Consensus 84 v~e~~~~-~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 84 VMEYVEH-DLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREY 156 (293)
T ss_pred EehhcCc-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence 9999975 9999887644 36899999999999999999999 899999999999999999999999999998876
Q ss_pred CCCCceeeccccccCCcCCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHh-----
Q 045453 211 PEGETCVKDKVTGTMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCI----- 284 (346)
Q Consensus 211 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 284 (346)
..... ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||........ .........
T Consensus 157 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~------~~~~~~~~~~~~~~ 229 (293)
T cd07843 157 GSPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ------LNKIFKLLGTPTEK 229 (293)
T ss_pred cCCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHHHhCCCchH
Confidence 54321 12234567889999998764 468999999999999999999999976543211 111000000
Q ss_pred -----hc------CccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 285 -----EN------NEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 285 -----~~------~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.. ..........+....+. ......+.+++.+||+.+|++|||+.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 230 IWPGFSELPGAKKKTFTKYPYNQLRKKFPA---LSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HHHHhhccchhcccccccccchhhhccccc---cCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00 00000000011111110 013566889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=287.28 Aligned_cols=243 Identities=19% Similarity=0.203 Sum_probs=193.5
Q ss_pred cccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccCCC
Q 045453 65 IKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRT 139 (346)
Q Consensus 65 ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~gs 139 (346)
||.|+||.||++.+ +++.+++|.+..... .....+.+|...+..+ +||||+++++++..+...++||||+++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-QSPYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhC-CCcchhHHHHheecCcEEEEEEecCCCCc
Confidence 68999999999999 589999999865432 3445677788888888 89999999999999999999999999999
Q ss_pred hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCc----
Q 045453 140 LADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGET---- 215 (346)
Q Consensus 140 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~---- 215 (346)
|.+++.... .+++..+..++.|++.||+||| ..+++|+||+|+||++++++.++|+|||++........
T Consensus 80 L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 80 LASLLENVG----SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred HHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence 999997643 5899999999999999999999 89999999999999999999999999999875543321
Q ss_pred ---eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccc
Q 045453 216 ---CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEI 292 (346)
Q Consensus 216 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (346)
.......++..|+|||...+..++.++||||||++++++++|..||......+. ...... +
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~----------~~~~~~-~----- 216 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI----------FQNILN-G----- 216 (265)
T ss_pred cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH----------HHHHhc-C-----
Confidence 122344578899999999988899999999999999999999999975432211 111000 0
Q ss_pred cccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 045453 293 VDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRL 338 (346)
Q Consensus 293 ~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 338 (346)
....+........+.+++.+||+.+|++|||+.++.+.|
T Consensus 217 -------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 217 -------KIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred -------CcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 000000001256788999999999999999995555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=281.72 Aligned_cols=248 Identities=18% Similarity=0.206 Sum_probs=190.4
Q ss_pred HHHHHhcCCCccccc--ccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCC
Q 045453 51 ELEIATNNFDARNVI--KDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETR 126 (346)
Q Consensus 51 ~l~~~~~~f~~~~~i--g~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~ 126 (346)
+.....++|...+.+ |+|+||.||++.. ++..+|+|.......... |......+.+||||+++++++...+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCC
Confidence 333344566666665 9999999999998 678888888764321111 1111222227999999999999999
Q ss_pred cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCC-ceEEeccC
Q 045453 127 IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGY-IAKLFDFS 205 (346)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~-~~kl~Dfg 205 (346)
..++||||+++++|.+++.... ++++..+..++.|+++||.||| +.+++|+||||+||+++.++ .++|+|||
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg 155 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYG 155 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCc
Confidence 9999999999999999997653 6899999999999999999999 89999999999999999998 99999999
Q ss_pred CCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhh
Q 045453 206 LSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIE 285 (346)
Q Consensus 206 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (346)
++...... ....++..|+|||++.+..++.++||||||+++|+|++|..||........ ....+....
T Consensus 156 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~-- 223 (267)
T PHA03390 156 LCKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL-----DLESLLKRQ-- 223 (267)
T ss_pred cceecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh-----hHHHHHHhh--
Confidence 98765432 234678899999999999999999999999999999999999985433221 111111110
Q ss_pred cCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 045453 286 NNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPT-TVDVAK 336 (346)
Q Consensus 286 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~ev~~ 336 (346)
.... .........+.+++..||+.+|.+||+ ++|+++
T Consensus 224 --------~~~~------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 224 --------QKKL------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred --------cccC------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0000 001134566899999999999999996 588763
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=286.81 Aligned_cols=246 Identities=19% Similarity=0.210 Sum_probs=199.4
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
+|...+.||.|+||.||+|.+ ++..+++|.+..... .....+.+|+..+..+ +||||+++++++.++...++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHPFLVNLWYSFQDEENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-CCCChHHHHHhhcCCCeEEEEE
Confidence 477889999999999999999 588999999875432 3456677888888888 9999999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
||+++++|.+++... .++++..+..++.+++.||.||| ..+++|+||+|+||++++++.++|+|||++.....
T Consensus 80 e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 80 DLLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152 (258)
T ss_pred eCCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence 999999999999765 36889999999999999999999 89999999999999999999999999999876644
Q ss_pred CCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccc
Q 045453 213 GETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEI 292 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (346)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||........ ...+ .....
T Consensus 153 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~~~~-~~~~~------ 216 (258)
T cd05578 153 DT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR-------DQIR-AKQET------ 216 (258)
T ss_pred Cc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH-------HHHH-HHhcc------
Confidence 32 12345578899999999988899999999999999999999999986543211 0111 10000
Q ss_pred cccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCH--HHHH
Q 045453 293 VDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTT--VDVA 335 (346)
Q Consensus 293 ~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~--~ev~ 335 (346)
. ....+...+..+.+++.+||+.+|.+||++ .|++
T Consensus 217 -------~-~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 -------A-DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -------c-cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0 000111344678899999999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=282.63 Aligned_cols=250 Identities=26% Similarity=0.350 Sum_probs=203.1
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
+|...+.||+|+||.||++.+ ++..+++|++..... .....+..|+..+..+ +|||++++.+.+...+..++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhc-CCCChhheEEEEecCCEEEEEEE
Confidence 477788999999999999999 588999999875433 3455677788888888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
|+++++|.+++.........+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 99999999999875422357999999999999999999999 889999999999999999999999999998776544
Q ss_pred CceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccc
Q 045453 214 ETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIV 293 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (346)
. .......+++.|+|||...+..++.++||||+|+++++|++|..||........ .... ......
T Consensus 157 ~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~----------~~~~-~~~~~~--- 221 (258)
T cd08215 157 V-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLEL----------ALKI-LKGQYP--- 221 (258)
T ss_pred c-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHH----------HHHH-hcCCCC---
Confidence 3 123345688899999999988999999999999999999999999965432111 1111 011100
Q ss_pred ccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 294 DPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 294 d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.+ +......+.+++.+||+.+|++|||+.++++
T Consensus 222 --~~--------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 222 --PI--------PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred --CC--------CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 1133466889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=289.05 Aligned_cols=257 Identities=15% Similarity=0.105 Sum_probs=182.5
Q ss_pred hcCCCcccccccCCCcEEEEEEEC-----CeEEEEEEecCccCcchH-----------HHHHHHHHHhhhcCCCceeeEc
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFVE-----DRTVSVMKFNDILNDGHE-----------DCFNNIIFASKLSSHKNVLKLT 119 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~~-----~~~vavk~~~~~~~~~~~-----------~~~~e~~~~~~~~~h~niv~l~ 119 (346)
.+.|...++||+|+||+||+|.+. +..+++|........... ....+...+..+ .|+|+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~ 89 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGIPKYY 89 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCCCcEE
Confidence 357888999999999999999982 335555543322211111 112222334445 899999999
Q ss_pred ceeecCC----cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcC
Q 045453 120 GCCLETR----IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE 195 (346)
Q Consensus 120 g~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~ 195 (346)
+++.... ..++++|++.. ++.+.+... ...++..+..++.|++.||+||| +.+++||||||+|||++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~ 161 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDG 161 (294)
T ss_pred EeeeEecCCceEEEEEEehhcc-CHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcC
Confidence 9876543 33677887744 666666543 23678889999999999999999 899999999999999999
Q ss_pred CCceEEeccCCCcccCCCCce------eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccc
Q 045453 196 GYIAKLFDFSLSVSIPEGETC------VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEI 269 (346)
Q Consensus 196 ~~~~kl~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~ 269 (346)
++.++|+|||+++........ ......||+.|+|||+..+..++.++|||||||+++||++|..||........
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 999999999999776432211 11234689999999999999999999999999999999999999986533221
Q ss_pred ccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 045453 270 GAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRL 338 (346)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 338 (346)
........+ +.+...+... ....+..+.+++..||+.+|++||++.++.+.|
T Consensus 242 ------~~~~~~~~~--------~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 242 ------LIHAAKCDF--------IKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred ------HHHHhHHHH--------HHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 111111000 0000000000 012346688999999999999999999999876
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=283.43 Aligned_cols=241 Identities=20% Similarity=0.230 Sum_probs=192.7
Q ss_pred cccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccCCC
Q 045453 65 IKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRT 139 (346)
Q Consensus 65 ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~gs 139 (346)
||.|++|.||+|.. .++.+++|.+..... .....+.+|...+..+ +||||+++++++.+++..++|+||+++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-CCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 69999999999999 489999999865432 2345677788888888 99999999999999999999999999999
Q ss_pred hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCceeec
Q 045453 140 LADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKD 219 (346)
Q Consensus 140 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 219 (346)
|.+++.... .+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 80 L~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~ 150 (262)
T cd05572 80 LWTILRDRG----LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTW 150 (262)
T ss_pred HHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccc
Confidence 999997653 4889999999999999999999 8999999999999999999999999999988765432 123
Q ss_pred cccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccccccccc
Q 045453 220 KVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVS 299 (346)
Q Consensus 220 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 299 (346)
...++..|+|||.+.+..++.++|+||||+++|+|++|..||.....+.. ....... +.....
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------~~~~~~~---------~~~~~~ 213 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM--------EIYNDIL---------KGNGKL 213 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH--------HHHHHHh---------ccCCCC
Confidence 34678899999999888899999999999999999999999976543111 1111100 000000
Q ss_pred CCCCcchHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 045453 300 EGPRVGKEKQLQGFRELALMCVCESAEDRPT-----TVDVAK 336 (346)
Q Consensus 300 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~ 336 (346)
.. +......+.+++.+||+.+|++||| +.|+++
T Consensus 214 ~~----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 214 EF----PNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CC----CcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 01 1122567899999999999999999 555543
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=287.19 Aligned_cols=263 Identities=20% Similarity=0.224 Sum_probs=197.1
Q ss_pred CCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecC--CcceEEE
Q 045453 59 FDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLET--RIPVIVF 132 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~--~~~~lv~ 132 (346)
|+..+.||+|++|.||+|.. ++..+|+|++.... ......+..|+..+..+ +|||++++++++... +..++|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKL-RHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCeeeheeeEecCCCCcEEEEe
Confidence 55678899999999999998 57899999987653 23345577888888888 899999999999888 8899999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
||+++ +|.+++.... ..+++..++.++.+++.||+||| ..+++|+||+|+||++++++.+||+|||++.....
T Consensus 80 e~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 80 EYMDH-DLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTK 152 (287)
T ss_pred ccccc-cHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence 99975 8988886653 36899999999999999999999 88999999999999999999999999999877654
Q ss_pred CCceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcC---c
Q 045453 213 GETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENN---E 288 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 288 (346)
..........++..|+|||.+.+ ..++.++||||||+++|||+||..||........ +.. ........ .
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~------~~~-~~~~~~~~~~~~ 225 (287)
T cd07840 153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ------LEK-IFELCGSPTDEN 225 (287)
T ss_pred CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH------HHH-HHHHhCCCchhh
Confidence 43222234456788999998765 4679999999999999999999999976543221 111 11110000 0
Q ss_pred cccccc----cccccCCCCc------chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 289 FDEIVD----PIIVSEGPRV------GKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 289 ~~~~~d----~~l~~~~~~~------~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.....+ .......... .....+..+.+++.+||+.+|++|||+.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 226 WPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred ccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000 0000000000 00012567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=290.04 Aligned_cols=243 Identities=19% Similarity=0.308 Sum_probs=194.8
Q ss_pred ccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccCCC
Q 045453 62 RNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRT 139 (346)
Q Consensus 62 ~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~gs 139 (346)
...||+|+||.||++.. ++..+|+|++..........+.+|+..+..+ +||||+++++++...+..++||||+++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhc-CCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 35799999999999988 7889999998654444555677888888887 99999999999999999999999999999
Q ss_pred hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCceeec
Q 045453 140 LADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKD 219 (346)
Q Consensus 140 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 219 (346)
|.+++... .+++.....++.|++.||+||| +.+++|+||+|+||++++++.++|+|||++........ ...
T Consensus 104 L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~ 174 (292)
T cd06657 104 LTDIVTHT-----RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRK 174 (292)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccccc-ccc
Confidence 99987542 4899999999999999999999 88999999999999999999999999998876543221 123
Q ss_pred cccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccccccccc
Q 045453 220 KVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVS 299 (346)
Q Consensus 220 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 299 (346)
...++..|+|||++.+..++.++|+||||+++|+|++|..||........ ...... . ..+.+..
T Consensus 175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~-------~~~~~~----~-----~~~~~~~ 238 (292)
T cd06657 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-------MKMIRD----N-----LPPKLKN 238 (292)
T ss_pred ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHh----h-----CCcccCC
Confidence 35678899999999888899999999999999999999999975332111 111110 0 0000000
Q ss_pred CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 300 EGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 300 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.......+.+++.+||+.+|.+||++.++++
T Consensus 239 ------~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 239 ------LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ------cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 0123445788999999999999999999886
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=285.72 Aligned_cols=240 Identities=18% Similarity=0.254 Sum_probs=188.3
Q ss_pred cccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccCCC
Q 045453 65 IKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRT 139 (346)
Q Consensus 65 ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~gs 139 (346)
||+|+||+||++.. ++..+++|.+.... ......+..|+..+..+ +||||+++++++...+..++||||+++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhC-CCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 69999999999987 68899999876432 12234456788888888 99999999999999999999999999999
Q ss_pred hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCceeec
Q 045453 140 LADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKD 219 (346)
Q Consensus 140 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 219 (346)
|.+++..... ..+++..+..++.|++.||.||| ..+++|+||+|+||++++++.++|+|||++....... ...
T Consensus 80 L~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 152 (277)
T cd05577 80 LKYHIYNVGE--PGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIK 152 (277)
T ss_pred HHHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccc
Confidence 9999976542 36899999999999999999999 8999999999999999999999999999987654322 123
Q ss_pred cccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccccccccc
Q 045453 220 KVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVS 299 (346)
Q Consensus 220 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 299 (346)
...++..|+|||++.++.++.++||||||+++++|++|+.||........ ... . .... .... .
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~-~----~~~~----~~~~--~ 215 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE------KEE-L----KRRT----LEMA--V 215 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc------HHH-H----Hhcc----cccc--c
Confidence 34577899999999988899999999999999999999999975443211 000 0 0000 0000 0
Q ss_pred CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 045453 300 EGPRVGKEKQLQGFRELALMCVCESAEDRPTTVD 333 (346)
Q Consensus 300 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e 333 (346)
. ........+.+++.+||+.+|++||+..+
T Consensus 216 ~----~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 216 E----YPDKFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred c----CCccCCHHHHHHHHHHccCChhHccCCCc
Confidence 0 01133556889999999999999994443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=290.02 Aligned_cols=254 Identities=22% Similarity=0.358 Sum_probs=194.4
Q ss_pred HhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
..++|...+.||+|++|.||+|.+ +++.+|+|.+..... ....++..++..+.....||||++++++|.+....++|
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 346678889999999999999999 389999999875432 23445666777677775699999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+++ +|.+++.... .++++..+..++.+++.||+|||+ ..+++|+||+|+||++++++.+||+|||++..+.
T Consensus 93 ~e~~~~-~l~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 93 MELMST-CLDKLLKRIQ---GPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eeccCc-CHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 999854 7777765533 368999999999999999999993 2589999999999999999999999999987654
Q ss_pred CCCceeeccccccCCcCCccccccCC----CCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcC
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINTGD----FNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENN 287 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (346)
.... .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||....... ..........
T Consensus 167 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---------~~~~~~~~~~ 235 (296)
T cd06618 167 DSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF---------EVLTKILQEE 235 (296)
T ss_pred CCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH---------HHHHHHhcCC
Confidence 3222 22335778999999987553 7899999999999999999999996432211 0111111111
Q ss_pred ccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045453 288 EFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKR 337 (346)
Q Consensus 288 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 337 (346)
. +.+.. .......+.+++.+||+.+|++|||+.+++..
T Consensus 236 ~------~~~~~------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 236 P------PSLPP------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred C------CCCCC------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 00000 00234568999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=302.93 Aligned_cols=242 Identities=21% Similarity=0.361 Sum_probs=189.7
Q ss_pred ccccccCCCcEEEEEEECCeEEEE----EEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCc--ceEEEe
Q 045453 62 RNVIKDGYAYKFYKGFVEDRTVSV----MKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRI--PVIVFE 133 (346)
Q Consensus 62 ~~~ig~G~~g~Vy~~~~~~~~vav----k~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~--~~lv~e 133 (346)
..+||+|+|-+||+|.+....+.| +++.... .....++..|+.+|..+ +|||||+++.++.+... +.+|+|
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL-~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSL-KHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccC-CCCceeeeeeheecCCCceeeeeee
Confidence 457999999999999994433333 2222222 23346788888888888 99999999999987654 789999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcC-CCceEEeccCCCcccCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE-GYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~-~~~~kl~Dfgl~~~~~~ 212 (346)
++..|+|..|++..+ .++...+..|+.||++||.|||+. .++|||||||.+||+|+. -|.+||+|+|||+....
T Consensus 124 L~TSGtLr~Y~kk~~----~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHR----RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred cccCCcHHHHHHHhc----cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 999999999998764 588899999999999999999976 679999999999999985 58999999999987643
Q ss_pred CCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccc
Q 045453 213 GETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEI 292 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (346)
.. ...++||+.|||||+.. ..|++.+||||||+.++||+|+..||........ +-.-|. .+.....
T Consensus 199 s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ------IYKKV~----SGiKP~s 264 (632)
T KOG0584|consen 199 SH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ------IYKKVT----SGIKPAA 264 (632)
T ss_pred cc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH------HHHHHH----cCCCHHH
Confidence 32 34589999999999987 8999999999999999999999999987655432 111111 1111111
Q ss_pred cccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 293 VDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 293 ~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
+.+ -.-..+.++|..||.. .++|||+.|+++
T Consensus 265 l~k------------V~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 265 LSK------------VKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred hhc------------cCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 111 0113478899999998 999999999975
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=290.85 Aligned_cols=245 Identities=25% Similarity=0.373 Sum_probs=193.1
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
+.|+..+.||+|+||.||+|.. ++..+++|.+.... .....++.+|+..+..+ +|||++++++++......++|
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCcccEEEEEEcCCeeEEE
Confidence 3466678899999999999998 67889999876432 22344667888888888 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+. |+|.+.+.... .++++.++..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 94 ~e~~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 94 MEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EEccC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 99996 58888776543 45899999999999999999999 8999999999999999999999999999987653
Q ss_pred CCCceeeccccccCCcCCccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCc
Q 045453 212 EGETCVKDKVTGTMGFLAPEYIN---TGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE 288 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (346)
.. ....++..|+|||.+. .+.++.++||||||+++|+|++|..||......+. ..... . ..
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~----~-~~ 230 (308)
T cd06634 167 PA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIA----Q-NE 230 (308)
T ss_pred Cc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH------HHHHh----h-cC
Confidence 32 2345788999999985 35688899999999999999999999865322111 00000 0 00
Q ss_pred cccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045453 289 FDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKR 337 (346)
Q Consensus 289 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 337 (346)
.+..........+.+++.+||+.+|++||++.++++.
T Consensus 231 ------------~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 231 ------------SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred ------------CCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 0111111345668899999999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=289.26 Aligned_cols=255 Identities=19% Similarity=0.210 Sum_probs=199.4
Q ss_pred CCCcccccccCCCcEEEEEEE-----CCeEEEEEEecCcc----CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcc
Q 045453 58 NFDARNVIKDGYAYKFYKGFV-----EDRTVSVMKFNDIL----NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIP 128 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~-----~~~~vavk~~~~~~----~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~ 128 (346)
+|+..+.||+|++|.||++.. ++..+|+|.+.... ......+..|+..+..+.+||||+++++++..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 467788999999999999875 45789999876432 123345678888888886799999999999999999
Q ss_pred eEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 129 VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
++||||+++|+|.+++... ..+++..+..++.|++.||.||| ..+++|+||+|+||+++.++.++|+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR----EHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhhc----CCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 9999999999999998754 35889999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCceeeccccccCCcCCccccccCC--CCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhc
Q 045453 209 SIPEGETCVKDKVTGTMGFLAPEYINTGD--FNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIEN 286 (346)
Q Consensus 209 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (346)
..............++..|+|||.+.+.. .+.++||||||+++|+|++|..||........ ...........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~~~~~~~~~~~ 227 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS------QSEISRRILKS 227 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch------HHHHHHHHHcc
Confidence 66543332233456888999999987665 78899999999999999999999964322111 11111111110
Q ss_pred CccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 045453 287 NEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQ 340 (346)
Q Consensus 287 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 340 (346)
.+. .+......+.+++.+||+.+|++|||+.+|.+.|+.
T Consensus 228 -------~~~--------~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 -------KPP--------FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred -------CCC--------CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 000 011234568899999999999999999988877654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=286.16 Aligned_cols=264 Identities=16% Similarity=0.190 Sum_probs=195.6
Q ss_pred CCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEec
Q 045453 59 FDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFES 134 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~ 134 (346)
|+..+.||.|++|.||+|.+ ++..|++|++..... .....+.+|+..+..+ +|||++++++++.+.+..++||||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKEL-NHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhc-CCCCccCHhheeccCCeEEEEEec
Confidence 56678899999999999998 788999998865432 2235677888888888 999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCC
Q 045453 135 VKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE 214 (346)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~ 214 (346)
++ ++|.+++..... ..+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 80 LD-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV 153 (283)
T ss_pred cC-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence 95 699998876432 36899999999999999999999 8899999999999999999999999999987654322
Q ss_pred ceeeccccccCCcCCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcC------
Q 045453 215 TCVKDKVTGTMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENN------ 287 (346)
Q Consensus 215 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 287 (346)
. ......++..|+|||++.+. .++.++||||||+++|+|++|..||........ +...........
T Consensus 154 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------~~~~~~~~~~~~~~~~~~ 226 (283)
T cd07835 154 R-TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ------LFRIFRTLGTPDEDVWPG 226 (283)
T ss_pred c-ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHHHhCCCChHHhhh
Confidence 1 12233568899999988764 578999999999999999999999975432111 111111000000
Q ss_pred --ccccccccc--cccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 288 --EFDEIVDPI--IVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 288 --~~~~~~d~~--l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
...+..... ..........+.....+.+++.+||+.+|++|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 227 VTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000 0000000001123366889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=292.46 Aligned_cols=269 Identities=18% Similarity=0.259 Sum_probs=196.2
Q ss_pred HhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecC-----
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLET----- 125 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~----- 125 (346)
..+.|+..+.||+|+||.||+|.. ++..+|+|.+.... .....++.+|+..+..+ +||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLV-NHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhc-CCCCCcceeeeeccCCCccc
Confidence 347799999999999999999998 78899999876432 23345667788888887 999999999988643
Q ss_pred -CcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEecc
Q 045453 126 -RIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDF 204 (346)
Q Consensus 126 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Df 204 (346)
...++||||+.+ +|.+.+.. .+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+||
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Df 162 (353)
T cd07850 93 FQDVYLVMELMDA-NLCQVIQM------DLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDF 162 (353)
T ss_pred cCcEEEEEeccCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccC
Confidence 356999999964 88888753 2788899999999999999999 899999999999999999999999999
Q ss_pred CCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccc--------cchhhH
Q 045453 205 SLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIG--------AGHYWL 276 (346)
Q Consensus 205 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~--------~~~~~~ 276 (346)
|+++....... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+....- .....+
T Consensus 163 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 240 (353)
T cd07850 163 GLARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF 240 (353)
T ss_pred ccceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 99976643221 23345788999999999999999999999999999999999999754321100 000000
Q ss_pred HH----HHHHHhhcCc------cccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 277 LH----YVKKCIENNE------FDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 277 ~~----~~~~~~~~~~------~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.. .......... +.......+...............+.+++.+||+.||++|||+.|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 0000000000 000000000000000001134566889999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=287.35 Aligned_cols=269 Identities=19% Similarity=0.195 Sum_probs=196.9
Q ss_pred HHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecCC---
Q 045453 54 IATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETR--- 126 (346)
Q Consensus 54 ~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~--- 126 (346)
...++|+..+.||+|+||.||+|.+ ++..||+|.+..... .....+..|+..+..+ +|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL-NHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhC-CCCCeeeeeheecCcchhh
Confidence 4567899999999999999999999 678999999864432 2334566788888888 9999999999987654
Q ss_pred -------cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCce
Q 045453 127 -------IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIA 199 (346)
Q Consensus 127 -------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~ 199 (346)
..++|+||+++ +|.+.+.... ..+++..+..++.|++.||+||| +.+++|+||||+||++++++.+
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~ 155 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGL---VHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQI 155 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcE
Confidence 78999999976 7777776542 46899999999999999999999 8999999999999999999999
Q ss_pred EEeccCCCcccCCCCceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHH
Q 045453 200 KLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLH 278 (346)
Q Consensus 200 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 278 (346)
||+|||++...............++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+ .+..
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~------~~~~ 229 (302)
T cd07864 156 KLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA------QLEL 229 (302)
T ss_pred EeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH------HHHH
Confidence 999999987765433212223346778999998865 457899999999999999999999997543211 1111
Q ss_pred HHHHHhhc--Ccccccc--------cccccc-CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 279 YVKKCIEN--NEFDEIV--------DPIIVS-EGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 279 ~~~~~~~~--~~~~~~~--------d~~l~~-~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
........ .....+. +..... ..........+..+.+++.+||+.+|++|||+.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 230 ISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11110000 0000000 000000 0000000012466899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=310.73 Aligned_cols=272 Identities=18% Similarity=0.223 Sum_probs=188.2
Q ss_pred HhcCCCcccccccCCCcEEEEEEEC---CeEEEEE------------------EecCccCcchHHHHHHHHHHhhhcCCC
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFVE---DRTVSVM------------------KFNDILNDGHEDCFNNIIFASKLSSHK 113 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~~---~~~vavk------------------~~~~~~~~~~~~~~~e~~~~~~~~~h~ 113 (346)
..++|...+.||+|+||+||++.+. +...+.| +.. ........+.+|+.++..+ +||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l-~Hp 223 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRL-NHE 223 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhC-CCC
Confidence 4578999999999999999998762 1112211 111 1112234567888888888 999
Q ss_pred ceeeEcceeecCCcceEEEecccCCChhhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeE
Q 045453 114 NVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPH-FEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIF 192 (346)
Q Consensus 114 niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIl 192 (346)
|||++++++...+..++|++++. ++|.+++...... ...........++.|++.||.||| +.+|+||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEE
Confidence 99999999999999999999995 4788877543211 122345667889999999999999 899999999999999
Q ss_pred EcCCCceEEeccCCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCC-CCCCCCccccc
Q 045453 193 LDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKI-FDPSRGDEIGA 271 (346)
Q Consensus 193 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p-~~~~~~~~~~~ 271 (346)
++.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..+ +........
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~-- 377 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG-- 377 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH--
Confidence 99999999999999987754443333456799999999999999999999999999999999998754 433222111
Q ss_pred chhhHHHHHHHHhh-cCcc-------ccccccccccCCCCcc-----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 272 GHYWLLHYVKKCIE-NNEF-------DEIVDPIIVSEGPRVG-----KEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 272 ~~~~~~~~~~~~~~-~~~~-------~~~~d~~l~~~~~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
..+......... ...+ .+.++.......+... .......+.+++.+||+.||++|||+.|++.
T Consensus 378 --~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 378 --KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred --HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 111111111000 0000 0000000000000000 0012345778899999999999999999975
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=287.90 Aligned_cols=266 Identities=17% Similarity=0.215 Sum_probs=193.5
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecCCc----
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRI---- 127 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~---- 127 (346)
-++|+..+.||+|+||.||+|.. +++.+|+|.+..... .......+|+..+..+ +||||++++++|...+.
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhC-CCCCccceEEEEecccccccC
Confidence 35688899999999999999998 688999998764322 2233456788888888 99999999999876543
Q ss_pred ----ceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEec
Q 045453 128 ----PVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFD 203 (346)
Q Consensus 128 ----~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~D 203 (346)
.++||||+.+ +|.+.+.... ..+++.+++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECc
Confidence 4999999965 8888886543 35899999999999999999999 88999999999999999999999999
Q ss_pred cCCCcccCCCCce---eeccccccCCcCCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHH
Q 045453 204 FSLSVSIPEGETC---VKDKVTGTMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHY 279 (346)
Q Consensus 204 fgl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 279 (346)
||++......... ......++..|+|||.+.+. .++.++||||||+++|||++|..||....... ....
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~-------~~~~ 235 (310)
T cd07865 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH-------QLTL 235 (310)
T ss_pred CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-------HHHH
Confidence 9998766432221 11234577889999988664 47889999999999999999999997544321 1111
Q ss_pred HHHHhh---cCccccc-----ccc-ccccCCCC-----cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 280 VKKCIE---NNEFDEI-----VDP-IIVSEGPR-----VGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 280 ~~~~~~---~~~~~~~-----~d~-~l~~~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
+..... ....... .+. ........ .........+.+++.+||+.+|++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 236 ISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 111110 0000000 000 00000000 000012345779999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=283.33 Aligned_cols=266 Identities=18% Similarity=0.245 Sum_probs=198.4
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEec
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFES 134 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~ 134 (346)
+|+..+.||.|++|.||+|.. ++..+|+|.+..... .....+.+|+..+..+ +||||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKEL-KHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhh-cCCCEeeeeeeEeeCCcEEEEEec
Confidence 577889999999999999998 688999998875533 2345667788888888 999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCC
Q 045453 135 VKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE 214 (346)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~ 214 (346)
+++ +|.+++..... ..++++..+..++.|++.||+||| +.+++|+||||+||++++++.++|+|||++.......
T Consensus 80 ~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 80 MDK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred CCc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 985 89888865432 246899999999999999999999 8999999999999999999999999999987654322
Q ss_pred ceeeccccccCCcCCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhc--Ccccc
Q 045453 215 TCVKDKVTGTMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIEN--NEFDE 291 (346)
Q Consensus 215 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 291 (346)
. ......++..|++||.+.+. .++.++||||||+++|++++|..||......+. ........... .....
T Consensus 155 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~ 227 (284)
T cd07836 155 N-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ------LLKIFRIMGTPTESTWPG 227 (284)
T ss_pred c-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH------HHHHHHHhCCCChhhHHH
Confidence 1 12334578899999988654 578999999999999999999999976543221 11110000000 00000
Q ss_pred ccc-cccccCCCCcc-------hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 292 IVD-PIIVSEGPRVG-------KEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 292 ~~d-~~l~~~~~~~~-------~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
..+ +......+... .+.....+.+++..||+.+|.+|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 228 ISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred HhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 00000000000 0123456889999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=285.41 Aligned_cols=265 Identities=17% Similarity=0.213 Sum_probs=194.5
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
++|+..+.||+|++|.||+|.+ +++.+|+|++..... .....+.+|+..+..+ +||||+++++++...+..++||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhc-cCCCEeeEEEEEecCCeEEEEE
Confidence 4688889999999999999998 678999998764332 2335677888888888 9999999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcC-CCceEEeccCCCcccC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE-GYIAKLFDFSLSVSIP 211 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~-~~~~kl~Dfgl~~~~~ 211 (346)
||++ ++|.+++..... ..+++.....++.|++.||.||| +.+++|+||+|+||+++. ++.+||+|||++....
T Consensus 81 e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 81 EYLD-LDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred eccc-ccHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 9996 488888765432 34678888999999999999999 899999999999999985 5679999999987654
Q ss_pred CCCceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCc--
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE-- 288 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 288 (346)
.... ......+++.|+|||++.+ ..++.++||||||+++|+|+||..||......+. +..... ......
T Consensus 155 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~------~~~~~~-~~~~~~~~ 226 (294)
T PLN00009 155 IPVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE------LFKIFR-ILGTPNEE 226 (294)
T ss_pred CCcc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHH-HhCCCChh
Confidence 3221 1233457889999999876 4578999999999999999999999975433211 111000 000000
Q ss_pred ----cccccccc-cccCCCCc----chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 289 ----FDEIVDPI-IVSEGPRV----GKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 289 ----~~~~~d~~-l~~~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.....+-. .....+.. ..+.....+.+++.+|++.+|++||++.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 227 TWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000000 00000000 00123456889999999999999999999986
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=289.25 Aligned_cols=265 Identities=18% Similarity=0.210 Sum_probs=195.5
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecC--Ccce
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLET--RIPV 129 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~--~~~~ 129 (346)
.++|+..+.||+|+||.||+|.+ ++..||+|++..... .......+|+..+..+ +|+||+++++++... +..+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL-RHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhC-CCCCCcceEEEEecCCCCeEE
Confidence 46788999999999999999998 688999999864432 2233456788888888 999999999998754 5689
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcc
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVS 209 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~ 209 (346)
+||||+.+ +|.+++.... ..+++..+..++.|++.||+||| +.+++|+||||+||+++.++.+||+|||++..
T Consensus 85 lv~e~~~~-~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~ 157 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLART 157 (309)
T ss_pred EEEecCCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeee
Confidence 99999965 8888886543 46899999999999999999999 89999999999999999999999999999877
Q ss_pred cCCCCceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCc
Q 045453 210 IPEGETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE 288 (346)
Q Consensus 210 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (346)
...... ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+..+. ...+........
T Consensus 158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~-------~~~~~~~~~~~~ 229 (309)
T cd07845 158 YGLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ-------LDLIIQLLGTPN 229 (309)
T ss_pred cCCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHHhcCCCC
Confidence 654321 1223345778999999875 4579999999999999999999999975443221 111111100000
Q ss_pred --c-ccccc----cccc-cCCCCcc----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 289 --F-DEIVD----PIIV-SEGPRVG----KEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 289 --~-~~~~d----~~l~-~~~~~~~----~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
. ..... .... ...+... .......+.+++..||+.||++|||+.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 230 ESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 00000 0000 0000000 0012456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=277.44 Aligned_cols=249 Identities=21% Similarity=0.282 Sum_probs=201.7
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecC--CcceEE
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLET--RIPVIV 131 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~--~~~~lv 131 (346)
+|...+.||+|++|.||+|.. ++..+++|.+..... .....+.+|+..+.++ +||||+++++++... +..++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-QHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHc-CCCCEeeEEEEEecCCCCeEEEE
Confidence 467788999999999999999 588999999865432 3456677888888888 999999999999988 889999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
+||+++++|.+++.... .+++..+..++.+++.||+||| +.+++|+||+|+||+++.++.++|+|||.+....
T Consensus 80 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 152 (260)
T cd06606 80 LEYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLG 152 (260)
T ss_pred EEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence 99999999999997653 6899999999999999999999 8999999999999999999999999999987765
Q ss_pred CCCce-eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 212 EGETC-VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 212 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
..... ......++..|+|||...+..++.++||||||++++++++|..||....... ............
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---------~~~~~~~~~~~~- 222 (260)
T cd06606 153 DIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM---------AALYKIGSSGEP- 222 (260)
T ss_pred cccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH---------HHHHhccccCCC-
Confidence 44321 1234568889999999998889999999999999999999999997654111 001110000000
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.. .+......+.+++.+||+.+|++|||+.+++.
T Consensus 223 --------~~----~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 223 --------PE----IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred --------cC----CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 00 01133567899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=286.82 Aligned_cols=262 Identities=20% Similarity=0.267 Sum_probs=192.7
Q ss_pred cccccCCCcEEEEEEECCeEEEEEEecCc--cCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccCCCh
Q 045453 63 NVIKDGYAYKFYKGFVEDRTVSVMKFNDI--LNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTL 140 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~~~~~vavk~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 140 (346)
+.+|.|+++.||++..++..+|+|++... .......+..|+..+..+ +||||+++++++.+.+..+++|||+++|+|
T Consensus 8 ~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQL-QHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhc-CCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 34555666666676668999999998754 234456778888888888 999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCc-----
Q 045453 141 ADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGET----- 215 (346)
Q Consensus 141 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~----- 215 (346)
.+++..... ..+++.....++.|++.||.||| +.+|+|+||||+||+++.++.+|++|||.+........
T Consensus 87 ~~~l~~~~~--~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 87 EDLLKTHFP--EGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 999976432 35888999999999999999999 89999999999999999999999999998865532211
Q ss_pred -eeeccccccCCcCCcccccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHh----h---
Q 045453 216 -CVKDKVTGTMGFLAPEYINT--GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCI----E--- 285 (346)
Q Consensus 216 -~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----~--- 285 (346)
.......++..|+|||++.. ..++.++||||||+++|||++|..||........ ......... .
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~------~~~~~~~~~~~~~~~~~ 235 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM------LLEKVRGTVPCLLDKST 235 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhccCccccccCc
Confidence 11123456778999999876 4588999999999999999999999975432211 111110000 0
Q ss_pred ----cCcccc----ccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 286 ----NNEFDE----IVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 286 ----~~~~~~----~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
...... ..++.................+.+++..||+.+|++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 236 YPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 000000 111111111111112244567899999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=278.17 Aligned_cols=246 Identities=22% Similarity=0.343 Sum_probs=200.4
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
+|+..+.||+|++|.||+|.. .++.+++|.+..... .....+.+|+..+..+ +|||++++++++.+.+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-KHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEEEEEEe
Confidence 467788999999999999988 678999999876543 3456678888888888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
|+++++|.+++... ..+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 80 YAENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred cCCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 99999999998765 36899999999999999999999 899999999999999999999999999999876543
Q ss_pred CceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccc
Q 045453 214 ETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIV 293 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (346)
... .....++..|+|||...+..++.++||||+|+++++|++|..||........ . ... .....
T Consensus 153 ~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~------~---~~~--~~~~~---- 216 (254)
T cd06627 153 SKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA------L---FRI--VQDDH---- 216 (254)
T ss_pred ccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH------H---HHH--hccCC----
Confidence 321 2334678899999999888899999999999999999999999975332110 0 000 00100
Q ss_pred ccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 294 DPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 294 d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
+.+ +......+.+++.+||+.+|++|||+.+++.
T Consensus 217 -~~~--------~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 217 -PPL--------PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -CCC--------CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 000 1123456889999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=287.04 Aligned_cols=242 Identities=23% Similarity=0.366 Sum_probs=191.4
Q ss_pred CCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 59 FDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
|...+.||+|+||.||+|.. ++..+++|++..... .....+..|+..+..+ +|||++++++++.+.+..++|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhC-CCCCCccEEEEEEeCCEEEEEEe
Confidence 55567799999999999998 778999998864432 2234567788888888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
|+. |+|.+++.... .++++.++..++.|++.||.||| +.+++|+||+|+||+++.++.+||+|||++.....
T Consensus 102 ~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~- 173 (313)
T cd06633 102 YCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP- 173 (313)
T ss_pred cCC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-
Confidence 996 58888876543 46899999999999999999999 89999999999999999999999999998754322
Q ss_pred CceeeccccccCCcCCccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 214 ETCVKDKVTGTMGFLAPEYIN---TGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
.....++..|+|||++. ...++.++||||||+++|+|++|..||........ +..... ...
T Consensus 174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~----------~~~~~~-~~~- 237 (313)
T cd06633 174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----------LYHIAQ-NDS- 237 (313)
T ss_pred ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH----------HHHHHh-cCC-
Confidence 22456888999999984 45688899999999999999999999865432111 111000 000
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
+.. ........+.+++.+||+.+|++||++.+++.
T Consensus 238 ----~~~-------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 238 ----PTL-------QSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred ----CCC-------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 11123456889999999999999999999885
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=281.74 Aligned_cols=241 Identities=17% Similarity=0.243 Sum_probs=184.7
Q ss_pred ccccCCCcEEEEEEE--CCeEEEEEEecCccCc---chHHHHHHHHHH--hhhcCCCceeeEcceeecCCcceEEEeccc
Q 045453 64 VIKDGYAYKFYKGFV--EDRTVSVMKFNDILND---GHEDCFNNIIFA--SKLSSHKNVLKLTGCCLETRIPVIVFESVK 136 (346)
Q Consensus 64 ~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~---~~~~~~~e~~~~--~~~~~h~niv~l~g~~~~~~~~~lv~e~~~ 136 (346)
.||+|+||.||+|.. +++.||+|.+...... ....+..+...+ .....||||+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999988 6789999987654221 111223332222 222379999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCce
Q 045453 137 NRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETC 216 (346)
Q Consensus 137 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 216 (346)
+|+|.+++... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++.......
T Consensus 81 g~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 81 GGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 99999988654 36999999999999999999999 8999999999999999999999999999987553322
Q ss_pred eeccccccCCcCCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccccc
Q 045453 217 VKDKVTGTMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDP 295 (346)
Q Consensus 217 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 295 (346)
.....|+..|+|||.+.++ .++.++||||+|+++|+|++|..||......... ..... .. ....
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~-------~~~~~-~~------~~~~ 216 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-------EIDRM-TL------TMAV 216 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH-------HHHHH-hh------ccCC
Confidence 2234689999999999754 6899999999999999999999999765332210 00000 00 0000
Q ss_pred ccccCCCCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 045453 296 IIVSEGPRVGKEKQLQGFRELALMCVCESAEDRP-----TTVDVAK 336 (346)
Q Consensus 296 ~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~ 336 (346)
.+ +...+..+.+++.+||+.+|.+|| ++.++++
T Consensus 217 ~~--------~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 217 EL--------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CC--------CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 11 002345688999999999999999 9999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=292.99 Aligned_cols=265 Identities=16% Similarity=0.181 Sum_probs=194.9
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecC-----Cc
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLET-----RI 127 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~-----~~ 127 (346)
+++|...+.||+|+||.||+|.+ ++..||+|++..... .....+.+|+..+..+ +||||+++++++... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF-KHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhC-CCCCcCchhheeecccccccce
Confidence 46899999999999999999988 788999999864322 3345567788888888 999999999987654 35
Q ss_pred ceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCC
Q 045453 128 PVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS 207 (346)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~ 207 (346)
.++|+||+++ +|.+.+.. ..+++..+..++.|++.||+||| +.+++||||||+|||++.++.+||+|||++
T Consensus 83 ~~lv~e~~~~-~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 83 VYIVQELMET-DLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred EEEEehhccc-CHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccce
Confidence 7999999965 88887754 35899999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCce--eeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHh
Q 045453 208 VSIPEGETC--VKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCI 284 (346)
Q Consensus 208 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (346)
......... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... .........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~-------~~~~~~~~~ 226 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH-------QLNLILGVL 226 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHHHc
Confidence 765432221 1123467889999998765 568999999999999999999999996543211 001011100
Q ss_pred hcC---ccccccccc-------cccCCCCc---chHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045453 285 ENN---EFDEIVDPI-------IVSEGPRV---GKEKQLQGFRELALMCVCESAEDRPTTVDVAKR 337 (346)
Q Consensus 285 ~~~---~~~~~~d~~-------l~~~~~~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 337 (346)
... ....+.+.. ........ ..+.....+.+++.+||+.+|++|||+.|+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 227 GTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred CCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 000000000 00000000 001224568899999999999999999998864
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=294.19 Aligned_cols=264 Identities=14% Similarity=0.232 Sum_probs=197.2
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeec----CCc
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLE----TRI 127 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~----~~~ 127 (346)
.++|+..+.||+|++|.||+|.. ++..||+|++..... .....+.+|+..+..+ +||||+++++++.. ...
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-KHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhc-CCCCccCHHHhccccCCCCce
Confidence 37788899999999999999998 789999999875432 3445677888888888 89999999998753 346
Q ss_pred ceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCC
Q 045453 128 PVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS 207 (346)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~ 207 (346)
.++||||+. ++|.+++... ..+++..+..++.|++.||+||| ..+++||||||+||+++.++.+||+|||++
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~ 154 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSD----QPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMA 154 (334)
T ss_pred EEEEEehhh-hhHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccc
Confidence 799999995 5899988654 35899999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCcee---eccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHH
Q 045453 208 VSIPEGETCV---KDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKC 283 (346)
Q Consensus 208 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 283 (346)
.......... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ...+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~-------~~~~~~~ 227 (334)
T cd07855 155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ-------LKLILSV 227 (334)
T ss_pred eeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH-------HHHHHHH
Confidence 7654322211 123467889999999865 4689999999999999999999999976543211 1111110
Q ss_pred hhcC-----------ccccccccccccCCCCcc---hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 284 IENN-----------EFDEIVDPIIVSEGPRVG---KEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 284 ~~~~-----------~~~~~~d~~l~~~~~~~~---~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.... ......+. ......... .+.....+.+++..||+.+|++|||+.+++.
T Consensus 228 ~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 228 LGSPSEEVLNRIGSDRVRKYIQN-LPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hCCChhHhhhhhchhhHHHHHhh-cccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0000 00000000 000000000 0123577999999999999999999999876
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=280.08 Aligned_cols=248 Identities=20% Similarity=0.241 Sum_probs=194.2
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc-----CcchHHHHHHHHHHhhhcCCCceeeEcceeecC--Cc
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL-----NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLET--RI 127 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~-----~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~--~~ 127 (346)
.+|...+.||+|+||.||+|.+ ++..+++|.+.... ......+.+|+..+..+ +||||+++++++.+. ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHc-CCCCcceEEEEEEcCCCCE
Confidence 5788899999999999999998 68899999875321 12334567788888888 999999999998764 45
Q ss_pred ceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCC
Q 045453 128 PVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS 207 (346)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~ 207 (346)
.++|+||+++++|.+++.... .+++.....++.+++.||.||| +.+++|+||||+||+++.++.++|+|||++
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~ 153 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAYG----ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGAS 153 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccc
Confidence 789999999999999987643 4789999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCc--eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhh
Q 045453 208 VSIPEGET--CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIE 285 (346)
Q Consensus 208 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (346)
+....... .......++..|+|||++.+..++.++||||||++++++++|..||........ +.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----------~~~~~~ 223 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA----------IFKIAT 223 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH----------HHHHHc
Confidence 76532111 111234588899999999988899999999999999999999999964322110 011000
Q ss_pred cCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 286 NNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 286 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
... ....+......+.+++.+||+ +|..|||+.+++.
T Consensus 224 ~~~-------------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 224 QPT-------------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCC-------------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 000 000111445678999999998 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=284.61 Aligned_cols=251 Identities=18% Similarity=0.235 Sum_probs=194.4
Q ss_pred CCCcccccccCCCcEEEEEEE-----CCeEEEEEEecCccC----cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcc
Q 045453 58 NFDARNVIKDGYAYKFYKGFV-----EDRTVSVMKFNDILN----DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIP 128 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~-----~~~~vavk~~~~~~~----~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~ 128 (346)
+|+..+.||.|+||.||++.. ++..+|+|.+..... ....++..|+..+..+.+|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467788999999999999986 578899998864321 22345667888888886799999999999999999
Q ss_pred eEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 129 VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
++||||+++++|.+++... .++++..+..++.|++.||.||| +.+++||||+|+|||++.++.+||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQR----ERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 9999999999999999764 35888999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCceeeccccccCCcCCccccccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhc
Q 045453 209 SIPEGETCVKDKVTGTMGFLAPEYINTG--DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIEN 286 (346)
Q Consensus 209 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (346)
..............++..|+|||.+.+. .++.++||||||+++|+|++|..||........ ...........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~~~~~~~~~~~ 227 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS------QAEISRRILKS 227 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc------HHHHHHHhhcc
Confidence 7644332222345688899999998753 478899999999999999999999964322111 11111111110
Q ss_pred CccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 045453 287 NEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRP-----TTVDVAK 336 (346)
Q Consensus 287 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~ 336 (346)
. + + .+......+.+++.+||+.+|++|| ++.++++
T Consensus 228 ~-------~------~--~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 228 E-------P------P--YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred C-------C------C--CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0 0 0 0112345688999999999999997 5666543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=290.05 Aligned_cols=268 Identities=22% Similarity=0.290 Sum_probs=196.4
Q ss_pred HhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecC--Ccc
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLET--RIP 128 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~--~~~ 128 (346)
..++|+..+.||+|+||.||+|.+ ++..+|+|++.... ......+..|+..+..+.+||||++++++|... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 346788889999999999999998 67899999875432 233455677888777776999999999998653 367
Q ss_pred eEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 129 VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
++||||++ ++|.+++... .++|..+..++.|++.||+||| +.+++|+||||+||+++.++.+||+|||++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999997 4998888653 5889999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCce----eeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHH-
Q 045453 209 SIPEGETC----VKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKK- 282 (346)
Q Consensus 209 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~- 282 (346)
........ ......++..|+|||++.+ ..++.++||||||+++|+|+||+.||......+. .......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~------~~~~~~~~ 229 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ------LEKIIEVI 229 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHHHh
Confidence 66433221 2233468889999998865 4578999999999999999999999975433221 0000000
Q ss_pred ---------HhhcCccccccccccccCCCCc--chHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045453 283 ---------CIENNEFDEIVDPIIVSEGPRV--GKEKQLQGFRELALMCVCESAEDRPTTVDVAKR 337 (346)
Q Consensus 283 ---------~~~~~~~~~~~d~~l~~~~~~~--~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 337 (346)
.+........++.......... ..+.....+.+++..||+.+|++|||+.++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 230 GPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred CCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000011110000000000 000235678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=281.56 Aligned_cols=265 Identities=17% Similarity=0.184 Sum_probs=195.4
Q ss_pred CCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcC-CCceeeEcceeecCCcceEEEec
Q 045453 59 FDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSS-HKNVLKLTGCCLETRIPVIVFES 134 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~-h~niv~l~g~~~~~~~~~lv~e~ 134 (346)
|...+.||+|++|+||+|.. .++.+++|++..... .......+|+..+..+ + ||||+++++++..++..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKL-NEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhc-cCCCCchhHHHHhhcCCcEEEEEec
Confidence 55678899999999999999 578899998865432 2223445678888888 6 99999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCC
Q 045453 135 VKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE 214 (346)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~ 214 (346)
+ +|+|.+.+..... ..+++..+..++.|++.+|.||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~-~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 80 M-EGNLYQLMKDRKG--KPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153 (283)
T ss_pred C-CCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence 9 7899998876542 46899999999999999999999 8999999999999999999999999999987664332
Q ss_pred ceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchh------hHHHHHHHHhhcC
Q 045453 215 TCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHY------WLLHYVKKCIENN 287 (346)
Q Consensus 215 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~------~~~~~~~~~~~~~ 287 (346)
. .....++..|+|||++.. ..++.++|+||||++++||++|..||......+...... ....|........
T Consensus 154 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 154 P--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred C--cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 2 123457889999998854 558999999999999999999999997654322100000 0000111100000
Q ss_pred ccccccccccccCCCCcc---hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 288 EFDEIVDPIIVSEGPRVG---KEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 288 ~~~~~~d~~l~~~~~~~~---~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
. .+..+....+... .+.....+.+++.+||+.+|++|||+.|++.
T Consensus 232 ~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 232 K----LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred c----ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0 0100000000000 0012466899999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=279.92 Aligned_cols=248 Identities=19% Similarity=0.262 Sum_probs=192.0
Q ss_pred CCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc-----CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 59 FDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL-----NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~-----~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
|...+.||+|+||.||++.+ .+..+++|.+.... .....++..|...+..+ +||||+++++++.+.+..++|
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-DHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhC-CCCcHHHHHHHHhcCCceEEE
Confidence 67788999999999999988 34455555544321 12333456677777777 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+++++|.+++.........+++..++.++.|++.||.||| +.+++|+||+|+||+++. +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988753333357999999999999999999999 899999999999999986 469999999987664
Q ss_pred CCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccc
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDE 291 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (346)
.... ......++..|+|||...+..++.++|+||||+++|+|++|..||...... ........ +
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~----------~~~~~~~~-~---- 220 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL----------SVVLRIVE-G---- 220 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH----------HHHHHHHc-C----
Confidence 3322 223455788999999998888999999999999999999999998643211 11111110 1
Q ss_pred ccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 292 IVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 292 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
..+. .+......+.+++.+||+.+|++||++.|+++
T Consensus 221 --------~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 221 --------PTPS-LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred --------CCCC-CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 0011 11144567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=279.33 Aligned_cols=264 Identities=19% Similarity=0.247 Sum_probs=193.3
Q ss_pred CCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCc--chHHHHHHHHHHhhhc--CCCceeeEcceeecCCc-----
Q 045453 59 FDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILND--GHEDCFNNIIFASKLS--SHKNVLKLTGCCLETRI----- 127 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~--~~~~~~~e~~~~~~~~--~h~niv~l~g~~~~~~~----- 127 (346)
|+..+.||+|+||.||+|.+ ++..+|+|.+...... ....+.+|+..+..+. .|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 55678999999999999999 5789999998643221 2234455665555442 69999999999988776
Q ss_pred ceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCC
Q 045453 128 PVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS 207 (346)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~ 207 (346)
.+++|||+.+ +|.+++..... ..+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.+||+|||++
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999975 89998876432 35899999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcC
Q 045453 208 VSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENN 287 (346)
Q Consensus 208 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (346)
........ .....++..|+|||++.+..++.++||||||+++|+|++|..||......+. +...........
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~------~~~~~~~~~~~~ 226 (287)
T cd07838 155 RIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ------LDKIFDVIGLPS 226 (287)
T ss_pred eeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH------HHHHHHHcCCCC
Confidence 77643322 1233478899999999999999999999999999999999999876443221 111111000000
Q ss_pred cc--c-cc-c-ccccccCCCC---cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 288 EF--D-EI-V-DPIIVSEGPR---VGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 288 ~~--~-~~-~-d~~l~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.. . .. . .......... ...+.....+.+++.+||+.+|++||++.|++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00 0 00 0 0000000000 001133467889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=292.09 Aligned_cols=265 Identities=17% Similarity=0.205 Sum_probs=196.7
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecC-----C
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLET-----R 126 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~-----~ 126 (346)
.+.|...+.||+|+||+||+|.. ++..||+|++.... .........|+..+..+ +||||+++++++... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-DHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhc-CCCCccchHHheecccccccC
Confidence 35688889999999999999998 78899999986532 23345667788888887 999999999988654 3
Q ss_pred cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCC
Q 045453 127 IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSL 206 (346)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl 206 (346)
..++|+||+. ++|.+++... .++++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||+
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~ 154 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSS----QTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGL 154 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcc
Confidence 5799999996 6898888654 35899999999999999999999 89999999999999999999999999999
Q ss_pred CcccCCCCceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhh
Q 045453 207 SVSIPEGETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIE 285 (346)
Q Consensus 207 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (346)
+....... .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||........ .........
T Consensus 155 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-------~~~~~~~~~ 226 (337)
T cd07858 155 ARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQ-------LKLITELLG 226 (337)
T ss_pred ccccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH-------HHHHHHHhC
Confidence 87664332 12234457889999998875 4689999999999999999999999975432110 111111000
Q ss_pred c-----------CccccccccccccCCCC--cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045453 286 N-----------NEFDEIVDPIIVSEGPR--VGKEKQLQGFRELALMCVCESAEDRPTTVDVAKR 337 (346)
Q Consensus 286 ~-----------~~~~~~~d~~l~~~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 337 (346)
. ......+.......... ...+.....+.+++.+||+.+|++|||+.|+++-
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 227 SPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred CCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0 00000000000000000 0001345668899999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=314.34 Aligned_cols=258 Identities=19% Similarity=0.274 Sum_probs=209.5
Q ss_pred HHHHHHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCc--cCcchHHHHHHHHHHhhhcCCCceeeEcceeec
Q 045453 49 IRELEIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDI--LNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLE 124 (346)
Q Consensus 49 ~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~ 124 (346)
.+++....++|.+.++||+|+||.|..++. +++.+|+|++++. .......++.|+..++...+.+.|+.++..|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 356666678999999999999999999999 7889999998863 235567788888888887799999999999999
Q ss_pred CCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEecc
Q 045453 125 TRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDF 204 (346)
Q Consensus 125 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Df 204 (346)
.+++|+|||||+||+|..++..-. +++......++..|+.||.-|| +.|+|||||||+|||+|.+|++||+||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccc
Confidence 999999999999999999997653 5888999999999999999999 999999999999999999999999999
Q ss_pred CCCcccCCCCceeeccccccCCcCCcccccc-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHH
Q 045453 205 SLSVSIPEGETCVKDKVTGTMGFLAPEYINT-----GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHY 279 (346)
Q Consensus 205 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 279 (346)
|.|-.+..++.-.....+|||.|++||++.. +.|..-+|+||+||++|||+.|..||....- ...
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl----------veT 289 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL----------VET 289 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH----------HHH
Confidence 9998888776666778899999999999963 5689999999999999999999999974322 111
Q ss_pred HHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCC---HHHHH
Q 045453 280 VKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPT---TVDVA 335 (346)
Q Consensus 280 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~ev~ 335 (346)
-...+.. .. ....|.....++...+||...+ -+|+.|.. .+++.
T Consensus 290 Y~KIm~h---k~--------~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik 336 (1317)
T KOG0612|consen 290 YGKIMNH---KE--------SLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIK 336 (1317)
T ss_pred HHHHhch---hh--------hcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHH
Confidence 1111111 00 0111112245677888888877 47788877 66553
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=281.14 Aligned_cols=262 Identities=18% Similarity=0.210 Sum_probs=198.0
Q ss_pred CCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCc--chHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEec
Q 045453 59 FDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILND--GHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFES 134 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~--~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~ 134 (346)
|+..+.||+|++|.||+|.. ++..+++|++...... ....+..|+..+..+ +||||+++++++..++..++|+||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-NHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHh-cCCCcchHHHhhccCCCEEEEEec
Confidence 45667899999999999998 6889999987654322 345677888888888 899999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCC
Q 045453 135 VKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE 214 (346)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~ 214 (346)
+++ +|.+++.... ..+++..+..++.+++.||.||| ..+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 80 ~~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 80 MDT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred cCC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence 975 8888887643 46899999999999999999999 8999999999999999999999999999987765433
Q ss_pred ceeeccccccCCcCCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcC---ccc
Q 045453 215 TCVKDKVTGTMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENN---EFD 290 (346)
Q Consensus 215 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 290 (346)
. ......++..|+|||.+.+. .++.++|+||||+++|+|+||+.||......+. +.... ...... ...
T Consensus 153 ~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~------~~~~~-~~~~~~~~~~~~ 224 (283)
T cd05118 153 R-PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ------LFKIF-RTLGTPDPEVWP 224 (283)
T ss_pred c-cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHH-HHcCCCchHhcc
Confidence 1 12234577889999999876 789999999999999999999999975443211 10000 000000 000
Q ss_pred cccc------cccccCCCC---cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 291 EIVD------PIIVSEGPR---VGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 291 ~~~d------~~l~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
...+ ......... ...+.....+.+++..||+.+|.+||++.+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 225 KFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred cchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000 000000000 001134677999999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=285.72 Aligned_cols=262 Identities=18% Similarity=0.235 Sum_probs=186.7
Q ss_pred cccccC--CCcEEEEEEE--CCeEEEEEEecCccC-c-chHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEeccc
Q 045453 63 NVIKDG--YAYKFYKGFV--EDRTVSVMKFNDILN-D-GHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVK 136 (346)
Q Consensus 63 ~~ig~G--~~g~Vy~~~~--~~~~vavk~~~~~~~-~-~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~ 136 (346)
..||+| +||+||++.+ .++.||+|.+..... . ..+.+.+|...+..+ +||||+++++++..++..++|+||++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFF-RHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcceEeeeEecCCceEEEEeccc
Confidence 346666 8999999998 889999999764332 2 234445555555555 99999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCce
Q 045453 137 NRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETC 216 (346)
Q Consensus 137 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 216 (346)
+++|.+++..... ..+++..+..++.|++.||+||| +.+++||||||+|||++.++.++++||+.+.........
T Consensus 83 ~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 83 YGSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred CCCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 9999999876532 35889999999999999999999 899999999999999999999999999854332211100
Q ss_pred e------eccccccCCcCCccccccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHH------
Q 045453 217 V------KDKVTGTMGFLAPEYINTG--DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKK------ 282 (346)
Q Consensus 217 ~------~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------ 282 (346)
. .....++..|+|||++.+. .++.++|||||||++|+|++|..||........ .......
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~------~~~~~~~~~~~~~ 231 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM------LLQKLKGPPYSPL 231 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH------HHHHhcCCCCCCc
Confidence 0 1122345679999999763 478999999999999999999999976543211 0000000
Q ss_pred ----------HhhcC--cccc-ccccc--------ccc-CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 283 ----------CIENN--EFDE-IVDPI--------IVS-EGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 283 ----------~~~~~--~~~~-~~d~~--------l~~-~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
..... .... +.+.. +.. .............+.+|+.+||+.+|++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 232 DITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred cccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00000 0000 00000 000 0001112245678999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=290.44 Aligned_cols=252 Identities=19% Similarity=0.291 Sum_probs=200.8
Q ss_pred hcCCCcccccccCCCcEEEEEEE-CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
...|++.++||+||.+.||++.. +.+-+|+|+..... ......+.+|+..|.++-.|.+||++++|-..++.+|+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 35688889999999999999999 66788888865432 3456678999999999988999999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
||=+- +|..+|..... ....| .+..+..|++.++.+.| ..||||.||||.|+|+-+ |.+||+|||.|..+..
T Consensus 440 E~Gd~-DL~kiL~k~~~--~~~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 440 ECGDI-DLNKILKKKKS--IDPDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred ecccc-cHHHHHHhccC--CCchH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 98744 99999987653 23345 78889999999999999 999999999999999875 4799999999999887
Q ss_pred CCcee-eccccccCCcCCccccccCC-----------CCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHH
Q 045453 213 GETCV-KDKVTGTMGFLAPEYINTGD-----------FNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYV 280 (346)
Q Consensus 213 ~~~~~-~~~~~gt~~y~aPE~~~~~~-----------~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 280 (346)
+.+.. ....+||+.||+||.+.... .+.+|||||+|||||+|+.|+.||..... ..
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n------------~~ 579 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN------------QI 579 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH------------HH
Confidence 66543 35678999999999886432 46789999999999999999999974221 11
Q ss_pred HHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 281 KKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 281 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.++..+.|+--.-.++.... ...+.++++.||+.||++|||..|+++
T Consensus 580 ------aKl~aI~~P~~~Iefp~~~~---~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 580 ------AKLHAITDPNHEIEFPDIPE---NDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred ------HHHHhhcCCCccccccCCCC---chHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 12233444432223322222 122899999999999999999999875
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=289.62 Aligned_cols=259 Identities=17% Similarity=0.230 Sum_probs=190.0
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecCC------
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETR------ 126 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~------ 126 (346)
++|...+.||+|+||.||+|.+ +++.+|+|++.... ......+.+|+..+..+ +||||+++++++....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM-QHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhc-CCCCccchhheecccccCCCCc
Confidence 7898999999999999999997 68899999876432 22334577888888888 9999999999987543
Q ss_pred cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCC
Q 045453 127 IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSL 206 (346)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl 206 (346)
..++|+||+.. +|.+++. ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 45899999964 7766542 25889999999999999999999 89999999999999999999999999999
Q ss_pred CcccCCCCceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHH---
Q 045453 207 SVSIPEGETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKK--- 282 (346)
Q Consensus 207 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--- 282 (346)
++..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ +......
T Consensus 164 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~------~~~~~~~~~~ 233 (342)
T cd07879 164 ARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ------LTQILKVTGV 233 (342)
T ss_pred CcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHHhcCC
Confidence 8765322 123457888999999876 4689999999999999999999999975432110 1000000
Q ss_pred -------HhhcCcccccccc--ccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 283 -------CIENNEFDEIVDP--IIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 283 -------~~~~~~~~~~~d~--~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
..........+.. ...........+.....+.+++.+||+.+|++|||+.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 234 PGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred CCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000000000000 00000000000022355889999999999999999999984
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=282.21 Aligned_cols=247 Identities=18% Similarity=0.235 Sum_probs=198.5
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcC-CCceeeEcceeecCCcceE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSS-HKNVLKLTGCCLETRIPVI 130 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~-h~niv~l~g~~~~~~~~~l 130 (346)
++|...+.||+|++|.||+|.. +++.+++|.+.... ......+..|...+..+ + ||||+++++++...+..++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~~i~~~~~~~~~~~~~~l 79 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRL-NGHPGIIKLYYTFQDEENLYF 79 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhc-ccCCCchhHHHHhcCCceEEE
Confidence 4688889999999999999998 78999999886532 12335567777888888 6 9999999999999999999
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCccc
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI 210 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~ 210 (346)
||||+++++|.+++.... .+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++++|||++...
T Consensus 80 v~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~ 152 (280)
T cd05581 80 VLEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVL 152 (280)
T ss_pred EEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCcccccc
Confidence 999999999999997653 6999999999999999999999 899999999999999999999999999998766
Q ss_pred CCCCc-------------------eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccccc
Q 045453 211 PEGET-------------------CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGA 271 (346)
Q Consensus 211 ~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~ 271 (346)
..... .......++..|+|||...+..++.++||||||++++++++|..||.......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--- 229 (280)
T cd05581 153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL--- 229 (280)
T ss_pred CCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH---
Confidence 43321 11233457889999999998889999999999999999999999997543211
Q ss_pred chhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCH----HHHHH
Q 045453 272 GHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTT----VDVAK 336 (346)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~----~ev~~ 336 (346)
...... . . ...+ +......+.+++.+||+.+|++|||+ .++++
T Consensus 230 ----~~~~~~---~-~------~~~~--------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 230 ----TFQKIL---K-L------EYSF--------PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ----HHHHHH---h-c------CCCC--------CCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 101000 0 0 0000 01234568899999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=285.20 Aligned_cols=246 Identities=19% Similarity=0.287 Sum_probs=206.3
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
+-|...+-||+|.|..|-+|++ +|..||||++.+.. .-...+.++|+.-+.-. +|||||++|.+..+...+|||.
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLV-QHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLV-QHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHh-cCcCeeeeeehhcccceEEEEE
Confidence 4477778899999999999998 99999999987543 23345677887777666 9999999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEc-CCCceEEeccCCCcccC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~-~~~~~kl~Dfgl~~~~~ 211 (346)
|+=.+|+|.+++-... ..+.+....++..||+.|+.|.| +..+|||||||+||.+. +-|.+||.|||++..+.
T Consensus 97 ELGD~GDl~DyImKHe---~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHE---EGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EecCCchHHHHHHhhh---ccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 9999999999998765 46899999999999999999999 99999999999998765 67899999999998876
Q ss_pred CCCceeeccccccCCcCCccccccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINTGDFN-EKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
.+.. -+..+|+..|-|||.+.+..|. +++||||+|||||.++.|+.||+..++.+. +.
T Consensus 171 PG~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET-------------------LT 229 (864)
T KOG4717|consen 171 PGKK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET-------------------LT 229 (864)
T ss_pred Ccch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh-------------------hh
Confidence 5543 3567899999999999999885 679999999999999999999998777654 11
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
-++|= .+.. +.-...++.+|+..||..||.+|.|.+||+.
T Consensus 230 mImDC----KYtv--PshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 230 MIMDC----KYTV--PSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred hhhcc----cccC--chhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 11221 1111 1255677999999999999999999999874
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=287.69 Aligned_cols=263 Identities=18% Similarity=0.227 Sum_probs=199.5
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecCC-----cc
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETR-----IP 128 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~-----~~ 128 (346)
+|...+.||+|++|.||+|.. ++..+++|++.... ......+..|+..+..+ +||||+++++++.... ..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhc-CCcchhhhhhhhcccCcccccce
Confidence 477788999999999999998 57899999987644 23445678888888888 9999999999998775 78
Q ss_pred eEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 129 VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
++||||+++ +|.+++.... ++++..+..++.+++.||+||| +.+++|+||||+|||++.++.++|+|||++.
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~ 151 (330)
T cd07834 80 YIVTELMET-DLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLAR 151 (330)
T ss_pred EEEecchhh-hHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceE
Confidence 999999974 8988886543 6999999999999999999999 8999999999999999999999999999988
Q ss_pred ccCCCCc--eeeccccccCCcCCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhh
Q 045453 209 SIPEGET--CVKDKVTGTMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIE 285 (346)
Q Consensus 209 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (346)
....... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||......+. ...+.....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~-------~~~i~~~~~ 224 (330)
T cd07834 152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ-------LNLIVEVLG 224 (330)
T ss_pred eecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH-------HHHHHHhcC
Confidence 7654331 112334578899999999887 789999999999999999999999976653221 000100000
Q ss_pred -----------cCccccccccccccCCCC--cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 286 -----------NNEFDEIVDPIIVSEGPR--VGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 286 -----------~~~~~~~~d~~l~~~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.......+.......... ...+.....+.+++.+||+.+|++|||+.+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 225 TPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred CCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 000000000000000000 000123466889999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=267.92 Aligned_cols=246 Identities=20% Similarity=0.313 Sum_probs=194.0
Q ss_pred ccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccCC
Q 045453 62 RNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNR 138 (346)
Q Consensus 62 ~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~g 138 (346)
..-||+|+.|.|++++. +|..+|||....... ...++++..+.++......|.||+.+|+|..+...++.||.|.-
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~- 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST- 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-
Confidence 45699999999999999 679999999876543 44566777888777764689999999999999999999999943
Q ss_pred ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCceee
Q 045453 139 TLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVK 218 (346)
Q Consensus 139 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 218 (346)
-++.++..-. .++++...-++...+++||.||-. .++|+|||+||+|||+|..|++|++|||.+-.+-+... .
T Consensus 176 C~ekLlkrik---~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA--h 248 (391)
T KOG0983|consen 176 CAEKLLKRIK---GPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA--H 248 (391)
T ss_pred HHHHHHHHhc---CCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecccc--c
Confidence 5566665543 468888888999999999999996 78999999999999999999999999999866644332 3
Q ss_pred ccccccCCcCCcccccc---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccccc
Q 045453 219 DKVTGTMGFLAPEYINT---GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDP 295 (346)
Q Consensus 219 ~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 295 (346)
+...|-+.|||||.+.. ..|..++||||||+.++|+.||+.||...+.+-. .+...+ ++. . |
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe-----~ltkvl----n~e-P-----P 313 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE-----VLTKVL----NEE-P-----P 313 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH-----HHHHHH----hcC-C-----C
Confidence 34568889999999964 3689999999999999999999999987655332 111111 100 0 1
Q ss_pred ccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 296 IIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 296 ~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.+... ...+..+.+++..||++|+.+||...++++
T Consensus 314 ~L~~~------~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 314 LLPGH------MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CCCcc------cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 11111 135667899999999999999999988765
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=283.28 Aligned_cols=267 Identities=19% Similarity=0.200 Sum_probs=193.7
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecCC-----
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETR----- 126 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~----- 126 (346)
.++|+..+.||+|+||.||+|.+ +++.+++|++..... .......+|+..+..+ +||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-KHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhc-CCCCccchhhheecccccccc
Confidence 57899999999999999999998 678999998764432 2234567788888888 9999999999875543
Q ss_pred ---cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEec
Q 045453 127 ---IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFD 203 (346)
Q Consensus 127 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~D 203 (346)
..++|+||+.+ +|...+.... ..+++..+..++.|+++||+||| +.+++|+||||+||++++++.++|+|
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~d 158 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENPS---VKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIAD 158 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECc
Confidence 45999999965 7777776533 46999999999999999999999 89999999999999999999999999
Q ss_pred cCCCcccCCCCce----------eeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccc
Q 045453 204 FSLSVSIPEGETC----------VKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAG 272 (346)
Q Consensus 204 fgl~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~ 272 (346)
||++......... ..+...++..|+|||.+.+ ..++.++||||||+++|||++|+.||........
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~--- 235 (311)
T cd07866 159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ--- 235 (311)
T ss_pred CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH---
Confidence 9998765432211 1123456788999998865 4589999999999999999999999976443221
Q ss_pred hhhHHHHHHHHhh--------cCccccccccccccCCCCcch---HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 273 HYWLLHYVKKCIE--------NNEFDEIVDPIIVSEGPRVGK---EKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 273 ~~~~~~~~~~~~~--------~~~~~~~~d~~l~~~~~~~~~---~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.......... ........+.......+.... ......+.+++.+||+.+|++|||+.|++.
T Consensus 236 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 236 ---LHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred ---HHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1110000000 000000000000000000000 012356889999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=298.11 Aligned_cols=245 Identities=20% Similarity=0.256 Sum_probs=198.5
Q ss_pred ccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccCCC
Q 045453 62 RNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRT 139 (346)
Q Consensus 62 ~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~gs 139 (346)
...||.|+||.||+|.. .+-..|.|.+..........++-|+.++..+ .||+||+|++.|.-.+.+++..|||.||-
T Consensus 37 iGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~C-dHP~ivkLl~ayy~enkLwiliEFC~GGA 115 (1187)
T KOG0579|consen 37 IGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAEC-DHPVIVKLLSAYYFENKLWILIEFCGGGA 115 (1187)
T ss_pred HhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcC-CChHHHHHHHHHhccCceEEEEeecCCch
Confidence 35699999999999998 3334455777666667778899999999999 99999999999999999999999999999
Q ss_pred hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCceeec
Q 045453 140 LADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKD 219 (346)
Q Consensus 140 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 219 (346)
....+-.-+ .+++..++..++.+++.||.||| +..|||||||..|||++.+|.++|+|||.+.... .......
T Consensus 116 VDaimlEL~---r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~-~t~qkRD 188 (1187)
T KOG0579|consen 116 VDAIMLELG---RVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK-STRQKRD 188 (1187)
T ss_pred HhHHHHHhc---cccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccch-hHHhhhc
Confidence 988876654 57999999999999999999999 9999999999999999999999999999875432 1223346
Q ss_pred cccccCCcCCccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccc
Q 045453 220 KVTGTMGFLAPEYIN-----TGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVD 294 (346)
Q Consensus 220 ~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 294 (346)
...||+.|||||+.. ..+|..++||||||+.|.||..+.+|-...+.- ..++..+. ....
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM------RVllKiaK-----SePP---- 253 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAK-----SEPP---- 253 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH------HHHHHHhh-----cCCC----
Confidence 778999999999885 467999999999999999999999997543221 11111111 1111
Q ss_pred cccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 295 PIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 295 ~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
. ...+..+...+.+++..||..+|..||++.++++
T Consensus 254 -T------LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 254 -T------LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred -c------ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 1 1122267788999999999999999999999875
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=269.90 Aligned_cols=250 Identities=19% Similarity=0.254 Sum_probs=203.1
Q ss_pred HhcCCCcc-cccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeec----CCc
Q 045453 55 ATNNFDAR-NVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLE----TRI 127 (346)
Q Consensus 55 ~~~~f~~~-~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~----~~~ 127 (346)
.|++|++. .+||-|-.|.|-.+.. +++.+|+|.+... ....+|+..--....|||||.+++++.+ ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 56677664 5899999999999988 8899999998632 4556666665556599999999999865 346
Q ss_pred ceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEc---CCCceEEecc
Q 045453 128 PVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLD---EGYIAKLFDF 204 (346)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~---~~~~~kl~Df 204 (346)
+.+|||.|+||.|.+.+.+++. .++++.+...|+.||+.|+.||| +.+|.||||||+|+|.. .|..+||+||
T Consensus 134 LLiVmE~meGGeLfsriq~~g~--~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGD--QAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eEeeeecccchHHHHHHHHccc--ccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEeccc
Confidence 6899999999999999988764 57999999999999999999999 99999999999999996 5678999999
Q ss_pred CCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHh
Q 045453 205 SLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCI 284 (346)
Q Consensus 205 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (346)
|+|+...... .-...+.|+.|.|||++....|...+|+||+||++|-|+.|.+||..........
T Consensus 209 GFAK~t~~~~--~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aisp------------- 273 (400)
T KOG0604|consen 209 GFAKETQEPG--DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP------------- 273 (400)
T ss_pred ccccccCCCc--cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCCh-------------
Confidence 9998654322 2356788999999999999999999999999999999999999998876644311
Q ss_pred hcCccccccccccccC-CCCcch--HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 285 ENNEFDEIVDPIIVSE-GPRVGK--EKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 285 ~~~~~~~~~d~~l~~~-~~~~~~--~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
-+.+++... +..+.+ .+.++...++++.+|+.+|++|.|++++++
T Consensus 274 -------gMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 274 -------GMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred -------hHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 122233222 222222 245688999999999999999999999874
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=292.47 Aligned_cols=275 Identities=20% Similarity=0.249 Sum_probs=210.9
Q ss_pred CCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecC------Ccce
Q 045453 59 FDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLET------RIPV 129 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~------~~~~ 129 (346)
+.....||+|+||.||+|++ +|+.||||.++.... ...+...+|+.++.++ +|||||+++++=.+. +...
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKL-nh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKL-NHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHc-CchhhhhhcccCCccccCcccccce
Confidence 34567899999999999997 899999999987653 5567788999999999 899999999986543 4668
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEc----CCCceEEeccC
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLD----EGYIAKLFDFS 205 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~----~~~~~kl~Dfg 205 (346)
+|||||.+|||...|.+..+. ..+++.+.+.++.+++.||.||| ..+|+||||||.||++. ..-.-||+|||
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~-~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENA-YGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred EEEeecCCCcHHHHhcCcccc-cCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 999999999999999876543 46999999999999999999999 99999999999999994 33368999999
Q ss_pred CCcccCCCCceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHh
Q 045453 206 LSVSIPEGETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCI 284 (346)
Q Consensus 206 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (346)
.|+.+.++. ...+.+||..|.+||++.. ..|+..+|.|||||++|+.+||..||.+......... ..|....-
T Consensus 170 ~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~----~~~~~~tk 243 (732)
T KOG4250|consen 170 AARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKE----IMWHIITK 243 (732)
T ss_pred ccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccch----hhhhhhcc
Confidence 999987766 4567899999999999995 7899999999999999999999999987655432100 11111110
Q ss_pred hcCccccccccccccC--------CCCcchHHHHHHHHHHHHHcccCCCCCCC--CHHHHHHHHHHHHHh
Q 045453 285 ENNEFDEIVDPIIVSE--------GPRVGKEKQLQGFRELALMCVCESAEDRP--TTVDVAKRLKQIYQH 344 (346)
Q Consensus 285 ~~~~~~~~~d~~l~~~--------~~~~~~~~~~~~l~~l~~~cl~~~p~~RP--s~~ev~~~L~~i~~~ 344 (346)
....+.....+...+. .+....+.....+.+++..+|..+|.+|= ...+....+.+|+..
T Consensus 244 kp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 244 KPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred CCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 1111111111111111 11112225567788888899999999998 777788777777653
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=289.95 Aligned_cols=248 Identities=19% Similarity=0.228 Sum_probs=210.4
Q ss_pred HHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcce
Q 045453 54 IATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV 129 (346)
Q Consensus 54 ~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~ 129 (346)
.-.+.|.+...||+|.|++|.+|.+ ++..||+|.+.+..- .....+.+|+.++..+ +|||||+++.+......++
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l-~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSL-NHPNIVKLFSVIETEATLY 131 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhc-CCcceeeeeeeeeecceeE
Confidence 3457888999999999999999999 899999999876543 3345688999999999 9999999999999999999
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcc
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVS 209 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~ 209 (346)
+||||..+|.+.++|.... ++.......+..|+.+|++||| ++.|+|||||++||||+.+.++||+|||++..
T Consensus 132 lV~eya~~ge~~~yl~~~g----r~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~ 204 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHG----RMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTF 204 (596)
T ss_pred EEEEeccCchhHHHHHhcc----cchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeecccccee
Confidence 9999999999999998775 4566888889999999999999 99999999999999999999999999999988
Q ss_pred cCCCCceeeccccccCCcCCccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCc
Q 045453 210 IPEGETCVKDKVTGTMGFLAPEYINTGDF-NEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE 288 (346)
Q Consensus 210 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (346)
+..+. .....+|++.|.|||+..+..| .+.+|+||+|+++|-|+.|..||++..-.+.
T Consensus 205 ~~~~~--~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L------------------- 263 (596)
T KOG0586|consen 205 FDYGL--MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL------------------- 263 (596)
T ss_pred ecccc--cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc-------------------
Confidence 76333 3456789999999999999876 6789999999999999999999987655443
Q ss_pred cccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 289 FDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 289 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
-++.+.+.+..+. -...++.+|++++|-.+|.+|+++.++.+
T Consensus 264 ----r~rvl~gk~rIp~--~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 264 ----RPRVLRGKYRIPF--YMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred ----cchheeeeecccc--eeechhHHHHHHhhccCccccCCHHHhhh
Confidence 2233333332211 23456889999999999999999999875
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=285.10 Aligned_cols=269 Identities=16% Similarity=0.167 Sum_probs=196.7
Q ss_pred HHHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeec-CC
Q 045453 52 LEIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLE-TR 126 (346)
Q Consensus 52 l~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~-~~ 126 (346)
+...+++|+..+.||.|+||.||+|.. ++..+|+|++.... ......+..|+..+..+ +||||+++.+++.. .+
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-RHENIISLSDIFISPLE 83 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhc-CCCCeeeEeeeEecCCC
Confidence 445778899999999999999999987 78899999875432 23345677888888888 99999999999865 56
Q ss_pred cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCC
Q 045453 127 IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSL 206 (346)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl 206 (346)
..++|+||+ +++|.+++... ++++.....++.|++.||.||| +.+++|+||+|+||++++++.++|+|||+
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~ 154 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGL 154 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCcccc
Confidence 789999998 56898888642 4788888999999999999999 89999999999999999999999999999
Q ss_pred CcccCCCCceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchh-----hHHHHH
Q 045453 207 SVSIPEGETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHY-----WLLHYV 280 (346)
Q Consensus 207 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~-----~~~~~~ 280 (346)
+...... .....++..|+|||.+.+ ..++.++||||||+++|+|+||..||............. ....+.
T Consensus 155 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 230 (328)
T cd07856 155 ARIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVI 230 (328)
T ss_pred ccccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 8754322 123456788999998866 568999999999999999999999997543211000000 000000
Q ss_pred HHHhhcCccccccccccccCCCCcch---HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 281 KKCIENNEFDEIVDPIIVSEGPRVGK---EKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 281 ~~~~~~~~~~~~~d~~l~~~~~~~~~---~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
....... ...... .+....+.+.. +.....+.+++.+||+.+|++|||+.+++.
T Consensus 231 ~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 231 NTICSEN-TLRFVQ-SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred Hhccchh-hHHHHh-hccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000 000000 00000000000 023467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=275.87 Aligned_cols=262 Identities=19% Similarity=0.254 Sum_probs=196.8
Q ss_pred CCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEec
Q 045453 59 FDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFES 134 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~ 134 (346)
|+....||+|++|.||+|.. +++.+++|.+.... ......+..|+..+..+ +|||++++++++.+.+..++||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL-KHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhc-CCCCHHHHHhhhhcCCceEEEecC
Confidence 45567899999999999999 58999999987653 23345667788888888 999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCC
Q 045453 135 VKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE 214 (346)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~ 214 (346)
++ ++|.+++.... ..+++..+..++.+++.||.||| ..+++|+||+|+||++++++.++|+|||++.......
T Consensus 80 ~~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 152 (282)
T cd07829 80 CD-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL 152 (282)
T ss_pred cC-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence 97 59999997653 35899999999999999999999 8899999999999999999999999999987764432
Q ss_pred ceeeccccccCCcCCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcC------
Q 045453 215 TCVKDKVTGTMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENN------ 287 (346)
Q Consensus 215 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 287 (346)
. ......++..|+|||.+.+. .++.++||||||++++|+++|..||......+. +.. +.......
T Consensus 153 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~------~~~-~~~~~~~~~~~~~~ 224 (282)
T cd07829 153 R-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ------LFK-IFQILGTPTEESWP 224 (282)
T ss_pred c-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH------HHH-HHHHhCCCcHHHHH
Confidence 2 12233456789999998876 789999999999999999999999966442211 000 00000000
Q ss_pred ccccc--cccccccCCCC---cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 288 EFDEI--VDPIIVSEGPR---VGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 288 ~~~~~--~d~~l~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
..... .+......... ...+.....+.+++..||+.+|++||++.+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 225 GVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred hhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000 00000000000 000022467999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=282.77 Aligned_cols=260 Identities=19% Similarity=0.228 Sum_probs=191.8
Q ss_pred cccccccCCCcEEEEEEE--CCeEEEEEEecCccCcc--------------hHHHHHHHHHHhhhcCCCceeeEcceeec
Q 045453 61 ARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDG--------------HEDCFNNIIFASKLSSHKNVLKLTGCCLE 124 (346)
Q Consensus 61 ~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~--------------~~~~~~e~~~~~~~~~h~niv~l~g~~~~ 124 (346)
..+.||+|+||.||+|.+ .++.||+|++....... ...+.+|+..+..+ +||||+++++++..
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 91 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI-KHENIMGLVDVYVE 91 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC-CCcceeeeeEEEec
Confidence 356799999999999997 68899999876432211 12466788888888 99999999999999
Q ss_pred CCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEecc
Q 045453 125 TRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDF 204 (346)
Q Consensus 125 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Df 204 (346)
.+..++||||+. |+|.+++... ..+++.....++.|++.||.||| +.+++|+||+|+||+++.++.++|+||
T Consensus 92 ~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 92 GDFINLVMDIMA-SDLKKVVDRK----IRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred CCcEEEEEeccc-cCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECCc
Confidence 999999999996 5999988654 35899999999999999999999 899999999999999999999999999
Q ss_pred CCCcccCCCC-------------ceeeccccccCCcCCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccc
Q 045453 205 SLSVSIPEGE-------------TCVKDKVTGTMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIG 270 (346)
Q Consensus 205 gl~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~ 270 (346)
|++....... ........++..|+|||.+.+. .++.++||||||+++|+|++|..||......+.
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~- 242 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ- 242 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 9987654211 0111223467889999998764 478999999999999999999999976543221
Q ss_pred cchhhHHHHHHHHhhcCccc---cccccc----cccCCCCc---chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 271 AGHYWLLHYVKKCIENNEFD---EIVDPI----IVSEGPRV---GKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~---~~~d~~----l~~~~~~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
...+.......... ...+-. .....+.. ........+.+++.+||+.+|++|||+.|++.
T Consensus 243 ------~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 243 ------LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred ------HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 11111111111000 000000 00000000 00022456889999999999999999999975
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=287.74 Aligned_cols=271 Identities=16% Similarity=0.190 Sum_probs=198.9
Q ss_pred cCCCHHHHHHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcc
Q 045453 45 RGFTIRELEIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTG 120 (346)
Q Consensus 45 ~~~~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g 120 (346)
++....++...+++|...+.||+|+||.||+|.. ++..||+|++..... .....+.+|+..+.++ +||||+++++
T Consensus 5 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~iv~~~~ 83 (345)
T cd07877 5 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 83 (345)
T ss_pred hhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHc-CCCcccceee
Confidence 3445567777889999999999999999999987 788999999864322 2245567788888888 9999999999
Q ss_pred eeecC------CcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEc
Q 045453 121 CCLET------RIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLD 194 (346)
Q Consensus 121 ~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~ 194 (346)
++... ...+++++++ +++|.+++... .+++..+..++.|++.||.||| +.+++||||||+||+++
T Consensus 84 ~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~ 154 (345)
T cd07877 84 VFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVN 154 (345)
T ss_pred eeeecccccccccEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEc
Confidence 88643 3467888877 77998887542 4899999999999999999999 89999999999999999
Q ss_pred CCCceEEeccCCCcccCCCCceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccch
Q 045453 195 EGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGH 273 (346)
Q Consensus 195 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~ 273 (346)
+++.+||+|||+++..... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........
T Consensus 155 ~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~---- 226 (345)
T cd07877 155 EDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ---- 226 (345)
T ss_pred CCCCEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----
Confidence 9999999999998764322 223467889999999876 5688999999999999999999999965432111
Q ss_pred hhHHHHHHHHh----------hcCccccc---cccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 274 YWLLHYVKKCI----------ENNEFDEI---VDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 274 ~~~~~~~~~~~----------~~~~~~~~---~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
+........ ........ +......... .........+.+++..||+.+|.+|||+.+++.
T Consensus 227 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 227 --LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred --HHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 110000000 00000000 0000000000 000012345889999999999999999999875
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=285.52 Aligned_cols=264 Identities=18% Similarity=0.244 Sum_probs=192.5
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecC---------
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLET--------- 125 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~--------- 125 (346)
++|...+.||.|+||.||+|.. ++..||+|++..........+.+|+..+..+ +||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhc-CCCcchhhHhhhcccccccccccc
Confidence 6788899999999999999998 6789999998765555566788889998888 999999999876553
Q ss_pred -----CcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEc-CCCce
Q 045453 126 -----RIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIA 199 (346)
Q Consensus 126 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~-~~~~~ 199 (346)
...++||||++ ++|.+++... .+++.....++.|++.||.||| +.+++||||||+||+++ .++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG-----PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceE
Confidence 35789999997 4898887542 4889999999999999999999 89999999999999998 45678
Q ss_pred EEeccCCCcccCCCCce--eeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhH
Q 045453 200 KLFDFSLSVSIPEGETC--VKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWL 276 (346)
Q Consensus 200 kl~Dfgl~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~ 276 (346)
|++|||+++........ ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||......+. .
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~------~ 228 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ------M 228 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------H
Confidence 99999998765322111 1123357889999998754 5688999999999999999999999976543211 0
Q ss_pred HHHHHHHhh-----cCccccccccccc--cCCCCcch----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 277 LHYVKKCIE-----NNEFDEIVDPIIV--SEGPRVGK----EKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 277 ~~~~~~~~~-----~~~~~~~~d~~l~--~~~~~~~~----~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
......... ............. ........ +.....+.+++..||+.+|++|||+.|++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 229 QLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000000000 0000000000000 00000000 023456889999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=280.30 Aligned_cols=270 Identities=15% Similarity=0.157 Sum_probs=190.9
Q ss_pred CCCcccccccCCCcEEEEEEE--C--CeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecC----Cc
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--E--DRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLET----RI 127 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~--~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~----~~ 127 (346)
+|...+.||+|+||.||++.. . +..+|+|++..... .....+.+|+..+..+..||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 467788999999999999998 3 67899998764322 23456778888888885699999999875432 45
Q ss_pred ceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCC
Q 045453 128 PVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS 207 (346)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~ 207 (346)
.++++||+. ++|.+++... ..+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG----QPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 688889886 5899988654 36899999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCce---eeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhh-----HHH
Q 045453 208 VSIPEGETC---VKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYW-----LLH 278 (346)
Q Consensus 208 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~-----~~~ 278 (346)
+........ ......|+..|+|||+..+ ..++.++||||||+++|++++|..||.............. ...
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 766432221 1123468899999998765 4689999999999999999999999976442211000000 000
Q ss_pred HHHHHhhcCccccccccccccCCCCc--chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 279 YVKKCIENNEFDEIVDPIIVSEGPRV--GKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 279 ~~~~~~~~~~~~~~~d~~l~~~~~~~--~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
....... ..........-....... ..+.....+.+++.+||+.+|++|||+.+++.
T Consensus 233 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 233 TLSRIGS-PKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHhhhh-hhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000 000000000000000000 00012456889999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=281.89 Aligned_cols=268 Identities=15% Similarity=0.184 Sum_probs=193.9
Q ss_pred HHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecCC---
Q 045453 54 IATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETR--- 126 (346)
Q Consensus 54 ~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~--- 126 (346)
...++|+..+.||+|+||.||+|.. ++..||+|++..... .....+.+|+..+..+ +||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-KHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCccceeeeecCCcccc
Confidence 3567899999999999999999988 788999998754322 2334577888888888 9999999999987654
Q ss_pred ---cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEec
Q 045453 127 ---IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFD 203 (346)
Q Consensus 127 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~D 203 (346)
..++||||+ +++|.+++.. ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEee
Confidence 358999999 6799888764 35899999999999999999999 89999999999999999999999999
Q ss_pred cCCCcccCCCCceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchh-----hHH
Q 045453 204 FSLSVSIPEGETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHY-----WLL 277 (346)
Q Consensus 204 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~-----~~~ 277 (346)
||++....... ....++..|+|||.+.+ ..++.++|+||||++++++++|..||............. ...
T Consensus 162 fg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 162 FGLARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred cccccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 99987653321 23457889999999876 458899999999999999999999997543211100000 000
Q ss_pred HHHHHHhhcCccccccccccccCCCC--cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 278 HYVKKCIENNEFDEIVDPIIVSEGPR--VGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 278 ~~~~~~~~~~~~~~~~d~~l~~~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.+.... ................... .........+.+++.+|++.+|++|||+.+++.
T Consensus 238 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 238 EFVQKL-QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHhh-cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 0000000000000000000 000122345889999999999999999999883
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=315.69 Aligned_cols=249 Identities=20% Similarity=0.275 Sum_probs=197.0
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
-++...++||.|.||.||-|.. +|.-.|+|-+.... ........+|..++..+ .|||+|+++|+-...+..+|.|
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~l-nHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGL-NHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhc-cCccccccCceeecHHHHHHHH
Confidence 3455678999999999999988 78888888765332 34455677788888888 9999999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
|||++|+|.+.+.... ..++.....+..|++.|++||| ++|||||||||+|||++.+|.+|++|||.|..+..
T Consensus 1314 EyC~~GsLa~ll~~gr----i~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGR----IEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHhccCcHHHHHHhcc----hhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecC
Confidence 9999999999997653 4677777888999999999999 99999999999999999999999999999988765
Q ss_pred CCcee---eccccccCCcCCccccccC---CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhc
Q 045453 213 GETCV---KDKVTGTMGFLAPEYINTG---DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIEN 286 (346)
Q Consensus 213 ~~~~~---~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (346)
..... .....||+.|||||++.+. +-.-+.||||+|||++||+||++||...+..=. +.-.|
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a------IMy~V------ 1454 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA------IMYHV------ 1454 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH------HHhHH------
Confidence 43211 2456799999999999864 356689999999999999999999976544211 11111
Q ss_pred CccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 287 NEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 287 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
-.+..|.. +...+..=.+++.+||..||+.|=++.|+++
T Consensus 1455 ----------~~gh~Pq~-P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1455 ----------AAGHKPQI-PERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred ----------hccCCCCC-chhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 11222221 1235566778999999999999987776654
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=265.62 Aligned_cols=275 Identities=19% Similarity=0.204 Sum_probs=203.2
Q ss_pred cCCCcccccccCCCcEEEEEEE----C--CeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeec-CCc
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV----E--DRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLE-TRI 127 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~----~--~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~-~~~ 127 (346)
..|+....||+|.||.||+|.. + ...+|+|++....+ .-.....+|+..+..+ +|||++.+..++.+ +..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl-~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLREL-KHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHh-cCCcchhHHHHHhccCce
Confidence 4577788999999999999966 2 23789999876533 2345678899999888 99999999999988 778
Q ss_pred ceEEEecccCCChhhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCC----CceEEe
Q 045453 128 PVIVFESVKNRTLADHIYQNQPH-FEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEG----YIAKLF 202 (346)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~----~~~kl~ 202 (346)
+++++||.+. +|++.++-.... ...++-..+..|+.||+.|+.||| +.=|+||||||.|||+..+ |.+||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEee
Confidence 8999999988 999998754321 245788889999999999999999 7889999999999999877 999999
Q ss_pred ccCCCcccCCCCc--eeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHH
Q 045453 203 DFSLSVSIPEGET--CVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHY 279 (346)
Q Consensus 203 Dfgl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 279 (346)
|+|+++.+...-. .....++.|+.|+|||.+.+ ..||.+.|||+.|||+.||+|-++.|.+...+......++..+.
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 9999998864432 23456788999999999987 56999999999999999999999999776544333323333333
Q ss_pred HHH--HhhcCcccccccc-----------ccccCC-CCcchHH-------HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 280 VKK--CIENNEFDEIVDP-----------IIVSEG-PRVGKEK-------QLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 280 ~~~--~~~~~~~~~~~d~-----------~l~~~~-~~~~~~~-------~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.+. .+....-.++-+- .....+ ...+... -.....+|+..+|+.||.+|.|++++++
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence 222 1111110000000 000000 0000000 1123778999999999999999999876
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=264.38 Aligned_cols=270 Identities=20% Similarity=0.319 Sum_probs=213.2
Q ss_pred CCHHHHHHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeec
Q 045453 47 FTIRELEIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLE 124 (346)
Q Consensus 47 ~~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~ 124 (346)
=+++++.+.|+ ..||+|+|+.|--+.. ++..+|||++.+.......+.++|+.++...-.|+||++++.+|.+
T Consensus 73 g~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd 147 (463)
T KOG0607|consen 73 GKFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED 147 (463)
T ss_pred chHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence 35778888875 4699999999988776 9999999999888778888999999999999889999999999999
Q ss_pred CCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCC---ceEE
Q 045453 125 TRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGY---IAKL 201 (346)
Q Consensus 125 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~---~~kl 201 (346)
+...|||||-|.||+|..++..+. .+++.+...++.+|+.||.||| .+||.||||||+|||...-. -+||
T Consensus 148 d~~FYLVfEKm~GGplLshI~~~~----~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKi 220 (463)
T KOG0607|consen 148 DTRFYLVFEKMRGGPLLSHIQKRK----HFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKI 220 (463)
T ss_pred cceEEEEEecccCchHHHHHHHhh----hccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceee
Confidence 999999999999999999998764 5999999999999999999999 99999999999999996443 5799
Q ss_pred eccCCCcccCCCCce------eeccccccCCcCCccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccc
Q 045453 202 FDFSLSVSIPEGETC------VKDKVTGTMGFLAPEYIN-----TGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIG 270 (346)
Q Consensus 202 ~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~ 270 (346)
+||.+...+.....+ .-..++|+..|||||++. ...|..++|.||+|||||-|++|.+||.+.-+.+-+
T Consensus 221 CDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG 300 (463)
T KOG0607|consen 221 CDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG 300 (463)
T ss_pred eccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC
Confidence 999987554322211 124567899999999874 245889999999999999999999999988776655
Q ss_pred cchhhHHHHHHHHhhcCccccccccccccCCCCcchH--HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 271 AGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKE--KQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~--~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
++.-.......+. ++.+.-.+.+..+..+ -.+....+++...+..+|.+|.++.+++.
T Consensus 301 WdrGe~Cr~CQ~~--------LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 301 WDRGEVCRVCQNK--------LFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccCCCccHHHHHH--------HHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 4332222221111 1111111222222211 23466788999999999999999988865
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=285.54 Aligned_cols=261 Identities=17% Similarity=0.247 Sum_probs=194.8
Q ss_pred HhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCc---
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRI--- 127 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~--- 127 (346)
..++|...+.||+|++|.||+|.+ ++..+|+|++.... ......+.+|+..+..+ +||||+++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM-DHENVIGLLDVFTPASSLED 91 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhc-cCCCHHHHHHHhhccccccc
Confidence 467899999999999999999999 67899999876432 22335567788888888 99999999998876554
Q ss_pred ---ceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEecc
Q 045453 128 ---PVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDF 204 (346)
Q Consensus 128 ---~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Df 204 (346)
.++|+||+ +++|.+++.. .++++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEccc
Confidence 89999999 5699998865 35899999999999999999999 899999999999999999999999999
Q ss_pred CCCcccCCCCceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHH
Q 045453 205 SLSVSIPEGETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKC 283 (346)
Q Consensus 205 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 283 (346)
|++...... .....++..|+|||.+.+ ..++.++||||||+++|++++|+.||........ +.. +...
T Consensus 163 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~------~~~-i~~~ 231 (343)
T cd07851 163 GLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ------LKR-IMNL 231 (343)
T ss_pred ccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHH-HHHh
Confidence 998765432 223457888999999865 4678999999999999999999999975433211 100 0000
Q ss_pred hh-----------cCccccccccccccCCCCcc--hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 284 IE-----------NNEFDEIVDPIIVSEGPRVG--KEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 284 ~~-----------~~~~~~~~d~~l~~~~~~~~--~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.. .......+............ .......+.+++.+||+.+|++|||+.||+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 232 VGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred cCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00 00000000000000000000 0012467899999999999999999999874
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=267.48 Aligned_cols=235 Identities=21% Similarity=0.238 Sum_probs=189.8
Q ss_pred cccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccCCC
Q 045453 65 IKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRT 139 (346)
Q Consensus 65 ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~gs 139 (346)
||+|+||.||++.. +++.+++|.+..... .....+..|...+..+ +||||+++++.+..++..++||||+++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHc-CCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 69999999999998 578999998765432 2344667777887777 99999999999999999999999999999
Q ss_pred hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCceeec
Q 045453 140 LADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKD 219 (346)
Q Consensus 140 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 219 (346)
|.+++.... .+++.....++.|++.||.||| ..+++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 80 L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~ 151 (250)
T cd05123 80 LFSHLSKEG----RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTN 151 (250)
T ss_pred HHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC-ccc
Confidence 999997653 5899999999999999999999 89999999999999999999999999999876644321 223
Q ss_pred cccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccccccccc
Q 045453 220 KVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVS 299 (346)
Q Consensus 220 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 299 (346)
...++..|+|||...+...+.++|+||||+++|++++|..||....... . ...... .
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-------~---~~~~~~-~------------ 208 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE-------I---YEKILK-D------------ 208 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-------H---HHHHhc-C------------
Confidence 4567889999999998889999999999999999999999996543211 1 111100 0
Q ss_pred CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 045453 300 EGPRVGKEKQLQGFRELALMCVCESAEDRPTTVD 333 (346)
Q Consensus 300 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e 333 (346)
..+ .+...+..+.+++.+||..+|++|||+.+
T Consensus 209 ~~~--~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 209 PLR--FPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCC--CCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 000 01122466889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=265.74 Aligned_cols=221 Identities=19% Similarity=0.157 Sum_probs=176.0
Q ss_pred CCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccCCChhhhhh
Q 045453 68 GYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIY 145 (346)
Q Consensus 68 G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~ 145 (346)
|.+|.||++.+ +++.+|+|++.... ....+...+... .||||+++++++.+.+..++||||+++|+|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPH-CVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhc-CCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 89999999999 78899999986542 223344444455 79999999999999999999999999999999987
Q ss_pred hcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCceeeccccccC
Q 045453 146 QNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTM 225 (346)
Q Consensus 146 ~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~ 225 (346)
... ++++..+..++.|++.||.||| ..+++||||||+||+++.++.++++|||.+....... ....++.
T Consensus 78 ~~~----~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~ 146 (237)
T cd05576 78 KFL----NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVEN 146 (237)
T ss_pred Hhc----CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCc
Confidence 643 5899999999999999999999 8999999999999999999999999999876554321 2234567
Q ss_pred CcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcc
Q 045453 226 GFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVG 305 (346)
Q Consensus 226 ~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 305 (346)
.|+|||...+..++.++||||+|+++|||++|..|+........ ......+
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~---------------------~~~~~~~-------- 197 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN---------------------THTTLNI-------- 197 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc---------------------cccccCC--------
Confidence 89999999888899999999999999999999988753211000 0000000
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 045453 306 KEKQLQGFRELALMCVCESAEDRPTTVDV 334 (346)
Q Consensus 306 ~~~~~~~l~~l~~~cl~~~p~~RPs~~ev 334 (346)
+......+.+++.+||+.||++|||+.+.
T Consensus 198 ~~~~~~~~~~li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 198 PEWVSEEARSLLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred cccCCHHHHHHHHHHccCCHHHhcCCCcc
Confidence 01234568899999999999999997433
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=272.67 Aligned_cols=270 Identities=17% Similarity=0.250 Sum_probs=206.2
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCC-Cc----eeeEcceeecCCcc
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSH-KN----VLKLTGCCLETRIP 128 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h-~n----iv~l~g~~~~~~~~ 128 (346)
++.|.+...+|+|.||.|-.+.+ .+..||||++... ....+...-|+..+.++..+ || +|++.+++.-.++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 77888999999999999999988 6689999987654 34456677888888888443 33 88899999999999
Q ss_pred eEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcC-------------
Q 045453 129 VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE------------- 195 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~------------- 195 (346)
|+|+|.+ |.|+.++|..+.. .+++..++..|+.|++++++||| +.+++|-||||+|||+.+
T Consensus 167 Civfell-G~S~~dFlk~N~y--~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENNY--IPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred EEEEecc-ChhHHHHhccCCc--cccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCcc
Confidence 9999999 6699999988654 68999999999999999999999 999999999999999932
Q ss_pred -------CCceEEeccCCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc
Q 045453 196 -------GYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDE 268 (346)
Q Consensus 196 -------~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~ 268 (346)
+..++|+|||.|+...+.. ...+.|..|+|||++.+.+++.++||||+||||.|+.||...|+...+.+
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 3478999999998765544 45678999999999999999999999999999999999999999877544
Q ss_pred cc--------cchhhHHH-H-HHHHhhcCcc-----------ccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCC
Q 045453 269 IG--------AGHYWLLH-Y-VKKCIENNEF-----------DEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAED 327 (346)
Q Consensus 269 ~~--------~~~~~~~~-~-~~~~~~~~~~-----------~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~ 327 (346)
.. ........ . ....+..+.+ ....++...-.........+...|++|+..+|.+||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 21 00011110 0 1111111110 00011100000111122356677999999999999999
Q ss_pred CCCHHHHHH
Q 045453 328 RPTTVDVAK 336 (346)
Q Consensus 328 RPs~~ev~~ 336 (346)
|+|+.|++.
T Consensus 397 RiTl~EAL~ 405 (415)
T KOG0671|consen 397 RITLREALS 405 (415)
T ss_pred cccHHHHhc
Confidence 999999875
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=303.34 Aligned_cols=253 Identities=21% Similarity=0.303 Sum_probs=189.0
Q ss_pred HHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc-CcchHHHHHHHHHHhhhcCCCceeeEcceeecC-----
Q 045453 54 IATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL-NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLET----- 125 (346)
Q Consensus 54 ~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~----- 125 (346)
...++|+....||+||||.||+++. +|..+|||++.... .......++|+..+.++ +|||+|+++..+.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArL-nHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARL-NHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhc-CCcceeeeehhhhccCCccc
Confidence 4567899999999999999999999 99999999987553 34556788999999999 999999998765300
Q ss_pred --------------------------------------------------------------------------------
Q 045453 126 -------------------------------------------------------------------------------- 125 (346)
Q Consensus 126 -------------------------------------------------------------------------------- 125 (346)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 045453 126 ----------------------------------RIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIA 171 (346)
Q Consensus 126 ----------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~ 171 (346)
-.+||-||||+..+|.+++..+... -.-...+.+..+|+.||+
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~---~~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN---SQRDEAWRLFREILEGLA 711 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc---hhhHHHHHHHHHHHHHHH
Confidence 0136789999887777777655311 135677899999999999
Q ss_pred HHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC----------------C-CCceeeccccccCCcCCccccc
Q 045453 172 YLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP----------------E-GETCVKDKVTGTMGFLAPEYIN 234 (346)
Q Consensus 172 ~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~----------------~-~~~~~~~~~~gt~~y~aPE~~~ 234 (346)
|+| +.|+|||||||.||++|++..+||+|||+++... . ......+..+||.-|+|||++.
T Consensus 712 YIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 712 YIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred HHH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence 999 9999999999999999999999999999998721 0 0111235668999999999998
Q ss_pred cC---CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHH
Q 045453 235 TG---DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQ 311 (346)
Q Consensus 235 ~~---~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 311 (346)
+. .|+.|+|+||+|+|++||+. ||...-... .+-..+..+.+..- +. .......
T Consensus 789 ~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa----------~iL~~LR~g~iP~~--~~--------f~~~~~~ 845 (1351)
T KOG1035|consen 789 DTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERA----------SILTNLRKGSIPEP--AD--------FFDPEHP 845 (1351)
T ss_pred ccccccccchhhhHHHHHHHHHHhc---cCCchHHHH----------HHHHhcccCCCCCC--cc--------cccccch
Confidence 65 49999999999999999997 464321111 01111112221111 00 0112333
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 312 GFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 312 ~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.=.+++.++++.||++|||+.|++.
T Consensus 846 ~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 846 EEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHHHHHhcCCCccCCCHHHHhh
Confidence 3567999999999999999999875
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=267.15 Aligned_cols=253 Identities=19% Similarity=0.216 Sum_probs=194.1
Q ss_pred cccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccC
Q 045453 61 ARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKN 137 (346)
Q Consensus 61 ~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~ 137 (346)
....||.|+||+|++-.+ .|+..|||+++.... .+..++..|....++..+.||||+++|.+..++.+|+.||+|.-
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~ 147 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI 147 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh
Confidence 346799999999999888 889999999886554 45667888888888887899999999999999999999999965
Q ss_pred CChhhhhhhc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCce
Q 045453 138 RTLADHIYQN-QPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETC 216 (346)
Q Consensus 138 gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 216 (346)
||..+-..- ......+++.-.-.|+.-.++||.||-. ...|||||+||+|||+|..|.+||+|||.+-.+.+ +.
T Consensus 148 -SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~--Si 222 (361)
T KOG1006|consen 148 -SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD--SI 222 (361)
T ss_pred -hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHH--HH
Confidence 665543210 0112468888888899999999999986 77899999999999999999999999998855432 22
Q ss_pred eeccccccCCcCCcccccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccc
Q 045453 217 VKDKVTGTMGFLAPEYINT--GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVD 294 (346)
Q Consensus 217 ~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 294 (346)
..+...|-..|||||.+.. ..|..+|||||+|++|+|+.||..||...+. ..+.+... ..+....+..
T Consensus 223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s---------vfeql~~V-v~gdpp~l~~ 292 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS---------VFEQLCQV-VIGDPPILLF 292 (361)
T ss_pred HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH---------HHHHHHHH-HcCCCCeecC
Confidence 2345568889999999975 3589999999999999999999999975433 11111111 1122111111
Q ss_pred cccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 295 PIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 295 ~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
+. .....+..+.+++..||.+|-++||+..++.+
T Consensus 293 -----~~---~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 293 -----DK---ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred -----cc---cccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 10 01145677999999999999999999998765
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=267.55 Aligned_cols=241 Identities=17% Similarity=0.204 Sum_probs=198.1
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVI 130 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~l 130 (346)
-++|...++||+|.||+|-+++- +++.+|+|.+.+... ....+.+.|-..+... +||.+..+...+...+.+|+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~-~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNC-RHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhc-cCcHHHHhhhhhccCceEEE
Confidence 37788899999999999999988 889999999887653 3445566777888888 99999999999999999999
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCccc
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI 210 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~ 210 (346)
||||..||.|.-+|... ..+++.....+..+|+.||.||| +.+||+||||.+|.|+|++|++||+|||+++.-
T Consensus 246 VMeyanGGeLf~HLsre----r~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRE----RVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEEccCceEeeehhhh----hcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhc
Confidence 99999999999998765 35888899999999999999999 899999999999999999999999999998643
Q ss_pred CCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 211 PEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 211 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
-. ........+||+.|.|||++....|..++|+|.+||++|||+.|+.||...+.+.. -..
T Consensus 319 I~-~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL-------FeL----------- 379 (516)
T KOG0690|consen 319 IK-YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL-------FEL----------- 379 (516)
T ss_pred cc-ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH-------HHH-----------
Confidence 22 22234578999999999999999999999999999999999999999986554332 000
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCC
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPT 330 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs 330 (346)
.+..+.. .+.....+...|+...|..||.+|.-
T Consensus 380 -----Il~ed~k--FPr~ls~eAktLLsGLL~kdP~kRLG 412 (516)
T KOG0690|consen 380 -----ILMEDLK--FPRTLSPEAKTLLSGLLKKDPKKRLG 412 (516)
T ss_pred -----HHhhhcc--CCccCCHHHHHHHHHHhhcChHhhcC
Confidence 0111100 01133445677889999999999953
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=274.84 Aligned_cols=242 Identities=20% Similarity=0.226 Sum_probs=195.2
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVI 130 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~l 130 (346)
..+|+...+||+|+||.|.+|.. ++..+|||++.++.. ...+--+.|-..+.-..+-|.+++++.++.+-+.+|.
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 35688899999999999999998 668999999876542 2223234444555555578999999999999999999
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCccc
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI 210 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~ 210 (346)
||||+.||+|-..+.+-+ .+.++....+|.+||-||-+|| +++||+||||.+|||+|.+|++||+|||+++.-
T Consensus 428 VMEyvnGGDLMyhiQQ~G----kFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVG----KFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred EEEEecCchhhhHHHHhc----ccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccccc
Confidence 999999999999987654 4778899999999999999999 999999999999999999999999999998653
Q ss_pred CCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 211 PEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 211 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
--+. ..+...+||+.|+|||.+..++|+.++|+|||||+||||+.|++||++.+.++.. .
T Consensus 501 i~~~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF-------------------~ 560 (683)
T KOG0696|consen 501 IFDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF-------------------Q 560 (683)
T ss_pred ccCC-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH-------------------H
Confidence 2222 2345678999999999999999999999999999999999999999987766541 1
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCC
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPT 330 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs 330 (346)
.+.+... .+ +...+.+...+....|...|.+|.-
T Consensus 561 aI~ehnv--sy----PKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 561 AIMEHNV--SY----PKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred HHHHccC--cC----cccccHHHHHHHHHHhhcCCccccC
Confidence 1111111 11 1144556777888899999999954
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=284.84 Aligned_cols=239 Identities=20% Similarity=0.305 Sum_probs=194.9
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
+..|.....+|.|+|+.|-.+.. +++..++|.+... ..+..+|...+....+||||+++.+.+.++.+.++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 56677778899999999999988 8889999998755 22334556566666699999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEE-cCCCceEEeccCCCcccCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFL-DEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll-~~~~~~kl~Dfgl~~~~~~ 212 (346)
++.++-|.+.+.... ..-..+..|+.+|+.++.||| .+|++||||||+|||+ ++.++++|+|||.++....
T Consensus 397 ~l~g~ell~ri~~~~-----~~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKP-----EFCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hccccHHHHHHHhcc-----hhHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 999998888776643 222788899999999999999 8999999999999999 6999999999999987654
Q ss_pred CCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccc
Q 045453 213 GETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEI 292 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (346)
+ ....+-|..|.|||++....|++++||||||++||+|++|+.||.....+.. + ...+..+.+
T Consensus 469 ~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e------i----~~~i~~~~~--- 531 (612)
T KOG0603|consen 469 S----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE------I----HTRIQMPKF--- 531 (612)
T ss_pred h----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH------H----HHhhcCCcc---
Confidence 4 2344678899999999999999999999999999999999999986555411 1 011111111
Q ss_pred cccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 293 VDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 293 ~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
....++...+|+.+||+.||.+||+|.++..
T Consensus 532 -------------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 532 -------------SECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred -------------ccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 1255677899999999999999999999853
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=289.00 Aligned_cols=259 Identities=22% Similarity=0.302 Sum_probs=212.5
Q ss_pred CHHHHHHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeec-
Q 045453 48 TIRELEIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLE- 124 (346)
Q Consensus 48 ~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~- 124 (346)
.++.+.-.++-|.+...||.|.+|.||+++. +++.+|+|+..... +..++...|..+++.+..|||++.++|++.-
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 3455556678899999999999999999887 88888998877554 3445667777888888899999999999864
Q ss_pred ----CCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceE
Q 045453 125 ----TRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAK 200 (346)
Q Consensus 125 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~k 200 (346)
++.+|||||||.+||..|++++.. +..+.|..+..|+.+++.||.+|| ...++|||||-.|||++.++.+|
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEE
Confidence 578899999999999999998876 478999999999999999999999 99999999999999999999999
Q ss_pred EeccCCCcccCCCCceeeccccccCCcCCccccccC-----CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhh
Q 045453 201 LFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTG-----DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYW 275 (346)
Q Consensus 201 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~ 275 (346)
|+|||.+..+.. ........+||+.|||||++... .|+..+|+||+|++..||.-|.+|+..+-+--
T Consensus 164 LvDFGvSaQlds-T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr------- 235 (953)
T KOG0587|consen 164 LVDFGVSAQLDS-TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR------- 235 (953)
T ss_pred Eeeeeeeeeeec-ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh-------
Confidence 999999876642 33345667899999999999753 37788999999999999999999997543311
Q ss_pred HHHHHHHHhhcCccccccccccccCCCCc-chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 276 LLHYVKKCIENNEFDEIVDPIIVSEGPRV-GKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.+-+...+..+.+ .+..+...+.+++..||.+|.+.||++.++++
T Consensus 236 ----------------aLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 236 ----------------ALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ----------------hhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1111222222211 23478899999999999999999999998874
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=298.70 Aligned_cols=144 Identities=17% Similarity=0.150 Sum_probs=125.9
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
++|...+.||+|+||+||+|.+ .++.||+|++..... .....+..|...+..+ +||||+++++++...+..++|
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS-KSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhc-CCCCcCeEEEEEEECCEEEEE
Confidence 5788899999999999999999 588999999864321 1234556666667666 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
|||+++++|.+++.... .+++..++.++.||+.||.||| ..+|+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~----~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999997543 5888999999999999999999 8899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=261.98 Aligned_cols=266 Identities=17% Similarity=0.253 Sum_probs=197.9
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecC--ccCcchHHHHHHHHHHhhhcCCCceeeEcceeecC-------
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFND--ILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLET------- 125 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~--~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~------- 125 (346)
+.|....+||+|.||.||+|+. .++.||+|+..- .....-....+|+.++..+ .|+|++.++..|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~l-kHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHh-cchhHHHHHHHHhhccCCcccc
Confidence 4455677899999999999988 778889987543 2223345678899999988 999999999998642
Q ss_pred -CcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEecc
Q 045453 126 -RIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDF 204 (346)
Q Consensus 126 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Df 204 (346)
..+++||.+|+. +|...|.+.. ..++..++.+++.++..||.|+| ...|+|||+||+|+|++.++.+||+||
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn~~---vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSNRK---VRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcCcc---ccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeecc
Confidence 247999999987 8999887764 57999999999999999999999 899999999999999999999999999
Q ss_pred CCCcccCCCCcee---eccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHH
Q 045453 205 SLSVSIPEGETCV---KDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYV 280 (346)
Q Consensus 205 gl~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 280 (346)
|+++.+...+... .+..+.|..|++||.+.+ ..|+++.|||+.|||+.||+|+.+.+++....... .++...
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql----~~Is~L 244 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQL----HLISQL 244 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHH----HHHHHH
Confidence 9998775433211 245667999999999986 56999999999999999999999999876553321 111111
Q ss_pred HHHhhcC--------cccccc--ccccccCCCCcchHHHH------HHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 281 KKCIENN--------EFDEIV--DPIIVSEGPRVGKEKQL------QGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 281 ~~~~~~~--------~~~~~~--d~~l~~~~~~~~~~~~~------~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
...+... .+-..+ .|...+.... .++.. ....+|+..++..||.+||++.+++.
T Consensus 245 cGs~tkevWP~~d~lpL~~sie~ePl~~~~~rk--v~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 245 CGSITKEVWPNVDNLPLYQSIELEPLPKGQKRK--VKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred hccCCcccCCCcccchHHHhccCCCCCcchhhh--hhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 1111111 000011 1100010000 00111 35678999999999999999988764
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=277.26 Aligned_cols=264 Identities=14% Similarity=0.131 Sum_probs=181.3
Q ss_pred HhcCCCcccccccCCCcEEEEEEE------------------CCeEEEEEEecCccCcchHH--------------HHHH
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV------------------EDRTVSVMKFNDILNDGHED--------------CFNN 102 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~------------------~~~~vavk~~~~~~~~~~~~--------------~~~e 102 (346)
..++|+..++||+|+||+||+|.+ .++.||||++.........+ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 477999999999999999999964 34579999986543222222 2335
Q ss_pred HHHHhhhcCCCc-----eeeEcceeec--------CCcceEEEecccCCChhhhhhhcCC--------------------
Q 045453 103 IIFASKLSSHKN-----VLKLTGCCLE--------TRIPVIVFESVKNRTLADHIYQNQP-------------------- 149 (346)
Q Consensus 103 ~~~~~~~~~h~n-----iv~l~g~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~-------------------- 149 (346)
+..+.++ +|.| +++++++|.. .+..+|||||+++++|.++++....
T Consensus 223 ~~~l~~l-~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 223 AYMCAKI-KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHh-hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 5556666 5554 4677888753 3567999999999999999875321
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCceeeccccccCCcCC
Q 045453 150 HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLA 229 (346)
Q Consensus 150 ~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~a 229 (346)
....++|..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++.....+.........+|+.|+|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 0123578889999999999999999 8899999999999999999999999999987654433222223345789999
Q ss_pred ccccccCCC----------------------CcccchHHHHHHHHHHHhCCC-CCCCCCCccc--ccchhhHHHHHHHHh
Q 045453 230 PEYINTGDF----------------------NEKCDVFSFGMLLLVLLTGQK-IFDPSRGDEI--GAGHYWLLHYVKKCI 284 (346)
Q Consensus 230 PE~~~~~~~----------------------~~~~Dv~s~G~vl~elltg~~-p~~~~~~~~~--~~~~~~~~~~~~~~~ 284 (346)
||.+..... ..+.||||+||++++|++|.. ||........ ......+..|...
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~-- 456 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY-- 456 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh--
Confidence 998864321 234799999999999999874 6653221111 0000011111110
Q ss_pred hcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCC---CCCCCHHHHHH
Q 045453 285 ENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESA---EDRPTTVDVAK 336 (346)
Q Consensus 285 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p---~~RPs~~ev~~ 336 (346)
.... ..............+|+.++|..+| .+|+|+.|+++
T Consensus 457 ~~~~------------~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 457 KGQK------------YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cccC------------CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 0000 0000111335668889999999766 68999999874
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=286.07 Aligned_cols=261 Identities=16% Similarity=0.145 Sum_probs=169.7
Q ss_pred HhcCCCcccccccCCCcEEEEEEE--C----CeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcce------e
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV--E----DRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGC------C 122 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~--~----~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~------~ 122 (346)
..++|...+.||+|+||.||+|.+ + +..||+|++..... .+...... +... .+.+++.+... +
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e~-l~~~-~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNER-VRRA-CPNSCADFVYGFLEPVSS 204 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHHH-HHhh-chhhHHHHHHhhhccccc
Confidence 678899999999999999999999 4 68999998764321 11111111 1111 22233322221 2
Q ss_pred ecCCcceEEEecccCCChhhhhhhcCCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCC
Q 045453 123 LETRIPVIVFESVKNRTLADHIYQNQPH----------------FEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKI 186 (346)
Q Consensus 123 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dl 186 (346)
......++||||+++++|.+++...... ........+..++.|++.||.||| +.+|+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcC
Confidence 4566889999999999999998754210 001123345679999999999999 899999999
Q ss_pred CCCCeEEcC-CCceEEeccCCCcccCCCCceeeccccccCCcCCccccccC----------------------CCCcccc
Q 045453 187 RPSRIFLDE-GYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTG----------------------DFNEKCD 243 (346)
Q Consensus 187 kp~NIll~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D 243 (346)
||+|||++. ++.+||+|||+++.+............+++.|+|||.+... .++.++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999985 68999999999987654443334556789999999966422 2345679
Q ss_pred hHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCc-cc---ccccccc----ccCCCCcchHHHHHHHHH
Q 045453 244 VFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE-FD---EIVDPII----VSEGPRVGKEKQLQGFRE 315 (346)
Q Consensus 244 v~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~---~~~d~~l----~~~~~~~~~~~~~~~l~~ 315 (346)
||||||++|||+++..+++.. +..+.......+. .. ..+.+.. ...... .........+
T Consensus 362 VwSlGviL~el~~~~~~~~~~-----------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~d~~~~~~~d 428 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSN-----------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEV--LDLDGGAGWE 428 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchH-----------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhh--ccccchHHHH
Confidence 999999999999976654321 1111111000000 00 0000000 000000 0011223568
Q ss_pred HHHHcccCCCCCCCCHHHHHH
Q 045453 316 LALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 316 l~~~cl~~~p~~RPs~~ev~~ 336 (346)
|+.+||+.||++|||+.|+++
T Consensus 429 Li~~mL~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 429 LLKSMMRFKGRQRISAKAALA 449 (566)
T ss_pred HHHHHccCCcccCCCHHHHhC
Confidence 999999999999999999975
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=254.22 Aligned_cols=237 Identities=24% Similarity=0.294 Sum_probs=191.6
Q ss_pred CCcEEEEEEE--CCeEEEEEEecCccCcc-hHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccCCChhhhhh
Q 045453 69 YAYKFYKGFV--EDRTVSVMKFNDILNDG-HEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIY 145 (346)
Q Consensus 69 ~~g~Vy~~~~--~~~~vavk~~~~~~~~~-~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~ 145 (346)
+||.||+|.+ ++..+++|++....... ...+.+|+..+..+ +|+|++++++++......++++||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKL-KHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhC-CCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 5899999999 46899999987665444 67788888888888 99999999999999999999999999999999987
Q ss_pred hcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCceeeccccccC
Q 045453 146 QNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTM 225 (346)
Q Consensus 146 ~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~ 225 (346)
... .+++..++.++.+++.++.+|| ..+++|+||+|+||+++.++.++++|||.+....... ......++.
T Consensus 80 ~~~----~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~ 150 (244)
T smart00220 80 KRG----RLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTP 150 (244)
T ss_pred hcc----CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCc
Confidence 643 3899999999999999999999 8899999999999999999999999999987765432 223456788
Q ss_pred CcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcc
Q 045453 226 GFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVG 305 (346)
Q Consensus 226 ~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 305 (346)
.|++||...+..++.++||||||++++++++|..||........ ..... ...... . . ..
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~------~~~~~----~~~~~~----~----~---~~ 209 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE------LFKKI----GKPKPP----F----P---PP 209 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH------HHHHH----hccCCC----C----c---cc
Confidence 99999999988899999999999999999999999975322111 11111 000000 0 0 00
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 306 KEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 306 ~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.......+.+++.+||..+|++||++.++++
T Consensus 210 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 210 EWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred cccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 0014567899999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=273.50 Aligned_cols=242 Identities=20% Similarity=0.287 Sum_probs=196.2
Q ss_pred ccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccC
Q 045453 62 RNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKN 137 (346)
Q Consensus 62 ~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~ 137 (346)
+++||+|.||+||-|.+ +|+.||||.+.+.. .....+..+|+.+++.+ .||.||.+-..|.+.+.+++|||-+ +
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l-~HPGiV~le~M~ET~ervFVVMEKl-~ 646 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNL-HHPGIVNLECMFETPERVFVVMEKL-H 646 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhc-CCCCeeEEEEeecCCceEEEEehhh-c
Confidence 57899999999999998 89999999987654 34557788999999999 9999999999999999999999999 4
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCC---CceEEeccCCCcccCCCC
Q 045453 138 RTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEG---YIAKLFDFSLSVSIPEGE 214 (346)
Q Consensus 138 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~---~~~kl~Dfgl~~~~~~~~ 214 (346)
|+..+.+-.... .+++......++.||+-||.||| .++|+|+||||+|||+.+. ..+||+|||+|+.+++..
T Consensus 647 GDMLEMILSsEk--gRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 647 GDMLEMILSSEK--GRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred chHHHHHHHhhc--ccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence 577777655443 47999999999999999999999 9999999999999999644 479999999999997654
Q ss_pred ceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccc
Q 045453 215 TCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVD 294 (346)
Q Consensus 215 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 294 (346)
....++||+.|.|||++.+..|+.+-|+||+||++|--++|..||....+-. +. +. +
T Consensus 722 --FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn---------dQ----IQ--------N 778 (888)
T KOG4236|consen 722 --FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN---------DQ----IQ--------N 778 (888)
T ss_pred --hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh---------HH----hh--------c
Confidence 3677899999999999999999999999999999999999999996432200 00 00 0
Q ss_pred cccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 045453 295 PIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVA 335 (346)
Q Consensus 295 ~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~ 335 (346)
.... ++..+=.+......+|+...|+..-.+|-|...-+
T Consensus 779 AaFM--yPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 779 AAFM--YPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred cccc--cCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 0000 11111125566788899999988888888766543
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=232.32 Aligned_cols=264 Identities=17% Similarity=0.207 Sum_probs=198.2
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
+|....+||+|.||+||+|+. +++-||+|+.+-+.+ .-.....+|+-.+..+ .|.|||+++++...+..+.+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkel-khknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHh-hhcceeehhhhhccCceeEEeHH
Confidence 455667899999999999998 778999998875443 2345678999999999 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
||.. +|..++..-+ ..++......++.|+++||.|.| +++++|||+||.|.|++.||..|++|||+++.++.+
T Consensus 82 ~cdq-dlkkyfdsln---g~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgip 154 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSLN---GDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP 154 (292)
T ss_pred HhhH-HHHHHHHhcC---CcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence 9965 8999987765 35888999999999999999999 999999999999999999999999999999998776
Q ss_pred CceeeccccccCCcCCccccccC-CCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHH--hhc---
Q 045453 214 ETCVKDKVTGTMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKC--IEN--- 286 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~--- 286 (346)
-.+.. ..+.|..|.+|.++.+. -|+++.|+||-||++.|+.. |++.|.+.+-++. +....+.. +.+
T Consensus 155 vrcys-aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddq------lkrif~~lg~p~ed~w 227 (292)
T KOG0662|consen 155 VRCYS-AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ------LKRIFRLLGTPTEDQW 227 (292)
T ss_pred eEeee-ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHH------HHHHHHHhCCCccccC
Confidence 55433 34578999999999875 48999999999999999998 6666766544332 21111111 111
Q ss_pred CccccccccccccCCCCc-----chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 287 NEFDEIVDPIIVSEGPRV-----GKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 287 ~~~~~~~d~~l~~~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
..+..+-|-..-..++.. -.+.....=.+++...+.-+|..|.++++.++
T Consensus 228 ps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 228 PSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 111111111110001000 00112223457788888889999999998764
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=286.38 Aligned_cols=247 Identities=23% Similarity=0.328 Sum_probs=191.1
Q ss_pred CCCcccccccCCCcE-EEEEEECCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEeccc
Q 045453 58 NFDARNVIKDGYAYK-FYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVK 136 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~-Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~ 136 (346)
-|....++|.|+-|+ ||+|.++++.||||++... ...-..+|+..++..-.|||||++++.-.+....|+..|.|.
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeCCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 355667899999876 5999999999999997643 244567888889888889999999999888899999999996
Q ss_pred CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcC---C--CceEEeccCCCcccC
Q 045453 137 NRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE---G--YIAKLFDFSLSVSIP 211 (346)
Q Consensus 137 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~---~--~~~kl~Dfgl~~~~~ 211 (346)
- ||.+++...........-...+.+..|+++||++|| +.+||||||||.||||+. + ..++|+|||+++.+.
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5 999999874111111111345778899999999999 899999999999999976 2 579999999999987
Q ss_pred CCCceee--ccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCc
Q 045453 212 EGETCVK--DKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE 288 (346)
Q Consensus 212 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (346)
.+..... ....||-||+|||++.....+.++|+||+||++|+.++ |.+||...-..+. +......
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~------------NIl~~~~ 730 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA------------NILTGNY 730 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh------------hhhcCcc
Confidence 6654332 45679999999999999888999999999999999999 5999986433321 1111110
Q ss_pred cccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 045453 289 FDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVA 335 (346)
Q Consensus 289 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~ 335 (346)
-...+.+ ...+ ...+|+.+|++.+|..||++.+|+
T Consensus 731 ~L~~L~~----------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 731 TLVHLEP----------LPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred ceeeecc----------CchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 0000000 1022 678999999999999999999997
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=255.38 Aligned_cols=269 Identities=19% Similarity=0.291 Sum_probs=209.5
Q ss_pred HHHHHHHhcCCCcccccccCCCcEEEEEEEC-------CeEEEEEEecCcc-CcchHHHHHHHHHHhhhcCCCceeeEcc
Q 045453 49 IRELEIATNNFDARNVIKDGYAYKFYKGFVE-------DRTVSVMKFNDIL-NDGHEDCFNNIIFASKLSSHKNVLKLTG 120 (346)
Q Consensus 49 ~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~-------~~~vavk~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~l~g 120 (346)
.+++......+.....+-+|.||.||+|.|. .+.|.+|.+.... .-....+..|-..+-.. .|||+.++.|
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~-sH~nll~V~~ 354 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGA-SHPNLLSVLG 354 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcC-cCCCccceeE
Confidence 3555666677888888999999999999772 2344555544322 22334455555556666 8999999999
Q ss_pred eeec-CCcceEEEecccCCChhhhhhhcC----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcC
Q 045453 121 CCLE-TRIPVIVFESVKNRTLADHIYQNQ----PHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE 195 (346)
Q Consensus 121 ~~~~-~~~~~lv~e~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~ 195 (346)
++.+ ....+.+|.++.-|+|..+|..-+ ...+.++-.+...++.|++.|++||| ..++||.||...|.++|+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehh
Confidence 9876 456789999999999999997221 22346777788999999999999999 999999999999999999
Q ss_pred CCceEEeccCCCcccCCCCc-eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccch
Q 045453 196 GYIAKLFDFSLSVSIPEGET-CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGH 273 (346)
Q Consensus 196 ~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~ 273 (346)
...+||+|=.+++.+-..+. +.......+..||+||.+.+..|+.++||||||++||||+| |+.||..-++.+.
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm---- 507 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM---- 507 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH----
Confidence 99999999999987765544 23344456778999999999999999999999999999999 9999986655443
Q ss_pred hhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 045453 274 YWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHL 345 (346)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~l 345 (346)
..++.++ +....+.+++++++.++.-||...|++||+++|++..|.+....|
T Consensus 508 -------~~ylkdG-------------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 508 -------EHYLKDG-------------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred -------HHHHhcc-------------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 1222222 222223377888999999999999999999999999999987665
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=266.73 Aligned_cols=238 Identities=18% Similarity=0.236 Sum_probs=194.9
Q ss_pred CcccccccCCCcEEEEEEECCeE--EEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEec
Q 045453 60 DARNVIKDGYAYKFYKGFVEDRT--VSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFES 134 (346)
Q Consensus 60 ~~~~~ig~G~~g~Vy~~~~~~~~--vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~ 134 (346)
+...-||-||||.|=++...++. +|+|.+++.. ....++.+.|-.+++.+ +.|.||++|..|.+...+|+.||-
T Consensus 423 ~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~-~s~fIvrLYrTfrd~kyvYmLmEa 501 (732)
T KOG0614|consen 423 KRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMEC-RSDFIVRLYRTFRDSKYVYMLMEA 501 (732)
T ss_pred hhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhc-CchHHHHHHHHhccchhhhhhHHh
Confidence 34456999999999999986555 6777665443 34556788899999999 899999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCC
Q 045453 135 VKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE 214 (346)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~ 214 (346)
|-||.|+..|+.++ .++..+...++..+..|++||| .++||+|||||+|.|+|.+|-+||.|||+|+.++.+.
T Consensus 502 ClGGElWTiLrdRg----~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 502 CLGGELWTILRDRG----SFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hcCchhhhhhhhcC----CcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 99999999998875 5888899999999999999999 9999999999999999999999999999999997665
Q ss_pred ceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccc
Q 045453 215 TCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVD 294 (346)
Q Consensus 215 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 294 (346)
. +...+||+.|.|||.+.+.....++|.||+|++++|+++|.+||.+.++-.. ++ .+ +. + +|
T Consensus 575 K--TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt----Yn---~I---Lk-G-----id 636 (732)
T KOG0614|consen 575 K--TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT----YN---LI---LK-G-----ID 636 (732)
T ss_pred c--eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH----HH---HH---Hh-h-----hh
Confidence 4 4567899999999999999999999999999999999999999987554211 00 00 00 0 11
Q ss_pred cccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCC
Q 045453 295 PIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPT 330 (346)
Q Consensus 295 ~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs 330 (346)
.. . .+........+|+++....+|.+|.-
T Consensus 637 ~i---~----~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 637 KI---E----FPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred hh---h----cccccchhHHHHHHHHHhcCcHhhhc
Confidence 10 0 01134455678888888899999965
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=234.10 Aligned_cols=207 Identities=16% Similarity=0.228 Sum_probs=170.8
Q ss_pred HhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc-CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL-NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
..++......||+|++|.|=+-++ +|...|+|.+.... .+...+.++++.+..+....|.+|.++|........++.
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc 123 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC 123 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence 334445567899999999866666 99999999987554 355667888999888888899999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
||.|.- ||+.+-..--..+..+++...-+|+..+.+||.|||+ ...++|||+||+|||++.+|.+|++|||.+-.+.
T Consensus 124 ME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 124 MELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred HHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 999966 8877655433334678999999999999999999997 6789999999999999999999999999986553
Q ss_pred CCCceeeccccccCCcCCcccccc----CCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINT----GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRG 266 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~ 266 (346)
++- ..+-..|-..|||||.+.. ..|+.+|||||+|+.+.||.+++.||+...+
T Consensus 201 dSi--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 201 DSI--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred hhh--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 321 1223457788999998864 3699999999999999999999999986554
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=262.56 Aligned_cols=211 Identities=17% Similarity=0.209 Sum_probs=176.1
Q ss_pred HHHHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecC
Q 045453 51 ELEIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLET 125 (346)
Q Consensus 51 ~l~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~ 125 (346)
.-+....-|...+-||-|+||.|.++.- +...+|+|.+.+... ....+...|-.+|... ..+.+|+|+..|.+.
T Consensus 623 RaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLyySFQDk 701 (1034)
T KOG0608|consen 623 RAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDK 701 (1034)
T ss_pred HhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEEEEeccC
Confidence 3334446688888999999999999876 667888888775432 3344556677777777 999999999999999
Q ss_pred CcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccC
Q 045453 126 RIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFS 205 (346)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg 205 (346)
+.+|+||+|++||++-.+|-..+ -+.+.....++.++..|+.+.| ..|+|||||||+|||||.+|++||.|||
T Consensus 702 dnLYFVMdYIPGGDmMSLLIrmg----IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFG 774 (1034)
T KOG0608|consen 702 DNLYFVMDYIPGGDMMSLLIRMG----IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFG 774 (1034)
T ss_pred CceEEEEeccCCccHHHHHHHhc----cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeecc
Confidence 99999999999999999987764 4778888899999999999999 9999999999999999999999999999
Q ss_pred CCcccC---CCCc--------------------------------------eeeccccccCCcCCccccccCCCCcccch
Q 045453 206 LSVSIP---EGET--------------------------------------CVKDKVTGTMGFLAPEYINTGDFNEKCDV 244 (346)
Q Consensus 206 l~~~~~---~~~~--------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv 244 (346)
||+-+. +... ......+||..|+|||++....|+..+|+
T Consensus 775 LCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdw 854 (1034)
T KOG0608|consen 775 LCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDW 854 (1034)
T ss_pred ccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchh
Confidence 986431 0000 00123369999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCccc
Q 045453 245 FSFGMLLLVLLTGQKIFDPSRGDEI 269 (346)
Q Consensus 245 ~s~G~vl~elltg~~p~~~~~~~~~ 269 (346)
||.|||||||+.|+.||......+.
T Consensus 855 ws~gvil~em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 855 WSVGVILYEMLVGQPPFLADTPGET 879 (1034)
T ss_pred hHhhHHHHHHhhCCCCccCCCCCcc
Confidence 9999999999999999987776654
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=256.67 Aligned_cols=254 Identities=23% Similarity=0.303 Sum_probs=193.8
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc-------CcchHHHHHHHHHHhhhcCCCceeeEcceee-cCC
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL-------NDGHEDCFNNIIFASKLSSHKNVLKLTGCCL-ETR 126 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~-------~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~-~~~ 126 (346)
+.|-..+.||+|||+.||+|.+ ..+.||+|.-.... ....+...+|..+-..+ .||.||++|+++. +.+
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-Ccceeeeeeeeeeeccc
Confidence 3444567899999999999998 67788888743221 12345667888888888 9999999999986 567
Q ss_pred cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEc---CCCceEEec
Q 045453 127 IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLD---EGYIAKLFD 203 (346)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~---~~~~~kl~D 203 (346)
.+|-|.|||+|.+|.=+|+.+. .+++.+...|+.||+.||.||... ..+|||-||||.|||+. .-|.+||.|
T Consensus 542 sFCTVLEYceGNDLDFYLKQhk----lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHK----LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred cceeeeeecCCCchhHHHHhhh----hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence 8899999999999999998764 589999999999999999999854 67999999999999995 457899999
Q ss_pred cCCCcccCCCCce------eeccccccCCcCCccccccC----CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccch
Q 045453 204 FSLSVSIPEGETC------VKDKVTGTMGFLAPEYINTG----DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGH 273 (346)
Q Consensus 204 fgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~ 273 (346)
||+++.+..+... .+....||..|++||-+.-+ ..+.|+||||+|||+|..+.|+.||...-....
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd---- 692 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD---- 692 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH----
Confidence 9999888654432 23456799999999977533 468899999999999999999999975433221
Q ss_pred hhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 045453 274 YWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVA 335 (346)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~ 335 (346)
.+....+ +... +-..+..+........++++||+..-++|....++.
T Consensus 693 ---------ILqeNTI---lkAt---EVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 693 ---------ILQENTI---LKAT---EVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred ---------HHhhhch---hcce---eccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 1111111 1111 111222334556678899999999999998776654
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=243.43 Aligned_cols=250 Identities=18% Similarity=0.208 Sum_probs=192.6
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCc---chHHHHHHHHHHhhhcCCCceeeEcceeecCCcceE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILND---GHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVI 130 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~---~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~l 130 (346)
.++|...++||+|+|.+|.++++ +++-+|+|++.+.... ...=...|-.......+||.+|-+..++.+...+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 46788999999999999999999 7889999987654321 111123344445555599999999999999999999
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCccc
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI 210 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~ 210 (346)
|.||++||+|-=++...+ .+++.+...+..+|+.||.||| +.|||+||||.+|+|+|..|++||.|+|+++.-
T Consensus 329 vieyv~ggdlmfhmqrqr----klpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEecCcceeeehhhhh----cCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcC
Confidence 999999999987776543 5899999999999999999999 999999999999999999999999999998653
Q ss_pred CCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 211 PEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 211 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
-. +...+...+||+.|+|||.+.+..|..++|+|++||+++||+.|+.||+....+.... +..++.-.
T Consensus 402 l~-~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~---ntedylfq-------- 469 (593)
T KOG0695|consen 402 LG-PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDM---NTEDYLFQ-------- 469 (593)
T ss_pred CC-CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCccc---chhHHHHH--------
Confidence 22 2223567899999999999999999999999999999999999999997644322211 11111111
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCC
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPT 330 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs 330 (346)
-++++.+.-.. ..+.....+++.-|++||.+|.-
T Consensus 470 vilekqiripr------slsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 470 VILEKQIRIPR------SLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred HHhhhcccccc------eeehhhHHHHHHhhcCCcHHhcC
Confidence 12222222211 22333556788889999999854
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=243.79 Aligned_cols=265 Identities=17% Similarity=0.237 Sum_probs=201.4
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecC-----Cc
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLET-----RI 127 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~-----~~ 127 (346)
.+.+.++-||-|+||.||.+.+ +++.|++|++.+... ...+.+++|..++... +|.|++..+++.... .+
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfF-kHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSF-RHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhh-ccccHHHHHHhcCCCCchHHHH
Confidence 4566789999999999999999 889999999876543 3567889999999888 999999998886543 35
Q ss_pred ceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCC
Q 045453 128 PVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS 207 (346)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~ 207 (346)
+|+|+|+|.. +|...+-.. ++++-.++.-++.||++||.||| +.+|+||||||.|.|+++|...||+|||++
T Consensus 132 iYV~TELmQS-DLHKIIVSP----Q~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLA 203 (449)
T KOG0664|consen 132 LYVLTELMQS-DLHKIIVSP----QALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLA 203 (449)
T ss_pred HHHHHHHHHh-hhhheeccC----CCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccc
Confidence 6889999965 888877553 57888999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhc
Q 045453 208 VSIPEGETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIEN 286 (346)
Q Consensus 208 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (346)
+....++....+..+.|.-|+|||.+.+ ..|+.+.||||+||++.|++..+..|+....-+. .+.+...+..
T Consensus 204 Rvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQ-------L~lItdLLGT 276 (449)
T KOG0664|consen 204 RTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQ-------LQMIIDLLGT 276 (449)
T ss_pred cccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHH-------HHHHHHHhCC
Confidence 9887666656667778899999999987 5699999999999999999999988876554221 1122221111
Q ss_pred Ccc-----------cccccc-----ccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045453 287 NEF-----------DEIVDP-----IIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKR 337 (346)
Q Consensus 287 ~~~-----------~~~~d~-----~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 337 (346)
... ..++.. ...--+..............+...++.+||.+|.+-++.+..
T Consensus 277 Ps~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~ 343 (449)
T KOG0664|consen 277 PSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH 343 (449)
T ss_pred CcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence 100 001110 000001111111233456678888999999999998877643
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-31 Score=223.70 Aligned_cols=209 Identities=26% Similarity=0.428 Sum_probs=181.4
Q ss_pred cccCCCcEEEEEEEC--CeEEEEEEecCccCc-chHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccCCChh
Q 045453 65 IKDGYAYKFYKGFVE--DRTVSVMKFNDILND-GHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLA 141 (346)
Q Consensus 65 ig~G~~g~Vy~~~~~--~~~vavk~~~~~~~~-~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 141 (346)
||+|++|.||++... +..+++|.+...... ....+.+|+..+..+ +|++++++++++......++++||+++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhc-CCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 689999999999995 899999998755432 346678888888888 9999999999999989999999999989999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcC-CCceEEeccCCCcccCCCCceeecc
Q 045453 142 DHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE-GYIAKLFDFSLSVSIPEGETCVKDK 220 (346)
Q Consensus 142 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~-~~~~kl~Dfgl~~~~~~~~~~~~~~ 220 (346)
+++.... ..+++..+..++.+++++|.+|| +.+++|+||+|.||+++. ++.++|+|||.+........ ....
T Consensus 80 ~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~ 152 (215)
T cd00180 80 DLLKENE---GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKT 152 (215)
T ss_pred HHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhc
Confidence 9997653 35899999999999999999999 889999999999999999 89999999999876644321 1233
Q ss_pred ccccCCcCCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccccccccc
Q 045453 221 VTGTMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVS 299 (346)
Q Consensus 221 ~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 299 (346)
..+...|++||..... .++.++|+|++|++++++
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 4577889999999887 889999999999999998
Q ss_pred CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045453 300 EGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKR 337 (346)
Q Consensus 300 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 337 (346)
..+.+++..|++.+|++||++.++++.
T Consensus 188 -----------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -----------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -----------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 347789999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=231.04 Aligned_cols=266 Identities=20% Similarity=0.261 Sum_probs=196.8
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecC------C
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLET------R 126 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~------~ 126 (346)
..|.....+|.|.. .|-.+.+ .+++||+|+..... .+..++..+|...+..+ .|+||++++.+++.. .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v-~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCV-NHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhh-cccceeeeeeccCccccHHHHH
Confidence 45666778999998 7777777 89999999875432 34566778888888887 999999999998754 3
Q ss_pred cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCC
Q 045453 127 IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSL 206 (346)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl 206 (346)
..|+|||||.. +|.+.+.. .++=.++.++..|++.|+.||| +.+|+||||||+||++..++.+||.|||+
T Consensus 95 e~y~v~e~m~~-nl~~vi~~------elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVILM------ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred hHHHHHHhhhh-HHHHHHHH------hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchh
Confidence 66999999954 99998873 2566788999999999999999 99999999999999999999999999999
Q ss_pred CcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccc--------c----cchh
Q 045453 207 SVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEI--------G----AGHY 274 (346)
Q Consensus 207 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~--------~----~~~~ 274 (346)
++.-... ...+..+.|.-|.|||++.+..|.+.+||||+||++.||++|...|.+.+.-+. + ....
T Consensus 165 ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 165 ARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred hcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence 9875443 345677889999999999999999999999999999999999999976542110 0 0111
Q ss_pred hHHHHHHHHhhcC-ccccccccccccCCCCc----chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 275 WLLHYVKKCIENN-EFDEIVDPIIVSEGPRV----GKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 275 ~~~~~~~~~~~~~-~~~~~~d~~l~~~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
++...++...... .........+..+...+ ........+.+++.+||-.+|++|.|..+++.
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 2333333333211 01001111110110000 01133455788999999999999999999874
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=235.34 Aligned_cols=132 Identities=17% Similarity=0.252 Sum_probs=110.1
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCC-------ceeeEcceeec--
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHK-------NVLKLTGCCLE-- 124 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~-------niv~l~g~~~~-- 124 (346)
.+.|...++||.|.|++||++.+ ..+.||+|+.... ....+....|+.+++.+..+. .||+|+++|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 36677889999999999999999 7789999986532 344556778888888875332 59999999864
Q ss_pred --CCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEE
Q 045453 125 --TRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFL 193 (346)
Q Consensus 125 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll 193 (346)
+.++|+|+|++ |-+|..+|..... ..++...+.+|+.||+.||.|||.. .+|||-||||+|||+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~Y--rGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNY--RGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCC--CCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeee
Confidence 56899999999 5599999987654 4588899999999999999999984 499999999999999
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=222.18 Aligned_cols=198 Identities=27% Similarity=0.375 Sum_probs=171.2
Q ss_pred CCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCc-chHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecc
Q 045453 59 FDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILND-GHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESV 135 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~-~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~ 135 (346)
|...+.||+|++|.||++.. ++..+++|.+...... ....+.+|+..+..+ +|+|++++++++......++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKL-KHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCChhhheeeeecCCceEEEEecc
Confidence 45678899999999999999 4689999998865544 566778888888888 9999999999999989999999999
Q ss_pred cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCc
Q 045453 136 KNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGET 215 (346)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~ 215 (346)
++++|.+++..... .+++.....++.+++.++.+|| ..+++|+||+|+||+++.++.++|+|||.+........
T Consensus 80 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 80 EGGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred CCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 99999999976531 2889999999999999999999 88999999999999999999999999999877754431
Q ss_pred eeeccccccCCcCCcccc-ccCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 045453 216 CVKDKVTGTMGFLAPEYI-NTGDFNEKCDVFSFGMLLLVLLTGQKIFDP 263 (346)
Q Consensus 216 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~G~vl~elltg~~p~~~ 263 (346)
.......++..|++||.. ....++.++|||+||+++++|++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 122345677889999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-32 Score=253.03 Aligned_cols=252 Identities=21% Similarity=0.263 Sum_probs=202.5
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
..+|.....+|+|.||.|||+++ .+...|+|.+.-.......-..+|+.++... +|||||.++|.+...+.++++||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc-~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDC-RHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecC-CCcChHHHHhhhhhhcCcEEEEE
Confidence 46788889999999999999999 8899999998877667777777888888888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
||.+|+|.+.-+-.. ++++.++..++.....||.||| +.+=+|||||-.|||+++.|.+|++|||.+-.++.-
T Consensus 93 ycgggslQdiy~~Tg----plselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred ecCCCcccceeeecc----cchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhh
Confidence 999999998765543 6899999999999999999999 999999999999999999999999999987655321
Q ss_pred CceeeccccccCCcCCccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 214 ETCVKDKVTGTMGFLAPEYIN---TGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
..+.....||+-|||||+.. .+.|.+++|||+.|+...|+-.-++|....-.-. +-.++....+.
T Consensus 166 -i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr-----------~l~LmTkS~~q 233 (829)
T KOG0576|consen 166 -IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR-----------ALFLMTKSGFQ 233 (829)
T ss_pred -hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH-----------HHHHhhccCCC
Confidence 22345678999999999885 5789999999999999999988887753221100 00000111000
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
-+.+. ......+.+-++++.|+..+|++|||++.++.
T Consensus 234 ---pp~lk------Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 234 ---PPTLK------DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ---CCccc------CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 01111 12256778999999999999999999987654
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=218.18 Aligned_cols=261 Identities=16% Similarity=0.245 Sum_probs=194.5
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecC--CcceEE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLET--RIPVIV 131 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~--~~~~lv 131 (346)
.++|++.+++|+|-++.||.|.. ++++++||.+.+. ..+...+|+.++..+..||||++++++..+. ....||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 46788889999999999999996 8899999998754 3567889999999997799999999998764 456899
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcC-CCceEEeccCCCccc
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE-GYIAKLFDFSLSVSI 210 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~-~~~~kl~Dfgl~~~~ 210 (346)
+||+.+.+...+- +.++-..+..++.++++||.|+| +.||.|||+||.|+++|. .-..+|+|+|+|.+.
T Consensus 114 FE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhc
Confidence 9999886665543 45788889999999999999999 999999999999999994 557999999999887
Q ss_pred CCCCceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhc---
Q 045453 211 PEGETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIEN--- 286 (346)
Q Consensus 211 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 286 (346)
..+... +-.+.+.-|-.||.+.. +.|..+-|+|||||++..|+..+.||-...+..- +++..++-.--+
T Consensus 184 Hp~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D-----QLVkIakVLGt~el~ 256 (338)
T KOG0668|consen 184 HPGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-----QLVKIAKVLGTDELY 256 (338)
T ss_pred CCCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHH-----HHHHHHHHhChHHHH
Confidence 665543 23455667889999876 5688999999999999999999999855433221 232222211100
Q ss_pred ---Ccccccccccccc---CCC--------CcchH-HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 287 ---NEFDEIVDPIIVS---EGP--------RVGKE-KQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 287 ---~~~~~~~d~~l~~---~~~--------~~~~~-~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.+..-.+|+...+ ... ..... -...+..+++...|..|-.+|||+.|.+.
T Consensus 257 ~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 257 AYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 0011112222211 000 00000 12356788999999999999999999864
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=244.26 Aligned_cols=196 Identities=19% Similarity=0.271 Sum_probs=167.9
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--------CcchHHHHHHHHHHhhhcC---CCceeeEccee
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--------NDGHEDCFNNIIFASKLSS---HKNVLKLTGCC 122 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--------~~~~~~~~~e~~~~~~~~~---h~niv~l~g~~ 122 (346)
..+|+..+.+|.|+||.|+.|.+ +...|+||.+.+.. +...-..-.|+.+|..+ + |+||++++++|
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l-~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATL-NKHSHENILKLLDFF 638 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHh-hhcCccchhhhhhee
Confidence 35688889999999999999999 66778888766442 11222345788888887 5 99999999999
Q ss_pred ecCCcceEEEecc-cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEE
Q 045453 123 LETRIPVIVFESV-KNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKL 201 (346)
Q Consensus 123 ~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl 201 (346)
.+.+.+||+||-- ++-+|.+++... +.+++.+...|..|++.|+++|| ..+|||||||-+|++++.+|-+||
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~k----p~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~kl 711 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFK----PRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKL 711 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhcc----CccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEE
Confidence 9999999999986 445899999765 46999999999999999999999 999999999999999999999999
Q ss_pred eccCCCcccCCCCceeeccccccCCcCCccccccCCC-CcccchHHHHHHHHHHHhCCCCCC
Q 045453 202 FDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDF-NEKCDVFSFGMLLLVLLTGQKIFD 262 (346)
Q Consensus 202 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~ 262 (346)
+|||.+.....+. ....+||.+|.|||++.+..| ...-|||++|++||.++....||.
T Consensus 712 idfgsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 712 IDFGSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eeccchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999987775554 356789999999999999888 456999999999999999999985
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=221.11 Aligned_cols=255 Identities=16% Similarity=0.216 Sum_probs=192.2
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEccee-ecCCcceEEEe
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCC-LETRIPVIVFE 133 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~-~~~~~~~lv~e 133 (346)
+.|++.+.+|+|.||.+-++++ +...+++|-+... .....+|.+|...--.+..|.||+..+.+. .+.+..++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 5688899999999999999999 6678888876543 355678899998888888899999988874 45667788999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEc--CCCceEEeccCCCcccC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLD--EGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~--~~~~~kl~Dfgl~~~~~ 211 (346)
|+|.|+|.+-+... .+.+..-..++.|+++||.|+| +.++||||||.+|||+- +...+||+|||+.+..+
T Consensus 103 ~aP~gdL~snv~~~-----GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAA-----GIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred cCccchhhhhcCcc-----cccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccC
Confidence 99999999888654 3778888999999999999999 99999999999999994 44589999999987653
Q ss_pred CCCceeeccccccCCcCCccccccC-----CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhc
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINTG-----DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIEN 286 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (346)
. .......+..|.+||+.... ...+.+|||.||++++.++||+.||+.....+..+ .....|...
T Consensus 175 ~----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y--~~~~~w~~r---- 244 (378)
T KOG1345|consen 175 T----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPY--WEWEQWLKR---- 244 (378)
T ss_pred c----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchH--HHHHHHhcc----
Confidence 2 12233456679999987542 35788999999999999999999998544333210 011222211
Q ss_pred CccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 045453 287 NEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341 (346)
Q Consensus 287 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 341 (346)
. .+.+..... ...+.+.++.++-+..+|++|-...++.+.-...
T Consensus 245 -k-----~~~~P~~F~-----~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~ 288 (378)
T KOG1345|consen 245 -K-----NPALPKKFN-----PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCL 288 (378)
T ss_pred -c-----CccCchhhc-----ccCHHHHHHHHHhcCCcccccchhHHHHHHHHHH
Confidence 1 112212211 3456688899999999999997777766655544
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=237.17 Aligned_cols=272 Identities=19% Similarity=0.205 Sum_probs=201.4
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcC-----CCceeeEcceeecCCcc
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSS-----HKNVLKLTGCCLETRIP 128 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~-----h~niv~l~g~~~~~~~~ 128 (346)
.+.|......|+|-|++|.+|.+ .++.||||++.+. ....+.=..|+.+|.++.. --++++|+..|...+++
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHL 509 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHL 509 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhccee
Confidence 34455566789999999999999 7889999998754 2334555788888888842 34799999999999999
Q ss_pred eEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCC-CceEEeccCCC
Q 045453 129 VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEG-YIAKLFDFSLS 207 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~-~~~kl~Dfgl~ 207 (346)
|||+|-+.- +|.++|..-+. ...|....+..++.|+..||..|- ..+|+|.||||+|||+++. ..+||||||.|
T Consensus 510 ClVFE~Lsl-NLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 510 CLVFEPLSL-NLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred EEEehhhhc-hHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCccc
Confidence 999999955 99999976432 246888999999999999999999 8999999999999999854 57899999998
Q ss_pred cccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhH-----------
Q 045453 208 VSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWL----------- 276 (346)
Q Consensus 208 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~----------- 276 (346)
....+... +....+..|.|||.+.+-+|+...|+||+||.|||+.||+..|.+.....+......+
T Consensus 585 ~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRK 661 (752)
T KOG0670|consen 585 SFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRK 661 (752)
T ss_pred cccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhh
Confidence 77765543 2334566899999999999999999999999999999999999987765431100000
Q ss_pred HHHHHHHhhcC-----------------cccccccc------ccccC-CCCcchHHHHHHHHHHHHHcccCCCCCCCCHH
Q 045453 277 LHYVKKCIENN-----------------EFDEIVDP------IIVSE-GPRVGKEKQLQGFRELALMCVCESAEDRPTTV 332 (346)
Q Consensus 277 ~~~~~~~~~~~-----------------~~~~~~d~------~l~~~-~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ 332 (346)
.++....+... .+...+.| .+... ............|.+|+..|+..||++|.|..
T Consensus 662 gqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~n 741 (752)
T KOG0670|consen 662 GQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVN 741 (752)
T ss_pred cchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHH
Confidence 00111111100 01111111 11111 01112225567899999999999999999999
Q ss_pred HHHH
Q 045453 333 DVAK 336 (346)
Q Consensus 333 ev~~ 336 (346)
+++.
T Consensus 742 qAL~ 745 (752)
T KOG0670|consen 742 QALK 745 (752)
T ss_pred HHhc
Confidence 8764
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=224.02 Aligned_cols=203 Identities=25% Similarity=0.363 Sum_probs=167.5
Q ss_pred HHHhcCCCcccccccCCCcEEEEEEE-----CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCc
Q 045453 53 EIATNNFDARNVIKDGYAYKFYKGFV-----EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRI 127 (346)
Q Consensus 53 ~~~~~~f~~~~~ig~G~~g~Vy~~~~-----~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~ 127 (346)
....+.|...++||.|.|++||++.+ .+..||+|.+...+ .......|+..+..+..+.||+++.+++..++.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 33446688899999999999999987 35799999987543 345578999999999999999999999999999
Q ss_pred ceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcC-CCceEEeccCC
Q 045453 128 PVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE-GYIAKLFDFSL 206 (346)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~-~~~~kl~Dfgl 206 (346)
.++|+||++.-...++... ++...+..++..+..||.++| ..|||||||||+|+|.+. -+.-.|.|||+
T Consensus 110 v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechh
Confidence 9999999999888887753 778999999999999999999 999999999999999984 46678999999
Q ss_pred CcccC-----------------C--C---------------Cce---------eeccccccCCcCCcccccc-CCCCccc
Q 045453 207 SVSIP-----------------E--G---------------ETC---------VKDKVTGTMGFLAPEYINT-GDFNEKC 242 (346)
Q Consensus 207 ~~~~~-----------------~--~---------------~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~ 242 (346)
|.... . + ... ......||+||.|||++.. ..-++++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 86110 0 0 000 0113358999999999976 4568999
Q ss_pred chHHHHHHHHHHHhCCCCCCCCCCc
Q 045453 243 DVFSFGMLLLVLLTGQKIFDPSRGD 267 (346)
Q Consensus 243 Dv~s~G~vl~elltg~~p~~~~~~~ 267 (346)
||||.|||++-++++..||-....+
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd 284 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDD 284 (418)
T ss_pred ceeeccceeehhhccccccccCccc
Confidence 9999999999999999998655443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-30 Score=261.48 Aligned_cols=193 Identities=17% Similarity=0.161 Sum_probs=137.9
Q ss_pred CC-CceeeEccee-------ecCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCce
Q 045453 111 SH-KNVLKLTGCC-------LETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPIL 182 (346)
Q Consensus 111 ~h-~niv~l~g~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ii 182 (346)
+| +||++++++| ...+.+++++||+ +++|.++|.... .++++.+++.++.||+.||+||| +.+|+
T Consensus 30 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH---~~gIv 102 (793)
T PLN00181 30 SHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAH---SQGIV 102 (793)
T ss_pred hHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHH---hCCee
Confidence 55 6888888887 2334677889988 559999997543 46999999999999999999999 89999
Q ss_pred ecCCCCCCeEEcCC-------------------CceEEeccCCCcccCCCCc---------------eeeccccccCCcC
Q 045453 183 HRKIRPSRIFLDEG-------------------YIAKLFDFSLSVSIPEGET---------------CVKDKVTGTMGFL 228 (346)
Q Consensus 183 H~dlkp~NIll~~~-------------------~~~kl~Dfgl~~~~~~~~~---------------~~~~~~~gt~~y~ 228 (346)
||||||+||||+.. +.+|++|||+++....... .......||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 99999999999654 4556666666543211000 0001235788899
Q ss_pred CccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHH
Q 045453 229 APEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEK 308 (346)
Q Consensus 229 aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 308 (346)
|||++.+..++.++|||||||+||||++|..|+..... ........ ...+.. ..
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--------~~~~~~~~---------~~~~~~---------~~ 236 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--------TMSSLRHR---------VLPPQI---------LL 236 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--------HHHHHHHh---------hcChhh---------hh
Confidence 99999999999999999999999999998887642110 00000000 000000 01
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 309 QLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 309 ~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
......+++..||+.+|.+||||.|+++
T Consensus 237 ~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 237 NWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred cCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 1233567889999999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=205.73 Aligned_cols=170 Identities=19% Similarity=0.265 Sum_probs=128.4
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCcee
Q 045453 138 RTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCV 217 (346)
Q Consensus 138 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 217 (346)
|||.+++.... .+++|.+++.++.|++.||.||| +.+ ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVRG---RPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc---
Confidence 68999997643 46999999999999999999999 555 999999999999999 99987654322
Q ss_pred eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccccccc
Q 045453 218 KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPII 297 (346)
Q Consensus 218 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 297 (346)
..||+.|+|||++.+..++.++|||||||++|||+||+.||........ .+........ .. ++
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-----~~~~~~~~~~-~~------~~-- 126 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-----ILEILLNGMP-AD------DP-- 126 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-----HHHHHHHHhc-cC------Cc--
Confidence 2688999999999999999999999999999999999999965332111 1111111100 00 00
Q ss_pred ccCCCCcchHHHHH--HHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 298 VSEGPRVGKEKQLQ--GFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 298 ~~~~~~~~~~~~~~--~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
.. ......... .+.+++.+||+.+|++|||+.|+++.+..+..+
T Consensus 127 -~~--~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 127 -RD--RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred -cc--cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 00 001112233 699999999999999999999999998877653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=196.32 Aligned_cols=248 Identities=18% Similarity=0.199 Sum_probs=184.8
Q ss_pred cccccCCCcEEEEEEECCeEEEEEEecCcc-CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccCCChh
Q 045453 63 NVIKDGYAYKFYKGFVEDRTVSVMKFNDIL-NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLA 141 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 141 (346)
.+|.....|..|+|+|.+..+++|.+.... .....+.++|+.--.+++.||||..++|.|....++.++..||+.|||+
T Consensus 196 tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsly 275 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLY 275 (448)
T ss_pred hhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHH
Confidence 467888999999999988888888876432 2233344455444445559999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCceeeccc
Q 045453 142 DHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKV 221 (346)
Q Consensus 142 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 221 (346)
..|+.... ...+-.+..+++.++|+|++|||+- ..-|.---|.+..+++|++.+++|+--. +++ +......
T Consensus 276 nvlhe~t~--vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad-~kf-----sfqe~gr 346 (448)
T KOG0195|consen 276 NVLHEQTS--VVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMAD-TKF-----SFQEVGR 346 (448)
T ss_pred HHHhcCcc--EEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheeccc-cee-----eeecccc
Confidence 99987542 4566788999999999999999952 1224444688999999999998875211 111 0111123
Q ss_pred cccCCcCCccccccCC---CCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccccccc
Q 045453 222 TGTMGFLAPEYINTGD---FNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIV 298 (346)
Q Consensus 222 ~gt~~y~aPE~~~~~~---~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 298 (346)
.-.+.||+||.++..+ .-.++|+|||++++||+.|...||....+-+.+- .-.+.
T Consensus 347 ~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm----------------------kiale 404 (448)
T KOG0195|consen 347 AYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM----------------------KIALE 404 (448)
T ss_pred ccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh----------------------hhhhc
Confidence 4567999999998655 3467999999999999999999998765544310 00111
Q ss_pred cCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 045453 299 SEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIY 342 (346)
Q Consensus 299 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~ 342 (346)
+-... -++..+..+.+|+.-|...||.+||.+..|+-.|+++.
T Consensus 405 glrv~-ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 405 GLRVH-IPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccccc-CCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 11111 12266778999999999999999999999999999875
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=206.19 Aligned_cols=168 Identities=13% Similarity=0.087 Sum_probs=128.9
Q ss_pred HHHHHHhcCCCcccccccCCCcEEEEEEE---CCeEEEEEEecCcc-----CcchHHHHHHHHHHhhhcCCCceee-Ecc
Q 045453 50 RELEIATNNFDARNVIKDGYAYKFYKGFV---EDRTVSVMKFNDIL-----NDGHEDCFNNIIFASKLSSHKNVLK-LTG 120 (346)
Q Consensus 50 ~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~---~~~~vavk~~~~~~-----~~~~~~~~~e~~~~~~~~~h~niv~-l~g 120 (346)
+.....-++|...+.||+|+||+||+|.+ +++.+|||++.... ......+.+|+..+..+ +|+|++. +++
T Consensus 11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L-~h~~iv~~l~~ 89 (365)
T PRK09188 11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTV-RGIGVVPQLLA 89 (365)
T ss_pred cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhc-cCCCCCcEEEE
Confidence 34455668899999999999999999987 46677998865321 12244577888999888 9999985 443
Q ss_pred eeecCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCC-CCCCeEEcCCCce
Q 045453 121 CCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKI-RPSRIFLDEGYIA 199 (346)
Q Consensus 121 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dl-kp~NIll~~~~~~ 199 (346)
+ +..++||||+++++|.. +.. .. ...++.+++.||.||| +.+|+|||| ||+|||++.++.+
T Consensus 90 ~----~~~~LVmE~~~G~~L~~-~~~-------~~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~i 151 (365)
T PRK09188 90 T----GKDGLVRGWTEGVPLHL-ARP-------HG---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEA 151 (365)
T ss_pred c----CCcEEEEEccCCCCHHH-hCc-------cc---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCE
Confidence 2 45799999999999963 211 11 1457889999999999 899999999 9999999999999
Q ss_pred EEeccCCCcccCCCCceee-------ccccccCCcCCccccccC
Q 045453 200 KLFDFSLSVSIPEGETCVK-------DKVTGTMGFLAPEYINTG 236 (346)
Q Consensus 200 kl~Dfgl~~~~~~~~~~~~-------~~~~gt~~y~aPE~~~~~ 236 (346)
||+|||+|+.+........ +...+++.|+|||++...
T Consensus 152 kLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 152 AVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred EEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9999999987754332111 345678889999988643
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-25 Score=184.82 Aligned_cols=270 Identities=16% Similarity=0.227 Sum_probs=201.1
Q ss_pred CHHHHHHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecC
Q 045453 48 TIRELEIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLET 125 (346)
Q Consensus 48 ~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~ 125 (346)
+.+++.. .+.|...+.||+|+||.+|.|.. +|..||||.=. ......+...|..+...+..-..|..+..+..+.
T Consensus 7 s~~~~iv-~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es--~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~ 83 (341)
T KOG1163|consen 7 SLEELIV-GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLES--SKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEK 83 (341)
T ss_pred chhhhee-ccceEEEEeecCCchhheeeeeeccCCceEEEEeec--ccCCCcchhHHHHHHHHhccCCCCchhhhhcccc
Confidence 3344433 36788999999999999999998 89999999843 3345566777888887774557888899899999
Q ss_pred CcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCC---CceEEe
Q 045453 126 RIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEG---YIAKLF 202 (346)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~---~~~kl~ 202 (346)
..-.+||+++ |.||++++.-.. ..++..+.+-++-|++.-+.|+| ..+++||||||+|+|..-+ ..+-++
T Consensus 84 ~ynvlVMdLL-GPsLEdLfnfC~---R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LI 156 (341)
T KOG1163|consen 84 DYNVLVMDLL-GPSLEDLFNFCS---RRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLI 156 (341)
T ss_pred ccceeeeecc-CccHHHHHHHHh---hhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEE
Confidence 9999999999 789999986543 46999999999999999999999 9999999999999999744 357899
Q ss_pred ccCCCcccCCCCc------eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhH
Q 045453 203 DFSLSVSIPEGET------CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWL 276 (346)
Q Consensus 203 Dfgl~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~ 276 (346)
|||+|+...+..+ .......||..|.+-....+-.-+..-|+=|+|.+|..+..|..||++.......
T Consensus 157 DFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~------ 230 (341)
T KOG1163|consen 157 DFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK------ 230 (341)
T ss_pred eccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH------
Confidence 9999987643322 1234567999999888777777888999999999999999999999987654321
Q ss_pred HHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 277 LHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 277 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
.+.+.+.+..+.......+. ..+.++.-.+.-|-..--++-|.-.-+-+...-+...
T Consensus 231 ----------QKyEkI~EkK~s~~ie~LC~-G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ 287 (341)
T KOG1163|consen 231 ----------QKYEKISEKKMSTPIEVLCK-GFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRT 287 (341)
T ss_pred ----------HHHHHHHHhhcCCCHHHHhC-CCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhh
Confidence 11111112111111111111 3455677777778777777888877666665555544
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=187.14 Aligned_cols=265 Identities=12% Similarity=0.179 Sum_probs=200.8
Q ss_pred HhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
..-+|...++||+|+||..+.|.. ++++||||.=.. .+...+...|......+...++|...+.+-.++-+-.||+
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 345688999999999999999988 999999987332 3456677888888888878899999999988888999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcC-----CCceEEeccCCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE-----GYIAKLFDFSLS 207 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~-----~~~~kl~Dfgl~ 207 (346)
|++ |.||+|++.-.+ ..++..++.-+|.|++.-+.|+| ++..|+|||||+|+||.. ...+.++|||+|
T Consensus 104 dLL-GPSLEDLFD~Cg---R~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCG---RRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhh-CcCHHHHHHHhc---CcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccch
Confidence 999 789999886543 57999999999999999999999 999999999999999963 346889999999
Q ss_pred cccCCCCcee------eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHH
Q 045453 208 VSIPEGETCV------KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVK 281 (346)
Q Consensus 208 ~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 281 (346)
+...+..+.. .....||..||+-....+..-+..-|.=|+|-++.+.|.|..||++...+....
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~---------- 246 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKE---------- 246 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHH----------
Confidence 8775544321 235569999999999999999999999999999999999999999876544210
Q ss_pred HHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 045453 282 KCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHL 345 (346)
Q Consensus 282 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~l 345 (346)
++..+-+..-..+...++ ...++++..-+.-.-..+-.+-|..+-+..-+.++++.+
T Consensus 247 ------kYeKIGe~Kr~T~i~~Lc-~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 247 ------KYEKIGETKRSTPIEVLC-EGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred ------HHHHhccccccCCHHHHH-hcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence 011111111000000000 022334444444444466677788888887777777654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.2e-24 Score=193.43 Aligned_cols=261 Identities=19% Similarity=0.170 Sum_probs=191.3
Q ss_pred CCCcccccccCCCcEEEEEEECC---eEEEEEEecCccCcchHHHHHHHHHHhhhc---CCCceeeEccee-ecCCcceE
Q 045453 58 NFDARNVIKDGYAYKFYKGFVED---RTVSVMKFNDILNDGHEDCFNNIIFASKLS---SHKNVLKLTGCC-LETRIPVI 130 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~~~---~~vavk~~~~~~~~~~~~~~~e~~~~~~~~---~h~niv~l~g~~-~~~~~~~l 130 (346)
.|...+.||+|+||.||.+.... ..+|+|.-.............|...+..+. .-+++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 78899999999999999999833 367777755443333235667777777773 235788888888 47778899
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCC-----CceEEeccC
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEG-----YIAKLFDFS 205 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~-----~~~kl~Dfg 205 (346)
||+.+ |.||.++..... ...++..+.+.++.|++.+|.+|| +.|++||||||+|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99999 779999876554 357999999999999999999999 9999999999999999865 468999999
Q ss_pred CCc--ccCCCCc----ee---eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhH
Q 045453 206 LSV--SIPEGET----CV---KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWL 276 (346)
Q Consensus 206 l~~--~~~~~~~----~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~ 276 (346)
+++ ....... .. .....||..|.++....+...+.+.|+||++.++.|++.|..||........
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~------- 245 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL------- 245 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-------
Confidence 998 3221111 11 1234599999999999999999999999999999999999999965443221
Q ss_pred HHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 277 LHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 277 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
..-......... ..+ . ....+..+.++...+-..+..++|....+...|.+....
T Consensus 246 ~~~~~~~~~~~~----~~~-----~----~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 246 KSKFEKDPRKLL----TDR-----F----GDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred HHHHHHHhhhhc----ccc-----c----cCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 000001000000 000 0 002234455566666668999999999999998877653
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-23 Score=187.13 Aligned_cols=261 Identities=24% Similarity=0.353 Sum_probs=196.2
Q ss_pred CCcccccccCCCcEEEEEEECCeEEEEEEecCccCc---chHHHHHHHHHHhhhcCCC-ceeeEcceeecCCcceEEEec
Q 045453 59 FDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILND---GHEDCFNNIIFASKLSSHK-NVLKLTGCCLETRIPVIVFES 134 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~---~~~~~~~e~~~~~~~~~h~-niv~l~g~~~~~~~~~lv~e~ 134 (346)
|.....||.|+||.||++.+. ..+++|.+...... ....+.+|...+..+ .|+ |++++.+++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASL-NHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHc-cCCcceeeEEEEEecCCEEEEEEec
Confidence 556678999999999999988 78888888765433 366788888888888 666 899999999777778999999
Q ss_pred ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCC-ceEEeccCCCcccCCC
Q 045453 135 VKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGY-IAKLFDFSLSVSIPEG 213 (346)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~-~~kl~Dfgl~~~~~~~ 213 (346)
+.++++.+++...... ..+.......++.+++.++.|+| ..+++|||+||+||+++..+ .++++|||.++.....
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999777654311 25888999999999999999999 88999999999999999998 7999999998765443
Q ss_pred Cce-----eeccccccCCcCCcccccc---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhh
Q 045453 214 ETC-----VKDKVTGTMGFLAPEYINT---GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIE 285 (346)
Q Consensus 214 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (346)
... ......++..|+|||.+.+ ..++...|+||+|++++++++|..||........ .......+.....
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~---~~~~~~~~~~~~~ 232 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSA---TSQTLKIILELPT 232 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcccc---HHHHHHHHHhcCC
Confidence 321 2356679999999999987 5789999999999999999999999765543200 0011111111110
Q ss_pred cCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045453 286 NNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKR 337 (346)
Q Consensus 286 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 337 (346)
. .......... . ......+.+++..|+..+|..|.++.+....
T Consensus 233 ~-~~~~~~~~~~----~----~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 P-SLASPLSPSN----P----ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred c-ccccccCccc----c----chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 0000000000 0 1234568889999999999999999887654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.5e-25 Score=215.95 Aligned_cols=247 Identities=19% Similarity=0.199 Sum_probs=184.3
Q ss_pred CCCcccccccCCCcEEEEEEECCeEEEEEEecCccC----cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 58 NFDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILN----DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~----~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
++...+.||++.|=+|.+|+++.+.|+||++.+..+ ....+...++. ..+.+|||.+++.-+-....-.|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik--~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK--FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH--HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 577788999999999999999777899999886653 22334444444 334499999999988878888899999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCccc--C
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI--P 211 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~--~ 211 (346)
|..+ +|.|.|..+ +-+...+...|+.|+++||...| ..+|+|||||.+|||+++-..+.|+||..-+.. +
T Consensus 102 yvkh-nLyDRlSTR----PFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTR----PFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HHhh-hhhhhhccc----hHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCC
Confidence 9977 999999765 45788899999999999999999 999999999999999999999999999875433 3
Q ss_pred CCCceeec----cccccCCcCCccccccC----------C-CCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhh
Q 045453 212 EGETCVKD----KVTGTMGFLAPEYINTG----------D-FNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYW 275 (346)
Q Consensus 212 ~~~~~~~~----~~~gt~~y~aPE~~~~~----------~-~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~ 275 (346)
++.....+ ....-.+|+|||.+... . .+++-||||+||++.|+++ |++||.
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~------------- 240 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT------------- 240 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc-------------
Confidence 33322222 22233589999988542 1 5778999999999999988 788884
Q ss_pred HHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 045453 276 LLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRL 338 (346)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 338 (346)
+.+....-..+....+.+-..+. ...+.+++..|++.||++|.|+++.++.-
T Consensus 241 LSQL~aYr~~~~~~~e~~Le~Ie-----------d~~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 241 LSQLLAYRSGNADDPEQLLEKIE-----------DVSLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred HHHHHhHhccCccCHHHHHHhCc-----------CccHHHHHHHHHccCchhccCHHHHHHhh
Confidence 33332221111110111111111 12478899999999999999999998863
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-24 Score=211.95 Aligned_cols=251 Identities=17% Similarity=0.199 Sum_probs=183.6
Q ss_pred cccccccCCCcEEEEEEE--CCeEEEEEEecCc--cCcch----HHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 61 ARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDI--LNDGH----EDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 61 ~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~--~~~~~----~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
..+++|.|++|.|+.... .....+.|.+... ..... .....|+.+-..+ .|||++..+..+.+.....-+|
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l-~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSL-SHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccc-cCCchhhhHHHHhhcccchhhh
Confidence 567899999998877766 3344444433210 11111 1133344444445 9999999888887776666669
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
||+++ +|..++... ..++-..+-.+..|+..|+.|+| ..|+.|||+|++|++++.+|.+|++|||.+.....
T Consensus 401 E~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99999 999999765 24788889999999999999999 99999999999999999999999999999876643
Q ss_pred CCc---eeeccccccCCcCCccccccCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCc
Q 045453 213 GET---CVKDKVTGTMGFLAPEYINTGDFNEK-CDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE 288 (346)
Q Consensus 213 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (346)
+.. ......+|+.+|+|||++.+..|.+. .||||.|+++..|++|+.||......+... .....
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~----------~~~~~-- 540 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF----------KTNNY-- 540 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch----------hhhcc--
Confidence 332 34456789999999999999999764 999999999999999999997665543210 00000
Q ss_pred cccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 289 FDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 289 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.+..-....+.......+.....++.++|+.+|.+|.|+.+|++
T Consensus 541 ----~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 541 ----SDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ----ccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00000011111112255677889999999999999999999975
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-23 Score=178.43 Aligned_cols=172 Identities=12% Similarity=0.121 Sum_probs=133.5
Q ss_pred HHhcCCCcccccccCCCcEEEEEEECCeEEEEEEecCccCcchHH---------HHHHHHHHhhhcCCCceeeEcceeec
Q 045453 54 IATNNFDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHED---------CFNNIIFASKLSSHKNVLKLTGCCLE 124 (346)
Q Consensus 54 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~---------~~~e~~~~~~~~~h~niv~l~g~~~~ 124 (346)
...++|...+++|.|+||.||++..+++.+|+|.+.+........ +.+|+..+.++ .||+|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL-~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRV-RSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHH-HHCCCCcceEeeee
Confidence 346889999999999999999987788899999997654332221 45777788888 99999999888553
Q ss_pred C--------CcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCC
Q 045453 125 T--------RIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEG 196 (346)
Q Consensus 125 ~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~ 196 (346)
. +..+|||||++|.+|.++.. ++. ....+++.+|..+| ..+++|||++|+||+++++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~ 171 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKN 171 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCC
Confidence 2 35789999999999988632 222 24568999999999 9999999999999999999
Q ss_pred CceEEeccCCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHH
Q 045453 197 YIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLL 255 (346)
Q Consensus 197 ~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ell 255 (346)
+ ++|+|||......+... ...++....+..++|+||||+.+.-..
T Consensus 172 g-i~liDfg~~~~~~e~~a-------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKA-------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred C-EEEEECCCcccccchhh-------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 8 99999998755432211 011444566778999999999987554
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.3e-23 Score=190.59 Aligned_cols=213 Identities=24% Similarity=0.352 Sum_probs=161.7
Q ss_pred CCCceeeEcceeecCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCc-eecCCCCC
Q 045453 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPI-LHRKIRPS 189 (346)
Q Consensus 111 ~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i-iH~dlkp~ 189 (346)
.|.|+.+++|.+.++...+.|.+||..|+|.+.+.... ..++|.-...++.++++||.||| ..+| .|+.+++.
T Consensus 5 ~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~---~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 5 DHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED---IKLDYFFILSFIRDISKGLAYLH---NSPIGYHGALKSS 78 (484)
T ss_pred chhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc---cCccHHHHHHHHHHHHHHHHHHh---cCcceeeeeeccc
Confidence 89999999999999999999999999999999998754 56999999999999999999999 4554 99999999
Q ss_pred CeEEcCCCceEEeccCCCcccCCC-CceeeccccccCCcCCccccccC-------CCCcccchHHHHHHHHHHHhCCCCC
Q 045453 190 RIFLDEGYIAKLFDFSLSVSIPEG-ETCVKDKVTGTMGFLAPEYINTG-------DFNEKCDVFSFGMLLLVLLTGQKIF 261 (346)
Q Consensus 190 NIll~~~~~~kl~Dfgl~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~s~G~vl~elltg~~p~ 261 (346)
|.++|.+..+|++|||+....... .........-..-|.|||.+... ..+.+.||||||++++|+++...||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999997665320 11111122234579999999763 1477899999999999999999999
Q ss_pred CCCCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 045453 262 DPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341 (346)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 341 (346)
+.....+.. ..+...++. .+ .....|.+... . +....+..++.+||..+|+.||++.+|-..++.+
T Consensus 159 ~~~~~~~~~---~eii~~~~~---~~--~~~~rP~i~~~-----~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 159 DLRNLVEDP---DEIILRVKK---GG--SNPFRPSIELL-----N-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred ccccccCCh---HHHHHHHHh---cC--CCCcCcchhhh-----h-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 875544431 112222222 01 11111111111 0 3334689999999999999999999999988877
Q ss_pred HH
Q 045453 342 YQ 343 (346)
Q Consensus 342 ~~ 343 (346)
..
T Consensus 225 ~~ 226 (484)
T KOG1023|consen 225 NK 226 (484)
T ss_pred cc
Confidence 54
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.9e-22 Score=168.86 Aligned_cols=138 Identities=13% Similarity=0.136 Sum_probs=104.4
Q ss_pred ccccccCCCcEEEEEEE-CCeEEEEEEecCccCc--c-------hH-----------------HHHHHHHHHhhhcCCCc
Q 045453 62 RNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILND--G-------HE-----------------DCFNNIIFASKLSSHKN 114 (346)
Q Consensus 62 ~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~--~-------~~-----------------~~~~e~~~~~~~~~h~n 114 (346)
...||+|++|.||+|.. +|++||+|++...... . .. ....|...+..+ .+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRL-VTAG 80 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHH-HHCC
Confidence 35799999999999998 7899999998754211 1 01 112377777777 6666
Q ss_pred eeeEcceeecCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCceecCCCCCCeEE
Q 045453 115 VLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYL-HIGFSRPILHRKIRPSRIFL 193 (346)
Q Consensus 115 iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~iiH~dlkp~NIll 193 (346)
+.....+.. ...++||||++++++....... .++++.....++.|++.+|.++ | ..+|+||||||+|||+
T Consensus 81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli 151 (190)
T cd05147 81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLY 151 (190)
T ss_pred CCCCcEEEe--cCCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEE
Confidence 543332221 2238999999987776553322 3588899999999999999999 6 7899999999999999
Q ss_pred cCCCceEEeccCCCccc
Q 045453 194 DEGYIAKLFDFSLSVSI 210 (346)
Q Consensus 194 ~~~~~~kl~Dfgl~~~~ 210 (346)
+ ++.++|+|||+|...
T Consensus 152 ~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 152 H-DGKLYIIDVSQSVEH 167 (190)
T ss_pred E-CCcEEEEEccccccC
Confidence 8 478999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.5e-22 Score=164.99 Aligned_cols=189 Identities=11% Similarity=-0.023 Sum_probs=142.3
Q ss_pred CcccccccCCCcEEEEEEECCeEEEEEEecCccCcc----hHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecc
Q 045453 60 DARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDG----HEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESV 135 (346)
Q Consensus 60 ~~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~----~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~ 135 (346)
.....|++|+||+||.+...+.+++.+.+....... ...+.+|+..+..+.+|+++++++++ +..+++|||+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 356789999999999888888899988776543211 12467899999999566889999886 3469999999
Q ss_pred cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCC-CCCCeEEcCCCceEEeccCCCcccCCCC
Q 045453 136 KNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKI-RPSRIFLDEGYIAKLFDFSLSVSIPEGE 214 (346)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dl-kp~NIll~~~~~~kl~Dfgl~~~~~~~~ 214 (346)
.|.+|.+.+.. ....+..+++.+|.++| ..||+|||| ||+|||++.++.++|+|||++.......
T Consensus 81 ~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 81 AGAAMYQRPPR-----------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred cCccHHhhhhh-----------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 99888654311 11346788999999999 999999999 7999999999999999999997554322
Q ss_pred ce----e--------eccccccCCcCCccccccC-CCC-cccchHHHHHHHHHHHhCCCCCCCCCC
Q 045453 215 TC----V--------KDKVTGTMGFLAPEYINTG-DFN-EKCDVFSFGMLLLVLLTGQKIFDPSRG 266 (346)
Q Consensus 215 ~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~~Dv~s~G~vl~elltg~~p~~~~~~ 266 (346)
.. . ......++.|++|+...-. ..+ ...++++-|.-+|.++|+..+..+...
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 10 0 1122357788888755432 233 668999999999999999988765443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.9e-21 Score=163.22 Aligned_cols=139 Identities=13% Similarity=0.117 Sum_probs=107.1
Q ss_pred ccccccCCCcEEEEEEE-CCeEEEEEEecCccCcc--------------------------hHHHHHHHHHHhhhcCCCc
Q 045453 62 RNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILNDG--------------------------HEDCFNNIIFASKLSSHKN 114 (346)
Q Consensus 62 ~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~~--------------------------~~~~~~e~~~~~~~~~h~n 114 (346)
...||+|++|.||+|.+ +|+.||||.+....... ......|...+.++ .|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRL-YEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHH-HhCC
Confidence 45799999999999998 69999999987653210 01123567777777 8888
Q ss_pred eeeEcceeecCCcceEEEecccCCChhhh-hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCceecCCCCCCeE
Q 045453 115 VLKLTGCCLETRIPVIVFESVKNRTLADH-IYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFS-RPILHRKIRPSRIF 192 (346)
Q Consensus 115 iv~l~g~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~iiH~dlkp~NIl 192 (346)
+.....+... ..+|||||++++++... +.. .+++......++.+++.++.+|| + .+++||||||+|||
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIl 150 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNIL 150 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEE
Confidence 7544433332 24899999998765443 332 24677889999999999999999 7 89999999999999
Q ss_pred EcCCCceEEeccCCCcccCC
Q 045453 193 LDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 193 l~~~~~~kl~Dfgl~~~~~~ 212 (346)
++ ++.++|+|||++.....
T Consensus 151 l~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 151 YH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred EE-CCCEEEEEcccceecCC
Confidence 99 88999999999876643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-21 Score=172.71 Aligned_cols=233 Identities=18% Similarity=0.173 Sum_probs=147.3
Q ss_pred CCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcC---------CCceeeEcceee-
Q 045453 59 FDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSS---------HKNVLKLTGCCL- 123 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~---------h~niv~l~g~~~- 123 (346)
+.....||.|+++.||.+.+ +++.+|+|.+..... ...+++.+|......+.. |-.++-.++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 34567899999999999999 789999999764432 233344444433333211 211222222211
Q ss_pred --------cCC--------cceEEEecccCCChhhhhh---hcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceec
Q 045453 124 --------ETR--------IPVIVFESVKNRTLADHIY---QNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHR 184 (346)
Q Consensus 124 --------~~~--------~~~lv~e~~~~gsL~~~l~---~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~ 184 (346)
... ..+++|+-+. ++|.+++. ........+....++.+..|+++.+++|| +.|++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEec
Confidence 111 2367787774 48888754 33222234556778888899999999999 9999999
Q ss_pred CCCCCCeEEcCCCceEEeccCCCcccCCCCceeeccccccCCcCCccccccC--------CCCcccchHHHHHHHHHHHh
Q 045453 185 KIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTG--------DFNEKCDVFSFGMLLLVLLT 256 (346)
Q Consensus 185 dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~Dv~s~G~vl~ellt 256 (346)
||+|+|++++.+|.+.|+||+.....+.... . ...+..|.+||..... .++.+.|.|++|+++|.|++
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~---~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYR---C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEE---G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceee---c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 9999999999999999999987655432111 1 3455789999977542 47899999999999999999
Q ss_pred CCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCC
Q 045453 257 GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDR 328 (346)
Q Consensus 257 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R 328 (346)
|..||+........ +... . .+. ..++.+..|+..+|+.+|.+|
T Consensus 246 ~~lPf~~~~~~~~~-----------------------~~~f-~----~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADP-----------------------EWDF-S----RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTS-----------------------GGGG-T----TSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccc-----------------------cccc-h----hcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999865443220 0011 1 133 677889999999999999988
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.1e-23 Score=191.37 Aligned_cols=225 Identities=19% Similarity=0.156 Sum_probs=175.6
Q ss_pred ccccCCCcEEEEEE-----ECCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEeccc
Q 045453 64 VIKDGYAYKFYKGF-----VEDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVK 136 (346)
Q Consensus 64 ~ig~G~~g~Vy~~~-----~~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~ 136 (346)
.+|+|+||.|+++. ..+.-+|+|....... ........|..++....+||.+|++...+......+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999998643 3667788877654432 1122445666777777569999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCce
Q 045453 137 NRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETC 216 (346)
Q Consensus 137 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 216 (346)
+|.|...+.... .++......+...++-+++++| +.+++|||+|++||+++.+|++++.|||+++..-..+.
T Consensus 81 gg~lft~l~~~~----~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEV----MFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI- 152 (612)
T ss_pred cchhhhccccCC----chHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence 999998887653 4777888888999999999999 99999999999999999999999999999876543332
Q ss_pred eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccccc
Q 045453 217 VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPI 296 (346)
Q Consensus 217 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 296 (346)
.+||..|||||++. .....+|+||||++++||+||..||.. +. . ..++...
T Consensus 153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~----------~---------~~Il~~~ 203 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DT----------M---------KRILKAE 203 (612)
T ss_pred ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HH----------H---------HHHhhhc
Confidence 28999999999998 677889999999999999999999975 11 0 0011101
Q ss_pred cccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCH
Q 045453 297 IVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTT 331 (346)
Q Consensus 297 l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 331 (346)
+ ..+.+.+....+++..+...+|..|.-.
T Consensus 204 ~------~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 204 L------EMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred c------CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 1 1122556667788888888888888654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.2e-20 Score=157.29 Aligned_cols=138 Identities=13% Similarity=0.160 Sum_probs=105.6
Q ss_pred CCcccccccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHHHHHHHhhhc----CCCceeeEcceeecCC---c-ceE
Q 045453 59 FDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLS----SHKNVLKLTGCCLETR---I-PVI 130 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~----~h~niv~l~g~~~~~~---~-~~l 130 (346)
.+....||+|+||.||....+.. .+||+...........+.+|+..+..+. .||||++++|++.++. . ..+
T Consensus 4 L~~~~~LG~G~~~~Vy~hp~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYAHPEDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred cCCcceecCCCceEEEECCCCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 34567899999999996222433 4688876554445567888998888883 4799999999998864 3 237
Q ss_pred EEec--ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCceecCCCCCCeEEcC----CCceEEec
Q 045453 131 VFES--VKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAI-AYLHIGFSRPILHRKIRPSRIFLDE----GYIAKLFD 203 (346)
Q Consensus 131 v~e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L-~~LH~~~~~~iiH~dlkp~NIll~~----~~~~kl~D 203 (346)
|+|| +++|||.+++.+. .+++. ..++.+++.++ .||| +.+|+||||||+|||++. ++.++|+|
T Consensus 83 I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 8999 5579999999653 24444 35677888777 8999 999999999999999974 34899999
Q ss_pred -cCCC
Q 045453 204 -FSLS 207 (346)
Q Consensus 204 -fgl~ 207 (346)
||..
T Consensus 153 g~G~~ 157 (210)
T PRK10345 153 NIGES 157 (210)
T ss_pred CCCCc
Confidence 5543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=8e-20 Score=181.97 Aligned_cols=199 Identities=18% Similarity=0.177 Sum_probs=156.2
Q ss_pred HHHHHhcCCCcccccccCCCcEEEEEEE-CCeEEEEEEecCccCcch---HHHHHHHHHHhhhcCCCceeeEcceeecCC
Q 045453 51 ELEIATNNFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILNDGH---EDCFNNIIFASKLSSHKNVLKLTGCCLETR 126 (346)
Q Consensus 51 ~l~~~~~~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~~~---~~~~~e~~~~~~~~~h~niv~l~g~~~~~~ 126 (346)
+.+.....|.+.+.||+|+||+||+|.. +++.||+|+=........ .+...++. ... -+-|..+...+.-.+
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~~---~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLK-PQM---LPSIMHISSAHVFQN 767 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhc-hhh---hcchHHHHHHHccCC
Confidence 3344456688889999999999999999 889999998665443321 23333333 211 244666666666667
Q ss_pred cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEc-------CCCce
Q 045453 127 IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLD-------EGYIA 199 (346)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~-------~~~~~ 199 (346)
.-+||+||.+.|||.+++... ..++|.-...++.++++-+..|| ..+|||+||||+|.||. .+..+
T Consensus 768 ~S~lv~ey~~~Gtlld~~N~~----~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLINTN----KVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred cceeeeeccccccHHHhhccC----CCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccce
Confidence 779999999999999999743 46999999999999999999999 99999999999999994 34578
Q ss_pred EEeccCCCcccCC-CCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCC
Q 045453 200 KLFDFSLSVSIPE-GETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKI 260 (346)
Q Consensus 200 kl~Dfgl~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p 260 (346)
+|+|||-+.-+.- .+........+|-++-.+|+..+..++...|.|.++-+++-||.|+..
T Consensus 841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 9999998754421 111244567788999999999999999999999999999999998753
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.1e-20 Score=163.00 Aligned_cols=197 Identities=17% Similarity=0.265 Sum_probs=140.1
Q ss_pred CCCceeeEcceeec---------------------------CCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHH
Q 045453 111 SHKNVLKLTGCCLE---------------------------TRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIA 163 (346)
Q Consensus 111 ~h~niv~l~g~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 163 (346)
.|||||++.+.|.+ +..+|+||.-++. +|.+++-.+. .+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-----~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-----RSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-----CchHHHHHHH
Confidence 79999999998763 2245899988866 9999997643 5666778899
Q ss_pred HHHHHHHHHHHhCCCCCceecCCCCCCeEE--cCCC--ceEEeccCCCcccCCCC---cee--eccccccCCcCCccccc
Q 045453 164 VHIANAIAYLHIGFSRPILHRKIRPSRIFL--DEGY--IAKLFDFSLSVSIPEGE---TCV--KDKVTGTMGFLAPEYIN 234 (346)
Q Consensus 164 ~~ia~~L~~LH~~~~~~iiH~dlkp~NIll--~~~~--~~kl~Dfgl~~~~~~~~---~~~--~~~~~gt~~y~aPE~~~ 234 (346)
.|+++|+.||| .++|.|||+|++|||+ |+|+ ...|+|||.+-.-.... .+. .-...|...-||||+..
T Consensus 348 aQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 99999999999 9999999999999999 3444 56789999763322211 111 12234777899999987
Q ss_pred cCC------CCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHH
Q 045453 235 TGD------FNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEK 308 (346)
Q Consensus 235 ~~~------~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 308 (346)
..+ .-.|+|.|+.|.+.||+++...||.....-.. + ...+ .+..+ |.+ +..
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L--~---~r~Y-----qe~qL-----Pal--------p~~ 481 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL--D---TRTY-----QESQL-----PAL--------PSR 481 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee--c---hhhh-----hhhhC-----CCC--------ccc
Confidence 543 24689999999999999999999986221111 0 0000 00000 111 114
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 045453 309 QLQGFRELALMCVCESAEDRPTTVDVAKRLK 339 (346)
Q Consensus 309 ~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 339 (346)
++..+.+++...|+.||++|||..-....|+
T Consensus 482 vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 482 VPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred CChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 4556889999999999999999876665554
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.4e-19 Score=154.00 Aligned_cols=134 Identities=22% Similarity=0.222 Sum_probs=112.4
Q ss_pred cccccCCCcEEEEEEECCeEEEEEEecCccCc--------chHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEec
Q 045453 63 NVIKDGYAYKFYKGFVEDRTVSVMKFNDILND--------GHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFES 134 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~--------~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~ 134 (346)
+.||+|++|.||+|.+.+..+++|+....... ....+.+|...+..+ .|+|++....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRA-RKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHH-HHCCCCCCeEEEEeCCCCEEEEEE
Confidence 57999999999999999899999986643321 123456778888887 899988777777777788999999
Q ss_pred ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcc
Q 045453 135 VKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVS 209 (346)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~ 209 (346)
++|++|.+.+... .+ .+..++.+++.+|.+|| +.+++|+|++|.|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988643 12 88899999999999999 89999999999999999 78899999998754
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.2e-20 Score=181.15 Aligned_cols=209 Identities=23% Similarity=0.300 Sum_probs=146.3
Q ss_pred HhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
..++|+..+.|..|+||.||..++ ..+++|+ ++++... +. +||..+- +..+.|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~l-----il------------Rnilt~a------~npfvv- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL-----IL------------RNILTFA------GNPFVV- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhh-cccccch-----hh------------hcccccc------CCccee-
Confidence 457899999999999999999988 5789998 4443210 00 1122211 122223
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
|+-...++..+ +++ .+++.++.||| +.+|+|||+||+|.+|+.-|++|+.|||+++....
T Consensus 136 -----gDc~tllk~~g----~lP--------vdmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLm 195 (1205)
T KOG0606|consen 136 -----GDCATLLKNIG----PLP--------VDMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM 195 (1205)
T ss_pred -----chhhhhcccCC----CCc--------chhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence 34444444432 121 13388999999 99999999999999999999999999999764421
Q ss_pred CC--------------ceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHH
Q 045453 213 GE--------------TCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLH 278 (346)
Q Consensus 213 ~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 278 (346)
.. ......++||+.|+|||++..+.|...+|+|++|+++||.+-|+.||.+...++. +..
T Consensus 196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel------fg~ 269 (1205)
T KOG0606|consen 196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL------FGQ 269 (1205)
T ss_pred hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH------Hhh
Confidence 11 1123456899999999999999999999999999999999999999998877664 222
Q ss_pred HHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCC
Q 045453 279 YVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPT 330 (346)
Q Consensus 279 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs 330 (346)
++.......+ - .+....+..+++.+.|+.+|.+|--
T Consensus 270 visd~i~wpE---~-------------dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 270 VISDDIEWPE---E-------------DEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred hhhhhccccc---c-------------CcCCCHHHHHHHHHHHHhChHhhcc
Confidence 2222111110 0 1123455788999999999999943
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.9e-19 Score=151.31 Aligned_cols=130 Identities=19% Similarity=0.180 Sum_probs=105.5
Q ss_pred ccccCCCcEEEEEEECCeEEEEEEecCccC-c-------chHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecc
Q 045453 64 VIKDGYAYKFYKGFVEDRTVSVMKFNDILN-D-------GHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESV 135 (346)
Q Consensus 64 ~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~-~-------~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~ 135 (346)
.||+|++|.||+|.+.+..+++|....... . ...++.+|...+..+ +|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRA-RKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHH-HHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999999999999998654321 1 124456788888887 7777655555555666779999999
Q ss_pred cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcc
Q 045453 136 KNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVS 209 (346)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~ 209 (346)
+|++|.+.+.... . .++.+++.+|.+|| +.+++|+|++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~-----~------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN-----D------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH-----H------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999875431 1 78999999999999 89999999999999999 88999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.7e-19 Score=173.38 Aligned_cols=138 Identities=17% Similarity=0.128 Sum_probs=112.9
Q ss_pred HhcCCCcccccccCCCcEEEEEEECCeEEEEEEecCcc-C-------cchHHHHHHHHHHhhhcCCCceeeEcceeecCC
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDIL-N-------DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETR 126 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~-~-------~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~ 126 (346)
....|...+.||+|+||+||+|.+.+..+++|+..... . .....+.+|...+..+ +|+|++....++...+
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEA-RRAGVPTPVIYDVDPE 409 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhh-cccCCCeeEEEEEeCC
Confidence 34455678899999999999999977777766543221 1 1124567788888888 9999998888887777
Q ss_pred cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCC
Q 045453 127 IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSL 206 (346)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl 206 (346)
..++||||+++++|.+++. ....++.+++.+|.+|| +.+++||||||+|||+ .++.++|+|||+
T Consensus 410 ~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGl 473 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGL 473 (535)
T ss_pred CCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCcc
Confidence 8899999999999998884 34678999999999999 8999999999999999 677899999999
Q ss_pred Ccc
Q 045453 207 SVS 209 (346)
Q Consensus 207 ~~~ 209 (346)
++.
T Consensus 474 a~~ 476 (535)
T PRK09605 474 GKY 476 (535)
T ss_pred ccc
Confidence 865
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.5e-19 Score=152.75 Aligned_cols=141 Identities=14% Similarity=0.103 Sum_probs=106.9
Q ss_pred CCCcccccccCCCcEEEEEE-E--CCeEEEEEEecCccCc------------------------chHHHHHHHHHHhhhc
Q 045453 58 NFDARNVIKDGYAYKFYKGF-V--EDRTVSVMKFNDILND------------------------GHEDCFNNIIFASKLS 110 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~-~--~~~~vavk~~~~~~~~------------------------~~~~~~~e~~~~~~~~ 110 (346)
.|.+...||+|++|.||+|. . ++..||+|.+...... .......|...+..+
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L- 107 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL- 107 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH-
Confidence 46678899999999999998 3 8899999998743210 001234677778777
Q ss_pred CCC--ceeeEcceeecCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-ceecCCC
Q 045453 111 SHK--NVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRP-ILHRKIR 187 (346)
Q Consensus 111 ~h~--niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-iiH~dlk 187 (346)
.+. .+++++++ ...++||||+++++|....... ..+.......++.+++.++.+|| ..+ ++|+|||
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dik 176 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD----VEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLS 176 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCccccccccc----CCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCC
Confidence 542 23444432 2348999999998887654322 23555667899999999999999 889 9999999
Q ss_pred CCCeEEcCCCceEEeccCCCcccC
Q 045453 188 PSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 188 p~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|+||+++ ++.++|+|||.+...+
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhccC
Confidence 9999999 8899999999986543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.1e-20 Score=169.28 Aligned_cols=174 Identities=28% Similarity=0.435 Sum_probs=131.5
Q ss_pred cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCC
Q 045453 127 IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSL 206 (346)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl 206 (346)
.+++.|++|.-.+|.++|..+.. ....+|...+.+..|++.|+.| ++.+|+|+||.||+...+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence 57899999999999999975543 3568899999999999999998 6889999999999999999999999999
Q ss_pred CcccCCCC-----ceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHH
Q 045453 207 SVSIPEGE-----TCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYV 280 (346)
Q Consensus 207 ~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 280 (346)
........ ....+...||..||+||.+.+..|+.|+||||||++|+|+++ -..+++....
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t-------------- 468 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIAT-------------- 468 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHh--------------
Confidence 87776544 223356679999999999999999999999999999999998 3333321110
Q ss_pred HHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 045453 281 KKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDV 334 (346)
Q Consensus 281 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev 334 (346)
..-+.++ .+.+....+++ .=..|+.+++...|.+||++.++
T Consensus 469 ~~d~r~g----~ip~~~~~d~p---------~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 469 LTDIRDG----IIPPEFLQDYP---------EEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred hhhhhcC----CCChHHhhcCc---------HHHHHHHHhcCCCcccCchHHHH
Confidence 0001111 12222222221 12358999999999999955544
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.8e-18 Score=145.95 Aligned_cols=143 Identities=15% Similarity=0.067 Sum_probs=107.4
Q ss_pred HHHHHhcCCCcccccccCCCcEEEEEEE-CCeEEEEEEecCccCc----------------------chHHHHHHHHHHh
Q 045453 51 ELEIATNNFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILND----------------------GHEDCFNNIIFAS 107 (346)
Q Consensus 51 ~l~~~~~~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~----------------------~~~~~~~e~~~~~ 107 (346)
++......|...+.||+|+||.||++.. +++.||||++...... .......|...+.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 3444444477788999999999999998 7899999986543210 0112456667777
Q ss_pred hhcCCCc--eeeEcceeecCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecC
Q 045453 108 KLSSHKN--VLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRK 185 (346)
Q Consensus 108 ~~~~h~n--iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~d 185 (346)
.+ .|++ ++..++. ...++||||+++++|...... .....++.+++.++.++| ..+++|+|
T Consensus 89 ~l-~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh---~~gi~H~D 150 (198)
T cd05144 89 AL-YEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAY---KHGIIHGD 150 (198)
T ss_pred HH-HHcCCCCCceeec----CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHH---HCCCCcCC
Confidence 77 6664 4444432 345899999999998765421 234578889999999999 89999999
Q ss_pred CCCCCeEEcCCCceEEeccCCCcccC
Q 045453 186 IRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 186 lkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|+|+||++++++.++|+|||++....
T Consensus 151 l~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 151 LSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCcccEEEcCCCcEEEEECCccccCC
Confidence 99999999999999999999986553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.5e-16 Score=128.51 Aligned_cols=136 Identities=18% Similarity=0.188 Sum_probs=112.1
Q ss_pred cccccccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHHHHHHHhhhcCC-CceeeEcceeecCCcceEEEecccCCC
Q 045453 61 ARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSH-KNVLKLTGCCLETRIPVIVFESVKNRT 139 (346)
Q Consensus 61 ~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h-~niv~l~g~~~~~~~~~lv~e~~~~gs 139 (346)
+.+.||+|.++.||++...+..+++|....... ...+..|...+..+.++ .++++++++....+..++++||+++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 356799999999999999878999998765432 45677888888888333 689999988888888999999999877
Q ss_pred hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcc
Q 045453 140 LADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVS 209 (346)
Q Consensus 140 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~ 209 (346)
+..+ +......++.+++.+|++||.....+++|+|++|+||++++++.++++|||.+..
T Consensus 80 ~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 7653 4466778899999999999943235799999999999999999999999998754
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.4e-17 Score=136.20 Aligned_cols=135 Identities=16% Similarity=0.144 Sum_probs=94.5
Q ss_pred ccccccCCCcEEEEEEE-CCeEEEEEEecCccCcc--hHHH----------------------HHHHHHHhhhcCCC--c
Q 045453 62 RNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILNDG--HEDC----------------------FNNIIFASKLSSHK--N 114 (346)
Q Consensus 62 ~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~~--~~~~----------------------~~e~~~~~~~~~h~--n 114 (346)
.+.||+|+||+||+|.. +++.||||.+....... .... ..|...+..+ .+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRL-YEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHH-HHcCCC
Confidence 46799999999999998 59999999876543211 1111 2333344444 222 2
Q ss_pred eeeEcceeecCCcceEEEecccCCChhhh-hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCceecCCCCCCeE
Q 045453 115 VLKLTGCCLETRIPVIVFESVKNRTLADH-IYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFS-RPILHRKIRPSRIF 192 (346)
Q Consensus 115 iv~l~g~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~iiH~dlkp~NIl 192 (346)
+.+.+++ ...++||||++++++... +.... .. .....++.+++.++.++| . .+++|+||||+||+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nil 147 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNIL 147 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEE
Confidence 3333332 245899999999654322 21111 11 567889999999999999 7 99999999999999
Q ss_pred EcCCCceEEeccCCCcccC
Q 045453 193 LDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 193 l~~~~~~kl~Dfgl~~~~~ 211 (346)
++ ++.++++|||.+....
T Consensus 148 i~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 148 VD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred EE-CCcEEEEECccccccc
Confidence 99 8999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.7e-16 Score=137.25 Aligned_cols=135 Identities=15% Similarity=0.109 Sum_probs=104.8
Q ss_pred ccccc-cCCCcEEEEEEECCeEEEEEEecCcc-------------CcchHHHHHHHHHHhhhcCCCce--eeEcceeecC
Q 045453 62 RNVIK-DGYAYKFYKGFVEDRTVSVMKFNDIL-------------NDGHEDCFNNIIFASKLSSHKNV--LKLTGCCLET 125 (346)
Q Consensus 62 ~~~ig-~G~~g~Vy~~~~~~~~vavk~~~~~~-------------~~~~~~~~~e~~~~~~~~~h~ni--v~l~g~~~~~ 125 (346)
..+|| .||.|+||.+...+..++||.+.... ......+.+|...+..+ +|+++ +..+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L-~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQL-YEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHH-HhCCCCCceeEeeeeee
Confidence 45788 89999999999999999999874311 01224567788888888 88775 6777765433
Q ss_pred Cc----ceEEEecccC-CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceE
Q 045453 126 RI----PVIVFESVKN-RTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAK 200 (346)
Q Consensus 126 ~~----~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~k 200 (346)
.. .++|||++++ .+|.+++... +++.. .+.+++.+|.+|| ..||+|+||||.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEE
Confidence 22 2599999997 6898887542 34433 3568999999999 99999999999999999999999
Q ss_pred EeccCCCcc
Q 045453 201 LFDFSLSVS 209 (346)
Q Consensus 201 l~Dfgl~~~ 209 (346)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999998765
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.5e-17 Score=162.15 Aligned_cols=255 Identities=18% Similarity=0.200 Sum_probs=184.4
Q ss_pred hcCCCcccccccCCCcEEEEEEE---CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV---EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVI 130 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~---~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~l 130 (346)
...|...+-||+|+|+.|-.... ....+|+|.+.... .....+...|...-..+..|+|++.+++.....+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 34566677799999999987776 33455555554332 11222223344444444249999999999999999999
Q ss_pred EEecccCCChhhhhh-hcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCC-ceEEeccCCCc
Q 045453 131 VFESVKNRTLADHIY-QNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGY-IAKLFDFSLSV 208 (346)
Q Consensus 131 v~e~~~~gsL~~~l~-~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~-~~kl~Dfgl~~ 208 (346)
+.+|..++++.+-+. ... ...+......+..|+..++.|+|. ..++.|+||||+|.+++.++ ..+++|||+|.
T Consensus 99 ~~~~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred ccCcccccccccccccCCc---cCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhc
Confidence 999999999998883 322 135556777889999999999996 57899999999999999999 99999999998
Q ss_pred ccCC--CCceeeccccc-cCCcCCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHh
Q 045453 209 SIPE--GETCVKDKVTG-TMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCI 284 (346)
Q Consensus 209 ~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (346)
.... +.........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++.......
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~--------------- 238 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG--------------- 238 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc---------------
Confidence 7765 33334455677 9999999999874 457789999999999999999999876544332
Q ss_pred hcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 045453 285 ENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVA 335 (346)
Q Consensus 285 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~ 335 (346)
.+..+.+...... ...-........++...++..+|+.|.+.+++.
T Consensus 239 ---~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 239 ---RYSSWKSNKGRFT--QLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ---cceeecccccccc--cCccccCChhhhhcccccccCCchhcccccccc
Confidence 1111111110000 001113345577889999999999999988764
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=3.8e-16 Score=135.99 Aligned_cols=202 Identities=19% Similarity=0.278 Sum_probs=142.3
Q ss_pred HHHhhhcCCCceeeEcceeecCC-----cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 045453 104 IFASKLSSHKNVLKLTGCCLETR-----IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFS 178 (346)
Q Consensus 104 ~~~~~~~~h~niv~l~g~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~ 178 (346)
..+..+ -|.|||+++.|+.+.. ...+++|||..|+|.++|+........+......+|+-||..||.|||+ |.
T Consensus 119 dnllql-vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~ 196 (458)
T KOG1266|consen 119 DNLLQL-VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CD 196 (458)
T ss_pred HHHHHH-HHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence 344555 7999999999997643 4689999999999999998876656778888889999999999999994 58
Q ss_pred CCceecCCCCCCeEEcCCCceEEeccCCCcccC---CCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHH
Q 045453 179 RPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP---EGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLL 255 (346)
Q Consensus 179 ~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ell 255 (346)
++|+|+++..+-|++..+|.+|+.--.-..... ...........+.++|.|||+-.....+..+|||+||+..+||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 899999999999999999999886432111000 00001112234567899999888778889999999999999999
Q ss_pred hCCCC-CCCCCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 045453 256 TGQKI-FDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDV 334 (346)
Q Consensus 256 tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev 334 (346)
.+... -......+. ...+-..+.+..+.. =..++..|++..|..||+|.++
T Consensus 277 ilEiq~tnseS~~~~--------------------ee~ia~~i~~len~l--------qr~~i~kcl~~eP~~rp~ar~l 328 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEV--------------------EENIANVIIGLENGL--------QRGSITKCLEGEPNGRPDARLL 328 (458)
T ss_pred HheeccCCCcceeeh--------------------hhhhhhheeeccCcc--------ccCcCcccccCCCCCCcchhhh
Confidence 87753 111111110 000111111111000 1247889999999999999887
Q ss_pred H
Q 045453 335 A 335 (346)
Q Consensus 335 ~ 335 (346)
+
T Consensus 329 l 329 (458)
T KOG1266|consen 329 L 329 (458)
T ss_pred h
Confidence 5
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.55 E-value=9.9e-14 Score=131.36 Aligned_cols=141 Identities=15% Similarity=0.170 Sum_probs=97.5
Q ss_pred ccccccCCCcEEEEEEE-CCeEEEEEEecCccCcchH----------------------------------------HHH
Q 045453 62 RNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILNDGHE----------------------------------------DCF 100 (346)
Q Consensus 62 ~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~~~~----------------------------------------~~~ 100 (346)
.+-||+|++|.||+|.+ +|+.||||+..+....... .+.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 36799999999999999 8999999998654211100 122
Q ss_pred HHHHHHhhh---cCCCceeeEcceee-cCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHH-HHHHHHh
Q 045453 101 NNIIFASKL---SSHKNVLKLTGCCL-ETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIAN-AIAYLHI 175 (346)
Q Consensus 101 ~e~~~~~~~---~~h~niv~l~g~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~-~L~~LH~ 175 (346)
+|...+..+ .+|.+-+.+-.++. .....+|||||++|++|.+....... .. .+..++..++. .+..+|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~---~~~~ia~~~~~~~l~ql~- 274 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---GL---DRKALAENLARSFLNQVL- 274 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---CC---CHHHHHHHHHHHHHHHHH-
Confidence 333333332 12333333333332 23456999999999999988754321 12 23456666666 467889
Q ss_pred CCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 176 GFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 176 ~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
..|++|+|++|.||+++.++.++++|||++..++
T Consensus 275 --~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 275 --RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred --hCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 8999999999999999999999999999987764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=3e-14 Score=133.70 Aligned_cols=246 Identities=19% Similarity=0.178 Sum_probs=175.9
Q ss_pred CCCccccccc--CCCcEEEEEEE----CCeEEEEEEecCc--cCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcce
Q 045453 58 NFDARNVIKD--GYAYKFYKGFV----EDRTVSVMKFNDI--LNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV 129 (346)
Q Consensus 58 ~f~~~~~ig~--G~~g~Vy~~~~----~~~~vavk~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~ 129 (346)
.|.....+|. |.+|.||.+.. ++..+|+|+-..- .......-.+++.....+-.|+|.++.+..+.+.+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4566788999 99999998876 6678888873322 22333445667777777778999999999999999999
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCceecCCCCCCeEEcCC-CceEEecc
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIAN----AIAYLHIGFSRPILHRKIRPSRIFLDEG-YIAKLFDF 204 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~----~L~~LH~~~~~~iiH~dlkp~NIll~~~-~~~kl~Df 204 (346)
+-+|++. .+|.++-..... .++....+....+... ||.++| +.+++|-|+||.||+...+ ..++++||
T Consensus 195 iqtE~~~-~sl~~~~~~~~~---~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPCN---FLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeecccc-chhHHhhhcccc---cCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCc
Confidence 9999995 588887765542 2444444555555555 999999 9999999999999999999 89999999
Q ss_pred CCCcccCCCCceee----ccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHH
Q 045453 205 SLSVSIPEGETCVK----DKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYV 280 (346)
Q Consensus 205 gl~~~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 280 (346)
|+...++.+..... ....+..-|++||... +.++..+|+|++|.+..+..++..+..........
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~---------- 336 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS---------- 336 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCcc----------
Confidence 99988876553211 1225667899999765 67889999999999999999988776544222210
Q ss_pred HHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 045453 281 KKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVA 335 (346)
Q Consensus 281 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~ 335 (346)
...... +..++.. .-...+...+.++++.+|-.|++...+.
T Consensus 337 -------~~r~~~---ip~e~~~----~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 337 -------QLRQGY---IPLEFCE----GGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred -------cccccc---Cchhhhc----CcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 000000 1111111 1123344588899999999999887654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.46 E-value=5.5e-13 Score=110.28 Aligned_cols=126 Identities=19% Similarity=0.114 Sum_probs=92.4
Q ss_pred cccccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCc-eeeEcceeecCCcceEEEecccCCChh
Q 045453 63 NVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKN-VLKLTGCCLETRIPVIVFESVKNRTLA 141 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~n-iv~l~g~~~~~~~~~lv~e~~~~gsL~ 141 (346)
+.|+.|.++.||++...++.+++|....... .......|...+..+ .+.+ +++++++.. ...++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l-~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVANKKYVVRIPGNGTE-LLINRENEAENSKLA-AEAGIGPKLYYFDP--ETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEECCeEEEEEeCCCCcc-cccCHHHHHHHHHHH-HHhCCCCceEEEeC--CCCeEEEEecCCCccc
Confidence 4688999999999999999999998754432 223456677777766 4333 344554432 3458999999998876
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-----ceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 142 DHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRP-----ILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 142 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-----iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
+.- . .....+.+++++|+.|| ..+ ++|+|++|.||+++ ++.++++||+.+.
T Consensus 80 ~~~---------~---~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 80 TED---------F---SDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccc---------c---cCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 530 0 11235678999999999 665 59999999999999 6689999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.35 E-value=3.1e-11 Score=114.87 Aligned_cols=164 Identities=20% Similarity=0.198 Sum_probs=121.3
Q ss_pred CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccCCChhhhhhhcCCCCCCCCHHH
Q 045453 79 EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQ 158 (346)
Q Consensus 79 ~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~ 158 (346)
++++|.|+..............+.+..++.+ +||||++++..+.+.+..|||+|-+. .|..++.. ++-..
T Consensus 36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtl-RHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~~~ 105 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTL-RHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGKEE 105 (690)
T ss_pred cCCceEEEEEeCCCchhhHHHHHHHHHhhhc-cCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHHHH
Confidence 7788888877655442233445556667777 99999999999999999999999883 57777765 33456
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCceeeccccccCCcCCccccccCCC
Q 045453 159 RLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDF 238 (346)
Q Consensus 159 ~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 238 (346)
....+.||+.||.|||+ ..+++|++|.-+.|+++..|..||++|.++.....-.. .......-..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc-
Confidence 66778999999999986 56899999999999999999999999987654321111 011111222466666544333
Q ss_pred CcccchHHHHHHHHHHHhC
Q 045453 239 NEKCDVFSFGMLLLVLLTG 257 (346)
Q Consensus 239 ~~~~Dv~s~G~vl~elltg 257 (346)
-..|.|-||++++|++.|
T Consensus 182 -~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -cchhhhhHHHHHHHHhCc
Confidence 346999999999999999
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.7e-12 Score=122.07 Aligned_cols=254 Identities=18% Similarity=0.220 Sum_probs=181.4
Q ss_pred CCHHH-HHHHhcCCCcccccccCCCcEEEEEEE---CCeEEEEEEecCccCcc--hHHHHHHHHHHhhhcCCCceeeEcc
Q 045453 47 FTIRE-LEIATNNFDARNVIKDGYAYKFYKGFV---EDRTVSVMKFNDILNDG--HEDCFNNIIFASKLSSHKNVLKLTG 120 (346)
Q Consensus 47 ~~~~~-l~~~~~~f~~~~~ig~G~~g~Vy~~~~---~~~~vavk~~~~~~~~~--~~~~~~e~~~~~~~~~h~niv~l~g 120 (346)
|.-++ --..+.+|.....||.|.|+.|+.... ++..+++|.+.+..... ...-+.|+.....+..|.+.+..+.
T Consensus 254 ~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~ 333 (524)
T KOG0601|consen 254 FTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNS 333 (524)
T ss_pred ecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCC
Confidence 34344 333456788889999999999998766 56788888766554322 2234567777777778999999999
Q ss_pred eeecCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCC-Cce
Q 045453 121 CCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEG-YIA 199 (346)
Q Consensus 121 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~-~~~ 199 (346)
.+...+..++=-||++++++...+... ..+....++.+..+++.++.++| ++.++|+|+||+||++..+ +..
T Consensus 334 ~W~~~r~~~ip~e~~~~~s~~l~~~~~----~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~ 406 (524)
T KOG0601|consen 334 SWSQLRQGYIPLEFCEGGSSSLRSVTS----QMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFS 406 (524)
T ss_pred CccccccccCchhhhcCcchhhhhHHH----HhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhh
Confidence 999988889999999999877666322 35777888999999999999999 9999999999999999886 888
Q ss_pred EEeccCCCcccCCCCceeeccccccCCcC--CccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHH
Q 045453 200 KLFDFSLSVSIPEGETCVKDKVTGTMGFL--APEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLL 277 (346)
Q Consensus 200 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~ 277 (346)
++.|||.+..+.-. ........++. +|.......+..+.|+||||.-+.+.+++...-.......
T Consensus 407 ~~~~~~~~t~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~--------- 473 (524)
T KOG0601|consen 407 KLGDFGCWTRLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL--------- 473 (524)
T ss_pred hcccccccccccee----cccccccccccccchhhccccccccccccccccccccccccCcccCcccccce---------
Confidence 99999987643211 11111222333 5555556678899999999999999999876432211100
Q ss_pred HHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 045453 278 HYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLK 339 (346)
Q Consensus 278 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 339 (346)
....+..+... .....+..+...+...++..||.+.+.....+
T Consensus 474 -----------------~i~~~~~p~~~--~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 474 -----------------TIRSGDTPNLP--GLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred -----------------eeecccccCCC--chHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 00111111111 23366778888999999999999988765443
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.5e-12 Score=124.98 Aligned_cols=146 Identities=15% Similarity=0.152 Sum_probs=90.4
Q ss_pred cCCCcccccccCCCcEEEEEEE-C-CeEEEEEEecCccCcc----------------------------------hH---
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV-E-DRTVSVMKFNDILNDG----------------------------------HE--- 97 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~-~-~~~vavk~~~~~~~~~----------------------------------~~--- 97 (346)
.+|+. +-||+|++|.||+|.+ + |+.||||+..+..... ..
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34665 7899999999999999 4 8999999987542100 00
Q ss_pred ---HHHHHHHHHhhh---cCCCceeeEcceeec-CCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHH-
Q 045453 98 ---DCFNNIIFASKL---SSHKNVLKLTGCCLE-TRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANA- 169 (346)
Q Consensus 98 ---~~~~e~~~~~~~---~~h~niv~l~g~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~- 169 (346)
.+.+|...+.++ ..+.+.+.+-.++.+ ....+|||||++|+.+.+.-.-.. ...+ +..++...+..
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~---~g~d---~~~la~~~v~~~ 272 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRA---AGTD---MKLLAERGVEVF 272 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHh---cCCC---HHHHHHHHHHHH
Confidence 122233222222 123333333233222 345689999999999987532111 0111 11222222221
Q ss_pred HHHHHhCCCCCceecCCCCCCeEEcCCC----ceEEeccCCCcccCC
Q 045453 170 IAYLHIGFSRPILHRKIRPSRIFLDEGY----IAKLFDFSLSVSIPE 212 (346)
Q Consensus 170 L~~LH~~~~~~iiH~dlkp~NIll~~~~----~~kl~Dfgl~~~~~~ 212 (346)
+..+. ..|++|+|++|.||+++.++ .++++|||++..+..
T Consensus 273 ~~Qif---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 273 FTQVF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 22344 67999999999999999988 999999999876643
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.3e-12 Score=129.18 Aligned_cols=248 Identities=17% Similarity=0.160 Sum_probs=168.7
Q ss_pred HHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecC---ccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcc
Q 045453 54 IATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFND---ILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIP 128 (346)
Q Consensus 54 ~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~---~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~ 128 (346)
...+.|.+.+-+-+|.++.++.+.- .+...++|.... ......+....+-...... ++|.++.....+......
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p-~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITP-RSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccC-CCCceecccCCCCCCCCc
Confidence 3445666677788899999998766 333333333221 1111122222222222223 667788777666677888
Q ss_pred eEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 129 VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
.||++|+.+++|...|+... +.+..-....+..+..++.+|| +..+.|+|++|.|+|...++..++.|||...
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~ 952 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLS 952 (1205)
T ss_pred chhhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCcccccc
Confidence 99999999999999988754 2333333445667788999999 7889999999999999999999999998432
Q ss_pred ccCC---------------------CC---------ceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCC
Q 045453 209 SIPE---------------------GE---------TCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQ 258 (346)
Q Consensus 209 ~~~~---------------------~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~ 258 (346)
..+. +. ........+|+.|.+||...+......+|+|++|++++|.++|.
T Consensus 953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen 953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence 2210 00 00112346899999999999999999999999999999999999
Q ss_pred CCCCCCCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCc-chHHHHHHHHHHHHHcccCCCCCCCCHH
Q 045453 259 KIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRV-GKEKQLQGFRELALMCVCESAEDRPTTV 332 (346)
Q Consensus 259 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~ 332 (346)
.||........ ++..+....+.+ ...+......+++...+..+|.+|..|.
T Consensus 1033 pp~na~tpq~~-----------------------f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1033 PPFNAETPQQI-----------------------FENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCcchhhh-----------------------hhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 99987655443 111111111111 1224456677888888899999997765
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.22 E-value=2.5e-10 Score=95.77 Aligned_cols=136 Identities=10% Similarity=0.090 Sum_probs=94.3
Q ss_pred cccccCCCcEEEEEEEC--------CeEEEEEEecCccC----------------------cchHHH----HHHHHHHhh
Q 045453 63 NVIKDGYAYKFYKGFVE--------DRTVSVMKFNDILN----------------------DGHEDC----FNNIIFASK 108 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~~--------~~~vavk~~~~~~~----------------------~~~~~~----~~e~~~~~~ 108 (346)
..||.|-=+.||.|... +..+|||....... .....+ .+|...|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999999863 36999997542210 001112 267777777
Q ss_pred hcCC-CceeeEcceeecCCcceEEEecccCCChhh-hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCceecC
Q 045453 109 LSSH-KNVLKLTGCCLETRIPVIVFESVKNRTLAD-HIYQNQPHFEPLLLSQRLRIAVHIANAIAYL-HIGFSRPILHRK 185 (346)
Q Consensus 109 ~~~h-~niv~l~g~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~iiH~d 185 (346)
+... -+++.++++ ..-+|||||+.+..+.. .+.+ ..++......+..+++.+|..| | ..+++|+|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHH---hCCeecCC
Confidence 7432 456666654 35689999997643322 2322 1244455667788999999998 7 88999999
Q ss_pred CCCCCeEEcCCCceEEeccCCCcccC
Q 045453 186 IRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 186 lkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|++.|||++. +.+.|+|||.+....
T Consensus 151 Ls~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 151 LSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CCHHHEEEEC-CcEEEEECCCceeCC
Confidence 9999999974 679999999886554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.21 E-value=2e-10 Score=98.96 Aligned_cols=140 Identities=19% Similarity=0.227 Sum_probs=105.0
Q ss_pred cccccCCCcEEEEEEECC-eEEEEEEecCccC-cchHHHHHHHHHHhhhcCC--CceeeEcceeecC---CcceEEEecc
Q 045453 63 NVIKDGYAYKFYKGFVED-RTVSVMKFNDILN-DGHEDCFNNIIFASKLSSH--KNVLKLTGCCLET---RIPVIVFESV 135 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~~~-~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h--~niv~l~g~~~~~---~~~~lv~e~~ 135 (346)
..|+.|.++.||++...+ ..+++|....... ........|...+..+ .+ .++++++.++... +..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l-~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRAL-AGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHh-hCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 468999999999999855 8899998654322 1345567777777777 43 3456677776654 2568999999
Q ss_pred cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 045453 136 KNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGF-------------------------------------- 177 (346)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------------------------------------- 177 (346)
+|.++.+.+.. ..++...+..++.+++++|..||+..
T Consensus 83 ~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 83 DGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 99888876532 24677778888888888888888421
Q ss_pred ---------------CCCceecCCCCCCeEEcC--CCceEEeccCCCc
Q 045453 178 ---------------SRPILHRKIRPSRIFLDE--GYIAKLFDFSLSV 208 (346)
Q Consensus 178 ---------------~~~iiH~dlkp~NIll~~--~~~~kl~Dfgl~~ 208 (346)
...++|+|+.|.|||++. ++.+.|+||+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 245699999999999998 6778999999764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.9e-10 Score=93.61 Aligned_cols=131 Identities=19% Similarity=0.177 Sum_probs=95.8
Q ss_pred cccccCCCcEEEEEEECCeEEEEEEecCccC--c------chHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEec
Q 045453 63 NVIKDGYAYKFYKGFVEDRTVSVMKFNDILN--D------GHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFES 134 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~--~------~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~ 134 (346)
..+++|+=+.+|.+.+-|.++++|.-.+..- . ......+|..++.++ .--.+.-..=+..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a-~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKA-REAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHH-HHcCCCCCeEEEEcCCCCEEEEEE
Confidence 3578999999999988877777776433321 1 123445677777666 332333323334455667899999
Q ss_pred ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcc
Q 045453 135 VKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVS 209 (346)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~ 209 (346)
++|..|.+.+... ...++..+-.-+.-|| ..+|+|+||.++||++..+. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9998898888653 2457777888888999 99999999999999998876 89999999864
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=3.1e-09 Score=96.42 Aligned_cols=271 Identities=15% Similarity=0.112 Sum_probs=166.6
Q ss_pred CcccccccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEccee------ec-CCcceEEE
Q 045453 60 DARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCC------LE-TRIPVIVF 132 (346)
Q Consensus 60 ~~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~------~~-~~~~~lv~ 132 (346)
...+-||+|+-+.+|-.---+..| .|+...-.. ....+....+.....||-+-.-+.+= .+ +...-+.|
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d~V-AKIYh~Ppp---a~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRDQV-AKIYHAPPP---AAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCCccccCCccceeeecchhhchh-heeecCCCc---hHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 356789999999999544333333 344443221 22233444455554666443311110 11 12256777
Q ss_pred ecccCCChhhhhhh---cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcc
Q 045453 133 ESVKNRTLADHIYQ---NQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVS 209 (346)
Q Consensus 133 e~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~ 209 (346)
..+++.---..+.+ ++.+.+...|.-.+..+..+|.+.+-|| ..|.+-+|+.++|+|+++++.+.|.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccceee
Confidence 77766422222222 1223456889999999999999999999 99999999999999999999999998654322
Q ss_pred cCCCCceeeccccccCCcCCccccc-----cCCCCcccchHHHHHHHHHHHhC-CCCCCCCCCcccccchhhHHHHHHHH
Q 045453 210 IPEGETCVKDKVTGTMGFLAPEYIN-----TGDFNEKCDVFSFGMLLLVLLTG-QKIFDPSRGDEIGAGHYWLLHYVKKC 283 (346)
Q Consensus 210 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~ 283 (346)
...+. .....+|...|.+||.-. +-.-+..+|.|.+|+++++++-| ++||.+.......... + +.-
T Consensus 167 ~~ng~--~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p--~----E~~ 238 (637)
T COG4248 167 NANGT--LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNP--L----ETD 238 (637)
T ss_pred ccCCc--eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCc--c----hhh
Confidence 22222 234567889999999765 33457789999999999999885 9999775322110000 0 001
Q ss_pred hhcCccccccccccccCCCC--cchHHHHHHHHHHHHHcccC--CCCCCCCHHHHHHHHHHHHHhh
Q 045453 284 IENNEFDEIVDPIIVSEGPR--VGKEKQLQGFRELALMCVCE--SAEDRPTTVDVAKRLKQIYQHL 345 (346)
Q Consensus 284 ~~~~~~~~~~d~~l~~~~~~--~~~~~~~~~l~~l~~~cl~~--~p~~RPs~~ev~~~L~~i~~~l 345 (346)
+..+.+...-+....-..+. .+-.-.+..+.-|..+|... +|.-|||++-++..|..+.++|
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 11222222222111100000 01112345677788888765 3678999999999999998876
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.4e-10 Score=92.67 Aligned_cols=142 Identities=18% Similarity=0.154 Sum_probs=101.7
Q ss_pred cccccccCCCcEEEEEEECCeEEEEEEecCcc-C-------cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 61 ARNVIKDGYAYKFYKGFVEDRTVSVMKFNDIL-N-------DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 61 ~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~-~-------~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
....|.+|+=+.|+++.+.|+..+||.-.... . -...+..+|...+.++ +--.|.-..=++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~-~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKC-RALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHH-HHhCCCCceEEEEecCCCeEEE
Confidence 45688999999999999999998888643221 1 1234456777777777 3333333333445556668999
Q ss_pred ecccC-CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCC---ceEEeccCCCc
Q 045453 133 ESVKN-RTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGY---IAKLFDFSLSV 208 (346)
Q Consensus 133 e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~---~~kl~Dfgl~~ 208 (346)
||+++ .++.+++...... +..-.....++..+-..+.-|| ..+++|+||..+||++.+++ .+.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchh
Confidence 99977 4788887654321 1222233678888999999999 99999999999999997655 34799999974
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.07 E-value=3.2e-09 Score=93.90 Aligned_cols=140 Identities=11% Similarity=0.030 Sum_probs=98.1
Q ss_pred cccccCCCcEEEEEEECCeEEEEEEecCccC-----------cchHHHHHHHHHHhhhcCCCc--eeeEcceeec-----
Q 045453 63 NVIKDGYAYKFYKGFVEDRTVSVMKFNDILN-----------DGHEDCFNNIIFASKLSSHKN--VLKLTGCCLE----- 124 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~-----------~~~~~~~~e~~~~~~~~~h~n--iv~l~g~~~~----- 124 (346)
..+-......|.+..+.|+.+.||+.....- .....+.+|...+..+ ...+ .+.++++...
T Consensus 28 e~v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L-~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRL-HEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHH-HHcCCCCCCeeEEEEecCCCc
Confidence 4455444555778888999999997643321 1111356776666666 2222 2233334332
Q ss_pred CCcceEEEecccCC-ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcC-------C
Q 045453 125 TRIPVIVFESVKNR-TLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE-------G 196 (346)
Q Consensus 125 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~-------~ 196 (346)
....+||||++++. +|.+++..... .+.+...+..++.+++..+.-|| ..|++|+|++++|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCC
Confidence 23468999999886 89998854321 24556677899999999999999 999999999999999985 4
Q ss_pred CceEEeccCCCc
Q 045453 197 YIAKLFDFSLSV 208 (346)
Q Consensus 197 ~~~kl~Dfgl~~ 208 (346)
+.+.++||+.+.
T Consensus 182 ~~~~LIDl~r~~ 193 (268)
T PRK15123 182 LKLSVIDLHRAQ 193 (268)
T ss_pred ceEEEEECCccc
Confidence 689999999875
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.5e-09 Score=99.23 Aligned_cols=169 Identities=18% Similarity=0.236 Sum_probs=127.7
Q ss_pred CCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeec----CCcceEEEecccCC-Chh
Q 045453 69 YAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLE----TRIPVIVFESVKNR-TLA 141 (346)
Q Consensus 69 ~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~----~~~~~lv~e~~~~g-sL~ 141 (346)
.-.+.|++.. +|..+++|+++............-+..+.++ .|+|+|+|..++.. ...+++||+|+|+. +|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl-~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKL-CHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHh-ccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 3467799988 8899999999544433333445556777777 99999999998763 45789999999874 777
Q ss_pred hhhhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCccc
Q 045453 142 DHIYQNQP-----------HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI 210 (346)
Q Consensus 142 ~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~ 210 (346)
+.-..... .+...++...|.++.|+..||.++| +.|..-+-|.|.+||++.+.+++|+..|....+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeee
Confidence 76443221 1234677899999999999999999 899999999999999999999999988877665
Q ss_pred CCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCC
Q 045453 211 PEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQK 259 (346)
Q Consensus 211 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~ 259 (346)
..+.. +-+. --.+-|.=.||.+++.+.||..
T Consensus 444 ~~d~~---------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 444 QEDPT---------------EPLE---SQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred cCCCC---------------cchh---HHhhhhHHHHHHHHHHHhhccc
Confidence 44331 1111 1235688899999999999854
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.3e-08 Score=85.13 Aligned_cols=126 Identities=20% Similarity=0.205 Sum_probs=78.3
Q ss_pred EEEEEEE-CCeEEEEEEecCccCc--------------------------chHHHHHHHHHHhhhcCC-CceeeEcceee
Q 045453 72 KFYKGFV-EDRTVSVMKFNDILND--------------------------GHEDCFNNIIFASKLSSH-KNVLKLTGCCL 123 (346)
Q Consensus 72 ~Vy~~~~-~~~~vavk~~~~~~~~--------------------------~~~~~~~e~~~~~~~~~h-~niv~l~g~~~ 123 (346)
.||.|.. ++..+|||........ ......+|...|..+... -++++++++-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899998 8889999986532110 012245778888888332 2566666442
Q ss_pred cCCcceEEEeccc--CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCceecCCCCCCeEEcCCCceE
Q 045453 124 ETRIPVIVFESVK--NRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAY-LHIGFSRPILHRKIRPSRIFLDEGYIAK 200 (346)
Q Consensus 124 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~-LH~~~~~~iiH~dlkp~NIll~~~~~~k 200 (346)
.-+|||||++ |..+.. |.... ++......++.+++..+.. +| ..|++|+||.+.|||++++ .+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~-l~~~~-----~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPR-LKDVD-----LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ---TTEEEEE--EETTEEGGC-HHHCG-----GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEE
T ss_pred ---CCEEEEEecCCCccchhh-HHhcc-----ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEE
Confidence 3479999998 544444 43321 1223445677777775555 57 8899999999999999988 899
Q ss_pred EeccCCCcccC
Q 045453 201 LFDFSLSVSIP 211 (346)
Q Consensus 201 l~Dfgl~~~~~ 211 (346)
++|||.+....
T Consensus 147 iIDf~qav~~~ 157 (188)
T PF01163_consen 147 IIDFGQAVDSS 157 (188)
T ss_dssp E--GTTEEETT
T ss_pred EEecCcceecC
Confidence 99999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.85 E-value=8.7e-10 Score=105.58 Aligned_cols=149 Identities=23% Similarity=0.282 Sum_probs=101.6
Q ss_pred HHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCceee--------ccccccCCcCCcccccc
Q 045453 164 VHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVK--------DKVTGTMGFLAPEYINT 235 (346)
Q Consensus 164 ~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~--------~~~~gt~~y~aPE~~~~ 235 (346)
.+++.|+.|+|. +.++||++|.|++|.++.++..|++.|+.+.....+..... ....-...|.|||++.+
T Consensus 106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 345599999997 77899999999999999999999999998755433221111 11123457999999999
Q ss_pred CCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHH
Q 045453 236 GDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFR 314 (346)
Q Consensus 236 ~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~ 314 (346)
...+.++|+||+|+++|-+.. |+..+........... . ....+...... ..+.+.++.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~------------~----~~~~~~~~~~~-----s~~~p~el~ 242 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF------------S----RNLLNAGAFGY-----SNNLPSELR 242 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhh------------h----hcccccccccc-----cccCcHHHH
Confidence 889999999999999999984 5555544333221000 0 00001111111 114556677
Q ss_pred HHHHHcccCCCCCCCCHHHHH
Q 045453 315 ELALMCVCESAEDRPTTVDVA 335 (346)
Q Consensus 315 ~l~~~cl~~~p~~RPs~~ev~ 335 (346)
+=+...+..++..||++.++.
T Consensus 243 ~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 243 ESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred HHHHHHhcCCcccCcchhhhh
Confidence 788888999999999776654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.80 E-value=2e-07 Score=78.63 Aligned_cols=154 Identities=14% Similarity=0.064 Sum_probs=110.1
Q ss_pred HHHHHHhcCCCcccccccCCCcEEEEEEECCeEEEEEEecCcc------CcchHHHHHHHHHHhhhcCC-CceeeEccee
Q 045453 50 RELEIATNNFDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDIL------NDGHEDCFNNIIFASKLSSH-KNVLKLTGCC 122 (346)
Q Consensus 50 ~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~------~~~~~~~~~e~~~~~~~~~h-~niv~l~g~~ 122 (346)
+.+=....+.-..---|+||-+.|++..+.|..+-+|+-.+.. +.+...+.+|...+..+... -.+++.. ++
T Consensus 11 ~~~w~~~~~wve~pN~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~ 89 (216)
T PRK09902 11 NHWWATEGDWVEEPNYRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FG 89 (216)
T ss_pred HHHHhCCCceecCCCcCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-ee
Confidence 3333333333333345789999999999988889999854221 34667888998888887321 1244444 33
Q ss_pred e-c----CCcceEEEecccC-CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCC
Q 045453 123 L-E----TRIPVIVFESVKN-RTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEG 196 (346)
Q Consensus 123 ~-~----~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~ 196 (346)
. . ....+||+|-+++ -+|.+++..... .+.+...+..+..+++..+.-|| ..++.|+|+-+.|||++.+
T Consensus 90 ~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~--~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~ 164 (216)
T PRK09902 90 EAVKIEGEWRALLVTEDMAGFISIADWYAQHAV--SPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTE 164 (216)
T ss_pred eeeccCCceEEEEEEEeCCCCccHHHHHhcCCc--CCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCC
Confidence 2 1 1235899998864 389888865432 35677888999999999999999 9999999999999999866
Q ss_pred Cc--eEEeccCCCcc
Q 045453 197 YI--AKLFDFSLSVS 209 (346)
Q Consensus 197 ~~--~kl~Dfgl~~~ 209 (346)
+. ++++||.-++.
T Consensus 165 g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 165 GKAEAGFLDLEKSRR 179 (216)
T ss_pred CCeeEEEEEhhccch
Confidence 66 99999986543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.77 E-value=9.3e-08 Score=82.69 Aligned_cols=136 Identities=16% Similarity=0.082 Sum_probs=91.6
Q ss_pred CcccccccCCCcEEEEEEE-CCeEEEEEEecCccC----------------------cchHHHHHHHHHHhhhcCC-Cce
Q 045453 60 DARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILN----------------------DGHEDCFNNIIFASKLSSH-KNV 115 (346)
Q Consensus 60 ~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~----------------------~~~~~~~~e~~~~~~~~~h-~ni 115 (346)
.+.+.||-|-=+.||.|.. .|.++|||--....+ -......+|...|..+..+ -.+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 3568899999999999999 799999985321110 1123456788888887333 255
Q ss_pred eeEcceeecCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcC
Q 045453 116 LKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE 195 (346)
Q Consensus 116 v~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~ 195 (346)
++.+++ +...+||||++|-.|...--. .-+... ++..|+.-+.-+- ..|+||+|+++=||++++
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r~~------~en~~~---il~~il~~~~~~~---~~GiVHGDlSefNIlV~~ 237 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLRLD------VENPDE---ILDKILEEVRKAY---RRGIVHGDLSEFNILVTE 237 (304)
T ss_pred CCcccc----ccceeeeehcccceeecccCc------ccCHHH---HHHHHHHHHHHHH---HcCccccCCchheEEEec
Confidence 555543 345899999988655543211 122233 3333433343333 578999999999999999
Q ss_pred CCceEEeccCCCcccC
Q 045453 196 GYIAKLFDFSLSVSIP 211 (346)
Q Consensus 196 ~~~~kl~Dfgl~~~~~ 211 (346)
||.+.++||-.+....
T Consensus 238 dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 238 DGDIVVIDWPQAVPIS 253 (304)
T ss_pred CCCEEEEeCcccccCC
Confidence 9999999998776543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.73 E-value=8.4e-08 Score=81.96 Aligned_cols=107 Identities=21% Similarity=0.150 Sum_probs=80.0
Q ss_pred hHHHHHHHHHHhhhcC-CCceeeEcceeecC----CcceEEEecccCC-ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHH
Q 045453 96 HEDCFNNIIFASKLSS-HKNVLKLTGCCLET----RIPVIVFESVKNR-TLADHIYQNQPHFEPLLLSQRLRIAVHIANA 169 (346)
Q Consensus 96 ~~~~~~e~~~~~~~~~-h~niv~l~g~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~ 169 (346)
.....+|...+..+.. .=..++.+++.... ...+||+|++++. +|.+++.... ..+......++.+++..
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHH
Confidence 3456666666665521 12244555555442 2348999999885 7999887643 25556788899999999
Q ss_pred HHHHHhCCCCCceecCCCCCCeEEcCCC---ceEEeccCCCcc
Q 045453 170 IAYLHIGFSRPILHRKIRPSRIFLDEGY---IAKLFDFSLSVS 209 (346)
Q Consensus 170 L~~LH~~~~~~iiH~dlkp~NIll~~~~---~~kl~Dfgl~~~ 209 (346)
++-|| ..|++|+|+++.|||++.+. .+.++||+.++.
T Consensus 131 i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 131 IAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999 99999999999999999887 899999997754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.60 E-value=3.7e-07 Score=77.33 Aligned_cols=139 Identities=15% Similarity=0.088 Sum_probs=92.6
Q ss_pred HHhcCCCcccccccCCCcEEEEEEECCeEEEEEEecCccCcchHHH---------HHHHHHHhhhc--CCCceeeEccee
Q 045453 54 IATNNFDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDC---------FNNIIFASKLS--SHKNVLKLTGCC 122 (346)
Q Consensus 54 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~---------~~e~~~~~~~~--~h~niv~l~g~~ 122 (346)
...++|...+++.......|.+-..+++.+++|...+......+.+ .+.+..+.++. .--....++.++
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 3457788888888888888999999999999998776543221111 12222222221 111222222222
Q ss_pred -----ecCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCC
Q 045453 123 -----LETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGY 197 (346)
Q Consensus 123 -----~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~ 197 (346)
.-....++||||++|..|.+... ++. .++..++.++.-|| ..|++|+|..|.|+++++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~~ 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNNG 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECCc
Confidence 12234579999999988877542 221 24566778899999 99999999999999999665
Q ss_pred ceEEeccCCCc
Q 045453 198 IAKLFDFSLSV 208 (346)
Q Consensus 198 ~~kl~Dfgl~~ 208 (346)
++++||+..+
T Consensus 173 -i~iID~~~k~ 182 (229)
T PF06176_consen 173 -IRIIDTQGKR 182 (229)
T ss_pred -EEEEECcccc
Confidence 8999998653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.59 E-value=4.1e-07 Score=87.25 Aligned_cols=141 Identities=14% Similarity=0.114 Sum_probs=89.9
Q ss_pred cccccCCCcEEEEEEE-CCeEEEEEEecCccCcchHH----------------------------------------HHH
Q 045453 63 NVIKDGYAYKFYKGFV-EDRTVSVMKFNDILNDGHED----------------------------------------CFN 101 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~~~~~----------------------------------------~~~ 101 (346)
.-|+.++-|.||+|++ +|+.||||+.++........ +.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5688999999999999 69999999876543211110 112
Q ss_pred HHHHHhhh---c-CCCceeeEcceeecCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHH-HHHHHhC
Q 045453 102 NIIFASKL---S-SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANA-IAYLHIG 176 (346)
Q Consensus 102 e~~~~~~~---~-~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~-L~~LH~~ 176 (346)
|...+..+ + ..|++.-..=++.-.+...|+|||++|-.+.+...-.. ...+ +..++..++.+ +..+=
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d---~k~ia~~~~~~f~~q~~-- 282 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGID---RKELAELLVRAFLRQLL-- 282 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCC---HHHHHHHHHHHHHHHHH--
Confidence 22222222 1 23333322223333456689999999988988843322 1244 23333333332 22233
Q ss_pred CCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 177 FSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 177 ~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
..|++|.|..|.||+++.+|.+.+.|||+...+++
T Consensus 283 -~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 283 -RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred -hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 56899999999999999999999999999876653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.46 E-value=3.5e-06 Score=72.98 Aligned_cols=142 Identities=10% Similarity=0.014 Sum_probs=82.1
Q ss_pred ccccccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCC-ceeeEcceeecCCcceEEEecccCCC-
Q 045453 62 RNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHK-NVLKLTGCCLETRIPVIVFESVKNRT- 139 (346)
Q Consensus 62 ~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~-niv~l~g~~~~~~~~~lv~e~~~~gs- 139 (346)
...||+|..+.||+. .+..+++|...... ......+|...+..+.... -+.+.++++...+...+|||+++|.+
T Consensus 6 ~~~i~~G~t~~~y~~--~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 6 WTQTGEGGNGESYTH--KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred heeecCCCCcceeEe--cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 357899999999984 35567788765432 3344567777776663222 24667777777777789999998863
Q ss_pred hhhhhhhc-------------------CCCCCCCCHHHHHHHH-H----------HHHH-HHHHHHh-CCCCCceecCCC
Q 045453 140 LADHIYQN-------------------QPHFEPLLLSQRLRIA-V----------HIAN-AIAYLHI-GFSRPILHRKIR 187 (346)
Q Consensus 140 L~~~l~~~-------------------~~~~~~l~~~~~~~i~-~----------~ia~-~L~~LH~-~~~~~iiH~dlk 187 (346)
+...+... ..............-. . .+.. ...+|.. .....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 22111100 0000011111111000 0 0111 1222221 113457899999
Q ss_pred CCCeEEcCCCceEEeccCCCc
Q 045453 188 PSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 188 p~NIll~~~~~~kl~Dfgl~~ 208 (346)
|.||++++++ +.++||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999988 9999999764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.1e-06 Score=73.75 Aligned_cols=104 Identities=20% Similarity=0.192 Sum_probs=79.8
Q ss_pred HHHHHHhhhcCCCceeeEcceeecCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 045453 101 NNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRP 180 (346)
Q Consensus 101 ~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ 180 (346)
.|..+++.+...+++++++|+|- .++|.||...+++...-.. -...-..+|..|.+||.++++.+.+|+++....
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~-l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRP-LSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccc-cccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 35555666633379999999993 4789999987766532100 001124789999999999999999999766566
Q ss_pred ceecCCCCCCeEEcCCCceEEeccCCCcc
Q 045453 181 ILHRKIRPSRIFLDEGYIAKLFDFSLSVS 209 (346)
Q Consensus 181 iiH~dlkp~NIll~~~~~~kl~Dfgl~~~ 209 (346)
+.-.|++++|+-+++++.+|++|...+-.
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 88899999999999999999999986543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.43 E-value=6.8e-08 Score=92.06 Aligned_cols=182 Identities=19% Similarity=0.068 Sum_probs=132.3
Q ss_pred cccccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCc-eeeEcceeecCCcceEEEecccCC-Ch
Q 045453 63 NVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKN-VLKLTGCCLETRIPVIVFESVKNR-TL 140 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~n-iv~l~g~~~~~~~~~lv~e~~~~g-sL 140 (346)
+-+++|+++++||.+..........+.. .......++..|.++ +||| .+..++-+..+...+++++++..+ +-
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs----~~l~~rl~~eLLdK~-n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~ 322 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVS----QTLSRRLAIELLDKV-NNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS 322 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeec----cchhhHHHHHHHHHc-cCCCCcccccccCCcccccchhhhhhcCCccc
Confidence 4578999999999987433333222221 124455677788888 9999 777777788888899999999876 22
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCceeecc
Q 045453 141 ADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDK 220 (346)
Q Consensus 141 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 220 (346)
....... ...+...+...+...-++++++|| +..=+|+| ||+..+ +..+..||+....+.... ..+.
T Consensus 323 ~~~~~~s---e~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t 389 (829)
T KOG0576|consen 323 ALEMTVS---EIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRT 389 (829)
T ss_pred cccCChh---hHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcccCccc--cccc
Confidence 2222111 123555566777888899999999 55568888 777665 578999999877664432 3456
Q ss_pred ccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCC
Q 045453 221 VTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFD 262 (346)
Q Consensus 221 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~ 262 (346)
..+++.++|||+.....+..+.|+|+.|+-..++.-|.+|-.
T Consensus 390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 678999999999999999999999999987777777776643
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.40 E-value=5e-06 Score=72.91 Aligned_cols=141 Identities=11% Similarity=-0.001 Sum_probs=83.5
Q ss_pred cccCCC-cEEEEEEECCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccCCChhhh
Q 045453 65 IKDGYA-YKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADH 143 (346)
Q Consensus 65 ig~G~~-g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~ 143 (346)
|..|.. ..||+....+..+.+|...... ..+...|...+..+-.+--+.+++++....+..++|||+++|.+|.+.
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 444554 8899998877788888865432 234556666666664444466777777666678999999999777643
Q ss_pred h-------------------hhcCCCCCCCC--HHHHHHH-----------------------HHHHHHHHHHHH-hCCC
Q 045453 144 I-------------------YQNQPHFEPLL--LSQRLRI-----------------------AVHIANAIAYLH-IGFS 178 (346)
Q Consensus 144 l-------------------~~~~~~~~~l~--~~~~~~i-----------------------~~~ia~~L~~LH-~~~~ 178 (346)
. +.-.....++. +...... ..++...|.... ....
T Consensus 83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 162 (244)
T cd05150 83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED 162 (244)
T ss_pred hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence 2 11100001111 0011100 111111111111 0113
Q ss_pred CCceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 179 RPILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 179 ~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
..++|+|+.|.|||++++....|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 568999999999999998888999999763
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.33 E-value=7.4e-06 Score=70.87 Aligned_cols=144 Identities=17% Similarity=0.266 Sum_probs=81.5
Q ss_pred cccccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHHHHHHHhhhcCC-CceeeEcceeec---CCcceEEEecccCC
Q 045453 63 NVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSH-KNVLKLTGCCLE---TRIPVIVFESVKNR 138 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h-~niv~l~g~~~~---~~~~~lv~e~~~~g 138 (346)
+.++.|..+.||+....++.+++|..... ........|...+..+.++ .-+.+++.++.. ....+++|+++++.
T Consensus 3 ~~l~~G~~n~~~~v~~~~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDDGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETTSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECCcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 56899999999999997789999997644 3344555666666555323 235566664433 33468999999998
Q ss_pred Chhh----------------hh---hhcCCCCCCCCHHHH---------HHH------------HHHHHH-HHHHHHh--
Q 045453 139 TLAD----------------HI---YQNQPHFEPLLLSQR---------LRI------------AVHIAN-AIAYLHI-- 175 (346)
Q Consensus 139 sL~~----------------~l---~~~~~~~~~l~~~~~---------~~i------------~~~ia~-~L~~LH~-- 175 (346)
++.. .+ +.......+..+... ... ...+.. .+..++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (239)
T PF01636_consen 81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL 160 (239)
T ss_dssp EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence 7777 11 111011111221110 000 111222 2333331
Q ss_pred --CCCCCceecCCCCCCeEEc-CCCceEEeccCCCc
Q 045453 176 --GFSRPILHRKIRPSRIFLD-EGYIAKLFDFSLSV 208 (346)
Q Consensus 176 --~~~~~iiH~dlkp~NIll~-~~~~~kl~Dfgl~~ 208 (346)
.....++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus 161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred ccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2356799999999999999 66666799998763
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.27 E-value=2.1e-05 Score=66.42 Aligned_cols=135 Identities=16% Similarity=0.186 Sum_probs=91.7
Q ss_pred CcccccccCCCcEEEEEEECCeEEEEEEecCcc----------------CcchHHHHHHHHHHhhhc-----CCCceeeE
Q 045453 60 DARNVIKDGYAYKFYKGFVEDRTVSVMKFNDIL----------------NDGHEDCFNNIIFASKLS-----SHKNVLKL 118 (346)
Q Consensus 60 ~~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~----------------~~~~~~~~~e~~~~~~~~-----~h~niv~l 118 (346)
+....||+|+.-.||.-- ++....||+..... .....+..+|+.....+. .+..|.++
T Consensus 4 ~~~~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 4 SESDLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCCcccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 345689999999999543 44556777766544 123455566665555551 37889999
Q ss_pred cceeecCCcceEEEecccC--C----ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeE
Q 045453 119 TGCCLETRIPVIVFESVKN--R----TLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIF 192 (346)
Q Consensus 119 ~g~~~~~~~~~lv~e~~~~--g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIl 192 (346)
+|+..++-...+|+|.+.+ | ||.+++... .++. .....+.++ ..||- ...|+.+|++|+||+
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-----~~~~-~~~~~L~~f---~~~l~---~~~Iv~~dl~~~NIv 150 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-----GLTE-ELRQALDEF---KRYLL---DHHIVIRDLNPHNIV 150 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-----CccH-HHHHHHHHH---HHHHH---HcCCeecCCCcccEE
Confidence 9999999999999999753 2 688888543 2444 444444444 44555 677999999999999
Q ss_pred EcCCC----ceEEec-cCCC
Q 045453 193 LDEGY----IAKLFD-FSLS 207 (346)
Q Consensus 193 l~~~~----~~kl~D-fgl~ 207 (346)
+..+. .+.|+| ||-.
T Consensus 151 ~~~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 151 VQRRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred EEecCCCceEEEEEeCCCCc
Confidence 96332 466666 5543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.5e-05 Score=76.53 Aligned_cols=160 Identities=16% Similarity=0.080 Sum_probs=96.6
Q ss_pred CCccCCCHHHHHHHh------------cCCCcccccccCCCcEEEEEEE-CCeEEEEEEecCccCcchH-----------
Q 045453 42 NPIRGFTIRELEIAT------------NNFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILNDGHE----------- 97 (346)
Q Consensus 42 ~~~~~~~~~~l~~~~------------~~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~~~~----------- 97 (346)
+.++.++++|+...- ..|+ ..-||.-+.|.||+|++ +|+.||||+-++.......
T Consensus 135 D~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~-~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~ 213 (538)
T KOG1235|consen 135 DQAPPFPWEEAFKIFEEELGAPIEDIFSEFD-EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAK 213 (538)
T ss_pred ccCCCCCHHHHHHHHHHHhCCCHHHHHHhcC-cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHH
Confidence 345567777764332 2232 35689999999999999 8889999986544321100
Q ss_pred --------------------------HHHHHHHH---HhhhcCCCc------eeeEcceeecCCcceEEEecccCCChhh
Q 045453 98 --------------------------DCFNNIIF---ASKLSSHKN------VLKLTGCCLETRIPVIVFESVKNRTLAD 142 (346)
Q Consensus 98 --------------------------~~~~e~~~---~~~~~~h~n------iv~l~g~~~~~~~~~lv~e~~~~gsL~~ 142 (346)
.|.+|... ....+.|-+ |++++-.+. ....|+||||+|..+.+
T Consensus 214 ~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~D 291 (538)
T KOG1235|consen 214 VLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKIND 291 (538)
T ss_pred HHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCC
Confidence 11222221 112224444 444443333 34589999999987777
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcC----CCceEEeccCCCcccCC
Q 045453 143 HIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE----GYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 143 ~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~----~~~~kl~Dfgl~~~~~~ 212 (346)
.-.-.. ..++... ++..+.++. ++.-...|++|+|=.|.||++.. ++.+.+-|||+...+.+
T Consensus 292 l~~i~~---~gi~~~~---i~~~l~~~~--~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 292 LDAIDK---RGISPHD---ILNKLVEAY--LEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHHHH---cCCCHHH---HHHHHHHHH--HHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 643222 1244343 333333322 22222468999999999999984 67899999999876643
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.3e-05 Score=65.21 Aligned_cols=127 Identities=13% Similarity=0.050 Sum_probs=85.4
Q ss_pred cccccccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCcee-eEcceeecCCcceEEEecccCCC
Q 045453 61 ARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVL-KLTGCCLETRIPVIVFESVKNRT 139 (346)
Q Consensus 61 ~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv-~l~g~~~~~~~~~lv~e~~~~gs 139 (346)
....|++|.+|.||+|.+.+..+|+|+-..+ .....+..|..++..+ .-.++. +++.+- ..++.|||+.|.+
T Consensus 26 v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~d--s~r~~l~kEakiLeil-~g~~~~p~vy~yg----~~~i~me~i~G~~ 98 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWRGGEVALKVRRRD--SPRRNLEKEAKILEIL-AGEGVTPEVYFYG----EDFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhcccccEEEEeeccCceEEEEEecCC--cchhhHHHHHHHHHHh-hhcCCCceEEEec----hhhhhhhhhcCcc
Confidence 3567999999999999999999999996644 4556677787777777 544443 343332 2356699998878
Q ss_pred hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCC-CCeEEcCCCceEEeccCCCc
Q 045453 140 LADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRP-SRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 140 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp-~NIll~~~~~~kl~Dfgl~~ 208 (346)
|.+.-... + .+-+..++..-.-|- ..||-|+.|+- ...++..+..+.|+||..|+
T Consensus 99 L~~~~~~~-------~----rk~l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 99 LGKLEIGG-------D----RKHLLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hhhhhhcc-------c----HHHHHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence 87655321 1 122333444433344 77899999864 44444445589999999876
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.14 E-value=4.2e-05 Score=78.78 Aligned_cols=79 Identities=13% Similarity=0.099 Sum_probs=55.6
Q ss_pred ccccccCCCcEEEEEEECC----eEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCce--eeEcceeecC---CcceEE
Q 045453 62 RNVIKDGYAYKFYKGFVED----RTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNV--LKLTGCCLET---RIPVIV 131 (346)
Q Consensus 62 ~~~ig~G~~g~Vy~~~~~~----~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~ni--v~l~g~~~~~---~~~~lv 131 (346)
...++.|.++.+|+....+ ..+++|+...... .....+.+|...+..+..|+++ ++++++|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 4678899999999988743 4677777543321 2234567788888877446665 7788888664 467899
Q ss_pred EecccCCCh
Q 045453 132 FESVKNRTL 140 (346)
Q Consensus 132 ~e~~~~gsL 140 (346)
|||++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999988654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.06 E-value=7.3e-05 Score=64.34 Aligned_cols=153 Identities=14% Similarity=0.114 Sum_probs=95.6
Q ss_pred CCHHHHHHHhcCCCcccccc---cCCCcEEEEEEE-CCeEEEEEEecCccCcchH---------H---------------
Q 045453 47 FTIRELEIATNNFDARNVIK---DGYAYKFYKGFV-EDRTVSVMKFNDILNDGHE---------D--------------- 98 (346)
Q Consensus 47 ~~~~~l~~~~~~f~~~~~ig---~G~~g~Vy~~~~-~~~~vavk~~~~~~~~~~~---------~--------------- 98 (346)
.+.+.|....+...+....| .|--..||+|.. ++..+|+|++......... .
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 55666766666666665554 566678999887 7899999997644221100 0
Q ss_pred HHHHHHHHhhhcC-CCceeeEcceeecCCcceEEEecccCC-ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 045453 99 CFNNIIFASKLSS-HKNVLKLTGCCLETRIPVIVFESVKNR-TLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIG 176 (346)
Q Consensus 99 ~~~e~~~~~~~~~-h~niv~l~g~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~ 176 (346)
..+|+..|.++.. +=.+++.+++. .-.|||||+... .-.-.|..- ++.......+..++++++.-|-.
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv-----~~e~~e~~~~~~~~v~~~~~l~~- 184 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV-----PLELEEAEGLYEDVVEYMRRLYK- 184 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccC-----CcCchhHHHHHHHHHHHHHHHHH-
Confidence 1234444444421 12233333332 347999999543 222223221 22222455666777777777762
Q ss_pred CCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 177 FSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 177 ~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
..++||+||+.=|||+. ++.+.++|||.|....
T Consensus 185 -~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 185 -EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred -hcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 47899999999999999 8899999999886554
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.05 E-value=0.00011 Score=66.30 Aligned_cols=78 Identities=8% Similarity=0.014 Sum_probs=54.7
Q ss_pred cccccccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHHHHHHHhhhcCC--CceeeEcceeec---CCcceEEEecc
Q 045453 61 ARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSH--KNVLKLTGCCLE---TRIPVIVFESV 135 (346)
Q Consensus 61 ~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h--~niv~l~g~~~~---~~~~~lv~e~~ 135 (346)
...-||.|..+.||+....+..+.+|.... ......+..|...+..+..+ -.+++++++|.. .+..+||||++
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQGNPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eeeecCCccceeEEEEEcCCCCEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 345799999999999988666667666432 11234566777777766433 357778887754 35679999999
Q ss_pred cCCCh
Q 045453 136 KNRTL 140 (346)
Q Consensus 136 ~~gsL 140 (346)
+++++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 98765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.00011 Score=63.82 Aligned_cols=141 Identities=17% Similarity=0.172 Sum_probs=79.1
Q ss_pred cccccCCCcEEEEEEEC---CeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccCCC
Q 045453 63 NVIKDGYAYKFYKGFVE---DRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRT 139 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~~---~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~gs 139 (346)
+.|..|-...+|+.... +..+++|........ ......|...+..+..+.-.+++++.+. -.+||||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 45777888999999875 578888876543221 1223356666666633433455554432 248999999877
Q ss_pred hhhh-----------------hhhcCCCC--------CCCCHHHHHHHHH----------------------HHH---HH
Q 045453 140 LADH-----------------IYQNQPHF--------EPLLLSQRLRIAV----------------------HIA---NA 169 (346)
Q Consensus 140 L~~~-----------------l~~~~~~~--------~~l~~~~~~~i~~----------------------~ia---~~ 169 (346)
+... ++...... ....|..+..+.. .+. ..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 6422 11111100 1111222222211 111 11
Q ss_pred HH-HHHh-CCCCCceecCCCCCCeEEcC-CCceEEeccCCCc
Q 045453 170 IA-YLHI-GFSRPILHRKIRPSRIFLDE-GYIAKLFDFSLSV 208 (346)
Q Consensus 170 L~-~LH~-~~~~~iiH~dlkp~NIll~~-~~~~kl~Dfgl~~ 208 (346)
|. .+-. .....++|+|+.+.|||+++ ++.+.++||..|.
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 11 1111 12356899999999999998 5789999998763
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.94 E-value=9.7e-05 Score=66.71 Aligned_cols=144 Identities=14% Similarity=0.172 Sum_probs=83.1
Q ss_pred ccccccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCC-ceeeEccee------ecCCcceEEEec
Q 045453 62 RNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHK-NVLKLTGCC------LETRIPVIVFES 134 (346)
Q Consensus 62 ~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~-niv~l~g~~------~~~~~~~lv~e~ 134 (346)
...|..|....+|+...+++.+++|..... .......|...+..+.++- .+++++... ...+..++|++|
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 456777888999998887778999887642 2233444555555542221 244444321 223456899999
Q ss_pred ccCCChhh----h----------hhhcC-C------CCCCCCHHHHHH----------HHHHHHHHHHHHHh----CCCC
Q 045453 135 VKNRTLAD----H----------IYQNQ-P------HFEPLLLSQRLR----------IAVHIANAIAYLHI----GFSR 179 (346)
Q Consensus 135 ~~~gsL~~----~----------l~~~~-~------~~~~l~~~~~~~----------i~~~ia~~L~~LH~----~~~~ 179 (346)
++|.++.. . ++... . ......|..... ....+...+.++.. ....
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 99876543 0 11000 0 001123332211 11112334444442 1235
Q ss_pred CceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 180 PILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 180 ~iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
+++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 79999999999999998878999998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00015 Score=60.82 Aligned_cols=135 Identities=21% Similarity=0.239 Sum_probs=93.5
Q ss_pred CccCCCHHHHHHHhcCCCcccccccCCC-cEEEEEEECCeEEEEEEecC---ccC------------------cchHHHH
Q 045453 43 PIRGFTIRELEIATNNFDARNVIKDGYA-YKFYKGFVEDRTVSVMKFND---ILN------------------DGHEDCF 100 (346)
Q Consensus 43 ~~~~~~~~~l~~~~~~f~~~~~ig~G~~-g~Vy~~~~~~~~vavk~~~~---~~~------------------~~~~~~~ 100 (346)
..+.|+. .+.+|+....||.|.- |.||++...|+.+|+|.+.. ... .....|.
T Consensus 28 KL~~F~~-----h~~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~ 102 (207)
T PF13095_consen 28 KLEPFTH-----HGDDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFN 102 (207)
T ss_pred CcCCcCC-----CCCcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHH
Confidence 3455665 2378888999999999 99999999999999999332 111 0112356
Q ss_pred HHHHHHhhhc--CCCce--eeEcceeecC------------------CcceEEEecccCCChhhhhhhcCCCCCCCCHHH
Q 045453 101 NNIIFASKLS--SHKNV--LKLTGCCLET------------------RIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQ 158 (346)
Q Consensus 101 ~e~~~~~~~~--~h~ni--v~l~g~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~ 158 (346)
.|.....++- .+.++ |+.+||..-. ....||.||.+... .++
T Consensus 103 ~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~--- 166 (207)
T PF13095_consen 103 CECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQ--- 166 (207)
T ss_pred HHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccc---
Confidence 6777766662 34456 8999987322 11256777776533 111
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCC
Q 045453 159 RLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS 207 (346)
Q Consensus 159 ~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~ 207 (346)
..-+.+|.+-+..+| ..+|+-+|+++.|.. .-||+|||.+
T Consensus 167 -~~~~~~~~~dl~~~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 167 -IRDIPQMLRDLKILH---KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred -hhHHHHHHHHHHHHH---HCCeeeccCcccccc-----CCEEEecccC
Confidence 223456777788999 999999999999988 4589999864
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00023 Score=62.85 Aligned_cols=139 Identities=11% Similarity=0.023 Sum_probs=76.8
Q ss_pred cccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccCCChhhh-
Q 045453 65 IKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADH- 143 (346)
Q Consensus 65 ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~- 143 (346)
+..|-.+.+|+...+++.+++|...............|...+..+..+.-..++++.+. -++||||++|.++...
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~~ 79 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLDQ 79 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccccc
Confidence 55688889999988888888887543322211134556666666633322233444332 3699999998765431
Q ss_pred ----------------hhhcCCCCCCCCHHHH-HHHHHH---------HHHHHHHHHh-----CCCCCceecCCCCCCeE
Q 045453 144 ----------------IYQNQPHFEPLLLSQR-LRIAVH---------IANAIAYLHI-----GFSRPILHRKIRPSRIF 192 (346)
Q Consensus 144 ----------------l~~~~~~~~~l~~~~~-~~i~~~---------ia~~L~~LH~-----~~~~~iiH~dlkp~NIl 192 (346)
|+.......+++.... ..+..+ +..-+..+-. .....++|+|+.|.||+
T Consensus 80 ~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil 159 (256)
T TIGR02721 80 FVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLV 159 (256)
T ss_pred ccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEE
Confidence 1111111122222211 111111 1111222211 11345899999999999
Q ss_pred EcCCCceEEeccCCCc
Q 045453 193 LDEGYIAKLFDFSLSV 208 (346)
Q Consensus 193 l~~~~~~kl~Dfgl~~ 208 (346)
+++++ +.|+||..+.
T Consensus 160 ~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 160 VTPQG-LKLIDWEYAS 174 (256)
T ss_pred EeCCC-CEEEeccccC
Confidence 99887 7899998763
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00019 Score=62.50 Aligned_cols=31 Identities=16% Similarity=0.435 Sum_probs=26.4
Q ss_pred CCCceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 178 SRPILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 178 ~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
...++|+|+.+.|||++.+...-|+||+.+.
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred CceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 4458999999999999987767799999763
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.001 Score=60.68 Aligned_cols=159 Identities=13% Similarity=0.139 Sum_probs=81.5
Q ss_pred CCHHHHHHHhcCCCc-----ccccccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHHHHHHHhhhc----CCCceee
Q 045453 47 FTIRELEIATNNFDA-----RNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLS----SHKNVLK 117 (346)
Q Consensus 47 ~~~~~l~~~~~~f~~-----~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~----~h~niv~ 117 (346)
++.+++...-..|.. .+.|+.|....+|+...+++.+++|++. ... ......+...+..+. .-|.++.
T Consensus 7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g~~vLK~~~-~~~--~~~l~~~~~~l~~L~~~glpvP~~i~ 83 (319)
T PRK05231 7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQGEYVLTLFE-RLT--AEDLPFFLGLMQHLAARGVPVPAPVA 83 (319)
T ss_pred CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCCcEEEEEec-cCC--hHHhHHHHHHHHHHHHCCCCCCccee
Confidence 344444444344433 2456677788999998877789999875 211 122222333332321 2333332
Q ss_pred Ec-c--eeecCCcceEEEecccCCChhh-----------hh---hhcCCC-------CCCCCH-HHHHH-----------
Q 045453 118 LT-G--CCLETRIPVIVFESVKNRTLAD-----------HI---YQNQPH-------FEPLLL-SQRLR----------- 161 (346)
Q Consensus 118 l~-g--~~~~~~~~~lv~e~~~~gsL~~-----------~l---~~~~~~-------~~~l~~-~~~~~----------- 161 (346)
-. | +....+..+++++|++|..+.. .| +..... ...+.| .....
T Consensus 84 ~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (319)
T PRK05231 84 RRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQA 163 (319)
T ss_pred CCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHH
Confidence 11 1 1122455789999999875421 11 110000 011212 11111
Q ss_pred -HHHH-HHHHHHHHHh----CCCCCceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 162 -IAVH-IANAIAYLHI----GFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 162 -i~~~-ia~~L~~LH~----~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
.+.+ +...+..+.. .-..+++|+|+.|.|||++.+...-|+||+.+.
T Consensus 164 ~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 164 ALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 1111 1112222221 024589999999999999977667899999764
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00065 Score=61.75 Aligned_cols=145 Identities=12% Similarity=0.166 Sum_probs=79.8
Q ss_pred ccccccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHHHHHHHhhhcC-CCceeeEccee------ecCCcceEEEec
Q 045453 62 RNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSS-HKNVLKLTGCC------LETRIPVIVFES 134 (346)
Q Consensus 62 ~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~-h~niv~l~g~~------~~~~~~~lv~e~ 134 (346)
...++.|....+|+...+++.+++|....... ......+...+..+.. .-.+++++... ...+..+++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVGRYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred ccccCCccccceEEEEeCCCcEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 34567777789999887677888887654211 2233334444444311 11234443322 123456899999
Q ss_pred ccCCChhhh--------------hhhcCCC---C-----CCCCHHHHHH------------HHHHHHHHHHHHHh----C
Q 045453 135 VKNRTLADH--------------IYQNQPH---F-----EPLLLSQRLR------------IAVHIANAIAYLHI----G 176 (346)
Q Consensus 135 ~~~gsL~~~--------------l~~~~~~---~-----~~l~~~~~~~------------i~~~ia~~L~~LH~----~ 176 (346)
++|.++... ++..... . ..-.|..... ....+...++++.. .
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 988654211 1110000 0 0112221110 01123334555532 2
Q ss_pred CCCCceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 177 FSRPILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 177 ~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
...+++|+|+.+.||+++.++...|+||+.+.
T Consensus 185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 24789999999999999999877899999763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00039 Score=62.96 Aligned_cols=141 Identities=18% Similarity=0.169 Sum_probs=80.2
Q ss_pred cccccCCCcEEEEEEEC--------CeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEec
Q 045453 63 NVIKDGYAYKFYKGFVE--------DRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFES 134 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~~--------~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~ 134 (346)
+.+..|-...+|+.... ++.+++|...... ........|...+..+..+.-..++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 34566777899998874 3788888865443 2223445565565555333323455555532 368999
Q ss_pred ccCCChhhh-h----------------hhcCCCC-------CCCCHHHHHHH--------------------------HH
Q 045453 135 VKNRTLADH-I----------------YQNQPHF-------EPLLLSQRLRI--------------------------AV 164 (346)
Q Consensus 135 ~~~gsL~~~-l----------------~~~~~~~-------~~l~~~~~~~i--------------------------~~ 164 (346)
++|.++... + +...... .+.-|.....+ ..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 998776532 1 1111100 01112111111 11
Q ss_pred HHHHHHHHHHh------CCCCCceecCCCCCCeEEcCC----CceEEeccCCCc
Q 045453 165 HIANAIAYLHI------GFSRPILHRKIRPSRIFLDEG----YIAKLFDFSLSV 208 (346)
Q Consensus 165 ~ia~~L~~LH~------~~~~~iiH~dlkp~NIll~~~----~~~kl~Dfgl~~ 208 (346)
.+..-+.+|-. .....++|+|+.|.|||++++ +.+.++||..|.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22222333431 235678999999999999985 789999999763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.0025 Score=59.64 Aligned_cols=75 Identities=13% Similarity=0.035 Sum_probs=49.8
Q ss_pred cccccCCCcEEEEEEECC--eEEEEEEecCcc-------CcchHHHHHHHHHHhhhcCC--CceeeEcceeecCCcceEE
Q 045453 63 NVIKDGYAYKFYKGFVED--RTVSVMKFNDIL-------NDGHEDCFNNIIFASKLSSH--KNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~~~--~~vavk~~~~~~-------~~~~~~~~~e~~~~~~~~~h--~niv~l~g~~~~~~~~~lv 131 (346)
+.||.|.+..||++...+ +.++||.-.... .........|...+..+..+ .++++++.+. .+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEEE
Confidence 568999999999999944 489999843211 11334555666666654332 4567777663 3557899
Q ss_pred EecccCCC
Q 045453 132 FESVKNRT 139 (346)
Q Consensus 132 ~e~~~~gs 139 (346)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998743
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00033 Score=71.85 Aligned_cols=194 Identities=20% Similarity=0.200 Sum_probs=129.4
Q ss_pred HHHHHHHhhhcCCCceeeEcceeecCCc----ceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 045453 100 FNNIIFASKLSSHKNVLKLTGCCLETRI----PVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHI 175 (346)
Q Consensus 100 ~~e~~~~~~~~~h~niv~l~g~~~~~~~----~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~ 175 (346)
..|...+.+. .|+|++.++.+-.+... ..+..+++..-++...+..- ...+..+.+.+..++.+||+|+|
T Consensus 230 E~e~~~l~k~-~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v----~~i~~~~~r~~~~~~~~GL~~~h- 303 (1351)
T KOG1035|consen 230 EIELESLSKI-AHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV----GSIPLETLRILHQKLLEGLAYLH- 303 (1351)
T ss_pred HHHHHHHHhh-ccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc----cccCHHHHHHHHHHHhhhHHHHH-
Confidence 3455556666 99999999988765432 23455777777777777554 35788888999999999999999
Q ss_pred CCCCCceecCCCCC---CeEEcCCCceEEe--ccCCCcccCCCCceeeccccccCCcCCccccccCCCCc--ccchHHHH
Q 045453 176 GFSRPILHRKIRPS---RIFLDEGYIAKLF--DFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNE--KCDVFSFG 248 (346)
Q Consensus 176 ~~~~~iiH~dlkp~---NIll~~~~~~kl~--Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~Dv~s~G 248 (346)
+....|.-+..+ +--.+..+....+ ||+.+........ .....-+..+.+||......+.. ..|+|.+|
T Consensus 304 --~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~--~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 304 --SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK--SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred --HhccceeEEecccccccccCccceeecchhhhcccccCCCccc--chhhcCccccccccccccccchhhhhhHHHHHH
Confidence 555555555444 4455666677776 8887766543332 12223445677888777655544 47999999
Q ss_pred HHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCC
Q 045453 249 MLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDR 328 (346)
Q Consensus 249 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R 328 (346)
..+..+..|..+-...... ..+++. .....+.+....|+..++++|
T Consensus 380 ll~~~~~~~~~i~~~~~~~----------------------~~~l~~------------~~~~~~~d~~~~~~~~~~~~R 425 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSAVP----------------------VSLLDV------------LSTSELLDALPKCLDEDSEER 425 (1351)
T ss_pred HHHhhhhhcCcccccccch----------------------hhhhcc------------ccchhhhhhhhhhcchhhhhc
Confidence 9999998877653211110 001110 111146778889999999999
Q ss_pred CCHHHHHHH
Q 045453 329 PTTVDVAKR 337 (346)
Q Consensus 329 Ps~~ev~~~ 337 (346)
+++.+++..
T Consensus 426 l~~~~ll~~ 434 (1351)
T KOG1035|consen 426 LSALELLTH 434 (1351)
T ss_pred cchhhhhhc
Confidence 999998763
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.00038 Score=62.25 Aligned_cols=149 Identities=15% Similarity=0.069 Sum_probs=97.0
Q ss_pred CCCHHHHHHHhcC---CCcccccccCCCcEEEEEEE-CCeEEEEEEecCcc-------------------C---cchHHH
Q 045453 46 GFTIRELEIATNN---FDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDIL-------------------N---DGHEDC 99 (346)
Q Consensus 46 ~~~~~~l~~~~~~---f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~-------------------~---~~~~~~ 99 (346)
.+.+-.|+...+. ++..+.||-|-=+.||.+.+ +|.+.++|.-.-.. . -..-..
T Consensus 78 GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa 157 (465)
T KOG2268|consen 78 GYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAA 157 (465)
T ss_pred cchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHH
Confidence 3444445444432 45678999999999999999 68888887421100 0 012235
Q ss_pred HHHHHHHhhhcCCCc-eeeEcceeecCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 045453 100 FNNIIFASKLSSHKN-VLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFS 178 (346)
Q Consensus 100 ~~e~~~~~~~~~h~n-iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~ 178 (346)
.+|+..+..+-.|.. +++.+++ +..++|||++.+-.|.+.-+- .+.+++..-+.++.- -|- .
T Consensus 158 ~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v-------~d~~~ly~~lm~~Iv---~la---~ 220 (465)
T KOG2268|consen 158 TKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHV-------EDPPTLYDDLMGLIV---RLA---N 220 (465)
T ss_pred HHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeec-------CChHHHHHHHHHHHH---HHH---H
Confidence 677777777744433 3333433 345899999988777664322 223344333333333 344 7
Q ss_pred CCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 179 RPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 179 ~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
+|+||+|..-=||++++++.++++||-.+....
T Consensus 221 ~GlIHgDFNEFNimv~dd~~i~vIDFPQmvS~s 253 (465)
T KOG2268|consen 221 HGLIHGDFNEFNIMVKDDDKIVVIDFPQMVSTS 253 (465)
T ss_pred cCceecccchheeEEecCCCEEEeechHhhccC
Confidence 899999999999999999999999998654443
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0054 Score=55.51 Aligned_cols=138 Identities=17% Similarity=0.192 Sum_probs=80.7
Q ss_pred ccccccCCCcEEEEEEECCeEEEEEEecC-c-cCcchHHHHHHHHHHhhhcC-CCceeeEcceeecCC--cceEEEeccc
Q 045453 62 RNVIKDGYAYKFYKGFVEDRTVSVMKFND-I-LNDGHEDCFNNIIFASKLSS-HKNVLKLTGCCLETR--IPVIVFESVK 136 (346)
Q Consensus 62 ~~~ig~G~~g~Vy~~~~~~~~vavk~~~~-~-~~~~~~~~~~e~~~~~~~~~-h~niv~l~g~~~~~~--~~~lv~e~~~ 136 (346)
.+.+..|....+|.....+++.++. ... . .........+|...+..+.. --=....+++|.++. ..+.||+|++
T Consensus 30 v~~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve 108 (321)
T COG3173 30 VEEISGGWSNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE 108 (321)
T ss_pred eeeccCCcccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec
Confidence 3445455556666666667778877 331 1 12233344555555555522 112445677787766 6799999999
Q ss_pred CCChhhhhhhcCCCCCCCCHHHHHHHH-HHHHHHHH--------------------------------------------
Q 045453 137 NRTLADHIYQNQPHFEPLLLSQRLRIA-VHIANAIA-------------------------------------------- 171 (346)
Q Consensus 137 ~gsL~~~l~~~~~~~~~l~~~~~~~i~-~~ia~~L~-------------------------------------------- 171 (346)
|..+.+.+.... .+ ..++ ..++..|+
T Consensus 109 Ge~~~~~~~~~~-----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~ 179 (321)
T COG3173 109 GEVVWSALPPES-----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL 179 (321)
T ss_pred ceeccCcCCccc-----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence 854433221110 00 0111 13333333
Q ss_pred ------HHHhC-----CCCCceecCCCCCCeEEcCCCceEEeccCCCcc
Q 045453 172 ------YLHIG-----FSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVS 209 (346)
Q Consensus 172 ------~LH~~-----~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~ 209 (346)
||+.. ....++|+|+.+.|++++.+.-.=|.||+++..
T Consensus 180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 33321 124689999999999999998899999998854
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0024 Score=57.30 Aligned_cols=142 Identities=13% Similarity=0.027 Sum_probs=71.2
Q ss_pred cccccccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHHHHHHHhhhc--CCCceeeEcceeecCCcceEEEecccCC
Q 045453 61 ARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLS--SHKNVLKLTGCCLETRIPVIVFESVKNR 138 (346)
Q Consensus 61 ~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~--~h~niv~l~g~~~~~~~~~lv~e~~~~g 138 (346)
....++.|....+|+...+++.+.||.-.... ...+..|..-+..+. ..-.+++.+++....+..+||+||++.+
T Consensus 21 ~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~---~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLDTDGGSYFVKVNSESG---RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEEE--SSSSEEEEEETTS-EEEEEEEEGGG---CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eeEecCCCChhheEEEECCCccEEEEecChhh---HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 44668889999999999888999999876332 233445555555441 4556888888887777789999999876
Q ss_pred --C------hhh---hhhh-cCC-----------------CCCCCCHHHH-----HHHH--------------HHHHHHH
Q 045453 139 --T------LAD---HIYQ-NQP-----------------HFEPLLLSQR-----LRIA--------------VHIANAI 170 (346)
Q Consensus 139 --s------L~~---~l~~-~~~-----------------~~~~l~~~~~-----~~i~--------------~~ia~~L 170 (346)
+ |-. .|+. ... ....-+|.+- +.-. ..+...+
T Consensus 98 ~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~~~~ 177 (288)
T PF03881_consen 98 SPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLVERL 177 (288)
T ss_dssp ---CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHHHHH
Confidence 1 111 1222 110 0011334321 1111 1222222
Q ss_pred HH-HHh-CCCCCceecCCCCCCeEEcCCCceEEeccC
Q 045453 171 AY-LHI-GFSRPILHRKIRPSRIFLDEGYIAKLFDFS 205 (346)
Q Consensus 171 ~~-LH~-~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg 205 (346)
.. |+. ...+..+|+||-+.|++.+.+|.+.|.|-.
T Consensus 178 ~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa 214 (288)
T PF03881_consen 178 PSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPA 214 (288)
T ss_dssp HHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred HHHhcCCCCCceeeEcCccccceeecCCCCceeeccc
Confidence 21 221 123468999999999999999989999865
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0058 Score=57.16 Aligned_cols=81 Identities=9% Similarity=0.030 Sum_probs=52.9
Q ss_pred ccccccCCCcEEEEEEECCeEEEEEEecCccC-------cchHHHHHHHHHHhhhc--CCCceeeEcceeecCCcceEEE
Q 045453 62 RNVIKDGYAYKFYKGFVEDRTVSVMKFNDILN-------DGHEDCFNNIIFASKLS--SHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 62 ~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~-------~~~~~~~~e~~~~~~~~--~h~niv~l~g~~~~~~~~~lv~ 132 (346)
.+.||.|....||+....++.++||+-..... ....+...|...|.... ...++++++.+|.+ ..+++|
T Consensus 37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlvM 114 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIGM 114 (418)
T ss_pred EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEEE
Confidence 45789999999999988777899988542111 12333444455554442 22478888888873 458899
Q ss_pred ecccC--CChhhhh
Q 045453 133 ESVKN--RTLADHI 144 (346)
Q Consensus 133 e~~~~--gsL~~~l 144 (346)
|++++ ..+.+.+
T Consensus 115 E~L~~~~~ilr~~L 128 (418)
T PLN02756 115 RYLEPPHIILRKGL 128 (418)
T ss_pred eecCCcceehhhhh
Confidence 99976 2444433
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0025 Score=54.07 Aligned_cols=152 Identities=14% Similarity=0.113 Sum_probs=94.5
Q ss_pred CCCcEEEEEEECCeEEEEEEecCccCc-chHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccCCChhhhhhh
Q 045453 68 GYAYKFYKGFVEDRTVSVMKFNDILND-GHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQ 146 (346)
Q Consensus 68 G~~g~Vy~~~~~~~~vavk~~~~~~~~-~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~ 146 (346)
|+-++.-.+.-.-++..+|++...... ...-++.+..++.++ -.|+++..- .+-..-++.|.|--...
T Consensus 73 ~gNsTl~~~kt~iG~L~lKKi~slp~~~~~~~y~nky~v~Arm---hGilrL~ND--n~~~yGvIlE~Cy~~~i------ 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKIGPLFLKKIRSLPCCINDALYFNKYRVFARM---HGILRLKND--NNYKYGVILERCYKIKI------ 141 (308)
T ss_pred CCceEEEEeccccchhhhhhccCCCcccchhhhhhhhhHHHHh---hheeEeecC--CCceeEEEEeeccCccc------
Confidence 455566666555577788887755433 344556676776665 457777722 33345688888732100
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCceeeccccccCC
Q 045453 147 NQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMG 226 (346)
Q Consensus 147 ~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~ 226 (346)
...- ++.--.++|.-+|++ +.+.+|+|..|+||+.|+.|-+||.|-+.- +... .-
T Consensus 142 ----------~~~N-~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~L--l~~~-----------V~ 196 (308)
T PF07387_consen 142 ----------NFSN-FITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCL--LENQ-----------VN 196 (308)
T ss_pred ----------chhH-HHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhh--hhhe-----------ee
Confidence 0111 222224678888965 678999999999999999999999998742 1111 11
Q ss_pred cCCccccccCCCCcccchHHHHHHHHHHHhCC
Q 045453 227 FLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQ 258 (346)
Q Consensus 227 y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~ 258 (346)
|.-- .....|+++.+-+|=.-++++....
T Consensus 197 ~vN~---~Y~~lT~~aE~~~fv~s~l~~v~~~ 225 (308)
T PF07387_consen 197 MVNI---EYESLTQEAEVKVFVKSCLKLVEKQ 225 (308)
T ss_pred EEee---eccccChHHHHHHHHHHHHHHHHHH
Confidence 1111 1234577788888888888877643
|
The function of this family is unknown. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0085 Score=55.37 Aligned_cols=141 Identities=17% Similarity=0.102 Sum_probs=79.7
Q ss_pred cccccCCCcEEEEEEEC------CeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEeccc
Q 045453 63 NVIKDGYAYKFYKGFVE------DRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVK 136 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~~------~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~ 136 (346)
..+..|-...+|+.... +..++++........ .-....|...+..+..+.--.++++++..+ .|++|++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~-~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVEL-FFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCe-eechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 34556888999998762 257888876554322 222355666666664443344556655332 5899998
Q ss_pred CCChhhh-----------------hhhcCCCC--CCCCHHHHHHHHHHH-----------------HHHHHHH----Hh-
Q 045453 137 NRTLADH-----------------IYQNQPHF--EPLLLSQRLRIAVHI-----------------ANAIAYL----HI- 175 (346)
Q Consensus 137 ~gsL~~~-----------------l~~~~~~~--~~l~~~~~~~i~~~i-----------------a~~L~~L----H~- 175 (346)
+.+|... ++...... .+..|.+..++..++ ...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7666421 11111111 122244333333211 1112222 21
Q ss_pred CCCCCceecCCCCCCeEEcC-CCceEEeccCCCc
Q 045453 176 GFSRPILHRKIRPSRIFLDE-GYIAKLFDFSLSV 208 (346)
Q Consensus 176 ~~~~~iiH~dlkp~NIll~~-~~~~kl~Dfgl~~ 208 (346)
.....++|+|+++.|||+++ ++.+.++||..+.
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 12446899999999999986 5789999998763
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.04 E-value=9.9e-05 Score=77.43 Aligned_cols=150 Identities=12% Similarity=-0.045 Sum_probs=108.9
Q ss_pred CCCceeeEcceeec--CCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCCCCceecCC
Q 045453 111 SHKNVLKLTGCCLE--TRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHI--GFSRPILHRKI 186 (346)
Q Consensus 111 ~h~niv~l~g~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~--~~~~~iiH~dl 186 (346)
.|+++.....-... ..+.+.+++|+.+|.+.+.|-.+-...+++...-......+...+..-.|+ +-+.-.+|+++
T Consensus 1287 ~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~L 1366 (2724)
T KOG1826|consen 1287 KHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSL 1366 (2724)
T ss_pred hceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhh
Confidence 78888776554432 345689999999999999987665443444444333333333455555443 22445799999
Q ss_pred CCCCeEEcCCCceEEeccCCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCC
Q 045453 187 RPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIF 261 (346)
Q Consensus 187 kp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~ 261 (346)
|+-|.++..+..+|++++|+.+ +..+.........+++-|++|+......++.++|+|..|+-+|+...|..+|
T Consensus 1367 kf~lpmIVtny~v~~gk~gLdK-Iknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1367 KFTLPMIVTNYNVKLGKGGLDK-IKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred hhhccceecCCccccccccccc-ccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 9999999999999999999987 2223333344556777889999998889999999999999999998888776
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.013 Score=53.82 Aligned_cols=73 Identities=12% Similarity=0.082 Sum_probs=44.2
Q ss_pred ccccCCCcEEEEEEECC--eEEEEEEecCc-------cCcchHHHHHHHHHHhhhcC-CC-ceeeEcceeecCCcceEEE
Q 045453 64 VIKDGYAYKFYKGFVED--RTVSVMKFNDI-------LNDGHEDCFNNIIFASKLSS-HK-NVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 64 ~ig~G~~g~Vy~~~~~~--~~vavk~~~~~-------~~~~~~~~~~e~~~~~~~~~-h~-niv~l~g~~~~~~~~~lv~ 132 (346)
.||.|....||++...+ +.|+||.-... -.-...+..-|...+..... -| .+++++.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 47999999999999844 58999873311 12223344455555544422 24 34445443 344557999
Q ss_pred ecccCC
Q 045453 133 ESVKNR 138 (346)
Q Consensus 133 e~~~~g 138 (346)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 999654
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.0099 Score=54.62 Aligned_cols=140 Identities=19% Similarity=0.147 Sum_probs=76.1
Q ss_pred cccccCCCcEEEEEEECC-----eEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccC
Q 045453 63 NVIKDGYAYKFYKGFVED-----RTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKN 137 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~~~-----~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~ 137 (346)
+.|..|=...+|+....+ ..++++....... ..-...+|...+..+..+.--+++++++. ++ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 345557788999987633 2788887654432 22223455566655533333345565553 22 58999977
Q ss_pred CChhhh-----------------hhhcCCCC--CCCCHHHHHHHHHHH----------------------HHHHHHHHh-
Q 045453 138 RTLADH-----------------IYQNQPHF--EPLLLSQRLRIAVHI----------------------ANAIAYLHI- 175 (346)
Q Consensus 138 gsL~~~-----------------l~~~~~~~--~~l~~~~~~~i~~~i----------------------a~~L~~LH~- 175 (346)
.+|... ++...... .+-.|..+.++..++ ..-+..+..
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 655321 11111111 112344433333222 111111111
Q ss_pred ----CCCCCceecCCCCCCeEEcC-CCceEEeccCCC
Q 045453 176 ----GFSRPILHRKIRPSRIFLDE-GYIAKLFDFSLS 207 (346)
Q Consensus 176 ----~~~~~iiH~dlkp~NIll~~-~~~~kl~Dfgl~ 207 (346)
....-.+|.|+.+.|||+++ ++.++++||..|
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYa 211 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYG 211 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEccccc
Confidence 11234799999999999974 578999999876
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.02 Score=51.94 Aligned_cols=29 Identities=21% Similarity=0.308 Sum_probs=25.2
Q ss_pred CCCceecCCCCCCeEEcCCCceEEeccCCC
Q 045453 178 SRPILHRKIRPSRIFLDEGYIAKLFDFSLS 207 (346)
Q Consensus 178 ~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~ 207 (346)
..+++|+|+.+.||+++. +.+.|+||+.+
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYC 214 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECccc
Confidence 467899999999999998 56789999965
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.012 Score=53.39 Aligned_cols=31 Identities=19% Similarity=0.285 Sum_probs=28.0
Q ss_pred CCCceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 178 SRPILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 178 ~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
..+++|+|+.++|+|++.++.+-++||..+.
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 4579999999999999999999999998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.025 Score=50.54 Aligned_cols=30 Identities=23% Similarity=0.485 Sum_probs=24.8
Q ss_pred CCceecCCCCCCeEEcCCCc-eEEeccCCCc
Q 045453 179 RPILHRKIRPSRIFLDEGYI-AKLFDFSLSV 208 (346)
Q Consensus 179 ~~iiH~dlkp~NIll~~~~~-~kl~Dfgl~~ 208 (346)
..++|+|+.|.|||+++++. .-|+||+.+.
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 35899999999999997554 5699999764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.0026 Score=60.29 Aligned_cols=53 Identities=13% Similarity=0.205 Sum_probs=41.0
Q ss_pred cchHHHHHHHHHHhhhcCCCceeeEcceeecC-CcceEEEecccCCChhhhhhhcC
Q 045453 94 DGHEDCFNNIIFASKLSSHKNVLKLTGCCLET-RIPVIVFESVKNRTLADHIYQNQ 148 (346)
Q Consensus 94 ~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~-~~~~lv~e~~~~gsL~~~l~~~~ 148 (346)
....+..-.+..+..+ .|+|+-..+.+-... ....+|+|++ +.||++.+..+.
T Consensus 24 ~~s~~ilgr~~~lktl-~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~ 77 (725)
T KOG1093|consen 24 PNSIQILGRFQYLKSL-QHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN 77 (725)
T ss_pred CcHHHHhhhhHHHHhh-cCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc
Confidence 4556778888889998 999999988876442 3467899999 559999887653
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.018 Score=49.17 Aligned_cols=30 Identities=23% Similarity=0.416 Sum_probs=21.3
Q ss_pred CCceecCCCCCCeEE-cCCCceEEeccCCCc
Q 045453 179 RPILHRKIRPSRIFL-DEGYIAKLFDFSLSV 208 (346)
Q Consensus 179 ~~iiH~dlkp~NIll-~~~~~~kl~Dfgl~~ 208 (346)
..++|+|+.|.|||+ +.++.++++||..|.
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 467999999999999 889999999998763
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.055 Score=46.41 Aligned_cols=77 Identities=12% Similarity=-0.039 Sum_probs=52.6
Q ss_pred ccccccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHHHHHHHhhhc--CCCceeeEcceeecCCcceEEEecccCCC
Q 045453 62 RNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLS--SHKNVLKLTGCCLETRIPVIVFESVKNRT 139 (346)
Q Consensus 62 ~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~--~h~niv~l~g~~~~~~~~~lv~e~~~~gs 139 (346)
.+.+.-|-.-..|...+...++-||.-.... ..-+..|..-+..+. +.-++.+++.+-.+.++.+||+||++-|.
T Consensus 21 r~~v~gG~inea~~v~dg~~~~FvK~n~~~~---~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~ 97 (286)
T COG3001 21 REEVSGGDINEAWRLRDGTDPFFVKCNQREQ---LSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP 97 (286)
T ss_pred ccccCCccccceeEeecCCcceEEEecchhh---HHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence 3456666667778888888899998844322 233444444444332 44567788888888899999999999876
Q ss_pred hh
Q 045453 140 LA 141 (346)
Q Consensus 140 L~ 141 (346)
+.
T Consensus 98 ~d 99 (286)
T COG3001 98 LD 99 (286)
T ss_pred CC
Confidence 65
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.99 E-value=0.14 Score=46.89 Aligned_cols=142 Identities=14% Similarity=0.177 Sum_probs=78.7
Q ss_pred ccccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCc-----eeeEcceee--cCC--cceEEEec
Q 045453 64 VIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKN-----VLKLTGCCL--ETR--IPVIVFES 134 (346)
Q Consensus 64 ~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~n-----iv~l~g~~~--~~~--~~~lv~e~ 134 (346)
.|.+ .-..+|+...+++..++|..... ....+...|...+..+..+.- +..+-|-.. -.. ..+-+++|
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRYILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred cccc-ccCceEEEEecCCCeEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 3444 56778999997767788887654 334444555555555532211 222222111 122 56789999
Q ss_pred ccCCChhh-h--------------hhh--------cCCCCCCCCHHH-------------HHHHHHHHHHHHHHHHh---
Q 045453 135 VKNRTLAD-H--------------IYQ--------NQPHFEPLLLSQ-------------RLRIAVHIANAIAYLHI--- 175 (346)
Q Consensus 135 ~~~gsL~~-~--------------l~~--------~~~~~~~l~~~~-------------~~~i~~~ia~~L~~LH~--- 175 (346)
++|..+.. . |+. +........|.. ......++...+..+..
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 99987773 1 110 001111233430 01122334444444442
Q ss_pred -CC-CCC--ceecCCCCCCeEEcCCC-ceEEeccCCCc
Q 045453 176 -GF-SRP--ILHRKIRPSRIFLDEGY-IAKLFDFSLSV 208 (346)
Q Consensus 176 -~~-~~~--iiH~dlkp~NIll~~~~-~~kl~Dfgl~~ 208 (346)
.- ..+ +||+|+.|.||+++.+. .+.++||+-+.
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 11 223 99999999999999887 48999999763
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.065 Score=50.05 Aligned_cols=74 Identities=15% Similarity=0.070 Sum_probs=46.6
Q ss_pred ccccccCCCcEEEEEEEC--CeEEEEEEecCc------cCcchHHHHHHHHHHhhhcC-CC-ceeeEcceeecCCcceEE
Q 045453 62 RNVIKDGYAYKFYKGFVE--DRTVSVMKFNDI------LNDGHEDCFNNIIFASKLSS-HK-NVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 62 ~~~ig~G~~g~Vy~~~~~--~~~vavk~~~~~------~~~~~~~~~~e~~~~~~~~~-h~-niv~l~g~~~~~~~~~lv 131 (346)
...||.|.-..||++.+. ++.|+||.-... -.-...+..-|...|..... -| .+++++.+ +.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 357899999999999984 678999873321 12233445555555555422 23 45555544 34455789
Q ss_pred EecccC
Q 045453 132 FESVKN 137 (346)
Q Consensus 132 ~e~~~~ 137 (346)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999965
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.62 E-value=1.1 Score=41.15 Aligned_cols=97 Identities=15% Similarity=0.157 Sum_probs=51.1
Q ss_pred CccCCCHHHHHHHhcCCCcc---c-ccccCCCcEEEEEEE-CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCC-cee
Q 045453 43 PIRGFTIRELEIATNNFDAR---N-VIKDGYAYKFYKGFV-EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHK-NVL 116 (346)
Q Consensus 43 ~~~~~~~~~l~~~~~~f~~~---~-~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~-niv 116 (346)
+...++.+.+..+...+... + ..-.++-..||+... ++..+++|...... ....+...|...+..+..+. .++
T Consensus 7 ~~~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~ 85 (325)
T PRK11768 7 PFQTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVV 85 (325)
T ss_pred CCCCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCC
Confidence 44556667666665554321 1 222355678999888 46678888765322 23344445555554442211 122
Q ss_pred eE---cc--eeecCCcceEEEecccCCCh
Q 045453 117 KL---TG--CCLETRIPVIVFESVKNRTL 140 (346)
Q Consensus 117 ~l---~g--~~~~~~~~~lv~e~~~~gsL 140 (346)
.. -| ...-++..+.|+++++|...
T Consensus 86 ~p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 86 APLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred CCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 21 12 11223456789999987643
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.19 Score=53.19 Aligned_cols=31 Identities=23% Similarity=0.365 Sum_probs=25.8
Q ss_pred CCCceecCCCCCCeEEcCCC--ceE-EeccCCCc
Q 045453 178 SRPILHRKIRPSRIFLDEGY--IAK-LFDFSLSV 208 (346)
Q Consensus 178 ~~~iiH~dlkp~NIll~~~~--~~k-l~Dfgl~~ 208 (346)
...+||+|+.+.|||++.++ .+. |+|||-+.
T Consensus 202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred CcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 46799999999999999875 444 99999764
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.50 E-value=0.13 Score=48.26 Aligned_cols=74 Identities=19% Similarity=0.160 Sum_probs=43.9
Q ss_pred cccccCCCcEEEEEEECC---eE-----EEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEec
Q 045453 63 NVIKDGYAYKFYKGFVED---RT-----VSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFES 134 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~~~---~~-----vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~ 134 (346)
..|..|-.+.+|++...+ .. |++.... ......-...+|..++..+..+.--.++++.+.. ++|+||
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g-~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef 130 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS-TYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW 130 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEecc-CCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence 345568889999997632 12 3333322 2222222335567777777455555666666642 599999
Q ss_pred ccCCChh
Q 045453 135 VKNRTLA 141 (346)
Q Consensus 135 ~~~gsL~ 141 (346)
++|.+|.
T Consensus 131 IeGr~l~ 137 (383)
T PTZ00384 131 VEGNTMG 137 (383)
T ss_pred eccccCC
Confidence 9987765
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.66 E-value=0.15 Score=46.76 Aligned_cols=85 Identities=18% Similarity=0.192 Sum_probs=59.1
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCceeeccccccCCcCCccc
Q 045453 153 PLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEY 232 (346)
Q Consensus 153 ~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~ 232 (346)
.-.|.+...+..+-+.-++-+.. ..+.-|||+.-.|||++ +|++.|+||-+++.-..+.. ......--|-.
T Consensus 317 ~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfklsRl~~~q~~------isy~rldhp~l 387 (488)
T COG5072 317 ADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKLSRLSYSQGI------ISYNRLDHPDL 387 (488)
T ss_pred cccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeeeeecccCCce------eeccccCchhh
Confidence 35688888888888887777774 56789999999999999 99999999999985322221 11112223444
Q ss_pred cccCCCCcccchHHH
Q 045453 233 INTGDFNEKCDVFSF 247 (346)
Q Consensus 233 ~~~~~~~~~~Dv~s~ 247 (346)
+. +.-+.+-+||-+
T Consensus 388 F~-G~dd~QFeIYrl 401 (488)
T COG5072 388 FN-GVDDYQFEIYRL 401 (488)
T ss_pred hc-CccceeeeHHHH
Confidence 44 333666777754
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.62 E-value=0.4 Score=45.83 Aligned_cols=29 Identities=21% Similarity=0.340 Sum_probs=24.2
Q ss_pred CCCceecCCCCCCeEEcCCCceEEeccCCC
Q 045453 178 SRPILHRKIRPSRIFLDEGYIAKLFDFSLS 207 (346)
Q Consensus 178 ~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~ 207 (346)
....+|.|+.+.|||.+.++ ++++||..|
T Consensus 283 ~~VfCHNDl~~~NiL~~~~~-l~LIDfEYA 311 (442)
T PTZ00296 283 DIVFCHNDLQENNIINTNKC-LRLIDFEYS 311 (442)
T ss_pred CeeEEeCCCCccceeecCCC-EEEEeeccc
Confidence 34679999999999987654 999999865
|
|
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.58 E-value=0.86 Score=48.25 Aligned_cols=164 Identities=9% Similarity=0.023 Sum_probs=86.1
Q ss_pred CCccCCCHHHHHHHh-cCCCcc---cccccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHHHHHHHhhhc------C
Q 045453 42 NPIRGFTIRELEIAT-NNFDAR---NVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLS------S 111 (346)
Q Consensus 42 ~~~~~~~~~~l~~~~-~~f~~~---~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~------~ 111 (346)
.+...++.+++.... ..|... ..|+ |+.-.+|+...++..+++|+.+..... .+...+...+..+. .
T Consensus 12 ~~~p~ls~~~~~~ll~~~ygl~~~~~~L~-s~~d~nf~v~t~~~~yVLKi~~~~~~~--~~l~~e~~~l~hL~~~~~glp 88 (972)
T PRK06149 12 LPAPDVSEAQAERILAEHYGLSGTLTELG-SQQDRNFRVDSDGGRFVLKICHAAYAA--VELEAQHAALRHLAEREPALR 88 (972)
T ss_pred CCCCCCCHHHHHHHHHHhcCCceEEEecC-CcCcceEEEEecCCcEEEEeCCccCCh--HHHHHHHHHHHHHHhhCCCCC
Confidence 344568888887666 577653 3454 334468988876678888887754322 23333443443332 2
Q ss_pred CCceeeEc-ce----ee--cCCcceEEEecccCCChhhh-------hhh----------------cCCCCCCCCHHHH--
Q 045453 112 HKNVLKLT-GC----CL--ETRIPVIVFESVKNRTLADH-------IYQ----------------NQPHFEPLLLSQR-- 159 (346)
Q Consensus 112 h~niv~l~-g~----~~--~~~~~~lv~e~~~~gsL~~~-------l~~----------------~~~~~~~l~~~~~-- 159 (346)
-|.+++-. |- .. .....+-+++|++|..+.+. ... .......+.|..+
T Consensus 89 vp~pi~t~~G~~~~~~~~~g~~~~vrL~~~l~G~~~~~~~~~~~~~~~~lG~~lArlh~al~~f~hp~~~r~~~Wdl~~~ 168 (972)
T PRK06149 89 VPVVIPALDGEELLTLDVRGQGLRVRLLDYLPGQPLTRLGHLAPASVAGLGALCARVARALADFDHPGLDRTLQWDLRHA 168 (972)
T ss_pred CceeeECCCCCeEEEEecCCceEEEEEEEecCCccccccCCCCHHHHHHHHHHHHHHHHHHcCCCCCCCCCccccchhhh
Confidence 23333321 11 11 12345678999998655431 100 0011123444411
Q ss_pred ----------------HHHHHHHH----HHHHHHHhCCCCCceecCCCCCCeEEcCCC--c---eEEeccCCCc
Q 045453 160 ----------------LRIAVHIA----NAIAYLHIGFSRPILHRKIRPSRIFLDEGY--I---AKLFDFSLSV 208 (346)
Q Consensus 160 ----------------~~i~~~ia----~~L~~LH~~~~~~iiH~dlkp~NIll~~~~--~---~kl~Dfgl~~ 208 (346)
..++.+++ ..+.-+-..-..++||+|+.+.|||++.+. . .-|+|||-+.
T Consensus 169 ~~~~~~ll~~i~d~~~r~~l~~~~~~~~~~l~~~~~~L~~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~ 242 (972)
T PRK06149 169 GPVVAHLLSHITDPAQRARIAEATRDAARRLQPLAPALPLQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLV 242 (972)
T ss_pred HHHHHHHHhhcCCHHHHHHHHHHHHHHHHHhhhhhhhCcccccCCCCCcccEEEcCCCCCCcceeEEEEcccch
Confidence 11111111 112111112256899999999999998653 2 3799999753
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 346 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-38 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-36 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-29 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-28 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-21 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-21 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-20 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-12 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-12 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-11 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-11 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-11 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-11 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-11 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-11 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-11 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-11 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-11 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-11 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-11 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-11 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-11 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-11 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-11 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-11 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-11 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-11 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-10 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-10 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-10 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-10 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 9e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-09 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-09 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-09 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-09 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-09 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-09 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-09 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-09 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-09 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-09 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-09 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-09 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-09 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-09 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-09 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-09 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-09 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-09 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-09 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-09 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-09 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-09 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-08 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-08 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-08 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-08 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-08 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-08 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-08 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-08 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-08 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 9e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-07 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-07 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-07 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-07 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-07 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-07 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-07 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-07 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-07 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-07 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-07 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-07 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-07 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-07 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-07 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-07 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-07 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-07 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-07 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-07 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-07 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-07 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-07 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 7e-07 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-07 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-07 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 8e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-07 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-06 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-06 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-06 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-06 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-06 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-06 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-06 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-06 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-06 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-06 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-06 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-06 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-06 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-06 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-06 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-06 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-06 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-06 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-06 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-06 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-06 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-06 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-06 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-06 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-06 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-06 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-06 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-06 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-06 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-06 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-06 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-06 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-06 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-06 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-06 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-06 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-06 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-06 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-06 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-06 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-06 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-06 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-06 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-06 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-06 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-06 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-06 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-06 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-06 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-06 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-06 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-06 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-06 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-06 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-06 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-06 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-06 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-06 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 8e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 8e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 8e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-06 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-06 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 8e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-06 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-06 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 8e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 9e-06 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 9e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 9e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 9e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 9e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 9e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-05 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-05 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-05 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-05 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-05 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-05 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-05 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-05 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-05 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-05 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-05 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-05 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-05 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-05 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-05 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-05 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-05 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-05 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-05 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-05 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-05 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-05 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-05 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-05 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-05 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-05 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-05 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-05 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-05 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-05 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-05 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-05 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-05 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-05 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-05 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-05 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-05 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-05 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-05 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-05 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-05 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-05 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-05 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-05 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-05 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-05 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-05 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-05 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-05 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-05 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-05 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-05 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-05 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-05 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-05 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-05 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-05 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-05 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-05 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-05 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-05 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-05 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-05 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-05 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-05 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-05 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-05 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-05 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-05 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-05 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-05 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-05 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-05 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-05 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-05 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-05 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-05 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-05 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-05 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-05 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-05 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-05 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-05 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 8e-05 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-05 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 8e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-05 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 9e-05 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-05 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-05 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-04 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-04 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-04 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-04 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-04 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-04 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-04 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-04 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-04 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-04 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-04 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-04 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-04 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-04 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-04 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-04 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-04 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-04 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-04 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-04 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-04 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-04 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-04 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-04 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-04 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-04 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-04 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-04 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-04 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-04 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-04 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-04 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-04 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-04 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-04 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-04 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-04 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-04 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-04 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-04 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-04 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-04 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-04 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-04 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-04 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-04 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-04 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-04 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-04 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-04 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-04 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-04 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-04 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-04 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-04 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-04 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-04 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-04 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-04 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-04 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-04 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-04 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-04 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-04 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-04 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-04 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-04 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-04 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-04 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-04 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-04 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-04 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-04 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-04 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-04 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-04 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-04 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-04 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-04 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-04 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-04 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-04 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-04 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-04 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-04 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-04 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-04 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 6e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-04 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 9e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 2e-72
Identities = 86/302 (28%), Positives = 146/302 (48%), Gaps = 16/302 (5%)
Query: 45 RGFTIRELEIATNNFDARNVI-KDGYAYKFYKGFVED-RTVSVMKFNDILNDGHEDCFNN 102
+ +LE ATNNFD + +I + K YKG + D V++ + + G E+
Sbjct: 27 YRVPLVDLEEATNNFDHKFLIGHGVFG-KVYKGVLRDGAKVALKRRTPESSQGIEEFETE 85
Query: 103 IIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRI 162
I S H +++ L G C E +++++ ++N L H+Y + + QRL I
Sbjct: 86 IETLSFCR-HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEI 144
Query: 163 AVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG-ETCVKDKV 221
+ A + YLH I+HR ++ I LDE ++ K+ DF +S E +T + V
Sbjct: 145 CIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVV 201
Query: 222 TGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVK 281
GT+G++ PEY G EK DV+SFG++L +L + S E L +
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE----MVNLAEWAV 257
Query: 282 KCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341
+ N + ++IVDP + + + L+ F + A+ C+ S+EDRP+ DV +L+
Sbjct: 258 ESHNNGQLEQIVDPNLADKIR----PESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313
Query: 342 YQ 343
+
Sbjct: 314 LR 315
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 4e-71
Identities = 91/297 (30%), Positives = 163/297 (54%), Gaps = 7/297 (2%)
Query: 44 IRGFTIRELEIATNNFDARNVIKDGYAYKFYKGFVED-RTVSVMKFNDILNDGHEDCFNN 102
++ F++REL++A++NF +N++ G K YKG + D V+V + + G E F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 103 IIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRI 162
+ ++ H+N+L+L G C+ ++V+ + N ++A + + PL +R RI
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 163 AVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVT 222
A+ A +AYLH I+HR ++ + I LDE + A + DF L+ + +T V V
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 196
Query: 223 GTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKK 282
GT+G +APEY++TG +EK DVF +G++LL L+TGQ+ FD +R LL +VK
Sbjct: 197 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA--NDDDVMLLDWVKG 254
Query: 283 CIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLK 339
++ + + +VD + +++++ ++AL+C S +RP +V + L+
Sbjct: 255 LLKEKKLEALVDVDLQGNYK----DEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 7e-63
Identities = 81/312 (25%), Positives = 144/312 (46%), Gaps = 35/312 (11%)
Query: 45 RGFTIRELEIATNNFDAR------NVIKDGYAYKF---YKGFVEDRTVSVMKFNDILND- 94
F+ EL+ TNNFD R N + +G F YKG+V + TV+V K +++
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEG---GFGVVYKGYVNNTTVAVKKLAAMVDIT 69
Query: 95 ---GHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHF 151
+ I +K H+N+++L G + +V+ + N +L D +
Sbjct: 70 TEELKQQFDQEIKVMAKCQ-HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS-CLDGT 127
Query: 152 EPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211
PL R +IA AN I +LH +HR I+ + I LDE + AK+ DF L+ +
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 212 EGE-TCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIG 270
+ T + ++ GT ++APE + G+ K D++SFG++LL ++TG D R ++
Sbjct: 185 KFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL- 242
Query: 271 AGHYWLLHYVKKCI-ENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRP 329
LL ++ E ++ +D + ++ ++ +A C+ E RP
Sbjct: 243 -----LLDIKEEIEDEEKTIEDYIDKKM-NDAD----STSVEAMYSVASQCLHEKKNKRP 292
Query: 330 TTVDVAKRLKQI 341
V + L+++
Sbjct: 293 DIKKVQQLLQEM 304
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-45
Identities = 56/324 (17%), Positives = 119/324 (36%), Gaps = 42/324 (12%)
Query: 45 RGFTIRELEIATNNFDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNI- 103
L + V G +K + + V+V K I + + N
Sbjct: 12 VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAV-K---IFPIQDKQSWQNEY 67
Query: 104 -IFASKLSSHKNVLKLTGCCLETRIPV----IVFESVKNRTLADHIYQNQPHFEPLLLSQ 158
+++ H+N+L+ G ++ + +L+D + + ++
Sbjct: 68 EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-----KANVVSWNE 122
Query: 159 RLRIAVHIANAIAYLH------IGFSRP-ILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211
IA +A +AYLH +P I HR I+ + L A + DF L++
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182
Query: 212 EGETCVKDK-VTGTMGFLAPEYINTG-----DFNEKCDVFSFGMLLLVLLTGQKIFDPSR 265
G++ GT ++APE + D + D+++ G++L L + D
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242
Query: 266 GDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPR------VGKEKQLQGFRELALM 319
+ ++L + ++ ++ +++ + ++V + R K + E
Sbjct: 243 DE-------YMLPFEEEIGQHPSLEDMQE-VVVHKKKRPVLRDYWQKHAGMAMLCETIEE 294
Query: 320 CVCESAEDRPTTVDVAKRLKQIYQ 343
C AE R + V +R+ Q+ +
Sbjct: 295 CWDHDAEARLSAGCVGERITQMQR 318
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-33
Identities = 53/334 (15%), Positives = 114/334 (34%), Gaps = 51/334 (15%)
Query: 47 FTIRELEIATNNFDARNVIKDG-YAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNN--I 103
E + +N +I G Y YKG +++R V+V K + + + F N
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYG-AVYKGSLDERPVAV-K---VFSFANRQNFINEKN 57
Query: 104 IFASKLSSHKNVLKLTGCCLETRIPV-----IVFESVKNRTLADHIYQNQPHFEPLLLSQ 158
I+ L H N+ + +V E N +L ++ + +
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWV-----S 112
Query: 159 RLRIAVHIANAIAYLH------IGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212
R+A + +AYLH + I HR + + + + DF LS+ +
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 213 GETCVKDK-------VTGTMGFLAPEYI-------NTGDFNEKCDVFSFGMLLLVLLTGQ 258
+ GT+ ++APE + + ++ D+++ G++ +
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 259 KIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPR-------VGKEKQLQ 311
P + + + + + F+++ ++ E R ++
Sbjct: 233 TDLFPGESVPE-----YQMAFQTEVGNHPTFEDMQV-LVSREKQRPKFPEAWKENSLAVR 286
Query: 312 GFRELALMCVCESAEDRPTTVDVAKRLKQIYQHL 345
+E C + AE R T +R+ ++
Sbjct: 287 SLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-31
Identities = 56/274 (20%), Positives = 112/274 (40%), Gaps = 33/274 (12%)
Query: 74 YKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133
K + V++ + + F + +H N++KL G CL +V E
Sbjct: 25 CKAKWRAKDVAIKQIES---ESERKAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVME 79
Query: 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFL 193
+ +L + ++ +P + + + + +AYLH + ++HR ++P + L
Sbjct: 80 YAEGGSLYNVLHGAEPL-PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLL 138
Query: 194 DEGY-IAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLL 252
G + K+ DF + I T G+ ++APE +++EKCDVFS+G++L
Sbjct: 139 VAGGTVLKICDFGTACDIQTHMT----NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILW 194
Query: 253 VLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQG 312
++T +K F DEIG + ++ V P ++ P +
Sbjct: 195 EVITRRKPF-----DEIGGPAFRIMWAVHNGTR---------PPLIKNLP--------KP 232
Query: 313 FRELALMCVCESAEDRPTTVDVAKRLKQIYQHLA 346
L C + RP+ ++ K + + ++
Sbjct: 233 IESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-29
Identities = 51/210 (24%), Positives = 92/210 (43%), Gaps = 6/210 (2%)
Query: 51 ELEIATNNFDARNVIKDGYAYKFYKGFVEDRTVSV--MKFNDILNDGHEDCFNNIIFASK 108
+++I + + + I G ++ V+V + D + + + +
Sbjct: 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKR 90
Query: 109 LSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIAN 168
L H N++ G + IV E + +L ++++ L +RL +A +A
Sbjct: 91 LR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGARE-QLDERRRLSMAYDVAK 148
Query: 169 AIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFL 228
+ YLH + PI+HR ++ + +D+ Y K+ DF LS K GT ++
Sbjct: 149 GMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSK-SAAGTPEWM 206
Query: 229 APEYINTGDFNEKCDVFSFGMLLLVLLTGQ 258
APE + NEK DV+SFG++L L T Q
Sbjct: 207 APEVLRDEPSNEKSDVYSFGVILWELATLQ 236
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 9e-29
Identities = 60/249 (24%), Positives = 95/249 (38%), Gaps = 41/249 (16%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAI 170
H NVLK G + + + E +K TL I + SQR+ A IA+ +
Sbjct: 65 EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYP---WSQRVSFAKDIASGM 121
Query: 171 AYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDK---------- 220
AYLH S I+HR + + E + DF L+ + + +T +
Sbjct: 122 AYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178
Query: 221 ---VTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLL 277
V G ++APE IN ++EK DVFSFG++L ++ +L
Sbjct: 179 RYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP-----------DYLP 227
Query: 278 HYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKR 337
+ + F +D P F + + C E RP+ V +
Sbjct: 228 RTMDFGLNVRGF---LDRYCPPNCP--------PSFFPITVRCCDLDPEKRPSFVKLEHW 276
Query: 338 LKQIYQHLA 346
L+ + HLA
Sbjct: 277 LETLRMHLA 285
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-28
Identities = 47/298 (15%), Positives = 101/298 (33%), Gaps = 44/298 (14%)
Query: 74 YKGFVEDRTVSVMKFNDILNDGHEDCFNN--IIFASKLSSHKNVLKLTGCCLETRIPV-- 129
+ G V+V K + E + I+ + L H+N+L ++
Sbjct: 54 WMGKWRGEKVAV-K---VFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109
Query: 130 --IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLH-----IGFSRPIL 182
++ + +N +L D++ L L++A + + +LH I
Sbjct: 110 LYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIA 164
Query: 183 HRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVT---GTMGFLAPE------YI 233
HR ++ I + + + D L+V V GT ++ PE
Sbjct: 165 HRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNR 224
Query: 234 NTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIV 293
N D++SFG++L + ++ Y + ++++
Sbjct: 225 NHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL--------PYHDLVPSDPSYEDMR 276
Query: 294 DPIIVSEGPR------VGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHL 345
+ I+ + R ++ L+ +L C + R T + V K L ++ +
Sbjct: 277 E-IVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 63/242 (26%), Positives = 97/242 (40%), Gaps = 39/242 (16%)
Query: 107 SKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHI 166
S L+ H N++KL G P +V E V L + P+ S +LR+ + I
Sbjct: 78 SNLN-HPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDI 131
Query: 167 ANAIAYLHIGFSRPILHRKIRPSRIFLDEG-----YIAKLFDFSLSVSIPEGETCVKDKV 221
A I Y+ + PI+HR +R IFL AK+ DF LS + +
Sbjct: 132 ALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS----GL 186
Query: 222 TGTMGFLAPEYINTGD--FNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHY 279
G ++APE I + + EK D +SF M+L +LTG+ F DE G ++
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF-----DEYSYGKIKFINM 241
Query: 280 VKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLK 339
+ E P I + P R + +C + RP + K L
Sbjct: 242 I---REEGL-----RPTIPEDCP--------PRLRNVIELCWSGDPKKRPHFSYIVKELS 285
Query: 340 QI 341
++
Sbjct: 286 EL 287
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-27
Identities = 42/151 (27%), Positives = 81/151 (53%), Gaps = 11/151 (7%)
Query: 112 HKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIA 171
H N+L G ++ IV + + +L H++ ++ FE + + + IA A +
Sbjct: 79 HVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHASETKFE---MKKLIDIARQTARGMD 134
Query: 172 YLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS-VSIPEGETCVKDKVTGTMGFLAP 230
YLH ++ I+HR ++ + IFL E K+ DF L+ + ++++G++ ++AP
Sbjct: 135 YLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191
Query: 231 EYINTGD---FNEKCDVFSFGMLLLVLLTGQ 258
E I D ++ + DV++FG++L L+TGQ
Sbjct: 192 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-27
Identities = 40/216 (18%), Positives = 83/216 (38%), Gaps = 17/216 (7%)
Query: 50 RELEIATNNFDARNVIKDGYAYKFYKGFVEDRTVSV--MKFNDILNDGHEDCFNNIIFAS 107
+ I + + + ++ + +KG + + V +K D D FN
Sbjct: 3 KHSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRD-FNEECPRL 61
Query: 108 KLSSHKNVLKLTGCCLETRIP--VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVH 165
++ SH NVL + G C P ++ + +L + +++ + SQ ++ A+
Sbjct: 62 RIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF--VVDQSQAVKFALD 119
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTM 225
+A +A+LH I + + +DE A++ + S
Sbjct: 120 MARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRM------YAP 172
Query: 226 GFLAPEYIN---TGDFNEKCDVFSFGMLLLVLLTGQ 258
++APE + D++SF +LL L+T +
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTRE 208
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-27
Identities = 44/297 (14%), Positives = 107/297 (36%), Gaps = 44/297 (14%)
Query: 74 YKGFVEDRTVSVMKFNDILNDGHEDCFNN--IIFASKLSSHKNVLKLTGCCLETRIPV-- 129
++G V+V K I + E + I+ + + H+N+L +
Sbjct: 59 WRGKWRGEEVAV-K---IFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114
Query: 130 --IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLH-----IGFSRPIL 182
+V + ++ +L D++ + + + +++A+ A+ +A+LH I
Sbjct: 115 LWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 169
Query: 183 HRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVT---GTMGFLAPE------YI 233
HR ++ I + + + D L+V + GT ++APE +
Sbjct: 170 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 229
Query: 234 NTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIV 293
+ ++ D+++ G++ + I ++ Y + +E+
Sbjct: 230 KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP--------YYDLVPSDPSVEEMR 281
Query: 294 DPIIVSEGPR------VGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344
++ + R + L+ ++ C + R T + + K L Q+ Q
Sbjct: 282 K-VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 48/294 (16%), Positives = 108/294 (36%), Gaps = 44/294 (14%)
Query: 74 YKGFVEDRTVSVMKFNDILNDGHEDCFNN--IIFASKLSSHKNVLKLTGCCLETRIPV-- 129
++G + V+V K I + E + ++ + + H+N+L + +R
Sbjct: 25 WRGSWQGENVAV-K---IFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80
Query: 130 --IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLH-----IGFSRPIL 182
++ + +L D++ L LRI + IA+ +A+LH I
Sbjct: 81 LWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIA 135
Query: 183 HRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVT---GTMGFLAPE------YI 233
HR ++ I + + + D L+V + + GT ++APE +
Sbjct: 136 HRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQV 195
Query: 234 NTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIV 293
+ D ++ D+++FG++L + + + + F+++
Sbjct: 196 DCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK--------PPFYDVVPNDPSFEDMR 247
Query: 294 DPIIVSEGPR------VGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341
++ + R + L +L C ++ R T + + K L +I
Sbjct: 248 K-VVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 48/243 (19%), Positives = 88/243 (36%), Gaps = 43/243 (17%)
Query: 112 HKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIA 171
H+NV+ G C+ I+ K RTL + + + +++ +IA I +
Sbjct: 88 HENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLD---VNKTRQIAQEIVKGMG 144
Query: 172 YLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS----VSIPEGETCVKDKVTGTMGF 227
YLH ++ ILH+ ++ +F D G + + DF L V G +
Sbjct: 145 YLH---AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200
Query: 228 LAPEYINTGD---------FNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLH 278
LAPE I F++ DVF+ G + L + F
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF----------------- 243
Query: 279 YVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRL 338
+ + I+ + P + + + ++ L C E+RPT + L
Sbjct: 244 ------KTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDML 297
Query: 339 KQI 341
+++
Sbjct: 298 EKL 300
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 8e-26
Identities = 49/202 (24%), Positives = 80/202 (39%), Gaps = 31/202 (15%)
Query: 74 YKGFVEDRTVSVMKFNDILNDGHEDCFNN----IIFASKLSSHKNVLKLTGCCLETRIPV 129
Y+ F V+V ++ N + L H N++ L G CL+
Sbjct: 24 YRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HPNIIALRGVCLKEPNLC 82
Query: 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPS 189
+V E + L + + + + AV IA + YLH PI+HR ++ S
Sbjct: 83 LVMEFARGGPLNRVL-----SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSS 137
Query: 190 RIFLDEGY--------IAKLFDFSLSVSIPEGETCVKDK-----VTGTMGFLAPEYINTG 236
I + + I K+ DF L+ + G ++APE I
Sbjct: 138 NILILQKVENGDLSNKILKITDFGLA--------REWHRTTKMSAAGAYAWMAPEVIRAS 189
Query: 237 DFNEKCDVFSFGMLLLVLLTGQ 258
F++ DV+S+G+LL LLTG+
Sbjct: 190 MFSKGSDVWSYGVLLWELLTGE 211
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-18
Identities = 44/201 (21%), Positives = 76/201 (37%), Gaps = 18/201 (8%)
Query: 74 YKGF-VEDRTVSVMKFNDILNDGHEDC---FNNIIFASKLSSHKNVLKLTGCCLETRIPV 129
+K ED + +K + G +D + K+ H ++L E I
Sbjct: 74 FKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY 133
Query: 130 IVFESVKNRTLADHIYQNQPHF-EPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRP 188
+ E +L H E + A+A+LH S+ ++H ++P
Sbjct: 134 LQTELC-GPSLQQHCEAWGASLPEAQVW----GYLRDTLLALAHLH---SQGLVHLDVKP 185
Query: 189 SRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFG 248
+ IFL KL DF L V + + G ++APE + G + DVFS G
Sbjct: 186 ANIFLGPRGRCKLGDFGLLVELGTAGA--GEVQEGDPRYMAPE-LLQGSYGTAADVFSLG 242
Query: 249 MLLLVLLTGQKIFDPSRGDEI 269
+ +L + ++ P G+
Sbjct: 243 LTILEVACNMEL--PHGGEGW 261
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-18
Identities = 46/249 (18%), Positives = 89/249 (35%), Gaps = 40/249 (16%)
Query: 108 KLSSHKNVLKLTGCCLETRIPV----IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIA 163
+L +H N+L+L CL R ++ K TL + I + + L Q L +
Sbjct: 81 RLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLL 140
Query: 164 VHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDF-SLSVSIPEGETCVK---- 218
+ I + +H ++ HR ++P+ I L + L D S++ + E +
Sbjct: 141 LGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197
Query: 219 ---DKVTGTMGFLAPEYINT---GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAG 272
T+ + APE + +E+ DV+S G +L ++ G+ +D
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD---------M 248
Query: 273 HYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTV 332
+ V ++N I S +L + RP
Sbjct: 249 VFQKGDSVALAVQNQL--SIPQSPRHS-----------SALWQLLNSMMTVDPHQRPHIP 295
Query: 333 DVAKRLKQI 341
+ +L+ +
Sbjct: 296 LLLSQLEAL 304
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-18
Identities = 52/253 (20%), Positives = 87/253 (34%), Gaps = 68/253 (26%)
Query: 111 SHKNVLKLTGCCLETRIPV-IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANA 169
SH N+++L G C + + P+ IV E V+ + + L++ A
Sbjct: 170 SHPNIVRLIGVCTQKQ-PIYIVMELVQGGDFLTFLRTEGARLR---VKTLLQMVGDAAAG 225
Query: 170 IAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGF-- 227
+ YL S+ +HR + + E + K+ DF +S +G G
Sbjct: 226 MEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASG---GLRQVPV 279
Query: 228 --LAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEI---GAGHYWLLHYVKK 282
APE +N G ++ + DV+SFG +LL E GA Y
Sbjct: 280 KWTAPEALNYGRYSSESDVWSFG----ILLW-----------ETFSLGASPYP------- 317
Query: 283 CIENNEFDEIVDPIIVSEGPRVGKEKQLQGFR------------ELALMCVCESAEDRPT 330
+ N + E V+ +G R L C RP+
Sbjct: 318 NLSNQQTREFVE----------------KGGRLPCPELCPDAVFRLMEQCWAYEPGQRPS 361
Query: 331 TVDVAKRLKQIYQ 343
+ + L+ I +
Sbjct: 362 FSTIYQELQSIRK 374
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-17
Identities = 53/256 (20%), Positives = 92/256 (35%), Gaps = 36/256 (14%)
Query: 97 EDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV--IVFESVKNRTLADHIYQNQPHFEPL 154
+ + + +L H N+++ ++ IV E + LA I + + L
Sbjct: 50 QMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108
Query: 155 LLSQRLRIAVHIANAIAYLH--IGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212
LR+ + A+ H +LHR ++P+ +FLD KL DF L+ +
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 168
Query: 213 GETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAG 272
+ K V GT +++PE +N +NEK D++S G LL L F E+
Sbjct: 169 DTSFAKTFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL--- 224
Query: 273 HYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTV 332
K I +F I P S E+ + RP+
Sbjct: 225 -------AGK-IREGKFRRI--PYRYS-----------DELNEIITRMLNLKDYHRPSVE 263
Query: 333 D------VAKRLKQIY 342
+ + + +
Sbjct: 264 EILENPLILEHHHHHH 279
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-17
Identities = 59/278 (21%), Positives = 104/278 (37%), Gaps = 31/278 (11%)
Query: 74 YKGF-VEDRTVSVMKFNDILNDGH----EDCFNNIIFASKLSSHKNVLKLTGCCLETRIP 128
Y+ + D +K I + DC I +L+ H NV+K +E
Sbjct: 49 YRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNEL 107
Query: 129 VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRP 188
IV E L+ I + + + V + +A+ ++H SR ++HR I+P
Sbjct: 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKP 164
Query: 189 SRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFG 248
+ +F+ + KL D L +T + GT +++PE I+ +N K D++S G
Sbjct: 165 ANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLG 223
Query: 249 MLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEK 308
LL + Q F + + I + P + +
Sbjct: 224 CLLYEMAALQSPFYG---------------------DKMNLYSLCKKIEQCDYPPLPSDH 262
Query: 309 QLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHLA 346
+ R+L MC+ E RP V K+++ A
Sbjct: 263 YSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 8e-17
Identities = 53/254 (20%), Positives = 92/254 (36%), Gaps = 39/254 (15%)
Query: 97 EDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHI-YQNQPHFEPLL 155
E+ + + + H N+++ E IV + + L I Q F+
Sbjct: 68 EESRREVAVLANMK-HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQE-- 124
Query: 156 LSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGET 215
Q L V I A+ ++H R ILHR I+ IFL + +L DF ++ +
Sbjct: 125 -DQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTV 179
Query: 216 CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYW 275
+ GT +L+PE +N K D+++ G +L L T + F+
Sbjct: 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFE-------AGSMKN 232
Query: 276 LLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVD-- 333
L+ I + F + + S R L + DRP+
Sbjct: 233 LV----LKIISGSFPPV--SLHYS-----------YDLRSLVSQLFKRNPRDRPSVNSIL 275
Query: 334 ----VAKRLKQIYQ 343
+AKR+++
Sbjct: 276 EKGFIAKRIEKFLS 289
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 78.9 bits (194), Expect = 1e-16
Identities = 25/165 (15%), Positives = 53/165 (32%), Gaps = 23/165 (13%)
Query: 108 KLSSHKNVLKLTGCCLETRIPVIVF----ESVKNRTLADHIYQNQPHFEPLLLSQRLRIA 163
K K ++++ + + F +T + + + + L+ RL++
Sbjct: 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLT 212
Query: 164 VHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTG 223
+ + +A LH ++H +RP I LD+ L F V
Sbjct: 213 LQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSS-----V 264
Query: 224 TMGFLAPEYINT-----------GDFNEKCDVFSFGMLLLVLLTG 257
+ GF PE D ++ G+++ +
Sbjct: 265 SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-16
Identities = 42/147 (28%), Positives = 64/147 (43%), Gaps = 14/147 (9%)
Query: 111 SHKNVLKLTGCCLETRIPV-IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANA 169
SH NVL L G CL + +V +K+ L + I + + + + +A
Sbjct: 84 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKG 140
Query: 170 IAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFL- 228
+ YL S+ +HR + LDE + K+ DF L+ + + E TG L
Sbjct: 141 MKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK--LP 195
Query: 229 ----APEYINTGDFNEKCDVFSFGMLL 251
A E + T F K DV+SFG+LL
Sbjct: 196 VKWMALESLQTQKFTTKSDVWSFGVLL 222
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-16
Identities = 37/146 (25%), Positives = 60/146 (41%), Gaps = 12/146 (8%)
Query: 111 SHKNVLKLTGCCLETR-IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANA 169
+H NVL L G L +P ++ + + L I Q + + + + +A
Sbjct: 80 NHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN---PTVKDLISFGLQVARG 136
Query: 170 IAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGF-- 227
+ YL + +HR + LDE + K+ DF L+ I + E +
Sbjct: 137 MEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHAR-LPV 192
Query: 228 --LAPEYINTGDFNEKCDVFSFGMLL 251
A E + T F K DV+SFG+LL
Sbjct: 193 KWTALESLQTYRFTTKSDVWSFGVLL 218
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 3e-16
Identities = 56/247 (22%), Positives = 95/247 (38%), Gaps = 55/247 (22%)
Query: 111 SHKNVLKLTGCCLETRIPV-IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANA 169
H+ +++L + P+ IV E + +L D + + L L Q + +A IA+
Sbjct: 320 RHEKLVQLYAVV--SEEPIYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASG 375
Query: 170 IAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLA 229
+AY+ +HR +R + I + E + K+ DF L+ I + E + + + A
Sbjct: 376 MAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 432
Query: 230 PEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEF 289
PE G F K DV+SFG+LL L T G Y + N E
Sbjct: 433 PEAALYGRFTIKSDVWSFGILLTELTT------------KGRVPYPG-------MVNREV 473
Query: 290 DEIVDPIIVSEGPRVGKEKQLQGFR------------ELALMCVCESAEDRPTTVDVAKR 337
+ V+ +G+R +L C + E+RPT +
Sbjct: 474 LDQVE----------------RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAF 517
Query: 338 LKQIYQH 344
L+ +
Sbjct: 518 LEDYFTS 524
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 4e-16
Identities = 47/245 (19%), Positives = 92/245 (37%), Gaps = 52/245 (21%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAI 170
H N+++L G C I+ E + L D++ + + L +A I++A+
Sbjct: 274 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ--EVSAVVLLYMATQISSAM 331
Query: 171 AYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAP 230
YL + +HR + + E ++ K+ DF LS + + + AP
Sbjct: 332 EYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 388
Query: 231 EYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290
E + F+ K DV++FG+LL + T G Y I+ ++
Sbjct: 389 ESLAYNKFSIKSDVWAFGVLLWEIAT------------YGMSPYPG-------IDLSQVY 429
Query: 291 EIVDPIIVSEGPRVGKEKQLQGFR------------ELALMCVCESAEDRPTTVDVAKRL 338
E+++ + +R EL C + DRP+ ++ +
Sbjct: 430 ELLE----------------KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 473
Query: 339 KQIYQ 343
+ ++Q
Sbjct: 474 ETMFQ 478
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 77.8 bits (191), Expect = 4e-16
Identities = 24/130 (18%), Positives = 46/130 (35%), Gaps = 18/130 (13%)
Query: 139 TLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYI 198
T + + + + L+ RL++ + + +A LH ++H +RP I LD+
Sbjct: 193 TFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGG 249
Query: 199 AKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYI----------NTGDFNEKCDVFSFG 248
L F V +G + V GF PE + D ++ G
Sbjct: 250 VFLTGFEHLV--RDGASAV---SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG 304
Query: 249 MLLLVLLTGQ 258
+ + +
Sbjct: 305 LAIYWIWCAD 314
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 77.4 bits (190), Expect = 4e-16
Identities = 17/161 (10%), Positives = 47/161 (29%), Gaps = 13/161 (8%)
Query: 108 KLSSHKNVLKLTGCCLETRIP--VIVFESVK--NRTLADHIYQNQPHFEPLLLSQRLRIA 163
+ S +L+ + + +++ + L + + +
Sbjct: 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILT 200
Query: 164 VHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTG 223
+ A L S+ ++H P +F+ L D S + +
Sbjct: 201 AQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPA----SSV 253
Query: 224 TMGFLAPEYI--NTGDFNEKCDVFSFGMLLLVLLTGQKIFD 262
+ + E++ +T F + + G+ + + F
Sbjct: 254 PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 5e-16
Identities = 52/254 (20%), Positives = 97/254 (38%), Gaps = 48/254 (18%)
Query: 112 HKNVLKLTGCCLET-RIPV-IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANA 169
H N++K G C R + ++ E + +L D++ +++ + + L+ I
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKG 126
Query: 170 IAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGF-- 227
+ YL ++ +HR + I ++ K+ DF L+ +P+ + K K G
Sbjct: 127 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFW 183
Query: 228 LAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGH--YWLLHYVKKCI 284
APE + F+ DV+SFG++L L T +K P G+ +
Sbjct: 184 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI------ 237
Query: 285 ENNEFDEIVDPIIVSEGPRVGKEKQLQGFR---------EL-ALMCVC--ESAEDRPTTV 332
E++ R E+ +M C + RP+
Sbjct: 238 -VFHLIELLK----------------NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFR 280
Query: 333 DVAKRLKQIYQHLA 346
D+A R+ QI ++A
Sbjct: 281 DLALRVDQIRDNMA 294
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 5e-16
Identities = 52/254 (20%), Positives = 96/254 (37%), Gaps = 48/254 (18%)
Query: 112 HKNVLKLTGCCLET-RIPV-IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANA 169
H N++K G C R + ++ E + +L D++ +++ + + L+ I
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKG 157
Query: 170 IAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGF-- 227
+ YL ++ +HR + I ++ K+ DF L+ +P+ + K K G
Sbjct: 158 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFW 214
Query: 228 LAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGH--YWLLHYVKKCI 284
APE + F+ DV+SFG++L L T +K P G+ +
Sbjct: 215 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI------ 268
Query: 285 ENNEFDEIVDPIIVSEGPRVGKEKQLQGFR---------EL-ALMCVC--ESAEDRPTTV 332
E++ R E+ +M C + RP+
Sbjct: 269 -VFHLIELLK----------------NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFR 311
Query: 333 DVAKRLKQIYQHLA 346
D+A R+ QI +A
Sbjct: 312 DLALRVDQIRDQMA 325
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 6e-16
Identities = 41/147 (27%), Positives = 64/147 (43%), Gaps = 14/147 (9%)
Query: 111 SHKNVLKLTGCCLETRIPV-IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANA 169
SH NVL L G CL + +V +K+ L + I + + + + +A
Sbjct: 148 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKG 204
Query: 170 IAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFL- 228
+ +L S+ +HR + LDE + K+ DF L+ + + E TG L
Sbjct: 205 MKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK--LP 259
Query: 229 ----APEYINTGDFNEKCDVFSFGMLL 251
A E + T F K DV+SFG+LL
Sbjct: 260 VKWMALESLQTQKFTTKSDVWSFGVLL 286
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 6e-16
Identities = 38/158 (24%), Positives = 70/158 (44%), Gaps = 14/158 (8%)
Query: 108 KLSSHKNVLKLTGCCLETRIPV-IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHI 166
+ +H++V+ G E V +V E + R+L + + + EP + I
Sbjct: 96 RSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEP----EARYYLRQI 150
Query: 167 ANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVT--GT 224
YLH ++HR ++ +FL+E K+ DF L+ + K GT
Sbjct: 151 VLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK---VLCGT 204
Query: 225 MGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFD 262
++APE ++ + + DV+S G ++ LL G+ F+
Sbjct: 205 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 242
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 6e-16
Identities = 32/136 (23%), Positives = 54/136 (39%), Gaps = 16/136 (11%)
Query: 127 IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKI 186
+ IV E V ++L + L +++ + + I A++YLH S +++ +
Sbjct: 158 VGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLH---SIGLVYNDL 208
Query: 187 RPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFS 246
+P I L E + KL D I + GT GF APE I D+++
Sbjct: 209 KPENIMLTEEQL-KLIDLGAVSRI--NSF---GYLYGTPGFQAPE-IVRTGPTVATDIYT 261
Query: 247 FGMLLLVLLTGQKIFD 262
G L L +
Sbjct: 262 VGRTLAALTLDLPTRN 277
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 6e-16
Identities = 45/268 (16%), Positives = 84/268 (31%), Gaps = 62/268 (23%)
Query: 97 EDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLL 156
++ + + L H +V++ E +I E +LAD I +N
Sbjct: 55 QNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKE 114
Query: 157 SQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE-------------------GY 197
++ + + + + Y+H S ++H I+PS IF+
Sbjct: 115 AELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKV 171
Query: 198 IAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYIN-TGDFNEKCDVFSFGMLLLVLLT 256
+ K+ D I + G FLA E + K D+F+ + ++
Sbjct: 172 MFKIGDLGHVTRISSPQVEE-----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAG 226
Query: 257 GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFREL 316
+ + G W I I P ++S Q F EL
Sbjct: 227 AEPLPR--------NGDQW------HEIRQGRLPRI--PQVLS-----------QEFTEL 259
Query: 317 ALMCVCESAEDRPTTVDVAKRLKQIYQH 344
+ + E RP+ + +H
Sbjct: 260 LKVMIHPDPERRPSA-------MALVKH 280
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 8e-16
Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 13/162 (8%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAI 170
H N++KL + R +V E K L D I E I + + +
Sbjct: 94 DHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNE----VDAAVIIKQVLSGV 149
Query: 171 AYLHIGFSRPILHRKIRPSRIFL---DEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGF 227
YLH I+HR ++P + L ++ + K+ DF LS + +K+++ GT +
Sbjct: 150 TYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK-MKERL-GTAYY 204
Query: 228 LAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEI 269
+APE + ++EKCDV+S G++L +LL G F EI
Sbjct: 205 IAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI 245
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 8e-16
Identities = 57/246 (23%), Positives = 94/246 (38%), Gaps = 53/246 (21%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAI 170
H+ +++L E I IV E + +L D + + L L Q + +A IA+ +
Sbjct: 237 RHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGM 293
Query: 171 AYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAP 230
AY+ +HR +R + I + E + K+ DF L+ I + E + + + AP
Sbjct: 294 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 350
Query: 231 EYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290
E G F K DV+SFG+LL L T G Y + N E
Sbjct: 351 EAALYGRFTIKSDVWSFGILLTELTT------------KGRVPYPG-------MVNREVL 391
Query: 291 EIVDPIIVSEGPRVGKEKQLQGFR------------ELALMCVCESAEDRPTTVDVAKRL 338
+ V+ +G+R +L C + E+RPT + L
Sbjct: 392 DQVE----------------RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 435
Query: 339 KQIYQH 344
+ +
Sbjct: 436 EDYFTS 441
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 8e-16
Identities = 40/161 (24%), Positives = 73/161 (45%), Gaps = 20/161 (12%)
Query: 108 KLSSHKNVLKLTGCCLETRIPV-IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHI 166
+ +H++V+ G E V +V E + R+L + + + EP + I
Sbjct: 70 RSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEP----EARYYLRQI 124
Query: 167 ANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI-PEGE----TCVKDKV 221
YLH ++HR ++ +FL+E K+ DF L+ + +GE C
Sbjct: 125 VLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC----- 176
Query: 222 TGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFD 262
GT ++APE ++ + + DV+S G ++ LL G+ F+
Sbjct: 177 -GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 216
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 8e-16
Identities = 38/152 (25%), Positives = 69/152 (45%), Gaps = 18/152 (11%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLAD------HIYQNQPHFEPLLLSQRLRIAV 164
+ +V++L G + + +++ E + L N P P LS+ +++A
Sbjct: 86 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 165 HIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGT 224
IA+ +AYL+ + +HR + + E + K+ DF ++ I E + K G
Sbjct: 146 EIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK----GG 198
Query: 225 MGFL-----APEYINTGDFNEKCDVFSFGMLL 251
G L +PE + G F DV+SFG++L
Sbjct: 199 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 230
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-15
Identities = 49/286 (17%), Positives = 96/286 (33%), Gaps = 51/286 (17%)
Query: 78 VEDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIP-------V 129
V +K + + + F KLS H N+++ +
Sbjct: 50 VGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEF 109
Query: 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPS 189
++ + L + + + + PL L+I A+ ++H PI+HR ++
Sbjct: 110 LLLTELCKGQLVEFLKKMESR-GPLSCDTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVE 167
Query: 190 RIFLDEGYIAKLFDFSLS---------VSIPEGETCVKDKVT--GTMGFLAPEYINT--- 235
+ L KL DF + + V++++T T + PE I+
Sbjct: 168 NLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSN 227
Query: 236 GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDP 295
EK D+++ G +L +L Q F+ K I N ++
Sbjct: 228 FPIGEKQDIWALGCILYLLCFRQHPFEDG---------------AKLRIVNGKYSIPPHD 272
Query: 296 IIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341
Q F L + + E+R + +V +L++I
Sbjct: 273 ------------TQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-15
Identities = 59/250 (23%), Positives = 98/250 (39%), Gaps = 49/250 (19%)
Query: 112 HKNVLKLTGCCLETRI-PV-IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANA 169
H++++K GCC + + +V E V +L D++ ++ LLL A I
Sbjct: 92 HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLL-----FAQQICEG 146
Query: 170 IAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGF-- 227
+AYLH ++ +HR + + LD + K+ DF L+ ++PEG + + G
Sbjct: 147 MAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 203
Query: 228 LAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGH-YWLLHYVKKCIE 285
APE + F DV+SFG+ L LLT P G +
Sbjct: 204 YAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQ-------MT 256
Query: 286 NNEFDEIVDPIIVSEGPRVGKEKQLQGFR---------EL-ALMCVC--ESAEDRPTTVD 333
E+++ +G R E+ LM C A RPT +
Sbjct: 257 VLRLTELLE----------------RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFEN 300
Query: 334 VAKRLKQIYQ 343
+ LK +++
Sbjct: 301 LIPILKTVHE 310
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 48/250 (19%), Positives = 93/250 (37%), Gaps = 47/250 (18%)
Query: 112 HKNVLKLTGCCL-ETRIPV-IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANA 169
H+N++K G C + + ++ E + + +L +++ +N+ + L Q+L+ AV I
Sbjct: 82 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKG 138
Query: 170 IAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGF-- 227
+ YL SR +HR + + ++ + K+ DF L+ +I + K
Sbjct: 139 MDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFW 195
Query: 228 LAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGH-YWLLHYVKKCIE 285
APE + F DV+SFG+ L LLT P G + +
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQ-------MT 248
Query: 286 NNEFDEIVDPIIVSEGPRVGKEKQLQGFR---------EL-ALMCVC--ESAEDRPTTVD 333
+ +G R E+ LM C +R + +
Sbjct: 249 VTRLVNTLK----------------EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQN 292
Query: 334 VAKRLKQIYQ 343
+ + + + +
Sbjct: 293 LIEGFEALLK 302
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 46/200 (23%), Positives = 85/200 (42%), Gaps = 34/200 (17%)
Query: 85 VMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV-------------IV 131
+K + + ++ + L+ H+ V++ LE R V I
Sbjct: 35 AIKKIRHTEEKLSTILSEVMLLASLN-HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQ 93
Query: 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRI 191
E +N TL D I+ + + + R+ I A++Y+H S+ I+HR ++P I
Sbjct: 94 MEYCENGTLYDLIHSENLNQQR---DEYWRLFRQILEALSYIH---SQGIIHRDLKPMNI 147
Query: 192 FLDEGYIAKLFDFSLSVSIPEGETCVKD-------------KVTGTMGFLAPEYI-NTGD 237
F+DE K+ DF L+ ++ +K GT ++A E + TG
Sbjct: 148 FIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGH 207
Query: 238 FNEKCDVFSFGMLLLVLLTG 257
+NEK D++S G++ ++
Sbjct: 208 YNEKIDMYSLGIIFFEMIYP 227
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-15
Identities = 44/195 (22%), Positives = 79/195 (40%), Gaps = 21/195 (10%)
Query: 74 YKGFVEDRTVSV----MKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIP- 128
YKG + TV V ++ + + L H N+++ T
Sbjct: 43 YKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGK 101
Query: 129 ---VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRK 185
V+V E + + TL ++ + F+ + + I + +LH + PI+HR
Sbjct: 102 KCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLH-TRTPPIIHRD 156
Query: 186 IRPSRIFLD--EGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCD 243
++ IF+ G + K+ D L+ V GT F+APE ++E D
Sbjct: 157 LKCDNIFITGPTGSV-KIGDLGLATLKRASFA---KAVIGTPEFMAPEMYEEK-YDESVD 211
Query: 244 VFSFGMLLLVLLTGQ 258
V++FGM +L + T +
Sbjct: 212 VYAFGMCMLEMATSE 226
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 39/154 (25%), Positives = 63/154 (40%), Gaps = 20/154 (12%)
Query: 111 SHKNVLKLTGCCLETR------IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQR--LRI 162
H +V KL G L +R IP+++ +K+ L + ++ P L + +R
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 163 AVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVT 222
V IA + YL SR +HR + L E + DF LS I G+ +
Sbjct: 143 MVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQ---- 195
Query: 223 GTMGFL-----APEYINTGDFNEKCDVFSFGMLL 251
G L A E + + DV++FG+ +
Sbjct: 196 GCASKLPVKWLALESLADNLYTVHSDVWAFGVTM 229
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 37/153 (24%), Positives = 66/153 (43%), Gaps = 19/153 (12%)
Query: 111 SHKNVLKLTGCCLETR-----IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQR--LRIA 163
SH NV++L G C+E P+++ +K L ++ ++ P + + L+
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 164 VHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTG 223
V IA + YL +R LHR + L + + DF LS I G+ + G
Sbjct: 154 VDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQ----G 206
Query: 224 TMGFL-----APEYINTGDFNEKCDVFSFGMLL 251
+ + A E + + K DV++FG+ +
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTM 239
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 2e-15
Identities = 30/145 (20%), Positives = 61/145 (42%), Gaps = 14/145 (9%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAI 170
+ +V +L G CL + + ++ + + L D++ +++ + L L V IA +
Sbjct: 75 DNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYL---LNWCVQIAKGM 130
Query: 171 AYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGF--- 227
YL R ++HR + + + K+ DF L+ + E G
Sbjct: 131 NYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH--AEGGK-VPIK 184
Query: 228 -LAPEYINTGDFNEKCDVFSFGMLL 251
+A E I + + DV+S+G+ +
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTV 209
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 2e-15
Identities = 39/162 (24%), Positives = 60/162 (37%), Gaps = 21/162 (12%)
Query: 108 KLSSHKNVLKLTGCCLETRIPV-IVFESVKNRTLADHIYQNQPHF-EPLLLSQRLRIAVH 165
H ++L+L E V +V E N + ++ F E +
Sbjct: 66 CQLKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSEN----EARHFMHQ 120
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE-----TCVKDK 220
I + YLH S ILHR + S + L K+ DF L+ + C
Sbjct: 121 IITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC---- 173
Query: 221 VTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFD 262
GT +++PE + DV+S G + LL G+ FD
Sbjct: 174 --GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 3e-15
Identities = 36/139 (25%), Positives = 61/139 (43%), Gaps = 15/139 (10%)
Query: 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPS 189
I + + L D + + + L I + IA A+ +LH S+ ++HR ++PS
Sbjct: 138 IQMQLCRKENLKDWMNRRCSLEDREH-GVCLHIFIQIAEAVEFLH---SKGLMHRDLKPS 193
Query: 190 RIFLDEGYIAKLFDFSLS-----------VSIPEGETCVKDKVTGTMGFLAPEYINTGDF 238
IF + K+ DF L V P GT +++PE I+ ++
Sbjct: 194 NIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNY 253
Query: 239 NEKCDVFSFGMLLLVLLTG 257
+ K D+FS G++L LL
Sbjct: 254 SHKVDIFSLGLILFELLYS 272
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 75.0 bits (184), Expect = 3e-15
Identities = 35/177 (19%), Positives = 58/177 (32%), Gaps = 20/177 (11%)
Query: 108 KLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQN-QPHFEPLLLSQRLRIAVHI 166
K S +K L V+V E TL + I + + + A+ +
Sbjct: 122 KPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRM 181
Query: 167 ANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIA-----------KLFDFSLSV---SIPE 212
I +H I+H I+P L G++ L D S+ P+
Sbjct: 182 LYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK 238
Query: 213 GETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEI 269
G T GF E ++ +N + D F + +L G + + G E
Sbjct: 239 GTIFTAK--CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC 293
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 5e-15
Identities = 49/189 (25%), Positives = 84/189 (44%), Gaps = 14/189 (7%)
Query: 84 SVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADH 143
+ K E + +L H N++KL + +V E L D
Sbjct: 58 VISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDE 116
Query: 144 IYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFL---DEGYIAK 200
I + E RI + + I Y+H I+HR ++P + L + +
Sbjct: 117 IISRKRFSE----VDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIR 169
Query: 201 LFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKI 260
+ DF LS + +KDK+ GT ++APE ++ G ++EKCDV+S G++L +LL+G
Sbjct: 170 IIDFGLSTHFEASKK-MKDKI-GTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPP 226
Query: 261 FDPSRGDEI 269
F+ + +I
Sbjct: 227 FNGANEYDI 235
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 5e-15
Identities = 44/197 (22%), Positives = 81/197 (41%), Gaps = 27/197 (13%)
Query: 79 EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV--------- 129
D V+K + +E + +KL H N++ GC
Sbjct: 34 IDGKTYVIK---RVKYNNEKAEREVKALAKLD-HVNIVHYNGCWDGFDYDPETSSKNSSR 89
Query: 130 -------IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPIL 182
I E TL I + + E L L + I + Y+H S+ ++
Sbjct: 90 SKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQITKGVDYIH---SKKLI 144
Query: 183 HRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKC 242
+R ++PS IFL + K+ DF L S+ + + GT+ +++PE I++ D+ ++
Sbjct: 145 NRDLKPSNIFLVDTKQVKIGDFGLVTSL--KNDGKRTRSKGTLRYMSPEQISSQDYGKEV 202
Query: 243 DVFSFGMLLLVLLTGQK 259
D+++ G++L LL
Sbjct: 203 DLYALGLILAELLHVCD 219
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 74.7 bits (183), Expect = 7e-15
Identities = 39/160 (24%), Positives = 68/160 (42%), Gaps = 15/160 (9%)
Query: 108 KLSSHKNVLKL------TGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLR 161
K +H NV+ +P++ E + L ++ Q + + L
Sbjct: 67 KKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRT 125
Query: 162 IAVHIANAIAYLHIGFSRPILHRKIRPSRIFLD---EGYIAKLFDFSLSVSIPEGETCVK 218
+ I++A+ YLH I+HR ++P I L + I K+ D + + +GE C
Sbjct: 126 LLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC-- 180
Query: 219 DKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQ 258
+ GT+ +LAPE + + D +SFG L +TG
Sbjct: 181 TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 8e-15
Identities = 51/249 (20%), Positives = 94/249 (37%), Gaps = 45/249 (18%)
Query: 112 HKNVLKLTGCCLET-RIPV-IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANA 169
++K G R + +V E + + L D + +++ + L L + I
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL---LLYSSQICKG 139
Query: 170 IAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGF-- 227
+ YL SR +HR + I ++ K+ DF L+ +P + + G
Sbjct: 140 MEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 196
Query: 228 LAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIEN 286
APE ++ F+ + DV+SFG++L L T K PS G +
Sbjct: 197 YAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGC------ERDVPAL 250
Query: 287 NEFDEIVDPIIVSEGPRVGKEKQLQGFR---------EL-ALMCVC--ESAEDRPTTVDV 334
+ E+++ +G R E+ LM +C S +DRP+ +
Sbjct: 251 SRLLELLE----------------EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 294
Query: 335 AKRLKQIYQ 343
+L ++
Sbjct: 295 GPQLDMLWS 303
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-14
Identities = 33/165 (20%), Positives = 66/165 (40%), Gaps = 19/165 (11%)
Query: 108 KLSSHKNVLKLTGCCLETRIPV-IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVH- 165
++ L G + V I++E ++N ++ + +++
Sbjct: 98 TDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 166 ---IANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE---TCVKD 219
+ N+ +Y+H + I HR ++PS I +D+ KL DF S + + + +
Sbjct: 157 IKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSR--- 211
Query: 220 KVTGTMGFLAPEYINT--GDFNEKCDVFSFGMLLLVLLTGQKIFD 262
GT F+ PE+ + K D++S G+ L V+ F
Sbjct: 212 ---GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 2e-14
Identities = 35/145 (24%), Positives = 63/145 (43%), Gaps = 14/145 (9%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAI 170
SH ++K G C + IV E + N L +++ + EP L L + + +
Sbjct: 61 SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQL---LEMCYDVCEGM 117
Query: 171 AYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGF--- 227
A+L S +HR + +D K+ DF ++ + + + GT F
Sbjct: 118 AFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS---VGTK-FPVK 170
Query: 228 -LAPEYINTGDFNEKCDVFSFGMLL 251
APE + ++ K DV++FG+L+
Sbjct: 171 WSAPEVFHYFKYSSKSDVWAFGILM 195
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 38/142 (26%), Positives = 65/142 (45%), Gaps = 10/142 (7%)
Query: 111 SHKNVLKLTGCCLETRIPV-IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANA 169
H N+++L G +E + + IV E + +L D++ L L+ ++ + A
Sbjct: 244 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEA 301
Query: 170 IAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLA 229
+ YL +HR + + + E +AK+ DF L+ + K V T A
Sbjct: 302 MEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----A 354
Query: 230 PEYINTGDFNEKCDVFSFGMLL 251
PE + F+ K DV+SFG+LL
Sbjct: 355 PEALREKKFSTKSDVWSFGILL 376
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 39/142 (27%), Positives = 69/142 (48%), Gaps = 8/142 (5%)
Query: 111 SHKNVLKLTGCCLETRIPV-IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANA 169
H ++KL T+ P+ I+ E + +L D + ++ L + + + IA
Sbjct: 241 QHDKLVKLHAVV--TKEPIYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEG 296
Query: 170 IAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLA 229
+A++ R +HR +R + I + + K+ DF L+ I + E ++ + + A
Sbjct: 297 MAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA 353
Query: 230 PEYINTGDFNEKCDVFSFGMLL 251
PE IN G F K DV+SFG+LL
Sbjct: 354 PEAINFGSFTIKSDVWSFGILL 375
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-14
Identities = 41/159 (25%), Positives = 78/159 (49%), Gaps = 12/159 (7%)
Query: 106 ASKLSSHKNVLKL--TGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIA 163
+S+LS H+N++ + E +V E ++ TL+++I + P L + +
Sbjct: 65 SSQLS-HQNIVSMIDVDE--EDDCYYLVMEYIEGPTLSEYIESHGP----LSVDTAINFT 117
Query: 164 VHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTG 223
I + I + H I+HR I+P I +D K+FDF ++ ++ E + V G
Sbjct: 118 NQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLG 174
Query: 224 TMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFD 262
T+ + +PE +E D++S G++L +L G+ F+
Sbjct: 175 TVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFN 213
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-14
Identities = 38/138 (27%), Positives = 61/138 (44%), Gaps = 15/138 (10%)
Query: 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPS 189
I + + L D + + E S L I + IA A+ +LH S+ ++HR ++PS
Sbjct: 92 IQMQLCRKENLKDWM-NGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPS 147
Query: 190 RIFLDEGYIAKLFDFSLS-----------VSIPEGETCVKDKVTGTMGFLAPEYINTGDF 238
IF + K+ DF L V P GT +++PE I+ +
Sbjct: 148 NIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSY 207
Query: 239 NEKCDVFSFGMLLLVLLT 256
+ K D+FS G++L LL
Sbjct: 208 SHKVDIFSLGLILFELLY 225
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-14
Identities = 42/159 (26%), Positives = 67/159 (42%), Gaps = 18/159 (11%)
Query: 108 KLSSHKNVLKLTGCCLETRIPV-IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHI 166
H N+L+L G V ++ E T+ + + E + +
Sbjct: 64 SHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ----RTATYITEL 118
Query: 167 ANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE---TCVKDKVTG 223
ANA++Y H S+ ++HR I+P + L K+ DF SV P C G
Sbjct: 119 ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC------G 169
Query: 224 TMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFD 262
T+ +L PE I +EK D++S G+L L G+ F+
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-14
Identities = 38/143 (26%), Positives = 66/143 (46%), Gaps = 9/143 (6%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAI 170
H+N+++L G L + +V E +L D + ++Q HF L R AV +A +
Sbjct: 79 DHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLGTL---SRYAVQVAEGM 134
Query: 171 AYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGF--L 228
YL S+ +HR + + L + K+ DF L ++P+ + + + F
Sbjct: 135 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 191
Query: 229 APEYINTGDFNEKCDVFSFGMLL 251
APE + T F+ D + FG+ L
Sbjct: 192 APESLKTRTFSHASDTWMFGVTL 214
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 54/251 (21%), Positives = 94/251 (37%), Gaps = 58/251 (23%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAI 170
+ +++L G C + ++V E L + + +S + ++ +
Sbjct: 394 DNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIP---VSNVAELLHQVSMGM 449
Query: 171 AYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGF--L 228
YL + +HR + + L + AK+ DF LS ++ ++ + G
Sbjct: 450 KYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 506
Query: 229 APEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENN 287
APE IN F+ + DV+S+G+ + L+ GQK P Y + +
Sbjct: 507 APECINFRKFSSRSDVWSYGVTMWEALSYGQK---P----------YKKM-------KGP 546
Query: 288 EFDEIVDPIIVSEGPRVGKEKQLQGFR---------EL-ALMCVC--ESAEDRPTTVDVA 335
E ++ QG R EL ALM C EDRP + V
Sbjct: 547 EVMAFIE----------------QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVE 590
Query: 336 KRLKQIYQHLA 346
+R++ Y LA
Sbjct: 591 QRMRACYYSLA 601
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 4e-14
Identities = 30/145 (20%), Positives = 61/145 (42%), Gaps = 14/145 (9%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAI 170
+ +V +L G CL + + ++ + + L D++ +++ + L L V IA +
Sbjct: 75 DNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYL---LNWCVQIAKGM 130
Query: 171 AYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGF--- 227
YL R ++HR + + + K+ DF L+ + E G
Sbjct: 131 NYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH--AEGGK-VPIK 184
Query: 228 -LAPEYINTGDFNEKCDVFSFGMLL 251
+A E I + + DV+S+G+ +
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTV 209
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 4e-14
Identities = 34/160 (21%), Positives = 63/160 (39%), Gaps = 17/160 (10%)
Query: 108 KLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIA 167
+ H NV++ + + I E TL +++ Q L L+
Sbjct: 73 ESDEHPNVIRYFCTEKDRQFQYIAIELCAA-TLQEYVEQKDFAHLGLEPITLLQ---QTT 128
Query: 168 NAIAYLHIGFSRPILHRKIRPSRIFLDE-----GYIAKLFDFSLSVSIPEGETCVKDKVT 222
+ +A+LH S I+HR ++P I + A + DF L + G +
Sbjct: 129 SGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG 185
Query: 223 --GTMGFLAPEYIN---TGDFNEKCDVFSFGMLLLVLLTG 257
GT G++APE ++ + D+FS G + +++
Sbjct: 186 VPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 4e-14
Identities = 47/151 (31%), Positives = 74/151 (49%), Gaps = 15/151 (9%)
Query: 111 SHKNVLKLTGCCLETRIPV-IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANA 169
H N++KL E IV E L D I + + E RI + +
Sbjct: 79 DHPNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIKRKRFSE----HDAARIIKQVFSG 133
Query: 170 IAYLHIGFSRPILHRKIRPSRIFL---DEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMG 226
I Y+H I+HR ++P I L ++ K+ DF LS + +KD++ GT
Sbjct: 134 ITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRI-GTAY 188
Query: 227 FLAPEYINTGDFNEKCDVFSFGMLLLVLLTG 257
++APE + G ++EKCDV+S G++L +LL+G
Sbjct: 189 YIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 4e-14
Identities = 39/159 (24%), Positives = 63/159 (39%), Gaps = 18/159 (11%)
Query: 108 KLSSHKNVLKLTGCCL-ETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHI 166
H N+L++ RI ++ E L + ++ E + +
Sbjct: 69 SHLRHPNILRMYNYFHDRKRI-YLMLEFAPRGELYKELQKHGRFDEQ----RSATFMEEL 123
Query: 167 ANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGET---CVKDKVTG 223
A+A+ Y H R ++HR I+P + + K+ DF SV P C G
Sbjct: 124 ADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC------G 174
Query: 224 TMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFD 262
T+ +L PE I +EK D++ G+L L G FD
Sbjct: 175 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 5e-14
Identities = 39/153 (25%), Positives = 61/153 (39%), Gaps = 20/153 (13%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFE---PLLLSQRLRIAVHIA 167
+H+N+++ G L++ I+ E + L + + +P L + L +A IA
Sbjct: 91 NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 168 NAIAYLHIGFSRPILHRKIRPSR----IFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTG 223
YL +HR I +R G +AK+ DF ++ I K G
Sbjct: 151 CGCQYLE---ENHFIHRDIA-ARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK----G 202
Query: 224 TMGFL-----APEYINTGDFNEKCDVFSFGMLL 251
L PE G F K D +SFG+LL
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 235
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 5e-14
Identities = 45/151 (29%), Positives = 69/151 (45%), Gaps = 15/151 (9%)
Query: 111 SHKNVLKLTGCCLETRIPV-IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANA 169
H N++KL E + +V E + L + I E I I +
Sbjct: 104 DHPNIIKLFDVF-EDKKYFYLVTEFYEGGELFEQIINRHKFDE----CDAANIMKQILSG 158
Query: 170 IAYLHIGFSRPILHRKIRPSRIFL---DEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMG 226
I YLH I+HR I+P I L + K+ DF LS + +D++ GT
Sbjct: 159 ICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL-RDRL-GTAY 213
Query: 227 FLAPEYINTGDFNEKCDVFSFGMLLLVLLTG 257
++APE + +NEKCDV+S G+++ +LL G
Sbjct: 214 YIAPEVLK-KKYNEKCDVWSCGVIMYILLCG 243
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 5e-14
Identities = 53/251 (21%), Positives = 93/251 (37%), Gaps = 58/251 (23%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAI 170
+ +++L G C + ++V E L + + + + ++ +
Sbjct: 68 DNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNV---AELLHQVSMGM 123
Query: 171 AYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGF--L 228
YL + +HR + + L + AK+ DF LS ++ ++ + G
Sbjct: 124 KYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 180
Query: 229 APEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENN 287
APE IN F+ + DV+S+G+ + L+ GQK P Y + +
Sbjct: 181 APECINFRKFSSRSDVWSYGVTMWEALSYGQK---P----------YKKM-------KGP 220
Query: 288 EFDEIVDPIIVSEGPRVGKEKQLQGFR---------EL-ALMCVC--ESAEDRPTTVDVA 335
E ++ QG R EL ALM C EDRP + V
Sbjct: 221 EVMAFIE----------------QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVE 264
Query: 336 KRLKQIYQHLA 346
+R++ Y LA
Sbjct: 265 QRMRACYYSLA 275
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 6e-14
Identities = 38/163 (23%), Positives = 61/163 (37%), Gaps = 25/163 (15%)
Query: 107 SKLSSHKNVLKLTGCCLETRIPV-IVFESVKN----------RTLADHIYQNQPHFEPLL 155
+ H NV+ L G C + P+ ++ E K R
Sbjct: 85 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 156 LSQR--LRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213
L+ + + +A + +L SR +HR + I L E + K+ DF L+ I +
Sbjct: 145 LTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 201
Query: 214 ETCVKDKVTGTMGFL-----APEYINTGDFNEKCDVFSFGMLL 251
V+ L APE I + + DV+SFG+LL
Sbjct: 202 PDYVR----KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 240
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 7e-14
Identities = 48/264 (18%), Positives = 80/264 (30%), Gaps = 47/264 (17%)
Query: 108 KLSSHKNVLKLTGC--CLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQR--LRIA 163
K +HKN++KL TR V++ E +L + + + L + L +
Sbjct: 62 KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG---LPESEFLIVL 118
Query: 164 VHIANAIAYLHIGFSRPILHRKIRPSRIFL----DEGYIAKLFDFSLSVSIPEGETCVKD 219
+ + +L I+HR I+P I D + KL DF + + + E
Sbjct: 119 RDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--V 173
Query: 220 KVTGTMGFLAPEYINTGD--------FNEKCDVFSFGMLLLVLLTGQKIFDPSRGDE--- 268
+ GT +L P+ + D++S G+ TG F P G
Sbjct: 174 SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK 233
Query: 269 -----IGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCE 323
I G + EN D D + R + +
Sbjct: 234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANIL------ 287
Query: 324 SAEDRPTTVDVAKRL--KQIYQHL 345
D K Q +
Sbjct: 288 -------EADQEKCWGFDQFFAET 304
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 7e-14
Identities = 32/145 (22%), Positives = 66/145 (45%), Gaps = 14/145 (9%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAI 170
H ++++L G C + + +V + + +L DH+ Q++ P LL L V IA +
Sbjct: 73 DHAHIVRLLGLCPGSSL-QLVTQYLPLGSLLDHVRQHRGALGPQLL---LNWGVQIAKGM 128
Query: 171 AYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGF--- 227
YL ++HR + + L ++ DF ++ +P + + +
Sbjct: 129 YYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK--QLLYSEAK-TPIK 182
Query: 228 -LAPEYINTGDFNEKCDVFSFGMLL 251
+A E I+ G + + DV+S+G+ +
Sbjct: 183 WMALESIHFGKYTHQSDVWSYGVTV 207
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 7e-14
Identities = 47/198 (23%), Positives = 79/198 (39%), Gaps = 25/198 (12%)
Query: 91 ILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV-IVFESVKNRTLADHIYQNQP 149
I++ D I + H N++ L + V +V E +K L D I Q
Sbjct: 54 IIDKSKRDPTEEIEILLRYGQHPNIITLKDVY-DDGKYVYVVTELMKGGELLDKI-LRQK 111
Query: 150 HFEPLLLSQR--LRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFL----DEGYIAKLFD 203
F S+R + I + YLH ++ ++HR ++PS I ++ D
Sbjct: 112 FF-----SEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICD 163
Query: 204 FSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDP 263
F + + + T F+APE + ++ CD++S G+LL +LTG F
Sbjct: 164 FGFAKQLRAENGLLMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFAN 222
Query: 264 SRGD-------EIGAGHY 274
D IG+G +
Sbjct: 223 GPDDTPEEILARIGSGKF 240
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 9e-14
Identities = 39/153 (25%), Positives = 61/153 (39%), Gaps = 20/153 (13%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFE---PLLLSQRLRIAVHIA 167
+H+N+++ G L++ I+ E + L + + +P L + L +A IA
Sbjct: 132 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191
Query: 168 NAIAYLHIGFSRPILHRKIRPSR----IFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTG 223
YL +HR I +R G +AK+ DF ++ I K G
Sbjct: 192 CGCQYLE---ENHFIHRDIA-ARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK----G 243
Query: 224 TMGFL-----APEYINTGDFNEKCDVFSFGMLL 251
L PE G F K D +SFG+LL
Sbjct: 244 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 276
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-13
Identities = 37/146 (25%), Positives = 71/146 (48%), Gaps = 16/146 (10%)
Query: 111 SHKNVLKLTGCCLETRIPV-IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANA 169
SH +++L G CLE P+ +V E +++ L+D++ + F L L + + +
Sbjct: 61 SHPKLVQLYGVCLEQA-PICLVTEFMEHGCLSDYLRTQRGLFAAETL---LGMCLDVCEG 116
Query: 170 IAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGF-- 227
+AYL ++HR + + E + K+ DF ++ + + + TGT F
Sbjct: 117 MAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS---TGTK-FPV 169
Query: 228 --LAPEYINTGDFNEKCDVFSFGMLL 251
+PE + ++ K DV+SFG+L+
Sbjct: 170 KWASPEVFSFSRYSSKSDVWSFGVLM 195
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 1e-13
Identities = 40/192 (20%), Positives = 81/192 (42%), Gaps = 17/192 (8%)
Query: 97 EDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV-IVFESVKNRTLADHIYQNQPHFEPLL 155
+ I H N++KL ++ +V E + L + I + + HF
Sbjct: 50 ANTQKEITALKLCEGHPNIVKLHEVF-HDQLHTFLVMELLNGGELFERI-KKKKHF---- 103
Query: 156 LSQR--LRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFL---DEGYIAKLFDFSLSVSI 210
S+ I + +A++++H ++HR ++P + ++ K+ DF +
Sbjct: 104 -SETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159
Query: 211 PEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIG 270
P +K T+ + APE +N ++E CD++S G++L +L+GQ F
Sbjct: 160 PPDNQPLKTPC-FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC 218
Query: 271 AGHYWLLHYVKK 282
++ +KK
Sbjct: 219 TSAVEIMKKIKK 230
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-13
Identities = 45/182 (24%), Positives = 78/182 (42%), Gaps = 29/182 (15%)
Query: 108 KLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIA 167
K+S H N+++L +VF+ +K L D++ + E + +I +
Sbjct: 79 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE----KETRKIMRALL 134
Query: 168 NAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGF 227
I LH I+HR ++P I LD+ KL DF S + GE +++ GT +
Sbjct: 135 EVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-LREVC-GTPSY 189
Query: 228 LAPE------YINTGDFNEKCDVFSFGMLLLVLLTG---------QKIFDPSRGDEIGAG 272
LAPE N + ++ D++S G+++ LL G + I +G
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML-----RMIMSG 244
Query: 273 HY 274
+Y
Sbjct: 245 NY 246
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-13
Identities = 36/145 (24%), Positives = 69/145 (47%), Gaps = 14/145 (9%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAI 170
SH+ +++L G C + R I+ E + N L +++ + + F+ L L + + A+
Sbjct: 77 SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL---LEMCKDVCEAM 133
Query: 171 AYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGF--- 227
YL S+ LHR + +++ + K+ DF LS + + E G+ F
Sbjct: 134 EYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV---GSK-FPVR 186
Query: 228 -LAPEYINTGDFNEKCDVFSFGMLL 251
PE + F+ K D+++FG+L+
Sbjct: 187 WSPPEVLMYSKFSSKSDIWAFGVLM 211
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-13
Identities = 26/133 (19%), Positives = 53/133 (39%), Gaps = 7/133 (5%)
Query: 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPS 189
+ + LA + + PL + + I I +A+ H + HR ++P
Sbjct: 111 VDMRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPE 163
Query: 190 RIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGM 249
I + A L DF ++ + + + GT+ ++APE + + D+++
Sbjct: 164 NILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTC 223
Query: 250 LLLVLLTGQKIFD 262
+L LTG +
Sbjct: 224 VLYECLTGSPPYQ 236
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-13
Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 20/148 (13%)
Query: 111 SHKNVLKLTGCCLETRIPV-IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANA 169
H+ +++L T+ P+ I+ E ++N +L D + L +++ L +A IA
Sbjct: 66 QHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPSGI--KLTINKLLDMAAQIAEG 121
Query: 170 IAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKD------KVTG 223
+A++ R +HR +R + I + + K+ DF L+ I + E ++ K T
Sbjct: 122 MAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT- 177
Query: 224 TMGFLAPEYINTGDFNEKCDVFSFGMLL 251
APE IN G F K DV+SFG+LL
Sbjct: 178 -----APEAINYGTFTIKSDVWSFGILL 200
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 34/160 (21%), Positives = 60/160 (37%), Gaps = 22/160 (13%)
Query: 107 SKLSSHKNVLKLTGCCLETRIPVIVFESVKN----------RTLADHIYQNQPHFEPLLL 156
S L H+N++ L G C +++ E + +
Sbjct: 104 SHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAST 163
Query: 157 SQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETC 216
L + +A +A+L S+ +HR + + L G++AK+ DF L+ I
Sbjct: 164 RDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 220
Query: 217 VKDKVTGTMGFL-----APEYINTGDFNEKCDVFSFGMLL 251
+ L APE I + + DV+S+G+LL
Sbjct: 221 IV----KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 256
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 39/162 (24%), Positives = 63/162 (38%), Gaps = 24/162 (14%)
Query: 107 SKLSSHKNVLKLTGCCLETRIPVIVFESVKN----------RTLADHIYQNQPHFEPLLL 156
+ HKN++ L G C + ++ E R N H L
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 157 SQR--LRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE 214
S + + A +A + YL S+ +HR + + + E + K+ DF L+ I +
Sbjct: 189 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245
Query: 215 TCVKDKVTGTMGFL-----APEYINTGDFNEKCDVFSFGMLL 251
K T G L APE + + + DV+SFG+LL
Sbjct: 246 YYKK----TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 283
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 38/178 (21%), Positives = 72/178 (40%), Gaps = 20/178 (11%)
Query: 108 KLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIA 167
+ H ++++L + +VFE + L I + + I
Sbjct: 81 HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 168 NAIAYLHIGFSRPILHRKIRPSRIFL---DEGYIAKLFDFSLSVSIPEGETCVKDKVTGT 224
A+ Y H I+HR ++P + L + KL F +++ + E +V GT
Sbjct: 141 EALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GT 196
Query: 225 MGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTG--------QKIFDPSRGDEIGAGHY 274
F+APE + + + DV+ G++L +LL+G +++F + I G Y
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLF-----EGIIKGKY 249
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-13
Identities = 33/162 (20%), Positives = 61/162 (37%), Gaps = 24/162 (14%)
Query: 107 SKLSSHKNVLKLTGCCLETRIPVIVFESVKN----------RTLADHIYQNQPHFEPLLL 156
+ HKN++ L G C + ++ E R + +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 157 SQR--LRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE 214
+ + + +A + YL S+ +HR + + + E + K+ DF L+ I +
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 215 TCVKDKVTGTMGFL-----APEYINTGDFNEKCDVFSFGMLL 251
K T G L APE + + + DV+SFG+L+
Sbjct: 212 YYKK----TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-13
Identities = 40/177 (22%), Positives = 71/177 (40%), Gaps = 25/177 (14%)
Query: 111 SHKNVLKLTGCCLETRIPV-IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANA 169
H N++K+ E + IV E+ + L + I Q + L + + NA
Sbjct: 78 DHPNIIKIFEVF-EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA 136
Query: 170 IAYLHIGFSRPILHRKIRPSRIFL---DEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMG 226
+AY H S+ ++H+ ++P I K+ DF L+ E + GT
Sbjct: 137 LAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH-STNAA-GTAL 191
Query: 227 FLAPEYINTGDFNEKCDVFSFGMLLLVLLTG---------QKIFDPSRGDEIGAGHY 274
++APE D KCD++S G+++ LLTG +++ +
Sbjct: 192 YMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ-----QKATYKEP 242
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 2e-13
Identities = 39/177 (22%), Positives = 66/177 (37%), Gaps = 24/177 (13%)
Query: 108 KLSSHKNVLKLTGC--CLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQR--LRIA 163
K +HKN++KL TR V++ E +L + + + L + L +
Sbjct: 62 KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG---LPESEFLIVL 118
Query: 164 VHIANAIAYLHIGFSRPILHRKIRPSRIFL----DEGYIAKLFDFSLSVSIPEGETCVKD 219
+ + +L I+HR I+P I D + KL DF + + + E V
Sbjct: 119 RDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS- 174
Query: 220 KVTGTMGFLAPEYINTGD--------FNEKCDVFSFGMLLLVLLTGQKIFDPSRGDE 268
+ GT +L P+ + D++S G+ TG F P G
Sbjct: 175 -LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 3e-13
Identities = 36/148 (24%), Positives = 65/148 (43%), Gaps = 22/148 (14%)
Query: 111 SHKNVLKLTGCCLETRIPV-IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANA 169
H N+++L G +E + + IV E + +L D++ L L+ ++ + A
Sbjct: 72 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEA 129
Query: 170 IAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMG--- 226
+ YL +HR + + + E +AK+ DF L+ K+ +
Sbjct: 130 MEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLT----------KEASSTQDTGKL 176
Query: 227 ---FLAPEYINTGDFNEKCDVFSFGMLL 251
+ APE + F+ K DV+SFG+LL
Sbjct: 177 PVKWTAPEALREKKFSTKSDVWSFGILL 204
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 3e-13
Identities = 37/141 (26%), Positives = 60/141 (42%), Gaps = 9/141 (6%)
Query: 112 HKNVLKLTGCCLETRIPV-IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAI 170
H +++KL G E PV I+ E L + + + L + A ++ A+
Sbjct: 450 HPHIVKLIGVITEN--PVWIIMELCTLGELRSFLQVRKFSLDLASL---ILYAYQLSTAL 504
Query: 171 AYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAP 230
AYL S+ +HR I + + KL DF LS + + K + ++AP
Sbjct: 505 AYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 561
Query: 231 EYINTGDFNEKCDVFSFGMLL 251
E IN F DV+ FG+ +
Sbjct: 562 ESINFRRFTSASDVWMFGVCM 582
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 3e-13
Identities = 53/251 (21%), Positives = 95/251 (37%), Gaps = 59/251 (23%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAI 170
+ ++++ G C ++V E + L ++ QN+ + + + ++ +
Sbjct: 76 DNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGM 130
Query: 171 AYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGF--L 228
YL +HR + + L + AK+ DF LS ++ E K + G
Sbjct: 131 KYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 187
Query: 229 APEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENN 287
APE IN F+ K DV+SFG+L+ + GQK P Y + + +
Sbjct: 188 APECINYYKFSSKSDVWSFGVLMWEAFSYGQK---P----------YRGM-------KGS 227
Query: 288 EFDEIVDPIIVSEGPRVGKEKQLQGFR---------EL-ALMCVC--ESAEDRPTTVDVA 335
E +++ +G R E+ LM +C E+RP V
Sbjct: 228 EVTAMLE----------------KGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVE 271
Query: 336 KRLKQIYQHLA 346
RL+ Y +
Sbjct: 272 LRLRNYYYDVV 282
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 4e-13
Identities = 36/141 (25%), Positives = 63/141 (44%), Gaps = 9/141 (6%)
Query: 124 ETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILH 183
+P IV E V TL D ++ P+ + + + A+ + H I+H
Sbjct: 87 AGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSH---QNGIIH 139
Query: 184 RKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCV--KDKVTGTMGFLAPEYINTGDFNEK 241
R ++P+ I + K+ DF ++ +I + V V GT +L+PE + +
Sbjct: 140 RDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDAR 199
Query: 242 CDVFSFGMLLLVLLTGQKIFD 262
DV+S G +L +LTG+ F
Sbjct: 200 SDVYSLGCVLYEVLTGEPPFT 220
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-13
Identities = 47/216 (21%), Positives = 87/216 (40%), Gaps = 31/216 (14%)
Query: 94 DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV-IVFESVKNRTLADHIYQNQPHFE 152
F + + H+NVL+L E +VFE ++ ++ HI + HF
Sbjct: 52 HIRSRVFREVEMLYQCQGHRNVLELIEFF-EEEDRFYLVFEKMRGGSILSHI-HKRRHF- 108
Query: 153 PLLLSQR--LRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFL---DEGYIAKLFDFSLS 207
++ + +A+A+ +LH ++ I HR ++P I ++ K+ DF L
Sbjct: 109 ----NELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLG 161
Query: 208 VSIPEGETCVKDKVT------GTMGFLAPE-----YINTGDFNEKCDVFSFGMLLLVLLT 256
I C G+ ++APE ++++CD++S G++L +LL+
Sbjct: 162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLS 221
Query: 257 GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEI 292
G F G+ W +N F+ I
Sbjct: 222 GYPPFV----GRCGSDCGWDRGEACPACQNMLFESI 253
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 4e-13
Identities = 39/177 (22%), Positives = 65/177 (36%), Gaps = 32/177 (18%)
Query: 108 KLSSHKNVLKLTGCCLETRIPV-IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAV-- 164
+ H NV++ C T + I E L D + E L L +
Sbjct: 64 ESDDHPNVIRYY-CSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLL 121
Query: 165 -HIANAIAYLHIGFSRPILHRKIRPSRIFLD-------------EGYIAKLFDFSLSVSI 210
IA+ +A+LH S I+HR ++P I + E + DF L +
Sbjct: 122 RQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 178
Query: 211 PEGETCVKDKVT---GTMGFLAPEYINTGDF-------NEKCDVFSFGMLLLVLLTG 257
G++ + + GT G+ APE + + D+FS G + +L+
Sbjct: 179 DSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-13
Identities = 35/147 (23%), Positives = 63/147 (42%), Gaps = 16/147 (10%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAI 170
H N+++L G R+ +IV E ++N +L + + F + L + + + +
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL---VGMLRGVGAGM 164
Query: 171 AYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFL-- 228
YL +HR + + +D + K+ DF LS + + D T G
Sbjct: 165 RYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP----DAAYTTTGGKIP 217
Query: 229 ----APEYINTGDFNEKCDVFSFGMLL 251
APE I F+ DV+SFG+++
Sbjct: 218 IRWTAPEAIAFRTFSSASDVWSFGVVM 244
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 5e-13
Identities = 34/163 (20%), Positives = 63/163 (38%), Gaps = 26/163 (15%)
Query: 107 SKLSSHKNVLKLTGCCLETRIPVIVFESVKN----------RTLADHIYQNQPHFEPLLL 156
+ HKN++ L G C + ++ E R + +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 157 SQR--LRIAVHIANAIAYLHIGFSRPILHRKIRPSR-IFLDEGYIAKLFDFSLSVSIPEG 213
+ + + +A + YL S+ +HR + +R + + E + K+ DF L+ I
Sbjct: 201 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLA-ARNVLVTENNVMKIADFGLARDINNI 256
Query: 214 ETCVKDKVTGTMGFL-----APEYINTGDFNEKCDVFSFGMLL 251
+ K T G L APE + + + DV+SFG+L+
Sbjct: 257 DYYKK----TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 295
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 5e-13
Identities = 39/147 (26%), Positives = 59/147 (40%), Gaps = 19/147 (12%)
Query: 111 SHKNVLKLTGCCLETRIPV-IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANA 169
H +++KL G T PV I+ E L + + + L + A ++ A
Sbjct: 74 DHPHIVKLIGVI--TENPVWIIMELCTLGELRSFLQVRKYSLDLASL---ILYAYQLSTA 128
Query: 170 IAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFL- 228
+AYL S+ +HR I + + KL DF LS + + K G L
Sbjct: 129 LAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK-----GKLP 180
Query: 229 ----APEYINTGDFNEKCDVFSFGMLL 251
APE IN F DV+ FG+ +
Sbjct: 181 IKWMAPESINFRRFTSASDVWMFGVCM 207
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 5e-13
Identities = 38/145 (26%), Positives = 61/145 (42%), Gaps = 15/145 (10%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAI 170
H +++KL G E I+ E L ++ +N+ + L L + ++ I A+
Sbjct: 71 DHPHIVKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTL---VLYSLQICKAM 126
Query: 171 AYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGF--- 227
AYL S +HR I I + KL DF LS I + + K + T
Sbjct: 127 AYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY---KASVTR-LPIK 179
Query: 228 -LAPEYINTGDFNEKCDVFSFGMLL 251
++PE IN F DV+ F + +
Sbjct: 180 WMSPESINFRRFTTASDVWMFAVCM 204
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 6e-13
Identities = 34/146 (23%), Positives = 61/146 (41%), Gaps = 15/146 (10%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAI 170
H N+++L G C I+ E + L D++ + + + L +A I++A+
Sbjct: 67 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAM 124
Query: 171 AYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFL-- 228
YL + +HR + + E ++ K+ DF LS +
Sbjct: 125 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-----AKFPI 176
Query: 229 ---APEYINTGDFNEKCDVFSFGMLL 251
APE + F+ K DV++FG+LL
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLL 202
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 7e-13
Identities = 37/164 (22%), Positives = 58/164 (35%), Gaps = 26/164 (15%)
Query: 107 SKLSSHKNVLKLTGCCLETRIPVIVFESVKN--------------RTLADHIYQNQPHFE 152
S L +H N++ L G C +++ E +
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 153 PLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212
L L L + +A +A+L S+ +HR + I L G I K+ DF L+ I
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 213 GETCVKDKVTGTMGFL-----APEYINTGDFNEKCDVFSFGMLL 251
V L APE I + + DV+S+G+ L
Sbjct: 198 DSNYVV----KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFL 237
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 8e-13
Identities = 41/185 (22%), Positives = 82/185 (44%), Gaps = 35/185 (18%)
Query: 108 KLSSHKNVLKLTGCCLETRIPV-IVFESVKNRTLADHIYQNQPHFEPLLLSQR--LRIAV 164
+++ H +++ L E+ + +VF+ ++ L D++ + S++ I
Sbjct: 155 QVAGHPHIITLIDSY-ESSSFMFLVFDLMRKGELFDYLTEKV-AL-----SEKETRSIMR 207
Query: 165 HIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGT 224
+ A+++LH + I+HR ++P I LD+ +L DF S + GE +++ GT
Sbjct: 208 SLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-LRELC-GT 262
Query: 225 MGFLAPE------YINTGDFNEKCDVFSFGMLLLVLLTG---------QKIFDPSRGDEI 269
G+LAPE + ++ D+++ G++L LL G + I
Sbjct: 263 PGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILML-----RMI 317
Query: 270 GAGHY 274
G Y
Sbjct: 318 MEGQY 322
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 9e-13
Identities = 42/162 (25%), Positives = 61/162 (37%), Gaps = 27/162 (16%)
Query: 107 SKLSSHKNVLKLTGCCLETRIPVIVFESVKN----------RTLADHIYQNQPHFEPLLL 156
KL H N++ L G C + E + R L + L
Sbjct: 80 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 139
Query: 157 SQR--LRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE 214
S + L A +A + YL + +HR + I + E Y+AK+ DF LS
Sbjct: 140 SSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV-- 194
Query: 215 TCVKDKVTGTMGFL-----APEYINTGDFNEKCDVFSFGMLL 251
V TMG L A E +N + DV+S+G+LL
Sbjct: 195 -----YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 231
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 39/157 (24%), Positives = 67/157 (42%), Gaps = 23/157 (14%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFE-----------PLLLSQR 159
H+++++ G C E R ++VFE +++ L + + P + PL L Q
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 160 LRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKD 219
L +A +A + YL +HR + + +G + K+ DF +S I +
Sbjct: 161 LAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV- 216
Query: 220 KVTGTMGFL-----APEYINTGDFNEKCDVFSFGMLL 251
G L PE I F + DV+SFG++L
Sbjct: 217 ---GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVL 250
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 32/143 (22%), Positives = 64/143 (44%), Gaps = 8/143 (5%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAI 170
H N+++L G +++ +IV E ++N +L + ++ F + L + + IA+ +
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL---VGMLRGIASGM 160
Query: 171 AYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFL-- 228
YL +HR + I ++ + K+ DF L + + G +
Sbjct: 161 KYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 229 APEYINTGDFNEKCDVFSFGMLL 251
+PE I F DV+S+G++L
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVL 240
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-12
Identities = 36/147 (24%), Positives = 64/147 (43%), Gaps = 16/147 (10%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAI 170
SH N+++L G + + +I+ E ++N L + + F L L + + IA +
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQL---VGMLRGIAAGM 160
Query: 171 AYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTG------T 224
YL + +HR + I ++ + K+ DF LS + + G T
Sbjct: 161 KYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 217
Query: 225 MGFLAPEYINTGDFNEKCDVFSFGMLL 251
APE I+ F DV+SFG+++
Sbjct: 218 ----APEAISYRKFTSASDVWSFGIVM 240
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 1e-12
Identities = 30/150 (20%), Positives = 58/150 (38%), Gaps = 12/150 (8%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAI 170
H ++ L + V+++E + L + + + +R + +
Sbjct: 212 RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ---VCKGL 268
Query: 171 AYLHIGFSRPILHRKIRPSRIFL---DEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGF 227
++H +H ++P I + KL DF L+ + ++ VK GT F
Sbjct: 269 CHMH---ENNYVHLDLKPENIMFTTKRSNEL-KLIDFGLTAHLDPKQS-VKVTT-GTAEF 322
Query: 228 LAPEYINTGDFNEKCDVFSFGMLLLVLLTG 257
APE D++S G+L +LL+G
Sbjct: 323 AAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 39/193 (20%), Positives = 78/193 (40%), Gaps = 28/193 (14%)
Query: 108 KLSSHKNVLKLTGCCLETRIPV-----IVFESVKNRTLADHIYQNQPHFEPLLLSQR--L 160
+ S +++ + E I+ E ++ L I + ++R
Sbjct: 77 QASGGPHIVCILDVY-ENMHHGKRCLLIIMECMEGGELFSRIQERGDQA----FTEREAA 131
Query: 161 RIAVHIANAIAYLHIGFSRPILHRKIRPSRIFL---DEGYIAKLFDFSLSVSIPEGETCV 217
I I AI +LH S I HR ++P + ++ + KL DF + + +
Sbjct: 132 EIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--L 186
Query: 218 KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLL 277
+ T ++APE + +++ CD++S G+++ +LL G F + G I G
Sbjct: 187 QTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG----- 240
Query: 278 HYVKKCIENNEFD 290
+K+ I ++
Sbjct: 241 --MKRRIRLGQYG 251
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 39/190 (20%), Positives = 67/190 (35%), Gaps = 38/190 (20%)
Query: 108 KLSSHKNVLKLTGCCLETRIPV-----IVFESVKNRTLADHIYQNQPHFEPLLLSQR--L 160
+ S +++++ E IV E + L I ++R
Sbjct: 110 RASQCPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA----FTEREAS 164
Query: 161 RIAVHIANAIAYLHIGFSRPILHRKIRPSRIFL---DEGYIAKLFDFSLSVSIPEGETCV 217
I I AI YLH S I HR ++P + I KL DF + + +
Sbjct: 165 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-L 220
Query: 218 KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTG-------------QKIFDPS 264
T ++APE + +++ CD++S G+++ +LL G +
Sbjct: 221 TTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--- 276
Query: 265 RGDEIGAGHY 274
I G Y
Sbjct: 277 --TRIRMGQY 284
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 2e-12
Identities = 44/176 (25%), Positives = 79/176 (44%), Gaps = 26/176 (14%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAI 170
H N+++L E +VF+ V L + I + + E + I +I
Sbjct: 63 QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE----ADASHCIQQILESI 118
Query: 171 AYLHIGFSRPILHRKIRPSRIFL---DEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGF 227
AY H S I+HR ++P + L +G KL DF L++ + + E GT G+
Sbjct: 119 AYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFA-GTPGY 173
Query: 228 LAPEYINTGDFNEKCDVFSFGMLLLVLLTG---------QKIFDPSRGDEIGAGHY 274
L+PE + +++ D+++ G++L +LL G +++ +I AG Y
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY-----AQIKAGAY 224
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 2e-12
Identities = 50/177 (28%), Positives = 78/177 (44%), Gaps = 29/177 (16%)
Query: 111 SHKNVLKLTGCCLETRIPV-IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANA 169
H N++KL E IV E L D I + + E RI + +
Sbjct: 79 DHPNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIKRKRFSE----HDAARIIKQVFSG 133
Query: 170 IAYLHIGFSRPILHRKIRPSRIFL---DEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMG 226
I Y+H I+HR ++P I L ++ K+ DF LS + +KD++ GT
Sbjct: 134 ITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRI-GTAY 188
Query: 227 FLAPEYINTGDFNEKCDVFSFGMLLLVLLTG---------QKIFDPSRGDEIGAGHY 274
++APE + G ++EKCDV+S G++L +LL+G I + G Y
Sbjct: 189 YIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL-----KRVETGKY 239
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 39/181 (21%), Positives = 75/181 (41%), Gaps = 35/181 (19%)
Query: 111 SHKNVLKLTGCCLETRIPV-IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVH---- 165
H N+++L ++F+ V L + I + + E A H
Sbjct: 68 KHPNIVRLHDSI-SEEGHHYLIFDLVTGGELFEDIVAREYYSE--------ADASHCIQQ 118
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFL---DEGYIAKLFDFSLSVSIPEGETCVKDKVT 222
I A+ + H ++HR ++P + L +G KL DF L++ + +
Sbjct: 119 ILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA- 174
Query: 223 GTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTG---------QKIFDPSRGDEIGAGH 273
GT G+L+PE + + + D+++ G++L +LL G +++ +I AG
Sbjct: 175 GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLY-----QQIKAGA 229
Query: 274 Y 274
Y
Sbjct: 230 Y 230
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-12
Identities = 46/180 (25%), Positives = 80/180 (44%), Gaps = 34/180 (18%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVH----I 166
H N+++L E +VF+ V L + I + + E A H I
Sbjct: 86 QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE--------ADASHCIQQI 137
Query: 167 ANAIAYLHIGFSRPILHRKIRPSRIFL---DEGYIAKLFDFSLSVSIPEGETCVKDKVTG 223
+IAY H S I+HR ++P + L +G KL DF L++ + + E G
Sbjct: 138 LESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW-HGFA-G 192
Query: 224 TMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTG---------QKIFDPSRGDEIGAGHY 274
T G+L+PE + +++ D+++ G++L +LL G +++ +I AG Y
Sbjct: 193 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY-----AQIKAGAY 247
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 4e-12
Identities = 40/177 (22%), Positives = 73/177 (41%), Gaps = 29/177 (16%)
Query: 111 SHKNVLKLTGCCLETRIPV-IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANA 169
H N+++L E + +V E L + + + E S RI + +A
Sbjct: 64 DHPNIIRLYETF-EDNTDIYLVMELCTGGELFERVVHKRVFRE----SDAARIMKDVLSA 118
Query: 170 IAYLHIGFSRPILHRKIRPSRIFL---DEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMG 226
+AY H + HR ++P KL DF L+ G+ ++ KV GT
Sbjct: 119 VAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-MRTKV-GTPY 173
Query: 227 FLAPEYINTGDFNEKCDVFSFGMLLLVLLTG---------QKIFDPSRGDEIGAGHY 274
+++P+ + G + +CD +S G+++ VLL G ++ +I G +
Sbjct: 174 YVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM-----LKIREGTF 224
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 6e-12
Identities = 40/158 (25%), Positives = 66/158 (41%), Gaps = 24/158 (15%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFE------------PLLLSQ 158
H++++K G C + ++VFE +K+ L + + P L LSQ
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 159 RLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVK 218
L IA IA+ + YL S+ +HR + + + K+ DF +S + +
Sbjct: 135 MLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 191
Query: 219 DKVTGTMGFL-----APEYINTGDFNEKCDVFSFGMLL 251
G L PE I F + DV+SFG++L
Sbjct: 192 ----GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVIL 225
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 1e-11
Identities = 35/181 (19%), Positives = 65/181 (35%), Gaps = 28/181 (15%)
Query: 108 KLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQR--LRIAVH 165
S V+ L T +++ E + +S+ +R+
Sbjct: 84 LAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEM----VSENDVIRLIKQ 139
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFL---DEGYIAKLFDFSLSVSIPEGETCVKDKVT 222
I + YLH I+H ++P I L K+ DF +S I +++ +
Sbjct: 140 ILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIM- 194
Query: 223 GTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTG---------QKIFDPSRGDEIGAGH 273
GT +LAPE +N D+++ G++ +LLT Q+ + I +
Sbjct: 195 GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETY-----LNISQVN 249
Query: 274 Y 274
Sbjct: 250 V 250
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 45/180 (25%), Positives = 71/180 (39%), Gaps = 33/180 (18%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEP---LLLSQRLRIAVHIA 167
H N++ L V++ E V L D + Q + E + Q I
Sbjct: 73 LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ-------IL 125
Query: 168 NAIAYLHIGFSRPILHRKIRPSRIFL----DEGYIAKLFDFSLSVSIPEGETCVKDKVTG 223
+ + YLH ++ I H ++P I L KL DF L+ I +G K+ G
Sbjct: 126 DGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF-G 180
Query: 224 TMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTG---------QKIFDPSRGDEIGAGHY 274
T F+APE +N + D++S G++ +LL+G Q+ I A Y
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL-----ANITAVSY 235
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 3e-11
Identities = 40/179 (22%), Positives = 75/179 (41%), Gaps = 33/179 (18%)
Query: 111 SHKNVLKLTGCCLETRIPV-IVFESVKNRTLADHIYQNQPHFEPLLLSQRL--RIAVHIA 167
H+N++ L E+ +V + V L D I + + +++ + +
Sbjct: 64 KHENIVTLEDIY-ESTTHYYLVMQLVSGGELFDRILERG-VY-----TEKDASLVIQQVL 116
Query: 168 NAIAYLHIGFSRPILHRKIRPSRIFL---DEGYIAKLFDFSLSVSIPEGETCVKDKVTGT 224
+A+ YLH I+HR ++P + +E + DF LS G GT
Sbjct: 117 SAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM--STAC-GT 170
Query: 225 MGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTG---------QKIFDPSRGDEIGAGHY 274
G++APE + +++ D +S G++ +LL G K+F ++I G+Y
Sbjct: 171 PGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLF-----EKIKEGYY 224
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 3e-11
Identities = 30/158 (18%), Positives = 58/158 (36%), Gaps = 24/158 (15%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFE------------PLLLSQ 158
H NV+ L G + + ++F + L + + PH + L
Sbjct: 70 QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129
Query: 159 RLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVK 218
+ + IA + YL S ++H+ + + + + K+ D L + +
Sbjct: 130 FVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKL 186
Query: 219 DKVTGTMGFL-----APEYINTGDFNEKCDVFSFGMLL 251
L APE I G F+ D++S+G++L
Sbjct: 187 ----LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVL 220
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 48/182 (26%), Positives = 72/182 (39%), Gaps = 37/182 (20%)
Query: 111 SHKNVLKLTGCCLETRIPV-IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVH---- 165
SH N++KL ET + +V E V L D I + + E R A
Sbjct: 106 SHPNIIKLKEIF-ETPTEISLVLELVTGGELFDRIVEKGYYSE--------RDAADAVKQ 156
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFL---DEGYIAKLFDFSLSVSIPEGETCVKDKVT 222
I A+AYLH I+HR ++P + K+ DF LS + +K
Sbjct: 157 ILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-MKTVC- 211
Query: 223 GTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTG----------QKIFDPSRGDEIGAG 272
GT G+ APE + + + D++S G++ +LL G Q +F I
Sbjct: 212 GTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMF-----RRILNC 266
Query: 273 HY 274
Y
Sbjct: 267 EY 268
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 42/177 (23%), Positives = 72/177 (40%), Gaps = 25/177 (14%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRL--RIAVHIAN 168
+H ++K+ IV E ++ L D + N+ L + +
Sbjct: 198 NHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR------LKEATCKLYFYQMLL 250
Query: 169 AIAYLHIGFSRPILHRKIRPSRIFL---DEGYIAKLFDFSLSVSIPEGETCVKDKVTGTM 225
A+ YLH I+HR ++P + L +E + K+ DF S + E ++ GT
Sbjct: 251 AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLC-GTP 305
Query: 226 GFLAPEYINTGDF---NEKCDVFSFGMLLLVLLTGQKIFDPSRGDE-----IGAGHY 274
+LAPE + + N D +S G++L + L+G F R I +G Y
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 362
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 35/169 (20%), Positives = 61/169 (36%), Gaps = 31/169 (18%)
Query: 107 SKLSSHKNVLKLTGCCLETRIPVIVFESVKN-------------------RTLADHIYQN 147
++L SH+N++ L G C + ++FE +
Sbjct: 103 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162
Query: 148 QPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS 207
+ L L A +A + +L + +HR + + + G + K+ DF L+
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLA 219
Query: 208 VSIPEGETCVKDKVTGTMGFL-----APEYINTGDFNEKCDVFSFGMLL 251
I V L APE + G + K DV+S+G+LL
Sbjct: 220 RDIMSDSNYVV----RGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 264
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 4e-11
Identities = 45/180 (25%), Positives = 71/180 (39%), Gaps = 33/180 (18%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEP---LLLSQRLRIAVHIA 167
H NV+ L V++ E V L D + Q + E + Q I
Sbjct: 73 LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ-------IL 125
Query: 168 NAIAYLHIGFSRPILHRKIRPSRIFL----DEGYIAKLFDFSLSVSIPEGETCVKDKVTG 223
+ + YLH ++ I H ++P I L KL DF L+ I +G K+ G
Sbjct: 126 DGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF-G 180
Query: 224 TMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTG---------QKIFDPSRGDEIGAGHY 274
T F+APE +N + D++S G++ +LL+G Q+ I + Y
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL-----ANITSVSY 235
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 4e-11
Identities = 45/180 (25%), Positives = 71/180 (39%), Gaps = 33/180 (18%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEP---LLLSQRLRIAVHIA 167
H N++ L V++ E V L D + + + E L Q I
Sbjct: 66 RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQ-------IL 118
Query: 168 NAIAYLHIGFSRPILHRKIRPSRIFL----DEGYIAKLFDFSLSVSIPEGETCVKDKVTG 223
+ + YLH S+ I H ++P I L KL DF ++ I G K+ G
Sbjct: 119 DGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIF-G 173
Query: 224 TMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTG---------QKIFDPSRGDEIGAGHY 274
T F+APE +N + D++S G++ +LL+G Q+ I A +Y
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL-----TNISAVNY 228
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 6e-11
Identities = 45/180 (25%), Positives = 70/180 (38%), Gaps = 33/180 (18%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEP---LLLSQRLRIAVHIA 167
H NV+ L +++ E V L D + + + E L Q I
Sbjct: 72 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ-------IL 124
Query: 168 NAIAYLHIGFSRPILHRKIRPSRIFL----DEGYIAKLFDFSLSVSIPEGETCVKDKVTG 223
N + YLH S I H ++P I L K+ DF L+ I G K+ G
Sbjct: 125 NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIF-G 179
Query: 224 TMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTG---------QKIFDPSRGDEIGAGHY 274
T F+APE +N + D++S G++ +LL+G Q+ + A +Y
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL-----ANVSAVNY 234
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 6e-11
Identities = 32/159 (20%), Positives = 66/159 (41%), Gaps = 21/159 (13%)
Query: 112 HKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIA 171
+++L + + +V E N L + + + + +R ++ A+
Sbjct: 87 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVH 141
Query: 172 YLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGET-CVKDKVTGTMGFLAP 230
+H I+H ++P+ + +G + KL DF ++ + T VKD GT+ ++ P
Sbjct: 142 TIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197
Query: 231 EYI-----------NTGDFNEKCDVFSFGMLLLVLLTGQ 258
E I + + K DV+S G +L + G+
Sbjct: 198 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 8e-11
Identities = 37/123 (30%), Positives = 57/123 (46%), Gaps = 21/123 (17%)
Query: 143 HIYQ-NQPHFEPLLLSQRLRI-AVHIANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIA 199
HIY Q F R A I + LH I++R ++P I LD G+I
Sbjct: 274 HIYHMGQAGFPE----ARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHI- 325
Query: 200 KLFDFSLSVSIPEGET----CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLL 255
++ D L+V +PEG+T GT+G++APE + + D ++ G LL ++
Sbjct: 326 RISDLGLAVHVPEGQTIKGRV------GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMI 379
Query: 256 TGQ 258
GQ
Sbjct: 380 AGQ 382
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 8e-11
Identities = 32/163 (19%), Positives = 66/163 (40%), Gaps = 21/163 (12%)
Query: 112 HKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIA 171
+++L + + +V E N L + + + + +R ++ A+
Sbjct: 115 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVH 169
Query: 172 YLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGET-CVKDKVTGTMGFLAP 230
+H I+H ++P+ + +G + KL DF ++ + T VKD G + ++ P
Sbjct: 170 TIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225
Query: 231 EYI-----------NTGDFNEKCDVFSFGMLLLVLLTGQKIFD 262
E I + + K DV+S G +L + G+ F
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 1e-10
Identities = 33/151 (21%), Positives = 59/151 (39%), Gaps = 14/151 (9%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQR--LRIAVHIAN 168
H+N+L L V++FE + + + I + ++R + +
Sbjct: 59 RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFEL-----NEREIVSYVHQVCE 113
Query: 169 AIAYLHIGFSRPILHRKIRPSRIFL--DEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMG 226
A+ +LH S I H IRP I K+ +F + + G+ +
Sbjct: 114 ALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLLF-TAPE 168
Query: 227 FLAPEYINTGDFNEKCDVFSFGMLLLVLLTG 257
+ APE + D++S G L+ VLL+G
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-10
Identities = 32/153 (20%), Positives = 62/153 (40%), Gaps = 26/153 (16%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAI 170
SHK+++ G C+ ++V E VK +L ++ +N+ + +L +A +A A+
Sbjct: 70 SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCIN---ILWKLEVAKQLAAAM 126
Query: 171 AYLHIGFSRPILHRKI--------RPSRIFLDEGYIAKLFDFSLSVSIPEGETC---VKD 219
+L ++H + R KL D +S+++ + +
Sbjct: 127 HFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP- 182
Query: 220 KVTGTMGFLAPEYI-NTGDFNEKCDVFSFGMLL 251
++ PE I N + N D +SFG L
Sbjct: 183 -------WVPPECIENPKNLNLATDKWSFGTTL 208
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 1e-10
Identities = 37/104 (35%), Positives = 52/104 (50%), Gaps = 10/104 (9%)
Query: 161 RIAVHIANAIAYLHIGFSRPILHRKIRPSRIFL--DEGYIAKLFDFSLSVSIP---EGET 215
I I +A+ YLH ++ I HR I+P ++ + KL DF LS GE
Sbjct: 172 NIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY 228
Query: 216 CVKDKVTGTMGFLAPEYINTGD--FNEKCDVFSFGMLLLVLLTG 257
GT F+APE +NT + + KCD +S G+LL +LL G
Sbjct: 229 YGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMG 272
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-10
Identities = 37/153 (24%), Positives = 57/153 (37%), Gaps = 12/153 (7%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAI 170
S ++ L G E I E ++ +L I Q E L +
Sbjct: 108 SSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALY----YLGQALEGL 163
Query: 171 AYLHIGFSRPILHRKIRPSRIFLD-EGYIAKLFDF----SLSVSIPEGETCVKDKVTGTM 225
YLH +R ILH ++ + L +G A L DF L D + GT
Sbjct: 164 EYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTE 220
Query: 226 GFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQ 258
+APE + + K D++S ++L +L G
Sbjct: 221 THMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 1e-10
Identities = 36/165 (21%), Positives = 65/165 (39%), Gaps = 32/165 (19%)
Query: 112 HKNVLKLTGCCLETRIPVIVFE--------------------SVKNRTLADHIYQNQPHF 151
H +V+KL G C + +++ E + + + + P
Sbjct: 85 HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 152 EPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211
L + + A I+ + YL ++HR + I + EG K+ DF LS +
Sbjct: 145 RALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 212 EGETCVKDKVTGTMGFL-----APEYINTGDFNEKCDVFSFGMLL 251
E ++ VK + G + A E + + + DV+SFG+LL
Sbjct: 202 EEDSYVK----RSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 25/94 (26%), Positives = 41/94 (43%), Gaps = 7/94 (7%)
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFL--DEGYIAKLFDFSLSVSIPEGETCVKDKVTG 223
+ ++H I+H I+P I + K+ DF L+ + E VK
Sbjct: 158 ACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI-VKVTT-A 212
Query: 224 TMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTG 257
T F APE ++ D+++ G+L VLL+G
Sbjct: 213 TAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 37/168 (22%), Positives = 67/168 (39%), Gaps = 36/168 (21%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFE--------------------SVKNRTLADHIYQNQPH 150
+ N++KL G C + ++FE S+ + L+ + P
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167
Query: 151 FEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKI--RPSRIFLDEGYIAKLFDFSLSV 208
PL +++L IA +A +AYL R +HR + R + E + K+ DF LS
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATR--NCLVGENMVVKIADFGLSR 222
Query: 209 SIPEGETCVKDKVTGTMGFL-----APEYINTGDFNEKCDVFSFGMLL 251
+I + + PE I + + DV+++G++L
Sbjct: 223 NIYSADYYKA----DGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 266
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 32/159 (20%), Positives = 66/159 (41%), Gaps = 21/159 (13%)
Query: 112 HKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIA 171
+++L + + +V E N L + + + + +R ++ A+
Sbjct: 68 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVH 122
Query: 172 YLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGET-CVKDKVTGTMGFLAP 230
+H I+H ++P+ + +G + KL DF ++ + T VKD GT+ ++ P
Sbjct: 123 TIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
Query: 231 EYI-----------NTGDFNEKCDVFSFGMLLLVLLTGQ 258
E I + + K DV+S G +L + G+
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-10
Identities = 38/165 (23%), Positives = 67/165 (40%), Gaps = 28/165 (16%)
Query: 108 KLSSHKNVLKL-----TGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRI 162
K+ +H N++KL T E + ++ E + D++ + E +
Sbjct: 69 KILNHPNIVKLFEVIET----EKTL-YLIMEYASGGEVFDYLVAHGRMKEK----EARSK 119
Query: 163 AVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE----TCVK 218
I +A+ Y H + I+HR ++ + LD K+ DF S G C
Sbjct: 120 FRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC-- 174
Query: 219 DKVTGTMGFLAPEYINTGDFN-EKCDVFSFGMLLLVLLTGQKIFD 262
G + APE ++ + DV+S G++L L++G FD
Sbjct: 175 ----GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 4e-10
Identities = 39/235 (16%), Positives = 81/235 (34%), Gaps = 43/235 (18%)
Query: 142 DHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKL 201
D + + +L ++++ + + YL I+HR ++PS I ++ KL
Sbjct: 119 DQVLKKAGRIPEQILG---KVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKL 173
Query: 202 FDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIF 261
DF VS ++ V GT +++PE + ++ + D++S G+ L+ + G+
Sbjct: 174 CDFG--VSGQLIDSMANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230
Query: 262 DPSRGDEIGAGHYWLLHYVKKCIENNEFD-------------------EIVDPIIVSEGP 302
P E+ + E++D I+ P
Sbjct: 231 PPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPP 290
Query: 303 RVGKEKQLQGFRELALMCVCESAEDRPT----------------TVDVAKRLKQI 341
++ F++ C+ ++ +R VD A L
Sbjct: 291 KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCST 345
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 6e-10
Identities = 31/122 (25%), Positives = 57/122 (46%), Gaps = 21/122 (17%)
Query: 143 HIYQNQPHFEPLLLSQRLRI-AVHIANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIAK 200
H+ Q+ E +R A I + ++H +R +++R ++P+ I LD G++ +
Sbjct: 282 HLSQHGVFSEA-----DMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHV-R 332
Query: 201 LFDFSLSVSIPEGET---CVKDKVTGTMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLT 256
+ D L+ + + GT G++APE + G ++ D FS G +L LL
Sbjct: 333 ISDLGLACDFSKKKPHASV------GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 386
Query: 257 GQ 258
G
Sbjct: 387 GH 388
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 7e-10
Identities = 30/95 (31%), Positives = 45/95 (47%), Gaps = 9/95 (9%)
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFL---DEGYIAKLFDFSLSVSIPEGETCVKDKVT 222
I I ++H ILH ++P I D I K+ DF L+ E +K
Sbjct: 196 ICEGIRHMH---QMYILHLDLKPENILCVNRDAKQI-KIIDFGLARRYKPREK-LKVNF- 249
Query: 223 GTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTG 257
GT FLAPE +N + D++S G++ +LL+G
Sbjct: 250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 9e-10
Identities = 33/118 (27%), Positives = 58/118 (49%), Gaps = 8/118 (6%)
Query: 143 HIYQNQPHFEPLLLSQRLRI-AVHIANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIAK 200
HIY N P R I + + +LH R I++R ++P + LD +G + +
Sbjct: 275 HIY-NVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNV-R 329
Query: 201 LFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQ 258
+ D L+V + G+T K GT GF+APE + +++ D F+ G+ L ++ +
Sbjct: 330 ISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 45/181 (24%), Positives = 76/181 (41%), Gaps = 27/181 (14%)
Query: 108 KLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEP---LLLSQRLRIAV 164
K +H ++K+ + IV E ++ L D + N+ E L Q
Sbjct: 70 KKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ------ 122
Query: 165 HIANAIAYLHIGFSRPILHRKIRPSRIFL---DEGYIAKLFDFSLSVSIPEGETCVKDKV 221
+ A+ YLH I+HR ++P + L +E + K+ DF S + E ++
Sbjct: 123 -MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLC 177
Query: 222 TGTMGFLAPEYINTGD---FNEKCDVFSFGMLLLVLLTGQKIFDPSRGDE-----IGAGH 273
GT +LAPE + + +N D +S G++L + L+G F R I +G
Sbjct: 178 -GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 236
Query: 274 Y 274
Y
Sbjct: 237 Y 237
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 1e-09
Identities = 29/120 (24%), Positives = 50/120 (41%), Gaps = 12/120 (10%)
Query: 142 DHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKL 201
+ + + L L + + +A + +L SR +HR + I L E + K+
Sbjct: 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKI 234
Query: 202 FDFSLSVSIPEGETCVKDKVTGTMGFL-----APEYINTGDFNEKCDVFSFGMLLLVLLT 256
DF L+ I + V+ L APE I + + DV+SFG+LL + +
Sbjct: 235 CDFGLARDIYKDPDYVR----KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-09
Identities = 43/161 (26%), Positives = 69/161 (42%), Gaps = 16/161 (9%)
Query: 108 KLSSHKNVLKL---TGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAV 164
K H NV+KL E + +VFE V + + + +P E Q
Sbjct: 91 KKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVME-VPTLKPLSED----QARFYFQ 144
Query: 165 HIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGT 224
+ I YLH + I+HR I+PS + + E K+ DF +S + +G + GT
Sbjct: 145 DLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVS-NEFKGSDALLSNTVGT 200
Query: 225 MGFLAPEYINTGDFN---EKCDVFSFGMLLLVLLTGQKIFD 262
F+APE ++ + DV++ G+ L + GQ F
Sbjct: 201 PAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 3e-09
Identities = 46/161 (28%), Positives = 76/161 (47%), Gaps = 20/161 (12%)
Query: 108 KLSSHKNVLKLTGCCLETRIPV-IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHI 166
KL H +++KL + T +V E V L D+I ++ E + R+ I
Sbjct: 66 KLFRHPHIIKLYQV-ISTPTDFFMVMEYVSGGELFDYICKHGRVEEM----EARRLFQQI 120
Query: 167 ANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE----TCVKDKVT 222
+A+ Y H ++HR ++P + LD AK+ DF LS + +GE +C
Sbjct: 121 LSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC------ 171
Query: 223 GTMGFLAPEYINTGDFN-EKCDVFSFGMLLLVLLTGQKIFD 262
G+ + APE I+ + + D++S G++L LL G FD
Sbjct: 172 GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 3e-09
Identities = 28/124 (22%), Positives = 48/124 (38%), Gaps = 14/124 (11%)
Query: 161 RIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYI-AKLFDFSLSVSIPEG--ETCV 217
+ A+ + H + +LHR I+ I +D KL DF + +
Sbjct: 153 SFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 209
Query: 218 KDKVTGTMGFLAPEYINTGDFN-EKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWL 276
GT + PE+I ++ V+S G+LL ++ G F+ +EI G +
Sbjct: 210 -----GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE--HDEEIIRGQVFF 262
Query: 277 LHYV 280
V
Sbjct: 263 RQRV 266
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 3e-09
Identities = 38/154 (24%), Positives = 71/154 (46%), Gaps = 14/154 (9%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRL--RIAVHIAN 168
HKN+++ G E I E V +L+ + + + PL +++ I
Sbjct: 77 KHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALL---RSKWGPLKDNEQTIGFYTKQILE 133
Query: 169 AIAYLHIGFSRPILHRKIRPSRIFLD--EGYIAKLFDFSLSVSIPEGETCVKDKVTGTMG 226
+ YLH I+HR I+ + ++ G + K+ DF S + C + TGT+
Sbjct: 134 GLKYLH---DNQIVHRDIKGDNVLINTYSGVL-KISDFGTSKRLAGINPCTET-FTGTLQ 188
Query: 227 FLAPEYINTGD--FNEKCDVFSFGMLLLVLLTGQ 258
++APE I+ G + + D++S G ++ + TG+
Sbjct: 189 YMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-09
Identities = 31/121 (25%), Positives = 50/121 (41%), Gaps = 18/121 (14%)
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFLDE--GYIAKLFDFSLSVSIPEGE---TCVKDK 220
+ AI + H SR ++HR I+ I +D G KL DF + +
Sbjct: 148 VVAAIQHCH---SRGVVHRDIKDENILIDLRRGCA-KLIDFGSGALLHDEPYTDFD---- 199
Query: 221 VTGTMGFLAPEYINTGDFN-EKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHY 279
GT + PE+I+ ++ V+S G+LL ++ G F+ R EI +
Sbjct: 200 --GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE--RDQEILEAELHFPAH 255
Query: 280 V 280
V
Sbjct: 256 V 256
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 8e-09
Identities = 18/148 (12%), Positives = 34/148 (22%), Gaps = 37/148 (25%)
Query: 127 IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKI 186
++V E ++ +L + +R +A A H +
Sbjct: 105 GGLVVAEWIRGGSLQEVAD------TSPSPVGAIRAMQSLAAAADAAH---RAGVALSID 155
Query: 187 RPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFS 246
PSR+ + L + N + D+
Sbjct: 156 HPSRVRVSIDGDVVLAYP---------------------ATMPDA-------NPQDDIRG 187
Query: 247 FGMLLLVLLTGQKIFDPSRGDEIGAGHY 274
G L LL + + A
Sbjct: 188 IGASLYALLVNRWPLPEAGVRSGLAPAE 215
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 27/119 (22%), Positives = 50/119 (42%), Gaps = 14/119 (11%)
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE---TCVKDKVT 222
+ +A+ YL + I+HR I+ I + E + KL DF + + G+ T
Sbjct: 139 LVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC----- 190
Query: 223 GTMGFLAPEYINTGDFN-EKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYV 280
GT+ + APE + + + +++S G+ L L+ + F E + V
Sbjct: 191 GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE--ETVEAAIHPPYLV 247
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 5e-08
Identities = 25/108 (23%), Positives = 50/108 (46%), Gaps = 10/108 (9%)
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIAKLFDFSLSVSIPEGETCVKDKVTGT 224
+ A+ YL ++ I+HR ++P I LD G++ + DF+++ +P + GT
Sbjct: 124 LVMALDYLQ---NQRIIHRDMKPDNILLDEHGHV-HITDFNIAAMLPRETQI--TTMAGT 177
Query: 225 MGFLAPEYINTGDF---NEKCDVFSFGMLLLVLLTGQKIFDPSRGDEI 269
++APE ++ + D +S G+ LL G++ +
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS 225
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 7e-08
Identities = 35/103 (33%), Positives = 54/103 (52%), Gaps = 9/103 (8%)
Query: 161 RIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDK 220
++ V I A+ YL ++HR ++PS I LDE KL DF +S + KD+
Sbjct: 128 KMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDF--GISGRLVDDKAKDR 183
Query: 221 VTGTMGFLAPEYINTGD-----FNEKCDVFSFGMLLLVLLTGQ 258
G ++APE I+ D ++ + DV+S G+ L+ L TGQ
Sbjct: 184 SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 9e-08
Identities = 28/102 (27%), Positives = 51/102 (50%), Gaps = 8/102 (7%)
Query: 161 RIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDK 220
+IAV I A+ +LH ++HR ++PS + ++ K+ DF +S + KD
Sbjct: 113 KIAVSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDF--GISGYLVDDVAKDI 168
Query: 221 VTGTMGFLAPEYI----NTGDFNEKCDVFSFGMLLLVLLTGQ 258
G ++APE I N ++ K D++S G+ ++ L +
Sbjct: 169 DAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 38/277 (13%), Positives = 76/277 (27%), Gaps = 47/277 (16%)
Query: 92 LNDGHEDCFNNI---IFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQ 148
L + + + SKL +H N++ + +V + + D I +
Sbjct: 62 LEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHF 121
Query: 149 PHF--EPLLLSQRLRIAV---HIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFD 203
E IA + A+ Y+H +HR ++ S I + L
Sbjct: 122 MDGMNELA-------IAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSG 171
Query: 204 FSLSVSIPEG------ETCVKDKVTGTMGFLAPEYI--NTGDFNEKCDVFSFGMLLLVLL 255
++S+ + +L+PE + N ++ K D++S G+ L
Sbjct: 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELA 231
Query: 256 TGQ---------------------KIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVD 294
G + D S + ++
Sbjct: 232 NGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPR 291
Query: 295 PIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTT 331
P F C+ + + RP+
Sbjct: 292 PSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSA 328
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 1e-07
Identities = 32/99 (32%), Positives = 52/99 (52%), Gaps = 16/99 (16%)
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIAKLFDFSLS-VSIPEGET----CVKD 219
I+ A+ +LH + I++R ++P I L+ +G++ KL DF L SI +G C
Sbjct: 130 ISMALGHLH---QKGIIYRDLKPENIMLNHQGHV-KLTDFGLCKESIHDGTVTHTFC--- 182
Query: 220 KVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQ 258
GT+ ++APE + N D +S G L+ +LTG
Sbjct: 183 ---GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-07
Identities = 35/172 (20%), Positives = 69/172 (40%), Gaps = 9/172 (5%)
Query: 87 KFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQ 146
+ ++ ++ N I + + + N++ L +V E + +L D +
Sbjct: 51 RQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVT 109
Query: 147 NQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSL 206
E Q + A+ +LH S ++HR I+ I L KL DF
Sbjct: 110 ETCMDEG----QIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGF 162
Query: 207 SVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQ 258
I E + + GT ++APE + + K D++S G++ + ++ G+
Sbjct: 163 CAQITP-EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 2e-07
Identities = 45/158 (28%), Positives = 72/158 (45%), Gaps = 11/158 (6%)
Query: 108 KLSSHKNVLKLTGCCLETRIPV-IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHI 166
K+ +H+NV+K G + E L D I + EP R +
Sbjct: 60 KMLNHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPEP----DAQRFFHQL 114
Query: 167 ANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS-VSIPEGETCVKDKVTGTM 225
+ YLH I HR I+P + LDE K+ DF L+ V + +K+ GT+
Sbjct: 115 MAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 226 GFLAPEYINTGDFN-EKCDVFSFGMLLLVLLTGQKIFD 262
++APE + +F+ E DV+S G++L +L G+ +D
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 2e-07
Identities = 37/99 (37%), Positives = 55/99 (55%), Gaps = 16/99 (16%)
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIAKLFDFSLS-VSIPEGET----CVKD 219
+A A+ +LH S I++R ++P I LD EG+I KL DF LS SI + C
Sbjct: 135 LALALDHLH---SLGIIYRDLKPENILLDEEGHI-KLTDFGLSKESIDHEKKAYSFC--- 187
Query: 220 KVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQ 258
GT+ ++APE +N + D +SFG+L+ +LTG
Sbjct: 188 ---GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 47/165 (28%), Positives = 76/165 (46%), Gaps = 28/165 (16%)
Query: 108 KLSSHKNVLKL-----TGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRI 162
KL H +++KL T + I +V E V L D+I +N E + R+
Sbjct: 71 KLFRHPHIIKLYQVIST----PSDI-FMVMEYVSGGELFDYICKNGRLDEK----ESRRL 121
Query: 163 AVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE----TCVK 218
I + + Y H ++HR ++P + LD AK+ DF LS + +GE +C
Sbjct: 122 FQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-- 176
Query: 219 DKVTGTMGFLAPEYINTGDFN-EKCDVFSFGMLLLVLLTGQKIFD 262
G+ + APE I+ + + D++S G++L LL G FD
Sbjct: 177 ----GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 2e-07
Identities = 38/162 (23%), Positives = 73/162 (45%), Gaps = 10/162 (6%)
Query: 97 EDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLL 156
E FN ++ H NV+++ L ++ E ++ L D I E
Sbjct: 87 ELLFNEVVIMRD-YQHFNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEE--- 141
Query: 157 SQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETC 216
Q + + A+AYLH ++ ++HR I+ I L KL DF I + +
Sbjct: 142 -QIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK-DVP 196
Query: 217 VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQ 258
+ + GT ++APE I+ + + D++S G++++ ++ G+
Sbjct: 197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 33/103 (32%), Positives = 55/103 (53%), Gaps = 16/103 (15%)
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIAKLFDFSLS-VSIPEGET----CVKD 219
IA + +L S+ I++R ++ + LD EG+I K+ DF + +I +G T C
Sbjct: 130 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHI-KIADFGMCKENIWDGVTTKTFC--- 182
Query: 220 KVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFD 262
GT ++APE I + + D ++FG+LL +L GQ F+
Sbjct: 183 ---GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 222
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 31/113 (27%), Positives = 55/113 (48%), Gaps = 16/113 (14%)
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIAKLFDFSLS-VSIPEGET----CVKD 219
I+ A+ YLH R I++R ++ + LD EG+I KL D+ + + G+T C
Sbjct: 162 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHI-KLTDYGMCKEGLRPGDTTSTFC--- 214
Query: 220 KVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAG 272
GT ++APE + D+ D ++ G+L+ ++ G+ FD +
Sbjct: 215 ---GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 264
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 45/158 (28%), Positives = 72/158 (45%), Gaps = 11/158 (6%)
Query: 108 KLSSHKNVLKLTGCCLETRIPV-IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHI 166
K+ +H+NV+K G + E L D I + EP R +
Sbjct: 60 KMLNHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPEP----DAQRFFHQL 114
Query: 167 ANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS-VSIPEGETCVKDKVTGTM 225
+ YLH I HR I+P + LDE K+ DF L+ V + +K+ GT+
Sbjct: 115 MAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 226 GFLAPEYINTGDFN-EKCDVFSFGMLLLVLLTGQKIFD 262
++APE + +F+ E DV+S G++L +L G+ +D
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 34/106 (32%), Positives = 56/106 (52%), Gaps = 16/106 (15%)
Query: 163 AVHIANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIAKLFDFSLS-VSIPEGET----C 216
A IA + +L S+ I++R ++ + LD EG+I K+ DF + +I +G T C
Sbjct: 448 AAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHI-KIADFGMCKENIWDGVTTKTFC 503
Query: 217 VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFD 262
GT ++APE I + + D ++FG+LL +L GQ F+
Sbjct: 504 ------GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 4e-07
Identities = 31/113 (27%), Positives = 55/113 (48%), Gaps = 16/113 (14%)
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIAKLFDFSLS-VSIPEGET----CVKD 219
I+ A+ YLH R I++R ++ + LD EG+I KL D+ + + G+T C
Sbjct: 119 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHI-KLTDYGMCKEGLRPGDTTSTFC--- 171
Query: 220 KVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAG 272
GT ++APE + D+ D ++ G+L+ ++ G+ FD +
Sbjct: 172 ---GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 221
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 5e-07
Identities = 27/99 (27%), Positives = 47/99 (47%), Gaps = 10/99 (10%)
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIAKLFDFSLSVSIPEGETCVKDKVTGT 224
+ AI +H +HR I+P I +D G+I +L DF + + E T GT
Sbjct: 184 MVIAIDSVH---QLHYVHRDIKPDNILMDMNGHI-RLADFGSCLKLMEDGTVQSSVAVGT 239
Query: 225 MGFLAPEYINT-----GDFNEKCDVFSFGMLLLVLLTGQ 258
+++PE + G + +CD +S G+ + +L G+
Sbjct: 240 PDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 6e-07
Identities = 37/154 (24%), Positives = 62/154 (40%), Gaps = 15/154 (9%)
Query: 108 KLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAV--- 164
V K G L+ I+ E + + D + + P E IA
Sbjct: 75 SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQ-------IATILR 126
Query: 165 HIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGT 224
I + YLH S +HR I+ + + L E KL DF ++ + ++ GT
Sbjct: 127 EILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNTFVGT 182
Query: 225 MGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQ 258
++APE I ++ K D++S G+ + L G+
Sbjct: 183 PFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 216
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 6e-07
Identities = 26/98 (26%), Positives = 47/98 (47%), Gaps = 9/98 (9%)
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIAKLFDFSLSVSIPEGETCVKDKVTGT 224
+ A+ +H S +HR ++P + LD G++ KL DF + + + D GT
Sbjct: 177 VVLALDAIH---SMGFIHRDVKPDNMLLDKSGHL-KLADFGTCMKMNKEGMVRCDTAVGT 232
Query: 225 MGFLAPEYI----NTGDFNEKCDVFSFGMLLLVLLTGQ 258
+++PE + G + +CD +S G+ L +L G
Sbjct: 233 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 6e-07
Identities = 31/103 (30%), Positives = 51/103 (49%), Gaps = 16/103 (15%)
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIAKLFDFSLS-VSIPEGET----CVKD 219
I + +LH S+ I++R ++ I LD +G+I K+ DF + ++ C
Sbjct: 127 IILGLQFLH---SKGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFC--- 179
Query: 220 KVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFD 262
GT ++APE + +N D +SFG+LL +L GQ F
Sbjct: 180 ---GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH 219
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 7e-07
Identities = 32/103 (31%), Positives = 53/103 (51%), Gaps = 16/103 (15%)
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIAKLFDFSLS-VSIPEGET----CVKD 219
I +A+ YLH SR +++R I+ + LD +G+I K+ DF L I +G T C
Sbjct: 114 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHI-KITDFGLCKEGISDGATMKTFC--- 166
Query: 220 KVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFD 262
GT +LAPE + D+ D + G+++ ++ G+ F
Sbjct: 167 ---GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 206
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 9e-07
Identities = 29/103 (28%), Positives = 52/103 (50%), Gaps = 15/103 (14%)
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIAKLFDFSLS-VSIPEGET----CVKD 219
I +A+ YLH + +++R ++ + LD +G+I K+ DF L I +G T C
Sbjct: 257 IVSALDYLHS--EKNVVYRDLKLENLMLDKDGHI-KITDFGLCKEGIKDGATMKTFC--- 310
Query: 220 KVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFD 262
GT +LAPE + D+ D + G+++ ++ G+ F
Sbjct: 311 ---GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 350
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 34/102 (33%), Positives = 52/102 (50%), Gaps = 14/102 (13%)
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE----TCVKDKV 221
I AI Y H I+HR ++P + LD+ K+ DF LS + +G +C
Sbjct: 117 IICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC----- 168
Query: 222 TGTMGFLAPEYINTGDFN-EKCDVFSFGMLLLVLLTGQKIFD 262
G+ + APE IN + + DV+S G++L V+L G+ FD
Sbjct: 169 -GSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 45/202 (22%), Positives = 80/202 (39%), Gaps = 28/202 (13%)
Query: 74 YKGF-VEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV--- 129
YKG V+ ++ +K D+ D E+ I K S H+N+ G ++ P
Sbjct: 41 YKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 100
Query: 130 ---IVFESVKNRTLAD--HIYQNQPHFEPLLLSQRLRIAV---HIANAIAYLHIGFSRPI 181
+V E ++ D + E IA I +++LH +
Sbjct: 101 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-------IAYICREILRGLSHLH---QHKV 150
Query: 182 LHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYI-----NTG 236
+HR I+ + L E KL DF +S + + ++ GT ++APE I
Sbjct: 151 IHRDIKGQNVLLTENAEVKLVDFGVSAQL-DRTVGRRNTFIGTPYWMAPEVIACDENPDA 209
Query: 237 DFNEKCDVFSFGMLLLVLLTGQ 258
++ K D++S G+ + + G
Sbjct: 210 TYDFKSDLWSLGITAIEMAEGA 231
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 1e-06
Identities = 25/95 (26%), Positives = 50/95 (52%), Gaps = 6/95 (6%)
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIAKLFDFSLS-VSIPEGETCVKDKVTG 223
I +A+ YLH + I+HR ++P I L+ + +I ++ DF + V PE + + G
Sbjct: 139 IVSALEYLH---GKGIIHRDLKPENILLNEDMHI-QITDFGTAKVLSPESKQARANSFVG 194
Query: 224 TMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQ 258
T +++PE + + D+++ G ++ L+ G
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 33/99 (33%), Positives = 50/99 (50%), Gaps = 16/99 (16%)
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIAKLFDFSLS-VSIPEGET----CVKD 219
IA+A+ YLH S I++R ++P I LD +G+I L DF L +I T C
Sbjct: 148 IASALGYLH---SLNIVYRDLKPENILLDSQGHI-VLTDFGLCKENIEHNSTTSTFC--- 200
Query: 220 KVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQ 258
GT +LAPE ++ ++ D + G +L +L G
Sbjct: 201 ---GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 1e-06
Identities = 35/168 (20%), Positives = 66/168 (39%), Gaps = 27/168 (16%)
Query: 108 KLSSHKNVLKL-TGCCLETRIPV-IVFESVKN--RTLADHIYQNQPHFEPLLLSQRLRIA 163
+ HKNV++L E + + +V E + + D + + + Q
Sbjct: 61 RRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-----RFPVCQAHGYF 115
Query: 164 VHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE-------TC 216
+ + + YLH S+ I+H+ I+P + L G K+ ++ ++ +
Sbjct: 116 CQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ 172
Query: 217 VKDKVTGTMGFLAPEYINTGDFNE--KCDVFSFGMLLLVLLTGQKIFD 262
G+ F PE N D K D++S G+ L + TG F+
Sbjct: 173 ------GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 1e-06
Identities = 30/103 (29%), Positives = 50/103 (48%), Gaps = 16/103 (15%)
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIAKLFDFSLS-VSIPEGET----CVKD 219
I +A+ +LH + I++R ++ + LD EG+ KL DF + I G T C
Sbjct: 133 IISALMFLH---DKGIIYRDLKLDNVLLDHEGHC-KLADFGMCKEGICNGVTTATFC--- 185
Query: 220 KVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFD 262
GT ++APE + + D ++ G+LL +L G F+
Sbjct: 186 ---GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFE 225
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 36/167 (21%), Positives = 68/167 (40%), Gaps = 8/167 (4%)
Query: 92 LNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHF 151
+ ++ I + +V+K G + IV E +++D I + +
Sbjct: 64 VESDLQEIIKEISIMQQ-CDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNK- 120
Query: 152 EPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211
L + I + YLH +HR I+ I L+ AKL DF ++ +
Sbjct: 121 -TLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT 176
Query: 212 EGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQ 258
+ ++ V GT ++APE I +N D++S G+ + + G+
Sbjct: 177 D-TMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 29/101 (28%), Positives = 45/101 (44%), Gaps = 12/101 (11%)
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIAKLFDFSLSVSIPEGETCVKDKVTGT 224
I AI +H +HR I+P I LD G+I +L DF + + T GT
Sbjct: 171 IVMAIDSVH---RLGYVHRDIKPDNILLDRCGHI-RLADFGSCLKLRADGTVRSLVAVGT 226
Query: 225 MGFLAPEYI-------NTGDFNEKCDVFSFGMLLLVLLTGQ 258
+L+PE + TG + +CD ++ G+ + GQ
Sbjct: 227 PDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 3e-06
Identities = 32/105 (30%), Positives = 52/105 (49%), Gaps = 14/105 (13%)
Query: 161 RIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE---TCV 217
+I + A+ +L + I+HR I+PS I LD KL DF +S G+ +
Sbjct: 129 KITLATVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGIS-----GQLVDSIA 181
Query: 218 KDKVTGTMGFLAPEYI----NTGDFNEKCDVFSFGMLLLVLLTGQ 258
K + G ++APE I + ++ + DV+S G+ L L TG+
Sbjct: 182 KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 3e-06
Identities = 29/105 (27%), Positives = 49/105 (46%), Gaps = 11/105 (10%)
Query: 162 IAV---HIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVK 218
IA + + YLH +HR ++ I L E ++ DF +S + G +
Sbjct: 123 IATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR 179
Query: 219 DKVTGTM-G---FLAPEYINTGD-FNEKCDVFSFGMLLLVLLTGQ 258
+KV T G ++APE + ++ K D++SFG+ + L TG
Sbjct: 180 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.9 bits (113), Expect = 3e-06
Identities = 41/421 (9%), Positives = 102/421 (24%), Gaps = 166/421 (39%)
Query: 51 ELEIATNNFDARNVIKDGYAYKFYKGF----VEDRTVSVMK---FNDILNDGHEDCFNNI 103
+ E + + ++++ + F F V+D S++ + I+
Sbjct: 8 DFETGEHQYQYKDILSV-FEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLR 66
Query: 104 IFASKLSSHKNVLK-----------------LTGCCLETRIPVIVFESVKNRTLAD---- 142
+F + LS + +++ + + + ++ ++R D
Sbjct: 67 LFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVF 126
Query: 143 ---HIYQNQPHFE--PLLLSQR--LRIAVH-----------------------IANAIAY 172
++ + QP+ + LL R + + + I +
Sbjct: 127 AKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFW 186
Query: 173 LHIG----------------------------FSRPILHR----KIRPSRIFLDEGY--- 197
L++ S I R + R+ + Y
Sbjct: 187 LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENC 246
Query: 198 -----------IAKLFDFSLSVSIPEGETCVKDKVTGT-----------MGFLAPE---- 231
F+ S + + V D ++ M E
Sbjct: 247 LLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSL 306
Query: 232 ---YINTGDF---NEKCDVFSFGMLLLVLLTGQKIFD-PSRGDEIGAGHYW-------LL 277
Y++ E + + + I D + D W L
Sbjct: 307 LLKYLDCRPQDLPREVLT----TNPRRLSIIAESIRDGLATWD------NWKHVNCDKLT 356
Query: 278 HYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKR 337
++ + E E +++ F L++ +
Sbjct: 357 TIIESSLNVLEPAEY---------------RKM--FDRLSVF-----PPSAHIPTILLSL 394
Query: 338 L 338
+
Sbjct: 395 I 395
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 8e-06
Identities = 46/313 (14%), Positives = 85/313 (27%), Gaps = 91/313 (29%)
Query: 2 DMSCFLRTRKHFEKTENREFMIENGKILVETLV----VCCYGKFNP--IRGFTI--RELE 53
D S ++ R H + E R + K L+ V N F + + L
Sbjct: 218 DHSSNIKLRIHSIQAELRRLLKS--KPYENCLLVLLNVQ-----NAKAWNAFNLSCKIL- 269
Query: 54 IATNNFDARNVIKDGYAYKFY-----KGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASK 108
+ T + + D S +
Sbjct: 270 LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKS-------------------LLLKY 310
Query: 109 LSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIAN 168
L C +P E + P LS IA I +
Sbjct: 311 LD-----------CRPQDLPR---EVLTT--------------NPRRLSI---IAESIRD 339
Query: 169 AIA----YLHIGFSRPILHRKIRPSRIFLDEGYIAKLFD----FSLSVSIPEGETCV--K 218
+A + H+ + L I S L+ K+FD F S IP +
Sbjct: 340 GLATWDNWKHVNCDK--LTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWF 397
Query: 219 DKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLL- 277
D + + + + ++ + + + L K+ + A H ++
Sbjct: 398 DVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKL------ENEYALHRSIVD 451
Query: 278 HY-VKKCIENNEF 289
HY + K ++++
Sbjct: 452 HYNIPKTFDSDDL 464
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 7e-06
Identities = 29/107 (27%), Positives = 48/107 (44%), Gaps = 12/107 (11%)
Query: 155 LLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE 214
LL Q L I +LH S I+HR ++PS I + K+ DF L+ +
Sbjct: 169 LLYQMLC-------GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218
Query: 215 TCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIF 261
+ V T + APE I + E D++S G ++ ++ + +F
Sbjct: 219 M-MTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 263
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 8e-06
Identities = 37/169 (21%), Positives = 62/169 (36%), Gaps = 34/169 (20%)
Query: 108 KLSSHKNVLKLTGCCL-ETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAV-- 164
+ H N+++ L T + I+ E L + I R
Sbjct: 71 RSLRHPNIVRFKEVILTPTHL-AIIMEYASGGELYERICNAG----------RFSEDEAR 119
Query: 165 ----HIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIA--KLFDFSLSVSIPEGE---- 214
+ + ++Y H S I HR ++ LD K+ DF S S
Sbjct: 120 FFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 176
Query: 215 TCVKDKVTGTMGFLAPEYINTGDFN-EKCDVFSFGMLLLVLLTGQKIFD 262
T GT ++APE + +++ + DV+S G+ L V+L G F+
Sbjct: 177 TV------GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE 219
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 30/107 (28%), Positives = 48/107 (44%), Gaps = 12/107 (11%)
Query: 155 LLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE 214
LL Q L I +LH S I+HR ++PS I + K+ DF L+ +
Sbjct: 132 LLYQMLC-------GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181
Query: 215 TCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIF 261
+ V T + APE I + E D++S G ++ ++ G +F
Sbjct: 182 M-MTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 226
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 32/112 (28%), Positives = 51/112 (45%), Gaps = 19/112 (16%)
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIAKLFDFSLS-VSIPEGET-----CVK 218
I A+ +LH I++R I+ I LD G++ L DF LS + + C
Sbjct: 168 IVLALEHLH---KLGIIYRDIKLENILLDSNGHV-VLTDFGLSKEFVADETERAYDFC-- 221
Query: 219 DKVTGTMGFLAPEYINTGD--FNEKCDVFSFGMLLLVLLTGQKIFDPSRGDE 268
GT+ ++AP+ + GD ++ D +S G+L+ LLTG F
Sbjct: 222 ----GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 269
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 29/100 (29%), Positives = 50/100 (50%), Gaps = 15/100 (15%)
Query: 163 AVHIANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIAKLFDFSLSVSIPEGET---CVK 218
A I YLH S +++R ++P + +D +GYI ++ DF + + +G T C
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI-QVTDFGFAKRV-KGRTWTLC-- 199
Query: 219 DKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQ 258
GT LAPE I + +N+ D ++ G+L+ + G
Sbjct: 200 ----GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 28/93 (30%), Positives = 45/93 (48%), Gaps = 11/93 (11%)
Query: 169 AIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFL 228
+AYLH S ++HR ++ I L E + KL DF + + + V GT ++
Sbjct: 166 GLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWM 217
Query: 229 APEYINT---GDFNEKCDVFSFGMLLLVLLTGQ 258
APE I G ++ K DV+S G+ + L +
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 1e-04
Identities = 39/190 (20%), Positives = 61/190 (32%), Gaps = 59/190 (31%)
Query: 108 KLSSHKNVLKLTGCCLETRIPV-----IVFESVKNRTLADHIYQNQPHFEPLLLSQR--L 160
+ S +++++ E IV E + L I ++R
Sbjct: 66 RASQCPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA----FTEREAS 120
Query: 161 RIAVHIANAIAYLHIGFSRPILHRKIRPSRIFL---DEGYIAKLFDFSLSVSIPEGETCV 217
I I AI YLH S I HR ++P + I KL DF
Sbjct: 121 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDF------------- 164
Query: 218 KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTG-------------QKIFDPS 264
GF A E +++ CD++S G+++ +LL G +
Sbjct: 165 --------GF-AKETTGEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--- 211
Query: 265 RGDEIGAGHY 274
I G Y
Sbjct: 212 --TRIRMGQY 219
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 41.7 bits (99), Expect = 2e-04
Identities = 32/96 (33%), Positives = 54/96 (56%), Gaps = 13/96 (13%)
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIAKLFDFSLSVSIPEGET--CVKDKVT 222
+ A+ YLH S+ I++R ++P I LD G+I K+ DF + +P+ C
Sbjct: 115 VCLALEYLH---SKDIIYRDLKPENILLDKNGHI-KITDFGFAKYVPDVTYTLC------ 164
Query: 223 GTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQ 258
GT ++APE ++T +N+ D +SFG+L+ +L G
Sbjct: 165 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 28/108 (25%), Positives = 52/108 (48%), Gaps = 15/108 (13%)
Query: 155 LLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE 214
L+ Q L+ + Y+H + I+HR ++P + ++E K+ DF L+
Sbjct: 133 LVYQMLK-------GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM 182
Query: 215 TCVKDKVTGTMGFLAPEYI-NTGDFNEKCDVFSFGMLLLVLLTGQKIF 261
T V T + APE I N + + D++S G ++ ++TG+ +F
Sbjct: 183 T---GYVV-TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF 226
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 3e-04
Identities = 29/108 (26%), Positives = 53/108 (49%), Gaps = 15/108 (13%)
Query: 155 LLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE 214
L+ Q L+ + Y+H S ++HR ++P + ++E K+ DF L+
Sbjct: 131 LVYQMLK-------GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM 180
Query: 215 TCVKDKVTGTMGFLAPEYI-NTGDFNEKCDVFSFGMLLLVLLTGQKIF 261
T V T + APE I + +N+ D++S G ++ +LTG+ +F
Sbjct: 181 T---GYVV-TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 224
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 4e-04
Identities = 33/108 (30%), Positives = 55/108 (50%), Gaps = 15/108 (13%)
Query: 155 LLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE 214
L+ Q LR + Y+H S I+HR ++PS + ++E K+ DF L+ +
Sbjct: 137 LIYQILR-------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM 186
Query: 215 TCVKDKVTGTMGFLAPEYI-NTGDFNEKCDVFSFGMLLLVLLTGQKIF 261
T V T + APE + N +N+ D++S G ++ LLTG+ +F
Sbjct: 187 T---GYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 6e-04
Identities = 25/101 (24%), Positives = 43/101 (42%), Gaps = 15/101 (14%)
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEP----LLLSQRLRIAVHI 166
H+N++ L C + + +VFE V + T+ D + + L Q +
Sbjct: 82 RHENLVNLLEVCKKKKRWYLVFEFV-DHTILDDLELFPNGLDYQVVQKYLFQIIN----- 135
Query: 167 ANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS 207
I + H S I+HR I+P I + + + KL DF +
Sbjct: 136 --GIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFA 171
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 6e-04
Identities = 22/95 (23%), Positives = 45/95 (47%), Gaps = 9/95 (9%)
Query: 169 AIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFL 228
A+ +LH S+ I+HR ++ + + +L DF +S + +D GT ++
Sbjct: 129 ALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK-TLQKRDSFIGTPYWM 184
Query: 229 APEYI-----NTGDFNEKCDVFSFGMLLLVLLTGQ 258
APE + ++ K D++S G+ L+ + +
Sbjct: 185 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 6e-04
Identities = 29/118 (24%), Positives = 49/118 (41%), Gaps = 22/118 (18%)
Query: 155 LLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE 214
+ Q LR A+ LH ++HR ++PS + ++ K+ DF L+ I E
Sbjct: 117 FIYQTLR-------AVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166
Query: 215 TCVKDKVTGTMGFL----------APEYI-NTGDFNEKCDVFSFGMLLLVLLTGQKIF 261
+ TG + APE + + ++ DV+S G +L L + IF
Sbjct: 167 A-DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF 223
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 346 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.74 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.5 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.24 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.07 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.81 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.55 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.53 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.51 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.49 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.47 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.3 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.19 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.16 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.06 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.75 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.72 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.67 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.53 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.51 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.47 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.45 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.33 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.28 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.23 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.16 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.46 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.35 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.55 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 91.12 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 90.85 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 80.16 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-62 Score=438.42 Aligned_cols=261 Identities=21% Similarity=0.330 Sum_probs=215.9
Q ss_pred hcCCCcccccccCCCcEEEEEEE-------CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcc
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV-------EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIP 128 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~-------~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~ 128 (346)
.++|...+.||+|+||+||+|.+ ++..||||++.........++.+|+.++.++ +|||||+++|+|.+.+..
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeCCEE
Confidence 35678889999999999999987 3678999999876656677889999999999 999999999999999999
Q ss_pred eEEEecccCCChhhhhhhcC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCce
Q 045453 129 VIVFESVKNRTLADHIYQNQ---------PHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIA 199 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~ 199 (346)
+||||||++|+|.++|.... .....++|.+++.++.|+|.||+||| +++|+||||||+|||+++++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcE
Confidence 99999999999999997642 22357999999999999999999999 8999999999999999999999
Q ss_pred EEeccCCCcccCCCCcee-eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHH
Q 045453 200 KLFDFSLSVSIPEGETCV-KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLL 277 (346)
Q Consensus 200 kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 277 (346)
||+|||+|+......... .....||+.|||||++.++.|+.++|||||||++|||+| |+.||......+ +.
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~-------~~ 240 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VI 240 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HH
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HH
Confidence 999999998765444332 234569999999999999999999999999999999999 899997654322 11
Q ss_pred HHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 278 HYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 278 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
..+. .+... . .+..++..+.+|+.+||+.||++||||.||++.|+++.+.
T Consensus 241 ~~i~----~~~~~------------~-~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 241 ECIT----QGRVL------------Q-RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHH----HTCCC------------C-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHH----cCCCC------------C-CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 1111 11110 0 1114456789999999999999999999999999998764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-61 Score=433.90 Aligned_cols=266 Identities=23% Similarity=0.354 Sum_probs=209.5
Q ss_pred HHHHhcCCCcccccccCCCcEEEEEEECCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcce
Q 045453 52 LEIATNNFDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV 129 (346)
Q Consensus 52 l~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~ 129 (346)
|++..++|...+.||+|+||+||+|.+.+ .||||++.... ......+.+|+.++.++ +|||||+++|+|.+ +.++
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~-~~~~ 107 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKT-RHVNILLFMGYMTK-DNLA 107 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS-SSCE
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEC-CeEE
Confidence 45566788889999999999999999865 58999986433 23456788899999998 99999999999865 5689
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcc
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVS 209 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~ 209 (346)
||||||++|+|.++|.... .+++|.+++.|+.|+|.||+||| +.+||||||||+|||+++++.+||+|||+|+.
T Consensus 108 iVmEy~~gGsL~~~l~~~~---~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 181 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQE---TKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATV 181 (307)
T ss_dssp EEEECCSSCBHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC
T ss_pred EEEEcCCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCcee
Confidence 9999999999999997654 46999999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCC-ceeeccccccCCcCCcccccc---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhh
Q 045453 210 IPEGE-TCVKDKVTGTMGFLAPEYINT---GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIE 285 (346)
Q Consensus 210 ~~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (346)
..... ........||+.|||||++.+ +.|+.++|||||||++|||+||+.||........ +...+ .
T Consensus 182 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~------~~~~~----~ 251 (307)
T 3omv_A 182 KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ------IIFMV----G 251 (307)
T ss_dssp ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HHHHH----H
T ss_pred cccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH------HHHHH----h
Confidence 65332 223355689999999999964 4689999999999999999999999976544221 11111 1
Q ss_pred cCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 045453 286 NNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHL 345 (346)
Q Consensus 286 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~l 345 (346)
.+.. .+.+.. ....++..+.+|+.+||+.+|++||||.||++.|+.+...|
T Consensus 252 ~~~~----~p~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 252 RGYA----SPDLSK-----LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp TTCC----CCCSTT-----SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred cCCC----CCCccc-----ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 1111 111100 11144567899999999999999999999999999887654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-61 Score=438.25 Aligned_cols=261 Identities=21% Similarity=0.329 Sum_probs=209.1
Q ss_pred hcCCCcccccccCCCcEEEEEEE-------CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcc
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV-------EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIP 128 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~-------~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~ 128 (346)
.++|...+.||+|+||+||+|.+ ++..||||++.........++.+|+.++.++ +|||||+++|+|.+.+..
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML-QHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEE
Confidence 35677788999999999999986 3678999999876656667889999999999 999999999999999999
Q ss_pred eEEEecccCCChhhhhhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCC
Q 045453 129 VIVFESVKNRTLADHIYQNQP-----------HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGY 197 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~ 197 (346)
+||||||++|+|.++|..... ...+++|.+++.++.|+|.||+||| +.+|+||||||+|||+++++
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTT
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCC
Confidence 999999999999999976432 1246999999999999999999999 89999999999999999999
Q ss_pred ceEEeccCCCcccCCCCc-eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhh
Q 045453 198 IAKLFDFSLSVSIPEGET-CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYW 275 (346)
Q Consensus 198 ~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~ 275 (346)
.+||+|||+++....... .......||+.|||||++.+..|+.++|||||||++|||+| |+.||......+
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~------- 268 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE------- 268 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH-------
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH-------
Confidence 999999999987654432 22345679999999999999999999999999999999999 999997654322
Q ss_pred HHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 276 LLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
+...+. .+.. + ..+..++..+.+|+.+||+.||++||||.||++.|+.|.+.
T Consensus 269 ~~~~i~----~g~~------------~-~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 269 AIDCIT----QGRE------------L-ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHHHH----HTCC------------C-CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHH----cCCC------------C-CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 111111 1110 0 01113456789999999999999999999999999998764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-61 Score=432.27 Aligned_cols=257 Identities=18% Similarity=0.304 Sum_probs=209.8
Q ss_pred cCCCcccccccCCCcEEEEEEE-------CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcc
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV-------EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIP 128 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~-------~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~ 128 (346)
+++...+.||+|+||+||+|.+ ++..||||++..... ....++.+|+.++.++ +|||||+++|+|.+.+..
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL-QHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSC
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhC-CCCCCCCcceEEEECCEE
Confidence 3455578899999999999997 357899999875543 3456788899999998 999999999999999999
Q ss_pred eEEEecccCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCC
Q 045453 129 VIVFESVKNRTLADHIYQNQP------------HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEG 196 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~ 196 (346)
+||||||++|||.++|..... ....++|..++.++.|+|.||+||| +.+||||||||+|||++++
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDK 181 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCC
Confidence 999999999999999975421 1246999999999999999999999 8999999999999999999
Q ss_pred CceEEeccCCCcccCCCCc-eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchh
Q 045453 197 YIAKLFDFSLSVSIPEGET-CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHY 274 (346)
Q Consensus 197 ~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~ 274 (346)
+.+||+|||+++....... ...+...||+.|||||++.++.|+.++|||||||++|||+| |..||.+....+
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~------ 255 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD------ 255 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH------
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH------
Confidence 9999999999987643332 22345679999999999999999999999999999999999 899997654322
Q ss_pred hHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 045453 275 WLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341 (346)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 341 (346)
+...+ ..+... +.+..++..+.+|+.+||+.||++||||.||++.|+.+
T Consensus 256 -~~~~i----~~~~~~-------------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 256 -VVEMI----RNRQVL-------------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp -HHHHH----HTTCCC-------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred -HHHHH----HcCCCC-------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 12111 111111 11124566789999999999999999999999999854
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-60 Score=434.09 Aligned_cols=272 Identities=20% Similarity=0.298 Sum_probs=223.7
Q ss_pred CCHHHHHHHhcCCCcccccccCCCcEEEEEEEC-------CeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeE
Q 045453 47 FTIRELEIATNNFDARNVIKDGYAYKFYKGFVE-------DRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKL 118 (346)
Q Consensus 47 ~~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~-------~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l 118 (346)
+..++|++..++|...+.||+|+||+||+|.+. ++.||||++..... .....+.+|+.++.++.+|||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 556788889999999999999999999999972 25899999876543 3456788999999999556999999
Q ss_pred cceeec-CCcceEEEecccCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecC
Q 045453 119 TGCCLE-TRIPVIVFESVKNRTLADHIYQNQP------------HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRK 185 (346)
Q Consensus 119 ~g~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~d 185 (346)
+|+|.+ ++.++||||||++|+|.++|+.... ....++|.+++.++.|+|.||.||| +.+|||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCc
Confidence 999976 4578999999999999999976421 1245899999999999999999999 89999999
Q ss_pred CCCCCeEEcCCCceEEeccCCCcccCCCCc-eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCC
Q 045453 186 IRPSRIFLDEGYIAKLFDFSLSVSIPEGET-CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDP 263 (346)
Q Consensus 186 lkp~NIll~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~ 263 (346)
|||+|||+++++.+||+|||+|+.+..+.. .......||+.|||||++.++.|+.++|||||||++|||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987754443 33456779999999999999999999999999999999998 9999987
Q ss_pred CCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 045453 264 SRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQ 343 (346)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 343 (346)
....+. +...+ ..+... ..+..++..+.+++.+||+.||++||||.||++.|+++++
T Consensus 291 ~~~~~~------~~~~i----~~g~~~-------------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 291 VKIDEE------FCRRL----KEGTRM-------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp CCCSHH------HHHHH----HHTCCC-------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHHH------HHHHH----HcCCCC-------------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 554331 11111 111100 0111345678899999999999999999999999999987
Q ss_pred h
Q 045453 344 H 344 (346)
Q Consensus 344 ~ 344 (346)
.
T Consensus 348 ~ 348 (353)
T 4ase_A 348 A 348 (353)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-59 Score=424.03 Aligned_cols=270 Identities=17% Similarity=0.250 Sum_probs=201.8
Q ss_pred CCCcccccccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHH--HHHHHhhhcCCCceeeEcceeecCC----cceEE
Q 045453 58 NFDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFN--NIIFASKLSSHKNVLKLTGCCLETR----IPVIV 131 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~--e~~~~~~~~~h~niv~l~g~~~~~~----~~~lv 131 (346)
+|...+.||+|+||+||+|.++|+.||||++.... ..++.. |+..+..+ +|||||+++|+|.+.+ .++||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l-~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhhHHHHHHHHHHhcC-CCCCCCcEEEEEEecCCCceEEEEE
Confidence 46677899999999999999999999999986432 233333 33444455 9999999999998654 57999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCceecCCCCCCeEEcCCCceEEeccCC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGF-----SRPILHRKIRPSRIFLDEGYIAKLFDFSL 206 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~iiH~dlkp~NIll~~~~~~kl~Dfgl 206 (346)
||||++|+|.++|+.. +++|..+..++.|+|.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+
T Consensus 80 ~Ey~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ecCCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 9999999999999764 5999999999999999999999421 23999999999999999999999999999
Q ss_pred CcccCCCCcee---eccccccCCcCCccccccC------CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccch----
Q 045453 207 SVSIPEGETCV---KDKVTGTMGFLAPEYINTG------DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGH---- 273 (346)
Q Consensus 207 ~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~---- 273 (346)
|+......... .....||+.|||||++.+. .++.++|||||||++|||+||..||............
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~ 234 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence 98765443221 2345799999999999754 4788999999999999999999887654433221100
Q ss_pred -hhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 274 -YWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 274 -~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
......... ..... .++.+.... ...+....+.+|+.+||+.||++||||.||++.|++|.++
T Consensus 235 ~~~~~~~~~~-~~~~~----~rp~~p~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 235 DPSVEEMRKV-VCEQK----LRPNIPNRW---QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp SCCHHHHHHH-HTTSC----CCCCCCGGG---GSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cchHHHHHHH-Hhccc----CCCCCCccc---cchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 011111111 11111 112111111 1125677899999999999999999999999999999764
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-58 Score=415.85 Aligned_cols=255 Identities=17% Similarity=0.179 Sum_probs=208.2
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
.+.|...++||+|+||+||+|.+ +++.||||++..... ..+|+.++..+ +|||||++++++.+.+.+|||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l-~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGL-SSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTC-CCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEe
Confidence 35577778899999999999998 789999999875421 23578888888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCC-ceEEeccCCCcccCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGY-IAKLFDFSLSVSIPE 212 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~-~~kl~Dfgl~~~~~~ 212 (346)
||++|+|.++|.... ++++..+..++.|++.||+||| +.+|+||||||+|||++.++ .+||+|||+|+.+..
T Consensus 131 y~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~ 203 (336)
T 4g3f_A 131 LLEGGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQP 203 (336)
T ss_dssp CCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred ccCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence 999999999998753 6999999999999999999999 99999999999999999987 699999999987754
Q ss_pred CCce----eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCc
Q 045453 213 GETC----VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE 288 (346)
Q Consensus 213 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (346)
.... .....+||+.|||||++.+..|+.++|||||||++|||+||+.||...+..+. ... + .....
T Consensus 204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~-i---~~~~~ 273 (336)
T 4g3f_A 204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL------CLK-I---ASEPP 273 (336)
T ss_dssp ----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC------HHH-H---HHSCC
T ss_pred CCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH------HHH-H---HcCCC
Confidence 3321 22346799999999999999999999999999999999999999987655443 111 1 11110
Q ss_pred cccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 045453 289 FDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHL 345 (346)
Q Consensus 289 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~l 345 (346)
.. ..+ ++..+..+.+++.+||+.||++|||+.|+++.|...++.+
T Consensus 274 ~~----~~~--------~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 274 PI----REI--------PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp GG----GGS--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred Cc----hhc--------CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 00 000 1134567889999999999999999999999999988764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-58 Score=422.77 Aligned_cols=249 Identities=22% Similarity=0.289 Sum_probs=201.5
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
++|...+.||+|+||+||+|.+ +++.||||++.... ......+.+|+.++..+ +|||||++++++.+.+.+||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-KHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHC-CCCCCCcEEEEEEECCEEEEEE
Confidence 5788999999999999999998 78999999987543 23456788899999998 9999999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
|||++|+|.++|..... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 103 Ey~~gg~L~~~i~~~~~--~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp ECCTTCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred eCCCCCcHHHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 99999999999976542 45789999999999999999999 89999999999999999999999999999987643
Q ss_pred CCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccc
Q 045453 213 GETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEI 292 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (346)
.. ......+||+.|||||++.+..|+.++|||||||++|||+||+.||...+..+. ...... +.+
T Consensus 178 ~~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~----------~~~i~~-~~~--- 242 (350)
T 4b9d_A 178 TV-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL----------VLKIIS-GSF--- 242 (350)
T ss_dssp HH-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----------HHHHHH-TCC---
T ss_pred Cc-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH----------HHHHHc-CCC---
Confidence 21 123456799999999999999999999999999999999999999976433221 111111 111
Q ss_pred cccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 293 VDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 293 ~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
+.. ....+..+.+|+.+||+.||++|||+.|+++
T Consensus 243 ---------~~~-~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 243 ---------PPV-SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp ---------CCC-CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---------CCC-CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 1134567889999999999999999999875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-57 Score=415.82 Aligned_cols=248 Identities=19% Similarity=0.305 Sum_probs=208.7
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEec
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFES 134 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~ 134 (346)
..|+..+.||+|+||+||+|.+ +++.||||++..........+.+|+.++..+ +|||||++++++.+.+.+||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEECC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEeC
Confidence 4588889999999999999999 7899999999766555667788999999998 999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCC
Q 045453 135 VKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE 214 (346)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~ 214 (346)
|++|+|.+++... .+++.++..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 153 ~~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 153 LEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp CTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred CCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence 9999999999763 4999999999999999999999 8999999999999999999999999999998775433
Q ss_pred ceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccc
Q 045453 215 TCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVD 294 (346)
Q Consensus 215 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 294 (346)
. .....+||+.|||||++.+..|+.++|||||||++|||++|+.||......+ ....+. . .. .
T Consensus 225 ~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-------~~~~i~---~-~~-----~ 287 (346)
T 4fih_A 225 P-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-------AMKMIR---D-NL-----P 287 (346)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHH---H-SS-----C
T ss_pred C-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-------HHHHHH---c-CC-----C
Confidence 2 2356789999999999999999999999999999999999999997543221 111111 1 10 0
Q ss_pred cccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 295 PIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 295 ~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
+.+ ......+..+.+|+.+||+.||++|||+.|+++
T Consensus 288 ~~~------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 288 PRL------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CCC------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCC------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000 011134567899999999999999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-57 Score=403.90 Aligned_cols=243 Identities=19% Similarity=0.297 Sum_probs=194.5
Q ss_pred CcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeec----CCcceEE
Q 045453 60 DARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLE----TRIPVIV 131 (346)
Q Consensus 60 ~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~----~~~~~lv 131 (346)
.....||+|+||+||+|.+ ++..||+|++.... ......+.+|+.++..+ +|||||+++++|.+ .+.++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEeeccCCCcEEEEE
Confidence 4456799999999999999 68899999986543 23445678899999998 99999999999865 3457999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCCeEEc-CCCceEEeccCCCc
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRP--ILHRKIRPSRIFLD-EGYIAKLFDFSLSV 208 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--iiH~dlkp~NIll~-~~~~~kl~Dfgl~~ 208 (346)
||||++|+|.+++.... ++++..+..++.|++.||+||| +.+ |+||||||+|||++ .++.+||+|||+|+
T Consensus 108 mEy~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 99999999999998753 6999999999999999999999 776 99999999999998 48999999999997
Q ss_pred ccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCc
Q 045453 209 SIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE 288 (346)
Q Consensus 209 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (346)
..... .....+||+.|||||++. +.|+.++|||||||++|||+||+.||........ + ... ...+.
T Consensus 181 ~~~~~---~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~------~---~~~-i~~~~ 246 (290)
T 3fpq_A 181 LKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------I---YRR-VTSGV 246 (290)
T ss_dssp GCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------H---HHH-HTTTC
T ss_pred eCCCC---ccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH------H---HHH-HHcCC
Confidence 64332 234568999999999886 4699999999999999999999999975433211 1 111 11111
Q ss_pred cccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 289 FDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 289 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.... .+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 247 ~~~~------------~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 247 KPAS------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CCGG------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCC------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1100 11122345889999999999999999999875
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-56 Score=416.87 Aligned_cols=248 Identities=19% Similarity=0.306 Sum_probs=209.0
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEec
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFES 134 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~ 134 (346)
+.|+..+.||+|+||+||+|.+ +++.||||++..........+.+|+.++..+ +|||||++++++.+.+.+||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCCCceEEEEEECCEEEEEEeC
Confidence 5688899999999999999999 7899999999866656667788999999998 999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCC
Q 045453 135 VKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE 214 (346)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~ 214 (346)
|++|+|.+++... .+++..+..++.|++.||+||| +.+|+||||||+||||+.+|.+||+|||+|+.+....
T Consensus 230 ~~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 230 LEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp CTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred CCCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 9999999999764 4999999999999999999999 8999999999999999999999999999998775433
Q ss_pred ceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccc
Q 045453 215 TCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVD 294 (346)
Q Consensus 215 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 294 (346)
. .....+||+.|||||++.+..|+.++|||||||++|||++|+.||......+ ....+. . .. .
T Consensus 302 ~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-------~~~~i~---~-~~-----~ 364 (423)
T 4fie_A 302 P-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-------AMKMIR---D-NL-----P 364 (423)
T ss_dssp C-CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHH---H-SC-----C
T ss_pred c-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-------HHHHHH---c-CC-----C
Confidence 2 3456789999999999999999999999999999999999999997543221 111111 1 10 0
Q ss_pred cccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 295 PIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 295 ~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
+.+.. ....+..+.+|+.+||+.||++|||+.|+++
T Consensus 365 ~~~~~------~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 365 PRLKN------LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp CCCSC------TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCcc------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11100 1133466889999999999999999999875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-57 Score=407.31 Aligned_cols=246 Identities=18% Similarity=0.258 Sum_probs=207.0
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
++|...+.||+|+||+||+|.+ +++.||||++.... ......+.+|+.++..+ +|||||++++++.+.+.+|||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEE
Confidence 5799999999999999999998 78999999987432 23456788899999998 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+++|+|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+|+.+.
T Consensus 111 mEy~~gG~L~~~i~~~~----~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~ 183 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 183 (311)
T ss_dssp ECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence 99999999999998753 6999999999999999999999 8999999999999999999999999999998875
Q ss_pred CCC-ceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 212 EGE-TCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 212 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
... .......+||+.|||||++.+..|+.++||||+||++|||+||+.||...+..+ +.. .... ..+
T Consensus 184 ~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-------~~~---~i~~-~~~- 251 (311)
T 4aw0_A 184 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL-------IFA---KIIK-LEY- 251 (311)
T ss_dssp TTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHH---HHHH-TCC-
T ss_pred CCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-------HHH---HHHc-CCC-
Confidence 433 233456789999999999999999999999999999999999999997643322 111 1111 111
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVA 335 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~ 335 (346)
.+ + ...+..+.+|+.+||+.||++|||+.|+.
T Consensus 252 -----~~----p----~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 -----DF----P----EKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -----CC----C----TTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -----CC----C----cccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 00 0 12345688999999999999999999864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-56 Score=394.31 Aligned_cols=244 Identities=22% Similarity=0.328 Sum_probs=190.0
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
++|+..+.||+|+||+||+|.+ +++.||+|++.... ......+.+|+.++..+ +|||||++++++.+.+.+++|
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL-RHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEEE
Confidence 6899999999999999999998 78999999987543 23345678899999998 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+ +|+|.+++.... ++++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+|+...
T Consensus 92 mEy~-~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRD----KMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp EECC-CEEHHHHHHHSC----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred EeCC-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 9999 679999997753 6999999999999999999999 8999999999999999999999999999998765
Q ss_pred CCCceeeccccccCCcCCccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINTGDF-NEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
... .....+||+.|||||++.+..| +.++||||+||++|+|+||+.||...+..+ +...+ ..+..
T Consensus 164 ~~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~-------~~~~i----~~~~~- 229 (275)
T 3hyh_A 164 DGN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV-------LFKNI----SNGVY- 229 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHH----HHTCC-
T ss_pred CCC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHH----HcCCC-
Confidence 433 2345689999999999998876 579999999999999999999997543211 11111 11110
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.+ +...+..+.+|+.+||+.||++|||+.|+++
T Consensus 230 -----~~--------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 -----TL--------PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -----CC--------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -----CC--------CCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 00 0123456889999999999999999999876
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-56 Score=400.37 Aligned_cols=241 Identities=19% Similarity=0.229 Sum_probs=193.4
Q ss_pred cCCCcccccccCCCcEEEEEEE-----CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcce
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV-----EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV 129 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~-----~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~ 129 (346)
++|+..+.||+|+||+||+|+. .++.||+|.+.... .....++.+|+.++..+ +|||||++++++.+.+.+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV-NHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCC-CCTTEECEEEEEEETTEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEE
Confidence 5799999999999999999987 46789999987543 22344677888888888 9999999999999999999
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcc
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVS 209 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~ 209 (346)
+||||++||+|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+|+.
T Consensus 103 ivmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EEECCCTTCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EEEEcCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 9999999999999998753 6999999999999999999999 89999999999999999999999999999986
Q ss_pred cCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcc
Q 045453 210 IPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEF 289 (346)
Q Consensus 210 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (346)
...... .....+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..+. ...+ .. ...
T Consensus 176 ~~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~-------~~~i---~~-~~~ 243 (304)
T 3ubd_A 176 SIDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET-------MTMI---LK-AKL 243 (304)
T ss_dssp -----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHH---HH-CCC
T ss_pred ccCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH-------HHHH---Hc-CCC
Confidence 543322 23456899999999999999999999999999999999999999976433221 1111 11 110
Q ss_pred ccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCH
Q 045453 290 DEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTT 331 (346)
Q Consensus 290 ~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 331 (346)
+. +...+..+.+|+.+||+.||++|||+
T Consensus 244 ------------~~--p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 244 ------------GM--PQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp ------------CC--CTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred ------------CC--CCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 00 01234568899999999999999995
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-55 Score=393.22 Aligned_cols=249 Identities=21% Similarity=0.320 Sum_probs=188.3
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCC-------
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETR------- 126 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~------- 126 (346)
++|+..+.||+|+||+||+|.+ +++.||||++..... .....+.+|+.++..+ +|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEecCccccccc
Confidence 4688899999999999999998 789999999865433 3345678899999998 9999999999987544
Q ss_pred -----cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEE
Q 045453 127 -----IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKL 201 (346)
Q Consensus 127 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl 201 (346)
.+|+||||+++|+|.+++..... .....+..++.++.|++.||+||| +.+|+||||||+|||++.++.+||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEE
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEE
Confidence 36899999999999999976542 234677888999999999999999 899999999999999999999999
Q ss_pred eccCCCcccCCCCce-----------eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccc
Q 045453 202 FDFSLSVSIPEGETC-----------VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIG 270 (346)
Q Consensus 202 ~Dfgl~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~ 270 (346)
+|||+|+.+...... ..+..+||+.|||||++.+..|+.++|||||||++|||++ ||....
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~----- 231 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM----- 231 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-----
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-----
Confidence 999999877543221 1234579999999999999999999999999999999996 664211
Q ss_pred cchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 271 AGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
........ ..... .+ +........+.+|+.+||+.||++|||+.|+++
T Consensus 232 ----~~~~~~~~-~~~~~------------~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 232 ----ERVRTLTD-VRNLK------------FP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp ----HHHHHHHH-HHTTC------------CC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----HHHHHHHH-HhcCC------------CC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01111111 11111 11 111133455778999999999999999999976
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=376.34 Aligned_cols=288 Identities=30% Similarity=0.499 Sum_probs=240.3
Q ss_pred cCCCHHHHHHHhcCCCcccccccCCCcEEEEEEE-CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceee
Q 045453 45 RGFTIRELEIATNNFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCL 123 (346)
Q Consensus 45 ~~~~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~ 123 (346)
..+++.++..++++|...+.||+|+||+||+|.+ +++.||+|++..........+.+|+..+..+ +||||+++++++.
T Consensus 27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 105 (321)
T 2qkw_B 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC-RHPHLVSLIGFCD 105 (321)
T ss_dssp ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSC-CCTTBCCEEEECC
T ss_pred eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEc
Confidence 3455667777899999999999999999999998 6899999998776656667788888888888 9999999999999
Q ss_pred cCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEec
Q 045453 124 ETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFD 203 (346)
Q Consensus 124 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~D 203 (346)
+.+..++||||+++|+|.+++.........++|..++.++.|++.||.||| +.+++||||||+|||++.++.+||+|
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~D 182 (321)
T 2qkw_B 106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITD 182 (321)
T ss_dssp CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECC
T ss_pred CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEee
Confidence 999999999999999999999776544456999999999999999999999 89999999999999999999999999
Q ss_pred cCCCcccCCCCc-eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHH
Q 045453 204 FSLSVSIPEGET-CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKK 282 (346)
Q Consensus 204 fgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (346)
||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. .....+...
T Consensus 183 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~----~~~~~~~~~ 258 (321)
T 2qkw_B 183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREM----VNLAEWAVE 258 (321)
T ss_dssp CTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSC----CCHHHHTHH
T ss_pred cccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHH----HHHHHHhhh
Confidence 999976543222 223445689999999999999999999999999999999999999987655443 234455555
Q ss_pred HhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 283 CIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 283 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
....+.+...+++.+... .....+..+.+++.+||+.||++|||+.||++.|+.+.+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 259 SHNNGQLEQIVDPNLADK----IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp HHTTTCCCSSSSSSCTTC----SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ccccccHHHhcChhhccc----cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 555555555555544332 2347788999999999999999999999999999998763
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=375.92 Aligned_cols=291 Identities=31% Similarity=0.544 Sum_probs=240.5
Q ss_pred CccCCCHHHHHHHhcCCCcccccccCCCcEEEEEEE-CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcc
Q 045453 43 PIRGFTIRELEIATNNFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTG 120 (346)
Q Consensus 43 ~~~~~~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g 120 (346)
..+.|+++++..++++|...+.||+|+||.||+|.+ ++..||+|++..... .....+.+|+..+..+ +||||+++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~ 94 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRG 94 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTC-CCTTBCCCCE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhc-cCCCccceEE
Confidence 457799999999999999999999999999999998 788999999876543 2334677888888888 9999999999
Q ss_pred eeecCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceE
Q 045453 121 CCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAK 200 (346)
Q Consensus 121 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~k 200 (346)
+|.+.+..++||||+++|+|.+++........+++|..+..++.|++.||+|||+.+..+|+||||||+|||++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 99999999999999999999999987765556799999999999999999999943333999999999999999999999
Q ss_pred EeccCCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHH
Q 045453 201 LFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYV 280 (346)
Q Consensus 201 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 280 (346)
|+|||++...............||+.|+|||.+.+..++.++||||||+++|+|++|..||+...... ........++
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~ 252 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN--DDDVMLLDWV 252 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTT--TSCSBHHHHH
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccccc--ccchhHHHHH
Confidence 99999998776555545556679999999999999999999999999999999999999996321111 0112355566
Q ss_pred HHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 045453 281 KKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQ 340 (346)
Q Consensus 281 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 340 (346)
.............+..+... ........+.+++..||+.+|++|||+.||++.|++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 253 KGLLKEKKLEALVDVDLQGN----YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TTTTSSCCSTTSSCTTCTTS----CCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHHhhchhhhhhcChhhccc----cCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 55555555555555544333 234778899999999999999999999999999974
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=378.00 Aligned_cols=201 Identities=19% Similarity=0.293 Sum_probs=172.4
Q ss_pred HHhcCCCcccccccCCCcEEEEEEE-----CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcc
Q 045453 54 IATNNFDARNVIKDGYAYKFYKGFV-----EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIP 128 (346)
Q Consensus 54 ~~~~~f~~~~~ig~G~~g~Vy~~~~-----~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~ 128 (346)
...+.|...+.||+|+||+||+|.. .++.||+|++... ....++.+|+..+..+.+|||||++++++.+.+.+
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 4467899999999999999999986 3678999998654 33456788999998887899999999999999999
Q ss_pred eEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCC-CceEEeccCCC
Q 045453 129 VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEG-YIAKLFDFSLS 207 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~-~~~kl~Dfgl~ 207 (346)
++||||+++|+|.+++. .+++.++..++.|++.||+||| +.+|+||||||+|||++.+ +.+||+|||+|
T Consensus 96 ~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 99999999999999983 4899999999999999999999 8999999999999999977 79999999999
Q ss_pred cccCCCCc---------------------------eeeccccccCCcCCccccccC-CCCcccchHHHHHHHHHHHhCCC
Q 045453 208 VSIPEGET---------------------------CVKDKVTGTMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLTGQK 259 (346)
Q Consensus 208 ~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~ 259 (346)
+....... ......+||+.|+|||++.+. .|+.++||||+||++|||+||+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 76543221 012345799999999999875 58999999999999999999999
Q ss_pred CCCCCCC
Q 045453 260 IFDPSRG 266 (346)
Q Consensus 260 p~~~~~~ 266 (346)
||....+
T Consensus 246 Pf~~~~~ 252 (361)
T 4f9c_A 246 PFYKASD 252 (361)
T ss_dssp SSSCCSS
T ss_pred CCCCCCC
Confidence 9976543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=385.45 Aligned_cols=264 Identities=14% Similarity=0.232 Sum_probs=200.6
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeec------CC
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLE------TR 126 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~------~~ 126 (346)
++|...+.||+|+||+||+|.+ +|+.||||++..... .....+.+|+.++..+ +|||||++++++.. .+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHF-KHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhc-CCCCcceEeeeeecccccccCC
Confidence 4688889999999999999998 789999999975432 3345678899999998 99999999998754 36
Q ss_pred cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCC
Q 045453 127 IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSL 206 (346)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl 206 (346)
.+|||||||+ |+|.+++... .++++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~----~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSS----QPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSS----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEEeCCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecce
Confidence 7899999995 6899999765 36999999999999999999999 89999999999999999999999999999
Q ss_pred CcccCCCC---ceeeccccccCCcCCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHH
Q 045453 207 SVSIPEGE---TCVKDKVTGTMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKK 282 (346)
Q Consensus 207 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (346)
|+.+.... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||.+.+..+ ....+..
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~-------~l~~I~~ 277 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH-------QLQLIMM 277 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-------HHHHHHH
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH-------HHHHHHH
Confidence 98764332 1223467899999999998875 56999999999999999999999998654322 1111111
Q ss_pred HhhcCccccc--cc--------cccccCCCCcch---HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 283 CIENNEFDEI--VD--------PIIVSEGPRVGK---EKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 283 ~~~~~~~~~~--~d--------~~l~~~~~~~~~---~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.......... +. ..+....+.... +.....+.+|+.+||+.||++|||+.|+++
T Consensus 278 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 278 VLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp HHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 1111100000 00 000000000000 012456889999999999999999999864
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=395.62 Aligned_cols=250 Identities=16% Similarity=0.227 Sum_probs=208.0
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEec
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFES 134 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~ 134 (346)
++|...+.||+|+||+||+|.+ +++.||+|.+..........+.+|+.++..+ +|||||++++++.+.+.+++||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEEee
Confidence 6788999999999999999999 7899999998766555566778899999888 999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCC--CceEEeccCCCcccCC
Q 045453 135 VKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEG--YIAKLFDFSLSVSIPE 212 (346)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~--~~~kl~Dfgl~~~~~~ 212 (346)
|++|+|.++|.... ..+++.++..++.||+.||.||| +.+|+||||||+|||++.+ +.+||+|||+|+.+..
T Consensus 236 ~~gg~L~~~i~~~~---~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 236 MSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCBHHHHHTCTT---SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred cCCCcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 99999999996543 36999999999999999999999 8999999999999999854 8999999999988765
Q ss_pred CCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccc
Q 045453 213 GETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEI 292 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (346)
... ....+||+.|||||++.+..|+.++||||+||++|||++|..||.+.+..+. .. ... .....
T Consensus 310 ~~~--~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~-------~~---~i~-~~~~~-- 374 (573)
T 3uto_A 310 KQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-------LR---NVK-SCDWN-- 374 (573)
T ss_dssp TSE--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-------HH---HHH-TTCCC--
T ss_pred CCc--eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-------HH---HHH-hCCCC--
Confidence 443 3456799999999999999999999999999999999999999976543221 11 111 11000
Q ss_pred cccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 293 VDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 293 ~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.+.......+..+.+|+.+||+.||++|||+.|+++
T Consensus 375 --------~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 375 --------MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp --------CCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000011133466889999999999999999999875
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=393.96 Aligned_cols=246 Identities=17% Similarity=0.253 Sum_probs=196.2
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHH---HHHHhhhcCCCceeeEcceeecCCcc
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNN---IIFASKLSSHKNVLKLTGCCLETRIP 128 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e---~~~~~~~~~h~niv~l~g~~~~~~~~ 128 (346)
++|...++||+|+||+||+|.. +++.||||++.... .........| +..+..+ +|||||++++++.+.+.+
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~-~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECSSEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhC-CCCCEeEEEEEEEECCEE
Confidence 6788999999999999999999 78999999986432 1222223333 3334444 899999999999999999
Q ss_pred eEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 129 VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
||||||++||+|.++|.... .+++..+..++.||+.||.||| +.+||||||||+|||++.+|++||+|||+|+
T Consensus 268 ylVmEy~~GGdL~~~l~~~~----~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceee
Confidence 99999999999999998753 5999999999999999999999 9999999999999999999999999999998
Q ss_pred ccCCCCceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcC
Q 045453 209 SIPEGETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENN 287 (346)
Q Consensus 209 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (346)
.+.... ....+||+.|||||++.. ..|+.++||||+||++|||++|..||........ ..+. ..... .
T Consensus 341 ~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~----~~i~---~~i~~-~ 409 (689)
T 3v5w_A 341 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK----HEID---RMTLT-M 409 (689)
T ss_dssp ECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH----HHHH---HHHHH-C
T ss_pred ecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH----HHHH---HhhcC-C
Confidence 775433 245689999999999975 5799999999999999999999999975433221 1111 11111 0
Q ss_pred ccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCC-----HHHHH
Q 045453 288 EFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPT-----TVDVA 335 (346)
Q Consensus 288 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~ 335 (346)
. + .. +...+..+.+|+..||+.||++|++ +.||.
T Consensus 410 ~--------~--~~----p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~ 448 (689)
T 3v5w_A 410 A--------V--EL----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 448 (689)
T ss_dssp C--------C--CC----CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred C--------C--CC----CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence 0 0 00 1133456889999999999999998 56654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-49 Score=354.85 Aligned_cols=285 Identities=27% Similarity=0.458 Sum_probs=230.0
Q ss_pred CccCCCHHHHHHHhcCCCcc------cccccCCCcEEEEEEECCeEEEEEEecCcc----CcchHHHHHHHHHHhhhcCC
Q 045453 43 PIRGFTIRELEIATNNFDAR------NVIKDGYAYKFYKGFVEDRTVSVMKFNDIL----NDGHEDCFNNIIFASKLSSH 112 (346)
Q Consensus 43 ~~~~~~~~~l~~~~~~f~~~------~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~----~~~~~~~~~e~~~~~~~~~h 112 (346)
+...|+++++..++++|... +.||+|+||.||+|.+++..||+|++.... ......+.+|+..+..+ +|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC-QH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC-CC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc-CC
Confidence 45679999999999999988 889999999999999999999999987543 12345677888888888 99
Q ss_pred CceeeEcceeecCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeE
Q 045453 113 KNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIF 192 (346)
Q Consensus 113 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIl 192 (346)
|||+++++++.+.+..++||||+++++|.+++..... ..++++..++.++.|++.||.||| +.+++||||||+|||
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil 165 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANIL 165 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEE
Confidence 9999999999999999999999999999999975432 246999999999999999999999 899999999999999
Q ss_pred EcCCCceEEeccCCCcccCCCCc-eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccccc
Q 045453 193 LDEGYIAKLFDFSLSVSIPEGET-CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGA 271 (346)
Q Consensus 193 l~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~ 271 (346)
++.++.+||+|||++........ .......||+.|+|||.+.+ .++.++||||||+++|+|++|..||........
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-- 242 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-- 242 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--
Confidence 99999999999999987654332 22344578999999998864 589999999999999999999999987654432
Q ss_pred chhhHHHHHHHHhh-cCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 272 GHYWLLHYVKKCIE-NNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 272 ~~~~~~~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
+..+...... ...+...+++.+. ......+..+.+++..||+.+|++|||+.+|++.|+++.++
T Consensus 243 ----~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~s 307 (307)
T 2nru_A 243 ----LLDIKEEIEDEEKTIEDYIDKKMN-----DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307 (307)
T ss_dssp ----TTHHHHHHHTTSCCHHHHSCSSCS-----CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC--
T ss_pred ----HHHHHHHhhhhhhhhhhhcccccc-----ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhcC
Confidence 1111111111 1122233333221 12336778899999999999999999999999999998653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=357.26 Aligned_cols=261 Identities=23% Similarity=0.312 Sum_probs=214.3
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
.++|...+.||+|+||+||+|.+ ++..||+|++..........+.+|+..+..+ +||||+++++++.+.+..++|||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL-EHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCcCcccEEEEEecCCeeEEEEE
Confidence 35688889999999999999999 6889999998765555667788899999888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
|+++|+|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 88 YIKGGTLRGIIKSMD---SQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp CCTTCBHHHHHHHCC---TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred ecCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 999999999998754 46999999999999999999999 899999999999999999999999999999876543
Q ss_pred Cceee-------------ccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHH
Q 045453 214 ETCVK-------------DKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYV 280 (346)
Q Consensus 214 ~~~~~-------------~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 280 (346)
..... ....||+.|+|||.+.+..++.++||||||+++|||++|..|+........... .......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~-~~~~~~~ 240 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG-LNVRGFL 240 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS-BCHHHHH
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh-hhhhccc
Confidence 32111 145689999999999999999999999999999999999999876544332110 0011100
Q ss_pred HHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 045453 281 KKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHL 345 (346)
Q Consensus 281 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~l 345 (346)
+..... ..+..+.+++.+||+.+|++|||+.++++.|+.+.+.+
T Consensus 241 -------------~~~~~~--------~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 241 -------------DRYCPP--------NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp -------------HHTCCT--------TCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -------------cccCCC--------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 111101 22345889999999999999999999999999998765
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-49 Score=359.18 Aligned_cols=273 Identities=19% Similarity=0.215 Sum_probs=211.6
Q ss_pred HHhcCCCcccccccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCc----ce
Q 045453 54 IATNNFDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRI----PV 129 (346)
Q Consensus 54 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~----~~ 129 (346)
...++|...+.||+|+||+||+|.+.++.||||++.... ........|+..+..+ +||||+++++++..... .+
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD-KQSWQNEYEVYSLPGM-KHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG-HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEE
T ss_pred cchhhchhhheecccCceEEEEEEECCCEEEEEEeecCc-hHHHHHHHHHHHHhcC-CCCCchhhcceeccCCCCCceEE
Confidence 345778899999999999999999999999999986432 2333445577777777 99999999999987543 69
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC----------CceecCCCCCCeEEcCCCce
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSR----------PILHRKIRPSRIFLDEGYIA 199 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~----------~iiH~dlkp~NIll~~~~~~ 199 (346)
+||||+++|+|.+++... .++|..++.++.|++.||+||| +. +|+||||||+|||++.++.+
T Consensus 99 lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~ 170 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA 170 (322)
T ss_dssp EEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCE
T ss_pred EEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeE
Confidence 999999999999999764 4999999999999999999999 77 99999999999999999999
Q ss_pred EEeccCCCcccCCCCce-eeccccccCCcCCccccccC-----CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccch
Q 045453 200 KLFDFSLSVSIPEGETC-VKDKVTGTMGFLAPEYINTG-----DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGH 273 (346)
Q Consensus 200 kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~ 273 (346)
||+|||+++........ ......||+.|+|||++.+. .++.++||||||+++|||+||+.||............
T Consensus 171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 250 (322)
T 3soc_A 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250 (322)
T ss_dssp EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence 99999999876544332 22345789999999999863 4677899999999999999999999876543321110
Q ss_pred h------hHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 274 Y------WLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 274 ~------~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
. ....+...... ......+.... ........+.+|+.+||+.||++|||+.||++.|++|.+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 251 EEIGQHPSLEDMQEVVVH-KKKRPVLRDYW-------QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHHCSSCCHHHHHHHHTT-SCCCCCCCGGG-------GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhccCCchhhhhhhhhc-ccCCCCccccc-------cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0 11111111111 11111111100 1125567799999999999999999999999999999875
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=360.89 Aligned_cols=269 Identities=21% Similarity=0.289 Sum_probs=207.1
Q ss_pred CCHHHHHHHhcCCCcccccccCCCcEEEEEEECCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeec
Q 045453 47 FTIRELEIATNNFDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLE 124 (346)
Q Consensus 47 ~~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~ 124 (346)
+..+++....++|...+.||+|+||+||+|.+.+..||+|.+..... ....++.+|+..+..+ +||||+++++++.+
T Consensus 27 ~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~ 105 (309)
T 3p86_A 27 MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIVLFMGAVTQ 105 (309)
T ss_dssp -----CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS
T ss_pred CCcccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEE
Confidence 44455556678899999999999999999999999999999875532 2345678899999998 99999999999999
Q ss_pred CCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCCeEEcCCCceEEe
Q 045453 125 TRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRP--ILHRKIRPSRIFLDEGYIAKLF 202 (346)
Q Consensus 125 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--iiH~dlkp~NIll~~~~~~kl~ 202 (346)
.+..++||||+++|+|.+++..... ...+++..++.++.|++.||+||| +.+ |+||||||+|||++.++.+||+
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~ 181 (309)
T 3p86_A 106 PPNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVC 181 (309)
T ss_dssp TTCCEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEEC
T ss_pred CCceEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEEC
Confidence 9999999999999999999976431 124899999999999999999999 888 9999999999999999999999
Q ss_pred ccCCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHH
Q 045453 203 DFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKK 282 (346)
Q Consensus 203 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (346)
|||+++...... .......||+.|+|||.+.+..++.++||||||+++|+|++|..||......+. ...+.
T Consensus 182 Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~-------~~~~~- 252 (309)
T 3p86_A 182 DFGLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV-------VAAVG- 252 (309)
T ss_dssp CCC------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH-------HHHHH-
T ss_pred CCCCCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHH-
Confidence 999997554322 223456789999999999999999999999999999999999999975433221 11110
Q ss_pred HhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 283 CIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 283 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
..... . . .+......+.+|+.+||+.+|++|||+.++++.|+.+.+.
T Consensus 253 --~~~~~-------~--~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 253 --FKCKR-------L--E----IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp --HSCCC-------C--C----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred --hcCCC-------C--C----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 00000 0 0 0113345688999999999999999999999999999875
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=351.49 Aligned_cols=249 Identities=19% Similarity=0.284 Sum_probs=207.5
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
.+.|...+.||+|+||+||+|.+ +++.||+|++..........+.+|+..+..+ +||||+++++++...+..++|||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcC-CCCCCCeEeEEEEECCEEEEEEE
Confidence 46788999999999999999987 7899999998766656667778888888888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
|+++|+|.+++... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++......
T Consensus 98 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 98 YLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp CCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred CCCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 99999999999764 4899999999999999999999 889999999999999999999999999998776543
Q ss_pred CceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccc
Q 045453 214 ETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIV 293 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (346)
.. ......||+.|+|||.+.+..++.++||||||+++|+|++|..||........ ..........
T Consensus 170 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----------~~~~~~~~~~---- 234 (297)
T 3fxz_A 170 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA----------LYLIATNGTP---- 234 (297)
T ss_dssp TC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH----------HHHHHHHCSC----
T ss_pred cc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----------HHHHHhCCCC----
Confidence 32 23456799999999999999999999999999999999999999975433211 1111111100
Q ss_pred ccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 294 DPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 294 d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
....+...+..+.+++.+||+.||++|||+.|+++
T Consensus 235 --------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 235 --------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp --------CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --------CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 00011134566889999999999999999999875
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=360.90 Aligned_cols=263 Identities=18% Similarity=0.299 Sum_probs=213.4
Q ss_pred hcCCCcccccccCCCcEEEEEEE---------CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecC
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV---------EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLET 125 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~---------~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~ 125 (346)
.++|...+.||+|+||.||+|.+ .+..||+|.+..... .....+.+|+..+..+.+||||++++++|.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 46778888999999999999986 235799999875533 33456788888888887899999999999999
Q ss_pred CcceEEEecccCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEE
Q 045453 126 RIPVIVFESVKNRTLADHIYQNQP------------HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFL 193 (346)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll 193 (346)
+..++||||+++|+|.+++..... ....+++..++.++.|++.||.||| +.+|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence 999999999999999999987542 1235899999999999999999999 8999999999999999
Q ss_pred cCCCceEEeccCCCcccCCCCce-eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccccc
Q 045453 194 DEGYIAKLFDFSLSVSIPEGETC-VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGA 271 (346)
Q Consensus 194 ~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~ 271 (346)
+.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||+| |..||......+.
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~-- 314 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-- 314 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH--
Confidence 99999999999999876543322 2234457789999999999999999999999999999999 9999976543321
Q ss_pred chhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 045453 272 GHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHL 345 (346)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~l 345 (346)
...+ ..+... . .+...+..+.+++..||+.+|++|||+.|+++.|+.++...
T Consensus 315 -----~~~~----~~~~~~---------~----~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 315 -----FKLL----KEGHRM---------D----KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp -----HHHH----HTTCCC---------C----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----HHHH----hcCCCC---------C----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 1111 111100 0 01134566899999999999999999999999999998753
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=363.74 Aligned_cols=274 Identities=20% Similarity=0.303 Sum_probs=221.8
Q ss_pred CCCHHHHHHHhcCCCcccccccCCCcEEEEEEE-------CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceee
Q 045453 46 GFTIRELEIATNNFDARNVIKDGYAYKFYKGFV-------EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLK 117 (346)
Q Consensus 46 ~~~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~-------~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~ 117 (346)
.+....|....++|...+.||+|+||.||+|.+ +++.||||++..... .....+.+|+..+..+.+||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 367788888999999999999999999999984 447999999976443 334568899999999978999999
Q ss_pred EcceeecCC-cceEEEecccCCChhhhhhhcCCC----------------------------------------------
Q 045453 118 LTGCCLETR-IPVIVFESVKNRTLADHIYQNQPH---------------------------------------------- 150 (346)
Q Consensus 118 l~g~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------- 150 (346)
++++|.+.+ ..++||||+++|+|.+++......
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 999998755 489999999999999999765321
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCC
Q 045453 151 ----------------FEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE 214 (346)
Q Consensus 151 ----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~ 214 (346)
...+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 122899999999999999999999 8899999999999999999999999999998765433
Q ss_pred c-eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCccccc
Q 045453 215 T-CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEI 292 (346)
Q Consensus 215 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (346)
. .......+|+.|+|||++.+..++.++||||||+++|||+| |..||......+. ....+ ......
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~~~~~----~~~~~~-- 315 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRL----KEGTRM-- 315 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH------HHHHH----HHTCCC--
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH------HHHHH----HcCCCC--
Confidence 2 23345668899999999999999999999999999999999 9999976544321 11111 111100
Q ss_pred cccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 045453 293 VDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHL 345 (346)
Q Consensus 293 ~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~l 345 (346)
. .+......+.+++..||+.+|++|||+.||++.|+.+.+..
T Consensus 316 -------~----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 316 -------R----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp -------C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -------C----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 0 01123456889999999999999999999999999998764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=357.10 Aligned_cols=271 Identities=20% Similarity=0.306 Sum_probs=208.5
Q ss_pred hcCCCcccccccCCCcEEEEEEE------CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeec--CCc
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV------EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLE--TRI 127 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~------~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~--~~~ 127 (346)
.++|...+.||+|+||+||+|.+ ++..||+|++..........+.+|+..+..+ +||||++++++|.. ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECHHHHTS
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCCc
Confidence 36688889999999999999984 6789999998866555566788899999998 99999999999865 356
Q ss_pred ceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCC
Q 045453 128 PVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS 207 (346)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~ 207 (346)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+|||++.++.+||+|||++
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCG---GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred eEEEEEeCCCCCHHHHHHhcc---cccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 899999999999999998754 35999999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCce--eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccc-----ccchhhHHHHH
Q 045453 208 VSIPEGETC--VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEI-----GAGHYWLLHYV 280 (346)
Q Consensus 208 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~-----~~~~~~~~~~~ 280 (346)
+........ ......++..|+|||.+.+..++.++||||||+++|||+||..|+........ ...........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence 876543321 12334567789999999999999999999999999999999999864321100 00000000011
Q ss_pred HHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhhC
Q 045453 281 KKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHLA 346 (346)
Q Consensus 281 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~l~ 346 (346)
....... .....+...+..+.+++..||+.+|++|||+.|+++.|+++.++++
T Consensus 242 ~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~ 294 (295)
T 3ugc_A 242 IELLKNN-------------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294 (295)
T ss_dssp HHHHHTT-------------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HHHHhcc-------------CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence 1111111 1111112445679999999999999999999999999999999874
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-49 Score=348.67 Aligned_cols=257 Identities=19% Similarity=0.323 Sum_probs=213.7
Q ss_pred hcCCCcccccccCCCcEEEEEEE-CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEec
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFES 134 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~ 134 (346)
.++|...+.||+|+||.||+|.+ +++.||+|++.... ....++.+|+..+..+ +||||+++++++.+.+..++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCceEEEEEe
Confidence 46788889999999999999999 88899999987543 3446788899999998 999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCC
Q 045453 135 VKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE 214 (346)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~ 214 (346)
+++++|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+|||++.++.+||+|||+++......
T Consensus 87 ~~~~~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 87 MEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp CTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCCcHHHHHHhcC---cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 99999999997654 46899999999999999999999 8999999999999999999999999999998765443
Q ss_pred ceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccc
Q 045453 215 TCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIV 293 (346)
Q Consensus 215 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (346)
........+|+.|+|||.+.+..++.++||||||+++|+|++ |..||......+. .........
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~----------~~~~~~~~~----- 225 (269)
T 4hcu_A 161 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV----------VEDISTGFR----- 225 (269)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----------HHHHHTTCC-----
T ss_pred cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH----------HHHHhcCcc-----
Confidence 333344557788999999999999999999999999999999 9999975433221 111111000
Q ss_pred ccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 294 DPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 294 d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
. ..+...+..+.+++..||+.+|++|||+.|+++.|+++.++
T Consensus 226 -~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 226 -L--------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp -C--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -C--------CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 0 00112345688999999999999999999999999999874
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=357.38 Aligned_cols=257 Identities=18% Similarity=0.327 Sum_probs=207.6
Q ss_pred cCCCcccccccCCCcEEEEEEE-----CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV-----EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVI 130 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~-----~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~l 130 (346)
++|...+.||+|+||.||+|.+ .+..||||++..... .....+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-DHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECGGGCCEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCccEE
Confidence 4566778999999999999998 234699999876533 3445678888888888 99999999999999999999
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCccc
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI 210 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~ 210 (346)
||||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 128 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHD---GQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeeCCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 999999999999997653 46999999999999999999999 899999999999999999999999999999877
Q ss_pred CCCCce--eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcC
Q 045453 211 PEGETC--VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENN 287 (346)
Q Consensus 211 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (346)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||......+. .... ..+
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~----------~~~~-~~~ 270 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV----------ISSV-EEG 270 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH----------HHHH-HTT
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH----------HHHH-HcC
Confidence 543321 2233446778999999999999999999999999999999 9999976433221 1111 111
Q ss_pred ccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 288 EFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 288 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
. ....+...+..+.+|+..||+.+|++|||+.+|++.|+.+.+.
T Consensus 271 ~-------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 271 Y-------------RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp C-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred C-------------CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 0 0001113456789999999999999999999999999999875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=367.52 Aligned_cols=264 Identities=20% Similarity=0.313 Sum_probs=215.0
Q ss_pred HHHHHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCC
Q 045453 50 RELEIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETR 126 (346)
Q Consensus 50 ~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~ 126 (346)
+.|....++|...+.||+|+||.||+|.+ ++..||||.+..... ....++.+|+..+..+ +||||++++++|...+
T Consensus 107 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~ 185 (377)
T 3cbl_A 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQ 185 (377)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTC-CCTTBCCEEEEECSSS
T ss_pred cccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEecCC
Confidence 44556667888899999999999999999 688999999875433 2334677888888888 9999999999999999
Q ss_pred cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCC
Q 045453 127 IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSL 206 (346)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl 206 (346)
..++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+|||++.++.+||+|||+
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 259 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGM 259 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred CcEEEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCC
Confidence 9999999999999999998654 35899999999999999999999 89999999999999999999999999999
Q ss_pred CcccCCCCceee-ccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHh
Q 045453 207 SVSIPEGETCVK-DKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCI 284 (346)
Q Consensus 207 ~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (346)
++.......... ....++..|+|||.+.++.++.++||||||+++|||+| |..||......+ .... .
T Consensus 260 s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~-------~~~~----~ 328 (377)
T 3cbl_A 260 SREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-------TREF----V 328 (377)
T ss_dssp CEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH-------HHHH----H
T ss_pred ceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHH----H
Confidence 986543322111 12335778999999999999999999999999999999 999997643322 1111 1
Q ss_pred hcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 285 ENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 285 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
..+.. .+.+..++..+.+|+.+||+.+|++|||+.++++.|+++.+.
T Consensus 329 ~~~~~-------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 329 EKGGR-------------LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp HTTCC-------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HcCCC-------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 11110 001113456788999999999999999999999999999864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=349.78 Aligned_cols=260 Identities=20% Similarity=0.293 Sum_probs=214.8
Q ss_pred cCCCHHHHHHHhcC----------CCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCC
Q 045453 45 RGFTIRELEIATNN----------FDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSH 112 (346)
Q Consensus 45 ~~~~~~~l~~~~~~----------f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h 112 (346)
..+++++++.+++. |+..+.||+|+||.||+|.+ +++.||||++..........+.+|+..+..+ +|
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h 101 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QH 101 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTC-CC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhC-CC
Confidence 45899999999876 56667899999999999998 6899999999866666667788999999888 99
Q ss_pred CceeeEcceeecCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeE
Q 045453 113 KNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIF 192 (346)
Q Consensus 113 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIl 192 (346)
|||+++++++...+..++||||+++++|.+++.. ..+++..+..++.|++.||.||| +.+++||||||+|||
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIl 173 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSIL 173 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEE
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEE
Confidence 9999999999999999999999999999999865 35999999999999999999999 889999999999999
Q ss_pred EcCCCceEEeccCCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccc
Q 045453 193 LDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAG 272 (346)
Q Consensus 193 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~ 272 (346)
++.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+
T Consensus 174 l~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~---- 248 (321)
T 2c30_A 174 LTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---- 248 (321)
T ss_dssp ECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----
T ss_pred ECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----
Confidence 99999999999999987654322 2345679999999999999999999999999999999999999997543211
Q ss_pred hhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 273 HYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
....+. . .. .+.+. .....+..+.+++.+||+.||++|||+.|+++
T Consensus 249 ---~~~~~~---~-~~-----~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 249 ---AMKRLR---D-SP-----PPKLK------NSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp ---HHHHHH---H-SS-----CCCCT------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---HHHHHh---c-CC-----CCCcC------ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111 1 10 00000 01133456889999999999999999999975
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=345.35 Aligned_cols=265 Identities=19% Similarity=0.287 Sum_probs=203.3
Q ss_pred hcCCCcccccccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHHHHHHHhhh-cCCCceeeEcceeecC----CcceE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKL-SSHKNVLKLTGCCLET----RIPVI 130 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~-~~h~niv~l~g~~~~~----~~~~l 130 (346)
.++|...+.||+|+||+||+|.++++.||||++... ....+..|...+... .+||||+++++++... ...++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 467889999999999999999999999999998643 334445555555442 3999999999997653 45799
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCceecCCCCCCeEEcCCCceEEeccC
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGF-----SRPILHRKIRPSRIFLDEGYIAKLFDFS 205 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~iiH~dlkp~NIll~~~~~~kl~Dfg 205 (346)
||||+++|+|.+++.. ..+++..++.++.|++.||+|||+.. +.+|+||||||+|||++.++.+||+|||
T Consensus 84 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 158 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG 158 (301)
T ss_dssp EECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred ehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCC
Confidence 9999999999999954 35999999999999999999999322 5789999999999999999999999999
Q ss_pred CCcccCCCCcee---eccccccCCcCCccccccC------CCCcccchHHHHHHHHHHHhC----------CCCCCCCCC
Q 045453 206 LSVSIPEGETCV---KDKVTGTMGFLAPEYINTG------DFNEKCDVFSFGMLLLVLLTG----------QKIFDPSRG 266 (346)
Q Consensus 206 l~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~G~vl~elltg----------~~p~~~~~~ 266 (346)
+++......... .....||+.|+|||.+.+. .++.++||||||+++|||+|| ..||.....
T Consensus 159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~ 238 (301)
T 3q4u_A 159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238 (301)
T ss_dssp TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence 997665433322 2344799999999999876 456799999999999999999 777765443
Q ss_pred cccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 045453 267 DEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341 (346)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 341 (346)
... ............... +.+.. .......+..+.+|+.+||+.||++|||+.||++.|++|
T Consensus 239 ~~~-----~~~~~~~~~~~~~~~-----~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 239 NDP-----SFEDMRKVVCVDQQR-----PNIPN---RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SSC-----CHHHHHHHHTTSCCC-----CCCCG---GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCc-----chhhhhHHHhccCCC-----CCCCh---hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 332 111111111111110 00100 001225778899999999999999999999999999986
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=346.08 Aligned_cols=257 Identities=19% Similarity=0.278 Sum_probs=212.7
Q ss_pred hcCCCcccccccCCCcEEEEEEE-CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEec
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFES 134 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~ 134 (346)
.++|...+.||+|+||.||+|.+ .+..||+|++.... ....++.+|+..+..+ +||||+++++++.+.+..++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKL-SHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCceEEEEEc
Confidence 46788899999999999999999 66789999987543 3456788899999998 999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCC
Q 045453 135 VKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE 214 (346)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~ 214 (346)
+++++|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 85 ISNGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp CTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred cCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 99999999997754 35999999999999999999999 8999999999999999999999999999998776555
Q ss_pred ceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccc
Q 045453 215 TCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIV 293 (346)
Q Consensus 215 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (346)
........+|+.|+|||.+.+..++.++||||||+++|+|+| |..||......+. .... .....
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~----------~~~~-~~~~~---- 223 (268)
T 3sxs_A 159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV----------VLKV-SQGHR---- 223 (268)
T ss_dssp EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH----------HHHH-HTTCC----
T ss_pred hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH----------HHHH-HcCCC----
Confidence 444445567788999999999899999999999999999999 9999975443221 1111 11100
Q ss_pred ccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 294 DPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 294 d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
...+...+..+.+++..||+.+|++|||+.|+++.|+.+.+.
T Consensus 224 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 224 ---------LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp ---------CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred ---------CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 000112345688999999999999999999999999987653
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-48 Score=366.24 Aligned_cols=256 Identities=21% Similarity=0.301 Sum_probs=211.8
Q ss_pred HHHhcCCCcccccccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCC-cceEE
Q 045453 53 EIATNNFDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETR-IPVIV 131 (346)
Q Consensus 53 ~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~-~~~lv 131 (346)
....++|...+.||+|+||.||+|.+.+..||||.+.... ....+.+|+..+..+ +||||++++++|.+.+ ..++|
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT--TSHHHHHHHHHHHTC-CCTTBCCEEEEEECTTSCEEEE
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch--HHHHHHHHHHHHHhc-cCCCEEEEEEEEEcCCCceEEE
Confidence 3455778888999999999999999999999999987543 556788999999998 9999999999987765 78999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+++|+|.+++..... ..+++..++.++.|++.||+||| +.+++||||||+|||++.++.+||+|||+++...
T Consensus 266 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EECCTTCBHHHHHHHHCT--TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 999999999999987642 34799999999999999999999 8999999999999999999999999999997543
Q ss_pred CCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
.. .....++..|+|||.+.+..++.++||||||+++|||+| |..||......+. ...+ ..+.
T Consensus 341 ~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~-------~~~i----~~~~-- 403 (450)
T 1k9a_A 341 ST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-------VPRV----EKGY-- 403 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH-------HHHH----HTTC--
T ss_pred cc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHH----HcCC--
Confidence 22 122357889999999999999999999999999999999 9999986554332 1111 1110
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
....+..++..+.+|+..||+.+|++|||+.++++.|+.+..+
T Consensus 404 -----------~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 404 -----------KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp -----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -----------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 0011114456789999999999999999999999999999764
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=378.12 Aligned_cols=268 Identities=24% Similarity=0.322 Sum_probs=212.0
Q ss_pred cCCCHHHHHHHhcCCCcccccccCCCcEEEEEEE-CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceee
Q 045453 45 RGFTIRELEIATNNFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCL 123 (346)
Q Consensus 45 ~~~~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~ 123 (346)
..++.+.|....++|...+.||+|+||.||+|.+ .+..||||++.... .....+.+|+..+..+ +||||+++++++.
T Consensus 172 ~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 249 (452)
T 1fmk_A 172 QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKL-RHEKLVQLYAVVS 249 (452)
T ss_dssp SSSSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHC-CCTTBCCEEEEEC
T ss_pred CCCCccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhC-CCCCEeeEEEEEc
Confidence 3445566777788899999999999999999999 55789999987543 3456788999999998 9999999999987
Q ss_pred cCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEec
Q 045453 124 ETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFD 203 (346)
Q Consensus 124 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~D 203 (346)
+ +..++||||+++|+|.+++..... ..+++..++.++.|++.||+||| +.+++||||||+|||++.++.+||+|
T Consensus 250 ~-~~~~iv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~D 323 (452)
T 1fmk_A 250 E-EPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVAD 323 (452)
T ss_dssp S-SSCEEEECCCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECC
T ss_pred C-CceEEEehhhcCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECC
Confidence 6 678999999999999999975321 35899999999999999999999 89999999999999999999999999
Q ss_pred cCCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHH
Q 045453 204 FSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKK 282 (346)
Q Consensus 204 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (346)
||+++..............++..|+|||.+.++.++.++||||||+++|||+| |..||......+. ...+
T Consensus 324 fG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~-------~~~i-- 394 (452)
T 1fmk_A 324 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-------LDQV-- 394 (452)
T ss_dssp CCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-------HHHH--
T ss_pred CccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH-------HHHH--
Confidence 99998765443333334457789999999999999999999999999999999 9999976443221 1111
Q ss_pred HhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 283 CIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 283 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
..+. ..+.+..++..+.+|+.+||+.+|++|||+.++++.|+.+...
T Consensus 395 --~~~~-------------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 395 --ERGY-------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp --HTTC-------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred --HcCC-------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 1110 0011114456789999999999999999999999999987653
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=376.21 Aligned_cols=265 Identities=21% Similarity=0.335 Sum_probs=217.3
Q ss_pred CCHHHHHHHhcCCCcccccccCCCcEEEEEEE-CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecC
Q 045453 47 FTIRELEIATNNFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLET 125 (346)
Q Consensus 47 ~~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~ 125 (346)
+..++|....++|...+.||+|+||.||+|.+ .+..||||++.... .....+.+|+..+..+ +||||+++++++. .
T Consensus 178 ~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~-~ 254 (454)
T 1qcf_A 178 WEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTL-QHDKLVKLHAVVT-K 254 (454)
T ss_dssp CCTTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTC-CCTTBCCEEEEEC-S
T ss_pred ccccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhC-CCCCEeeEEEEEe-C
Confidence 44566778888999999999999999999999 67899999987543 4567888999999998 9999999999986 5
Q ss_pred CcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccC
Q 045453 126 RIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFS 205 (346)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg 205 (346)
+..++||||+++|+|.+++..... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||
T Consensus 255 ~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG 329 (454)
T 1qcf_A 255 EPIYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFG 329 (454)
T ss_dssp SSCEEEECCCTTCBHHHHHHSHHH--HTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTT
T ss_pred CccEEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCC
Confidence 678999999999999999975421 25889999999999999999999 8899999999999999999999999999
Q ss_pred CCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHh
Q 045453 206 LSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCI 284 (346)
Q Consensus 206 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (346)
+++..............+|..|+|||.+..+.++.++||||||+++|||+| |+.||......+ ....+.
T Consensus 330 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~-------~~~~i~--- 399 (454)
T 1qcf_A 330 LARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-------VIRALE--- 399 (454)
T ss_dssp GGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHHHHH---
T ss_pred CceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHH---
Confidence 998765433222233456788999999999999999999999999999999 999997644322 111111
Q ss_pred hcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 045453 285 ENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQ 343 (346)
Q Consensus 285 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 343 (346)
.+. ..+.+..++..+.+|+.+||+.+|++|||+.+|++.|+++..
T Consensus 400 -~~~-------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 400 -RGY-------------RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp -HTC-------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred -cCC-------------CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 110 000111345678999999999999999999999999998754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=362.13 Aligned_cols=258 Identities=17% Similarity=0.321 Sum_probs=198.8
Q ss_pred hcCCCcccccccCCCcEEEEEEE-----CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcce
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV-----EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV 129 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~-----~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~ 129 (346)
.++|...+.||+|+||.||+|.+ .+..||||.+..... .....+.+|+..+..+ +||||++++++|.+.+..+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSCE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCceE
Confidence 35788899999999999999987 356799999875433 3445678888888888 9999999999999999999
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcc
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVS 209 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~ 209 (346)
+||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 123 lv~e~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp EEEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 9999999999999997653 46999999999999999999999 88999999999999999999999999999987
Q ss_pred cCCCCcee--eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhc
Q 045453 210 IPEGETCV--KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIEN 286 (346)
Q Consensus 210 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (346)
........ .....++..|+|||++.+..++.++||||||+++|||++ |..||......+ +...+ ..
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~-------~~~~i----~~ 265 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-------VIKAV----DE 265 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH-------HHHHH----HT
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHH----Hc
Confidence 65433211 122345778999999999999999999999999999998 999997543321 11111 11
Q ss_pred CccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 287 NEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 287 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
+ .... .....+..+.+++.+||+.+|++|||+.+|++.|+++.++
T Consensus 266 ~---------~~~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 266 G---------YRLP----PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp T---------EECC----CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred C---------CCCC----CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 1 0000 0113456789999999999999999999999999999764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=347.69 Aligned_cols=259 Identities=21% Similarity=0.303 Sum_probs=198.9
Q ss_pred HHhcCCCcccccccCCCcEEEEEEEC-----CeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCc
Q 045453 54 IATNNFDARNVIKDGYAYKFYKGFVE-----DRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRI 127 (346)
Q Consensus 54 ~~~~~f~~~~~ig~G~~g~Vy~~~~~-----~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~ 127 (346)
...++|...+.||+|+||.||+|.+. +..||+|....... .....+.+|+..+..+ +||||+++++++. .+.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-~~~ 89 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVIT-ENP 89 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC-SSS
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCccceEEEEEc-cCc
Confidence 44577888999999999999999982 34699998875433 3345677888888888 9999999999985 567
Q ss_pred ceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCC
Q 045453 128 PVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS 207 (346)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~ 207 (346)
.++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++||||||+|||++.++.+||+|||++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 163 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLS 163 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----
T ss_pred cEEEEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccc
Confidence 899999999999999997654 46899999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhc
Q 045453 208 VSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIEN 286 (346)
Q Consensus 208 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (346)
+..............+|+.|+|||.+.+..++.++||||||+++|||++ |..||......+. ...+ ..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~-------~~~i----~~ 232 (281)
T 1mp8_A 164 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-------IGRI----EN 232 (281)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-------HHHH----HT
T ss_pred cccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH-------HHHH----Hc
Confidence 8775544333444567789999999999999999999999999999997 9999986544331 1111 11
Q ss_pred CccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 287 NEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 287 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
.... ..+...+..+.+++.+||+.+|++|||+.|+++.|+++.+.
T Consensus 233 ~~~~-------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 233 GERL-------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp TCCC-------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCC-------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1100 00113456788999999999999999999999999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=349.43 Aligned_cols=263 Identities=18% Similarity=0.273 Sum_probs=213.1
Q ss_pred HHHHHhcCCCcccccccCCCcEEEEEEE-CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcce
Q 045453 51 ELEIATNNFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV 129 (346)
Q Consensus 51 ~l~~~~~~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~ 129 (346)
.+....++|...+.||+|+||.||+|.+ .+..||+|++.... ....++.+|+..+..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 95 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNL-SHEKLVQLYGVCTKQRPIF 95 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEE
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcC-CCCCEeeEEEEEecCCCeE
Confidence 3445567888899999999999999999 66789999987543 3456788899999998 9999999999999999999
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcc
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVS 209 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~ 209 (346)
+||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++||||||+|||++.++.+||+|||+++.
T Consensus 96 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 169 (283)
T 3gen_A 96 IITEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY 169 (283)
T ss_dssp EEECCCTTCBHHHHHHCGG---GCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGG
T ss_pred EEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcccccccc
Confidence 9999999999999997643 35999999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCc
Q 045453 210 IPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE 288 (346)
Q Consensus 210 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (346)
.............+|+.|+|||.+.+..++.++||||||+++|+|+| |..||......+. .... ....
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~----------~~~~-~~~~ 238 (283)
T 3gen_A 170 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET----------AEHI-AQGL 238 (283)
T ss_dssp BCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH----------HHHH-HTTC
T ss_pred ccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH----------HHHH-hccc
Confidence 65443333334456788999999999999999999999999999999 9999976443221 1111 1110
Q ss_pred cccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 045453 289 FDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHL 345 (346)
Q Consensus 289 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~l 345 (346)
. .. .+...+..+.+++..||+.+|++|||+.++++.|+++.++-
T Consensus 239 -----~----~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 239 -----R----LY----RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp -----C----CC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -----C----CC----CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 0 00 01123456889999999999999999999999999998763
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-48 Score=352.79 Aligned_cols=247 Identities=19% Similarity=0.269 Sum_probs=204.9
Q ss_pred HhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceE
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVI 130 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~l 130 (346)
..++|...+.||+|+||.||+|.+ +++.||+|++..... .....+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKIL-NHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCEEEE
Confidence 356799999999999999999998 889999999875432 3445677888888888 99999999999999999999
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCccc
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI 210 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~ 210 (346)
||||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 92 v~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 164 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAHG----RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEF 164 (328)
T ss_dssp EECCCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGG
T ss_pred EEECCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceec
Confidence 999999999999997753 5899999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCceeeccccccCCcCCccccccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcc
Q 045453 211 PEGETCVKDKVTGTMGFLAPEYINTGDFN-EKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEF 289 (346)
Q Consensus 211 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (346)
..... .....||+.|+|||++.+..++ .++|||||||++|+|++|..||...+..+. ..... .+.
T Consensus 165 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----------~~~i~-~~~- 230 (328)
T 3fe3_A 165 TVGGK--LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL----------RERVL-RGK- 230 (328)
T ss_dssp SSSCG--GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------HHHHH-HCC-
T ss_pred CCCCc--cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH----------HHHHH-hCC-
Confidence 54332 3456799999999999988775 799999999999999999999976433221 11111 111
Q ss_pred ccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 290 DEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 290 ~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
... +...+..+.+|+.+||+.||++|||+.|+++
T Consensus 231 -----------~~~--p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 231 -----------YRI--PFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp -----------CCC--CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred -----------CCC--CCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000 0023456889999999999999999999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=373.10 Aligned_cols=263 Identities=20% Similarity=0.313 Sum_probs=218.3
Q ss_pred HHHHHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCc
Q 045453 50 RELEIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRI 127 (346)
Q Consensus 50 ~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~ 127 (346)
+.|+...++|...+.||+|+||.||+|.+ .+..||||.+.... ....++.+|+..+..+ +|||||+++++|.+.+.
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 290 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPP 290 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSS
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhc-CCCCEeeEEEEEecCCc
Confidence 45556677888899999999999999999 48899999987543 3467788999999998 99999999999999999
Q ss_pred ceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCC
Q 045453 128 PVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS 207 (346)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~ 207 (346)
.++||||+++|+|.+++..... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 365 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLS 365 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred EEEEEEccCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccc
Confidence 9999999999999999986432 46899999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhc
Q 045453 208 VSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIEN 286 (346)
Q Consensus 208 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (346)
+..............++..|+|||.+.+..++.++||||||+++|||+| |..||......+. ...+ ..
T Consensus 366 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~-------~~~~----~~ 434 (495)
T 1opk_A 366 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-------YELL----EK 434 (495)
T ss_dssp ECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-------HHHH----HT
T ss_pred eeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH-------HHHH----Hc
Confidence 8775544333344556789999999999999999999999999999999 9999986544321 1111 11
Q ss_pred CccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 045453 287 NEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQ 343 (346)
Q Consensus 287 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 343 (346)
+. ....+..++..+.+|+.+||+.+|++|||+.+|++.|+.+.+
T Consensus 435 ~~-------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 435 DY-------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp TC-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CC-------------CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 10 000111345678899999999999999999999999988754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=347.17 Aligned_cols=263 Identities=20% Similarity=0.321 Sum_probs=220.3
Q ss_pred HHHHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcc
Q 045453 51 ELEIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIP 128 (346)
Q Consensus 51 ~l~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~ 128 (346)
++....++|...+.||+|+||+||+|.+ .+..||+|.+... ......+.+|+..+..+ +||||+++++++.+.+..
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPF 84 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSE
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCCE
Confidence 4555678899999999999999999999 5889999998753 33456788899999998 999999999999999999
Q ss_pred eEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 129 VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
++||||+++++|.+++..... ..+++..++.++.+++.||.||| +.+++|+||||+||+++.++.+||+|||++.
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSR 159 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCCT--TTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred EEEEEcCCCCcHHHHHHhccc--CCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccce
Confidence 999999999999999976542 46999999999999999999999 8899999999999999999999999999998
Q ss_pred ccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcC
Q 045453 209 SIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENN 287 (346)
Q Consensus 209 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (346)
..............+|+.|+|||.+.+..++.++||||||+++|+|++ |..||........ ...+. ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~-------~~~~~----~~ 228 (288)
T 3kfa_A 160 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-------YELLE----KD 228 (288)
T ss_dssp TSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-------HHHHH----TT
T ss_pred eccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHh----cc
Confidence 776555544555667889999999999999999999999999999999 9999976544321 11111 00
Q ss_pred ccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 288 EFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 288 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
.... .+...+..+.+++..||+.+|++|||+.++++.|+.+.+.
T Consensus 229 ---------~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 229 ---------YRME----RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp ---------CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------CCCC----CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 0000 1113446789999999999999999999999999998875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=339.30 Aligned_cols=264 Identities=11% Similarity=0.115 Sum_probs=213.5
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
.++|...+.||+|+||.||+|.+ +++.||+|.+.... ....+.+|+..+..+.+|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 36788999999999999999997 88999999986432 334577888888888789999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCc-----eEEeccCCCc
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYI-----AKLFDFSLSV 208 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~-----~kl~Dfgl~~ 208 (346)
|+ +++|.+++.... .++++..++.++.|++.||.||| +.+|+||||||+|||++.++. +||+|||+++
T Consensus 87 ~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 87 LL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 99 899999998654 46999999999999999999999 999999999999999987776 9999999998
Q ss_pred ccCCCCce------eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHH
Q 045453 209 SIPEGETC------VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKK 282 (346)
Q Consensus 209 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (346)
........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... .....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~----~~~~~~~~ 235 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK----QKYERIGE 235 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH----HHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccH----HHHHHHHh
Confidence 76543321 134556999999999999999999999999999999999999999875543321 11111111
Q ss_pred HhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 045453 283 CIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHL 345 (346)
Q Consensus 283 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~l 345 (346)
........ .+. ...+..+.+++..||+.+|++|||+.+|++.|+++.+.+
T Consensus 236 ~~~~~~~~-----~~~--------~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 236 KKQSTPLR-----ELC--------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp HHHHSCHH-----HHT--------TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred hccCccHH-----HHH--------hhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 10001000 000 023457889999999999999999999999999998875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=355.81 Aligned_cols=267 Identities=18% Similarity=0.277 Sum_probs=216.4
Q ss_pred HHHHhcCCCcccccccCCCcEEEEEEEC---------CeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcce
Q 045453 52 LEIATNNFDARNVIKDGYAYKFYKGFVE---------DRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGC 121 (346)
Q Consensus 52 l~~~~~~f~~~~~ig~G~~g~Vy~~~~~---------~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~ 121 (346)
+....++|...+.||+|+||+||+|.+. +..||+|++..... ....++.+|+..+..+.+||||++++++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 143 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 143 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence 3455678888999999999999999962 25799999876543 3346678889899888799999999999
Q ss_pred eecCCcceEEEecccCCChhhhhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCC
Q 045453 122 CLETRIPVIVFESVKNRTLADHIYQNQPH------------FEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPS 189 (346)
Q Consensus 122 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~ 189 (346)
|.+.+..++||||+++|+|.+++...... ...+++..++.++.|++.||+||| +.+|+||||||+
T Consensus 144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~ 220 (382)
T 3tt0_A 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAAR 220 (382)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGG
T ss_pred eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcc
Confidence 99999999999999999999999875421 235999999999999999999999 889999999999
Q ss_pred CeEEcCCCceEEeccCCCcccCCCCc-eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCc
Q 045453 190 RIFLDEGYIAKLFDFSLSVSIPEGET-CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGD 267 (346)
Q Consensus 190 NIll~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~ 267 (346)
|||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~ 300 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987654332 22344567889999999999999999999999999999999 99999754332
Q ss_pred ccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 045453 268 EIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHL 345 (346)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~l 345 (346)
+ +... ...+... .. +......+.+|+.+||+.+|++|||+.||++.|+.+.+..
T Consensus 301 ~-------~~~~----~~~~~~~---------~~----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 301 E-------LFKL----LKEGHRM---------DK----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp H-------HHHH----HHTTCCC---------CC----CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred H-------HHHH----HHcCCCC---------CC----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 2 1111 1111100 00 0133456889999999999999999999999999998754
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=342.37 Aligned_cols=275 Identities=17% Similarity=0.251 Sum_probs=208.3
Q ss_pred CCHHHHHHHhcCCCcccccccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHHHHHHHhhh-cCCCceeeEcceeecC
Q 045453 47 FTIRELEIATNNFDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKL-SSHKNVLKLTGCCLET 125 (346)
Q Consensus 47 ~~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~-~~h~niv~l~g~~~~~ 125 (346)
.....-....++|...+.||+|+||.||+|.+.+..||||++... .......+...+... .+||||+++++++...
T Consensus 27 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp SCHHHHTTHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred CCcccccccccceEEEeEeecCCCeEEEEEEECCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 444444556678999999999999999999999999999998643 233344444444333 3899999999999887
Q ss_pred ----CcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC--------CceecCCCCCCeEE
Q 045453 126 ----RIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSR--------PILHRKIRPSRIFL 193 (346)
Q Consensus 126 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~--------~iiH~dlkp~NIll 193 (346)
...++||||+++|+|.+++... .+++..++.++.|++.||+||| +. +|+||||||+|||+
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill 175 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILV 175 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEE
T ss_pred CCCCCceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEE
Confidence 6789999999999999999764 5999999999999999999999 77 99999999999999
Q ss_pred cCCCceEEeccCCCcccCCCCcee---eccccccCCcCCccccccCCCCcc------cchHHHHHHHHHHHhC-------
Q 045453 194 DEGYIAKLFDFSLSVSIPEGETCV---KDKVTGTMGFLAPEYINTGDFNEK------CDVFSFGMLLLVLLTG------- 257 (346)
Q Consensus 194 ~~~~~~kl~Dfgl~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~s~G~vl~elltg------- 257 (346)
+.++.+||+|||+++......... .....||+.|+|||++.+..++.+ +|||||||++|||+||
T Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~ 255 (337)
T 3mdy_A 176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV 255 (337)
T ss_dssp CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccc
Confidence 999999999999997765433221 234579999999999988776655 9999999999999999
Q ss_pred ---CCCCCCCCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 045453 258 ---QKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDV 334 (346)
Q Consensus 258 ---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev 334 (346)
..||........ ..... .......... +.... ......++..+.+|+.+||+.||++|||+.||
T Consensus 256 ~~~~~p~~~~~~~~~-----~~~~~-~~~~~~~~~~----~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 322 (337)
T 3mdy_A 256 EEYQLPYHDLVPSDP-----SYEDM-REIVCIKKLR----PSFPN---RWSSDECLRQMGKLMTECWAHNPASRLTALRV 322 (337)
T ss_dssp CCCCCTTTTTSCSSC-----CHHHH-HHHHTTSCCC----CCCCG---GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred ccccccHhhhcCCCC-----chhhh-HHHHhhhccC----ccccc---cchhhHHHHHHHHHHHHhhhhChhhCCCHHHH
Confidence 555544333221 01111 1111111111 11100 01122678889999999999999999999999
Q ss_pred HHHHHHHHHhh
Q 045453 335 AKRLKQIYQHL 345 (346)
Q Consensus 335 ~~~L~~i~~~l 345 (346)
++.|+++.++.
T Consensus 323 l~~L~~l~~~~ 333 (337)
T 3mdy_A 323 KKTLAKMSESQ 333 (337)
T ss_dssp HHHHHHHHHTT
T ss_pred HHHHHHHHhhc
Confidence 99999998863
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-47 Score=345.26 Aligned_cols=263 Identities=14% Similarity=0.168 Sum_probs=212.3
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
.++|...+.||+|+||+||+|.. +++.||||.+.... ....+.+|+..+..+.+||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 36788999999999999999997 88999999986543 234577888888888799999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCc-----eEEeccCCCc
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYI-----AKLFDFSLSV 208 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~-----~kl~Dfgl~~ 208 (346)
|+ +++|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++. +||+|||+++
T Consensus 86 ~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 86 LL-GPSLEDLFDLCD---RTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred eC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99 899999998653 46999999999999999999999 889999999999999999887 9999999998
Q ss_pred ccCCCCce------eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHH
Q 045453 209 SIPEGETC------VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKK 282 (346)
Q Consensus 209 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (346)
........ ......||+.|+|||++.+..++.++||||||+++|||++|..||......... .....+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~----~~~~~i~~ 234 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK----ERYQKIGD 234 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHH----HHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHH----HHHHHHHh
Confidence 76443321 124567999999999999999999999999999999999999999876543321 11111111
Q ss_pred HhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 045453 283 CIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHL 345 (346)
Q Consensus 283 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~l 345 (346)
....... ..+.. ..+ .+.+++..||+.+|.+||++.+|.+.|+++.+++
T Consensus 235 ~~~~~~~-----~~~~~--------~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 235 TKRATPI-----EVLCE--------NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp HHHHSCH-----HHHTT--------TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred hhccCCH-----HHHhc--------cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 0000000 00000 123 7999999999999999999999999999998764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-48 Score=352.06 Aligned_cols=256 Identities=19% Similarity=0.309 Sum_probs=202.7
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCe----EEEEEEecCcc-CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcc
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDR----TVSVMKFNDIL-NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIP 128 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~----~vavk~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~ 128 (346)
.++|...+.||+|+||+||+|.+ +++ +||+|.+.... .....++.+|+..+..+ +||||++++++|.+.. .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~-~ 91 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTST-V 91 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHC-CBTTBCCEEEEEESSS-E
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCC-e
Confidence 35688899999999999999998 444 45888875443 24556788899999888 9999999999998764 7
Q ss_pred eEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 129 VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
++|+||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEEECCTTCBHHHHHHHST---TSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred EEEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCccee
Confidence 89999999999999998754 46999999999999999999999 8899999999999999999999999999998
Q ss_pred ccCCCCce-eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhc
Q 045453 209 SIPEGETC-VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIEN 286 (346)
Q Consensus 209 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (346)
........ ......+|..|+|||++.+..++.++||||||+++|||+| |..||......+. ...+ ..
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-------~~~~----~~ 234 (327)
T 3poz_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-------SSIL----EK 234 (327)
T ss_dssp HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-------HHHH----HT
T ss_pred EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH-------HHHH----Hc
Confidence 76543322 2234456889999999999999999999999999999999 9999976544332 1111 11
Q ss_pred CccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 045453 287 NEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQ 343 (346)
Q Consensus 287 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 343 (346)
+.. ..........+.+++.+||+.+|++|||+.|+++.|+.+.+
T Consensus 235 ~~~-------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 235 GER-------------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp TCC-------------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred CCC-------------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 100 00111345568899999999999999999999999999875
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=344.92 Aligned_cols=260 Identities=20% Similarity=0.326 Sum_probs=204.6
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVI 130 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~l 130 (346)
.++|...+.||+|+||.||+|.+ .+..||+|.+..... .....+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CBTTBCCEEEEEECSSEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC-CCCCCceEEEeeeeCCeEEE
Confidence 35688899999999999999998 788999999864432 2345677888888888 99999999999999999999
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCccc
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI 210 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~ 210 (346)
||||+++++|.+++.... ++++..++.++.|++.||.||| +.+++||||||+|||++.++.+||+|||++...
T Consensus 89 v~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161 (294)
T ss_dssp EEECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred EEeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence 999999999999997753 6999999999999999999999 899999999999999999999999999999877
Q ss_pred CCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 211 PEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 211 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
............||+.|+|||.+.+..++.++||||||+++|+|+||+.||......+. ........ ..
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~----------~~~~~~~~-~~ 230 (294)
T 4eqm_A 162 SETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI----------AIKHIQDS-VP 230 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH----------HHHHHSSC-CC
T ss_pred ccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH----------HHHHhhcc-CC
Confidence 55444344556799999999999999999999999999999999999999976433211 11111111 00
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHHHH
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRP-TTVDVAKRLKQIYQ 343 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~ev~~~L~~i~~ 343 (346)
.. .... ....+..+.+++.+||+.+|++|| ++.++.+.|+.+..
T Consensus 231 ~~-~~~~--------~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 231 NV-TTDV--------RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp CH-HHHS--------CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred Cc-chhc--------ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 00 0000 013346788999999999999998 89999999887643
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=352.16 Aligned_cols=268 Identities=22% Similarity=0.337 Sum_probs=200.4
Q ss_pred HHHHHHhcCCCcccccccCCCcEEEEEEE--CCe---EEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEccee
Q 045453 50 RELEIATNNFDARNVIKDGYAYKFYKGFV--EDR---TVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCC 122 (346)
Q Consensus 50 ~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~---~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~ 122 (346)
+++....++|...+.||+|+||.||+|.+ .++ .||+|.+.... ......+.+|+..+..+ +||||+++++++
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~ 94 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-DHPHVAKLVGVS 94 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTC-CCTTBCCCCEEE
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHC-CCCceehhhcee
Confidence 34445567899999999999999999998 232 79999987542 34456788899999998 999999999999
Q ss_pred ecCCcc------eEEEecccCCChhhhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEc
Q 045453 123 LETRIP------VIVFESVKNRTLADHIYQNQP--HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLD 194 (346)
Q Consensus 123 ~~~~~~------~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~ 194 (346)
...+.. ++||||+++|+|.+++..... ....+++..++.++.|++.||+||| +.+++||||||+|||++
T Consensus 95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~ 171 (323)
T 3qup_A 95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLA 171 (323)
T ss_dssp ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEc
Confidence 877655 999999999999999965431 1235899999999999999999999 88999999999999999
Q ss_pred CCCceEEeccCCCcccCCCCce-eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccc
Q 045453 195 EGYIAKLFDFSLSVSIPEGETC-VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAG 272 (346)
Q Consensus 195 ~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~ 272 (346)
.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+.
T Consensus 172 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--- 248 (323)
T 3qup_A 172 EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI--- 248 (323)
T ss_dssp TTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---
T ss_pred CCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH---
Confidence 9999999999999876543322 1233456788999999999999999999999999999999 9999986554332
Q ss_pred hhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 045453 273 HYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHL 345 (346)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~l 345 (346)
...+ .. .. ........+..+.+|+.+||+.||++|||+.++++.|+++.+++
T Consensus 249 ----~~~~---~~-~~-------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 249 ----YNYL---IG-GN-------------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp ----HHHH---HT-TC-------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ----HHHH---hc-CC-------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1111 00 00 00011134467899999999999999999999999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-48 Score=358.27 Aligned_cols=261 Identities=21% Similarity=0.316 Sum_probs=209.2
Q ss_pred hcCCCcccccccCCCcEEEEEEE-------CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCc
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV-------EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRI 127 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~-------~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~ 127 (346)
.++|...+.||+|+||+||+|.+ .+..||||++..... ....++.+|+..+..+ +||||+++++++.+...
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCC
Confidence 46688889999999999999995 456899999865432 3445678888888888 99999999999999999
Q ss_pred ceEEEecccCCChhhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCC---ceEE
Q 045453 128 PVIVFESVKNRTLADHIYQNQP---HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGY---IAKL 201 (346)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~---~~kl 201 (346)
.++||||+++|+|.+++..... ....+++..++.++.|++.||+||| +.+|+||||||+|||++.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEE
Confidence 9999999999999999987542 2245999999999999999999999 89999999999999999555 5999
Q ss_pred eccCCCcccCCCC-ceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHH
Q 045453 202 FDFSLSVSIPEGE-TCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHY 279 (346)
Q Consensus 202 ~Dfgl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 279 (346)
+|||+++...... ........+|+.|+|||++.+..++.++|||||||++|||+| |..||......+. ...
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~-------~~~ 298 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV-------LEF 298 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-------HHH
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHH
Confidence 9999987543221 112234567889999999999999999999999999999998 9999976433221 111
Q ss_pred HHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 280 VKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 280 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
+ ..+.. . ......+..+.+|+..||+.+|++|||+.+|++.|+.+.+.
T Consensus 299 i----~~~~~------------~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 299 V----TSGGR------------M-DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp H----HTTCC------------C-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred H----HcCCC------------C-CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 1 11110 0 00113345688999999999999999999999999998764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-48 Score=355.01 Aligned_cols=268 Identities=21% Similarity=0.358 Sum_probs=214.0
Q ss_pred HHHHHHhcCCCcccccccCCCcEEEEEEECC-------eEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcce
Q 045453 50 RELEIATNNFDARNVIKDGYAYKFYKGFVED-------RTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGC 121 (346)
Q Consensus 50 ~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~~-------~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~ 121 (346)
..+....++|...+.||+|+||.||+|.+.+ ..||+|.+..... .....+.+|+..+..+ +||||++++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~ 118 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGV 118 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEE
Confidence 3444566889999999999999999999843 7899999876543 3345677888888888 99999999999
Q ss_pred eecCCcceEEEecccCCChhhhhhhcCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 045453 122 CLETRIPVIVFESVKNRTLADHIYQNQPH--------------------FEPLLLSQRLRIAVHIANAIAYLHIGFSRPI 181 (346)
Q Consensus 122 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 181 (346)
|.+.+..++||||+++|+|.+++...... ...+++..++.++.|++.||.||| +.+|
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~i 195 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKF 195 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 99999999999999999999999864311 146999999999999999999999 8999
Q ss_pred eecCCCCCCeEEcCCCceEEeccCCCcccCCCCc-eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCC
Q 045453 182 LHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGET-CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQK 259 (346)
Q Consensus 182 iH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~ 259 (346)
+||||||+|||++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|+|+| |..
T Consensus 196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence 9999999999999999999999999876643322 12234567889999999999999999999999999999999 999
Q ss_pred CCCCCCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 045453 260 IFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLK 339 (346)
Q Consensus 260 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 339 (346)
||......+. .. . ...+.... .+...+..+.+++..||+.+|++|||+.++++.|+
T Consensus 276 p~~~~~~~~~-------~~---~-~~~~~~~~-------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~ 331 (343)
T 1luf_A 276 PYYGMAHEEV-------IY---Y-VRDGNILA-------------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 331 (343)
T ss_dssp TTTTSCHHHH-------HH---H-HHTTCCCC-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cCCCCChHHH-------HH---H-HhCCCcCC-------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHH
Confidence 9975433221 11 1 11111100 01133456889999999999999999999999999
Q ss_pred HHHHhh
Q 045453 340 QIYQHL 345 (346)
Q Consensus 340 ~i~~~l 345 (346)
++.+.+
T Consensus 332 ~~~~~~ 337 (343)
T 1luf_A 332 RMCERA 337 (343)
T ss_dssp HTTC--
T ss_pred HHHhhh
Confidence 987653
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=344.15 Aligned_cols=268 Identities=21% Similarity=0.305 Sum_probs=217.7
Q ss_pred HHHHhcCCCcccccccCCCcEEEEEEE-------CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceee
Q 045453 52 LEIATNNFDARNVIKDGYAYKFYKGFV-------EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCL 123 (346)
Q Consensus 52 l~~~~~~f~~~~~ig~G~~g~Vy~~~~-------~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~ 123 (346)
+....++|...+.||+|+||.||+|.+ .+..||+|.+..... .....+.+|+..+..+.+||||+++++++.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 445567888999999999999999985 457999999875543 334567788888888878999999999999
Q ss_pred cCCcceEEEecccCCChhhhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCC
Q 045453 124 ETRIPVIVFESVKNRTLADHIYQNQPH--------------FEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPS 189 (346)
Q Consensus 124 ~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~ 189 (346)
+.+..++||||+++|+|.+++...... ..++++..++.++.|++.||.||| +.+++||||||+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~ 174 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAAR 174 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGG
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccc
Confidence 999999999999999999999865421 125899999999999999999999 889999999999
Q ss_pred CeEEcCCCceEEeccCCCcccCCCCce-eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCc
Q 045453 190 RIFLDEGYIAKLFDFSLSVSIPEGETC-VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGD 267 (346)
Q Consensus 190 NIll~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~ 267 (346)
|||++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|+|+| |..||......
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 999999999999999999877644332 2334557889999999999999999999999999999999 99999765443
Q ss_pred ccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 045453 268 EIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHL 345 (346)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~l 345 (346)
.. ....+.. .. ... .....+..+.+++.+||+.+|++|||+.|+++.|+++.++.
T Consensus 255 ~~------~~~~~~~----~~-----~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 255 SK------FYKMIKE----GF-----RML--------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp HH------HHHHHHH----TC-----CCC--------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred hH------HHHHhcc----CC-----CCC--------CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 21 1111111 10 000 01133466899999999999999999999999999998764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=339.48 Aligned_cols=257 Identities=19% Similarity=0.307 Sum_probs=212.2
Q ss_pred hcCCCcccccccCCCcEEEEEEE-CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEec
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFES 134 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~ 134 (346)
.++|...+.||+|+||.||+|.+ +++.||+|.+.... .....+.+|+..+..+ +||||+++++++.+.+..++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSCEEEECC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCCeEEEEeC
Confidence 46788889999999999999999 78899999987543 3346788899999988 999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCC
Q 045453 135 VKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE 214 (346)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~ 214 (346)
+++++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 85 MEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp CTTCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCCcHHHHHhhCc---ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence 99999999997754 46899999999999999999999 8999999999999999999999999999998765433
Q ss_pred ceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccc
Q 045453 215 TCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIV 293 (346)
Q Consensus 215 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (346)
........++..|+|||.+.+..++.++||||||+++|+|++ |..||......+. .... ..+..
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~----------~~~i-~~~~~---- 223 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV----------VEDI-STGFR---- 223 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----------HHHH-HTTCC----
T ss_pred ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH----------HHHH-hcCCc----
Confidence 222334557788999999999999999999999999999999 8999975432211 1111 11100
Q ss_pred ccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 294 DPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 294 d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
. . .+...+..+.+++.+||+.+|++|||+.++++.|+++.++
T Consensus 224 -~----~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 224 -L----Y----KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp -C----C----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -C----C----CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0 0 0112345688999999999999999999999999999863
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=352.58 Aligned_cols=268 Identities=19% Similarity=0.311 Sum_probs=213.3
Q ss_pred HHHHHhcCCCcccccccCCCcEEEEEEE-------CCeEEEEEEecCcc-CcchHHHHHHHHHHhhhcCCCceeeEccee
Q 045453 51 ELEIATNNFDARNVIKDGYAYKFYKGFV-------EDRTVSVMKFNDIL-NDGHEDCFNNIIFASKLSSHKNVLKLTGCC 122 (346)
Q Consensus 51 ~l~~~~~~f~~~~~ig~G~~g~Vy~~~~-------~~~~vavk~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~l~g~~ 122 (346)
++....++|...+.||+|+||.||+|.+ .+..||+|.+.... ......+.+|+..+..+.+||||+++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 3455678899999999999999999996 34689999987543 234567788888888887899999999999
Q ss_pred ecCCcceEEEecccCCChhhhhhhcCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcee
Q 045453 123 LETRIPVIVFESVKNRTLADHIYQNQPH-------------------FEPLLLSQRLRIAVHIANAIAYLHIGFSRPILH 183 (346)
Q Consensus 123 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH 183 (346)
...+..++||||+++|+|.+++...... ...+++..++.++.|++.||.||| +.+|+|
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH 195 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVH 195 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccc
Confidence 9999999999999999999999765421 124899999999999999999999 899999
Q ss_pred cCCCCCCeEEcCCCceEEeccCCCcccCCCCc-eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCC
Q 045453 184 RKIRPSRIFLDEGYIAKLFDFSLSVSIPEGET-CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIF 261 (346)
Q Consensus 184 ~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~ 261 (346)
|||||+|||++.++.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|+|+| |..||
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 99999999999999999999999986654332 22345567889999999999999999999999999999998 99999
Q ss_pred CCCCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 045453 262 DPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341 (346)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 341 (346)
........ .... ...+.. .. .+...+..+.+|+.+||+.+|++|||+.++++.|+.+
T Consensus 276 ~~~~~~~~------~~~~----~~~~~~---------~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 332 (344)
T 1rjb_A 276 PGIPVDAN------FYKL----IQNGFK---------MD----QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332 (344)
T ss_dssp TTCCCSHH------HHHH----HHTTCC---------CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCcHHH------HHHH----HhcCCC---------CC----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 76544321 1111 111100 00 0113346688999999999999999999999999998
Q ss_pred HHh
Q 045453 342 YQH 344 (346)
Q Consensus 342 ~~~ 344 (346)
.+.
T Consensus 333 ~~~ 335 (344)
T 1rjb_A 333 LAD 335 (344)
T ss_dssp C--
T ss_pred HHH
Confidence 765
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=348.04 Aligned_cols=265 Identities=20% Similarity=0.332 Sum_probs=214.9
Q ss_pred HHHHhcCCCcccccccCCCcEEEEEEE-------CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceee
Q 045453 52 LEIATNNFDARNVIKDGYAYKFYKGFV-------EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCL 123 (346)
Q Consensus 52 l~~~~~~f~~~~~ig~G~~g~Vy~~~~-------~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~ 123 (346)
+....++|...+.||+|+||.||+|.+ .+..||+|.+..... .....+.+|+..+..+ +||||+++++++.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 96 (314)
T 2ivs_A 18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV-NHPHVIKLYGACS 96 (314)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEC
T ss_pred cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCceeeEEEEEe
Confidence 334467788899999999999999986 237899999875433 3346677888888888 9999999999999
Q ss_pred cCCcceEEEecccCCChhhhhhhcCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcee
Q 045453 124 ETRIPVIVFESVKNRTLADHIYQNQP--------------------HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILH 183 (346)
Q Consensus 124 ~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH 183 (346)
+.+..++||||+++|+|.+++..... ....+++..++.++.|++.||.||| +.+++|
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH 173 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVH 173 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEEC
T ss_pred cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcc
Confidence 99999999999999999999987542 1134899999999999999999999 899999
Q ss_pred cCCCCCCeEEcCCCceEEeccCCCcccCCCCce-eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCC
Q 045453 184 RKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETC-VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIF 261 (346)
Q Consensus 184 ~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~ 261 (346)
|||||+|||++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 253 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999999877544332 2234457788999999999999999999999999999999 99999
Q ss_pred CCCCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 045453 262 DPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341 (346)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 341 (346)
........ ...+ ..+... . .....+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 254 ~~~~~~~~-------~~~~----~~~~~~---------~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 254 PGIPPERL-------FNLL----KTGHRM---------E----RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp TTCCGGGH-------HHHH----HTTCCC---------C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCHHHH-------HHHh----hcCCcC---------C----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 76544321 1111 111100 0 0113456789999999999999999999999999999
Q ss_pred HHh
Q 045453 342 YQH 344 (346)
Q Consensus 342 ~~~ 344 (346)
.+.
T Consensus 310 ~~~ 312 (314)
T 2ivs_A 310 MVK 312 (314)
T ss_dssp HHT
T ss_pred Hhh
Confidence 875
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=354.31 Aligned_cols=252 Identities=19% Similarity=0.227 Sum_probs=199.7
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVI 130 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~l 130 (346)
.++|...+.||+|+||+||+|.+ +++.+|+|++..... .....+..|..++..+.+|||||++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 46788999999999999999998 688999999875432 2334567788888877799999999999999999999
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCccc
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI 210 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~ 210 (346)
||||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 131 V~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 999999999999998753 5999999999999999999999 899999999999999999999999999999753
Q ss_pred CCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 211 PEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 211 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... .........+....
T Consensus 204 ~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~--~~~~~~~~~i~~~~-- 278 (396)
T 4dc2_A 204 LRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ--NTEDYLFQVILEKQ-- 278 (396)
T ss_dssp CCTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC--------CCHHHHHHHHHHCC--
T ss_pred ccCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch--hhHHHHHHHHhccc--
Confidence 3222 224456899999999999999999999999999999999999999975433221000 00111111111111
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCH
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTT 331 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 331 (346)
+ .. +......+.+|+.+||+.||++||++
T Consensus 279 ------~--~~----p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 279 ------I--RI----PRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ------C--CC----CTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ------c--CC----CCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 0 00 11334568899999999999999996
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=339.03 Aligned_cols=253 Identities=19% Similarity=0.231 Sum_probs=205.4
Q ss_pred hcCCCcccccccCCCcEEEEEEECCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecC--CcceEE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLET--RIPVIV 131 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~--~~~~lv 131 (346)
.++|...+.||+|+||.||+|.+.+..+|+|++..... .....+.+|+..+..+ +||||+++++++.+. +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF-SHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCC-SCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCchhheEEEEccCCCCCeEee
Confidence 35688899999999999999999999999999875532 3345677888888888 999999999999887 788999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCCeEEcCCCceEEeccCCCcc
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRP--ILHRKIRPSRIFLDEGYIAKLFDFSLSVS 209 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--iiH~dlkp~NIll~~~~~~kl~Dfgl~~~ 209 (346)
|||+++|+|.+++..... ..+++..++.++.|++.||.||| +.+ ++||||||+|||++.++.++|+|||++..
T Consensus 88 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EECCTTCBHHHHHHSCSS--CCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred ecccCCCcHHHHHhhccc--CCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 999999999999986542 36899999999999999999999 788 99999999999999999999999988754
Q ss_pred cCCCCceeeccccccCCcCCccccccCCCCc---ccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhc
Q 045453 210 IPEGETCVKDKVTGTMGFLAPEYINTGDFNE---KCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIEN 286 (346)
Q Consensus 210 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (346)
... ....+|+.|+|||.+.+..++. ++||||||+++|||++|..||......+. .......
T Consensus 163 ~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----------~~~~~~~ 226 (271)
T 3kmu_A 163 FQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI----------GMKVALE 226 (271)
T ss_dssp TSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH----------HHHHHHS
T ss_pred ecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH----------HHHHHhc
Confidence 322 2346889999999998765544 79999999999999999999975433221 1111111
Q ss_pred CccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 045453 287 NEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQ 343 (346)
Q Consensus 287 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 343 (346)
... +.+ +...+..+.+++..||+.+|++|||+.|+++.|+++.+
T Consensus 227 ~~~-----~~~--------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 227 GLR-----PTI--------PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CCC-----CCC--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CCC-----CCC--------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 110 011 11334568899999999999999999999999999864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=340.16 Aligned_cols=251 Identities=25% Similarity=0.356 Sum_probs=194.0
Q ss_pred hcCCCcccccccCCCcEEEEEEECCeEEEEEEecCccC----cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILN----DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~----~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
.++|...+.||+|+||.||+|.+.++.+|+|.+..... .....+.+|...+..+ +||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHC-CCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhc-CCCCEeeEEEEEecCCceEEE
Confidence 46788899999999999999999999999999865432 2345677788888888 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---ceecCCCCCCeEEcC--------CCceE
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRP---ILHRKIRPSRIFLDE--------GYIAK 200 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~---iiH~dlkp~NIll~~--------~~~~k 200 (346)
|||+++++|.+++.. ..+++..++.++.|++.||.||| +.+ ++||||||+|||++. ++.+|
T Consensus 85 ~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k 156 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILK 156 (271)
T ss_dssp EECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred EEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceE
Confidence 999999999999864 35899999999999999999999 666 999999999999986 77899
Q ss_pred EeccCCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHH
Q 045453 201 LFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYV 280 (346)
Q Consensus 201 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 280 (346)
|+|||++....... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||........ .
T Consensus 157 l~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----------~ 223 (271)
T 3dtc_A 157 ITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV----------A 223 (271)
T ss_dssp ECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH----------H
T ss_pred EccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----------H
Confidence 99999997654332 2345689999999999999999999999999999999999999976433211 1
Q ss_pred HHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 045453 281 KKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341 (346)
Q Consensus 281 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 341 (346)
....... .. .. .+...+..+.+++.+||+.+|++|||+.|+++.|++|
T Consensus 224 ~~~~~~~-~~--------~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 224 YGVAMNK-LA--------LP----IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HHHHTSC-CC--------CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred HhhhcCC-CC--------CC----CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 1110110 00 00 1113446688999999999999999999999999864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=380.33 Aligned_cols=292 Identities=23% Similarity=0.310 Sum_probs=227.6
Q ss_pred HHHHHhchhhhHHHHHhhcCCCCCccCCCHHHHHHHhcCCCcccccccCCCcEEEEEEE-CCeEEEEEEecCccCcchHH
Q 045453 20 EFMIENGKILVETLVVCCYGKFNPIRGFTIRELEIATNNFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILNDGHED 98 (346)
Q Consensus 20 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~~~~~ 98 (346)
+.+..+...+...+...|.........+..+.|++..++|...+.||+|+||.||+|.+ .+..||||++.... ....+
T Consensus 230 ~~y~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~ 308 (535)
T 2h8h_A 230 AYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEA 308 (535)
T ss_dssp HHHHHCCTTSSSCCCEECCCCCCCCSSSSTTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHH
T ss_pred eeeccccCccccccccccccccccccccCccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHH
Confidence 33444444444444444443323333455566777888899999999999999999999 55789999987543 34567
Q ss_pred HHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 045453 99 CFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFS 178 (346)
Q Consensus 99 ~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~ 178 (346)
+.+|+.++..+ +||||+++++++.+ +..++||||+++|+|.+++..... ..+++..++.++.|++.||+||| +
T Consensus 309 ~~~E~~~l~~l-~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH---~ 381 (535)
T 2h8h_A 309 FLQEAQVMKKL-RHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVE---R 381 (535)
T ss_dssp HHHHHHHHHHC-CCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred HHHHHHHHHhC-CCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHH---h
Confidence 88999999998 99999999999876 678999999999999999975321 35899999999999999999999 8
Q ss_pred CCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-C
Q 045453 179 RPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-G 257 (346)
Q Consensus 179 ~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g 257 (346)
.+|+||||||+|||++.++.+||+|||+++..............++..|+|||.+.+..++.++||||||+++|||+| |
T Consensus 382 ~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g 461 (535)
T 2h8h_A 382 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 461 (535)
T ss_dssp TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTT
T ss_pred CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999998765432222233456788999999999999999999999999999999 9
Q ss_pred CCCCCCCCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045453 258 QKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKR 337 (346)
Q Consensus 258 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 337 (346)
..||......+. ...+ ..+. .......++..+.+|+.+||+.+|++|||+.+|++.
T Consensus 462 ~~P~~~~~~~~~-------~~~i----~~~~-------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 462 RVPYPGMVNREV-------LDQV----ERGY-------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp CCSSTTCCHHHH-------HHHH----HTTC-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHH-------HHHH----HcCC-------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 999976433221 1111 1110 000111345678999999999999999999999999
Q ss_pred HHHHHH
Q 045453 338 LKQIYQ 343 (346)
Q Consensus 338 L~~i~~ 343 (346)
|+.+..
T Consensus 518 L~~~~~ 523 (535)
T 2h8h_A 518 LEDYFT 523 (535)
T ss_dssp HHTSSC
T ss_pred HHHHhh
Confidence 998754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=353.38 Aligned_cols=269 Identities=16% Similarity=0.149 Sum_probs=206.0
Q ss_pred HhcCCCcccccccCCCcEEEEEEE-C------CeEEEEEEecCccCcc-----------hHHHHHHHHHHhhhcCCCcee
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV-E------DRTVSVMKFNDILNDG-----------HEDCFNNIIFASKLSSHKNVL 116 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~-~------~~~vavk~~~~~~~~~-----------~~~~~~e~~~~~~~~~h~niv 116 (346)
..++|...+.||+|+||.||+|.+ . +..||+|.+....... ......++..+..+ +||||+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~~iv 111 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKL-KYLGVP 111 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTC-SCCCSC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhc-cCCCCC
Confidence 356899999999999999999988 2 4789999986543211 11223344445555 899999
Q ss_pred eEcceeecC----CcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeE
Q 045453 117 KLTGCCLET----RIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIF 192 (346)
Q Consensus 117 ~l~g~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIl 192 (346)
++++++... ...++||||+ +++|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nil 184 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA---KRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLL 184 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEE
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEE
Confidence 999998764 4579999999 999999998753 46999999999999999999999 889999999999999
Q ss_pred Ec--CCCceEEeccCCCcccCCCCce------eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 045453 193 LD--EGYIAKLFDFSLSVSIPEGETC------VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPS 264 (346)
Q Consensus 193 l~--~~~~~kl~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~ 264 (346)
++ .++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264 (364)
T ss_dssp EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 99 8999999999999776432211 113345999999999999999999999999999999999999999854
Q ss_pred CCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 265 RGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
..... .......... .....++++.+... ..+..+.+++..||+.+|++|||+.++++.|+++++.
T Consensus 265 ~~~~~------~~~~~~~~~~-~~~~~~~~~~~~~~-------~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 265 LKDPK------YVRDSKIRYR-ENIASLMDKCFPAA-------NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp TTCHH------HHHHHHHHHH-HCHHHHHHHHSCTT-------CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ccCHH------HHHHHHHHhh-hhHHHHHHHhcccc-------cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 33221 1111111111 12223333332111 2345688999999999999999999999999999886
Q ss_pred h
Q 045453 345 L 345 (346)
Q Consensus 345 l 345 (346)
+
T Consensus 331 ~ 331 (364)
T 3op5_A 331 I 331 (364)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=342.33 Aligned_cols=257 Identities=21% Similarity=0.395 Sum_probs=200.9
Q ss_pred cCCCcccccccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEeccc
Q 045453 57 NNFDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVK 136 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~ 136 (346)
++|...+.||+|+||+||+|.+.++.||+|++... .....+.+|+..+..+ +||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE--SERKAFIVELRQLSRV-NHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST--THHHHHHHHHHHHHHC-CCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh--hHHHHHHHHHHHHhcC-CCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 56778899999999999999999999999998643 3456788899999998 99999999999874 5899999999
Q ss_pred CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCc-eEEeccCCCcccCCCCc
Q 045453 137 NRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYI-AKLFDFSLSVSIPEGET 215 (346)
Q Consensus 137 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~-~kl~Dfgl~~~~~~~~~ 215 (346)
+|+|.+++..... ...+++..++.++.|++.||+|||+....+|+||||||+|||++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 9999999976532 235789999999999999999999322289999999999999998886 799999998765432
Q ss_pred eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccccc
Q 045453 216 CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDP 295 (346)
Q Consensus 216 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 295 (346)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ...... ..+...
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--------~~~~~~-~~~~~~----- 223 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF--------RIMWAV-HNGTRP----- 223 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH--------HHHHHH-HTTCCC-----
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH--------HHHHHH-hcCCCC-----
Confidence 2234689999999999999999999999999999999999999975433221 001110 111100
Q ss_pred ccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 045453 296 IIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHL 345 (346)
Q Consensus 296 ~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~l 345 (346)
.. ....+..+.+++.+||+.+|++|||+.++++.|+.+.+.+
T Consensus 224 ~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 224 PL--------IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp CC--------BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred Cc--------ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 00 1133456889999999999999999999999999987654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=346.87 Aligned_cols=247 Identities=18% Similarity=0.231 Sum_probs=203.7
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVI 130 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~l 130 (346)
.++|...+.||+|+||+||+|.. +++.||+|.+.... ......+.+|...+..+ +||||+++++++.+.+..++
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-CCCcCcceEEEEEeCCEEEE
Confidence 36788899999999999999998 68999999987542 23456678888888888 99999999999999999999
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCccc
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI 210 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~ 210 (346)
||||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 83 v~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 155 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhc
Confidence 999999999999997653 5899999999999999999999 899999999999999999999999999999764
Q ss_pred CCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 211 PEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 211 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
..... ......||+.|+|||++.+..++.++||||||+++|||++|..||....... + ...... ...
T Consensus 156 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------~---~~~i~~-~~~- 222 (337)
T 1o6l_A 156 ISDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------L---FELILM-EEI- 222 (337)
T ss_dssp CCTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------H---HHHHHH-CCC-
T ss_pred ccCCC-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH-------H---HHHHHc-CCC-
Confidence 32221 2345679999999999999999999999999999999999999997543221 1 111111 100
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRP-----TTVDVAK 336 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~ 336 (346)
.+ + ...+..+.+|+.+||+.+|++|| ++.|+++
T Consensus 223 -----~~----p----~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 223 -----RF----P----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -----CC----C----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -----CC----C----CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 00 0 12345688999999999999999 8888864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=363.09 Aligned_cols=262 Identities=17% Similarity=0.226 Sum_probs=209.4
Q ss_pred CHHHHHHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEccee
Q 045453 48 TIRELEIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCC 122 (346)
Q Consensus 48 ~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~ 122 (346)
.++++...+++|...++||+|+||+||+|.+ +++.||+|++.... ......+..|..++..+ +||||++++++|
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLHYAF 143 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-CTTTBCCEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-CCCCEEEEEEEE
Confidence 3455666778999999999999999999999 67899999986432 12233466777777777 999999999999
Q ss_pred ecCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEe
Q 045453 123 LETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLF 202 (346)
Q Consensus 123 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~ 202 (346)
.+.+..++||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~---~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~ 217 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKFE---DRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLA 217 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEc
Confidence 99999999999999999999997643 46999999999999999999999 8999999999999999999999999
Q ss_pred ccCCCcccCCCCceeeccccccCCcCCccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHH
Q 045453 203 DFSLSVSIPEGETCVKDKVTGTMGFLAPEYIN-----TGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLL 277 (346)
Q Consensus 203 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~ 277 (346)
|||+++.............+||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+.
T Consensus 218 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~-------- 289 (437)
T 4aw2_A 218 DFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-------- 289 (437)
T ss_dssp CCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--------
T ss_pred chhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH--------
Confidence 99999877665554455678999999999997 56789999999999999999999999976433221
Q ss_pred HHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 045453 278 HYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAED--RPTTVDVAK 336 (346)
Q Consensus 278 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~ev~~ 336 (346)
......... .+ ..+.. ....+..+.+|+.+||..+|++ ||++.|+++
T Consensus 290 --~~~i~~~~~-------~~--~~p~~-~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 290 --YGKIMNHKE-------RF--QFPTQ-VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp --HHHHHTHHH-------HC--CCCSS-CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred --HHhhhhccc-------cc--cCCcc-cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 111111000 00 00000 0023456889999999988888 999999864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=345.37 Aligned_cols=250 Identities=17% Similarity=0.215 Sum_probs=204.4
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
.++|...+.||+|+||+||+|.+ ++..+|+|.+... ......+.+|+..+..+ +||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIA-RHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHS-CCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhC-CCCCCCeEeEEEecCCEEEEEEE
Confidence 46788899999999999999999 6889999988643 23445567888888888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcC--CCceEEeccCCCcccC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE--GYIAKLFDFSLSVSIP 211 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~--~~~~kl~Dfgl~~~~~ 211 (346)
|+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||++. ++.+||+|||+++...
T Consensus 82 ~~~g~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 82 FISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred eCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 999999999997643 46999999999999999999999 899999999999999997 7899999999998775
Q ss_pred CCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccc
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDE 291 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (346)
.... .....||+.|+|||++.+..++.++||||||+++|+|++|..||......+. ...... ....
T Consensus 156 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----------~~~i~~-~~~~- 221 (321)
T 1tki_A 156 PGDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI----------IENIMN-AEYT- 221 (321)
T ss_dssp TTCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----------HHHHHH-TCCC-
T ss_pred CCCc--cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH----------HHHHHc-CCCC-
Confidence 4432 3445789999999999988899999999999999999999999976433221 111111 1000
Q ss_pred ccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 292 IVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 292 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.+.. .....+..+.+++.+||+.||++|||+.|+++
T Consensus 222 -~~~~--------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 222 -FDEE--------AFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -CCHH--------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -CChh--------hhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0000 00123467889999999999999999999986
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-47 Score=349.19 Aligned_cols=250 Identities=20% Similarity=0.285 Sum_probs=204.7
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCc------chHHHHHHHHHHhhhcCCCceeeEcceeecCCc
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILND------GHEDCFNNIIFASKLSSHKNVLKLTGCCLETRI 127 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~------~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~ 127 (346)
.+.|...+.||+|+||+||+|.. ++..||+|.+...... ....+.+|+..+..+ +||||+++++++.+.+.
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-LHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhC-CCcCCCcEEEEEEeCCE
Confidence 46788999999999999999999 6899999998754321 346678899999888 99999999999999999
Q ss_pred ceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCC----ceEEec
Q 045453 128 PVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGY----IAKLFD 203 (346)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~----~~kl~D 203 (346)
.++||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++ .+||+|
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTC----SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 99999999999999999764 36999999999999999999999 89999999999999998877 799999
Q ss_pred cCCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHH
Q 045453 204 FSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKC 283 (346)
Q Consensus 204 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 283 (346)
||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||......+. ....
T Consensus 163 FG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~----------~~~i 230 (361)
T 2yab_A 163 FGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET----------LANI 230 (361)
T ss_dssp CSSCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH----------HHHH
T ss_pred cCCceEcCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH----------HHHH
Confidence 999987654332 3456799999999999999999999999999999999999999976433221 1111
Q ss_pred hhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 284 IENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 284 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
...... .++.. ....+..+.+|+..||+.||++|||+.|+++
T Consensus 231 -~~~~~~--~~~~~--------~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 231 -TAVSYD--FDEEF--------FSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp -HTTCCC--CCHHH--------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -HhcCCC--CCchh--------ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111000 00000 0123456889999999999999999999874
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=348.13 Aligned_cols=244 Identities=19% Similarity=0.249 Sum_probs=195.7
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
++|...+.||+|+||+||+|.+ +++.||||++..... ........|+..+..+.+||||++++++|.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 6788899999999999999999 689999999765432 334456677777777779999999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
||+ +++|.+++.... ..++|..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++.....
T Consensus 137 e~~-~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG---ASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp ECC-CCBHHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred ecc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 999 669999987764 46999999999999999999999 88999999999999999999999999999877644
Q ss_pred CCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccc
Q 045453 213 GETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEI 292 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (346)
.. ......||+.|+|||++.+ .++.++||||||+++|||++|..|+..... + ..+.....
T Consensus 210 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~------------~--~~~~~~~~--- 269 (311)
T 3p1a_A 210 AG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG------------W--QQLRQGYL--- 269 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH------------H--HHHTTTCC---
T ss_pred CC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH------------H--HHHhccCC---
Confidence 32 2344568999999998875 799999999999999999999776643111 0 00111110
Q ss_pred cccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 293 VDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 293 ~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.+.+ .......+.+++.+||+.+|++|||+.|+++
T Consensus 270 -~~~~--------~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 270 -PPEF--------TAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp -CHHH--------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -Cccc--------ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 0000 1123467899999999999999999999975
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=341.11 Aligned_cols=263 Identities=22% Similarity=0.367 Sum_probs=213.9
Q ss_pred HHHHHhcCCCcccccccCCCcEEEEEEE-CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcce
Q 045453 51 ELEIATNNFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV 129 (346)
Q Consensus 51 ~l~~~~~~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~ 129 (346)
+|....++|...+.||+|+||.||+|.+ .+..||+|.+.... .....+.+|+..+..+ +||||+++++++.. +..+
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-~~~~ 83 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQL-QHQRLVRLYAVVTQ-EPIY 83 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCE
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhC-CCcCcceEEEEEcC-CCcE
Confidence 4455567888999999999999999999 66789999986543 3456788899999988 99999999999864 5689
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcc
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVS 209 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~ 209 (346)
+||||+++++|.+++..... ..+++..++.++.|++.||.||| +.+++|+||||+|||++.++.+||+|||++..
T Consensus 84 ~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 158 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARL 158 (279)
T ss_dssp EEEECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEecCCCCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCccccc
Confidence 99999999999999975321 25899999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCc
Q 045453 210 IPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE 288 (346)
Q Consensus 210 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (346)
.............++..|+|||.+.+..++.++||||||+++|||++ |..||......+. .... ..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~----------~~~~-~~~~ 227 (279)
T 1qpc_A 159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV----------IQNL-ERGY 227 (279)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH----------HHHH-HTTC
T ss_pred ccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH----------HHHH-hccc
Confidence 76544433445567889999999998899999999999999999999 9999975433221 1111 1110
Q ss_pred cccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 045453 289 FDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHL 345 (346)
Q Consensus 289 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~l 345 (346)
... .....+..+.+++..||+.+|++|||+.++++.|+++....
T Consensus 228 -----~~~--------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 228 -----RMV--------RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp -----CCC--------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -----CCC--------CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 000 01133467889999999999999999999999999998753
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=337.88 Aligned_cols=258 Identities=22% Similarity=0.310 Sum_probs=206.0
Q ss_pred HhcCCCcccccccCCCcEEEEEEEC-----CeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcc
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFVE-----DRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIP 128 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~~-----~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~ 128 (346)
..++|...+.||+|+||+||+|.+. +..||+|.+..... .....+.+|+..+..+ +||||+++++++.+ +..
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-~~~ 87 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-DHPHIVKLIGIIEE-EPT 87 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHH-CCTTBCCEEEEECS-SSC
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhC-CCCCcceEEEEEcC-CCC
Confidence 4577889999999999999999872 23599999876533 3456678888889888 99999999999865 457
Q ss_pred eEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 129 VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++||||||+|||++.++.+||+|||++.
T Consensus 88 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERNK---NSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp EEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred EEEEecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCc
Confidence 99999999999999997654 46899999999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcC
Q 045453 209 SIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENN 287 (346)
Q Consensus 209 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (346)
..............+|+.|+|||.+.+..++.++||||||+++|+|+| |+.||......+. ...+.. .
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~-------~~~~~~----~ 230 (281)
T 3cc6_A 162 YIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV-------IGVLEK----G 230 (281)
T ss_dssp CC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH-------HHHHHH----T
T ss_pred ccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH-------HHHHhc----C
Confidence 765544333445567889999999999999999999999999999998 9999975444321 111111 1
Q ss_pred ccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 288 EFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 288 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
... ..+...+..+.+++.+||+.+|++|||+.|+++.|+++.+.
T Consensus 231 ~~~-------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 231 DRL-------------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp CCC-------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCC-------------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 000 00112345688999999999999999999999999998763
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=337.20 Aligned_cols=252 Identities=27% Similarity=0.412 Sum_probs=202.4
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcc-------hHHHHHHHHHHhhhcCCCceeeEcceeecCC
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDG-------HEDCFNNIIFASKLSSHKNVLKLTGCCLETR 126 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~-------~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~ 126 (346)
.++|...+.||+|+||+||+|.+ +++.||+|++....... ...+.+|+..+..+ +||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHPNIVKLYGLMHNPP 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC-CCTTBCCEEEEETTTT
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC-CCCCchhhheeecCCC
Confidence 46788899999999999999999 78899999986543221 15677888889888 9999999999986654
Q ss_pred cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCCeEEcCCCc-----e
Q 045453 127 IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRP--ILHRKIRPSRIFLDEGYI-----A 199 (346)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--iiH~dlkp~NIll~~~~~-----~ 199 (346)
++||||+++|+|.+++.... .++++..++.++.|++.||+||| +.+ ++||||||+|||++.++. +
T Consensus 97 --~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~ 168 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCA 168 (287)
T ss_dssp --EEEEECCTTCBHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred --eEEEEecCCCCHHHHHhccc---CCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeE
Confidence 79999999999999987654 46999999999999999999999 888 999999999999988776 9
Q ss_pred EEeccCCCcccCCCCceeeccccccCCcCCccccc--cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHH
Q 045453 200 KLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYIN--TGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLL 277 (346)
Q Consensus 200 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~ 277 (346)
||+|||+++.... ......||+.|+|||.+. ...++.++||||||+++|+|++|..||........ ...
T Consensus 169 kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----~~~ 239 (287)
T 4f0f_A 169 KVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI-----KFI 239 (287)
T ss_dssp EECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH-----HHH
T ss_pred EeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH-----HHH
Confidence 9999999875433 233467899999999984 45678999999999999999999999976544332 111
Q ss_pred HHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 045453 278 HYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341 (346)
Q Consensus 278 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 341 (346)
... ..... .+.+ ....+..+.+++..||+.||++|||+.|+++.|+++
T Consensus 240 ~~~---~~~~~-----~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 240 NMI---REEGL-----RPTI--------PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHH---HHSCC-----CCCC--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHH---hccCC-----CCCC--------CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 111 11110 0011 113446789999999999999999999999999863
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=348.49 Aligned_cols=255 Identities=20% Similarity=0.317 Sum_probs=202.6
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeE----EEEEEecCcc-CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcce
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRT----VSVMKFNDIL-NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV 129 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~----vavk~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~ 129 (346)
++|...+.||+|+||+||+|.+ ++.. ||+|.+.... ......+.+|+..+..+ +||||++++++|. ++..+
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-DHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTC-CCTTBCCEEEEEC-BSSEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEc-CCccE
Confidence 5678889999999999999998 4443 7888775443 23345667788888888 9999999999986 45689
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcc
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVS 209 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~ 209 (346)
+||||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEECCTTCBSHHHHHSSG---GGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEeCCCCCHHHHHHHcc---ccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccc
Confidence 9999999999999997653 36899999999999999999999 88999999999999999999999999999987
Q ss_pred cCCCCce-eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcC
Q 045453 210 IPEGETC-VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENN 287 (346)
Q Consensus 210 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (346)
....... ......+|..|+|||.+.+..++.++||||||+++|+|+| |..||......+. ...+ ...
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~----~~~ 233 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV-------PDLL----EKG 233 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH-------HHHH----HTT
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH-------HHHH----HcC
Confidence 7544332 2344567889999999999999999999999999999999 9999986544332 1111 111
Q ss_pred ccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 045453 288 EFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQ 343 (346)
Q Consensus 288 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 343 (346)
... .. +...+..+.+++..||+.+|++|||+.|+++.|+.+.+
T Consensus 234 ~~~--~~-----------~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 234 ERL--AQ-----------PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp CBC--CC-----------CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred CCC--CC-----------CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 100 00 00123347789999999999999999999999998864
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=338.55 Aligned_cols=278 Identities=17% Similarity=0.254 Sum_probs=215.5
Q ss_pred CCCHHHHHHHhcCCCcccccccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHHHHHHHhhh-cCCCceeeEcceeec
Q 045453 46 GFTIRELEIATNNFDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKL-SSHKNVLKLTGCCLE 124 (346)
Q Consensus 46 ~~~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~-~~h~niv~l~g~~~~ 124 (346)
...+..-....++|...+.||+|+||.||+|.++++.||+|.+... ....+.+|...+... .+||||+++++++..
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 4555555566788999999999999999999999999999998643 345566777777663 399999999999988
Q ss_pred CC----cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCceecCCCCCCeEEcC
Q 045453 125 TR----IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGF-----SRPILHRKIRPSRIFLDE 195 (346)
Q Consensus 125 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~iiH~dlkp~NIll~~ 195 (346)
.. ..++||||+++|+|.+++... .+++..++.++.|++.||.|||+.. +.+++||||||+|||++.
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~ 182 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 182 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECT
T ss_pred cCCccceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECC
Confidence 76 789999999999999999763 5899999999999999999999321 468999999999999999
Q ss_pred CCceEEeccCCCcccCCCCce---eeccccccCCcCCccccccC------CCCcccchHHHHHHHHHHHhC---------
Q 045453 196 GYIAKLFDFSLSVSIPEGETC---VKDKVTGTMGFLAPEYINTG------DFNEKCDVFSFGMLLLVLLTG--------- 257 (346)
Q Consensus 196 ~~~~kl~Dfgl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~G~vl~elltg--------- 257 (346)
++.+||+|||++......... ......||+.|+|||.+.+. .++.++||||||+++|||+||
T Consensus 183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~ 262 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262 (342)
T ss_dssp TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence 999999999999776544322 22445789999999999875 234789999999999999999
Q ss_pred -CCCCCCCCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 258 -QKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 258 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
..||........ ....+...... ... .+.+... .........+.+|+.+||+.+|++|||+.||++
T Consensus 263 ~~~p~~~~~~~~~-----~~~~~~~~~~~-~~~----~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~ 329 (342)
T 1b6c_B 263 YQLPYYDLVPSDP-----SVEEMRKVVCE-QKL----RPNIPNR---WQSCEALRVMAKIMRECWYANGAARLTALRIKK 329 (342)
T ss_dssp CCCTTTTTSCSSC-----CHHHHHHHHTT-SCC----CCCCCGG---GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cccCccccCcCcc-----cHHHHHHHHHH-HHh----CCCCccc---ccchhHHHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 677765443322 11111211111 111 1111110 011267788999999999999999999999999
Q ss_pred HHHHHHHh
Q 045453 337 RLKQIYQH 344 (346)
Q Consensus 337 ~L~~i~~~ 344 (346)
.|+++.++
T Consensus 330 ~L~~i~~~ 337 (342)
T 1b6c_B 330 TLSQLSQQ 337 (342)
T ss_dssp HHHHHHHT
T ss_pred HHHHHHHH
Confidence 99999875
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=338.04 Aligned_cols=275 Identities=17% Similarity=0.180 Sum_probs=211.0
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc-CcchHHHHHHHHHHhhhcCCCceeeEcceeecCC--cceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL-NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETR--IPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~--~~~lv 131 (346)
+.|...+.||+|+||+||+|.+ +++.||||++.... ......+.+|+..+..+ +||||+++++++.... ..++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCcceEEEEeecCCCceEEEE
Confidence 5688889999999999999999 58999999987544 23456677888899888 9999999999987655 77999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEE----cCCCceEEeccCCC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFL----DEGYIAKLFDFSLS 207 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll----~~~~~~kl~Dfgl~ 207 (346)
|||+++++|.+++...... ..+++..++.++.|++.||+||| +.+|+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGGGT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 9999999999999765321 34999999999999999999999 8999999999999999 88889999999999
Q ss_pred cccCCCCceeeccccccCCcCCccccc--------cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHH
Q 045453 208 VSIPEGETCVKDKVTGTMGFLAPEYIN--------TGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHY 279 (346)
Q Consensus 208 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 279 (346)
+....... .....||..|+|||++. +..++.++|||||||++|||+||..||.......... ..+...
T Consensus 164 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~ 239 (319)
T 4euu_A 164 RELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK--EVMYKI 239 (319)
T ss_dssp EECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCH--HHHHHH
T ss_pred eecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhH--HHHHHH
Confidence 87754432 23456899999999986 5778999999999999999999999997654433210 011111
Q ss_pred HHHHhhcCcccc---cccccc----ccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 045453 280 VKKCIENNEFDE---IVDPII----VSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341 (346)
Q Consensus 280 ~~~~~~~~~~~~---~~d~~l----~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 341 (346)
..... ...... .....+ .-.............+.+++..||+.||++|||+.|+++..++.
T Consensus 240 ~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 240 ITGKP-SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHCC-TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred hcCCC-cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 11110 000000 000000 00011112336778899999999999999999999999987753
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=343.89 Aligned_cols=271 Identities=17% Similarity=0.239 Sum_probs=199.4
Q ss_pred hcCCCcccccccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHHHHHHHh-hhcCCCceeeEcceeec-----CCcce
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFAS-KLSSHKNVLKLTGCCLE-----TRIPV 129 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~-~~~~h~niv~l~g~~~~-----~~~~~ 129 (346)
.++|...+.||+|+||.||+|.++++.||||++.... ...+..+..... ...+||||+++++++.. ....+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 4678889999999999999999999999999986432 233333333322 22499999999985432 33568
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC---------CceecCCCCCCeEEcCCCceE
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSR---------PILHRKIRPSRIFLDEGYIAK 200 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~---------~iiH~dlkp~NIll~~~~~~k 200 (346)
+||||+++|+|.+++... ..++..++.++.|++.||+||| +. +|+||||||+|||++.++.+|
T Consensus 89 lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLH-----TSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred EEEecCCCCcHHHHHhhc-----ccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEE
Confidence 999999999999999764 3689999999999999999999 77 999999999999999999999
Q ss_pred EeccCCCcccCCCCc-------eeeccccccCCcCCcccccc-------CCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Q 045453 201 LFDFSLSVSIPEGET-------CVKDKVTGTMGFLAPEYINT-------GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRG 266 (346)
Q Consensus 201 l~Dfgl~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~ 266 (346)
|+|||+++.+..... .......||+.|+|||++.+ ..++.++||||||+++|||++|..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999987653221 11234569999999999986 4567899999999999999999777654433
Q ss_pred cccccchh--------hHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 045453 267 DEIGAGHY--------WLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRL 338 (346)
Q Consensus 267 ~~~~~~~~--------~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 338 (346)
........ ..... ......... .+.+.... ......+..+.+|+.+||+.||++|||+.|+++.|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L 313 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDM-QVLVSREKQ----RPKFPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERM 313 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHH-HHHHTTSCC----CCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHH-Hhhhccccc----CCCCCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHH
Confidence 22100000 00000 111111110 11111111 11225677899999999999999999999999999
Q ss_pred HHHHHh
Q 045453 339 KQIYQH 344 (346)
Q Consensus 339 ~~i~~~ 344 (346)
+++.+.
T Consensus 314 ~~ll~~ 319 (336)
T 3g2f_A 314 AELMMI 319 (336)
T ss_dssp HHHHHC
T ss_pred HHHHHH
Confidence 999864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=351.15 Aligned_cols=244 Identities=20% Similarity=0.254 Sum_probs=196.4
Q ss_pred HhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcce
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV 129 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~ 129 (346)
..++|...+.||+|+||+||+|.+ +++.||+|++.... .........|..++..+.+||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 357899999999999999999998 68899999987532 2344566778888887768999999999999999999
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcc
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVS 209 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~ 209 (346)
+||||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 101 lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSR----RFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceee
Confidence 9999999999999997753 5999999999999999999999 89999999999999999999999999999975
Q ss_pred cCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcc
Q 045453 210 IPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEF 289 (346)
Q Consensus 210 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (346)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|..||...+..+. ...... ..
T Consensus 174 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~----------~~~i~~-~~- 240 (353)
T 3txo_A 174 GICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL----------FEAILN-DE- 240 (353)
T ss_dssp SCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------HHHHHH-CC-
T ss_pred cccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHH----------HHHHHc-CC-
Confidence 43222 223456799999999999998999999999999999999999999976543221 111111 10
Q ss_pred ccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCH
Q 045453 290 DEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTT 331 (346)
Q Consensus 290 ~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 331 (346)
. ..+ ......+.+|+..||+.+|++||++
T Consensus 241 -------~--~~p----~~~~~~~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 241 -------V--VYP----TWLHEDATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp -------C--CCC----TTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred -------C--CCC----CCCCHHHHHHHHHHhhhCHHHccCC
Confidence 0 000 1234568899999999999999998
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=343.92 Aligned_cols=272 Identities=20% Similarity=0.305 Sum_probs=219.8
Q ss_pred CCHHHHHHHhcCCCcccccccCCCcEEEEEEE-------CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeE
Q 045453 47 FTIRELEIATNNFDARNVIKDGYAYKFYKGFV-------EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKL 118 (346)
Q Consensus 47 ~~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~-------~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l 118 (346)
+....+....++|...+.||+|+||+||+|.+ +++.||+|.+..... .....+.+|+..+..+.+||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 56677777889999999999999999999985 457999999876543 3345678889999888779999999
Q ss_pred cceeecCC-cceEEEecccCCChhhhhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecC
Q 045453 119 TGCCLETR-IPVIVFESVKNRTLADHIYQNQPH------------FEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRK 185 (346)
Q Consensus 119 ~g~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~d 185 (346)
++++...+ ..++||||+++|+|.+++...... ...+++..++.++.|++.||.||| +.+++|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCccccc
Confidence 99987754 589999999999999999865421 123899999999999999999999 88999999
Q ss_pred CCCCCeEEcCCCceEEeccCCCcccCCCCc-eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCC
Q 045453 186 IRPSRIFLDEGYIAKLFDFSLSVSIPEGET-CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDP 263 (346)
Q Consensus 186 lkp~NIll~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~ 263 (346)
|||+|||++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|+|+| |..||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999987654332 23345568889999999999999999999999999999998 9999976
Q ss_pred CCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 045453 264 SRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQ 343 (346)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 343 (346)
...... ....+ ..+... .. +......+.+++.+||+.+|++|||+.|+++.|+.+.+
T Consensus 254 ~~~~~~------~~~~~----~~~~~~-----~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 254 VKIDEE------FCRRL----KEGTRM-----RA--------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp CCCSHH------HHHHH----HHTCCC-----CC--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchhHH------HHHHh----ccCccC-----CC--------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 543321 11111 111100 00 01234568899999999999999999999999999987
Q ss_pred h
Q 045453 344 H 344 (346)
Q Consensus 344 ~ 344 (346)
.
T Consensus 311 ~ 311 (316)
T 2xir_A 311 A 311 (316)
T ss_dssp H
T ss_pred h
Confidence 5
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=358.67 Aligned_cols=258 Identities=16% Similarity=0.238 Sum_probs=207.8
Q ss_pred HHHHHHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceee
Q 045453 49 IRELEIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCL 123 (346)
Q Consensus 49 ~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~ 123 (346)
++++....++|...+.||+|+||+||+|.+ +++.||+|++.... ......+.+|..++..+ +|||||+++++|.
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQ 139 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-CCTTBCCEEEEEE
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEE
Confidence 345566678999999999999999999999 67899999986421 12334466777777777 9999999999999
Q ss_pred cCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEec
Q 045453 124 ETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFD 203 (346)
Q Consensus 124 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~D 203 (346)
+.+..++||||+++|+|.+++... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~D 211 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLAD 211 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred ECCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEec
Confidence 999999999999999999999763 4899999999999999999999 89999999999999999999999999
Q ss_pred cCCCcccCCCCceeeccccccCCcCCccccccCC----CCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHH
Q 045453 204 FSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGD----FNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHY 279 (346)
Q Consensus 204 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 279 (346)
||+++.............+||+.|+|||++.+.. ++.++|||||||++|||++|..||...+..+.
T Consensus 212 FG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---------- 281 (410)
T 3v8s_A 212 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---------- 281 (410)
T ss_dssp CTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----------
T ss_pred cceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH----------
Confidence 9999877655544455678999999999998765 88999999999999999999999975433221
Q ss_pred HHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 045453 280 VKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAED--RPTTVDVAK 336 (346)
Q Consensus 280 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~ev~~ 336 (346)
......... .+ ..+ .....+..+.+|+.+||+.+|.+ ||++.||++
T Consensus 282 ~~~i~~~~~-------~~--~~p--~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 282 YSKIMNHKN-------SL--TFP--DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HHHHHTHHH-------HC--CCC--TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred HHHHHhccc-------cc--cCC--CcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 111111000 00 000 00123456889999999999988 999999874
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=348.27 Aligned_cols=250 Identities=21% Similarity=0.291 Sum_probs=203.5
Q ss_pred HHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCc
Q 045453 53 EIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRI 127 (346)
Q Consensus 53 ~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~ 127 (346)
....++|...+.||+|+||+||+|.+ +++.||+|.+.... .........|...+..+.+||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 44568899999999999999999999 68999999987542 23455667788888777699999999999999999
Q ss_pred ceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCC
Q 045453 128 PVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS 207 (346)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~ 207 (346)
.++||||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhh
Confidence 999999999999999998653 5899999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcC
Q 045453 208 VSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENN 287 (346)
Q Consensus 208 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (346)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|..||...+..+. ...+ .. .
T Consensus 166 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-------~~~i---~~-~ 233 (345)
T 1xjd_A 166 KENMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL-------FHSI---RM-D 233 (345)
T ss_dssp BCCCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHH---HH-C
T ss_pred hhcccCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH-------HHHH---Hh-C
Confidence 76432221 23456799999999999999999999999999999999999999975433221 1111 11 1
Q ss_pred ccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 045453 288 EFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTV-DVA 335 (346)
Q Consensus 288 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-ev~ 335 (346)
. ... + ......+.+|+.+||+.+|++||++. +++
T Consensus 234 ~------~~~----p----~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 234 N------PFY----P----RWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp C------CCC----C----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred C------CCC----C----cccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 0 000 0 12345688999999999999999997 553
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=336.20 Aligned_cols=257 Identities=22% Similarity=0.268 Sum_probs=203.9
Q ss_pred CCcccccccCCCcEEEEEEE--CC---eEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcc-eEE
Q 045453 59 FDARNVIKDGYAYKFYKGFV--ED---RTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIP-VIV 131 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~~--~~---~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~-~lv 131 (346)
|...+.||+|+||+||+|.+ ++ ..+|+|.+..... .....+.+|+..+..+ +||||+++++++.+.+.. ++|
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-NHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSSSCCEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEecCCCCcEEE
Confidence 44568899999999999987 22 2799999875443 3345677888888888 999999999999876655 999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+.+|+|.+++.... ..+++..++.++.|++.||.||| +.+++||||||+|||++.++.+||+|||+++...
T Consensus 102 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 99999999999997643 46899999999999999999999 8899999999999999999999999999998664
Q ss_pred CCCc---eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCc
Q 045453 212 EGET---CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE 288 (346)
Q Consensus 212 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (346)
.... .......+|..|+|||.+.+..++.++||||||+++|+|++|..|+........ ....+. ...
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~------~~~~~~----~~~ 245 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD------LTHFLA----QGR 245 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG------HHHHHH----TTC
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH------HHHHhh----cCC
Confidence 4321 122345678899999999999999999999999999999996555433222111 111111 110
Q ss_pred cccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 045453 289 FDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHL 345 (346)
Q Consensus 289 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~l 345 (346)
....+...+..+.+++..||+.+|++|||+.++++.|+++.+.+
T Consensus 246 -------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 246 -------------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp -------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -------------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 00011133456889999999999999999999999999999876
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=344.09 Aligned_cols=244 Identities=23% Similarity=0.306 Sum_probs=201.8
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
++|...+.||+|+||.||+|.+ +++.||+|.+.... ......+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEE
Confidence 6788899999999999999998 88899999986432 22345677888888888 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+ +|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 88 ~E~~-~g~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK----RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 779999987653 5999999999999999999999 8899999999999999999999999999998765
Q ss_pred CCCceeeccccccCCcCCccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINTGDF-NEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
.+.. .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||........
T Consensus 160 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~--------------------- 216 (336)
T 3h4j_B 160 DGNF--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL--------------------- 216 (336)
T ss_dssp TSBT--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---------------------
T ss_pred CCcc--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---------------------
Confidence 4332 244579999999999988776 7899999999999999999999976544332
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.......... .+...+..+.+|+.+||+.||.+|||+.|+++
T Consensus 217 --~~~i~~~~~~--~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 217 --FKKVNSCVYV--MPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp --BCCCCSSCCC--CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred --HHHHHcCCCC--CcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 0100001111 11134466889999999999999999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=342.09 Aligned_cols=249 Identities=21% Similarity=0.274 Sum_probs=203.5
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC------cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcc
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN------DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIP 128 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~------~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~ 128 (346)
+.|...+.||+|+||.||+|.. ++..||+|.+..... .....+.+|+..+..+ +||||+++++++.+.+..
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEE
Confidence 4588899999999999999999 688999999875432 1356678899999988 999999999999999999
Q ss_pred eEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCC----ceEEecc
Q 045453 129 VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGY----IAKLFDF 204 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~----~~kl~Df 204 (346)
++||||+++|+|.+++... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++ .+||+||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS----SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 9999999999999999754 36999999999999999999999 89999999999999999887 8999999
Q ss_pred CCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHh
Q 045453 205 SLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCI 284 (346)
Q Consensus 205 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (346)
|+++....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||......+. ...+.
T Consensus 163 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------~~~~~--- 230 (326)
T 2y0a_A 163 GLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-------LANVS--- 230 (326)
T ss_dssp TTCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-------HHHHH---
T ss_pred CCCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-------HHHHH---
Confidence 99987754332 2345799999999999999999999999999999999999999975433211 11110
Q ss_pred hcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 285 ENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 285 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
. .... .... .....+..+.+|+.+||+.||++|||+.|+++
T Consensus 231 ~-~~~~--~~~~--------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 231 A-VNYE--FEDE--------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp H-TCCC--CCHH--------HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred h-cCCC--cCcc--------ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 0000 0000 00123456889999999999999999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=358.71 Aligned_cols=262 Identities=18% Similarity=0.237 Sum_probs=208.5
Q ss_pred CCHHHHHHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcce
Q 045453 47 FTIRELEIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGC 121 (346)
Q Consensus 47 ~~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~ 121 (346)
+.++++....++|...+.||+|+||+||+|.. +++.||+|++.... ......+..|..++..+ +||||++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~ 129 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQLHFA 129 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-CTTTBCCEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-CCCCeeeEEEE
Confidence 44566777789999999999999999999999 78999999986432 12234466777777777 99999999999
Q ss_pred eecCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEE
Q 045453 122 CLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKL 201 (346)
Q Consensus 122 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl 201 (346)
+.+.+..++||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||
T Consensus 130 ~~~~~~~~lVmE~~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL 203 (412)
T 2vd5_A 130 FQDENYLYLVMEYYVGGDLLTLLSKFG---ERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRL 203 (412)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHHS---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEE
T ss_pred EeeCCEEEEEEcCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEE
Confidence 999999999999999999999998653 36999999999999999999999 899999999999999999999999
Q ss_pred eccCCCcccCCCCceeeccccccCCcCCccccc-------cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchh
Q 045453 202 FDFSLSVSIPEGETCVKDKVTGTMGFLAPEYIN-------TGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHY 274 (346)
Q Consensus 202 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~ 274 (346)
+|||+++.............+||+.|+|||++. +..++.++|||||||++|||++|+.||...+..+.
T Consensus 204 ~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~----- 278 (412)
T 2vd5_A 204 ADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET----- 278 (412)
T ss_dssp CCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----
T ss_pred eechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH-----
Confidence 999999877655444445568999999999997 35689999999999999999999999976443221
Q ss_pred hHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCC---CCHHHHHH
Q 045453 275 WLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDR---PTTVDVAK 336 (346)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R---Ps~~ev~~ 336 (346)
...+......... +.. ....+..+.+|+.+||+ +|++| |++.|+++
T Consensus 279 --~~~i~~~~~~~~~-----p~~--------~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 279 --YGKIVHYKEHLSL-----PLV--------DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp --HHHHHTHHHHCCC-----C------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred --HHHHHhcccCcCC-----Ccc--------ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 0101000000000 000 01234568899999999 99998 58888753
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=368.66 Aligned_cols=250 Identities=21% Similarity=0.350 Sum_probs=202.0
Q ss_pred ccccCCCcEEEEEEE----CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccCC
Q 045453 64 VIKDGYAYKFYKGFV----EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNR 138 (346)
Q Consensus 64 ~ig~G~~g~Vy~~~~----~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~g 138 (346)
.||+|+||.||+|.+ .+..||||.+..... ....++.+|+.++..+ +|||||+++++|.. +..++||||+++|
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-~~~~lv~E~~~~g 420 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA-EALMLVMEMAGGG 420 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTC-CCTTBCCEEEEEES-SSEEEEEECCTTC
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEecc-CCeEEEEEeCCCC
Confidence 699999999999987 345799999876543 3567788999999888 99999999999976 5689999999999
Q ss_pred ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCceee
Q 045453 139 TLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVK 218 (346)
Q Consensus 139 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 218 (346)
+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++..........
T Consensus 421 ~L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 494 (613)
T 2ozo_A 421 PLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 494 (613)
T ss_dssp BHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-------
T ss_pred cHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceee
Confidence 9999997653 46999999999999999999999 89999999999999999999999999999987754332221
Q ss_pred --ccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccccc
Q 045453 219 --DKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDP 295 (346)
Q Consensus 219 --~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 295 (346)
....+|+.|+|||++.+..++.++|||||||++|||+| |+.||......+. ... +..+..
T Consensus 495 ~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~-------~~~----i~~~~~------ 557 (613)
T 2ozo_A 495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-------MAF----IEQGKR------ 557 (613)
T ss_dssp -------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH-------HHH----HHTTCC------
T ss_pred eccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH-------HHH----HHcCCC------
Confidence 23345689999999999999999999999999999998 9999987554331 111 111110
Q ss_pred ccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 045453 296 IIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHL 345 (346)
Q Consensus 296 ~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~l 345 (346)
...+..++..+.+|+..||+.+|++|||+.+|++.|+.++.++
T Consensus 558 -------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 558 -------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp -------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred -------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 0011144567899999999999999999999999999998765
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=343.72 Aligned_cols=251 Identities=24% Similarity=0.302 Sum_probs=201.3
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
.++|...+.||+|+||+||+|.+ +++.||+|.+..... .....+.+|+..+..+ +||||+++++++.+.+..++||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCeEEEEE
Confidence 36788999999999999999998 788999999865432 2335567888888888 9999999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
||+++|+|.+++... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 85 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 157 (323)
T 3tki_A 85 EYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (323)
T ss_dssp ECCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EcCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence 999999999999754 35999999999999999999999 89999999999999999999999999999976543
Q ss_pred CCc-eeeccccccCCcCCccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 213 GET-CVKDKVTGTMGFLAPEYINTGDF-NEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 213 ~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
... .......||+.|+|||++.+..+ +.++||||||+++|+|++|..||........ ....+. ....
T Consensus 158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-----~~~~~~----~~~~-- 226 (323)
T 3tki_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-----EYSDWK----EKKT-- 226 (323)
T ss_dssp TTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-----HHHHHH----TTCT--
T ss_pred CCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-----HHHHHh----cccc--
Confidence 222 22345679999999999988775 7899999999999999999999976544322 011110 0000
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
...........+.+|+.+||+.||++|||+.|+++
T Consensus 227 -----------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 227 -----------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp -----------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----------cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00011134566789999999999999999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=338.07 Aligned_cols=248 Identities=21% Similarity=0.286 Sum_probs=195.6
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--------------------------cchHHHHHHHHHHh
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--------------------------DGHEDCFNNIIFAS 107 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--------------------------~~~~~~~~e~~~~~ 107 (346)
.++|...+.||+|+||.||+|.+ +++.||+|.+..... .....+.+|+..+.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 36788999999999999999998 789999999865421 11345788999999
Q ss_pred hhcCCCceeeEcceeec--CCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecC
Q 045453 108 KLSSHKNVLKLTGCCLE--TRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRK 185 (346)
Q Consensus 108 ~~~~h~niv~l~g~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~d 185 (346)
.+ +||||+++++++.+ .+..++||||+++++|.+++.. .++++..++.++.|++.||.||| +.+|+|||
T Consensus 92 ~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~D 162 (298)
T 2zv2_A 92 KL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRD 162 (298)
T ss_dssp TC-CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCC
T ss_pred hC-CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccC
Confidence 98 99999999999986 5678999999999999987643 36999999999999999999999 88999999
Q ss_pred CCCCCeEEcCCCceEEeccCCCcccCCCCceeeccccccCCcCCccccccCC---CCcccchHHHHHHHHHHHhCCCCCC
Q 045453 186 IRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGD---FNEKCDVFSFGMLLLVLLTGQKIFD 262 (346)
Q Consensus 186 lkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~G~vl~elltg~~p~~ 262 (346)
|||+|||++.++.+||+|||+++....... ......||+.|+|||.+.+.. ++.++||||||+++|+|++|..||.
T Consensus 163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 163 IKPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 999999999999999999999987654332 234567999999999998765 4788999999999999999999997
Q ss_pred CCCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 263 PSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
...... ....... .... . +.....+..+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~----------~~~~~~~-~~~~------~------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 242 DERIMC----------LHSKIKS-QALE------F------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp CSSHHH----------HHHHHHH-CCCC------C------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CccHHH----------HHHHHhc-ccCC------C------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 532211 1111111 1000 0 001123456889999999999999999999864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=338.39 Aligned_cols=262 Identities=21% Similarity=0.361 Sum_probs=197.7
Q ss_pred HHhcCCCcccccccCCCcEEEEEEECCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 54 IATNNFDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 54 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
...++|...+.||+|+||+||+|.+.+ .+|+|.+..... .....+.+|+..+..+ +||||+++++++ ..+..++|
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE-CSSSCEEE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCcEEEEEeec-cCCccEEE
Confidence 445779999999999999999999855 599999875432 3345677888888888 999999999976 45668999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++||||||+|||++.++.+||+|||++....
T Consensus 98 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 98 TQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEecCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccccc
Confidence 99999999999997554 46999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCC-ceeeccccccCCcCCccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcC
Q 045453 212 EGE-TCVKDKVTGTMGFLAPEYIN---TGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENN 287 (346)
Q Consensus 212 ~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (346)
... ........||+.|+|||.+. +..++.++||||||+++|+|++|..||......+. +...+. .+
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~----~~ 241 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIEMVG----RG 241 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH------HHHHHH----HT
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH------HHHHhc----cc
Confidence 322 22234456899999999987 56789999999999999999999999976544221 111111 11
Q ss_pred ccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 045453 288 EFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQ 343 (346)
Q Consensus 288 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 343 (346)
........ .....+..+.+++..||+.+|++|||+.++++.|+++.+
T Consensus 242 ~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 242 SLSPDLSK---------VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp SCCCCTTS---------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ccCcchhh---------ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 11110000 011345678999999999999999999999999998764
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=346.30 Aligned_cols=268 Identities=20% Similarity=0.296 Sum_probs=215.1
Q ss_pred HHHHHhcCCCcccccccCCCcEEEEEEE--CC-----eEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEccee
Q 045453 51 ELEIATNNFDARNVIKDGYAYKFYKGFV--ED-----RTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCC 122 (346)
Q Consensus 51 ~l~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~-----~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~ 122 (346)
.+....++|...+.||+|+||.||+|.+ .+ ..||+|.+..... .....+.+|+..+..+.+||||++++++|
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 4556678899999999999999999998 22 3799999876543 33456778888888886899999999999
Q ss_pred ecCCcceEEEecccCCChhhhhhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeE
Q 045453 123 LETRIPVIVFESVKNRTLADHIYQNQP----------HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIF 192 (346)
Q Consensus 123 ~~~~~~~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIl 192 (346)
.+.+..++||||+++|+|.+++..... ....+++..++.++.|++.||.||| +.+|+||||||+|||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEE
Confidence 999999999999999999999975421 1235899999999999999999999 889999999999999
Q ss_pred EcCCCceEEeccCCCcccCCCCc-eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccc
Q 045453 193 LDEGYIAKLFDFSLSVSIPEGET-CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIG 270 (346)
Q Consensus 193 l~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~ 270 (346)
++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|+|+| |..||........
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~- 275 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK- 275 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-
Confidence 99999999999999986643332 22344567889999999999999999999999999999999 9999976544321
Q ss_pred cchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 271 AGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
....+.. ... .. .+...+..+.+++..||+.+|++|||+.||++.|+++.+.
T Consensus 276 -----~~~~~~~----~~~---------~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 276 -----FYKLVKD----GYQ---------MA----QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp -----HHHHHHH----TCC---------CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----HHHHHhc----CCC---------CC----CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 1111111 100 00 0112345688999999999999999999999999998764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=338.37 Aligned_cols=269 Identities=21% Similarity=0.322 Sum_probs=202.9
Q ss_pred HHHHHHhcCCCcccccccCCCcEEEEEEE-----CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEccee
Q 045453 50 RELEIATNNFDARNVIKDGYAYKFYKGFV-----EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCC 122 (346)
Q Consensus 50 ~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~-----~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~ 122 (346)
+++....++|...+.||+|+||.||+|.+ .+..||+|.+..... .....+.+|+..+..+ +||||+++++++
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 105 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF-SHPNVIRLLGVC 105 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcC-CCCCeeeeeEEE
Confidence 34445567788889999999999999987 234799999875432 3345678888889888 999999999999
Q ss_pred ecCCc-----ceEEEecccCCChhhhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcC
Q 045453 123 LETRI-----PVIVFESVKNRTLADHIYQNQ--PHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE 195 (346)
Q Consensus 123 ~~~~~-----~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~ 195 (346)
.+.+. .++||||+++|+|.+++.... .....+++..++.++.|++.||.||| +.+++||||||+|||++.
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~ 182 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRD 182 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECT
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcC
Confidence 87553 499999999999999985432 22356999999999999999999999 899999999999999999
Q ss_pred CCceEEeccCCCcccCCCCce-eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccch
Q 045453 196 GYIAKLFDFSLSVSIPEGETC-VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGH 273 (346)
Q Consensus 196 ~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~ 273 (346)
++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+.
T Consensus 183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---- 258 (313)
T 3brb_A 183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM---- 258 (313)
T ss_dssp TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH----
T ss_pred CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH----
Confidence 999999999999876543322 2234457789999999999999999999999999999999 8999976544332
Q ss_pred hhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhhC
Q 045453 274 YWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHLA 346 (346)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~l~ 346 (346)
...+ ..+.. . ......+..+.+++.+||+.+|++|||+.++++.|+++.+.++
T Consensus 259 ---~~~~----~~~~~------------~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 259 ---YDYL----LHGHR------------L-KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp ---HHHH----HTTCC------------C-CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred ---HHHH----HcCCC------------C-CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 1111 01100 0 0111344678999999999999999999999999999998863
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-47 Score=341.23 Aligned_cols=266 Identities=20% Similarity=0.257 Sum_probs=207.3
Q ss_pred cCCCcccccccCCCcEEEEEEE------CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecC--Cc
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV------EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLET--RI 127 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~------~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~--~~ 127 (346)
+.|...+.||+|+||.||+|.+ +++.||+|++..... .....+.+|+..+..+ +||||+++++++... ..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCce
Confidence 4577889999999999999984 788999999875432 3456778888899888 999999999999876 66
Q ss_pred ceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCC
Q 045453 128 PVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS 207 (346)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~ 207 (346)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+|||++.++.+||+|||++
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNK---NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEEeCCCCcHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccc
Confidence 899999999999999996654 46999999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCce--eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccc-----ccchhhHHHHH
Q 045453 208 VSIPEGETC--VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEI-----GAGHYWLLHYV 280 (346)
Q Consensus 208 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~-----~~~~~~~~~~~ 280 (346)
......... ......+|..|+|||.+.+..++.++||||||+++|+|+||..|+........ ...........
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 877654432 23445688889999999999999999999999999999999998643211000 00000011111
Q ss_pred HHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 045453 281 KKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQ 343 (346)
Q Consensus 281 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 343 (346)
...... .....+...+..+.+|+.+||+.||++|||+.++++.|+.+++
T Consensus 254 -~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 254 -NTLKEG-------------KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp -HHHHTT-------------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred -HHHhcc-------------CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 111111 0111111345678999999999999999999999999999864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=343.25 Aligned_cols=256 Identities=19% Similarity=0.310 Sum_probs=201.1
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCe----EEEEEEecCcc-CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcc
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDR----TVSVMKFNDIL-NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIP 128 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~----~vavk~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~ 128 (346)
.++|...+.||+|+||+||+|.+ +++ +|++|.+.... ......+.+|+..+..+ +||||++++++|.... .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~-~ 91 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTST-V 91 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTC-CBTTBCCCCEEEESSS-E
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEecCC-c
Confidence 36788899999999999999998 444 35777775443 34566788888888888 9999999999998765 7
Q ss_pred eEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 129 VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
++|+||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 92 ~~v~~~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEECCCSSCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred eEEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 89999999999999998754 46999999999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCc-eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhc
Q 045453 209 SIPEGET-CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIEN 286 (346)
Q Consensus 209 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (346)
....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||......+. ...+ ..
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-------~~~~----~~ 234 (327)
T 3lzb_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-------SSIL----EK 234 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-------HHHH----HT
T ss_pred EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH-------HHHH----Hc
Confidence 7653332 12233456788999999999999999999999999999999 9999976544332 1111 11
Q ss_pred CccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 045453 287 NEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQ 343 (346)
Q Consensus 287 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 343 (346)
.. ....+...+..+.+++..||+.+|++|||+.|+++.|+++.+
T Consensus 235 ~~-------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 235 GE-------------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp TC-------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred CC-------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 10 000111344568899999999999999999999999999875
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=343.77 Aligned_cols=251 Identities=20% Similarity=0.244 Sum_probs=198.6
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
++|...+.||+|+||.||+|.+ +++.||+|++..... .....+..|...+..+.+||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 5688899999999999999998 689999999875432 22345667778887776899999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+++|+|.+++.... .+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 99999999999997653 5899999999999999999999 8999999999999999999999999999997643
Q ss_pred CCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccc
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDE 291 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (346)
... .......||+.|+|||++.+..++.++|||||||++|||++|..||........... .........+.....
T Consensus 162 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--~~~~~~~~~i~~~~~-- 236 (345)
T 3a8x_A 162 RPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ--NTEDYLFQVILEKQI-- 236 (345)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC---------CHHHHHHHHHHCCC--
T ss_pred CCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc--ccHHHHHHHHHcCCC--
Confidence 222 123456799999999999999999999999999999999999999975432211000 000111111111110
Q ss_pred ccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCH
Q 045453 292 IVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTT 331 (346)
Q Consensus 292 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 331 (346)
.+ + ...+..+.+|+.+||+.||++||++
T Consensus 237 ----~~----p----~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 ----RI----P----RSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ----CC----C----TTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ----CC----C----CCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 00 0 1234568899999999999999996
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=338.63 Aligned_cols=256 Identities=20% Similarity=0.292 Sum_probs=202.7
Q ss_pred HHHhcCCCcccccccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecC-CcceEE
Q 045453 53 EIATNNFDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLET-RIPVIV 131 (346)
Q Consensus 53 ~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~-~~~~lv 131 (346)
....++|...+.||+|+||+||+|.+.+..||+|.+... .....+.+|+..+..+ +||||+++++++.+. +..++|
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~lv 93 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND--ATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIV 93 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCC--C--HHHHHTHHHHTTC-CCTTBCCEEEEECCC--CCEEE
T ss_pred cCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecch--hHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCCceEEE
Confidence 344577889999999999999999999999999998644 3456778889999888 999999999997654 578999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+++++|.+++..... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 94 TEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp ECCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred EecCCCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 999999999999976431 23889999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
... ....++..|+|||.+.+..++.++||||||+++|+|+| |..||......+. ... ...+.
T Consensus 169 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~-------~~~----~~~~~-- 231 (278)
T 1byg_A 169 STQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-------VPR----VEKGY-- 231 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH-------HHH----HTTTC--
T ss_pred ccc----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHH----HhcCC--
Confidence 321 23457889999999999999999999999999999998 9999976543221 110 11110
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
... .....+..+.+++..||+.+|++|||+.|+++.|+.+...
T Consensus 232 ---~~~--------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 232 ---KMD--------APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp ---CCC--------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCC--------CcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 000 1113456788999999999999999999999999999764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=352.95 Aligned_cols=252 Identities=18% Similarity=0.282 Sum_probs=203.6
Q ss_pred HhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceE
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVI 130 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~l 130 (346)
..++|...+.||+|+||+||+|.. +++.+|+|++..... .....+.+|+.++..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHC-CBTTBCCEEEEEECSSEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCcCCCeEEEEEEECCEEEE
Confidence 356788999999999999999998 889999999875432 2345677888888888 99999999999999999999
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEc---CCCceEEeccCCC
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLD---EGYIAKLFDFSLS 207 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~---~~~~~kl~Dfgl~ 207 (346)
||||+++|+|.+.+.... .+++..+..++.|++.||.||| +.+|+||||||+|||++ .++.+||+|||++
T Consensus 88 v~E~~~gg~L~~~i~~~~----~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a 160 (444)
T 3soa_A 88 IFDLVTGGELFEDIVARE----YYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLA 160 (444)
T ss_dssp EECCCBCCBHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred EEEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence 999999999999998753 5999999999999999999999 89999999999999998 5688999999999
Q ss_pred cccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcC
Q 045453 208 VSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENN 287 (346)
Q Consensus 208 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (346)
........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+. ...+ ..+
T Consensus 161 ~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~-------~~~i----~~~ 228 (444)
T 3soa_A 161 IEVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL-------YQQI----KAG 228 (444)
T ss_dssp BCCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------HHHH----HHT
T ss_pred EEecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH-------HHHH----HhC
Confidence 77654332 23446799999999999999999999999999999999999999975433221 1111 111
Q ss_pred ccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 288 EFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 288 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
... .+.+.....+..+.+|+..||+.||++|||+.|+++
T Consensus 229 ~~~----------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 229 AYD----------FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp CCC----------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCC----------CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 100 000001133466889999999999999999999976
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=341.80 Aligned_cols=264 Identities=19% Similarity=0.293 Sum_probs=212.8
Q ss_pred HHhcCCCcccccccCCCcEEEEEEE---------CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceee
Q 045453 54 IATNNFDARNVIKDGYAYKFYKGFV---------EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCL 123 (346)
Q Consensus 54 ~~~~~f~~~~~ig~G~~g~Vy~~~~---------~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~ 123 (346)
...++|...+.||+|+||.||+|.+ ++..||+|.+..... .....+.+|+..+..+.+||||+++++++.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 3457888999999999999999986 346799999875533 344567888888888878999999999999
Q ss_pred cCCcceEEEecccCCChhhhhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCe
Q 045453 124 ETRIPVIVFESVKNRTLADHIYQNQPH------------FEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRI 191 (346)
Q Consensus 124 ~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NI 191 (346)
+.+..++||||+++|+|.+++...... ...+++..++.++.|++.||.||| +.+++||||||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NI 188 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNV 188 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceE
Confidence 999999999999999999999865421 134899999999999999999999 88999999999999
Q ss_pred EEcCCCceEEeccCCCcccCCCCcee-eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccc
Q 045453 192 FLDEGYIAKLFDFSLSVSIPEGETCV-KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEI 269 (346)
Q Consensus 192 ll~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~ 269 (346)
|++.++.+||+|||+++......... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~- 267 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE- 267 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH-
Confidence 99999999999999998775443322 234457788999999998899999999999999999999 999997543221
Q ss_pred ccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 270 GAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
+...+. .+... .. ....+..+.+++..||+.+|++|||+.|+++.|+.+.+.
T Consensus 268 ------~~~~~~----~~~~~-----~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 268 ------LFKLLK----EGHRM-----DK--------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp ------HHHHHH----HTCCC-----CC--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------HHHHHh----cCCCC-----CC--------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 111111 11100 00 113345688999999999999999999999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=335.88 Aligned_cols=265 Identities=18% Similarity=0.232 Sum_probs=202.1
Q ss_pred hcCCCcccccccCCCcEEEEEEE-CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
.++|...+.||+|+||+||+|.+ +++.||+|++..... .....+.+|+..+..+ +||||+++++++.+.+..++||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL-HHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHC-CCTTBCCEEEEECCSSCEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHc-CCCCEeeeeeEEccCCEEEEEE
Confidence 36788899999999999999999 888999999875432 2245677888999888 9999999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
||+++ +|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 99 e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 99 EFMEK-DLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp ECCSE-EHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred cCCCC-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 99975 8888887654 45899999999999999999999 89999999999999999999999999999987653
Q ss_pred CCceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccc
Q 045453 213 GETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDE 291 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (346)
... ......+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+. +.. +...........
T Consensus 172 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~-i~~~~~~~~~~~ 243 (311)
T 3niz_A 172 PVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ------LPK-IFSILGTPNPRE 243 (311)
T ss_dssp CCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH------HHH-HHHHHCCCCTTT
T ss_pred Ccc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH------HHH-HHHHHCCCChHH
Confidence 322 2334578999999999876 5689999999999999999999999987655442 111 111111111000
Q ss_pred ---ccc------cccccCCCCc---chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 292 ---IVD------PIIVSEGPRV---GKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 292 ---~~d------~~l~~~~~~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
..+ .......... ..+.....+.+|+.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 244 WPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp SGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000 0000000000 00022356889999999999999999999975
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=345.33 Aligned_cols=271 Identities=20% Similarity=0.294 Sum_probs=212.8
Q ss_pred hcCCCcccccccCCCcEEEEEEE------CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCC--c
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV------EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETR--I 127 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~------~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~--~ 127 (346)
.++|...+.||+|+||.||+|.+ ++..||+|++..........+.+|+..+..+ +||||+++++++...+ .
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTC-CCTTBCCEEEEECC----C
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEecCCCc
Confidence 35678889999999999999984 6789999999876555667788999999998 9999999999987644 7
Q ss_pred ceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCC
Q 045453 128 PVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS 207 (346)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~ 207 (346)
.++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++||||||+|||++.++.+||+|||++
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHST---TSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred eEEEEECCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence 899999999999999998754 46999999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCcee--eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccc---c--cchhhHHHHH
Q 045453 208 VSIPEGETCV--KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEI---G--AGHYWLLHYV 280 (346)
Q Consensus 208 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~---~--~~~~~~~~~~ 280 (346)
.......... .....++..|+|||.+.+..++.++||||||+++|+|+||..|+........ . ..........
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence 8775443322 2234567789999999998999999999999999999999999863210000 0 0000000011
Q ss_pred HHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhhC
Q 045453 281 KKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHLA 346 (346)
Q Consensus 281 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~l~ 346 (346)
........ ....+...+..+.+++.+||+.+|++|||+.||++.|+++.++|+
T Consensus 273 ~~~~~~~~-------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~ 325 (326)
T 2w1i_A 273 IELLKNNG-------------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325 (326)
T ss_dssp HHHHHTTC-------------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHhhcCC-------------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 11111110 001111345678999999999999999999999999999999873
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=349.42 Aligned_cols=256 Identities=25% Similarity=0.397 Sum_probs=195.3
Q ss_pred CCcccccccCCCcEEEEEEE--CC---eEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeec-CCcceEE
Q 045453 59 FDARNVIKDGYAYKFYKGFV--ED---RTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLE-TRIPVIV 131 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~~--~~---~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~-~~~~~lv 131 (346)
|...+.||+|+||+||+|.+ .+ ..||+|.+..... ....++.+|+..+..+ +||||++++++|.+ .+..++|
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTC-CCTTBCCCCEEECCCSSCCEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCCCeEEE
Confidence 44567899999999999987 22 3688898865433 3456778888888888 99999999998765 4578999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 170 ~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccccccc
Confidence 99999999999997654 45899999999999999999999 8999999999999999999999999999998664
Q ss_pred CCCce---eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcC
Q 045453 212 EGETC---VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENN 287 (346)
Q Consensus 212 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (346)
..... ......+|+.|+|||.+.+..++.++||||||+++|||+| |..||......+. ...+ ..+
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~-------~~~~----~~~ 312 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-------TVYL----LQG 312 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH-------HHHH----HTT
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH-------HHHH----HcC
Confidence 33221 1233456788999999999999999999999999999999 7778876544332 1111 111
Q ss_pred ccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 045453 288 EFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHL 345 (346)
Q Consensus 288 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~l 345 (346)
.. . ..+...+..+.+++.+||+.+|++|||+.|+++.|+.+...+
T Consensus 313 ~~-------~------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 313 RR-------L------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp CC-------C------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CC-------C------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 10 0 001134456889999999999999999999999999998765
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=341.73 Aligned_cols=257 Identities=19% Similarity=0.334 Sum_probs=200.9
Q ss_pred cCCCcccccccCCCcEEEEEEEC------CeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcce
Q 045453 57 NNFDARNVIKDGYAYKFYKGFVE------DRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV 129 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~~------~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~ 129 (346)
++|...+.||+|+||.||+|.+. +..||+|.+..... .....+.+|+..+..+ +||||+++++++.+.+..+
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecCCCcE
Confidence 44556789999999999999882 23599999875433 2345677888888888 9999999999999999999
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcc
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVS 209 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~ 209 (346)
+||||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+++||||||+|||++.++.+||+|||+++.
T Consensus 123 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 9999999999999997654 46999999999999999999999 88999999999999999999999999999987
Q ss_pred cCCCCce--eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhc
Q 045453 210 IPEGETC--VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIEN 286 (346)
Q Consensus 210 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (346)
....... ......+|..|+|||.+.+..++.++||||||+++|||++ |..||......+ +.. . ...
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-------~~~---~-~~~ 265 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-------VMK---A-IND 265 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHH---H-HHT
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH-------HHH---H-HHC
Confidence 6543221 1223346778999999999999999999999999999999 999997543321 111 1 111
Q ss_pred CccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 287 NEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 287 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
+.. . +.....+..+.+++.+||+.+|++|||+.++++.|+++.+.
T Consensus 266 ~~~-------~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 266 GFR-------L------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp TCC-------C------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCc-------C------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 100 0 00113446688999999999999999999999999998764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=346.30 Aligned_cols=254 Identities=19% Similarity=0.260 Sum_probs=203.3
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc-----CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcc
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL-----NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIP 128 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~-----~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~ 128 (346)
.+.|...+.||+|+||+||+|.+ +++.||+|.+.... ......+.+|+.++..+ +||||+++++++.+.+..
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-KHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEE
Confidence 35688899999999999999998 78999999985321 12356678888888888 999999999999999999
Q ss_pred eEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCc---eEEeccC
Q 045453 129 VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYI---AKLFDFS 205 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~---~kl~Dfg 205 (346)
++||||+++|+|.+.+.........+++..+..++.|++.||.||| +.+|+||||||+|||++.++. +||+|||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 9999999999999888654333346899999999999999999999 899999999999999987655 9999999
Q ss_pred CCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhh
Q 045453 206 LSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIE 285 (346)
Q Consensus 206 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (346)
++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... .+ ......
T Consensus 179 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~---~~~i~~ 246 (351)
T 3c0i_A 179 VAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--------RL---FEGIIK 246 (351)
T ss_dssp TCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--------HH---HHHHHH
T ss_pred ceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--------HH---HHHHHc
Confidence 9987754332 23455799999999999999999999999999999999999999975311 01 111111
Q ss_pred cCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 286 NNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 286 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
+... ..+.. ....+..+.+|+.+||+.||++|||+.|+++
T Consensus 247 -~~~~--~~~~~--------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 247 -GKYK--MNPRQ--------WSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp -TCCC--CCHHH--------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -CCCC--CCccc--------cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1100 00000 0123467889999999999999999999975
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=338.76 Aligned_cols=244 Identities=20% Similarity=0.295 Sum_probs=201.4
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVI 130 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~l 130 (346)
.++|...+.||+|+||+||+|.. +++.||+|.+.... ......+.+|...+..+ +||||+++++++.+.+..++
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-CCCCCceEeEEEEeCCEEEE
Confidence 35788899999999999999998 78999999986532 23345566777778777 99999999999999999999
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCccc
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI 210 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~ 210 (346)
||||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 84 v~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~ 156 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV 156 (318)
T ss_dssp EECCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred EEeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceec
Confidence 999999999999998653 5899999999999999999999 999999999999999999999999999999876
Q ss_pred CCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 211 PEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 211 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
... .....||+.|+|||++.+..++.++||||||+++|||++|..||......+ .........
T Consensus 157 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----------~~~~i~~~~--- 219 (318)
T 1fot_A 157 PDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK----------TYEKILNAE--- 219 (318)
T ss_dssp SSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----------HHHHHHHCC---
T ss_pred CCc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH----------HHHHHHhCC---
Confidence 432 234579999999999999999999999999999999999999997543211 111111110
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRP-----TTVDVAK 336 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~ 336 (346)
+ ..+ ......+.+++.+||+.+|++|| +++|+++
T Consensus 220 ------~--~~p----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 220 ------L--RFP----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp ------C--CCC----TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ------C--CCC----CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 0 000 12345688999999999999999 7888763
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=345.91 Aligned_cols=251 Identities=18% Similarity=0.205 Sum_probs=193.1
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
.++|...+.||+|+||+||++.. +++.||+|++.... .....+.+|+..+..+ +||||+++++++.+.+..++|||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhC-CCCCCCcEEEEEeeCCEEEEEEE
Confidence 46788999999999999999999 78899999987543 2345677888888888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCc--eEEeccCCCcccC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYI--AKLFDFSLSVSIP 211 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~--~kl~Dfgl~~~~~ 211 (346)
|+++|+|.+++.... ++++..++.++.|++.||.||| +.+|+||||||+|||++.++. +||+|||+++...
T Consensus 97 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 97 YASGGELYERICNAG----RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp CCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred eCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 999999999997653 5999999999999999999999 899999999999999987765 9999999987543
Q ss_pred CCCceeeccccccCCcCCccccccCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINTGDFNEK-CDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
... ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........ ............
T Consensus 170 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~------~~~~~~~~~~~~--- 238 (361)
T 3uc3_A 170 LHS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD------YRKTIQRILSVK--- 238 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC------HHHHHHHHHTTC---
T ss_pred ccC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH------HHHHHHHHhcCC---
Confidence 222 2244579999999999988887665 8999999999999999999986544332 111121111110
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
...+.....+..+.+|+.+||+.+|++|||+.|+++
T Consensus 239 ----------~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 239 ----------YSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp ----------CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ----------CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 000111123456889999999999999999999875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=337.80 Aligned_cols=262 Identities=23% Similarity=0.336 Sum_probs=207.8
Q ss_pred HHHHHhcCCCccc-ccccCCCcEEEEEEE----CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceee
Q 045453 51 ELEIATNNFDARN-VIKDGYAYKFYKGFV----EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCL 123 (346)
Q Consensus 51 ~l~~~~~~f~~~~-~ig~G~~g~Vy~~~~----~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~ 123 (346)
++....++|.... .||+|+||+||+|.+ .+..||+|.+..... ....++.+|+..+..+ +||||+++++++
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~- 87 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGIC- 87 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEE-
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEE-
Confidence 3334456677777 999999999999965 467899999875432 2346678888889888 999999999999
Q ss_pred cCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEec
Q 045453 124 ETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFD 203 (346)
Q Consensus 124 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~D 203 (346)
..+..++||||+++++|.+++... ..+++..++.++.|++.||.||| +.+++|+||||+|||++.++.+||+|
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~D 160 (291)
T 1xbb_A 88 EAESWMLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISD 160 (291)
T ss_dssp ESSSEEEEEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECC
T ss_pred CCCCcEEEEEeCCCCCHHHHHHhC----cCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEcc
Confidence 566789999999999999999875 35899999999999999999999 88999999999999999999999999
Q ss_pred cCCCcccCCCCceee--ccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHH
Q 045453 204 FSLSVSIPEGETCVK--DKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYV 280 (346)
Q Consensus 204 fgl~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 280 (346)
||++........... ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+ ....
T Consensus 161 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~- 232 (291)
T 1xbb_A 161 FGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAM- 232 (291)
T ss_dssp CTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHH-
T ss_pred CCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHH-
Confidence 999987754443222 23346788999999998899999999999999999999 999997643322 1111
Q ss_pred HHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 045453 281 KKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHL 345 (346)
Q Consensus 281 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~l 345 (346)
...+... . .+...+..+.+++..||+.+|++|||+.++++.|++++...
T Consensus 233 ---~~~~~~~-----~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 233 ---LEKGERM-----G--------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp ---HHTTCCC-----C--------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred ---HHcCCCC-----C--------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 1111100 0 01134567899999999999999999999999999998764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=333.70 Aligned_cols=257 Identities=20% Similarity=0.351 Sum_probs=208.5
Q ss_pred cCCCccc-ccccCCCcEEEEEEE----CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceE
Q 045453 57 NNFDARN-VIKDGYAYKFYKGFV----EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVI 130 (346)
Q Consensus 57 ~~f~~~~-~ig~G~~g~Vy~~~~----~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~l 130 (346)
++|.... .||+|+||.||+|.+ .+..||+|.+..... .....+.+|+..+..+ +||||+++++++ ..+..++
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE-ESSSEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEe-cCCCcEE
Confidence 4455555 899999999999986 567899999876543 3456678888889888 999999999999 5567899
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCccc
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI 210 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~ 210 (346)
||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++||||||+|||++.++.+||+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHhCC---ccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 999999999999997543 46999999999999999999999 889999999999999999999999999999877
Q ss_pred CCCCcee--eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcC
Q 045453 211 PEGETCV--KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENN 287 (346)
Q Consensus 211 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (346)
....... .....+|+.|+|||.+.+..++.++||||||+++|+|+| |..||......+. ...+ ..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-------~~~i----~~~ 229 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-------MAFI----EQG 229 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH-------HHHH----HTT
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH-------HHHH----hcC
Confidence 5443322 233456889999999998899999999999999999999 9999976544221 1111 111
Q ss_pred ccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 045453 288 EFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHL 345 (346)
Q Consensus 288 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~l 345 (346)
... . .+...+..+.+++..||+.+|++|||+.++++.|+.++.+.
T Consensus 230 ~~~-----~--------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 274 (287)
T 1u59_A 230 KRM-----E--------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274 (287)
T ss_dssp CCC-----C--------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CcC-----C--------CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 100 0 01134567899999999999999999999999999998753
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=338.21 Aligned_cols=264 Identities=24% Similarity=0.355 Sum_probs=200.8
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVI 130 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~l 130 (346)
.++|...+.||+|+||.||+|.. ++..||+|++.... ......+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCcEEE
Confidence 45788899999999999999998 78999999987532 23345677888888888 99999999999999999999
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCccc
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI 210 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~ 210 (346)
||||+++++|.+++.........+++..++.++.+++.||.||| +.+++|+||||+|||++.++.+||+|||++...
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 99999999999999753222356899999999999999999999 899999999999999999999999999998766
Q ss_pred CCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 211 PEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 211 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
..... ......++..|+|||.+.+..++.++||||||+++|+|++|..||....... ...... .......
T Consensus 187 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~-~~~~~~~ 256 (310)
T 2wqm_A 187 SSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL--------YSLCKK-IEQCDYP 256 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH--------HHHHHH-HHTTCSC
T ss_pred cCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH--------HHHHHH-hhcccCC
Confidence 43322 2234568999999999999999999999999999999999999997543221 111111 1111111
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHL 345 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~l 345 (346)
. ......+..+.+++.+||+.||++|||+.+|++.|+++....
T Consensus 257 ~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 257 P------------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp C------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred C------------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 0 011133456889999999999999999999999999998753
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=348.97 Aligned_cols=251 Identities=19% Similarity=0.237 Sum_probs=205.2
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
.+.|...+.||+|+||.||+|.+ ++..+|+|.+..........+.+|+..+..+ +||||+++++++.+.+..++|||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECSSEEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhC-CCcCCCeEEEEEEeCCEEEEEEE
Confidence 46788999999999999999998 6889999998765444556678888888888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcC--CCceEEeccCCCcccC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE--GYIAKLFDFSLSVSIP 211 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~--~~~~kl~Dfgl~~~~~ 211 (346)
|+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 129 FLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp CCCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred cCCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 999999999997643 36999999999999999999999 899999999999999974 5789999999998775
Q ss_pred CCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccc
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDE 291 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (346)
.... .....||+.|+|||++.+..++.++|||||||++|||++|..||......+ ....+. . ....
T Consensus 203 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-------~~~~i~---~-~~~~- 268 (387)
T 1kob_A 203 PDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-------TLQNVK---R-CDWE- 268 (387)
T ss_dssp TTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHH---H-CCCC-
T ss_pred CCcc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH-------HHHHHH---h-CCCC-
Confidence 4432 234578999999999999999999999999999999999999997643211 111111 1 1000
Q ss_pred ccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 292 IVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 292 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.+.. .....+..+.+|+..||+.||++|||+.|+++
T Consensus 269 -~~~~--------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 269 -FDED--------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp -CCSS--------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred -CCcc--------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0000 01133456889999999999999999999975
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=346.69 Aligned_cols=247 Identities=19% Similarity=0.257 Sum_probs=202.1
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
++|...+.||+|+||.||+|.. +++.||+|.+.... ......+.+|+.++..+ +|||||++++++.+.+..++|
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEEEE
Confidence 6688899999999999999998 67899999986432 23456778899999998 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQN----VHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp ECCCTTEEHHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 9999999999999764 35999999999999999999999 8999999999999999999999999999998765
Q ss_pred CCCceeeccccccCCcCCcccccc---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCc
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINT---GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE 288 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (346)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||........ ....... ....
T Consensus 167 ~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~-------~~~~~~~-~~~~ 236 (384)
T 4fr4_A 167 RET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-------KEIVHTF-ETTV 236 (384)
T ss_dssp TTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH-------HHHHHHH-HHCC
T ss_pred CCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH-------HHHHHHH-hhcc
Confidence 433 2345679999999999974 4589999999999999999999999976544322 1111111 0000
Q ss_pred cccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCC-HHHHH
Q 045453 289 FDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPT-TVDVA 335 (346)
Q Consensus 289 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~ev~ 335 (346)
. .. +...+..+.+|+..||+.+|++||+ +.++.
T Consensus 237 --------~--~~----p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 237 --------V--TY----PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp --------C--CC----CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred --------c--CC----CCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 0 00 1133466889999999999999999 55554
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=345.40 Aligned_cols=252 Identities=21% Similarity=0.319 Sum_probs=204.5
Q ss_pred HHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcce
Q 045453 54 IATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV 129 (346)
Q Consensus 54 ~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~ 129 (346)
...++|...+.||+|+||.||+|.+ ++..||+|.+..... .....+.+|+.++..+ +||||+++++++.+.+..+
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEE
Confidence 3456799999999999999999998 688999999875432 3345677888888888 9999999999999999999
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCC---CceEEeccCC
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEG---YIAKLFDFSL 206 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~---~~~kl~Dfgl 206 (346)
+||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.+ +.+||+|||+
T Consensus 105 lv~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp EEECCCCSCBHHHHHTTC----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 999999999999998764 35899999999999999999999 8899999999999999865 4599999999
Q ss_pred CcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhc
Q 045453 207 SVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIEN 286 (346)
Q Consensus 207 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (346)
+........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||......+ +...+. .
T Consensus 178 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-------~~~~i~----~ 244 (362)
T 2bdw_A 178 AIEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LYAQIK----A 244 (362)
T ss_dssp CBCCTTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHH----H
T ss_pred ceEecCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHH----h
Confidence 987654332 334679999999999999999999999999999999999999997543211 111111 1
Q ss_pred CccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 287 NEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 287 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
+... .+.......+..+.+|+.+||+.||++|||+.|+++
T Consensus 245 ~~~~----------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 245 GAYD----------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp TCCC----------CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCCC----------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1100 000011133566889999999999999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=343.42 Aligned_cols=272 Identities=19% Similarity=0.334 Sum_probs=218.0
Q ss_pred CccCCCHHHHHHHhcCCCcccccccCCCcEEEEEEEC-------CeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCc
Q 045453 43 PIRGFTIRELEIATNNFDARNVIKDGYAYKFYKGFVE-------DRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKN 114 (346)
Q Consensus 43 ~~~~~~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~-------~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~n 114 (346)
....+..+++....++|...+.||+|+||.||+|.+. +..||+|.+..... .....+.+|+..+..+ +|||
T Consensus 11 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ 89 (322)
T 1p4o_A 11 AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHH 89 (322)
T ss_dssp CCSCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTT
T ss_pred cccccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCC
Confidence 3445667788888899999999999999999999863 57899999875433 3344577888888888 9999
Q ss_pred eeeEcceeecCCcceEEEecccCCChhhhhhhcC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCC
Q 045453 115 VLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQ------PHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRP 188 (346)
Q Consensus 115 iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp 188 (346)
|+++++++.+.+..++||||+++|+|.+++.... ....++++..++.++.|++.||.||| +.+|+||||||
T Consensus 90 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp 166 (322)
T 1p4o_A 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAA 166 (322)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSG
T ss_pred EeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCcc
Confidence 9999999999999999999999999999987532 11245799999999999999999999 88999999999
Q ss_pred CCeEEcCCCceEEeccCCCcccCCCCce-eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCC
Q 045453 189 SRIFLDEGYIAKLFDFSLSVSIPEGETC-VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRG 266 (346)
Q Consensus 189 ~NIll~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~ 266 (346)
+|||++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 167 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 246 (322)
T 1p4o_A 167 RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 246 (322)
T ss_dssp GGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH
T ss_pred ceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH
Confidence 9999999999999999999766433221 1233456889999999999999999999999999999999 8999975433
Q ss_pred cccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 045453 267 DEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIY 342 (346)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~ 342 (346)
.+. .... ..+.... .....+..+.+++.+||+.+|++|||+.|+++.|+++.
T Consensus 247 ~~~----------~~~~-~~~~~~~-------------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 247 EQV----------LRFV-MEGGLLD-------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp HHH----------HHHH-HTTCCCC-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHH----------HHHH-HcCCcCC-------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 211 1111 1111100 01134456889999999999999999999999998764
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=330.38 Aligned_cols=264 Identities=16% Similarity=0.229 Sum_probs=204.8
Q ss_pred HhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEccee-ecCCcceEE
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCC-LETRIPVIV 131 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~-~~~~~~~lv 131 (346)
..++|...+.||+|+||+||+|.+ +++.||+|...... ...++.+|...+..+ +|+|++..++.+ ...+..++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l-~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMM-QGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHH-TTSTTCCCEEEEEEETTEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHh-cCCCCCCeeeeecCCCCceEEE
Confidence 457899999999999999999997 88999999865432 234577888888888 777666655555 667788999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEE---cCCCceEEeccCCCc
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFL---DEGYIAKLFDFSLSV 208 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll---~~~~~~kl~Dfgl~~ 208 (346)
|||+ +++|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|||+++
T Consensus 84 ~e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EECC-CCBHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEcc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 9999 889999997543 46999999999999999999999 8999999999999999 889999999999998
Q ss_pred ccCCCCce------eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHH
Q 045453 209 SIPEGETC------VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKK 282 (346)
Q Consensus 209 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (346)
........ ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......... ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~ 233 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ---KYERISEK 233 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS---HHHHHHHH
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhh---hhhhhhcc
Confidence 76543321 2235578999999999999999999999999999999999999998765443211 11111111
Q ss_pred HhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 045453 283 CIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHL 345 (346)
Q Consensus 283 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~l 345 (346)
..... . +.+. ...+..+.+++..||+.+|++|||+.+|++.|+++.+++
T Consensus 234 ~~~~~-~-----~~~~--------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 234 KMSTP-I-----EVLC--------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HHHSC-H-----HHHT--------TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccch-h-----hhhh--------ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence 10000 0 0000 022456899999999999999999999999999998864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=347.71 Aligned_cols=245 Identities=20% Similarity=0.239 Sum_probs=196.2
Q ss_pred ccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccCCC
Q 045453 62 RNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRT 139 (346)
Q Consensus 62 ~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~gs 139 (346)
.+.||+|+||.||+|.. ++..||+|++..........+.+|+..+..+ +||||+++++++.+.+..++||||+++++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-DHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 46799999999999998 6889999998765545566788899999888 99999999999999999999999999999
Q ss_pred hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEE--cCCCceEEeccCCCcccCCCCcee
Q 045453 140 LADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFL--DEGYIAKLFDFSLSVSIPEGETCV 217 (346)
Q Consensus 140 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll--~~~~~~kl~Dfgl~~~~~~~~~~~ 217 (346)
|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|||+++.......
T Consensus 173 L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-- 244 (373)
T 2x4f_A 173 LFDRIIDES---YNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244 (373)
T ss_dssp EHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred HHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence 999987643 36899999999999999999999 8999999999999999 5778999999999987754332
Q ss_pred eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccccccc
Q 045453 218 KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPII 297 (346)
Q Consensus 218 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 297 (346)
.....||+.|+|||++.+..++.++|||||||++|||++|..||......+. ........ .. ...
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----------~~~i~~~~-~~--~~~-- 309 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET----------LNNILACR-WD--LED-- 309 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----------HHHHHHTC-CC--SCS--
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH----------HHHHHhcc-CC--CCh--
Confidence 2345699999999999989999999999999999999999999976543221 11111110 00 000
Q ss_pred ccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 298 VSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 298 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.........+.+|+..||+.+|++|||+.|+++
T Consensus 310 ------~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 310 ------EEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp ------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ------hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 001133467899999999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=334.85 Aligned_cols=258 Identities=25% Similarity=0.380 Sum_probs=204.1
Q ss_pred cCCCcccccccCCCcEEEEEEEC-----CeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceee-cCCcce
Q 045453 57 NNFDARNVIKDGYAYKFYKGFVE-----DRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCL-ETRIPV 129 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~~-----~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~-~~~~~~ 129 (346)
..|...+.||+|+||+||+|.+. ...+|+|.+..... .....+.+|+..+..+ +||||++++++|. ..+..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSSSCCE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhC-CCCCEeeeeeEEEcCCCceE
Confidence 45777899999999999999972 22588898876443 3445677888888888 9999999999865 456789
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcc
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVS 209 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~ 209 (346)
+||||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+++||||||+|||++.++.+||+|||+++.
T Consensus 104 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEECCTTCBHHHHHHCTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEeCCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccccccc
Confidence 9999999999999997643 46899999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCce---eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhh
Q 045453 210 IPEGETC---VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIE 285 (346)
Q Consensus 210 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (346)
....... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||......+. .... .
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~-------~~~~----~ 246 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-------TVYL----L 246 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH-------HHHH----H
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH-------HHHH----h
Confidence 6543321 1234457788999999999999999999999999999999 5666655443322 1111 0
Q ss_pred cCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 045453 286 NNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHL 345 (346)
Q Consensus 286 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~l 345 (346)
.+. .. ..+...+..+.+++..||+.+|++|||+.|+++.|+.+.+.+
T Consensus 247 ~~~------------~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 247 QGR------------RL-LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp TTC------------CC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred cCC------------CC-CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 010 00 001123456889999999999999999999999999998864
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=345.30 Aligned_cols=244 Identities=23% Similarity=0.351 Sum_probs=198.8
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
+.|...+.||+|+||+||+|.. ++..||||++..... .....+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCeEEEE
Confidence 4578889999999999999997 789999999875432 2335678889999888 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+. |+|.+++.... .++++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 133 ~e~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp EECCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EecCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 99997 68888886543 46999999999999999999999 8899999999999999999999999999997654
Q ss_pred CCCceeeccccccCCcCCccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCc
Q 045453 212 EGETCVKDKVTGTMGFLAPEYIN---TGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE 288 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (346)
.. ....||+.|+|||++. ++.++.++||||||+++|||++|..||....... ..........
T Consensus 206 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~----------~~~~~~~~~~ 270 (348)
T 1u5q_A 206 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----------ALYHIAQNES 270 (348)
T ss_dssp SB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----------HHHHHHHSCC
T ss_pred CC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH----------HHHHHHhcCC
Confidence 32 3457899999999985 5678999999999999999999999997543211 1111111110
Q ss_pred cccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 289 FDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 289 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
+.. .....+..+.+++..||+.+|++|||+.++++
T Consensus 271 ------~~~-------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 271 ------PAL-------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp ------CCC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ------CCC-------CCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 001 01133456889999999999999999999875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=368.87 Aligned_cols=251 Identities=22% Similarity=0.337 Sum_probs=201.9
Q ss_pred cccccCCCcEEEEEEE----CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEeccc
Q 045453 63 NVIKDGYAYKFYKGFV----EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVK 136 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~----~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~ 136 (346)
+.||+|+||.||+|.+ .+..||||++..... ....++.+|+.++..+ +|||||+++++|.. +..++||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEA-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHC-CCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEec-CCEEEEEEccC
Confidence 3699999999999976 457899999875432 2356788899999998 99999999999964 56899999999
Q ss_pred CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCce
Q 045453 137 NRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETC 216 (346)
Q Consensus 137 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 216 (346)
+|+|.+++... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.+......
T Consensus 453 ~g~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 453 LGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp TEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred CCCHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 99999999765 36899999999999999999999 899999999999999999999999999999877544321
Q ss_pred --eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccc
Q 045453 217 --VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIV 293 (346)
Q Consensus 217 --~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (346)
......+|+.|+|||++.+..++.++|||||||++|||++ |..||......+. . ..+..+...
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~-------~----~~i~~~~~~--- 591 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-------T----AMLEKGERM--- 591 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-------H----HHHHTTCCC---
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------H----HHHHcCCCC---
Confidence 2233456788999999999999999999999999999998 9999976544221 1 111111100
Q ss_pred ccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhhC
Q 045453 294 DPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHLA 346 (346)
Q Consensus 294 d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~l~ 346 (346)
..+..++..+.+|+..||+.||++|||+.+|++.|++++.++.
T Consensus 592 ----------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l~ 634 (635)
T 4fl3_A 592 ----------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 634 (635)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHC
T ss_pred ----------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhc
Confidence 0111345678999999999999999999999999999998763
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=343.44 Aligned_cols=244 Identities=20% Similarity=0.235 Sum_probs=199.8
Q ss_pred HhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcce
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV 129 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~ 129 (346)
..++|...+.||+|+||+||+|.. +++.||+|.+.... .........|...+..+.+||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 357899999999999999999999 56889999987542 2345567788888877768999999999999999999
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcc
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVS 209 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~ 209 (346)
+||||+++|+|.+++.... .+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 98 lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 9999999999999998653 5899999999999999999999 89999999999999999999999999999976
Q ss_pred cCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcc
Q 045453 210 IPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEF 289 (346)
Q Consensus 210 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (346)
...... ......||+.|+|||++.+..++.++|||||||++|||++|..||......+. ...... ...
T Consensus 171 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~----------~~~i~~-~~~ 238 (353)
T 2i0e_A 171 NIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL----------FQSIME-HNV 238 (353)
T ss_dssp CCCTTC-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------HHHHHH-CCC
T ss_pred cccCCc-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH----------HHHHHh-CCC
Confidence 432221 23456799999999999999999999999999999999999999976433221 111111 100
Q ss_pred ccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCH
Q 045453 290 DEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTT 331 (346)
Q Consensus 290 ~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 331 (346)
. .+ ...+..+.+|+.+||+.+|++||++
T Consensus 239 ------~----~p----~~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 239 ------A----YP----KSMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp ------C----CC----TTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred ------C----CC----CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 0 00 1334568899999999999999964
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=340.62 Aligned_cols=259 Identities=22% Similarity=0.345 Sum_probs=205.7
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEE--EEEEecCcc-CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTV--SVMKFNDIL-NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~v--avk~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
++|...+.||+|+||.||+|.+ ++..+ ++|.+.... ......+.+|+..+..+.+||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 6788899999999999999998 56644 888876533 234556778888888887899999999999999999999
Q ss_pred EecccCCChhhhhhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCce
Q 045453 132 FESVKNRTLADHIYQNQ------------PHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIA 199 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~ 199 (346)
|||+++|+|.+++.... .....+++..++.++.|++.||.||| +.+++||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeE
Confidence 99999999999997653 22346999999999999999999999 8999999999999999999999
Q ss_pred EEeccCCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHH
Q 045453 200 KLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLH 278 (346)
Q Consensus 200 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 278 (346)
||+|||+++..... .......+++.|+|||.+.+..++.++||||||+++|+|+| |..||......+.
T Consensus 182 kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~--------- 250 (327)
T 1fvr_A 182 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--------- 250 (327)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---------
T ss_pred EEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH---------
Confidence 99999998743221 11233456789999999998889999999999999999998 9999975433211
Q ss_pred HHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 279 YVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 279 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
.... ..+. . .. .....+..+.+|+.+||+.+|++|||+.|+++.|+++.+.
T Consensus 251 -~~~~-~~~~-----~----~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 251 -YEKL-PQGY-----R----LE----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp -HHHG-GGTC-----C----CC----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -HHHh-hcCC-----C----CC----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1111 1110 0 00 0113346688999999999999999999999999999875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=335.48 Aligned_cols=251 Identities=20% Similarity=0.302 Sum_probs=202.4
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CC-------eEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCC
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--ED-------RTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETR 126 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~-------~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~ 126 (346)
.++|...+.||+|+||+||+|.+ ++ ..||+|.+..........+.+|+..+..+ +||||+++++++.+.+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL-SHKHLVLNYGVCVCGD 85 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTS-CCTTBCCEEEEECCTT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEeCC
Confidence 35688889999999999999988 33 57999998766656667788899999998 9999999999999999
Q ss_pred cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCc--------
Q 045453 127 IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYI-------- 198 (346)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~-------- 198 (346)
..++||||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKNK---NCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred CCEEEEECCCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccce
Confidence 9999999999999999998754 35899999999999999999999 899999999999999998887
Q ss_pred eEEeccCCCcccCCCCceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHH
Q 045453 199 AKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLL 277 (346)
Q Consensus 199 ~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~ 277 (346)
+||+|||++..... .....+|..|+|||.+.+ ..++.++||||||+++|||++|..|+........ ..
T Consensus 160 ~kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~------~~ 228 (289)
T 4fvq_A 160 IKLSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR------KL 228 (289)
T ss_dssp EEECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HH
T ss_pred eeeccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH------HH
Confidence 99999999865532 233468899999999987 6799999999999999999996544432222110 11
Q ss_pred HHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 045453 278 HYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQ 343 (346)
Q Consensus 278 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 343 (346)
. ....... +.. ..+..+.+++..||+.||++|||+.|+++.|++++.
T Consensus 229 ~---~~~~~~~--------~~~--------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 229 Q---FYEDRHQ--------LPA--------PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp H---HHHTTCC--------CCC--------CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred H---HhhccCC--------CCC--------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1 0000000 000 112347889999999999999999999999998754
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=341.63 Aligned_cols=264 Identities=23% Similarity=0.318 Sum_probs=207.7
Q ss_pred CCcccccccCCCcEEEEEEE------CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecC--Ccce
Q 045453 59 FDARNVIKDGYAYKFYKGFV------EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLET--RIPV 129 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~~------~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~--~~~~ 129 (346)
|...+.||+|+||+||++.+ +++.||+|++..... .....+.+|+..+..+ +||||+++++++.+. ...+
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-YHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTTTEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhC-CCcchhhEEEEEecCCCceEE
Confidence 47889999999999999875 678999999876543 3345678888888888 999999999999874 5779
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcc
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVS 209 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~ 209 (346)
+||||+++|+|.+++... .+++..++.++.|++.||+||| +.+++||||||+|||++.++.+||+|||++..
T Consensus 112 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp EEECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence 999999999999999764 4899999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCce--eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccc-----cchhhHHHHHHH
Q 045453 210 IPEGETC--VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIG-----AGHYWLLHYVKK 282 (346)
Q Consensus 210 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~-----~~~~~~~~~~~~ 282 (346)
....... ......+|..|+|||.+.+..++.++||||||+++|+|+||..||......... ....... ....
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~ 262 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL-RLTE 262 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHH-HHHH
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHH-HHHH
Confidence 7654332 223455788899999999999999999999999999999999998643211000 0000000 0111
Q ss_pred HhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 045453 283 CIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHL 345 (346)
Q Consensus 283 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~l 345 (346)
..... .........+..+.+|+.+||+.+|++|||+.|+++.|+.+.+.+
T Consensus 263 ~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 263 LLERG-------------ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HHHTT-------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHhcc-------------cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 11111 001111144567999999999999999999999999999998865
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=335.71 Aligned_cols=250 Identities=21% Similarity=0.333 Sum_probs=197.8
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCc-----
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRI----- 127 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~----- 127 (346)
.++|...+.||+|+||.||+|.+ ++..||||++..... .....+.+|+..+..+ +||||++++++|.+.+.
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSC-CCTTBCCEEEEEEECCSCHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEeccchhhh
Confidence 35688899999999999999999 789999999875433 3456778888999888 99999999999865432
Q ss_pred ----------------------------------------------------ceEEEecccCCChhhhhhhcCCCCCCCC
Q 045453 128 ----------------------------------------------------PVIVFESVKNRTLADHIYQNQPHFEPLL 155 (346)
Q Consensus 128 ----------------------------------------------------~~lv~e~~~~gsL~~~l~~~~~~~~~l~ 155 (346)
.++||||+++|+|.+++..... ....+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~ 162 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDRE 162 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSC
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchh
Confidence 7999999999999999987543 24567
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCc-----------eeecccccc
Q 045453 156 LSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGET-----------CVKDKVTGT 224 (346)
Q Consensus 156 ~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~-----------~~~~~~~gt 224 (346)
+..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....... .......||
T Consensus 163 ~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred hHHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 8889999999999999999 89999999999999999999999999999987754421 112345699
Q ss_pred CCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCc
Q 045453 225 MGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRV 304 (346)
Q Consensus 225 ~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 304 (346)
+.|+|||.+.+..++.++||||||+++|||++|..|+.. ....... ..... .+ .
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~------------~~~~~~~-~~~~~------------~~-~ 293 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME------------RVRIITD-VRNLK------------FP-L 293 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH------------HHHHHHH-HHTTC------------CC-H
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH------------HHHHHHH-hhccC------------CC-c
Confidence 999999999999999999999999999999998766421 1111111 01110 01 1
Q ss_pred chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 305 GKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 305 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
........+.+++.+||+.||++|||+.|+++
T Consensus 294 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 294 LFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred ccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 11244566789999999999999999999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=347.48 Aligned_cols=251 Identities=19% Similarity=0.316 Sum_probs=192.3
Q ss_pred cCCCcc-cccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeec----CCcce
Q 045453 57 NNFDAR-NVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLE----TRIPV 129 (346)
Q Consensus 57 ~~f~~~-~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~----~~~~~ 129 (346)
++|... +.||+|+||+||+|.+ ++..||||++.. .....+|+..+.+..+||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 445544 6899999999999999 688999999863 24566777777777799999999999865 56789
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcC---CCceEEeccCC
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE---GYIAKLFDFSL 206 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~---~~~~kl~Dfgl 206 (346)
+||||+++|+|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+|||++. ++.+||+|||+
T Consensus 136 lv~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeCCCCcHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence 99999999999999976432 46999999999999999999999 899999999999999997 78999999999
Q ss_pred CcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhc
Q 045453 207 SVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIEN 286 (346)
Q Consensus 207 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (346)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|..||........... ....+. .
T Consensus 211 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---~~~~i~----~ 281 (400)
T 1nxk_A 211 AKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRIR----M 281 (400)
T ss_dssp CEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS---HHHHHH----H
T ss_pred ccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH---HHHHHH----c
Confidence 98664332 23456789999999999999999999999999999999999999987654332110 111111 1
Q ss_pred CccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 287 NEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 287 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
+... .+.......+..+.+|+..||+.||++|||+.|+++
T Consensus 282 ~~~~----------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 282 GQYE----------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp TCCC----------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred Cccc----------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1100 000001134567899999999999999999999986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=329.08 Aligned_cols=249 Identities=19% Similarity=0.287 Sum_probs=204.6
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
.+.|...+.||+|+||.||+|.+ ++..+|+|++..........+.+|+..+..+ +||||+++++++.+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-DHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCeEEEEEe
Confidence 45688899999999999999999 6678999998876666677888999999998 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEE---cCCCceEEeccCCCccc
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFL---DEGYIAKLFDFSLSVSI 210 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll---~~~~~~kl~Dfgl~~~~ 210 (346)
|+++++|.+++.... .+++..++.++.|++.||.||| +.+++|+||||+|||+ +.++.+||+|||++...
T Consensus 87 ~~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 87 LCTGGELFERVVHKR----VFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp CCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ccCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 999999999987753 5899999999999999999999 8999999999999999 88899999999999876
Q ss_pred CCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 211 PEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 211 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
..... .....+|+.|+|||.+.+ .++.++||||||+++|+|++|..||......+. .... ..+...
T Consensus 160 ~~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----------~~~~-~~~~~~ 225 (277)
T 3f3z_A 160 KPGKM--MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV----------MLKI-REGTFT 225 (277)
T ss_dssp CTTSC--BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------HHHH-HHCCCC
T ss_pred cCccc--hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHH----------HHHH-HhCCCC
Confidence 54332 344578999999998865 499999999999999999999999976433221 1111 111000
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.+.......+..+.+++.+||+.+|++|||+.++++
T Consensus 226 ----------~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 226 ----------FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp ----------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ----------CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000023467889999999999999999999975
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=341.76 Aligned_cols=244 Identities=16% Similarity=0.199 Sum_probs=202.9
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVI 130 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~l 130 (346)
.++|...+.||+|+||.||+|.+ +++.||+|.+.... ......+.+|...+..+ +||||+++++++.+.+..++
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEEE
Confidence 36788999999999999999999 68999999986432 23456677888888888 99999999999999999999
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCccc
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI 210 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~ 210 (346)
||||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 119 v~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~ 191 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EEECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceec
Confidence 999999999999998753 5899999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 211 PEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 211 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
... .....||+.|+|||++.+..++.++|||||||++|||++|..||......+. ...... +..
T Consensus 192 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----------~~~i~~-~~~- 255 (350)
T 1rdq_E 192 KGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI----------YEKIVS-GKV- 255 (350)
T ss_dssp SSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------HHHHHH-CCC-
T ss_pred cCC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH----------HHHHHc-CCC-
Confidence 432 2345799999999999999999999999999999999999999975432111 111111 110
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPT-----TVDVAK 336 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~ 336 (346)
.+ +...+..+.+++.+||+.||++||+ +.|+++
T Consensus 256 -----~~--------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 -----RF--------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -----CC--------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -----CC--------CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 00 0123456889999999999999998 777753
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=343.56 Aligned_cols=269 Identities=19% Similarity=0.249 Sum_probs=210.5
Q ss_pred hcCCCcccccccCCCcEEEEEEE------CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceee--cCCc
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV------EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCL--ETRI 127 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~------~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~--~~~~ 127 (346)
.++|...+.||+|+||.||+|.+ .+..||+|++..........+.+|+..+..+ +||||+++++++. +.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCCce
Confidence 35688889999999999999984 6789999999876555566788899999998 9999999999886 4566
Q ss_pred ceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCC
Q 045453 128 PVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS 207 (346)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~ 207 (346)
.++||||+++++|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+|||++.++.+||+|||++
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLA 174 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred EEEEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccc
Confidence 899999999999999997643 35999999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCce--eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccccc----chhhHHHHHH
Q 045453 208 VSIPEGETC--VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGA----GHYWLLHYVK 281 (346)
Q Consensus 208 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~----~~~~~~~~~~ 281 (346)
......... ......+|..|+|||.+.+..++.++||||||+++|+|++|..||.......... ..........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 877544332 2234557888999999999999999999999999999999999986432211000 0000000011
Q ss_pred HHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 282 KCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 282 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
.....+ .........+..+.+|+..||+.+|++|||+.|+++.|+.+...
T Consensus 255 ~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 255 ELLEEG-------------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp HHHHTT-------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred HHhhcc-------------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 111111 11111124456789999999999999999999999999988764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=329.41 Aligned_cols=265 Identities=15% Similarity=0.182 Sum_probs=200.7
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
++|...+.||+|+||+||+|.+ +++.||+|++..... .....+.+|+..+..+ +||||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcC-CCCCEeeEEeEEEeCCEEEEEE
Confidence 4688889999999999999999 688999999875433 2346677888888888 9999999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
||+++ +|.+.+.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~~-~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 81 EFCDQ-DLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp ECCSE-EHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred ecCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 99976 6666665543 46999999999999999999999 88999999999999999999999999999987653
Q ss_pred CCceeeccccccCCcCCccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccc
Q 045453 213 GETCVKDKVTGTMGFLAPEYINTGD-FNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDE 291 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (346)
... ......+|+.|+|||++.+.. ++.++||||||+++|+|++|..||....... .....+...........
T Consensus 154 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~------~~~~~i~~~~~~~~~~~ 226 (292)
T 3o0g_A 154 PVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD------DQLKRIFRLLGTPTEEQ 226 (292)
T ss_dssp CCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH------HHHHHHHHHHCCCCTTT
T ss_pred ccc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH------HHHHHHHHHhCCCChhh
Confidence 322 234457899999999998766 8999999999999999999888865433221 11111111111110000
Q ss_pred ---cc---cc----ccc-cCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 292 ---IV---DP----IIV-SEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 292 ---~~---d~----~l~-~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.. +. ... ........+.....+.+|+.+||+.||++|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00 00 000 00000001134567889999999999999999999875
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=342.38 Aligned_cols=251 Identities=22% Similarity=0.328 Sum_probs=189.4
Q ss_pred HHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 54 IATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 54 ~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
...+.|...+.||+|+||+||+|.+ ++..||+|.+.... ....+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRL-SHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHC-CCTTBCCEEEEEECSSEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhC-CCCCCcceeeeEecCCeEEEE
Confidence 3456788999999999999999999 57889999987543 335567788888888 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcC---CCceEEeccCCCc
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE---GYIAKLFDFSLSV 208 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~---~~~~kl~Dfgl~~ 208 (346)
|||+++|+|.+++... ..+++..++.++.|++.||.||| +.+|+||||||+|||++. ++.+||+|||+++
T Consensus 127 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~ 199 (349)
T 2w4o_A 127 LELVTGGELFDRIVEK----GYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK 199 (349)
T ss_dssp ECCCCSCBHHHHHTTC----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred EEeCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence 9999999999999764 35899999999999999999999 889999999999999975 8999999999997
Q ss_pred ccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCc
Q 045453 209 SIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE 288 (346)
Q Consensus 209 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (346)
...... ......||+.|+|||++.+..++.++|||||||++|||++|..||........ . ..... ...
T Consensus 200 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~---~~~i~-~~~ 267 (349)
T 2w4o_A 200 IVEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF------M---FRRIL-NCE 267 (349)
T ss_dssp ---------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH------H---HHHHH-TTC
T ss_pred ccCccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH------H---HHHHH-hCC
Confidence 664332 23345789999999999999999999999999999999999999976443221 1 11111 111
Q ss_pred cccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 289 FDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 289 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.. ... +.....+..+.+|+.+||+.||++|||+.|+++
T Consensus 268 ~~-~~~---------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 268 YY-FIS---------PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp CC-CCT---------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred Cc-cCC---------chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 000 001134566889999999999999999999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=326.81 Aligned_cols=263 Identities=16% Similarity=0.230 Sum_probs=207.6
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEccee-ecCCcceEEE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCC-LETRIPVIVF 132 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~-~~~~~~~lv~ 132 (346)
.++|...+.||+|+||.||+|.+ +++.||+|.+.... ...++.+|...+..+ +|+|++..++.+ .+.+..++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l-~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMM-QGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHH-TTSTTCCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHh-hcCCCCCccccccCCCCceEEEE
Confidence 46789999999999999999997 88999999976543 334678888889888 777766555554 5677889999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEE---cCCCceEEeccCCCcc
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFL---DEGYIAKLFDFSLSVS 209 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll---~~~~~~kl~Dfgl~~~ 209 (346)
||+ +++|.+++.... ..+++..++.++.|++.||.||| +.+++||||||+|||+ +.++.+||+|||++..
T Consensus 85 e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Eec-CCCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 999 889999997543 46999999999999999999999 8999999999999999 5889999999999987
Q ss_pred cCCCCce------eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHH
Q 045453 210 IPEGETC------VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKC 283 (346)
Q Consensus 210 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 283 (346)
....... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......... .........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~ 234 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ---KYERISEKK 234 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS---HHHHHHHHH
T ss_pred ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhh---hhhhhcccc
Confidence 6543321 1245578999999999999999999999999999999999999998754433211 111111111
Q ss_pred hhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 045453 284 IENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHL 345 (346)
Q Consensus 284 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~l 345 (346)
.... . +.+. ...+..+.+++.+||+.+|++|||+.+|++.|+++.+..
T Consensus 235 ~~~~-~-----~~~~--------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 235 MSTP-I-----EVLC--------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HHSC-H-----HHHT--------TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred cCCc-h-----HHHH--------hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 1000 0 0000 023456889999999999999999999999999998764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=341.03 Aligned_cols=212 Identities=21% Similarity=0.291 Sum_probs=183.0
Q ss_pred CccCCCHHHHHHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhc----CCCcee
Q 045453 43 PIRGFTIRELEIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLS----SHKNVL 116 (346)
Q Consensus 43 ~~~~~~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~----~h~niv 116 (346)
....+++++.....++|...+.||+|+||+||+|.+ ++..||||++... .........|...+..+. .||||+
T Consensus 21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 345577777777889999999999999999999999 7889999998643 233445666777777772 399999
Q ss_pred eEcceeecCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcC-
Q 045453 117 KLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE- 195 (346)
Q Consensus 117 ~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~- 195 (346)
++++++...+..++||||+ +++|.+++..... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~ 173 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDP 173 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCT
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccc
Confidence 9999999999999999999 8899999987543 35899999999999999999999 899999999999999975
Q ss_pred ------------------------CCceEEeccCCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHH
Q 045453 196 ------------------------GYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLL 251 (346)
Q Consensus 196 ------------------------~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl 251 (346)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 249 (360)
T 3llt_A 174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL 249 (360)
T ss_dssp TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred cccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence 889999999999765432 2345789999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCC
Q 045453 252 LVLLTGQKIFDPSR 265 (346)
Q Consensus 252 ~elltg~~p~~~~~ 265 (346)
|+|++|+.||....
T Consensus 250 ~ell~g~~pf~~~~ 263 (360)
T 3llt_A 250 AELYTGSLLFRTHE 263 (360)
T ss_dssp HHHHHSSCSCCCSS
T ss_pred HHHHHCCCCCCCCc
Confidence 99999999997654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=333.31 Aligned_cols=263 Identities=19% Similarity=0.319 Sum_probs=200.3
Q ss_pred cCCCc-ccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 57 NNFDA-RNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 57 ~~f~~-~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
+.|.. .+.||+|+||+||+|.. +++.||||++..........+.+|+..+.++.+||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 45666 47899999999999998 7899999999766556677888999999887689999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCc---eEEeccCCCccc
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYI---AKLFDFSLSVSI 210 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~---~kl~Dfgl~~~~ 210 (346)
|+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++. +||+|||++...
T Consensus 92 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 92 KMRGGSILSHIHKRR----HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp CCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred cCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 999999999998753 5899999999999999999999 889999999999999998776 999999998765
Q ss_pred CCCCc------eeeccccccCCcCCcccccc-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhh----
Q 045453 211 PEGET------CVKDKVTGTMGFLAPEYINT-----GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYW---- 275 (346)
Q Consensus 211 ~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~---- 275 (346)
..... .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||......+.......
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 42221 11123458999999999975 5588999999999999999999999987654432111000
Q ss_pred HHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 276 LLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
...........+... .+.......+..+.+|+.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~i~~~~~~----------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 245 CQNMLFESIQEGKYE----------FPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHCCCC----------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHhccCcc----------cCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 000011111111100 000000123466899999999999999999999986
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=329.83 Aligned_cols=264 Identities=18% Similarity=0.225 Sum_probs=198.6
Q ss_pred cCCCcccccccCCCcEEEEEEE-CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
++|...+.||+|+||+||+|.. .++.||+|++..... .....+.+|+..+..+ +||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhc-CCCCEeeeeeEEccCCeEEEEEE
Confidence 4678889999999999999999 689999999865432 2346677888888888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
|+++ +|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 81 HLDQ-DLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp CCSE-EHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ecCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 9975 9999987653 45899999999999999999999 889999999999999999999999999998766432
Q ss_pred CceeeccccccCCcCCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcc---
Q 045453 214 ETCVKDKVTGTMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEF--- 289 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 289 (346)
.. ......+|+.|+|||++.+. .++.++||||||+++|+|++|..||......+. +.... ........
T Consensus 154 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~------~~~~~-~~~~~~~~~~~ 225 (288)
T 1ob3_A 154 VR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ------LMRIF-RILGTPNSKNW 225 (288)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHH-HHHCCCCTTTS
T ss_pred cc-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHH-HHHCCCChhhc
Confidence 21 22345689999999999764 589999999999999999999999976433221 11111 11111000
Q ss_pred cc-----ccccccccCCCCc---chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 290 DE-----IVDPIIVSEGPRV---GKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 290 ~~-----~~d~~l~~~~~~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.. ..++......+.. ........+.+|+.+||+.||++|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 0011110000000 00123466889999999999999999999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=331.71 Aligned_cols=259 Identities=17% Similarity=0.232 Sum_probs=198.6
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCc---chHHHHHHHHHHhhhcCCCceeeEcceeecCCcceE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILND---GHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVI 130 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~---~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~l 130 (346)
.++|...+.||+|+||.||+|.+ +++.||+|.+...... ....+.+|+..+..+ +||||+++++++...+..++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-QEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc-CCCCeeEEEEEEeeCCeEEE
Confidence 47899999999999999999998 7889999998754322 235677888888888 99999999999999999999
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCccc
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI 210 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~ 210 (346)
||||+++++|.+++.... ++++..++.++.|++.||.||| +.+++|+||||+|||++.++.+||+|||++...
T Consensus 112 v~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EEECCCCEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 999999999999998753 5899999999999999999999 889999999999999999999999999998776
Q ss_pred CCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 211 PEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 211 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
............+++.|+|||.+.+..++.++||||||+++|+|++|..||...... ............
T Consensus 185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----------~~~~~~~~~~~~ 253 (309)
T 2h34_A 185 TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-----------VMGAHINQAIPR 253 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-----------HHHHHHHSCCCC
T ss_pred cccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-----------HHHHHhccCCCC
Confidence 544333334567899999999999999999999999999999999999999753221 111111111000
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHHHHh
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRP-TTVDVAKRLKQIYQH 344 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~ev~~~L~~i~~~ 344 (346)
+. . .....+..+.+++.+||+.+|++|| |+.++++.|+.+.+.
T Consensus 254 ----~~--~-----~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 254 ----PS--T-----VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp ----GG--G-----TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred ----cc--c-----cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 00 0 0113345688999999999999999 999999999987543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=340.60 Aligned_cols=259 Identities=16% Similarity=0.210 Sum_probs=206.2
Q ss_pred HHHHHhcCCCcccccccCCCcEEEEEE-----E--CCeEEEEEEecCccCcchHHHHHHHHHHhhhc--CCCceeeEcce
Q 045453 51 ELEIATNNFDARNVIKDGYAYKFYKGF-----V--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLS--SHKNVLKLTGC 121 (346)
Q Consensus 51 ~l~~~~~~f~~~~~ig~G~~g~Vy~~~-----~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~--~h~niv~l~g~ 121 (346)
++....++|...+.||+|+||+||+|. . .++.||+|++... ...++..|...+..+. .|+||++++++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 344456778888999999999999993 2 7889999998754 3445566666666651 39999999999
Q ss_pred eecCCcceEEEecccCCChhhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcC-----
Q 045453 122 CLETRIPVIVFESVKNRTLADHIYQNQP-HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE----- 195 (346)
Q Consensus 122 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~----- 195 (346)
+...+..++||||+++|+|.+++..... ....+++..++.++.|++.||+||| +.+|+||||||+|||++.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCc
Confidence 9999999999999999999999975321 1256999999999999999999999 899999999999999998
Q ss_pred ------CCceEEeccCCCcccCC-CCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc
Q 045453 196 ------GYIAKLFDFSLSVSIPE-GETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDE 268 (346)
Q Consensus 196 ------~~~~kl~Dfgl~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~ 268 (346)
++.+||+|||+++.+.. ..........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 292 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292 (365)
T ss_dssp ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence 89999999999976532 22233456679999999999999999999999999999999999999986433221
Q ss_pred cccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCC-CCHHHHHHHHHHHHHh
Q 045453 269 IGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDR-PTTVDVAKRLKQIYQH 344 (346)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R-Ps~~ev~~~L~~i~~~ 344 (346)
. .+...+ ... ...+.+.+++..|++.+|.+| |++.++.+.|+++.+.
T Consensus 293 ~----------------------~~~~~~----~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 293 C----------------------KPEGLF----RRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp E----------------------EECSCC----TTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred e----------------------eechhc----ccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 1 011111 111 124456789999999999999 6788999999888764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=332.03 Aligned_cols=268 Identities=18% Similarity=0.257 Sum_probs=190.6
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
.++|...+.||+|+||+||+|.+ ++..||+|.+..... .....+.+|+..+..+ +||||+++++++.+.+..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL-KHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTC-CBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhc-CCCCcceEEEEEEECCeEEEEE
Confidence 46788899999999999999998 688999999875443 3346678889999888 9999999999999999999999
Q ss_pred ecccCCChhhhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCccc
Q 045453 133 ESVKNRTLADHIYQNQ--PHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI 210 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~ 210 (346)
||++ |+|.+++.... .....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9998 59999987542 12235899999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCc-
Q 045453 211 PEGETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE- 288 (346)
Q Consensus 211 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 288 (346)
..... ......+|+.|+|||++.+ ..++.++|||||||++|||++|..||......+. ...+........
T Consensus 159 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-------~~~i~~~~~~~~~ 230 (317)
T 2pmi_A 159 GIPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ-------LKLIFDIMGTPNE 230 (317)
T ss_dssp TSCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------HHHHHHHHCSCCT
T ss_pred CCCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-------HHHHHHHhCCCCh
Confidence 43322 2234578999999999976 4689999999999999999999999976543221 111111111000
Q ss_pred --ccc-----ccccccccCCCCc--------chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 289 --FDE-----IVDPIIVSEGPRV--------GKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 289 --~~~-----~~d~~l~~~~~~~--------~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
... ...+.+....+.. ........+.+|+.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 231 SLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp TTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 000 0000000000000 00022456899999999999999999999874
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=335.79 Aligned_cols=247 Identities=18% Similarity=0.277 Sum_probs=178.6
Q ss_pred ccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccCCC
Q 045453 62 RNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRT 139 (346)
Q Consensus 62 ~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~gs 139 (346)
.+.||+|+||+||+|.+ +++.||+|.+... ......+|+..+..+.+||||+++++++.+.+..++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 47899999999999999 6889999998643 345667888888888459999999999999999999999999999
Q ss_pred hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCC---ceEEeccCCCcccCCCCce
Q 045453 140 LADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGY---IAKLFDFSLSVSIPEGETC 216 (346)
Q Consensus 140 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~---~~kl~Dfgl~~~~~~~~~~ 216 (346)
|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++ .+||+|||+++.......
T Consensus 93 L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~- 164 (325)
T 3kn6_A 93 LFERIKKK----KHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ- 164 (325)
T ss_dssp HHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred HHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-
Confidence 99999875 36999999999999999999999 89999999999999998765 899999999986644322
Q ss_pred eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccccc
Q 045453 217 VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPI 296 (346)
Q Consensus 217 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 296 (346)
......+|+.|+|||++.+..++.++||||||+++|+|++|..||........... ....... +..+
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---~~~~~~~-i~~~--------- 231 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTS---AVEIMKK-IKKG--------- 231 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCC---HHHHHHH-HTTT---------
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccccc---HHHHHHH-HHcC---------
Confidence 23455689999999999999999999999999999999999999986544321111 1111111 1111
Q ss_pred cccCCCCcc--hHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 045453 297 IVSEGPRVG--KEKQLQGFRELALMCVCESAEDRPTTVDVA 335 (346)
Q Consensus 297 l~~~~~~~~--~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~ 335 (346)
...... ....+..+.+|+..||+.||++|||+.|++
T Consensus 232 ---~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell 269 (325)
T 3kn6_A 232 ---DFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR 269 (325)
T ss_dssp ---CCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred ---CCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence 111111 112356789999999999999999999876
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=354.87 Aligned_cols=247 Identities=16% Similarity=0.216 Sum_probs=194.6
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVI 130 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~l 130 (346)
.++|...+.||+|+||.||+|.. +++.||+|++.... ......+.+|...+..+ +||||++++++|.+.+..++
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCC-SCTTSCCEEEEEEETTEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhC-CCCeEeeEEEEEeeCCEEEE
Confidence 46788899999999999999998 78899999987532 23345566777777777 99999999999999999999
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCceecCCCCCCeEEcCCCceEEeccCCCcc
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFS-RPILHRKIRPSRIFLDEGYIAKLFDFSLSVS 209 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~ 209 (346)
||||+++|+|.+++.... .+++..+..++.|++.||+||| + .+|+||||||+|||++.++.+||+|||+++.
T Consensus 226 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE 298 (446)
T ss_dssp EECCCSSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred EEeeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence 999999999999997653 5899999999999999999999 7 8999999999999999999999999999976
Q ss_pred cCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcc
Q 045453 210 IPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEF 289 (346)
Q Consensus 210 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (346)
...... ......||+.|+|||++.+..++.++|||||||++|||++|..||........ . ....... .
T Consensus 299 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-------~---~~i~~~~-~ 366 (446)
T 4ejn_A 299 GIKDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-------F---ELILMEE-I 366 (446)
T ss_dssp TCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------H---HHHHHCC-C
T ss_pred ccCCCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH-------H---HHHHhCC-C
Confidence 433222 23456799999999999999999999999999999999999999975433221 1 1111110 0
Q ss_pred ccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 045453 290 DEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRP-----TTVDVAK 336 (346)
Q Consensus 290 ~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~ 336 (346)
.+ + ......+.+|+..||+.||++|| |+.|+++
T Consensus 367 ------~~----p----~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 ------RF----P----RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ------CC----C----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ------CC----C----ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 00 0 12345688999999999999999 9999875
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=329.50 Aligned_cols=267 Identities=19% Similarity=0.252 Sum_probs=199.3
Q ss_pred HhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-----cchHHHHHHHHHHhhhc--CCCceeeEcceeecC
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-----DGHEDCFNNIIFASKLS--SHKNVLKLTGCCLET 125 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-----~~~~~~~~e~~~~~~~~--~h~niv~l~g~~~~~ 125 (346)
.+++|...+.||+|+||+||+|.+ +++.||+|++..... .......+|+..+..+. +||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999997 788999999864321 12345556666655552 599999999999876
Q ss_pred C-----cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceE
Q 045453 126 R-----IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAK 200 (346)
Q Consensus 126 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~k 200 (346)
. ..++||||+. ++|.+++..... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+|
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP--PGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT--TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEE
Confidence 5 4799999997 599999977542 34999999999999999999999 88999999999999999999999
Q ss_pred EeccCCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHH
Q 045453 201 LFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYV 280 (346)
Q Consensus 201 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 280 (346)
|+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||......+. +.. +
T Consensus 161 l~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~------~~~-i 231 (308)
T 3g33_A 161 LADFGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ------LGK-I 231 (308)
T ss_dssp ECSCSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH------HHH-H
T ss_pred EeeCccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHH-H
Confidence 999999987643322 3456789999999999999999999999999999999999999976443221 111 1
Q ss_pred HHHhhcCccccc------cccccccCCCCcc---hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 281 KKCIENNEFDEI------VDPIIVSEGPRVG---KEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 281 ~~~~~~~~~~~~------~d~~l~~~~~~~~---~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
...........+ .........+... .+.....+.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 232 FDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 111111100000 0000000000000 0123467889999999999999999999875
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=345.91 Aligned_cols=247 Identities=20% Similarity=0.213 Sum_probs=193.4
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVI 130 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~l 130 (346)
.++|...+.||+|+||.||+|.. ++..+|+|++..... ........|...+.+..+||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 46789999999999999999999 678999999875432 2334456666665454599999999999999999999
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCccc
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI 210 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~ 210 (346)
||||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 999999999999997653 5899999999999999999999 899999999999999999999999999999764
Q ss_pred CCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 211 PEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 211 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
.... .......||+.|+|||++.+..++.++|||||||++|||++|..||...+..+. ....... .
T Consensus 190 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~----------~~~i~~~-~-- 255 (373)
T 2r5t_A 190 IEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM----------YDNILNK-P-- 255 (373)
T ss_dssp BCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH----------HHHHHHS-C--
T ss_pred ccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH----------HHHHHhc-c--
Confidence 3222 123456799999999999999999999999999999999999999975433221 1111111 0
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVA 335 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~ 335 (346)
+. .+ ......+.+|+.+||+.||++||++.+.+
T Consensus 256 ------~~--~~----~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 256 ------LQ--LK----PNITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp ------CC--CC----SSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred ------cC--CC----CCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 00 00 12345688999999999999999986443
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=343.05 Aligned_cols=274 Identities=18% Similarity=0.198 Sum_probs=213.2
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCC--cceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETR--IPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~--~~~lv 131 (346)
+.|...+.||+|+||+||+|.+ +++.||||++..... .....+.+|+..+..+ +||||+++++++...+ ..++|
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCCCeEEEeeccCCCCeeEEE
Confidence 5688889999999999999999 589999999875432 3456677888899888 9999999999988755 67999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEE----cCCCceEEeccCCC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFL----DEGYIAKLFDFSLS 207 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll----~~~~~~kl~Dfgl~ 207 (346)
|||+++|+|.+++...... ..+++..++.++.|++.||+||| +.+|+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 9999999999999765321 34999999999999999999999 8999999999999999 78888999999999
Q ss_pred cccCCCCceeeccccccCCcCCcccccc--------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHH
Q 045453 208 VSIPEGETCVKDKVTGTMGFLAPEYINT--------GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHY 279 (346)
Q Consensus 208 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 279 (346)
+....... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||......... ...
T Consensus 164 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~------~~~ 235 (396)
T 4eut_A 164 RELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN------KEV 235 (396)
T ss_dssp EECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC------HHH
T ss_pred eEccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch------HHH
Confidence 87654332 234568999999999875 56788999999999999999999999765443321 111
Q ss_pred HHHHhhcCcccccc-------cccc--cc--CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 280 VKKCIENNEFDEIV-------DPII--VS--EGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 280 ~~~~~~~~~~~~~~-------d~~l--~~--~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
........ ....+ +..+ .. .............+.+++..||+.||++|||+.|+++.++++++.
T Consensus 236 ~~~~~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 236 MYKIITGK-PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHHHHHSC-CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred HHHHhcCC-CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 11111111 10000 0000 00 011112246778899999999999999999999999999998764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=342.83 Aligned_cols=274 Identities=14% Similarity=0.158 Sum_probs=202.4
Q ss_pred HhcCCCcccccccC--CCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcc
Q 045453 55 ATNNFDARNVIKDG--YAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIP 128 (346)
Q Consensus 55 ~~~~f~~~~~ig~G--~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~ 128 (346)
..++|...+.||+| +||+||+|.+ +++.||||++..... .....+.+|+..+..+ +|||||++++++.+.+..
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF-NHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCCCcEeEEEEECCEE
Confidence 35678999999999 9999999999 689999999875432 2334566688888887 999999999999999999
Q ss_pred eEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 129 VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
++||||+++|+|.+++..... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||.+.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~ 176 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNL 176 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEccCCCCHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccce
Confidence 999999999999999987532 35899999999999999999999 8999999999999999999999999999876
Q ss_pred ccCCCCc------eeeccccccCCcCCcccccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHH
Q 045453 209 SIPEGET------CVKDKVTGTMGFLAPEYINT--GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYV 280 (346)
Q Consensus 209 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 280 (346)
....... .......||..|+|||++.+ ..++.++|||||||++|||++|+.||........... ......
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~--~~~~~~ 254 (389)
T 3gni_B 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE--KLNGTV 254 (389)
T ss_dssp ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHH--C-----
T ss_pred eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH--HhcCCC
Confidence 5432211 11233468899999999987 6799999999999999999999999987554332100 000000
Q ss_pred HHHhhc------------------Cccccccc---ccc--ccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 281 KKCIEN------------------NEFDEIVD---PII--VSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 281 ~~~~~~------------------~~~~~~~d---~~l--~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
...... ......+. +.. ...............+.+|+.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 000000 00000000 000 000000011133467999999999999999999999974
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=331.64 Aligned_cols=251 Identities=22% Similarity=0.283 Sum_probs=197.1
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
+.|...+.||+|+||+||+|.. ++..+|+|++..... .....+.+|+..+..+ +||||+++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-DHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhC-CCchHHhHHHheecCCeEEEEEE
Confidence 4588899999999999999998 688999999876543 3456778889999888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEE---cCCCceEEeccCCCccc
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFL---DEGYIAKLFDFSLSVSI 210 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll---~~~~~~kl~Dfgl~~~~ 210 (346)
|+++|+|.+++.........+++..++.++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999998654222256999999999999999999999 8999999999999999 55688999999999766
Q ss_pred CCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 211 PEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 211 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
..... .....+|+.|+|||.+. +.++.++||||||+++|+|++|..||......+. ........
T Consensus 178 ~~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~----------~~~~~~~~--- 241 (285)
T 3is5_A 178 KSDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV----------QQKATYKE--- 241 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------HHHHHHCC---
T ss_pred CCccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH----------HhhhccCC---
Confidence 44322 34556899999999875 5789999999999999999999999976432221 11110000
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
+....... .....+.+|+.+||+.||++|||+.|+++
T Consensus 242 ----~~~~~~~~-----~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 242 ----PNYAVECR-----PLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ----CCCCC--C-----CCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ----cccccccC-----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000000 12356789999999999999999999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=337.24 Aligned_cols=266 Identities=20% Similarity=0.278 Sum_probs=194.1
Q ss_pred CCHHHHHHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceee-
Q 045453 47 FTIRELEIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCL- 123 (346)
Q Consensus 47 ~~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~- 123 (346)
+.-+.+.....+|...+.||+|+||.||+|.+ +++.||+|++..........+.+|+..+..+.+||||+++++++.
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 97 (337)
T 3ll6_A 18 FVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASI 97 (337)
T ss_dssp STTCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred hhcceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence 33344445566888999999999999999999 889999999865554556678889999999855999999999984
Q ss_pred -------cCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCCeEEc
Q 045453 124 -------ETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRP--ILHRKIRPSRIFLD 194 (346)
Q Consensus 124 -------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--iiH~dlkp~NIll~ 194 (346)
.....++||||+. |+|.+++..... ..++++..++.++.|++.||.||| +.+ ++||||||+|||++
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~ 172 (337)
T 3ll6_A 98 GKEESDTGQAEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLS 172 (337)
T ss_dssp CTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEEC
T ss_pred cccccccCCceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEEC
Confidence 3345799999995 699998865321 136999999999999999999999 888 99999999999999
Q ss_pred CCCceEEeccCCCcccCCCCcee-----------eccccccCCcCCcccc---ccCCCCcccchHHHHHHHHHHHhCCCC
Q 045453 195 EGYIAKLFDFSLSVSIPEGETCV-----------KDKVTGTMGFLAPEYI---NTGDFNEKCDVFSFGMLLLVLLTGQKI 260 (346)
Q Consensus 195 ~~~~~kl~Dfgl~~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~s~G~vl~elltg~~p 260 (346)
.++.+||+|||+++......... .....+|+.|+|||++ .+..++.++||||||+++|+|++|..|
T Consensus 173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p 252 (337)
T 3ll6_A 173 NQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252 (337)
T ss_dssp TTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCC
T ss_pred CCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCC
Confidence 99999999999998765432211 1134589999999998 566789999999999999999999999
Q ss_pred CCCCCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 045453 261 FDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQ 340 (346)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 340 (346)
|........ +....... ........+.+|+..||+.+|++|||+.|+++.|+.
T Consensus 253 ~~~~~~~~~-----------------------~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 305 (337)
T 3ll6_A 253 FEDGAKLRI-----------------------VNGKYSIP----PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE 305 (337)
T ss_dssp C-----------------------------------CCCC----TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred CcchhHHHh-----------------------hcCcccCC----cccccchHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 965332111 00000000 000222347889999999999999999999999999
Q ss_pred HHHh
Q 045453 341 IYQH 344 (346)
Q Consensus 341 i~~~ 344 (346)
+.+.
T Consensus 306 ~~~~ 309 (337)
T 3ll6_A 306 IAAA 309 (337)
T ss_dssp HHHH
T ss_pred HHhc
Confidence 8764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=349.59 Aligned_cols=246 Identities=23% Similarity=0.269 Sum_probs=203.1
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVI 130 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~l 130 (346)
.++|...+.||+|+||.||+|.+ +++.||||.+.... ......+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEE
Confidence 36788899999999999999998 78999999986432 12345677888888888 99999999999999999999
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCccc
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI 210 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~ 210 (346)
||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++...
T Consensus 94 v~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~ 166 (476)
T 2y94_A 94 VMEYVSGGELFDYICKN----GRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 166 (476)
T ss_dssp EEECCSSEEHHHHTTSS----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhc
Confidence 99999999999999754 36999999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCceeeccccccCCcCCccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcc
Q 045453 211 PEGETCVKDKVTGTMGFLAPEYINTGDF-NEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEF 289 (346)
Q Consensus 211 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (346)
..... .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||........ .... ..+..
T Consensus 167 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~----------~~~i-~~~~~ 233 (476)
T 2y94_A 167 SDGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL----------FKKI-CDGIF 233 (476)
T ss_dssp CTTCC--BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH----------HHHH-HTTCC
T ss_pred ccccc--ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH----------HHHH-hcCCc
Confidence 54332 334579999999999998776 7899999999999999999999975433221 1111 11110
Q ss_pred ccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 290 DEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 290 ~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.. +......+.+|+.+||+.||++|||+.|+++
T Consensus 234 ------------~~--p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 234 ------------YT--PQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ------------CC--CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ------------CC--CccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 00 0123356889999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=332.66 Aligned_cols=253 Identities=19% Similarity=0.282 Sum_probs=187.9
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
.++|...+.||+|+||+||+|.+ +++.||+|++..... ....+...++..+.+..+||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46788999999999999999999 889999999875532 233445555655555559999999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSR-PILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
||++ |+|.+++.........+++..++.++.|++.||+||| +. +++||||||+|||++.++.+||+|||++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 4888887653222357999999999999999999999 76 99999999999999999999999999997764
Q ss_pred CCCceeeccccccCCcCCcccc----ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcC
Q 045453 212 EGETCVKDKVTGTMGFLAPEYI----NTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENN 287 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (346)
.... .....||+.|+|||.+ .+..++.++||||||+++|+|++|..||........ .........
T Consensus 162 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---------~~~~~~~~~ 230 (290)
T 3fme_A 162 DDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ---------QLKQVVEEP 230 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH---------HHHHHHHSC
T ss_pred cccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH---------HHHHHhccC
Confidence 4322 2344689999999996 556789999999999999999999999975332111 111111111
Q ss_pred ccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 288 EFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 288 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
. +.......+..+.+++.+||+.+|++|||+.|+++
T Consensus 231 ~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 231 S-------------PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp C-------------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C-------------CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 0 00011134456899999999999999999999986
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=333.33 Aligned_cols=250 Identities=20% Similarity=0.279 Sum_probs=204.1
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCc------chHHHHHHHHHHhhhcCCCceeeEcceeecCCc
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILND------GHEDCFNNIIFASKLSSHKNVLKLTGCCLETRI 127 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~------~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~ 127 (346)
.+.|...+.||+|+||.||+|.+ ++..||+|.+...... ....+.+|+..+..+ +||||+++++++.+.+.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-LHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCE
Confidence 35688899999999999999998 6889999998754321 356678889999888 99999999999999999
Q ss_pred ceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCC----ceEEec
Q 045453 128 PVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGY----IAKLFD 203 (346)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~----~~kl~D 203 (346)
.++||||+++++|.+++... ..+++..++.++.|++.||.||| +.+++||||||+|||++.++ .+||+|
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTC----SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEcc
Confidence 99999999999999999764 36899999999999999999999 88999999999999999888 799999
Q ss_pred cCCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHH
Q 045453 204 FSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKC 283 (346)
Q Consensus 204 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 283 (346)
||++........ .....||+.|+|||.+.+..++.++||||||+++|+|++|..||......+. ....
T Consensus 163 fg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----------~~~i 230 (321)
T 2a2a_A 163 FGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET----------LANI 230 (321)
T ss_dssp CTTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH----------HHHH
T ss_pred CccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH----------HHHH
Confidence 999987654332 2345689999999999999999999999999999999999999975433211 1111
Q ss_pred hhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 284 IENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 284 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
..... ..++.. ....+..+.+++..||+.||++|||+.|+++
T Consensus 231 -~~~~~--~~~~~~--------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 231 -TSVSY--DFDEEF--------FSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp -HTTCC--CCCHHH--------HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred -Hhccc--ccChhh--------hcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11100 000000 0123456889999999999999999999985
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=326.43 Aligned_cols=247 Identities=19% Similarity=0.296 Sum_probs=182.0
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
++|...+.||+|+||.||+|.. +++.||+|.+.... ......+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-CCTTBCCEEEEEECSSEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-CCCCeEeEEEEEccCCeEEEE
Confidence 5688899999999999999998 78899999986432 12345677888888888 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+++++|.+++.... .++++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EECCTTEEHHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 99999999999998653 46899999999999999999999 8899999999999999999999999999997765
Q ss_pred CCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccc
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDE 291 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (346)
.... ......+|+.|+|||.+.+..++.++||||||+++|+|++|..||........
T Consensus 164 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---------------------- 220 (278)
T 3cok_A 164 MPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT---------------------- 220 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------------------
T ss_pred CCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH----------------------
Confidence 3322 12345689999999999998999999999999999999999999976543321
Q ss_pred ccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 292 IVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 292 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
+.......... +...+..+.+++.+||+.||++|||+.++++
T Consensus 221 -~~~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 221 -LNKVVLADYEM--PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ----CCSSCCCC--CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -HHHHhhcccCC--ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 00000001000 1123456889999999999999999999875
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=345.56 Aligned_cols=250 Identities=14% Similarity=0.144 Sum_probs=190.2
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHH---HHhhhcCCCceeeEc-------c
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNII---FASKLSSHKNVLKLT-------G 120 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~---~~~~~~~h~niv~l~-------g 120 (346)
.++|...+.||+|+||+||+|.+ +++.||||++.... ......+.+|+. .+..+ +|||||+++ +
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l-~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI-KNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTC-CSHHHHHHHHCBCCCSE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhcccc-CCHHHHHHHhhhhhhhh
Confidence 35677789999999999999997 68999999987432 233456667773 44444 899999998 4
Q ss_pred eeecCC-----------------cceEEEecccCCChhhhhhhcCCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 045453 121 CCLETR-----------------IPVIVFESVKNRTLADHIYQNQPH---FEPLLLSQRLRIAVHIANAIAYLHIGFSRP 180 (346)
Q Consensus 121 ~~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ 180 (346)
++.+.+ ..++||||+ +|+|.+++...... ...+++..++.++.|++.||+||| +.+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYG 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCC
Confidence 444332 278999999 67999999764211 123556889999999999999999 889
Q ss_pred ceecCCCCCCeEEcCCCceEEeccCCCcccCCCCceeeccccccCCcCCccccccC-----------CCCcccchHHHHH
Q 045453 181 ILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTG-----------DFNEKCDVFSFGM 249 (346)
Q Consensus 181 iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~s~G~ 249 (346)
|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 99999999999999999999999999986432 2334567 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCC
Q 045453 250 LLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRP 329 (346)
Q Consensus 250 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP 329 (346)
++|||++|+.||........ ........ . ..+..+.+|+.+||+.||++||
T Consensus 302 il~elltg~~Pf~~~~~~~~-----------------------~~~~~~~~-~-----~~~~~~~~li~~~L~~dp~~Rp 352 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGG-----------------------SEWIFRSC-K-----NIPQPVRALLEGFLRYPKEDRL 352 (377)
T ss_dssp HHHHHHHSSCCC------CC-----------------------SGGGGSSC-C-----CCCHHHHHHHHHHTCSSGGGCC
T ss_pred HHHHHHHCCCCCcccccccc-----------------------hhhhhhhc-c-----CCCHHHHHHHHHHcCCCchhCC
Confidence 99999999999975443222 01111000 0 2345688999999999999999
Q ss_pred CHHHHHH--HHHHHHHh
Q 045453 330 TTVDVAK--RLKQIYQH 344 (346)
Q Consensus 330 s~~ev~~--~L~~i~~~ 344 (346)
|+.|+++ .++++.+.
T Consensus 353 t~~e~l~hp~f~~~~~~ 369 (377)
T 3byv_A 353 LPLQAMETPEYEQLRTE 369 (377)
T ss_dssp CHHHHHTSHHHHHHHHH
T ss_pred CHHHHhhChHHHHHHHH
Confidence 9999986 45554443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=340.16 Aligned_cols=260 Identities=21% Similarity=0.235 Sum_probs=200.2
Q ss_pred HHHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCc-----cCcchHHHHHHHHHHhhhcCCCceeeEcceeec
Q 045453 52 LEIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDI-----LNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLE 124 (346)
Q Consensus 52 l~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~-----~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~ 124 (346)
+....++|...+.||+|+||+||+|.+ ++..||+|.+... .......+.+|+..+..+ +||||+++++++.+
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~ 99 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-HHPNIARLYEVYED 99 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHC-CCTTBCCEEEEEEC
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhC-CCCCcceeehhhcc
Confidence 445667799999999999999999998 7789999998643 224456778889999888 99999999999999
Q ss_pred CCcceEEEecccCCChhhhhhhcCC------------------------------------CCCCCCHHHHHHHHHHHHH
Q 045453 125 TRIPVIVFESVKNRTLADHIYQNQP------------------------------------HFEPLLLSQRLRIAVHIAN 168 (346)
Q Consensus 125 ~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------~~~~l~~~~~~~i~~~ia~ 168 (346)
.+..++||||+++|+|.+++..... ....+++..++.++.|++.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 9999999999999999999852100 0112457788899999999
Q ss_pred HHHHHHhCCCCCceecCCCCCCeEEcCCC--ceEEeccCCCcccCC---CCceeeccccccCCcCCcccccc--CCCCcc
Q 045453 169 AIAYLHIGFSRPILHRKIRPSRIFLDEGY--IAKLFDFSLSVSIPE---GETCVKDKVTGTMGFLAPEYINT--GDFNEK 241 (346)
Q Consensus 169 ~L~~LH~~~~~~iiH~dlkp~NIll~~~~--~~kl~Dfgl~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~ 241 (346)
||+||| +.+|+||||||+|||++.++ .+||+|||+++.... ..........||+.|+|||.+.+ ..++.+
T Consensus 180 ~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 999999 88999999999999998776 899999999976532 12222345679999999999975 678999
Q ss_pred cchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcc
Q 045453 242 CDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCV 321 (346)
Q Consensus 242 ~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl 321 (346)
+||||||+++|||++|..||......+. .......... .+.+........+.+|+..||
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~~----------~~~~~~~~~~-----------~~~~~~~~~~~~~~~li~~~l 315 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDADT----------ISQVLNKKLC-----------FENPNYNVLSPLARDLLSNLL 315 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHH----------HHHHHHCCCC-----------TTSGGGGGSCHHHHHHHHHHS
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHHH----------HHHHHhcccc-----------cCCcccccCCHHHHHHHHHHc
Confidence 9999999999999999999976543221 1111111100 000011124567889999999
Q ss_pred cCCCCCCCCHHHHHH
Q 045453 322 CESAEDRPTTVDVAK 336 (346)
Q Consensus 322 ~~~p~~RPs~~ev~~ 336 (346)
+.+|++|||+.|+++
T Consensus 316 ~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 316 NRNVDERFDAMRALQ 330 (345)
T ss_dssp CSCTTTSCCHHHHHH
T ss_pred CCChhHCCCHHHHhc
Confidence 999999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=339.06 Aligned_cols=263 Identities=16% Similarity=0.177 Sum_probs=204.4
Q ss_pred HhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceee----cCCcc
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCL----ETRIP 128 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~----~~~~~ 128 (346)
..++|...+.||+|+||.||++.. +++.||+|++..........+.+|+..+..+ +||||+++++++. .....
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-NHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEEEETTEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhc-CCCCeeeEEEEEEeccCCCcee
Confidence 456789999999999999999997 7899999998665445566778888888888 9999999999987 34478
Q ss_pred eEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 129 VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
++||||+++|+|.+++.........+++..++.++.|++.||.||| +.+++||||||+|||++.++.+||+|||++.
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 9999999999999999864333357999999999999999999999 8899999999999999999999999999987
Q ss_pred ccCCCCcee--------eccccccCCcCCccccccCC---CCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHH
Q 045453 209 SIPEGETCV--------KDKVTGTMGFLAPEYINTGD---FNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLL 277 (346)
Q Consensus 209 ~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~ 277 (346)
......... .....||+.|+|||.+.+.. ++.++||||||+++|+|++|..||........ ...
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-----~~~ 257 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-----SVA 257 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-----CHH
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-----hhh
Confidence 653211100 12334689999999987654 68999999999999999999999953211110 000
Q ss_pred HHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 045453 278 HYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQ 343 (346)
Q Consensus 278 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 343 (346)
... .. .. ..+.....+..+.+++.+||+.+|++|||+.++++.|+.+..
T Consensus 258 ~~~----~~---------~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 258 LAV----QN---------QL----SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp HHH----HC---------C------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred HHh----hc---------cC----CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 000 00 00 000111334678999999999999999999999999988643
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=335.79 Aligned_cols=257 Identities=19% Similarity=0.302 Sum_probs=194.5
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCc---chHHHHHHHHHHhhhcCCCceeeEcceeecCCcc--
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILND---GHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIP-- 128 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~---~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~-- 128 (346)
.++|...+.||+|+||.||+|.+ +++.||+|++...... ....+.+|+..+..+ +||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC-CCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcC-CCCCcceEEEeeeccCCCCc
Confidence 36788899999999999999997 8899999998765322 234566777777777 999999999998765544
Q ss_pred --eEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCC
Q 045453 129 --VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSL 206 (346)
Q Consensus 129 --~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl 206 (346)
++||||+++++|.+++.... ++++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 162 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGI 162 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred ccEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccC
Confidence 99999999999999997653 5899999999999999999999 88999999999999999999999999999
Q ss_pred CcccCCCCc--eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHh
Q 045453 207 SVSIPEGET--CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCI 284 (346)
Q Consensus 207 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (346)
++....... .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......+. .....
T Consensus 163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~----------~~~~~ 232 (311)
T 3ork_A 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV----------AYQHV 232 (311)
T ss_dssp C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----------HHHHH
T ss_pred cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH----------HHHHh
Confidence 987654322 122345689999999999999999999999999999999999999976433221 11111
Q ss_pred hcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHH-HHHHHH
Q 045453 285 ENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVA-KRLKQI 341 (346)
Q Consensus 285 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~-~~L~~i 341 (346)
...... +.. .....+..+.+++.+||+.||++||++.+++ ..|..+
T Consensus 233 ~~~~~~----~~~-------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 233 REDPIP----PSA-------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp HCCCCC----HHH-------HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred cCCCCC----ccc-------ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 111000 000 0002346688999999999999999765544 455444
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=338.05 Aligned_cols=249 Identities=18% Similarity=0.302 Sum_probs=193.3
Q ss_pred hcCCCcccccccCCCcEEEEEEE-CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCC--CceeeEcceeecCCcceE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSH--KNVLKLTGCCLETRIPVI 130 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h--~niv~l~g~~~~~~~~~l 130 (346)
.+.|...+.||+|+||.||+|.. +++.||+|++..... .....+.+|+..+..+ +| |||+++++++.+.+..++
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHH-TTTCTTBCCEEEEEECSSEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhh-hhcCCceEEEeeeEeeCCEEEE
Confidence 35688899999999999999998 788999999875432 3345678899999988 65 999999999999999999
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCccc
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI 210 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~ 210 (346)
|||+ .+++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++ ++.+||+|||+++..
T Consensus 87 v~e~-~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 87 VMEC-GNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EECC-CSEEHHHHHHHS----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEeC-CCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 9995 578999999875 36899999999999999999999 88999999999999997 678999999999877
Q ss_pred CCCCce-eeccccccCCcCCcccccc-----------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHH
Q 045453 211 PEGETC-VKDKVTGTMGFLAPEYINT-----------GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLH 278 (346)
Q Consensus 211 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 278 (346)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||....... .
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---------~ 228 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---------S 228 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH---------H
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH---------H
Confidence 543322 2345679999999999865 678999999999999999999999997533211 1
Q ss_pred HHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 279 YVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 279 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
..... +++......+. .....+.+|+..||+.||++|||+.|+++
T Consensus 229 ~~~~~---------~~~~~~~~~~~----~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 229 KLHAI---------IDPNHEIEFPD----IPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp HHHHH---------HCTTSCCCCCC----CSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHH---------hcCCcccCCcc----cCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 11111 11111111111 22346889999999999999999999975
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=327.63 Aligned_cols=246 Identities=22% Similarity=0.320 Sum_probs=198.6
Q ss_pred HhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcce
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV 129 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~ 129 (346)
+.++|...+.||+|+||+||+|.+ ++..||+|.+.... ......+.+|+..+..+ +||||+++++++.+.+..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 85 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVY 85 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcC-CCCCCcchhheEecCCEEE
Confidence 346788899999999999999998 66789999986432 12345567788888888 9999999999999999999
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcc
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVS 209 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~ 209 (346)
+||||+++|+|.+++.... .+++..++.++.|++.||.||| +.+++|+||||+|||++.++.+||+|||++..
T Consensus 86 lv~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~ 158 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH 158 (279)
T ss_dssp EEECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESC
T ss_pred EEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEecccccc
Confidence 9999999999999997653 5899999999999999999999 89999999999999999999999999998865
Q ss_pred cCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcc
Q 045453 210 IPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEF 289 (346)
Q Consensus 210 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (346)
..... .....+|+.|+|||.+.+..++.++||||||+++|+|++|..||......+. ...+ ....
T Consensus 159 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~----~~~~- 223 (279)
T 3fdn_A 159 APSSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-------YKRI----SRVE- 223 (279)
T ss_dssp C-----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHH----HHTC-
T ss_pred CCccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH-------HHHH----HhCC-
Confidence 43322 2345789999999999999999999999999999999999999975432211 1111 0000
Q ss_pred ccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 290 DEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 290 ~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.. . +......+.+|+.+||+.+|++|||+.|+++
T Consensus 224 -----~~----~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 224 -----FT----F----PDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp -----CC----C----CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred -----CC----C----CCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00 0 0123456889999999999999999999986
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=334.98 Aligned_cols=247 Identities=18% Similarity=0.234 Sum_probs=192.6
Q ss_pred hcCCCcccccccCCCcEEEEEEE-----CCeEEEEEEecCcc----CcchHHHHHHHHHHhhhcCCCceeeEcceeecCC
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV-----EDRTVSVMKFNDIL----NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETR 126 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~-----~~~~vavk~~~~~~----~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~ 126 (346)
.++|...+.||+|+||.||+|.. ++..||+|++.... ......+.+|+..+..+ +||||+++++++.+.+
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHPFIVDLIYAFQTGG 94 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHC-CCTTBCCEEEEEECSS
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhC-CCCCccceeEEEEcCC
Confidence 46788999999999999999987 67899999987542 12334566788888888 9999999999999999
Q ss_pred cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCC
Q 045453 127 IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSL 206 (346)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl 206 (346)
..++||||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGL 167 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred EEEEEEeCCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCc
Confidence 9999999999999999997653 5899999999999999999999 88999999999999999999999999999
Q ss_pred CcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhc
Q 045453 207 SVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIEN 286 (346)
Q Consensus 207 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (346)
++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+. ......
T Consensus 168 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----------~~~i~~- 235 (327)
T 3a62_A 168 CKESIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT----------IDKILK- 235 (327)
T ss_dssp C-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----------HHHHHH-
T ss_pred ccccccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH----------HHHHHh-
Confidence 875433221 23455799999999999999999999999999999999999999975433211 111111
Q ss_pred CccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 045453 287 NEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRP-----TTVDVAK 336 (346)
Q Consensus 287 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~ 336 (346)
.. . .. +......+.+++.+||+.+|++|| ++.|+++
T Consensus 236 ~~--------~--~~----p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 236 CK--------L--NL----PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp TC--------C--CC----CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred CC--------C--CC----CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 00 0 00 012345688999999999999999 6667654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=340.64 Aligned_cols=263 Identities=17% Similarity=0.201 Sum_probs=196.6
Q ss_pred hcCCCcccccccCCCcEEEEEEE-----CCeEEEEEEecCccCc-----------chHHHHHHHHHHhhhcCCCceeeEc
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV-----EDRTVSVMKFNDILND-----------GHEDCFNNIIFASKLSSHKNVLKLT 119 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~-----~~~~vavk~~~~~~~~-----------~~~~~~~e~~~~~~~~~h~niv~l~ 119 (346)
.++|...+.||+|+||.||+|.+ .+..+|+|+....... ....+.+|...+..+ +||||++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~ni~~~~ 114 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL-DYLGIPLFY 114 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC-SCCCCCCEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc-cccCcceee
Confidence 35788899999999999999998 4578999998754321 112345666667777 999999999
Q ss_pred ceeec----CCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcC
Q 045453 120 GCCLE----TRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE 195 (346)
Q Consensus 120 g~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~ 195 (346)
+++.. ....++||||+ +++|.+++.... .+++..++.++.|++.||+||| +.+|+||||||+|||++.
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~ 186 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGY 186 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEES
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEcc
Confidence 99987 77899999999 899999997653 6999999999999999999999 889999999999999998
Q ss_pred CC--ceEEeccCCCcccCCCCce------eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc
Q 045453 196 GY--IAKLFDFSLSVSIPEGETC------VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGD 267 (346)
Q Consensus 196 ~~--~~kl~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~ 267 (346)
++ .+||+|||+++.+...... ......||..|+|||++.+..++.++||||||+++|||++|..||......
T Consensus 187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 266 (345)
T 2v62_A 187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD 266 (345)
T ss_dssp SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc
Confidence 87 9999999999776432211 113457899999999999999999999999999999999999999643222
Q ss_pred ccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 045453 268 EIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341 (346)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 341 (346)
.. .... ........ ....+...... ...+..+.+++..||+.+|++|||+.+|++.|+++
T Consensus 267 ~~-----~~~~-~~~~~~~~-~~~~~~~~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 267 PV-----AVQT-AKTNLLDE-LPQSVLKWAPS-------GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HH-----HHHH-HHHHHHHT-TTHHHHHHSCT-------TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred cH-----HHHH-HHHhhccc-ccHHHHhhccc-------cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 21 1111 11111111 11111110000 02345689999999999999999999999999764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=326.30 Aligned_cols=250 Identities=20% Similarity=0.319 Sum_probs=203.2
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
.++|...+.||+|+||.||+|.+ ++..||+|++..... .....+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEcCCEEEEE
Confidence 47788999999999999999998 688999999875432 2345667888888888 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCc---eEEeccCCCc
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYI---AKLFDFSLSV 208 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~---~kl~Dfgl~~ 208 (346)
|||+++++|.+.+.... .+++..+..++.|++.||.||| +.+++||||||+||+++.++. +||+|||++.
T Consensus 84 ~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 84 FDLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp ECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 99999999999987653 5899999999999999999999 889999999999999986655 9999999997
Q ss_pred ccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCc
Q 045453 209 SIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE 288 (346)
Q Consensus 209 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (346)
....... .....||+.|+|||.+.+..++.++||||||+++|+|++|..||........ ...+ ..+.
T Consensus 157 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-------~~~~----~~~~ 223 (284)
T 3kk8_A 157 EVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL-------YAQI----KAGA 223 (284)
T ss_dssp ECCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHH----HHTC
T ss_pred EcccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH-------HHHH----Hhcc
Confidence 7654332 2345789999999999999999999999999999999999999975433211 1111 1111
Q ss_pred cccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 289 FDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 289 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.. .+.......+..+.+++..||+.+|++|||+.|+++
T Consensus 224 ~~----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 224 YD----------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp CC----------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cc----------CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00 000011133456889999999999999999999976
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=338.19 Aligned_cols=252 Identities=19% Similarity=0.301 Sum_probs=200.1
Q ss_pred HhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
..++|...+.||+|+||.||+|.+ +++.||+|.+..... ...+|+..+.++.+||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 356788999999999999999999 689999999875432 23457777777768999999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCC----CceEEeccCCCc
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEG----YIAKLFDFSLSV 208 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~----~~~kl~Dfgl~~ 208 (346)
||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||+..+ +.+||+|||+++
T Consensus 96 E~~~gg~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 96 ELMKGGELLDKILRQ----KFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp CCCCSCBHHHHHHTC----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred eCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 999999999999765 35899999999999999999999 8999999999999998533 359999999998
Q ss_pred ccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCc
Q 045453 209 SIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE 288 (346)
Q Consensus 209 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (346)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ...... +..+.
T Consensus 169 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-------~~~~~~-i~~~~ 239 (342)
T 2qr7_A 169 QLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP-------EEILAR-IGSGK 239 (342)
T ss_dssp ECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH-------HHHHHH-HHHCC
T ss_pred cCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH-------HHHHHH-HccCC
Confidence 7644322 23456789999999999988899999999999999999999999975432221 111111 11111
Q ss_pred cccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 289 FDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 289 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
+. +.... ....+..+.+|+..||+.||++|||+.|+++
T Consensus 240 ~~------~~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 240 FS------LSGGY----WNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp CC------CCSTT----TTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cc------cCccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 10 00000 0134566889999999999999999999875
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=353.01 Aligned_cols=249 Identities=17% Similarity=0.258 Sum_probs=203.4
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
++|...+.||+|+||.||+|.+ +++.||+|++.... ......+..|..++..+ +||||+++++++.+.+..++|
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-CCCCEeeEEEEEeeCCEEEEE
Confidence 6678888999999999999998 68999999986442 23445678888889888 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+++|+|.+++.........+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999999765433457999999999999999999999 8999999999999999999999999999998765
Q ss_pred CCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccc
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDE 291 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (346)
.... ......||+.|+|||++.+..++.++|||||||++|||++|..||........ ............
T Consensus 341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~------~~~~~~~i~~~~---- 409 (543)
T 3c4z_A 341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE------NKELKQRVLEQA---- 409 (543)
T ss_dssp TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC------HHHHHHHHHHCC----
T ss_pred CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh------HHHHHHHHhhcc----
Confidence 4332 22345799999999999999999999999999999999999999986543221 111111111110
Q ss_pred ccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCH
Q 045453 292 IVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTT 331 (346)
Q Consensus 292 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 331 (346)
. .. +...+..+.+|+..||+.+|++||++
T Consensus 410 -----~--~~----p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 410 -----V--TY----PDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp -----C--CC----CTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred -----c--CC----CcccCHHHHHHHHHhccCCHhHCCCC
Confidence 0 00 01334668899999999999999976
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=336.84 Aligned_cols=262 Identities=17% Similarity=0.209 Sum_probs=205.5
Q ss_pred CCHHHHHHHhcCCCcc-cccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcce
Q 045453 47 FTIRELEIATNNFDAR-NVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGC 121 (346)
Q Consensus 47 ~~~~~l~~~~~~f~~~-~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~ 121 (346)
+.++......+.|... +.||+|+||.||+|.. +++.||+|.+..... .....+.+|+..+..+.+||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3344445555667666 8899999999999998 689999999875432 3456788899999988678999999999
Q ss_pred eecCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcC---CCc
Q 045453 122 CLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE---GYI 198 (346)
Q Consensus 122 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~---~~~ 198 (346)
+.+.+..++||||+++|+|.+++.... ...+++..++.++.|++.||+||| +.+|+||||||+|||++. ++.
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~ 172 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGD 172 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCC
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCc
Confidence 999999999999999999999986542 246999999999999999999999 889999999999999998 789
Q ss_pred eEEeccCCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHH
Q 045453 199 AKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLH 278 (346)
Q Consensus 199 ~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 278 (346)
+||+|||+++....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||......+. ..
T Consensus 173 ~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------~~ 243 (327)
T 3lm5_A 173 IKIVDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET-------YL 243 (327)
T ss_dssp EEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HH
T ss_pred EEEeeCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-------HH
Confidence 99999999987653322 2345789999999999999999999999999999999999999976433221 00
Q ss_pred HHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 279 YVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 279 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.+.. ... ..+..........+.+++..||+.+|++|||+.|+++
T Consensus 244 ~i~~----~~~----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 244 NISQ----VNV----------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp HHHH----TCC----------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHh----ccc----------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 0000 000 0000011134566889999999999999999999874
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=339.03 Aligned_cols=263 Identities=14% Similarity=0.208 Sum_probs=206.4
Q ss_pred cCCCcccccccCCCcEEEEEEEC----------CeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceee---------
Q 045453 57 NNFDARNVIKDGYAYKFYKGFVE----------DRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLK--------- 117 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~~----------~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~--------- 117 (346)
++|...+.||+|+||.||+|.+. ++.||+|.+... ..+.+|+..+..+ +||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRA-AKPLQVNKWKKLYSTP 115 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHH-CCHHHHHHHHHHTTCT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHh-cccchhhhhhhhccCC
Confidence 67889999999999999999982 689999998643 4577888899888 9999998
Q ss_pred ------Ecceeec-CCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCC
Q 045453 118 ------LTGCCLE-TRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSR 190 (346)
Q Consensus 118 ------l~g~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~N 190 (346)
+++++.. .+..++||||+ +++|.+++..... ..+++..++.++.|++.||.||| +.+|+||||||+|
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~N 189 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK--HVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAEN 189 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc--CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHH
Confidence 5666665 67889999999 9999999986521 36999999999999999999999 8899999999999
Q ss_pred eEEcCCC--ceEEeccCCCcccCCCCce------eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCC
Q 045453 191 IFLDEGY--IAKLFDFSLSVSIPEGETC------VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFD 262 (346)
Q Consensus 191 Ill~~~~--~~kl~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~ 262 (346)
||++.++ .+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 9999999999776532211 1134478999999999999999999999999999999999999997
Q ss_pred CCCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 045453 263 PSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIY 342 (346)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~ 342 (346)
....... .+........... ....+.... ....+..+.+|+..||+.+|++|||+.+|++.|+++.
T Consensus 270 ~~~~~~~-----~~~~~~~~~~~~~--~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 270 NCLPNTE-----DIMKQKQKFVDKP--GPFVGPCGH-------WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp GGTTCHH-----HHHHHHHHHHHSC--CCEECTTSC-------EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred cCCcCHH-----HHHHHHHhccCCh--hhhhhhccc-------cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 6542221 1222222111111 111111100 0022466889999999999999999999999999998
Q ss_pred Hhh
Q 045453 343 QHL 345 (346)
Q Consensus 343 ~~l 345 (346)
+.+
T Consensus 336 ~~~ 338 (352)
T 2jii_A 336 QDL 338 (352)
T ss_dssp HHT
T ss_pred Hhc
Confidence 864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=334.71 Aligned_cols=240 Identities=18% Similarity=0.235 Sum_probs=200.8
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--------cchHHHHHHHHHHhhhcCCCceeeEcceeecC
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--------DGHEDCFNNIIFASKLSSHKNVLKLTGCCLET 125 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--------~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~ 125 (346)
.++|...+.||+|+||+||+|.+ ++..||+|.+..... .....+.+|+..+..+ +||||+++++++.+.
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-EHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-CCTTBCCEEEEEECS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEeeC
Confidence 46788899999999999999987 889999999875432 1234567788899988 999999999999999
Q ss_pred CcceEEEecccCC-ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEecc
Q 045453 126 RIPVIVFESVKNR-TLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDF 204 (346)
Q Consensus 126 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Df 204 (346)
+..++||||+.+| +|.+++... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRH----PRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTC----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999999777 999999765 35999999999999999999999 889999999999999999999999999
Q ss_pred CCCcccCCCCceeeccccccCCcCCccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHH
Q 045453 205 SLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDF-NEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKC 283 (346)
Q Consensus 205 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 283 (346)
|++........ .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||......
T Consensus 175 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------------- 236 (335)
T 3dls_A 175 GSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------------- 236 (335)
T ss_dssp TTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------------
T ss_pred ccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------------
Confidence 99987754432 234578999999999998877 88999999999999999999999642110
Q ss_pred hhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 284 IENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 284 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
........ ...+..+.+|+..||+.+|++|||+.|+++
T Consensus 237 ---------~~~~~~~~------~~~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 237 ---------VEAAIHPP------YLVSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp ---------TTTCCCCS------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------HhhccCCC------cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111000 023456889999999999999999999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=355.91 Aligned_cols=253 Identities=22% Similarity=0.312 Sum_probs=206.0
Q ss_pred HhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcce
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV 129 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~ 129 (346)
..++|...+.||+|+||.||+|.. +++.||+|++.... ......+.+|..++..+ +|||||++++++.+.+..+
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-CCCCEeeEEEEEeeCCEEE
Confidence 346788889999999999999999 78999999986532 23445677888889888 9999999999999999999
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcc
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVS 209 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~ 209 (346)
+||||+++|+|.+++..... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 261 lVmEy~~gg~L~~~l~~~~~--~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVH 335 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSS--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEeccccee
Confidence 99999999999999976532 35999999999999999999999 88999999999999999999999999999987
Q ss_pred cCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcc
Q 045453 210 IPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEF 289 (346)
Q Consensus 210 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (346)
...... .....||+.|+|||++.+..++.++|||||||++|||++|..||......... ..+...+.. ..
T Consensus 336 ~~~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~---~~i~~~i~~----~~- 405 (576)
T 2acx_A 336 VPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLVKE----VP- 405 (576)
T ss_dssp CCTTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH---HHHHHHHHH----CC-
T ss_pred cccCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH---HHHHHHhhc----cc-
Confidence 754432 23457999999999999999999999999999999999999999865432210 011111110 00
Q ss_pred ccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 045453 290 DEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRP-----TTVDVAK 336 (346)
Q Consensus 290 ~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~ 336 (346)
...+ ...+..+.+|+.+||+.||++|| ++.||++
T Consensus 406 ---------~~~p----~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 406 ---------EEYS----ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp ---------CCCC----TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ---------ccCC----ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 0000 13345688999999999999999 6777764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=335.73 Aligned_cols=262 Identities=22% Similarity=0.325 Sum_probs=206.1
Q ss_pred HhcCCCcccccccCCCcEEEEEEE-------CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCC
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV-------EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETR 126 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~-------~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~ 126 (346)
..++|...+.||+|+||.||+|.+ ++..||+|.+..... ....++.+|+..+..+ +||||+++++++.+.+
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhC-CCCCCCeEEEEEcCCC
Confidence 357799999999999999999984 456899999865432 3455678888888888 9999999999999999
Q ss_pred cceEEEecccCCChhhhhhhcCCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcC---CCceE
Q 045453 127 IPVIVFESVKNRTLADHIYQNQPH---FEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE---GYIAK 200 (346)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~---~~~~k 200 (346)
..++||||+++++|.+++...... ...+++..++.++.|++.||.||| +.+++||||||+|||++. +..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEE
Confidence 999999999999999999875421 135899999999999999999999 889999999999999984 45699
Q ss_pred EeccCCCcccCCCCc-eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHH
Q 045453 201 LFDFSLSVSIPEGET-CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLH 278 (346)
Q Consensus 201 l~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 278 (346)
|+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|+|+| |..||......+ ...
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~ 256 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------VLE 256 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHH
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH-------HHH
Confidence 999999875533222 12234567889999999999999999999999999999999 999997543221 111
Q ss_pred HHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 279 YVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 279 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
.+ ..+... . .....+..+.+++..||+.+|++|||+.++++.|+.+.+.
T Consensus 257 ~~----~~~~~~-----~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 257 FV----TSGGRM-----D--------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp HH----HTTCCC-----C--------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HH----hcCCCC-----C--------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 11 111100 0 0113345688999999999999999999999999988763
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=341.40 Aligned_cols=253 Identities=17% Similarity=0.209 Sum_probs=202.7
Q ss_pred hcCCCcccccccCCCcEEEEEEE-----CCeEEEEEEecCcc----CcchHHHHHHHHHHhhhcCCCceeeEcceeecCC
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV-----EDRTVSVMKFNDIL----NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETR 126 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~-----~~~~vavk~~~~~~----~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~ 126 (346)
.++|...+.||+|+||.||+|.. +++.||||++.... ......+.+|+..+..+.+||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36788999999999999999998 67899999986432 1234456678888888867999999999999999
Q ss_pred cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCC
Q 045453 127 IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSL 206 (346)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl 206 (346)
..++||||+++|+|.+++.... .+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 9999999999999999998753 5899999999999999999999 88999999999999999999999999999
Q ss_pred CcccCCCCceeeccccccCCcCCcccccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHh
Q 045453 207 SVSIPEGETCVKDKVTGTMGFLAPEYINT--GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCI 284 (346)
Q Consensus 207 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (346)
++..............||+.|+|||++.+ ..++.++|||||||++|||++|..||........ .........
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~------~~~~~~~~~ 279 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS------QAEISRRIL 279 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC------HHHHHHHHH
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch------HHHHHHHHh
Confidence 98765443333445679999999999986 3478999999999999999999999976544322 111111111
Q ss_pred hcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 045453 285 ENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRP-----TTVDVAK 336 (346)
Q Consensus 285 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~ 336 (346)
... +. .+......+.+|+.+||+.||++|| |+.|+++
T Consensus 280 ~~~-------~~--------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~ 321 (355)
T 1vzo_A 280 KSE-------PP--------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 321 (355)
T ss_dssp HCC-------CC--------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ccC-------CC--------CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence 100 00 0113345688999999999999999 8888875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=344.09 Aligned_cols=202 Identities=25% Similarity=0.364 Sum_probs=163.5
Q ss_pred HhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecCC--cc
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETR--IP 128 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~--~~ 128 (346)
..++|...+.||+|+||.||+|.+ +++.||||++.... ........+|+..+..+..||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 457899999999999999999998 78999999986442 2345667889999999945999999999997544 68
Q ss_pred eEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 129 VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
++||||++ ++|.+++... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 87 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 99999997 5999999763 5899999999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCC--------------------ceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 045453 209 SIPEGE--------------------TCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSR 265 (346)
Q Consensus 209 ~~~~~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~ 265 (346)
...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 653211 111234579999999999986 679999999999999999999999998654
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=362.49 Aligned_cols=263 Identities=21% Similarity=0.306 Sum_probs=207.5
Q ss_pred HHHHHHhcCCCcccccccCCCcEEEEEEEC-----CeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceee
Q 045453 50 RELEIATNNFDARNVIKDGYAYKFYKGFVE-----DRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCL 123 (346)
Q Consensus 50 ~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~-----~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~ 123 (346)
.++....++|...+.||+|+||+||+|.+. +..||+|++..... .....+.+|+..+..+ +||||+++++++.
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~ 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVIT 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEC
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEe
Confidence 344445567888899999999999999982 35799998765433 3345677888888888 9999999999985
Q ss_pred cCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEec
Q 045453 124 ETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFD 203 (346)
Q Consensus 124 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~D 203 (346)
.+..++||||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 462 -~~~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~D 534 (656)
T 2j0j_A 462 -ENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGD 534 (656)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTT---TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC
T ss_pred -cCceEEEEEcCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEe
Confidence 456899999999999999998654 46899999999999999999999 88999999999999999999999999
Q ss_pred cCCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHH
Q 045453 204 FSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKK 282 (346)
Q Consensus 204 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (346)
||+++..............+|+.|+|||.+.+..++.++||||||+++|||++ |..||......+ ....+.
T Consensus 535 FG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-------~~~~i~- 606 (656)
T 2j0j_A 535 FGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIE- 606 (656)
T ss_dssp CCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHH-
T ss_pred cCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH-------HHHHHH-
Confidence 99998776544433444567789999999999999999999999999999997 999997643322 111111
Q ss_pred HhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 283 CIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 283 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
.+... ..+...+..+.+++.+||+.+|++|||+.++++.|+++.+.
T Consensus 607 ---~~~~~-------------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 607 ---NGERL-------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp ---HTCCC-------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---cCCCC-------------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 11100 00113446788999999999999999999999999999764
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=345.64 Aligned_cols=262 Identities=18% Similarity=0.253 Sum_probs=193.9
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecCC-----
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETR----- 126 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~----- 126 (346)
.++|...+.||+|+||+||+|.+ +++.||||++.... .....++.+|+..+..+ +||||+++++++...+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhC-CCCCCCcEEEEEccCCccccC
Confidence 46788899999999999999998 78999999987542 23456677888888888 9999999999996553
Q ss_pred -cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccC
Q 045453 127 -IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFS 205 (346)
Q Consensus 127 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg 205 (346)
..++||||+++ +|.+.+.. .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG 209 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG 209 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred CeEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEE
Confidence 56999999976 57676642 4899999999999999999999 8899999999999999999999999999
Q ss_pred CCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHH---
Q 045453 206 LSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKK--- 282 (346)
Q Consensus 206 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--- 282 (346)
+++...... ......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+. +...+..
T Consensus 210 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~------~~~i~~~lg~ 281 (464)
T 3ttj_A 210 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ------WNKVIEQLGT 281 (464)
T ss_dssp CC-----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHHHCS
T ss_pred eeeecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHHhcCC
Confidence 998765432 23456799999999999999999999999999999999999999976543221 1111110
Q ss_pred ---------------HhhcC-cccccccccccc----CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 283 ---------------CIENN-EFDEIVDPIIVS----EGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 283 ---------------~~~~~-~~~~~~d~~l~~----~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
..... .......+.... .............+.+|+.+||+.||++|||+.|+++
T Consensus 282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 282 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp CCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000 000000000000 0000001123567899999999999999999999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=323.57 Aligned_cols=249 Identities=22% Similarity=0.347 Sum_probs=203.8
Q ss_pred HhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeec--------
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLE-------- 124 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~-------- 124 (346)
..++|...+.||+|+||.||+|.+ +++.||+|.+.... ..+.+|+..+..+ +||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKL-DHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHC-CCTTBCCEEEEEEEEEEC----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhC-CCCCEEEEeeeEeccccCcccc
Confidence 345688899999999999999999 68999999987542 3566788888888 99999999998854
Q ss_pred --------CCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCC
Q 045453 125 --------TRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEG 196 (346)
Q Consensus 125 --------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~ 196 (346)
....++||||+++++|.+++..... ..+++..++.++.|++.||.||| +.+++|+||||+|||++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDT 158 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEET
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCC
Confidence 3457999999999999999976432 46899999999999999999999 8899999999999999999
Q ss_pred CceEEeccCCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhH
Q 045453 197 YIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWL 276 (346)
Q Consensus 197 ~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~ 276 (346)
+.+||+|||++........ .....+|+.|+|||.+.+..++.++||||||+++|+|++|..|+.. .
T Consensus 159 ~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~------------~ 224 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE------------T 224 (284)
T ss_dssp TEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH------------H
T ss_pred CCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh------------H
Confidence 9999999999987654332 2345689999999999999999999999999999999999988731 1
Q ss_pred HHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 277 LHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 277 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
...... ..... +.. .....+.+++..||+.+|++|||+.|+++.|..+.+.
T Consensus 225 ~~~~~~-~~~~~--------~~~--------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 225 SKFFTD-LRDGI--------ISD--------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp HHHHHH-HHTTC--------CCT--------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred HHHHHH-hhccc--------ccc--------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 111111 11111 100 2234578999999999999999999999999988654
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=341.34 Aligned_cols=252 Identities=20% Similarity=0.276 Sum_probs=192.6
Q ss_pred HHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--------cchHHHHHHHHHHhhhcCCCceeeEcceee
Q 045453 54 IATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--------DGHEDCFNNIIFASKLSSHKNVLKLTGCCL 123 (346)
Q Consensus 54 ~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--------~~~~~~~~e~~~~~~~~~h~niv~l~g~~~ 123 (346)
...++|...+.||+|+||+||+|.+ ++..||+|.+..... .....+.+|+..+..+ +||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~ 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFD 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-CCTTBCCCCEEEE
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-CCCCEeeEEEEEe
Confidence 4568899999999999999999998 678999999865321 1223467889999998 9999999999975
Q ss_pred cCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCC---CceE
Q 045453 124 ETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEG---YIAK 200 (346)
Q Consensus 124 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~---~~~k 200 (346)
. +..++||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.+ +.+|
T Consensus 211 ~-~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 211 A-EDYYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp S-SEEEEEEECCTTCBGGGGTSSS----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEE
T ss_pred c-CceEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEE
Confidence 4 5579999999999999998764 36999999999999999999999 8899999999999999754 4599
Q ss_pred EeccCCCcccCCCCceeeccccccCCcCCcccccc---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHH
Q 045453 201 LFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINT---GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLL 277 (346)
Q Consensus 201 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~ 277 (346)
|+|||+++...... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||........ +.
T Consensus 283 l~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~------~~ 354 (419)
T 3i6u_A 283 ITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS------LK 354 (419)
T ss_dssp ECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC------HH
T ss_pred EeecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH------HH
Confidence 99999998765432 2345679999999999863 6788999999999999999999999976544322 11
Q ss_pred HHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 278 HYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 278 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
..+ ..+.... .+. .....+..+.+|+.+||+.+|++|||+.|+++
T Consensus 355 ~~i----~~~~~~~--~~~--------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 355 DQI----TSGKYNF--IPE--------VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHH----HTTCCCC--CHH--------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHH----hcCCCCC--Cch--------hhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 111 1111000 000 00123467899999999999999999999885
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=330.83 Aligned_cols=262 Identities=18% Similarity=0.234 Sum_probs=197.2
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCc--chHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILND--GHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~--~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
++|...+.||+|+||+||+|.+ +++.||+|++...... ....+.+|+..+..+ +||||+++++++.+.+..++||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL-KHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCCccchhheeecCCeEEEEE
Confidence 5788899999999999999999 5899999998655432 245567888888888 9999999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
||+++++|.+++... ..+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||++.....
T Consensus 82 e~~~~~~l~~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 82 EYCDHTVLHELDRYQ----RGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp ECCSEEHHHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EeCCCchHHHHHhhh----cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 999999999888654 35899999999999999999999 89999999999999999999999999999987653
Q ss_pred CCceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHh-------
Q 045453 213 GETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCI------- 284 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------- 284 (346)
... ......+|..|+|||.+.+ ..++.++||||||+++|+|++|..||......+. ...+....
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~~~~~~ 226 (311)
T 4agu_A 155 PSD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ-------LYLIRKTLGDLIPRH 226 (311)
T ss_dssp ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------HHHHHHHHCSCCHHH
T ss_pred ccc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHHHhccccccc
Confidence 322 2234578999999999976 6689999999999999999999999976544321 11111110
Q ss_pred ----hcCccccccccccccCCCCcc----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 285 ----ENNEFDEIVDPIIVSEGPRVG----KEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 285 ----~~~~~~~~~d~~l~~~~~~~~----~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
......... .+........ .+..+..+.+|+..||+.||++|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 227 QQVFSTNQYFSGV--KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HHHHHTCGGGTTC--CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccccccccccC--cCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000000 0000000000 0123456889999999999999999999974
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=328.61 Aligned_cols=247 Identities=19% Similarity=0.277 Sum_probs=199.1
Q ss_pred HhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceE
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVI 130 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~l 130 (346)
.+++|...+.||+|+||+||+|.+ +++.||+|.+.... .....++.+|+..+..+.+||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 356788999999999999999999 68999999987543 23456778888888888799999999999999999999
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCC--------------
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEG-------------- 196 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~-------------- 196 (346)
||||+++++|.+++.........+++..++.++.|++.||.||| +.+|+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 99999999999999765322246899999999999999999999 8999999999999999844
Q ss_pred -----CceEEeccCCCcccCCCCceeeccccccCCcCCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccc
Q 045453 197 -----YIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIG 270 (346)
Q Consensus 197 -----~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~ 270 (346)
..+||+|||++....... ...||..|+|||.+.+. .++.++||||||+++|+|++|.+|+.....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---- 236 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---- 236 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----
T ss_pred ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----
Confidence 479999999998765432 24589999999999876 567899999999999999999987642210
Q ss_pred cchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 271 AGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
. .....+... .+ +...+..+.+++.+||+.||++|||+.|+++
T Consensus 237 -----~-----~~~~~~~~~-----~~--------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 237 -----W-----HEIRQGRLP-----RI--------PQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp -----H-----HHHHTTCCC-----CC--------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----H-----HHHHcCCCC-----CC--------CcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 0 001111110 11 0123456889999999999999999999875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=329.35 Aligned_cols=257 Identities=23% Similarity=0.350 Sum_probs=197.4
Q ss_pred hcCCCcccccccCCCcEEEEEEE---CC--eEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCc
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV---ED--RTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRI 127 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~---~~--~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~ 127 (346)
.++|...+.||+|+||+||+|.+ ++ ..||+|.+.... ......+.+|+..+..+ +||||+++++++.+..
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSS-
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEccCC-
Confidence 46788899999999999999986 22 268999876542 23456778888999888 9999999999998765
Q ss_pred ceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCC
Q 045453 128 PVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS 207 (346)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~ 207 (346)
.++||||+++++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||||+|||++.++.+||+|||++
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~ 168 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLM 168 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred ceeeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEcccccc
Confidence 899999999999999998653 35899999999999999999999 889999999999999999999999999999
Q ss_pred cccCCCCcee--eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHh
Q 045453 208 VSIPEGETCV--KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCI 284 (346)
Q Consensus 208 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (346)
.......... .....+|..|+|||.+.+..++.++||||||+++|+|++ |..||......+. .....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~----------~~~~~ 238 (291)
T 1u46_A 169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI----------LHKID 238 (291)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----------HHHHH
T ss_pred ccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH----------HHHHH
Confidence 8775443321 234457788999999998889999999999999999999 9999976533221 11111
Q ss_pred hcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 045453 285 ENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQ 343 (346)
Q Consensus 285 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 343 (346)
..... .......+..+.+++..||+.+|++|||+.++++.|+++..
T Consensus 239 ~~~~~-------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 239 KEGER-------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp TSCCC-------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred ccCCC-------------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 11100 00111345678999999999999999999999999998754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=340.27 Aligned_cols=249 Identities=18% Similarity=0.300 Sum_probs=194.6
Q ss_pred cCCCcccccccCCCcEEEEEEE-CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcC-CCceeeEcceeecCCcceEEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSS-HKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~-h~niv~l~g~~~~~~~~~lv~ 132 (346)
+.|...+.||+|+||+||+|.. .++.||||++..... .....+.+|+..+..+.. ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 4588899999999999999998 788999999865432 344667889999999843 699999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
| +.+++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++ ++.+||+|||+++....
T Consensus 136 E-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp E-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred e-cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 9 56889999998753 6899999999999999999999 89999999999999996 57899999999987754
Q ss_pred CCce-eeccccccCCcCCcccccc-----------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHH
Q 045453 213 GETC-VKDKVTGTMGFLAPEYINT-----------GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYV 280 (346)
Q Consensus 213 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 280 (346)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||....... ...
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~---------~~~ 277 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---------SKL 277 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---------HHH
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH---------HHH
Confidence 3322 2345679999999999875 468999999999999999999999997543211 111
Q ss_pred HHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 281 KKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 281 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.... ++......+. .....+.+|+..||+.||++|||+.|+++
T Consensus 278 ~~~~---------~~~~~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 278 HAII---------DPNHEIEFPD----IPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp HHHH---------CTTSCCCCCC----CSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHh---------CccccCCCCc----cchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 1111 1111111111 12356889999999999999999999975
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=329.50 Aligned_cols=254 Identities=21% Similarity=0.271 Sum_probs=201.6
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceee--cCCcce
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCL--ETRIPV 129 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~--~~~~~~ 129 (346)
.++|...+.||+|+||.||+|.+ +++.||+|.+..... .....+.+|+..+..+ +||||+++++++. .....+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhc-CCCCCCeEEEEEecCCCceEE
Confidence 46788899999999999999999 788999999875432 3345677888888888 9999999999875 356789
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-----ceecCCCCCCeEEcCCCceEEecc
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRP-----ILHRKIRPSRIFLDEGYIAKLFDF 204 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-----iiH~dlkp~NIll~~~~~~kl~Df 204 (346)
+||||+++++|.+++.........+++..++.++.|++.||.||| +.+ ++|+||||+|||++.++.+||+||
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 999999999999999765433356999999999999999999999 666 999999999999999999999999
Q ss_pred CCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHh
Q 045453 205 SLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCI 284 (346)
Q Consensus 205 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (346)
|+++....... ......+|..|+|||.+.+..++.++||||||+++|+|++|..||......+ +... +
T Consensus 161 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~----i 228 (279)
T 2w5a_A 161 GLARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGK----I 228 (279)
T ss_dssp CHHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHH----H
T ss_pred chheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH-------HHHH----H
Confidence 99877643322 1234568999999999999999999999999999999999999997643211 1111 1
Q ss_pred hcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 045453 285 ENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRL 338 (346)
Q Consensus 285 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 338 (346)
..+... .+ +...+..+.+++.+||+.+|++|||+.|+++.+
T Consensus 229 ~~~~~~-----~~--------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 229 REGKFR-----RI--------PYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp HHTCCC-----CC--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred hhcccc-----cC--------CcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 111111 00 013345688999999999999999999998754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=322.14 Aligned_cols=251 Identities=24% Similarity=0.318 Sum_probs=202.7
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
.++|...+.||+|+||.||+|.+ +++.||+|.+..... .....+.+|+..+..+ +||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhc-CCCCceeeeeEEEcCCEEEEEE
Confidence 46688899999999999999998 688999999875433 3345677788888887 9999999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
||+++++|.+++... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++.....
T Consensus 85 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 85 EYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp ECCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EecCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 999999999999654 36899999999999999999999 89999999999999999999999999999876543
Q ss_pred CCc-eeeccccccCCcCCccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 213 GET-CVKDKVTGTMGFLAPEYINTGDF-NEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 213 ~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
... .......||..|+|||.+.+..+ +.++||||||+++|+|++|..||........ ....+. .....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~----~~~~~- 227 (276)
T 2yex_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-----EYSDWK----EKKTY- 227 (276)
T ss_dssp TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-----HHHHHH----TTCTT-
T ss_pred CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-----HHHHhh----hcccc-
Confidence 222 12344568999999999987775 7899999999999999999999976544321 111111 00000
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
. .........+.+++..||+.+|++|||+.|+++
T Consensus 228 --~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 228 --L----------NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp --S----------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --c----------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0 001133456889999999999999999999875
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=325.15 Aligned_cols=252 Identities=20% Similarity=0.294 Sum_probs=198.3
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEec
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFES 134 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~ 134 (346)
++|....+||+|+||.||+|.+ ++..||+|.+..........+.+|+..+..+ +||||+++++++.+.+..++||||
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-KHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhC-CCCCEeeEeeEEEeCCcEEEEEEe
Confidence 3455667999999999999998 7789999998766555566778888888888 999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcC-CCceEEeccCCCcccCCC
Q 045453 135 VKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE-GYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~-~~~~kl~Dfgl~~~~~~~ 213 (346)
+++++|.+++..... ...+++..+..++.|++.||.||| +.+++|+||||+|||++. ++.+||+|||++......
T Consensus 101 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 101 VPGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp CSEEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred CCCCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 999999999976532 235779999999999999999999 889999999999999997 899999999999776432
Q ss_pred CceeeccccccCCcCCccccccCC--CCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccc
Q 045453 214 ETCVKDKVTGTMGFLAPEYINTGD--FNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDE 291 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (346)
.. ......||+.|+|||.+.+.. ++.++||||||+++|+|++|..||........ ........ .
T Consensus 177 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------~~~~~~~~-~---- 242 (295)
T 2clq_A 177 NP-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA--------AMFKVGMF-K---- 242 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH--------HHHHHHHH-C----
T ss_pred CC-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH--------HHHhhccc-c----
Confidence 22 223456899999999997654 88999999999999999999999964332111 00000000 0
Q ss_pred ccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 292 IVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 292 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
..+.+ +...+..+.+++.+||+.+|++|||+.|+++
T Consensus 243 -~~~~~--------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 243 -VHPEI--------PESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp -CCCCC--------CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred -ccccc--------cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00111 1133456889999999999999999999874
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=328.11 Aligned_cols=249 Identities=18% Similarity=0.276 Sum_probs=200.8
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
.++|...+.||+|+||.||+|.. +++.||+|.+..........+.+|+..+..+ +||||+++++++.+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI-KHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhC-CCCCeeehhhhcccCCEEEEEEE
Confidence 35688899999999999999998 6899999998765444456677888889888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEE---cCCCceEEeccCCCccc
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFL---DEGYIAKLFDFSLSVSI 210 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll---~~~~~~kl~Dfgl~~~~ 210 (346)
|+++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||||+||++ +.++.+||+|||++...
T Consensus 87 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 87 LVSGGELFDRILERG----VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred cCCCccHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 999999999997653 5899999999999999999999 8899999999999999 78899999999998754
Q ss_pred CCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 211 PEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 211 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
... ......||+.|+|||.+.+..++.++||||||+++|+|++|..||....... +. ... ..+...
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~---~~i-~~~~~~ 225 (304)
T 2jam_A 160 QNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK-------LF---EKI-KEGYYE 225 (304)
T ss_dssp CCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HH---HHH-HHCCCC
T ss_pred CCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-------HH---HHH-HcCCCC
Confidence 332 1234568999999999999999999999999999999999999997543211 11 111 111100
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
. +.......+..+.+++..||+.||++|||+.|+++
T Consensus 226 ------~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 226 ------F----ESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp ------C----CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ------C----CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 00001134467889999999999999999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=360.38 Aligned_cols=245 Identities=20% Similarity=0.232 Sum_probs=202.4
Q ss_pred HHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcc
Q 045453 54 IATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIP 128 (346)
Q Consensus 54 ~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~ 128 (346)
...++|...+.||+|+||.||+|.+ +++.||||++.... .........|..++..+.+||||+++++++.+.+.+
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 3457899999999999999999999 67889999987532 344566778888888877899999999999999999
Q ss_pred eEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 129 VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
++||||+++|+|.+++.... .+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred EEEEeCcCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceee
Confidence 99999999999999998753 5999999999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCc
Q 045453 209 SIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE 288 (346)
Q Consensus 209 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (346)
....... ......||+.|+|||++.+..++.++||||||+++|||++|..||...+..+. ...... ..
T Consensus 491 ~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~----------~~~i~~-~~ 558 (674)
T 3pfq_A 491 ENIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL----------FQSIME-HN 558 (674)
T ss_dssp ECCCTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------HHHHHS-SC
T ss_pred ccccCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH----------HHHHHh-CC
Confidence 6433222 24456799999999999999999999999999999999999999986443221 111111 10
Q ss_pred cccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCH
Q 045453 289 FDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTT 331 (346)
Q Consensus 289 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 331 (346)
+ .. +......+.+|+..||+.||++||++
T Consensus 559 --------~--~~----p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 559 --------V--AY----PKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp --------C--CC----CTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred --------C--CC----CccCCHHHHHHHHHHccCCHHHCCCC
Confidence 0 00 11345668899999999999999998
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=341.57 Aligned_cols=264 Identities=17% Similarity=0.232 Sum_probs=210.1
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
.++|...+.||+|+||.||+|.+ ++..||||++.... ...++..|..++..+..|++++.+..++.+.+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46789999999999999999998 68999999876443 334577888888888445777777777888889999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEE---cCCCceEEeccCCCccc
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFL---DEGYIAKLFDFSLSVSI 210 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll---~~~~~~kl~Dfgl~~~~ 210 (346)
|+ +++|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||+++..
T Consensus 84 ~~-g~sL~~ll~~~~---~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred CC-CCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 99 889999997543 46999999999999999999999 8999999999999999 68899999999999876
Q ss_pred CCCCce------eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHh
Q 045453 211 PEGETC------VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCI 284 (346)
Q Consensus 211 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (346)
...... ......||..|+|||.+.+..++.++|||||||++|||++|+.||......... .....+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~----~~~~~i~~~~ 232 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK----QKYEKISEKK 232 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHH----HHHHHHHHHH
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHH----HHHHHHhhcc
Confidence 543321 123567999999999999999999999999999999999999999876553321 1111111100
Q ss_pred hcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 045453 285 ENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHL 345 (346)
Q Consensus 285 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~l 345 (346)
.... +.. +.. ..+..+.+|+..||+.+|++||++.+|++.|+++....
T Consensus 233 ~~~~----~~~-l~~--------~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 233 VATS----IEA-LCR--------GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp HHSC----HHH-HHT--------TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred cccc----HHH-Hhc--------CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 0000 000 000 22456899999999999999999999999999998753
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=338.77 Aligned_cols=270 Identities=14% Similarity=0.254 Sum_probs=203.1
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
.++|...+.||+|+||+||+|.+ ++..||+|.+..... .....+.+|+..+..+ +||||+++++++.+.+..++||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHC-CCCCEEEEeEEEEECCEEEEEE
Confidence 35688899999999999999999 688999999876543 3345677888888888 9999999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSR-PILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
||+++++|.+++.... .+++..+..++.+++.||.||| +. +|+||||||+|||++.++.+||+|||++....
T Consensus 111 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp CCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred ECCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 9999999999998753 5899999999999999999999 64 89999999999999999999999999986543
Q ss_pred CCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchh-----------------
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHY----------------- 274 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~----------------- 274 (346)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+......
T Consensus 184 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 184 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp HH---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred cc---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 21 1234578999999999999999999999999999999999999998654322100000
Q ss_pred --hHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 275 --WLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 275 --~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
....+.............++.......+.......+..+.+|+..||+.||++|||+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00000000000000001111111111111111134567899999999999999999999975
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=333.36 Aligned_cols=254 Identities=20% Similarity=0.356 Sum_probs=203.0
Q ss_pred HHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCc--------chHHHHHHHHHHhhhcCCCceeeEccee
Q 045453 53 EIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILND--------GHEDCFNNIIFASKLSSHKNVLKLTGCC 122 (346)
Q Consensus 53 ~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~--------~~~~~~~e~~~~~~~~~h~niv~l~g~~ 122 (346)
....++|...+.||+|+||.||+|.+ +++.||||++...... ....+.+|+..+..+.+||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 44557788889999999999999998 6899999998754321 1345667888888876899999999999
Q ss_pred ecCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEe
Q 045453 123 LETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLF 202 (346)
Q Consensus 123 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~ 202 (346)
...+..++||||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||||+|||++.++.+||+
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEE
Confidence 9999999999999999999999765 35999999999999999999999 8899999999999999999999999
Q ss_pred ccCCCcccCCCCceeeccccccCCcCCcccccc------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhH
Q 045453 203 DFSLSVSIPEGETCVKDKVTGTMGFLAPEYINT------GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWL 276 (346)
Q Consensus 203 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~ 276 (346)
|||++..+..... .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||....... .
T Consensus 243 DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-------~ 313 (365)
T 2y7j_A 243 DFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL-------M 313 (365)
T ss_dssp CCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------H
T ss_pred ecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH-------H
Confidence 9999987654332 345679999999999863 358899999999999999999999997533211 1
Q ss_pred HHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 277 LHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 277 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
...+. .+... ...+ .....+..+.+++.+||+.||++|||+.|+++
T Consensus 314 ~~~i~----~~~~~-~~~~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 314 LRMIM----EGQYQ-FSSP---------EWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHH----HTCCC-CCHH---------HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHH----hCCCC-CCCc---------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111 11100 0000 00022456889999999999999999999975
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=336.83 Aligned_cols=264 Identities=17% Similarity=0.271 Sum_probs=194.3
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCc-chHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILND-GHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~-~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
++|...+.||+|+||+||+|.+ +++.||+|++...... ....+.+|+..+..+ +||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCC-CCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhc-CCCCCCeeeeEEeeCCEEEEEec
Confidence 4688889999999999999999 6889999998654322 122345688888888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
|++ |+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 153 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCG---NIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP 153 (324)
T ss_dssp CCS-EEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred ccc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence 997 59999987754 46899999999999999999999 899999999999999999999999999998765433
Q ss_pred CceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCc---c
Q 045453 214 ETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE---F 289 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 289 (346)
.. ......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||......+ ....+........ .
T Consensus 154 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-------~~~~i~~~~~~~~~~~~ 225 (324)
T 3mtl_A 154 TK-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE-------QLHFIFRILGTPTEETW 225 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHHHCCCCTTTS
T ss_pred cc-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHHHhCCCChHhc
Confidence 22 2234568999999999876 568999999999999999999999997654322 1122222111110 0
Q ss_pred cccccc---------ccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 290 DEIVDP---------IIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 290 ~~~~d~---------~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
...... ...........+.....+.+|+.+||+.||++|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 226 PGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp TTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000 00000000000123456889999999999999999999875
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=323.04 Aligned_cols=244 Identities=20% Similarity=0.299 Sum_probs=201.7
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
++|...+.||+|+||.||+|.. ++..||+|.+.... ......+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcC-CCCCEeeEEEEEEcCCEEEEE
Confidence 5688899999999999999999 67899999986432 22345677888888888 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+++++|.+++.... .+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG----RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp ECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 99999999999997753 5899999999999999999999 8999999999999999999999999999986654
Q ss_pred CCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccc
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDE 291 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (346)
... .....|+..|+|||.+.+..++.++||||||+++|+|++|..||......+. ..... ...
T Consensus 166 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----------~~~~~-~~~--- 228 (284)
T 2vgo_A 166 SLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET----------HRRIV-NVD--- 228 (284)
T ss_dssp SSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH----------HHHHH-TTC---
T ss_pred ccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH----------HHHHh-ccc---
Confidence 322 2345789999999999999999999999999999999999999975432211 11111 110
Q ss_pred ccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 292 IVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 292 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
..+ + ...+..+.+++..||+.+|++|||+.++++
T Consensus 229 ---~~~----~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 229 ---LKF----P----PFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp ---CCC----C----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---cCC----C----CcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 000 0 123456889999999999999999999985
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=326.71 Aligned_cols=248 Identities=23% Similarity=0.334 Sum_probs=204.1
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc-CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL-NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
.+.|...+.||+|+||.||+|.+ +++.||+|.+.... ......+.+|+..+..+ +||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCCeEEEEE
Confidence 35688889999999999999998 68899999987554 34456778888888888 9999999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
||+++++|.+++.. .++++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++.....
T Consensus 100 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 100 EYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp ECCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred EeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCc
Confidence 99999999999865 35899999999999999999999 88999999999999999999999999999977654
Q ss_pred CCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccc
Q 045453 213 GETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEI 292 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (346)
... ......||..|+|||.+.+..++.++||||||+++|+|++|..||....... ....+ .....
T Consensus 172 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~----~~~~~--- 236 (303)
T 3a7i_A 172 TQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK-------VLFLI----PKNNP--- 236 (303)
T ss_dssp TBC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHH----HHSCC---
T ss_pred ccc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH-------HHHHh----hcCCC---
Confidence 322 2344578999999999999999999999999999999999999997543211 11111 11110
Q ss_pred cccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045453 293 VDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKR 337 (346)
Q Consensus 293 ~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 337 (346)
+.+.. ..+..+.+++..||+.+|++|||+.|+++.
T Consensus 237 --~~~~~--------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 237 --PTLEG--------NYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp --CCCCS--------SCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred --CCCcc--------ccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 01111 234568899999999999999999999863
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=322.31 Aligned_cols=244 Identities=19% Similarity=0.284 Sum_probs=194.2
Q ss_pred CCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeec----CCcceE
Q 045453 59 FDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLE----TRIPVI 130 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~----~~~~~l 130 (346)
|...+.||+|+||+||+|.+ ++..||+|.+.... ......+.+|+..+..+ +||||+++++++.. ....++
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeeccccCCCceEEE
Confidence 55667899999999999998 67889999887543 23345677888888888 99999999998865 456899
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCCeEEc-CCCceEEeccCCC
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRP--ILHRKIRPSRIFLD-EGYIAKLFDFSLS 207 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--iiH~dlkp~NIll~-~~~~~kl~Dfgl~ 207 (346)
||||+++++|.+++.... .+++..++.++.+++.||.||| +.+ ++|+||||+|||++ .++.+||+|||++
T Consensus 107 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEecCCCCHHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 999999999999997653 5899999999999999999999 777 99999999999998 8899999999999
Q ss_pred cccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcC
Q 045453 208 VSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENN 287 (346)
Q Consensus 208 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (346)
....... .....||+.|+|||.+. +.++.++||||||+++|+|++|..||........ ..... ..+
T Consensus 180 ~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---------~~~~~-~~~ 245 (290)
T 1t4h_A 180 TLKRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ---------IYRRV-TSG 245 (290)
T ss_dssp GGCCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH---------HHHHH-TTT
T ss_pred ccccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH---------HHHHH-hcc
Confidence 7654332 23456899999999876 5699999999999999999999999975433221 11111 111
Q ss_pred ccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 288 EFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 288 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
..... ........+.+++..||+.+|++|||+.|+++
T Consensus 246 ~~~~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 246 VKPAS------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CCCGG------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCccc------------cCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 10000 01122356889999999999999999999975
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=322.68 Aligned_cols=255 Identities=20% Similarity=0.287 Sum_probs=202.7
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC------cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcc
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN------DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIP 128 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~------~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~ 128 (346)
++|...+.||+|+||.||+|.+ +++.||+|.+..... .....+.+|+..+..+ +||||+++++++.+.+..
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-RHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhC-CCCCeeehhheecCCCeE
Confidence 4688889999999999999999 688999998865432 1356778888999888 999999999999999999
Q ss_pred eEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCC----ceEEecc
Q 045453 129 VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGY----IAKLFDF 204 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~----~~kl~Df 204 (346)
++||||+++++|.+++... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++ .+||+||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK----ESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEec
Confidence 9999999999999999765 35899999999999999999999 89999999999999999877 8999999
Q ss_pred CCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHh
Q 045453 205 SLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCI 284 (346)
Q Consensus 205 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (346)
|++........ .....+|+.|+|||.+.+..++.++||||||+++|+|++|..||......+. ....
T Consensus 157 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----------~~~~- 223 (283)
T 3bhy_A 157 GIAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET----------LTNI- 223 (283)
T ss_dssp TTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----------HHHH-
T ss_pred ccceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH----------HHHh-
Confidence 99987654332 2345689999999999999999999999999999999999999976433211 1110
Q ss_pred hcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHHH
Q 045453 285 ENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK--RLKQIY 342 (346)
Q Consensus 285 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~i~ 342 (346)
...... ..... ....+..+.+++.+||+.+|++|||+.|+++ .++.+.
T Consensus 224 ~~~~~~--~~~~~--------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 224 SAVNYD--FDEEY--------FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp HTTCCC--CCHHH--------HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred HhcccC--Ccchh--------cccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 001000 00000 0123456889999999999999999999987 444443
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=334.67 Aligned_cols=262 Identities=20% Similarity=0.283 Sum_probs=200.4
Q ss_pred cCCCHHHHHHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEccee
Q 045453 45 RGFTIRELEIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCC 122 (346)
Q Consensus 45 ~~~~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~ 122 (346)
..+.+.++....++|...+.||+|+||.||+|.+ +++.||+|.+.... .....+.+|+..+..+.+||||+++++++
T Consensus 12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 3455555666788899999999999999999999 78899999986543 34567788888888887899999999999
Q ss_pred ec------CCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCC
Q 045453 123 LE------TRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEG 196 (346)
Q Consensus 123 ~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~ 196 (346)
.. .+..++||||+++|+|.+++..... ..+++..++.++.|++.||.||| +.+++|+||||+|||++.+
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~ 165 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTEN 165 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTT
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCC
Confidence 76 4678999999999999999976432 36899999999999999999999 8899999999999999999
Q ss_pred CceEEeccCCCcccCCCCceeeccccccCCcCCccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccccc
Q 045453 197 YIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYIN-----TGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGA 271 (346)
Q Consensus 197 ~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~ 271 (346)
+.+||+|||++........ ......||+.|+|||.+. +..++.++||||||+++|+|++|..||........
T Consensus 166 ~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-- 242 (326)
T 2x7f_A 166 AEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-- 242 (326)
T ss_dssp CCEEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH--
T ss_pred CCEEEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH--
Confidence 9999999999876643221 223456899999999997 56789999999999999999999999965432111
Q ss_pred chhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 272 GHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
........ .. .. .....+..+.+++.+||+.+|++|||+.++++
T Consensus 243 --------~~~~~~~~-~~-----~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 243 --------LFLIPRNP-AP-----RL-------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp --------HHHHHHSC-CC-----CC-------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --------HHHhhcCc-cc-----cC-------CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11111111 00 00 01123456889999999999999999999976
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=329.95 Aligned_cols=268 Identities=19% Similarity=0.221 Sum_probs=197.6
Q ss_pred HHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCc-----chHHHHHHHHHHhhhcCCCceeeEcceeecC
Q 045453 53 EIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILND-----GHEDCFNNIIFASKLSSHKNVLKLTGCCLET 125 (346)
Q Consensus 53 ~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~-----~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~ 125 (346)
....++|...+.||+|+||.||+|.+ +++.||+|++...... ....+.+|+..+..+ +||||+++++++.+.
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 84 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHK 84 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC-CCCCCCeEEEEEeeC
Confidence 34457899999999999999999998 6889999998643321 134577888899888 999999999999999
Q ss_pred CcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccC
Q 045453 126 RIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFS 205 (346)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg 205 (346)
+..++||||+++ +|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 85 ~~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (346)
T 1ua2_A 85 SNISLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFG 157 (346)
T ss_dssp TCCEEEEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCG
T ss_pred CceEEEEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecc
Confidence 999999999976 8998887654 46888999999999999999999 8999999999999999999999999999
Q ss_pred CCcccCCCCceeeccccccCCcCCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHh
Q 045453 206 LSVSIPEGETCVKDKVTGTMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCI 284 (346)
Q Consensus 206 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (346)
+++....... ......+|+.|+|||++.+. .++.++||||||+++|+|++|..||......+. +...... .
T Consensus 158 ~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~------~~~i~~~-~ 229 (346)
T 1ua2_A 158 LAKSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ------LTRIFET-L 229 (346)
T ss_dssp GGSTTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHH-H
T ss_pred cceeccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH------HHHHHHH-c
Confidence 9987653322 23445789999999999764 589999999999999999999999976533221 1111111 1
Q ss_pred hcCccc------cccccccccCCCCcch----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 285 ENNEFD------EIVDPIIVSEGPRVGK----EKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 285 ~~~~~~------~~~d~~l~~~~~~~~~----~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
...... ...+.......+.... ......+.+|+.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 230 GTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp CCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 110000 0000000000010000 123467999999999999999999999875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=341.80 Aligned_cols=193 Identities=21% Similarity=0.318 Sum_probs=153.3
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeec-----CC
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLE-----TR 126 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~-----~~ 126 (346)
.++|...+.||+|+||+||+|.+ +++.||||++..... ....++.+|+.++..+ +|||||++++++.. ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhC-CCCCCCceEEEEecCCcccCc
Confidence 36799999999999999999988 788999999865432 3446678899999998 99999999999854 35
Q ss_pred cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCC
Q 045453 127 IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSL 206 (346)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl 206 (346)
..++||||+ +++|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGl 202 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRTP----VYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGL 202 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-ccchhhhcccC----CCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeeccccc
Confidence 689999998 56999998764 36999999999999999999999 88999999999999999999999999999
Q ss_pred CcccCCCCc--------------------------eeeccccccCCcCCcccc-ccCCCCcccchHHHHHHHHHHHhC
Q 045453 207 SVSIPEGET--------------------------CVKDKVTGTMGFLAPEYI-NTGDFNEKCDVFSFGMLLLVLLTG 257 (346)
Q Consensus 207 ~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~G~vl~elltg 257 (346)
++....... ......+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 987643221 112345689999999986 456799999999999999999993
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=347.17 Aligned_cols=249 Identities=20% Similarity=0.342 Sum_probs=197.8
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
.+.|...+.||+|+||+||+|.+ ++..+|+|++.... ......+.+|+..+..+ +||||++++++|.+.+..++|
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-DHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEE
Confidence 34588899999999999999999 78899999987543 23456778888888888 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcC---CCceEEeccCCCc
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE---GYIAKLFDFSLSV 208 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~---~~~~kl~Dfgl~~ 208 (346)
|||+++|+|.+.+.... .+++..+..++.|++.||.||| +.+|+||||||+|||++. ++.+||+|||++.
T Consensus 115 ~e~~~~g~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 115 MECYKGGELFDEIIHRM----KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp EECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 99999999999987653 5899999999999999999999 899999999999999976 4559999999998
Q ss_pred ccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCc
Q 045453 209 SIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE 288 (346)
Q Consensus 209 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (346)
....... .....||+.|+|||++. +.++.++|||||||++|+|++|..||......+. ...+. .+.
T Consensus 188 ~~~~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------~~~i~----~~~ 253 (494)
T 3lij_A 188 VFENQKK--MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI-------LRKVE----KGK 253 (494)
T ss_dssp ECBTTBC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHH----HTC
T ss_pred ECCCCcc--ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHH----hCC
Confidence 7654332 34567999999999886 5799999999999999999999999976443221 11111 111
Q ss_pred cccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 289 FDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 289 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.. . +.+.....+..+.+|+.+||+.+|++|||+.|+++
T Consensus 254 ~~--~--------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 254 YT--F--------DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CC--C--------CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CC--C--------CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 00 0 00001133456889999999999999999999875
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=329.00 Aligned_cols=252 Identities=18% Similarity=0.252 Sum_probs=198.6
Q ss_pred HhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
..+.|...+.||+|+||.||+|.+ ++..+|+|.+..........+.+|+..+..+ +||||+++++++...+..++||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATC-DHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHC-CCTTBCCEEEEEECC-CEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcC-CCCCEeeeeeeeeeCCeEEEEE
Confidence 346788899999999999999999 5889999998766666677888999999988 9999999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||||+|||++.++.+||+|||++.....
T Consensus 96 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169 (302)
T ss_dssp ECCTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred EeCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence 9999999999987644 45999999999999999999999 88999999999999999999999999998753211
Q ss_pred CCceeeccccccCCcCCcccc-----ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcC
Q 045453 213 GETCVKDKVTGTMGFLAPEYI-----NTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENN 287 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (346)
. ........||..|+|||.+ .+..++.++||||||+++|+|++|..||....... .........
T Consensus 170 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----------~~~~~~~~~ 238 (302)
T 2j7t_A 170 T-LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR----------VLLKIAKSD 238 (302)
T ss_dssp H-HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----------HHHHHHHSC
T ss_pred c-ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH----------HHHHHhccC
Confidence 1 0112334689999999998 36778999999999999999999999997543211 111111111
Q ss_pred ccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 288 EFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 288 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.... ......+..+.+++..||+.+|++|||+.++++
T Consensus 239 -~~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 239 -PPTL-----------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -CCCC-----------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -Cccc-----------CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000 011134566889999999999999999999975
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=324.55 Aligned_cols=247 Identities=20% Similarity=0.281 Sum_probs=202.3
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVI 130 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~l 130 (346)
.++|...+.||+|+||.||+|.+ +++.+|+|.+..... .....+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCEEEE
Confidence 35688889999999999999999 578899999865432 2345667788888888 99999999999999999999
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCccc
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI 210 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~ 210 (346)
||||+++++|.+++.... .+++..++.++.|++.||.||| +.+++|+||||+|||++.++.+||+|||++...
T Consensus 93 v~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 93 VLELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp EEECCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 999999999999987653 5899999999999999999999 889999999999999999999999999999876
Q ss_pred CCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 211 PEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 211 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
..... ......||+.|+|||.+.+..++.++||||||+++|+|++|..||......+. .... .....
T Consensus 166 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----------~~~~-~~~~~- 232 (294)
T 2rku_A 166 EYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET----------YLRI-KKNEY- 232 (294)
T ss_dssp CSTTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----------HHHH-HTTCC-
T ss_pred ccCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----------HHHH-hhccC-
Confidence 53322 23345689999999999998999999999999999999999999975432211 1111 11100
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.+ +......+.+++.+||+.+|++|||+.|+++
T Consensus 233 -----~~--------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 233 -----SI--------PKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp -----CC--------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -----CC--------ccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 00 0123356889999999999999999999876
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=333.01 Aligned_cols=272 Identities=17% Similarity=0.216 Sum_probs=199.7
Q ss_pred CHHHHHHHhcCCCcccccccCCCcEEEEEEE-CCeEEEEEEecCccCc-----------chHHHHHHHHHHhhhcCCCce
Q 045453 48 TIRELEIATNNFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILND-----------GHEDCFNNIIFASKLSSHKNV 115 (346)
Q Consensus 48 ~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~-----------~~~~~~~e~~~~~~~~~h~ni 115 (346)
.++++....++|...+.||+|+||.||+|.. .+..||||++...... ....+.+|+..+..+ +||||
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i 91 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-HHPNI 91 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC-CCTTB
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC-CCcCc
Confidence 4577888899999999999999999999988 8899999998654321 126678899999998 99999
Q ss_pred eeEcceeec-----CCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCC
Q 045453 116 LKLTGCCLE-----TRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSR 190 (346)
Q Consensus 116 v~l~g~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~N 190 (346)
+++++++.. ....++||||++ |+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~N 164 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR---IVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGN 164 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGG
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHH
Confidence 999999854 345799999997 58988887543 46999999999999999999999 8899999999999
Q ss_pred eEEcCCCceEEeccCCCcccCCCCceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccc
Q 045453 191 IFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEI 269 (346)
Q Consensus 191 Ill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~ 269 (346)
||++.++.+||+|||++....... ......+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+.
T Consensus 165 Il~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 242 (362)
T 3pg1_A 165 ILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242 (362)
T ss_dssp EEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred EEEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999999997544322 2344578899999999987 6789999999999999999999999976543221
Q ss_pred ccchhhHHHHHHHHhhcCccc-----------cccccccccCCCCc---chHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 045453 270 GAGHYWLLHYVKKCIENNEFD-----------EIVDPIIVSEGPRV---GKEKQLQGFRELALMCVCESAEDRPTTVDVA 335 (346)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~-----------~~~d~~l~~~~~~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~ 335 (346)
...+.......... ..+...+....... ..+.....+.+|+..||+.||++|||+.|++
T Consensus 243 -------~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 315 (362)
T 3pg1_A 243 -------LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQAL 315 (362)
T ss_dssp -------HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred -------HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHH
Confidence 11111111111000 00000000000000 0012245688999999999999999999997
Q ss_pred H
Q 045453 336 K 336 (346)
Q Consensus 336 ~ 336 (346)
+
T Consensus 316 ~ 316 (362)
T 3pg1_A 316 R 316 (362)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=344.97 Aligned_cols=249 Identities=22% Similarity=0.322 Sum_probs=201.9
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
.+.|...+.||+|+||+||+|.+ +++.||+|++.... ......+.+|+.++..+ +||||+++++++.+.+..++|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhC-CCCCcCeEEEEEEcCCEEEEE
Confidence 35688999999999999999998 68999999986432 33456788999999998 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEc---CCCceEEeccCCCc
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLD---EGYIAKLFDFSLSV 208 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~---~~~~~kl~Dfgl~~ 208 (346)
|||+++|+|.+.+.... .+++..+..++.|++.||.||| +.+|+||||||+|||++ .++.+||+|||+++
T Consensus 100 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp ECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 99999999999987653 5899999999999999999999 89999999999999995 56689999999998
Q ss_pred ccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCc
Q 045453 209 SIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE 288 (346)
Q Consensus 209 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (346)
....... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||......+ ....+. .+.
T Consensus 173 ~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~----~~~ 238 (486)
T 3mwu_A 173 CFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-------ILKRVE----TGK 238 (486)
T ss_dssp TBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHH----HTC
T ss_pred ECCCCCc--cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHH----hCC
Confidence 7654332 345579999999999875 69999999999999999999999997643322 111111 111
Q ss_pred cccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 289 FDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 289 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.. .+.+.....+..+.+|+..||+.+|++|||+.|+++
T Consensus 239 ~~----------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 239 YA----------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp CC----------SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CC----------CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 10 000111134567889999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=324.99 Aligned_cols=250 Identities=20% Similarity=0.278 Sum_probs=199.6
Q ss_pred HhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
..+.|...+.||+|+||.||+|.+ ++..||+|.+... .....+.+|+..+..+ +||||+++++++...+..++||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQC-DSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhC-CCCCCccEEEEEEeCCEEEEEe
Confidence 456788999999999999999999 5889999998754 3456788899999998 9999999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
||+++++|.+++.... ..+++..++.++.+++.||.||| +.+++|+||||+||+++.++.+||+|||++.....
T Consensus 104 e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 104 EYCGAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp ECCTTEEHHHHHHHHT---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred ecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 9999999999997543 46999999999999999999999 89999999999999999999999999999976643
Q ss_pred CCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccc
Q 045453 213 GETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEI 292 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (346)
... ......||..|+|||.+.+..++.++||||||+++|+|++|..||........ ...... .....
T Consensus 178 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----------~~~~~~-~~~~~- 244 (314)
T 3com_A 178 TMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA----------IFMIPT-NPPPT- 244 (314)
T ss_dssp TBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH----------HHHHHH-SCCCC-
T ss_pred hcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH----------HHHHhc-CCCcc-
Confidence 322 23345689999999999999999999999999999999999999975432110 111001 10000
Q ss_pred cccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 293 VDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 293 ~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
. ......+..+.+++..||+.+|++|||+.++++
T Consensus 245 ----~------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 245 ----F------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ----C------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----c------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0 011133467889999999999999999999975
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=336.08 Aligned_cols=266 Identities=21% Similarity=0.308 Sum_probs=204.4
Q ss_pred CCHHHHHHHhcCCCcccccccCCCcEEEEEEECCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeec
Q 045453 47 FTIRELEIATNNFDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLE 124 (346)
Q Consensus 47 ~~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~ 124 (346)
...+++....++|...+.||+|+||.||+|.+.+ .+|+|++..... .....+.+|+..+..+ +||||+++++++.+
T Consensus 23 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 100 (319)
T 2y4i_B 23 IFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQT-RHENVVLFMGACMS 100 (319)
T ss_dssp CCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTC-CCTTBCCCCEEEEC
T ss_pred cccccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcC-CCCCEeEEEEEEec
Confidence 4456666777899999999999999999999865 589998865432 2334566778888888 99999999999999
Q ss_pred CCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEecc
Q 045453 125 TRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDF 204 (346)
Q Consensus 125 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Df 204 (346)
.+..++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++||||||+|||++ ++.+||+||
T Consensus 101 ~~~~~iv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Df 173 (319)
T 2y4i_B 101 PPHLAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDF 173 (319)
T ss_dssp SSCEEEECBCCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCC
T ss_pred CCceEEEeecccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeec
Confidence 999999999999999999997653 46899999999999999999999 88999999999999998 679999999
Q ss_pred CCCcccCCCCc----eeeccccccCCcCCcccccc---------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccccc
Q 045453 205 SLSVSIPEGET----CVKDKVTGTMGFLAPEYINT---------GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGA 271 (346)
Q Consensus 205 gl~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~ 271 (346)
|+++....... .......||+.|+|||.+.+ ..++.++||||||+++|+|++|..||........
T Consensus 174 g~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-- 251 (319)
T 2y4i_B 174 GLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI-- 251 (319)
T ss_dssp SCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH--
T ss_pred CCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--
Confidence 99876532211 11234458999999999874 4578999999999999999999999975433221
Q ss_pred chhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 272 GHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
... ...+.. +.... ...+..+.+++..||+.+|++|||+.++++.|+++.+.
T Consensus 252 --------~~~-~~~~~~-----~~~~~-------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 252 --------IWQ-MGTGMK-----PNLSQ-------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp --------HHH-HHTTCC-----CCCCC-------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred --------HHH-hccCCC-----CCCCc-------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 111 111111 11100 01234588999999999999999999999999988764
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=345.73 Aligned_cols=250 Identities=22% Similarity=0.321 Sum_probs=200.3
Q ss_pred HhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-------------cchHHHHHHHHHHhhhcCCCceeeEc
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-------------DGHEDCFNNIIFASKLSSHKNVLKLT 119 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-------------~~~~~~~~e~~~~~~~~~h~niv~l~ 119 (346)
..+.|...+.||+|+||+||+|.. ++..+|+|.+..... .....+.+|+.++..+ +||||++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~ 112 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNIIKLF 112 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC-CCTTBCCEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC-CCCCCCeEE
Confidence 357799999999999999999998 678999999875431 2345678899999998 999999999
Q ss_pred ceeecCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCC--
Q 045453 120 GCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGY-- 197 (346)
Q Consensus 120 g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~-- 197 (346)
+++.+.+..++||||+++|+|.+++.... .+++..++.++.|++.||.||| +.+|+||||||+|||++.++
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~ 185 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINRH----KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSL 185 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCC
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCC
Confidence 99999999999999999999999997653 5999999999999999999999 89999999999999998776
Q ss_pred -ceEEeccCCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhH
Q 045453 198 -IAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWL 276 (346)
Q Consensus 198 -~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~ 276 (346)
.+||+|||++........ .....||+.|+|||++. +.++.++|||||||++|+|++|..||......+.
T Consensus 186 ~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------- 255 (504)
T 3q5i_A 186 LNIKIVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI------- 255 (504)
T ss_dssp SSEEECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------
T ss_pred ccEEEEECCCCEEcCCCCc--cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-------
Confidence 699999999987654332 34567999999999987 5799999999999999999999999976443221
Q ss_pred HHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 277 LHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 277 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
...+. .+... .+. ......+..+.+|+..||+.+|.+|||+.|+++
T Consensus 256 ~~~i~----~~~~~--~~~--------~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 256 IKKVE----KGKYY--FDF--------NDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHH----HCCCC--CCH--------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHH----cCCCC--CCc--------cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 11111 11100 000 000123466899999999999999999999875
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=335.62 Aligned_cols=268 Identities=16% Similarity=0.205 Sum_probs=195.8
Q ss_pred HHHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecC----
Q 045453 52 LEIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLET---- 125 (346)
Q Consensus 52 l~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~---- 125 (346)
+....++|...+.||+|+||+||+|.+ ++..||+|++...... ..+|+.++..+ +||||+++++++...
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVL-DHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTC-CCTTBCCEEEEEEEC----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHc-CCCCccchhheeeecCccc
Confidence 445678899999999999999999998 7899999998654322 23678888888 999999999998543
Q ss_pred ----------------------------------CcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 045453 126 ----------------------------------RIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIA 171 (346)
Q Consensus 126 ----------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~ 171 (346)
...++||||++ |+|.+.+.........+++..+..++.|++.||+
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 34789999998 4888877642222257999999999999999999
Q ss_pred HHHhCCCCCceecCCCCCCeEEc-CCCceEEeccCCCcccCCCCceeeccccccCCcCCccccccC-CCCcccchHHHHH
Q 045453 172 YLHIGFSRPILHRKIRPSRIFLD-EGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTG-DFNEKCDVFSFGM 249 (346)
Q Consensus 172 ~LH~~~~~~iiH~dlkp~NIll~-~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~ 249 (346)
||| +.+|+||||||+|||++ .++.+||+|||+++....... .....+|..|+|||.+.+. .++.++|||||||
T Consensus 156 ~LH---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 156 FIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp HHH---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred HHH---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 999 99999999999999998 689999999999987654332 3345789999999998865 4899999999999
Q ss_pred HHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhh---------cCccccccccccccCC-CCcchHHHHHHHHHHHHH
Q 045453 250 LLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIE---------NNEFDEIVDPIIVSEG-PRVGKEKQLQGFRELALM 319 (346)
Q Consensus 250 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~d~~l~~~~-~~~~~~~~~~~l~~l~~~ 319 (346)
++|||++|+.||......+. +...+...-. ........-+.+.... ....+...+..+.+|+.+
T Consensus 231 il~ell~g~~pf~~~~~~~~------~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 304 (383)
T 3eb0_A 231 VFGELILGKPLFSGETSIDQ------LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQ 304 (383)
T ss_dssp HHHHHHHSSCSSCCSSHHHH------HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCCChHHH------HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHH
Confidence 99999999999986543221 1111111000 0000100001000000 000011234568999999
Q ss_pred cccCCCCCCCCHHHHHH
Q 045453 320 CVCESAEDRPTTVDVAK 336 (346)
Q Consensus 320 cl~~~p~~RPs~~ev~~ 336 (346)
||+.+|++|||+.|+++
T Consensus 305 ~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 305 ILRYEPDLRINPYEAMA 321 (383)
T ss_dssp HCCSSGGGSCCHHHHHT
T ss_pred HccCChhhCCCHHHHhc
Confidence 99999999999999974
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=338.21 Aligned_cols=254 Identities=9% Similarity=0.024 Sum_probs=180.8
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhc-CCCceeeEc-------cee
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLS-SHKNVLKLT-------GCC 122 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~-~h~niv~l~-------g~~ 122 (346)
..+|...+.||+|+||+||+|.+ +++.||+|++..... .....+.+|+..+..+. +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 44588889999999999999998 789999999886542 22334455544444442 599988855 333
Q ss_pred ecC-----------------CcceEEEecccCCChhhhhhhcCCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCC
Q 045453 123 LET-----------------RIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQR------LRIAVHIANAIAYLHIGFSR 179 (346)
Q Consensus 123 ~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~ia~~L~~LH~~~~~ 179 (346)
... ...++||||++ |+|.+++.... ..+.+..+ +.++.|++.||+||| +.
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~ 213 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQ---SK 213 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHHHHHH---HC
Confidence 222 33799999998 89999998653 23455566 788899999999999 89
Q ss_pred CceecCCCCCCeEEcCCCceEEeccCCCcccCCCCceeeccccccCCcCCcccccc--CCCCcccchHHHHHHHHHHHhC
Q 045453 180 PILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINT--GDFNEKCDVFSFGMLLLVLLTG 257 (346)
Q Consensus 180 ~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg 257 (346)
+|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999876422 224556799999999987 6799999999999999999999
Q ss_pred CCCCCCCCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 258 QKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 258 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
+.||.......... ...... ..........+.....+..+.+|+.+||+.||++|||+.|+++
T Consensus 290 ~~Pf~~~~~~~~~~------------~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 290 FLPFGLVTPGIKGS------------WKRPSL----RVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SCSTTBCCTTCTTC------------CCBCCT----TSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCcCcccccc------------hhhhhh----hhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99998764432200 000000 0000001111111134567899999999999999999999964
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=330.16 Aligned_cols=266 Identities=17% Similarity=0.220 Sum_probs=200.2
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeec-------
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLE------- 124 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~------- 124 (346)
.++|...+.||+|+||+||+|.+ +++.||+|++..... .....+.+|+..+..+ +||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEEC------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCcccHhheeecccccccc
Confidence 36788999999999999999999 788999999865432 3345677899999888 99999999999987
Q ss_pred -CCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEec
Q 045453 125 -TRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFD 203 (346)
Q Consensus 125 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~D 203 (346)
.+..++||||+++ +|.+.+.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~D 167 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLAD 167 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred CCceEEEEEeccCC-CHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEcc
Confidence 3468999999975 8888876543 45999999999999999999999 89999999999999999999999999
Q ss_pred cCCCcccCCCCc---eeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHH
Q 045453 204 FSLSVSIPEGET---CVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHY 279 (346)
Q Consensus 204 fgl~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 279 (346)
||+++....... .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||....... ....
T Consensus 168 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------~~~~ 240 (351)
T 3mi9_A 168 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-------QLAL 240 (351)
T ss_dssp CTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHH
T ss_pred chhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH-------HHHH
Confidence 999987653221 22245568999999999876 458999999999999999999999998654322 1111
Q ss_pred HHHHhhcCc---ccccccccc-----ccCCCCcchHH------HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 280 VKKCIENNE---FDEIVDPII-----VSEGPRVGKEK------QLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 280 ~~~~~~~~~---~~~~~d~~l-----~~~~~~~~~~~------~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
+........ ....-+... ........... ....+.+|+.+||+.||++|||+.|+++
T Consensus 241 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 241 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp HHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 111111100 000000000 00000000101 1345889999999999999999999875
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=329.35 Aligned_cols=265 Identities=23% Similarity=0.340 Sum_probs=197.7
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCc--chHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILND--GHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~--~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
++|...+.||+|+||.||+|.+ ++..||+|++...... ....+.+|+..+..+ +||||+++++++.+.+..++||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL-RHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhC-CCCCEeeEEEEeecCCEEEEEE
Confidence 5678889999999999999999 5889999998654432 234466788888888 9999999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
||+++++|.+++... ..+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||++.....
T Consensus 104 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLELFP----NGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHHST----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 999998888876544 35999999999999999999999 88999999999999999999999999999976643
Q ss_pred CCceeeccccccCCcCCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHH---------
Q 045453 213 GETCVKDKVTGTMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKK--------- 282 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------- 282 (346)
... ......+|..|+|||.+.+. .++.++||||||+++|+|++|..||......+. +......
T Consensus 177 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~~~~~~~~~~~ 249 (331)
T 4aaa_A 177 PGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ------LYHIMMCLGNLIPRHQ 249 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHHHCSCCHHHH
T ss_pred Ccc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH------HHHHHHHhCCCChhhh
Confidence 322 22345689999999999875 789999999999999999999999976543221 1111100
Q ss_pred -Hh-hcCccccccccccccCCCCc-chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 283 -CI-ENNEFDEIVDPIIVSEGPRV-GKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 283 -~~-~~~~~~~~~d~~l~~~~~~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.+ ..........+.+....+.. ..+..+..+.+|+.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 250 ELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 01111111111111110000 00123567999999999999999999999875
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=331.51 Aligned_cols=261 Identities=19% Similarity=0.284 Sum_probs=204.3
Q ss_pred hcCCCcccccccCCCcEEEEEEECCeEEEEEEecCccCcc-----------------hHHHHHHHHHHhhhcCCCceeeE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDG-----------------HEDCFNNIIFASKLSSHKNVLKL 118 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~-----------------~~~~~~e~~~~~~~~~h~niv~l 118 (346)
.++|...+.||+|+||.||+|.+++..||+|.+....... ...+.+|+..+..+ +||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI-KNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC-CCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC-CCCCcceE
Confidence 4678899999999999999999999999999987442211 17788899999998 99999999
Q ss_pred cceeecCCcceEEEecccCCChhhh------hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCceecCCCCCCe
Q 045453 119 TGCCLETRIPVIVFESVKNRTLADH------IYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFS-RPILHRKIRPSRI 191 (346)
Q Consensus 119 ~g~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~iiH~dlkp~NI 191 (346)
++++.+.+..++||||+++|+|.++ +.... ...+++..++.++.|++.||.||| + .+++|+||||+||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY--TCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNI 183 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS--CCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc--ccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhE
Confidence 9999999999999999999999999 54421 257999999999999999999999 7 9999999999999
Q ss_pred EEcCCCceEEeccCCCcccCCCCceeeccccccCCcCCccccccC-CCCc-ccchHHHHHHHHHHHhCCCCCCCCCCccc
Q 045453 192 FLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTG-DFNE-KCDVFSFGMLLLVLLTGQKIFDPSRGDEI 269 (346)
Q Consensus 192 ll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~s~G~vl~elltg~~p~~~~~~~~~ 269 (346)
|++.++.+||+|||++...... ......+|..|+|||.+.+. .++. ++||||||+++|+|++|..||........
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred EEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 9999999999999999776433 23456789999999999887 6666 99999999999999999999986544211
Q ss_pred ccchhhHHHHHHHHhhcCccccc------cccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 270 GAGHYWLLHYVKKCIENNEFDEI------VDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~------~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
. ... +.......- ..+..... ........+..+.+|+.+||+.+|++|||+.|+++
T Consensus 261 ------~---~~~-i~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 261 ------L---FNN-IRTKNIEYPLDRNHFLYPLTNKK-STCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp ------H---HHH-HTSCCCCCCCSSSSSTTTTCC---------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ------H---HHH-HhccCcCCccchhhhhccccccc-cccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1 111 111110000 00000000 00000134567899999999999999999999985
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=330.47 Aligned_cols=247 Identities=21% Similarity=0.288 Sum_probs=202.5
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVI 130 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~l 130 (346)
.++|...+.||+|+||.||++.+ +++.+|+|.+..... .....+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCeEEE
Confidence 46788889999999999999999 678999999865432 2345667788888888 99999999999999999999
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCccc
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI 210 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~ 210 (346)
||||+++++|.+++.... .+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++...
T Consensus 119 v~e~~~~~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 191 (335)
T ss_dssp EECCCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEecCCCCCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence 999999999999987653 5899999999999999999999 889999999999999999999999999999876
Q ss_pred CCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 211 PEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 211 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
..... ......||..|+|||.+.+..++.++||||||+++|+|++|..||......+. ...... ...
T Consensus 192 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----------~~~~~~-~~~- 258 (335)
T 2owb_A 192 EYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET----------YLRIKK-NEY- 258 (335)
T ss_dssp CSTTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----------HHHHHH-TCC-
T ss_pred ccCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH----------HHHHhc-CCC-
Confidence 53322 23445689999999999999999999999999999999999999975432211 111101 100
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.+ + ......+.+|+.+||+.||++|||+.|+++
T Consensus 259 -----~~----~----~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 -----SI----P----KHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp -----CC----C----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -----CC----C----ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0 023345788999999999999999999876
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=319.81 Aligned_cols=246 Identities=23% Similarity=0.288 Sum_probs=193.9
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVI 130 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~l 130 (346)
.++|...+.||+|+||.||+|.+ +++.||+|.+.... ......+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcC-CCCCEeEEEEEEecCCeEEE
Confidence 36788899999999999999998 68999999986432 23345677888888888 99999999999999999999
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCccc
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI 210 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~ 210 (346)
||||+++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++...
T Consensus 89 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHG----RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EEECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred EEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeeccccccc
Confidence 999999999999997653 5899999999999999999999 889999999999999999999999999998776
Q ss_pred CCCCceeeccccccCCcCCccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcc
Q 045453 211 PEGETCVKDKVTGTMGFLAPEYINTGDF-NEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEF 289 (346)
Q Consensus 211 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (346)
..... .....+|+.|+|||.+.+..+ +.++||||||+++|+|++|..||....... ....+ .....
T Consensus 162 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~----~~~~~ 228 (276)
T 2h6d_A 162 SDGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT-------LFKKI----RGGVF 228 (276)
T ss_dssp CC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHH----HHCCC
T ss_pred CCCcc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-------HHHHh----hcCcc
Confidence 54322 234568999999999987765 689999999999999999999997532211 11111 11100
Q ss_pred ccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 290 DEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 290 ~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.+ +......+.+++.+||+.+|++|||+.|+++
T Consensus 229 ------~~--------~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 229 ------YI--------PEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp ------CC--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------cC--------chhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 00 0123456889999999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=336.83 Aligned_cols=198 Identities=19% Similarity=0.276 Sum_probs=166.3
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecC-----C
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLET-----R 126 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~-----~ 126 (346)
.++|...+.||+|+||.||+|.+ ++..||||++..... .....+.+|+..+..+ +||||+++++++... +
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-KSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHc-CCCCcceEEEEEecCCCCcCC
Confidence 46799999999999999999998 789999999875432 3446778899999998 999999999999766 5
Q ss_pred cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCC
Q 045453 127 IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSL 206 (346)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl 206 (346)
..++||||+. |+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTP----IFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecCC-cCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCC
Confidence 7899999996 5999999764 35999999999999999999999 88999999999999999999999999999
Q ss_pred CcccCCCCce---------------------eeccccccCCcCCcccc-ccCCCCcccchHHHHHHHHHHHhCCCCCC
Q 045453 207 SVSIPEGETC---------------------VKDKVTGTMGFLAPEYI-NTGDFNEKCDVFSFGMLLLVLLTGQKIFD 262 (346)
Q Consensus 207 ~~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~G~vl~elltg~~p~~ 262 (346)
++........ .....+||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 9876543211 12456789999999986 45679999999999999999998655554
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=347.56 Aligned_cols=249 Identities=20% Similarity=0.328 Sum_probs=204.0
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVI 130 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~l 130 (346)
.+.|...+.||+|+||.||+|.. +++.||||++.... ......+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEEE
Confidence 45688899999999999999999 78999999986543 24556788899999998 99999999999999999999
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEE---cCCCceEEeccCCC
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFL---DEGYIAKLFDFSLS 207 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll---~~~~~~kl~Dfgl~ 207 (346)
||||+.+|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|||++
T Consensus 104 v~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISR----KRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp EECCCCSCBHHHHHHTC----SCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 99999999999999765 35999999999999999999999 8899999999999999 57789999999999
Q ss_pred cccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcC
Q 045453 208 VSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENN 287 (346)
Q Consensus 208 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (346)
+....... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||......+ ....+. .+
T Consensus 177 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~----~~ 242 (484)
T 3nyv_A 177 THFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD-------ILKKVE----KG 242 (484)
T ss_dssp HHBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHH----HC
T ss_pred EEcccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHH----cC
Confidence 87654332 344579999999999875 79999999999999999999999997643322 111111 11
Q ss_pred ccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 288 EFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 288 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
... .+.+.....+..+.+|+.+||+.+|++|||+.|+++
T Consensus 243 ~~~----------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 243 KYT----------FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CCC----------CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCC----------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 110 000111134567889999999999999999999875
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=330.17 Aligned_cols=267 Identities=15% Similarity=0.200 Sum_probs=193.4
Q ss_pred HHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcce
Q 045453 54 IATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV 129 (346)
Q Consensus 54 ~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~ 129 (346)
...++|...+.||+|+||+||+|.+ +++.||+|++..... .....+.+|+..+..+ +||||+++++++.+.+..+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL-QHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGC-CCTTBCCEEEEEEETTEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHc-CCCCcceEEEEEecCCEEE
Confidence 4457899999999999999999988 789999999865432 2234567888888888 9999999999999999999
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEE-----cCCCceEEecc
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFL-----DEGYIAKLFDF 204 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll-----~~~~~~kl~Df 204 (346)
+||||+++ +|.+++.... .+++..++.++.|++.||.||| +.+|+||||||+|||+ +.++.+||+||
T Consensus 110 lv~e~~~~-~L~~~~~~~~----~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df 181 (329)
T 3gbz_A 110 LIFEYAEN-DLKKYMDKNP----DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDF 181 (329)
T ss_dssp EEEECCSE-EHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred EEEecCCC-CHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcC
Confidence 99999975 9999997753 5899999999999999999999 8899999999999999 45566999999
Q ss_pred CCCcccCCCCceeeccccccCCcCCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHH
Q 045453 205 SLSVSIPEGETCVKDKVTGTMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKC 283 (346)
Q Consensus 205 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 283 (346)
|+++....... ......+|..|+|||++.+. .++.++|||||||++|||++|..||......+. +.......
T Consensus 182 g~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~~~~~ 254 (329)
T 3gbz_A 182 GLARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ------LFKIFEVL 254 (329)
T ss_dssp THHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHHH
T ss_pred CCccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH------HHHHHHHh
Confidence 99977643322 23345689999999999874 489999999999999999999999976433221 11111111
Q ss_pred hhcC--ccccccc-cccccCCC---Ccch-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 284 IENN--EFDEIVD-PIIVSEGP---RVGK-----EKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 284 ~~~~--~~~~~~d-~~l~~~~~---~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.... ....... +......+ .... ......+.+|+.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 255 GLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000 0000000 00000000 0000 013467889999999999999999999975
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=321.55 Aligned_cols=252 Identities=20% Similarity=0.315 Sum_probs=203.4
Q ss_pred HhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC---------cchHHHHHHHHHHhhhcCCCceeeEcceee
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---------DGHEDCFNNIIFASKLSSHKNVLKLTGCCL 123 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---------~~~~~~~~e~~~~~~~~~h~niv~l~g~~~ 123 (346)
..++|...+.||+|+||.||+|.+ +++.||+|.+..... .....+.+|+..+.++..||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 357888999999999999999999 789999999865431 123456788888888845999999999999
Q ss_pred cCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEec
Q 045453 124 ETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFD 203 (346)
Q Consensus 124 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~D 203 (346)
..+..++||||+++++|.+++... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECC
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEec
Confidence 999999999999999999999865 35899999999999999999999 89999999999999999999999999
Q ss_pred cCCCcccCCCCceeeccccccCCcCCccccc------cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHH
Q 045453 204 FSLSVSIPEGETCVKDKVTGTMGFLAPEYIN------TGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLL 277 (346)
Q Consensus 204 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~ 277 (346)
||++........ .....+++.|+|||++. ...++.++||||||+++|+|++|..||....... .
T Consensus 168 fg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~- 237 (298)
T 1phk_A 168 FGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------M- 237 (298)
T ss_dssp CTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------H-
T ss_pred ccchhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH-------H-
Confidence 999987654332 33456899999999985 4568999999999999999999999997543211 1
Q ss_pred HHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 278 HYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 278 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.... ...... .+.+.....+..+.+++.+||+.+|++|||+.|+++
T Consensus 238 --~~~~-~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 238 --LRMI-MSGNYQ----------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp --HHHH-HHTCCC----------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred --HHHH-hcCCcc----------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1111 111100 000111134567899999999999999999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=330.01 Aligned_cols=268 Identities=18% Similarity=0.250 Sum_probs=191.1
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecCC-----
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETR----- 126 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~----- 126 (346)
.++|...+.||+|+||.||+|.. +++.||||++..... .....+.+|+..+..+ +||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSCCSTTTC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhc-CCCCccceEEeeccccccccc
Confidence 36788899999999999999998 789999999875432 3345677888888888 9999999999987654
Q ss_pred -cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccC
Q 045453 127 -IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFS 205 (346)
Q Consensus 127 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg 205 (346)
..++||||+++ +|.+.+.. .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 172 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG 172 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cceEEEEEcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEee
Confidence 67999999975 88888852 4889999999999999999999 8899999999999999999999999999
Q ss_pred CCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccc------------h
Q 045453 206 LSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAG------------H 273 (346)
Q Consensus 206 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~------------~ 273 (346)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.... .
T Consensus 173 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 173 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp C------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred ccccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 997664322 23345789999999999999999999999999999999999999976543211000 0
Q ss_pred hhHHHHHHHHhhcC-ccccc-cc---cccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 274 YWLLHYVKKCIENN-EFDEI-VD---PIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 274 ~~~~~~~~~~~~~~-~~~~~-~d---~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
..+...+....... ..... .. +.................+.+|+.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 00000000000000 00000 00 000000000011134677999999999999999999999976
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=330.69 Aligned_cols=260 Identities=15% Similarity=0.184 Sum_probs=193.3
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecCC-----
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETR----- 126 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~----- 126 (346)
.+.|...+.||+|+||.||+|.+ +++.||||++..... ....++.+|+..+..+ +||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCcCCCCceeeEecCCccccC
Confidence 46788899999999999999998 789999999865432 2345677889999888 9999999999997653
Q ss_pred -cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccC
Q 045453 127 -IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFS 205 (346)
Q Consensus 127 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg 205 (346)
..++||||+ +++|.+++... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 173 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFG 173 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred ceEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeee
Confidence 459999999 78999999763 5899999999999999999999 8999999999999999999999999999
Q ss_pred CCcccCCCCceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHh
Q 045453 206 LSVSIPEGETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCI 284 (346)
Q Consensus 206 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (346)
+++..... .....+|..|+|||++.+ ..++.++|||||||+++||++|+.||.+.+..+. +..... ..
T Consensus 174 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------l~~i~~-~~ 242 (367)
T 1cm8_A 174 LARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ------LKEIMK-VT 242 (367)
T ss_dssp TCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHH-HH
T ss_pred cccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHH-hc
Confidence 99876432 234578999999999987 6799999999999999999999999986543221 111111 00
Q ss_pred hcCc-----------ccccccc--ccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 285 ENNE-----------FDEIVDP--IIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 285 ~~~~-----------~~~~~d~--~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.... ....+.. .................+.+|+.+||+.||++|||+.|+++
T Consensus 243 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 243 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp CCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0000 0000000 00000000000123456889999999999999999999876
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=323.46 Aligned_cols=250 Identities=21% Similarity=0.290 Sum_probs=196.1
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--------cchHHHHHHHHHHhhhcCCCceeeEcceeecC
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--------DGHEDCFNNIIFASKLSSHKNVLKLTGCCLET 125 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--------~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~ 125 (346)
.++|...+.||+|+||.||+|.+ +++.||||.+..... .....+.+|+..+..+ +||||+++++++...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-CCTTBCCEEEEEESS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-CCCCCceEeeEEcCC
Confidence 46788999999999999999998 678999999864321 1233567888888888 999999999998765
Q ss_pred CcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCc---eEEe
Q 045453 126 RIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYI---AKLF 202 (346)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~---~kl~ 202 (346)
. .++||||+++++|.+++... ..+++..++.++.|++.||.||| +.+++||||||+|||++.++. +||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTT----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred c-eEEEEecCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEc
Confidence 5 89999999999999998754 36899999999999999999999 899999999999999987664 9999
Q ss_pred ccCCCcccCCCCceeeccccccCCcCCccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHH
Q 045453 203 DFSLSVSIPEGETCVKDKVTGTMGFLAPEYIN---TGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHY 279 (346)
Q Consensus 203 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 279 (346)
|||++....... ......||+.|+|||++. ...++.++||||||+++|+|++|..||........ +...
T Consensus 160 Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~ 231 (322)
T 2ycf_A 160 DFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS------LKDQ 231 (322)
T ss_dssp CCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC------HHHH
T ss_pred cCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH------HHHH
Confidence 999998764332 123456899999999974 56789999999999999999999999976544322 1111
Q ss_pred HHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 280 VKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 280 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
+. .+... ..+.. ....+..+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~----~~~~~--~~~~~--------~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 232 IT----SGKYN--FIPEV--------WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HH----HTCCC--CCHHH--------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HH----hCccc--cCchh--------hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 11 11100 00000 0123467889999999999999999999974
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=323.75 Aligned_cols=260 Identities=17% Similarity=0.235 Sum_probs=199.6
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeec--CCcceEEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLE--TRIPVIVF 132 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~--~~~~~lv~ 132 (346)
++|...+.||+|+||+||+|.+ +++.||+|.+... ....+.+|+..+..+..||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 6688889999999999999988 7889999998643 356788899999999459999999999987 66789999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCC-ceEEeccCCCcccC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGY-IAKLFDFSLSVSIP 211 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~-~~kl~Dfgl~~~~~ 211 (346)
||+++++|.+++. .+++..+..++.|++.||+||| +.+|+||||||+|||++.++ .+||+|||+++...
T Consensus 113 e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp ECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 9999999999884 3888999999999999999999 89999999999999999777 89999999998765
Q ss_pred CCCceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHH-------
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKC------- 283 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------- 283 (346)
.... .....+|..|+|||.+.+ ..++.++||||||+++|+|++|..||........ .+.......
T Consensus 183 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-----~l~~~~~~~~~~~~~~ 255 (330)
T 3nsz_A 183 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-----QLVRIAKVLGTEDLYD 255 (330)
T ss_dssp TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-----HHHHHHHHHCHHHHHH
T ss_pred CCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-----HHHHHHHhcCCchhhh
Confidence 4332 344578899999999987 6789999999999999999999999965433221 111111100
Q ss_pred -hhcCc--cc----ccccc----ccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 284 -IENNE--FD----EIVDP----IIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 284 -~~~~~--~~----~~~d~----~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
..... .. ..... .................+.+|+..||+.||++|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 00 00000 00000000011124567899999999999999999999985
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=330.66 Aligned_cols=269 Identities=17% Similarity=0.266 Sum_probs=202.4
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhc-------CCCceeeEcceee---
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLS-------SHKNVLKLTGCCL--- 123 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~-------~h~niv~l~g~~~--- 123 (346)
.++|...+.||+|+||+||+|.+ +++.||+|++... ......+.+|+..+..+. .||||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 47799999999999999999988 7899999998643 233456778888888773 2889999999987
Q ss_pred -cCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CceecCCCCCCeEEcCCC----
Q 045453 124 -ETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSR-PILHRKIRPSRIFLDEGY---- 197 (346)
Q Consensus 124 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~iiH~dlkp~NIll~~~~---- 197 (346)
.....++||||+ +++|.+.+..... ..+++..++.++.|++.||.||| +. +|+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNY--QGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhh
Confidence 566889999999 5577777665432 46999999999999999999999 77 999999999999999775
Q ss_pred ---------------------------------------------ceEEeccCCCcccCCCCceeeccccccCCcCCccc
Q 045453 198 ---------------------------------------------IAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEY 232 (346)
Q Consensus 198 ---------------------------------------------~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~ 232 (346)
.+||+|||++...... .....||..|+|||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChh
Confidence 7999999999776432 234578999999999
Q ss_pred cccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhc--------Cccc-ccccc-----ccc
Q 045453 233 INTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIEN--------NEFD-EIVDP-----IIV 298 (346)
Q Consensus 233 ~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~-~~~d~-----~l~ 298 (346)
+.+..++.++|||||||++|||+||..||......+.......+.... ..... +... ..... .+.
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALII-ELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHH-HHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHH-HhcCCCChHHhhcccccccccCCcccccccc
Confidence 999999999999999999999999999998766544322111111111 11110 0000 00000 000
Q ss_pred cCCC----------CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 299 SEGP----------RVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 299 ~~~~----------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
...+ ..........+.+|+.+||+.||++|||+.|+++
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0000 0112366778999999999999999999999975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=327.54 Aligned_cols=266 Identities=20% Similarity=0.327 Sum_probs=187.3
Q ss_pred HHHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc-CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcc
Q 045453 52 LEIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL-NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIP 128 (346)
Q Consensus 52 l~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~ 128 (346)
+....++|...+.||+|+||.||+|.+ ++..||+|.+.... .....++.+|+..+..+ +||||+++++++...+..
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 88 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC-HHPNIVSYYTSFVVKDEL 88 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCC-CCTTBCCEEEEEESSSCE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhc-CCCCEeeEEEEEeecCCc
Confidence 445568899999999999999999988 78899999886543 23345667788888887 999999999999999999
Q ss_pred eEEEecccCCChhhhhhhc----CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEecc
Q 045453 129 VIVFESVKNRTLADHIYQN----QPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDF 204 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Df 204 (346)
++||||+++++|.+++... ......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||+||
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~df 165 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADF 165 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEec
Confidence 9999999999999998741 111246899999999999999999999 889999999999999999999999999
Q ss_pred CCCcccCCCCc----eeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHH
Q 045453 205 SLSVSIPEGET----CVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHY 279 (346)
Q Consensus 205 gl~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 279 (346)
|++........ .......||+.|+|||.+.+ ..++.++||||||+++|+|++|..||........ ..
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~-- 237 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV------LM-- 237 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH------HH--
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH------HH--
Confidence 99876643321 11234568999999999876 5689999999999999999999999976543221 10
Q ss_pred HHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 280 VKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 280 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
...... ...... ...... .....+..+.+++.+||+.||++|||+.|+++
T Consensus 238 --~~~~~~-~~~~~~-~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 238 --LTLQND-PPSLET-GVQDKE---MLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp --HHHTSS-CCCTTC------C---CCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --HHhccC-CCcccc-ccccch---hhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 011110 000000 000000 00123456889999999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=327.53 Aligned_cols=275 Identities=17% Similarity=0.141 Sum_probs=191.9
Q ss_pred HHHHHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCc
Q 045453 50 RELEIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRI 127 (346)
Q Consensus 50 ~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~ 127 (346)
.......++|...+.||+|+||+||+|.+ ++..||||++.... ........++..+..+ +||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVL-HHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHH-CCTTBCCEEEEEEEECS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhc-CCCCcccHHHhhhcccc
Confidence 56677789999999999999999999998 68899999886542 2334566777777777 99999999999876433
Q ss_pred -------ceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcC-CCce
Q 045453 128 -------PVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE-GYIA 199 (346)
Q Consensus 128 -------~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~-~~~~ 199 (346)
.++||||+++ +|.+.+.........+++..+..++.|++.||.|||.. +.+|+||||||+|||++. ++.+
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEE
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcE
Confidence 7899999986 66555543222235689999999999999999999932 578999999999999997 8999
Q ss_pred EEeccCCCcccCCCCceeeccccccCCcCCccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHH
Q 045453 200 KLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGD-FNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLH 278 (346)
Q Consensus 200 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 278 (346)
||+|||+++....... .....||+.|+|||++.+.. ++.++||||||+++|+|++|..||........ +..
T Consensus 172 kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~------~~~ 243 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ------LHE 243 (360)
T ss_dssp EECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHH
T ss_pred EEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH------HHH
Confidence 9999999987654332 33456899999999987654 89999999999999999999999986543221 111
Q ss_pred HHHHHhhcC-ccc-----cccccccccCCCCc-------chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 279 YVKKCIENN-EFD-----EIVDPIIVSEGPRV-------GKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 279 ~~~~~~~~~-~~~-----~~~d~~l~~~~~~~-------~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.+....... ... ...+.......... ........+.+|+.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 244 IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 111100000 000 00000000000000 00124567999999999999999999999875
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=334.99 Aligned_cols=200 Identities=21% Similarity=0.246 Sum_probs=170.8
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhc-----CCCceeeEcceeecCCcc
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLS-----SHKNVLKLTGCCLETRIP 128 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~-----~h~niv~l~g~~~~~~~~ 128 (346)
..+|...+.||+|+||+||+|.+ +++.||||++.... ....++..|+.++..+. +|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 35688889999999999999998 68999999987532 23345556666666552 678999999999999999
Q ss_pred eEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCc--eEEeccCC
Q 045453 129 VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYI--AKLFDFSL 206 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~--~kl~Dfgl 206 (346)
++||||+. ++|.+++..... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++. +||+|||+
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEeccC-CCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 99999996 599999987542 35899999999999999999999 889999999999999999987 99999999
Q ss_pred CcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Q 045453 207 SVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRG 266 (346)
Q Consensus 207 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~ 266 (346)
++..... .....||+.|+|||++.+..++.++|||||||++|||+||..||.....
T Consensus 249 a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 249 SCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp CEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 9765432 2345789999999999999999999999999999999999999986543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=328.70 Aligned_cols=265 Identities=15% Similarity=0.187 Sum_probs=200.6
Q ss_pred HhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecC-----C
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLET-----R 126 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~-----~ 126 (346)
..++|...+.||+|+||.||+|.+ ++..||+|++..... .....+.+|+..+..+ +||||+++++++... .
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhc-CCCCCccceeEEecCCccccc
Confidence 346799999999999999999998 788999999875433 3346677889999888 999999999998654 3
Q ss_pred cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCC
Q 045453 127 IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSL 206 (346)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl 206 (346)
..++||||+. |+|.+++... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 174 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGL 174 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcc
Confidence 6799999997 5999999763 4899999999999999999999 89999999999999999999999999999
Q ss_pred CcccCCCCcee--eccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHH
Q 045453 207 SVSIPEGETCV--KDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKC 283 (346)
Q Consensus 207 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 283 (346)
+.......... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+. + ..+...
T Consensus 175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~-~~i~~~ 247 (364)
T 3qyz_A 175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ------L-NHILGI 247 (364)
T ss_dssp CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH------H-HHHHHH
T ss_pred eEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH------H-HHHHHH
Confidence 98765332211 234578999999998764 4589999999999999999999999976554332 1 111111
Q ss_pred hhcCccc---cccc-------cccccCCCCcc---hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 284 IENNEFD---EIVD-------PIIVSEGPRVG---KEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 284 ~~~~~~~---~~~d-------~~l~~~~~~~~---~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
....... ...+ ..+........ .+.....+.+|+.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 248 LGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1100000 0000 00000000000 0023456889999999999999999999975
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=326.72 Aligned_cols=252 Identities=19% Similarity=0.314 Sum_probs=174.3
Q ss_pred HhcCCCcc-cccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeec----CCc
Q 045453 55 ATNNFDAR-NVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLE----TRI 127 (346)
Q Consensus 55 ~~~~f~~~-~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~----~~~ 127 (346)
..++|... ++||+|+||+||+|.+ +++.||+|++... .....++........||||+++++++.. ...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 35678874 4699999999999999 6899999998643 2334455555555599999999999876 445
Q ss_pred ceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcC---CCceEEecc
Q 045453 128 PVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE---GYIAKLFDF 204 (346)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~---~~~~kl~Df 204 (346)
.++||||+++|+|.+++..... ..+++..++.++.|++.||.||| +.+++||||||+|||++. ++.+||+||
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEecc
Confidence 8999999999999999986542 46999999999999999999999 889999999999999986 456999999
Q ss_pred CCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHh
Q 045453 205 SLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCI 284 (346)
Q Consensus 205 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (346)
|+++...... .....+|+.|+|||++.+..++.++||||||+++|+|++|..||........... .....
T Consensus 176 g~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-------~~~~~ 245 (336)
T 3fhr_A 176 GFAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG-------MKRRI 245 (336)
T ss_dssp TTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred ccceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh-------HHHhh
Confidence 9997654322 2345689999999999888999999999999999999999999976544322000 00000
Q ss_pred hcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 285 ENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 285 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
... .. ..+.......+..+.+|+..||+.||++|||+.|+++
T Consensus 246 ~~~--------~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 246 RLG--------QY--GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ---------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hcc--------cc--ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000 00 0010111134567889999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=317.54 Aligned_cols=249 Identities=18% Similarity=0.218 Sum_probs=196.3
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc----CcchHHHHHHHHHHhhhcCCCceeeEcceee--cCCc
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL----NDGHEDCFNNIIFASKLSSHKNVLKLTGCCL--ETRI 127 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~----~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~--~~~~ 127 (346)
.++|...+.||+|+||.||+|.+ ++..+|+|.+.... ......+.+|+..+..+ +||||+++++++. +.+.
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECC---C
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCCe
Confidence 47899999999999999999999 77899999986542 23456678888888888 9999999999984 4567
Q ss_pred ceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCC
Q 045453 128 PVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS 207 (346)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~ 207 (346)
.++||||++++ |.+++..... ..+++..++.++.|++.||.||| +.+++||||||+|||++.++.+||+|||++
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~ 156 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVA 156 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTT--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEehhccCC-HHHHHHhCcc--cccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeeccccc
Confidence 89999999875 7777765432 46999999999999999999999 889999999999999999999999999999
Q ss_pred cccCCCC-ceeeccccccCCcCCccccccCC--CCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHh
Q 045453 208 VSIPEGE-TCVKDKVTGTMGFLAPEYINTGD--FNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCI 284 (346)
Q Consensus 208 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (346)
....... ........||..|+|||++.+.. ++.++||||||+++|+|++|..||......+ . ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~---~~~i- 225 (305)
T 2wtk_C 157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK-------L---FENI- 225 (305)
T ss_dssp EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------H---HHHH-
T ss_pred cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH-------H---HHHH-
Confidence 8764322 22234556899999999998654 4789999999999999999999997543211 1 1111
Q ss_pred hcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 285 ENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 285 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
..... .+ +......+.+++.+||+.||++|||+.|+++
T Consensus 226 ~~~~~------~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 226 GKGSY------AI--------PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp HHCCC------CC--------CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hcCCC------CC--------CCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11110 00 0123456889999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=333.28 Aligned_cols=262 Identities=19% Similarity=0.223 Sum_probs=191.9
Q ss_pred cCCCcccccccCCCcEEEEEEE-CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCc------ce
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRI------PV 129 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~------~~ 129 (346)
.+|...+.||+|+||+||+|.+ .++.+|+|++...... ..+|+.++..+ +||||+++++++...+. .+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIV-KHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTC-CCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhC-CCCCcceEEEEEEecCCCCCceEEE
Confidence 4588889999999999999999 6677999988654322 22577888888 99999999999865433 78
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEc-CCCceEEeccCCCc
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIAKLFDFSLSV 208 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~-~~~~~kl~Dfgl~~ 208 (346)
+||||+++ ++.+.+.........+++..+..++.|++.||+||| +.+|+||||||+|||++ .++.+||+|||+++
T Consensus 115 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 115 LVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 99999987 444444321112246999999999999999999999 89999999999999999 89999999999998
Q ss_pred ccCCCCceeeccccccCCcCCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcC
Q 045453 209 SIPEGETCVKDKVTGTMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENN 287 (346)
Q Consensus 209 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (346)
....... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+. +...+.. ....
T Consensus 191 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~------l~~i~~~-~g~p 261 (394)
T 4e7w_A 191 ILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ------LVEIIKV-LGTP 261 (394)
T ss_dssp ECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHH-HCCC
T ss_pred cccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHHH-hCCC
Confidence 7644332 3345789999999999765 589999999999999999999999986543221 1111111 0000
Q ss_pred cc-------ccccccccccCCCCcc----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 288 EF-------DEIVDPIIVSEGPRVG----KEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 288 ~~-------~~~~d~~l~~~~~~~~----~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.. ............+... ....+..+.+|+.+||+.||++|||+.|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp CHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 00 0000000000000000 0023467899999999999999999999875
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=330.42 Aligned_cols=258 Identities=17% Similarity=0.255 Sum_probs=181.9
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecC------
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLET------ 125 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~------ 125 (346)
.++|...+.||+|+||.||+|.+ +++.||||++..... .....+.+|+..+..+ +||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecCCccccC
Confidence 36788999999999999999998 789999999865432 3445677889999888 999999999998654
Q ss_pred CcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccC
Q 045453 126 RIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFS 205 (346)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg 205 (346)
...++|+||+ +++|.+++.. ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp CCCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC--
T ss_pred CeEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecc
Confidence 5679999999 6799998865 35999999999999999999999 8999999999999999999999999999
Q ss_pred CCcccCCCCceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHh
Q 045453 206 LSVSIPEGETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCI 284 (346)
Q Consensus 206 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (346)
+++..... .....+|..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+. + ..+....
T Consensus 178 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------l-~~i~~~~ 246 (367)
T 2fst_X 178 LARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ------L-KLILRLV 246 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH------H-HHHHHHH
T ss_pred cccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------H-HHHHHHh
Confidence 99765432 234578999999999987 6789999999999999999999999976543211 1 1111111
Q ss_pred hcCc-----------cccccccccccCCCCcch----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 285 ENNE-----------FDEIVDPIIVSEGPRVGK----EKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 285 ~~~~-----------~~~~~d~~l~~~~~~~~~----~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.... ....+.. +.. .+.... ......+.+|+.+||+.||++|||+.|+++
T Consensus 247 g~p~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 247 GTPGAELLKKISSESARNYIQS-LTQ-MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp CSCCHHHHTTCCCHHHHHHHHT-SCC-CCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCHHHHHHhhhHHHHHHHhc-cCC-CCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 1000 0000000 000 000000 012456889999999999999999999875
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=334.13 Aligned_cols=263 Identities=22% Similarity=0.252 Sum_probs=193.2
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecC------Ccc
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLET------RIP 128 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~------~~~ 128 (346)
..|...+.||+|+||.||+|.+ +++.||||++..... ...+|+.++..+ +|||||+++++|... ...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTC-CCTTBCCEEEEEEEEETTTTEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHc-CCCCccceeeEEeccCCCCcceeE
Confidence 4588889999999999999999 689999999865422 223678888888 999999999998542 236
Q ss_pred eEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCC-CceEEeccCCC
Q 045453 129 VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEG-YIAKLFDFSLS 207 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~-~~~kl~Dfgl~ 207 (346)
++||||+++ +|.+.+.........+++..+..++.|++.||.||| +.+|+||||||+|||++.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence 799999976 677666532112256999999999999999999999 8999999999999999965 67899999999
Q ss_pred cccCCCCceeeccccccCCcCCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhh-
Q 045453 208 VSIPEGETCVKDKVTGTMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIE- 285 (346)
Q Consensus 208 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 285 (346)
+....... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+ .+...+...-.
T Consensus 205 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~------~l~~i~~~lg~p 276 (420)
T 1j1b_A 205 KQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD------QLVEIIKVLGTP 276 (420)
T ss_dssp EECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHHHCSC
T ss_pred hhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHHHhCCC
Confidence 87654332 2345789999999999765 79999999999999999999999998654322 12222211000
Q ss_pred --------cCccccccccccccCCC-CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 286 --------NNEFDEIVDPIIVSEGP-RVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 286 --------~~~~~~~~d~~l~~~~~-~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.........+.+..... ..........+.+|+.+||+.||++|||+.|+++
T Consensus 277 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 277 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp CHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 11111111111100000 0000123467899999999999999999999874
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=321.36 Aligned_cols=254 Identities=18% Similarity=0.271 Sum_probs=179.4
Q ss_pred HhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
..++|...+.||+|+||.||+|.+ +++.||||++..... ....++..|+..+.+..+||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 347788899999999999999999 689999999876533 33455667777555655999999999999999999999
Q ss_pred EecccCCChhhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CceecCCCCCCeEEcCCCceEEeccCCCcc
Q 045453 132 FESVKNRTLADHIYQNQ-PHFEPLLLSQRLRIAVHIANAIAYLHIGFSR-PILHRKIRPSRIFLDEGYIAKLFDFSLSVS 209 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~ 209 (346)
|||+++ +|.+++.... .....+++..+..++.+++.||.||| +. +++||||||+|||++.++.+||+|||+++.
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 999975 8888775311 11246899999999999999999999 77 999999999999999999999999999977
Q ss_pred cCCCCceeeccccccCCcCCcccc----ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhh
Q 045453 210 IPEGETCVKDKVTGTMGFLAPEYI----NTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIE 285 (346)
Q Consensus 210 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (346)
...... .....||..|+|||.+ .+..++.++||||||+++|+|++|..||........
T Consensus 176 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---------------- 237 (327)
T 3aln_A 176 LVDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD---------------- 237 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------------------
T ss_pred cccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH----------------
Confidence 643322 2334689999999998 456789999999999999999999999975432110
Q ss_pred cCccccccc---cccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 286 NNEFDEIVD---PIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 286 ~~~~~~~~d---~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
....... +.+... ........+.+|+..||+.+|++|||+.|+++
T Consensus 238 --~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 238 --QLTQVVKGDPPQLSNS----EEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp ----CCCCCSCCCCCCCC----SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --HHHHHhcCCCCCCCCc----ccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 0000111 011110 01134567899999999999999999999975
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=329.67 Aligned_cols=271 Identities=19% Similarity=0.211 Sum_probs=181.5
Q ss_pred CCc-ccccccCCCcEEEEEEE----CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeec--CCcceEE
Q 045453 59 FDA-RNVIKDGYAYKFYKGFV----EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLE--TRIPVIV 131 (346)
Q Consensus 59 f~~-~~~ig~G~~g~Vy~~~~----~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~--~~~~~lv 131 (346)
|.. .++||+|+||+||+|.+ ++..||+|++... .....+.+|+.++..+ +||||+++++++.. ....++|
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHC-CCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhc-CCCCeeeEeeEEecCCCCeEEEE
Confidence 444 45899999999999996 4678999998643 2345678899999998 99999999999954 6788999
Q ss_pred EecccCCChhhhhhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEE----cCCCceEEe
Q 045453 132 FESVKNRTLADHIYQNQ-----PHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFL----DEGYIAKLF 202 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll----~~~~~~kl~ 202 (346)
|||+.+ +|.+++.... .....+++..++.++.|++.||+||| +.+|+||||||+|||+ +.++.+||+
T Consensus 99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 999964 8888876321 11135999999999999999999999 8999999999999999 788999999
Q ss_pred ccCCCcccCCCCc--eeeccccccCCcCCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhh--HH
Q 045453 203 DFSLSVSIPEGET--CVKDKVTGTMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYW--LL 277 (346)
Q Consensus 203 Dfgl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~--~~ 277 (346)
|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|..||.............. ..
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l 254 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence 9999987653321 223456789999999999874 589999999999999999999999987654322111111 11
Q ss_pred HHHHHHhhcCccccccc------------cccccCCCCcchH--------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 278 HYVKKCIENNEFDEIVD------------PIIVSEGPRVGKE--------KQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 278 ~~~~~~~~~~~~~~~~d------------~~l~~~~~~~~~~--------~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
..+...+.......+-+ ............. .....+.+|+.+||+.||++|||+.|+++
T Consensus 255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11111111100000000 0000000000000 01346789999999999999999999875
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=333.58 Aligned_cols=251 Identities=20% Similarity=0.281 Sum_probs=185.3
Q ss_pred CCcccccccCCCcEEEEEE-ECCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccC
Q 045453 59 FDARNVIKDGYAYKFYKGF-VEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKN 137 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~-~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~ 137 (346)
|...++||+|+||+||.+. .+++.||||++... ....+.+|+..+..+.+|||||++++++.+.+..++||||+.
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~- 92 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN- 92 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence 3446789999999997544 48999999998643 234567888888877689999999999999999999999995
Q ss_pred CChhhhhhhcCCCCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCC-------------CceEE
Q 045453 138 RTLADHIYQNQPHFEP---LLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEG-------------YIAKL 201 (346)
Q Consensus 138 gsL~~~l~~~~~~~~~---l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~-------------~~~kl 201 (346)
|+|.+++......... .++..++.++.|++.||+||| +.+|+||||||+|||++.+ +.+||
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 6999999765432221 133456789999999999999 8999999999999999754 48999
Q ss_pred eccCCCcccCCCCce---eeccccccCCcCCcccccc-------CCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccc
Q 045453 202 FDFSLSVSIPEGETC---VKDKVTGTMGFLAPEYINT-------GDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIG 270 (346)
Q Consensus 202 ~Dfgl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~ 270 (346)
+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||+| |..||......+.
T Consensus 170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~- 248 (434)
T 2rio_A 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES- 248 (434)
T ss_dssp CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH-
T ss_pred cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH-
Confidence 999999877644322 1234579999999999975 678999999999999999999 9999965432211
Q ss_pred cchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 271 AGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
... . +.. . . ...........+..+.+|+.+||+.||++|||+.||++
T Consensus 249 -------~i~----~-~~~----~--~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 249 -------NII----R-GIF----S--L-DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp -------HHH----H-TCC----C--C-CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------HHh----c-CCC----C--c-ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 111 1 000 0 0 00011122356788999999999999999999999975
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=318.73 Aligned_cols=264 Identities=17% Similarity=0.209 Sum_probs=192.3
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceee-----------
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCL----------- 123 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~----------- 123 (346)
++|...+.||+|+||.||+|.+ +++.||+|++.........++.+|+..+..+ +||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECTTSCBCCC---
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhc-CCCCeeEEEEeccccccccccccc
Confidence 6688899999999999999999 5899999998765555567788899999998 9999999998873
Q ss_pred ---cCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEc-CCCce
Q 045453 124 ---ETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIA 199 (346)
Q Consensus 124 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~-~~~~~ 199 (346)
+....++||||++ |+|.+++.. .++++..++.++.|++.||+||| +.+++||||||+|||++ .++.+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeE
Confidence 4467899999997 599999864 35899999999999999999999 89999999999999997 57799
Q ss_pred EEeccCCCcccCCCCc--eeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhH
Q 045453 200 KLFDFSLSVSIPEGET--CVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWL 276 (346)
Q Consensus 200 kl~Dfgl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~ 276 (346)
||+|||+++....... .......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||......+. .
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~------~ 234 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ------M 234 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------H
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH------H
Confidence 9999999987643221 11234457899999998875 6789999999999999999999999986543221 1
Q ss_pred HHHHHHHhhc---------CccccccccccccCCCCc--chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 277 LHYVKKCIEN---------NEFDEIVDPIIVSEGPRV--GKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 277 ~~~~~~~~~~---------~~~~~~~d~~l~~~~~~~--~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.......... ......+........... ..+..+..+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 1111100000 000000000000000000 00123567899999999999999999999975
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=317.52 Aligned_cols=268 Identities=18% Similarity=0.235 Sum_probs=199.5
Q ss_pred HHhcCCCcccccccCCCcEEEEEEE---CCeEEEEEEecCccC--cchHHHHHHHHHHhhhc--CCCceeeEcceee---
Q 045453 54 IATNNFDARNVIKDGYAYKFYKGFV---EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLS--SHKNVLKLTGCCL--- 123 (346)
Q Consensus 54 ~~~~~f~~~~~ig~G~~g~Vy~~~~---~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~--~h~niv~l~g~~~--- 123 (346)
.+.++|...+.||+|+||.||+|.+ ++..||+|++..... .....+.+|+..+..+. +||||++++++|.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3567899999999999999999998 468899998864332 22234555655554442 8999999999987
Q ss_pred --cCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEE
Q 045453 124 --ETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKL 201 (346)
Q Consensus 124 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl 201 (346)
.....++||||++ |+|.+++..... ..+++..++.++.|++.||.||| +.+++|+||||+|||++.++.+||
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl 161 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKL 161 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEE
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEE
Confidence 5567899999997 599999977542 35899999999999999999999 889999999999999999999999
Q ss_pred eccCCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHH
Q 045453 202 FDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVK 281 (346)
Q Consensus 202 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 281 (346)
+|||+++...... ......+|..|+|||++.+..++.++||||||+++|+|++|..||......+. +....
T Consensus 162 ~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~i~- 232 (326)
T 1blx_A 162 ADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ------LGKIL- 232 (326)
T ss_dssp CSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHH-
T ss_pred ecCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHH-
Confidence 9999987664322 23445789999999999999999999999999999999999999976543221 11111
Q ss_pred HHhhcCccccc---c---ccccccCCCC---cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 282 KCIENNEFDEI---V---DPIIVSEGPR---VGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 282 ~~~~~~~~~~~---~---d~~l~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
........... . .......... .........+.+|+.+||+.+|++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 233 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp HHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11110000000 0 0000000000 000134567889999999999999999999974
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=325.93 Aligned_cols=259 Identities=16% Similarity=0.241 Sum_probs=194.4
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcc---
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIP--- 128 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~--- 128 (346)
.++|...+.||+|+||+||+|.+ +++.||+|++..... .....+.+|+..+..+ +||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSSTTC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhc-CCCCchhhhhheeccCCcccc
Confidence 46788899999999999999998 789999999875432 2345677888888888 999999999999887655
Q ss_pred ---eEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccC
Q 045453 129 ---VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFS 205 (346)
Q Consensus 129 ---~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg 205 (346)
++||||+. ++|.+.+. ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg 189 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFG 189 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred eeEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecC
Confidence 99999997 58888773 24899999999999999999999 8899999999999999999999999999
Q ss_pred CCcccCCCCceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHh
Q 045453 206 LSVSIPEGETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCI 284 (346)
Q Consensus 206 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (346)
+++..... .....+|+.|+|||++.+ ..++.++||||||+++|+|++|..||......+. +.......-
T Consensus 190 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~i~~~~~ 259 (371)
T 4exu_A 190 LARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ------LTQILKVTG 259 (371)
T ss_dssp CC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHHHC
T ss_pred cccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHHHhC
Confidence 99765432 234578999999999987 6799999999999999999999999976543221 111111000
Q ss_pred hcC-ccccccc--------cccccCCCCcch----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 285 ENN-EFDEIVD--------PIIVSEGPRVGK----EKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 285 ~~~-~~~~~~d--------~~l~~~~~~~~~----~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
... .....+. ..+... +.... +.....+.+|+.+||+.||++|||+.|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 260 VPGTEFVQKLNDKAAKSYIQSLPQT-PRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp CCCHHHHTTCSCHHHHHHHHHSCCC-CCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCcHHHHHHhhhhhhhhhhhccCCC-cchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 000 0000000 000000 00000 023467899999999999999999999875
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=320.48 Aligned_cols=207 Identities=17% Similarity=0.246 Sum_probs=172.8
Q ss_pred HHHHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCC-----ceeeEcceee
Q 045453 51 ELEIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHK-----NVLKLTGCCL 123 (346)
Q Consensus 51 ~l~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~-----niv~l~g~~~ 123 (346)
.-....++|...+.||+|+||+||+|.+ +++.||||++.... ....++..|+..+..+..|+ +|+++++++.
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 3344567899999999999999999998 68899999987432 23345566777777664455 4999999999
Q ss_pred cCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEc--CCCceEE
Q 045453 124 ETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLD--EGYIAKL 201 (346)
Q Consensus 124 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~--~~~~~kl 201 (346)
..+..++||||++ |+|.+++..... ..+++..+..++.|++.||.|||+. ..+|+||||||+|||++ .++.+||
T Consensus 127 ~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL 202 (382)
T 2vx3_A 127 FRNHLCLVFEMLS-YNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKI 202 (382)
T ss_dssp ETTEEEEEEECCC-CBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred cCCceEEEEecCC-CCHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEE
Confidence 9999999999996 499999987542 3589999999999999999999932 36899999999999994 5788999
Q ss_pred eccCCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Q 045453 202 FDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRG 266 (346)
Q Consensus 202 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~ 266 (346)
+|||+++..... .....+|+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 203 ~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 203 VDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp CCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999876432 2345789999999999999999999999999999999999999986543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=319.18 Aligned_cols=262 Identities=18% Similarity=0.250 Sum_probs=200.2
Q ss_pred hcCCCcccccccCCCcEEEEEEE---CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCC------ceeeEcceeecCC
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV---EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHK------NVLKLTGCCLETR 126 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~---~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~------niv~l~g~~~~~~ 126 (346)
.++|...+.||+|+||+||+|.+ +++.||+|++... ......+.+|+..+..+ +|+ +++++++++...+
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l-~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHL-NTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHH-HHHCTTCTTCBCCEEEEEEETT
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHh-hhcCCCCceeeEeeecccccCC
Confidence 35788999999999999999987 6789999998643 23345566777777766 554 5999999999999
Q ss_pred cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcC-----------
Q 045453 127 IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE----------- 195 (346)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~----------- 195 (346)
..++||||+ +++|.+++..... .++++..+..++.|++.||+||| +.+|+||||||+|||++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC---
T ss_pred cEEEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCcc
Confidence 999999999 8899999977542 46899999999999999999999 889999999999999987
Q ss_pred --------CCceEEeccCCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc
Q 045453 196 --------GYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGD 267 (346)
Q Consensus 196 --------~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~ 267 (346)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|..||......
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred ccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 678999999999765432 23457899999999999999999999999999999999999999865432
Q ss_pred ccccchhhHHHHHHHHhhcC--------ccccccc-cccc-----------------cCCCCcchHHHHHHHHHHHHHcc
Q 045453 268 EIGAGHYWLLHYVKKCIENN--------EFDEIVD-PIIV-----------------SEGPRVGKEKQLQGFRELALMCV 321 (346)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~--------~~~~~~d-~~l~-----------------~~~~~~~~~~~~~~l~~l~~~cl 321 (346)
+. ........... ....... .... ..............+.+|+.+||
T Consensus 241 ~~-------~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 313 (339)
T 1z57_A 241 EH-------LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKML 313 (339)
T ss_dssp HH-------HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHT
T ss_pred HH-------HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHh
Confidence 21 11111111000 0000000 0000 00000011256778999999999
Q ss_pred cCCCCCCCCHHHHHH
Q 045453 322 CESAEDRPTTVDVAK 336 (346)
Q Consensus 322 ~~~p~~RPs~~ev~~ 336 (346)
+.||++|||+.|+++
T Consensus 314 ~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 314 EYDPAKRITLREALK 328 (339)
T ss_dssp CSSTTTSCCHHHHTT
T ss_pred CcCcccccCHHHHhc
Confidence 999999999999974
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=322.84 Aligned_cols=261 Identities=18% Similarity=0.301 Sum_probs=197.6
Q ss_pred cCCCHHHHHHHhcCCCcccccccCCCcEEEEEEE-CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcC-CCceeeEcc
Q 045453 45 RGFTIRELEIATNNFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSS-HKNVLKLTG 120 (346)
Q Consensus 45 ~~~~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~-h~niv~l~g 120 (346)
+.+.++.+....++|...+.||+|+||.||+|.+ +++.||+|++..... .....+.+|+..+..+.. ||||+++++
T Consensus 16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp ----CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred CCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence 3455555566678899999999999999999998 788999999865432 344667888888888833 699999999
Q ss_pred eeecCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceE
Q 045453 121 CCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAK 200 (346)
Q Consensus 121 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~k 200 (346)
++.+.+..++||| +.+++|.+++.... .+++..++.++.|++.||.||| +.+++||||||+|||+++ +.+|
T Consensus 96 ~~~~~~~~~lv~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~k 166 (313)
T 3cek_A 96 YEITDQYIYMVME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLK 166 (313)
T ss_dssp EEECSSEEEEEEC-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEE
T ss_pred EeecCCEEEEEEe-cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEE
Confidence 9999999999999 55789999998753 6899999999999999999999 889999999999999975 8999
Q ss_pred EeccCCCcccCCCCce-eeccccccCCcCCcccccc-----------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc
Q 045453 201 LFDFSLSVSIPEGETC-VKDKVTGTMGFLAPEYINT-----------GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDE 268 (346)
Q Consensus 201 l~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~ 268 (346)
|+|||++......... ......||+.|+|||.+.+ ..++.++||||||+++|+|++|..||.......
T Consensus 167 L~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (313)
T 3cek_A 167 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 246 (313)
T ss_dssp ECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH
T ss_pred EeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH
Confidence 9999999876543321 2234568999999999875 468899999999999999999999997543311
Q ss_pred cccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 269 IGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
. ...... ++......+. .....+.+++.+||+.+|++|||+.|+++
T Consensus 247 ~---------~~~~~~---------~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 247 S---------KLHAII---------DPNHEIEFPD----IPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp H---------HHHHHH---------CTTSCCCCCC----CSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred H---------HHHHHH---------hcccccCCcc----cchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 1 111111 1111111111 12356889999999999999999999985
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=313.57 Aligned_cols=249 Identities=22% Similarity=0.324 Sum_probs=201.2
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
.++|...+.||+|+||.||+|.. +++.||+|.+.... ......+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-cCCCccEEEEEEeCCCeEEEE
Confidence 46688999999999999999999 68899999986543 23456788899999998 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCC---CceEEeccCCCc
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEG---YIAKLFDFSLSV 208 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~---~~~kl~Dfgl~~ 208 (346)
|||+++++|.+++.... .+++..++.++.|++.||.||| +.+++|+||||+||+++.+ +.+||+|||++.
T Consensus 100 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 100 GELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp ECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 99999999999987653 5899999999999999999999 8899999999999999754 479999999987
Q ss_pred ccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCc
Q 045453 209 SIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE 288 (346)
Q Consensus 209 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (346)
....... .....+|+.|+|||.+.+ .++.++||||||+++|+|++|..||......+ ....+ ..+.
T Consensus 173 ~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~----~~~~ 238 (287)
T 2wei_A 173 CFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-------ILKRV----ETGK 238 (287)
T ss_dssp TBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHH----HHCC
T ss_pred eecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH-------HHHHH----HcCC
Confidence 7654332 233458899999998875 58999999999999999999999997643221 11111 1111
Q ss_pred cccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 289 FDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 289 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
... +.+.....+..+.+++.+||+.+|++|||+.|+++
T Consensus 239 ~~~----------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 239 YAF----------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CCC----------CSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCC----------CchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 100 00001133456889999999999999999999987
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=317.65 Aligned_cols=250 Identities=20% Similarity=0.337 Sum_probs=189.8
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeec---------
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLE--------- 124 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~--------- 124 (346)
.++|...+.||+|+||.||+|.. ++..||+|.+... ......+.+|+..+..+ +||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASL-NHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEECCCCCC---
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhc-CchHHHHHHHHHHhhcchhhhhc
Confidence 46788899999999999999998 7889999998642 23446677888888888 99999999998865
Q ss_pred ----CCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceE
Q 045453 125 ----TRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAK 200 (346)
Q Consensus 125 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~k 200 (346)
.+..++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+++|+||||+|||++.++.+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEE
Confidence 356799999999999999998654 46888999999999999999999 88999999999999999999999
Q ss_pred EeccCCCcccCCCC-------------ceeeccccccCCcCCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCC
Q 045453 201 LFDFSLSVSIPEGE-------------TCVKDKVTGTMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRG 266 (346)
Q Consensus 201 l~Dfgl~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~ 266 (346)
|+|||++....... ........||..|+|||.+.+. .++.++||||||+++|+|++ ||.....
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~ 233 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME 233 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence 99999987664321 1112345689999999999864 68999999999999999998 4432110
Q ss_pred cccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 267 DEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
........ .... ...... .....+..+.+++.+||+.||++|||+.++++
T Consensus 234 ---------~~~~~~~~-~~~~------~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 234 ---------RVNILKKL-RSVS------IEFPPD----FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp ---------HHHHHHHH-HSTT------CCCCTT----CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------HHHHHHhc-cccc------cccCcc----ccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 11111111 1110 000011 11134456889999999999999999999985
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=320.06 Aligned_cols=263 Identities=17% Similarity=0.188 Sum_probs=197.6
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecC-----Cc
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLET-----RI 127 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~-----~~ 127 (346)
.++|...+.||+|+||.||+|.+ +++.||||++..... .....+.+|+..+..+ +||||+++++++... ..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF-KHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCSTTCCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhC-cCCCcCCeeeeecccccCccce
Confidence 46788999999999999999998 689999999865432 2345667888888888 999999999988654 67
Q ss_pred ceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCC
Q 045453 128 PVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS 207 (346)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~ 207 (346)
.++||||+. ++|.+++... .+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||++
T Consensus 89 ~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp EEEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccc
Confidence 899999997 5999998763 5899999999999999999999 889999999999999999999999999999
Q ss_pred cccCCCCce---------eeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHH
Q 045453 208 VSIPEGETC---------VKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLL 277 (346)
Q Consensus 208 ~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~ 277 (346)
......... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||......+. +
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~- 232 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ------L- 232 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------H-
T ss_pred cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH------H-
Confidence 876532211 1123468999999998765 6789999999999999999999999986542211 1
Q ss_pred HHHHHHhhcCccccc---c-cc-------ccccCCCCcc----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 278 HYVKKCIENNEFDEI---V-DP-------IIVSEGPRVG----KEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 278 ~~~~~~~~~~~~~~~---~-d~-------~l~~~~~~~~----~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
..+............ + .. .+.. .+... .+..+..+.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 233 LLIFGIIGTPHSDNDLRCIESPRAREYIKSLPM-YPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCC-CCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhCCCchhccccccccchhhHHhhcccC-CCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 111111110000000 0 00 0000 00000 0123466889999999999999999999975
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=323.60 Aligned_cols=268 Identities=15% Similarity=0.185 Sum_probs=197.1
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhc----------CCCceeeEcceee
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLS----------SHKNVLKLTGCCL 123 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~----------~h~niv~l~g~~~ 123 (346)
.++|...+.||+|+||+||+|.+ +++.||+|.+.... .....+.+|+..+..+. .||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 36788999999999999999998 78999999987432 23445667777777662 2899999999987
Q ss_pred cCC----cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CceecCCCCCCeEEc----
Q 045453 124 ETR----IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSR-PILHRKIRPSRIFLD---- 194 (346)
Q Consensus 124 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~iiH~dlkp~NIll~---- 194 (346)
..+ ..++||||+ +++|.+++..... ..+++..++.++.|++.||.||| +. +|+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEET
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhc--cCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCC
Confidence 654 789999999 8899999986532 35899999999999999999999 77 999999999999994
Q ss_pred --CCCceEEeccCCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccc
Q 045453 195 --EGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAG 272 (346)
Q Consensus 195 --~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~ 272 (346)
.++.+||+|||++...... .....+|+.|+|||++.+..++.++||||||+++|||+||..||...........
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 4458999999999776432 2345789999999999999999999999999999999999999987654332211
Q ss_pred hhhHHHHHHHHhhc-------C----------ccccccc--------cccccCCCCcchHHHHHHHHHHHHHcccCCCCC
Q 045453 273 HYWLLHYVKKCIEN-------N----------EFDEIVD--------PIIVSEGPRVGKEKQLQGFRELALMCVCESAED 327 (346)
Q Consensus 273 ~~~~~~~~~~~~~~-------~----------~~~~~~d--------~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~ 327 (346)
...+.......-.. . .....+. ..+.... .........+.+|+.+||+.||++
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKY--KFSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTT--CCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcc--cCCcchHHHHHHHHHHHhccCccc
Confidence 11222222111000 0 0000000 0000000 112366788999999999999999
Q ss_pred CCCHHHHHH
Q 045453 328 RPTTVDVAK 336 (346)
Q Consensus 328 RPs~~ev~~ 336 (346)
|||+.|+++
T Consensus 325 Rpt~~ell~ 333 (373)
T 1q8y_A 325 RADAGGLVN 333 (373)
T ss_dssp CBCHHHHHT
T ss_pred cCCHHHHhh
Confidence 999999975
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=313.45 Aligned_cols=252 Identities=21% Similarity=0.350 Sum_probs=179.8
Q ss_pred HhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
..++|...+.||+|+||.||+|.+ +++.||+|++..... ....+...++..+....+||||+++++++.+.+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 356788889999999999999999 688999999875543 23344555555545555999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CceecCCCCCCeEEcCCCceEEeccCCCccc
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSR-PILHRKIRPSRIFLDEGYIAKLFDFSLSVSI 210 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~ 210 (346)
|||+ ++.+..+..... ..+++..++.++.+++.||.||| +. +++|+||||+|||++.++.+||+|||++...
T Consensus 103 ~e~~-~~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRMQ---GPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL 175 (318)
T ss_dssp ECCC-SEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred Eecc-CCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence 9999 545555554432 46899999999999999999999 74 9999999999999999999999999998766
Q ss_pred CCCCceeeccccccCCcCCccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhh
Q 045453 211 PEGETCVKDKVTGTMGFLAPEYIN-----TGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIE 285 (346)
Q Consensus 211 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (346)
..... .....+|+.|+|||.+. ...++.++||||||+++|+|++|..||....... ........
T Consensus 176 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---------~~~~~~~~ 244 (318)
T 2dyl_A 176 VDDKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF---------EVLTKVLQ 244 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH---------HHHHHHHH
T ss_pred cCCcc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH---------HHHHHHhc
Confidence 43322 23456899999999994 4568999999999999999999999997543321 11111111
Q ss_pred cCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 286 NNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 286 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
... +.+.. ....+..+.+++.+||+.||.+|||+.|+++
T Consensus 245 ~~~------~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 245 EEP------PLLPG------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp SCC------CCCCS------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cCC------CCCCc------cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 110 00000 0023456889999999999999999999976
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=317.07 Aligned_cols=258 Identities=15% Similarity=0.212 Sum_probs=194.2
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecCCc----
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRI---- 127 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~---- 127 (346)
.++|...+.||+|+||.||+|.+ +++.||||++..... .....+.+|+..+..+ +||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCcccHhheEecccccccc
Confidence 36788899999999999999998 789999999875432 2345677888888888 99999999999987654
Q ss_pred --ceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccC
Q 045453 128 --PVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFS 205 (346)
Q Consensus 128 --~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg 205 (346)
.++||||+. ++|.+++.. .+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg 171 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFG 171 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTT
T ss_pred eeEEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecc
Confidence 499999997 588887742 4899999999999999999999 8899999999999999999999999999
Q ss_pred CCcccCCCCceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHh
Q 045453 206 LSVSIPEGETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCI 284 (346)
Q Consensus 206 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (346)
+++..... .....+|+.|+|||.+.+ ..++.++||||||+++|+|++|..||......+. +..... ..
T Consensus 172 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~------~~~i~~-~~ 240 (353)
T 3coi_A 172 LARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ------LTQILK-VT 240 (353)
T ss_dssp CTTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH------HHHHHH-HH
T ss_pred cccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHH-Hh
Confidence 98765432 234578999999999987 6789999999999999999999999976543211 111111 00
Q ss_pred hcCc------c-----ccccc---cccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 285 ENNE------F-----DEIVD---PIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 285 ~~~~------~-----~~~~d---~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.... . ...+. ......... ........+.+|+.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 241 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp CBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTT-TCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHH-hcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000 0 00000 000000000 01134567899999999999999999999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=319.23 Aligned_cols=248 Identities=19% Similarity=0.289 Sum_probs=198.7
Q ss_pred CHHHHHHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCc------chHHHHHHHHHHhhhc-CCCceeeE
Q 045453 48 TIRELEIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILND------GHEDCFNNIIFASKLS-SHKNVLKL 118 (346)
Q Consensus 48 ~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~------~~~~~~~e~~~~~~~~-~h~niv~l 118 (346)
..++.....++|...+.||+|+||.||+|.+ ++..||||.+...... ....+.+|+..+..+. .||||+++
T Consensus 34 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~ 113 (320)
T 3a99_A 34 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 113 (320)
T ss_dssp ------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred cccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEE
Confidence 3345555678899999999999999999998 7899999998754321 2244567888888883 26999999
Q ss_pred cceeecCCcceEEEecccC-CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEc-CC
Q 045453 119 TGCCLETRIPVIVFESVKN-RTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLD-EG 196 (346)
Q Consensus 119 ~g~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~-~~ 196 (346)
++++...+..++|+|++.+ ++|.+++.... .+++..++.++.|++.||.||| +.+|+||||||+|||++ .+
T Consensus 114 ~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~ 186 (320)
T 3a99_A 114 LDWFERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNR 186 (320)
T ss_dssp EEEEECSSEEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTT
T ss_pred EEEEecCCcEEEEEEcCCCCccHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCC
Confidence 9999999999999999976 89999998753 5899999999999999999999 89999999999999999 78
Q ss_pred CceEEeccCCCcccCCCCceeeccccccCCcCCccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhh
Q 045453 197 YIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDF-NEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYW 275 (346)
Q Consensus 197 ~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~ 275 (346)
+.+||+|||+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|..||.....
T Consensus 187 ~~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--------- 254 (320)
T 3a99_A 187 GELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------- 254 (320)
T ss_dssp TEEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------
T ss_pred CCEEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh---------
Confidence 999999999998765432 234568999999999987776 7889999999999999999999963210
Q ss_pred HHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 276 LLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
... ... ... ...+..+.+|+.+||+.+|++|||+.|+++
T Consensus 255 -------~~~-~~~------~~~--------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 255 -------IIR-GQV------FFR--------QRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp -------HHH-CCC------CCS--------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------hhc-ccc------ccc--------ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 000 000 023456889999999999999999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=315.53 Aligned_cols=246 Identities=20% Similarity=0.273 Sum_probs=188.7
Q ss_pred HHHHHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCc------chHHHHHHHHHHhhhc---CCCceeeE
Q 045453 50 RELEIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILND------GHEDCFNNIIFASKLS---SHKNVLKL 118 (346)
Q Consensus 50 ~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~------~~~~~~~e~~~~~~~~---~h~niv~l 118 (346)
++.....++|...+.||+|+||.||+|.+ +++.||+|.+...... ....+.+|+..+..+. +||||+++
T Consensus 24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~ 103 (312)
T 2iwi_A 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103 (312)
T ss_dssp ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence 44556678899999999999999999998 7889999998654321 1223445666666664 79999999
Q ss_pred cceeecCCcceEEEec-ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEc-CC
Q 045453 119 TGCCLETRIPVIVFES-VKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLD-EG 196 (346)
Q Consensus 119 ~g~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~-~~ 196 (346)
++++...+..++|+|| +.+++|.+++.... .+++..++.++.|++.||.||| +.+++||||||+|||++ .+
T Consensus 104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~ 176 (312)
T 2iwi_A 104 LDWFETQEGFMLVLERPLPAQDLFDYITEKG----PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRR 176 (312)
T ss_dssp EEEC-----CEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTT
T ss_pred EEEEecCCeEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCC
Confidence 9999999999999999 78899999998753 5899999999999999999999 88999999999999999 89
Q ss_pred CceEEeccCCCcccCCCCceeeccccccCCcCCccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhh
Q 045453 197 YIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDF-NEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYW 275 (346)
Q Consensus 197 ~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~ 275 (346)
+.+||+|||++....... .....||..|+|||++.+..+ +.++||||||+++|+|++|+.||.....
T Consensus 177 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------- 244 (312)
T 2iwi_A 177 GCAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE--------- 244 (312)
T ss_dssp TEEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------
T ss_pred CeEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH---------
Confidence 999999999998765432 234568999999999987776 4589999999999999999999963210
Q ss_pred HHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 276 LLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
. .. . ... . .......+.+++.+||+.+|++|||+.|+++
T Consensus 245 ---~----~~-~--------~~~--~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 245 ---I----LE-A--------ELH--F----PAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp ---H----HH-T--------CCC--C----CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---H----hh-h--------ccC--C----cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00 0 000 0 0123456889999999999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=312.99 Aligned_cols=262 Identities=16% Similarity=0.221 Sum_probs=198.0
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CC-eEEEEEEecCccCcchHHHHHHHHHHhhhcCCCc------eeeEcceeecCC
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--ED-RTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKN------VLKLTGCCLETR 126 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~-~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~n------iv~l~g~~~~~~ 126 (346)
.++|...+.||+|+||+||+|.+ ++ ..||+|.+... ......+.+|+..+..+ +|+| ++.+++++...+
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKI-KEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHH-HHHCTTSCSCBCCEEEEEEETT
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHH-hhcCCCCceeEEEeeeeeeeCC
Confidence 46788999999999999999998 34 78999998643 23345566777777777 6655 999999999999
Q ss_pred cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEE-------------
Q 045453 127 IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFL------------- 193 (346)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll------------- 193 (346)
..++||||+ +++|.+++..... .++++..++.++.|++.||.||| +.+|+||||||+|||+
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eEEEEEecc-CCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccccc
Confidence 999999999 6677777766432 46999999999999999999999 8999999999999999
Q ss_pred ------cCCCceEEeccCCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc
Q 045453 194 ------DEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGD 267 (346)
Q Consensus 194 ------~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~ 267 (346)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|..||......
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 67889999999999765432 23457899999999999999999999999999999999999999865432
Q ss_pred ccccchhhHHHHHHHHhhcC--------cccccc-cccccc-----------------CCCCcchHHHHHHHHHHHHHcc
Q 045453 268 EIGAGHYWLLHYVKKCIENN--------EFDEIV-DPIIVS-----------------EGPRVGKEKQLQGFRELALMCV 321 (346)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~--------~~~~~~-d~~l~~-----------------~~~~~~~~~~~~~l~~l~~~cl 321 (346)
+. ...+....... ...... ...... .............+.+|+.+||
T Consensus 246 ~~-------~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 318 (355)
T 2eu9_A 246 EH-------LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRML 318 (355)
T ss_dssp HH-------HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHT
T ss_pred HH-------HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHh
Confidence 21 11111111000 000000 000000 0000111245668999999999
Q ss_pred cCCCCCCCCHHHHHH
Q 045453 322 CESAEDRPTTVDVAK 336 (346)
Q Consensus 322 ~~~p~~RPs~~ev~~ 336 (346)
+.||++|||+.|+++
T Consensus 319 ~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 319 EFDPAQRITLAEALL 333 (355)
T ss_dssp CSSTTTSCCHHHHTT
T ss_pred cCChhhCcCHHHHhc
Confidence 999999999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=327.26 Aligned_cols=251 Identities=21% Similarity=0.306 Sum_probs=187.7
Q ss_pred HHhcCCCcccccccCCCcEE-EEEEECCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 54 IATNNFDARNVIKDGYAYKF-YKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 54 ~~~~~f~~~~~ig~G~~g~V-y~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
....+|...++||+|+||+| |++..+++.||||++..... ....+|+..+..+.+|||||++++++.+....++||
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 34456888899999999985 55666999999999865432 234578888888768999999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcC-----CCceEEeccCCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE-----GYIAKLFDFSLS 207 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~-----~~~~kl~Dfgl~ 207 (346)
||+. |+|.+++..... ...+..++.++.|++.||.||| +.+|+||||||+|||++. ...+||+|||++
T Consensus 98 E~~~-g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKDF---AHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp ECCS-EEHHHHHHSSSC---CCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred ECCC-CCHHHHHHhcCC---CccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 9996 599999986542 3444566789999999999999 899999999999999953 336789999999
Q ss_pred cccCCCCc--eeeccccccCCcCCccccc---cCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHH
Q 045453 208 VSIPEGET--CVKDKVTGTMGFLAPEYIN---TGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVK 281 (346)
Q Consensus 208 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 281 (346)
+....... .......||+.|+|||++. ...++.++|||||||++|||+| |..||........ .
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-----------~ 239 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-----------N 239 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-----------H
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-----------H
Confidence 87654322 2234567999999999998 4567889999999999999999 9999964332111 0
Q ss_pred HHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 282 KCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 282 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
........ ... .........+.+|+.+||+.||++|||+.||++
T Consensus 240 ~~~~~~~~----------~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 240 ILLGACSL----------DCL-HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp HHTTCCCC----------TTS-CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhccCCc----------ccc-CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 00000000 000 011145566889999999999999999999983
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=337.53 Aligned_cols=271 Identities=20% Similarity=0.270 Sum_probs=203.6
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeec------CCc
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLE------TRI 127 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~------~~~ 127 (346)
++|...+.||+|+||+||+|.+ ++..||||++..... .....+.+|+..+..+ +||||+++++++.. ++.
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHC-CBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCceeeeecccccccCCCe
Confidence 6799999999999999999998 789999999875433 3455678889999888 99999999999765 677
Q ss_pred ceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCc---eEEecc
Q 045453 128 PVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYI---AKLFDF 204 (346)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~---~kl~Df 204 (346)
.++||||+++|+|.+++..... ...+++..++.++.+++.||+||| +.+|+||||||+|||++.++. +||+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEccc
Confidence 8999999999999999976432 235889999999999999999999 899999999999999997664 999999
Q ss_pred CCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHh
Q 045453 205 SLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCI 284 (346)
Q Consensus 205 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (346)
|++........ .....||+.|+|||.+.+..++.++||||||+++|+|++|..||....... .|.....
T Consensus 169 G~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~---------~~~~~i~ 237 (676)
T 3qa8_A 169 GYAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV---------QWHGKVR 237 (676)
T ss_dssp CCCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH---------HSSTTCC
T ss_pred ccccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh---------hhhhhhh
Confidence 99987654432 344678999999999999999999999999999999999999997542111 0000000
Q ss_pred hcC----ccccccccccc--c--CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHH-----HHHHHHHHHH
Q 045453 285 ENN----EFDEIVDPIIV--S--EGPRVGKEKQLQGFRELALMCVCESAEDRPTTVD-----VAKRLKQIYQ 343 (346)
Q Consensus 285 ~~~----~~~~~~d~~l~--~--~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e-----v~~~L~~i~~ 343 (346)
... .........+. . ..+.......+..+.+++..||+.||++|||+.| +.+.++++++
T Consensus 238 ~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 238 EKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp ------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred cccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 000 00000000000 0 0011112246788999999999999999999988 6677776654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=299.81 Aligned_cols=228 Identities=12% Similarity=0.029 Sum_probs=183.5
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCc---chHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILND---GHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~---~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
+.|...+.||+|+||.||+|.+ +++.||+|.+...... ....+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-CCCCcceeeEEEEECCcEEEE
Confidence 5688999999999999999999 5899999998765432 236678888888888 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+++++|.+++... ....+...++.|++.||.||| +.+|+||||||+|||++.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred EEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc------
Confidence 9999999999999542 355578899999999999999 8999999999999999999999998543
Q ss_pred CCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccc
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDE 291 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (346)
|++ .++.++||||||+++|||+||+.||......+.. .
T Consensus 175 ---------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~--------------------~ 212 (286)
T 3uqc_A 175 ---------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL--------------------A 212 (286)
T ss_dssp ---------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS--------------------E
T ss_pred ---------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh--------------------H
Confidence 333 3789999999999999999999999876543310 0
Q ss_pred ccccccccCCCCc--chHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 045453 292 IVDPIIVSEGPRV--GKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQ 343 (346)
Q Consensus 292 ~~d~~l~~~~~~~--~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 343 (346)
.....+....... .....+..+.+++.+||+.||++| |+.|+++.|+++..
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 213 PAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp ECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred HHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 0000011110000 001344668999999999999999 99999999998764
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=335.18 Aligned_cols=241 Identities=20% Similarity=0.265 Sum_probs=195.0
Q ss_pred hcCCCcccccccCCCcEEEEEEE---CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCc----
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV---EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRI---- 127 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~---~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~---- 127 (346)
.++|...+.||+|+||+||+|.+ +++.||||++..... .....+.+|...+..+ +||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV-VHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhc-CCCCcCeEeeeEeecCCCCCc
Confidence 47899999999999999999998 578999999865433 3344567888888888 99999999999987665
Q ss_pred -ceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCC
Q 045453 128 -PVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSL 206 (346)
Q Consensus 128 -~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl 206 (346)
.++||||+++++|.+++.. .++|..++.++.|++.||.||| +.+|+||||||+|||++.+ .+||+|||+
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp EEEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred eeEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEeccc
Confidence 6999999999999987743 5899999999999999999999 8999999999999999986 899999999
Q ss_pred CcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhc
Q 045453 207 SVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIEN 286 (346)
Q Consensus 207 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (346)
++..... ....||++|+|||++.++ ++.++||||||+++|+|++|..||........
T Consensus 228 a~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------------- 284 (681)
T 2pzi_A 228 VSRINSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------------- 284 (681)
T ss_dssp CEETTCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC-----------------
T ss_pred chhcccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc-----------------
Confidence 9876543 345799999999998765 48999999999999999999988864221111
Q ss_pred CccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHHHHHHHHh
Q 045453 287 NEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPT-TVDVAKRLKQIYQH 344 (346)
Q Consensus 287 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~ev~~~L~~i~~~ 344 (346)
. ...........+.+++.+||+.||++||+ ++++...|..+.+.
T Consensus 285 -----------~---~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 329 (681)
T 2pzi_A 285 -----------P---EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE 329 (681)
T ss_dssp -----------C---TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred -----------c---ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence 0 00011134467889999999999999995 77788888777653
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=298.92 Aligned_cols=228 Identities=18% Similarity=0.301 Sum_probs=179.4
Q ss_pred cCCCcc-cccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeec----CCcce
Q 045453 57 NNFDAR-NVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLE----TRIPV 129 (346)
Q Consensus 57 ~~f~~~-~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~----~~~~~ 129 (346)
++|... +.||+|+||.||+|.+ ++..||+|.+.. .....+|+..+.+..+||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 556665 7799999999999998 788999999863 34567788888677699999999999876 67789
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcC---CCceEEeccCC
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE---GYIAKLFDFSL 206 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~---~~~~kl~Dfgl 206 (346)
+||||+++|+|.+++..... ..+++..++.++.|++.||.||| +.+++||||||+|||++. ++.+||+|||+
T Consensus 92 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 99999999999999987542 46999999999999999999999 899999999999999998 88999999998
Q ss_pred CcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhc
Q 045453 207 SVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIEN 286 (346)
Q Consensus 207 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (346)
+.... +..++.++||||||+++|||++|..||.........
T Consensus 167 a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~---------------- 207 (299)
T 3m2w_A 167 AKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---------------- 207 (299)
T ss_dssp CEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----------------------
T ss_pred ccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh----------------
Confidence 85432 245788999999999999999999999765432210
Q ss_pred CccccccccccccCCCCcch--HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 287 NEFDEIVDPIIVSEGPRVGK--EKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 287 ~~~~~~~d~~l~~~~~~~~~--~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
..............+.. ...+..+.+++..||+.||++|||+.|+++
T Consensus 208 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 208 ---PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp ---CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---HHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00000001111111100 134567999999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=316.69 Aligned_cols=242 Identities=16% Similarity=0.129 Sum_probs=179.2
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCC-CceeeEc----------
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSH-KNVLKLT---------- 119 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h-~niv~l~---------- 119 (346)
+.+|...+.||+|+||+||+|.+ +++.||||++..... .....+.+|+..+..+ +| +|.....
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l-~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL-RGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGS-TTCCSHHHHHHHTCBCCCCE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhh-ccCCCHHHHHHhcccccchh
Confidence 34577778999999999999998 689999999874332 2345667777777766 65 3221111
Q ss_pred -----------ceeec-----CCcceEEEecccCCChhhhhhhc---CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 045453 120 -----------GCCLE-----TRIPVIVFESVKNRTLADHIYQN---QPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRP 180 (346)
Q Consensus 120 -----------g~~~~-----~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ 180 (346)
.++.. ....+++|+++ +++|.+++... .....++++..++.++.|++.||+||| +.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYG 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCC
Confidence 11111 22456777766 67999988421 112246889999999999999999999 899
Q ss_pred ceecCCCCCCeEEcCCCceEEeccCCCcccCCCCceeeccccccCCcCCcccc----------ccCCCCcccchHHHHHH
Q 045453 181 ILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYI----------NTGDFNEKCDVFSFGML 250 (346)
Q Consensus 181 iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~s~G~v 250 (346)
|+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||+
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 999999999999999999999999998765432 344567 999999999 55568899999999999
Q ss_pred HHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCC
Q 045453 251 LLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPT 330 (346)
Q Consensus 251 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs 330 (346)
+|||+||+.||......+. .+..+.... ..+..+.+|+.+||+.+|++|||
T Consensus 307 l~elltg~~Pf~~~~~~~~-----------------------~~~~~~~~~------~~~~~~~~li~~~l~~dP~~Rpt 357 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGG-----------------------SEWIFRSCK------NIPQPVRALLEGFLRYPKEDRLL 357 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSC-----------------------SGGGGSSCC------CCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHHCCCCCCCcchhhh-----------------------HHHHHhhcc------cCCHHHHHHHHHHccCChhhCcC
Confidence 9999999999976443221 111111111 22356889999999999999999
Q ss_pred HHHHHH
Q 045453 331 TVDVAK 336 (346)
Q Consensus 331 ~~ev~~ 336 (346)
+.++++
T Consensus 358 ~~~~l~ 363 (413)
T 3dzo_A 358 PLQAME 363 (413)
T ss_dssp HHHHTT
T ss_pred HHHHHh
Confidence 888854
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=297.70 Aligned_cols=244 Identities=13% Similarity=0.125 Sum_probs=182.2
Q ss_pred hcCCCcccccccCCCcEEEEEEECCeEEEEEEecCcc--------CcchHHHHHHHHHHhhhc--------CCCceeeE-
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDIL--------NDGHEDCFNNIIFASKLS--------SHKNVLKL- 118 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~--------~~~~~~~~~e~~~~~~~~--------~h~niv~l- 118 (346)
.++|...+.||+|+||+||+|.++++.||||++.... ......+.+|+.++..+. +|||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 4668888999999999999999999999999987543 123367788888888773 25555554
Q ss_pred ----------------cceeec-------------CCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHH
Q 045453 119 ----------------TGCCLE-------------TRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANA 169 (346)
Q Consensus 119 ----------------~g~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~ 169 (346)
++++.+ .+..++||||+++|++.+.+.. ..+++..++.++.|++.|
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHHH
Confidence 444443 6789999999999987777744 358999999999999999
Q ss_pred HHHHHhCCCCCceecCCCCCCeEEcCCC--------------------ceEEeccCCCcccCCCCceeeccccccCCcCC
Q 045453 170 IAYLHIGFSRPILHRKIRPSRIFLDEGY--------------------IAKLFDFSLSVSIPEGETCVKDKVTGTMGFLA 229 (346)
Q Consensus 170 L~~LH~~~~~~iiH~dlkp~NIll~~~~--------------------~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~a 229 (346)
|+|||+ +.+|+||||||+|||++.++ .+||+|||+|+.... ....||+.|+|
T Consensus 174 L~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------~~~~gt~~y~a 245 (336)
T 2vuw_A 174 LAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------GIVVFCDVSMD 245 (336)
T ss_dssp HHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------TEEECCCCTTC
T ss_pred HHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------CcEEEeecccC
Confidence 999993 36899999999999999887 999999999986643 23479999999
Q ss_pred ccccccCCCCcccchHHHHHH-HHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHH
Q 045453 230 PEYINTGDFNEKCDVFSFGML-LLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEK 308 (346)
Q Consensus 230 PE~~~~~~~~~~~Dv~s~G~v-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 308 (346)
||++.+.. +.++||||++++ .+++++|..||... .+............... ..........
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---------~~~~~~~~~~~~~~~~~--------~~~~~~~~~~ 307 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV---------LWLHYLTDKMLKQMTFK--------TKCNTPAMKQ 307 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---------HHHHHHHHHHHHTCCCS--------SCCCSHHHHH
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcch---------hhhhHHHHhhhhhhccC--------cccchhhhhh
Confidence 99998666 899999998777 77788899988420 00011111111111100 1111112336
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHH
Q 045453 309 QLQGFRELALMCVCESAEDRPTTVDVA 335 (346)
Q Consensus 309 ~~~~l~~l~~~cl~~~p~~RPs~~ev~ 335 (346)
.+..+.+|+.+||+.+ |+.|++
T Consensus 308 ~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 308 IKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred cCHHHHHHHHHHhccC-----CHHHHH
Confidence 7788999999999976 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-33 Score=273.84 Aligned_cols=184 Identities=14% Similarity=0.101 Sum_probs=130.4
Q ss_pred cccCCCcEEEEEEE--CCeEEEEEEecCccC----------cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 65 IKDGYAYKFYKGFV--EDRTVSVMKFNDILN----------DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 65 ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~----------~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
.+.|+.|.+..++. .|+.+++|.+..... ....++.+|+.++.++..|+||+++++++.+++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 45666666665544 788999999875421 234568899999999988999999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
||++|++|.++|.... +++.. .|+.||+.||+|+| +.|||||||||+|||++.+|.+||+|||+|+....
T Consensus 322 Eyv~G~~L~d~i~~~~----~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGE----EIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp ECCCSEEHHHHHHTTC----CCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred ecCCCCcHHHHHHhCC----CCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 9999999999997653 45543 58899999999999 99999999999999999999999999999987754
Q ss_pred CCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCC
Q 045453 213 GETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKI 260 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p 260 (346)
... .....+||++|||||++.+ .+..++|+||+|++++++.++..+
T Consensus 392 ~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 332 2345679999999999874 567789999999998877655433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.9e-30 Score=249.35 Aligned_cols=185 Identities=14% Similarity=0.104 Sum_probs=148.8
Q ss_pred CcccccccCCCcEEEEEEECCeEEEEEEecCccCc--------chHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 60 DARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILND--------GHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 60 ~~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~--------~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
...+.||+|+||+||+|.+.+..+++|+....... ...++.+|+..+..+ +||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALV-KDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHG-GGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhc-CCCCcCceEEEEEeCCccEEE
Confidence 34578999999999999889999999986543211 123468899999998 999999777777788888999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+++++|.+++.. +..++.|++.||.||| +.+|+||||||+|||++. .+||+|||+++...
T Consensus 418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 999999999999864 4579999999999999 899999999999999999 99999999998875
Q ss_pred CCCcee------eccccccCCcCCcccccc--CCCCcccchHHHHHHHHHHHhCCCCCC
Q 045453 212 EGETCV------KDKVTGTMGFLAPEYINT--GDFNEKCDVFSFGMLLLVLLTGQKIFD 262 (346)
Q Consensus 212 ~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~~ 262 (346)
...... .....||+.|||||++.. ..|+..+|+||..+-..+.+.++.+|.
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 433211 135679999999999987 678899999999999999998887764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-25 Score=198.99 Aligned_cols=148 Identities=12% Similarity=0.050 Sum_probs=117.0
Q ss_pred HHhcCCCcccccccCCCcEEEEEEE-CCeEEEEEEecCccC------------------cchHHHHHHHHHHhhhcCCCc
Q 045453 54 IATNNFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILN------------------DGHEDCFNNIIFASKLSSHKN 114 (346)
Q Consensus 54 ~~~~~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~------------------~~~~~~~~e~~~~~~~~~h~n 114 (346)
.....|...+.||+|+||.||+|.+ +++.||+|.+..... .....+.+|+..+..+ + |
T Consensus 87 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l-~--~ 163 (282)
T 1zar_A 87 RSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-Q--G 163 (282)
T ss_dssp HTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-T--T
T ss_pred hCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc-c--C
Confidence 3344455669999999999999999 789999999864321 1234578899999988 5 5
Q ss_pred eeeEcceeecCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEc
Q 045453 115 VLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLD 194 (346)
Q Consensus 115 iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~ 194 (346)
+++.+++.. +..++||||+++++|.+ +.. .....++.|++.||.||| +.+|+||||||+|||++
T Consensus 164 -~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~ 227 (282)
T 1zar_A 164 -LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS 227 (282)
T ss_dssp -SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE
T ss_pred -CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE
Confidence 666665544 56799999999999998 522 123469999999999999 89999999999999999
Q ss_pred CCCceEEeccCCCcccCCCCceeeccccccCCcCCcccccc
Q 045453 195 EGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINT 235 (346)
Q Consensus 195 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 235 (346)
++.+||+|||+++. +..++|||++..
T Consensus 228 -~~~vkl~DFG~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 228 -EEGIWIIDFPQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp -TTEEEECCCTTCEE--------------TTSTTHHHHHHH
T ss_pred -CCcEEEEECCCCeE--------------CCCCCHHHHHHH
Confidence 99999999999853 234688988753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=5.6e-21 Score=168.14 Aligned_cols=136 Identities=12% Similarity=0.064 Sum_probs=102.1
Q ss_pred CCcccccccCCCcEEEEEEE--CCeE--EEEEEecCccCcc------------------------hHHHHHHHHHHhhhc
Q 045453 59 FDARNVIKDGYAYKFYKGFV--EDRT--VSVMKFNDILNDG------------------------HEDCFNNIIFASKLS 110 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~~--~~~~--vavk~~~~~~~~~------------------------~~~~~~e~~~~~~~~ 110 (346)
|.....||+|+||.||+|.+ +|.. ||||.+....... ...+.+|...+..+
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l- 127 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA- 127 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH-
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH-
Confidence 45678899999999999998 8888 9999865431110 12467788888888
Q ss_pred CCCce--eeEcceeecCCcceEEEecccC-C----ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcee
Q 045453 111 SHKNV--LKLTGCCLETRIPVIVFESVKN-R----TLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILH 183 (346)
Q Consensus 111 ~h~ni--v~l~g~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH 183 (346)
.|+|+ +.++++ +..+|||||+.+ | +|.+.... .++.....++.|++.||.|||. ..+|+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~--~~givH 194 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQ--EAELVH 194 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHH--TSCEEC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHH--HCCEEe
Confidence 77654 333332 357899999942 4 55554422 2344667899999999999995 568999
Q ss_pred cCCCCCCeEEcCCCceEEeccCCCccc
Q 045453 184 RKIRPSRIFLDEGYIAKLFDFSLSVSI 210 (346)
Q Consensus 184 ~dlkp~NIll~~~~~~kl~Dfgl~~~~ 210 (346)
|||||+|||++. .++|+|||+|...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 8999999998654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.74 E-value=2e-18 Score=158.57 Aligned_cols=139 Identities=11% Similarity=0.018 Sum_probs=96.5
Q ss_pred CCcccccccCCCcEEEEEEE-CCeEEEEEEecCccC--------------cchHHHHHHHHHHhhhcCCCceeeEcceee
Q 045453 59 FDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILN--------------DGHEDCFNNIIFASKLSSHKNVLKLTGCCL 123 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~--------------~~~~~~~~e~~~~~~~~~h~niv~l~g~~~ 123 (346)
|.....||.|++|.||+|.. +|+.||||.+..... ................ .|+|+.+++....
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~k-E~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIK-EFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHH-HHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHH-HHHHHHHHHhcCC
Confidence 77889999999999999998 889999998653211 0111122222222222 3445444433221
Q ss_pred c------CCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCC
Q 045453 124 E------TRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGY 197 (346)
Q Consensus 124 ~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~ 197 (346)
. ....+|||||+++++|.++... .....++.|++.+|.+|| ..+||||||||.|||+++++
T Consensus 176 ~vp~p~~~~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 176 PVPEPIAQSRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEK 242 (397)
T ss_dssp SCCCEEEEETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEE
T ss_pred CCCeeeeccCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCC
Confidence 1 1223799999999888765421 123467889999999999 88999999999999998877
Q ss_pred ----------ceEEeccCCCcccC
Q 045453 198 ----------IAKLFDFSLSVSIP 211 (346)
Q Consensus 198 ----------~~kl~Dfgl~~~~~ 211 (346)
.+.|+||+.+....
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEETT
T ss_pred CcccccccccceEEEEeCCcccCC
Confidence 48999999876543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=9.5e-14 Score=121.88 Aligned_cols=147 Identities=14% Similarity=0.080 Sum_probs=114.2
Q ss_pred HHHHhcCCCcccccccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 52 LEIATNNFDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 52 l~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
+......|.....++.|+.+.||++...++.+++|............+..|...+..+..+.+++++++++...+..++|
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 34445678778888889999999998888899999986532223345778888888875577888999999888889999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIG----------------------------------- 176 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~----------------------------------- 176 (346)
|||++|.+|.+.+.. ......++.+++.+|+.||+-
T Consensus 89 ~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 89 MSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 999999998876321 112346888999999999961
Q ss_pred ---------------------CCCCceecCCCCCCeEEcCCCceEEeccCCC
Q 045453 177 ---------------------FSRPILHRKIRPSRIFLDEGYIAKLFDFSLS 207 (346)
Q Consensus 177 ---------------------~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~ 207 (346)
....++|+|++|.|||++.+..+.|+||+.+
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a 211 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence 0145899999999999988766779999976
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.28 E-value=2e-11 Score=106.44 Aligned_cols=137 Identities=12% Similarity=0.020 Sum_probs=96.5
Q ss_pred cCCCcccccccCCCcEEEEEEE-CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCC-ceeeEcceeecCCcceEEEec
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHK-NVLKLTGCCLETRIPVIVFES 134 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~-niv~l~g~~~~~~~~~lv~e~ 134 (346)
.++....+.+.|..+.||++.. ++..+++|..... ....+..|...+..+..+. .+++++++....+..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 3444433444666799999987 4678999986543 2244667777777773442 255688888877788999999
Q ss_pred ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 045453 135 VKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGF------------------------------------- 177 (346)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------------- 177 (346)
++|.+|. ... .+ ...++.+++..|..||+..
T Consensus 97 i~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 97 VPGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp CSSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred cCCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 9998884 211 11 2356778888888888421
Q ss_pred ------------------CCCceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 178 ------------------SRPILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 178 ------------------~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
...++|+|++|.|||++.++.+.|+||+.+.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999888777899999763
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.24 E-value=4.2e-11 Score=109.91 Aligned_cols=143 Identities=17% Similarity=0.147 Sum_probs=106.0
Q ss_pred cccccccCCCcEEEEEEECCeEEEEEEec--CccC-cchHHHHHHHHHHhhhcC-CCceeeEcceeecC---CcceEEEe
Q 045453 61 ARNVIKDGYAYKFYKGFVEDRTVSVMKFN--DILN-DGHEDCFNNIIFASKLSS-HKNVLKLTGCCLET---RIPVIVFE 133 (346)
Q Consensus 61 ~~~~ig~G~~g~Vy~~~~~~~~vavk~~~--~~~~-~~~~~~~~e~~~~~~~~~-h~niv~l~g~~~~~---~~~~lv~e 133 (346)
..+.|+.|.++.||+....++.+++|+.. .... .....+.+|...+..+.. +..++++++++.+. +..++|||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEEECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred eEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 35678999999999999877888888865 3221 223456677777777732 45688888888776 44799999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGF------------------------------------ 177 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------------ 177 (346)
|++|.++.+.. ...++...+..++.+++..|+.||+..
T Consensus 122 ~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 122 FVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp CCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred ecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99998885522 134778889999999999999999620
Q ss_pred -------------------CCCceecCCCCCCeEEcCCCc--eEEeccCCCcc
Q 045453 178 -------------------SRPILHRKIRPSRIFLDEGYI--AKLFDFSLSVS 209 (346)
Q Consensus 178 -------------------~~~iiH~dlkp~NIll~~~~~--~kl~Dfgl~~~ 209 (346)
...++|+|++|.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 256999999999999997753 68999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.07 E-value=1.6e-10 Score=103.51 Aligned_cols=186 Identities=13% Similarity=0.161 Sum_probs=119.2
Q ss_pred ccccccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCc--eeeEcceeecCC---cceEEEeccc
Q 045453 62 RNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKN--VLKLTGCCLETR---IPVIVFESVK 136 (346)
Q Consensus 62 ~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~n--iv~l~g~~~~~~---~~~lv~e~~~ 136 (346)
...++.|....||+.. ..+++|..... .....+..|...+..+..+.. +.++++.....+ ..++||++++
T Consensus 25 i~~~~~G~~n~v~~v~---~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN---RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST---TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC---CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 4568999999999864 56888875432 234556777777776633332 344554443333 3489999999
Q ss_pred CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 045453 137 NRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGF--------------------------------------- 177 (346)
Q Consensus 137 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--------------------------------------- 177 (346)
|.+|.+.... .++..++..++.+++..|+.||+..
T Consensus 100 G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 100 GVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9888764322 3677778888888888888888511
Q ss_pred ----------------CCCceecCCCCCCeEEcC--CCceEEeccCCCcccCCCCceeecc--------------ccccC
Q 045453 178 ----------------SRPILHRKIRPSRIFLDE--GYIAKLFDFSLSVSIPEGETCVKDK--------------VTGTM 225 (346)
Q Consensus 178 ----------------~~~iiH~dlkp~NIll~~--~~~~kl~Dfgl~~~~~~~~~~~~~~--------------~~gt~ 225 (346)
...++|+|++|.||+++. +..+.|+||+.+..-.. ....... .....
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~-~~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDP-DNDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECT-THHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCCh-HHHHHHHHhhccccCHHHHHHHHHHc
Confidence 135799999999999998 56688999998754311 1000000 00001
Q ss_pred CcCC-ccccccCCCCcccchHHHHHHHHHHHhCCCCC
Q 045453 226 GFLA-PEYINTGDFNEKCDVFSFGMLLLVLLTGQKIF 261 (346)
Q Consensus 226 ~y~a-PE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~ 261 (346)
+... |+.... .....+.|++|.++|.+.+|..+|
T Consensus 253 ~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1122 222211 122368999999999999998876
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.55 E-value=5.6e-07 Score=78.71 Aligned_cols=134 Identities=10% Similarity=0.054 Sum_probs=92.5
Q ss_pred ccccCCCc-EEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccCCCh
Q 045453 64 VIKDGYAY-KFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTL 140 (346)
Q Consensus 64 ~ig~G~~g-~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 140 (346)
.+..|..| .||+... .+..+++|.-... ....+..|...+..+..+--+.++++++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 44556655 6898776 4567888875432 2345566777776664443477788888888899999999999887
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------------
Q 045453 141 ADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIG-------------------------------------------- 176 (346)
Q Consensus 141 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-------------------------------------------- 176 (346)
.+...... .....++.+++..|+-||+-
T Consensus 108 ~~~~~~~~--------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 108 FQVLEEYP--------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHCG--------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred cccccCCH--------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 76553211 12334556666666666621
Q ss_pred -----------CCCCceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 177 -----------FSRPILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 177 -----------~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
....++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 01136899999999999988777899999763
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.53 E-value=6.6e-07 Score=80.00 Aligned_cols=136 Identities=13% Similarity=0.168 Sum_probs=90.6
Q ss_pred ccccccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHHHHHHHhhhcCC-C-ceeeEcceee-cCCcceEEEecccCC
Q 045453 62 RNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSH-K-NVLKLTGCCL-ETRIPVIVFESVKNR 138 (346)
Q Consensus 62 ~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h-~-niv~l~g~~~-~~~~~~lv~e~~~~g 138 (346)
...++.|....||+. ++.+++|.-.. ......+..|...+..+..| + .+.+.+.++. ..+..++|||+++|.
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeecCCCcceeEEEE---CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 356788989999988 67788887421 22345677888888887333 2 3556666664 445678999999998
Q ss_pred ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 045453 139 TLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIG------------------------------------------ 176 (346)
Q Consensus 139 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------------------------------------------ 176 (346)
+|.+..- ..++...+..++.+++..|+.||+-
T Consensus 99 ~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 99 ILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp ECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred ECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 8876321 1234444555555555555555531
Q ss_pred ---------------CCCCceecCCCCCCeEEcC---CCc-eEEeccCCCc
Q 045453 177 ---------------FSRPILHRKIRPSRIFLDE---GYI-AKLFDFSLSV 208 (346)
Q Consensus 177 ---------------~~~~iiH~dlkp~NIll~~---~~~-~kl~Dfgl~~ 208 (346)
....++|+|+.|.|||++. ++. ..|+||+.+.
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 1335699999999999997 344 5899999764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.47 E-value=5.3e-07 Score=82.28 Aligned_cols=80 Identities=6% Similarity=-0.086 Sum_probs=53.0
Q ss_pred ccc-ccCCCcEEEEEEEC--------CeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCC--CceeeEcceeecC---
Q 045453 63 NVI-KDGYAYKFYKGFVE--------DRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSH--KNVLKLTGCCLET--- 125 (346)
Q Consensus 63 ~~i-g~G~~g~Vy~~~~~--------~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h--~niv~l~g~~~~~--- 125 (346)
+.| +.|..+.+|+.... ++.+++|...... .........|...+..+..+ -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 557 88889999998765 6788888755332 00123455666666665333 3466777777654
Q ss_pred CcceEEEecccCCChhh
Q 045453 126 RIPVIVFESVKNRTLAD 142 (346)
Q Consensus 126 ~~~~lv~e~~~~gsL~~ 142 (346)
+..++||||++|.++.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 34689999999877654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.30 E-value=8.2e-06 Score=73.58 Aligned_cols=142 Identities=11% Similarity=0.087 Sum_probs=78.6
Q ss_pred cccccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHHHHHHHhhhc----CCCceeeEc-c--eeecCCcceEEEecc
Q 045453 63 NVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLS----SHKNVLKLT-G--CCLETRIPVIVFESV 135 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~----~h~niv~l~-g--~~~~~~~~~lv~e~~ 135 (346)
..|+.|..+.||+....++.+++|..... ..+...+...+..+. ..|.++... | +....+..++||+|+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp EECC----CEEEEEEETTEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eeccccccCcEEEEEeCCCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 34666778999999887778999988652 122222333333221 234444321 1 112356678999999
Q ss_pred cCCChh--------------hhhhhcCC-C--C-------CCCCHHHHH-------------------------------
Q 045453 136 KNRTLA--------------DHIYQNQP-H--F-------EPLLLSQRL------------------------------- 160 (346)
Q Consensus 136 ~~gsL~--------------~~l~~~~~-~--~-------~~l~~~~~~------------------------------- 160 (346)
+|.++. ..++.... . . ....|....
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 986553 11111100 0 0 012343211
Q ss_pred HHHHHHHHHHHHHHh----------CCCCCceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 161 RIAVHIANAIAYLHI----------GFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 161 ~i~~~ia~~L~~LH~----------~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
.+...+..++.+|+. .....++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 011123345666652 125789999999999999888889999999763
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.19 E-value=1.5e-05 Score=73.78 Aligned_cols=75 Identities=15% Similarity=0.118 Sum_probs=47.3
Q ss_pred ccccccCCCcEEEEEEE--CCeEEEEEEecCccC-------cchHHHHHHHHHHhhhcCC-Cc-eeeEcceeecCCcceE
Q 045453 62 RNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-------DGHEDCFNNIIFASKLSSH-KN-VLKLTGCCLETRIPVI 130 (346)
Q Consensus 62 ~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-------~~~~~~~~e~~~~~~~~~h-~n-iv~l~g~~~~~~~~~l 130 (346)
.+.||.|..+.||++.. .++.+++|....... ........|...+..+..+ |. +++++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 45789999999999965 567899997643211 1223456676676665332 33 4455544 3445689
Q ss_pred EEecccCC
Q 045453 131 VFESVKNR 138 (346)
Q Consensus 131 v~e~~~~g 138 (346)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.16 E-value=1.4e-05 Score=74.51 Aligned_cols=77 Identities=12% Similarity=0.093 Sum_probs=46.8
Q ss_pred CCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCceeecccc--ccCCcCCccccccC---CCCcccchHHHHHHHH
Q 045453 178 SRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVT--GTMGFLAPEYINTG---DFNEKCDVFSFGMLLL 252 (346)
Q Consensus 178 ~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~---~~~~~~Dv~s~G~vl~ 252 (346)
...++|+|++|.|||++.++ +.|+||+.+..-.. .... .... -...|.+|+..... ......++.+....+|
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p-~~Dl-a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPM-GFDI-GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECH-HHHH-HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCch-HHHH-HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 67899999999999999877 99999998754211 0000 0001 11245666554311 1122345567777777
Q ss_pred HHHhC
Q 045453 253 VLLTG 257 (346)
Q Consensus 253 elltg 257 (346)
+..++
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77664
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.06 E-value=3.3e-05 Score=68.99 Aligned_cols=141 Identities=13% Similarity=-0.005 Sum_probs=91.5
Q ss_pred cccccccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHHHHHHHhhhcC--CCceeeEcceeecCCcceEEEecccCC
Q 045453 61 ARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSS--HKNVLKLTGCCLETRIPVIVFESVKNR 138 (346)
Q Consensus 61 ~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~--h~niv~l~g~~~~~~~~~lv~e~~~~g 138 (346)
....|+.|....+|+...+++.+++|..... ....+..|...+..+.. ...++++++++...+..++||||+++.
T Consensus 40 ~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDEVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEEECCSSSSEEEEEESSSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eeEEeCCccceeeeEEEECCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 3456899999999999888888999886533 23445667666666633 356888888888778899999999987
Q ss_pred Chhh-----------hhhhcCC---C---------------CCCCCHHHHH---HHH----------------HHHHHHH
Q 045453 139 TLAD-----------HIYQNQP---H---------------FEPLLLSQRL---RIA----------------VHIANAI 170 (346)
Q Consensus 139 sL~~-----------~l~~~~~---~---------------~~~l~~~~~~---~i~----------------~~ia~~L 170 (346)
++.. .|+.... . ...-+|.... .+. ..++..+
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 6532 1222211 0 0112565332 111 1122222
Q ss_pred -HHHH-hCCCCCceecCCCCCCeEEcCCCceEEeccC
Q 045453 171 -AYLH-IGFSRPILHRKIRPSRIFLDEGYIAKLFDFS 205 (346)
Q Consensus 171 -~~LH-~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg 205 (346)
..|. ......++|+|+.+.|++++.++ +.|+|++
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 2342 12246799999999999999887 8899984
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.75 E-value=0.0002 Score=63.08 Aligned_cols=78 Identities=13% Similarity=0.012 Sum_probs=52.2
Q ss_pred CCcccccccCCCcEEEEEEE-CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCC--ceeeEcceeecCCcceEEEecc
Q 045453 59 FDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHK--NVLKLTGCCLETRIPVIVFESV 135 (346)
Q Consensus 59 f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~--niv~l~g~~~~~~~~~lv~e~~ 135 (346)
+.....+|.|..+.||+... +|+.+++|+...........+..|...+..+.... -+++++++. .-++||||+
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l 92 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWV 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECC
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEee
Confidence 44566789999999999999 77899999865443333334556777777663321 234444432 348999999
Q ss_pred cCCCh
Q 045453 136 KNRTL 140 (346)
Q Consensus 136 ~~gsL 140 (346)
+++..
T Consensus 93 ~~~~~ 97 (288)
T 3f7w_A 93 DERPP 97 (288)
T ss_dssp CCCCC
T ss_pred cccCC
Confidence 87654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00047 Score=61.53 Aligned_cols=160 Identities=12% Similarity=0.073 Sum_probs=86.4
Q ss_pred CCHHHHHHHhcCCCc-----ccccccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCC-ceeeEcc
Q 045453 47 FTIRELEIATNNFDA-----RNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHK-NVLKLTG 120 (346)
Q Consensus 47 ~~~~~l~~~~~~f~~-----~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~-niv~l~g 120 (346)
++.+++...-..|.. ...|+.|....+|+...+++.+++|....... ......|...+..+..+. .+.+++.
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~--~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCccEEEEEeCCCCC--HHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 566666666666654 23466788899999988667889998765211 122334444444442221 1233332
Q ss_pred e------eecCCcceEEEecccCCChhh--------------hhhhcC-CCCCC-------CCHHHHHHH----------
Q 045453 121 C------CLETRIPVIVFESVKNRTLAD--------------HIYQNQ-PHFEP-------LLLSQRLRI---------- 162 (346)
Q Consensus 121 ~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~-~~~~~-------l~~~~~~~i---------- 162 (346)
. ....+..+++++|++|.++.. .++... ....+ ..|.....-
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 1 112345689999999865432 112110 00000 123321110
Q ss_pred --HHHHHHHHHHHHhC----CCCCceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 163 --AVHIANAIAYLHIG----FSRPILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 163 --~~~ia~~L~~LH~~----~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
...+...+..+... ...+++|+|+.+.|||++.+..+.|+||+.+.
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 11234455555521 13568999999999999987666899998763
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.67 E-value=0.00022 Score=63.24 Aligned_cols=73 Identities=8% Similarity=-0.003 Sum_probs=42.2
Q ss_pred ccccccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecc-cCCCh
Q 045453 62 RNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESV-KNRTL 140 (346)
Q Consensus 62 ~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~-~~gsL 140 (346)
...|+.|....+|+. +.+++|........ ......|...+..+..+.--.++++++ .+.-++|+||+ ++.+|
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQTM 95 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEEC
T ss_pred eeEcCCcccccccee----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCccC
Confidence 567889999999999 67888887643221 112234554444442222124555543 33357999999 66555
Q ss_pred h
Q 045453 141 A 141 (346)
Q Consensus 141 ~ 141 (346)
.
T Consensus 96 ~ 96 (301)
T 3dxq_A 96 S 96 (301)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00019 Score=67.12 Aligned_cols=74 Identities=16% Similarity=0.118 Sum_probs=48.4
Q ss_pred ccccccCCCcEEEEEEEC---------CeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 62 RNVIKDGYAYKFYKGFVE---------DRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 62 ~~~ig~G~~g~Vy~~~~~---------~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
...|+.|....+|+.... ++.+++|+.... ........|...+..+..+.-.+++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 356788889999999874 467888887432 1114455677777766444334567766542 3899
Q ss_pred ecccCCChh
Q 045453 133 ESVKNRTLA 141 (346)
Q Consensus 133 e~~~~gsL~ 141 (346)
||++|.+|.
T Consensus 152 e~l~G~~l~ 160 (429)
T 1nw1_A 152 EYIPSRPLS 160 (429)
T ss_dssp CCCCEEECC
T ss_pred EEeCCcccC
Confidence 999865543
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00076 Score=56.25 Aligned_cols=99 Identities=14% Similarity=0.080 Sum_probs=66.0
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCcee
Q 045453 138 RTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCV 217 (346)
Q Consensus 138 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 217 (346)
-||.+.|...+ .++++.++|.++.|.+.+|.-+-. ...-..+=+.|..|++..+|.+.+.+ +.+.
T Consensus 33 vSL~eIL~~~~---~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRLYN---QPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHHcC---CCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc---------
Confidence 37999998766 689999999999999999877621 11111333456899999999887763 1110
Q ss_pred eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh
Q 045453 218 KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT 256 (346)
Q Consensus 218 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt 256 (346)
.....+.|||... ...+.+.-|||+|+++|.-+-
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1122456888763 456788999999999998886
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.0012 Score=59.20 Aligned_cols=32 Identities=13% Similarity=0.154 Sum_probs=27.5
Q ss_pred CCCceecCCCCCCeEEcCC----CceEEeccCCCcc
Q 045453 178 SRPILHRKIRPSRIFLDEG----YIAKLFDFSLSVS 209 (346)
Q Consensus 178 ~~~iiH~dlkp~NIll~~~----~~~kl~Dfgl~~~ 209 (346)
...++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 5679999999999999875 6889999998753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.45 E-value=0.0011 Score=62.44 Aligned_cols=75 Identities=9% Similarity=-0.039 Sum_probs=46.6
Q ss_pred ccccccCCCcEEEEEEECC--eEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecccCCC
Q 045453 62 RNVIKDGYAYKFYKGFVED--RTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRT 139 (346)
Q Consensus 62 ~~~ig~G~~g~Vy~~~~~~--~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~~gs 139 (346)
...|+.|-...+|+....+ ..+++|........ ......|...+..+..+.-.+++++++. + .+||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 3467788899999999865 88888886543211 1122467777777733333456777663 2 36999998765
Q ss_pred hh
Q 045453 140 LA 141 (346)
Q Consensus 140 L~ 141 (346)
|.
T Consensus 188 l~ 189 (458)
T 2qg7_A 188 LS 189 (458)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.33 E-value=0.0042 Score=55.38 Aligned_cols=161 Identities=16% Similarity=0.109 Sum_probs=85.8
Q ss_pred ccCCCHHHHHHHhcCCCc-----ccccccCCCcEEEEEEE-CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCC-Ccee
Q 045453 44 IRGFTIRELEIATNNFDA-----RNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSH-KNVL 116 (346)
Q Consensus 44 ~~~~~~~~l~~~~~~f~~-----~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h-~niv 116 (346)
...++.+.+...-..|.. ...++ |....||+... +|+.+++|...... ........|...+..+..+ -.++
T Consensus 8 ~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp 85 (328)
T 1zyl_A 8 FQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVA 85 (328)
T ss_dssp CCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBC
T ss_pred CCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeec
Confidence 444666666555544432 23466 88899999887 45579999976331 1233444555555554222 1134
Q ss_pred eEcce-----eecCCcceEEEecccCCChhh-----------h---hhhc---CC--CCCCCCHHHH----HHHH-----
Q 045453 117 KLTGC-----CLETRIPVIVFESVKNRTLAD-----------H---IYQN---QP--HFEPLLLSQR----LRIA----- 163 (346)
Q Consensus 117 ~l~g~-----~~~~~~~~lv~e~~~~gsL~~-----------~---l~~~---~~--~~~~l~~~~~----~~i~----- 163 (346)
+++.. ....+..++||+|++|.++.. . ++.. .. ....+++... ..++
T Consensus 86 ~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 165 (328)
T 1zyl_A 86 APVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATL 165 (328)
T ss_dssp CCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSS
T ss_pred ceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCc
Confidence 44433 112345578999998855431 0 1110 00 0112333221 0010
Q ss_pred ----------HHHHHHHHHHHh----CCCCCceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 164 ----------VHIANAIAYLHI----GFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 164 ----------~~ia~~L~~LH~----~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
..+...+..+.. .....++|+|+++.|||++ + .+.|+||+.+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 166 IPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp SCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 011112222221 1245689999999999999 4 89999998764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.28 E-value=0.0011 Score=60.63 Aligned_cols=142 Identities=16% Similarity=0.145 Sum_probs=82.3
Q ss_pred ccccccCCCcEEEEEEEC---------CeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 62 RNVIKDGYAYKFYKGFVE---------DRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 62 ~~~ig~G~~g~Vy~~~~~---------~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
...|..|-...+|+.... ++.+++++.... ........+|...+..+..+.--.++++++.+ .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 346777889999999873 367888875332 22344555777777666444434667766643 2999
Q ss_pred ecccCCChhhh-----------------hhhcCC-CCCCC--CHHHHHHHHHHHHH-------------------HHHHH
Q 045453 133 ESVKNRTLADH-----------------IYQNQP-HFEPL--LLSQRLRIAVHIAN-------------------AIAYL 173 (346)
Q Consensus 133 e~~~~gsL~~~-----------------l~~~~~-~~~~l--~~~~~~~i~~~ia~-------------------~L~~L 173 (346)
||++|.+|..- |+.... ...+. .|.++.++..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99998665421 111111 11122 24555555543321 22333
Q ss_pred ----Hh-CCCCCceecCCCCCCeEEcCC----CceEEeccCCCc
Q 045453 174 ----HI-GFSRPILHRKIRPSRIFLDEG----YIAKLFDFSLSV 208 (346)
Q Consensus 174 ----H~-~~~~~iiH~dlkp~NIll~~~----~~~kl~Dfgl~~ 208 (346)
.. .....++|+|+.+.|||++.+ +.+.++||..+.
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 21 123468999999999999876 789999998764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00085 Score=61.20 Aligned_cols=74 Identities=11% Similarity=0.066 Sum_probs=41.2
Q ss_pred ccccccCCCcEEEEEEECC----------eEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 62 RNVIKDGYAYKFYKGFVED----------RTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 62 ~~~ig~G~~g~Vy~~~~~~----------~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
...|+.|....+|+....+ +.+++|........ ......|...+..+..+.-.+++++.. .-++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec----CCcEE
Confidence 3467788899999998854 67888876543211 112245555555553332234555443 13789
Q ss_pred EecccCCCh
Q 045453 132 FESVKNRTL 140 (346)
Q Consensus 132 ~e~~~~gsL 140 (346)
|||++|.++
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987554
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0024 Score=57.62 Aligned_cols=31 Identities=10% Similarity=0.230 Sum_probs=27.3
Q ss_pred CCCceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 178 SRPILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 178 ~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
...++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPM 235 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence 3568999999999999988889999998764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.35 E-value=0.026 Score=52.34 Aligned_cols=141 Identities=12% Similarity=0.110 Sum_probs=82.1
Q ss_pred ccccccCCCcEEEEEEEC---------CeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 62 RNVIKDGYAYKFYKGFVE---------DRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 62 ~~~ig~G~~g~Vy~~~~~---------~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
.+.+..|-...+|+.... ++.++++....... ......+|...+..+..+.-..++++.+. -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 345777889999999885 57888888644321 11223455555555533333455555432 37899
Q ss_pred ecccCCChhhh-h----------------hhc-------CC--CCCCCCHHHHHHHHHHH-------------------H
Q 045453 133 ESVKNRTLADH-I----------------YQN-------QP--HFEPLLLSQRLRIAVHI-------------------A 167 (346)
Q Consensus 133 e~~~~gsL~~~-l----------------~~~-------~~--~~~~l~~~~~~~i~~~i-------------------a 167 (346)
||++|.+|..- + +.. .. ...+..|..+..+..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 99998764321 0 100 00 11222355544444322 2
Q ss_pred HHHHHHHh---------------------CCCCCceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 168 NAIAYLHI---------------------GFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 168 ~~L~~LH~---------------------~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
..+.+|.. .....++|+|+.+.||+ +.++.+.++||..+.
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 22333321 11346899999999999 888899999998764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.55 E-value=0.23 Score=45.57 Aligned_cols=29 Identities=28% Similarity=0.344 Sum_probs=24.3
Q ss_pred CceecCCCCCCeEE------cCCCceEEeccCCCc
Q 045453 180 PILHRKIRPSRIFL------DEGYIAKLFDFSLSV 208 (346)
Q Consensus 180 ~iiH~dlkp~NIll------~~~~~~kl~Dfgl~~ 208 (346)
.++|+|+.+.|||+ +++..+.++||..|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 35799999999999 456779999998774
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=91.12 E-value=0.55 Score=39.02 Aligned_cols=83 Identities=11% Similarity=0.122 Sum_probs=60.5
Q ss_pred CCCceeeEcceeecCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCceecCCCCC
Q 045453 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIA-YLHIGFSRPILHRKIRPS 189 (346)
Q Consensus 111 ~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~-~LH~~~~~~iiH~dlkp~ 189 (346)
.||++ -..+-.+.+.+.+.|+.-+++.=...+. .++...++.++..++.... +++ .-+|--|.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCc
Confidence 77888 3334456677777777665543333442 3788899999988887666 444 4678889999
Q ss_pred CeEEcCCCceEEeccCCC
Q 045453 190 RIFLDEGYIAKLFDFSLS 207 (346)
Q Consensus 190 NIll~~~~~~kl~Dfgl~ 207 (346)
|+++|.++.+++.-.|+-
T Consensus 114 NL~f~~~~~p~i~hRGi~ 131 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVK 131 (219)
T ss_dssp GEEECTTCCEEESCCEET
T ss_pred eEEEeCCCcEEEEEcCCc
Confidence 999999999999988864
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=90.85 E-value=0.44 Score=39.47 Aligned_cols=116 Identities=15% Similarity=0.142 Sum_probs=78.1
Q ss_pred CCCceeeEcceeecCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCC
Q 045453 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSR 190 (346)
Q Consensus 111 ~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~N 190 (346)
.||+++.. .+-.+.+.+.+.|+.-+.+.=+..+. .++...++.++..++....+++ .-+|--|.|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik-------~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK-------SFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG-------GSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH-------hcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecce
Confidence 78888876 35555666666666554332222242 4788999999999988876655 34788899999
Q ss_pred eEEcCCCceEEeccCCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCC
Q 045453 191 IFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFD 262 (346)
Q Consensus 191 Ill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~ 262 (346)
++++.++.+++.-.|+-..+ +|. ..+...=.-.+=+++..+++++..|+
T Consensus 110 L~f~~~~~p~i~~RGik~~l------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVV------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EEECTTSCEEESCCEETTTB------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEEcCCCCEEEEEccCccCC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999988864322 111 11111122256778888888888774
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=80.16 E-value=0.21 Score=46.87 Aligned_cols=58 Identities=3% Similarity=-0.153 Sum_probs=17.0
Q ss_pred ccccccCCCcEEEEEEECC--eEEEE------EEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceee
Q 045453 62 RNVIKDGYAYKFYKGFVED--RTVSV------MKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCL 123 (346)
Q Consensus 62 ~~~ig~G~~g~Vy~~~~~~--~~vav------k~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~ 123 (346)
.+.|| ||.||+|.+.+ .+||+ |...... ......+.++....... +|||+++.+++..
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~-~H~niv~~h~f~~ 214 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENE-QIPKYEKIHNFKV 214 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccc-cccccCCCcceEE
Confidence 45565 99999999943 57888 6654322 12234566676766666 9999999988754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 346 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-42 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-38 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-38 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-36 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-36 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-35 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-35 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-34 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-34 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-34 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-34 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-33 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-33 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-33 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-33 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-33 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-32 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-32 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-32 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-32 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-32 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-31 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-30 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-29 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-29 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-29 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-29 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-29 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-29 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-28 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-28 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-27 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-27 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-26 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-25 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-24 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-24 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-24 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-24 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-24 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-23 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-23 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-21 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-21 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-20 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-20 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-20 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-20 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-19 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-19 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-19 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-19 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-18 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-18 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-16 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-16 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-16 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-16 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-15 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-12 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-12 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-10 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-05 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 6e-42
Identities = 60/300 (20%), Positives = 121/300 (40%), Gaps = 32/300 (10%)
Query: 51 ELEIATNNFDARNVIKDGYAYKFYKGFVEDRTVSVMKFN-DILNDGHEDCFNNIIFASKL 109
+ EI I G YKG V+V N F N + +
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKG-KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK 60
Query: 110 SSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANA 169
+ H N+L G ++ IV + + +L H++ + FE + + IA A
Sbjct: 61 TRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHIIETKFEM---IKLIDIARQTAQG 116
Query: 170 IAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVK-DKVTGTMGFL 228
+ YLH + I+HR ++ + IFL E K+ DF L+ + ++++G++ ++
Sbjct: 117 MDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173
Query: 229 APEYINTGD---FNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIE 285
APE I D ++ + DV++FG++L L+TGQ + + ++ V +
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIFMVGRGYL 227
Query: 286 NNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHL 345
+ + ++ + + L C+ + ++RP + ++ + + L
Sbjct: 228 SPDLSKVRSNC-------------PKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 3e-38
Identities = 45/314 (14%), Positives = 109/314 (34%), Gaps = 37/314 (11%)
Query: 52 LEIATNNFDARNVIKDGYAYKFYKGFVED--RTVSVMKFNDILNDGHEDCFNNIIFASKL 109
+E+ ++F+ + + G +K + ++ + + + +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 110 SSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANA 169
+ ++ G I E + +L + + + ++++ +
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKG 116
Query: 170 IAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLA 229
+ YL I+HR ++PS I ++ KL DF +S + + + GT +++
Sbjct: 117 LTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMS 171
Query: 230 PEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEI-------------------G 270
PE + ++ + D++S G+ L+ + G+ P E+
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231
Query: 271 AGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPT 330
L Y E++D I+ P++ F++ C+ ++ +R
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291
Query: 331 TVDVAKRLKQIYQH 344
LKQ+ H
Sbjct: 292 -------LKQLMVH 298
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 6e-38
Identities = 63/292 (21%), Positives = 118/292 (40%), Gaps = 30/292 (10%)
Query: 51 ELEIATNNFDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLS 110
E E+ + G + + G+ T +K + + +L
Sbjct: 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ 66
Query: 111 SHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAI 170
H+ +++L + I I+ E ++N +L D + L +++ L +A IA +
Sbjct: 67 -HQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGI--KLTINKLLDMAAQIAEGM 122
Query: 171 AYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAP 230
A++ R +HR +R + I + + K+ DF L+ I + E ++ + + AP
Sbjct: 123 AFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 179
Query: 231 EYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290
E IN G F K DV+SFG+LL ++T +I P G + ++ +++
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP------GMTNPEVIQNLERGY------ 227
Query: 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIY 342
+V P E +L +C E EDRPT + L+ +
Sbjct: 228 RMVRPDNCPE-----------ELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 3e-36
Identities = 55/293 (18%), Positives = 102/293 (34%), Gaps = 36/293 (12%)
Query: 53 EIATNNFDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSH 112
+ I G G V+V ND F H
Sbjct: 3 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK---NDATAQAFLAEASVMTQLRH 59
Query: 113 KNVLKLTGCCLETRIPV-IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIA 171
N+++L G +E + + IV E + +L D++ L L+ ++ + A+
Sbjct: 60 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAME 117
Query: 172 YLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPE 231
YL +HR + + + E +AK+ DF L+ + + + APE
Sbjct: 118 YLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD----TGKLPVKWTAPE 170
Query: 232 YINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDE 291
+ F+ K DV+SFG+LL + + ++ P ++ V+K + + D
Sbjct: 171 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYP------RIPLKDVVPRVEKGYKMDAPDG 224
Query: 292 IVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344
E+ C A RP+ + + ++L+ I H
Sbjct: 225 CPPA-----------------VYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 3e-36
Identities = 53/287 (18%), Positives = 110/287 (38%), Gaps = 30/287 (10%)
Query: 57 NNFDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVL 116
+ I G + G+ ++ +K ED KLS H ++
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLS-HPKLV 63
Query: 117 KLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIG 176
+L G CLE +VFE +++ L+D++ + F L + + + +AYL
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLE-- 118
Query: 177 FSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTG 236
++HR + + E + K+ DF ++ + + + + + +PE +
Sbjct: 119 -EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 237 DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPI 296
++ K DV+SFG+L+ + + KI +R + ++ + + P
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVEDISTGF------RLYKPR 225
Query: 297 IVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQ 343
+ S ++ C E EDRP + ++L +I +
Sbjct: 226 LAST-----------HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 1e-35
Identities = 42/288 (14%), Positives = 106/288 (36%), Gaps = 28/288 (9%)
Query: 74 YKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV---- 129
++G V+V F+ + I+ + + H+N+L +
Sbjct: 20 WRGKWRGEEVAVKIFSS--REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77
Query: 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGF-----SRPILHR 184
+V + ++ +L D++ + + + +++A+ A+ +A+LH+ I HR
Sbjct: 78 LVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR 132
Query: 185 KIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVT---GTMGFLAPEYINT------ 235
++ I + + + D L+V + GT ++APE ++
Sbjct: 133 DLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKH 192
Query: 236 GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDP 295
+ ++ D+++ G++ + I ++ + + ++ + P
Sbjct: 193 FESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRP 252
Query: 296 IIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQ 343
I R + L+ ++ C + R T + + K L Q+ Q
Sbjct: 253 NI---PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 3e-35
Identities = 63/300 (21%), Positives = 107/300 (35%), Gaps = 30/300 (10%)
Query: 46 GFTIRELEIATNNFDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIF 105
G EI + + G + + G T +K E
Sbjct: 6 GLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQV 65
Query: 106 ASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVH 165
KL H+ +++L E I IV E + +L D + + L Q + +A
Sbjct: 66 MKKLR-HEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQ 121
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTM 225
IA+ +AY+ +HR +R + I + E + K+ DF L+ I + E + +
Sbjct: 122 IASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 178
Query: 226 GFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIE 285
+ APE G F K DV+SFG+LL L T ++ P + +L V++
Sbjct: 179 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLDQVERGYR 232
Query: 286 NNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHL 345
E + +L C + E+RPT + L+ +
Sbjct: 233 MPCPPECPES-----------------LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 1e-34
Identities = 55/305 (18%), Positives = 108/305 (35%), Gaps = 39/305 (12%)
Query: 50 RELEIATNNFDARNV-IKDGYAYKFYKGFVEDR----TVSVMKFNDILNDGHEDCFNNII 104
++L + +N ++ + G +G R V++ +
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 105 FASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAV 164
+ +++L G C + ++V E L + E + +S +
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLH 116
Query: 165 HIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGET--CVKDKVT 222
++ + YL + +HR + + L + AK+ DF LS ++ ++ +
Sbjct: 117 QVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 223 GTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVK 281
+ + APE IN F+ + DV+S+G+ + L+ GQK + +G E+
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-----------M 222
Query: 282 KCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341
IE + E L C EDRP + V +R++
Sbjct: 223 AFIEQGKRMECPPEC-------------PPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
Query: 342 YQHLA 346
Y LA
Sbjct: 270 YYSLA 274
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 126 bits (318), Expect = 1e-34
Identities = 49/318 (15%), Positives = 108/318 (33%), Gaps = 51/318 (16%)
Query: 47 FTIRELEIATNNFDARNVIKD----------GYAYKFYKGFV-----EDRTVSVMKFNDI 91
FT + A F I + + G + + V++
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFG-EVCSGHLKLPGKREIFVAIKTLKSG 65
Query: 92 LNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHF 151
+ F + H NV+ L G ++ +I+ E ++N +L + QN F
Sbjct: 66 YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF 125
Query: 152 EPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211
+ Q + + IA + YL +HR + I ++ + K+ DF LS +
Sbjct: 126 TVI---QLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 212 EGETCVKDKVT----GTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRG 266
+ + + + APE I F DV+S+G+++ +++ G++ +
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 239
Query: 267 DEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAE 326
++ ++ +++ + +L L C +
Sbjct: 240 QDV-------INAIEQDYRLPPPMDCPSA-----------------LHQLMLDCWQKDRN 275
Query: 327 DRPTTVDVAKRLKQIYQH 344
RP + L ++ ++
Sbjct: 276 HRPKFGQIVNTLDKMIRN 293
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 1e-34
Identities = 53/262 (20%), Positives = 94/262 (35%), Gaps = 42/262 (16%)
Query: 83 VSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLAD 142
+ V+ + G E + H N+L+L G + ++ E T+
Sbjct: 36 LKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYR 95
Query: 143 HIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLF 202
+ + + +ANA++Y H S+ ++HR I+P + L K+
Sbjct: 96 ELQKLSK----FDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 148
Query: 203 DFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFD 262
DF SV P + GT+ +L PE I +EK D++S G+L L G+ F+
Sbjct: 149 DFGWSVHAPSSRRT---TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 205
Query: 263 PSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVC 322
+ E Y + F + V G R+L +
Sbjct: 206 ANTYQET---------YKRISRVEFTFPDFVTE----------------GARDLISRLLK 240
Query: 323 ESAEDRPTTVDVAKRLKQIYQH 344
+ RP L+++ +H
Sbjct: 241 HNPSQRPM-------LREVLEH 255
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 124 bits (313), Expect = 4e-34
Identities = 56/296 (18%), Positives = 113/296 (38%), Gaps = 32/296 (10%)
Query: 51 ELEIATNNFDARNVIKDGYAYKFYKGFVED--RTVSVMKFNDILNDGHEDCFNNIIFASK 108
+ E+ + ++ + G + Y+G + TV+V + + + F K
Sbjct: 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVMK 68
Query: 109 LSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIAN 168
H N+++L G C I+ E + L D++ + + L +A I++
Sbjct: 69 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ--EVSAVVLLYMATQISS 126
Query: 169 AIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFL 228
A+ YL + +HR + + E ++ K+ DF LS + + +
Sbjct: 127 AMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 183
Query: 229 APEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE 288
APE + F+ K DV++FG+LL + T P + ++
Sbjct: 184 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-------------------DLSQ 224
Query: 289 FDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344
E+++ E P E + EL C + DRP+ ++ + + ++Q
Sbjct: 225 VYELLEKDYRMERP----EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 2e-33
Identities = 51/315 (16%), Positives = 105/315 (33%), Gaps = 53/315 (16%)
Query: 53 EIATNNFDARNVIKDGYAYKFYKGFVED-------RTVSVMKFNDILNDGHEDCFNN-II 104
E N + V+ G K V+V + + + + +
Sbjct: 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 92
Query: 105 FASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFE------------ 152
++L SH+N++ L G C + ++FE L +++ + F
Sbjct: 93 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152
Query: 153 -------PLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFS 205
L L A +A + +L + +HR + + + G + K+ DF
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFG 209
Query: 206 LSVSIPEGET-CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPS 264
L+ I V+ + ++APE + G + K DV+S+G+LL + + +P
Sbjct: 210 LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV--NPY 267
Query: 265 RGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCES 324
G + F +++ + P + + C
Sbjct: 268 PGIP----------------VDANFYKLIQNGFKMDQP----FYATEEIYIIMQSCWAFD 307
Query: 325 AEDRPTTVDVAKRLK 339
+ RP+ ++ L
Sbjct: 308 SRKRPSFPNLTSFLG 322
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 3e-33
Identities = 55/304 (18%), Positives = 105/304 (34%), Gaps = 45/304 (14%)
Query: 57 NNFDARNVIKDGYAYKFYKGFVED----RTVSVMKFNDILN-DGHEDCFNNIIFASKLSS 111
N+ ++VI +G + K ++ ++ + + + D H D + KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 112 HKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFE------------PLLLSQR 159
H N++ L G C + E + L D + +++ L Q
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 160 LRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKD 219
L A +A + YL + +HR + I + E Y+AK+ DF LS K
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KT 184
Query: 220 KVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHY 279
+ ++A E +N + DV+S+G+LL +++ G L
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC------GMTCAELYEK 238
Query: 280 VKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLK 339
+ + + D +L C E +RP+ + L
Sbjct: 239 LPQGYRLEKPLNCDDE-----------------VYDLMRQCWREKPYERPSFAQILVSLN 281
Query: 340 QIYQ 343
++ +
Sbjct: 282 RMLE 285
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 122 bits (306), Expect = 5e-33
Identities = 55/321 (17%), Positives = 110/321 (34%), Gaps = 54/321 (16%)
Query: 49 IRELEIATNNFDARNVIKDGYAYKFYKG-------FVEDRTVSVMKFNDILNDGHEDCFN 101
+ LE NN + I +G + ++ + V+V + + + F
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 102 NIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHF---------- 151
+ N++KL G C + ++FE + L + + PH
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 152 ----------EPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKL 201
PL +++L IA +A +AYL R +HR + + E + K+
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKI 181
Query: 202 FDFSLSVSIPEGE-TCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKI 260
DF LS +I + + ++ PE I + + DV+++G++L + +
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 261 FDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMC 320
E + D I++ E L +C
Sbjct: 242 PYYGMAHE------------------EVIYYVRDGNILACPENCPLE-----LYNLMRLC 278
Query: 321 VCESAEDRPTTVDVAKRLKQI 341
+ DRP+ + + L+++
Sbjct: 279 WSKLPADRPSFCSIHRILQRM 299
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 7e-33
Identities = 55/300 (18%), Positives = 107/300 (35%), Gaps = 37/300 (12%)
Query: 53 EIATNNFDARNVIKDGYAYKFYKGFVED------RTVSVMKFNDILNDGHEDCFNNIIFA 106
EI + + VI G + YKG ++ V++ + F
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 107 SKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHI 166
SH N+++L G + + +I+ E ++N L + + F L Q + + I
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVL---QLVGMLRGI 119
Query: 167 ANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE--TCVKDKVTGT 224
A + YL + +HR + I ++ + K+ DF LS + + T
Sbjct: 120 AAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176
Query: 225 MGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCI 284
+ + APE I+ F DV+SFG+++ ++T +
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL------------------- 217
Query: 285 ENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344
N+E + ++ P +L + C + RP D+ L ++ +
Sbjct: 218 SNHEVMKAINDGFRLPTP----MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 7e-33
Identities = 47/285 (16%), Positives = 104/285 (36%), Gaps = 30/285 (10%)
Query: 57 NNFDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVL 116
+ + G G + +K + ++ LS H+ ++
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS-HEKLV 62
Query: 117 KLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIG 176
+L G C + R I+ E + N L +++ + + F+ Q L + + A+ YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLES- 118
Query: 177 FSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTG 236
+ LHR + +++ + K+ DF LS + + E + + PE +
Sbjct: 119 --KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 237 DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPI 296
F+ K D+++FG+L+ + + K+ + ++ + + + P
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------ETAEHIAQGL------RLYRPH 224
Query: 297 IVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341
+ SE + C E A++RPT + + +
Sbjct: 225 LASE-----------KVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 1e-32
Identities = 52/266 (19%), Positives = 96/266 (36%), Gaps = 37/266 (13%)
Query: 83 VSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLET--RIPVIVFESVKNRTL 140
+ + + + + + +L H N+++ ++ IV E + L
Sbjct: 34 WKELDYGSMTEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDL 92
Query: 141 ADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLH--IGFSRPILHRKIRPSRIFLDEGYI 198
A I + + L LR+ + A+ H +LHR ++P+ +FLD
Sbjct: 93 ASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN 152
Query: 199 AKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQ 258
KL DF L+ + + K GT +++PE +N +NEK D++S G LL L
Sbjct: 153 VKLGDFGLARILNHDTSFAKA-FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 211
Query: 259 KIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELAL 318
F E+ I +F I P S+ E+
Sbjct: 212 PPFTAFSQKEL-----------AGKIREGKFRRI--PYRYSD-----------ELNEIIT 247
Query: 319 MCVCESAEDRPTTVDVAKRLKQIYQH 344
+ RP+ +++I ++
Sbjct: 248 RMLNLKDYHRPS-------VEEILEN 266
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 2e-32
Identities = 62/279 (22%), Positives = 105/279 (37%), Gaps = 38/279 (13%)
Query: 74 YKGFVEDRT-----VSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETR-I 127
Y G + D +V N I + G F K SH NVL L G CL +
Sbjct: 44 YHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 103
Query: 128 PVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIR 187
P++V +K+ L + I + + + +A + +L + +HR +
Sbjct: 104 PLVVLPYMKHGDLRNFIRNETHNPTV---KDLIGFGLQVAKGMKFLAS---KKFVHRDLA 157
Query: 188 PSRIFLDEGYIAKLFDFSLSVSIPEGE---TCVKDKVTGTMGFLAPEYINTGDFNEKCDV 244
LDE + K+ DF L+ + + E K + ++A E + T F K DV
Sbjct: 158 ARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDV 217
Query: 245 FSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRV 304
+SFG+LL L+T P + + Y+ + ++ P +
Sbjct: 218 WSFGVLLWELMTRGAPPYP------DVNTFDITVYLLQG------RRLLQPEYCPD---- 261
Query: 305 GKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQ 343
E+ L C AE RP+ ++ R+ I+
Sbjct: 262 -------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 3e-32
Identities = 57/329 (17%), Positives = 108/329 (32%), Gaps = 48/329 (14%)
Query: 38 YGKFNPIRGFTIRELEIATNNFDARNVIKDGYAYKFYKGFVED-------RTVSVMKFND 90
Y +P + + E N + G K + TV+V
Sbjct: 4 YVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP 63
Query: 91 ILNDGHEDCFNN-IIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQP 149
+ + + + S L +H N++ L G C +++ E L + + + +
Sbjct: 64 SAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRD 123
Query: 150 HFE--------------PLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE 195
F L L L + +A +A+L S+ +HR + I L
Sbjct: 124 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTH 180
Query: 196 GYIAKLFDFSLSVSIPEGET-CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVL 254
G I K+ DF L+ I VK + ++APE I + + DV+S+G+ L L
Sbjct: 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240
Query: 255 LTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFR 314
+ P +++F +++ P E
Sbjct: 241 FSLGSSPYPGMP------------------VDSKFYKMIKEGFRMLSP----EHAPAEMY 278
Query: 315 ELALMCVCESAEDRPTTVDVAKRLKQIYQ 343
++ C RPT + + +++
Sbjct: 279 DIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 5e-32
Identities = 57/261 (21%), Positives = 99/261 (37%), Gaps = 31/261 (11%)
Query: 83 VSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLAD 142
V +K + + D F + A H+N+++L G L + +V E +L D
Sbjct: 41 VKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLD 99
Query: 143 HIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLF 202
+ ++Q HF LL R AV +A + YL S+ +HR + + L + K+
Sbjct: 100 RLRKHQGHF---LLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIG 153
Query: 203 DFSLSVSIPEGET--CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKI 260
DF L ++P+ + +++ + APE + T F+ D + FG+ L + T +
Sbjct: 154 DFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 213
Query: 261 FDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMC 320
+LH + K E E + + C
Sbjct: 214 PWIGLNGS------QILHKIDKEGERLPRPEDCPQ----------------DIYNVMVQC 251
Query: 321 VCESAEDRPTTVDVAKRLKQI 341
EDRPT V + L +
Sbjct: 252 WAHKPEDRPTFVALRDFLLEA 272
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 7e-32
Identities = 58/278 (20%), Positives = 105/278 (37%), Gaps = 40/278 (14%)
Query: 74 YKGFVED----RTVSVMKF-NDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIP 128
KG+ + +TV+V N+ + +D + + ++++ G C E
Sbjct: 24 KKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 82
Query: 129 VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRP 188
++V E + L ++ QN+ + + + ++ + YL +HR +
Sbjct: 83 MLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAA 135
Query: 189 SRIFLDEGYIAKLFDFSLSVSIPEGETCVK--DKVTGTMGFLAPEYINTGDFNEKCDVFS 246
+ L + AK+ DF LS ++ E K + + APE IN F+ K DV+S
Sbjct: 136 RNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWS 195
Query: 247 FGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVG 305
FG+L+ + GQK + +G E+ +E E P
Sbjct: 196 FGVLMWEAFSYGQKPYRGMKGSEV-----------TAMLEKGERMGC--PAGCPR----- 237
Query: 306 KEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQ 343
+L +C E+RP V RL+ Y
Sbjct: 238 ------EMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 3e-31
Identities = 54/299 (18%), Positives = 102/299 (34%), Gaps = 35/299 (11%)
Query: 51 ELEIATNNFDARNVIKDGYAYKFYKGFVED-----RTVSVMKFNDILNDGHEDCFNNIIF 105
+ EI + I +G ++G V++ + +D + F
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 106 ASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVH 165
+ H +++KL G E + I+ E L + + + L+ + A
Sbjct: 61 TMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYSLD---LASLILYAYQ 116
Query: 166 IANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTM 225
++ A+AYL S+ +HR I + + KL DF LS + + K +
Sbjct: 117 LSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 173
Query: 226 GFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIE 285
++APE IN F DV+ FG+ + +L P +G + + ++ ++ E
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGV--KPFQGVK----NNDVIGRIENG-E 226
Query: 286 NNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344
P L C RP ++ +L I +
Sbjct: 227 RLPMPPNCPP----------------TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 7e-30
Identities = 49/272 (18%), Positives = 94/272 (34%), Gaps = 39/272 (14%)
Query: 74 YKGF-VEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132
Y V ++ ++ ++ N I + + + N++ L +V
Sbjct: 37 YTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96
Query: 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIF 192
E + +L D + + Q + A+ +LH S ++HR I+ I
Sbjct: 97 EYLAGGSLTDVVTETCMD-----EGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNIL 148
Query: 193 LDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLL 252
L KL DF I ++ V GT ++APE + + K D++S G++ +
Sbjct: 149 LGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAI 207
Query: 253 VLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQG 312
++ G+ + I N E+ +P +S
Sbjct: 208 EMIEGEPPYLNENPLR-----------ALYLIATNGTPELQNPEKLSA-----------I 245
Query: 313 FRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344
FR+ C+ E R + K++ QH
Sbjct: 246 FRDFLNRCLDMDVEKRGS-------AKELLQH 270
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (282), Expect = 1e-29
Identities = 56/315 (17%), Positives = 105/315 (33%), Gaps = 47/315 (14%)
Query: 51 ELEIATNNFDARNVIKDGYAYKFYKGFVED-------RTVSVMKFN-DILNDGHEDCFNN 102
+ E + + G + + RTV+V + H +
Sbjct: 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 66
Query: 103 IIFASKLSSHKNVLKLTGCCLETRIPV-IVFESVKNRTLADHIYQNQPHFEP-------- 153
+ + H NV+ L G C + P+ ++ E K L+ ++ + F P
Sbjct: 67 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126
Query: 154 ----LLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVS 209
L L + + +A + +L SR +HR + I L E + K+ DF L+
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARD 183
Query: 210 IPEGETCVKDK-VTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDE 268
I + V+ + ++APE I + + DV+SFG+LL + + P
Sbjct: 184 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP----- 238
Query: 269 IGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDR 328
+ + ++ D + L C R
Sbjct: 239 ----GVKIDEEFCRRLKEGTRMRAPDYTT-------------PEMYQTMLDCWHGEPSQR 281
Query: 329 PTTVDVAKRLKQIYQ 343
PT ++ + L + Q
Sbjct: 282 PTFSELVEHLGNLLQ 296
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 112 bits (282), Expect = 2e-29
Identities = 49/265 (18%), Positives = 87/265 (32%), Gaps = 45/265 (16%)
Query: 83 VSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLAD 142
+ M ++ ++ + + H N ++ GC L +V E
Sbjct: 45 IKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDL 104
Query: 143 HIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLF 202
+P E + + +AYLH S ++HR ++ I L E + KL
Sbjct: 105 LEVHKKPLQEV----EIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLG 157
Query: 203 DFSLSVSIPEGETCVKDKVTGTMGFLAPEYI---NTGDFNEKCDVFSFGMLLLVLLTGQK 259
DF + + + V GT ++APE I + G ++ K DV+S G+ + L +
Sbjct: 158 DFGSASIMAPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212
Query: 260 IFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALM 319
I NE + FR
Sbjct: 213 PLFNMNAMSA-----------LYHIAQNESPALQSGHWSEY------------FRNFVDS 249
Query: 320 CVCESAEDRPTTVDVAKRLKQIYQH 344
C+ + +DRPT + + +H
Sbjct: 250 CLQKIPQDRPT-------SEVLLKH 267
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 3e-29
Identities = 51/269 (18%), Positives = 100/269 (37%), Gaps = 39/269 (14%)
Query: 74 YKGFVED--RTVSVMKFND-ILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLET----R 126
YKG + V+ + D L F K H N+++ T +
Sbjct: 26 YKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 85
Query: 127 IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKI 186
V+V E + + TL ++ + + + + I + +LH + PI+HR +
Sbjct: 86 CIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDL 140
Query: 187 RPSRIFL-DEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVF 245
+ IF+ K+ D L+ V GT F+APE ++E DV+
Sbjct: 141 KCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFMAPEMYE-EKYDESVDVY 196
Query: 246 SFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVG 305
+FGM +L + T + + + + V ++ FD++ P
Sbjct: 197 AFGMCMLEMATSEYPYSECQNAA------QIYRRVTSGVKPASFDKVAIP---------- 240
Query: 306 KEKQLQGFRELALMCVCESAEDRPTTVDV 334
+E+ C+ ++ ++R + D+
Sbjct: 241 ------EVKEIIEGCIRQNKDERYSIKDL 263
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 4e-29
Identities = 59/307 (19%), Positives = 120/307 (39%), Gaps = 40/307 (13%)
Query: 51 ELEIATNNFDARNVIKDGYAYKFYKGF-------VEDRTVSVMKFNDILNDGHEDCFNNI 103
E E+A + G Y+G + V++ N+ + F N
Sbjct: 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73
Query: 104 IFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQ------NQPHFEPLLLS 157
K + +V++L G + + +++ E + L ++ N P P LS
Sbjct: 74 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 158 QRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE-TC 216
+ +++A IA+ +AYL+ + +HR + + E + K+ DF ++ I E +
Sbjct: 134 KMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190
Query: 217 VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWL 276
K + +++PE + G F DV+SFG++L + T + +E +
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------QV 244
Query: 277 LHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336
L +V + ++ D D EL MC + + RP+ +++
Sbjct: 245 LRFVMEGGLLDKPDNCPDM-----------------LFELMRMCWQYNPKMRPSFLEIIS 287
Query: 337 RLKQIYQ 343
+K+ +
Sbjct: 288 SIKEEME 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 4e-29
Identities = 48/265 (18%), Positives = 90/265 (33%), Gaps = 39/265 (14%)
Query: 90 DILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQP 149
D D + + + HKN++ L G C + ++ E L +++ +P
Sbjct: 56 DATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRP 115
Query: 150 H------------FEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGY 197
E L + A +A + YL S+ +HR + + + E
Sbjct: 116 PGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDN 172
Query: 198 IAKLFDFSLSVSIPEGETCVKDKVT-GTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT 256
+ K+ DF L+ I + K + ++APE + + + DV+SFG+LL + T
Sbjct: 173 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232
Query: 257 GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFREL 316
P E L +K+ ++ + +
Sbjct: 233 LGGSPYPGVPVE------ELFKLLKEGHRMDKPSNCTNE-----------------LYMM 269
Query: 317 ALMCVCESAEDRPTTVDVAKRLKQI 341
C RPT + + L +I
Sbjct: 270 MRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 4e-29
Identities = 52/277 (18%), Positives = 93/277 (33%), Gaps = 42/277 (15%)
Query: 74 YKGF-VEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132
YK E ++ K D ++ + + I H N++KL I+
Sbjct: 29 YKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88
Query: 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIF 192
E + + + + PL SQ + +A+ YLH I+HR ++ I
Sbjct: 89 EFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNIL 142
Query: 193 LDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYI-----NTGDFNEKCDVFSF 247
KL DF +S +D GT ++APE + ++ K DV+S
Sbjct: 143 FTLDGDIKLADFGVSAKNTRTIQR-RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSL 201
Query: 248 GMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKE 307
G+ L+ + + + I +E + P S
Sbjct: 202 GITLIEMAEIEPPHHELNPMRV-----------LLKIAKSEPPTLAQPSRWSS------- 243
Query: 308 KQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344
F++ C+ ++ + R T Q+ QH
Sbjct: 244 ----NFKDFLKKCLEKNVDARWT-------TSQLLQH 269
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 1e-28
Identities = 57/267 (21%), Positives = 97/267 (36%), Gaps = 38/267 (14%)
Query: 80 DRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRT 139
+ V+V + + I +K+ +H+NV+K G E I + E
Sbjct: 30 EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 89
Query: 140 LADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIA 199
L D I + EP R + + YLH I HR I+P + LDE
Sbjct: 90 LFDRIEPDIGMPEP----DAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNL 142
Query: 200 KLFDFSLSVSI-PEGETCVKDKVTGTMGFLAPEYINTGDFN-EKCDVFSFGMLLLVLLTG 257
K+ DF L+ + +K+ GT+ ++APE + +F+ E DV+S G++L +L G
Sbjct: 143 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 202
Query: 258 QKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELA 317
+ +D + +K N + +I L
Sbjct: 203 ELPWDQPSDSCQ-----EYSDWKEKKTYLNPWKKIDSA-----------------PLALL 240
Query: 318 LMCVCESAEDRPTTVDVAKRLKQIYQH 344
+ E+ R T + I +
Sbjct: 241 HKILVENPSARIT-------IPDIKKD 260
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 1e-28
Identities = 40/276 (14%), Positives = 94/276 (34%), Gaps = 31/276 (11%)
Query: 70 AYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV 129
+G V++ + + + + + + +V +L G CL + +
Sbjct: 28 GLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ- 86
Query: 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPS 189
++ + + L D++ +++ + L V IA + YL R ++HR +
Sbjct: 87 LITQLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMNYLED---RRLVHRDLAAR 140
Query: 190 RIFLDEGYIAKLFDFSLSVSIPEGET-CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFG 248
+ + K+ DF L+ + E + + ++A E I + + DV+S+G
Sbjct: 141 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 200
Query: 249 MLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEK 308
+ + L+T + +E E P I +
Sbjct: 201 VTVWELMTFGSKPYDGIPASE----------ISSILEKGERLPQ--PPICTI-------- 240
Query: 309 QLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344
+ + C A+ RP ++ ++ +
Sbjct: 241 ---DVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 106 bits (265), Expect = 8e-27
Identities = 44/274 (16%), Positives = 86/274 (31%), Gaps = 39/274 (14%)
Query: 74 YKGF-VEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132
++ KF ++ ++ I + H ++ L + V+++
Sbjct: 43 HRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102
Query: 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIF 192
E + L + + + + + + ++H +H ++P I
Sbjct: 103 EFMSGGELFEKVADEHNKMSE---DEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIM 156
Query: 193 L--DEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGML 250
KL DF L+ + ++ TGT F APE D++S G+L
Sbjct: 157 FTTKRSNELKLIDFGLTAHLDPKQSV--KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVL 214
Query: 251 LLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQL 310
+LL+G F DE L VK C + D+ I +
Sbjct: 215 SYILLSGLSPFGGENDDE-------TLRNVKSC--DWNMDDSAFSGISED---------- 255
Query: 311 QGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344
++ + R T + Q +H
Sbjct: 256 --GKDFIRKLLLADPNTRMT-------IHQALEH 280
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 9e-27
Identities = 44/263 (16%), Positives = 85/263 (32%), Gaps = 34/263 (12%)
Query: 83 VSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLAD 142
+ +++ I+ + H +KL + KN L
Sbjct: 38 IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 97
Query: 143 HIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLF 202
+I + I +A+ YLH + I+HR ++P I L+E ++
Sbjct: 98 YIR----KIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQIT 150
Query: 203 DFSLS-VSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIF 261
DF + V PE + + GT +++PE + + D+++ G ++ L+ G F
Sbjct: 151 DFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 210
Query: 262 DPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCV 321
Y + + K +F E P R+L +
Sbjct: 211 R-------AGNEYLIFQKIIKL--EYDFPEKFFP----------------KARDLVEKLL 245
Query: 322 CESAEDRPTTVDVAKRLKQIYQH 344
A R + + + H
Sbjct: 246 VLDATKRL-GCEEMEGYGPLKAH 267
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 103 bits (259), Expect = 6e-26
Identities = 51/274 (18%), Positives = 90/274 (32%), Gaps = 39/274 (14%)
Query: 74 YKGF-VEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132
++ V V KF + + N I H ++ L + V++
Sbjct: 46 HRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105
Query: 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIF 192
E + L D I ++ + + ++H I+H I+P I
Sbjct: 106 EFLSGGELFDRIAAEDYKMSE---AEVINYMRQACEGLKHMH---EHSIVHLDIKPENIM 159
Query: 193 LD--EGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGML 250
+ + K+ DF L+ + E T T F APE ++ D+++ G+L
Sbjct: 160 CETKKASSVKIIDFGLATKLNPDEIV--KVTTATAEFAAPEIVDREPVGFYTDMWAIGVL 217
Query: 251 LLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQL 310
VLL+G F G L VK+C + EFDE + E
Sbjct: 218 GYVLLSGLSPFA-------GEDDLETLQNVKRC--DWEFDEDAFSSVSPE---------- 258
Query: 311 QGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344
++ + + R T + +H
Sbjct: 259 --AKDFIKNLLQKEPRKRLT-------VHDALEH 283
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 101 bits (252), Expect = 2e-25
Identities = 56/271 (20%), Positives = 97/271 (35%), Gaps = 43/271 (15%)
Query: 80 DRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRT 139
D T + + + E + K+S H N+++L +VF+ +K
Sbjct: 37 DVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGE 96
Query: 140 LADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIA 199
L D++ + L + +I + I LH I+HR ++P I LD+
Sbjct: 97 LFDYLTEKV----TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNI 149
Query: 200 KLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYI------NTGDFNEKCDVFSFGMLLLV 253
KL DF S + GE +V GT +LAPE I N + ++ D++S G+++
Sbjct: 150 KLTDFGFSCQLDPGEKL--REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYT 207
Query: 254 LLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGF 313
LL G F +L + E D S+
Sbjct: 208 LLAGSPPFW-------HRKQMLMLRMIMSGNYQFGSPEWDD---YSD-----------TV 246
Query: 314 RELALMCVCESAEDRPTTVDVAKRLKQIYQH 344
++L + + R T ++ H
Sbjct: 247 KDLVSRFLVVQPQKRYT-------AEEALAH 270
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.7 bits (248), Expect = 2e-24
Identities = 44/250 (17%), Positives = 78/250 (31%), Gaps = 38/250 (15%)
Query: 97 EDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLL 156
+ I ++ H+N+L L V++FE + + + I +
Sbjct: 45 QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNE--- 101
Query: 157 SQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLD--EGYIAKLFDFSLSVSIPEGE 214
+ + + A+ +LH S I H IRP I K+ +F + + G+
Sbjct: 102 REIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158
Query: 215 TCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHY 274
+ + APE + D++S G L+ VLL+G F +I
Sbjct: 159 NF--RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI----- 211
Query: 275 WLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDV 334
FDE I E + + + + R T
Sbjct: 212 ----IENIMNAEYTFDEEAFKEISIE------------AMDFVDRLLVKERKSRMT---- 251
Query: 335 AKRLKQIYQH 344
+ QH
Sbjct: 252 ---ASEALQH 258
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 100 bits (249), Expect = 2e-24
Identities = 48/296 (16%), Positives = 95/296 (32%), Gaps = 42/296 (14%)
Query: 57 NNFDARNVIKDGYAYKFYKGFVED--RTVSV--MKFNDILNDGHEDCFNNIIFASKLSS- 111
N+F +I G + Y D + ++ + I E N L S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 112 --HKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANA 169
++ ++ + + + L H+ Q+ E A I
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA----DMRFYAAEIILG 119
Query: 170 IAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLA 229
+ ++H +R +++R ++P+ I LDE ++ D L+ + + GT G++A
Sbjct: 120 LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMA 173
Query: 230 PEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE 288
PE + G ++ D FS G +L LL G F + + E
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD------KHEIDRMTLTMAVE 227
Query: 289 FDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344
+ P R L + R + + +++ +
Sbjct: 228 LPDSFSP----------------ELRSLLEGLLQRDVNRRLGC--LGRGAQEVKES 265
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 97.9 bits (243), Expect = 3e-24
Identities = 46/267 (17%), Positives = 98/267 (36%), Gaps = 35/267 (13%)
Query: 83 VSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLET----RIPVIVFESVKNR 138
V V++ + + F + +H ++ + +P IV E V
Sbjct: 37 VKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGV 96
Query: 139 TLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYI 198
TL D ++ P+ + + + A+ + H I+HR ++P+ I +
Sbjct: 97 TLRDIVH----TEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNA 149
Query: 199 AKLFDFSLSVSIPEGETCVKDK--VTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT 256
K+ DF ++ +I + V V GT +L+PE + + DV+S G +L +LT
Sbjct: 150 VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 209
Query: 257 GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFREL 316
G+ F + + E+ + ++ +
Sbjct: 210 GEPPFTGDSPVSV---------AYQHVREDPIPPSARHEGLSAD------------LDAV 248
Query: 317 ALMCVCESAEDRPTTV-DVAKRLKQIY 342
L + ++ E+R T ++ L +++
Sbjct: 249 VLKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 98.6 bits (245), Expect = 3e-24
Identities = 56/300 (18%), Positives = 101/300 (33%), Gaps = 42/300 (14%)
Query: 50 RELEIATNNFDARNVIKDGYAYKFYKGF--VEDRTVSVMKFNDILNDGHEDCFNNIIFAS 107
++ E + +D R+V+ G + + V++ +G E N I
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 108 KLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIA 167
H N++ L ++ + V L D I + R+ +
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF----YTERDASRLIFQVL 117
Query: 168 NAIAYLHIGFSRPILHRKIRPSRIFL---DEGYIAKLFDFSLSVSIPEGETCVKDKVTGT 224
+A+ YLH I+HR ++P + DE + DF LS G GT
Sbjct: 118 DAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL--STACGT 172
Query: 225 MGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCI 284
G++APE + +++ D +S G++ +LL G F ++ + +
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL---------FEQILK 223
Query: 285 ENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344
EFD I ++ + + E R T +Q QH
Sbjct: 224 AEYEFDSPYWDDISDS------------AKDFIRHLMEKDPEKRFT-------CEQALQH 264
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.9 bits (243), Expect = 6e-24
Identities = 53/263 (20%), Positives = 89/263 (33%), Gaps = 40/263 (15%)
Query: 83 VSVMKFNDILNDGHEDCF-NNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLA 141
+ +K + +L D +C S H + + V E + L
Sbjct: 32 IKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLM 91
Query: 142 DHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKL 201
HI LS+ A I + +LH S+ I++R ++ I LD+ K+
Sbjct: 92 YHIQSCHK----FDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKI 144
Query: 202 FDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIF 261
DF + G+ GT ++APE + +N D +SFG+LL +L GQ F
Sbjct: 145 ADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 203
Query: 262 DPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCV 321
G L H ++ +N + ++ ++L +
Sbjct: 204 H-------GQDEEELFHSIRM--DNPFYPRWLEK----------------EAKDLLVKLF 238
Query: 322 CESAEDRPTTVDVAKRLKQIYQH 344
E R I QH
Sbjct: 239 VREPEKRLGVRG------DIRQH 255
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.2 bits (236), Expect = 7e-23
Identities = 45/251 (17%), Positives = 83/251 (33%), Gaps = 38/251 (15%)
Query: 101 NNIIFASKLSSHKNVLKLTGCC----LETRIPVIVFESVKNRTLADHIYQNQPHFEPLLL 156
+ + S +++++ + +IV E + L I
Sbjct: 53 REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ--AFTE 110
Query: 157 SQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLD---EGYIAKLFDFSLSVSIPEG 213
+ I I AI YLH S I HR ++P + I KL DF +
Sbjct: 111 REASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 167
Query: 214 ETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGH 273
+ T ++APE + +++ CD++S G+++ +LL G F + G I G
Sbjct: 168 NSL--TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM 225
Query: 274 YWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVD 333
+ + N E+ E+ + + L + R T
Sbjct: 226 KTRIRMGQYEFPNPEWSEVSEE-----------------VKMLIRNLLKTEPTQRMT--- 265
Query: 334 VAKRLKQIYQH 344
+ + H
Sbjct: 266 ----ITEFMNH 272
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 94.8 bits (235), Expect = 8e-23
Identities = 40/187 (21%), Positives = 86/187 (45%), Gaps = 11/187 (5%)
Query: 83 VSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLAD 142
+ V+K ++ + N+ + +H ++++ G + + ++ + ++ L
Sbjct: 34 MKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFS 93
Query: 143 HIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLF 202
+ ++Q P A + A+ YLH S+ I++R ++P I LD+ K+
Sbjct: 94 LLRKSQRFPNP----VAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKIT 146
Query: 203 DFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFD 262
DF + +P+ + GT ++APE ++T +N+ D +SFG+L+ +L G F
Sbjct: 147 DFGFAKYVPDVTY----TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY 202
Query: 263 PSRGDEI 269
S +
Sbjct: 203 DSNTMKT 209
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.1 bits (225), Expect = 1e-21
Identities = 38/261 (14%), Positives = 82/261 (31%), Gaps = 17/261 (6%)
Query: 83 VSVMKFNDILNDGHEDCFNNIIFASKLSS--HKNVLKLTGCCLETRIP-----VIVFESV 135
+ ++ + L + H NV++L C +R +VFE V
Sbjct: 38 LKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV 97
Query: 136 KNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE 195
+P + + + + +LH S ++HR ++P I +
Sbjct: 98 DQDLTTYLDKVPEP---GVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTS 151
Query: 196 GYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLL 255
KL DF L+ V T+ + APE + + D++S G + +
Sbjct: 152 SGQIKLADFGLARIYSFQMAL--TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 209
Query: 256 TGQKIFDPSRGDEIGAGHYWLLHYVKK--CIENNEFDEIVDPIIVSEGPRVGKEKQLQGF 313
+ +F S + ++ + + ++ +
Sbjct: 210 RRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELG 269
Query: 314 RELALMCVCESAEDRPTTVDV 334
++L L C+ + R +
Sbjct: 270 KDLLLKCLTFNPAKRISAYSA 290
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.3 bits (223), Expect = 3e-21
Identities = 44/257 (17%), Positives = 78/257 (30%), Gaps = 21/257 (8%)
Query: 93 NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFE 152
DG I + SH N++ L +VF+ ++ +
Sbjct: 40 KDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTP 99
Query: 153 PLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212
S + + YLH ILHR ++P+ + LDE + KL DF L+ S
Sbjct: 100 ----SHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 152
Query: 213 GETCVKDKVTGTMGFLAPEYINTGD-FNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGA 271
+V T + APE + + D+++ G +L LL +
Sbjct: 153 PNRAYTHQV-VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT 211
Query: 272 GHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQG----FRELALMCVCESAED 327
+ L + + + D + P + +L +
Sbjct: 212 RIFETL-GTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCA 270
Query: 328 RPTTVDVAKRLKQIYQH 344
R T Q +
Sbjct: 271 RIT-------ATQALKM 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.7 bits (219), Expect = 2e-20
Identities = 45/256 (17%), Positives = 83/256 (32%), Gaps = 23/256 (8%)
Query: 100 FNNIIFASKLSSHKNVLKLTGCCLETRIP------VIVFESVKNRTLADHIYQNQPHFEP 153
N + + H N+++L + +V + V + ++ +
Sbjct: 60 KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QT 118
Query: 154 LLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIAKLFDFSLSVSIPE 212
L + + ++AY+H S I HR I+P + LD + + KL DF + +
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175
Query: 213 GETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAG 272
GE + D+ DV+S G +L LL GQ IF G +
Sbjct: 176 GEPN-VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234
Query: 273 HYWLL----HYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDR 328
+L + + N + I +V + + L + + R
Sbjct: 235 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294
Query: 329 PTTVDVAKRLKQIYQH 344
T + H
Sbjct: 295 LT-------PLEACAH 303
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.1 bits (215), Expect = 3e-20
Identities = 49/266 (18%), Positives = 87/266 (32%), Gaps = 41/266 (15%)
Query: 83 VSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLAD 142
+ + + + K H NV+ L +++ E V L D
Sbjct: 43 IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 102
Query: 143 HIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE----GYI 198
+ + + E + I N + YLH S I H ++P I L +
Sbjct: 103 FLAEKESLTEE----EATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPR 155
Query: 199 AKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQ 258
K+ DF L+ I G + GT F+APE +N + D++S G++ +LL+G
Sbjct: 156 IKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 213
Query: 259 KIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELAL 318
F E N EF++ + ++
Sbjct: 214 SPFLGDTKQET---------LANVSAVNYEFEDEYFSNTSAL------------AKDFIR 252
Query: 319 MCVCESAEDRPTTVDVAKRLKQIYQH 344
+ + + R T ++ QH
Sbjct: 253 RLLVKDPKKRMT-------IQDSLQH 271
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 87.2 bits (215), Expect = 3e-20
Identities = 34/261 (13%), Positives = 76/261 (29%), Gaps = 33/261 (12%)
Query: 92 LNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHF 151
+ H + + + C E V+V E + + ++
Sbjct: 42 VKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFS 101
Query: 152 EPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIF---LDEGYIAKLFDFSLSV 208
L +A + + I Y+H S+ +HR ++P +G + + DF L+
Sbjct: 102 LK----TVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154
Query: 209 SIPEGET------CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFD 262
+ T +TGT + + + + + D+ S G +L+ G +
Sbjct: 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 214
Query: 263 PSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVC 322
+ Y + + V F C
Sbjct: 215 GLKAATK------RQKYERISEKKMSTPIEVLCKGYPS-----------EFATYLNFCRS 257
Query: 323 ESAEDRPTTVDVAKRLKQIYQ 343
+D+P + + + ++
Sbjct: 258 LRFDDKPDYSYLRQLFRNLFH 278
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 86.4 bits (213), Expect = 6e-20
Identities = 27/284 (9%), Positives = 81/284 (28%), Gaps = 37/284 (13%)
Query: 74 YKGF-VEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132
++G + + +KF +D + L+ + + E V+V
Sbjct: 22 FEGTNLLNNQQVAIKFEPRRSD-APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80
Query: 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIF 192
+ + + A + + +H + +++R I+P
Sbjct: 81 DLLGPSLEDLLDLCGRKFSVK----TVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFL 133
Query: 193 LDEGYI-----AKLFDFSLSVSIPEGET------CVKDKVTGTMGFLAPEYINTGDFNEK 241
+ + DF + + T K ++GT +++ + + +
Sbjct: 134 IGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRR 193
Query: 242 CDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEG 301
D+ + G + + L G + + + + + ++ E+
Sbjct: 194 DDLEALGHVFMYFLRGSLPWQGLKAAT----NKQKYERIGEKKQSTPLRELCAGFP---- 245
Query: 302 PRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHL 345
+ F + + + P + ++ + L
Sbjct: 246 ---------EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.4 bits (210), Expect = 1e-19
Identities = 36/267 (13%), Positives = 77/267 (28%), Gaps = 20/267 (7%)
Query: 83 VSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLAD 142
+ ++ +D I +L HKN+++L + +VFE
Sbjct: 32 LKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKY 90
Query: 143 HIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLF 202
N + + + H R +LHR ++P + ++ KL
Sbjct: 91 FDSCNGDLDPE----IVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLA 143
Query: 203 DFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFD 262
+F L+ + C +V ++ D++S G + L +
Sbjct: 144 NFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203
Query: 263 PSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQL-----QGFRELA 317
P + + L + ++ D P + R+L
Sbjct: 204 PGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLL 263
Query: 318 LMCVCESAEDRPTTVDVAKRLKQIYQH 344
+ + R + ++ QH
Sbjct: 264 QNLLKCNPVQRIS-------AEEALQH 283
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 84.6 bits (208), Expect = 2e-19
Identities = 44/277 (15%), Positives = 86/277 (31%), Gaps = 20/277 (7%)
Query: 74 YKGFVEDRTVSVMKF--NDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131
YK +K + ++G I K H N++KL + V+V
Sbjct: 19 YKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78
Query: 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRI 191
FE + + + N IAY H R +LHR ++P +
Sbjct: 79 FEHLDQDLKKLLDVCEGGLESV----TAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNL 131
Query: 192 FLDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLL 251
++ K+ DF L+ + ++ + + ++ D++S G +
Sbjct: 132 LINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIF 191
Query: 252 LVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQ 311
++ G +F + + +L N + + + E L+
Sbjct: 192 AEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLK 251
Query: 312 G----FRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344
G +L + R T KQ +H
Sbjct: 252 GLDESGIDLLSKMLKLDPNQRIT-------AKQALEH 281
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.5 bits (208), Expect = 5e-19
Identities = 42/286 (14%), Positives = 89/286 (31%), Gaps = 30/286 (10%)
Query: 74 YKGF--VEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCC----LETRI 127
+ V V++ K + + + I H+N++ + +E
Sbjct: 25 CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84
Query: 128 PVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIR 187
V + + L + + L I + Y+H S +LHR ++
Sbjct: 85 DVYLVTHLMGADLYKLL-----KTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLK 136
Query: 188 PSRIFLDEGYIAKLFDFSLSVSIPEGET--CVKDKVTGTMGFLAPEYINTGD-FNEKCDV 244
PS + L+ K+ DF L+ + T + APE + + + D+
Sbjct: 137 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 196
Query: 245 FSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRV 304
+S G +L +L+ + IF + +L + N + ++S +
Sbjct: 197 WSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKN 256
Query: 305 GKEKQL------QGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344
+L + + R ++Q H
Sbjct: 257 KVPWNRLFPNADSKALDLLDKMLTFNPHKRIE-------VEQALAH 295
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.8 bits (204), Expect = 7e-19
Identities = 31/163 (19%), Positives = 58/163 (35%), Gaps = 12/163 (7%)
Query: 103 IIFASKLSS-HKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLR 161
++ K+SS V++L V++ E + + +
Sbjct: 58 VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE---ELARS 114
Query: 162 IAVHIANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIAKLFDFSLSVSIPEGETCVKDK 220
+ A+ + H + +LHR I+ I +D KL DF + +
Sbjct: 115 FFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT---D 168
Query: 221 VTGTMGFLAPEYINTGDF-NEKCDVFSFGMLLLVLLTGQKIFD 262
GT + PE+I + V+S G+LL ++ G F+
Sbjct: 169 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 211
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.3 bits (205), Expect = 1e-18
Identities = 33/187 (17%), Positives = 67/187 (35%), Gaps = 8/187 (4%)
Query: 83 VSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLAD 142
+ +++ I+ + + H + L V E L
Sbjct: 35 MKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFF 94
Query: 143 HIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLF 202
H+ + + E R + A ++ L SR +++R I+ + LD+ K+
Sbjct: 95 HLSRERVFTEE-------RARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKIT 147
Query: 203 DFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFD 262
DF L +K GT +LAPE + D+ D + G+++ ++ G+ F
Sbjct: 148 DFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 206
Query: 263 PSRGDEI 269
+ +
Sbjct: 207 NQDHERL 213
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.6 bits (203), Expect = 1e-18
Identities = 37/266 (13%), Positives = 82/266 (30%), Gaps = 18/266 (6%)
Query: 83 VSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLAD 142
+ ++ + I +L+ H N++KL +VFE + ++ L
Sbjct: 32 LKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK 89
Query: 143 HIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLF 202
+ + + L + +A+ H S +LHR ++P + ++ KL
Sbjct: 90 FMDAS--ALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLA 144
Query: 203 DFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFD 262
DF L+ + +V + ++ D++S G + ++T + +F
Sbjct: 145 DFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP 204
Query: 263 PSRGDE----IGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELAL 318
+ I V + + + P + + R L
Sbjct: 205 GDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLS 264
Query: 319 MCVCESAEDRPTTVDVAKRLKQIYQH 344
+ R + K H
Sbjct: 265 QMLHYDPNKRIS-------AKAALAH 283
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.8 bits (188), Expect = 2e-16
Identities = 47/266 (17%), Positives = 89/266 (33%), Gaps = 34/266 (12%)
Query: 83 VSVMKFNDILND--GHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTL 140
+ V+K I+ E + ++ L ++ + + L
Sbjct: 57 MKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGEL 116
Query: 141 ADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAK 200
H+ Q + E + +++ + L I++R I+ I LD
Sbjct: 117 FTHLSQRERFTEH-------EVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVV 169
Query: 201 LFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGD--FNEKCDVFSFGMLLLVLLTGQ 258
L DF LS ET GT+ ++AP+ + GD ++ D +S G+L+ LLTG
Sbjct: 170 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
Query: 259 KIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELAL 318
F G + + I +E P +S ++L
Sbjct: 230 SPFT-------VDGEKNSQAEISRRILKSEPPY---PQEMSA-----------LAKDLIQ 268
Query: 319 MCVCESAEDRPTTVDVAKRLKQIYQH 344
+ + + R + +I +H
Sbjct: 269 RLLMKDPKKRLGC--GPRDADEIKEH 292
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 76.8 bits (188), Expect = 2e-16
Identities = 34/187 (18%), Positives = 72/187 (38%), Gaps = 11/187 (5%)
Query: 83 VSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLAD 142
+ ++ ++ + N + + ++KL + +V E V +
Sbjct: 71 MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130
Query: 143 HIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLF 202
H+ + EP A I YLH S +++R ++P + +D+ ++
Sbjct: 131 HLRRIGRFSEP----HARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVT 183
Query: 203 DFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFD 262
DF + + + GT LAPE I + +N+ D ++ G+L+ + G F
Sbjct: 184 DFGFAKRVKGRTWTLC----GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239
Query: 263 PSRGDEI 269
+ +I
Sbjct: 240 ADQPIQI 246
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.3 bits (184), Expect = 6e-16
Identities = 45/285 (15%), Positives = 88/285 (30%), Gaps = 34/285 (11%)
Query: 80 DRTVSVMKFN-DILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV--------I 130
+ V++ K + +G I +L H+NV+ L C P +
Sbjct: 35 GQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYL 94
Query: 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSR 190
VF+ ++ S+ R+ + N L+ ILHR ++ +
Sbjct: 95 VFDFCEHDLAGLLSNVLVKFTL----SEIKRVMQMLLNG---LYYIHRNKILHRDMKAAN 147
Query: 191 IFLDEGYIAKLFDFSLSVSIPEGETCVKDKVT---GTMGFLAPEYI-NTGDFNEKCDVFS 246
+ + + KL DF L+ + + ++ T T+ + PE + D+ D++
Sbjct: 148 VLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWG 207
Query: 247 FGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVK-------KCIENNEFDEIVDPIIVS 299
G ++ + T I + A L + E E E+V
Sbjct: 208 AGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRK 267
Query: 300 EGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344
R+ + +L + R H
Sbjct: 268 VKDRLKAYVRDPYALDLIDKLLVLDPAQRID-------SDDALNH 305
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 74.9 bits (183), Expect = 9e-16
Identities = 52/318 (16%), Positives = 111/318 (34%), Gaps = 30/318 (9%)
Query: 42 NPIRGFTIRELEIATNNFDARNVIKD----GYAYKFYKGF-VEDRTVSVMKFNDILNDGH 96
P + + N D +++ Y+ + ++ + + V+K +
Sbjct: 17 RPREYWDYESHVVEWGNQDDYQLVRKLGRGKYS-EVFEAINITNNEKVVVKI--LKPVKK 73
Query: 97 EDCFNNIIFASKLSSHKNVLKLTGCCLE--TRIPVIVFESVKNRTLADHIYQNQPHFEPL 154
+ I L N++ L + +R P +VFE V N + L
Sbjct: 74 KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTL 126
Query: 155 LLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIAKLFDFSLSVSIPEG 213
I A+ Y H S I+HR ++P + +D E +L D+ L+ G
Sbjct: 127 TDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183
Query: 214 ETCVKDKVTGTMGFLAPE-YINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGD-EIGA 271
+ + + F PE ++ ++ D++S G +L ++ ++ F + +
Sbjct: 184 QEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 241
Query: 272 GHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAED---R 328
+L ++++ +DP R +++ + V A D +
Sbjct: 242 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 301
Query: 329 PTTVDVAKRL--KQIYQH 344
D RL ++ +H
Sbjct: 302 LLRYDHQSRLTAREAMEH 319
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.7 bits (180), Expect = 2e-15
Identities = 39/272 (14%), Positives = 82/272 (30%), Gaps = 20/272 (7%)
Query: 80 DRTVSVMKFN-DILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNR 138
V++ K ++ + K H+NV+ L +
Sbjct: 43 GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM 102
Query: 139 TLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYI 198
E L + + + + Y+H + I+HR ++P + ++E
Sbjct: 103 PFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCE 159
Query: 199 AKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQ 258
K+ DF L+ T V +N + + D++S G ++ ++TG+
Sbjct: 160 LKILDFGLARQADSEMT---GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216
Query: 259 KIF----DPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGK--EKQLQG 312
+F + EI + ++++E + + E
Sbjct: 217 TLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPL 276
Query: 313 FRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344
L + AE R T + H
Sbjct: 277 AVNLLEKMLVLDAEQRVT-------AGEALAH 301
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.9 bits (157), Expect = 2e-12
Identities = 49/274 (17%), Positives = 93/274 (33%), Gaps = 24/274 (8%)
Query: 80 DRTVSVMKFN-DILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNR 138
V+V K + + H + K H+NV+ L R +
Sbjct: 43 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 102
Query: 139 TLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYI 198
L N + L + I + Y+H S I+HR ++PS + ++E
Sbjct: 103 HLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCE 159
Query: 199 AKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQ 258
K+ DF L+ + + V +N +N+ D++S G ++ LLTG+
Sbjct: 160 LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
Query: 259 KIFDPSRGDE----IGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFR 314
+F + + I + K I + + + ++ P++ G
Sbjct: 217 TLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL--TQMPKMNFANVFIGAN 274
Query: 315 ELAL----MCVCESAEDRPTTVDVAKRLKQIYQH 344
LA+ + ++ R T Q H
Sbjct: 275 PLAVDLLEKMLVLDSDKRIT-------AAQALAH 301
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 63.1 bits (152), Expect = 9e-12
Identities = 28/211 (13%), Positives = 67/211 (31%), Gaps = 16/211 (7%)
Query: 93 NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFE 152
+ + + + I + + + K + ++ + K + + E
Sbjct: 49 DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGE 108
Query: 153 PLL------------LSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLD-EGYIA 199
LL L +I+ + + Y+H I+H I+P + ++
Sbjct: 109 NLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPE 166
Query: 200 KLFDFSLSVSIPEGETCVKDK-VTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQ 258
L ++ T + +PE + + D++S L+ L+TG
Sbjct: 167 NLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
Query: 259 KIFDPSRGDEIGAGHYWLLHYVKKCIENNEF 289
+F+P G + ++ E +
Sbjct: 227 FLFEPDEGHSYTKDDDHIAQIIELLGELPSY 257
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.0 bits (144), Expect = 1e-10
Identities = 40/189 (21%), Positives = 71/189 (37%), Gaps = 19/189 (10%)
Query: 80 DRTVSVMKFN-DILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCL------ETRIPVIVF 132
DR V++ K + N H + K +HKN++ L E + +V
Sbjct: 42 DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 101
Query: 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIF 192
E + I H + + + I +LH S I+HR ++PS I
Sbjct: 102 ELMDANLC-QVIQMELDH------ERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIV 151
Query: 193 LDEGYIAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLL 252
+ K+ DF L+ + T + APE I + E D++S G ++
Sbjct: 152 VKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 209
Query: 253 VLLTGQKIF 261
++ + +F
Sbjct: 210 EMVRHKILF 218
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 41.7 bits (97), Expect = 4e-05
Identities = 17/117 (14%), Positives = 36/117 (30%), Gaps = 11/117 (9%)
Query: 94 DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEP 153
D + F+ + S + + + KL G + +
Sbjct: 47 DYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW-------EGNAVLMELIDAKELYR 99
Query: 154 LLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI 210
+ + + I +A + R I+H + + + E I + DF SV +
Sbjct: 100 VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEV 152
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 346 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.83 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.14 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.88 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.29 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.02 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.81 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-59 Score=412.19 Aligned_cols=256 Identities=18% Similarity=0.294 Sum_probs=201.7
Q ss_pred cCCCcccccccCCCcEEEEEEE-CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecc
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESV 135 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~ 135 (346)
++|+..+.||+|+||+||+|.+ +++.||||++... .....++.+|+..+.++ +|||||+++|+|.+.+..++||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhc-CCCCcccccceeccCCceEEEEEec
Confidence 5688889999999999999999 7789999998754 34457789999999998 9999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCc
Q 045453 136 KNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGET 215 (346)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~ 215 (346)
++|+|.+++.... ..++|..++.++.|+|.||.||| +.+|+||||||+|||+++++.+||+|||+++.......
T Consensus 83 ~~g~L~~~l~~~~---~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 83 EHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp TTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred CCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 9999999987654 46899999999999999999999 89999999999999999999999999999987765544
Q ss_pred eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhC-CCCCCCCCCcccccchhhHHHHHHHHhhcCccccccc
Q 045453 216 CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTG-QKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVD 294 (346)
Q Consensus 216 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 294 (346)
.......||+.|+|||++.+..++.++|||||||++|||+|+ .+||...... .+...+.. +...
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~-------~~~~~i~~----~~~~---- 221 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-------EVVEDIST----GFRL---- 221 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH-------HHHHHHHH----TCCC----
T ss_pred eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH-------HHHHHHHh----cCCC----
Confidence 444556789999999999999999999999999999999995 5555432221 12221111 1000
Q ss_pred cccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 295 PIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 295 ~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
. .+..++..+.+|+.+||+.||++||||.||++.|++|.++
T Consensus 222 -----~----~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 222 -----Y----KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp -----C----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----C----CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 0 0113345688999999999999999999999999999874
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-59 Score=414.79 Aligned_cols=268 Identities=22% Similarity=0.353 Sum_probs=210.9
Q ss_pred HHHHHhcCCCcccccccCCCcEEEEEEECCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcc
Q 045453 51 ELEIATNNFDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIP 128 (346)
Q Consensus 51 ~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~ 128 (346)
+|++..++|...+.||+|+||+||+|.+.+ .||||++.... ......+.+|+..+.++ +|||||+++|++.+ +..
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~-~~~ 78 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYSTA-PQL 78 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTC-CCTTBCCEEEEECS-SSC
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeeeEEEec-cEE
Confidence 344556789999999999999999999765 59999986543 34456778899999998 99999999999865 568
Q ss_pred eEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 129 VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
++||||+++|+|.+++.... .+++|..+..++.|+|.||+||| +.+|+||||||+|||++.++.+||+|||+|+
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~ 152 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT 152 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSC
T ss_pred EEEEecCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEcccccee
Confidence 99999999999999997654 46999999999999999999999 8899999999999999999999999999998
Q ss_pred ccCCCCc-eeeccccccCCcCCcccccc---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHh
Q 045453 209 SIPEGET-CVKDKVTGTMGFLAPEYINT---GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCI 284 (346)
Q Consensus 209 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (346)
....... .......||+.|||||++.+ ..|+.++|||||||++|||+||+.||........ +...+..
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~------~~~~~~~-- 224 (276)
T d1uwha_ 153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIFMVGR-- 224 (276)
T ss_dssp C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HHHHHHH--
T ss_pred eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH------HHHHHhc--
Confidence 7654332 23345679999999999964 3589999999999999999999999976543221 1111111
Q ss_pred hcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhhC
Q 045453 285 ENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHLA 346 (346)
Q Consensus 285 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~l~ 346 (346)
+.. .+.+.. ....++..+.+|+.+||+.+|++||||.||++.|+.|.++|.
T Consensus 225 --~~~----~p~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 225 --GYL----SPDLSK-----VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp --TSC----CCCGGG-----SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred --CCC----CCcchh-----ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 111 111100 011345678999999999999999999999999999998763
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.1e-59 Score=417.52 Aligned_cols=267 Identities=19% Similarity=0.321 Sum_probs=204.5
Q ss_pred CCHHHHHHHhcCC---------CcccccccCCCcEEEEEEE--CCe---EEEEEEecCccC-cchHHHHHHHHHHhhhcC
Q 045453 47 FTIRELEIATNNF---------DARNVIKDGYAYKFYKGFV--EDR---TVSVMKFNDILN-DGHEDCFNNIIFASKLSS 111 (346)
Q Consensus 47 ~~~~~l~~~~~~f---------~~~~~ig~G~~g~Vy~~~~--~~~---~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~ 111 (346)
++++++..++.+| +..++||+|+||+||+|.+ +++ .||||++..... .....+.+|+..+.++ +
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~ 85 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-D 85 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-C
T ss_pred CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-C
Confidence 4555566665544 3457899999999999998 332 588888765443 3446788999999998 9
Q ss_pred CCceeeEcceeecCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCe
Q 045453 112 HKNVLKLTGCCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRI 191 (346)
Q Consensus 112 h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NI 191 (346)
|||||+++|+|.+.+..++||||+++|+|.+++.... ..++|.+++.++.|+|.||.||| +.+|+||||||+||
T Consensus 86 HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~---~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NI 159 (299)
T d1jpaa_ 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNI 159 (299)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGE
T ss_pred CCCCccEEEEEeeCCEEEEEEEecCCCcceeeecccc---CCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceE
Confidence 9999999999999999999999999999999887654 46999999999999999999999 89999999999999
Q ss_pred EEcCCCceEEeccCCCcccCCCCcee----eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCC
Q 045453 192 FLDEGYIAKLFDFSLSVSIPEGETCV----KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRG 266 (346)
Q Consensus 192 ll~~~~~~kl~Dfgl~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~ 266 (346)
|++.++.+||+|||+++.+....... .....+|+.|||||.+.++.++.++|||||||++|||+| |+.||.....
T Consensus 160 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~ 239 (299)
T d1jpaa_ 160 LVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 239 (299)
T ss_dssp EECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred EECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999998775433211 123457889999999999999999999999999999998 8999976543
Q ss_pred cccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 267 DEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
.+ +...+. .+. ..+.+...+..+.+|+.+||+.+|++||||.||++.|++++++
T Consensus 240 ~~-------~~~~i~----~~~-------------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 240 QD-------VINAIE----QDY-------------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp HH-------HHHHHH----TTC-------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HH-------HHHHHH----cCC-------------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 22 111111 110 0011124556789999999999999999999999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-59 Score=417.83 Aligned_cols=265 Identities=20% Similarity=0.292 Sum_probs=220.7
Q ss_pred HHHHHHHhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCC
Q 045453 49 IRELEIATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETR 126 (346)
Q Consensus 49 ~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~ 126 (346)
+++|++..++|...+.||+|+||+||+|.+ ++..||||++.... ...+++.+|+.++.++ +|||||+++|+|.+++
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~ 86 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREP 86 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSS
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhC-CCCCEecCCccEeeCC
Confidence 346667778899999999999999999999 68899999987543 4456788999999998 9999999999999999
Q ss_pred cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCC
Q 045453 127 IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSL 206 (346)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl 206 (346)
..++||||+++|+|.+++..... ..++|..++.++.|+|.||.||| +.+|+||||||+|||+++++.+||+|||+
T Consensus 87 ~~~iv~E~~~~g~l~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~ 161 (287)
T d1opja_ 87 PFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 161 (287)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCC
T ss_pred eeEEEeecccCcchHHHhhhccc--cchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccc
Confidence 99999999999999999976542 47999999999999999999999 88999999999999999999999999999
Q ss_pred CcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhc
Q 045453 207 SVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIEN 286 (346)
Q Consensus 207 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (346)
|+..............||+.|+|||++.+..|+.++|||||||++|||++|..|+....... .+...+ ..
T Consensus 162 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~------~~~~~i----~~ 231 (287)
T d1opja_ 162 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELL----EK 231 (287)
T ss_dssp TTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHHHH----HT
T ss_pred eeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH------HHHHHH----hc
Confidence 99877665555566678999999999999999999999999999999999776664332211 111111 11
Q ss_pred CccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 045453 287 NEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQ 343 (346)
Q Consensus 287 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 343 (346)
+. ... .+...+..+.+|+.+||+.||++||||.||++.|+.+.+
T Consensus 232 ~~---------~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 232 DY---------RME----RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp TC---------CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred CC---------CCC----CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11 001 111345678999999999999999999999999998754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-59 Score=412.53 Aligned_cols=264 Identities=23% Similarity=0.356 Sum_probs=215.1
Q ss_pred HHHHHHhcCCCcccccccCCCcEEEEEEE-CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcc
Q 045453 50 RELEIATNNFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIP 128 (346)
Q Consensus 50 ~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~ 128 (346)
++|++..++|...+.||+|+||+||+|.+ ++..||||++.... ....++.+|+..+.++ +|||||+++|+|.+ +..
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~-~~~ 82 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQL-QHQRLVRLYAVVTQ-EPI 82 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSC
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhC-CCCCEeEEEeeecc-CCe
Confidence 34555677888999999999999999999 66889999987543 4456789999999999 99999999998865 567
Q ss_pred eEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 129 VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
++||||+++|+|.+++..... .+++|..++.++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+|+
T Consensus 83 ~iv~Ey~~~g~L~~~~~~~~~--~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~ 157 (272)
T d1qpca_ 83 YIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLAR 157 (272)
T ss_dssp EEEEECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceE
Confidence 999999999999998765432 35999999999999999999999 8999999999999999999999999999999
Q ss_pred ccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCc
Q 045453 209 SIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE 288 (346)
Q Consensus 209 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (346)
.+............||+.|+|||++.++.++.++|||||||++|||+||..|+....... .+...+ ..+.
T Consensus 158 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~------~~~~~i----~~~~ 227 (272)
T d1qpca_ 158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP------EVIQNL----ERGY 227 (272)
T ss_dssp ECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHH----HTTC
T ss_pred EccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH------HHHHHH----HhcC
Confidence 887665555566789999999999999999999999999999999999665554322211 111111 1110
Q ss_pred cccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 289 FDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 289 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
.+ ..+...+..+.+|+.+||+.+|++||||.||++.|+++..+
T Consensus 228 -----~~--------~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 228 -----RM--------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp -----CC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----CC--------CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 00 01113446689999999999999999999999999998753
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-57 Score=404.38 Aligned_cols=258 Identities=20% Similarity=0.352 Sum_probs=210.9
Q ss_pred hcCCCcccc-cccCCCcEEEEEEE----CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcce
Q 045453 56 TNNFDARNV-IKDGYAYKFYKGFV----EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV 129 (346)
Q Consensus 56 ~~~f~~~~~-ig~G~~g~Vy~~~~----~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~ 129 (346)
.++|..... ||+|+||+||+|.+ ++..||||++..... ....++.+|+.++.++ +|||||+++|+|.+ +..+
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~-~~~~ 84 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA-EALM 84 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEES-SSEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhC-CCCCEeeEeeeecc-CeEE
Confidence 345666664 99999999999987 345799999876543 3456788899999998 99999999999865 5689
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcc
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVS 209 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~ 209 (346)
+||||+++|+|.+++.... ..+++..++.++.|+|.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 85 lvmE~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp EEEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEeCCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhc
Confidence 9999999999999986544 46999999999999999999999 89999999999999999999999999999988
Q ss_pred cCCCCcee--eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhc
Q 045453 210 IPEGETCV--KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIEN 286 (346)
Q Consensus 210 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (346)
+....... .....||+.|+|||++.++.++.++|||||||++|||+| |+.||......+. ...+ ..
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~-------~~~i----~~ 227 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-------MAFI----EQ 227 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH-------HHHH----HT
T ss_pred ccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH-------HHHH----Hc
Confidence 76544322 234568899999999999999999999999999999998 9999986544221 1111 11
Q ss_pred CccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 045453 287 NEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHL 345 (346)
Q Consensus 287 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~l 345 (346)
+... ..++..+..+.+|+.+||+.+|++||||.+|++.|+.+..++
T Consensus 228 ~~~~-------------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 228 GKRM-------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp TCCC-------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCC-------------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 1110 011144567889999999999999999999999999988765
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-57 Score=397.42 Aligned_cols=252 Identities=18% Similarity=0.271 Sum_probs=213.3
Q ss_pred cCCCcccccccCCCcEEEEEEE-CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEecc
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESV 135 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~ 135 (346)
++|+..+.||+|+||+||+|++ +++.||||++.... ....++.+|+..+.++ +|||||+++|+|.+.+..++||||+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l-~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNL-SHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTC-CCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEEEEcc
Confidence 6889999999999999999999 67799999987643 3456789999999999 9999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCc
Q 045453 136 KNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGET 215 (346)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~ 215 (346)
++|+|.+++.... ..+++..++.++.|+++||.||| +.+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 82 ~~g~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 82 ANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp TTEEHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred CCCcHHHhhhccc---cCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 9999999977654 46899999999999999999999 89999999999999999999999999999987765554
Q ss_pred eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccc
Q 045453 216 CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVD 294 (346)
Q Consensus 216 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 294 (346)
.......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......+. ...+ ..+..
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~-------~~~i----~~~~~----- 219 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-------AEHI----AQGLR----- 219 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH-------HHHH----HTTCC-----
T ss_pred eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH-------HHHH----HhCCC-----
Confidence 44455678999999999999999999999999999999998 8999976544322 1111 11110
Q ss_pred cccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 045453 295 PIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQ 340 (346)
Q Consensus 295 ~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 340 (346)
...+...+..+.+|+.+||+.+|++|||+.|+++.|.+
T Consensus 220 --------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 220 --------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp --------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred --------CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 00111344678999999999999999999999999865
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-56 Score=399.25 Aligned_cols=258 Identities=19% Similarity=0.288 Sum_probs=202.2
Q ss_pred hcCCCcccccccCCCcEEEEEEEC--C----eEEEEEEecCccCc-chHHHHHHHHHHhhhcCCCceeeEcceeecCCcc
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFVE--D----RTVSVMKFNDILND-GHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIP 128 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~~--~----~~vavk~~~~~~~~-~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~ 128 (346)
.+.|+..++||+|+||+||+|.+. + ..||||++...... ...++.+|+.++.++ +|||||+++|+|.+.+..
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISKYKPM 84 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhc-CCCCEeeeeEEEecCCce
Confidence 456888999999999999999982 2 37999998755433 345678899999998 999999999999999999
Q ss_pred eEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 129 VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
++||||+.+|++.+.+.... ..++|..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 85 ~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp EEEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEEEecccCcchhhhhccc---ccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhh
Confidence 99999999999999887654 46999999999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCce--eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhc
Q 045453 209 SIPEGETC--VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIEN 286 (346)
Q Consensus 209 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (346)
........ ......||+.|+|||++.++.++.++|||||||++|||+||..|+....... .+... ...
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~------~~~~~----i~~ 228 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH------EVMKA----IND 228 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHH----HHT
T ss_pred cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH------HHHHH----Hhc
Confidence 76543321 2234568999999999999999999999999999999999666654332211 11111 111
Q ss_pred CccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 045453 287 NEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQ 343 (346)
Q Consensus 287 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 343 (346)
+. ..+.+...+..+.+|+.+||+.+|++||||.||++.|+++.+
T Consensus 229 ~~-------------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 229 GF-------------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp TC-------------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred cC-------------CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 11 001111345678999999999999999999999999999876
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-56 Score=397.80 Aligned_cols=249 Identities=22% Similarity=0.333 Sum_probs=201.2
Q ss_pred cccccCCCcEEEEEEE----CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEeccc
Q 045453 63 NVIKDGYAYKFYKGFV----EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFESVK 136 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~----~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~~~ 136 (346)
+.||+|+||+||+|.+ .++.||||++..... ....++.+|+.++.++ +|||||+++|+|.+ +..+|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhC-CCCCCceEEEEecc-CCEEEEEEcCC
Confidence 5799999999999987 246899999865432 2345788999999998 99999999999965 56789999999
Q ss_pred CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCCce
Q 045453 137 NRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGETC 216 (346)
Q Consensus 137 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 216 (346)
+|+|.+++... .+++|..++.++.|+|.||+||| +.+|+||||||+|||++.++.+||+|||+++.+......
T Consensus 91 ~g~L~~~l~~~----~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 91 LGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp TEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 99999999875 36999999999999999999999 899999999999999999999999999999877544332
Q ss_pred e--eccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccc
Q 045453 217 V--KDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIV 293 (346)
Q Consensus 217 ~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (346)
. .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||......+ +...+ ..+...
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~-------~~~~i----~~~~~~--- 229 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAML----EKGERM--- 229 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHH----HTTCCC---
T ss_pred cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH-------HHHHH----HcCCCC---
Confidence 2 234568999999999999999999999999999999998 899997644322 11111 111110
Q ss_pred ccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 294 DPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 294 d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
..+..++..+.+|+.+||+.||++|||+.+|++.|+....+
T Consensus 230 ----------~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 230 ----------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ----------CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 01113456788999999999999999999999999988765
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-56 Score=397.57 Aligned_cols=248 Identities=19% Similarity=0.285 Sum_probs=207.6
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEec
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFES 134 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~ 134 (346)
+.|...+.||+|+||+||+|.+ +++.||||++..........+.+|+.++..+ +|||||++++++.+.+..++||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhC-CCCCEeeEeEEEEECCEEEEEEEe
Confidence 4688899999999999999998 7899999998766555667788999999888 999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCC
Q 045453 135 VKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE 214 (346)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~ 214 (346)
+++|+|.+++..+ .+++.++..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 99 ~~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp CTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred cCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 9999999988653 4899999999999999999999 8999999999999999999999999999998775433
Q ss_pred ceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccccc
Q 045453 215 TCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVD 294 (346)
Q Consensus 215 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 294 (346)
. ......||+.|+|||++.+..++.++|||||||++|+|+||..||......+. ..........
T Consensus 171 ~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~----------~~~~~~~~~~----- 234 (293)
T d1yhwa1 171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA----------LYLIATNGTP----- 234 (293)
T ss_dssp C-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH----------HHHHHHHCSC-----
T ss_pred c-cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH----------HHHHHhCCCC-----
Confidence 2 33456799999999999999999999999999999999999999975432111 1111111110
Q ss_pred cccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 295 PIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 295 ~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
....+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 235 -------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 235 -------ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp -------CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -------CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00111234567889999999999999999999864
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-57 Score=397.38 Aligned_cols=251 Identities=24% Similarity=0.295 Sum_probs=203.1
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
.++|+..+.||+|+||+||+|.+ +++.||||++..... .....+.+|+.++..+ +|||||++++++.+.+..++||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhC-CCCCEeeEeeeeccCceeEEEE
Confidence 35788899999999999999998 689999999875432 3345678899898888 9999999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
||+++|+|.+++... ..+++.++..++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+|+....
T Consensus 83 Ey~~gg~L~~~l~~~----~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~ 155 (271)
T d1nvra_ 83 EYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 155 (271)
T ss_dssp ECCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred eccCCCcHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeecc
Confidence 999999999999754 36999999999999999999999 89999999999999999999999999999987654
Q ss_pred CCc-eeeccccccCCcCCccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 213 GET-CVKDKVTGTMGFLAPEYINTGDF-NEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 213 ~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
... ......+||+.|||||++.+..+ +.++|||||||++|||+||+.||........ ... .......
T Consensus 156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-----~~~----~~~~~~~-- 224 (271)
T d1nvra_ 156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-----EYS----DWKEKKT-- 224 (271)
T ss_dssp TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH-----HHH----HHHTTCT--
T ss_pred CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH-----HHH----HHhcCCC--
Confidence 332 22345689999999999988876 6789999999999999999999976544321 000 0000000
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
........+..+.+|+.+||+.||++|||+.|+++
T Consensus 225 -----------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 225 -----------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -----------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----------CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00011133466789999999999999999999864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-56 Score=407.16 Aligned_cols=263 Identities=19% Similarity=0.311 Sum_probs=210.3
Q ss_pred HHHHhcCCCcccccccCCCcEEEEEEE--CC-----eEEEEEEecCcc-CcchHHHHHHHHHHhhhcCCCceeeEcceee
Q 045453 52 LEIATNNFDARNVIKDGYAYKFYKGFV--ED-----RTVSVMKFNDIL-NDGHEDCFNNIIFASKLSSHKNVLKLTGCCL 123 (346)
Q Consensus 52 l~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~-----~~vavk~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~ 123 (346)
|++..++|...+.||+|+||+||+|.+ .+ ..||+|++.... ......+.+|+..+.++.+|||||+++|+|.
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 334557888999999999999999998 22 368999886543 3445678889999988878999999999999
Q ss_pred cCCcceEEEecccCCChhhhhhhcCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceec
Q 045453 124 ETRIPVIVFESVKNRTLADHIYQNQPH-------------------FEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHR 184 (346)
Q Consensus 124 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~ 184 (346)
+.+..++||||+++|+|.++|...... ...++|..++.++.|++.||+||| +.+|+||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHR 188 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHR 188 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEET
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeec
Confidence 999999999999999999999765321 235899999999999999999999 8999999
Q ss_pred CCCCCCeEEcCCCceEEeccCCCcccCCCCc-eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCC
Q 045453 185 KIRPSRIFLDEGYIAKLFDFSLSVSIPEGET-CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFD 262 (346)
Q Consensus 185 dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~ 262 (346)
||||+|||++.++.+||+|||+|+....... .......||+.|||||++.++.++.++|||||||++|||+| |..||.
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987654333 23345678999999999999999999999999999999998 899998
Q ss_pred CCCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 045453 263 PSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQ 340 (346)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 340 (346)
+....+. +...+ ..+. ....+...+..+.+|+.+||+.+|++||||.||++.|..
T Consensus 269 ~~~~~~~------~~~~~----~~~~-------------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 269 GIPVDAN------FYKLI----QNGF-------------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp TCCCSHH------HHHHH----HTTC-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCHHHH------HHHHH----hcCC-------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 6544332 11111 1110 001111345678999999999999999999999999863
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-56 Score=392.46 Aligned_cols=244 Identities=22% Similarity=0.347 Sum_probs=204.6
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
++|...+.||+|+||+||+|.+ +++.||+|++.... ......+.+|+.++..+ +|||||++++++.+.+..++|
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-CCCCCCeEEEEEEECCEEEEE
Confidence 4688899999999999999999 68899999986432 23455677888888888 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+++|+|.+++.... ++++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+|+...
T Consensus 85 mEy~~~g~L~~~l~~~~----~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~ 157 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 157 (263)
T ss_dssp EECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred EeecCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecC
Confidence 99999999999998653 6999999999999999999999 8999999999999999999999999999998765
Q ss_pred CCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccc
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDE 291 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (346)
... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...+..+. .... .....
T Consensus 158 ~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~----------~~~i-~~~~~-- 221 (263)
T d2j4za1 158 SSR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET----------YKRI-SRVEF-- 221 (263)
T ss_dssp CCC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH----------HHHH-HTTCC--
T ss_pred CCc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH----------HHHH-HcCCC--
Confidence 433 2456799999999999999999999999999999999999999975432221 1111 11110
Q ss_pred ccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 292 IVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 292 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.+ +...+..+.+|+.+||+.||++|||+.|+++
T Consensus 222 ----~~--------p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 ----TF--------PDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ----CC--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CC--------CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 00 1123456889999999999999999999975
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-57 Score=400.72 Aligned_cols=267 Identities=22% Similarity=0.300 Sum_probs=208.0
Q ss_pred CCHHHHHHHhcCCCcccccccCCCcEEEEEEE-CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecC
Q 045453 47 FTIRELEIATNNFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLET 125 (346)
Q Consensus 47 ~~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~ 125 (346)
...++|++..++|...+.||+|+||+||+|.+ ++..||||++... ......+.+|+..+.++ +|||||+++|+|.+
T Consensus 7 ~~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~- 83 (285)
T d1fmka3 7 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE- 83 (285)
T ss_dssp SSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-
T ss_pred CCCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhc-ccCCEeEEEEEEec-
Confidence 33445555667899999999999999999999 6678999998654 34457788999999888 99999999999855
Q ss_pred CcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccC
Q 045453 126 RIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFS 205 (346)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg 205 (346)
+..++||||+++|+|..++..... ..++|.+++.++.|+|.||+||| +.+|+||||||+|||++.++.+||+|||
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~~~--~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfG 158 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFG 158 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred CCeEEEEEecCCCchhhhhhhccc--ccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccc
Confidence 568999999999999999876432 35999999999999999999999 8899999999999999999999999999
Q ss_pred CCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhh
Q 045453 206 LSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIE 285 (346)
Q Consensus 206 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (346)
+++..............||+.|+|||++.++.++.++|||||||++|||+||..|+....... .....+.
T Consensus 159 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~------~~~~~i~---- 228 (285)
T d1fmka3 159 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLDQVE---- 228 (285)
T ss_dssp TTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHHH----
T ss_pred hhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH------HHHHHHH----
Confidence 998876555545556779999999999999999999999999999999999766654433211 1112111
Q ss_pred cCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 286 NNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 286 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
.+. ..+.+...++.+.+|+.+||+.+|++||||.+|++.|++...+
T Consensus 229 ~~~-------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 229 RGY-------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp TTC-------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred hcC-------------CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 110 0001114456789999999999999999999999999876543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-57 Score=397.95 Aligned_cols=254 Identities=20% Similarity=0.265 Sum_probs=191.7
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeec--CCcceE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLE--TRIPVI 130 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~--~~~~~l 130 (346)
++|+..+.||+|+||+||+|.+ +++.||+|.+..... .....+.+|+.++..+ +|||||++++++.+ .+.+++
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSC-CCTTBCCEEEEEEC----CEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEeCCCCEEEE
Confidence 5788999999999999999998 688999999875532 2345577888888888 99999999999865 456899
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGF--SRPILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
||||+++|+|.+++.........+++..++.++.|++.||.|||+.. ..+|+||||||+|||++.++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999999998754322357999999999999999999999421 2359999999999999999999999999998
Q ss_pred ccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCc
Q 045453 209 SIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE 288 (346)
Q Consensus 209 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (346)
.+..+.. ......||+.|+|||++.+..|+.++|||||||++|||+||+.||...+..+ +...+ ..+.
T Consensus 163 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~-------~~~~i----~~~~ 230 (269)
T d2java1 163 ILNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKI----REGK 230 (269)
T ss_dssp HC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHH----HHTC
T ss_pred ecccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH-------HHHHH----HcCC
Confidence 7754332 2345679999999999999999999999999999999999999997543321 11111 1111
Q ss_pred cccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 289 FDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 289 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
... + +...+..+.+|+.+||+.||++|||+.|+++
T Consensus 231 ~~~-----~--------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 231 FRR-----I--------PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CCC-----C--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCC-----C--------CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 110 1 1133456889999999999999999999874
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-56 Score=396.86 Aligned_cols=250 Identities=20% Similarity=0.266 Sum_probs=206.9
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEec
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFES 134 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~ 134 (346)
+.|+..+.||+|+||+||+|.+ ++..||||++..........+.+|+.++..+ +|||||++++++.+.+..++||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCeEEEEEec
Confidence 4578889999999999999998 7889999999876666777889999999998 999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCC
Q 045453 135 VKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE 214 (346)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~ 214 (346)
+++|+|.+++.... .++++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+|+......
T Consensus 91 ~~~g~L~~~~~~~~---~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 91 CAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp CTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred CCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 99999999987654 46999999999999999999999 8999999999999999999999999999987553211
Q ss_pred ceeeccccccCCcCCccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcc
Q 045453 215 TCVKDKVTGTMGFLAPEYIN-----TGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEF 289 (346)
Q Consensus 215 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (346)
.......||+.|+|||++. +..|+.++|||||||++|||+||+.||......+. +.. + .. +..
T Consensus 165 -~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~------~~~-i---~~-~~~ 232 (288)
T d2jfla1 165 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV------LLK-I---AK-SEP 232 (288)
T ss_dssp -HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH------HHH-H---HH-SCC
T ss_pred -ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH------HHH-H---Hc-CCC
Confidence 1234567999999999984 45689999999999999999999999976544332 111 1 11 110
Q ss_pred ccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 290 DEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 290 ~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.. ...+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~-----------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 233 PT-----------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp CC-----------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CC-----------CCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0011244567899999999999999999999975
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-56 Score=395.02 Aligned_cols=259 Identities=21% Similarity=0.303 Sum_probs=200.7
Q ss_pred HHhcCCCcccccccCCCcEEEEEEEC-----CeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCc
Q 045453 54 IATNNFDARNVIKDGYAYKFYKGFVE-----DRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRI 127 (346)
Q Consensus 54 ~~~~~f~~~~~ig~G~~g~Vy~~~~~-----~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~ 127 (346)
+..++|...+.||+|+||+||+|.+. +..||||++..... .....+.+|+..+.++ +|||||+++|+|. .+.
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~-~~~ 81 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVIT-ENP 81 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC-SSS
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEe-cCe
Confidence 34567888999999999999999882 24688888865443 3345678888888888 9999999999996 467
Q ss_pred ceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCC
Q 045453 128 PVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS 207 (346)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~ 207 (346)
.++||||+++|+|.+++.... .++++..++.++.|++.||.||| +.+++||||||+|||+++++.+||+|||++
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a 155 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLS 155 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----
T ss_pred EEEEEEeccCCcHHhhhhccC---CCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhh
Confidence 899999999999999887654 46899999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhc
Q 045453 208 VSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIEN 286 (346)
Q Consensus 208 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (346)
+..............||+.|+|||++.+..++.++|||||||++|||+| |..||......+. ...+ ..
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~-------~~~i----~~ 224 (273)
T d1mp8a_ 156 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-------IGRI----EN 224 (273)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-------HHHH----HT
T ss_pred eeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH-------HHHH----Hc
Confidence 8776555444556678999999999999999999999999999999998 8999987654332 1111 11
Q ss_pred CccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 287 NEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 287 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
+... +.++..+..+.+|+.+||+.||++|||+.||++.|++|++.
T Consensus 225 ~~~~-------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 225 GERL-------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp TCCC-------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCC-------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 1110 01114456789999999999999999999999999999875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-56 Score=405.38 Aligned_cols=271 Identities=14% Similarity=0.243 Sum_probs=205.7
Q ss_pred HhcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
..++|+..+.||+|+||+||+|.+ ++..||+|++..... ....++.+|+.++..+ +|||||+++++|.+.+..++|
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGC-CCTTBCCEEEEEECSSEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEE
Confidence 357899999999999999999998 789999999876543 3345677888888888 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCceecCCCCCCeEEcCCCceEEeccCCCccc
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFS-RPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI 210 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~ 210 (346)
|||+++|+|.+++.... .+++..+..++.|++.||.||| + .+|+||||||+|||++.++.+||+|||+|+..
T Consensus 83 mEy~~gg~L~~~l~~~~----~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155 (322)
T ss_dssp EECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EEcCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence 99999999999997653 5999999999999999999999 6 48999999999999999999999999999865
Q ss_pred CCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchh-hHHHHHHHH------
Q 045453 211 PEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHY-WLLHYVKKC------ 283 (346)
Q Consensus 211 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~-~~~~~~~~~------ 283 (346)
... .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+..+...... .........
T Consensus 156 ~~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
T d1s9ja_ 156 IDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232 (322)
T ss_dssp HHH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred CCC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccc
Confidence 322 1235689999999999999999999999999999999999999998765432100000 000000000
Q ss_pred --------hhc----CccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 284 --------IEN----NEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 284 --------~~~----~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
... ....+..+.......+.......+..+.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp -------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 000 00000000000001111111123456889999999999999999999976
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-55 Score=396.48 Aligned_cols=272 Identities=19% Similarity=0.290 Sum_probs=209.7
Q ss_pred CCHHHHHHHhcCCCcccccccCCCcEEEEEEE-------CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeE
Q 045453 47 FTIRELEIATNNFDARNVIKDGYAYKFYKGFV-------EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKL 118 (346)
Q Consensus 47 ~~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~-------~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l 118 (346)
+..+.|+...++|...+.||+|+||.||+|.+ +++.||||++..... .....+..|+..+.++.+|+|||.+
T Consensus 3 ~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 34566777778899999999999999999987 236899999875443 3456678888888888789999999
Q ss_pred cceeecC-CcceEEEecccCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecC
Q 045453 119 TGCCLET-RIPVIVFESVKNRTLADHIYQNQP------------HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRK 185 (346)
Q Consensus 119 ~g~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~d 185 (346)
++++.+. ...++||||+++|+|.+++..... ....++|..++.++.|++.||+||| +.+|+|||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrD 159 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD 159 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCc
Confidence 9998764 568999999999999999975431 1235899999999999999999999 89999999
Q ss_pred CCCCCeEEcCCCceEEeccCCCcccCCCCc-eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhC-CCCCCC
Q 045453 186 IRPSRIFLDEGYIAKLFDFSLSVSIPEGET-CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTG-QKIFDP 263 (346)
Q Consensus 186 lkp~NIll~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg-~~p~~~ 263 (346)
|||+|||+++++.+||+|||+|+....... .......||+.|+|||++.++.++.++|||||||++|||+|| ..||..
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987654333 233456799999999999999999999999999999999996 567765
Q ss_pred CCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 045453 264 SRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQ 343 (346)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 343 (346)
....+. +...+ ..+... . .+...+..+.+++.+||+.||++|||+.||++.|++|++
T Consensus 240 ~~~~~~------~~~~~----~~~~~~-----~--------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 240 VKIDEE------FCRRL----KEGTRM-----R--------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp CCCSHH------HHHHH----HHTCCC-----C--------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHHH------HHHHH----hcCCCC-----C--------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 443321 11111 111110 0 011334568899999999999999999999999999987
Q ss_pred h
Q 045453 344 H 344 (346)
Q Consensus 344 ~ 344 (346)
.
T Consensus 297 ~ 297 (299)
T d1ywna1 297 A 297 (299)
T ss_dssp H
T ss_pred C
Confidence 4
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-55 Score=396.86 Aligned_cols=266 Identities=20% Similarity=0.341 Sum_probs=214.3
Q ss_pred HHHHHHhcCCCcccccccCCCcEEEEEEEC-------CeEEEEEEecCccCc-chHHHHHHHHHHhhhcCCCceeeEcce
Q 045453 50 RELEIATNNFDARNVIKDGYAYKFYKGFVE-------DRTVSVMKFNDILND-GHEDCFNNIIFASKLSSHKNVLKLTGC 121 (346)
Q Consensus 50 ~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~-------~~~vavk~~~~~~~~-~~~~~~~e~~~~~~~~~h~niv~l~g~ 121 (346)
.+|+...++|+..+.||+|+||+||+|++. +..||||++...... ...++.+|+.++..+ +||||++++++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~ 84 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGV 84 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhc-CCCCcccceee
Confidence 445567789999999999999999999873 368999998765433 356688999999988 99999999999
Q ss_pred eecCCcceEEEecccCCChhhhhhhcCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 045453 122 CLETRIPVIVFESVKNRTLADHIYQNQP--------------------HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPI 181 (346)
Q Consensus 122 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 181 (346)
|.+.+..++||||+++|+|.+++..... ....++|..++.++.|++.||+||| +.++
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCe
Confidence 9999999999999999999999975421 1235899999999999999999999 8999
Q ss_pred eecCCCCCCeEEcCCCceEEeccCCCcccCCCCc-eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCC-C
Q 045453 182 LHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGET-CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQ-K 259 (346)
Q Consensus 182 iH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~-~ 259 (346)
+||||||+|||+|.++.+||+|||+|+....... ...+...+|+.|+|||.+.+..++.++|||||||++|||++|. +
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 9999999999999999999999999986643332 2234567889999999999999999999999999999999985 5
Q ss_pred CCCCCCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 045453 260 IFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLK 339 (346)
Q Consensus 260 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 339 (346)
||......+. ...+ ..+.... .+...+..+.+|+.+||+.+|++||||.||++.|+
T Consensus 242 p~~~~~~~e~-------~~~v----~~~~~~~-------------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~ 297 (301)
T d1lufa_ 242 PYYGMAHEEV-------IYYV----RDGNILA-------------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297 (301)
T ss_dssp TTTTSCHHHH-------HHHH----HTTCCCC-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCHHHH-------HHHH----HcCCCCC-------------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 6765433221 1111 1121110 01134456899999999999999999999999999
Q ss_pred HHHH
Q 045453 340 QIYQ 343 (346)
Q Consensus 340 ~i~~ 343 (346)
+|.+
T Consensus 298 ~i~~ 301 (301)
T d1lufa_ 298 RMCE 301 (301)
T ss_dssp HTTC
T ss_pred HhcC
Confidence 8753
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-55 Score=387.86 Aligned_cols=254 Identities=21% Similarity=0.286 Sum_probs=201.8
Q ss_pred HhcCCCcccccccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeec-CCcceEEEe
Q 045453 55 ATNNFDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLE-TRIPVIVFE 133 (346)
Q Consensus 55 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~-~~~~~lv~e 133 (346)
..++|+..+.||+|+||.||+|.+.+..||||++... ...+++.+|+..+.++ +|||||+++|+|.+ .+.+++|||
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND--ATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCC--C--HHHHHTHHHHTTC-CCTTBCCEEEEECCC--CCEEEEC
T ss_pred CHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcH--HHHHHHHHHHHHHHhC-CCCCEeeEEEEEEecCCcEEEEEe
Confidence 3456778899999999999999999999999998653 3456788999999998 99999999999865 456899999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
|+++|+|.++|..... ..++|..++.++.|++.||.||| +.+|+||||||+|||++.++.+|++|||+++.....
T Consensus 82 y~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp CCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred ccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCC
Confidence 9999999999976431 35899999999999999999999 899999999999999999999999999999765432
Q ss_pred CceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcCccccc
Q 045453 214 ETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEI 292 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (346)
.....+|..|+|||++.++.++.++||||||+++|||+| |+.||......+. ...+ ..+..
T Consensus 157 ----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~-------~~~i----~~~~~--- 218 (262)
T d1byga_ 157 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-------VPRV----EKGYK--- 218 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH-------HHHH----TTTCC---
T ss_pred ----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH-------HHHH----HcCCC---
Confidence 234567889999999999999999999999999999998 6888765443322 1111 11110
Q ss_pred cccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 293 VDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 293 ~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
+. .+...+..+.+|+.+||+.||++||||.|+++.|++|..+
T Consensus 219 --~~--------~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 219 --MD--------APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp --CC--------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CC--------CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 00 1113346788999999999999999999999999998754
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-54 Score=384.05 Aligned_cols=243 Identities=19% Similarity=0.299 Sum_probs=193.6
Q ss_pred CcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeec----CCcceEE
Q 045453 60 DARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLE----TRIPVIV 131 (346)
Q Consensus 60 ~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~----~~~~~lv 131 (346)
.....||+|+||+||+|.+ ++..||+|++.... ......+.+|+.++.++ +|||||++++++.+ ...+++|
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeccccCCEEEEE
Confidence 4456799999999999999 67899999987543 23345677899999888 99999999999864 3467999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCCeEEc-CCCceEEeccCCCc
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRP--ILHRKIRPSRIFLD-EGYIAKLFDFSLSV 208 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--iiH~dlkp~NIll~-~~~~~kl~Dfgl~~ 208 (346)
|||+++|+|.+++.... .+++..+..++.|++.||+||| +.+ |+||||||+|||++ +++.+||+|||+|+
T Consensus 91 mE~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp EECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EeCCCCCcHHHHHhccc----cccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 99999999999997753 6999999999999999999999 776 99999999999996 58899999999997
Q ss_pred ccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCc
Q 045453 209 SIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE 288 (346)
Q Consensus 209 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (346)
...... .....||+.|||||++.+ .++.++|||||||++|||++|+.||........ + ... ...+.
T Consensus 164 ~~~~~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~------~---~~~-i~~~~ 229 (270)
T d1t4ha_ 164 LKRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------I---YRR-VTSGV 229 (270)
T ss_dssp GCCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------H---HHH-HTTTC
T ss_pred eccCCc---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH------H---HHH-HHcCC
Confidence 654322 245689999999998864 699999999999999999999999975433211 1 111 11111
Q ss_pred cccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 289 FDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 289 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
..... .......+.+|+.+||+.||++|||+.|+++
T Consensus 230 ~~~~~------------~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 230 KPASF------------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp CCGGG------------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCccc------------CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11001 1122345889999999999999999999875
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.5e-55 Score=393.52 Aligned_cols=243 Identities=23% Similarity=0.333 Sum_probs=200.0
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
.|+..+.||+|+||+||+|.+ +++.||||++..... .....+.+|+.++.++ +|||||++++++.+.+..++||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEECCEEEEEE
Confidence 488889999999999999998 789999999875432 2335678899999998 9999999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
||+++|+|..++... .++++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~~----~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 999999997776554 36999999999999999999999 89999999999999999999999999999976543
Q ss_pred CCceeeccccccCCcCCcccccc---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcc
Q 045453 213 GETCVKDKVTGTMGFLAPEYINT---GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEF 289 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (346)
.....||+.|||||++.+ +.|+.++|||||||++|||++|..||......+. ........
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~----------~~~i~~~~-- 230 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----------LYHIAQNE-- 230 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH----------HHHHHHSC--
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH----------HHHHHhCC--
Confidence 234579999999999864 4689999999999999999999999975432111 11111111
Q ss_pred ccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 290 DEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 290 ~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.+.......++.+.+|+.+||+.||++|||+.|+++
T Consensus 231 -----------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 231 -----------SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -----------CCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -----------CCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 111111134567899999999999999999999875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-55 Score=391.31 Aligned_cols=272 Identities=17% Similarity=0.242 Sum_probs=202.8
Q ss_pred cCCCcccccccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHHHHH--HHhhhcCCCceeeEcceeecCC----cceE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNII--FASKLSSHKNVLKLTGCCLETR----IPVI 130 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~--~~~~~~~h~niv~l~g~~~~~~----~~~l 130 (346)
.+|...+.||+|+||+||+|+++|+.||||++... ...++..|.. .+..+ +|||||+++|+|.+.+ .+++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECcc---chhHHHHHHHHHHHhhC-CCCcCcceEEEEEeCCCcceEEEE
Confidence 34667788999999999999999999999998643 2333444433 33345 9999999999998654 5799
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCceecCCCCCCeEEcCCCceEEeccC
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGF-----SRPILHRKIRPSRIFLDEGYIAKLFDFS 205 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~iiH~dlkp~NIll~~~~~~kl~Dfg 205 (346)
||||+++|+|.++|... +++|..++.++.++|.||+|||+.. .++|+||||||+|||++.++.+||+|||
T Consensus 79 v~Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 99999999999999764 5999999999999999999999321 2699999999999999999999999999
Q ss_pred CCcccCCCCce---eeccccccCCcCCccccccCC------CCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchh--
Q 045453 206 LSVSIPEGETC---VKDKVTGTMGFLAPEYINTGD------FNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHY-- 274 (346)
Q Consensus 206 l~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~-- 274 (346)
+++........ ......||+.|+|||++.+.. ++.++|||||||++|||+||..|+.............
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence 99877543322 224567999999999987542 6789999999999999999998886544332211100
Q ss_pred --hHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 275 --WLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 275 --~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
............... ++.+... .........+.+|+.+||+.||++||||.||++.|++|.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~----~p~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQKL----RPNIPNR---WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp SSCCHHHHHHHHTTSCC----CCCCCGG---GGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHhcccc----CCCCCcc---cCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 011111111111111 1111111 11225667799999999999999999999999999999874
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=392.08 Aligned_cols=255 Identities=19% Similarity=0.307 Sum_probs=204.9
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCe----EEEEEEecCcc-CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcce
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDR----TVSVMKFNDIL-NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV 129 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~----~vavk~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~ 129 (346)
++|+..+.||+|+||+||+|.+ +++ +||+|++.... ....+++.+|+.++.++ +|||||+++|+|.++ ..+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHC-CCTTBCCEEEEEESS-SEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC-Cee
Confidence 4688999999999999999998 333 68999886543 34567788999999998 999999999999875 568
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcc
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVS 209 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~ 209 (346)
+++||+.+|+|.+++.... ..+++..++.++.|+|.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp EEEECCTTCBHHHHHHHTS---SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred EEEEeccCCcccccccccc---cCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeecccccee
Confidence 8899999999999887754 57999999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCce-eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhhcC
Q 045453 210 IPEGETC-VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIENN 287 (346)
Q Consensus 210 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (346)
....... ......||+.|+|||++.++.++.++|||||||++|||+| |..||......+. ...+. .+
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~-------~~~i~----~~ 229 (317)
T d1xkka_ 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-------SSILE----KG 229 (317)
T ss_dssp TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH-------HHHHH----HT
T ss_pred cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH-------HHHHH----cC
Confidence 7544332 2344568999999999999999999999999999999999 8899876544332 11111 11
Q ss_pred ccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 045453 288 EFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQ 343 (346)
Q Consensus 288 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 343 (346)
.. + ..+..++..+.+|+.+||+.+|++|||+.||++.|+++.+
T Consensus 230 ~~------------~-~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 230 ER------------L-PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp CC------------C-CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC------------C-CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 10 0 0111345678999999999999999999999999998865
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.5e-54 Score=394.96 Aligned_cols=250 Identities=16% Similarity=0.232 Sum_probs=207.6
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEec
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFES 134 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~ 134 (346)
++|...+.||+|+||+||+|.+ +|+.||||++..........+.+|+.++..+ +|||||++++++.+.+..++||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEEETTEEEEEECC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEEc
Confidence 5799999999999999999998 7899999999766555566778899999998 999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEc--CCCceEEeccCCCcccCC
Q 045453 135 VKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLD--EGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~--~~~~~kl~Dfgl~~~~~~ 212 (346)
+++|+|.+++.... .++++..+..++.||+.||.||| +.+|+||||||+|||++ .++.+||+|||+++.+..
T Consensus 105 ~~gg~L~~~l~~~~---~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHTCTT---SCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 99999999996543 36999999999999999999999 89999999999999996 468899999999988754
Q ss_pred CCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccc
Q 045453 213 GETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEI 292 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (346)
... .....||+.|||||++.+..++.++|||||||++|||+||+.||.+.+..+. . ..... ....
T Consensus 179 ~~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-------~---~~i~~-~~~~-- 243 (350)
T d1koaa2 179 KQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-------L---RNVKS-CDWN-- 243 (350)
T ss_dssp TSC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------H---HHHHH-TCCC--
T ss_pred ccc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH-------H---HHHHh-CCCC--
Confidence 433 3456799999999999999999999999999999999999999975433221 1 11111 1000
Q ss_pred cccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 293 VDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 293 ~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.+.......+..+.+|+.+||+.||++|||+.|+++
T Consensus 244 --------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 244 --------MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp --------SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred --------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000011134467889999999999999999999976
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-55 Score=388.70 Aligned_cols=247 Identities=18% Similarity=0.247 Sum_probs=202.4
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
++|+..+.||+|+||+||+|.+ +++.||||++.... ......+.+|+.++.++ +|||||++++++.+.+..++|
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CSTTBCCEEEEEECSSEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-CCCCeeEEEEEEEECCEEEEE
Confidence 5789999999999999999998 68899999986432 23456678899998888 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+|+.+.
T Consensus 87 mEy~~gg~L~~~~~~~~----~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 159 (288)
T ss_dssp ECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEccCCCCHHHhhhccC----CCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecc
Confidence 99999999999988764 6999999999999999999999 8999999999999999999999999999998775
Q ss_pred CCCc-eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 212 EGET-CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 212 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
.... .......||+.|+|||++.+..|+.++|||||||++|||+||..||...+..+. . ... .....
T Consensus 160 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-------~---~~i-~~~~~- 227 (288)
T d1uu3a_ 160 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI-------F---QKI-IKLEY- 227 (288)
T ss_dssp ----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------H---HHH-HTTCC-
T ss_pred cCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH-------H---HHH-HcCCC-
Confidence 4332 233456799999999999999999999999999999999999999976432211 1 111 11110
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.+ + ...+..+.+|+.+||+.||++|||++|+..
T Consensus 228 -----~~----p----~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 -----DF----P----EKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp -----CC----C----TTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred -----CC----C----ccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 00 0 123456889999999999999999999754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-54 Score=390.37 Aligned_cols=250 Identities=19% Similarity=0.275 Sum_probs=189.4
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
.+.|+..+.||+|+||+||+|.+ +++.||||.+..... .....+.+|+.++..+ +|||||++++++.+.+..++||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEE
Confidence 35688899999999999999998 688999999875542 3334567888999888 9999999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEc---CCCceEEeccCCCcc
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLD---EGYIAKLFDFSLSVS 209 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~---~~~~~kl~Dfgl~~~ 209 (346)
||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++ +++.+||+|||+|+.
T Consensus 87 E~~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 87 QLVSGGELFDRIVEK----GFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp CCCCSCBHHHHHHTC----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred eccCCCcHHHhhhcc----cCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEE
Confidence 999999999999764 36999999999999999999999 89999999999999995 578999999999987
Q ss_pred cCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcc
Q 045453 210 IPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEF 289 (346)
Q Consensus 210 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (346)
...... ....+||+.|||||++.+..|+.++|||||||++|||++|..||......+. ...... ...
T Consensus 160 ~~~~~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~----------~~~i~~-~~~ 226 (307)
T d1a06a_ 160 EDPGSV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL----------FEQILK-AEY 226 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----------HHHHHT-TCC
T ss_pred ccCCCe--eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH----------HHHHhc-cCC
Confidence 654332 3456799999999999999999999999999999999999999975433221 111111 110
Q ss_pred ccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 290 DEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 290 ~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.. +.+.....+..+.+|+.+||+.||++|||+.|+++
T Consensus 227 ------~~----~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 227 ------EF----DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp ------CC----CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ------CC----CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 00 00011134567899999999999999999999976
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-54 Score=387.77 Aligned_cols=274 Identities=20% Similarity=0.299 Sum_probs=220.9
Q ss_pred cCCCHH-HHHHHhcCCCcccccccCCCcEEEEEEE-------CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCce
Q 045453 45 RGFTIR-ELEIATNNFDARNVIKDGYAYKFYKGFV-------EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNV 115 (346)
Q Consensus 45 ~~~~~~-~l~~~~~~f~~~~~ig~G~~g~Vy~~~~-------~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~ni 115 (346)
++++++ .|+...++|+..+.||+|+||.||+|.+ .+..||||++..... ....++.+|+..+..+.+||||
T Consensus 10 ~~~~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnI 89 (311)
T d1t46a_ 10 TQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89 (311)
T ss_dssp TTSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred ccCCCcccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCE
Confidence 345543 3666678899999999999999999986 346899999876543 3445678899999988779999
Q ss_pred eeEcceeecCCcceEEEecccCCChhhhhhhcCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 045453 116 LKLTGCCLETRIPVIVFESVKNRTLADHIYQNQP--------------HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPI 181 (346)
Q Consensus 116 v~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 181 (346)
|+++|+|.+.+..++||||+++|+|.+++..... ....+++..++.++.|++.||+||| ++++
T Consensus 90 v~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~i 166 (311)
T d1t46a_ 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNC 166 (311)
T ss_dssp CCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred EEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 9999999999999999999999999999976431 1236899999999999999999999 8999
Q ss_pred eecCCCCCCeEEcCCCceEEeccCCCcccCCCCc-eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCC
Q 045453 182 LHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGET-CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQK 259 (346)
Q Consensus 182 iH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~ 259 (346)
+||||||+|||++.++.+|++|||+++....... .......||+.|+|||++.++.++.++|||||||++|||+| |.+
T Consensus 167 vHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p 246 (311)
T d1t46a_ 167 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 246 (311)
T ss_dssp CCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred eecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCC
Confidence 9999999999999999999999999988765433 33456779999999999999999999999999999999999 566
Q ss_pred CCCCCCCcccccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 045453 260 IFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLK 339 (346)
Q Consensus 260 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 339 (346)
||......+. +...+. .+.. ...+...+..+.+|+.+||+.||++||||.||++.|+
T Consensus 247 ~~~~~~~~~~------~~~~i~----~~~~-------------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~ 303 (311)
T d1t46a_ 247 PYPGMPVDSK------FYKMIK----EGFR-------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303 (311)
T ss_dssp SSTTCCSSHH------HHHHHH----HTCC-------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCHHHH------HHHHHh----cCCC-------------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 6655444321 111111 1110 0011134466899999999999999999999999999
Q ss_pred HHHHh
Q 045453 340 QIYQH 344 (346)
Q Consensus 340 ~i~~~ 344 (346)
++++.
T Consensus 304 ~~i~~ 308 (311)
T d1t46a_ 304 KQISE 308 (311)
T ss_dssp HHHHH
T ss_pred Hhhcc
Confidence 88765
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-54 Score=382.77 Aligned_cols=254 Identities=24% Similarity=0.354 Sum_probs=197.3
Q ss_pred cCCCcccccccCCCcEEEEEEE---CC--eEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcc
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV---ED--RTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIP 128 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~---~~--~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~ 128 (346)
++|+..+.||+|+||+||+|.+ ++ ..||||++.... ....+++.+|+..+.++ +|||||+++|+|.+ +..
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEee-cch
Confidence 5688889999999999999987 22 378999886543 23346788999999998 99999999999976 467
Q ss_pred eEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 129 VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
++||||+++|+|.+++.... .++++..++.++.|+|.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred heeeeeecCcchhhhhhccc---CCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhh
Confidence 99999999999999887654 46999999999999999999999 8999999999999999999999999999999
Q ss_pred ccCCCCce--eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccccchhhHHHHHHHHhh
Q 045453 209 SIPEGETC--VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDEIGAGHYWLLHYVKKCIE 285 (346)
Q Consensus 209 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (346)
........ ......++..|+|||.+.+..++.++||||||+++|||+| |..||...+..+. ......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~----------~~~i~~ 229 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI----------LHKIDK 229 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----------HHHHHT
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH----------HHHHHh
Confidence 87554332 2234567889999999999999999999999999999998 8999975443221 111111
Q ss_pred cCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 045453 286 NNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQI 341 (346)
Q Consensus 286 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 341 (346)
.+... ......+..+.+|+..||+.||++||||.||++.|++.
T Consensus 230 ~~~~~-------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 230 EGERL-------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp SCCCC-------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCC-------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11110 01113345688999999999999999999999999875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-54 Score=387.14 Aligned_cols=259 Identities=21% Similarity=0.328 Sum_probs=206.2
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCe--EEEEEEecCcc-CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDR--TVSVMKFNDIL-NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~--~vavk~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
++|+..+.||+|+||+||+|.+ ++. .||||++.... ......+.+|+..+..+.+|||||+++|+|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 6788889999999999999998 444 57788876443 335567889999999986799999999999999999999
Q ss_pred EecccCCChhhhhhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCce
Q 045453 132 FESVKNRTLADHIYQNQ------------PHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIA 199 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~ 199 (346)
|||+++|+|.++|.... .....++|..++.++.|+|.||.||| +.+|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence 99999999999997542 22357999999999999999999999 8999999999999999999999
Q ss_pred EEeccCCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCC-CCCCCCCCcccccchhhHHH
Q 045453 200 KLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQ-KIFDPSRGDEIGAGHYWLLH 278 (346)
Q Consensus 200 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~-~p~~~~~~~~~~~~~~~~~~ 278 (346)
||+|||+++...... ......||..|+|||.+.++.++.++|||||||++|||++|. .||...+..+. .
T Consensus 167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~-------~- 236 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-------Y- 236 (309)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-------H-
T ss_pred EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHH-------H-
Confidence 999999997654322 223456899999999999999999999999999999999976 46654432221 1
Q ss_pred HHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 279 YVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 279 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
.. +..+. .+. .+...+..+.+|+.+||+.||++||||.||++.|+++.+.
T Consensus 237 --~~-i~~~~------------~~~-~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 237 --EK-LPQGY------------RLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp --HH-GGGTC------------CCC-CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred --HH-HHhcC------------CCC-CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 11 11110 010 1113456789999999999999999999999999999864
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-53 Score=383.24 Aligned_cols=253 Identities=25% Similarity=0.372 Sum_probs=203.0
Q ss_pred ccccccCCCcEEEEEEE-C-C---eEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeec-CCcceEEEec
Q 045453 62 RNVIKDGYAYKFYKGFV-E-D---RTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLE-TRIPVIVFES 134 (346)
Q Consensus 62 ~~~ig~G~~g~Vy~~~~-~-~---~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~-~~~~~lv~e~ 134 (346)
.++||+|+||+||+|.+ . + ..||||++..... ....++.+|+..+.++ +|||||+++|+|.+ .+..++||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCEeEEeEEEEecCCceEEEEEE
Confidence 46899999999999998 2 2 2689999875433 4456788999999998 99999999999876 4578999999
Q ss_pred ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCC
Q 045453 135 VKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE 214 (346)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~ 214 (346)
+++|+|.+++.... ..+++..++.++.|+|.||.||| +.+|+||||||+|||+++++.+||+|||+++......
T Consensus 111 ~~~g~l~~~~~~~~---~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 111 MKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp CTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred eecCchhhhhcccc---ccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 99999999987654 46889999999999999999999 8999999999999999999999999999998775443
Q ss_pred ce---eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccc
Q 045453 215 TC---VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDE 291 (346)
Q Consensus 215 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (346)
.. ......||+.|+|||.+.++.++.++||||||+++|||+||..||........ +...+ ..+.
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~------~~~~i----~~g~--- 251 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD------ITVYL----LQGR--- 251 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------------CHHHH----HTTC---
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH------HHHHH----HcCC---
Confidence 22 22345689999999999999999999999999999999998888764332111 11111 1111
Q ss_pred ccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 292 IVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 292 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
.+. .+...+..+.+|+.+||+.||++||||.||++.|+++++.
T Consensus 252 ---------~~~-~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 252 ---------RLL-QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp ---------CCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---------CCC-CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 000 1113446688999999999999999999999999999875
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8.7e-54 Score=391.69 Aligned_cols=251 Identities=18% Similarity=0.236 Sum_probs=207.5
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
.++|+..+.||+|+||+||+|.+ +++.||||++..........+.+|+.++..+ +|||||++++++.+.+.+++|||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECSSEEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEE
Confidence 35688999999999999999998 7899999998765545556677899999888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEc--CCCceEEeccCCCcccC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLD--EGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~--~~~~~kl~Dfgl~~~~~ 211 (346)
|+++|+|.+++.... .++++.+++.++.||+.||.||| +.+|+||||||+|||++ .++.+||+|||+|+.+.
T Consensus 107 ~~~gg~L~~~~~~~~---~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 107 FLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp CCCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred cCCCChHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecC
Confidence 999999999876543 46999999999999999999999 89999999999999998 67899999999998876
Q ss_pred CCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccc
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDE 291 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (346)
.... .....||+.|+|||++.+..++.++|||||||++|||+||..||.+....+. ...+. . ....
T Consensus 181 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-------~~~i~---~-~~~~- 246 (352)
T d1koba_ 181 PDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET-------LQNVK---R-CDWE- 246 (352)
T ss_dssp TTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-------HHHHH---H-CCCC-
T ss_pred CCCc--eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHH---h-CCCC-
Confidence 5433 3456789999999999999999999999999999999999999975433221 11111 1 1100
Q ss_pred ccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 292 IVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 292 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
. +.......+..+.+|+.+||+.||++|||+.|+++
T Consensus 247 -----~----~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 247 -----F----DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp -----C----CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred -----C----CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00011134466889999999999999999999975
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-54 Score=384.46 Aligned_cols=266 Identities=19% Similarity=0.289 Sum_probs=210.9
Q ss_pred HHHhcCCCcccccccCCCcEEEEEEE--CC-------eEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEccee
Q 045453 53 EIATNNFDARNVIKDGYAYKFYKGFV--ED-------RTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCC 122 (346)
Q Consensus 53 ~~~~~~f~~~~~ig~G~~g~Vy~~~~--~~-------~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~ 122 (346)
.+..++|...+.||+|+||.||+|++ .+ ..||||++..... ....++.+|+..+.++.+|||||+++++|
T Consensus 9 ~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~ 88 (299)
T d1fgka_ 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 88 (299)
T ss_dssp BCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence 34457788889999999999999987 21 3799999876554 34567888999998987899999999999
Q ss_pred ecCCcceEEEecccCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCC
Q 045453 123 LETRIPVIVFESVKNRTLADHIYQNQP------------HFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSR 190 (346)
Q Consensus 123 ~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~N 190 (346)
.+.+..++||||+++|+|.+++..... ....+++.+++.++.|++.||+||| +.+|+||||||+|
T Consensus 89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~N 165 (299)
T d1fgka_ 89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARN 165 (299)
T ss_dssp CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGG
T ss_pred ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccc
Confidence 999999999999999999999976532 1246899999999999999999999 8999999999999
Q ss_pred eEEcCCCceEEeccCCCcccCCCCce-eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcc
Q 045453 191 IFLDEGYIAKLFDFSLSVSIPEGETC-VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLT-GQKIFDPSRGDE 268 (346)
Q Consensus 191 Ill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~ 268 (346)
||++.++.+||+|||+++........ ......+|+.|+|||.+.++.|+.++||||||+++|||++ |..||......+
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~ 245 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH
Confidence 99999999999999999877543322 2345678999999999999999999999999999999998 788886543321
Q ss_pred cccchhhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 045453 269 IGAGHYWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHL 345 (346)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~l 345 (346)
+.. .+..+... .. +...+..+.+|+.+||+.+|++|||+.||++.|++|.+--
T Consensus 246 -------~~~----~i~~~~~~---------~~----p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~~ 298 (299)
T d1fgka_ 246 -------LFK----LLKEGHRM---------DK----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 298 (299)
T ss_dssp -------HHH----HHHTTCCC---------CC----CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -------HHH----HHHcCCCC---------CC----CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhcC
Confidence 111 11111111 00 1123456899999999999999999999999999997643
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-53 Score=379.68 Aligned_cols=249 Identities=20% Similarity=0.257 Sum_probs=204.6
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC------cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcc
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN------DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIP 128 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~------~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~ 128 (346)
+.|...+.||+|+||+||+|.+ +|+.||||++..... .....+.+|+.++..+ +|||||++++++.+.+..
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEE
Confidence 5688999999999999999998 688999999864321 2346788899999998 999999999999999999
Q ss_pred eEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCC----ceEEecc
Q 045453 129 VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGY----IAKLFDF 204 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~----~~kl~Df 204 (346)
++||||+++|+|.+++.... .+++..++.++.|++.||+||| +.+|+||||||+|||++.++ .+|++||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhcccc----ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecch
Confidence 99999999999999997753 6999999999999999999999 89999999999999998776 5999999
Q ss_pred CCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHh
Q 045453 205 SLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCI 284 (346)
Q Consensus 205 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (346)
|++........ .....||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+..+. ....
T Consensus 162 G~a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~----------~~~i- 228 (293)
T d1jksa_ 162 GLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET----------LANV- 228 (293)
T ss_dssp TTCEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------HHHH-
T ss_pred hhhhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH----------HHHH-
Confidence 99987754432 3456789999999999999999999999999999999999999976433221 1111
Q ss_pred hcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 285 ENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 285 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
...... .+.......+..+.+|+.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~----------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 229 SAVNYE----------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HTTCCC----------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HhcCCC----------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111000 000001123456889999999999999999999975
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-54 Score=386.65 Aligned_cols=266 Identities=20% Similarity=0.352 Sum_probs=214.4
Q ss_pred HHHHHHhcCCCcccccccCCCcEEEEEEEC-------CeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcce
Q 045453 50 RELEIATNNFDARNVIKDGYAYKFYKGFVE-------DRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGC 121 (346)
Q Consensus 50 ~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~-------~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~ 121 (346)
++|++..++|...+.||+|+||+||+|.+. +..||||++..... .....+.+|+.++.++ +|||||+++|+
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~ 91 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGV 91 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCEEEE
T ss_pred cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHc-CCCCEeeeeeE
Confidence 456667788999999999999999999873 46899999875433 3344578889998888 99999999999
Q ss_pred eecCCcceEEEecccCCChhhhhhhcC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcC
Q 045453 122 CLETRIPVIVFESVKNRTLADHIYQNQ------PHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE 195 (346)
Q Consensus 122 ~~~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~ 195 (346)
|...+..++||||+++|+|.+++.... .....+++..+..++.|+|.||.||| +.+|+||||||+|||+++
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~ 168 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAE 168 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECT
T ss_pred EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecC
Confidence 999999999999999999999986431 22245899999999999999999999 889999999999999999
Q ss_pred CCceEEeccCCCcccCCCCce-eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCC-CCCCCCCCcccccch
Q 045453 196 GYIAKLFDFSLSVSIPEGETC-VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQ-KIFDPSRGDEIGAGH 273 (346)
Q Consensus 196 ~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~-~p~~~~~~~~~~~~~ 273 (346)
++++||+|||+++........ ......+|+.|+|||.+.++.++.++||||||+++|||+||. .||...+..+.
T Consensus 169 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~---- 244 (308)
T d1p4oa_ 169 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV---- 244 (308)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH----
T ss_pred CceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHH----
Confidence 999999999999876544332 234456899999999999999999999999999999999985 66754433221
Q ss_pred hhHHHHHHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 045453 274 YWLLHYVKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQ 343 (346)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 343 (346)
...+ ..+.... .+...+..+.+|+.+||+.+|++||||.+|++.|++..+
T Consensus 245 ---~~~i----~~~~~~~-------------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 245 ---LRFV----MEGGLLD-------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp ---HHHH----HTTCCCC-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ---HHHH----HhCCCCC-------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1111 1111110 111344679999999999999999999999999987643
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=382.01 Aligned_cols=247 Identities=18% Similarity=0.230 Sum_probs=205.8
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceE
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVI 130 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~l 130 (346)
-++|...+.||+|+||+||+|.. +++.||||++.... .....++.+|+.++..+ +|||||++++++.+.+.+++
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECSSEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhC-CCCCEEEEEeeecccccccc
Confidence 36789999999999999999998 78999999987432 23456788899999888 99999999999999999999
Q ss_pred EEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCccc
Q 045453 131 VFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSI 210 (346)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~ 210 (346)
||||+++|+|.+++.... .+++..++.++.|++.||.||| +.+|+||||||+|||++++|.+||+|||+|+..
T Consensus 83 v~ey~~gg~L~~~~~~~~----~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~ 155 (337)
T d1o6la_ 83 VMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred ceeccCCCchhhhhhccc----CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeeccccccc
Confidence 999999999999998764 5899999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccc
Q 045453 211 PEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFD 290 (346)
Q Consensus 211 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (346)
..... .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||...+..+. . .... ...+
T Consensus 156 ~~~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-------~---~~i~-~~~~- 222 (337)
T d1o6la_ 156 ISDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-------F---ELIL-MEEI- 222 (337)
T ss_dssp CCTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------H---HHHH-HCCC-
T ss_pred ccCCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH-------H---HHHh-cCCC-
Confidence 43322 23456899999999999999999999999999999999999999986543221 1 1111 1110
Q ss_pred cccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 045453 291 EIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPT-----TVDVAK 336 (346)
Q Consensus 291 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~ 336 (346)
.+ + ...+..+.+|+..||+.||++||+ +.|+++
T Consensus 223 -----~~----p----~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 -----RF----P----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -----CC----C----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -----CC----C----ccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 00 0 123456889999999999999995 777764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.2e-52 Score=371.24 Aligned_cols=258 Identities=19% Similarity=0.311 Sum_probs=201.7
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC---cchHHHHHHHHHHhhhcCCCceeeEcceeecCC----c
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN---DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETR----I 127 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~----~ 127 (346)
++|...+.||+|+||+||+|.+ +++.||||++..... .....+.+|+..+..+ +|||||++++++...+ .
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEECSSSEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc-CCCCCCcccceeeeccCCCce
Confidence 5688999999999999999998 799999999875432 2344678889988888 9999999999987654 3
Q ss_pred ceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCC
Q 045453 128 PVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS 207 (346)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~ 207 (346)
.++||||+++++|.+++.... ++++.+++.++.|++.||+||| +.+|+||||||+|||++.++..+++|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~----~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcccC----CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhh
Confidence 789999999999999987763 6999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCc--eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhh
Q 045453 208 VSIPEGET--CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIE 285 (346)
Q Consensus 208 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (346)
........ .......||+.|+|||++.+..++.++|||||||++|||+||+.||......+ .......
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~----------~~~~~~~ 228 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS----------VAYQHVR 228 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----------HHHHHHH
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH----------HHHHHHh
Confidence 76543322 23345679999999999999999999999999999999999999997543322 1111111
Q ss_pred cCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHHHH
Q 045453 286 NNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRP-TTVDVAKRLKQIYQ 343 (346)
Q Consensus 286 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~ev~~~L~~i~~ 343 (346)
..... +.. .....+..+.+++.+||+.||++|| |++++.+.|..+..
T Consensus 229 ~~~~~----~~~-------~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 229 EDPIP----PSA-------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp CCCCC----GGG-------TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred cCCCC----Cch-------hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 11110 000 0013346788999999999999999 89999999988753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.9e-52 Score=377.71 Aligned_cols=243 Identities=20% Similarity=0.283 Sum_probs=202.9
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
++|...+.||+|+||+||+|.+ +++.||||++.... ......+.+|+.++..+ +|||||++++++.+.+..++|
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhc-cCcChhheeeeEeeCCeeeeE
Confidence 5688899999999999999998 68999999986432 23456677888888888 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+++|+|..++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+|+...
T Consensus 83 mE~~~gg~l~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~ 155 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 155 (316)
T ss_dssp ECCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eeecCCccccccccccc----cccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEec
Confidence 99999999999987764 5888999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccc
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDE 291 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (346)
.. .....||+.|+|||++.+..|+.++|||||||++|||+||+.||...+..+. ...... +
T Consensus 156 ~~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~----------~~~i~~-~---- 216 (316)
T d1fota_ 156 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT----------YEKILN-A---- 216 (316)
T ss_dssp SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH----------HHHHHH-C----
T ss_pred cc----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH----------HHHHHc-C----
Confidence 43 2356899999999999999999999999999999999999999976433221 111111 1
Q ss_pred ccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 045453 292 IVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRP-----TTVDVAK 336 (346)
Q Consensus 292 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~ 336 (346)
.... +...+..+.+++.+||+.+|++|| |++|+++
T Consensus 217 --------~~~~--p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 217 --------ELRF--PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp --------CCCC--CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --------CCCC--CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 0000 012345688999999999999996 8888864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-52 Score=379.70 Aligned_cols=250 Identities=19% Similarity=0.301 Sum_probs=200.6
Q ss_pred hcCCCccc-ccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeec----CCcc
Q 045453 56 TNNFDARN-VIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLE----TRIP 128 (346)
Q Consensus 56 ~~~f~~~~-~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~----~~~~ 128 (346)
.++|.... .||+|+||+||+|.+ +++.||||++.. .....+|+..+.++.+|||||++++++.+ ...+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 36787764 699999999999998 789999999863 34567788887777689999999999865 4678
Q ss_pred eEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcC---CCceEEeccC
Q 045453 129 VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE---GYIAKLFDFS 205 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~---~~~~kl~Dfg 205 (346)
++|||||+||+|.+++..... ..+++.++..++.|++.||+||| +.+|+||||||+|||++. ++.+||+|||
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEECCCCCcHHHHHHhcCC--CCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccccc
Confidence 999999999999999976432 46999999999999999999999 899999999999999985 5679999999
Q ss_pred CCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhh
Q 045453 206 LSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIE 285 (346)
Q Consensus 206 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (346)
+|+....... .....||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.......
T Consensus 160 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~--------------- 222 (335)
T d2ozaa1 160 FAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--------------- 222 (335)
T ss_dssp TCEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------------
T ss_pred eeeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH---------------
Confidence 9987754433 34567999999999999999999999999999999999999999765443320
Q ss_pred cCccccccccccccCC--CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 286 NNEFDEIVDPIIVSEG--PRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 286 ~~~~~~~~d~~l~~~~--~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
..+......... +.......+..+.+|+.+||+.||++|||+.|+++
T Consensus 223 ----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 223 ----PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ---------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ----HHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 000001111111 11112245677999999999999999999999876
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.7e-52 Score=369.83 Aligned_cols=250 Identities=21% Similarity=0.328 Sum_probs=204.7
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCc---------chHHHHHHHHHHhhhcCCCceeeEcceeecC
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILND---------GHEDCFNNIIFASKLSSHKNVLKLTGCCLET 125 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~---------~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~ 125 (346)
++|+..+.||+|+||+||+|++ +++.+|||++...... ....+.+|+..+.++..|||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5788999999999999999998 7899999998754321 1235778999999994599999999999999
Q ss_pred CcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccC
Q 045453 126 RIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFS 205 (346)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg 205 (346)
+..++||||+++|+|.++|.... ++++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccch
Confidence 99999999999999999997653 6999999999999999999999 8999999999999999999999999999
Q ss_pred CCcccCCCCceeeccccccCCcCCcccccc------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHH
Q 045453 206 LSVSIPEGETCVKDKVTGTMGFLAPEYINT------GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHY 279 (346)
Q Consensus 206 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 279 (346)
+++.+..... .....||..|+|||.+.+ ..++.++||||+||++|||+||+.||......+. .
T Consensus 156 ~a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~-------~-- 224 (277)
T d1phka_ 156 FSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM-------L-- 224 (277)
T ss_dssp TCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------H--
T ss_pred heeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH-------H--
Confidence 9988765332 345679999999999863 3578899999999999999999999986433221 1
Q ss_pred HHHHhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 280 VKKCIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 280 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
..... +... .+.+.....++.+.+|+.+||+.+|++|||+.||++
T Consensus 225 -~~i~~-~~~~----------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 225 -RMIMS-GNYQ----------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp -HHHHH-TCCC----------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -HHHHh-CCCC----------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11111 1110 011111244567899999999999999999999864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=379.62 Aligned_cols=246 Identities=21% Similarity=0.284 Sum_probs=203.5
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
++|...+.||+|+||+||+|.+ +++.||||++.... ......+..|+..+....+|||||++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5788899999999999999999 88999999986432 334556778887777555999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~~~----~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhcc
Confidence 99999999999998764 5899999999999999999999 8999999999999999999999999999998665
Q ss_pred CCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccc
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDE 291 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (346)
.... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+..+. ...+ ....
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~-------~~~i----~~~~--- 219 (320)
T d1xjda_ 155 LGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL-------FHSI----RMDN--- 219 (320)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHH----HHCC---
T ss_pred cccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH-------HHHH----HcCC---
Confidence 3332 33456799999999999999999999999999999999999999976443221 1111 1111
Q ss_pred ccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 045453 292 IVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTV-DVA 335 (346)
Q Consensus 292 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-ev~ 335 (346)
+.. +...+..+.+|+.+||+.||++|||+. |++
T Consensus 220 ---~~~--------p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 220 ---PFY--------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp ---CCC--------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ---CCC--------CccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 000 012345688999999999999999996 664
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.9e-52 Score=380.92 Aligned_cols=247 Identities=17% Similarity=0.244 Sum_probs=196.6
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHH---HHHHhhhcCCCceeeEcceeecCCcc
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNN---IIFASKLSSHKNVLKLTGCCLETRIP 128 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e---~~~~~~~~~h~niv~l~g~~~~~~~~ 128 (346)
++|...+.||+|+||+||+|.+ +++.||||++.... ......+.+| +..+..+ +|||||++++++.+.+..
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~-~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECSSEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcC-CCCcEEEEEEEEEECCEE
Confidence 6788999999999999999999 78999999986432 1222233333 3444444 899999999999999999
Q ss_pred eEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 129 VIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
++||||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+|+
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEEecCCCcHHHHHHhcc----cccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceee
Confidence 99999999999999998753 5899999999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcC
Q 045453 209 SIPEGETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENN 287 (346)
Q Consensus 209 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (346)
.+.... .....||+.|+|||++.. ..|+.++|||||||++|||+||+.||......+. ......
T Consensus 156 ~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-------~~~~~~----- 220 (364)
T d1omwa3 156 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-------HEIDRM----- 220 (364)
T ss_dssp ECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-------HHHHHH-----
T ss_pred ecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHh-----
Confidence 765433 345679999999999975 5689999999999999999999999986554332 010100
Q ss_pred ccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 045453 288 EFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPT-----TVDVAK 336 (346)
Q Consensus 288 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~ 336 (346)
....... .+...+..+.+|+.+||+.||++||| ++|+++
T Consensus 221 --------~~~~~~~--~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 221 --------TLTMAVE--LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp --------SSSCCCC--CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred --------cccCCCC--CCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0000000 01133456889999999999999999 577653
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-51 Score=377.12 Aligned_cols=243 Identities=16% Similarity=0.199 Sum_probs=203.5
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc---CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL---NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv 131 (346)
++|+..+.||+|+||+||+|.+ +++.||||++.... ......+.+|+.++..+ +|||||++++++.+.+..++|
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-CCCcEeecccccccccccccc
Confidence 5799999999999999999998 78999999986432 23456678899999888 999999999999999999999
Q ss_pred EecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccC
Q 045453 132 FESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIP 211 (346)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~ 211 (346)
|||+.+|+|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+|+.+.
T Consensus 120 ~e~~~~g~l~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~ 192 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred cccccccchhhhHhhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence 99999999999997764 5999999999999999999999 8999999999999999999999999999998775
Q ss_pred CCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccc
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDE 291 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (346)
.. .....||+.|||||++.+..++.++|||||||++|||+||..||...+... +...+ .. +..
T Consensus 193 ~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-------~~~~i---~~-~~~-- 255 (350)
T d1rdqe_ 193 GR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-------IYEKI---VS-GKV-- 255 (350)
T ss_dssp SC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHH---HH-CCC--
T ss_pred cc----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH-------HHHHH---hc-CCC--
Confidence 33 235679999999999999999999999999999999999999997543211 11111 11 100
Q ss_pred ccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 045453 292 IVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRP-----TTVDVAK 336 (346)
Q Consensus 292 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~ 336 (346)
.. +...+..+.+|+.+||+.||++|+ |+.|+++
T Consensus 256 ----~~--------p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 ----RF--------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----CC--------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CC--------CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 00 013345688999999999999994 8888874
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-51 Score=371.23 Aligned_cols=250 Identities=17% Similarity=0.207 Sum_probs=203.3
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
.+.|...+.||+|+||+||+|.+ +++.||||.+.... .....+.+|+.++..+ +|||||++++++.+.+.+++|||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIA-RHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHS-CCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEEe
Confidence 35688899999999999999998 78899999987543 2334567888888888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCC--CceEEeccCCCcccC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEG--YIAKLFDFSLSVSIP 211 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~--~~~kl~Dfgl~~~~~ 211 (346)
|+++|+|.+++.... .++++.++..++.|++.||.||| +.+|+||||||+|||++.+ +.+||+|||+++...
T Consensus 82 ~~~gg~L~~~i~~~~---~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 82 FISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred cCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccc
Confidence 999999999997653 36999999999999999999999 8999999999999999854 589999999998775
Q ss_pred CCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccc
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDE 291 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (346)
.... .....+|+.|+|||...+..++.++||||+||++|+|++|..||...+..+. ...... ....
T Consensus 156 ~~~~--~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~----------~~~i~~-~~~~- 221 (321)
T d1tkia_ 156 PGDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI----------IENIMN-AEYT- 221 (321)
T ss_dssp TTCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----------HHHHHH-TCCC-
T ss_pred cCCc--ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH----------HHHHHh-CCCC-
Confidence 4332 3446789999999999999999999999999999999999999976543221 111111 1000
Q ss_pred ccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 292 IVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 292 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.+.. .....+..+.+|+.+||+.||++|||+.|+++
T Consensus 222 -~~~~--------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 222 -FDEE--------AFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -CCHH--------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -CChh--------hccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 00123456889999999999999999999986
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=363.03 Aligned_cols=259 Identities=19% Similarity=0.188 Sum_probs=194.2
Q ss_pred ccccccCCCcEEEEEEE--CCeEEEEEEecCccCc-----chHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEec
Q 045453 62 RNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILND-----GHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFES 134 (346)
Q Consensus 62 ~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~-----~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e~ 134 (346)
.++||+|+||+||+|.+ +++.||||++...... ....+.+|+.++..+ +|||||++++++.+.+..++||||
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCTTCCEEEEEC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhC-CCCCEeEEEeeeccCCceeehhhh
Confidence 46899999999999998 7889999998644321 234578899999988 999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCCC
Q 045453 135 VKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEGE 214 (346)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~~ 214 (346)
+.++++....... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~~~~----~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred hcchHHhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 9887776655433 46888999999999999999999 8999999999999999999999999999998765433
Q ss_pred ceeeccccccCCcCCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCcccccc
Q 045453 215 TCVKDKVTGTMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEIV 293 (346)
Q Consensus 215 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (346)
. .....+||+.|+|||++.+. .++.++|||||||++|||+||..||......+ ....+.............
T Consensus 155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-------~l~~i~~~~~~~~~~~~~ 226 (299)
T d1ua2a_ 155 R-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-------QLTRIFETLGTPTEEQWP 226 (299)
T ss_dssp C-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHHHCCCCTTTSS
T ss_pred c-cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH-------HHHHHHHhcCCCChhhcc
Confidence 2 23345799999999998754 57999999999999999999999997654322 111111111111000000
Q ss_pred c------cccccCCCCcch----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 294 D------PIIVSEGPRVGK----EKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 294 d------~~l~~~~~~~~~----~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
+ .......+.... ......+.+|+.+||+.||++|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 227 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred chhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0 000000000000 022467899999999999999999999875
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-50 Score=360.46 Aligned_cols=266 Identities=17% Similarity=0.220 Sum_probs=199.7
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
++|+..+.||+|+||+||+|.+ +++.||||++..... ....++.+|+.++.++ +|||||++++++.+.+..++||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEEeccccccccceeEEE
Confidence 5788999999999999999998 689999999864432 3456788999999988 9999999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
||+.+ ++.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+|+....
T Consensus 81 e~~~~-~~~~~~~~~~~--~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~ 154 (298)
T d1gz8a_ 81 EFLHQ-DLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 154 (298)
T ss_dssp ECCSE-EHHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred eecCC-chhhhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccC
Confidence 99975 55555544322 46999999999999999999999 89999999999999999999999999999977654
Q ss_pred CCceeeccccccCCcCCccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcC--cc
Q 045453 213 GETCVKDKVTGTMGFLAPEYINTGD-FNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENN--EF 289 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 289 (346)
... ......||+.|+|||.+.... ++.++|||||||++|+|++|+.||...+..+. +........... ..
T Consensus 155 ~~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~------~~~i~~~~~~~~~~~~ 227 (298)
T d1gz8a_ 155 PVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ------LFRIFRTLGTPDEVVW 227 (298)
T ss_dssp CSB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHHHCCCCTTTS
T ss_pred Ccc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH------HHHHHHhcCCCchhhc
Confidence 332 234567999999999987765 58899999999999999999999976543221 111111110000 00
Q ss_pred cccc-ccccccCCCC---cc----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 290 DEIV-DPIIVSEGPR---VG----KEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 290 ~~~~-d~~l~~~~~~---~~----~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.... .+......+. .. .......+.+|+.+||+.||++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp TTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 0000 0000000000 00 0022367889999999999999999999976
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=359.09 Aligned_cols=239 Identities=18% Similarity=0.288 Sum_probs=194.5
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCc------chHHHHHHHHHHhhhc-CCCceeeEcceeecCCc
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILND------GHEDCFNNIIFASKLS-SHKNVLKLTGCCLETRI 127 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~------~~~~~~~e~~~~~~~~-~h~niv~l~g~~~~~~~ 127 (346)
++|...+.||+|+||+||+|.+ +++.||||++...... ...++.+|+.++.++. .|||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5688899999999999999998 7899999998654211 1234567888888873 39999999999999999
Q ss_pred ceEEEecccC-CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCC-CceEEeccC
Q 045453 128 PVIVFESVKN-RTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEG-YIAKLFDFS 205 (346)
Q Consensus 128 ~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~-~~~kl~Dfg 205 (346)
.++||||+.+ +++.+++.... .+++.++..++.|++.||.||| +.+|+||||||+|||++.+ +.+||+|||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~----~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEeccCcchHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccc
Confidence 9999999976 57888887653 6999999999999999999999 8999999999999999854 799999999
Q ss_pred CCcccCCCCceeeccccccCCcCCccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHh
Q 045453 206 LSVSIPEGETCVKDKVTGTMGFLAPEYINTGDF-NEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCI 284 (346)
Q Consensus 206 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (346)
+|+...... .+...||+.|+|||++.+..+ +.++|||||||++|||+||+.||..... .
T Consensus 157 ~a~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----------------i- 216 (273)
T d1xwsa_ 157 SGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------------I- 216 (273)
T ss_dssp TCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------------H-
T ss_pred cceeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH----------------H-
Confidence 998754332 345679999999999987765 6779999999999999999999964210 0
Q ss_pred hcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 285 ENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 285 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
..... .+. ...+..+.+|+.+||+.||++|||+.|+++
T Consensus 217 ~~~~~------~~~--------~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 217 IRGQV------FFR--------QRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp HHCCC------CCS--------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhccc------CCC--------CCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 00100 000 023456889999999999999999999875
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-50 Score=359.60 Aligned_cols=266 Identities=17% Similarity=0.207 Sum_probs=196.1
Q ss_pred hcCCCcccccccCCCcEEEEEEE--C-CeEEEEEEecCccC--cchHHHHHHHHHHhhh--cCCCceeeEcceeec----
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--E-DRTVSVMKFNDILN--DGHEDCFNNIIFASKL--SSHKNVLKLTGCCLE---- 124 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~-~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~--~~h~niv~l~g~~~~---- 124 (346)
.++|+..+.||+|+||+||+|.+ + ++.||||++..... ....++.+|+..+..+ .+||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999998 3 56799999864332 2234456666665544 289999999999853
Q ss_pred -CCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEec
Q 045453 125 -TRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFD 203 (346)
Q Consensus 125 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~D 203 (346)
....+++|||+.++++........ ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhccC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecc
Confidence 346799999998876655444332 46899999999999999999999 89999999999999999999999999
Q ss_pred cCCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHH
Q 045453 204 FSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKC 283 (346)
Q Consensus 204 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 283 (346)
||+++...... ......||+.|+|||++.+..|+.++||||+||++|||+||+.||...+..+. +.... ..
T Consensus 160 fg~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~------~~~i~-~~ 230 (305)
T d1blxa_ 160 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ------LGKIL-DV 230 (305)
T ss_dssp CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHH-HH
T ss_pred hhhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH------HHHHH-Hh
Confidence 99987654322 23566799999999999999999999999999999999999999976543221 11111 11
Q ss_pred hhcCccccc------cccccccCCCC---cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 284 IENNEFDEI------VDPIIVSEGPR---VGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 284 ~~~~~~~~~------~d~~l~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
........+ ........... .........+.+|+.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 231 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 111000000 00000000000 001123456889999999999999999999875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.1e-49 Score=352.46 Aligned_cols=264 Identities=17% Similarity=0.204 Sum_probs=198.1
Q ss_pred cCCCcccccccCCCcEEEEEEE-CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
++|...+.||+|+||+||+|.+ +++.||||++.... .....++.+|+.++.++ +|||||++++++...+..++++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEeeeeecccCCceeEEEE
Confidence 4688889999999999999999 78999999986543 23356788999999888 99999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCCC
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPEG 213 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~~ 213 (346)
|+.++.+..+.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+|++|||.+......
T Consensus 81 ~~~~~~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CCSEEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred eehhhhHHHHHhhc----CCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 99876666655433 46999999999999999999999 899999999999999999999999999998776543
Q ss_pred CceeeccccccCCcCCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCccccc
Q 045453 214 ETCVKDKVTGTMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNEFDEI 292 (346)
Q Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (346)
.. ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...+..+. +...... .........
T Consensus 154 ~~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~------~~~i~~~-~~~~~~~~~ 225 (286)
T d1ob3a_ 154 VR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ------LMRIFRI-LGTPNSKNW 225 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHH-HCCCCTTTS
T ss_pred cc-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH------HHHHHHh-hCCCChhhc
Confidence 22 23445689999999999764 569999999999999999999999976543221 1111111 111000000
Q ss_pred --------cccccccCCCCc---chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 293 --------VDPIIVSEGPRV---GKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 293 --------~d~~l~~~~~~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.+.......+.+ ........+.+|+.+||+.||++|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000000 01123457889999999999999999999874
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=8e-48 Score=344.23 Aligned_cols=264 Identities=11% Similarity=0.125 Sum_probs=209.4
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEEe
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~e 133 (346)
.++|...+.||+|+||+||+|.+ +++.||||.+.... ...++.+|+..+..+.+|+|++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 36788999999999999999998 78999999876443 234566778888888556999999999999999999999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcC-----CCceEEeccCCCc
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDE-----GYIAKLFDFSLSV 208 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~-----~~~~kl~Dfgl~~ 208 (346)
|+ +++|.+++.... ..+++.++..++.|++.||.||| +.+|+||||||+|||++. ++.+||+|||+|+
T Consensus 82 ~~-~~~l~~~~~~~~---~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 82 LL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHhhc---cchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeE
Confidence 99 679999987654 46999999999999999999999 999999999999999974 5789999999998
Q ss_pred ccCCCCc------eeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHH
Q 045453 209 SIPEGET------CVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKK 282 (346)
Q Consensus 209 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (346)
....... .......||+.|||||.+.+..++.++||||||+++|||+||..||......... .....+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~----~~~~~i~~ 230 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK----QKYERIGE 230 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH----HHHHHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHH----HHHHHHHh
Confidence 7643321 1123457999999999999999999999999999999999999999865544321 11111111
Q ss_pred HhhcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 045453 283 CIENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQHL 345 (346)
Q Consensus 283 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~l 345 (346)
........ .+.. ..+..+.+++..|++.+|++||++..+.+.|+++.+++
T Consensus 231 ~~~~~~~~-----~l~~--------~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 231 KKQSTPLR-----ELCA--------GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp HHHHSCHH-----HHTT--------TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ccCCCChH-----HhcC--------CCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 10111100 0100 23356889999999999999999999999999988764
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5e-48 Score=346.78 Aligned_cols=261 Identities=16% Similarity=0.238 Sum_probs=199.6
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCc-eeeEcceeecCCcceEEEe
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKN-VLKLTGCCLETRIPVIVFE 133 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~n-iv~l~g~~~~~~~~~lv~e 133 (346)
+.|+..+.||+|+||+||+|.+ +++.||||...... ...++..|+.++..+ +|+| |+.+.++..+.+..++|||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l-~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMM-QGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHS-TTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHc-cCCCcccEEEEEEecCCEEEEEEE
Confidence 4588899999999999999998 68999999876543 334577888888888 6655 5555666677888899999
Q ss_pred cccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEc---CCCceEEeccCCCccc
Q 045453 134 SVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLD---EGYIAKLFDFSLSVSI 210 (346)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~---~~~~~kl~Dfgl~~~~ 210 (346)
|+ +++|.+.+.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++ .+..+|++|||+|+..
T Consensus 84 ~~-~~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 84 LL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred Ec-CCchhhhhhhcc---CCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 99 557777766544 46999999999999999999999 89999999999999986 4567999999999877
Q ss_pred CCCCce------eeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHh
Q 045453 211 PEGETC------VKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCI 284 (346)
Q Consensus 211 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (346)
...... ......||+.|+|||.+.+..++.++|||||||++|||+||..||.......... ..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~---~~~~~~~~~~ 233 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ---KYERISEKKM 233 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC----------HHHHHHHHH
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHH---HHHHhhcccC
Confidence 543321 2245579999999999999999999999999999999999999998765543211 0111111000
Q ss_pred hcCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 045453 285 ENNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAKRLKQIYQH 344 (346)
Q Consensus 285 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 344 (346)
. ... +.+. ...+..+.+++..||+.+|++||++.++.+.|+++..+
T Consensus 234 ~-~~~-----~~~~--------~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 234 S-TPI-----EVLC--------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp H-SCH-----HHHT--------TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred C-CCh-----hHhc--------cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 0 000 0000 02346688999999999999999999999999988654
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-48 Score=354.02 Aligned_cols=262 Identities=22% Similarity=0.256 Sum_probs=191.6
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecC------Ccce
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLET------RIPV 129 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~------~~~~ 129 (346)
+|+..++||+|+||+||+|.+ +++.||||++...... ..+|+.++..+ +|||||+++++|... .+++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l-~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHC-CCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhc-CCCCCCcEEEEEEecCccCCceEEE
Confidence 577889999999999999999 7899999998754322 23688888888 999999999998543 3478
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCC-ceEEeccCCCc
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGY-IAKLFDFSLSV 208 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~-~~kl~Dfgl~~ 208 (346)
+||||++++.+ +.+.........+++.++..++.|++.||.||| +.+|+||||||+|||++.++ .+||+|||+++
T Consensus 96 lv~Ey~~~~~~-~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 96 LVLDYVPETVY-RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEEECCSEEHH-HHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEEeccCCccH-HHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchh
Confidence 99999987543 333321111257999999999999999999999 99999999999999999775 89999999998
Q ss_pred ccCCCCceeeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhh--
Q 045453 209 SIPEGETCVKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIE-- 285 (346)
Q Consensus 209 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 285 (346)
....... .....||..|+|||.+.+ ..++.++||||+||++|||++|..||......+. +.........
T Consensus 172 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~------l~~i~~~~g~~~ 243 (350)
T d1q5ka_ 172 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ------LVEIIKVLGTPT 243 (350)
T ss_dssp ECCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH------HHHHHHHHCCCC
T ss_pred hccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH------HHHHHHHhCCCh
Confidence 7754432 334679999999998875 5689999999999999999999999976543221 1111111000
Q ss_pred -------cCccccccccccccC-CCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 286 -------NNEFDEIVDPIIVSE-GPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 286 -------~~~~~~~~d~~l~~~-~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
........-+..... ............+.+|+.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000000000 000001133456889999999999999999999985
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-48 Score=349.84 Aligned_cols=266 Identities=16% Similarity=0.188 Sum_probs=195.1
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCcc--CcchHHHHHHHHHHhhhcCCCceeeEcceeec-------
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL--NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLE------- 124 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~------- 124 (346)
.++|+..+.||+|+||+||+|.+ +++.||||++.... .....++.+|+.++..+ +||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHh-cCCCccceEeeeecccccccc
Confidence 36788999999999999999998 78999999976442 34456788999999998 99999999999865
Q ss_pred -CCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEec
Q 045453 125 -TRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFD 203 (346)
Q Consensus 125 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~D 203 (346)
.+..++||||++++++....... ..++...+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~----~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~d 160 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLAD 160 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTT----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECC
T ss_pred cCceEEEEEeccCCCccchhhhcc----cccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeee
Confidence 34679999999886665444332 46889999999999999999999 89999999999999999999999999
Q ss_pred cCCCcccCCCCce---eeccccccCCcCCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHH
Q 045453 204 FSLSVSIPEGETC---VKDKVTGTMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHY 279 (346)
Q Consensus 204 fgl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 279 (346)
||+++.+...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+ ....
T Consensus 161 fg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~-------~~~~ 233 (318)
T d3blha1 161 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-------QLAL 233 (318)
T ss_dssp CTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHH
T ss_pred cceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH-------HHHH
Confidence 9999876543321 22345699999999999865 68999999999999999999999997643322 1111
Q ss_pred HHHHhhcCc---ccccccc----ccccC-CCCcchH------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 280 VKKCIENNE---FDEIVDP----IIVSE-GPRVGKE------KQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 280 ~~~~~~~~~---~~~~~d~----~l~~~-~~~~~~~------~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
+........ ....... .+... ....... .....+.+|+.+||+.||++|||+.|+++
T Consensus 234 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 234 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp HHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 222111110 0000000 00000 0000110 11345778999999999999999999975
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=350.63 Aligned_cols=265 Identities=15% Similarity=0.186 Sum_probs=193.8
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC-cchHHHHHHHHHHhhhcCCCceeeEcceeecCC----cce
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN-DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETR----IPV 129 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~----~~~ 129 (346)
+.|...+.||+|+||+||+|.+ +++.||||++..... ....++.+|+.++..+ +||||+++++++.... ..+
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHc-CCCCCCcEEEEEeeccccccceE
Confidence 4688889999999999999998 789999999875432 3455778899999998 9999999999986543 234
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcc
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVS 209 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~ 209 (346)
++++|+.+|+|.+++... .+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++.
T Consensus 87 ~l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 555667799999999763 4899999999999999999999 89999999999999999999999999999976
Q ss_pred cCCCCce--eeccccccCCcCCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhc
Q 045453 210 IPEGETC--VKDKVTGTMGFLAPEYINT-GDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIEN 286 (346)
Q Consensus 210 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (346)
....... ......||+.|+|||++.. ..++.++||||+||++|||++|+.||......+. ...........
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~------~~~~~~~~~~~ 232 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ------LNHILGILGSP 232 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHHHCSC
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH------HHHHhhhccCC
Confidence 6433221 2345678999999999854 5679999999999999999999999976543221 00000000000
Q ss_pred Cc--ccccc-----c--cccccCCCCcc---hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 287 NE--FDEIV-----D--PIIVSEGPRVG---KEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 287 ~~--~~~~~-----d--~~l~~~~~~~~---~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.. ..... + ........... .+.....+.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00000 0 00000000000 0012346889999999999999999999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-47 Score=347.82 Aligned_cols=261 Identities=16% Similarity=0.187 Sum_probs=192.0
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecCC-----
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETR----- 126 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~----- 126 (346)
.+.|...+.||+|+||+||+|.+ +++.||||++..... .....+.+|+.++..+ +|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhc-CCCCeeEEEEEeccCcccccc
Confidence 46788899999999999999998 689999999875432 3345678899999988 9999999999997654
Q ss_pred -cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccC
Q 045453 127 -IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFS 205 (346)
Q Consensus 127 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg 205 (346)
.+++||||+ +.+|...+... ++++..++.++.|++.||.||| +.+|+||||||+|||++.++.+|++|||
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred ceEEEEEecc-cccHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhccccccccccccc
Confidence 469999999 55787777553 5999999999999999999999 8999999999999999999999999999
Q ss_pred CCcccCCCCceeeccccccCCcCCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHh
Q 045453 206 LSVSIPEGETCVKDKVTGTMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCI 284 (346)
Q Consensus 206 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (346)
+|+..... .+...||+.|+|||++.+. .++.++||||+||++|+|++|+.||...+.... +........
T Consensus 167 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~------~~~~~~~~~ 236 (346)
T d1cm8a_ 167 LARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ------LKEIMKVTG 236 (346)
T ss_dssp TCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHHHC
T ss_pred ceeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH------HHHHHhccC
Confidence 99876433 2456799999999998864 568999999999999999999999976543221 111111000
Q ss_pred h-------cCccc---ccc--ccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 285 E-------NNEFD---EIV--DPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 285 ~-------~~~~~---~~~--d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
. ..... ... .+.................+.+|+.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0 00000 000 0000000000000123356789999999999999999999985
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-48 Score=348.78 Aligned_cols=252 Identities=17% Similarity=0.203 Sum_probs=203.6
Q ss_pred cCCCcccccccCCCcEEEEEEE-----CCeEEEEEEecCcc----CcchHHHHHHHHHHhhhcCCCceeeEcceeecCCc
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV-----EDRTVSVMKFNDIL----NDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRI 127 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~-----~~~~vavk~~~~~~----~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~ 127 (346)
++|+..+.||+|+||+||+|.. +|+.||||.+.... ......+.+|+.++.++.+||||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5688999999999999999987 46899999986432 12345677899999999444899999999999999
Q ss_pred ceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCC
Q 045453 128 PVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLS 207 (346)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~ 207 (346)
.++||||+.+|+|.+++.... .++......++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~----~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHhcc----cccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccch
Confidence 999999999999999998764 4778899999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCceeeccccccCCcCCccccccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhh
Q 045453 208 VSIPEGETCVKDKVTGTMGFLAPEYINTG--DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIE 285 (346)
Q Consensus 208 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (346)
+.+............|++.|+|||.+.+. .++.++|||||||+||+|+||+.||......+. ..........
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~------~~~i~~~~~~ 250 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS------QAEISRRILK 250 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC------HHHHHHHHHH
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHHhccc
Confidence 87765555445567899999999999765 468899999999999999999999987655443 1111111111
Q ss_pred cCccccccccccccCCCCcchHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 045453 286 NNEFDEIVDPIIVSEGPRVGKEKQLQGFRELALMCVCESAEDRPT-----TVDVAK 336 (346)
Q Consensus 286 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~ 336 (346)
.. . . .+...+..+.+|+.+||+.||++||| ++|+++
T Consensus 251 ~~-~------~--------~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 251 SE-P------P--------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp CC-C------C--------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CC-C------C--------CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 10 0 0 01134567889999999999999995 778764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.2e-46 Score=342.10 Aligned_cols=263 Identities=16% Similarity=0.225 Sum_probs=198.1
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeec--CCcceEEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLE--TRIPVIVF 132 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~--~~~~~lv~ 132 (346)
++|...+.||+|+||+||+|.+ +++.||||++... ...++.+|+.++..+..||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5788999999999999999998 7899999998643 356778899999998569999999999874 45689999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCC-ceEEeccCCCcccC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGY-IAKLFDFSLSVSIP 211 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~-~~kl~Dfgl~~~~~ 211 (346)
||+.+++|..+. ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++ .+||+|||+|+...
T Consensus 112 e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 112 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp ECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred eecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceecc
Confidence 999999997764 35899999999999999999999 89999999999999998655 69999999998765
Q ss_pred CCCceeeccccccCCcCCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHH-----HHHHHhh
Q 045453 212 EGETCVKDKVTGTMGFLAPEYINTG-DFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLH-----YVKKCIE 285 (346)
Q Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~ 285 (346)
.... .....+|+.|+|||.+.+. .++.++||||+||+++||++|..||........... .... .......
T Consensus 182 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~--~i~~~~g~~~~~~~~~ 257 (328)
T d3bqca1 182 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV--RIAKVLGTEDLYDYID 257 (328)
T ss_dssp TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHH--HHHHHHCHHHHHHHHH
T ss_pred CCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHH--HHHHHHCCchhhhhhh
Confidence 4432 3456789999999998865 479999999999999999999999976544221000 0000 0000000
Q ss_pred cC--c----cccccccc----cccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 286 NN--E----FDEIVDPI----IVSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 286 ~~--~----~~~~~d~~----l~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.. . ........ ................+.+|+.+||+.||++|||++|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0 00000000 0000111111234567899999999999999999999975
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=335.74 Aligned_cols=265 Identities=15% Similarity=0.184 Sum_probs=203.0
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
+.|...+.||+|+||+||+|.+ +++.||||++..... ....++.+|+.++..+ +||||++++++|.+....++|+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhc-CcCCEEeeccccccccceeEEe
Confidence 4688889999999999999999 788999999864432 3456778999999888 9999999999999999999999
Q ss_pred ecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCCCcccCC
Q 045453 133 ESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSVSIPE 212 (346)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~~~~~ 212 (346)
+++.+++|..++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||.++....
T Consensus 81 ~~~~~~~l~~~~~~~----~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 81 EFCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp ECCSEEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eeccccccccccccc----cccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccC
Confidence 999998888877654 36889999999999999999999 89999999999999999999999999999987654
Q ss_pred CCceeeccccccCCcCCccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhhcCc---
Q 045453 213 GETCVKDKVTGTMGFLAPEYINTGD-FNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIENNE--- 288 (346)
Q Consensus 213 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 288 (346)
... ......++..|+|||.+.... ++.++|||||||++|||++|+.||....... .....+........
T Consensus 154 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~ 226 (292)
T d1unla_ 154 PVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD------DQLKRIFRLLGTPTEEQ 226 (292)
T ss_dssp CCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH------HHHHHHHHHHCCCCTTT
T ss_pred CCc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH------HHHHHHHhhcCCCChhh
Confidence 332 233445778899999988765 6899999999999999999999975433322 11222222111110
Q ss_pred cc---cccc----cccc-cCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 289 FD---EIVD----PIIV-SEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 289 ~~---~~~d----~~l~-~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.. ...+ +... ..............+.+|+.+||+.||++|||++|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0000 0000 00000011133466889999999999999999999874
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-46 Score=342.27 Aligned_cols=267 Identities=18% Similarity=0.233 Sum_probs=188.7
Q ss_pred cCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeec------CC
Q 045453 57 NNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLE------TR 126 (346)
Q Consensus 57 ~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~------~~ 126 (346)
+.|...+.||+|+||+||+|.+ +++.||||++..... ....++.+|+.++..+ +|||||++++++.. ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEecccccccCc
Confidence 5688899999999999999998 699999999875542 2334577888888888 99999999999864 36
Q ss_pred cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCC
Q 045453 127 IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSL 206 (346)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl 206 (346)
.+|+||||+.++ +.+.+. ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+|++|||+
T Consensus 96 ~~~iv~Ey~~~~-l~~~~~------~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp EEEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred eeEEEEeccchH-HHHhhh------cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhh
Confidence 789999999764 444443 34899999999999999999999 89999999999999999999999999999
Q ss_pred CcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccc------------hh
Q 045453 207 SVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAG------------HY 274 (346)
Q Consensus 207 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~------------~~ 274 (346)
++...... ......+|+.|+|||++.+..++.++||||+||++++|++|+.||.+.+....... ..
T Consensus 166 ~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (355)
T d2b1pa1 166 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_dssp -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred hhcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence 87665433 23556789999999999999999999999999999999999999976532211000 00
Q ss_pred hHHHHHHHHhhcC-cccccccccc----ccCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 275 WLLHYVKKCIENN-EFDEIVDPII----VSEGPRVGKEKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 275 ~~~~~~~~~~~~~-~~~~~~d~~l----~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
............. .....-.+.. ...............+.+|+.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000001111110 0000000000 001111122245678999999999999999999999974
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-46 Score=339.18 Aligned_cols=260 Identities=17% Similarity=0.228 Sum_probs=193.3
Q ss_pred hcCCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccC--cchHHHHHHHHHHhhhcCCCceeeEcceeecC-----C
Q 045453 56 TNNFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILN--DGHEDCFNNIIFASKLSSHKNVLKLTGCCLET-----R 126 (346)
Q Consensus 56 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~-----~ 126 (346)
++.|...+.||+|+||+||+|.+ +++.||||++..... ....++.+|+.++..+ +|||||++++++... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeccccccC
Confidence 46788999999999999999998 799999999875432 3345678899999998 999999999998643 3
Q ss_pred cceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceEEeccCC
Q 045453 127 IPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAKLFDFSL 206 (346)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl 206 (346)
..++|++|+.+|+|.+++... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+|++|||+
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred ceEEEEEeecCCchhhhcccc-----cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccch
Confidence 446777888899999998643 5999999999999999999999 89999999999999999999999999999
Q ss_pred CcccCCCCceeeccccccCCcCCccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhHHHHHHHHhh
Q 045453 207 SVSIPEGETCVKDKVTGTMGFLAPEYINTGD-FNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWLLHYVKKCIE 285 (346)
Q Consensus 207 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (346)
+..... ......||..|+|||...+.. ++.++|||||||++|+|++|..||.+.+.... ...+.....
T Consensus 168 a~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~-------~~~i~~~~~ 236 (348)
T d2gfsa1 168 ARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-------LKLILRLVG 236 (348)
T ss_dssp --CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------HHHHHHHHC
T ss_pred hcccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH-------HHHHHHhcC
Confidence 865432 223567889999999877654 68999999999999999999999976543211 111111110
Q ss_pred cCcc--ccc-----c---ccccccCCCCcch----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045453 286 NNEF--DEI-----V---DPIIVSEGPRVGK----EKQLQGFRELALMCVCESAEDRPTTVDVAK 336 (346)
Q Consensus 286 ~~~~--~~~-----~---d~~l~~~~~~~~~----~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 336 (346)
.... ... . ...+. ..+.... ......+.+|+.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 237 TPGAELLKKISSESARNYIQSLT-QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CCCHHHHTTCCCHHHHHHHTTSC-CCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCChHHhhhccchhhhhhhhhcc-cCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0000 000 0 00000 0000000 022456889999999999999999999975
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.9e-40 Score=304.98 Aligned_cols=270 Identities=13% Similarity=0.126 Sum_probs=185.7
Q ss_pred CCCcccccccCCCcEEEEEEE--CCeEEEEEEecCccCcchHHHHHHHHHHhhhc----------CCCceeeEcceeecC
Q 045453 58 NFDARNVIKDGYAYKFYKGFV--EDRTVSVMKFNDILNDGHEDCFNNIIFASKLS----------SHKNVLKLTGCCLET 125 (346)
Q Consensus 58 ~f~~~~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~----------~h~niv~l~g~~~~~ 125 (346)
.|...+.||+|+||+||+|++ +++.||||+++... .......+|+.++..+. .|+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 388899999999999999998 78999999987542 22345566666666551 468899999988653
Q ss_pred --CcceEEEecccCCChh-hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCC-----
Q 045453 126 --RIPVIVFESVKNRTLA-DHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGY----- 197 (346)
Q Consensus 126 --~~~~lv~e~~~~gsL~-~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~----- 197 (346)
...+++++++..+... ....... ...+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTE
T ss_pred cccceeeeeeeccccccccccccccc--ccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCccccc
Confidence 4556667666554333 3232222 2568999999999999999999994 38999999999999998665
Q ss_pred -ceEEeccCCCcccCCCCceeeccccccCCcCCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccccchhhH
Q 045453 198 -IAKLFDFSLSVSIPEGETCVKDKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLLLVLLTGQKIFDPSRGDEIGAGHYWL 276 (346)
Q Consensus 198 -~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~ 276 (346)
.++++|||.+...... .....||+.|+|||++.+..++.++||||+||++++|++|+.||..............+
T Consensus 169 ~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred ceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 3899999998765322 24567999999999999999999999999999999999999999865443221111122
Q ss_pred HHHHHHHhh-------cCc-ccccccc-----ccccCC----------CCcchHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 045453 277 LHYVKKCIE-------NNE-FDEIVDP-----IIVSEG----------PRVGKEKQLQGFRELALMCVCESAEDRPTTVD 333 (346)
Q Consensus 277 ~~~~~~~~~-------~~~-~~~~~d~-----~l~~~~----------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e 333 (346)
...+...-. ... .....+. .+.... ...........+.+|+.+||+.||.+|||+.|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 222111100 000 0000000 000000 00112356778999999999999999999999
Q ss_pred HHH
Q 045453 334 VAK 336 (346)
Q Consensus 334 v~~ 336 (346)
+++
T Consensus 325 ~L~ 327 (362)
T d1q8ya_ 325 LVN 327 (362)
T ss_dssp HHT
T ss_pred Hhc
Confidence 875
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=2.9e-25 Score=184.75 Aligned_cols=166 Identities=14% Similarity=0.106 Sum_probs=116.3
Q ss_pred CcccccccCCCcEEEEEEE-CCeEEEEEEecCccCc------------------chHHHHHHHHHHhhhcCCCceeeEcc
Q 045453 60 DARNVIKDGYAYKFYKGFV-EDRTVSVMKFNDILND------------------GHEDCFNNIIFASKLSSHKNVLKLTG 120 (346)
Q Consensus 60 ~~~~~ig~G~~g~Vy~~~~-~~~~vavk~~~~~~~~------------------~~~~~~~e~~~~~~~~~h~niv~l~g 120 (346)
...+.||+|+||+||+|.+ +|+.||||.+...... .......|...+..+ .|++++..++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-QGLAVPKVYA 81 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-TTSSSCCEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc-cCCCcceEEE
Confidence 3467899999999999998 8899999986532110 012234566777777 8999988876
Q ss_pred eeecCCcceEEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEEcCCCceE
Q 045453 121 CCLETRIPVIVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGFSRPILHRKIRPSRIFLDEGYIAK 200 (346)
Q Consensus 121 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~k 200 (346)
+. ..++||||+++..+.+ ++......++.|++.+|+||| ..+|+||||||+|||+++++ ++
T Consensus 82 ~~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~~-~~ 142 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEEG-IW 142 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETTE-EE
T ss_pred ec----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCCC-EE
Confidence 53 2479999998865533 222345678999999999999 89999999999999999764 89
Q ss_pred EeccCCCcccCCCCceee--ccccccCCcCCccccccCCCCcccchHHHHHHH
Q 045453 201 LFDFSLSVSIPEGETCVK--DKVTGTMGFLAPEYINTGDFNEKCDVFSFGMLL 251 (346)
Q Consensus 201 l~Dfgl~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl 251 (346)
|+|||+|.....+..... ...... .+. -...|+.++|+||..--+
T Consensus 143 liDFG~a~~~~~~~~~~~l~rd~~~~-----~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 143 IIDFPQSVEVGEEGWREILERDVRNI-----ITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ECCCTTCEETTSTTHHHHHHHHHHHH-----HHH-HHHHHCCCCCHHHHHHHH
T ss_pred EEECCCcccCCCCCcHHHHHHHHHHH-----HHH-HcCCCCCcccHHHHHHHH
Confidence 999999876543321000 000000 011 135678899999986543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.83 E-value=1.9e-08 Score=85.71 Aligned_cols=150 Identities=14% Similarity=0.075 Sum_probs=100.9
Q ss_pred HHHHHHhcCCCcccccccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcce
Q 045453 50 RELEIATNNFDARNVIKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPV 129 (346)
Q Consensus 50 ~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~ 129 (346)
.++...-..|...+..+.++.+.||+...+++.+++|+..............|...+..+..+--+.+++.++..++..+
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 45666666776655555555679999988888889998765544344455666666665533433567777777888889
Q ss_pred EEEecccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------
Q 045453 130 IVFESVKNRTLADHIYQNQPHFEPLLLSQRLRIAVHIANAIAYLHIGF-------------------------------- 177 (346)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------------------------------- 177 (346)
+||+++++.++.+..... .. ...++.+++..++.||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEECCSSEEHHHHTTTC------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred EEEEeccccccccccccc------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence 999999998876543211 11 2224445555555555211
Q ss_pred ------------------------CCCceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 178 ------------------------SRPILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 178 ------------------------~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
...++|+|+.|.|||+++++..-|+||+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1236899999999999988777899999763
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.14 E-value=6.3e-06 Score=69.08 Aligned_cols=75 Identities=9% Similarity=-0.035 Sum_probs=46.8
Q ss_pred cccCCC-cEEEEEEE-CCeEEEEEEecCccCcchHHHHHHHHHHhhhcC-CCceeeEcceeecCCcceEEEecccCCChh
Q 045453 65 IKDGYA-YKFYKGFV-EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSS-HKNVLKLTGCCLETRIPVIVFESVKNRTLA 141 (346)
Q Consensus 65 ig~G~~-g~Vy~~~~-~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~-h~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 141 (346)
+..|.. +.||+... .+..+++|........ ....|...+..+.. .--+.++++++.+.+..++||++++|.++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 444543 67899988 4556777765443322 23444444443322 223667788888888889999999886654
Q ss_pred h
Q 045453 142 D 142 (346)
Q Consensus 142 ~ 142 (346)
+
T Consensus 95 ~ 95 (255)
T d1nd4a_ 95 S 95 (255)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.88 E-value=4.4e-05 Score=68.35 Aligned_cols=76 Identities=14% Similarity=0.118 Sum_probs=47.1
Q ss_pred cccccCCCcEEEEEEE--CCeEEEEEEecCcc-------CcchHHHHHHHHHHhhhcCC--CceeeEcceeecCCcceEE
Q 045453 63 NVIKDGYAYKFYKGFV--EDRTVSVMKFNDIL-------NDGHEDCFNNIIFASKLSSH--KNVLKLTGCCLETRIPVIV 131 (346)
Q Consensus 63 ~~ig~G~~g~Vy~~~~--~~~~vavk~~~~~~-------~~~~~~~~~e~~~~~~~~~h--~niv~l~g~~~~~~~~~lv 131 (346)
+.||.|....||+... .++.++||.-.... .....+...|...+..+..+ ..+++++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 4689999999999987 45688888744211 11223445566666555333 345556654 34456899
Q ss_pred EecccCCCh
Q 045453 132 FESVKNRTL 140 (346)
Q Consensus 132 ~e~~~~gsL 140 (346)
||++++..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999977543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.29 E-value=0.0015 Score=55.87 Aligned_cols=160 Identities=12% Similarity=0.089 Sum_probs=82.0
Q ss_pred CCHHHHHHHhcCCCcccc-----cccCCCcEEEEEEECCeEEEEEEecCccCcchHHHHHHHHHHhhhcC----CCceee
Q 045453 47 FTIRELEIATNNFDARNV-----IKDGYAYKFYKGFVEDRTVSVMKFNDILNDGHEDCFNNIIFASKLSS----HKNVLK 117 (346)
Q Consensus 47 ~~~~~l~~~~~~f~~~~~-----ig~G~~g~Vy~~~~~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~----h~niv~ 117 (346)
++.+|+.....+|..... |..|.--+.|+...+++.+++|++....+.. +...++..+..+.+ -|..+.
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~~~~--~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVEKN--DLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC---CC--HHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCcEEEEEcCCCCCHH--HHHHHHHHHHhhhhccccccccce
Confidence 667888888888877544 3456668899999977889999986532222 22223333333311 122221
Q ss_pred Ec-c--eeecCCcceEEEecccCCChhhh--------------hhh---cCCC--CCCCCHH------------------
Q 045453 118 LT-G--CCLETRIPVIVFESVKNRTLADH--------------IYQ---NQPH--FEPLLLS------------------ 157 (346)
Q Consensus 118 l~-g--~~~~~~~~~lv~e~~~~gsL~~~--------------l~~---~~~~--~~~l~~~------------------ 157 (346)
.. | +.........++.++.+...... ++. .... .......
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 11 0 01113345667777765432211 000 0000 0000100
Q ss_pred HHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCeEEcCCCceEEeccCCCc
Q 045453 158 QRLRIAVHIANAIAYLHI-GFSRPILHRKIRPSRIFLDEGYIAKLFDFSLSV 208 (346)
Q Consensus 158 ~~~~i~~~ia~~L~~LH~-~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl~~ 208 (346)
.....+......+.-.+. .-..++||+|+.++||+++.+...-|+||+.+.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 111222222233333221 224679999999999999999888899999764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.02 E-value=0.00081 Score=59.82 Aligned_cols=74 Identities=16% Similarity=0.119 Sum_probs=48.3
Q ss_pred ccccccCCCcEEEEEEECC---------eEEEEEEecCccCcchHHHHHHHHHHhhhcCCCceeeEcceeecCCcceEEE
Q 045453 62 RNVIKDGYAYKFYKGFVED---------RTVSVMKFNDILNDGHEDCFNNIIFASKLSSHKNVLKLTGCCLETRIPVIVF 132 (346)
Q Consensus 62 ~~~ig~G~~g~Vy~~~~~~---------~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~l~g~~~~~~~~~lv~ 132 (346)
...|+.|-.-.+|++...+ ..|++.... . ........+|..++..+..+.-.+++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 3568889999999998732 345555544 2 22334455677777777555445577877743 6899
Q ss_pred ecccCCChh
Q 045453 133 ESVKNRTLA 141 (346)
Q Consensus 133 e~~~~gsL~ 141 (346)
||+++.+|.
T Consensus 121 efi~g~~l~ 129 (395)
T d1nw1a_ 121 EYIPSRPLS 129 (395)
T ss_dssp CCCCEEECC
T ss_pred EEeccccCC
Confidence 999876544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.81 E-value=0.0018 Score=55.81 Aligned_cols=94 Identities=15% Similarity=0.106 Sum_probs=50.6
Q ss_pred cCCCHHHHHHHhcCCC--cc-cccc-cCCCcEEEEEEE-CCeEEEEEEecCccCcchHHHHHHHHHHhhhcCCC-ceeeE
Q 045453 45 RGFTIRELEIATNNFD--AR-NVIK-DGYAYKFYKGFV-EDRTVSVMKFNDILNDGHEDCFNNIIFASKLSSHK-NVLKL 118 (346)
Q Consensus 45 ~~~~~~~l~~~~~~f~--~~-~~ig-~G~~g~Vy~~~~-~~~~vavk~~~~~~~~~~~~~~~e~~~~~~~~~h~-niv~l 118 (346)
..++.+.+..+...+. .. ..+- .|.--.||++.. +|..+++|..+... ....++..|...+..+..+. -++..
T Consensus 6 ~~L~pd~i~~al~~~g~~~~~~~~~L~s~EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p 84 (325)
T d1zyla1 6 QTLHPDTIMDALFEHGIRVDSGLTPLNSYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAP 84 (325)
T ss_dssp CCCCHHHHHHHHHHTTCCCCSCCEEECCSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCC
T ss_pred cccCHHHHHHHHHHcCCCCCcCccccccccceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCc
Confidence 3456666654443331 11 1111 233468999998 77789999876442 23455666666666653221 01111
Q ss_pred cc-----eeecCCcceEEEecccCCC
Q 045453 119 TG-----CCLETRIPVIVFESVKNRT 139 (346)
Q Consensus 119 ~g-----~~~~~~~~~lv~e~~~~gs 139 (346)
+. .....+..+.++++++|..
T Consensus 85 ~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 85 VAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp CCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred eecCCCeeeeeeeEEEEEEeecCCcC
Confidence 11 1123455688999997743
|